>AAS90620.1|FEATURES|farme|aminoglycoside|DF40_017605|antibiotic inactivation|1
MSNELHLPTTLQPYLQHMTPEPIFDGYSGAKVWRWTGQNPTLYLKVDTDLRREKDCLMWL
KDEIAVPQVVAWHKTPTAHYLLMTEITGIDATSFEHDPATCVRLMAQGLREFHAIPMANC
PLDRRLDVVIDAARANVEQGLVNANDFDSQRLGRTAVDLYAELLATRPASEDLVVVHGDY
CLPNIFFAGGRVSGFIDVGRAGVGDRYIDLALAVRSILYNLGDDPQWIDLFFAEYGISTS
EIDWAKVEYFKLLDEFF
>AAS90626.1|FEATURES|farme|aminoglycoside|AAC(6')-I30|antibiotic inactivation|1
MQITNVPHGNAEIVNQMAELLIVAFREHWDAWATKPEALDEIQMILGKGFIRVALDDAGQ
KVLGWIGGLPEYDGNVWELHPLVVQPEHQFQGIGRALVADFEQQAAARGALTITLGSDDE
DDMTSLAGVDLYDGLPDKIANIRNLKRHPYEFYLKCGYRIIGVVPDANGRGKPDIILGKR
VESRP
>ACN58930.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MQPILSVSNLSKTYKSGLQALKAINLEIQKGEIFALLGPNGAGKTTLISIICGIVNPSGG
KVSVAGHDIIAEYRAARVQIGLVPQELTLSIFETVQDTVNFSRGLFGKKPDPVYIEKMLK
ELALWEKKDTTIRALSGGMKRRVLIAKALSHQPQILFLDEPTAGVDVELRKQMWNIVRHL
RETGVTVILTTHYIDEAEEMADRIGVINRGEIILVEDKRELMHKLGKKQLTLDLQEPLAA
IPTSLAAYQLERTKDGNELVYTYDTQATRTGITALLKDLGDAGIRFKDLHTKQSSLEEIF
VSLVKHK
>ACN58864.1|FEATURES|farme|multidrug|mexE|antibiotic efflux|1
MNILAALASSRWFKLSLLFALLAGCGKHEEGAPQGGPPAVSVAPAVKRDVKEFDEFTARL
EAPDTVDIRSRVAGTLMQVHFREGQMVHKGDPLFTIDPRPFAAEAARVEAQLVAARTSGE
LSKTELARAEKLVAVRGVSQQELDQLKAALANANSNVKAYEAALVQARLNLEFTRIVAPV
TGRTSRANVTAGNLVNIGDPVLTTVVSNDRMYAYFDASEAIYLKYMRSARDGSRPSSRDV
PNAVRLGLANEEGFPHEGHMDFVDNRLNPATASMRGRAVFDNKDGLYTPGLFARIQLVGS
GSYAATLVSDRAITTDQTRKVVLVVGKNNIVEQREIKPGALIGGMRVVTGINAGELVIVD
GLLRAFPGAPVAPQVLKVDEQGLPIPAPPPGAAPVAKG
>ACN58788.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MQPILSVSGVSKTYKSGLQALKNIDLEIKPGEIFALLGPNGAGKTTLISVICGIVNATAG
KISVAGHDIVTDFRAARSLIGLVPQELTLGMFETVLDTVGFSRGLFGKKANPAYLEKMLK
DLSLWDKKDTTIRALSGGMKRRVLIAKALSHEPQVLFLDEPTAGVDVELRRHMWNIVRRL
RESGVTIILTTHYIDEAEEMADRIGVINRGEIILVEDKKELMHKLGKKQLTLDLQEPLDA
IPASLAAYGLERIKDGNVLVYTYDTQASRTGITALLKDLGEAGIRFKDLHTKQSSLEDIF
VNLVKHP
>ACH59000.1|FEATURES|farme|beta_lactam|WS86_03395|antibiotic inactivation|1
MSPADLFVFRFLLASCGCLAAGLGAWGVTALCGRWLPGIAMQRSVWLLGQVTVVAAFLLI
LLPHSERLRLVPPIDLAEVTATRAAAAATTAAAASAALPASTPDAGAADRSWLVDGARAW
LLFYVLGLGYSIATLVQARRMLNGLAAAGGRLPALDRHDGFAGAPAPTPEVIEVDAPISP
MLFGLLRPRLLLPLHLRSFEASQQQMIVAHELTHLRRRDLHWMSAGIVLQTLLWFNPFMR
LLLARLSWAQELGCDRDVLHGRPAAQRKAYAAALVAQLKLPASPVASALAFGGASASTLA
GRIALIRDPAAARQGRWTRVAVIGGLAGILAASLAFQPALTATPPVLAAISCTELADAAS
GTRLLREGQCDTRITPASTFNIAVSLMGYDSGILADEHAPALPFQQGYADWNPEWRATTD
PASWLKYSVVWFAQQITSRLGAARFQGYVNSFNYGNRDVSGDAGEGNGLTQSWISSSLKI
SPAEQVDFLRNMVNRQLPVTARAYDMTFRIMPSETLANGWEVHGKTGTASPVLPDGRDDA
EHQYGWYVGWASKGQRTIVFARMVLDRRQQGFAGGRAKAAFLRDLTTRLDSL
>ACH58990.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MNVQNCMVKAVSVSIILFASLSLAAQKVKEPTVSNADWSKPYRPFRIAGNLYYIGTYDLA
CYLITTKQGNIIVNTGLAASALQIKNNIKALGFKLTDTKILLTTQAHYDHLGAMAEIKKI
TGAKLMADEGDATVMADGGSSDYAFGGHGSMFEPIIADRLLHDKDTIQLGDTKLVMLHHP
GHTKGSCSFLFDTKDEQRSYRILIANMPTIVIEKKFSEVSSYPGIAKDYAYTLQAMKNLS
FDIWVASHASQFSMHSKHKPGDGYNPKSFMDRKGYDESLDKLQKEYEKHLNEN
>ACH58988.1|FEATURES|farme|beta_lactam|LRA-8|antibiotic inactivation|1
MSKSSLKGLVLLALVAAIAAPSWAARKEKPAAKAPPCEQCAVWNADQEPFKIWGNTYYVG
VKGLSSVLVTSDWGHVLLDGGLPESAPKIAANIEKLGFKVTDVKAILSSHVHADHAGGIA
ELQRRSGAKVYQRRPSDQVLRTGKPDPGDPQLARAGPIPPVENVWVVHDEELLGLGPTRF
TVVATPGHTPGGTSWAWESCEGAQCLKIVYADSLNAVSAEGFRFTASTTYPNVLQDLEQS
FKRVESLPCDVIVSVHPEQSDFFPRMAKRVDGKPESIKDPEGCKRYVAGARERLALRVAS
EKQGS
>ACN58767.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
MQGTTAYAPFRHRAFAVLWGATLLSNIGSWMHDVAAGWLMTTLAATPFMVALVQAATTAP
VFLLALPAGALADLMDRRRLLIVVQSTMLVLAAILGVVVLRGAVTPALLLGFTLAIGCCT
AVLSPTWQSILPKLVPRADFPPAVALHSVGINVSRAIGPALGGAIIVALGIAWPFFLNAV
SFLAVIAALVWWKPPADPPPPAGTQPRPAENYWRAIGSGLAHVRSSFSLRATLARCLLFF
FFGSAYWALLPLVAREHLHGGAPLYGLLVACIGVGAVSGALLLPKLRTSIGSDGVVLAGT
VGTVLAMTAYALATAPLLGLIASLIAGASWIAALSTLNVAAQLALPDWVRARGMAMFSAV
LYGSLAAGSVTWGQIANHAGLSTTLLIAAGGALACLALARKLPLQH
>ACS83714.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MHQWPAKSVNMRIENTSASALPTLREELVQLADDDYQAHNDEDLFYDAAKGDTDAFGELV
RRNYGIVYAVGLARLGQRDEAEDLAQEVFLRAFLLLDRLDDPAKFPHWLTRIARNLSVDW
QRRGTRAKRLVSMVPMTGLELPASTTDARDAASLSEQNAALQTALDGLAPPQREIILLHY
MEGLSHGEIALRLAVARSTVSRQIARAVDAMRGFVDANLKESTAQLRPRKGAAGRTLSIL
VAVTTLSAKSRNSLAAQANFPIPGNAVPSQEAVQLWNEIKSLFWSGARRLLFKTAMAVGA
VGVIVPLGYWYCESPAQAVQNATPQASPGAAPSPGGPKTADLSQRLAEIARRAGGQVGVS
VMNIENGDSADFNGDEPRSLYSVFKFPVAVAVLKDVETGKLKLDQKVAVKKSDLSGTAPS
SSNRWQNMPVTYTVQQLLEFAMIESDNTAVDKLLTLVGGPSTVTKQIQSLGISGIEMAAD
SREAAKLADHPNTGSANAIVRLLAGLQKGEVLKPAERTVLWDMMQRATTGVKRLRAGLPA
RTVLMHKTGTGPNDSGTNDVGIINLPDGKGHLAIAVLINKSTLSSASQEQVIAAIAAAAW
DAMTQQ
>ACS83748.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MPPSHHMLRPIEQCSILWNDVRYSNSVRLKEAGMTATTQASAPAARTYLSLRAAWIPLFA
LCLAFFVEMVDNTLLTIALPTIGRDLGASVTSLQWVTGAYSLTFGGLLLTAGSLADRFGR
RRVLQIGLLAFGLISLTVIAVATAGQLIAVRAALGLAAAAMAPITNSLVFRLFEGEDLRR
RAMTLMIVVGMSGFILGPLLGGTVLAHASWQWLLLINAPIALIALIGVRLGVPADDAEGL
TKDRLDVKGSALSIAAIGLACYTLTSGVEHGWMSAVTWACGIGAAAALMGFVWHERRTDH
PMLDLDVFRNRTVRGASIAQVGTSIAMASLMFGLILHFQGAYGWSPMRAGLANLPLILTM
ILATPVSEGLAKRFGHRIAMLIGAGLLAGSLAGLAWGVGHGYLVIAVFMVTFTLGLRTVM
TIAAVGLVGAMPENRTSLGAALNDTAQEVGTSLGMAVIGTLIAVLXTTTLPNGDXSLDLA
TSYFAGERIAYLFLAVVVGVIAGWGALTLSNSKEMEDVH
>ACS83690.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MIKSFLTCVIIILMIFPSPAPAQQHDLRKSIQDIIRASGENVAVAIMGLEDKDTLSVNGR
IHCPMQSVYKLPLGMAVLKQVDLGKLSLDQKIHITKKDLLPNTWSPLQKKYPEGNVDVPL
SEILMYTVSQSDNSGCDILFRLLGGPSNVEKYIHSLGVRGMAIATTEEEMHGDWNVQFSN
WSEPVAMVQLLQLVHEDEVLSPSSNDFLLKLMTETTTGPNRIKGLLPKDAKVAHKTGTSG
PNEEGVTAAINDAGIVTLPNGKHYAIAVFMLNSRSDPKKLEAVIAAIAKSAWDHYSR
>ACT97572.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLAVLFGGISSEHDISCLSAASILRNLNKDKYEIYPVGITRDGEWFYCPDCDPDRVESG
AWERMTGKVKVVLAPDRGMHGMVLLREGEIEVVRLDCVFPVLHGVGGEDGTMQGLLELAG
IPYVGCGVAASANTMDKALTKKVIEGTGVRQARYYLALRYDFERNAEAVVAAAAETLGAF
PVFVKPCSQGSSVGVAKANNLLELAEGLTEALKLDTKVLVEEFIDGHEVECAVLGNLEPQ
ASTVGEIAPTQEFYTFDAKYKDESSRLYIPAHITEEQLATVRQDAVRVYTALGCRGLSRV
DFFVTHDSGEVVFNELNAIPGFTSISMYPKLFDYEGIGYAELLDRLISLALEEHNG
>ACT97570.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAEEVIVEAFMDGTELTCGCYKTKEKSVIFPPTXXXTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKLEVLSIKYKVLTMLEWTQSNT
>ACT97547.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRN
DTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVF
VKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKA
SGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEDEKKAAVEIFKAVDGYGLSRVD
FFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97537.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSEHGVSMKSAEGIYSFIDQDKYTLYIVELTKARWEAILSDGSRAQVD
KNDFSFMDHGQKIIPDFAYITIHGTPGENGILQGYFELLGIPYSTCDVLVSALTFSKFTL
NQYLKGFGVRVAESMLVNKRHGISDEDVIAKIGLPCFIKPNASGSSFGVTKVKTKEQIQP
ALEAAFKESDDVMIEAFMDGIELANGCYKTKKNEVVFPITEVVSQNEFFDYNAKYKGEVT
EITPARLSPELTSRVQQLTSAIYDILGCKGIVRVDYIITEGEKINMLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIEDHFN
>ACT97455.1|FEATURES|farme|beta_lactam|BL2e_cepa|antibiotic inactivation|1
MKTNRLILLLFILFPAYVLAGNRFQELYTNIHQFISQQKAEVGVAIIADGKDTVTIENNR
RYPLMSVFKLHQALAVGDYCKRHQLSFDTLLTVDSTDLQPNTYSPLRDRYPHGGKFSLKQ
LMEYTLHLSDNNACDILFKFTGGPAVTDRYIRSLGINDFSIQYTEDDMHQDLNLGYENWS
TPLATAEVIEALLKKTLFDKPHQEFIKEALVTCQTGTSRIVHPLQDKQVTVGHKTGTGDR
NASGQLIAINDAGFVQFPNGHRYTLVVFVKDSQESMEDTEAIIAQISEMVYQAFSNT
>ACT97384.1|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MKLWTSLCLFLLLGATAFAVRENPLESRLRRIIRLSNTDVGVAVISGSRNWAVGNRKRPL
LSVFKFFIAVQTLRQMEQTGTALNAKLTVEENMTDANMYSPMLKKHPRRPFEISLAELLE
YMIAESDNNAADILLKYSGGTGQLEKFLHDLGFSGIDIRVNEKQMNQKAENQYLNQAAPS
DVAGLIKLVLEKDVLSAEHRKFLSDIMLKTSTGTDKIKQGLPPGVMFGHKTGSSSRTADG
IKIADNDAGFVTLTNGRTYYIAVMITESKLDDRANAALAAQISQTVYNYLTTEKTD
>ACT97618.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVFFGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>ACT97610.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPKEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>ACT97571.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKNLKRTIAIVCGGDSSEHDVSLRSAQGLYSFFDKERYDVYIVDVRGTDWRVQLPDGEEA
KIDRNDFSFVKTDGTAVVFDYAYITIHGQPGENGPMQGYFDLIHVPYSTSGVLVEAMTFD
KFVLNRYLGSFGIHVADSVLLRRGETYNEEEIAKRIGMPCFVKPANDGSSFGVSKVKNAD
QLEPALRVAFMESSDVMVEAYLDGTEITQGIYKTRERSVPFPITEVVTTNEFFDYDAKYN
GQVDEITPARISPETAERVTEITSRIYDILHANGIIRIDYIITHDAEGNEVINMLEVNTT
PGMTTTSFIPQQVRAAGLDIKDVLTEIIENQF
>ACT97544.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMKETIAVLFGGQSSEHVVSCMSAANVIDQIDKDKYDLLLIGITEEGEWILTPSVEEIRN
DTWRDGRTHAVLSPDATRKCVIISEGDATKEVRVDVVFPVLHGLRGEDGTVQGLLELARI
PYVGCGVLASAVSMDKLYTKLIVDSLGIRQADYVPVRRSQLQDMNSVIASVENKLSYPVF
VKPSNAGSSRGVNKADNREELVFALNEAAKHDRKILVEETIIGHEVECAVFGGGLQEVKA
SGVGEIMAAAEFYDFDAKYYNAESKTVVDPELPGHAAEDVSKAAVEIFKAVDGYGLSRVD
FFVTDAGEVVFNEINTLPGFTAISMYPMLWEARGISKSRLVDDLINHAKERYDV
>ACT97534.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDVFTLPDH
GLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGENGKLQA
SFDLLDIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQSLGLTLP
VVVKPCSGGSSIGVYIVNTDEEYAEALKKSFHYEDELVVEPYIKGREFACGIIDGTALPP
IEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNALKLNVYSRADFLL
DADGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSMEARY
>ACT97504.1|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
MVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFG
YEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGC
YVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILM
TSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFS
KKQ
>ACT97454.1|FEATURES|farme|multidrug|cmeB|antibiotic efflux|0
MTSLAFVLGVMPLLFATGAGAGSRVALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKF
GKNKGK
>CBI71178.1|FEATURES|farme|fosfomycin|FosC2|antibiotic inactivation|1
MFSIECLDHVALLVKDLERSVEWYTRVLGLKRHYAEAWDIPVVLYAGTTGVALFPANSKV
SSINPRQAIVMQHFAFRVSRADFEEAQRDFQRRDIKYEFQDHDVAHSIYIYDPDGYEVEL
TTYDL
>AET35500.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFMGYSDREEDLTGIFDRADE
ISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMADIVFMALHGENGENGKIQA
AFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGISMTRATRQDDITKLDLTLP
CVVKPCCGGSSIGVTIVKDAAEFKAALDDAFKWENELVIEEFVQGREFSVGVIEGKALPI
IEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAEEVARVIGLDTYSRSDFLL
NDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLIDISLKKYEV
>AET35481.1|FEATURES|farme|beta_lactam|TEM-57|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYCAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>AFQ60595.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>ACI02041.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGATSEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRFEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLASYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKIM
>ACI02048.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MDTANENKMGIMPVGKLLITMSLPMMISMVVQALYNIVDSVFVSRVSEDALTAVSMAFPL
QALCIALGAGMGVGVNALLSKSLGAKDNDMVNKSALNGLFMTFVSYLVLLVIGIFAVKPF
YMIQTDSADIIQYGTDYLSVICCFSFGMFFQFTFERLLQSTGRTFQTMITQTVGAVTNII
LDPIFIFGYFGVPAFGVKGAAIATVIGQIIAAILALIMNIKVNTDIDFSLKGFKPDIKII
GMIYKVGLPSIIMQSIGSVMVFCLNKILIVFSSTAVAVFGVYFKLQSFVFMPVFGLNNGL
IPIMAYNYGAKKKDRMIKTIKCGLLIAFSIMSVGMVVFELFPDAILALFEASDNMLAMGK
VALRTIAIHFPIAAICIVLGSAFQALGNAVYSMFVSIARQLVVLIPVAYALSKLGNVNYV
WWCFPIAEIMSLTITVIFFIKLKREVIDKI
>AFH53889.1|FEATURES|farme|aminoglycoside|AFK71_11355|antibiotic inactivation|1
MMNSYEVTKKLLPVQVSAVTALLQKILQKQLIGVYLYGSAVLGGLKHESDLDILVVIKEY
LSEAHRLTLTKRLLELSGEIGDKNNRPLEVTIVSEHILTLTEKIPECEYMYGEWLRADIE
SGKIPQRYVEPDVILLLFQARSSSIVLYGVPAENLLPEIGFEKINKAILHSLPALMKTIN
GDERNVLLTLARMWYSLSSQKICPKDIAAYWAAENVPEELAYLLIMAAEGYTGKIKDCWE
DKTEELNKLTDFLQQKIKGFA
>AFH53884.1|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQ
SISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIXYAX
XIKHINDYIXRLSIDSFQTSRKTEDGMQLPAFEAVYRNLEILLXLXSBY
>AGC09639.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MERKNYKGPFLPGYKARKSTYKAEPIGLKYIDHCVGNVELGKMNTWVDFYEKVMGFSLLV
TFDDKDISTEYSALMSKVVSNGNGYIKFPINEPAAGKKKSQIEEYLDFYHGPGVQHVAIA
TDDIIHTITELRKRGVEFLHVPEVYYEDVLDRVGKIDEALEDLKKLNILIDRDEEGYLLQ
IFTKPIQDRPTMFFEIIERHGAKSFGKGNFKALFESIEREQELRGNL
>AHN92773.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
VKIEKDEITIRDFTETDLSLMFQWLTDQRVLEYYEGRDVKFTMDTLSAHFLEAIPDGFRM
IIEYQKSPIGYAQAYQLSGELFDEYDYPDDGHIVYAMDQFIGEPKYWSKGIGSSFLKMMA
SHLKENMAAQRVLLDPHQDNKRAIRAYEKAGFKIIKPLPKHELFEGEKVDCWLMELAL
>AHN92770.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRQATVSDAAAVAALSLRLWPDHTMEEMTAEFAALLASPEAAVFLAEDGAPVGFAQCQL
RHDYVEGASASPTGYLEGVYVAPSHQHRGIAGKLLSACEVWAKAHGCTEFASDCEIDNAA
SLAFHLAKGFTEASRNIHFIKPL
>AHN92767.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MVKKAKQDDITVIAELAVQMWEVDSIQELIDDISENMAKDDAQYFLKYVNDMPVGFAECQ
LRHDYVEGTDSSPVGYLEGIFVKEEFRHKGFAKEILIECEKWTKEKGCIEFASDCELDNE
ESLHFHIAMGFVEAGRIICFKKEL
>AHN92764.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MKDLPVLAELACWLWPHHTTQEMQADLGEIMAKPDAAFFLAYVDKTAIGFAQCQLRHDYV
EGTESSPVGYLEGIYVAEEFRKQGIARVLLTACECWAKTKGCTEFASDCELSNVQSLQFH
LNVGFEEANRIICFTKKL
>AHN92763.1|FEATURES|farme|aminoglycoside|sat-3|antibiotic inactivation|0
MNLIELTHKNDILQTYEIYKHCMFMPTEEKFNKKVEQFLNNNSVKIFACFRHGKIVGVMA
VSFIEQKKVEILGIAIDLSARGKGIGSYMIKQVINNYDLLSVYAETDNDAVGFYQKNNFS
ITEFSEIYDGETVIRYKCELTQFQ
>AHN92762.1|FEATURES|farme|aminoglycoside|AAC(6')-Iad|antibiotic inactivation|1
MIRKAETNDAATVAELALLLWPEHSLEELTEEFEELISQDDAACFLAYAGDTAVGFAQCQ
LRHDYVEGTDSSPVGYLEGIFVRENHRHQGYAKKLLAACEAWAREQGCTEFASDCELTNT
DSLKFHLGVGFEEANRIICFTKKL
>AHN92758.1|FEATURES|farme|aminoglycoside|PROVALCAL_00921|antibiotic inactivation|0
MNKNDYVIRLERKEEFREVEFLVREAFWNVYRPGCLEHYVLNQLRNDPLFVPELDFVMVK
DGQLIGQNMFMRAVIRADDGRDVPIMTMGPICIRKDLQRMGYGKILLDHSIEAAARLGCG
ALCFEGNIRFYGKSCFTYAREYGLRYRGLPAGADDSFFLCRELIPGYLDGVTGEYGPPQG
YFVDAAAAEEFDRAFPPKEKLVLPGQLSH
>AHN92750.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MVRIAINGDSRVLAEMAVQMWDSHTVDELETEFVETLNDKQSAFFIKYINDLPVGFAQCG
LRTDYVEGTESSPVGYLEGIFVKEEYRKNGYAKELLFACEIWAKEIGCSEFASDCEIDNI
DSFKFHMAMGFDEANRIICFKKRL
>AHN92748.1|FEATURES|farme|aminoglycoside|LS69_04805|antibiotic inactivation|1
MAVQMWDSHTVDELEAEFVETLNDSQSAFFIKYINDLPVGFAQCGLRTDYVEGTETFPVG
YLEGIFVKEEYRKNGYAKELLSACETWAKESGCSEFASDCEIDNMDSFKFHMAMGFDEAN
RIICFKKKL
>AHN92746.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MKIEKDEITIRDFTETDLSLMFQWLTDQRVLEYYEGRDVKFTMDTLSAHFLEAIPDGFRM
IIEYQKSPIGYAQAYQLSGELFDEYDYPDDGHIVYAMDQFIGEPKYWSKGIGSSFLKMMA
SHLKENMAAQRVLLDPHQDNKRAIRAYEKAGFKIIKPLPKHELFEGEKVDCWLMELAL
>AHN92722.1|FEATURES|farme|chloramphenicol|cat4|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHRLYPAMIWLLTKTVNDIP
EFRTSLTSEGLGIYDEMHPMYTVFNKEKKNFSGIWSYFSEDYDTFLKNYEVDAEKYSTSA
CYAPKDGTPSNSFNISMVPWLEFTGFNINVFDDGHFLLPIFTMGKYFDRDGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKHIDHFG
>AHN92720.1|FEATURES|farme|chloramphenicol|cat14|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHRLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDEMHPMYTVFNKENKNFSGIWSYFSEDYDTFLKNYEIDAEKYSTST
RYAPKDGTPPNSFNISMVPWLEFAGFNINVFDDGHFLLPIFTMGKYF
>AHN92719.1|FEATURES|farme|chloramphenicol|cat10|antibiotic inactivation|1
MAFRPIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHKLYPAMIWLLTKTVNDMP
EFRTSLTSEGLGIYDDMHPMYTVFNKEKKNFSGIWSYFSEDYNTFLKNYEIDAEKYSSST
RYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLPIFTMGKYFDRDGKRMLPLAIQ
VHHAVCDGYHAGLFVEKLQKYIDHFS
>AHN92716.1|FEATURES|farme|chloramphenicol|cat28|antibiotic inactivation|1
MAFHLIDMENWDRREFYEHFINEVVCSYSVTVNLDITNLRDARLYPAMIWLLTKTVNEMQ
EFRTSLTKAGLGVYDSMHPMYTVFNKENKNFSGIWSYYSENYIDFLKNYDEDVRVYSKST
RYAPKDGTPENSFNISMVPWLEFTSCNLNVYDDGKFLLPIFTMGKYFERDGKRLLPLAIQ
VHHAVCDGYHVGLFVELLQTNIIRFSAK
>AHN92708.1|FEATURES|farme|chloramphenicol|cat11|antibiotic inactivation|1
MAFRLIDIENWERKEFYEHFINQVVCTYSVVVNLDITNLKNHKLYPAMIWLLTKAVNDMP
EFRTSLTSEGLGIYDDMHPMYTVFNKDKKNFSGIWSYFSEDYDTFLKNYEIDAEKYSSST
RYAPKDGTPSNSFNISMVPWLEFSGFNINVFDDGHFLLSIFTMGKYFDRDGKRMLPLAIQ
VHHAVCDGYHVGLFVEKLQKYIDHFS
>AHN92705.1|FEATURES|farme|chloramphenicol|cat20|antibiotic inactivation|1
MALKLIDLETWERREFYEHFIREVVCTYSAVVNIDITNLKGQKLYPAMIWLLTKTVNDMP
EFRTVLTPDGPGIYDDMHPMYTVFKKENKNFSGIWSYFSKDYEGFLKSYEADAEKYSKST
RYAPKDGTPANSFNISMVPWLEFTGFNINVFDDGKFLLPIFTMGKFFERDGKRFLPLAIQ
VHHAVCDGYHVGAFVERLQEYVDGFHPV
>AHN92699.1|FEATURES|farme|beta_lactam|cepA|antibiotic inactivation|1
MNRKLTIIFSILLTVLTPLTCLSKQKDVNTSLQKQVEQLLEGKNVQVGIAVYYQGKMLCT
KNADQSFPMMSVFKLHQAVAILHCLKQDSLTLKKPMLITKDMLSPDTYSPLRDKYPDGDI
RLKVSQLIEYSVAQSDNNASNILFNLFDGTHYANQVIQDLGCTNTQIKWTEDEMAMDHSR
AYFNSTTPNDAILLLEMLVDNRTQRQQDFLWLTEVMSGTQTGPNRLAKYLPTLGTKLYHK
TGTGYVKDDGTIVAVNDIGFVILPNGKHYSIAVFCKDSKLSSEKTEELIAEISRLTYEYI
HRKISNQ
>AGW01015.1|FEATURES|farme|multidrug|MdtL|antibiotic efflux|1
MPLILLLVLLVLFSPLAIDIYLPAIPQMAEQLGAEVTLMQGTITWFLFSMGLGQLLVGPL
ADRYGRKPIALGGVLLYGLSALAAGFAASLGELMLARVLQGFGACATSVAAFSVVRDSYG
PKKSGQMISYLNGAICFIPALAPLLGGWLTAKAGWSANFWFMAGYAAIVGSWLLWRMPET
RPGETSSSGPLISWSRYSPVLRSPSFLFNACLCMLAMAVILAYVTAAPVQLMVKLGLDMS
GFSYWFTANAALNILACFLAPRFIARVGPRRTLRIGLLVITLSAMALTLVQHIDHPLAMM
GPVFFSSIGFAMVLGAAAGMALAPFGHCAGTAAALLGLFQMSGSGALVGITGWLMPDPLN
QLALHMWLLLPPLLLLLTRQGRRLCLQ
>AIA18391.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRSRGHVVTALDPARGVISAAEERELSTGKVGT
EPPSLETLSKFAEGAFLPNLTSMKEVKDADVAFLALHGGQGEDGTIQALLDMANVKYTGS
GHLSSALAMDKDLSKKLFRSEDVKTADWLMAPVTVEQVEGMLGLPVVVKPSKQGSTVGLS
LVKKREDLAKAIEEASKYDDEVMVESFVPGRELTVGILGDVALPVGEILPKHEIYDYECK
YTAGMATEEFPAKLSPEATEKVQQQALAAFRALKLRGYARIDFRLTSEGEFYCLEANTLP
GMTELSLIPQGAAAMGISFPELCEQIVRLALG
>AIA17871.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTKVLSQIKTNPQSRRLVVSAWNVAEIDKMALPPCHAFFQFYVAGDKLSLQLYQRSADIF
LGVPFNIASYALLLMMVAQECELKPFEFIHTLGDAHLYSNHVEQARLQLTREPKKLSVMK
LNPSVKSVFEFRFEDFTLERYESHPTIKEEISV
>AIA17830.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQIIKAAVVLGLLSVIGPLAIDMYLPALPAIGADLGADVAQVQLTLMAYMAAIAVCQL
LYGPLSDMYGRKPPIYFGIGLYIVASLGAAWAPSIEWLTAFRFLQGVGACASMSLPRAIV
RDGYTGAQAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMAVVGVLSLLLLVF
GLKETRPKEARLQSSLGGALSAYWTLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEH
YGLTPTLYSLAFSVNAVSFFAVSQATGFLVGRFGLPRVVRVAVTGYVTAMLTLLVLFLAG
FDSIWVLATLMFIAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTLQMVIASVVMGIVG
AFTDGTALPMVVAFAACAVAALVITLITLRGASRGNVSAPLAAPAE
>AIA16098.1|FEATURES|farme|macrolide-lincosamide-streptogramin|chrB|antibiotic target alteration|0
MPTEFTIARALVEAAQILRRAGVEEARREAASLLEHITGHDRTFLITSAETALAPSDVSR
LRGLVERRAAGEPLQYITGHQEFYKLDFEVTPDVLIPRPETELLVETALDLLDEWDGPTF
ICDVGTGSGCIAVSLLHELPLARAIGLDISQPALRVAARNAARAGVNERLSLVVSDGLAA
LDPARARFTMIVSNPPYIAEDALAGLQREVRDHEPRVALTPGGDGLRIIRALVADAPRFL
DSGGHLLIEIGFDQHEAVKKLIDPRVWELLDIHEDLQGIPRTVALMKI
>AIA14023.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGEDLHAGTAAVQMSLLIFFLSMGFGQI
VVGPISDMVGRKLPLYGGLALFIAGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIV
RDLHTGTEAAKLMSLLMLVFSVSPILAPLTGSQIIENFGWRAVFWTVTGAALLATILLAT
SLKETRPAAERVGSSFGTALAGYRFLMGDRNFLGLVAIAGFGIASFFVYLSSSSFILIDH
YGLSPSVYSVFFSINAVAFIGMSQLTGMLSERFGLKRVVWVAVTGYATTMVVLFAVMATG
VDRLDVMAALLFVGYGFLGLVIPTTSVLAMEDHGEIAGTASALMGTLHFAIGALAMGVAG
IFFDGTPLPMVAGITLCAVISFTLAKLTLGRTREAAEAPAE
>AIA13956.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLRPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYDPHPHIKAEVAV
>AIA13937.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGRPLPGREMIVVTRNES
FAPEGCFIARSVEDAIQFAKERGESELFICGGAEIYAQTLDRADRLYLTLVHADCDADTF
FPDWNSDEWIETESAHCTSDEKNQYSFTFKVLERKHVDLLQSPGEH
>AIA13614.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISLARERGEGELFICGGAEIYAQAMSAADRMYLTLVH
ADANADTFFPEWSREQWIERESQSHAADEKNQYPFTFKLLVKQPTD
>AIA13422.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISRLIEQIK
STPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPAVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13423.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPAGCFIAHSISDAISLARERGESELFVCGGAEIYAQMLGVADRMYLTLVH
ADSEADTFFPEWDSSEWVEMESEHRTADEKNQYPFTFKVLARRSQV
>AIA13123.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKSDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRASDGRTIDQISRLIEQIK
STPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPAVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12127.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKNDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRAWRSSDGRTIDQISQVIEQIK
SNPDSRRLIINAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYLNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA12005.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKNDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIEYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA11933.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPGDFVHTLGDAHLYSNHLEQARLQLAREPRPLPQMSINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA10482.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MNNIKIKKATINDVDRLQKIGRETFYETFSAANTEENMKQYLRNEFTIEKLTAELSDLNS
EFYFATLDNNVIGYLKLNFGQSQTELKDEKAVEIERIYVLKEFHGKKVGQILYEKAMWIA
RQTNADFVWLGVWEENPRAINFYKKNGFVEFDKHVFKLGDDEQTDIMMKLQLNDN
>AIA18843.1|FEATURES|farme|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MSSRVSTRSSLAEDLRAIGLADGDAVLVHAALRKVGKIVGGPDDILDAMRDVIGPAGTVL
GYADWQLEDEIRDDPAMREHIPAFDPLRSRSIRDNGFWPELIRTTPGALRSASPGASMAA
IGGEAEWFTADHALDYGYGPRSPLGKLVEAKGKVLMLGAPLDTMTLLHHAEHLADFPNKR
ILRYEAPILVDGEKVWRWFEEFDTSDPPDGLADDYFAGIVEEFLATGRGKRGKIGEASSV
LVPADEIVAFAVDWLERWGRTARR
>AIA18361.1|FEATURES|farme|multidrug|mdtG|antibiotic efflux|0
MKKHYIEHWDAEDVDAWEAGGKDIAKRNLIWSVVAEHVGFSVWSIWSVMVLFMPTDIYGI
DAAGKFFLVAVPTLVGSILRIPYTVATARFGGRNWTVFSALVLLVPTLFTLYLMMNPGAS
YTTFILVAALAGVGGGNFASSMTNINAFYPQRLKGWALGLNAGGGNIGVPMIQVIGLLVI
ATLGNTEPWIVCAVYLVFIAVAAVGAALFMDNLGNQKSDLRSMAKALKFSDSWVISFLYI
GTFGSFIGFSFAFGQVLQINFLAGGATPAAAALHAAQIAFIGPLLGSIARPMGGKLADRI
GGGKITLYTFVAMALAAAVLVTAGTIDDGTPGAATAGVLVAFVFGFITLILLAGIGNGSV
YKMIPSIFEAKAQGLEGLSRDAKAAWSRAMS
>AIA18362.1|FEATURES|farme|tetracycline|tetZ|antibiotic efflux|0
MISLVTLLRGRLLVFCAIAMSALVLRLAVTSFTPLASQIREDIGFSPTVVGVFGMVPTAM
FALFGLGTPLIAKRWGLERTALVAMLMAAVGMLTRALMSDTWSLLALSALALAGMGIGNV
VIPPLVKRYFSDRLAVMSSVYIVGVQLGTIAPAFVAVPLAEAFGWRFSIGVWALLGFAAA
VPWIFLLARERRRAVVVTAQPPADVPAERPHGKAWRSPVGWGMAGMFGMTSMITYSMFTW
IPDILSDAGASEAFGGAMVGLFSFMGLVAAFGAPTLCARMRNPFPIVIGCAVCYLVSFSG
LLLAPMSAPILWIVLLGLGPSTFPMSLTLINLRTRSHLGSATLSGFTQGVGYAVACLGPL
LFGVFHDASGGWTLSFGFLTCGVVILLIAAFQACKPRMLEDSWHVDSEPQDALRHV
>AIA15911.1|FEATURES|farme|aminoglycoside|APH(4)-Ia|antibiotic inactivation|0
MQSSEFDLTELVGLNHLVPALIEATGQDAWARTEVELITGGKSNLTFLLRSAAGELILRR
PPTGHLLPSAHDMVREARVQQGLVGTDVPVARVVLADAGELIGLGCYVMEKVPGHVIRAE
LPDAYAERPEQRLTMGLAFADTLAALHAVDPAEVGLGDYGRPEGFMARQIRRWTGQWEAS
RTHEVLEIDELGRRLAAAVPGQQYASIVHGDFRLDNVVFDAADPGRINAVLDWELSTLGD
PLTDVGLLMFFWAGADDPTFTLIPGVTHLPGFPTRDEMLERYAATSGADLSDMAFYQAFA
RYKFAIIAQGVQARAAAGSMGGQDFGNLDDEIRQLGQTGLELI
>AIA14563.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTPTTTSAPAHTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQW
VTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLVTFGVLSLCVVTVSTAGELITLRAALG
LAAAAMAPITNSLVFRLFEGQALRMRAMTVMIVVGMSGFILGPLIGGTALAHVSWEWLLL
ANAPIALIAFVGVRFGVAKDRPEDLTADVLDIPGAALTI
>AIA14436.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRGQMWDTIRELVATGSTVLLTTQYLDEAD
QLADRIAVIDRGRVVAEGTADELKASVGTTSLQLRIEDPEDTEDALTVIERVLGVRGSLS
PEAARITAPMADADRVTDLLVTLREAGIHLTEMSVRQPSLDEVFLTITGHDAADQSMPEP
EDGAGEKEKVNA
>AIA14437.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MSAIAPSPAAPGRIVPPSERRLKNHTSARETLRNTFTMAYRGLVKIRRTPEQLVDVTVQP
IIFTLMFAYLFGGAIAGNVQNYLPLLIPGILVQTVITTSVVTGVQLREDMDKGVFDRFRS
LPIARIAPLSGALLADTVRYAIATTITFVVGYIIGYHPAGGFWNVVLAGLLVIACSWAIS
WIFAFFGVIARTASSVQGISMLVLFPLTFLSNAYVPVKSLPDVLQWFVNINPISHLVTAV
RDLANSGTIGADLWISLLGAAIIVAVFAPLTVRAYMRKA
>AIA13610.1|FEATURES|farme|macrolide-lincosamide-streptogramin|lnuD|antibiotic inactivation|0
MPSIRQFAETHGVSRFTVVEAYDRLVAKGYMESRRGSGFYVRERSPMIAAGNPRPAEMPP
QQLDVVWLVRNMFRQYPAQHTPGSGLLPSDWLDGELIANGLRAISRQNLSLLLQYGNPQG
FLPLRQQLQLKLAELEIAATPEQIVTTSGITQGLDLVARHFAQPGDTIFVDDPAWFLMFG
SFATLGAKVVGIPRLPDGPDRILPSWPSWQQCTSRASMSSIPYCTIRRRLHCRPPRHSRS
>AIA13203.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILVFVAGICAVVAAVPVPAAWAAQPAAWSEPTSPFEIVDDIYYVGTKGLASYLIVSD
GEGILLDGTLDENVGHIEQNIQALGFKLVDVKIIVNTHAHFDHAAGIAGLKRDTGAKVMA
MEQERSALENGRHEGDNVYGATRFPAVKVDRALHDGDTISVGSVTMTATLTPGHTKGCTT
WSMSAKDGEVTRQVVFPCSLTVAGNKLVGNAGHPTIVEDYEKSFELLKSMKADIVLPAHP
EFGDIFERKAKRDAGDADAFVDTGLLQKLAETSRVAFEKELKAAQK
>AIA12985.1|FEATURES|farme|polymyxin|arnA|antibiotic inactivation|0
MPQARYKQLVDRLAADIRAGRLQPGTRLPTHRQLAAQEGLALVTATRVYAELDAMGLVSG
ETGRGTFVKETSLPHSGIDQQVVAADVVDLNFNYPSLPGQAELLRAALRQLASTGDLEAL
LRYQPHGGRQHERASVARHLAARGLSVTAPQVMLVDGAQHGLATSVMALLKPGDVVAADA
LTYPG
>AIA19291.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ASRRIIVSAWNTADIDEMSKAGIPPCHLLFQFYVADGKLSCQMYQRSADTFLGVPFNIAS
YSLLTVMMAQVTGLQPGDFVHTFGDTHLYVNHLEQVDEQLSRQPRKLPIMKINPRVESID
DFKFEDFELVGYDPHQAIKAPIAV
>AIA19214.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIVSQIAAMAKNRVIGKNNSLPWKLPEDLKFFKEKTDGKILIMGRKTFESLPGHLPNRFH
IVISRSPIESDEEDVRFVTSIDEALKVAEEMTEEWPEEVFVVGGGEIYQQTLHLVDKIYL
TIIDQEIEGDAYFPDFGPENFKLVEEARRDKPWPFRFCTYLRK
>AIA19199.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSKLEIVLVVAVAENWVIGKDGQLPWHLPADLRHFKSVTMGAPMIMGRKTFESLPGILPG
RPHIVMTRDREWKAEGAITVNSIAEAVGAVSGDRVSVIGGAEIFKLFQDSATRLELTRIW
RKYDGDIYYQAIDQGLWIEVKREFHEAEGDNPAFTIFSCVPDPERGYPVEPLHAAWD
>AIA19190.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKKKFVTSELQYLNLLKDVMKNGKYKENRTGVGTVSVFGRQIRFNLKEGFPLLTTKKVFL
RGIIHELLWFLNGDGNIKYLVDNDVHIWDEWPYRFYAQKVEKKGETPLSQKDFIQKIKND
TKFAKKWGNLGPVYGVQWRHWKGADGKETDQIAELVEHIKEVKKNPFASYGRRLIVSAWN
PSEIEEMAKAGLPPCHSLFQFYVIENKLSCQLYQRSADLFLGVPFNIASYALLLMMVAQV
TGLEVGEFVHTFGDAHIYSNHMDQVKEQLSREIRPFPKMVLNSEVNDIFTFNFDDFKLED
YDPHPAIKATVAV
>AIA19188.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKHQEYQYLDLAREILKDGITKVDRGTDIKLKSLFARQMRFDLSKDFPLLTTKRVYWKGV
IHELYWFMSGQTNIKYLVDHDVHVWDDYPYKIYMGKVKKGIVKDNKNLTKDEFIGRVKED
KKFAKAFGDLPRIYGEMWRHWPTRKKGRTIDQLKWVMQELKDDPDAKNLIVNSWNPEYLY
TMAQFEDASRFPICHNMYQVSNRNGKLSLQLYHRSADLFLGTPFNIASYSLLTAILAQVA
GLKPGEFIHTFGDVHIYNNHIDAIKEQLKRKPKPFPKIKIDKSVRSIDDFRPELVELIDY
EPHPSIKAELTIAGGLYDPKTGKMAS
>AIA19088.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTLFVGRPLDLFGNKVMNAQIVKAAVVLGLLSVIGPLAIDMYLPALPAIGADLNAGVAAV
QQSLMAYMAAIAVCQLAYGPLSDMFGRKPPIYFGIVLYIVASLGAAWAPSIEWLVLFRFL
QGVGACASMSLPRAIVRDGYTGAEAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMF
YVMAVVGVLSLLLLVFGLKETRPKEARLESSLGGAFRAYWQLLRDWRFIGLSLIGAFGMA
SFMAFLGNSSFVYIEHYGLTPTLYSLAFSVNAVSFFAVSQATGYLVGRFGLPRVVRVAVG
GYVTAMLALLALFLLGIDSIWALAVLMFIAFGFLGLVLPSTGVLAMEEQGEIAGSASALM
GTLQMVIASVVMGIVGAFADGTAMPMVIGFAGCALAALVITLVTLRGSAQSEPVAAPAE
>AIA19046.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDMLQHILDNGVDGDDRTKTGTRSVFGYQNRYNLADGFPLVTTKKIFLRAVIIELL
WFIRGDTNIAWLNENRVNIWNEWADENGDLGPVYGEQWRSYQAADGRTIDQLSLVIDQIK
SSPKSRRLLVDAWNVGELDRMKLAPCHCLFQFYVSGGKLSCQLYQRSADSFLGVPFNIAS
YALLTMMIAQVCDLEPGEFIHTFGDLHLYSNHFEQAKLQLTREPLPLPRVLINPERRSID
DFVYEDFTLEDYQAHESIAAPIAV
>AIA18961.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHVLEQGAKKHDRTGTGTLSVFGHQMRFNLAEGFPLLTTKKLHIKSIVYELL
WFLRGDTNVKYLQEHGVNIWNEWARENGELGPVYGAQWRSWKTPDGRAIDQISQVIDQIK
SNPDSRRLIVNAWNVGEIPSMALPPCHLLFQFYVADGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMVAQVCDLEPGEFIITLGDAHLYSNHFEQTRLQLSREPLKLPQMRINRSVRSIF
EFDYDDFELAGYEAHPHIKAEVAV
>AIA18933.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MRLTIVVAMDRNRVIGKNGDIPWAGKLRADMEHFKQFTMGKVVVMGRKTYDSIPARFKPL
SGRENIVLTKNLEFKALGCAVFHEVEPVEMISVSREVCVLGGAEIYKLFFEATDELIVTE
VDTEVLGGDTFFPEILPVEWDRRVLFRQEVDEKNQFSFTVCQYTRVLEM
>AIA18878.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNTQHPEYQYLNLLQDILDHGIDKKVFNAETTIRSVFGRQIRFDLSQGFPLLTTKKVFL
RGIIIELLWFLQGNSNIKYLVDNNVHIWDEWAYKPYKKLMEKGLVQHLDQPAFIEKIKAE
GEFAAKWGDLGNVYGVQWRNWKTSDGRTIDQIKWLLSELRTTPFRKSLVVSAWNPDFIYE
MAAPGKSMALPPCHTLWQVNVNEGRLSLQLYQRSADMFLGVPFNIASYSLLTMMLAAVAG
FQPGEFVHTFGDVHIYSNHIDQVHEQLRREPRPFPTMKLTPGVKDIDSFKLEDFTLENYD
PHPPIKGQVTVVGGF
>AIA18831.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLALVKDVLENGRPPSGGVRQDRTGVGTYSVFGRQLRFDLSEGFPLVTTKKVHLRSI
IHELLWFLRGETNVQYLRDNKVTIWDEWADKDGELGHIYGKQWRSWEGPKGVVDQIKNLI
ENIKKNPTSRRLLVVSYNPADLPDVAPPACHTLFQFYVSGDKLSLQLYQRSADLMLGVPF
NIASYALLLMMVAQVTGLEAHEFVHTFGDVHIYSNHLDGAKEQLKREPRTLPKMKLNPAV
QEIFGFKYEDFTLEDYAPWDHIKFDIAV
>AIA18749.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAIAGLPPCHTMFQFNVRGDYLDCQLYQRSADLFLGVPFNIASYALLTSMMAQVTGLKPG
EFVHTFGDTHIYNNHIDQVNEQLSREPLPLPKLVLNPEVHSIFDFKFEDIQLADYQSHPA
IKAPIAV
>AIA18727.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MSCPLLPARALIPDFEHCGRKLGAAPRGFDKMNSTMLRAALVLGLLSAIGPFAIDMYLPA
LPAIGVGLNASTAEVQASLMAFMVAIAACQLFYGPISDMVGRKPPLYFGIALFTLGAVGC
ALAPSIEWLIAARFVQGVGACAAMALPRAIVRDGYTGADAAQLQSLLMLVFSVSPILAPL
AGSLMVQFGDWRTIFWAISIIGVLGLLLLAFFLKETRPASERLESSVGSAMRGYGVLLRD
RNFLGLSLIGAFGISSFMAYLANSSFILIDHYGLNPTLYSVMFSINAVSFIGVSQLTGVL
TRRFGLSNVVRVSVSGFITVMVALAALFVLGVDQLPVLAVLLFVGYGFLGLVVPTTAVLA
LENHGSIAGTASALMGTLQMVTAAIVMGVVGAFFDGTAKPMVIGIAACAIIAFALTRLTM
KSETGQPVAAE
>AIA18679.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELLEDIKKNGVKKADRTGVGTISVFGRQLRFDLSQGFPAMTTKKLFMRGVIHELL
WFLQGSTNIKYLVDNDVHIWDDWPYKAYLMKQGKKVPTPNSDEWKKGITEFTDRIKKDAD
FARWHGELGPVYGYQWRSWPAPDGRHIDQISQAVNAIKHSPDSRRIIVSAWNVADVEEMA
ISGLPPCHLLFQFYVANGKLSCQMYQRSADTFLGVPFNIASYALLTLMMAHVAGLKPGDF
VHTLGDTHLYANHLKQVEQQLKRKPRPLPKMKLNQDVKSIFDFTIDDFELSGYNPDPAIY
APIAV
>AIA18619.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLGLLQHILESGVTKTDRTGTGTTSVFGYQMRFDLSEGFPLVTTKKLHVKSIIYELL
WFLQGDTNVKYLNDNGVRIWNEWADENGDLGPVYGKQWRSWQGANGKVTDQVSDVIKQIK
TNPDSRRMIISAWNVGELGEMALMPCHALFQFYVAPGKVGGKGKLSCQLYQRSADVFLGV
PFNIASYALLTMMIAQVCDLEYGEFIHTFGDAHIYSNHMEQVKLQLTRTPYPLPQMRINP
EVKDIFSFRFEDFALENYHSHPHIKGEVAV
>AIA18610.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLDLVRHVLDKGIKKANRTGVDTLSTFGYQNRYDLSAGFPLVTTKKVHTRSIIHELL
WFLQGNTNISYLKENKVGIWDEWADENGDLGPVYGHQWRSWPNKRGDAIDQIAQVVNEIK
TNPDSRRLIVSAWNPADIPEMALAPCHCLFQFYVAEGKLSCQLYQRSADVFLGVPFNIAS
YALLTLMMAQVTGLKPGEFIHSFGDTHIYTNHLEQVKLQLTRTPYALPRMELNPYVKDIF
SFKYEDFELLNYQHHAAIKGEVAV
>AIA18444.1|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MSNLIQNLETFTEKPRVCSGPKTTQAQATLFGKVGVLYGGRSSERAISLQSGENILNSLL
KQGIDAHGIDVDQNLAAKLIEAKFDRIFIALHGKEGEDGVIQGLLQMLGIPFTGSGVASS
ALAMDKARAKLVMHGLQIPTPIFGVAKTVENAESIAQKIGFPISIKPVAEGSSIGVTRVA
DAKGIALAYAKA
>AIA18317.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISLIVAVSQNNVIGKDGKIPWFVRGEQKRFKELTSGHPVIMGRKTHESIGMELPGRLN
VVITSNPNFPAYGKSVVVHSLQQALELEQVKQADEVFVIGGQQVFDEAMPLADRIYLTKV
ETVVAHGDKFFDFDAKGWKLVASEHYPKDEVPDRPFDFNIYTYDRQPQQ
>AIA18318.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLGLLEDIKANGIKKMDRTGTGTLSVFGRQIRFDLSEGFPAVTTKKLFMRGIIHELI
WFLQGSTNIKYLVDNDVHIWDEWPYRHYLMERGKEVPASDSDEWKKGIKEFTEKIKADEG
FAKEWGELGPVYGYQWRSWPTPDGKHIDQIKNVIESIKNNPDSRRHLVSAWNVADIDEMA
KAGIPPCHTLFHFYVADGKLSCQLYQRSADTFLGVPFNIASYALLTMMVAQVAGLKPGDF
VHTFGDTHLYVNHLEQVDLQLSRKPKPLPKMKISPKIKNIDDFKFEDFELTGYDPHPAIW
APIAV
>AIA18290.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNSPLKICAIVAMDEARVIGLNGKLPWHLPEDMKRFSKLTTGHTVLMGRKTYESLPPKFR
PLPARKNIIVSRSFNAPEGVEVWNSPVECLQHYRAHPEKLPSDRLWVIGGAQIYQETEQF
WDEIDLTFVKGKHEGDTFFDSFERDFSLVTEEPFSAGSFRIYKRNW
>AIA18272.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNIIGRNNDLPWHLPADMKYFKDTTMGHCVVMGRKNFESIPPKYSPLVG
RTNIVITRQKDYNANGAIVVNSIQEAIDFSRNQNETECFITGGGEIFKQSIRLCNRIYLT
RIHAVIEGDIYFPELNKEEWKEVSRKDIEPDEKNKFPFSFLIYERI
>AIA18263.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MTTQLTKQTRIGVLYGGMSSERDVSLISGKNCYEALKRLGYENTVLIDVAPNVAQRLKEE
NIEVAYNALHGKFGEDGCIQGLLQIMGIPCTGCGVEASAITMNKAVTKSILKDAGLPVLP
SLLYRKIVKPVTVPASNNTEWEVAGSVQKPERFPVMVKPISEGSSIGMSKVDREEDLNAA
LEEAFKYADEVMVEVFVKGKSLTVGVVDIEKKPKVLPILELRPVKSEWYDLEAKYTKGLT
EFILPAELSENTTRQVQDATLKAHIAAGCSGMSRTDFVVDSDNNFYILEINTVPGMTPLS
DLPAQAQAVGISYDELVEYILKSAF
>AIA18249.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKKTVKARHPEYQYLDLLKDILDNGFEKKEFNSGIAIKSVFGRSMRYDLSKDFPLLTTKK
VFMRGIIHELVWFLRGETNIKYLVDNDVHIWDDWPYKEYKKKMEAGEVPALTQDEFISKI
KNDASYAKKWGELGPVYGRQWRKWPASDGREIDQLAWAIEKTKKYPDRKHVVISAWNPEY
VYEMARPGTSMAIPPCHTMFNLNVTNGKLSLALYQRSCDMFLGIPFNIASYSLLALVLAQ
ICGYKPGEFVHMLGDTHLYGNHYDQAKEQIKRKPRPFPRIKINPNLKDINAIKFEDFELL
DYDPHPPIKGEITVVGGFNEKDRKDFSFKKKEAKGKKPAKKGKK
>AIA18200.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSIVVAIAQNNAIGKDNKLLWHLPKDLKHFKEITSGHTIIMGRKTYESVGKPLPNRRN
IIITRQNITIDGCEVVNSLPDALKLADGVHEVFIVGGAEIYKQAMQLTDRIYLTIVHENF
DGDTYFPEIKEDIWKETEREDHQSDEKHAFSYSFITLERR
>AIA18166.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAASENNVIGRNNDLPWYLPLDLKYFKDTTMGHCVVMGRKNFESIPPKYSPLVG
RTNIVITRQKDYKANGAVVVNSIEDAIEYARRQSETECFITGGGEIFRQSLQYCDRIYLT
RIHAVIEGDVYFPELNMNEWKEVSRDDRPADEKNNYSFSFLRFERIK
>AIA18163.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MDRNRGIGKNQTLPWSLPGDMKYFKRLTCQTSDPQKQNAVIMGRKTWESIPPKFRPLSNR
LNVVLTRDAHYQAAADVVIANDLAAALEQCDRSDIEKIFVIGGASIYEQALQGRHVDRIF
LTQIDAQYDCDTFFPVFEDRFGEVGDSTGGSDAGVSYRFKEFASLVSAFCLLLFLSCMPA
HAADLRNGAAVFERATCAMCHPNGDNTLCPDKPLKGPAFMRRFSSDAAIEKVIRKGVPNS
AMAPFDRDRISDKEMKDVVAYIRTFSANQKQPATKQPLSKSIPFKATPTKKAPAKKS
>AIA18070.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSLLEEVLKQGIKNVDRGTGAVSYSVFGRQTRYDLSQGFPLLTTKKVYWKGVLHELYWFM
KGDSNIKYLVDNNVHIWDDYPYKIYTNKEKEDITKEEFVEKIKTDNTFAKKWGELPKIYG
ESWRRWPTRTPGRTIDQLSWVLQELKDDPDARNLIVTSWNPEYLYTMATHEDASRFPICH
NMYQVSQKGGKLYLQLSAECGFIFRCAI
>AIA18061.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSTSPKISLVAAVAENGVIRDSTGLPWRIRSELKHFMQTTLHKPVIMGRKTFETLKAPLK
DRANIVVTLDAAYKKPGAIVATSLDKALEIARAIAAETGADEIIVAGGAEIYRQALPFAD
RLHLTEIHAKPEGSVLFPSFDRKAWKQTRHEPRKALEGESADYTITVLERA
>AIA18030.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTQLIHNIKTNPDSRRLIVSAWNVAEIPDMALPPCHALFQFYVANGKLSCQLYQRSADIF
LGVPFNIASYALLTMMVAQVTNLAPGEFVHTFGDAHLYSNHKEQATLQLSRTPLALPTMQ
INPTIKSIFDFSFADFALQNYHCHEAIRAPIAV
>AIA17997.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
MLLEIKNLHAGIEGKEILKGLSLNINKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVTTGE
VIYEGKNLLELEPDERAKEGIFLAFQYPVEVPGVSNAQFLRLAYNEKMKHLGEEELDPLE
FNDYLKEKAKIVEMSSDFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVAGGVNKLRSSENAIILVTHYQRLLNYIVPDYVHVLANGRIAQSGGKELALALEEK
GYDWIKEATAGK
>AIA17995.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLTLLDDVLKNGTEKTDRTGTGTLSVFGRQVRYDLAEGFPLLTTKKLHIRSILHELL
WFLKGSTNIKYLQENGVKIWDEWATPDGELGPVYGYQWRFWPDGKGGHVDQIAVLMEGLK
NRPDSRRHLFHAWNVAYLPDETKKPWENAASGRMALPPCHLLYQFYVAQNKLSCLLYIRS
NDLFLGNPYNTASVAFLTHMVAQQCGFEPGEVIISMGDLHLYKNHLEQAKLQLTREPRPL
PKLVIKRKPSSIFDYKFEDFEIVGYDPHPHIPAPIAV
>AIA17855.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSEFKKTRVGVIFGGRSGEHEVSLRSAESVIRSLDPSKYEVVPIAITHEGRWLGTRDAMK
LLSPGEAIQAALKTGEPMAVVPEPQRNGAVDVFFPIVHGTYGEDGTIQGLLELAGVPYVG
AGVLGSAVGMDKDVMKRLLREAGLPVGDFWVTRAKDIDAFIREFGKQLPYPVFVKPANLG
SSVGITKVHNAGELPAAIAFAAEFDRKIIIEKGIDAREIEISVLGNDELKASIPGEIIPS
REFYDYQAKYVDDDSRLIIPAPLSEQQVRQAQDLAIRSFQALDCSGMARVDLFLEKPTGK
FLVNEINTLPGFTSISMYPKLWEATGLAYPDLVDRLITLAVERHAEKKKLRTKV
>AIA17810.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMEQYHDLLKLILDHGTEKSDRTGTGTFSVFGHQMRFDLEKGFPLVTTKKVHLKSIIYEL
LWFLRGDTNVKWLQENKVSIWDEWADKETGDLGPVYGAQWRSWKTPDGRTIDQITEVINQ
IKTNPDSRRLMVVAFNPGDLDKMALPPCHAFFQFYVANGRLSCQLYQRSGDVFLGVPFNI
ASYALLTMMVAQVCGLRAGEFIHTLGDAHLYKNHIDQAKLQLSREHRALPRMKMNPDVKN
IFDFKYEDFTLEGYDPHPPIKAVVAV
>AIA17756.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FKVENHKLLHCQLYQRSADAFLGVPFNISSYALMIHLVAHVCELEVGEFVYTLGDYHIYQ
NHMDQVDELLGREPLPLPELQINDSEGRLRGLEGLLSFNYEHLNLVGYKSHGKIGAPVAV
>AIA17576.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MHTTIVAAVTANGFIARSTNELADWTSKEDKKFFVEETKKAGVMIMGRTTFATIGRALPG
RLIVVLTGKPEEVEATEGVETASGDLKTILEGLEKRGYSSVVIAGGANVYSQFLNAGLVD
ELALTVEAKLFTSGVPLAQNLSHELSLTLLETKKLGEKSVLLRYRVNLSTEAR
>AIA17547.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYHELLQHILDHGTPKTDRTGTGTMSWFGYQMRFDLGKGFPLVTTKKIHLKSIVYELL
WFLRGETNIAYLKENGVSIWNEWADENGELGPVYGKQWRSWLTSNGETVDQISDAVKQLK
NNSDSRRIIVSAWNVADLPDMALMPCHTLFQFYSAPDENGKRKLSCQLYQRSADVFLGVP
FNIASYALLTMMMAQVCNMEPGDFVHTFGDVHIYNNHIEQVKLQLSRTPYHLPTMKLNPA
VKNIFDFKFEDFTLENYQCHPAIKAPVAV
>AIA17485.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNQGRISIIAAIDEKRGLGKNNDLLFKISGDMQRVRSLTTGHPLVMGRKTFASLGRLLPK
RSHVVVTRDASSLESLSFQPEAVVGSLEEALEKAKEFEGAEEIFIFGGGQIFTEAVEKGL
VDRLYLTIVKGEYDADTFFPDYSMFTKILKKEEHEEEGYSYTFLDLEK
>AIA17423.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSLPNEAPQPNENNSFLSILRESVWGSTRDFTKGPLGTAIFILAVPMIIEMFAESLFALV
DIFFVSHLGARAIAIVGITESMMYLVYSIAIGVSIGATATVARRIGEKDPDGAARAATHS
IYLGLAASTVMGAIGVIFAPEFLALMGADADVVAQGTAFTRIMLGGNVVVMGLFLLNAIF
RGAGDAAIAMRVLWFANILNMVLGPCFIFGLWIFPEMGVTGAAIGTTIGRGCGALYASYE
LFFANRRFTVNREHWALQPDRLWRLVKVSAPAVFQFFVQTASWIGLVRVMTGFGTTAVAG
YQIAIRVVIFALLPSIGLANAAATLVGQNLGAGKPERAEKAVWQACLYNAIVQTAIGLAF
VIFAGTIAGVFTSDGEVLTYASDALRIIAYGFLFYAIGMVLETAFNGAGDTWTPTYLALG
IFWAFEIPLAYILAYHFELGPYGVFWSITIAFSLLAIAAALLFRRGKWKTKLV
>AIA17355.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNTKHPENQYLDLMREILEKGDRKVDRGTGDASYSLFGRQIRFDLSKDFPLLTTKKVFWK
GVVEELYWFMSGQSNVAYLANKGVHIWDDYPYRIYNKKNPGLTKDEFVEKLKDPEFAKAH
GELPRIYGELWRRWPTRSGRTIDQLAWLVQELKDDPNAHNLIVNSWNPEYLYSMATLEDA
SRFPICHNMYQVDMIDGKLNLQLYQRSADLFLGVPFNIASYALLTIILAQITGYQPGEFV
HTFGDVHIYENHLEQAREQITREPKQFPKIELDQSVKSIDDFRPEHVKLIGYDSHPALKA
ELSVSGGLFEKKL
>AIA17341.1|FEATURES|farme|multidrug|PmpM|antibiotic efflux|0
MKVKDLGEHTGQQVPGGTDKAKDLKLFYLTWPIFLEVALFMMMGIADTFMLSEISDNAVS
GVGASNHYLHIAILLLEVIGNGASIVVAQYIGSKKFFEAAKISALAVTLNLVVGIVLSVA
FVAFNSHLLSSLNLQGEVYDYAQSYLQIVGGAIFLQAIINSLAAIIRVHGYTKEAMFVAL
GMNVIHIIGNYALIFGNWGMPALGVEGAAISTIGSRLIAVVVFFWLLYRVMKVRIAFRYY
FNLSKEFVGKILKIGIPSALEQVMYHSCQIVFLAYTTYLGEASLAAKQYASNISMLIYLF
AFAVGIGTSIMVGRFVGAGRPDDAYRRVWMSVRSASMGTLLVVVLVMVFREQLVGFFTDD
PEVLRLGAQVLLYSFILETGRTINIVIVNSLRASGDAKYPLFIGMFSMLGMSLPLGYLLV
FHWNMGLPGVWLAIAADEWVRAVIFYFRWRSRKWEKHALVKPDAPSPVEGNATSVQA
>AIA17323.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|0
MLDYKTSQVYLDGNLVPFKDANISIASSPVLYGLTIYTVFCLNWNDQQQKLYAFRLKDHF
KRLVNSARIMDFGQFINDWTYEKFEQTMLELISKNNVREDALVRVAVYVDELIAGTKIHG
LKNSVSAYIYPMGEILPLTGINACVSSWVRTQDNAMPSRAKINGSYVNASLMKNEAVLNG
YDEAIALDHNGHVAEGTVANIFIVKNGTLITPDDSTDILEGITRSSILQIARDLDLRVKQ
CAIDRSELYIADEVFMCGSSARIAPILSIDKRPIGNGQIGKVTGELMKYYKEVQLGNNSA
YTHWLHQV
>AIA17315.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EDRTGTGTISTFGYQMRFDLQEGFPMVTTKKLHLKSIVYELLWFLAGDSNIQYLCKNGVG
IWNDWPYAKYQKSAEFAGETMKEFAQKIANDDAFAAKWGELGPVYGHQWRHWPDGKGGEI
DQIKQLIHQIKTKPDSRRLIVSAWNVADIEALLMLYLR
>AIA17297.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFPLVTTKKVHLKSIIYELLWFLRGDTNVKWLQDNKVSIWDEWANETGDLGPVYGAQWRS
WKTPDGRTIDQITEVINQIKTNPDSRRLLVVAFNPGEIDKMALPPCHAFFQFYVANGRLS
CQLYQRSGDVFLGVPFNIASYALLTQMVAQVCGLRAGEFIHTLGDAHLYKNHIEQAKLQL
TRDHRPLPRMIMNPDVKSIFDFKYEDFQLEGYDPHPPIKAVVAV
>AIA17300.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILTAIAAMASNRVIGVDNDLPWNIPEDFKFFKDKTSGHAMIMGRKTFESLPFALPGRLH
IIITRQADYAPELPANAKPGTAIKVVPTIDEAVAYARTQISKYGDEVFIAGGGEIYKQML
PITDRIYLTEIHKDFEGEAKFPEFSKTEFKEVYRSARKAGENGATVDFDFVTYERTR
>AIA17237.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNQYHDLLERILADGAEKHDRTGTGTLSIFGHQMRFNLAAGFPMLTTKRLPLKAIVHELL
WFLAGDTNIKYLRDNGVSIWDEWADENGDLGPVYGSQWRSWPAPDGRSIDQISNVIDMIR
RNPDSRRLIVSAWNPADVDKMALPPCHCLFQFYVANGKLSCQLYQRSADVFLGVPFNIAS
YSLLTMMVAQVTGLKPGDFVHSFGDAHLYSNHLEQARLQLTRPTRQLPVMKINPDVKDIF
AFRYEDFALEGYDPHPHIKAAVAV
>AIA17214.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLWHILENGVQKNDRTGTGTLSVFGYQMRINLQEGFPLLTTKKMATKAIIHELL
WFLQGNTNIKYLVDNDVHIWDEWPFQDYLIAQKLTEQYPMYSDSWKEQKTQFIQKIKDDA
AFAQQWGDLGPVYGKQWRRWEGADGNTYDQLAAAIETIKKNPDSRRILVSAWNVSDVYGH
TKTAPPLCHTLFQFYVANGKLSCQLYQRSADVFLGVPFNIASYSLLTHMIAQVCGLEVGD
FIHSFGDTHLYSNHLEQAKEQLSRVPKKLPILKLSPAIKNINDFRFEDIEIVNYDPYPPI
KAPIAV
>AIA17204.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYQQLLQFILDNGVQKTDRTGTGTISYFGYQMRFNLAEGFPLVTTKKVHLKSIIYELL
WFLRGETNIKYLKDNGVRIWDEWADENGELGPVYGKQWRSWEGAKGETIDQISDAIKQIK
NNCQLYQRSADVFLGVPFNIASYALLTIMMAQVCDLEPGDFIHTFGDVHIYNNHIEQVQL
QLSRTPYTLPTIKLNPAVKNIFDFKYEDFTLENYQFHPAIKAPVAV
>AIA17205.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIKSLVVAASTNNAIGKDNQLLWHLPNDLKFLKNKTWAMPVLMGRKSFESLGNKPLKGRV
NIVLTSSKFFKKEGIVLVNNLKDAYFFAGQNDYNEIMILGGGHVYEQTINESDKIYITRV
HHVFEEADAFFPVIDENKWKLSFNEDHYKDEKHAYDYSFQLWERK
>AIA17184.1|FEATURES|farme|aminoglycoside|APH(9)-Ib|antibiotic inactivation|0
MKMHRITRWTRAVYVLWTLLTFALDVALEAKGWFGRKARREARLRQQAIQLRGRLIKLGP
TFIKMGQMLATRADLLPLDYLKELSELQDRVPPFPDSQARAILEAELGRPIEKIFTELSE
PPVASASLAQVYRGRLLTGEEVAVKVQRPLLEEQIRFDLDLLRGIGRWLDRHPNLLPGAE
WLGAIDEFDRVIHEEMDYRREAASADEFRRNFRDWPGLYVPHIFHQLSTSRVIVMEFITG
IKVTHLDQLRAAGHSPRRINELIYRAYFKQLLEDGFFHADPHPGNLLVMPDGRLAVFDFG
MVGRVSDELQRQMINAFFHLYNRDVKAIVGDLVGLGFLAPAADVTAIGAIVAEVFERKLN
LKLGEVRFKDLTYDLAPIVYEHPITTPARFTYLIRAIMTLEGISIVMNPEFNFFDVARPY
VKEFLFRRESSHLRQMALQSLRDARTGRFSLDRLWSMAKMAYSLYIGD
>AIA17169.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELMRHVLKHGSTKTDRTGTGTLSVFGYQMRFDLQEGFPLLTTKKLHVRSIIHELL
WFLKGDTNIKYLKDNNVTIWDEWADENGNLGPVYGYQWRSWPTADGRHIDQITQVINQIK
NNPDSRRMIVSAWNVGEIEKMKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVCNLKPGDFVHTLGDAHLYSNHIEQTKLQLTRDIRKLPVMKINPAVKDIF
SFKFEDFTLEGYDPHPHIKAAVAI
>AIA17104.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKENTPEIAIIVAMDQKRGIGNDGKLPWPRIPEDMARFKELTVGHPVIMGRKTYESLPPK
YRPLPDRPNIVLTRELGLSIPRCYTSHSISEALQLGELLDSKRICVIGGGEIYKKALPLA
DVLYLTNIDADFEADTFFPEFSDQFSIELKSRASHHNGLQYSFEDLARKK
>AIA17075.1|FEATURES|farme|beta_lactam|AO353_20470|antibiotic target alteration|0
MMDEPLEQPYLELMKYVLAHGARKDDRTGIGTLSIFGHQMRFDLGRGFPLLTTKKLHLKS
IIYELLWFLRGETNVKYLRDHNVTIWDEWADAEGELGPVYGAQWRRLARGGWPDDRPDQR
ID
>AIA17065.1|FEATURES|farme|glycopeptide|vanB|antibiotic target alteration|1
MSNKIRVAVLYGGRSGEHEVSLMSAANVIQYLDRSRFEVVPIGIDKQGVWFLGDDTLRKE
LNAPKTLELLRDSDRMLFNPDYIGRNFQAVQASQLISHLKKSERLFDVIFPVIHGTLCED
GTVQGLLELAEIPYVGCGVLASAVGMDKDVSKRLVMNAGMQVAPFVVIKRGQWNCEPKHF
CDLVTQQLKYPVFVKPANTGSSVGVEKIKSADELHDAINRAFQYDTKVLVEEGINAREIE
VAVLESLEYGKDPILSIPGEVRPTHEFYSYAAKYLDEKGAELMIPAPLSEELQARVQQFA
KNIFAVLECEGMARVDLFLEKNTNEIYFNEVNTIPGFTQISMYPKLMAATGVSYPELLTH
LVMLAINRHKLKSELSRECQETFVS
>AIA17033.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDAGFAAEGVHVVHTWEEAVAKGAELATRMGADSVAVAGGAEIYALALPQVQSI
FLTKVQAEPEGDAVFPDFDRSQFRETRREDHPKGGDDEHSFTFIDLERRR
>AIA17025.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLNLMQHILDNGVSKEDRTGTGTLSVFGHQMRFDLSAGFPLVTTKKAHLRSIIHELL
WFLRGDTNVGYLNENKVTIWDEWADENGELGRVYGAQWRHWRRADGTELDQIAAVVKSLR
ENPNSRRHMVVAFNPGELEQMALPPCHAFFQFYVASGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMMAQVCNLQPGEFVHTLGDAHLYSNHLDQARLQLSREPRRLPEMKINPAVTDIF
SFKYDDFELVGYDPHPPIKAKVSV
>AIA16950.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MSISFLLAMDRNHGIGLNNKLPWRLPADLAHVKKLTMGHTLVMGRKTYESLGRPLPGRTN
VVLTQNRDYQAPGCVVVHTVEEALSRFREGELFIFGGAEIFQLFMPYAEKMYVTYIDEEF
AADTFLPEIDAREWELVSNQQGVKDEANPYTYYFRRYERRNGRQ
>AIA16916.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQAYLNLLSHVRQHGIEKTDRTGTGTLSVFGYQSRYNLREGFPLLTTKKMHLRSIIHELL
WFLSGQTNVRALQAEGASIWDEWAAANGDLGPVYGKQWRSWPDEAGGVIDQISNLIQEIK
TNPDSRRLIVSAWNVGQIPLMALPPCHCLFQFYVSKGELSCQLYQRSADVFLGVPFNIAS
YALLTLMIAQVCELEVGEFIHTLGDAHLYLNHLEQADEQLSRAPHALPKMHLNPKINNIF
DFRYEDFSLRDYISHPRIQAPIAV
>AIA16833.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQENNVRIWNEWADENGELGPVYGSQWRAWPTPEGDHIDQISRVVESIRHNPDSRRHLVV
AWNVAEVDRMALPPCHYAFQFYVAEGKLSCLLNMRSVDTFLGLPFNIASYSLLTHMMAQQ
CGLEVGEFVWSGGDVHIYSNHLEQVKLQLTREPYPLPKLNIKRKPETIFDYKYEDFEFVG
YECHPSIKATIAV
>AIA16807.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIKDNGTIKTDRTGVGTKSVFGRQMRFDLSEGFPLVTTKKVFLRGIIHELL
WFLQGDSNIEYLVKNNVHIWDEWPFRAYLVATNQPLPEQGSEAWKQRLSEFTENIATDHE
FAKKYGELGPVYGYQWRHWPARDGGEIDQITEVIEAIKTNPDSRRHIVSAWNVADIKEMA
KAGLPPCHTLFQFYVTDGRLSCQLYQRSGDTFLGVPFNIASYALFTMMVAHVTGLKPGEF
VHTLGDAHIYLNHQEQVDLQLTREPRGL
>AIA16712.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSIIVAVSENGVIGKDNKLIWHLPADMKFFREKTTGHFIITGRKNYESIPEKFRPLPD
RTNIVITRQKNYHPAGTIIASSIPDALSFAEEFSNKEEVFIIGGAEIFNQVLPSCHRVYL
TRIHEKFEGDVFFKDLPPEWKLIFSEKHEPDAKNKYPFTFETWEKN
>AIA16642.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSTSNEFGKVGVLFGGRSAEREISILSGTGVLQALQSKGIDAHAFDPAERSLADLAAEKF
DRVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIVWLAHGVSTPKYA
VIDTDTDLDKVVADLGLPLIVKPPLEGSTIGITKVTRAEDLKAAVDLAHKYDKLVLAEQF
IEGREFSVPLLGTGPSARALPIVEIVAPEGNYDYQNKYFTDDTKYHCPAPLDAATTEAIQ
REVEKAYRALGCEGWSRIDVLLRESDKQFFLLEVNTSPGMTTHSLVPMAARAEGTSYEDL
CVQILRSASLKIGTKEKA
>AIA16638.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSVLPKKIAVLMGGPGSERDVSLATGRGVVKALRSLGCDVAEVDVKGADFTLPDDVELAF
LTIHGTFGEDGQIQQILEDRGVPYTGEGVAGSALAFDKISSKKAFRQHEVATPYWQTINV
GQRPTIPIPLVIKAPRQGSTVGVHIIRNEREIDAAITDASTYDRELLVEKFVPGRELTVG
ILGDQVLPIIEIIPKGGFYDFTNKYPFLNPSAGGAATHVCPAEIGAAKTEEVQQLALRAF
RALGLQVYARVDVLLPEDGEATVLEANTIPGMTEASLLPEAAAVAGISYPELCARIIELS
GKRAK
>AIA16572.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTTREKLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVRNEDFQLPNDVD
LAFNTIHGTFGEDGHLQTILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEV
IHAGQRPTIPLPIVVKAPRQGSTVGVVIVKNESELESAIAEASKYGRELLIEKFVAGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQGGGGAEHVCPANIDAGKTKEIQELGA
PRISLSWPAGVCACGRNSIRRRTAVHFGDQHHSRNDRG
>AIA16522.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
RKIALVTGGYSREAEISYQSVITVNNNVDRNKFDVYVIDINPEGWFYEDANAEKIPVDKN
DFSITVNDSKINFDGVLMCIHGTPGEDGKLQGYFDCIGLPYTTCDAATSALTFNKRYTVA
VAGFAGINVARSLHIFRNDIIDEETIINKLKFPVFVKPNNGGSSIGMSKVNQPSEEIGIA
LQKAFNEDDQVLVEEFIEGREFTIGVFKTKGEIITLPITEIKSKKDFFDFEAKYKGMSEE
ITPAQADEAVLDKVRAAARKIYSVLNCRGVVRIDFIYNEEKGEPFMLEVNTVPGQSAASL
VPQQVKAMGWTLEQFYTALIEECWN
>AIA16454.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKLRVGVIFGGQSGEHEVSIRSAASVIQAIDRKKYDVLPIAISREGKWLSPPEAYRLL
PAKAQQLLATETATKPEANVAILGDPSHQGLIAINEPGDAQPSERIDVVFPVLHGPFGED
GTLQGLLEMANVPYVGCGVLASSCGMDKVAMKLLFLQAGLPMCRYIWFLRSHWGKNRDQV
LARISREIGFPCFVKPANLGSSVGISKAVDKQSLVKAIELANQYDRKIIVEEGVDGREIE
CAVLGNDEPRASLPGEYVVHDNSAGFLDYAEKYNSTGHVDFIVPAQVSKAMTAKIQRMAI
RAFQAVDGSGLARVDFFLKRDTKELLINELNTMPGLTDVSGYPKMWAASGLNYTRMLDSL
IQLAFERHREKSLNKATL
>AIA16386.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|0
MIRPFIIAAMTTDGFIAKDANHPAFWTSKEDKVRFVELTKRAGVVVMGSQTYKTLPRPLA
ERINIVYSRDKKFEGAEMTNDEPRALLSKLESRGFSEVAICGGSQIYNMFMKAKVVDKLY
LTVEPLLFGKGVTLFKDDIVADLTLLSESKTEKGTVFLEYKVNYHGAQNL
>AIA16302.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MTKREELPRKIAVLMGGPGSEREVSLATGRGVAKALRSLGIEVVEVDVRDENFQLPDDVD
LAFITIHGTFGEDGQVQKILERRGIPYTGEGVNGSEIAFDKIRTKEKFREHDVTTPPSEV
IEPGQRPTIALPMVVKAPRQGSTVGVVIVKDESELDSAINEAGKYGRELLIEKFVAGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANIDAGKTKEIQELAL
RAFRAAGLQVYARVDAILSDSGKPYILEINTIPGMTEASLLPEAAAAAGIGYANLCARII
ALSRARTEGKR
>AIA16174.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RKENRTGVDALTVAGVMFEHDMAHGYPLLTTKKMPFKTMRVELEFFIKGLTDKQWLQDRR
CMIWNEWANPKKAPYGHDEESKKRMMEERDLGPVYGFQWRHFDATYQNYDTEYTGTGIDQ
LANVIETLKKNPNDRRMIVMAWNPKALPEQALPPCHYGFQVTVINGKLNLLWNQRSVDTM
LGLPFNIASYALLLHLLAKESGLQEGKLIGFLADTHIYVNHIDGAKEQLAREPRALPKIT
TDPFTSIFDWTGEHTTLEGYDPQDKIDFPIAV
>AIA16116.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLNPTDQQYHDLLRHIMENGSGKEDRTGTGTRSVFGYQMRFDLAKGFPLITTKKVHLKSI
IYELLWFLKGDTNVKWLNDRGVTIWDEWADENGELGPIYGKQWTAWEAKDGTKINQIANA
VDLIKNNPTTRRIIVSGWNVGDLQTLIRGQKSAPPPCHTMFQFYVVDNKLSCQLYQRSGD
VFLGVPFNIASYALLTMMMAQVTGKELGDFVHTFGDVHIYNNHVDQVNLQLTRDSRPMPT
MKINPEVKDIFGFKFEDFTLEGYDPHPGIKAPIAI
>AIA16112.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTEKHVTGDLRRLALIWAQSSTGVIGRGNDIPWHLPEDQARFKQLTLGQTVVMGRLTWES
LPAKVRPLPGRRNVVITRNPGYVADGAEVVTEIGDVFRGWVIGGAQIYAQALRFADRCEV
TEIDLDLPPAEGDAMAPELDDSWTKTTGDWLTSSSGLRYRYCSYARTL
>AIA16095.1|FEATURES|farme|aminoglycoside|ASD83_19545|antibiotic inactivation|0
RKNMVEVVNTEMSDLEQIFELFEHSINYQEKKGYPVWRNYDKNAIIRDIADRNQYKIIID
SKTAMIFSVCYTDKIIWRDLDEGDSIYLHRIVVNPEFKGQKLFGTILDWVITHSKQKRLS
SIRMDTWAANPTIIDYYKSFGFAFIENYTTPDSEELPVHNRNLALTLLEYKLQY
>AIA16082.1|FEATURES|farme|trimethoprim|TS_Pyrimidine_HMase|antibiotic target alteration|0
MHKEDRHPEYRYLDILQDIMENGFEKTDFATGTKLKSVFGRQIRFDLSKGFPLLTTKKVF
YRGIIHELLWFLRGSTNIKYLVDNDVHIWDDWPYREYKKAAEKGEVPPMTQQVFIEMLKS
LPVEHAFVKKWGELGPVYGRQWRK
>AIA15916.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MTTEAIIPGAKRELKNHTSIGMTISNSLTMARRGLLKIKRTPEQLFDVTIQPVLFTVMFT
YLFGGAISGDVASYLPLIIPGILIQTVITTSVVTGVQLREDMDKGVFNRFKSLPIARISP
LAGALLADTLRYAIATIITFAVGYLMGYRPGAGLGGVVAGGLLVIGFSWSVSWIFAFFGV
LARTAASVQGISLLILFPLTFLSNAFVPTNTLPDWLKWFADVNPLSHLIAAVRDLANSGT
IGSDFWMSLIGAVGIVAVMAPLTVKAYMRKA
>AIA15909.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MQPVKLPIDSSFKQRLGRVGVLLGGTSSEREVSLQSGGAVVAALAEANVDHVAIDIGANA
IQDIQSAKIDRAFLALHGAGGEDGRMQALLEFLNIPYTGSGVQASALAMDKLRTKQLWRG
VNLSTPDFAVLSKNTDWQKTLAELGGEAMVKPAHEGSSIGMARVKTAQELESAFAEAAKY
DGSVIAERLIVGSEYTVAILDDEALPPIKLETDHAFYDFNAKYIADDTRYICPCGLSPEK
EAELKALALDAFNSAGCEGWGRVDVMADKSMNFYLLEVNTAPGMTSHSLVPMAAKARGLS
FSELVLTILQSSL
>AIA15871.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTEKKKTRIGVIFGGRSGEHEVSLRSAESIIRSLDTSKYEVVPLAITHEGRWLTAAPAVA
MLPAGKAIEAVLKEGKPMTLTPEPGANGVVDVFFPIVHGTYGEDGTLQGLLELAGVPYVG
AGVLGSAVGMDKEIMKRLLREAGLPVGDYWVTRSKNIDAFVRQIGSELPYPVFVKPANLG
SSVGISKAHDIGELPGALGLAAQFDRKIVVEQGIEAREIEISVLGNDDPRASVPGEIVPA
REFYDYQAKYVNDDSKLLIPAPLTEGQVRDAQDLAIRSFQALDCAGMARVDLFLEKSTGK
FFVNEINTLPGFTSISMYPKLWEASGLAYSDLLDRLIVLALERNAEKKKLKTKYS
>AIA15852.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HGVTIWDEWADAQGELGPVYGCQWRSWPGRHGETIDQISEVIEQIRTKPGSRRLIVSAWN
VAEVPRMALPPCHLMFQFYVADGRLSCQMYQRSADVFLGVPFNIASYALLTMMVAQVTEL
EPGEFIHTLGDAHLYENHLEQTQLQLTREPRPLPTMSIDPSVHSIFDFQFEHFRLDNYQS
HPHISAPIAV
>AIA15773.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVAMDEKRGIGKAGKLPWHLSSDLRTFRELTMGHHLIVGRKTFESIGKPLPGRHTVVVTR
NSNFKPEGCSVSHSVEDAIALARERGETEAFVIGGAEIYARALASADRIYLTEVHAEVDA
DVFFPEFDRADWVETQHIDHPAGEKNQYAFTFKVLERGSQKVEV
>AIA15759.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLQHVIDHGVEKSDRTGTGTLSVFGYQMRFDLRAGFPLLTTKKVHIRSVVAELL
WFLQGATNVKWLHEQGVTIWDEWADDSGELGPIYGYQWRSWPTPDERHVDQIAAVIGGLK
ADPDSRRHLVSAWNVSDLEQMALPPCHTMFQFYVAPAPAGSDDPRGRLSCQLYQRSADIF
LGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHLYTNHLEQARLQLTREPRGLPTLR
LDPSITAIDDFGLEHISIEGYDPYAGIKAPIAV
>AIA15575.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MASAATMTTLPENIAVLMGGPGSEREVSLATGRGVANALRSLGATVTEVDVRGPDFVLPE
GVELAFISLHGTFGEDGQVQKILEERGVAYTGEGVEESRLAFDKIESKNRFRAAQVATPY
WQIILAKQRPTIPPPFVVKAPRQGSTVGIYIVHSDREIEAAITSASQYDEQLLIEKFVSG
RELTVGVLGDLALPVLEIIPKGGVYDFTNKYPFLNPGAGGGAQHVCPAAISEEQTATIQK
LALQAHRALGLQVYSRVDILLPEEEEPTVLEVNTIPGMTEASLLPEAAAAAGIPYPHLCA
RIIELSAKARPSKG
>AIA15529.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTNSTFDAASFGKVGVLFGGRSAEREISLISGNGVLAALKSRGIDAHPFDPGTHSLSELA
AQNFDRVFIALHGRYGEDGSLQGALELLGIPYTGSGVMASSVGMDKITTKKIWLMEGLPT
PKYLSIDAASDLSSVVADLGLPMIVKPPLEGSSIGITKVTKADELQGAIDLVASMDEAVL
AEEFVTGREFTVAVLGQGASARALPIVEIVAPGGKYDYQNKYFTDDTQYHCPAPLPESLT
QEIQRHAVNAFRALGCEGWARIDVLVRESDMRPFLLEVNTSPGMTTHSLVPMAARAVGIA
YEDLCIEILRSARLKMGNKSSKAKG
>AIA15488.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VIDHGVEKSDRTGTGTLSVFGYQLRFDLTQGFPLLTTKKVHIWDEWADDSGELGPIYGHQ
WRSWPTPDDRHIDQIAAVISGLKTNPDSRRHLVSAWNVGDLDQMALPPCHTMFQFYVAPA
PPGSADQRGRLSCQLYQRSADIFLGVPFNIASYALLTHLVAQVCDLAVGDFVHTLGDAHL
YLNHLDQARRQLAREPRPLPTLRLDPAITDIDGFGLEHIVIEGYDPHPGIKAPIAV
>AIA15451.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MALNALAIDVMLPALPYMGEDLGVDNENERQLVVSAYMIGFGLAQLAFGPLTDRFGRRAP
LFFGIGLYVVCAFAATFAPTFAILLGLRFVQGLGAASTRVIATSIVRDRFSGREMAEVMS
LTFMVFMAIPIVAPGIGQIILLTGPWHYIFLFMAGLSAAIWVWAWFRLPETLHPEYRREL
KLSVIVEGFRMVFTNRVAFFYGLAGMFLFGAMFGFIISTQQIFVGIYGLGPWFPLAFATM
AGFMAVSSFLNSRIVKHFGMRRLSHTAMLVYVTCAVILLVLSLTMSVVPFWLFFLLLMII
QVSFGNAASNMNSLSMEPLGAVAGTAASVFGFCQTVGGAILGTFIGQQFNGTLTPNATGY
VVMGTLVLCCVLIAEKGKLFGVGKEYEPTGVVAHAD
>AIA15402.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMRHVLEHGAQKHDRTGTGTISVFGYQMRFNLEEGFPMVTTKKLHLKSIIHELI
WFLSGDTNIKYLKDNNVRIWDEWADENGDLGPVYGSQWRSWPTADGRHIDQISQIIKTIK
ENPDSRRIIVSAWNVGEIEDMALPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIAS
YAMLTMMVAQVCGLQYGEFIHTLGDAHLYNNHLEQARLQLSRDPKPLPVLKINPEVKDIF
AFTYEDFTLENYDPHPHIKATVAV
>AIA15391.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MLRAALVLGLLSAIGPFAIDMYLPALPAIGVNLQASTAEVQMSLMAFMAAIAVCQLFYGP
ISDMIGRKPPLYFGIALFSLGAVGCALAPSIEWLIAARFVQGVGACAGMALPRAIVRDGY
TGADAAQLQSLLMLVFSVSPILAPLAGSLMVQFGDWRTIFWAIAVIGVLGLLLIAFFLKE
TRPASQRLESSVGSAMSGYGLLLRDRNFLGLSLIGAFGMSSFMAYLANSSFILIDHYHLT
PTLYSVMFSINAVSFIGVSQLTGVLTRRFGLNTVVRTSVTGFITVMVTLAALFILGVDQL
PVLAILLFIGYGCLGLVVPTTAVLALENHGSIAGTASALMGTLQMVTAATVMGIVGAFFD
GTARPMVIGIAICSIIAFALTRLTIKSTVARPVAAE
>AIA15364.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKPGKLRIGILFGGRSGEHEVSLLSAASILNAINKSKYEVVPIGITKQGHWIASTAAE
RLLAGSSKPAPIQHKSMQLSTSLAQQNGPLARQLDVIFPVLHGTFGEDGTIQGLLELADI
AYVGSGVLGSATGMDKVAMRQLFTAANLPQTPHLALTRSEWKSDPKRCAKLIEKKLTYPI
FVKPANLGSSVGISKVHDRSELAAAMELAASFDRKLMIEQGVGGPGVKPREFEVAVLGND
NPEASVVGEIVPGAEFYDYEAKYVSDTSVPIIPAKLTKQEAKQIREMAVAAFRTCDCAGL
ARVDFLMEPARKGKKSRIYLNEINTMPGFTSISMYPKLWQASGLSYTKLIDRLIELAIER
NQEKQQTAFSRS
>AIA15331.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MNGQNRIAVLMGGPGAERAVSLATGAGVAKALRSLGAEVTEVDVRGPDFQLPPDVDLAFI
ALHGTFGEDGQVQKILEERGMAYTGEDVEGSRLAFDKILSKEKFKAQNITTPEWEILKAG
QRPSLPRPFVIKPPRQGSTVGVYIVRQEQEIDDTLKKAAEFDQELLVEEFVEGRELTIGI
LGDQALPVLEIIPEGGFYDFQTKYPFLNPGAGGGAQHICPAPLQDEQTRAIQDLALRAHR
SLGLKVYSRVDIMLPENGAPSVLEINTIPGMTEVSLLPDAARAAGIEYPELCARIIELSQ
AARPKK
>AIA15306.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSDETPTGERPEVVGIAAVARNGVIGAGNDIPWRIREDWARFKEITMGHVLIMGRKTYDS
IGRPLPGRTTIVVTRDPTWRADGVIVAPDLDAAFDGAFALGPAKVFVAGGGQVYAEAWGR
LDTLEITEVDAEPAGDVIFPAIGSDWHESGRDERDGFAFITFRRLSE
>AIA15230.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVILVAALSSDGFIARAASHGADWTGTADKKIFVKLTKAMGIMVMGSTTFATIGRALPG
RRTIVYTSNPQSITAEGVETTTEPPLDLINRLEQRGATGVAICGGAQIYTQFMQAGLIQD
FYLTYVPVVFGEGITLFSSPLDVHLDLVTSEPIGEGAVLMHYRLKSLSS
>AIA15134.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAVELVFEKRSKPFMNVRDSLIMIKRSSRHIIRNRDQLLGAFFQPIMFLVLFSTVFGGAI
SKALPPGVSYLNFLMAGIIVQTAAFGCTTTATAVCNDLQKGIVDRFRSLPMSNLAVLNGH
VVSDLFRNSISTIVMLLAGLAIGFRPHASFTGWLEIAGILFLFTLSFSWLAAIVGVLAKS
VEGVQWLTFVLVFPLTFASTAFVPAEGMNRALRAFAENQPITQVVDAVRSLILGTPLGNH
GWLAVAWSIGTLIVAMPIASWLFRRKTTS
>AIA15018.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKSVIATPYEDLLRETLEHGSTKSDRTGTGTRSVFGRQLRFDLADGFPLITTKRVHFKSI
AYELLWFLRGDSNVGWLRENGVTIWDEWADESGDLGPVYGVQWRSWPTPDGGHIDQIAQV
IETLRTNPDSRRMIVSAWNVSEIPAMALAPCHALFQFYVADGKLSCQLYQRSADLFLGVP
FNIASYALLTLMVADQVGLAPGEFVWTGGDCHIYDNHVEQVTEQLRREPFPAPTLRILRQ
PASIFDYRFEDFALVDYRHHPAIKGAVAV
>AIA15009.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRASMPQISLVVAVSDNGMIGQNNQLLWHLSNDLKRFKAITLGKPIIMGRKTYQSIGRPL
PGRKNIIVTHQKDLTIAGCEIAQTVEQALALAGDVPEIMVIGGGEIYQLFLPRAQIIHMT
QVHTQIAGDTQFVTLDPNAWEEVFREEHAKDPQHEYDYSFVTLRRISPSR
>AIA14941.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MADKVAVLMGGTSAEREVSLNSGQAVLAGLREMGIDAHGIDTRDVSVLTLKEQGFTKAFI
ALHGRGGEDGTLQAVLEFLQLPSTGSGVMASAVTMDKLRTKLLWQGRGLPSGKFVWLTRQ
QFDAGLDAENNAAIAALGLPLFVKPACEGSSVGISRVNDLSALPAALDMAFKHDNDVLVE
AFLSGAEYTVAIVGDRILPSIEIKSASEFYDYEAKYISDDTQYVCPADLSAEREAELRRW
YWRPGVRWDVAAGDGLM
>AIA14937.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MLATKVDRVADAVSRLGSESAFEVLARAKALEAEGKRVVHMEIGEPDFDTPAHIKEAGIQ
AIRENYTHYSPSAGIIQLRDVIAGYAAKFRGVEPFSAENVVVSPGAKPVIWNILSAILSP
GDEFVYFDPAYPAYASCANYLGAKVVPIPLYEEKNWRMDLDELERRVSDKTRAIMINSPH
NPTGGVLTKGDLERIAQMAIKHDFLVIADEIYSRNFYESSFASIVAVHGMRERTIIVDGF
SKAYAMTGWRLGYAIMPPSLAKIVTLFNNNTFSCVATFVQQAGIAALLGPDEPVREMNET
FRTRRDRLVNGLNNLPGVSCTMPEGAFYAFPNVKQITADDKALATFLLSEGGVACLGGSA
FGSAGKGYLRFSYAASLEDIDYALEQMARCIPQFKG
>AIA14926.1|FEATURES|farme|aminoglycoside|AAC(3)-Ic|antibiotic inactivation|1
MGQNMEIDNFLKIERLAENDLPKFIQLIRLFEAVFEMKNFSIPDSEHLQKLLNQNNFYVF
VALLENKIVGGLTSYVLEQYYSEKPLAYIYDLAVDTNWQRQGIGKKLITATNQFYTEKGF
EEVFVQADKVDDYALDFYRSTKPTAEEQVVHFYYTLKN
>AIA14921.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAAAPRMASCRRCAKCAAFPLPGPARRRRTWPSTSSRRKDSRRIAGVPAPAGVALENLDA
AFAEYGRLIAKPARDGSSYGLIFVNAKQDLVAVRNAARTEEYLIEPFVAGVEATCGVLEQ
SDGTLMSLPPIEIVPGEGAFDYTAKYLLKSTQEICPGRFTPEITAQLQDQALRAHKALSC
SGYSRTDFIVSANGPIYLETNTLPGLTAASLYPKALKAQGIELPDFLRDQITLAERRSRE
RS
>AIA14911.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLAHVMNAGSDRGDRTGTGTRSVFGYQMRFDLSEGFPVLTTKKLHLRSIIHELL
WFLKGDTNIAYLKENGVSIWDEWADENGNLGPVYGAQWRSWPAPDGRQIDQVALLIESLK
VNPNSRRHIVSAWNPALVDDMALPPCHCLFQFYVADGKLSCQLYQRSADIFLGVPFNIAS
YALLTMMVAQVTGLKPGDFVHTLGDAHIYANHFEQAKLQMTRTPKPLPTMRLNPDVTSLF
DFTFEDFTLENYEADASIKAPIAV
>AIA14883.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVKHVLEHGNEKGDRTGTGTKSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELL
WFLNGDTNIKYLNDNGVRIWDDWADENGNLGPVYGAQWRNWDGREIDQITELIDTLKANP
NSRRMLVSAWNPRVLPDTSQSFADNVADGKVALPPCHAFFQFYVADGKLSCQLYQRSADI
FLGVPFNIASYALLTLMIAQVCGYQPGDFIHTFGDAHIYNNHMEQLELQLSREPRPLPKM
TLNPEVKNIFDFTFEDFTLTEYDPHPHIKGVVAV
>AIA14816.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEQYLKLLQHIIDQGSVKTDRTGTGTTSCFGAQLRFNLQEGFPLVTTKKLHLKSIIYELL
WFLNGDTNIKYLKDHGVSIWNEWADENGELGPVYGKQWRSWETKDGRVIDQITEAVKTIK
NNPDSRRIIVNAWNVGDLPQMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YAILTMMMAQVCDLEPGDFVHTFGDVHLYSNHIEQAKLQLSRQPFELPTLKINPAVKDIF
GFKFEDFEVLNYQHHPHIKAPVAI
>AIA14787.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLETEKSMSRSEISTTPKRTAELEELLIDAEADDEQVQQSHPLVRRPWLLLLGLILVAL
NLRPALSSMAPLLSDVSKSLGLSAAQAGLLTTLPVLCLGLFAPLAPILARRFGAERVVLG
ILLTLAGGIILRSNFGEIGLFAGSVLGGASIGIIGVLLPGIVKRDFAKHAGTMTGVYTMA
LCLGAAMAAGSSVPLSEHFGHSWAMGLGFWVIPALVAAVFWLPQVGQKHGAHNVAYRVRG
LLRDPLAWQVTLYMGLQSSLAYIVFGWLPSILIGRGLTPTQAGLVLSGSVIIQLASSLAA
PWLATRGKDQRLAIVVVMALTLGGLFGCLYAPIEGLWGWAILLGLGQGGTFSLALTLIVL
RSRDSHVAANLSSMSQGFGYTLASMGPFAVGVVHDWTGGWNAVGWIFGIIGTGAIIAGLG
AGRALYVQVQSERI
>AIA14775.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRDIKDNGVKKEDRTGTGTVSVFGRQVRYNLNDGFPAVTTKKLYFNSVVHELL
WFLQGTGNIEYLARNNVHIWDEWPYKAYLQKNNLPVPSSDSAEWKTGIKEFIARIASDHE
FAEQWGDLGPVYGVQWRKWPDGKGGYIDQIATAIDTIKHNPSSRRIIVSAWNVAEIDEIV
SIGGLPPCHSLFQFNVADGKLDLHLYQRSADTFLGVPFNIASYSLLLAMIAQVTGLKPGE
FVHTLADAHIYLNHFDQVDEQLSRTPKELPHLWLNPDVTSIDKFTFEDIRLEGYDPYPPI
KAPIAV
>AIA14754.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSFESQSPLNGDKNSSFLSILSEAVWGTERDLTAGSLGTAIFVLAVPMIIEMFAESLFAL
VDIFFVSHLGAGAIAVVGITESMMFLIYSIAIGVSIGATATVARRIGEKDPHGAAQAATH
SIYLGVAASIVLGLIGAIFAPTFLHWMGADADVVAQGTTFTRIMLGGNIVVMLLFLLNAI
FRGTGDAAIAMRVLWFANILNMILGPCFIFGVSFFPELGVTGAAVGTVIGRGAGAAYAAY
CLFLKNTRFEIRREHWTIDTKKLWKLVNVSAPAVFQFFVQTASWIGLVRVMTGFGTTAVA
GYQIAIRMVMFALLPSIGLANAAATLVGQNLGAERPDRAEQAVWRACLYNAIVQTAIGLL
FVIFSGTVAGVFTSDPEVHRYASDALRIIAYGFLFYAVGMVLETAFNGAGDTWTPTYLAL
GIFWVFEIPLAYVLSYNVGMGPYGVFWSITIAFSVLAVVAALLFRRGKWKHKDV
>AIA14602.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFD
DGEVLVDGHNVKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQ
ELLEEFNLLDAAERPAKTYSGGMRRRLDLAVSLISTPPIIFLDEPTTGLDPRSRIAMWDI
IKRLMENGTTILLTTQYLEEADQLADRIVVIDGGKVIAEGTANELKGKVGNDRLELTFKD
AKVREQATKILGNSVVSSDEKEHSVTVVIQDTNKDVKDTLELLSQKQLTLTSMAIHKPTL
DDVFLSLTGKQKQAAEEQA
>AIA14581.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTATLRPARPDDVPVIVDLIRGLARYEKLEDNVAATEDGIRSALFGPSPRVFCDLAEADG
QVAGFALWFYTFSTFVGRHGIYLEDLFVRAEFRGQGIGKALIRNLARRCAVENLGRFEWS
VLDWNQPAIQFYRSQGARLLDDWIICRVEGEALQALGGAA
>AIA14579.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDIIDNGVDKNDRTGTGTRSVFGRQVRYNLADGFPAVTTKKLYFNSVVHELL
WFLKGTGNIEYLAQNNVHIWDEWPFKAYLEKNNLPMPEVNSDEWKSQMKEFIQKIATDHE
FALKWGDLGPVYGVQWRQWPDGKGGHIDQIANVVEMIKKSPDSRRMIVSAWNVAEIDEIV
EIGGLPPCHNLFQFYVANGKLSLHLYQRSADTFLGVPFNIASYSLLLAIIAQVTGLEQGE
FVHTLADTHIYSNHFEQVKEQLSRTPKELPTLWLNPDIKSIDDFTFDDVKLENYDPDPAI
KAPIAV
>AIA14580.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AIVVAFGKNHEIGADNDMPWSNSLKDDLKNFKELTSGSTIVVGRKTFDSFGGRPLANREN
IVVTRLNEEIDGALVAHSLDDAYKLATNDDIFIIGGGQVYADSINDMDILYITEVHASFN
NATVFFPQIDESLWLEVSREHHAADERNKYDFDFVKYERVSK
>AIA14515.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MNARAYESLKSNVAPSDFGRVAVLYGGTSAEREVSLKSGAQVLGALQAAGVNAFGIDVGP
DLLQILLREKIDRAFIILHGRGGEDGSMQGLLECLNIPYTGSGILASALAMDKLRTKQVW
QSQGISTPRHAVLASEEDCVNAVTELGLPLIVKPTHEGSSIGMAKVTSSNELVSAWKDAS
AYDSQVLVEQWIDGPEFTVAVLRDQVLPAIALGTPHTFYDYDAKYLANDTQYRIPCGLSP
EKEEELMELSQRACAAIGISGWGRVDVMQDATGTFWLLEVNTAPGMTDHSLVPMAARAAG
LDFQQLVLSILTDSLQARG
>AIA14502.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQIIKAAVVLGLLSVIGPLAIDMYLPALPAIGADLGADVAQVQLTLMAYMAAIAVCQL
LYGPLSDMYGRKPPIYFGIGLYVVASLGAAWAPSIEWLTVFRFLQGVGACASMSLPRAIV
RDGYTGAQAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMAVVGVLSLLLLVF
GLKETRPKEARLESSLRGALSAYWKLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEH
YGLTPTLYSLAFSVNAVSFFAVSQATGFLVGRFGLPRVVRVAVTGYVTAMLALLALFLAG
FDSIWVLATLMFVAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTIQMVIASVVMGIVG
AFTDGTARPMVVAFAACAVAALVITLVTLRGSSRRNIAGAMAAPAE
>AIA14398.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MKKLFLAAIALASGLSAALAQDNPTIDKHMAAATKAAKADLLGALGLCKTATSQEATGFM
ENYTKMKAEPPLEPMQVMDDLYFLGNYWTSAWAVKTSKGIVILDALDNADEAKQYIEGGL
KKLKLDPSDIKYVIVSHAHGDHYGGAAYLKKKFDAKIVMSDIDWKVFDDPSFNPKRIPLF
DDPPKRDMAVKDGDTIKVGNTEFKLYVIPGHTLGTLATVVTVHDKGKSYRAVDWGGTAYN
FGPLADRLQIYADTTEKYRPIMKKEKAEVLLSNHVSYDNAVGKMGTLKERKPNQPNPFLV
GEDTVDRFLTVLGECALATKAYVEAGQPGKEKKDEPAAAAPAAEKK
>AIA14377.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLVSAWNPRVLPDTSQSFADNVADGKVALPPCHAFFQFYVADGKLSCQLYQRSADIFLGV
PFNIASYALLTLMIAQVCGYQPGDFIHTFGDAHIYNNHMEQLELQLSREPRPLPKMTLNP
EVKNIFDFTFEDFTLTEYDPHPHIKGVVAV
>AIA14331.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLELMRRVLETGADRGDRTGTGTRSVFGHQMRFDLADGFPMLTTKKLHLKSIVHELL
WFLRGDTNIAYLNDNGVSIWNEWADENGDLGPVYGYQWRSWPARDGRHIDQIENLLNGLR
RSPHSRRHIVSAWNPALVDEMALPPCHCLF
>AIA14249.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVRISIIAALGKNREIGKGSELLWYIPDDLKRFKALTLGHPCVMGRKTFESIVGMLKKPL
PGRQNIVITRDPAWQYESVITASSVQDALAKARELDQQEIFVIGGAQIYKAVLPMVDRLY
LTRIDASKDADKYFPAYEHIFTKKLAEESREHDGLKYTWVDLER
>AIA14220.1|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRASINDAARYDRRIIVERAVVGREIEVSLLGNDHPMASLPGEIITGHEFYDYEDKYVDT
TSRTEVPARLPKKILERIQRDAVKAFQAIDGSGLARVDFFVERETNRVIINEINTMPGFT
SISMYAKMWEASGISYAELIDRLIQLAIERHGDRSRNLTSYKPRQ
>AIA14215.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VAMGENRAIGRGGRLPWHLRSDMRYFREITMGKPVIMGRRTFRSLPRVLDGRLNIVLTRD
RGFVAPDAIMAHSLDEGLAAARDSAARTDAGEIMVIGGEDVFREVLPQAHRIYLTEVHAS
PEADTWFPDFDKREWREVFRERHEAGPRDEHAFSFVVLERTDGP
>AIA14207.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDQIAQLIQSLKQNPDSRRLIVNAWNVGEIDKMALAPCHCLFQFYVANGRLSCQLYQRSA
DVFLGVPFNIASYALLTQMIAQVTGLKCGEFIHTLGDAHLYLNHLEQAETQLKRTPFPLP
TMVLNPDITSIFDFRFEDFQLQNYQSHARIPAPVAI
>AIA14208.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MHISLIAAMTEKSIIGKDNQLPWHIPEDLKYFKQITLGKPVVMGRKTFESMRSKPLPNRH
NIILTTDLKFKSETCSVVHSISEAIKVVGQCEEMMVIGGATIYQQFLPLATRLYLSIVHE
NYDGDTYFPSITWDEWELKKENPGVLFTTKIYERRDSLR
>AIA14200.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MSDKKSEYVIRAKGLTKSYGDNHVLQGIDIDVRRGTMLALLGPNGAGKTTTVKILSTLLK
HDEGSVTIEGFDVQNEADKVRQVIGLTGQSAAVDELLTGRENLVMMGRLYRLTKASAKAR
AQELLEEFDLVEAAERPVKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRLAMW
DIINKLKQGGATILLTTQYLEEADQLADRIIVIDGGKVIAEGTAAELKSKVGKDRLELTF
DDAKAMQAARRALGKGVVDVDERENSVTTVINDTNQDVKRALELINGAGVSLRSMSVHQP
TLDDVFLSLTGKQKKTDTEKSEDK
>AIA14186.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLKERGVNIWNEWADESGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SNPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDFELSDYEPHPHIRAEVAV
>AIA14173.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MASKYAITVKNLKKSYGKTDVLKGVTFNVERGTMLALLGPNGAGKTTTVRIMSTLLKYDS
GSVTVEGIDVSKQSDAVRNVIGLTGQSAAVDELLTGRENLIMMGQLYRLTKASAVARATE
LLERFDLVKAADRPLKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWDII
NELKKEGTTILLTTQYLEEADQLADRIVVIDGGKVIAVGTAKELKAKIGNDRLELTFATD
KAYARALDVLGVSLIDQNHSERTVTVLIKDTDKDVERTLGRIHDAKLKIEAMAIHKPTLD
DVFLSVTGRAKQTKKEDK
>AIA14174.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MATALEFTKRPKVISLLNDSLLMIKRSSTHIIRNTDQLIGTFFQPIMFLILFTAVFNVVG
TSLPPGVTFINFLMAGIIIQTVSFGSTTTAIAVCSDLQKGIIDRFRSLPMSNIAVLNGHV
VSDVFRNGISTAVIVLAGLLFGFRSNASLIDWLAIAGIIVLFTLAFSWLAAIMGVLAKSV
EGVQWMSFVVVFPLTFASSAFVPADSMVSWLRPFAENQPLTHIIEAIRALMIGAPIGNHG
WLAFAWCVGILIVSIPLASYLFRRKTTS
>AIA14165.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MASKYAITVKNLKKSYGKTDVLKGVTFNVERGTMLALLGPNGAGKTTTVRIMSTLLKYDS
GSVTVEGIDVSKQSDAVRNVIGLTGQSAAVDELLTGRENLIMMGQLYRLTKASAVARATE
LLERFDLVKAADRPLKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWDII
NELKKEGTTILLTTQYLEEADQLADRIVVIDGGKVISEGTAKELKAKIGNDRLELTFATD
KAYARALDVLGVSLIDQNHSERTVTVLIKDTDKDVERTLGRIHDAKLKIEAMAIHKPTLD
DVFLSVTGRAKQTKKEDK
>AIA14162.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MSDKKSEYVIRAKGLTKSYGDNHVLQGIDIDVRRGTMLALLGPNGAGKTTTVKILSTLLK
HDEGSVTIEGFDVQNEADKVRQVIGLAGQSAAVDELLTGRENLVMMGRLYRLTKASAKAR
AQELLEEFDLVEAAERPVKTYSGGMRRRLDLAVSLIATPPVIFLDEPTTGLDPRSRLAMW
DIINKLKQGGATILLTTQYLEEADQLADRIIVIDGGKVIAEGTAAELKSKVGKDRLELTF
DDAKAMQAARRALGKEVVDVDERENSVTTVINDTNQDVKRALELINGAGVSLRSMSVHQP
TLDDVFLSLTGKQKKTDTEKSEDK
>AIA14157.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MRDMVVETERAGATKGTGEGFVSARINAVPPSGIRRFFDIAATMKDVITLGIGEPDFVTP
QPIVEAGVESLRAGHTSYTSNSGILELREGISRQLDKLYNVNYDPETELLVTVGVSEALL
LALMAVLETGDEVIVPEPCFVAYQPTVIFAGGTPVSVPTYVSQDFQVTVDDLEKARTPRT
RAVLLGYPNNPTGAVLERSRLAEIAEWAEKHDLLVVSDEIYDRLVYGIEHTCFSSLPGMW
ERTVVLGGFSKSYAMTGWRIGYAAAPPAILAAMRKIHQYVIMSAPTTGQEAAIEALKSAE
PYVESMREEYDRRRRTIVDGFNRLGLECFEPKGAFYAFPSIKSSGLSDQEFSERLIMEEK
VAMVPGSAFGQSGAGHVRASYATSLQNIEEALNRIEGFLKKLRA
>AIA14130.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNDEGNVDMSVTLIAAAASNGVIGSNNKLPWRLPAEMAYFKRETLHKPVVMGRKTFESLP
KPLSERTNVILSRTMPEAPEGCVLVRSVSEALEKYAGERLMVIGGADVYGQFLPFADRIL
LTEIDRRIEGDAYFPSFDRAVWKLVSRVPGTQDEKNPLPYAFCVYERADVE
>AIA14120.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MEGTSKAEIKQDTEKPRLEMSSRRRWAVTIGVMTGMFIAALEATVVGTAMPTVIATLGGL
NRYSWVFTAYIVTSTVTVPVWGKLSDLYGRRLLYQVGIGVFLLGTLLSGLSASMNQLIVF
RAIQGLGAGALIPLAMTIIGDIFTLKERARMQALFSGVWGLSSVIGPIIGGFITDNISWR
WVFFINLPIGVVAAIIIGFALKEPKLDEKPKIDYAGAAILMAAISLLMLAMVEGGTSIAT
LLAPLNLLLFGASVLLLAIFVWVEKRAADPIIPFALFSNRTVSVSVIAGFLAGFAMFGGI
SFIPLFAQGGLGATATEAGSLLTPLMLSWVIMSVIGGRVLLKIGYRTISIIGFIILSAGF
LMLTQFERTTPYFWLYFDLVLIGSGLGLTMLTLLIAVQQAVERTKLGIATSLNQFTRSIG
GAFGVAIMGAVLTAGLATQLHNVALSGTTSLTVAQAEVFASNPNALIDPEAKASLPPGTL
VILQDAMAAAIHPAFWVAAFISVLALIATFFLPRDRHDMYSEIHRTDGNAGERMIMAEQT
TINARNQPVAEGDSPG
>AIA14110.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLRPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYDPHPHIKAEVAV
>AIA14027.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGETNIKYLKERGVNIWNEWADESGDLGPVYGAQWRTWRACDGQTVDQISRVIEQIK
SDPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGRLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPLMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA14030.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAISLARERGEGELFVCGGAEIYAEMLEVADRMYLTLVH
ADSEADTFFPEWNSSEWIETESEHHAADEKNQYPFTFKVLARKSQV
>AIA13976.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SNPVSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLNPGEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13965.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KLANPDRTRRSHMKQYHDLLHSILEHGKEHQDRTGVGTISHFGYQTRFCLSEGFPIVTTK
KIPFRWVAEELFWFLSGDTNEASLRTRGVDIWKEWADLEHTSRFGRAAGDLGPVYGYLWR
SFGGHYPERDGVDQIARLIHNIEHEPNSRRLIVTGWDPAQSELVDLPPCHTLFQFKVEED
AKLIHCQLYQRSADAFLGVPFNISSYALLTHLIAHVCDLRVGDFIYTLGDYHIYQNHLTQ
VEELLAREPLPLPQLEIKDEDGRLRGLPGLLSFRYEHLNLIGYKSHSKIAAPVAV
>AIA13960.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGTKKGDRTGTGTLSTFGYQMRFNLSEGFPLLTTKKLHTKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SDPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13931.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDNGIKKDDRTHTGTLSTFGYQMRFNLGEGFPLLTTKKLHTKSIIYELL
WFLRGDTNIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQTK
STPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLKPAEFVHTLGDAHLYSNHLEQARLQLTREPRALPQMKINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13932.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGRSLPGRQT
IILSRNESFRPEGCLIARSVEDALRLAEDRGEGEAFICGGAEIYAQSLDKADRIYLTLVH
ADSGADTFFPAYNGDQWVERESEHHAADEKNQHAFTFKLLVKKAS
>AIA13918.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SDPDSRRLIVSAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDLELSDYEPHPHIRAEVAV
>AIA13919.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVMIIITRSES
IAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAETLGAADRLYLTLVHADCDADTF
FPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA13874.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRSESIAVEGCFIARSVEEAVGLARERGESELFICGGAEIYAETLGAADRLYLTLVH
ADCDADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA13865.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADAHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
SNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVSDLNPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQMKINPSVKSIF
EFDYSDFELSGYDPHPHIKAEVAV
>AIA13866.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
IIITRNESFAPEGCFSVHSISDAISFARERGESELFICGGAEIYAQTLGAADRLYLTLVH
ADCDADTFFPDWNSDEWIETESEHHTADEKNQYSFTFKVLERKHEA
>AIA13852.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHELLKHLLEHGARKEDRTGTGTLSVFGYQMRFNLQEGFPLLTTKKLHTRSIIYELL
WFLRGETNTAYLKENGVSIWDEWADEQGNLGPVYGYQWRSWPNPDGSHTDQITNLITGLK
KNPDSRRHIVSAWNPSFIDQMALPPCHCLFQFYVANGKLSCQLYQRSCDTFLGVPFNIAS
YALLTLMVAQVCGLQPGDFVWTGGDVHLYSNHLEQARLQLTRDLRPLPLMMINPEVKDIF
QFRFEDFTLLNYDPHPHIRAAVAV
>AIA13834.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLELMQHVLEHGTPKDDRTGTGTLSVFGYQMRFDLGAGFPLLTTKKLHVKSIIYELL
WFLRGDTNINYLQAHGVNIWNQWADETGDLGPVYGAQWRAWRAGDGRTIDQISQVIEQIK
TSPDSRRLIVNAWNVGELDKMRLAPCHLLFQFYVANGKLSCQLYQRSADIFLGVPFNIAS
YGLLTMMIAQVCNLEPGELVHTLGDAHLYANHLEQARLQLTRQARPLPQMQINPAVKSIF
DFDYADFELTGYEPHPHIKAEVAV
>AIA13829.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELL
WFLQGSTNVRYLREHGVTIWDEWADENGDLGPVYGRQWRAWPTPDGRHIDQIARVVESLK
RDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTQMMARVTGFEPGEFVHTFGDAHLYLTHLD
>AIA13823.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISFLVAMDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIVVGRKTFESIGKPLPGRQM
IIVTHSESFAPEGCFSVHSISDAISFARERGESELFVCGGAEIYAQMFGVADRMYLTLVH
ADSEADTFFPEWDSSEWIEVESEHRTADEKNQYPFTFKVLARKSQV
>AIA13811.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYNDVLKRIMDQGVDRQGRNAVTRALFVEQMRFKMSDGFPAMTTKRLAFKAVKSELLW
FLEGSNDDNRLKELNGSEKTIWTANAQASYWKPKAKFDGDLGRIYGVQWRSWLGPDGRVI
DQIAQAIDKIKNDPSNRRIIVSAWNPGEIDQMALPPCHMLFQFFVANGKLSLHMVQRSCD
MFLGVPFNIASYSLLLHMVAQVTGTTADECILTLNDAHIYHPHFDAVNEQLSREPMKLCS
LWLNPEIKDINDFTMDDIRLENYESHPTIPAEMIE
>AIA13807.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLMKHVLDGGTKKDDRTGTGTLSTFGYQMRFNLDEGFPLLTTKKLHIKSIIYELL
WFLRGDTSIKYLQEHGVNIWNEWADEHGDLGPVYGAQWRAWRASDGRTIDQISQVIEQIK
STPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIAS
YALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQMKINPSVKSIF
EFDYSDFELSDYEPHPHIRAEVAV
>AIA13771.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLMKHVLDSGARKDDRTGTGTLSVFGHQMRFDLSEGFPLLTTKKLHVKSIIYELL
WFLRGDTNIRYLKEKGVNIWNEWADESGDLGPVYGAQWRGWRAADGRVIDQISQVVEQIK
SNPDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIAS
YSLLTMMMAQVCGLKPGDFIHTLGDAHLYSNHLEQARLQLAREPRRLPQMRINPSVKSIF
EFDYSDFELSGYEPHPHIKAEVAV
>AIA13754.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MIGKSVSPITYHLSPITYHYFQECRLVKKLRVGVIFGGRSGEHEVSVRSARAVIDAMDAG
KYDVVPIAITKEGKWLSSAEATRLLPEETKRLLTDEVVSEERRPSILVGDVAGNGLVAQS
KDEPHAPVKQLDVVFPVLHGTYGEDGTIQGWLEMVGMPYVGCGVLASSCGMDKVTMKALF
REAGLPICNHTWFLRKAWDDDRQSILRRVAREVGFPCFVKPANLGSSVGVSRATDKASLE
QAIELAARYDRKIIIEEGLDAREIECAVMGNEAPQASLPGEYVVRDQAAAFLDYTEKYSN
TGHVEFVVPASLSKALIRRIQRMATRAFQAVDGTGLARVDFFLRRDTHELLINELNTMPG
LTDVSGFPKMWAASGIPFPQVIDRLIQLALEHHQEKSRNETSI
>AIA13725.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|1
MLHCFINGVETLDGFIAEDKTQISTSWNSKEDKKRFVEITKRAGVVVMGSSTYETFMRPL
KDRLNIIYSRSKKFEGVEMTNDLPEILLQKLEARGFKEVAICGGASIYTKFLKAGVVDTL
YLTIEPVIFGQGVKFFNENLNLKLSLVSEEKTPSGALFLEYKVLK
>AIA13685.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRERGHQVTALDPARGVITQAEERELSTGKVGT
KPPSLESLSKVAEGAFLPNLTSMKEIRSADVVFLALHGGQGEDGTIQALLDMAHVRYTGS
GHLSSALAMDKDLSKKLFRAEDVKTADWLMAPVEIEQVEGILGLPVIVKPSKQGSTVGLS
IVKKREELLPAIEEASKYDDEVMIERFVPGRELTVGVLGDVALPVGEIISKHEIYDYECK
YTPGMAREEFPAKLSPEATARVQQQALDGFKALKLRGYARIDFRLTEEGEFYCLEANTLP
GMTELSLIPQGAAAMGISFPDLCERIVKLALA
>AIA13668.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPKDID
LAFLAIHGTFGEDGQLQQILENRGVPYTGDGVEQSRTAFDKIESKKRFEAAGITTPRWQV
IDANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETVLAEARKFDRQLLVEEFVPGREL
TIGILGDQALPILEILRSFPKAAFTISPTSIHFSTRKPAAARNMFVRRKLKRN
>AIA13596.1|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKTREELPKKIAVLMGGPGSERAVSLATGRGVAKALRSLGAEVVEVDVRSDEFQLPNDVD
FAFNTIHGTFGEDGQLQKILERRGIAYTGDGVSASEIAFDKIRTKQKFQEHGVTTPPWEV
INPGQQPTIPLPIVVKTPRQGSTVGVVIVKNENELESAIGEASKYDRELLIEKFVSGREL
TIGILGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGGAEHVCPANINAGKTKEIQELAL
RAFRSAGLQVYARVDAILSENGQPHILEINSIPGMTEASLLPEAAAAAGIGYADLCARII
ALSRLRQGYGGQARARTEGKR
>AIA13571.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAQESKVSLIAAIATSNRAIGKDGKLLWNLKEDMERFKTLTAGHPVIMGRKTWESIPEKY
RPLPGRTNIVITRTRDYAAPGAVLAQTFPEALSLAKDAEGNDEIFAIGGQRVYECALPFA
SRMYLTLVERDFEGDAFFPSYPDFTKEVACEKKSEGDMHYTFVTLERTES
>AIA13437.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLSTGVVKDDRTGTGTISTFGYQMRFDLAAGFPLLTTKKLHTKSIVAELL
WFLRGSTNVAWLREQGVTIWDEWADDNGELGPIYGYQWRSWPTPAGEHVDQIKTVIDAIK
TNPNSRRHVVSAWNVADLGTMALPPCHTMFQFYVAEGRLSCQLYQRSADIFLGVPFNIAS
YALLTALVAQVCDLEVGDFVHTLGDAHLYQNHVDQAKRQLEREPRSLPKLVLNPDVRDID
GFTLADIGIESYDPHPGIKAPIAV
>AIA13438.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQELVGIAAVARNGVIGSDGDIPWRIREDWQRFKAVTMGSVLIMGRKTYDSIGRPLPGRT
TIVVTRDRRWRGDGVRVAPTVDEAFELASSLAPTGTVFVAGGGEIYRESWPRLDRLEITE
VDAEPKGNVTLPAISVDDWEETVRDPHEGFAFVSYRRRLR
>AIA13358.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|0
MLLEIKNLHAGIDGKEILKGLNLQVDKGEVHAIMGPNGSGKSTLAKVLAGHPSYEVLQGE
VVYEGKDLLGLEPDERAKEGIFMAFQYPVEVPGVSNSQFLRLAYNEKMKHLGEEELDPLE
FNDYLKEKAKVVDMSPEFFKRSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDID
ALRIVAEGVNKLRSADKAIILVTHYQRLLNYIEPDFVHVLADGKIVKEGGKELALELEEK
GYDWVKAAVK
>AIA13336.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKRVGIIFGGRSAEHEVSLQLAMSIIANIDNEKYEVVPIGITKTGQWALVPGPQNLIDT
EQPKPLEVNDDNDKPGVLVRGQAATLTEAVDPLKVLSSVDVVFPVLHGPYGEDGTIQGML
KVANIPFVGPSVLGSAVAMDKDVMKRLFKASGVPTPKLLVFHKADEDSIQFSKISAELGT
LVFVKPANLGSSVGVSKVTNEEQLKRAVDEAFKYDTKILIEEGIDGREIECSVLGNENPI
ASVPGEIVVHADFYSYDAKYLNETSSSLIIPAELSPELTKKVQDLSIAAFEALCCEGMAR
VDFFLRGKELLVNEVNTIPGFTKISMYPKLWEASGMPYSELIDRLIELAIARFEQDIFKV
>AIA13333.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVSAWNVGELDKMKLPPCHAFFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTMMI
AQVCDLEAGEFVHTLGDAHIYSNHFEQVALQLSRDTRSLPEMKLNPSVKNIFDFKFEDFS
LLNYDPHPVIKAPIAI
>AIA13325.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKEMNALPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPRDID
LAFLAIHGTFGEDGQLQQILENRGVPYTGDGVKESWTAFDKIESKKKFEAAGVTTPRWQV
IGANEKPTLPVPLVIKAPRQGSTVGVYIIKEAGKLETALAEARKFDRQLLVEEFVPGREL
TIGILGDQALPILEIIPKGGFYDFTNKYPFLNPQAGGGAEHVCPAKIEAKLTRKIQDLAL
RAYRSLGLQVYSRVDVLLPENAEPSVLEVNTIPGMTEASLLPEAAAAAGIKYDELCLRII
ELSCARREGAK
>AIA13253.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MNQDMKHIQPNNGDWAVEAQGLVKIFGDNRAVDGVDLKVRAGTIYGVLGPNGAGKTTTIR
MLATLLRPDAGSARIFGHDVQKESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLG
RAESRRKAAELLEEFGLTEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDP
RTRSQMWDTIRRLVKTGSTVVLTTQYLDEADQLADRIAVIDVGRVVAEGTVDELKASVGT
SSLHLRVQDSQDIEKARRTIEQVLKVPSSVTSELAKITAPMADADLVTDLLIALRAEGIH
LTEMSVQKPTLDEVFLTITGKGVKQDEVQESEEWNKKEVARV
>AIA13212.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIAIVAVDKNLAIGKGGVIPWHYSADMKFFRRQTTGHACVMGYRTWESLGKPLKGRLN
IVLSRKNTVDGQPEVIHFTDINSVLSLAEYLRCDLYVIGGAQIYKAFSERIDRWLVTEVP
EPAEGADTFLNADFLSGFTANGVEVLEGGLKVTTYERYDGNSD
>AIA13171.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MILSSIAAMAKNRVIGKDNKLPWSIPEDMKFFREKTKGHVMIMGRKTFESLEKPLPNRFH
IVITRNQSYDYHDPMVEVVSGMPQALELSHMLLKKFSQRFGDEVFIIGGAEIYKQSMDLI
NRLYLTVIEKDFEGDAYFPEFDEKELKLVKKEDRSEPIPFSFRVYER
>AIA13159.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFRPEGCLIARSVEDAVRLAEDRGESEAFICGGAEIYAQSLDKADRIYLTLVH
ADSDADTFFPEYNGDQWIERESEHHDADEKNQYPFTFKLLVKKASLDDRAKDQTA
>AIA13025.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYLDLLQDILDNGTDKNDRTGTGTRSVFGRQVRYNLAEGFPAVTTKKLYFNSVVHELL
WFLQGTGNIEYLAQNNVHIWDEWPFKAYLQKNNLPIPEVNSDEWKTQQKDFITKVATDHT
FAEQWGDLGPVYGVQLRKWPDGKGGYIDQIANAINMIKTTPDSRRIIVSAWNVAETDEIV
AMGGLPPCHSLFQFYVANGKLSLHLYQRSADTFLGVPFNIASYSLLLAMVAQVTGLKQGE
FVHTLADTHIYSNHFDQVKEQLSRTPKALPTLWLNPDVKNLDDFTFDDIRLDNYDPDPPI
KAPIAV
>AIA13000.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKVFLIAAISADGFIARETNEVADWTSKEDKKLFVELTKRAGVMVMGRTTFETIGHALPG
RKTIVYTHRDVEIEDVEVTDDAPANLVHRLHTEGYKEVAICGGSAMYTQFMQAGVVDELY
LTIEPVLFGSGVPLFAGQLETRMQLIESRSLNDNVVLMHYEVEK
>AIA12992.1|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MAKLKVGILFGGKSGEHEVSIVSALSIYQALDKSKYDPTLIGIDKTGRWLLPDQSRILAE
RQNARLIKLNKEHQTVSLLPFDTDKNLVPVVEDAVPTAQRGLHFDVILPILHGTYGEDGT
VQGLLELANLPYIGSGVLGSAVSMDKETAKRLLRDAGIPVVPFMTVHRNDFKKQAANILA
EAKRRFGLPYFVKPANMGSSVGVNKVKTEAEALAKFEDALLYDTKVLVEQAIDARELEVS
VLGNHDPQASIVGEIIPNHEFYTYEAKYLDENGADLAIPARDLSAATTKRVQEVAIAGFR
ALECAGLARVDFFLDRKTSEIYLNEVNTIPGFTQISMYPKLWAASGLPYPQLLDRLIELA
LERHREKNSLKTTYEPK
>AIA12974.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MKITGLMACDPSGLIGKNGWIPWYYPKEFEHFKLTIGSSPLVMGSKTFESLPENILRDRM
SIVFSHNGSNARGHDVTFISSLDEFLTLGIGEEIFMIGGAEVAHLFLKNKMIKKFILTKI
KKAYDGDAFLDISLLDGFDKELIEDAPDYAIYRYRALS
>AIA12952.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKKISLVVAMSENGVIGHDNKLPWHLPNDLKHFKSLTLGKPIIMGRKTYESIGRPLPDRQ
NIVVTHQKDFSAPGCEVVHSVEEALKLTQDAPEAMVIGGGEIYRLFLSSANRIYQTIVHT
EIQGETTFAAIDKKTWEETAHEEYFQDAKHAYDYSFVTLERRE
>AIA12953.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQQYLSLLKWVLEKGAPKSDRTGTGTVSVFGHQMRFDLNAGFPLVTTKKCHLKSIIHELL
WFIKGDTNIGYLKENGVKIWDEWADENGNLGPVYGKQWRSWPTHKGETVDQLAKVIEDIR
TNPDSRRLIVSAWNVADIPDMALAPCHCLFQFYVVNGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVTGLQLGEFVHTFGDVHLYSNHIEQAKTQLERTPFALPKMLLNPDIKHIN
DFRFEDFVLTDYESHPAIKAPIAV
>AIA12926.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MKDKVMTASFYRPAIILGLLSAIGPFAIDMYLPALPAIGRDLGSDTAVTQLSLLAFFISF
ALSQLVYGPLSDMWGRKLPLYLGIGIFALASIGCALATDIETLIAFRFLQGIGGAAGMVI
PRAVVRDMHTGVEAARLMSLLMLVFSISPILAPLSGSAVIEFYGWRGVFWAVMIAALIGL
VLLATQMKETRPVEQRRESSIKAAMSAYGLLLRDKNFLTLTFIGGLGISSFLVYLANSPF
VLIEHYGLTPAQYSIAFSINAVSFFSVSQLTGFFGARYGLVRVMRVAVTAFALTMVVMAA
VMASGFDSLPVMAVFLFIGYGFLGLVIPTSAVLALEEHGEIAGTASSLMGTLHFVAAAFA
MVLVSTVFDGTALPMVAGIALVAALAFILTQVTIGRRAAAVSAAE
>AIA12799.1|FEATURES|farme|multidrug|MepA|antibiotic efflux|0
MSNEADVSREETHDNSFWAVVNEGLRGSTRDFTKGPILVALIILAIPMILEMSMESLFAI
VDIFFVGKLGAEAITIVALTEAIMALIYAVAFGLAIGATATVARRMGEKDEKEAARTAAH
VIYLGMIISAVISVIGIILAPRLLGWLGGSPEVVRDGTLFMRIMIGGNAAVLFIFLLNAI
FRGAGDAAIAMRVLILANGLNIVLSPLFIFGVGFFPELGVTGAAVGTTTGRSCGVLYAAW
HLFRPGGRIHVSSESWKLDPSLLWKLLRLSSTGMLQMLIATASWSVLIPIIAGFGEVAIA
GYQIALRVVVFVLLPALGLANAAATMMGQNLGAGKPERAERAVWTAAGINMAVYFVMGVI
LWLFSGQIVSIFTNDPEVFAYGAACLHTVAYGFAFYGAGMALETAFNGAGDTWTPTLINV
VIFWMVEIPLAYLLAYYFGWGPSGVFWSITISFSLLAIMSALLFRRNKWKEKMV
>AIA12777.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSDTITNFGKVGVLFGGRSAERDVSIMSGTGVLQALKSRGIDAHGFDPAERSLAELAAEN
FDCVFIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLSKNIPTPRY
ATVAPGDDLDAIVLDLGLPLIVKPPLEGSTIGITKVEAAEQFEAAVALALGFDETVLAEE
FVTGREFTVAVLGTGKHARALPIVEIVAPQGNYDYQNKYFTDDTKYLCPAPLDAALSAEI
QKHAVDAYRALGCEGWGRVDVLVRESDMRPFLLEVNTSPGMTSHSLVPMAARAEGISYEE
LCVEILRSARCKMVKAQG
>AIA12759.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MSKNSAVSSAVAQSPTLSMSVRRRWAVTAGVLTGMFLAALEATVVGTAMPTVISSLGGLN
HYSWVFSAYLITSTVTVPVWGKLSDIYGRRMLYQVGIAIFLIGSALSGMSVSMTQLIIFR
AIQGLGAGALVPLGMTIIGDIYTVAERAKMQALFSGVWGLSSVVGPVVGGFITDQLSWRW
VFYINLPVGLAAALIIGIALKEPKLTERPKIDYAGAALLMAAITLLMLALVEGGASLTTL
LSFRNVALLTGAALMTALFVWVERRAADPVVPFKLFRNRVVTVAVIAGFLAGVAMFGAIS
YVPLFAQGALGATATQAGSLLTPLMLSWVGMSVISGRLLLKVGYRPTTIAGFALLTLGFV
FLSTFQREMARVWLYVDLVLIGAGLGMTMLTLLIAVQQAVSRTQLGIATSLNQFSRSIGG
AIGVAVMGAVLSAGLASQLNNLARGGNTALTPESAAELSANPNALIDPHARAALPANVLD
ALQGAMAAATHNVFWVGTVLAGLALLVSFYMPRSGHDATAPLTEDECSAETGERMVMAEL
TTIDPEHEPSASPGD
>AIA12662.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MAKTTATAFKPQKHSELYWAFSNCATLIVRSTKHIIKNPDQLMSVAFQPIMFMLLFRYVF
GGAINTGGTTYVNFLVAGILIQSAAFGASYTALGIATDMQRGIVDRFKSLPMLPSAVLVG
HTVADLIRNTVSSIIMILVGLAVGFRPVANVWEWTLVFGILLLFTFAMSWLSSIMGLLAK
SVEAVQWMTFVFVFPLTFASSAFVPTDGMPKYLRIFAENQPVTQVIEAIRALLVGTPIGN
YGWNALAWCLGILIISIPVSAHLFRTRSPN
>AIA12576.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNNPTDQQYHNLLRHIMENGTGKDDRTGTGTRSIFGYQMRFNLAEGFPLITTKKVHLKSI
IYELLWFLKGDTNIKWLNDHGVTIWAEWADENGDLGPIYGKQWTAWEANDGSKINQIAVA
EEKIKTNPKDRRIIVSGWNVGDLQSLIKAEKAAPPPCHTMFQFYVADNKLSCQLYQRSAD
VFLGVPFNIASYALLTMMMAQVTGRELGDFVHTFGDAHIYNNHVDQVELQLSRDSRPMPT
MKINPDVKSIFDFQFEDFTLENYDPHPGIKAPIAI
>AIA12460.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNDIKTNPNSRRLIVTGWDPRYADQVDLPPCHTLFHFKVQNERVLHCQLYQRSADAFLGV
PFNISSYALLTHLVAHVSGLEVGEFVYTLGDYHIYKNHLTQVEELLSRQPLSLPTLQIND
GDAPLRGLEGLLSARYENLALVGYESHGKIAAPVAV
>AIA12430.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
FPLLTTKKVYWKGVIQELYWFMSGQTNIKYLVDNNVHIWDDYPYKIYKQKINVIASKAKQ
SHKIESSIKDRRVAHAPRDDKSREMTKEEFIEKIKNDAAFAKKWGELPKIYGEMWRSWPT
RKGGKIDQLGWVLKELKEDPDARNLLVTSWNPEYLYTMAAHEDASRFPICHNMYQVSQKD
GKLYLQLYQRSADLFLGVPFNIASYSLLLLILCKITGYKPGEFVHTFGDAHIYANHIEQV
KEQLKRKPKPFPKVVIDKSVKKLADFRPDLVTLEDYDPYPTLKGELTIAGGLYEKSVKST
RNG
>AIA12329.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VGTISHFGYQTRFDLRQGFPIVTTKKIPFRWVAEELFWFLSGDTNEANLRARGVDIWDEW
ADEEHTSRFQRSAGDLGPVYGYLWRSFGGDYPKRNGVDQIANLINEIQTRPNSRRLIVTG
WDPRQADNVDLPPCHTLFQFKVENESVLHCQLYQRSADAFLGVPFNISSYALLMHLVAHV
CKLEVGEFVYTLGDYHIYQNHLAQVEELLQREPYPLPQLEIAGEGERKQGLDGLLAMRYE
DIKLVGYQS
>AIA12309.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTDTRHPEYQYLDLLQDILDNGVEKKDHNTGNSLTSVFGRQIRFELSQGFPLLTTKKVYW
NGVLHELVWFMTGQSNIKYLLDNNVHIWDDYPYKDYQKLVADGKAEDLSKDDFISRIKED
DTFAKQYGELPHIYGQQWRNWPRTNGGGIDQLAWALNNIKEFPQRKHSVVSVWNPEHLYS
MALPGEALSFPLCHIFFHFNVADGKLSCQLYQRSADMFLGVPFNIGSYSMLTLVMAHLAG
LQPGEFVHTFGDAHIYGNHVEQVKEQLKREPRPFPTLAISDELQDLDSAKAEHFSLENYD
PHDTIKAELTVAGGFQEKDRRDFAKPSKS
>AIA12229.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIVSQLVAMDERRGIGKQGRLPWRLSADLKRFRQLTMGHHIVVGRKTYESIGKPLAGRQM
IIVTRDADYKAAGCFTAHSITEAIELARARGEAELFICGGTEVYAQTLDLTERIYLTQVH
ADCDADTFFPEFNCDDWLETASERHAADEKNEYPFTFLVLVRKRAG
>AIA12221.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIVSLLVAMDEKRGIGKDGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGREM
IIVTRGESFAPEGCFIARSVEDAILFARDRGESELFICGGAEIYAQTLGAADRIYLTLVH
ADCDADTFFPECNSDEWVEQASERHSADEKNQHPFTFKVLARK
>AIA12137.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSADLKRFKALTMGSAMVMGRKTFESLPGLLPGRRHIVLTSNPSWTANGAEVARDVESAL
RLAGDDRVSVIGGAEIFSLFMPRADRIELTEVLEDVPGDTFMPDPRAGRDWNISEQSVAT
TADGLPFRFVTLDKV
>AIA12103.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYQDALRQILADGVRHEDRTGVGTTSVFGEVQMSFDLEKNFPIMTTKKVPLRWIFEEL
MWFLGGRTDNQWLNERKISIWDEWSTVEQTARFGRKEGDLGPVYGYLWRSFGGHYPEMDG
SDQIARLMRDLKENPNSRRHLVSGWDPRVADEVALPPCHTLFQFKVEQINNEQYLSCKLY
QRSADFFLGVPFNISSYALLTCMIAHIMGMKPRKFIHTFGDAHIYSNHHAAVDELLARTP
LDLPNLEFVNTEHLVGKGLEGLLGFKWEN
>AIA12099.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRGVEKGDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTRSIIGELLWFIQGSTNVKWL
HEQGVTIWDEWADADGELGPIYGYQWRSWPTPTGGHIDQLASVISSIKAVPDSRRHMVSA
WNVADLGDMALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTHMVAQVC
ELEVGDFVHTLGDAHLYLNHLDQARMQLGREPRPLPKLVLNPSVRSNRRLQL
>AIA12032.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSVAGPLQEGKNLREITIVVARAENGVIGKDGKLPWHLPADLKHFKAVTSGAPMIMGRKT
FESLPGLLPGRRHIVITRDPDWQAEGAEVAHSADEALSLAGNDRVSVIGGAEIIRLFEPH
ATAWELTKLHFDADGNTLLEAPNALWQEISREDHPAEDGRPAYTFVRLERA
>AIA12024.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MTESKYVIEAQNLTKSYGKTEVLKGINLSVKRGTMLALLGPNGAGKTTTVRILSTLLPFN
GGTVTVEGHDVAADADNVRRVIGLTGQSAAVDELLTGRENLVMMGRLYRLTHASAKARAQ
ELLEQFDLLDAAERPAKTYSGGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWSI
IKDLKAAGTTILLTTQYLEEADQLADRIAVIDGGVVIAEGTADELKSKVGKDRLELTFEN
EESLQRATKVLDGAATASTDESFTLMLVIQNIDKDVKDTLTKLATAGVSVTALAVHKPTL
DDVFLSLTGKQKATEPDAQAEEK
>AIA12001.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEPYHQLMREILAHGARKEDRTGTGTLSLFGYQMRFDLQKGFPLVSTKKLHLRSIIHELL
WFLKGDTNIQYLKENKVGIWDEWADENGNLGPVYGKQWRSWEAADGRTIDQISNVIEQIK
KNPDSRRLLVIAFNPGDVDKMALPPCHAFFQFYVANGKLSCQLYQRSADVFLGVPFNIAS
YALLTHMVAQVCNLEVGVTLGDAHLYLNHLEQTKLQLTREHKAMPQLKLNPNIKNIFDFK
FEDIEIVGYEAHPAIKAEVAV
>AIA11984.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDALRQILADGVRHEDRTGVGTTSVFGEVQMSFDLEKNFPIMTTKKVPLRWIFEEL
MWFLGGRTDNQWLNERKISIWDEWSTVEQTARFGRKEGDLGPVYGYLWRSFGGDYPKRNG
VDQIANLINEIQTRPNSRRLIVTGWDPRQADNVDLPPCHTLFQFKVENESVLHLSALSAI
R
>AIA11941.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MHQYLDLLARIRNTGTRKDDRTNTGTLSIFGHQMRFDLAEGFPLVTTKKLHVKSIIHELL
WFLQGSTNVRYLREHGVTIWDEWADENGDLGPVYGRQWRAWPTPDGRHIDQIARVVESLK
RDPDSRRHIVSAWNVGELDKMALSPCHCLFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTQMMARVTGFEPGEFVHTFGDAHLYLTHLDQADEQLKRSPRALPRMEINPEVRSLF
DFAYEDFKLAGYDPHPAISAKVAV
>AIA11927.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNVFLIAAISADGFIARDAHQPANWTSKEDKKVFVELTKRARVMIMGRNTFETIGRALPG
RRNIVYSSKPIDVEGIEVTNEKPTTLLEKLENEGYQEVAICGGQKIYDLFLAEGLVNTLY
LTLEPKLFGNGLSIAKTSVDVDLHLKDVSKLNDDTLLLEYEVQNGSNPS
>AIA11889.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MSIIGIVAVDRKGAIGKGGQLPWHYSADMKFFKETTTGHACVMGHKTWLTLKKPLPNRLN
IVLSRQSQIEAQELVAVHRNVESVLALSRDLKSDLFVIGGSKIYRAFLPYIEKWIVTEVP
LTVEGADTFVPANYLEGFHRVGSKELGEGLVVRYYDRSEA
>AIA11858.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLRSILANGNEHRDRTGVGTISHFGYQTRFDLRQGFPIVTTKKIPFRWVAEELF
WFLSGDTNEANLRARGVDIWAEWADEEHTSRFQRSAGDLGPVLWLSVAVFWRRLSEAQRR
GSNCEPHQRKIQTRPNSRRLIVTGW
>AIA11835.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKTYLDLLDHVLTRGAEKSDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTRSIIGELL
WFIQGSTNVKWLHEQGVTIWDEWADADGELGPIYGYQWRSWPTPAGAHVDQLAGVINSIK
AAPDSRRHIVSAWNVADLADMALPPCHTMFQFYVAQGRLSCQLYQRSADIFLGVPFNIAS
YALLTHLVAQVCDLEVGDFVHTLGDAHLYLNHLDQARLQLGREPRALPKLLLNTGVSSID
EFGFNDIAIEGYDPHPGIKAPIAV
>AIA11759.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAIIGIVAVDRNGAIGKGGSIPWHYSADLKFFKEQTTGHACVMGRRTWLSLKRPLKERLN
TVLSRSPDAGAGQEGILALPDKRSVLALAPYLSCNLYVIGGEQIYRTFQNEIERWIVTEI
PLSVEGADTFMPQDFLRNFKPHRSISLADELKVIFYERTSAYNSED
>AIA11746.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTPRRYFLFILILGTLSAIGPFSIDMYLPGFPAIAADLNTSVARVTLSLSSFFIGISAGQ
LLYGPLLDRFGRKKPLYFGLSLYVLASIGCALATTVDTLIVLRFFQALGGCAGMVASRAM
VRDLFPVEENARVLALLMLVIGVSPLIAPTTGGYVSAAFGWHYIFIILTVIGAAILAGVH
FVLPETANAGRVFFS
>AIA11677.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TIKTSGVRTMKQYLDLMKHVLDHGTKKDDRTGTGTLSTFGHQMRFNLGEGFPLLTTKKLH
TKSIIYELLWFLRGDTNIGYLKEHGVNIWNEWADERGDLGPVYGAQWRTWRACDGRTIDQ
ISQVIEQIKSNPDSRRLIVNAWNVGELSKMRLAPCHLLFQFYVAGGHLSCQLYQRSADIF
LGVPFNIASYALLTMMIAQVSDLRPGEFVHTLGDAHLYSNHLEQARLQLAREPRALPQM
>AIA11487.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MHSSLFRTALVLGLLSAIGPFSIDMYLPALPQIAEGLSVTETDVQMTITLYFLAFGVSQF
LWGPMADAYGRKLPLVLGILIFAVGAVGCAFAPTIGWLVAARFVQGIGGAAVGVVPRAII
RDRFTGLEATRLMAMVMLVISVSPMLAPLAGSVVLQFGGWRVIFGVLVLVAAMSLLVTLF
ALPETLARQDRFPVNLRSMGSGCRRLLGSFSFMGLTLVGAFGFGSFFVFIASASFVYTET
FGLTPTQFSLAFALNALGFFAASQAAAPLGMRFGMVRVMRIALWGFAAANVLLLALTLGG
AGTLPVLMACLFVGNAFMGLVMPVTFVMALEEHGDIAGLASSLGGTIQMVTGSILVAATA
PFFDGSALPMVATICFCAVAALVVGLAVLRRGIQMAPAPAAAE
>AIA11390.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDENRGIGIDNKLPWRLPEDLAFFRRTTSGHTVLMGRKTFESIGKPLPKRHNVILTRDAQ
FQAEGCEVIHSTDDFVHKYGAGAQEELFVIGGAEVYKQLLPYADRLYITEIAHTFHVDTY
LESLDLTQWVEVSRVKGLRNEANPYDYDFVLYERKA
>AIA11302.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQLLGRQQREAFAEIEAHLVAKCAERASASPIVREGFPLLTTKKLHTRSIIGELLWFIQG
STNVKWLHEQGVTIWDEWADERGDLGPVYGAQWREWRAAGAADGRVIDQISQVVEQIKSN
PDSRRLIVSAWNVGELDRMALMPCHLLFQFYVAGGKLSCQLYQRSADIFLGLPFNIASYS
LLTMMMAQICGLKPGDFIHTLGDAHLYSNHLEQACLQLAREPRRLPQMRINPSVKSIFDV
G
>AIA11228.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSQEKRKLRIGVIFGGRSGEHEVSIRSARSVIEAIDKSKYDVVPIAITKEGNWLGPAAAV
KLLPEDTQRKLSINAQKQSTEDVAILGDPSRRGLMRLDSSDQSRDKLDVVFPVLHGTYGE
DGTLQGLLEMAAMPLVGCGTLASACGMDKVTMKALFKEADLPICAYTWFLRSSWEDDPDK
ITRRVMREIGFPCFVKPANLGSSVGVSKATDKASFARAADLAARYDRKIIVEELVDGREI
ECAVMGNDEPQASLPGEYVIHEESARFLDYTEKYSSTGNVEFIVPARISKSVIKKIQGMA
ARAYRAIDASGLSRVDFFLKKDGELLVNEINTLPGLTDVSGFPKMWEATGVSFTRVIDQL
IQFALERHRERARNETSI
>AIA11225.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIMSTDNLIKQLGKVGVLYGGRSAEREVSLMSGSGVLKALKDKGVDAHGFDTGEKDIAEL
AAQQFDRVFIALHGRYGEDGTLQGALEQLGIPYTGSGVMASSIAMDKIMTKRVWLSHGLP
TPRFKVLDAKTTTPEQLRLVPDELGLPLMLKAPHEGSTIGISKVTGYSELNGGFADCAKY
DEVVLAEEFVTGREFTVPVLGKGRDARALPIVEIRAPEGNYDYQHKYFSDDTQYLCPAPL
DAALTQRMQAIAVQAFNALGCVGWARVDFMLRAADNEPFLLEINTSPGMTGHSLVPMSAK
AAGVSYEDLCLNILKTAALEMTPVKK
>AIA11213.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MRQKLNLITLGVDDFDRSVGFFEDGLGWNKSSASVPGLALFPLGGIVLALHPRKDLADDA
MVPQEGSGFSGITLSYNAKSEKEVDEVLKKVEGLGATIIKPAQQVYWGGYSGYFKDFDGH
LFEVAHNPFWEFDNQDNLILP
>AIA11166.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GVGTISHFGYQTRFDLRQGFPIVTTKKVPFRWIAEELFWFLSGDTNEANLRARGVDIWAE
WADEDHTRRFDREAGDLGPVYGYLWRSFGGHYPQRNGVDQIANLISEIGSNPNSRRLIVT
GWDPRQANLVDLPPCHTLFQFKVENGTVLHCQLYQRSADAFLGVPFNISSYYALLMHMVA
HVCGLEVGDFVYTLGDYHIYKNHLEQVEELLARAPFPLPALEILDQEKRLRGLEGLLSMR
YEHLNLVGYQSHGKIAASVAV
>AIA10774.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSNVQLPKKIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEIDVRDENFELPQNVDI
AFLTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRIAFDKIESKKKFDAAGVTTPRWQIV
AADERPTFSPPIVIKAPRQGSSVGVYIIKSADQLENGLAEARKFDRRLLVEEFVPGRELT
VGILGDQALPIIEMIPKSGFYDFTNKYPFLNPKAGGGAEHVCPANIEETLTHQIQELALR
AYRSIGLCVYSRVDVLLPENGVPTVLEVNTIPGMTEASLLPEAAAAAGISYEDLCLRIIE
LSRARREDAK
>AIA10753.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MSRLNDPHALDLLVSDVQGSAKYRDMSLDLIRTIAAQELTKRRTHKEAVKATKNKLHQVS
AAYLDPRENYTAWLQELREAQQTGTAEANKQTCKQIMSHHASTRERLPLLEQFYSTLLAE
LPAPHSVLDLACGLNALTLPWFPHMEAITYYACDIYRPMIDFLNATMEIMHIRGCAEVRD
ILQSCPTQEADLALVLKTIPCLEQIDKQAGTRLLRAINARYMIVSFPAQSLGGRNKGMVT
NYEARFYQLVEGENWEIQKYEFATELVFVIKK
>AIA10677.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIAWSVVLRRLGFTKRKLATLLDQSLVVNIRGVARGRGSAVLWRQIFTVQKRGHEREMMS
EPLEQPYLNLMKDVLAHGARKDDRTGTGTLSIFGHQMRFDLERGFPLLTTKKLHLKSIIY
ELLWFLRGETNVKYLRDHNVTIWDEWADAEGELGPVYGAQWRRWRSADGRTIDQISELID
QIRRNPDSRRLIVSAWNVAEIERMALPPCHAFMQFYVVDGKLSSQLYQRSADIFLGVPFN
IASYALLTMMIAQVCDLAPGHFVHTLGDAHLYLNHLEQAQLQLARQPYPAPQMRLNPAIK
SIFEFNYEDFELVGYEAHPHIKAKVAV
>AIA10648.1|FEATURES|farme|beta_lactam|PER-2|antibiotic inactivation|1
MDSVKSEADGRLGKAQVVAAQPNTTRLQEQLNNLDLSSAQGDVGIGVLDLDTGERWFRNG
KQRFPMQSVFKLPVGIVVLKLVDEGKLSLNQTVTITREQFVPAWSPILKEIKGDRGQFTV
QYLLQRAVGDSDNTAADALVRLVGGPEQVTANLGKLNLRDIRVDRLEQQLQPDTVGLTNF
RPELVDKQKYEEAVQQIPDAVKKAAMERYLTDPRDTATPEGMIDLLAKLQSRQLLSEDST
ALLLKIM
>AIA10606.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTAAVPARPEIVIIVAAAENGVIGRDNTIPWKLKADQQRLKAMTMGKPIVMGRKTFESLR
RPLPGRTNIVITRDASYRAPGAIVTNSFENALVIARGDALRRGAPEIAILGGVDIYTRAL
PITDRLEITEVHARVDGDTRFPPIDPALWQETGRTRHAAGPDDTADYSYVTYCRQQPN
>AIA10527.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTLPLILVVAIAENGVIGRDNHLLWRIKTDMGRFRRLTMGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDEGFAAEGAHVAHTLEEAVAKGEELAARIGADAIAVVGGAEIYALALPQVQTL
FLTEVHTAPEGDAVFPSFDRSQFREMKREDHLKGPG
>AIA10521.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VAGDTNIKYLSDNGVKIWDEWADKEGNLGPVYGYQWRSWPTADGRHIDQISNIIERIRAN
PDDRRLIVSAWNVGEIGKMALPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYA
LLTLMVAQVTGLKPGEFVHTFGDAHLYLNHLEQAKLQLSRDPKPLPEMHLNPHVKSIFD
>AIA10519.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MARNRVIGARNTIPWRLPGEQQTFKSITMGHHIIMGRNTWESIGRLLPGRTTVIVTRRPG
YQVAGAIVAPSLEDAITACGGDEEIFVIGGAQLYAAALPLADRIYLTTVDADVQGDTLMP
EFDLSEWRESSSQVFNADAKNQYDYGLAVYDRT
>AIA10516.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNACVMGYKTWLTLKRPLPNRLNI
VLSRQSEIEPQDSVIVCRDVESVLSKARDFKGDLFVIGGEQVYRSFLPYIEKWIVTEVPP
AIQDADAFVPENYLDGFTQSESKKIDDELTTLFYNRTCRL
>AIA10517.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYHDLLKSILANGNEHKDRTGVGTISHFGYQTRFDLRDGFPIVTTKKIPFRWIAEELF
WFLSGDTNEANLRAKGVDIWAEWADEDHTRRFSRAAGDLGPVYGYLWRSFGGNYPQRDGV
DQIANLISEIQTNLNSRRLIVTGWDPRQADQVDLPPCHTLFQFKVEAGRVLHCQLYQRSA
DAFLGVPFNISSYALLMHMVAHVCGLEAGEFVYTLGDYHIYQNHLEQVQELLGREPYPLP
KLELLDEGGQLRGLEGLPAIRYENLKLVGYQSHGKIAAAVAV
>AIA10452.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
EVYPVFISKEGEWRKGQKLLGPVETVETLQFGDDTGKANDITSFLPAENSAQELDASTGN
EGLDVIFPLLHGPNGEDGTVQGLLEVLNLPYVGNGVLASAAGMDKVVMKQLFAQAGLKQV
PFVHFIRKEWKNNQALLLEKIESSLKWPLFVKPANLGSSVGITKANNREELIKAIDLAFK
YDRKILVEQGIVAREIEMSVLGNDTPRCSVAGEVLPTKDFYDYSAKYIDGTTNYAIPAKV
SDRLQKSLEDAAIRAFKVLDCSGLVRADFFVTDTEEVLINEVNTMPGFTPISMYPKLWMA
SGLSYSDLIEELISLAIERYEEKQQLEHSKDGE
>AIA19287.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKISLIVATAENGVIGKDGKIPWFVRGEQARFKAITMGHPIIMGRNTHQSIGRTLPGRLN
IVISSDPNLQLSEGSRLAHSFEEAVSMAEDSGAEEVFVIGGERVFKDAQPLADKLYLTKV
HTEVEGDTFFQFDPKQWKMISCELFKKNEVPDRPFDFEVCLYERTSS
>AIA19235.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MTATTVPASSRTYPSLRAAWIPLAALCLAFFVEMVDITLLSIALPTIGRDLGSGTTALQW
VTGAYSLTFGGLLLTAGSMADRLGRRRVLLVGLAVFGLLSLCVVAVSSAGQLIALRAGLG
IAAAAMAPITNSLVFRLFDDQALRMRAMTLMIVVGMSGFVLGPLLGGTALAHVSWQWLLV
INAPIALIAAIGVRLGVAADRPEDLTQDRLDLPGAALSVL
>AIA19232.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MVMSPLGDMLMKSMGLTTKQFGFAVSAYAFSAGISGLLTAGFADKFDRKKLLLFFYIGFI
AGTLCCSLATTYPLLLAARIVTGIFGGVIGSISLAIVADLFPLQQRGRAMGFMQMGFGAS
QVLGIPISLYIANHWGWQSPFMMIVGLATIIWLAVVFKMQPINKHLEVQSDKTAIKHLWH
TVRQRHYRIGFLSTALLSLGGFMMMPWGSAFAVNNLGVTYNQLPILFMVGGVASLFIMPL
VGKLSDKFDKFKIFTIAAVWMMIVVVIYTNLAMVPFWFVIIMNIVMMIGIMSRMVPAMAL
TSALPQMQDRGAYMSISSSLQQIAGGIAAVVGAMIVAQNTKTSPLQHYDTLGYVIVVIII
VSIIMVYRVSKIIKSRMHAEKL
>AIA19205.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIGKDGKIPWFVRGEQARFKAITMGHPIIMGRNTHQSIGRTLPGRLNIVISSDPNLQLSE
GSRLAHSFEEAVSMAEDSGAEEVFVIGGERVFKDAQPLADKLYLTKVHTEVEGDTFFQFD
PKQWKMISCELFKKNEVPDRPFDFEVCLYERTSS
>AIA19186.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MHTFLIAAISLDGFIAEKTDQISTSWTSKEDKKFFSERTKQAGVIVMGSSTYKTIGRPLP
GRLNVVYSKNSTFEFKDPSEGFVTDLEPKELLKKLQSEGQEEVAICGGAAIYSMFMKAGL
IDTLYVTIEPVVFGSGVKLFSDDIKTSLQLMKAEKMGENAMLLEY
>AIA19185.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTISIIVAVSRNNVIGKEGDLPWRLPADLAHFKKITMGHPILMGQVTYDSIGRPLPGRKN
IVITKDKNFKAEGCKIAYSINEALSLAKGFDEVFIIGGDSIYKQTIDLADKLYVTQVHAH
VDGDRTFVFDKKKWRKVSSITHKVDANNALEFDWQEWVRK
>AIA19175.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
KPQNERGSRMRQYLDLIRTVLADGEKREDRTGTGTISLFGTQAKYDLRQGFPLLTTKKVN
FGAVVRELLWFLKGSTNINDDLHEHTNIWDAWADENGELGPIYGYQWRSWPAYDLDEKTG
LYKKRHIDQIQNAIDLIKTNPDSRRIIVTAWNVADVPKMALPPCHMMFQFYVINGRLDCQ
LYQRSADLAVGVPFNIASYSLLMIMMAQECGLTPGIFTHTIGDAHIYQNHLEGLQKQLDR
KPGSLPEVEIPNKSLFDLKFEDFTLKNYDHQGFIKFPVAV
>AIA19147.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MNAQIIKAAVVLGLLSVIGPLAIDMYLPALPAIGNDLGASDAAVQQSLMAYMAAIAVCQL
IYGPVSDMFGRKPPIYFGIGIYIVASLGAAWSPNIEWLVFFRFLQGVGACASMSLPRAIV
RDGYTGAPAAQLMSLLMLVFSISPILAPLSGSIVLGFGDWRVMFYVMAIVGGLSLVLLMF
GLKETRPKEARLESSLGGAISAYWKLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEH
YGLTPTLYSLAFSVNAVSFFAVSQATGYLVGRFGLPRVVRFAVTGYVSAMLALLLIFLAG
VDSFWVLGVLMFIAFGFLGLVLPSTGVLAMEEQGEIAGSASALMGTLQMVIASVVMGIVG
GFGDGTAMPMVVGFAACAVAALAITLVTLRRGADPVAAPAE
>AIA19116.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MNKALIVILAAVTLDAVGIGLIFPILPRLLEDVTHTGEVTTLIGIMLALYSAMQFLFSPV
LGVLSDRYGRRPVLLLSLAGAAIDYLIMAFAPELWMLVLGRAIAGVTSANMAVATAYITD
ISVEEERAKRFGYFHAMFGIGFIIGPVIGGILGDIWVRAPFLVAAGLNAVNFALALFVLP
ESRKGDSSSKFDFKTLNPFRPLGWAFSFTALLPLMAIFVIMNFVGTMYGTIWALFGQDMF
QWNGLMIGLSLGAFGLFHAGAQALLTGPVAARLGERWAMILGMACELTALLILGFATQGW
IVFALAPLFALGGIGMPALQSLTTQQVDADNQGKLQGVLASLVSLSAVFGPLFFSMVYFA
LKPTWPGLIWIVGGGVYLLALPLLLGIRRTPLATVTPEG
>AIA19095.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MKKALSVVYATVVLDAAGIGLTLPIFPRLLRDVGHTDDLGWRFGAFLALYALMQFLFSPV
LGSLSDRFGRKPVLLVSLAGAAIDYVFMALAPALWMLFLGRAIAGLTGASNAVAAACVTD
VTEEHERARRFAQLSACFGVGFIAGPAIGGILGEYSVRLPFIAAAVLNALNFAVAIFLLP
ETRKRSEGEEGQPLSPFTHFKWLFSFKPLLTLMAAYFLLAFIGEVGGTVWVLYGQDKFAW
SAMMVGISLAAFGFFHAVVQAFVAGPVSERWGERRAVLIGVIADSIAYVTIAFLSEGWMV
FFLMPLFCLGGIGAPALQSLVTANVDAEAQGRVQGLLASMVSLASIAGPLAISTIYFASR
DVFPGLVWVLGAAVYLGLLPLIFSRRPAVSS
>AIA19072.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTNNQASQPVTVAVLAGGTSAEREVSLRSGAAVQAALEAKGYAVLMLDPHDGLSQSLLEQ
ADVAFPVLHGIGGEDGSIQSLLDELKIAYVGTGAKESALCFDKWQYKQLLREHNLPVPDG
ALVNREEFAASPLTERPFVLKPNDGGSSVDTIIARDGLSGVDEHLRDDIFARHGRMLLEE
LIPGTEITVAVLDGHTLPVIEIVPPESGEFDYDNKYNGKSQELCPPQTVDPVVQQKAQAL
AAQIHTLVGCRDFSRTDMMIDSDQNLYVLETNTIPGMTDQSLFPKAAATAGIPMSELTDM
LVRAALARRTAKS
>AIA19050.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|1
MNDVKQTAMHHARKLTDKQKKIALLIVAFAFVMDLLDSTIVNIAIPSIQVNLGASYSTIQ
WLIAGYSLTFALLLITGGRLGDVYGYKKLFMIGVGGFTAASLLAGIAPNAGFLVAARLAQ
GAMAALMVPQVMSLMQVMYEPKERVGVMGMFGMLGGLAASLGPIVGGLIIKANFFGWDWR
PIFLINLPVGIFALVAGAKFLPEGKSPHPLHVDVKGTLLIILALSMFVFPLIEGRDLGWP
LWSIGMLAASIPVFAIFGWYEVRKDRRDKSALIVPALFKIKTFISGLGLNVLVESLMVGY
FLTFTLVLQAGLGYSPLKAALTGVPTAVGMTIGFTVLGQKLMARYGRAVISMGATIFGAG
LVGVAWVFTHYTLTTHPWQFSLPLLLLGIGLSLIMIPMFSAALQDVDPGHAGAASGALNA
VQQVGAAVGIAIIGVIFFGQLSSGATKSFAQIVPEMRQELSALHVPQAAQVEIIRQTGTC
FYDRSTAKDDTKIPASCQQAQASVPVDENGQKIVDVVAASAKAANAHNFASAFRSSVVYI
LIILVVVCGISLTLPRKLRVVEEAA
>AIA19031.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALPPCHCLFQFYVANGKLSCQLYQRSADIFLGVPFNIASYALLTHMIAQVTGLGVGDFV
HTLGDAHLYLNHLEQAKLQLTRETKQIPTLKLNPRTSIFDYVFDDIVIEGYDPHPSIKAP
ISV
>AIA19032.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISMIVAASKNDVIGRDNKLPWHLPDDMKYFRDLTKGKTVIMGRKTYESIWHPLPNRRN
IIISSTLKNVKDCEVFPTLGDALQALLHEKKSDEVFIIGGSRLFAEAIMEIMSDLRAHRL
YLTRIHANIEGDIVLPDINCKHWKKISEKEHPKDKDHAYDFTFEVYERD
>AIA18990.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVRGEVEKDNDLLFKIPEDFQHMKNLTKGHPIIMGRRTFESIGRILPNRYNIIITRDPD
FEFPGLSGDRGTIVNSLEAAITAAKRAPGSEEIIIFGGGQIFTEAVEKGLVDVLHLTVVD
GDYGADTFFPEYEKQFSKVLSSEEGQSGEYHFKFLDLGK
>AIA18960.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MISIVVAIDKNNVIGHENKIPWKLKSDLVKLKDLTKGHTVILGRKTYESMIWYYNQSGRK
MPGETYIVVSRQDFKPAEDRPEKTVVAHSIPEAIEIAHKIGDDQMFAIGGAGIFQEIFPQ
TDRIYLTRVDTEAEGDVFFPVIDMNDWNELSIEHHPQDEKNDHDYDMVVLERK
>AIA18951.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKISIIVAVSENNVIGRNNDLPWHLPADLKYFKEMTMGHCVVMGRKNYESIPPKFAPLVG
RTNIVITRQKDYKAEGAVVVNSIQEAIDHSRNHQETECFITGGGEIFAQSIDLCDMIYLT
RIHATIEGDVHFPELNDKEWKEISRKDIQPDEKNKYAFSFLVYERRK
>AIA18948.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MKINFKSALYFLTTFLCMIPSFLLAAVDQKDMINKAVHTFMEKNQIPGVAVEVFNDGEPN
SYYFGLANQEKKIPVSGKTIFELGSISKLMTSLLLAQEVDFANLQLNTPLREVLKDLPET
FNNVTLQSLATHVSGLPFRPSQPINDRVELEKYLNGFPKITLPDKQWAYSNFGINVLGYA
LETSTHKDFYQLYRSHILAPLKMQNLSEPKRKVSGFIAQGYDKEGKPASAVGPGLLPAAG
GLKASAEDMQRFLSAAIGLPKTPMRIFYPMRMTQSIYVKLSNHMQGLGWQIHPMDKSKIG
NLFTEATNPLALGTLNVLEIEQRPMFDPNALIDKTGGTDGFRSYIAVIPNKKSGVVILAN
KFVPSDEIVKLGREILLKMTNIIDT
>AIA18941.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MADLQFEKRPKLLFALTDSFIMIKRSSLHIIRNTDQLLGTFFQPLMFLVLFTAVYSGAIN
TGGTNYSDYLMAGIIVQTIAFGSTTTAIAVANDLQKGIIDRFRSLPMSNLAVVTGHVISD
LLRNGISAVVLILVGILLGFRPNADLGEWLMVILLLALITMALSWLSAILGIVAKSVEGV
QWMTFVIIFPLTMASSAFVRPETMTSWLRGFAENQPVTQIVDAVRGLLLGTPMSENAVVL
AIFWCLVVMAVSIPVAAFLFRRKTNQ
>AIA18937.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
NTLLSIALPTIGRDLGGGTTSLQWVVGAYSLTFGGLLLTAGSMADRFGRRRVLLGGLAVF
GLLSLCVIWVTTTGELIALRAALGIAAAAMAPITNSLVFRLFDDNQLRMRAMTVMIVVGM
AGFVLGPLLGGTALAHVSWEWLLLVNAPIALIACLGVRLGVPADRPEGLTHDPLDLPGAV
LSVCAIGLACYSLTRGVEHGWLSVATIASVVGAVAAAVAFVWHERRSASPMLDLSLFANG
TVRGAVIAQVGTSIAMASVMFGLILHFQYAYGWSPVRAGLANLPMIVTMIAATPFSEWLV
HRFGQRIACLVGAIFLAGSLAGLAWAVGHGYLAIAVCMVLMTIGLRTVMTICAVALVGAM
PSNRTSIGTALNDTAQEVGTSVGTAVIGTMIAALVTAQLPAGVWSSNLVHTFF
>AIA18926.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISAIAAMSTNRVIGIDGGLPWHQPRDMKFFKDTTLGHHIIMGRNNFASLDYRPLKGRT
NIVLTRDPFFITSSAMVMHSIEEALRFAQEEGEEEAFIIGGGEIYRQSMHFLDKIYLTEV
ITEVSGDTYFPEIDMDEWVVESSLYVEADAKNVFPMRFDVLLRKE
>AIA18895.1|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|0
MVNIEDIINDLQDPSITHFSAIKKGFSTATKYILHSKGNKSRYVLKIYGIEKADRRNAEF
DLLKRHYSHNVSCQMPVKFGINEEQQICYMILSYLDGVSGDTSLPLKSVEEQYSLGISAG
EELKKIHVITPQKPFNWYEKRMRKYHNKVDECKRQGLKFYKQECIESYIKDNIYLLKDSP
IHFQHDDFHPQNMIVKDDGTISIIDFDSYDWGDPLEEFFKLPKFTIHISAYFAKGQVIGY
FNHKIPDDFWRKYNLFVALNQHASKIAGAAANNLQAVEERTRFIIETHDFSNHGAPDWYQ
NTIL
>AIA18870.1|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|1
LSAILITTEFGHVLIDGGLPESAPVIKANIETLGFKLKDVKAIFNSHVHPDHAGGIAELQ
KESGADVYALRPSYEVLTTGKPNADDPQAARKGGPGVPKVERAWVAQDDQQIGIAGVRMH
VVATPGHTPGGTTWTWDACEGTKCLHMVYADSLSPVSADKYRFSDHPEVLQGFEKSFARI
ASLPCDVLLTPHPSASQLFERLDLGKENTEAVRDPEGCKKYVATARDALAKRLESEKTGA
VKK
>AIA18828.1|FEATURES|farme|trimethoprim|dfrA24|antibiotic target replacement|0
MKTIVLAAVTLDGKLARNSSHYVDWTSKEDKKLFYSTTKRAGVIILGDNTYKTFPAPLPG
RLHLVLTYTPAGKENIPGVVEYTSAPPEAILDDLQARGYEEAVIGGGAQINALFLQHDLV
DEIWLTIEPLIFGVGVDLFKGAQWQGRARLVQMEQLNEEGSVHLRYSLR
>AIA18820.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNKPKISIFAALSENHVIGVKGGLPWHIPDDFKRMKEVTMGHTIVMGRKTYESIGRVLPK
RTNIIISRDPDYKVDGGIVRLSLDEALTEAKKHETDEIFIFGGGQIFEQAMPITDKLYLT
IVHKNIEGDTYFPDYSMFIKKVFEQKGTSNGFDYTFLELKK
>AIA18802.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MPATASSKKSAMGFIFVTLLIDIMGWGLIIPVMANLIAELKHIPVNQASTYGAFLLSVFA
IMQFLFAPVMGNLSDRYGRRPILLLALLGLGIDYIVLAVAPTYGWLFLGRMIAGMTGASF
TTASAYIADISTDETRAKNFGMIGAAFGLGFVLGPALGALLATWGIRAPFYAAAALCLLN
CLWGYFMLPESLDEAHRRPFEWKRANPFGSLKFLTKHPEIGELAFCFFLIYLAAQAVQGN
WNFFTIYRFGWSEKMVGISLAVVGVLVGAVQAGLTRVVNPKIGDEKSIYLGLGLYTLGLV
LFAFASETWMMFAFLIPYCLGGICGPSLQSVIAGHVAKNQQGELQGALTSLMSVTTIIGP
LIMNNAFSYFTSDKAPIHFPGIHFLIGAVFMLTSLFIIYRVLSREKKEHPEMISVIEGSA
KKEEAAP
>AIA18641.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
SMKISFVIALTRSGVMGKNNALPWHLPEDLKHFKELTSGKPVLMGRKTYESIGRPLPARR
NIILSRQKDLQIPGVECVTSLEEALTRVAGSDELCIIGGAEILHLAQDLVTDLHFTWIEK
EFDGDIRFNLKNFPWQNFEELSREAHVEGAIPYTFVDYRRKDLRPRLDGTPQELS
>AIA18639.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIVSILVAMDEKRAIGTKGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRET
IIITHKENYNPEGCFIVHSLEEAIELARSRGETEAFICGGAEIYAQSIDLADRFYLTLVH
TVTDADTFFPEWNQGEWIEKESSDHPSDEKNQYSTTFKVLHKR
>AIA18598.1|FEATURES|farme|beta_lactam|BL2a_1|antibiotic inactivation|1
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVIVASSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINSVVPGH
GEVGDRGLLLHTLDLLK
>AIA18568.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|1
MRSASLLFIFVTIAIDAIGMGIIIPVLPDVIRRFLSDEAAISRVYGYFIAVYALMQLVSS
PLLGALSDRFGRRPVLLVSLLGAAVDYFFMALAPTLPLLFLGRIISGVSGASFTVASAYI
ADISNDENRSKNFGVMGAGFGLGFILGPAIGGLLAAYGPQYPFLAAGAFNLLNFLYGAFV
LPESLGTHQRRAVQWRSLNPLRSLHALSKMPAIRALVLVHVLIQLAGQTHPSIWTLYTEH
RYGWSASEVGLSLAFVGVLSALSQGLLTGVIVKRFGERKVLTMGCLGEALSFTLFGLAVN
GTMLYLVLLFSSVFWAAHPALQSLVSREVPPSEQGELQGSLMSLTSLMSILNPLIMTTLF
AAFSVRGTGHYVPGAPYLLAGALYLAAWGMAARWERKHPEHG
>AIA18567.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MDRTQPITQATPARTYPSLRAAAIPLFALCLAFFVEMVDNTLMSIALPTIGRDLGGDTLS
LQWVTSAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAIFGVVSLGVLAVDSTGQLIALRA
TLGIAAAMMAPITNSLVFRLFDDDVLRRKAFTMMITVGMAGFILGPVLGGTALAHVHWQR
LLIVNAPIALIAWMGVRIGVPADHPEDLTHDALDLPGALLSVAAIGLGCYTFTSGVVHGW
LSWQTLGSAIGALVALAAFVVHERRTAEPMLDLKLFSRDTVRGASLAQLATAIAMAAVMF
GLILHFQYAYGWSPVKAGLANLPLIVTMLLASPLAENLVTRFGHRVACMIGSAFLAGSLV
GMAWAVEVGYPAIVVFMVTFTIGLRVVMTTCAVALVDAMPSNRTSLATSLNDTAQEVGTS
IGTAFIGTMIAVLVTKVLPDGVWSDALVSSFFHGERVAFLALAGVVGVIAGWGSLTLTDS
HATEEH
>AIA18554.1|FEATURES|farme|beta_lactam|bla_2|antibiotic inactivation|1
MIHHNTIKNLFSLRPHFKRLLVCGIVFSCASWPLLANNNCFIAKENGRIIAEKGRCDQRH
SPFSTFKIAIALMGYESKILVDTNHPRVAYDRHMQQLFKDYYHPKKYPVMLLAARDQTPF
SWMRYSAIWYSQYVTMKLGKKQFQDYVTLLNYGNKDVSGDKTHRRGLLHAWLGTSLQISP
KEQVNFIERLTRKKLPVSQSAQTNTMRIMTLQPIFDDWQLHGKTGGPVPSGWFVGWIEKN
GRMISFAQYIEQPENSLLSGGRVAKEVAIDHLIALTLES
>AIA18553.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
MTSPISFSAARVDQRAWVMLIVLTMLTVIGMTVVLPVLPFVVLQYVSNENDLAIWVGVLE
AINGLCAFLVAPFLGRLSDRFGRRPVIIAAAFGAAFAMSLFGIGGALWVLVLARAIQGLT
AGDLPALFAYLADITPPEQRARRFGILGALSGIGMMIGPALGGLLAAVSINLPVFITAGV
SLTVAVLSVFLLPESLKPENRISTITLHDVQPFAVFKNAFGRKELRGLLIVFGLLALPFG
FFVNNFSVLALDSIQWGPTAIGLLTACVGVVDIVVQGVLLGILLPRIGERGVIVSGIVAQ
TIGLIALALVASLFAQPWVFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQS
LQAAMSTVAPLIAATLYATVSHAAPYWLGVAIMVVAAVVISRTHIVSTSKKPADEQPAEL
VGARG
>AIA18489.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAADARLGIGKDGKLPWHLSKDLAYFKRVTTEVRDPSKRNAVLMGRKTWESIPAKYRPLP
GRLNIVISEKGVVVPEGVIHTSDFDTAIYSAAIEDNIESVFVIGGGQIFRTALKHSACRL
LYLTDIHADFNCDVFLPDFREDFVPYSNQGTVERENGIEYEFKVFIRYDMLHGAESRPAG
AGANEG
>AIA18457.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
PQARAFLQRPAAEAVVRVHKELKKQGLGIVIFDGYRPWSITKLFWEVTPDDKRKYVANPK
TGSRHNRGCAVDLSIYDLKTGRLLPMPSDFDEFTERASPDYKGGTEEETRNRELLRKLME
AEGFTVNANEWWHFDYKDWQSYAIYDISFDDAGSLDKKPKKPKIEEKKEFKKIFDDAGIS
GGIYIYDLNRNKYTIFDRRRMDTGFVPASTSKILHSLIFLDSGAIKDENETLKWDGTLRS
VEAWNQDQNLRSALKVSAVWFYVEVSKRVGQEKMQKYYDAVGYGNRDTNGFGADYWNKGN
LRITPREQIEFLVKFQQNRLPFSPQVIAVVKDILIEEKTANYTLRAKTGWSDAFQPQVGW
WVGYVERGADVYFFATEIDIKKDEDAAHRKEITKKI
>AIA18437.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MHFDIVVAVDSKRGIGKDQTLPWRLPGELAHFKKLTSQNDSGKRNAVIMGRKTWQSLPAK
SRPLKDRLNIVVTSDKKYEVPEGVHTASSLDEALAIAQKETTEHCFVIGGAQLYEQAMQH
PRLAKSLHHRD
>AIA18429.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKRPIYTILLTVLISCTVAPANAQLTDLQTQITSISQSIIADIGVAVIDVQSNDTLSVNG
NKHFPMQSVFKFHIALAALRQVDEGKLSLDQKYHVTKDHYFNTWSVLMREHPEANVDVTL
RELITWCVMNSDNVACDLLFEILGGPSHVDKFIKSLNVNDIAITANERKMHTDWYEQFSN
WTTPSATARLLRLFYDGKILKDDSNKFLWKLMADTPNAPNRLKGLLPEGTVVARKPGTGA
SSEDGVLGAANDVGILVLPNGKKIIVAAFVTNTKEPLSTAEMAIAQISKAVYDYFKK
>AIA18311.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWSLPDDSKYFMVTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIGGAEIYTLALANANRLYLT
EIEADVDGDTYFPSFDKAQWKEVSRKHHDADQRHAYAFDFVVYERIA
>AIA18304.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKVILIAALSADGLLGRDSDDFSMDWTSPEDVQLFVKVTKEAGVMVMGSRTFATTIAAGR
KLPGRKMVVYTSKQYTDHHRTDPTEFTSEPPRDLLARLEAEGYTSVAICGGAAVYDMFLR
EGLVDELYITYEPVLFGTGVTLASSSFDLKLKLLDTEQLNENACMMHYEVEK
>AIA18269.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVSKNNAIGKQGKLPWHYSADMKFFRETTTGHAVVMGRKTWVSLGKPLKNRLNI
VLSRDSNIEPQESLVVLRDLDSVLSLNSSLQTDLFVIGGAQIYTEFLPHIERWHVTEVPM
NVEGADAFMPEDYLDGFKRLGTKKLEDDLRVVTYEKS
>AIA18217.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIAAIGANNELGHGNDLIWRIPADMKRFREKTAGHPVIMGRKTYESIGRLLPNRTNIIIS
REVEPFLVSHPELAMALSESERVSGSQNEIPGPPFGGRNDIGSVVDSIEKAIDQAKSQSG
SEEIFIIGGAQIYTLGLPLADKLYITKINSQNPIADAFFPDFSEFTKVVFKESHNDDGLE
YEFLELER
>AIA18220.1|FEATURES|farme|aminoglycoside|IP85_04510|antibiotic inactivation|0
FLRDATYKGEHFIKRGRTAYLERLIVDPAFQNKGIGTAFMIEVLDTLFYRSEFYDGKPAD
EVRLSIFNDKEASSVADEGRKGFDRNDYFFRQFGFENDEGTIDVDERTIQPYKLNIDRYE
LYRAKALATLTEKQPERKLILEEVWDELKDILRKKDPNYAKGR
>AIA18203.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MGPYEALLAAVLATGEDRPDRTGTGTLSLFAPQPLTFDLRGMHVPLITSKQVAWRMALKE
YMWMLSGSTSTVDLGGSSTQMANIWNNWADERGDIGPTYGAQYRDAGGTLLTEAPDDGGW
TYSKAGVDQLGEVIHRLAETPDTRRALISLWSVPELQDMALEPCMVLFQFSLRGPNLDQL
HLHIHQRSADMMLGVPFDLFQGGLLAHLVARELSYYTDRFIDATNLTWSAGDVHVYNTHL
PAAFEQLLQAQNAPKPAARLVLPPHQAPLRLLGGSLTAAHIDVIDYHSAPRITAGAIA
>AIA18111.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MQQKLAFAFQFDHKVLIEEYIKGRELECSVLGNDDPIASLPGEVIPQHEFYSYEAKYLDE
NGALFEIPAKLSESEIACIQALSIKAFQVLCCDGMARVDVFMQEDGRIVLNEINTIPGFT
KISMYPKLWAVSGLPYADLIDRLIELALERFKKTQSLKTIFTMLDAEMSPVPAVLG
>AIA18101.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKITVLMGGTSSERNVSLASGIRIVQALRGRGHEVIALDPARGVLSAKEEQELSTGKVGT
KPPSLEDLTKVAEGAFLPNLTSMKELREADVAFLALHGGQGEDGTIQALLDMARVKYTGS
GHLSSALAMDKDLSKKLFRSDEVKTADWLMAPASTEQIEGILGLPVIVKPSKQGSTVGLT
LVKKRQELVPAIEEAFKYDDEVMIERFVPGRELTVGVLGDVALPVGEIISKHEIYDYECK
YTAGMAREEFPAKLTPEATERVQNQALAAFRALKLKGYARIDFRLTSEGEFYCLEANTLP
GMTELSLIPQGAAAMGIDFPELCERIVRLALE
>AIA18039.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSVDYIPYEQRTPDTQYRDRLVLIRDHGIAAKSFHPIGSQTYMGLPAMRFDLRNGVPSPP
SATWKGSWRSAIGEILGFINGVRTQEALVGEFGVNEKFWGPTVTEAKCKIFGLQTGDLGA
GSYGAAMGAFPTPWGTTVSQMRNVLDQMRSMPDVRTHWIDPWIPFYTMKGGGGAESKGVV
APCHGWMHFRILNAELHLQMHQRAADMPAGSVFNTFQYAALTIAVAHVMDIKAAGFYHSF
SDAHYYDNQLDPWVNDLIDREPRRLPTLTLTEDAPDDLFAFRPRHFVLTDYDPHPAMNDI
PVAV
>AIA18022.1|FEATURES|farme|aminoglycoside|aphA3|antibiotic inactivation|0
MKQPPPETALRFIHRDYHPVNVLWQEGKVSGVVDWANACRGPAGVDLGHCRVELAQLYDV
ATADAFLEKYQRLAGAEFSYQPYWDILALFDILFGPPQVYPGWPAFGFTGLTEQILMERL
DLYLLSLLERAGVRP
>AIA17989.1|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
MKKSIYIMALGAFGIITTEFGIIGIMPAIAKHFQVSIDTAGWLLSGFALTIALTGPFSVL
LTAKINRKWMMCLVLFTFVLSNILSAVAPNFTVLMIARILPAFLHPVFWAVSTVAAARQV
EPKDAPKAVSVVLAGLSIATVLGVPLTTYVSELINWKASFWVSGVINLIAFAALAAFVPS
MPVTEKQSTKSQLVILRKGQMWVNLIATMIMIAGIFATYSYLAEYLGKISSMDGKQTSLM
LLLFGTTGIAGNWITGLALSRNVMITTRFFLLSLIAVHVMAYLFGGLFIPMTAIVGIWGF
IHTGGFLIGQTRSTSEAPEAPELAASLMVSFGNAGVTLGTFLGGIIIARFGVHQVIWISI
LLLLVSLALTFVFIGRRSVTPERETALPSAGLLEI
>AIA17981.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIAIVAVDRNGAIGRDGKLPWHYSSDMRFFKETTTGNSCVMGYKTWLTLKRPLPNRLNI
VLSRQSEIAPQDSVVLLRDVESVLSLAEELNGDLFVIGGEQVYRSFQPHIQKWIVTEVPL
SVEGADACVPKDYLEGFELTGTRKLEDNLNASFYERK
>AIA17977.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MRSFNMTKNFNDCVILFGGSSEERLVSVASAQNISVVIPEAPLWFWTKDGKIHEVTSAEL
GAHAEAFTKEFSPKSPVKASTLEEALKVNTGKTIIIALHGTEGEDGTLQRMLERMKITFT
GTGAAASEKAFNKAMTKAIARDNNLSVAPELVVENVEPANVKKLEHFLEQNKKIVLKPLA
NGSSVGLHIIASKADLEKALPAIKASGYLPYVSEPFITGREITVGVREDKDHKLSPLPCS
EVRVIQGRQFDYQGKYLGSGVEELTPAPLTKEESDACQKLALAIHKAIGCKGYSRTDMIL
TEKGPVMLEINTLPGLSKASFIPQQLKVAGMTLRDFFLEQINL
>AIA17961.1|FEATURES|farme|tetracycline|tet(30)|antibiotic efflux|1
GFIVGPIIGGLLSVYLLRAPFIVAAGLNALNLILALTVLKESRVPSREKLDLKSLNPFAP
LKWALSFPALAPLIALFLIFAINGDIPGTIWVLYGTEKFAWDGVTLGLSLATFGLCHALA
QAFITGPLTKRIGERWTLVVGIASDMIAFVCIGLATQGWMAFALSPLFAGGGVGLPALQS
LMSAQVGEDRQGELQGVLASAQSLTSIAGPLIGTTVYFFTKPVFPGAVWLIAAALYLLAF
PILSGLLRRPKAVAA
>AIA17962.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNRPLIIILAAVTLDAVGIGLIFPILPRLLEAVTHVDNIAPYVGIMYALYAAIQFVFSPV
LGVMSDRFGRRPVLLISLAGAAIDYLFMAFAPELWMLVVGRAIAGLTSANMAVATAYITD
ITPEAQRAQRFGMFHAVVGIGFIIGPVLGGLLGDIWIRAPFIAAAGLNALNFALALFVLP
ESRPGQKGVKFDFKALNPLVPLGWALGVKTLLPLIAVFFILNFVGNMYGTVWALFGVDAF
QWNGLMVGLSLAGYGLFHAIVQAVLPGPVAKRIGERNALLVGMAFESAGLLISAVATQGW
IIFAVLPLYALGGVGVPALQSLTTQQVGEDKQGQLQGVMASIVSLASIFGPLFFSAVYFG
IRDSWPGIVWAVGVGIYLLVIPVILTVRARPAAEKTA
>AIA17915.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MARFDELYQGLLSDIMERGVREVNGRTGHETAALPGLSFSIDLEQDGFPLLTLRKIPTKI
FIAEQVWFVSGARKPDIFLRDFTKIWDDFTNPGDVVTVAYGYRWRKHFGRDQLGKLIELL
TKDPSSRHGVIITWDPSSDGLGGIAKGNVPCPYSFTVNIIGGRLNMMNVVRSNDMILGFP
HDVAGFAFLQLMLAQKLGVKPGVYSHIIANAHVYDIHYDAAKEMIGRKTDHKPVHITLPK
NSFDRSEAKDASLVEEVNENLLEQYVPQEAIKGLRIVL
>AIA17884.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLVKDILDNGRPGDGLVRSDRTGVGTYSVFGRQLRFNLDEGFPLVTTKKVHLKSI
VYELLWFLRGDTNVKYLRDNKVTIWDEWADQHGDLGPVYGKQWRRWETPDGRKIDQIQNA
IDQITNNPTSRRIIVIAYNPGDLPEVAPPACHTFFQFYVSGGKLSLQLYQRSADLMLGVP
FNIASYALLLMMVAQVTNLEPHEFVHTFGDVHIYANHLAGAREQIKRDPKPLPRMTINPK
VKDIGAFCFEDFQLSGYEPWEHIKYDIAV
>AIA17823.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
QALPIPEIIPKGGFYDFTNKYPFLNPEAGGAAQHICPASIEPEKTKEIQELALRAFRSLG
LRVYARVDVILSRTGEPFVLEINTIPGMTEASLLPEAAAVAGISYVDLCRRVIALSRARI
EGAS
>AIA17805.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNKPLISLIAALSENRVIGNRGEIPWQIPGEQKRFKEITTPHPIIMGRKTYESIGRLLPN
RPNIIITGDHTFQVEGGHVVHTLDDAIKKAQELDKDEVFVIGGGKVFAEVIDKADKLYLT
IIHKEYEGDAYFPDYSQFSNITEKEEKSTDSLSYTFLTLIR
>AIA17807.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTEMNSSKKHGEYQYLDLLDEILKNGERKVDRGTDVVLYSLFGRQTRYDLSEGFPLLTTK
KVYWKGVLHELYWFMSGQTNINYLVDNNVHIWDDYPFKIYNWKRESDKKLPELTKEEFVE
KIQTDAAFAEKWGELPRIYGEMWRNWPTRSGRTIDQLKWVLQEMKDDPDAKNLIVNSWNP
EYLYTMATYEDASRFPICHNMYQISNRNGKLSLQLYQRSADIFLGVPFNIASYALLTIIL
AQISGLEPGEFVHTFGDVHVYENHIEQAKEQLSRKPRPFPTVTIDPAVKNLDDFRPEHVM
LDNYDPYPVLKGELTVAGGFYEKKK
>AIA17794.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MFFAIHSYKSPISIAIVPRIAYNQQVMAKFDEVYQQLLADIMDKGIREVNQRTGHETAGL
PGVSFSIDVEKDGFPLLALRKIPSKIFIAEQIWFISGARKPEVFLREFTKIWDDFTNPGD
VVTVAYGYRWRRHFGRDQLGLLVNLLQKDPSSRHGVVVTWDPAGDGLGGANKANIPCPYT
FTVNIMGGRLNMMNVVRSNDVILGLPHDAAGFCLLQLILAQKLGVKPGIYTHTIANAHVY
DIHYDAANEMVQRTPDSPKVILALPENAYERAEAKDVTLVEDINAPIVKQYQPGEAIKGL
RIVL
>AIA17787.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VATAQSMARTLGNPLCWFQASYGAVYDVPVNELLAHERPFEIDCDPKRPAVWPDLQQAFD
TMPVEDPVVILGFHGGAGEDGTVQRMLEQRGIPFTGSGSAASAAAFDKGRAKEMLKGKVK
VAESRTVGVSDADTIRSAVESMLSSHERIVLKPLAAGSSRGLFFVNRGEPIDDIIRKIVK
LKLPYIIEQFIKGRELTVGVFDRGGDVIPLPVVEIEVDAGHTFDYEGKYLGKGTREICPA
KIPASVAGAAQEMAVAAHRGLGCEGYSRTDIMAADDGPYFLETNTLPGLTKSSLVPQELR
TAGIEFREFLEAQIALARKRAATTPRKVSAAGSRS
>AIA17786.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MASFDSIYRSLLEDLVNKGVKEVNNRTGHETASLPGVSFSIDLEKDGFPLLALRKIPVKL
FIAEQIWFISGTRKPEIFLRNYTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLGSLIKLL
ENDKSSRHGVIVTWDPSSDGLGGVSKSNIPCPYTFTVNIIGGRLNLMNVVRSNDMILGFP
HDVAGFALLQSILAQKLGVKPGVYTHVIANAHIYDTHYKAAEELIRRPVDSAPTKLKLPK
DSFERAEAKDDSLVEEIYDSLASGYKPGEALEGLRIVL
>AIA17772.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|0
MARLKSKRLERYAESGQLQKEENMNDRMISIIGAFDRNGVFGIGEHLPWSGPDGRSLIRM
DMGRFVQATRDTVFGKGKQNVLVIGRGSMDAMGWRPLPRRHTIVLSQTINQKEANEKVPE
GKRVWVARNAAQALETALSITDCGHVFFGGGETVWLEALKSGLCNRAFITMIECDTVAAS
EHKGTVRKLPEMLLDETFEGMQVEHIRLDDTWGDREVMLDFRNYEKA
>AIA17702.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKPLISLIAALSENRVIGNRGEIPWQIPGEQKRFKEITTPHPIIMGRKTYESIGRLLPN
RPNIIITGDHTFQVEGGHVVHTLDDAIKKAQELDKDEVFVIGGGKVFAEVIDKADKLYLT
IIHKEYEGDAYFPDYSQFSNITEKEEKSTDSLSYTFLTLIR
>AIA17691.1|FEATURES|farme|puromycin|pac|antibiotic inactivation|0
MSVDVSPLQRGDVRAAAGVLARAFYDDPVTTWLLPDDRTRLKALTRSFAPLARHHFLPRA
GSEVGLRDGTVGAATLWDPPGKRKPSMVEQLITMPAMLWSFRSRIPASMRVMELMEKHHP
EEPHWYLMLIGSDPAVRGAGFGHALMRSRLDRCDAEGAPAYLENSNPKNESYYVRFGFEV
TGEIKLPDDGPTMWPMWRNPG
>AIA17650.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAAVEIRDVRKAFGPTQILHGVSIDIADGEFVILVGPSGCGKSTLLRMIAGLESVTSGEI
SIADRVVNNVPPKERDIAMVFQNYALYPHMTVADNMGFSLKLKKAPVAEIGQRVGQAAEI
LGLTPYLDRFPRQLSGGQRQR
>AIA17634.1|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MASIRDKGQTMQRKVILLFGGESQERFVSVATAQNLSRFLPNALCWFWAPNDAVYEVDAA
FLQEHKDPFNAAFEPQIPVLFETLPSALDCPDYKGHIFLLGLHGGRGEDGTVQKWLEDRD
LTFTGSHSEACGKAFDKVWAKSVLADFPIKMAPTLVVRGNDKLSLEALRTLFETHSKVVV
KPVHDGSSVGLCIIESDRALQAALDMVCSQLDRPFIAEPFIAGTELTVGVVDEAHGPRAL
PATEIRAQAGRTFDYNGKYLGHGVQEITPAEVSAEWVKKAQEMAVLAHKALGCVGYSRTD
LIMHEGEAYFLETNTLPGLTRASLVPQQLAAEGTTLTSFLEHVLDMAEKHREQK
>AIA17610.1|FEATURES|farme|beta_lactam|PEDO-2|antibiotic inactivation|0
MSLFRIRCFGVGDGLASADRFHSSYLHHLGGSSLLIDCGEPVSRSFKAAGLDYDSVDAIF
LSHLHSDHFAGFLMLMQSFWLEKRRRELSIYLPADAIPRVRELLTGVYLFPELLPFPVKY
EALRAGEAIKVGGVRITPSPTTHLEQLRGRFQAKYPGDYQAFCFLLEADGLRVVQSCDLG
APEDLKPLLEQPVDMLVCEVSHFTPESLFDFLKGREIRRLSLVHISRPLWQKRDALLEQA
KRALPKVTVSIAKDGDVFEG
>AIA17583.1|FEATURES|farme|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MTTKEDLVGDFGRLGICDGDTIMVHASLKAIGPVDGGPAMIVEALVDAVGQSGNLLAYVS
WDRSPYEETLNGRRLSDAEREAWPAFDPATAGAYRGFGVLNDFICGYPGAWRSAHPDASM
AAIGPRASELVRPHRLGDAYGPGSPLERFVSMRGRVLMLGAPLDAVTVLHYAEALADIPD
KRLVTYEMPLLDSSGKKVWQTAKEFDSNGILDCFAVEGQPDAVEQIATDFVRLGRCRQGR
VANADCFLFDAVQLVDFGVRWLERRFGATRQGSRAG
>AIA17552.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|0
MKVFIVAALTADGFIGRGSDHLATEWTNKDDQKVFTRLVKPANNMVMGRNTFLTIARKYK
SVFTKSMPGRRLFVYTPDPAELADYPEVEAVSEPPAELVKRLSGEGLEQLAICGGTQIYT
MFMAAGVVDDLYLDVQATVFGAGQGLFNAPLQAEIVLESTERLGDNNLLLHYRVQ
>AIA17545.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRITILFGGTNTERLVSVASAQALHRALPEADLWFWDVADTVHAVTSKQLLSHTRPFEDE
FKPGNRGLPLEAALDKARTEDRVLVLGLHGGRAENGELQAMCELRGIAFTGSGSASSNLA
FDKVAAKRFAAYAGVAVPAGVALENLDAAFAEHGRLIAKPARDGSSYGLIFVNAKQDLVA
VRNAARTEEYLIEPFVAGVEATCGVLERPDGEVLSLPPIEIVPGEGTFDYTAKYLLKST
>AIA17543.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRSLDPSKYDVVPIAITHEGRWLGSKDAVKMLTPGDAIQAALKGAEPMAVLPEPRQNGAV
DVFFPIVHGTYGEDGTIQGLLELAGVPYVGAGVLGSAVGMDKDVMKRLLREAGLPIGDYW
VTRSKDIGNFIREIGPTLPYPVFVKPANLGSSVGISKAHNLAELPAALAMASEFDRKIVV
EQGIDAREIELSVLGNDDPQASIPGEIVPSREFYDYQAKYVDD
>AIA17525.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHTISMIAAIGKNRELGKGNALLWHIPDDLKRFRTITNGHPCVMGRKTFESIVAILGKP
LPNRTNIVVTRDKNWSAEGALPVQSIEDAIQLGKRKPGGEEVFIIGGGEIYSLGISYADK
LYLTLIDDSKEAD
>AIA17519.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIIGIVAVDQNDAIGKGGKLPWHYPADMKFFKETTIGNACVMGYKTWLTLKKPLVDRLNI
VLSRSRDVEPQESVRVCRDVESVLELLKTLNTDLFVIGGEQVYRSFLPHIDKWLVTEVPL
SVEGADTFMPKNYLEGFDLNESKMLDEELWVSIYERAG
>AIA17510.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MEEKLEIVVAADLDNGIGKDNGLPWRIPGDMKFFQSLTSNATEGGINAIIVGRKTWESIP
EKRRPLKNRINIILTKNTAITAPDGVLVCNSLESALEALQGIEHQRCFIIGGAQIYKEAL
QHPLMTTIHLTRIMQEFDCDAHFPPIDDRFALAAVSDTMGENEIEYRFQRYEKKSAL
>AIA17511.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HTNIWDAWADENGELGPIYGYQWRSWPAYDLDEKTGLYKKRHIDQIQNAIDLIKTNPDSR
RIIVTAWNVADVPKMALPPCHMMFQFYVINGRLDCQLYQRSADLAVGVPFNIDSYSLLVI
LMAQDCGLTPGVFTHTIGDAHIYQNHLEGLQKQLDRKPGSLPEVEIPNKSLFDLKFEDFT
LKNYDHQGFIKFPVAV
>AIA17508.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLKLIAALSTNRVIGRENGLPFRLRDDLRRFKEQTGKEAVFGGSNTYFSIPAQFRPLPGR
ENIVLTRHPNRFDGEGVTVVTSLDIVVERAQTENIWVIGGGEIYTLTLPFVTEMYLTRVH
ANIRGDTQFPEWNPEEWTLVSSEYRPADEKNEYPLTWEIHRRKP
>AIA17471.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRKTWESLGKPLPGRDNIVVTRNADYEAPGAAIATSLEAALALCAGEKIAFVIGGEKLF
EESLPVAAGLVLTEIHRDFDGDTRFPEFDRTKWKAAQREAHTAADGMRFDFVMYERG
>AIA17449.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIAIVVAMDKNRAIGAENKIPWRIKSDLIRLSRLTRGNVVILGRKSFDSMVWYYDKSGKR
MPGAQYIVVTRNSAYKPARDNAQVAHSVQGAIALAQSLGSTICVIGGGSIFDATLPYADV
IYLTEVQTSIKDEVDAYFPELDPTEWREVSREHHRKNEQDQYDTEEIVLERV
>AIA17441.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTVHTSTISAKAAEVHAGRLVLILGGLAALGPLSVDMYLPAFPTIARSLETTLPSVEVSL
ASYFAGLSLGQLFYGPLADRYGRKVPLLVGLIIYALASVACALAQSIEAVITLRFIQALG
ACGGMVIPRAIVRDRFGHQESARIFSLLMLIMGVAPILAPLLGGYLGTHLGWRSIFWFLV
MFSSLAMAASALFLRETHGSHPEFKMSGSFATFGRLLRDREFLRYTLAGSIAQAGMFAYI
TGSPFVFIELFGIPAESFGWVFGGNALGLIAVSQLNARLLRTYSYERILTVAIRILAISG
SF
>AIA17438.1|FEATURES|farme|multidrug|efmA|antibiotic efflux|0
MLIDLSPLKASRDYRLLFTGQLVSFFGTMMTFIVVPWQMYQLTHSSAMVGYIYLAEFVPM
VILAFVGGAMADFLDKRRLLRLTEIGQTTATVVLLVNSLLPNPQVWVLFLAVAVHAGFAA
VQRPAFESFIQKVIPAEMMSAVMALNSIRYSVGAIVSPAVAGIIATQFSASIAYAFDLVT
FTASLWAVFLIRAVPPPENAEKPSFQSIKRAWKYAFGRQELVGTYFIDIAAMFFAMPQAL
YPALAVVYGPQYVGFFPASLAAGALVAGLTSGWTKKINRHGLMVTIAAILWGVAIIFFGL
ADSIVPALLFLGAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMMSYLTGPMLGSAKM
GIVAESFGVKAAIVSGGFMCIAAVLGSAVFLPKFIGYDGREGRRQREAEEAERAEMA
>AIA17433.1|FEATURES|farme|elfamycin|facT|antibiotic efflux|0
MVGLLINLTFESAMLGFFLPFTLILQIGLGFSVIKAALVGIPTAIGISVTMAVFSQKLIP
KLGRYTMVLGTFLMAGGLILLYELLNRQVLNISPWTFIPGLLLVGAGMALIMAPMFSVAL
ADVDAQHAGSASGILSAVQQLGGAIGTALLGLVFFSHLTTHATPSFNVVAPQIHQQLSEL
NLPVSAQEHIVQTAKVCFVDRSKANDASGTPESCKQTENTKSLAPASTQRIGSIVQNGVK
QANSNNFISAFKASIIFELCILAAIIVLSFLLPRHIKISAEPEAL
>AIA17430.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MLPVILTTIVLDAAGIGLTLPILPRLLQEVGHTSELGWLFGAFLSLYALMQFLFSPVLGG
LSDRFGRKPVLLVSLGGAAVDYLFMAFAPSLWLLFIGRAIAGITGANMAVASAVITDLTP
EDQRARRFGQLSACFGIGFIAGPAIGGLLGEVSIRAPFVAAAFLNAVNLALAFFTLRETR
RRDTEASESKNSFSPLGTLRWVSGLGGLLPLIGAYIVLAFVGEVGGTIWVLYGQDKFAWS
PITIGISLAGFGLFHAGIQAFVAGPISERWGERRALLISITTDSIAYILIAIATEGWMVF
ALLPLFCLGRHRRAGAAIAADIRRALRPARQAARRAIQHDQPCLYRRSAIDQHRLFHEPI
ELSGPGMDCGRSTLLALPARLSQPLKGGRGIAEPALRKRPSDVFRRTASR
>AIA17392.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGRRTWESLKGALPGRKNIVVTRTPGYQASGASVAPSLQAALAFCAGAPKAMVIGGNQLF
AESLPLAAGLELTEIHKDYPGDTWFPAYDRAQWQEIKREARTAADGTRFDYVLYEKRA
>AIA17388.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDKNGAIGKDGKLPWHYSADMKFFKETTIGNACVMGRKTWLTLKKPLPNRLNI
VLSRNSEVEPQESVLLLRDVDSVLAVAKNLDCDLYVIGGEQIYKAFLPHIDRWLVTEVPL
TINDADTFIPREYLQEFEGIEAREIGDNLTVRLYKRK
>AIA17387.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSEIVLVVAIAQNGVIGNNGLIPWHISDDMKRFKALTLGHTVVMGRKTWDSLPRKPLPGR
INVVVTRQTDWQAEGAVVANSLGQATAGTSGTVMVIGGAEIYERALPLASRIELTEIHKD
FDGDARFVLDRTGWHETLREEHVTPDGLRYSYVTLTR
>AIA17382.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVVAASDNNVIGKNNQLLWHLPKDMKFFKNVTWAMPVVMGRKTFESMKSKPLPGRK
NIVITRQAGWNAEGVSVVDSVDAAASLAEQLNYKEIFIIGGGMIYLIAFDRANKIYMTRV
HADLEGDTYFPVIEKNDWSLVSKTENPADEKHAYAFSFQLWERKVM
>AIA17366.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MTLKKHIAAHVREIPKSGIREFFDIVAQEKEVISLGVGEPDFDTPWHIREAAIYSLEHGR
THYTSNLGLPELRSSICRYVHKHFGVAYDPRTEVIITVGVSEAIDLALLSVLNPGDDVLY
HEPCYLSYSPSVNMAHGKAVAVPTRAEDNFRLTADALKAHITERSKVLMLNFPCNPTGAT
QTRAELEKIARLCIDHDLIVLTDEIYSELTYDGAEHVSIASLPGMRERCVFLHGFSKAFA
MTGWRIGYACAPAILTDAMMKIHQYAILCANTTSQDAAIEALEHGARGVETMRREYERRR
NYIVRAFNDLGLECLKPVGAFYIFPKISSTGLTSREFSLGLLEKKKVACVPGPAFGASGE
GFVRCCYATSLDQIKIAMERVAEFISEVKKK
>AIA17347.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MSATYKAVAAMAANRVIGKDGALPWKLTEDMKFFRALTTGHPIVMGRKTWESLGRPLPNR
RNIVLSRNMEPVEGAEVVRSLGELRALQLSGDVYVIGGAEIYRLLMPDCAAIYLTVLTTD
AEGDTCFPESEGEFPKVTVLQHIPGVAEWRLYERTNKNRS
>AIA17344.1|FEATURES|farme|aminoglycoside|N184_17645|antibiotic inactivation|0
ALAESHNLLHTVLATPEMFGAAMFSDQPIVGTLMAEYDGKLAGCAVWHRSFSTNRGAEVM
YLEDLSVLPEFRRRGVARALLKAVARLALAKNYPSIYWLMMDWNKEASALYQSIGAEIEP
GTAFCRIRDDALKALAS
>AIA17316.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAFKAVKSELLWFLAMKDKERASDEELKALNGSERTIWTDNAESEYWKPKIQFPGDLGRI
YGIQWRSWKSPDGKVVDQIAELIKKLKNTPYDRRLIVSAWNPGELDDMALPPCHMMFQCF
VSGDKLSLHMVQRSCDLFLGVPFNIASYSMLLHMLAQVTGLKAHECILTLQDAHVYHDHF
DAVKEQLSREPMALPQLWLNPEVKDIDSFTMEDIKLENYQSHPSIKAKMAV
>AIA17309.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|1
MKQYHELVQRVLDQGERREDRTGTGTLSVFGTQTRYDLREGFPLLTTKKVLWAGVVRELL
WFLRGSTNIKEDLAQHTPIWDAWADEQGELGPIYGHQWRKWGAPFRTHARDKQPETAARS
GAGIDQIQEAIQLIRKDPTSRRIIVSAWNVADLPHMALPPCHAFFQFYVQQGRLDMQLYQ
RSADIALGVPFNIASYALLLMMVAQECGLTPGVFIHVPRRRAHLSQPRGGAEGAADAPAL
PAAARHHCPEAARRDRLRRHPAARLPAPPVHPLRGIGMKFELVVAADEARGIGRAGGLPW
RLPGDMAFFKRVTSEAPAGRHNAVLMGRKTYASISPKFRPLRGRLNVVLSRQAALTVDEG
VLVFGSLEAALARLAAFTDLAHTFVIGGGELYAEAIAHPGLARVHLTRVHATFDCDTCLA
PFEDRFRLVTQDGPHHDDGVHYTFETYERA
>AIA17280.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTNDQQNVANKFPEPQEEIAMVVAASTNNVIGKNNQLVWHLPNDLKFFKNTTWGFPVIM
GRKTFEEVNKPLPGRINIVITRQADWNVAGAVKAADLQDAIVKARETNSRKIFIIGGGEI
YRQSMSVAGTIYITRVHGEFDGDTFFPEISEQEWQLVSNEDFPVDDKHAYAYSFQVWTKI
KHS
>AIA17273.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIISAIAAMSSNRVIGRDGDLPWHLPRDMKFFMNTTKGHHVIMGRNNFASMNYIPLKNRV
NIVLTRDPFFITSTAIVLHSIEEAINFAYEAGEEEAFIIGGGEIYTQALHLTEKIYLTEV
ITELPGDTYFPELDMREWEVVSSEYVEPDAKNEFPMRFDVLLRKE
>AIA17271.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTPEVIIIAAVAESNRVIGRNGKLPWRIPQDSKRFQEITLGHPVIMGRKTWEFDVEKRP
LSKRFNIVVSSSPEQEDVSKHCHNYPFELAFVNSVQDALKNTVNQEKAFIVGGASIYSQA
LNLADTLELTLVEGNFEGDTFFPDYQHLIGSQFKLVNQEKHPGFRYETYRRIG
>AIA17254.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
TVQAILEKKGIPYTGEGEEGSRLAFDKIASKERFVECGVPTAPYITLRKGEVPALPLPYV
VKVPCQGSSVGVYLVKTMSERFAALEEAFKLAETVLVEALVSGRELTIGILGDTPLPIIE
IRPQGGFYSYENKYTWTNRGGAAEHECPARLSRAEKKIVEAAALAAHRSLELEIYSRVDV
ILDAHRGPQVLEVNTIPGMTETSLLPEAAAAAGISMSQLCESIVRLSLERRLANNR
>AIA17249.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPKISSKALRMPASPIRKLVPFADAAKKRGTKIYHLNIGQPDIETPSTMLNAIKSSNIKV
VEYSNSAGIESYRKKLAEYYKSHRINVEYSDILITTGGSEALQFAFNTCFNPGDEVIIPE
PFYANYNGFATAVDIVVKPVVSGIETGFALPPISDFEKVITPKTKGILICNPGNPTGYLY
SRAELEALKALVLKYDLFLLADEVYREFCYDGREYVSVFHLDGLDNNVVLLDSISKRYSA
CGARIGAFITRNKEVLNAALKFAQARLSPPTFGQIGAEAALDTPKEYFDKVSKEYTERRN
FLVNELNKIPGVHCPMPGGAFYCIAKLPVDDSDKFCQWLLESFSHEGQTVMMAPASGFYS
GGGKGKDEVRLAYVLNRSDLEKAVTCLREALKKYPGSTLQGKN
>AIA17199.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWSLPDDSKYFMVTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFSAPGCIVVHNIDDALNLARTRGESEAFVIGGAEIYTLALANANRLYLT
EIEADVEGDTYFPSFDKAQWKEVSRKHHDADQRHAYAFDFVVYERIA
>AIA17179.1|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKHFKAIAAMSMNRVIGHGNTIPWHLPEDFKWFKKMTTGQVVLMGRKTFESIGKPLPNRE
TIVLSRSNFSYPGVKTISALNEINLEHESRDVFICGGAQIYEQTLPQCSDLYLTLVKRTV
EGDAFFPAFEDRFEVVEEITENADFKILRYRNRLLGE
>AIA17155.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEEKAKVALVAAMSKNSHALGKNNDLLWHIPEDMKRFKALTASHPVVMGRKTFESIIAIL
GKPLPGRPNIVITRNPHYAYEGVIVVSSLEEGLKRAEELDPEEIHIGGGAEIYTQALPYV
DLLFLTFVDDEKDADTFFPPFEKDFTVVKEHEKKDHNGLSYQWVDYKRI
>AIA17149.1|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MKQLQAIAAMSLNRVIGAGNQIPWHLPEDFKWFKQTTTGHVLVMGRKTFESIGKPLPNRE
TLVLSRSQFSHPGVKTIASLDELSALDGKREIFICGGAQVYAQALSLCSDLYLTLVKRAV
EGDTFFPPFEDQFDLAEEIRDTPEFKILHYRSRQS
>AIA17143.1|FEATURES|farme|beta_lactam|K678_12262|antibiotic target alteration|1
MKACGGDALGYARALTRVERIRRNAPALAAAATGGSLESRIRRLVDASYRERSTGGVSAG
LILLTTLFAAVLCVHAAFSGKISVPPTSERASDSPVKTVSEDFRSPAAFGEKSILPDEGF
AGENDELRRIARSALGRHHGSVIIMNPQTGRLETVVNQDLAFRREWNPASTFKLVTSLAA
LDKQKIAANDLIDLSETAENLNLTDALAFSRNEYFGILGRRVGSEKLFDYARRFGLGRLT
GVNLPGEIAGRLPVSDFGLNAGEVGIYGRQIEITPLQLAVLVSALANRGTVVRPFAGRPP
ENSRPAPAGLNVSPDSIAEIVAGMRSAVEKGTGRAAFNDSLAIAGKTGTAREGRDDIGLF
ASFAPIENPRFVVVVALREPDADGAAAAEIAGIIYRELGEMPIEN
>AIA17129.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDRNRLIGSNNALPWHLPPDLKRFKTLTMGKPVIMGRKTHESIGRPLPGRRNIVISRNAS
YKAEGCEVVGSLQQALELAAGDAEAMIIGGVTIYQSAMPLVRRMYLTLIDAGFSGDAWFP
EYDPKQWKITAEEKHRHREGEADFEYRFLQLDRV
>AIA17010.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GHQMRFDLAEGFPLVTTKKLHVKSIIHELLWFLQGSTNVRYLREHGVTIWDEWADENGDL
GPVYGRQWRAWPTLDGRHIDQIARVVESLKGDPDSRRHIVSAWNVGELDKMALSPCHCLF
QFYVADGRLSCQLYQRSADVFLGVPFNIASYALLTQMMARVTGFEPGEFVHTFGDAHLYL
THLDQADEQLKRSPRALPRMEINPEVRSLFDFAYEDFKLAGYDPHPAISAKVAV
>AIA16994.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MNYLINFSIFRRNRNFALLYIGQFVSLFGTMITGVALPYQIYTLTHSTLMVGLLSLCQLI
PLVFTALLGGVFADRYHRRRLLMIAETMLVMGCGLLAWNAHLAEPHLWIIFAAAMFMSAF
TGLHRPALESIVQQLVAKADFPVVGSLGTFKSSVCMIAGPAIGGVIIASAGVVITYVVDC
LTFAVSLTTLLLMTHIPKPVLTVPDDSAWTSLKASLLYAKSRQELLGTYFVDFVAMIFGM
PTALFPAIAMSFGGAKTLGLLYAAPAVGALIVSLFSGWAKDVKRHGAAVAISAVLWGVSI
IFFGLSTHLTAALIFLAFAGGFDAVSGIFRSVMWNQTIPIALRGRMAGIEMISYISGPRL
GDTEAGLMAAAFGITFSVISGGVLCVLGVGICCWYLPKFWHYEAKEFASTDEVVAG
>AIA16991.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MIIAGRQCRPINLKKERFMNAQLIRAAIVLGLLSVIGPLAIDMYLPALPAIGQDLNASVG
AVQQSLMAFMLAFAVGQLVYGPLSDMFGRKPPLYAGIGIFLAGTIGAAFAPSIEWLVFFR
FVQGLGACAPMSLPRAIVRDNYTGAPAAQL
>AIA16968.1|FEATURES|farme|aminoglycoside|IP83_02945|antibiotic inactivation|0
MNWYEKLSQYFPIEEMKSKKHIETLLQERSDIYHKNEGPHHVLMYVETDQFIVIDYLFVS
KDARGQGLGGKLIDELKQHNKPIILEVEPVDYKDSDSAKRLHFYKRADFKHAQTIGYNRR
SLATNEVNQMEILYWSPTSETEESILNKMKKTYELIHTYKDKEIYGASYQPADQVLKIDK
NRKDGDILADL
>AIA16930.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|0
RRYDPNELSISRSRGMAFTRLQSDTLKPLFDRSVMAMYPPGSIFKPILALAAMQEGVLDE
DRTIYCNGAYYSGGLKRGCHNHPSAHNVSAAIQYSCNTYFFTVYKDMIDISGYTMPEIGM
RKLNGILTEFGLGHKISIDVPSEKTGNLPGPSYFDQVYGSGKWRSPYILSMGIGQGELQL
TTLQMAHAAAIIANEGTYTDPHILKARVPAGELPQQEFYPRRRVSIDYRHFEPVIEGMSG
AVRAGTATLAYIPDIEVCGKTGTSENPHGEDHSVFFGFAPRDQPKIAIAVYIENAGWGGS
FATPVGGLMIEKYLRGEISEPRKYIETRMLEADLIHKPKS
>AIA16927.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTFIIAAVTADGFIGRDSGHTADWTGGADKKEFVRLTKEAGVVVMGARTFATIGRALPG
RRTIVYTTKPEEITAEGVETTNESPRQLLARLEQEGAHAVAICGGATIYDLFMREGLVDE
LYLTIVPIVFGQGIQLFTGELRAGLDLLEAKQLADSTILLHYKNHATPNR
>AIA16886.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKTFLFLFGLNDVFAFYFPKPLFFLFAVNNFKRKNKGFDLSAPFRGTGGKGGIVLSLLVA
ADEGNVIGKNNQLPWHLPNDLKYFKNLTWGLPIVMGRKTYESIGKPLPGRTNIVITRNKD
YAAEGIVVVHTIEEAL
>AIA16801.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIYLIAAMASNRVIGRENRLPWRLPEDLKRFKELTMGHPVVMGRKTYESIGRLLPGREN
IILSRDPGFVVEGATMVRSYDELVSAERARGRELFVIGGAQIYSRALQDADRIYLTEIDA
EIEGDAYFPEVPPSFRPVASEERAGDPAFRFVTYEKTGRD
>AIA16803.1|FEATURES|farme|beta_lactam|TaR3-like_MBL-fold|antibiotic target alteration|0
MRNRTREVLSRFVESAHGKRGDVEGFLKHLPPHLFGGFGGNTPCIEVSTGDSRVIIDGGS
GIRPLGYELMGGPCGKGQGEVHLIFTHFHWDHLIGLPFFVPIFIPGNKIHMYAVQPELEQ
VIRAVFKKPFFPVPYEYLGSKISFHALEPRKEFRLGDLSITPYQLDHPDPCWGYRFEHGG
KTYAHCVDTEARRDG
>AIA16790.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKPEICIVVAVAKNGVIGGHNQLPWHLTADLKHFKLLTLGHPTIMGRKTFESIGRALPGR
HNIVITRDPNFTAPDCTLTHSLEAAIDIATKDNPERICIIGGGQIFQQALPLTDTIYITY
VDAEPEGDIYFNINVDDWREISREDHMADEKNPSNYSFVQLVRS
>AIA16719.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSVKIAMIAGVAENGVIGNDQTIPWRIPSDMGFFKRTTLGKPIIMGRKQYETVGKPLPGR
TNIVVTRQESYQPEGVLVFGSIDAALDKAREIAESDGVDEIMIIGGGQLYAQLIDRADRL
YISHVDLAPAGDVRFPEIAPEDWAVVDLPEVEPSPKDEASYRVKVYERRKDPVH
>AIA16691.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MNVLVLGGGISAEREVSVRSTAAVVSALGAAGYAVVQADPADSDFDLATLAGKCDVVLPV
LHGAGGEDGVLQKQLETIGVPFVGSGSAACALTFDKAQYREFVIARGVRVAAGQVVDQAQ
FETSGLRTKPYVLKPIDGGSSVDTVIVHNVAQQPDETYFDDLFARYDRMLVEELIEGQEI
TVGVLGDQPLPVILIVPPSDGEFDYENKYNGRTQEIVGPSQIPSETQQKAQELALQIHQM
TGCRHLSRTDMILGLDGQLYVLETNTLPGMTDHSLFP
>AIA16687.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKVVLIVALTADGFIGRSNHHFADWTGQADKKLFVKVTKEMGTMVMGLRTFGTIGRALPG
RRTIVYAPQDEPAPEGVEITQEAPADLVARLKREGTTGLAVCGGASIYSQFMAAGVVDEL
YLTVVGKLFGTGVSLFSESLDVDLDLLDSTKLDAQTVLLHYAVKK
>AIA16670.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMG
IYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRNDLVEILIDSIEGVP
LQFNQTIESIKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAY
FSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRR
VLRDTFQDFGWEAPRILELMSDSDDFYFDSFTQVIMKSWTKGRVALLGDAAYSASPISGQ
GNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSK
EVAEERSNNIMEQVKIASNMIVLQDYANPH
>AIA16666.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MAPIQPEFALYRTLFYVIEHRSILERRSIRRFIMTTTTISRSSSRTYPSLRAAWIPLAAL
CLAFFVEMVDNTLLSIALPIIGRDLGSSTTDLQWVTGAYSLTFGGLLLTAGAMADRLGRR
RVLLVGLAVFGVLSLAVVAVSTSGELIALRAALGIAAAAMAPITNSLVFRLFDDKALRMR
AMTLMIVVGMSGFVLGPLLGGTALAHAGWGWLLIVNAPIALIACLGVRLGVPADRPEDLT
HDALDLPGAVLSVATIGLACYSLTSGVQHGWLSAITIATVLGAVAAGAAFIRHERRTAAP
MLDLDLFSNGTVRGAAIAQIGTSIAMASVMFGLILHFQYAYGWSPMKAGLANLPLILTMI
AATPLSEWLAKQFGHRIACLIGAGLMAGSLAGLSWGVQHGYAAIAVCMVVMTIGLRTVMT
ICAVALIDAMPGNRTSIGAALNDTAQEVGTSLGTAVVGTLIAVLVATQLPTGSWGNDIVT
SFFHGERVIYAVLALIVGLVTAGGALTLTDSRSTEEAH
>AIA16648.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIALIAAMTREGVIGIHNTLPWHIPEELQYFKKMTLGKPIIMGRKTFESMNCKPLPKRK
NIILTQSKFKSSDSFENGIVVHSIEEALSHVQESEEVMVIGGAKIYEAFLPLASRLYLTI
IEGEYKGDTYFPKIDWAEWTVIEENRNALFTTKILDRKLE
>AIA16634.1|FEATURES|farme|beta_lactam|CAU-1|antibiotic inactivation|1
MRKILSSVIAALFVAGMATAAMAGQPAAWTRPAKPFKILDNIYYVGTEGLASYLIVSDQG
AILLDGTLAENAGHIEKNIRALGFKLSDVKIIPNSHAHFDHAAGIGQLKQDTDAKVMARE
ADRSALENGKQEGDTNYGGASFPAVKVDRALKDGDVVELGKVKMVAIATPGHTKGCTTWQ
TTATDNGISRRVVFPCSITVAGNILVGNKGYPGIVEDFRRTFEKMASLEADVVLPAHPEF
ADVFQREAKQEAGDKDAYVDTQLLPRLVKKSKIAFEKELKAAQK
>AIA16617.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSRKIRVGVLFGGRSAEHEVSLQSAKNIIDAIDKSRYEVILIGIDRDGRWRLGDGSKMLD
AGSPEAGVPEPSGDDPDVALVPGRQADQFISLGGAQSPEAIDVVFPVLHGPFGEDGTVQG
LLKLANIPFVGAGVLGSAVGMDKDVMKRLLRDAGIPVGRFLSFQKYGAREPDFDAVVGEL
GLPLFIKPANLGSSVGIHKATDADSFHRAVDDAFGFDTKILVEEFIEGREIECSVLGNDQ
PIASVPGEILPRHEFYSYEAKYLDESGAALEIPAKLDLETSTRLRDLAVRTFLALCCEGM
ARVDFFLKKNGEILVNEINTIPGFTRISMYPKLWEASGISYGELIDRLIQLAIERHERER
KLRTTYR
>AIA16592.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MLVFSISPILAPLSGSIVIAFGDWRLLFWVMTAVGVLGFVLAVVGLKETRPKHLRTESSI
GGAIRGYGTLLLDLNFVGLSLIGAFGMSSFMSFLGNSSFVYIDHYGLNPTQYSLAFSVNA
VSFFAVSQSTGYMVKRFGLQRVVRWAVTGFASCMLLLAAIFYAGVDSMWVLSGLMFVAFG
FLGLVLPTTGVLGHWKNTASSPARRRH
>AIA16567.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTTKIRIGVIYGGRSGEHEVSVRSARSVIEAVDPEKYEVIPVAITKEGRWLSPAESASLL
PESAQRRLSNYAGVDSDGSTTLVVDPSRGGLLRQEGAGAVDQRLDVVFPVLHGTYGEDGT
IQGLLEMAGIPYVGCGVLASSTGMDKVTMKTLFRHAGLPVCKYVWFLRRDWEGKPSEVRE
RIEREIGYPCFVKPANLGSSVGVSRADDEESLVKAVNLAARYDRRIIVEEGLDAREIECA
VMGNDEPEASLPGEYVVHDEQARFLDYTEKYSSTGHVEFVVPAPIPKRLASRIRELAVRA
YKAVDGAGFARVDFFLRRDDNKLLVNELNTIPGLTDVSGFPQMWEASGVPFKQVIDRLVE
LAFERHAEKARNTTSL
>AIA16547.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLIT
SPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELQRASGAVV
VGSALSVAVMKTGEASKDDPQFGDLSKFAPAAGNARCRRWRGGDGRPLVGDRTLHAGPHA
GRRELDLAVGGRRTHGEHGLRRQHYGLRRSGLQI
>AIA16540.1|FEATURES|farme|beta_lactam|blaVEB-11|antibiotic inactivation|1
MLNPLLIVLSLASTGPTTASLQKDLQRVVTESDGKVGICSWSLAASEAVCINGLERFPLQ
SVMKLIVSAAVMDAIDQKRMKLEDLITVKPEHASPGPQEFADLVRKKGSLAVTVEELMRR
SIVDSDSTSIDILIEKLGGMRTVQSFLKAKNITDIRIDRNERDLQSEFCGFPWQAAYADP
QKFEATMKAVPPAKRDQALETYLKDPRDTATPLGMVKFLKALAEGKLLSRTSTEKLLSIM
EMTVTGPDRLKAGLPPGWKIGHKTGTSFTWNGRAAATNDVGILTAPNAARIAIAVFVTDS
RHSPDERALVIAKAAKAVTGSFAP
>AIA16455.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MWHERRTDHPMLDLDVFKNRTVRGASIAQVGTSIAMASLMFGLILHFQGAYGWSPMRAGL
ANLPLIITMIAATPLSEWLAERHGHRIACLIGTALLVVSLLGMAWGVDHGYLAIAVSMVV
LTLGLRTIMTICAVALVAAMPENRTSIGAALNDTAQEIGTSVGTAVVGTMIAALVTTGLP
PGIWSTELVQSLFHGERVTFLVLAAIVGLVATFGSLSLTDSRSTEEH
>AIA16444.1|FEATURES|farme|macrolide-lincosamide-streptogramin|HDEF_0539|antibiotic inactivation|0
MESPTPIQWQFSQRAEQLQSSVIREILKVTVRPEVISFAGGLPSPATFPVDRMQAAFDSV
LAKQGKVALQYGPTDGYAPLREWIANSLSTDGAKIAPEQVLMVSGSQQGLDLLAKVLIDE
GSKVLVETPSYLGALQAFSLYQPQFVSLPSDEHGLLPEHDL
>AIA16430.1|FEATURES|farme|aminoglycoside|ABB27_14230|antibiotic inactivation|0
PDQIETARLLFREYEAWLGMDLCFQDFETEVATLPGKYAEPRGRLLLAYVDQKPAGCIAL
RGIDDGVCEMKRLFVRDEFRGHRLGLLLVEKVIGEARAAGYLKMRLDTFPPKMGKAVKLY
ESHGFREIAPYYNNPHTGVLFMELDL
>AIA16412.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MAPKGVSSVLITSPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGS
IAELQRASGAVVVGSALSVAVIKTGEASKDDPQFGDLSKFAPAAATRVVGYGEVVTVGPL
SVTAHYTPGHTPGGVSWTWQSAEGGRTANMVYGDSITAYGAPGYKFSAHPEVLASLRNTF
ARVAALKCDILVTAHPEAGGPVAPRRETRAALAMQR
>AIA16410.1|FEATURES|farme|beta_lactam|MSI-1|antibiotic inactivation|1
MLDFSLQHPETIMKKIFAAASLFALSLPAFAGWDDPQEPFQLFGNSYYVGPKGVSSVLIT
SPAGHILIDAGTAKSHEQIIPHIRQLGFKVEDIKYILTSHEHHDHVGSIAELQRASGAVV
VGSALSVAVMKTGEASKDDPQFGDLSKFAPAAATRVVGDGEVVTVGPLSVTAHYTPGHTP
GGVSWTWQSAEGGRTANMVYGDSITAYGAPGYKFSAHPEVLASLRNTFARVAALKCDILV
TAHPEAGGLWPRVEKRAQLGNAALIDPDACRKYAAKGTARLETVLAEEKAKP
>AIA16339.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MIAALTADGFIGRSVDHLATSWTSKEDTRHFVKVSKELHCLVMGYNTYKTIGKGLPGRRT
LVYSPNAIDDPTIEVITEDPVDLVRRLHKEGEVSLAICGGATIYNMFMQAGLVDELYLTV
EPKLFGQGLSLFKDTLDKNLTLLDVASDANSVMLRYSIKQA
>AIA16286.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAQPRYKELVDTLAADIRSGHLRAGTRLPTHRQLASAHGLALVTATRVYAELAAMGLVSG
ETGRGTFVREISLPPRQGIDQFALAAGMVDLNFNYPALPGQADLLRSALRQLAASGDLES
LLRYQPHGGRQHERAAVARHLASRGLKVGWEQVSLVNGAQAGLAATVMALLGPGDVVAVD
TLTYPGFKVLAEACRLELAPIQASGQGFDLDALERLCRTRRVRAVYVMPTLHNPLGWVTG
AQWRRQLVSIARRHGLLIIEDAAYAFLADKPPAPLAALAPETAVYVSGFSKNIATGLRVG
FVVASAESMKAIERIIRATTWNTPGVMTSIACAWLDDGTVERLEAEKRRDAKIRQSMAAE
ILAGLNCVRHPSSYFVWLPLSHEVRADQVAAALMREQISVSTAEPYATSHHVPHAVRLAL
GSVELDVLRESLETVRRVISGYAY
>AIA16256.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|1
MLLDLSPLRVSRDYRLLFFGQLVSFFGSMITFVVVPWQMYQLTRSNAMVGYIALAEFVPM
VSLAFVGGALADYVDKRKMLRFTEIGQTVLTGGLVLNSILSQPSITVLFIIVALHAGLAA
LQRPAYESFIQKVIPPEMISSVMALNSIRFHIGMIVGPAVAGLIATQFSPTDAYLIDLIT
FAASLAAVFMIRFVPPPENAERPSLEGVKRGLKYAVSRQELLGTYFIDIAAMFFAFPQAL
YPALATVYGNEYVGFFPASIAVGALAASLTSGWAKNVQRHGLMVVIAAVLWGVGILFFGL
STSIAPALLFLGAAGFFDMISGIFRGSIWNQTIPNYLRGRLASIEMISYLTGPMLGSAKM
GIVAEYTSVRFALVSGGATCIVAVLLTAIFLPKFLKYQGREGLIQKQFEEAVREQGFEGD
REKWEELNRLTQSEF
>AIA16239.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RMMEERDLGPVYGFQWRHFDATYQNYDTEYTGTGIDQLANVIETLKKNPNDRRMIVMAWN
PKALPEQALPPCHYGFQVTVINGKLNLLWNQRSVDTMLGLPFNIASYALLLHLLAKESGL
QEGKLIGFLADTHIYVNHIDGAKEQLAREPRALPKITTDPFTSIFDWTGEHTTLEGYDPQ
DKIDFPIAV
>AIA16223.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRIYAVAALTVDGFIGRYSGHFADWTGEEDKKVFVRLTKEAGTMVMGSKTFATIGRALPE
RRNIVMTSKPDHITVEGVEATSETPEALVKRLEKEGVETLAVLGGAGIYTAFMQAGLMDE
LYITYVPVVFGGGITMFKGELDAKLEMREQTTLPDGSILVRYIVKKS
>AIA16195.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGSKTWRSIGKALPGRQSI
VLSRTEIEDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPE
TVEDADVYMPLQFLDDFELVDSKEIDEGLIVERR
>AIA16129.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKIILVAALSADGYIARTSTHGADWTGSADKKLFVKLTKEMGIMVMGSTTFATIGRALPG
RRTIVYTTRPETIDVEGIETTNEPPAVLIERLATEGATGVAICGGAQIYTQFMQAGLIQE
LYLTYIPIIFGQGVALFNAPLDHRLELLASEPIGEDAVLLHYQVYSQP
>AIA16093.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MKQLLIIILFVIIVSAVAATKHVDNLQKPAPDLSPFFKDTTGAFVLYDLKNDRYIRYNEQ
RCRERFSPKSTFKIPNSLIGLESGVIRDADFVIPWNRQKYPPQDNWNEEPFSHWGQDHTL
RSAIKYSVVWYYRELALRVGESRMKKLVSAFRYGNGNVSGEIDDFWLNGTLKISADEQVE
FLKAFYGERLPVSKRSIDIVKDILVLEKTPTYTLRGKTGGGSIAEGKYIGWFVGYLETNG
DVYFFATNIEGPNFNAIRDKRIELTKQILMQLGYLTN
>AIA16037.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
TMGHCVVMGRKNFQSIPDKYRPLSGRTNIVVTRQKDFKPAEVHTVHSIEEAIQLARNKNE
TECFIIGGGEIFAQSLDYCDRIYLTRIHSMIEGDVHFPVLNPGVWKEMSRKDIAPDEKNE
YPFSFLVYDRVK
>AIA15996.1|FEATURES|farme|aminoglycoside|MED297_13282|antibiotic inactivation|0
MTRQDSAPHIRRASIEDAKLLADLGARTFAETFSQDNSPEDMAVYLAASFSVGRLTEELT
DPLSVFFVAEVDGSAAGYAKLHPGEVSAGVEGQRPIELVRLYVLQEWLGRGVGPALMRRC
IDEARALGFQTIWLGVWERNQRAQAFYRKWDFHEVGEHIFQLGSDPQRDVVMQRAI
>AIA15957.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
METQEIFSIKPFALIVAIDAKTNGIGYENRLPWQRIPEDVEMFRNVTNDRSPDSRFEVPD
AKNILIMGRKTYESLGGITLENKNRTMVVISETMESKSGLWSFTSLREALIFFSNYHHKT
DRIFVIGGARLYSEAMTYRECKTLYISRIHHSKALEVDTFFPPISETYSLHSSSPVTSKD
CDINFELWKRREDAVKASEAEEHHSEEYHSEE
>AIA15954.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVSLLLAASENNVIGKDNGLPWHLPDDLKYFKNLTWGLPILMGRKTFDSIGKPLPGRKS
IVITRDRDWRHEGVEVVHSIEEAIDKAKTLGAKEIFVIGGAEIFKSSLPVANRIYLTRIH
HVFDGDVFFPEIDAERWSCTSERFCAADEKNAYDHTYHVWERK
>AIA15946.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MDFVRSLALTLVAATLVLAPPTSLASQKPRGDAALETELRRLAATLPGTVGIAVHHVGTG
RLVTVDADRAFPMGSVFKLPVAIAVLRRVQTGGLTLETPITIAPEAYYPGYSPLRDAKNR
AEATVTVRDLVETMMVDSDNTAVDVLMARMGGADAVNAELRAAGVPDVSVHRTEGEVMAD
LDGLGAAPAGGWTYSALVAGEARATAEGKRAGRAKFLADSRDTATPTALANLLARLDRGE
VLDAERTKILVGMLDRNKTGGRRFRAGLPAGVRIGDKTGTNPTVGTYNDAALVTLPSGAR
IALVVMTREAGDTGAAAEQLMASVARTVYAHFARP
>AIA15939.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MLSIVVALTENNVIGTGNKLPWRMSDDLKRVKALTMGHHLIMGRKTFESIGRPLPGRTTV
IITRSKDFVAEGCMVVNSLEEAIRVSENDNEAFVFGGGEIFKQALAFTHRIYLTKIHTVI
DGDTFFPELDPNEWLEVSNEFFPKNEKNDFDCTVLVLERK
>AIA15938.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MGARGALPWRLPEDLKRFKTLTLGKPVLMGRKTWDSLPRKPLPGRTNIVITRDPSFPAEG
ALIAHSFESAIEAAMNETPNEIMVIGGQAIFAAALPLATRIHWTEVEAAPEGDAFMPPID
NAQWKEVARQGPFESGGLRYAFITLERR
>AIA15907.1|FEATURES|farme|bacitracin|uppP|antibiotic efflux|0
MSTTATAVPPAKVETGILAGTRTLLYKEVLRFWKVSFQTVAAPVLTAVLYLLIFGHVLEG
RVKVFGSVGYTSFLIPGLVMMSVLQNAFANSSSSLIQSKITGNLVFLLVSPLSHWAWFLA
YVGASVVRGLVVGAGVFLVTIWFAPLQVANPLWIIFFTVAGAALMGALGLVAGLWAEKFD
QIAAFQNFIIMPMTFLSGVFYSVQSLPPVWREVSHLNPFFYMIDGFRHGFFGTSDVSPWL
SLGVVSVALAVVCGVCLH
>AIA15900.1|FEATURES|farme|tetracycline|tetA|antibiotic efflux|0
QILFGLFGEIVFKMGSVGIGTIWSFAGVGLVTGGVFAHWLGPRLTFRSYKRTISLCYLIH
GASYVIFSQMEQFWAALLFIALSRAAVAVSSVLNMTQLMLHVHDDFRGRVFATLETLTWG
VMMLSMMAAGGASEHYSPRTIGAWAGLLSSTTAIVWAIANVRGRLPEPPVVGRSPEEVEV
HGEPTV
>AIA15869.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MDFVRSLALTLVAATLVLAPPTSLASQKPRGDAALETELRRLAATLPGTVGIAVHHVGTG
RLVTVDAHRAFPMASVFKLPVAIAVLRRVQTGGLTLETPITIAPEAYYPGYSPLRDAKNR
AEATVTVRDLVETMMVDSDNTAVDVLMARMGGADAVNAELRAAGVPDVSVHRTEGEVMAD
LDGLGAAPAGGWTYSALVAGEARATAEGKRAGRAKFLADSRDTATPTALANLLARLDRGE
VLDAERTKILVGMLDRNKTGGRRFRAGLPAGVRIGDKTGTNPTVGTYNDAALVTLPSGAR
IALVVMTREAGDTGAAAEQLMASVARTVYAHFARP
>AIA15835.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKPEIVFVIARAENGAIGKAGALPWRIPEDLQRFKALTMGAPMIMGRKTFESLPRLLPGR
RHIVLTRGNWRAEGAEVARSVDEALALVGGPLVSIVGGAEIYRLFEPVADRTELTEVHRS
PEADTFVPPFTAWREIAREDHQGYSFVTLTR
>AIA15821.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MNVIIVAATSIDGFIARDTTELADWTGSEDKKVFVELTKRAGVVVMGSTTYKTIGHPLKG
RRNIVYSRSDTGIAVEDNNLEITQELPANLISRLEAEGHTEVAICGGSEIYDMFLQAGVV
DEIYLTVVPTVFGTGVPLFKNPIEQNLKLISQRDLGNSTLLLQYEVTK
>AIA15806.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDIAIYVAIAENGVIGREGGLPWRLSTDLKRFKADTMGKPIIMGRKTYEGIGRPLPGRLN
IVVTRDKGWRAEGVEVAHSLDEAITLAKVRGRCMVGAEEACVVGGGEIYAQALPLADRLH
VTHVLAQVDGDAHFPPIDPEIWRVVRSQDFAAGEKDSHATRYTVYERRRDGL
>AIA15789.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MAKVIVLNGVGSVGKSSTAKALQALAKAPLLHVSMDAFLEMLPAAMFGDADGLLFEPLVE
DGKPSIAIRTGPVVARTLAGMRHAVAAMAGQGNDLIVDEVLIGEGEAAEYRTLLSGHDLR
FVGLFAPLEVLEAREKARGDREIGLARWQFQRVHAGVDYDLTIDTLESSPEQSARRIAEA
FGL
>AIA15782.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
AGSIVIGFGAWPLLFWVMGVVGALGLLLLVFALKETRPKHRRTESSVGSALRGYGTLLLD
MNFMGLVLIGGFGMSAFMGFLGNSSFIFIEHYGLTPTLYSLAFSVNAVSFFAVSQSTGYM
VKRFGLPRVVRVAVTGFTVTMLLLGAIFWAGVDSLWVLSSLMFVAFG
>AIA15751.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTLSIRPAVASDAALIFRFIRELAEYERLAHEVDATEADIAKALFGSNPRVFADIAEWEG
EPAGFALWFYNFSTFRGRHGIYLEDLFVRPELRSKGIGRALLRHLARRCVAEGLARLEWW
VLDWNEPALKVYRSIGAMPMDEWTVQRVTGEALQQLAEEP
>AIA15741.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
EILTFRVSKSDGMRRPTVTPPLPVPAGGEPEIQKEPAIMNAFFYRTAVVLGLLSAIGPFA
IDMYLPALPPIGADLHAGTPAVQMSLLIFFLSMGFAQLAVVPLSDMFGRKAPLFAGLALF
MVGGIGSALAPSIEWLIAFRFLQGLGASAGMVVPRAVVRDLLTGNEAAKLMSLLMLVFSV
SPILAPLTGSFIIGGFGWRGVFWAVTIAAAIATVLLATALKETRPAEERVGSSFGVALAG
YRQLMGNAKFLSLASIGGFAISSFFVYLSSSSFILIDHYGLSPRVYSLFFSINAVSFFAM
SQLTGTLADRFGLTRVVKVAVTGYATTMVVLLALFASGVDHLAVLAVLLFVGYGFVGLVI
PSTSVLAMDDHGEIAGTASALLGTLQFAIGAVAMGVSGIFFDGTPLPMVVGIALCAVIAF
TLAQVSLGRVRGVAQVPAE
>AIA15719.1|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target alteration|1
MVKITERDMKDYWITIHPKKAEQKITKTDRKKVQDGKMTDEELYKRQLERISKKDLESFK
DELEVLAIKRQMEGGYSNTPKIIKSDVTNEQYAVISEHLDELPGVDTTTYWERSYPENST
LRTLLGNVSSANEGLPKEKIQYYLSRGYSRNDQVGTSYLEKQYEAQLRGQKEEVKYVTDK
KGSLLNTIQVSKGERGNDLVLTIDMKLQKAVEKQITDQLLAKKQMNGTEFLDRAFVIMMD
PHTGEILTMAGKKYTIDKTTGTPKIEDFSLGNISTSYEMGSVVKGATVLAGLDSGAITPN
TILVDNPIKIKGTPIKKSAEAVGLGPLNYSSALKYSSNVFMFKTVMAMAGLQYQPNMTLP
IKADTFTKLRFYYNQFGLGVSTGIDLDNESIGLQGGNTIAGTALDLGIGQYDTYTPLQIV
QYISTIANGGYRIKPQIVKEIRKPTIKTDEIGGTQYSFESEVLNRITMKEEYIKDIQNAF
KRVTQEKGGTGYVAFNTAKYNPAGKSGTAQAYQKNPNGGDPIEVNNSTFVAYAPADKPEI
AVAVAVPSAFLPNTPNTITKELARSALDTYFDLKKKGTV
>AIA15722.1|FEATURES|farme|beta_lactam|mecB|antibiotic target replacement|1
RGLAYSPIANGGKLIYPKLINNQKTPISKRIIEKNTANTIKQALHEVVSRPDGTAHSLQI
KGQSIAAKTGTAELKKKKGTDGIENGFLFAFDDKHSNYVVVSMIENVKGRGGSSYVVQKM
KPVIESFYQK
>AIA15702.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
MPEARYHHLSVRNRPDYKDDTTARGRVSMTIKRRIGFVLCSVFTITCLSALSAHAAQQLQ
CTVILDAKTGDALHREGTCDQAFAPQSSFKLPLAIMGYDADILVDATTPRWDYKAEWKKP
KREQKSVDPTVWERDSIVWYSQELTRKLGAQKFSDYVRRFDYGNADVRGVKGRTDGLTES
WLMSSLKISPDGQVDFLRRFLNGKLPVSKAAYDKTIAIIPAFDAADDWKVHGKTGSGRMR
TKAGKYDGNSWLGWFVGWADKGDRRVVFATLNIKDWKSEEPISFATRDKLIADLPKLVK
>AIA15678.1|FEATURES|farme|beta_lactam|AIM-1|antibiotic inactivation|1
MTGQIVVLDGERPQLIADREFTPLFTPGHTPGAMSWTWRECEGESCKSIVYVDSLNPISA
PGYRFSDHPAMVVAFRAGIAKIAALDCDIVLAPHPGAAKLRERLLGEAPLIDRGGCRTYA
ASVTERLDKRLAAEAQEDTSGG
>AIA15671.1|FEATURES|farme|beta_lactam|OXA-60|antibiotic inactivation|1
RGQPYKKGNDMNRLLLLTFSVLTILISSCTPNNVIVDNSLEKIFNESGVKGTFGIYDNGQ
NNFTIYDLGRFKDSAYLPASTFKIVNSLIGIETGKIIDEKMVIKWDGVQRSVPEWNKDLT
MAEAFKVSAVPYYQEVARRIGKDTMQHWLDSMGYASRYNKAVINKIDTFWLDNSIKITAD
EQLGLAKKLYFNQLPFQKRTMRIVKEVMLQEKNSNYALSYKTGWGTAENGNAIGWVVGWI
EENQHPYIFALNVEGSHDADMRTIRINILNQILDQLGFKKGKK
>AIA15643.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MISIVVAIDKNNVIGHENKIPWRLRSDLIRLNKLTKGHTVILGRKTYESMIWYYERSERK
MPGETYIVVSRQDYQPAHNRPEKTEVVHSIPDAIKRANELGDEQIFAIGGAGIFQEILPQ
TDRIYLTRVDTEAEGDVFFPVIDMSEWDELSIEHHPQDEKNDHSYDLVVLERK
>AIA15640.1|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|1
MLTSKLKIAVLAMGFLLVDFVAPAQKVFEPKDTPPEWSRPYKPFRIVGNLYYVGTYDLAC
YLVTTPEGNILINTGLAASAPMIKSNIEALGFKFADTKILLTTQAHYDHMGAMAAIKKST
GAKIMVDEQDAAVLLDGGRSDYALGGDTSVFAPVKPERLLHDRDVIKLGNMQLVMLHHPG
HTKGSCSFLFKVKDEHKSYTVLIANLPTIITYEKFNNVAAYPSIAKDYAYTMNAMKKLSF
DIWLSSHASQCDLHTKHKPGDAYNPAAFIDRKGYDAALNDLEQQYLKKVAEK
>AIA15629.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|0
MKVILIAALSADGLLGRNTDDFSMDWTSPEDVQLFVRITKEAGVIVMGSRTFATTVAAGR
KLPGRKMVVYTSRGHMDHDRKDATEFTSDDPAVLLKRLSEEGYESVAVCGGAAIYDMFLR
EGLVDELYITYEPILFGTGIALAHSSFALKLRLLETKQLNENTCMMHYEVQK
>AIA15626.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTLSIRSATVADTDLIVKFVMDLAIYEKLEHEAKTSPDDIARDLFGANPKVFCDIAEWDG
RPAGFALWFYTYSTFQGRHGIWLEDLFVDPELRGKGIGKALLAHLARRCATEKLGRLEWW
VLDWNAPSIAFYKAQGAEMQDDWTKCRLDGAALARLGA
>AIA15621.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MAISLIVAASDNDVIAKDGKVPWFVRGEQAIFKQVTMGHPIIMGRKTYETAKTYKSRPQL
LPGRLNVIITRQPDYKVPEGGVVAHSLDEALAIPQVRAADEVFIIGGGEIFDMAMPLADK
LYYTRVHTTIENGDKTFKFDPGQWRLVSSKLHRKHEVPDRPYDFEFQEWVRA
>AIA15602.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLETEKSMPRSELSTASKRTPELEELLIDAEADDEQVQQSHPLVKRPWLLLLGLILVAL
NLRPALSSMAPLLSEVSRSLGLSAAQAGLLTTLPVLCLGLFAPLAPILARRFGAERVVLG
ILLTLAGGIILRSNFGEIGLFAGSVLGGASIGIVGVLLPGIVKRDFAKHAGTMTGVYTMA
LCLGAAMAAGSTVPLSEHFGNSWAMGLGFWVIPALVAAVFWLPQVGSKHGAHNVAYRVRG
LLRDPLAWQVTLYMGLQSSLAYIVFGWLPSILIGRGLTPTQAGLVLSGSVIIQLASSLAA
PWLATRGKDQRLAIVVVMALTLAGLFGCLYAPIEGLWGWAILLGLGQGGTFSLALTLIVL
RSRDSHVAANLSSMSQGFGYTLASMGPFAVGVVHDWTGGWNALGWIFGIIGAGAILAGLG
AGRALYVQVQSEKI
>AIA15582.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
GQFMPEARYHHLSVRNRPDYKDDTTARGRVSMTIKRRIGFVLCSVFTITCLSALSAHAAQ
QLQCTVILDAKTGDALHREGTCDQAFAPQSSFKLPLAIMGYDADILVDATTPRWDYKAEW
KKPKREQKSVDPTVWERDSIVWYSQELTRKLGAQKFSDYVRRFDYGNADVRGVKGRTDGL
TESWLMSSLKISPDGQVDFLRRFLNGKLPVSKAAYDKTIAIIPAFDAADDWKVHGKTGSG
RMRTKAGKYDGNSWLGWFVGWADKGDRRVVFATLNIKDWKSEEPISFATRDKLIADLPKL
VK
>AIA15568.1|FEATURES|farme|tetracycline|tetB(48)|antibiotic efflux|0
MKLLREIYLFYARKIKESSRNPAFLVMGISTPILYLTLFAPLLKNFAVSMGAPSEGIYDM
FVPGMLVMNAFFGGFFSGFGVIDELRGGVIERFRVTPTSRFSILAGPVFHDLTAVIVLSV
LFIGLAVPFGFHIHVTGLLSLFVLLALLLVTSSSFSHALGLITKSEDSLAPIVHGINLPI
MLLSGMLLPIDFAPNWMKIVAHFNPVYYVVEAGRALAVGDFAKPIVTQAFCVMIPVAALT
MTWATRIYRKAVM
>AIA15569.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MKTIVETKALKKSFGSFQAVKGVNLSVYAGEIFGFLGPNGAGKTTTLRILTTLLSPDSGE
ATVAGFDLLKAQHEVRRRIGYVSQVGGADRQATGRENLLLQGRLYGMHQGEASKRAERLI
EMFTLGECANKITSTYSGGQRRRLDIALGMMHKPLVLFLDEPSTGLDPQNRVNLWEQIRQ
LKGEGMTIFLTTHYLEEADALSDRIAIMDHGQITTVGTPAELKGVEALSLHDVFLQKTGK
GLRE
>AIA15466.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MTKQLAIILATVALAATGIGLTMPVLPDLLRDVGRSGDLGWQYGSFLALYALMQFLFAPL
LGALSDRFGRRPLLLLALAGATVDYLFMAFAPTLPLLFLGRAISGITGAGSAVAAAYITD
ITSEPERARRFGQLSAAFGVGFIAGPAIGGLLGGHWIRAPFLAAALLSALTLAAAILALK
EPKRPAVSAEPLPLNPLAPLRWALRFSGLLPLIGAFMVVSLVGEVGGTIWVPYTQERFAW
DPVTVGISLTLFGLFHALAKAFLIGAISERWGERRAFIYGIGFDSAAYILIALATKGLMA
FGLLPLFCLGGMAAPALQSMLTARVPQDRQGRLQGVLASLASLVSVGGPLVISLSYFGTR
GTFPGIVWIGGAALYLLCLPLAAGRFSGPTPVGDNR
>AIA15464.1|FEATURES|NCBI|multidrug|mexN|antibiotic efflux|1
MGGVVGRLFNEFGMVVALAIVASAVVSLTVTPMLGSRLSGAEHHPGLMVRIFDAGFSRTL
RGYDRAVGWCLRNRAIILLVFLASVGASVYLFRTLPTSFFPQEDIGRLTISTRAREDISY
PAMRDLQAQVAAAVQKNPAVKHVTSIVGSNGRSSLNNGTIWVELKDRGERPPLDQTLREL
RQATSKFAGMKTFITPQQSLRFGGRATASQYQLVVQALNASQTSEWSDKIQTAMRADRTH
FTDVTSDAQNDAIEANIKVDPEKAASFGITDDELRKTLQMAFGGYTAAEIQSTGDSYDVI
TEFEQWNDQMLQGVRVMSSNGSLVPLSNFATIVRQTAPITINQTGQLVSTTVSFNLPAGV
SLSDATAAIDQIKANLQMPNDVFTSYGGTAQIFQQSQGNTPLLILAAVLTIYVVLGVLYE
SFIHPLTILSGLPAAAFGALLALKLFGFDLSIIALIGLLMLIGIVKKNAIMMIDVAVETM
RSKGETAAAAIHEACVRRFRPIMMTTFCALLGALPIALGTGASSELRQPLGVAVVGGLIV
SQALTLFITPVIFVEMDRFGRFLGRLWTKKDKDLHEANDDAPTQIAAE
>AIA15459.1|FEATURES|farme|beta_lactam|TLA-1|antibiotic inactivation|1
MKVKTLRRILLPALFVLPNLLFAQKSDFKSQLESITKQIDGIAGVAVKDLEGKETLILNA
DHKFPMLSSFKFPIAVAVLDQVDKGKLALDQKYHLTKEDIQLKTYSPLRDKFPDGNVDLT
IADLLASMVSLSDNIACDILFKLAGGTKPVQDYVHSLGVKDIAIVANEEQMGQDWNVQYT
NWCKPGAMLQLLDIFYKGKNLSKSSHDFLSKIMIDGPTGMNRIKGQLPKEAVVAHKTGTS
GTNHKGVMAAVNDVGIVKMANGKSFAIVLFMSNSTAELKAIESVMAQVSKAAYEHYAAK
>AIA15448.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
IEWLIAFRFLQGLGASAGMVVPRAVVRDLLTGNEAAKLMSLLMLVFSVSPILAPLTGSFI
IGGFGWRGGFWAVTIAAAIATVLLATALKETRPAEERVGSSFGVALAGYRQLMGNAKFLS
LASIGGFAISSFFVYLSSSSFILIDHYGLSPRVYSLFFSINAVSFFAMSQLTGTLADRFG
LTRVVKVAVTGYATTMVVLLALFASGVDHLAVLAVLLFVGYGFVGLVIPSTSVLAMDDHG
EIAGTASALLGTLQFAIGAVAMGVSGIF
>AIA15406.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSAIVSFVLARADNGVIGDRGTIPWRLSEDMKRFKAITMGKPIVMGRKTWDSFPRKPLPG
RTNIVITRDPVWRAEGAVAVTSLDAALKRAQSENPQEIAIIGGAEIWKLALPFARRIHLT
EVHMDATGDVSIPAFDAAHWRETDREDHATADGLRYSYVTLERR
>AIA15403.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target alteration|1
MKRFHLVVAATHVSQGIGRAGTIPWKLKGDMQYFKDVTSTVTKANAASLQNAVIMGKKTY
LSIPVKFRPLVGRINVVLSRSSGVREELGLPDTVLTASSLEEALQLLSSPSVESRIDQIF
VIGGASVYKEALESPRCGTIYLTKILKEYPDMDTFFPIIPADKFTLTSRTQVTTENDISY
QFCTFDPVEEDRFTTQVVQATENPEEQQYLDLIKQILETGVRRGDRTGTGTISRFGVQMR
FSLRDNVFPLLTTKKVFFRGVAEELLWFVAGCTNANVLSEKGVKIWDGNGSREFLDKSGL
SHREVGDLGPVYGFQVRVLHCSSSMMSCLNPY
>AIA15396.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MTVILFTLLLDAVGMSLVFPILPGLLRELSGGADATTFHYGGLLAVYAAMQFLFSPVLGA
LSDRFGRRPVLLASLAGAAADYVLMALAPNLAWLYLGRVLSGITGASMAVGTAYVTDVTP
EADRAKRYGQMGAAMGLGFVVGPLIGGALGEWSLRAPFVAAAAMNALNLAFAWVALPESN
QHRTARLEAGKLNAFSALHRLQGRPPLLPLIGVFAVVALVSQVPGSLWILYGQQRYDWSA
WIAGLSLACYGGLHAISQAFVTGPMVARLGERRALLAGLTADGLGFVLMGVATAGWMPFA
LLPLFAAGGLALPALQAMLARQVSPQHQGELQGTLASLTSLIGIGGPLVVTAAFAATQLS
WPGSVWIAAAAFYLLALPLLFSARASRG
>AIA15290.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MHVFLIAAMTADGFIGQDSHQSSMKWTSAEDKKWFGARTKQARVVVMGNSTFATVGRALP
ERLTVIYTKDPTEKPETDTTQIRYTNVEPVELLKQLEQEGYSEIAICGGSSIYYLFANAG
LIDTLYLTVEPKAFGKGVPLFSGPLDLNLQLKKMENLSPQTLLLEYSVVKNS
>AIA15282.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISILVAYDHKNGIGADNELLWQRDMPADLRRFKELTTGNAVIMGWKTYESIGRPLPNRQ
NIVMSRSARDAAEGVEIVGSLEEAYTAVEPGRETFVIGGGQVYAQALDSADRVLATEVDA
VFDEATVFFPVLDMTIWKEAARE
>AIA15277.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIQITLILAMADNGVIGNKGGIPWRLPEDMRRFKALTLGKPNIMGRKTWESLPKKPLPGR
TNIIVTRDRNYRAEGATIVATVSEAIGRAKVENPEEIMVIGGAEIYRAALSLATRIELTE
IHAEAEGDTTFAFDRAGWNEVAREDHKTEAGLAYSFVTLQRTNS
>AIA15264.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
MPRIIIVLSFLIASLGSLSARTYQEVPELAKCFAAQGVAGTFVLFDVANDTMFISDEARA
RKRFTPASTFKIANALIGLETGAVKNVDEVLPYGGKPQRIKEWERDMGLREAIKMSNVPI
YQELARRIGLERMREGVRKLGYGNMEIGNVVDRFWLEGPLAISAIEQTEFLQRLVKGSLP
FNPAAMRAVKEITLLEKTDTYELHAKTGWHVGPTPPEIGWWVGWIERDNKVYPFALNIDM
PGDADPPKRISIGRECLKALGKL
>AIA15255.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
PMLSTVKFPIALAILYKVEQGELAMKQKLLIKKAHLRENTWSPFRKLHPNGNVTITLEEA
MTWMVAESDNNLTDVLLRLIGGTETVKEFMDSEGFIIKNNEADMHKDWAAQFVNKIRPTV
AVQVLQEFDQQRILNPQHTKWLYTTMAGSKTGDKRLKGKLPENIVVAQKTGTSFTNDKGL
TGAINDIGIIELPGNKKIYIAVYVRDCAEPFETGEAIIADIAKVTYDYYLQKGN
>AIA15242.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLISIIVAMTPDRLIGAAGRLPWYLPEDLRRFKARTTGHAIIMGRKTFSSIGRALPKRRN
LVVSRNANPPATEGVEWFTSLDDALAFARTAGETECFIAGGTEIYAEGLAKAHRMYVTFV
QRDFPFQGDTYFPMWDQSQWQAVNHELVKDLEFVTYERVNPPPGANSGAEMEPGN
>AIA15236.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIWAEARDGTIGKDGSIPWRVPEDQVMFRELTMGATVVMGRATWDSLPARFRPLTGRRNV
VLTRDPSWTAPGAEVVHEIAEVDVSARQVWVIGGAAIYTAFLPVATHIVRTRVDLDVSGD
VRAPSLGDDWRVDRDTGWMTSSSGLRYVTQELVRARKAVTPGGAKID
>AIA15234.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
AAMDSKRGIGKNNDLLFKIPEDFVRMKELTDGHPIIMGRRTFESVGRILPNRYNVVITRD
PDFEFPGLSGDRGTIVNSLENAIIEAKKAPGSEEIIIFGGGQIFTEAVEKGLVDVLHLTI
VDGDFGADTFFPEYDSKFTKTLHEESGQSVEYHYKFLDLAKP
>AIA15233.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKITLVMVMTIDGKIAHNEHQFVNWSSKEDKRSFYAATKQAGAIIMGHHTFDTFPEPLPG
RLHIVITSTTEGKTNTPGQVEYTSQSPEEIAAGLDARGYKEAVLAGGAQVNALFLKANLV
DEIQLTVEPLIFGSGIDLVRGADLDVRASLISMEKLNESGSIQLRYSIDRG
>AIA15225.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIWAEARDGTIGKDGSIPWRVPEDQVMFRELTMGATVVMGRATWDSLPARFRPLTGRRNV
VLTRDPSWTAPGAEVVHEIAEVDVSARQVWVIGGAAIYTAFLPVATHIVRTRVDLGVSGD
VRAPSLGDDWRVDRDTGWMTSSSGLRYVTQELVRARKAVTPGGAKID
>AIA15185.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISIIVAVAENGVIGRGGQLPWKLSADLLRFKRLTMGHTIIMGRRTWESIGRPLPGRRT
VVVSRQLDYLTNERTVAVAKSVEQAVKIAEDAGDDEAFIIGGAELYRLALPEANRLYFTR
VAATPEGDTYFPEVDWSKWTLVESTPQYVDEKNEYASTFEIYERR
>AIA15159.1|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MSSIKSDQLAKQFGKVAVLLGGDSAEREVSLNSGRLVLQGLRDAGIDAHPFDPAERPLAA
LKEEGFVRAFNALHGGYGENGQIQGALDFYGIRYTGSGVLGSALGLDKFRTKLVWQQLGI
PTPPFETVLRGDDYAARATEIVAKLGLPLFVKPASEGSSVAVIKVKSADALPAALIEAVK
YDRIVVVEKSIEGGGEYTACIAGNLDLPVIRIVPAGEFYDYHAKYVANDTQYLIPCGLAA
DEEARLKVLARRAFDVLGCTDWGRADFMLDAQGNPYFLEVNTAPGMTDHSLPPKAARAVG
ISYQELVVGVLALTLQD
>AIA15152.1|FEATURES|farme|bacitracin|BcrA|antibiotic efflux|1
MGLPMSRVDEMLELVSLSQSEAKRRVKNYSLGMRQRLGIAPALLGDPSILILDEPANGLD
PAGIHWMRGLLREYAEHGGTVCLSSHLLHEVERIADELLLIGHGKIVAQGTKQELLHTRG
AYVKAVEHEQLLDALHREGITAVPSGDGLRSDAEAIQIGKVAVTHHITLVELRPADGAGL
EELFLELTAETQRDTTPTAVPTEGAVA
>AIA15145.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MIHRLPRGLLAAALGTALCGCASPPPAAQRPTEASIAAHVAAATRAAGSDLGEVLTLCKP
APAARPVQDETADRGLRALISRPAPPPGRAFDNLYFVGGDWSSAWAIDTPEGIILLDALN
NQAEAAALIEGGMRKLGLDPARIRYIVVSHGHGDHYGGAPYLAQKYGARVVMSDIDWTMM
ETRLEFATPIWGAPPKRDISVKDGDKLTLGGTSLTLYVTPGHTWGTLSPVFDVSWQGRKH
RVLLWGGTGFNFGADIPRMEAYGRSTQRMAQVARAEGIDVMLSNHSRVDGSQGKLARLRD
AGGTQNPFVIGESTVERTLTVMNECSLAQRDRFALLP
>AIA15123.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
PTPEWLMAPADVDDVEKKIGWPAVVKPSKQGSTLGLTIVKKPEDLAAAIKQAYEFDDEVM
IEKFIPGRELTVPVLGDEVLPVGEIFPKNEIFDYESKYQTGGAEEVFPADLTGPETVAVG
VLALNAHRALKLRGFSRIDFRLDDDGGFWCLEANTLPGLTAASLFPKGAAAAGIPFPDLC
ERLCRLAIEEHATRRRV
>AIA15119.1|FEATURES|farme|beta_lactam|SMB-1|antibiotic inactivation|1
MENRLKVLIAALCIVSTEAHAYPTDWDAPQKPFALYGNTYYVGTAGISAVLITSPQGHIL
IDGTGSKGAGIVADNIRSLGYKLSDVKYILNSHAHSDHAGGIAALQRLTNAPVLAGQANL
ATLASGKASRDDPQYGELPDFEQVTSLRGIGDGEVVAVGPLTVTAHATPGHTPGGTSWTW
KSCVNGQCETMVFGDSLSANAATSYRYTDHPDTVASLRQGFATFEAMPCDILVTAHPEAN
DLFGRLQQRAQNGSAAFIDPNACRDLVASYRERLDKRLATEKR
>AIA15061.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLGGVTSLLLLGQANAASIDCSYCEAWNKDQAPFQIYGNTYYVGPHGLSAVLITSAQGHV
LIDGALPQSAPLIAKHVEQLGFKMSDVKVILNSHTHFDHAGGIAELQKLSGAKVIASDKA
APVLRSGQVGPDDPQVGHLLPFPGVGNVEALGRRASIAVGTLKLSVIHTPGHSPGGTSWL
WQSCEAGRCLNMLYSDSLNAVADSQFKYSGDARYPTAAKDLISSMEAVAAAPCDVLITAH
PELSGVWATIDEQGKGDRAKLNDPAACKRYVETTKQRLEQRLASEKADKK
>AIA15052.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|1
MTIKRRIGFVIYSVFTMSCFGSFGVHAAETVQCTVILDAKTGEALHRNGECDKAFAPQSS
FKLPLAIMGYDAGILTNETTPRWDYKAEWKRPKREQQPTDPTIWERDSIVWYSQEVTRRL
GKEKFADYVRRFDYGNADVRGVKGQTDGLTESWLMSSLKISGDQQVDFLRRFLSRKLPVS
NVAYDKTMAIIPKFPAADGWQVQGKTGSGRMRTKAGKYDGDSWLGWFVGWAQKGDRQVVF
AKLNIQNWKSDEPISFATRDALIADLPKLVK
>AIA15015.1|FEATURES|farme|aminoglycoside|Q644_14880|antibiotic inactivation|0
MSDLHIRNAAPDDAPIILALLGELAAYEQQPFELSEAAIVRDMLGDKPVCRCDLAFWGGA
PAGIASWYWAYKSFGAARGIYLEDLFVRPEFRGRGTGRALLAHLAAIAARESGFMEWRVL
DWNASSIEFYKSLGGKPQEAWVTYRLQGEALLKLASP
>AIA14996.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKRKLGIIFGGRSGEHEISIRSAATVIAEADPDKFDLLPVAISENGSWLSPADSCALFPS
ETRDLIQSRFGEMPDTVHRITGDASIGGFLADGGEVIKVDCVFPVLHGTFGEDGTIQGLL
EMAGLAYIGCGVLGSSCGMDKVVMKTLFRDAGLPIGEYVWFLRSEWERAADVIVSQIESK
LGFPCFVKPANLGSSVGISRAENTDGLRAAIDLAAEYDAKIIVEAGLDVREIECAVLGND
DPAASEPGEYLIRDQTKAFLDYTEKYSATGNNEFVVPAPLSAELSAKIRKMAAEAFKAVN
GSGLARVDFFVRRDTGALILNEINTMPGLTDASGFPKMWAGSGKPFRQVIDELVELAIER
FNDKARNKTAR
>AIA14964.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MLQQIMREGVREVNQRTGHEVAAVPGLTFSMDLERDGFPLLTLRKIPTKIFIAEQIWFIS
GARKPDDFLREFTKIWDDFTNPGDVVTVAYGYRWRKHFGRDQLQKLVTLLQKDPSSRHGV
VVTWDPSNDGLGGVNKGNVPCPYTFTVNIIGGRLNMMNVVRSNDMILGFPHDVAGFALLQ
LILAQKLGVRPGVYSHIVANAHVYDTHYHAANTMSERLTDHEPVIITLPSNAYDRAEKKD
RALVEEINTQLTNQYTPDSAIKGLRIVL
>AIA14869.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSRVAFVVAVSRNGVIGRDGGLPWHISTDLKRFKAITMGKPVIMGRKTWESLPKKPLPGR
PNIVITRQKNYRAAGAIVVGDIPSALTAAGQVEEVCVIGGGEIFDMFLPQTDRIYLTEVD
LEVDGDTFFPPLDPAQWTETAREIHPRGSNDSAGFVLRVLDRNA
>AIA14818.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MPPKIALIAAVARNGVIGRDGDMPWRIPSDFAFFKRTTMGKPVVMGRKTFESIGKPLAGR
INIVVTRQQGYQPEGVLVFSSLMAAIEHARTMAAADGHDEVFIGGGAEIYREAMPLADRL
YITHVDLAPEGETRFPEIDADIWKAVAEVDVPLTGKDSATFRTVIYERRQPRAH
>AIA14752.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|1
FGRRPVIIAAAFGAAFAMSLFGIGGALWVLVLARAIQGMTAGDLPALFAYLADITPPEQR
ARRFGILGALSGIGMMIGPAIGGLLAAVSLNLPLFITAAISLIVAVLSIFLLPESLKAEH
RIDSIALRDVQPFTVFKNAFGRKELRGLLIGFGLLALTFGFFVNNFSVLALDSIHWGPTE
IGLMAASIGVIDILIQGVLLGILLPRIGERGVIISGFIAQAIGMIGLALVASIFSQPWLF
IVGALLLAAGQGASQATMDGAMSNAVGDDEQGWLGGATQSLNAAMSTLAPLIAGALYATV
SHAAPYWIGGAIMAVAVVVVSRAYIARPPRFLVDSQPLEP
>AIA14593.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MVKAPRQGSSVGVYIIKNADLLENGLAEARKFDRRLLVEEFVPGRELTVGILGDQALPII
EMIPKSGFYDFTNKYPFLNPQAGGGAEHVCPARIEEALTRQIQDLALRAYRSIGLRVYSR
VD
>AIA14594.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MSALPKRIAVLMGGPGSERDVSLATARGVAKALRSRGAEVFEVDVHDENFELPQNIDVAF
LTIHGTFGEDGQIQQILEDRGVPYTGDGVNESRTAFDKIESEKKFEAAGVTTPRWQIIGS
NE
>AIA14537.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNVLLVAAITADGFIGRSPDHLADWTGSADKKFFTEITKMAGTMIMGSRTFATIGRALPG
RHTIVYTSHPESITNDGVETTNEEPAALVARLAANGAQSLAVAGGASIYHQFMAAGVVNE
LYLTVSPLLFGSGVPLFGGELHVSLRLIESRQLDANTILLHYRVLTDTPLPVGSTNT
>AIA14510.1|FEATURES|farme|multidrug|floR|antibiotic efflux|1
MSDIRPSWAHTLPAALLLMAPFDILASLAMDIYLPVVPSMPGSLNTTPSVIQLTLSLYMV
LLGLGQVAFGPISDRIGRRPVLLSGAILFAAASLGAALSSTAFAFVCFRLLQAIGASAAL
VATFATVRDVYANEREGVTIYGMFGAILSFVPALGPIAGAAIADSFGWRAIFFVLTLLAV
PAILNAATRWPETRPCGATSKPPSILPIFASAPFWTYTWGFGAGMGTFFVFFSTAPRVLI
GRAGYSEFAFSLIFATVAVVMIVTTRFAKAFIDRWGIAGCLARGMVLLLCGAFALALGQL
FGSPSFVSFILPMWIMAVGIVLTASVTANGALAEFDEIAGAAVAFYFCVQSLIVSVFGT
>AIA14496.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MFMWIDLSPLRRNRDFRLLFTSQVGSFLGPMMTYVAIPVQVFEITKSSKMVGFVSIVQLI
PLVAFGLFGGSIADRLDRKKLLVTAELAMSVCALVLTANAFLASPSFVAIVVASFFLQAF
SAFHRPAMDALTQNIVSREDYASMGALGSLRHSGGAIVGPALGGILTGKWGAQSVYLFDA
VSFFFAAFCISRMSADLRKIEAKTSESLQHMWEGVIYAWRNPVLLGTYFVDMIAMAFAFP
VAVFPALALRLGSTEDAGHMFAAMALGSLIMTTFSGWTKSTVFKGRGVVFAAMAWALGIL
GLGFAPNLWTALGCLVFAGAFDMLSGLFRGIIWNESIPNDMRGRMAGIEMISYMSGPLIG
GARAGWMADLYGIGFSLSFGAVLAFIGTFIVGIAIKGFWNYRSETIPEPRPQPQDFPE
>AIA14480.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRPRISLVVAHSRNRVIGREGQLPWRLSGDLKRFKQLTMGHHLLMGRKTLESIGRILPGR
TSLVLTRQPEYVPPAGCEAAIRVPDFATAVKLAADAGDEEVFVIGGGEVYRLALPFADRI
HLTLVEAQIEGDTTFPALDAREWMLNSEERHPADARNEYPFAVQLWERTIPS
>AIA14460.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MRRPTVTPPLPVPAGGEPEIQKEPAIMNAFFYRTAVVLGLLSAIGPFAIDMYLPALPSIG
ADLHAGTPAVQMSLLIFFLSMGFAQLAVGPLSDMFGRKAPLFAGLALFMVGGIGSALAPS
IEWLIAFRFLQGLGASAGMVVPRAVVRDLLTGNEAAKLMSLLMLVFSVSPILAPLTGSFI
IGGFGWRGVFWAVTIAAAIATVLLATALKETRPAEERVGSSFGVALAGYRQLMGNAKFLS
LASIGGFAISSFFVYLSSSSFILIDHYGLSPRVYSLFFSINAVSFFAMSQLTGTLADRFG
LTRVVKVAVTGYATTMVVLLALFASGVDHLAVLAVLLFVGYGFVGLVIPSTSVLAMDDHG
EIAGTASALLGTLQFAIGAVAMGVSGIFFDGTPLPMVVGIALCAVIAFTLAQVSLGRVRG
VAQVPAE
>AIA14430.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDELYKVLLESILNKGYRELNSRTDHETAALSGLTFSVDIKKDGFPILNLRKIPVQL
FVAEQVWFISGARKPEIFLRNFTKIWDDFTNPGDVVTVAYGYRWRRHFGRDQLKLLVELL
AKDPSSRQGVVVTWDPASDGLGGVSKSNVPCPYTFTVNIIGGRLNLLNVVRSNDMILGFP
HDVAGFALLQCILAQKLGVEPGIYTHTIANAHVYDIHYEAAKDMIGRQSSKEPINLTLPD
KSFDRAEKADISLVSEISDNLSAQSQPQQPIKGLKIVL
>AIA14420.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MRKSVFISLLFLPLVGQAATTPMLSEEPSWQRYYEEAGVKGVFLLCDADASHCYTNDKAR
AETPFIPASTYKIPNSLIALETGVIKDPDQIFRWNGEPRRLKQWENDFTLRGAVQNSVVP
IFQQFARDIGERRMSSYLHKFHYGNEAVEGGIDHFWLDGALRISATQQVQFLQRLNLGQL
PASKINQLRVKDILISDATPDYVIHGKTGYSLGAPGYGDRNAPGVAWWVGWIEKGTATWY
FAGNIDVTRDTDVAARKSIPLKILQGRGILP
>AIA14406.1|FEATURES|farme|bacitracin|bcrA|antibiotic efflux|0
MRITVDKIGKKFIKEWIVRNASFELAAGEKYVFVGPNGSGKSTLLQLLTGMIPVSEGEIT
YTDRNGKEIEVDHWYKHIVIAAPYLELIEEFTLREQIEFHGKFKRFKNGISAKDFEDFIQ
LPHASGKIIRHFSSGMKQRVKLGLAFLSDVPVVFLDEPTTNLDVQGINWYLDHVMDNTQN
QLVLLGSNVQQEYEFCKNIISVSAFK
>AIA14357.1|FEATURES|farme|aminoglycoside|WS68_05870|antibiotic inactivation|0
RPAQVQDAAVIVGFIRDLAAYEKLSHEAKATEGDILRDLFGSAPKVFCEIAEWGGKPVGF
ALWFYTYSTFQGRHGIWLEDLFVDPSMRGRGIGKSLLVQLAQRCVAEALGRLEWWVLDWN
APSIEFYISQGGVMQDEWTKVRVDGEALQRLGAS
>AIA14338.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
HFKKVTMGTVMVMGRKTFDSLPGVLPGRRHIVLTRDRNWSAKGAEVVHSVEEALALAGAE
PVSVIGGAEIFALFKAHADRLELTDVSGAIPGDTIMADPRADGSWHEIAREEHPAEGATP
AFAFVTLQRA
>AIA14321.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
AAVARNGVIGAHNSIPWRLPSDFAFFKRTTMGKPVVMGRKTFESIGKPLAGRINIVVTRQ
QGYQPEGVLVFSSLMAAIEHARTMAAADGHDEVFIGGGAEIYREAMPLADRLYITHVDLA
PEGETRFPEIDADIWKAVAEVDVPLTGKDSATFRTVIYERRQPRAH
>AIA14303.1|FEATURES|farme|multidrug|efpA|antibiotic efflux|1
RFVAEAPRQPGRLDIGGAIASTLGVSALVYGFIRAAEVNWSDPLTIGSFAAAVVLLGAFV
GIERRVAQPILPFRLFNERKRTVAFINQMLVPATLFGVFFFLTQYLQVVLGMSAVQSGFA
FLPFSATIVIGSRLVPRAVARFGPRAVMIYGGLAVATGLVLMSRLDETASYFPMVFVSML
IMASGAVASFVSLSLAIMGAISPEDSGPASGLMQTNQQIGGAIGLA
>AIA14288.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|1
MNPQVKTEFTSYQKMIMLILALLQFVIVLDFMIIAPIGDLLIKTLDISTKQFGFVVSSYA
FSAAISGVAIAGFADKFDRKKMLLVFFLGFILGTLLCGLATSYIEILSARIITGIFAGVT
SSTLLTIVADIFAANMRGRVMGIVQMGFGFSQVIGIPLGLFIATRFDWHSTFLFIVALTI
LIWIGIALIFKPIAEHLKHQSEKNAFTHLWHTLKNKDYQIGFMATTFLTIGGFMLMPFST
IFLVNNVHIANENLPIIFLTTGLSSLVVMPIVGKLSDKYDRFRIFMFAGIAASFMTIIYT
HLTVTPLWIMVIFNMVFFATIMSRMSPAMALNSMVPKPEDRGAYMSISSSLQQTAGGLGS
IVAGLIVYQASETSALQHFDILGYVTVAAFIMCIYLVRQVDLSLKARPSPVLGGAQ
>AIA14255.1|FEATURES|farme|aminoglycoside|AAC(3)-IVa|antibiotic inactivation|1
MKRDYVLEQSLTFAATSRAMSAAEVSSQLLALGVRRGGVLLVHTSFRAVRPIAGGPTGLI
DALRDALGPEGTLVMPSWSGLDDEPFDPLTTPSADDLGIVAQTFWRLPGVRRSNHFHAFA
AVGPQAELVTADPLPLPPHIPASPVGRVHDLNGQVLLLGVGHDANTTLHLAELITSVPYR
TESYITVLENGQRVQIRYGENNHCCARFALADTWLGDAGRQAEGQVGHAHARLADARDIV
ALAVERLVADPLLFLHAPEAGCPECVEARQSVSVGEPIRNMG
>AIA14227.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKDGKLPWHYSSDMKFFKQTTTGNACVMGYHTWLTLNQPLPNRLNI
VLSRQAEIPPQESLVVMRDVDAVLAMAKVLETDLFVIGGAQIYQAFLPYIDKWIVTEVPL
SVAGADTFMPDNYLEGFELKGSQELDESLVVNTYSRQETPNEN
>AIA14180.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MRNPKQVAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
FLFAPVVGNLSDRYGRRPILLIALLGFGIDYIVLALAPTYGWLFLGRIIAGLTGASFTTA
SAYIADISTNENRAKNYGLIGAAFGLGFVLGPALGGFLATWGIRAPFYAAAALCLLNFLY
GYFLLPESLDKDHRRQFDWKRANPFGSLKFLTRHPEIGELAICFFLIYLAAQSVQGNWNF
FTIYRFHWSEKMVGISLAVVGVLVGAVQGGLTRVINPKIGDEKSIYLGISLYTLGLVLFA
VATETWMMFAFLVPYCLGGICGPSLQSVIAAHVPSNQQGELQGALTSLMSLTTIIGPLIM
NSTFAYFTSDKAPFHLPGVHFLIGAVCMLTCLLLTYKVLSRERKVKAVPVSSKST
>AIA14169.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
FISLVAALMALNALAIDIMLPALPYMGADLGVDSENERQLVVSAYMLGFGAAQIVFGPIT
DRFGRRAPLFVGMAIYIVCAFAATFVSSFYLLLGLRFVRGLGAAATRVIATSVVRDRYSG
REMAEVMSLTFMVFMAIPIVAPGVGQVLLLTGPWHYIFLFMGGLATHIFLWAFLRLPETL
RPEYRRPFKLSVIIEGFRIVFRNRVAFFYGLGGMFLFGAMFGFIISTQQIFVGIYGLGEY
FPVAFAVMAGFMALASFLNSRIVRHFGMRRIAHTAILIYIAVGLAMLLLSLAGPLPFWLF
FALLMVMQFVFSWVASNMNSLSMEPLGAVAGTAAAVFGFMQTVGGATLGTLIGQQFNGTL
TPNAAAFVVMGVLVLGCALIAEKGKLFGVGADYAPHAPAIAD
>AIA14148.1|FEATURES|farme|macrolide-lincosamide-streptogramin|MphC|antibiotic inactivation|0
MSWSSPIPLSATDGTGATWQILRAWPYTTPGDYTLEVRTSGRPGVRGARLRDGNFELVPP
DDPRLPALRTAAEQGVIVRYMPYKRAVVRAEGRYIKVFRRGSAAVPAERCAQMDVLLEAG
AFVAPEIISRSSQDVIVFGAIPGPTLYELGEDGSPAGDVPFARAWERWSQAWVAQVAGLH
GPAQQAVLDSLPLRSAETQAEDAWRRVERWLRHYQDVPGLSFERRTLLARAEQVAANLLR
TPPDPLVWAHADLHDKQIIASPGASPPGLLDFDGISRAEAALDLANIDAHLELHQRQGLL
APSRYLTAHTQVLAAAAELLVSPERFRAYSDALWLRLASSPLPGRLPLALGVLAERADQV
PQNVR
>AIA14075.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
TANLLSQEMTESREALTIVGDPSSSGLVSVAADHGRASSMPVDVVFPVLHGTYGEDGTIQ
GLFEMADVPYVGCGVLASSCGMDKVTMKKLFREAGLPICKHVWFLRAEWEQKRASVVGRV
ARELGFPCFVKPANLGSSVGVSKATDKRTLAAAIDLAARYDRKVIVEEGLDAREIECAVL
GNDEPEASQPGEYLIHDQQGAFLDYTEKYTNTGHVEFVVPAPIPKPLAARIRRMSVEAFK
AIDGTGLARVDFFLRRDTNELLVNEVNTSPGLTDVSGYPKMWAASGLSFKQVIARLIELA
LARHEDKSRNETSL
>AIA14065.1|FEATURES|farme|peptide|vph|antibiotic inactivation|0
MESGEQAIIRQVADLYGLEISRLLPSQKGYRNTSYPILLKDRSHVNFIMYKSEPHMLERI
KRIHSVSRILEHQGLPVRHALNNKIVKLKSVHGTSYGALYNYLPGETIPWQSYTKDHIKL
TGMAMSNLHAGFGHTPNVSVNVANEYEALVKRMHLYFGRLDVLEAMREKLSIVPTISFRR
LAAILNICGNLAYKQNLHMDFVRGNLLFNTVKPQSTLRVGSVAMTGILDFEKVAYGHPIF
DIARTLAFLFVDCPTKSPEKIEKYFLYSGYNKRGTSQFTRPVVSRDQIKMDLLIELVHLF
LVHDFYKFLVHNPYDFLHQNEHFIRTRNILHERGMIQFI
>AIA14047.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MQFLILLSLMLLPPVSHPAAPAQPQDLRPFFKNTNGAFVLYDSGRGRYIRYNERRCDERF
SPKSTFKIPNSLIGLESGIIRDAEFVIPWNRRKYPPQDNWNQEPFVHWGQDHTLRSAFKY
SVVWYYRELALRAGLQKMKGYVTAFNYGNKNISERVDEFWLGGSLKISANEQVEFLKAFY
SGHLPVSRRSTEIVKDILVLEKTPAYKLSAKTGGGSIAEGVYIGWFVGYVETEDNVYFFA
MNIEGASFAEVRDKRIKMTKEILTALGVLPK
>AIA14037.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWRLPDDMKYFMTTTRGHHAIMGRKNYDSLPDAYKPLPN
RTNIVVTRQRAFHAPGCIVVHDIDHALKLARTHGELETFVIGGAEIYALAMTQANRLYLT
EIDAEIQGDTYFPSFDATQWQEVSRKHHDADDKHAYAFDFVIYERIA
>AIA14002.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MGLLLFGHLVNRRDILTQKPFLLRHQLAKLLSVVLLVLPSIAKAQSDETSRAWNRPVEPF
RIIGNVYYVGATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSH
AHYDHAGGLADLKELTGAKLMTSEADAVLLANGGKGDFRWGDDLSYKPVKVDRLLRDNDK
VELGGVTLTARLTPGHTKGSTTWTMKVKESGRQLDVIFAGSTSAPGYKLIDEPNYPGIAG
DYDYTFRLLKSLHCDVFLGPHGSIFSLLDKAARLKQGEKNNPFIDPKGYRNFIEESEKNF
LAQLEKQRQAKKTE
>AIA14001.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
QANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMTSEADATLLANGGKGDFQ
WGDTLAYKPVKADRVLRDNDRVELGGVTLIARLTPGHTKGSTTWMMKVKEAGKQLDVIFV
GSTSAPGYKLVDNQKYPGIIKDYAHTFQLLKSLPCDVFLAPHGSIFSMLEKAGQL
>AIA13978.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKAAIVAYDHNRTIGKQGDIPWQGNMRADAHYFRDMTTSHPVIMGRGTYEAMGRLLPNRP
NIIVTHGDLEIEGAAVAHTLEEAYQAAGDDELVFVIGGGQIYELAMDSIDRIYATEIDAY
TDGDAHFPAIDSAKWREIKREHHEADEKNIYNYDFVTYERI
>AIA13894.1|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MIAALSKNHVIGKNNDLPWKLPDDMKFFMQKTKGHHTIMGRKNYDSIPEKFKPLPNRTNI
VVTRQINFKAPGCIVVDSLQEGLTIAKNNSELEAFIIGGAEIYKLGFPFATRLYLTEIHA
EIIGDTFFPEFNMKEWKEISRQHHSKDERHAYSFDFVVYEKK
>AIA13812.1|FEATURES|farme|beta_lactam|OXA-5|antibiotic inactivation|1
MNRISRAIAVILILLGCIISVLVQTQQSALTAPTPALESPPRPGDVAQTVNFGRHFQELG
VEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVISDEIAVLTWDGTQ
RQFPAWNRDLNMREAIKLSAVWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFW
LEGELRITPKEQIQFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANLGEQ
TKPQIGWYVGYLEKDKNVYFFATNIDIRNKNDPSARIELTRRCFKDLGLL
>AIA13793.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIISLIAALSENRVIGKNNDLPWYLPDDMKYFMQTTKGHHTIMGRKNYDSIPEKFRPLPN
RTNIVVTHQKDFKAPGCLVVNTLERGLEIARHNDEPETFIIGGSEIYKLGIPYANRLYLT
EIHAVIEGDTFFPEVNKYEWKESSRKKHAVDERHVYSFDFVVYDKVK
>AIA13766.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MIGALDQDIAKAEIKENKTWKRIFDATGVTGGIYIYDLKKNKFTVYDRARFDTGFVPAST
SKIFHSLIFLESGAVKDENEIIKWDGVKRWVPEWNQDHSLKTALKASAAWFYVEASKRAG
RETMQKYYDAAGYGNRSTEGFGEDYWVKGKLRITPRQQIEFLVKFYENRLPFSPKVPALV
KDLLVYEKTDKYIIRGKTGWSQDFDPWVGWWIGYVERGSDIYFFATELDMKKNEDAQKRY
EITKRVLRSLKVIE
>AIA13764.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MIARLTPGHTKGSTTWMMKVKEAGKQLDVIFVGSTSAPGYKLVDNPKYPGIVADYTYTFR
LLKSLHCDVFLGPHGSFFSLLEKSARLKQGEKNNPFIDPKGYRAFLEESEKGFLEQLEKQ
RQASKTK
>AIA13756.1|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
KAPHEGSTICISKVASASEMQAGFDNCVRYDDTVLAEEFISGRELTVPVMGAGRDAHALP
IVEIRAPQGNYDYEHKYFSDETQYLCPAPLDAALTARIQSLAVEAYRALGCSGWGRVDFM
LRDVDNAPFLLEINTSPGMTGHSLVPMSARAAGVSYEDLCIDILRLARLDLKPTPGWKPV
>AIA13747.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISFLVAMDEKRGIGKAGSLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
IIVTRSESFAPEGCFIAHSISDAINLARERGESELFVCGGAEIYAETLGAADRLYLTLVH
ADCDADTFFPDCNSGEWIETESEHHAADEKNQYSFTFKVLERKHEA
>AIA13740.1|FEATURES|farme|beta_lactam|OXA-62|antibiotic inactivation|1
MKRIFPITACALFLTLFSVVFSAAQGTYLNKKEADLIELIKLDNTIKLDIRYAASNNFVG
KPVYPEARAFLQRPAAEALLKVHKLLKKQGLGLVIFDGYRPWAITRLFWDVVSLEQRKFV
ADPEKGSKHNRGCAVDLSIYDLKTGALLDMPSGYDEFTERASPDYRGGTELQTKNRELLR
GLMEAEGFTVNPNEWWHFDYQGWENYGVYDIPFSVIGALDQDIAKAEIKENKTWKRIFDA
TGVTGGIYIYDLKKNKFTVYDRARFDTGFVPASTSKIFHSLIFLESGAVKDENEIIKWDG
VKRWVPEWNQDHSLKTALKASAAWFYVEASKRAGRETMQKYYDAAGYGNRSTEGFGEDYW
VKGKLRITPRQQIEFLVKFYENRLPFSPKVPALVKDLLVYEKTDKYIIRGKTGWSQDFDH
WVGWWIGYVERGSDIYFFATELDMKKNEDAQKRYEITKRVLRSLKVIE
>AIA13692.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MPILNGILENIMIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNACVMGYKTWLT
LKRPLPNRLNIVLSRQSEIEPQDSVIVCRDVESVLSKARDFKGDLFVIGGEQVYRSFLPY
IEKWIVTEVPLTIEDADAFVPENYLDGFTKSESKKIDDELTTLFYNRTSRL
>AIA13639.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
SCRLPKGGRHFFDQNHRQAEASVNARSTRRRRNKKKWRMPVKKIVVALVALLSVAGTVQA
QTVKDLLETLKVKWNTPTEPFKMIGNVYYVGTDGLASYLITSPQGHILVDTVMPEATSQI
KANIEKLGFKVTDIKYLVNTHAHIDHTGGLAEMKQASGAQMIAGEADKPLLEGGYYPGAQ
EDAALAFPPVKVDRTVREGDTVSVGDVTLTARETPGHSPGCTSWEFSVKDGDATRSVLIF
CSGTVALNRLVTNPTYSGIVTDYRKTFARAKDMKVDVLLAPHPEMYRMQDKRAMLSDGAP
NPFVNPGEFNAYAATLEKAFEDALAKQTADAQEKKG
>AIA13567.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSVRVAMIAAVAENGVIGSAQSIPWRIPSDMAFFKQTTLGKPIVMGRKQYETVGRPLPGR
ANIVVTRQTDYRGDGILVCGDVEAALAKATEIAGIDGVEEIMIIGGGDIYAQCLPFADRL
YISHVDLTPQGDVCFPAISETQWAVVDLPEVQPHPKDEATYRVKVYERRQA
>AIA13564.1|FEATURES|farme|tetracycline|tet33|antibiotic efflux|0
MSTEAVSPAVQRRITLTLFIVQSIFGAALIATFTLTSIVAARLSGFESLAGVPSTLVLGG
RAFIGYPIGWVMDRYGRRPAFVIGYALGIIGMLISAWAITLSSFWVFCAGAAVIGMGRGI
SEQTRYAAAEVYPPNQRAKVIGWLVFAGTIGSIGGPLLVPPSSGWVASFGLDPQTGPFVL
AAFLSCFALALTFFFLRPDPLVIGRQMDDSQQTQQAIVPARPLGEIFASNAVRLAVASMV
IGQLVMTSIMVITPLHMAHHNHGLQAVSLVLMAHTLGMFGLATVTGWLIDRLGRLSMIMI
GGVTLAIASLLTPASTSMFVLAFALFLLGLGWSFCFVAGSALFADSVAANERGRAQGFSE
TLVAIASGAGSLGTGVAFQYGGIVMVSAIGLAFSLIFLAGALWSSQRRQLMTAGESR
>AIA13556.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEEIKLGLANGSLIAGGKLPSVRRLSQHFSCSNNTVIKAYSELEKEHLIYSVPKSGYYVV
AEFQYKTSENEVIDFLSAGPDKNVMPYLEFQHCINQAIEQYKEELFTYSDQQGSYSLRVQ
LVKHLQNLQVFTQAERLVVVSGSQQALHLLVSMPFPNGKNNILIEQPTYFGFIESLTLHQ
ATTFGIQLSMKGIDLDRLEYIFRNNDIKFFYIIPRFHNPLGHCYTNFEKKKIVELAEKYD
VYIVEDDFLGDLDPDAKSDPLFSFNPCGRVIYIKSFSKVFLPGLRIAAVVLPSLMNSNFL
RYKFSSDFNSSALSQGALEIYLKSGMFTSHLKKIKEVYHTKMQILVEACDSLLAAHT
>AIA13524.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHKLYHLPNPTRALTLACFLLILAALAWGQQQGAPQSSSCDNCPEWNKPQQPFRIYGNTY
YVGPHGLSSILITSKAGHILIDSALPESVPQVVANIRALGFRIEDVKLIVNSHVHFDHGG
GISELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPKATTRQALPEPRLCR
QPDAGLSRRLSLLGQPRIP
>AIA13517.1|FEATURES|NCBI|tetracycline|tet41|antibiotic efflux|1
MALFLLPETRKIGAEAESQEFSPLAHFRWLLGYRLLLPLAGAYFVLALVGEVGGTIWVLY
GQDKFSWSPMMVGISLAAFGFFHAVVQAFIAGPISERWGEHRTLLIGIIADSAAYIIIAL
LTEGWMAFLLMPLFCLGGIGAPALQSLVTGRVDNAHQGRAQGMLASMTSLASIIGPLAIS
TIYFASRDVFPGLVWVLGAAFYALCLPIAFTRRPKDATA
>AIA13505.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MVFRSLAAAALGVALMGQSGVFRPHPPMKCSSCDEWNAVREPFRVFGNTSFVGTAGLGAG
LITSKDGHILLDGGLPQTAESIDRSVRALGFKTADIKLILNSHAHYDHAGGIAAIQRASG
ATVASSPSGAQALERGEPTDDDPQFAFGRAANAYPRVSKVRVVADGETLRVGELAIVAHF
TPGHTPGSTTWTWRSCEGERCVNLVYADSLNAVSAPSFRFTDHKERLAAFRKSIATVANL
PCDIILTVHPETSGLGDKFRRRGDKPAVDPFIDPEGCWKYAAAATTTLDKRLAEEKAVK
>AIA13492.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MIISLIAARSRNGVIGKNNDLPWRLPDDMKYFMTTTRGHHAIMGRKNYDSLPEAYKPLPN
RTNIVVTRQHGFHAPGCLVVHSIDRALEIAHKNSETEAFVIGGAEIYALAMTHADRLYLT
EIDADIPGDTYFPSFDTAHWREVSRKHHDADDRHAFAFDFVIYERSPRREINR
>AIA13440.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MTDLTIRSAVAADAGLIINFIEALAAYEKLSHEAKADEADIVRDLFGPEPKVFCEIAEWQ
GKPVGFTLWFYTYSTFQGRHGIWLEDLFVDPSMRGKGVGKALLVNLARRCVQEGLGRFEW
WVLDWNEPSIEFYKSQGGVMQDEWTKVRVDGEALLKLGAS
>AIA13441.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MTVRIAMIAGVAENGVIGSDQAIPWRVPSDMAFFKRTTMGKPIIMGRKQFETVGKPLPGR
TNIVITRQQGYQPEGVLVFNDIEAALARASEIARADGVDEMMIIGGGELYAQLMSRADRL
YITHIDLHPAGDVVFPAIAPEQWTVVDFPEVTPSPRDEATYRVKVYERRQDAAH
>AIA13396.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MLPEIILAQKNSPKLAIKQIIQSSKGTVGVAVIGLEDNFSMTMNDHKRFTLHSVYKFPLA
LAVLDQVDKGQLSLDQKLHVTKKDLLPNTWSPLRDEHPNGGDISLSELLGYTVSQSDNNG
CDFLFRLLGGTKNVQTYIRNLGIKDISIAATEEEVAKAWPVQYTNWSRPSAMLRLMVNAY
RGKYLSQSSTDFLWKLMRETSTGPNRMKGLLPPGTVVAHKTGTSGTNDKGLAPATNDVGI
VTLPNGKHFAIVVFVADSTDDQKTREGVIARITKVVWDYYLAKS
>AIA13352.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKVIVLCGGSSPEREVSLRSGAAVAAALEKNGHDVRIVDPQDGLQNYGAELEHADVVFP
VLHGVGGEDGSVQQVLEAIDVAYVGSSSAVSSLCFNKERTKKRLREAGIAVPEGMMVTSS
TVWESPLVSKPFVLKPVDGGSSIDTFIVRAPEEADKLAIENALGRHKQMLLEELIEGIEI
TVGVVGDDAMPAIEIIPPEGGEFDYDNKYNGKTAELCPPVHVTPGQQYKVQKLAAKVHHV
LGCRDLSRTDFIMDGSGAFYALELNTLPGMTDQSLLPKAAAAAGMSMEDLVDKLVRAAIK
RGPKR
>AIA13349.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MAKFDEIYKSLLKDILNNGQKELNTRTGHETAALAGLTFSLDIEKDGFPLLNLRKIPIRL
FVAEQIWFISGARKPEIFLRNFTNIWDDFTNPGDVVTVAYGYRWRRHFGRDQLKLLVDLL
AKDPSSRQGVVVTWDPAGDGLGGVSKSNVPCPYTFTVNIINGRLNLLNVVRSNDMILGFP
HDVAGFALLQCILAQKLGVKPGIYTHTIANAHIYDIHYKAAEEMISRQHKQSKINLLLAE
NAYERAEKADVKLVAEIADSLSSQYKPEDSIKGLKIVL
>AIA13313.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
MKTFIIAAVTADGLIGESSSQSSLEWTSAEDKKLFVTLTKEAGVMIMGSSTFATIGRGLP
GRKTFVYTSRPDEFADIEGVEPTSLEPAALLARLEAEGFTSAAICGGKSIYTMFLASGLV
DELYLTVEPVILGDGVRLADSLPAVGLTLLESRNLNQDTVLLHYAVKK
>AIA13259.1|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MILSLLVAASENNVIGRNNELPWHLPNDMKFFKNTTWGLPVIMGRKTYDSLKSEPLPGRT
NIVITRQQDWKPEGIIVVHSLQDAISAAQDTESNEIFVLGGGEIFKEAIEIGHRIYITRV
HAVVEGDVFFPKIDESKWKQVSKRDCFADEKHAYDYTFETWERRGE
>AIA13257.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMG
IYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVP
CYLNQSIDSIKQRDSDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAY
FSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKR
FLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQ
GNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSK
EVAEERSNKIMEEVKIVSNMISLPDYE
>AIA13168.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSTQLLLSALLNLTAHAGFSDILAVFPAAAALMVGLSKGRPSRQGQGSNGNQKMAHFILR
EAAALITGMSRSGFHFRTSPVWSSAMSELVIRAAEPSDTALILALLEEFAAYAKAPEFKL
NETDVLRDMFGGACHCELAFREKEPVGIACWYWTYKSFRAARGLFVEDLYVREAFRGQGL
GKALLAHLAAKARGAGGFLEWQVLDWNSSAISFYKMLGAQPLGQWLNYRLDGEPLERLAQ
SETR
>AIA13114.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MRQYHELLKSILEKGTEHQDRTGVGTISHFGHQTRFDLREGFPIVTTKRIPFRWVAEELF
WFLSGDTNEANLRSRGVDIWAEWADEEHTKRFGREAGDLGPIYGYLWRSFGGHYPKLDGV
DQIARLMREIRDNPNSRLIVTGWDPSQCDNVDLPPCHTLFQFKVENQKVLHCQLYQRSAD
AFLGVPFNISSYALLTHMIAHASGLEAGEFIYTLGDYHIYKNHLSQVEELLSRTPLKLPH
LEIHSETGGPSGLEGLLKMRFEDLKLVGYESHGKIAAPVAV
>AIA13112.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MPEIKFIAAIDDKRGIAKSKPGTAGIIPWKLPGDHKYFMDKLHDGPVLSGWNTFRANGLK
PFGVGANYILTRKDTESYPGVWIIHDLAEFFAKNVDDVWVAGGGQVFAEALPHATHLYLT
RVSGDFDCDVFFPSFEDDFRLQREEPELVENGIKYKYQVWVRR
>AIA13089.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
HTEVQFEAHQKVISMTSDKNPKVAEIAFCFRSQKILNNIRDKNEQQRFIRDTFQDFRWET
PKVLELMSYSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNNLALVGAYILA
GELKLAGGNYHQAFNRYNELLHPFVEANQKLGVLVNESFLIHDEVSKEVAEERSNKIMQE
VKIAANMISLPEYE
>AIA13033.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
ADLKELTGAKLMTSEADATLLANGGKGDFQWGDDLSYKPVKADRVLRDNDKVELGGVTLT
ARLTPGHTKGSTTWMMKVNEAGKQFDVIFVGSTSAPGYKLVDNPKYPGIVADYTYTFRLL
KSFHCDVFLGPHGSFFALLDKAGRLKQGEQNNPFIDPKGYREFLEESEKDFLEQLEKQRQ
AGKTK
>AIA13018.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIGVNNALPWNKLKTDMRRFQKITTGHPVIYGSSTFLASPQNGRALPNRTNIVLTRDTDK
AYEGCIMAHSLAEAIRTAEKHEGNDEIFIIGGSHIFEQALPLANRIYLTEVDTELQGDAY
FPELDQIRWKAEDEGAFDADEDNQYAGKFVRYTRTGEYPIVEPYNARTEEFKKYLNEIID
EGKCPFCPGGATHRNQEMIYQNDHWWVINTLQPLANTLHHFMIVPFRHIVTMDELTAAEW
EGFSKMLTWANGQFKANGLAYYWRQGEPMVTGASVSHLHVQAIAPAGLVQVNFGPYPKEK
>AIA13006.1|FEATURES|farme|beta_lactam|OXA-129|antibiotic inactivation|1
MTLALRAFVLLIAFLSMSAAEAAAQNLDRVFGNTKGAFVLYDMKSNRYVRHNPGRARLRF
TPASTFKMPNSLIGLETGVVRDADFRISWDRQRYPNEDRPNTAPFIHWWQDHTLRSAIKY
SVVWYYIEIARNVGAERMQKYVRQFRYGNGDTSGGIEQFWRNSSLQISAEEQVDFLRRFY
TGKLPVSSRSTGIVKDILLLEETPSYRLSGKTGAAPFEGGTLAWFVGYLEREGNVYFFAL
NMDGANYEAIRDERINLTKRILVELGY
>AIA12961.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MGAMRISSIVAIGRNYVIGKDGNMAWHLPEDFKYFRSKTIGKPILMGRKSYEALGKPLQK
RPNIVISHSFEPPINEDGPFFVKSIDEAIELCSEKARELGVDEIFITGGGQIYKETMDII
DRLYITVIDRDYEGDTYFPKFDWSEWNIVSEDKREGDPSFTFYILERKEKL
>AIA12945.1|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MIVAQLVAMDERRGIGKQGGLPWRLSTDMKRFRELTMGHHIVVGRKTFESIGKPLAGRQM
IIVTRDRDYKVAGCFTVHSIAEALELARARGETELFICGGAEVYRETLDLTERIYLTAVH
ADSHADTFFPEFNRDEWLATASEPHAADEKNEYPFTFVLLVKKRAG
>AIA12849.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MGLIVRDAVRGDAPVILDFVRKLAEYERLTHEVAATPVDIERELFGAAPKVFCQLAEVDG
APVGFALWYYTFSTFQGRHGIWLEDLFVNPETRGHGVGKALLADLAQRCVREGLGRDEWN
VLDWNQPSIDFYMSQGAVFLDDWRRCRVTGDALQKLGAAA
>AIA12844.1|FEATURES|farme|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|0
MNPVKLVGPRITLREFNTDDIDAVHALIGDDRVTRWLSFDSRTREQAAAMIDGVLQRTQE
QPRAEYYLAATLGDSSLIGFARLGLTGVKAAKLGYAIAADAWGNGYATEATQLIINFGFD
ELGR
>AIA12835.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MTDQPVEHLHIVLLAAVTADGKMARNATQLSNWTSPEDKRIFVAESKRARVIILGNSTYK
TLPRPLPGRLHIVLTTDTSDKTNIPGVVEYTSATPAEISADLLARGYSSAVLAGGAQINS
LFLAAGRVDEIWLTFEPYLFGRGIHVFEGTDFDLRLYLISLDQINLDTFIARYGVGPRTQ
EPKA
>AIA12820.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MNKALVVILAAVTLDAVGIGLIFPILPALLRDVGHISEVATLLGLMLALYSACQFLFSPI
LGVLSDRFGRRPVLLVSLAGAAIDYLIMAFAPELWILVLGRAISGITSANMAVATAYITD
ISTEEERAGRFGLFHAMFGIGFIIGPVLGGVLGDFWVRAPFIAAALLNGVNFALALFVLP
ESRKGTAGARFTWDTLNPFKPLKWALTFRALIPLMAIFVIMNFVGTMYGTIWALFSEDSF
GWSGLMIGLSLGAFGVCHAGAQAFLTGPAVSKLGERWALIVGMACELTALLILGMATQGW
VLFALAPLFALGGVGMPALQSLVTAQVGPDKQGQLQGVLASLVSLAAVFGPLFFSFSYFA
VQGTWPGLIWMIGAAIYLLALPLMLGIKRRPATVPAGTI
>AIA12730.1|FEATURES|farme|aminoglycoside|AAC(3)-Ib/AAC(6')-Ib''|antibiotic inactivation|0
MLKDGTTVNVILYKSEPGILDKIKAANAVSAHLAAKGFPVRHTVDSRITKMTNGSHEKYA
AVYTYLDGHTIPWEEYNQDHIKALGMTMSNMHAALADCDYLLPDVADEYLAIVARTRAYF
ADAPVQRALADKLLLAIKPEVFDGFEQLLVGSKLLPGKQPLH
>AIA12716.1|FEATURES|farme|beta_lactam|Shewmr7_3328|antibiotic inactivation|1
MVVAGCASASAQDLSPFFKDTKGAFVLYDLKNDRYTRYNEARCRERFSPKSTFKIPNSLI
GLETGVIRDANFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVWYYRELALRVG
QKRMKKYVTAFNYGNQDISGRIDDFWLGGQLRISADEQVEFLKKFYAGRLPVSKRSTEIV
KDILVLEKTPDYTLSAKTGGGSIREGTYIGWFVGYVEAKGNVYFFACNIEGTSYPEIRDK
RIDVTKRILAELGLLPKQGATQ
>AIA12657.1|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MYKKILVPVDLADTDLAKPALTTAIEMVRASSGSVRLLNVLAMTPVMLAEYVPPDFDVQQ
RKSAEEALGIIARECGLDAMHVSATVRQGGIYHEVLEEAKAFNADLIVMSSHRPAMRTYF
LGSNAGHVVRYAKCSVLVVRQ
>AIA12652.1|FEATURES|farme|beta_lactam|AF332_00150|antibiotic inactivation|0
MLKQVSFCLVLILLFSICISAQRTQPAPKNVVAPQTLDERINDAVKDFKGKVWIYAKNLD
TQKTFSLRGDERVRTASTIKLPIMVETYFQISEGKLKWTDEIILTKEKKVGGSGILGEFS
DNTKIDLRTAVNLMIVVSDNTATNLVLEKVTSDAVNARMESLGFNDTKSIRRIFGSEKDS
RVATDPIIKNFGLGMSSPKDMVGILEMLELGQLVNSEASKSMLHVLKRQQYKDGIGRNAL
DTVPVASKSGTLDRLRADVGIVYTRRGRIAMAITVDDMQVVHYATDNPGSLLIWQLSQIL
QEGLAK
>AIA12637.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MGRCAFVVLPAALIKNPQDFKIAIHHELQHHRSGDTLWAWMTELLHCGFFINPAIYLWQK
TITEIQEFSCDEALIGRRRVLPNDYGSCLLRVAEAALGVRRMQVGTTCMNAKSKNPKSFL
RRRIEMFRQHEKPPRKRVFGLTLGLVCLFATVMTAYATQSPRTPINAKVNQGHAEFDPKI
QAVTEKILREYVKKFKARGGFVLVSEPSTGRLLAAANVSDDHALQGNWALSYGFEPASAM
KTIIAASAIDHRLTSTNEVQNCENGTYSYGAHVYHDWKPFQTLTTAKTIVYSSNICGIKI
AEKLGTSGLHSTLTDFGFGVGGSASEFPEAMVGQIPDPNQMPAAEYIALGSTGYTENPGL
KITPLEILQAYGAIANEGRLMKPIMSSLHDSAASVVRQVISPGTALAMKKVLTDVVLTGT
GKNARSSIYTTAGKTSTAYNPNSPSHHLLGGQRGIGGFVGFAPVDRPRLVVYVAMIDPVG
SQDGQPHGNEHAAPVFREVIEKLLPMMP
>AIA12636.1|FEATURES|farme|beta_lactam|LRA-3|antibiotic inactivation|1
MKKSIEDLGFKLTDIKIITSTHGHFDHVGDLAAFQKVSKARVLMSERDAPVLESGGNLDY
RRPEGRGIIYDPIKVDQRLKDGDKFGLGGVQITTIDSPGHTPGSTSFSFPIQDGGRTYNV
LIANMPGINNGVKLLGSPGYPTIVQDFPNTIHRLQGMNPDIWLSSHAPQFNLHTVYKPGD
AYNPARFSDVAAFKAKLAGYEKAYNEQLAKERAEQKK
>AIA12585.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|0
MRLTSSKGQNDLRRFIKHSIIVLFTLALASLIFGKERNASIAHLPVMPDAFTSDALAQSS
LERAIKRLAESSGGIVGVSAIHIESGRRVSVNGDLRFPMASVYKLPIATAPSRSPRTTSL
>AIA12547.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRQGAIGKGGKLPWHYSADMRFFKETTTGNACVMGYKTWQTLKKPLPNRMNI
VLSRVAEIEPQDSVLLVRDVDSVLQLAESLSCDLYVIGGAKVYRAFLSHIDKWLVTNVPL
TVAGADTFVPPNYLDGFILAESIDLGEGLTVSVHKRADNNSKA
>AIA12539.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MRLRAALLNALLLLSALACATPTDADSTRTASTRTADPQTQGAPAREASPADLEPFFKEF
PNGAFVLYDLKRDRYLRYNEARCRERFSPFSTFKIPNSLIGLDTGVIPDAEFVIKWDEKK
YPAHDRDTLPFSAWWQDQTLRTAFKRSAVWYYRELALKVGEKRMREYVRNLHYGNEDASG
PVNNFWLNSSLKISADEQVDFLKRLYREELPVSKRSLAILKDIVKLEETPDYKLSGKTGG
GPLAENRYLGWFVGYVETKDNTYFFATEIEGTTYLSIRDERIALTKRVLAGLGYIRG
>AIA12532.1|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|0
DPNGARVPIHLECWVEMFPFLEPVLVEAAKLQTARYDRYETTKLDVWTKGKVALVGDAAH
AMCPALAQGAGCAMVNAYSLAMELEEIADLDEALPSWEKRIRPITDRCQAISGEYAANRS
LSKGNQFTASALEAARYDPLRRVYSW
>AIA12456.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|0
GYKTWRSLKKPLKDRLNIVLSRNSEVEPQPSVVVVRDILSVLSLKDYLSCDLFVIGGEQV
YRSFLPHVDKWLVTEVPLAVEGTDTFMPGDYLQGFKPSGSQQLEDNLRVTFYEKQG
>AIA12451.1|FEATURES|farme|multidrug|ABC1_ADCK3-like|antibiotic efflux|0
MIGKRYLHAKRSIYVLWTLISFALYVYLDSKGWLGKSEMRLRRQAARLRERLIRLGPTFI
KMGQMLATRADLLPLDYIKELSALQDQVPPFPDYQAVEIIETELGRSIKDLFADISERPI
ASASLGQVYRATLTSGEDVAVKVQRPGLAEKIRFDLDLLRWIGHLLDRYPKLFPGAEWMG
AIDEFDRVIHEEMDYRRELANADEFRQNFRDWRSIHVPLVFDKLSSERVDLEGG
>AIA12445.1|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKVLVVGGGISAERDVSLASAKAVFNAAVAGGHVAEFYDWDGTTQWLKQHGSTFDVVLPI
LHGEGGEDGTIQKILEASDVPFLGSDSTASELCFDKNRTIDLLAHNGINTPQGEVVTYQD
YLKNPLFNAAHVLKPYNGGSSVDTFIYPDPAQKNVQLIEEAFKRHSSMLLEPFIAGTEIT
VPILQDKLLPVIEIIPPEGGTFDFENKYNGKTRELVPAQNVSAQMQDKATKLGNEIHRLF
NCRHLSRIDMIIQDEVIYVLEINTMPGMTNHSLFPKAALASGIDFAALVSYLIQISAAAV
>AIA12380.1|FEATURES|farme|aminoglycoside|grm|antibiotic target alteration|1
MEDGLKSDDVVLDRVVEAVLGGSKYRHVSRALVREIGRVELGKGRGMKEAVKAVKNKLHQ
VAGAYVEGGDSGSRPYERWLGELREAAGSGDGESLKGGCRRIMGSHASTRERLPILEEFY
GRIFEELPPVRSVVDVACGLNPLAIPWMGLADGTGYVAYDIYEDMMGFLGGVLGIFGVEG
RGETRDVVAEPSVEEVDLALVLKAIPCLEQIDRSAGRRLLDGLKAKNMVVSFPVASLGGR
NKGMAANYEARFWELAEGQDWVVKKLVFRSELVFVVAREGSL
>AIA12369.1|FEATURES|farme|macrolide-lincosamide-streptogramin|oleC|antibiotic efflux|1
MTSKDTAISVTGLKKSYGDNHVLKGVSFSVKRGTMLALLGPNGAGKTTMVRILSTLLRHD
AGKVSIEGYDISKDSDKVRGVIGLTGQSASVDELLTGRENLVMMGRLYRLTKASATARYQ
LASRRENQAQNRDQDRGA
>AIA12339.1|FEATURES|farme|trimethoprim|dfrA21|antibiotic target replacement|1
MIHAIVAMTDSRVIGKRNALPWKLKGDLPRFKKLTSGHTVIMGRNTYESIGRPLPNRHNI
VLDFDQRPIEGAVVCDSITEALRVARSYGTEIFVIGGASIYEQMLPYVEVLHISHVKQDY
EGDVSFPTYDTVDWKEVEREDFEDFTAVTYERQSTPQQISL
>AIA12278.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
MNRISRAIAVILILLGCIISVLVQTPQSALTVPPPVQESPRRGGDVAETINFGRHFQELG
VEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVIADEIAVLTWDGTQ
RQFPAWNRDLNMREAMKLSAVWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFW
LEGELRITPYEQIHFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANFGEQ
TKPQIGWYVGYLEKDKNVYFFATNTDIRNTNDASARIELTRRCFKDLSLL
>AIA12264.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MHFDHGGGISELQRLSGAKVAASPWSAEVLTKTGIGKSDPQFGSIPPIALVPKVSVLRDG
QTLRVGDIKLTAHFTPGHTPGGTSWTWESCEAGRCLNLVYADSMTPVSSDGFRFSDSREY
PTAVQDFEKSFAFLRSTPCDILLTSHPDASGLWQRLEGRERGTKPDPMVSPKACKELADD
ASEQLRRRLASEKGQ
>AIA12258.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MIDSALPESVPQVVANIRALGFRVEAVQFIVNSHVHFDHAGGISELQRLSGAEVAASPWS
VEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVGDIKLTAHFTPGHTPGGTSWT
WQSCEGKRCLNLVYSDSMTAVSAKDFRFSDSREYPTALRDFEKSFAFLRAARCDILLTSH
PDASGLWQRLEGRERGVQPDPLISPNACKALAERASEQLGRRLAAEKGR
>AIA12206.1|FEATURES|farme|beta_lactam|OXA-54|antibiotic inactivation|1
MRTTFLTTLVLLAALGCGRTTGAGSVTSTPQTQPDLASYFKPFPAGAFVLYDLKRDRYLR
YNEARCRERFSPFSTFKIPNSLIGLDTGVITDAEYVIKWDKQKYPAHDRDTLPFSAWWQD
QTLRTAIKRSVVWYYRELALKVGERRMKEYVNRLDYGNEDASGPLNNFWLNSTLKISADE
QVEFLKRLYKEELPVSKRSTSIVKEIITLEETP
>AIA12202.1|FEATURES|farme|beta_lactam|OXA-247|antibiotic inactivation|1
MKLMRVALILLMLAAGYAVVPANAQDLSPFFKDTKGAFVLYDLKNDRYIRYNEARCRVRF
STKSTFKIPNSLIGLETGVIRDSEFVIPWNRQKYPPQDNWDQYPFKHWGQDHTLRSAIKY
SVVWYYRELALRVGEQRMKKHVTAFKYGNQDISGGIDNFWLGGGLRISADEQVEFLKKFY
AGRLPVSKRSLEIVKDILVLEQTPQYKLSAKTGGGSIAEGTYIGWFVGYLETQGNVYFFA
CNIEGASYPEIRDKRIDVTKRVLMELGYLPK
>AIA12196.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MRISFIVAKAENNVIGINNQLPWHLKADLQMFKRITMGHHILMGRKTFESIGKALPGRVS
LVISSTPRPVAENVLWFNSIFRAIKQAERSGETELFIIGGEQIFKYGLSLVDRIYLTEVK
GNIKGDVFFPQLSMKSWNKISEQHCLKDADNDHDFSMVVLDRRNR
>AIA12194.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDVAIVVAIAEDGVIGRDNGLPWRLSTDMRRFKVLTMGKPIIMGRKTWESFPRRPLPGRL
NIVVSRDPAYRAEGAEAVTSLDDALRLARAKVRCMSGMDEICIIGGGEIYRQAMDIADRL
YVTHVLASPEGDTRFPPIDPKTWKLVSVEDHPAGEKD
>AIA12075.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MATNRKAALGFIFITLLIDITGWGLVIPVFPTLIGELTHADISTIGRYGGWLTVAYAIMQ
FLFAPVMGNLSDQYGRRPVLLFSLLGFGADYLFLAFAPTLGWLFVGRLIAGLTGASITTA
TAYIADISTKEDRAKNFGLIGAAFGLGFIIGPAIGGLLAEFGSRVPFLVAAGLTLLNTLY
GYFVLPESLPKENRRKFEWIRANPFGSLKHLNKFPGIWGLVLSLVLVYIAGHSVQSTWSF
FTIERFQWSEGMIGISLAVVGALVAAVQGGLIRVVNPLLGNERSIYIGLLLYTVGLLLFA
FASQTWMMFVFLVPYCLGGIAGPALQAIISNHVPSNEQGELQGALTSLISLTTIIGPLVM
TNLFAYFTQPNAPIHFSGAPFLLGSVLMLASAIVAYVVLKREKIPTPKASS
>AIA12069.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
VAPSVGQLIITYAEWHWIFILLGIVASILFVWALLRLKESLPPDERIPLSFAAVGDGFKT
VLTNRITCGYMIGLTMFTGVISAYVISVQQVFGEVYTRNFGRLRVGNWHRQTDFGVHIRK
SNWIVHKIPKKPIATLKGLETRL
>AIA12055.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WNEWADERGDLGPVYGAQWRAWRSSDGRTIDQISLLIEQIKSNPDSRRLIINAWNVGELS
KMRLAPCHLLFQFYVADGHLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCDLKPAEF
VHTLGDAHLYLNHLEQARLQLTREPRALPQMKINPSVKSIFEFDYSDFELSGYEPHPHIK
AEVAV
>AIA11989.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKPPITLLVARARNGVIGRDGRLPWHISADLKRFKALTMGSAMVMGRKTFESLPGVLPGR
RHIVLTRDPNWTAHGAETARSIPEALDLAGEERVSVIGGAEIFAMVPAACRKDRAYGSAR
GRCGRYVLARSA
>AIA11973.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIIGIVAVDRNGAIGKGGKLPWHYSADMKFFKETTTGNACVMGYKTWLTLKKPLPNRLNI
VLSRQSQIEPQDSVIVCRDVESVLSEARDFKGDLFVIGGEQVYRSFLPYIEKWIVTEVPL
TIEGADAFVPENYLDGFTNSGSKQIDEELTATFYVRTKPA
>AIA11908.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MTTRNHLPNPTRALALATFLLVLAALGFGQTGTPQSSCADCPEWNKPQQPFRIYGNTYYV
GPHGLSSILVTSRSGHILIDGALPESVPQVVANIRSLGFRIEDVKLIVNSHVHFDHGGGI
SELQRLSGAEVAASPWSVEVLTKTGVGKGDPQFGSIRPVALVPRATTLRDDQVLRVGDIR
LTAHFTPGHTPGGTSWTWKSCEGKRCLSLVYSDSMTAVSAEGFRFSDSREYPAAVQDFEK
SFAFLRSTRCDILLTSHPDASGLWQRLEGRERGVRPDPVVSPNACKALAERASEQLRRRL
ESEKGRQ
>AIA11905.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MAIFLFLLTLIGAGGFTPAAAQDLAPDNPWVKPAEAFKILGPIHYVGTEDLAVYLIATPE
GHIVIDGGVKGSIPAIEGSIRALGFKPEDIKILLTTQAHYDHVASMAYFQRLSKARVEVM
AGDAKLLESGGEADYLAAEWGAKARFERVKATRILKDGDKVTLGGVTLTARHTPGHTPGC
TTFIMDVPAGGRAYNVVFPGSMTINSGTRLVGKESYPGIARDYARSLDFLESLKPDIILM
AHASAFDLPAKRDRLKKDPSSNPFGDVAGYRAWIAANRANLQKQIKEQEASR
>AIA11898.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MMKNVLLKICIVGLALSFHSACTPGQDVRTTEPAIPAVESGAADADLTKQIAALCNDAQG
EIGVTVIHVESGRTVEFEGEKKLPLYSVFKLPLAVEVLKRVEEKKISLDQKLHVDPADVA
PGSQFNADLWRKPADKTVAELLEFSIVRSDNTSSDKLLQLVVGPAVVTERMRGLGFPQID
IVSTVREYATSRDKPNLATTANLARLLNRLQKGELLEPAHLSLLLGFMERARTGGERRLR
ASLPTGTPVAEKTGSGADSTNDVGLITLPDGKGHLAMAVLIHNSKLTAEAQERLIAELAR
KA
>AIA11850.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKAYLDLLKDILENGVEKGDRTGTGTTSVFGRQMRIDLSEGFPLLTTKKIHFKSVVHELL
WFLSGSTNIGYLKENEVSIWDEWADEEGNLGRVYGAQWRTWLGPNGQTVDQIANVIRQIQ
TNPDSRRHLVSAWNPAEVDSMALPPCHYAFQFYVANGKLSCMFQMRSVDTFLGLPFNLAS
YALLTHMVADQCGLEVGDLIWTGGDVHIYMNHMEQVNRQLSREPYPLPKRVIKRKPDSIF
DYQYEDFEVIGYQSHKGIKAPIAI
>AIA11744.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSTRVTTPTAPTRTYPSLRAAAIPLFALCLAFFVEMVDNTLMGVALPTIGRDLGGGTLS
LQWVTSAYALTFGGLLLTAGSGGRPGSAGAAFFSWGWPSSAVSASACWRSTLRVSSSGCA
LPWVSLRR
>AIA11726.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAIIGIVAVDQNGAIGKEGGLPWHYSADMKFFKQQTTGHACVMGYRTWRSLKKPLKDRLN
IVLSRNSEVEPQPSVVIVRDLLSVLSLKEYLSCDLFVIGGEQVYRSFLPHVEKWLVTEIP
LAVEATDTFMPGDYLQGFKLSGSEQLEGNLRVNIYDRQG
>AIA11695.1|FEATURES|farme|multidrug|emrY|antibiotic efflux|0
MAVTGVLLLAGLALLPPLLQNMYGYSVLQSGFLTAPRGVGTLISMLLAGRLVGKVDSRAL
VGIGVALMGLSLWMMTGFAIDQPSRPVIVSGIVQGLGLGLIFVPLQSLAFETLAPRLRTT
AAALLNLSRNIGGSVGISVVSTQLVRMTQVSHQDLAANITQQTIPTLNPEVLQTIAPVAG
PAALAYINAEVTRQALFIAYLDDFKLMMIVTFAVLPLLLLMRRGNRVGTGRPAPAMD
>AIA11685.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|0
MSNPDAQGAETAKPAGLRDLLKNSNFRFLWLGQIISDFGDSLTNLSLLILVNQLTGSTAA
LATMLIVLTIPQITFGLIAGVYVDRLDRRRIMMASDALRGAMVLGFTLVGSADQLWLLYL
IGF
>AIA11681.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQIILIAALTDNYVLGKDNQLIWRLPEDLKNFKRLTSGFPVIMGRKTFESLGRPLPNRTN
IIITRNTDYQADGCVVAGSLEKAIDYAKPLTGEQVFVIGGGEIYAQALPLADRMYLTHVH
TQLDGDAFFPEFSTQDWHPAETQHFTKDEKHAYDFDIVTWERLAT
>AIA11672.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKISLIVAASDNNVIGGHNQLLWKLPDDMKRLKELTMGKPLIMGRKTHESVGRVLPGRRN
IVITRHPEKVMEGAEAVGSLQEALKLALADDAEEAIIFGGGEIYTQALPLADSVYMTRVH
GEFEGDTYFPELPKKEWKEVWSEEHEKDDKHAYAFTFQNWQRKAKN
>AIA11645.1|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LDEGERREDRTGTGTLSIFGTQTRYDLRQGFPLLTTKKVLWSGVVRELLWFLRGSTNVRD
GLTQFTPIWDAWADERGELGPVYGHQWRKWGAPFAQHAKDQSEVAPERTGPGIDQIKGAI
ELIRKDPSSRRIIVSAWNVADLPHMALPPCHAFFQFYVSRGRLDMQLYQRSADIA
>AIA11569.1|FEATURES|farme|beta_lactam|TLA-3|antibiotic inactivation|1
MIPAIKKAWFYTFCLLLLTLGCTSVNSSNREDTPNNETSTPSGITISNADRTNELRDRIE
QISQAARGRVGVTATVLETGESVTLNGDRQFPMQSVYKFPIAMAVLAQVDQGKLKLDRKI
RVETSDVLQGSRILDEKSQGMEFSLAELLKYMVSESDGTSCNVLLRQVGDPRIVTEYLRS
LGINDIVVANTEKELAQDPAVKYRNYATPDATVVLLRAFHEGKGLSKSSQALLLQLMTET
TTGPQRIKGLLPDGTVVAHKTGTSSTVNGVTAATNDVGLVTLPNGRHMAIAVFVSDSGAN
NATREEVIAKVTKAAWDEWSK
>AIA11541.1|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MAIIGIVAVDKNGAIGKNGSIPWHYSADVKFFKQQTIGHACVMGYKTWLSLKKPLKERLN
IVLSRKSEVKPQPNVIVLRDTLSILSLKKFLACDLFIIGGEQIYRSFLPHMDRWIVTQIP
VAVEGADTFMPEGYLKNFSPYDSQQLEENLKVTFYE
>AIA11435.1|FEATURES|farme|beta_lactam|Rm3|antibiotic inactivation|1
MLLATFLLVLAALASGQGGAPASSCTACPVWNKPQQPFRIYGNTYYVGPHGLSSILLTSK
SGHVLIDGALPESVPQIVANIRALGFRIEDVKLIVNSHVHFDHGGGIAELRRLSGARVAA
SPWSVEVLTKSGMGKGDPQFGGLVPVALIPRADTLRDGQTLRVGDIKLTAHFTPGHTPGG
TSWTWESCEGGRCLNLVYSDSMTPVSAEGFRFTDSREYPTAVQDFEKSFAFLRSTPCDIL
LTSHPDASGLWQRLEGRQQGVKPDPVVSPNACKELAGRAAQQLRHRLEGEKGQ
>AIA11428.1|FEATURES|farme|beta_lactam|CcrA|antibiotic inactivation|1
MVWMRLAFCFLLELALCLSAVAQERVKIQLADDVFVEKLEPGVWRHVSYNTLPHLGPVPS
NGGIITLGADVLLIDSAWNNEQTKLILDWSEKQLRAAPSIAVITHAHEDRIGGIHEIHRR
GIRTVSSRLTAQLAKQQGLEVPQQTFDGKLNLSLGGRTIEVYYPGPGHTKDNIVVWIPDK
HILFGGCLIKAAQAPDLGNIKDADVERWPKTMETLAREFKQVKLVVPGHGDPSGGEAMTH
TLELLGKAVPLKPPVPGSTSH
>AIA11389.1|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|0
MKIMLLAAMTLDGKIARNELHFVDWTSKEDKKLFFDTSKRAGVLILGNNTYKTLPVPLPG
RLHVVLTRTPGEKESMPGAVEYTDRSPEEIVADLEARGYTEAVLTGGAQINALFLQSRLV
DEVWLTVEPLIFGAGIDLFRGVEFDERATLIHVERLNEGGTVHLRYSLR
>AIA11388.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
MSLVIRKAEAGDAGMIYEFIRELAAFEKLTHEVDASQRDIEEALFGPQPCVFAEIAEWNG
TPAGFALWFYNFSLWFYNFSTFRGRHGLYLEDLFVRPDFRAKGVGKALLKNLARRCVTEG
LPRLEWWVLNWNEPALRFYRSIGAVPMDEWTVQRVTGEALETLADL
>AIA11313.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MTLPLILVVALAKNGVIGRDNHLLWRIKTDLGRFRSLTIGKPMIMGRKTFQSIGKPLPGR
ETIVLTRDMGFAAEGVHVVHTWDEAVAQGGGTRSPDGSRFCRRRRRGGNLRLGPASCPEH
LPDEGSGCAGGRCGLS
>AIA11267.1|FEATURES|farme|beta_lactam|OXA-10|antibiotic inactivation|1
MKIVKLLLLLAMSSSATASVVAQDLSQFFKNTNGAFVLYDLKQDHYLRYNEARCRQRFSP
KSTFKTPNSLIGLETGVINDASFVIPWDRVKYPPQDNWNQEPLSHWAQDHTLRSAIRYSV
VWYYKELALRVGGTRMQKYVRALNYGNKNISGGVDNFWLNNSLKISANEQIEFLKAFYTG
KLPVSKRTTEIVKDILVLEEGPTYKLSAKTGGGPIADGTFIGWFVGYLETKGNVYFFALN
IEGPDFSSIRDRRVLITKQILSELGYYPRN
>AIA11259.1|FEATURES|farme|beta_lactam|THIN-B|antibiotic inactivation|1
MVNVDKLVLGGLLSIAAVAAFAPGAPLLQPDPPKSCKASDEWNGKQQPFRVFGNTYYVGV
AGLSAVLIASDTGHILLDGGLPQSAPLIAENIRSLGFRIEDIRLIVNSHAHFDHAGGIAA
LQRASGAVVATSPSGARALEQGEPVPDDPQHGFGRESTGFPRVNAVRVVSDGEVLHHDGL
AITAHLTPGHTPGSTTWTWRSCEDTRCLDIVYADSLNSVSAPGFKYTGLPGVVEGFRRSI
AAVESLPCDVLLTVHPEFSDLSGKLRRRTAAANENPFIDPQACRVYAAAAARSLDRRLEE
EK
>AIA11248.1|FEATURES|farme|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
MKFMRAVLLLLMMVAAASASAQDLSPFFKDTKGSFVLYDLKNDRYTRYNEARCRERFSPK
STFKIPNSLIGLETGVIRDADFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVW
YYRELALRVGPQRMKKFVSDFDYGNENVSGRIDDFWLGGPLRISADEQVEFLKKFYAARL
PVSKRSVEIVKDILTLETTPAYKLSAKTGGGPIAEGKFIGWFVGYVETKDNVCFFAINIE
GTSYPEIRDKRIELTKQILSALGYLPK
>AIA11184.1|FEATURES|farme|fosfomycin|FosX|antibiotic inactivation|0
MIIPKIYNDPTTKIAVISIRIEGFTLSKMVYCCDIQKNDLFVNFLSVKPPLTYGLTHIAV
AVKDLNATKQFYCGVFDMEVMYDTDDFVQLTTPGTFDILVFEKSGGPFGETGGIVHFGFR
LKRPEDVEELTGRVKKFG
>AIA11167.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
MSSTIETTPAHAYPSLRAAWIPLFALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTGLQW
VTGAYSLTFGGLLLTAGSAADRLGRRRVLLVGLAAFGLISLAVVAVESAGQLIALRAVLG
IAAAAMAPITNSLVFRLFDQEALRMRAMTLMIVVGMSGFILGPLLGGTALAHVRWEWLLV
VNAPIALIAWVGVRLGVQADRPEDLTSEALDLPGAVLSITTIGLACYTLTSRVEHGWGSI
ATCGSALGALLALAAFLRHERRTPQPMLDLDAFAHRTVRGAALAQIGTSIAMAGVMFGLI
LHFQYAYGWSPMRAGLANLPLILTMIAATPISEFLAKRFGHRVACLIGAVLLAGSLAGLA
WGVDRGYPTIAVFMVTLTIGLRTVMTICAVALVSAMPSNRTSIAAALNDTAQEVGSSVGT
AVVGTLIAALVTVTLPAGTWSSDLVASFFHGERVTYATLAVIVGLVAGWGAMTLTDSRSS
EEPA
>AIA11146.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
IAIGKNGNWLNPSDSVGLLPVTSGEALGDAVDSYTQDSVVVAGDTNYKGLTRLGGSDDEE
RTLGLDVIFPVLHGTYGEDGTLQGLLEMAGLPYVGGGVLASACGMDKVVMKTLFRDADLP
ICKYVWFLRSEWERDNNAVIRQVEAKLGYPCFVKPANLGSSVGVSRAEDADSLKAAIELA
SEYDRKIIVEEALDMREIECA
>AIA11144.1|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|0
MDSSINTYVLFGGTSEERNVSTASAQHVVEYLPDAALLFWEKDDTIAIVDRDDLINFPNP
FYSDFKPRNPKSLGKITEAFKKMHPSTKVFLALHGGRGEDGWIQKILEDAKIFFSWIRKC
CL
>AIA11145.1|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MDKPLSKKLINKNGVKVAKELLLSTNPDQRENELRSFFAENGEVVLKPTDDGSSRGLKFI
RTDQDLTDALVELRNQTRAYLVETYISGRELTVGVLEKSDGSLIPLPCSEVELDPGRIFD
YDAKYLGKGCREITPARITADEARRAQEVALIAHKTFGCKSYSRTDVILQPDSVFFLETN
TLPGITKASFYPQQLAAAGIGFEQFLKTVLDLSK
>AIA11076.1|FEATURES|farme|aminoglycoside|WN59_12960|antibiotic inactivation|0
MPSSSITQSKNRSLRAQALPALLEDVVKAYDLPVRRILPPQKGYRNRSFPIQLKDGAYVN
FILYKEELGILEVIRSANRVSAYAADRGFPSRRPLGPIACLRGASGRTKYGALYDYLSGH
TIPWEAYTMDHLKLLGKTLGDLHAVLRPLSRKALPAVTDIYAGIVDRMTRYLADPGVQAA
LQHKLGLRLAPAQFQKYRRLLDACAALPRQQALHMDFVRGNILFNDEPATTRPSDLKVTI
SGILDFEKTAFGHPLFDIARTLAFLLVDCKFKTGDKVRKHFLFSGYARRSQASLPNQPEL
LDALIDLFLTYDFYKFLRHNPYEALPANEHFVRTKQLLAQRGLLQLSR
>AIA11028.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|0
IKVTELDRLRAAGHSPRRINELIYRAYFKQLLEDGFFHADPHPGNLLVMKDGRLAVFDFG
MVGRISDELQRQMINAFFHLYNRDVKAIVSDLVGLGFLAPAADVAAIGAIVAEVFERKLN
LKLGEVRFKDLTYDLAPIVYEHPITTPARFTYLIRAIMTLEGISIVM
>AIA11011.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MMKNVLLKICIVGLALSFHSACTPGQDVRTTEPAIPAVESGAADAELTKQIAALCNDSQG
EIGVTVIHVESGRTVNFEGEKKLPLYSVFKLPLALEVLKRVAEKKISLDQKIHVAPADVA
PGSQFNADLWRKPADKTVAELLEFSIVRSDNTSSDQLLQLVGGPAVVTERMRTLGFPNID
IVSTVREYATSQGKPNLATTANLARLLSRLQKGELLEPSHLSLLLGFMERARTGGERRLR
ASLPLGTTVAEKTGSGADSTNDVGLITLPDGKGHLAMAVLIHNSKLTAEAQERLIADLAR
KAYDAFVTSAATVPGR
>AIA10997.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MRRLSFLSALLITAAAVAAAQGRSNPSDWTTRVAPYKVMANIYYVGTLDLSSFLLTSPEG
HVLIDTGVEENAEAILANIKTLGFNVKDVRVILTTQAHYDHVAAHARLKKESGARVLVST
ADAPLVAGGGEGDYLFGPAYHFPPTPVDAMVKDGEVVTVGPTALKAHLTPGHTRGTTTWT
TTVRDAAGKDRSVVFLGSTSVNPGTKLVNNDKYPGIEADYKRAFTVEKGLTCEVFLAAHA
SAFRGPEKAAAAAAGKGDAAFIDPEGCRAAIERSEKAFLAELEKQRAGR
>AIA10966.1|FEATURES|farme|glycopeptide|RNase_Z|antibiotic target alteration|0
MRIIPLGTSSGKPTLKRNVSALAVAREGEWLLFDCGEGTQTQIARAGLNPGRLAAIFITH
LHGDHFNGLPGLLSTMGLDRRTRQLTLVGPQGMREYLDTLARLKILFVNYPFEVKEYGSM
RELTTVYDAADYTVIAYPLDHRIFDIGYRLQERPRPGRFDLERATALGIPEGPLFGRLQS
GKDVQLDDGRVIHPSDVLGSPRSGKAIAYCTDTRPFAGSVELARDADLLVHEATYTKELT
EEAREYGHSTAAQAGCVARDSGARQLLITHFSTRYTDATPLLEEARAVFSNTIMAQDLVE
VEV
>AIA10950.1|FEATURES|farme|aminoglycoside|N182_21955|antibiotic inactivation|0
MITVRPMKPGEGGALLSMIKALAHSHNLMHTVLATPEMYEAAMFSGQPIVGTLMAEYNGV
LAGCAVWHRSFSTNRGAEVMYLEDLSVLPEFRRRGVARALLKGVARLALEKNYPSVYWLM
MDWNKEANALYESVGAEIEPGTTFCRIRDDALKALAS
>AIA10940.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MIISLLVAMDEKRGIGKAGGLPWRLSSDMKRFRELTMGHHIMVGRKTFESIGKPLPGRQM
IIVTRSESIAVEGCFIVRSVEAAIGLARERGESELFVCGGAEIYAQTLGLADRLYLTLVH
ADCAADTFFPEWNSDDWIEMESEPRAADEKNQHPFTFKTFARKSQV
>AIA10938.1|FEATURES|farme|tetracycline|tet43|antibiotic efflux|1
RRVLLVGLAIFGVVSLGVLAVDSTGQLIALRATLGIAAAMMAPITNSLVFRLFDNDVLRR
KAFTVMITVGMTGFILGPVLGGTALAHVHWQWLLLVNAPIALIAWTGVRIGVPADHPDHL
THDALDLPGALLSVAAIGLGCYTFTSGVLHGWLSWQTLGSAIGALIALAAFVVHERRTAE
PMLDLKLFGRGTVRGASLAQLATAIAMAAVMFGLILHFQYAYGWSPVKAGLANLPLIVTM
LLASPLAENLVTRFGHRVACLIGSAFLAGSLVGMAWAVEVGYLAIVVFMVTFTIGLRVVM
TTCAVALVDAMPSNRTSLATSLNDTAQEVGTSIGTAFIGTMIAVLVTKVLPDGVWSDALV
SSFFHGERVAFLALAVVVGAIAGWGSLTLTDSHATEEH
>AIA10933.1|FEATURES|farme|multidrug|Mdr|antibiotic efflux|0
MFSNRTVSVSVIAGFLAGFAMFGGISFIPLFAQGGLGATATEAGSLLTPLMLAWVTMSVI
GGRVLLKIGYRTISIIGFVILSAGFLMLTQFERTTPYFWLYFDLVLIGSGLGLTMLTLLI
AVQQAVERTKLGIATSLNQFTRSIGGAFGVAIMGAVLTAGLATELHNVALSGTTSLTVEQ
AEVFASNPNALIDPEAKASLPPGTLVILQDAMAAAIHPAFWVAAFISVLALIATFFLPRD
QHDMYSEIHRTDGNAGERMIMAEQTTINARNQPVAEGEN
>AIA10917.1|FEATURES|farme|beta_lactam|BJP-1|antibiotic inactivation|1
MPVKKIVVALVALLSVAGAVQAQTVKDLLETLKVKWNTPTEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPEATSQIKANIEKLGFKVTDIKYLVNTHAHIDHTGGLAEMKQASG
AQMIAGEADKPLLEGGYYPGAQEDAALAFPPVKVDRTVREGDRVSVGDVTLTARETPGHS
PGCTSWEFSVKDGDATRSVLIFCSGTVALNRLGADPTYSGIVSDYRKTFARAKDMKVDVL
LAPHPEMYKMAEKRAKLADGAPNPFVNPGEFNAYAATLEKAFEDALAKQTAAAQEKKG
>AIA10888.1|FEATURES|farme|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|0
MSLALRRTTERDLDFVCAAETSEDNRAFVSVWTREQHINELYDEDIAHLIIEKDDRRVGY
LIVAGLSNEHQSVEFRRLVVTEKGSGIGREVFRLVKRMAFEEFGAHRLWLDVKEFNKRAI
SLYESEGFIVEGVMRECMKNGDEWESFILMSMLRHEYEAKSKAANRI
>AIA10878.1|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MKVILVAALSADGFIGRTADHHADWTGSADKKLFVKLTKEAGVMVMGRATFNTIGRALPE
RRTIVYTRQPNSITVPGIDTTQLEPAELLRQLKDDGYTRVAICGGSQIYGLFMKAGLVTD
LYLTYTPIVFGRGIPLFDQPLAARLKLINTQDLGEEAVLHHYELQS
>AIA10847.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MRRNRFKHLILLVGVLTATVGCSGRLFAQANDWTEPFPPFKIADNLYYVGSKGLASYLIT
TPQGHILINSDLKESVPLLRASVEKLGFKFGDIKILLISHAHWDHNAGSAAIKRLTGAKY
LVMDADVPAVESGGKSDFHYGGDSSTYYPPTRVDQVLHDGEEVKLGGAVLVAHITPGHTK
GCTTWTMKVQENGKTYNAVIIGSPNVNPGYKLVNNATYPGIAADYERTFRVLKELPIDIF
LGAHGSYFDLETKYPQLKKRGLAAFIDPDGYAKYVADREKAFRTELAKQTAAQRQ
>AIA10832.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
MKIFRGEKRVPLVAINLIVLILSGIGFTVHSRTPLGDAWVSAELFPPGVPLTLTQESDNV
ELSARLQKLCDRAGASIGLALMHVETGRTVEIQGKTSLPLYSVFKLPLAIAVLKDVEENR
LRLDQKVRVTPADVAPGSQGNAALWRKPVEKTVAELLELSIGRSDNTSSDKLLQLVGGPD
KVMQRMRSLGFQDIEIRSAVRELATRQGKPNTGTASDLARLLSGLQQGQVLQPPQRTLLL
GFMERATTGLRRLRGDLPAGTIVADKTGTGEDGSVTNDVGLITLPEGKGHLAMAVLISGS
KLPAEAQEKLIAELAKTAYDFHLSQVRQGSQKQSLSRP
>AIA10767.1|FEATURES|farme|beta_lactam|FEZ-1|antibiotic inactivation|1
MQKSSLLRHQLIKLLSVVLLFLPAIAKAQADETSRAWNRPVEPFRIIGNIYYVGATEVSS
FLITTPKGHILLDSGFAETVPLIQANLKKLGFKIKDVKILINSHAHLDHAGGLADLKELT
GAKLMTSEADAALLANGGKGVFRWGDDFSYKPVKVDRVCRDNDEVELGGVTMTARLTPGH
TKGSTTWMMKVNEAGKQFDVIFAGSTSAPGYKLVDNPKYPGIVADYTYTFRLLKSLHCDV
FLGPHGSFFSLLDKAGRLKQGEQNNPFIDPKGYREFLEKSEKDFLEQFEKQRQAGKTK
>AIA10747.1|FEATURES|farme|streptothricin|sta|antibiotic inactivation|0
RSKVTIRTRISRPKLPYEQWCEHLMPLAIRRARPGEAGLVLSFVRELADYEKLLHEMEAT
EADIDTALFGANPRLFCEIAEWDGEPAGFAVWFINFSTFSGRSGIYLEDLFVRPAQRGKG
IGKALLVHLAKECVANGWSRLQWSVLDWNTPSIEFYKSLGAVLMDEWTICRVGGSDLTAL
AQGAR
>AIA10707.1|FEATURES|farme|beta_lactam|LRA-5|antibiotic inactivation|1
EKTVAELLESSIVRSDNTSTDKLLPLIGGPAGVTDRMRTLGVANINIKYSSREFAAHRDK
PNTGTASDLAKLLAKLQKGELLQPAQLSLLLGFMEKARTGGERRIRANLPAGTQVAEKTG
TGDGTTNDVGLITLPDGKGHLAIAVLITRSKVSPEAQEKVIAELARAAYDALVAPAP
>AIA10698.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIISLVAAASENNVIGDTNAPNHAIPWDLPNDMQHFRDVTRGKPVIMGRKTLGFIGRALP
GRVNIVVTRQKDFAFDGVEVAESLEKALEIAIKNNPEEICIIGALADRVYLTRVHATIQG
DTTFPELGREWKAVWQERHEADENHAYAYTFLRFERTSK
>AIA10673.1|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MAVLETGDEVIVPEPCFVAYQPTVIFAGGSPVSVPTYVSQDFQVTVDDLEKARTPRTKAV
LLGYPNNPTGAVLERSRLAEIAEWAEKHDLLVVSDEIYDRLVYGVEHTCFSSLPGMWERT
IVLGGFSKSYAMTGWRIGYAAAPPAILAAMRKIHQYMIMSAPTTGQEAAIEALKSAEPYV
ESMRQEYDRRRRTIVDGFNRLGLDCFEPKGAFYAFPSIKSSGLSDQEFSERLIMEEKVAM
VPGSAFGQSGAGHVRASYATSLQNIEEALNRIEGFLKKLRA
>AIA10667.1|FEATURES|farme|beta_lactam|OXA-50|antibiotic inactivation|1
VERFTARSGYGNADVRDEAEQGSYWYDGSLRISANEQVRFLQRLHNGELGLSARTTDMIR
QVALVEETPRWRLVAKTGACRGVGEQTTTHWYVGWVEKADNTYYFALRLAADSFEPALRD
RVPIARDLLARLHILD
>AIA10665.1|FEATURES|farme|beta_lactam|oxaSH|antibiotic inactivation|1
MNRVSRAIAGILMVLGCILSVLVQTPQSALTVPPPVQVSPRGGGDVAETINFGRHFQELG
VEGSIAIYDLNSDRLYQHNPQRNATAFLPASTFKILNSLISLETGVISDEIAVLTWDGTQ
RQIPAWNRDLNMREAMKLSAVWFYQVLARRVGHEQMQKWVAKVGYGNQKIGNKDDIDKFW
LEGELRITPNEQIQFLRRLYKNDLPFSERSLSLVKDIIIVEQTPDYTIRAKTGWANFGEQ
TKPQIGWYVGYLEKDKNVYFFATNIDIRNENDASARIELTRRCFKDLALL
>AIA10662.1|FEATURES|farme|fusidic_acid|fusB|antibiotic efflux|0
MIGKRYLHAKRSLYVLWTLVSFALYVYLDSKGWFGKSQEKREMRLRRQAARLRARLIRLG
PTFIKMGQMLATRADLLPLDYIKELSALQDQVPPFSDKQAIEIIETELGRSIKDIFAEIS
ERPIASASLGQVYRATLASGEVVAVKVQRPGLSEKIRFDLDLLRWIGHLLDRYPKLFPGA
EWMGAIDEFDRVIHEEMDYRRELANANEFRHNFQDWPSIHVPRVFD
>AIA10638.1|FEATURES|farme|tetracycline|tetA(48)|antibiotic efflux|1
MGKTDYAISAADLYKSFGKVKVLQGVNLQVERGTMLALLGPNGAGKTTTVRILSTLLKQD
SGTVTIGGYDVRRQANEVRGVIGLTGQYAAVDELLTGRENLHMMGRLYHLDKASSRKRAT
ELLEQFDLVKAADRTVKTYSGGMRRRLDLAISLIASPPIIFLDEPTTGLDPRSRLAMWEI
IKKLMAAGATILLTTQYLEEADQLADKIAVIDGGIVIAEGTADELKSKVGKERLELVLES
GKDFAAASKLFSKDELHEDAGRRTISISVDGGAMHVKDILVQLEQAKIKVEGLSLHKPTL
DDVFLSLTGRQAEKTAEAEEGNEKTGGTT
>AIA10633.1|FEATURES|farme|tetracycline|tet41|antibiotic efflux|1
MTTSLKSAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
FLFAPVVGNLSDRYGRRPILLIALLGFGIDYIVLALAPTYGWLFLGRIIAGLTGASFTTA
SAYIADISTNENRAKNYGLIGAAFGLGFVLGPALGGFLATWGIRAPFYAAAVLCLLNFLY
GYFLLPESLDKDHRRQFDWRRANPFGSLKFLTRHPEIGELAICFFLIYLAAQSVQGNWNF
FTIYRFHWSEKMVGISLAVVGVLVGAVQGGLTRVINPKIGDEKSIYLGISLYTLGLLLFA
VATETWMMFAFLVPYCLGGICGPSLQSVIAAHVPSNQQGELQGALTSLMSLTTIIGPLIM
NSTFAYFTSDKAPFHLPGVHFLIGAVCMLTCLLLTYKVLSRERKVKAAVPVSSKST
>AIA10623.1|FEATURES|farme|tetracycline|tetV|antibiotic efflux|0
FIVVPWQMFQLTKSSEMVGYIYLAEFVPMFCLAFVGGALADALDKRKMLRFTEIGQTLVT
AILLLNSLLPNPQIWVLYVAVALHAGLAALQRPAFESFIQKVIPNELMSAVMALNSVRFS
IGAIVSPAIAGIIATQFSASVAYAIDLFTFTASLIAVFLLNSVPSPENAERPSWRSVKNG
WRYAFSRQELLGTYLIDIAAMFFAMPQALYPALAVIYGEKYVGFFPAAIAAGALLASLTS
GWTKNVHKHGIMVTIAAVLWGVAIIFFGFAESIWLALLFLGMAGFFDMISGIFRGSIWNQ
TIPNYLRGRLASIEMISYLTGPMLGSAKMGIVAERFSVKTAIISGGVLCVVFVGILALFL
PQFVTYDGREGVKQKEREEAERAELLRFSEGEF
>AIA10600.1|FEATURES|farme|beta_lactam|AS202_10895|antibiotic inactivation|1
MNARIGFLLLSLFIVGLNSAPAASQDLSPYFKNTNGAFVLYDLKENHYIRYNEQRCRERF
SPKSTFKIPNSLIGLDTGVIRDADFPIAWNRQKYPPQDNWNQEPFIHWAQDHTLRSAIKY
SVVWYYRELALRVGKQKMMKYITAFNYGNKTISKDIDNFWLDNSLKISADEQVEFLKEFY
AGRLPVSKLAIETVKDILVLENTPAYKLSAKTGGGSIAEGKYIGWFVGYLETKGNVYFFA
TNIEGASFAEIREKRVGLSKEILAALGYLPK
>AIA10581.1|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MIKPTVELVVARADNGVIGKDGTLPWHLPSDLRHFKIQTMGAPMIMGRKTFESLPKVLPG
REHIVLTRDPAWKAEGVKVARSRDEALALAAGDRVSIIGGAEIYREFLPIADRIHLTEVH
LSPDGDTWFPQLNGREWSVRRGDEVPAEGDRPAHTFVTLTRRAIAGG
>AIA10554.1|FEATURES|farme|aminoglycoside|Mmwyl1_0154|antibiotic inactivation|0
MKLDVEIRFALPDESEAIAEVIREAFAEMQSLYTPEAFAVTTPNAEKVRERFREGKIWAA
LEEEKMVGTVSVVPEENGRLYIRSMAVLSSVQGLGIGRKMLEAIENYAIENGFENLFLYT
LPFLEGAIRLYERN
>AIA10528.1|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MAIIGIVAVDQNGAIGKEGGLPWHYSADMKFFKQQTTGHACVMGYRTWRSLKKPLKDRLN
IVLSRNSEVEPQPSVVIVRDMLSVLSLKEYLSCDLFVIGGEQVYRSFLPHVEKWLVTEIP
LAVEATDTFMPGDYLQGFKLSGSEQLEGNLRVNIYDRQG
>AIA10453.1|FEATURES|farme|fosmidomycin|rosa|antibiotic efflux|0
MGGDEIICKPPGHLVSGHFLAKVPKAWILLACIGLLALNLRGPFVAVAPVVDLMQADLGF
SPVMLGLLTSIPVLCFAVAAPLASLATRKFGAEFAVSLTILGVLAGVIVRSAGGPGPVVV
GTVMIGVAITVGNIAVPLLIRRDFSPWRQGTAMGVYTAALNIGSFVTSMATAPLAEVAGW
RVALASVGILALVAIVFWTFAVGPRTAFVPSGAVVNGGQEHSAVKGSGWITAGLTLGFAG
QAFSYYAVTAWLPSYLHDELDMSASAAGAGSSLFQIFAIVGGLGVPLAAKYFSTTTTAVT
VGVLWMAVPAGLLLAPELWWLWSVSGGISQGGGITIIFIAIIKLAKDQVSAGRMSATVQG
IGYCFAAVSPPLIGFVHDAADSWTPALLVILVSTLVFFVSTTLSVRKVPKGR
>AIA10451.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MAIDEQAPAQKHATGEQFVSERVNNVPPSGIRKFFDIVATMKDVISLGIGEPDFVSPEPI
LNAGIDSLKAGHTAYTSNSGILELRELLSKHIERLYKVHYDAEREILVTVGVSEALLLAF
MATLEPGSEVIVPEPCFVAYQPTVVFAGGVPVPVPTYVSQDFQVTVEDLEKARTPRTRAI
LLGYPNNPTGAVLERSRLEEIAAWAVKHDLLVVSDEIYDRLVYGMSHAMTGWRIGYTAAP
PAILAAMRKVHQYIIMSAPTTGQEAAIEALKSGEPFVESMRQEYDRRRRLIVDGFNRLGL
KCFEPRGAFYAFPSIESTGLSDEEFCDRLLMEEKVAVVPGSAFGMSGTGHVRASYATAYE
RIEEALVRIERFLNKLK
>AMJ38519.1|FEATURES|farme|quinolone|oqxB|antibiotic efflux|1
FQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGD
>AMJ38507.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MKAAAKTQKPKRQEEHANFISWRFALLCGCILLALAFLLGRVAWLQVISPDMLVKEGDMR
SLRVQQVSTSRGMITDRSGRPLAVSVPVKAIWADPKEVHDAGGISVGDRWKALANALNIP
LDQLSARINANPKGRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIG
FTNVDSQGIEGVEKSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLTLSIDERL
QALVYRELNNAVAFNKAESGSAVLVDVNTGEVLAMANSPSYNPNNLSGTPKEAMRNRTIT
DVFEPGSTVKPMVVMTALQRGVVRENSVLNTVPYRINGHEIKDVARYSELTLTGVLQKSS
NVGVSKLALAMPSSALVDTYSRFGLGKATNLGLVGERSGLYPQKQRWSDIERATFSFGYG
LMVTPLQLARVYATIGSYGIYRPLSITKVDPPVPGERVFPESIVRTVVHMMESVALPGGG
GVKAAIKGYRIAIKTGTAKKVGPDGRYINKYIAYTAGVAPASQPRFALVVVINDPQAGKY
YGGAVSAPVFGAIMGGVLRTMNIEPDALTTGDKNEFVINQGEGTGGRS
>AMJ38480.1|FEATURES|farme|beta_lactam|ACT-7|antibiotic inactivation|1
MAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLP
VAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSYPNPARVEAAYHIL
EALQ
>AMJ38470.1|FEATURES|farme|multidrug|farB|antibiotic efflux|0
MANDLHGQNYYGVILGASSIATMTGLPIGAALMNRVRLVRLLVGATLVLVFGALVSAVAP
SVIVFVIGSILRGLAGSILAMTSLGAVALGLSGRARQLTLAFASASWVVASVVGPAYAAW
VTHLLSWRWAILLYLPFLLAARFVIAFNLKTESQKKDAPMSYQALFLIIIGVGVTIVPIA
GIGKILLLLVGIGLLTRVAILLMPSGTFSQRTQRRAALAGMFFLTGSYFAANELVSLTAH
DLFDASAKSLGYILTGGGLAWALLGVFCGIKPASSMLAYRIRSSIGLTLLLLSTAAISVV
SLTDSSLSHPTVFFVILWTLAGTGMGLTYLDTLNIFFEDPAVPDGITIEEMASSSVIVES
LSSTMFIPLTSSIVAMAFTNQQVTSTLPYGISWLIVVGLAFVAFYYLMGVQSSKNS
>AMJ38433.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
IFVDVDWIAGVSVILWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLL
GFLGEHYGLRSAMLVVLGLVIIAALEARAVAKPEAEPTSMEKGYER
>AMJ38429.1|FEATURES|NCBI|multidrug|mdtG|antibiotic efflux|0
MTGEKTMTQQSDGEAEPERYWRRNLWVCMAGSFTTLIAMTLLLPFLPLYVAELGVSEPAA
VARWSGVAYGATFFTAALTAPLWGRLGDRYGRKLMLIRASLGMAIAMSLIGMASAPWQLV
ALRLLAGLLGGYASGATIFIAAQTPKAHTGWALGMLSSGVMAGNVVGPLIGGLLPPLIGI
RATFWLAGGVIFLAFLATSLLLKEAPRPAPQQRQRETAALSLRQGML
>AMJ38356.1|FEATURES|farme|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVADTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AMJ38345.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MSWIVLVIAGLLEVVWAIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYA
IWTGIGAVGAAITGILLLGESASPARLLSLGLIVAGIVGLKLSTH
>AMJ38335.1|FEATURES|farme|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ38324.1|FEATURES|farme|beta_lactam|CFE-1|antibiotic inactivation|1
MMKKSLCCAWLLTASFSTFAAAKTEQQIADIVNHTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWALGAKRLYANSSIGLFGA
LAVKPSAMRYEEAMTRRVLQPLKLTHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSLVDMTRWVQTNMDASQVQEKTLRQGIEIAQARYWRIGDMYQGLGWEMLNWPVNP
NSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AMJ38298.1|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
QIKRRILNIASYENPTYWKRIKGLIAFFMTAILLFGCSPMLSTYASEECYTWDTSSKKIT
LVDLSSYFDGYKGSFVLYDLQKDNWNIYDIEQATIRISPNSTYKIYDALFALEENIITSE
NSFISCPQQNYPFESWNEDQTLFSAMNSSVNWYFQALDAKLGKSNLQSYIEQIGYGNQNI
NGELSSYWMESSLKISPIEQV
>AMJ38231.1|FEATURES|farme|multidrug|msbA|antibiotic efflux|1
DTVLILDEATSALDTESERAIQSALDELQKNRTSLVIAHRLSTIEQADEIVVVEDGVIVE
RGSHADLLEQRGVYAQLHKMQFGQ
>AMJ38218.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTRQQKIYYSGDSGYGPHFKAIGNEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ38180.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MTTRPHSSFKIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLFYGPMAD
>AMJ38141.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIADLPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSR
GIVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ38033.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKMGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ37983.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTATPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYP
>AMJ37979.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPPDISEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVH
>AMJ37872.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
YPWHGALGRFGAADREKVEEAISLVGLKPLAHRLVDSLSGGERQRAWIAMLVAQDSRCLL
LDEPTSALDIAHQVDVLALVHRLSQERGLTVIAVLHDINMAARYCDYLVALRGGEMIAQG
TPAEIMRGETLEMIYGIPMGILPHPAGAAPVSFVY
>AMJ37838.1|FEATURES|farme|macrolide-lincosamide-streptogramin|mefC|antibiotic efflux|1
MNNWKKKFIIIWTGQLFSILSSSIAQFSIVLWISLKTGSAEVLSFATIAALLPQALLGPF
AGVFVDRWNRKWTMIGADSFVALCSGVIALLFYLDIIELWHIYLLLMLRSVGGAFHTPAM
KSSVPLLAPEKELMRIAGINQAIQSICNIGGPALGAILLLAFDMSLVMLLDVLGAIIACT
ALLFVYIPNPKQENTSAKNVLYDMRDGFNVIMRNKGVSWVMVTEVLVTFFVMPMVALMPL
MTLKNFSGTAYQVSLIETLFGAGMLAGGALLGVWNPKIRKTLLIAISYFLLGAALAFCGI
LPADGFVLFAALTVAQGIVVPFFSGPFTSLLQTQFKPAYLGRVFSLFDSVSLLPSIIGLF
ITGFIADSLGIANIFICCGIAIVFTSILMMCIPAVRDLEKQSK
>AMJ37833.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTAKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQFNVPDGSAQMTLSTYILGFAL
GQLLYGPMADSLGRKPVILGGTLVFAAAAVACALSQTIDMLITMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTVAPLVAPMVGGAVLVWFSWHAIFWILALAALLASAM
IAFFISETLPPERRQKFHIRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
ININHVSPQHFGYYFALNVVFLFVMTMINSRFVRRVGALNMFRAGLWIQFAMAVWMVVCA
LFDVGFWALVFGVAAFIGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAI
>AMJ37739.1|FEATURES|farme|beta_lactam|bla_1|antibiotic inactivation|1
MGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEAD
KVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERN
RQIAEIGASLIKHW
>AMJ37650.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MPFVFSAIVTKVIVEIPLPPGTISVQPSALQDDLQTRLFTGDGPNFPEPDMSWIILVIAG
LLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSMALLAGAMKSLPVGTAYAVWTGIGAVGA
AITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ37621.1|FEATURES|farme|beta_lactam|LRA-13|antibiotic inactivation|0
MEDKLVTLAIHTFEKAQILKTILETEGIEVYIHNVNQIQPVVSAGVRVRIKESDLPHALR
IIEDNKWFEEPKEEEAKVNAVKKVLIPIDFSDYSAKACELGINYAHAVGAEVMIMHAYFS
PYFPSAIPMGDTLAYQVNEEESVQHILQRVRIDMENICTHINRKMSSGELPKVKYDYVLR
EGLPEEEIIAYSKEYHPTLIVMGTRGKSQKDMDLIGSVTGEVIEVNRVPVLAIPENVPFT
DLRDAKNIAFATSFNQRDLVAFDEFMEIIKGFDFNIHLFNISTSKDEWNEIRLTGVREYF
KKQYPHAHISHTVLADGDLLLAIEKFVRDKQIDVIALSTYRRNILARMFNPSIARKMLFH
TDTPLLVIDSKK
>AMJ37596.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
TVLSIGSMSGILCSAWLVKRFGTRNVILVTMSCALIGMMILSLALWLTSPLLFAVGLGVF
GASFGSAEVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATVHIL
LAALVGIAPIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGS
ANDWLPLLMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALMGAL
GIGLIIFVDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLV
GPPLLGYLGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ37555.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGRRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVQEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEMMFVLFAVL
AAISFVGLQRAMPETATRLGEKLSVKELGRDYRLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEQATSYEYGMLQVPIFGALIAGNLVLARLTSRRTVRSLIIMGGWPIMFGLI
LSAAATVVSSHAYLWMTAGLSFYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYELGGNGLFSLFNLLGGVLWLGLMIYFLKDKSVGNSQQA
>AMJ37543.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MLELNFSQTLGNHCLTINETLPANGITAIFGVSGAGKTSLINAISGLTRPQKGRIVLNGR
VLNDADKGICLTPEKRRVGYVFQDARLFPHYKVRGNLRYGMAKSMVNQAGGAFRH
>AMJ37504.1|FEATURES|farme|beta_lactam|MIR-16|antibiotic inactivation|1
MSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFEL
GSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQGIRMLDLATYTAGGLPLQVP
DEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVFKPL
KLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKTNVKDMASWVIANMKPDS
LQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDVKTVVGGSDNKVALAPLPVAEVN
PPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVEAAYRILDALQ
>AMJ37474.1|FEATURES|farme|beta_lactam|blaTEM|antibiotic inactivation|1
MSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMAT
TLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAA
LGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ37473.1|FEATURES|farme|beta_lactam|TEM-95|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRRI
MQCCHNHE
>AMJ37452.1|FEATURES|farme|beta_lactam|BL2a_pc|antibiotic inactivation|1
MIYKNYNCNIGGFILKRLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETSKSVMKEF
>AMJ37421.1|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRYMFQKVM
>AMJ37362.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQ
WNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGA
LAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEA
YGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNP
DIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLA
NKNYPNPARVTAAWQILNTLQ
>AMJ37357.1|FEATURES|farme|multidrug|YkkD|antibiotic efflux|0
GTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ37351.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKMGGTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ37311.1|FEATURES|farme|tetracycline|tetA(P)|antibiotic efflux|1
LFSAITAMCFSLVATVMIVYHIEIVHLNPLQLILVGTTLELACFIFEIPTGIVADVYSRK
LSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEI
YIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPG
DLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLG
NLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTR
NFSLMLIAYLATNTFRIINEPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGI
IATNISVSIGIVCTSLLVAPVLVLYIISMIMDKKIS
>AMJ37280.1|FEATURES|farme|beta_lactam|OXY-6-2|antibiotic inactivation|1
MCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAAL
QYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMA
ESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIA
VIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AMJ37233.1|FEATURES|farme|aminoglycoside|APH(3')-IIa|antibiotic inactivation|1
MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNEL
Q
>AMJ37202.1|FEATURES|farme|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHHTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AMJ37154.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATDGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ37141.1|FEATURES|farme|beta_lactam|bla|antibiotic inactivation|1
SLWASADAIQQKLANLEKRSGGRLGVALINTADDS
>AMJ37115.1|FEATURES|farme|tetracycline|tetM|antibiotic target protection|1
EQWDTVIEGNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIE
VITNKFYSSTHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVT
EMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEP
SKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIE
LKEPTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQS
FQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLTPIVLEQAFRKAG
TELLEPYLSFKVYAPQEYLSRAYNDAPKYCANIVNTQLKNNEVIIIGEIPARCIQDYRND
LTFFTNGLSVCLAELKGYQVTTGEPVCQTRRLNSRIDKVRYMFNKIT
>AMJ37015.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
MNKKVEIHFLPGKNAISHISFVGRPANASFTGDGPIVLEPDMSWIVLLIAGLLEVVWAIG
LKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGILLLG
ESASPARLLSLGLIVAGIIGLKLSTH
>AMJ37005.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYAGIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTRATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ36986.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
PKVKRVVTPLGVGSHLRYWGMKPEIIDERDWNQSVRISDALTVHVLPARHFSGRGIKRDR
TLWGSFMFVTPEQKVYYSGDSGYGPHFRAIGEQFGEVDVAIMENGQYDQDWKYIHMLPEE
TAQASADLNAKAVVPGHNGRFVLAKHAWNDPLIQLAKASQDKNYRLLTPELGEPVRVSDT
AQTFRAWWE
>AMJ36969.1|FEATURES|farme|beta_lactam|SHV-12|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLP
>AMJ36951.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGGVWFIVTCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>AMJ36948.1|FEATURES|farme|tetracycline|tet39|antibiotic efflux|0
MTVNSSRNALKRRTWALFMFFFLPGLLMASWATRTPAIRDILSVSIAEMGGVLFGLSIGS
MSGILCSAWLVKRFGTRNVILVTMSCALIGMMILSLALWLTSPLLFAVGLGVFGASFGSA
EVAINVEGAAVEREMNKTVLPMMHGFYSLGTLAGAGVGMALTAFGVPATVHILLAALVGI
APIYIAIQAIPDGTGKNAADGTQHGEKGVPFYRDIQLLLIGVVVLAMAFAEGSANDWLPL
LMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRVAVVRASALMGALGIGLIIF
VDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVSVVATTGYLAFLVGPPLLGY
LGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMENS
>AMJ36832.1|FEATURES|farme|multidrug|ceoB|antibiotic efflux|1
MNLRFFIDRPVFSGVISVVIVLLGMISMFSLPVEQYPDIAPPTINVFATYPGANAETVQK
AVITPLEEAINGVEDMTYMTSTASNTGDASINIYFKQGTNADMAAVNVQNRVNGALSQLP
AEATKTGVTTEKQQNAELMTFALYSPDDRFDQTFLSNYVKINVEPRLKRISGVGKAQLFG
SNYSMRR
>AMJ36797.1|FEATURES|farme|tetracycline|tetD|antibiotic efflux|1
VITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPLLGRWSDKLG
RRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTA
WFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKP
AEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLA
GLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGG
GIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLI
GTALYGLLLAICLLIRKPAPVAATC
>AMJ36791.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MQDDLQTPLFTGDGPNSPEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAM
IVSMALLAWAMKSLPVGTAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIG
LKLSTH
>AMJ36750.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKTYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGVTGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ36723.1|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
MEPDMSWIILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSMALLAGAMKSLPVG
TAYAVWTGIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>AMJ36679.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
ALLASSLLLTIGRGATLPFMTIYLTRRYQLDVDVIGYALSLALVVGVLFSMGFGILADKF
DKKRYMVWSVLVFILGFSAIP
>AMJ36654.1|FEATURES|farme|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTHHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFH
>AMJ36413.1|FEATURES|farme|tetracycline|tetB(P)|antibiotic target protection|1
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSS
TISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKEL
NIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIIND
DAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLD
GICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKV
KKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISA
IDKEKNPELFKALTLLAEEDPLLELEMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVE
FSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKS
FQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQ
TVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMK
IASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD
>AMJ36165.1|FEATURES|farme|beta_lactam|acc-1b|antibiotic inactivation|1
MRIGVQGSTYIRLKGHLFMRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDL
IQPLMQKNNIPGMSVAVTVNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLAS
YAQVSGKLSLDQSVSHYVPELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLK
AWKPADAAGTHRVIPISVLVC
>AMJ36068.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALDDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGY
>AMJ36008.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
SWYLQLAGKRILIDPVFSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDY
ATIRALLPKIKRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSG
RGLKRNQTLWASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKY
IHMMPDETAQAADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGE
PVWVADKTQSFNAWWR
>AMJ35886.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLASATTLPFVLNAGFGQAPQGAQLSLVEQSPHYHDGQFHNQLLTPGF
TGQKNMLAAWWEFLVAKRENARPAQPLPLVNTDLAGLPSGQDVMVWLGHSSWYLQLAGKR
ILIDPVFSNYAAPFSFINKAFAGDYPWHAEGMPDIDLLIISHDHYDHLDYATIKALMPKV
KRVVTPLGVGSHLRYWGMESAIISEADWNQSLQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGEVDLAIMENGQYDQDWKYIHMMPEETAQ
AADDVHARAVLPGHAGRFVLAKHTWDDPYKRLAEASTGRPWRLLTPMLGEPVWVADKTQS
FNAWWR
>AMJ35877.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
LLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFALGQLIYGPMADSFGRKP
VVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVINALMRDIYPKEEFSRMM
SFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAMIFFLIKETLPPERRQP
FHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVAPENFGYYFA
LNILFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISALLGLG
>AMJ35851.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLTGPDIPLTRYYGRLLMMKKSLCCALLLGISCSALAAPVSEK
QLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHYYTFGKADIAASKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMGYERAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ
>AMJ35834.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGI
FQGKPYYFSWGYAGIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATG
>AMJ35805.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AMJ35766.1|FEATURES|farme|beta_lactam|bla(ampc-EC7)|antibiotic inactivation|1
MFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLP
LQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRV
FQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNL
KPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPV
KPITPPTPAVRASWVHRTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILN
TLQ
>AMJ35639.1|FEATURES|farme|chloramphenicol|L414_02272|antibiotic inactivation|1
MTKITPEYTAVDLSSWARKEHFEVFQSFAQCTINQTVQLDITALLKHIKQVGWKFYPSII
SLISTVVNRHSEFRMAMKDNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVY
AEDVSRYGDNLAYWPKEEYRENIFFISDIPWVSFTSFNINVANMQNFFAPMFTFGKYFNQ
DGKVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHY
>AMJ35572.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
GVGMALTALGIAANVHILLAALVCIIPILTGIRAIPAGTGQHASDEQKSAAKGLPFYRDF
QLMLIGVVVLAMAFAEGSANDWLPLLMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFI
DRYSRVAVVRASALLGGLGIAMIIFVDVDWIAGVSVILWGLGASLGFPLTISAASDTGPD
APTRVSVVATTGYLAFLVGPPLLGFLGEHYGLRSAMLVVLGLVIIAALVARAVAKPEAEQ
TTMEKGYER
>AMJ35541.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGLGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ35471.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATAGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNTLQ
>AMJ35435.1|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
FIRDVAKSSVDDPLNARYTPFDGKPAFLQAAANWYRNVHGVELDWRSQLFAVEGAVDGLA
GLFAILIDRGDAVAFADPYYPSYHCMSVMHGAEEILLPARAELGWLPDLDAVDESVWRRL
RMLILNYPNNPTGAQAPASFFEHAVELAKRYGFLIVHDFAYTGLGVSDQQVSLLTVPGAS
DVSVEVDSLSKMYA
>AMJ35238.1|FEATURES|farme|quinolone|oqxA|antibiotic efflux|1
MSLQKTWGNIHLTALGAMMLSFLLVGCDDSVAQNAAPPAPAVSAAKVLVKSISQWDSFNG
RIEAVESVQLRPRVSGYIDKVNYTDGQEVKKGQVLFTIDDRTYRAALEQAQATLARAKTQ
ASLAQSEANRTDKLVHTNLVSREEWEQRRSAAVQAQADIRAAQAAVDAAQLNLDFTKVTA
PIDGRASRALITSGNLVTAGDTASVLTTLVSQKTVYVYFDVDESTYLHYQNLARRGQSAS
SDNQALPVEIGLVGEEGYPHQGKVDFLDNQLTPSTGTIRMRALLDNSQRLFTPGLFARVR
LPGSAAFQATLIDDKAVLTDQDRKYVYIVDKDGKAQRRDITPGRLVDGLRIVKQGLKPGD
SVIVDGLQKVFMPGMAVNAKTVAMTPSAALN
>AMJ35070.1|FEATURES|farme|beta_lactam|BL2b_ula|antibiotic inactivation|1
MWMRNKSVWRGLLLAGLLNLSLGSTVALADNTALTQKLAALEKSTGGRLGVAWIDGDGLR
YGYRADERFPMTSTFKTLAAAAILHNSVSQPNLLEKKIRIREADRVAWTPVTGNYFGKEM
SIAALCAAAIEYSDNLAANYLLKELGGPQGVTAYARLLGDTLTRLDRQETELNSAAPGDE
RDTSTPAAMAENLSKLTLGDALPTAQRQRLISWLKQNTTGDQSIRAGVPAGWTVGDKTGA
GAYGTTNDLAILWPEKGAPKILA
>AMJ35015.1|FEATURES|farme|aminocoumarin|novA|antibiotic efflux|1
MLSIKDLHVSVEDKAILRGLSLDVRPGEVHAIMGPNGSGKSTLSATLAGREDYEVTSGTV
EFKGKDLLALSPEDRAGEGIFMAFQYPVEIPGVSNQFFLQTALNAVRSYRGQETLDRFDF
QDLMEEKIAPLKMPEDLLTRSVNVGFSGGEKKRNDILQMAVLEPELCILDESDSGLDIDA
LKVVADGVNSLRDGKRSFIIVTHYQRILDYIKPDYVHVLYQGRIVKSGDFTLVKQLEEQG
YGWLTEQQ
>AMJ35005.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGDRRIW
>AMJ34936.1|FEATURES|farme|aminoglycoside|aminotran_1_2|antibiotic inactivation|0
RDIAEQYKRRRDVLVKGLHEAGWMVEMPKASMYVWAKIPEPYAAMGSLEFAKKLLNEAKV
CVS
>AMJ34737.1|FEATURES|farme|beta_lactam|SHV-67|antibiotic inactivation|1
MAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AMJ34682.1|FEATURES|farme|tetracycline|tetA(60)|antibiotic efflux|1
GTVANNIALGKPDATQAQIERVAQLASVHDDILRLPQGYETEVGERGVMLSGGQKQRISI
ARALLLEAEILILDDALSAVDGRTEHQILHNLRQWGEGRTVIISAHRLSALTEASEILVL
QHGHIAQRGRHEALAVQPGWYRDMYRYQQLEAALDEVPQTQEEALDA
>AMJ34681.1|FEATURES|farme|tetracycline|tetB(60)|antibiotic efflux|1
MRSFTELWPTLKRLLAYGSPWRKPLAIAVAMMWIAAAAEVSGPLLISYFIDNMVAKHTLP
LKLVAGLAVAYIGLQLLAALLHYNQSLLFNRAAVGVVQQLRSDVMDAALHQPLSEFDTQP
VGQLISRVTNDTEVIRDLYVTVVATVLRSAALIGAMLVAMFSLDWRMALVAIAIFPAVLI
VMIIYQRYSTPIVRRVRAWLADINDGFNEVINGMGVIQQFRQQARFGERMREASYAHYLA
RMQTLRLDGFLLRPLLSLFSSLVLCGLLMLFGFSAVGTIEVGVLYAFISYLGRLNEPLIE
LTTQQSMLQQAVVAGERVFELMDRPRQAWGRDDAPLSSGRVEIDHLSFAYRGDRLVLQDI
TLDIPSRSFVALVGHTGSGKSTLASLMMGYYPLTHGEIRIDGRPLASLSHSALRRGIAMV
QQDPVVLADTFYANVALGRDISEAQVWEALEAVQLAAVARSMSDGLYTQLGEQGNNLSVG
QKQLLALARVLVDTPQVLILDEATANIDSGTEQAIQQALTKVRQHTTLVVIAHRLSTIVE
ADTILVLHRGQAVERGTHQQLLAAKGRYWQMYQLQLAGEELAASAREESLSA
>AMJ34661.1|FEATURES|farme|beta_lactam|OXA-18|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILFDPVFSDYAAPFSFINKAFPGDYPWRAEGMPDIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALISEADWQQAIPVSDEFTVHVLPARHFSGRGLKRNQTLW
ASFLFVTPQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34643.1|FEATURES|farme|beta_lactam|OXY-2-4|antibiotic inactivation|1
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
YRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTL
AELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERD
TSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGD
YGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AMJ34542.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
ITGYLAFLVGPPLLGFLGEHFGLRSAMMVVLGLVMVAALVARAVAKPQSEPVMENS
>AMJ34490.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
PSREELVHPIIKVMLVGGKADGLLVSVADDATEVSVTPAQYGALPMDGLRRQVSAGGNIG
ERLMATGARHYGNIRATAEKWLQEVEIPPSRIDDLPTTFSGGMQQRLQIARNLVTQPKLV
FMDEPTGGLDVSVQARLLDLLRGLAVELNLADG
>AMJ34468.1|FEATURES|farme|tetracycline|tetB(60)|antibiotic efflux|1
MRSFSQLWPTLKRLLAYGSPWRKPLGIAVLMMWVAAAAEVSGPLLISYFIDNMVAKNNLP
LKVVAGLAAAYVGLQLFAAGLHYAQSLLFNRAAVGVVQQLRTDVMDAALRQPLSEFDTQP
VGQVISRVTNDTEVIRDLYVTVVATVLRSAALVGAMLVAMFSLDWRMALVAIMIFPVVLV
VMVIYQRYSTPIVRRVRAYLADINDGFNEIINGMSVIQQFRQQARFGERMGEASRSHYMA
RMQTLRLDGFLLRPLLSLFSSLILCGLLMLFGFSASGTIEVGVLYAFISYLGRLNEPLIE
LTTQQAMLQQAVVAGERVFELMDGPRQQYGNDDRPLQSGTIEVDNVSFAYRDDNLVLKNI
NLSVPSRNFVALVGHTGSGKSTLASLLMGYYPLTEGEIRLDGRPLSSLSHSALRQGVAMV
QQDPVVLADTFLANVTLGRDISEERVWQALETVQLAELARSMSDGIYTPLGEQGNNLSVG
QKQLLALARVLVETPQILILDEATASIDSGTEQAIQHALAAVREHTTLVVIAHRLSTIVD
ADTILVLHRGQAVEQGTHQQLLAAQGRYWQMYQLQLAGEELAASVREEESLSA
>AMJ34455.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLAAATTLPFVLNAGFGKAPQGAQLSQVEASPHYRDGQFHNQLPTPGF
TGQKNMLAAWWDFLMTKRENARPAQPLPLVKTDLATLPLGQDVMVWLGHSSWYLQLAGKR
ILIDPVLSDYAAPFSFINKAFPGDYPWRAEGMPEIDLLIISHDHYDHLDYATIRALLPKI
KRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTLW
ASFLFVTRQQKIYYSGDSGYGPHFKAIGDEFGPVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRARAVLPGHAGRFVLAKHSWDEPYQRLAAASEGRAWRLLTPVQGEPVWVADKTQS
FNAWWR
>AMJ34435.1|FEATURES|farme|aminoglycoside|CIMIT_00695|antibiotic inactivation|1
FVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAI
PGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVSRNAVNPD
FLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDL
GRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLT
WG
>AMJ34396.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
ITDRSGRPLAVSVPVKAIWADPKELHDAGGVTLDTRWKALADALNMPLDQLATRINTNPR
MRFIYLARQVNPDMADYIKKLKLPGIHLREESRRYYPSGEVTAHLIGFTNVDSQGIEGVE
KSFDKWLTGQPGERIVRKDRYGRVIEDISSTDSQAAHNLALSIDERLQALVYRELNNAVA
FNKAESGSAVLVDVNTGEVLAMANSPSYNPNNFAGTAKDTMRNRAITDVFEPGSTVKPMV
VMTALQRGIVNENTVLNTVPYRINGHEIKDVARYSELTLTGVLQKSSN
>AMJ34340.1|FEATURES|farme|tetracycline|tet42|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRFQLEVDVIGYALSLALV
VGVLFSMGFGILADRFDKKRYMVWSVLVFILGFSAIPLVNNALLVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHSINLPFWLAAAC
>AMJ34332.1|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLSLRRSTSALLASSLLLTIGRGATLPFMTIYLSRQYSLSVDLIGYAMTIALTIGVVFS
LGFGILADKFDKKRYMLLAITAFACGFIAIPLVNNVTLVVLFFALINCAYSVFATVLKAW
FADNLSSTSKTKIFSINYTMLNIGWTIGPPLGTLLVMQSINLPFWLAAICSAFPMLFIQI
WVKRSEKIIATETASAWSPKVLLQDKALLWFTCSGFLASFVSGAFASCISQYVMVIADGD
FAEKVVAVVLPVNAAMVVTLQYSVGRRLNPANIRTLMTAGT
>AMJ34265.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
LATIKALMPKIKRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFS
GRGIKRNQTLWASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWK
FIHMMPEETAQAAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLG
EPVILSEPDQLFTAWWQQVTQ
>AMJ34185.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLITVSCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKAGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>AMJ34139.1|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
MNRVTFSVVAIMLLASATALPFVLNAGFGRAPQGAQLSLVEQSPHYRDGQFHNQLPTPGF
TGQKNMLAAWWEFLVTKRENARPAQPLPLVNTDLASLPIGQDTMVWLGHSSWYVQLAGKR
ILIDPVFSDYAAPFSFINKAFPGDYPWRAERMPEIDLLIISHDHYDHLDYATIKALMPKI
KRVVTPLGVGSHLRYWGMESAIISEADWHQAVQVSDELTVHVLPARHFSGRGLKRNQTLW
ASFMFVTPQQKIYYSGDSGYGPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPDETAQ
AADDLRTRAVLPGHAGRFVLAKHSWDDPYKRLAAASQQRPWRLLTPMLGEPVWVADKTQS
FTTWWR
>AMJ34134.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|1
MTTRPHSSFKIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLFYGPMADSLGRKPVILGGTLVFAVAAVACALAQTIDHLIIMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLVAPMAGGAVLVWFSWHMIFWILALAALLASAM
IFFFIDETLPVERRQKFHIRTTIGNFASLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IELNHVSPQHFGYYFALNIVFLFIMTIINSRFVRRVGALNMFRAGLWIQFVMAVWLVVSA
FLGVGFWALVVGVAAFVGCVAMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LAMATFSTAWPMLWAMAFCATSSILFYLYASRPRKAAH
>AMJ34116.1|FEATURES|farme|macrolide-lincosamide-streptogramin|HMPREF9309_01063|antibiotic efflux|0
MSIEIVNIKKSFGRTQVLNDISLDIPSGQMVALLGPSGSGKTTLLRIIA
>AMJ34106.1|FEATURES|farme|beta_lactam|OXY-6-1|antibiotic inactivation|1
PLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
>AMJ34055.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
QFGAVDLAIMENGQYDQDWKYIHMMPEETAQAADDVRARAVLPGHAGRFVLAKHTWDDPY
IRLAEASTGRPWRLLTPMLGEPVWVADKTQSFNAWWR
>AMJ34045.1|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
AIISEADWHQAVQVSDELTVHVLPARHFSGRGLKRNQTLWASFMFVTPQQKIYYSGDSGY
GPHFKAIGEQFGAVDLAIMENGQYDQDWKYIHMMPDETAQAADDLRTRAVLPGHAGRFVL
AKHSWDDPYKRLAAASQQRPWRLLTPMLGEPVWVADKTQSFTTWWR
>AMJ34027.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MLNRSSSGSRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGIEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVAPWEGMFVLFAVL
AAIAFFGLHRAMPETATRIGEKLSLKELGRDYKAVLKNGRFVAGALATGFVSLPLLAWIA
QSPVIIISGEKLSSYEYGLL
>AMJ34011.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNYSLSGKRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLSVVEEFQVGNEWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVVWFIVTCLATLLAQTIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAMCIKITALMANVALIAPLLGPLVGAAWVHILPWEMMFVLFAVL
AAIAFVGLQRAMPETATRMGEKLSMKELGRDYGLVLKNLRFVAGALATGFVSLPLLAWIA
QSPVIIISGEKATSYEYGLLQVPIFGALIAGNLVLARLTSRRTVRSLIILGGWPIMFGLL
LSAVATVVSTHAYLWMTAGLSVYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYELGGSGVFSLFNLLSGVVWLAMIVYFLKDKSVGSSNDPQA
>AMJ33861.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MNISGNDNKRIEYTVRVLLCIAVVLVGRLFFLQIIDKSDLQAKNLSQVQVDRKLQSPRGT
IYDRNGRPLAMSVVTKSLYADPKMIKQSPSEVAELIAPYVTMSKADIVKSLQEDTAFVWI
DRMMEPEKSKAVAQLIEDKNVEGLNFVEESKRYYPNGNLAAQVLGFVGTDDKGLDGLEMV
LDDELKGGIQKELVATDRKGNAIFGSVLSKYLPDKGKSVTLTIDASIQFIAERALDKAME
DTGAKHASVIVMDPKTGEILAMANRPTYDPNHYSQGSEEDFKNIAVTNLYEPGSTFKPII
ASAALASGKWKLDQVYNDKGSFAANGHVMQNWNGEGYGPVRLIDHRSRYCGNTIANGPCF
WRYS
>AMJ33831.1|FEATURES|farme|beta_lactam|pbp2b|antibiotic target alteration|1
MSLKNKIRRFMEKKNLNPMNNRKKVGIILFATSIGLFFLFAVRFSYIVIGGHVAGTSLAE
KTKQLYQGSEVVKAKRGTIYDRNGVALAEDASSYSIKAILSKTYTSGDKKLYVEEKNFDK
IAEILHKNLSIDKKDALNILEDGAKKELYQVEFGSYGKNISQETKQNIEADMKKEGVAGL
YFVDHQARMYPNGVFSSHFIGYAVPDKDENGLVGKLGLESAYNDILSGKDGKIIYQKDNF
QNPLPGTVAEEEKAVDGQDIYTTLDSRLQSYLETLMDQVNEEYQPEELTAVLMKAKTGEI
LAMGQRPTFNPETMEGLTGKDAIWRNFLVQDSYEPGSTMKVFTTAAAIEEGEFNENETFQ
SGKIQVEDATINDHDFGEKGVLTMRQALSWSSNVGMVILEQRLGGRWYNYLQKLGFGQST
HSGLDDEVNGALPTSNIVDRAMSAYGQAVGVTNFQMMKAFTSIANNGTMIQPRYISKVVD
PQTGEERTTQTEVLGQPFSKETTEKVREYMRDVVESENYGSAYGVYSVPGYNVSAKTGTA
QIASDTGGYQTGDTAYLYSIVEMVPSEDPDYVLYLTMKHPKTYDRMALAKIANPLMKRAM
DFKETEEDSDTETKTEKVSVADYGNLEADVAAADAQKSGLQPVVIGNGKKVQKQSTAN
>AMJ33780.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|tlrC|antibiotic efflux|0
MHRVGKVVPPKRHILKNISLSFFPGAKIGVLGLNGAGKSTLLRIMAGIDT
>AMJ33753.1|FEATURES|farme|multidrug|mepB|antibiotic target alteration|0
MAAMLERAGDDAARPEWLEPEFGVRDGQYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYK
ELLEQIAELLHILGSADRLMEVIREELEAMREQFGDARRTEITANTADINIEDLINQEDV
VVTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRL
YWMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTA
LTEFSRPRSAGIIAVNLNEGDELIGVDLTNGNDEAMLFSAAGKVVRFKESAVRAMGRTAT
GVRGIKLAGDDKVVSLIIPRGEGAILTVTQNGYGKRTAAAEYPTKSRATQGVISIKVTER
NGSVVGAVQVDDCDQIMMITDAGTLVRTRVSEVSIVGRNTQGVILIRTAEDENVVGLQRV
AEPVDDEELDAIDGSVAEGDDEIAPETDADADDDAVEDEE
>AMJ33664.1|FEATURES|farme|beta_lactam|ACT-32|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILDALQ
>AMJ33654.1|FEATURES|farme|beta_lactam|cmy-48|antibiotic inactivation|1
ASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAV
EVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPAR
>AMJ33611.1|FEATURES|farme|multidrug|EmrD|antibiotic efflux|0
MTKTTIDIQAFINEHPFTRYQWMILALCFITVAMDGFDTAIIGFIASDLVQEWGVEKSAL
GPVMSAALVGLAVGALTAGPLADRIG
>AMJ33586.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
MTGKEIMITTLRRSTIALLASSLLLTIGRGATLPFMTIYLTRRYQLEVDVIGYALSLALV
VGVLFSMGFGILADKFDKKRYMVWSVLVFILGFSAIPLVNNAILVVIFFALINCAYSVFS
TVLKAWFADRLTAEKKARIFSLNYTILNIGWTVGPPIGTLLVMHS
>AMJ33503.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
ANDWLPLLMVDGHGFSPTSGSLIYAGFTLGMTLGRFTGGWFIDRYSRVTVVRGSAVMGAM
GIGLIIFVDNPWVAGISVLLWGIGASLGFPLTISAASDTGPDAPKRVSVVAITGYLAFLV
GPPLLGFLGEHFGLRSAMMVVLGLVMVAALVARAVAKPQSEPVMENS
>AMJ33463.1|FEATURES|farme|beta_lactam|OKP-B-6|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQMGDNVPRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AMJ33365.1|FEATURES|farme|beta_lactam|OXY-2-4|antibiotic inactivation|1
MLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQILYRGDERFAMC
STSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQY
SDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAES
LRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVI
WPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AMJ33346.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFVGDYPWSAQTMPEIDLLILSHDHYDHLDLATIKALMPKI
KRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLGEPVILSEPDQL
FTAWWQQVTQ
>AMJ33323.1|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MKRLTVCVVVIMLIGAAASLPFLLNAGFGQAPKGAQLSQVEQSPHYRDGQFHNQVPTPGY
TGNKSMLAAWWEFLVAKRENARPAHPLPLVATDLAGLSPEQDTLVWLGHSSWYLQLAGQR
ILIDPVFSNYAAPLSFLNKAFVGDYPWSAQTMPEIDLLILSHDHYDHLDLATIQALMPKI
KRVITPLGVGSHLRYWGMRGEIIDEMDWNQSIRVTDSLIVHALPARHFSGRGIKRNQTLW
ASFMFETPEQNVYYSGDSGYGPHFKAIGEQFGSVDLAIMENGQYDHDWKFIHMMPEETAQ
AAVDLHAKAVLPGHAGRFVLAKHTWDDPYKRLALASRRYNYRLLTPMLGEPVILSEPDQL
FTAWWQQVTQ
>AMJ33281.1|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAAIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETATRIGEKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLL
VAAAATVISSHAYLWMAAGLSLYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEISKHAWLNGGNGLFNLFNLVNGILWLLLMVIFLKDKQMGNSHEG
>AMJ33147.1|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
FFHGLAAAAASVVINALMRDVYPKEEFSRMMSFVMLVTTIAPLVAPMVGGAGRYLSIDSG
ISMASRPRINTILNDECGLVVTGFS
>AMJ32989.1|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MYLELDHLKKHFDGREVVRDLSLTLEQGQLLCILGASGCGKTTTLNMIGGFLEPDSGSVR
LDGQD
>AMJ32956.1|FEATURES|farme|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIALGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKRGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AMJ32952.1|FEATURES|farme|beta_lactam|BL1_ampc|antibiotic inactivation|1
KTHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQL
TGKQWQGIRMLDLATYTAGGLPLQVPDEVKSSSDLLRF
>AMJ32761.1|FEATURES|farme|beta_lactam|CMY-51|antibiotic inactivation|1
LGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQ
PQWKPGTTRLYA
>AMJ32751.1|FEATURES|farme|beta_lactam|blaCMY-135|antibiotic inactivation|1
MARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDS
KVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPAR
VEAAWRILEKLQ
>AMJ32749.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
AIGLKYTHGFTRLTPSIITIAAMIVSIAMLSWAMRTLPVGTAYAVWTGIGAVGAAITGIL
LLGESASPARLLSLGLIVAGIIGLKLSTH
>AMJ32665.1|FEATURES|farme|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLRAICLLIRKPAPVAATC
>AMJ32651.1|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLIAASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPAPAVRASWVHKTRATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>AMJ32643.1|FEATURES|farme|beta_lactam|ACT-14|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIAN
>AMJ32570.1|FEATURES|farme|beta_lactam|MIR-9|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALDDPVAKYWPELTGKQ
WQSIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AMJ32488.1|FEATURES|farme|multidrug|ykkD|antibiotic efflux|0
SIVLLSWAIRSLPVGTAYAVWTGIGAVGAAITGILLLGESASLARIASLALIVAGIVGLK
LSTH
>AMJ32458.1|FEATURES|farme|quinolone|PmrA|antibiotic efflux|0
VVVLAMAFAEGSANDWLPLLMVDGHGFSPTSGSLIYAGFTLGMTVGRFTGGWFIDRYSRV
AVVRASALMGALGIGLIIFVDSAWVAGVSVVLWGLGASLGFPLTISAASDTGPDAPTRVS
VVATTGYLAFLVGPPLLGYLGEHYGLRSAMLVVLALVILAAIVAKAVAKPDTKTQTAMEN
S
>AMJ32420.1|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|0
MKKPLFICVVLIMIIASAASLPFVLNAGFGQPPQGERLTEVEASPQYREGKFHNTLPTPG
YNGDKNMLVAMWEFLTKKTENARPAQPLPLVKTDLASLPLEQDTLVWLGHSSWYLQLAGK
RILIDPVLGNYAAPFSFLNKAFAGEYPWRAEIMPAIDLLIISHDHYDHLDYATIRALLPK
IKRVITPLGVGSHLRYWGMDGALITEADWQQAVPASDELTVHVLPARHFSGRGLKRNQTL
WASFLFVTRQQKIYYSGDSGYGPHF
>AMJ32415.1|FEATURES|farme|aminoglycoside|acetyltransf_3|antibiotic inactivation|0
MPEINLYGQTVGDIVPDWNGAAVLPREELAGQYCRLVPLNADSHAADLFDAYAQAPDDRD
WTWLASSRPTSVEATACWVEGKSTDASLVPYAVIEQRSGRAVGLVCFMAIEREHGSVEIG
HVTWSPRMKNTVLGTESIWLLLRQAFALG
>AMJ32310.1|FEATURES|farme|beta_lactam|MIR-10|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYHILNALQ
>GU721004.1_1000|FEATURES|farme|beta_lactam|TEM-219|antibiotic inactivation|1
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
TAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRK
LLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPD
GKPFARVFPVTTGSQATMDERNRQIAEIGASLIIALVNCQTKYSA
>JX009355.1_1031|FEATURES|farme|beta_lactam|blaRAHN-2|antibiotic inactivation|1
PQKVTEYARTLGDKTFRLDRTEPTLNTAIPGDDRDTTSPRAMALSLQHVTLGSALAEPQR
>JX009349.1_1035|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLS
>JX009297.1_1077|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MAATDLRQVVDSTVAPLMQQHGIAGLAVATIKNGQVQYFNYGVMSKTTQRPVTEDTLFEL
GSVSKTFTATLGGYAQATGALKLTDKASQHLPALKGSAFDRISLLQLATYSAGGLPLQFP
EAADSAKTMLGYFQHWKPTYAPGVQRLYSNPSIGLFGYLSAQSLGQPFNVAMEKTLLPQL
GLKHTYITVPADKADQYAQGYDKQQNPVRVGPGALDGEAYGVKSSTQDMARFVIANMHPQ
TLNAPLQQAIATTHTGYYTVNGMTQGLGWEYYPYPVKLQALLDGNSTLIALQPNKAHWLQ
PAQTQPGNVMFNKTGSTGGFGAYVAYVPGKDIGVVILANKNYPIADRVTAAHGILSAMDQ
>JX009271.1_1099|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
VTKLRVGVIFGGKSAEHEVSLQSAKNIVDAIDKEKFDVTLLGIDKQGHWHINDASNYLLN
AENPALIALNRSNKNVALIPGQEKQQLIESGSAGALGQLDVVFPIVHGTLGEDGSLQGLL
RMANLPFVGAGVLGSAVSMDKDVTKRLLRDAGLAVAPFVTLTRSNRAKFTFEQLSERLGL
PLFVKPANQGSSVGVSKVQD
>JX009211.1_1151|FEATURES|farme|beta_lactam|CARB-3|antibiotic inactivation|1
LTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTK
LAILWSLMLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLS
ARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADL
VTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRL
DRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLR
SVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGH
SIFDVYTSQSR
>JX009203.1_1161|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVGKLTALALFMAAGQCLAAADLRTVVDASVKPLMQQQSIPGLVVGIVKDGKT
QYFNYGVASKDAQQAVSENTLFEVGSVSKTFTATLAGYAVATGKLSLTAPASDYLPALRG
GRFDHISVLNLGTYTAGGLPLQFPAEADNNQRMISYFQHWKPDFAPGTHRLYSNPSLGLF
GYLAAQSLKQPFDQLMEKTLIPKLGLKHTFVTVPKSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLHYVSVNMNPAGLEKSLQQAIATTHTGYYSVNGMTQGLGWELYPYPI
TLAALVEGNSSQMALEPHKVDWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKGMGVVV
LANKNYPNGERVKVAHAILSALDH
>JX009346.1_1181|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
AAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFPNDDRVAATYRIVQALDKR
>JX009330.1_1194|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
MPHKIQFAVRHITTLGFFLTAGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVVKDGKT
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRG
GKFDHISLLNLGTYTAGGLPLQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQS
>JX009328.1_1196|FEATURES|farme|beta_lactam|BL1_sm|antibiotic inactivation|1
YAVPGMAIAVSVEGKQQFYHYGVASKQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGK
MSFADPASRYLPALRGSAFDHVTLLNLATHTSGLPLFVPDNVTNDAQLMAYYRQWQPPHA
VGSYRVYSNLGIGMLGMITAKSLNQPFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGY
NKKDQPVRVTPGPLDAEAYGIKSNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTG
VFTQDLMWESYAYPEKLATLTEGNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFS
TYAVFIPSQKIAVVMLANKWFPNDDRVAATYRIVQALDKR
>JX009274.1_1245|FEATURES|farme|multidrug|hp1181|antibiotic efflux|0
AGYVLTAATLLISVFGIGGTVLQLPIGWMADKSSYKTGQLICGLVVLLGTLAIPFSQGLP
WLSTLIVFVWGGAIGGMNTLAVIEAGDRVAEHQVSTAMTAIALFYTLGSVLGPIATGATV
SYVSPHGLMISVGVAGGLFIALLMLRRAP
>JX009266.1_1253|FEATURES|farme|multidrug|NorA|antibiotic efflux|0
MNLEPETTMPRSDNALEELLIDAEADDDKVQHSPPLVSRPWLLLLGLILVALNLRPALSS
MAPLLAEVSRSLGLSAAKAGLLTTLPVLCLGLFAPLAPILARRFGAERVVLGILLTLAGG
IILRSSLGEAGLFAGSLLAGASIGIIGVLLPGIVKRDFAKQAGTMTGVYTMALCLGAALA
AGSTVPLSHYFGDSWNIGLGFWILPALVAALFWLPQVGQKHGAHQVAYRVKGLLRDPLAW
QVTLYMGLQSSLAYIVFGWLPSILIGRGLTATEAGLVLSGSVIVQLASSLAAPWLATRGK
DQRLAIVVVMVLTLGGLFGCLYAPLDGLWGWAILLGLGQGGTFSLALTLIVLRSRDAHVA
ANLSSMAQGIGYTLASMGPFAVGLVHDWTGGWNATGWIFAVIGLGAIIAGLGAGRARYVA
VTSEKV
>JX009260.1_1260|FEATURES|farme|multidrug|Bcr|antibiotic efflux|0
MSRSIAHLALLLGLITAVGPFAIDIYLPALPTLGASLHASPAAVQMSLTVFFMIIGVCQL
FYG
>JX009248.1_1268|FEATURES|farme|aminoglycoside|AAC(6')-Ib9|antibiotic inactivation|1
VTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>JX009238.1_1276|FEATURES|farme|beta_lactam|UCMB321_2366|antibiotic inactivation|1
TQDDKSVRVGPGALDAEAYGIKTTSTDLLRFVEANLQPETLEAPLHKAIDLTQSGYYQID
GTTQGLGWEFYPYPVKLEPLLTGNSSEMAYEAHKITTQFNPAQPPQKNALFNKTGATRGF
GAYVVYVPAKKIGIVMLANKNYPNPVRVKAAYQILNALEAVK
>KF630355.1_11330|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKSDRTGTGTISVFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
QNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMVAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFKFEDFELVNYDPHPHIAGVVAV
>KF630354.1_11335|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKDKKIIVLMGGPSKEAEVPRRTGAAIAEALESKGYNAQTLELNPRTVLKDIEDLGGEVV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTAASESFN
GNLESAEAIIEHIRKDFTIPVVVKSATQGSSIGVTIVRDEAQLEEAVTEALKYDPILVVE
QFLDGREFTVSVLDGKALSVIEIRPHSGEYDYKSKYTVGATEYLVPAPISAEMTAEMQRI
GELVYREVQGSGVIRVDVMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEK
ILLTASIGKF
>KF630341.1_11362|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNLKQEKIAVLLGGTSAEREVSLNSGAAVLNALVSQGYNAHSIDPKEYNVANLKADGFDR
VFNILHGRGGEDGTMQGLLEQIGLPYTGCGVMASALTMDKMRTKMLWKAFGLPVADMEIV
TKENAHELNPQAVVEKLGLPLMVKPSLEGSSVGLTKVKAVEELKSAVDYALKFDNTILIE
EWLAGDELTVPVLGGEVLPAVRIVPEGEFYDYDAKYISDNTQYFCPAGLSAEREQELAKL
VKRAYDVVGCRGWSRIDVMTDAQGNFPFSRSKYKPWYDKSQFIP
>KF630337.1_11376|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGNSTEREVSIASGQGICKALRERNHRAIMIDPYFGRETLEEDLFPAEYDIEK
EAEQMRRNSAGLEATMKSRRGFFGPNVLSVCEKADIVFLALHGSNGEDGKVQSVLDLMGI
KYTGSNPLSSGMAMDKGITKMVFEAKGVPTPKGITLEKGDNSRLTDYGMEFPVVVKPCCG
GSSVGVFIVKNESEYAQALLEAFSYEDKVVVEQYITGREFSVAVVDGKAYPVIEIAPLQG
FYDYKNKYQAGSCVETCPAEISASLTKEMQRYAEQGYEALKLQAYARLDFIMDEEGNMYC
LEANTLPGMTPTSLIPQEAKVIGMNYPQLCEKLIEVSLKKYQ
>KF630336.1_11379|FEATURES|farme|beta_lactam|CTX-M-95|antibiotic inactivation|1
MRLRIGKKRAVLFLLFVFSMNTEWTRDNTDRGFSMMTLGVRRTMLMMMATIPLLLGSTAL
YAGTSSVQQKLEALEKSTGGRLGVALINTADDSQIVYRADERFAMCSTSKVMAAAAVLKQ
SESDKTLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAHLG
GPEKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGKALAETQ
RAQLVTWLKGNTTGSASIQAGLPTSWVVGDKTGSGDYGTTNDIAVIWPEDHAPLILVTYF
TQPEQKAESRRDVLAAAAKIVTEGL
>KF630327.1_11400|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
VDTFVTPDGTVMVNEINTMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF630326.1_11405|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
VSHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTDLDAALDIARQEAIP
DDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDMDALVDAGLWEVADP
GHWKRTQKDDSGIKRYRFVTYRKIG
>KF630324.1_11407|FEATURES|farme|beta_lactam|GM18_2318|antibiotic target replacement|1
YTNQLFMSQLSAEECGVFQEKLFKFRGFYIQRRTIRQYSYDAAAHALGDIGEVSAKEMEA
DEEGYYIRGDYVGKLGVEKSYEKYLRGEKGIEILLRDAHGRIQGHYMDGEYDRPSVPGKN
LTLSLDIDLQMLGERLLKNKIGSIVAIEPETGEILCLVSSPNYDPHLMIGRQRGKNHLML
QRDKMKPLLNRALMGVYPPGSTFKTAQGLTFLQEGIVTEQGPSFPCSRGFHYGRLTVGCH
AHGAPIPLIPAIATSCNSYFCWGLF
>KF630322.1_11410|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFRKAATGAIPNVPFELLAQKMRTCKTKLDFQ
KAFCYGILWKIAEEHTNGLTLDHNALPNKKKAYTYISNHRDIILDSGFLSILLVDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLEASTRMSRYMHYTIAEKNQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEGDLIDRLKEMNIAPLAISYEYDPCDFLKAREFQ
LKRDIEGYKKTTQDDLINMQTGLFGYKGKVHFQVASCINDELERIDRSLPKPELFAAISA
CIDQRIYRNYRMYPGNYVAYDWLNGTTEFTGIYSQEEKQQFVGYIDG
>KF630321.1_11415|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MTDKIAVLLGGTSAEREVSLNSGAAVLAGLREGGIDAYPVDPKEVDVTQLKSMGFQKVFI
ALHGRGGEDGTLQGMLELMGLPYTGSGVMASALSMDKLRSKLLWQSAGLPVAPWVALTRA
EFEKGLNDKQLAEISSLGLPVIVKPSREGSSVGMSKVVAENALQDALRLAFQHDEEVLIE
KWLSGPEFTVAILGEEILPSIRIQPAGTFYDYEAKYLSDETQYFCPAGLEASQEANLQAL
VLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQLVVR
ILELAD
>KF630308.1_11458|FEATURES|farme|trimethoprim|dfrA12|antibiotic target replacement|1
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
PNRHTLVISRQANYRATGCVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFL
SEVHQTFEGDAFFPMLNETEFELVSTETIQAVIPYTHSVYARRNG
>KF630292.1_11490|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSDKIVKIPPSGIRKFFDIVSEMKDAISLGVGEPDFETPWHIREEGIYSLEKGRTF
YTSNAGLKPLKVEICEYLKRRCGVTYDPDQEILVTVGGSEAIDIALRAMLNEGDEVLIPQ
PSYVSYMPCVTLADGVPVTIELEEKDQFKLTPEKLLEKITDKTKILVLPFPNNPTGAIME
KEELEEIVKIVLEKDLFVISDEIYSELTYNGKRHVTIASFPGMKERTVLINGFSKAYAMT
GWRLGYAAAPHIILEQMLKIHQYAIMCAPTTSQYAAVSAMKNGDPDVSMMRES
>KF630290.1_11497|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVTRTD
FAYDADTYFPDLDEMPEWKLVKESEEETYFDIEYQFLVYQK
>KF630290.1_11498|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF630288.1_11506|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSKKKIAVLFGGQSSEHVVSCVSAANVIDQIDKEKYDLLLIGITEEGHWVKADSVE
>KF630281.1_11515|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MKLSRNSQAMEFSPIRKFNPIATEVQESGVKIYHLNIGQPDIKTPRCFMDAVRAFDEDVL
MYEQSQGDIKFLESICDYYKREYGVGYKPTDIVVTMGASEALTMTFTTIIDPGDEILIAE
PFYSNYQTFALVRGGDIRPIPTSSKEGYRYAAKDKLEAALTDKTKAIVCINPGNPTGLAL
TAEEMDVIADFVIENDLWLIADEAYREYVYDGIKPRSFANIDRLKENLIVIDSVSKRFSA
CGARIGFVASKNEEFMTGIIKLAQSRLCVSTLEQIGSTELFKLPSSYYEEMKEEYCKRRD
AAYEEIMQIPDVICHKPGGAFYMMVDLPIDDAEDFLMFLLTEYRDNNETVMFAPAAGFYS
TPGKGRSEIRIAYVLESGYIKRACQLIRTGLEAYKTKMSK
>KF630274.1_11532|FEATURES|farme|beta_lactam|LRA-2|antibiotic inactivation|0
VEEMEKLIVLGTGNAMATKCYNTCFSITDGEEYFLVDAGGGNGILSMLDKANIKVSKIHN
MFVTHEHTDHVLGVTWIIRKIGTMILNDKYEGNFNIYCHEDLENTIVTIAKLTLQKKITN
LFGKRIIIYPVKNGEKKKILDYNITFFDIYSTKAKQFGFTMKLKNQKTLTCMGDEPYNSL
CESFIRNSNWLLSEAFCLYGDREKFKPYEKHHSTVKEASELAEELNIENLVLWHTEDSKI
EERKELYTNEGKEYYRGNLFVPNDLEVIEL
>KF630273.1_11534|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DKRRRYMSYADKVFIDMCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDLSKE
FPALTLRRTAIKSCVDELLWIWQKKSNNVNELKSHIWDSWADETGSIGKAYGYQMGVKHQ
YKEGRMDQTDRVIFDLKNNPYSRRIMTNIYVHNDLHEMHLYPCAYSMTFNVTKEKDSEKL
TLNAILNQRSQDVLAANNWNVCQYACGAASYAGTGV
>KF630271.1_11538|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
PPPEVDFSMGNPDGATPPHIVEKLCTVAQRPDTHGYSTSRGIPRLRRAISRWYQERYNVE
IDPESEAIVTIGSKEGLAHLMLATLDHGDTVLVPNPSYPIHIYGAVIAGAQVRSVPLVEG
VDFFNELERAIRESYPKPKMMILGFPSNPTAQCVELEFFEKVVALAKRYDVLVVHDLAYA
DIVYDGWKAPSIMEVPGARDVAVEFFTLSKSYNMAGWRIGFMVGNKTLVNALARIKSYHD
YGTFTPLQVAAIAALEGDQQCVHDIAAQYKRRRDVLVKGLHEAGWMVDMPKASMYVWAKI
PEQYAHMGSLEFAKKMLQDAKVCVSPGIGFGDYGDTHVRFALIENRDRIRQAIRGIKAMF
RADGLLPSEGKSAG
>KF630267.1_11550|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|0
MKIIVLAGGYSPERDVSLSSGSLIANALMERGHEVFFLDPWLGIKAGERVHYRTREEGLG
FAY
>KF630260.1_11565|FEATURES|farme|multidrug|efmA|antibiotic efflux|1
MSSSSTTTEPTARETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVALL
LVGQAFSLLGSSIVQYAIWWWIVLQTRTGSAMLLATLFGVVPQAVVSIFGGSWADRHNRK
LLIMLPDMVIAVVTVVLSLSFAMGWASLTMIFVVLFIRSAGGGVQTPAVQSFIPDVVPSG
KLLRVNSIYGVINSANMIVAPAVAAVLINTVPLWSILLVDVTTAIIGVGFVALIKAPKKS
AEHVARRMAEAENSGQPTLEPMSDANADRSLIASVRRVFADLKDGFSYTWRRANLRNVVL
GGALVCFVSVAPMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWSIGMLLGGAL
MSTIGAKLIRNNMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTI
IQTEADEKMVGRVFGLDTTLSALGMPLGMLIFAPLADVIPISLVFIIGGVLTLPIGIYLF
GQARRNVSAQVTRTAA
>KF630255.1_11572|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF630233.1_11614|FEATURES|farme|multidrug|cdeA|antibiotic efflux|0
VAKKSTAIDVTQGVIWQQLLSLCVPIFFSSFFQQAYTLIGTYIVGQFGGKLALGGIQATM
VLTELCIGFCVGVGAGCAVITGQYFGQHEDERLSRSVHTAMTLALVGGIAFSILGIVFVE
PMLVLMNTPHELLAEGVAYARCYFAAMVAALLLNMGTALLRAVGDTRGPAVIIASGCLVN
VVLDIIFVAVLHMEALGCGIAVALTICSNATMIVLRMMRAPGAWRLSLSKD
>KF630224.1_11635|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GYSDREEDLTGIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKMCQMAD
IVFMALHGENGENGKIQAAFDLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGIS
MTRATRQDDITKLDLTLPCVVKPCCGGSSIGVTIVRDAAEFKAALDDAFKWENELVIEEF
VQGREFSVGVIEGKALPIIEIAPKEGFYDYKNKYKAGSTVETCPAELPEQVTKDMQHYAE
EVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSLLPQEAAVIGMSFNQLCEHLI
DISLKKYEV
>KF630223.1_11639|FEATURES|farme|quinolone|qacH|antibiotic efflux|0
MKGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAY
AVWSGLGVVIIPHIAWLLHGQKLDAWGFVGMGLIIAAFLLARSPSWKSLR
>KF630217.1_11654|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICRTLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFKMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIGVYIVDTMDAYKEAVENSFRYEDEIVIEPYIKGREFAVGIIDGKALPV
IEIIPKTGFFDYANKYQDGCTEEICPANIDKEVTERMQRAAELAFKALKLDIYSRADFLL
DENNDIYCLEVNSLLGMTAASLLPKEARAAGITYGDLCELIIQKSLARYNA
>KF630201.1_11688|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
PPATSFGYVQTDYRYVSKFKDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEGMKAYTTE
DGHIVTFRPNLNAERMANSAKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVR
PYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAEPITIRVSDFDRAAPHGTGHIKAGL
NYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSI
TRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSG
MEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF630199.1_11695|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWTYGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF630190.1_11720|FEATURES|farme|beta_lactam|pbp1b|antibiotic target alteration|0
NRAYQSYRQPGSCIKPLNVYTPYLQLGNTPDTKVTDSQIDGGPANADASYAGEMTLTDAV
KWSKNTVAWNIYQQITPKTGSSFLIKMGFHKIWVDKDYNAGALGGFTYGVTTEEMAGGYA
ALANDGVYRKATCIRLIVNASNKTVVNETDRDSKVYDKSASRMMTQMLREVVLSGTGTSA
NVENAVVAGKTGTTNASKDVWFCGYSKYYTTTVWAGYDYPKEMSGVNSRVNAIFKDFMTA
VHTNLPVTDFSTVTQQTTQPETTAAVQEETESLPQETTAIVPETTGIEQVTPQQT
>KF630167.1_11774|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
WEVDNSGTIGERYGAVVKKHDIIRKILKQLEENPWNRRNVISLWDYEAFENTDGLLPCAF
QTMYDVRRVDGEIYLDATLTQRSNDMLVSHHINAMQYVALQMMIAKHFGWKVGKFFYFVN
NLHIYDNQFEQARELLSRESTDCKPRLVLNVPDGTDFFDIKPEDFELVDYEPVKPQIKFD
LAI
>KF630165.1_11781|FEATURES|farme|multidrug|MexB|antibiotic efflux|1
NGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRI
ALGAAVVFGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF630153.1_11812|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAEIEDAALTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF630152.1_11813|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAH
>KF630148.1_11822|FEATURES|farme|macrolide-lincosamide-streptogramin|vgaA|antibiotic target protection|0
DDDGNLMHLNNTITKVAVGSDESKWGLKALEIAANFAAAWDAELDVISAVPNMKGSDDEG
VMASFKDDLEVRIKPLEEAHPDLKINKQIVPGPAVGALTKASYDHDVVVVGSRGRGGFTG
LLLGSTSQGLLQHAVGPVYVVPRKYVEAAETRLDTVPSSPAEVKPKALDDIKGVEEVPVS
KAEPDVVEAIETKIDPDRQ
>KF630140.1_11847|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIA
PGLALEVGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKV
LVEKCIEGTEITVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGIAC
>KF630130.1_11882|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
YQRSCDMFLGVPFNIASYSLLTMMMAQQAGLKPGEFVWTGGDCHVYDNHVDQFLEQLGRK
PYPYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF630129.1_11884|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGTM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDPHEMNLYPCAYSMTFNVTQTPGNEKLTLNAIL
NQRSQDILTANNWNVCQYAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMIKGK
PCPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPVAI
>KF630128.1_11887|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
GFPMFVKPTRAGSSFGITKVDSVEELVPAIEEARRHDPKIIIEAGIVGREIECAVLDGHH
GEMPRASYPGEIEVVDQDHGFYDFEAKYVSESSAVTVCPANLPQDVQERLRELAVKAFLA
LDGEGLSRADFFYTEDGRLVINEVNTMPGFTPISMYKTMWENTGISYTDLISELLTLAME
RPLGLR
>KF630117.1_11911|FEATURES|farme|glycopeptide|vanM|antibiotic target alteration|0
VGVDTGGCNIQFAINPNTGRIIVIEMNPRVSRSSALASKATGFPIAKIATKLALGYTLDE
IQNDITQSTPASFEPTIDYVVTKVPRFAFEKFPGADPTLTTSMKSVGEAMALAGNFQESL
GKAMRSIDKRHMGFNWDGDKPDVQEVEQLLEAIKVPTEHRYLQIQRALWGGATEQQIFDA
TKIDPWFIRQFVLINETALEIKEASKLSRKLLKKAKLAGLSDLQIAHLRHLGDEGENTIR
ELRWSYDLRPVFKTVDTCAAEFDAVTPYYYSCYADESELRPREREAVIILGSGPNRIGQG
IEFDYTCVHAVQELGKDYDTIMVNCNPETVSTDYDMSDRLYFEPLTFEDVLEIYEAEKKM
GPVKGVIVQLGGQTPLSLAARLKAAGVPILGTTPESIDLAENRELFGEVLKKAEMNAPRY
GTALSLDEAREAAHNIGYPVLVRPSYVLGGRGMEIVYDDAQLCKYVDRALKEAQADTVVS
GRLPSPLLIDKFLQDAVEIDVDALFDGEELYIGGIMEHVEEAGVHSGDAACTLPPSTLSD
DQIRRLREGTYAIAKGCGVQGLINVQYAFMANTLYVIEANPRASRTVPFASKATGVALAK
AAARIMAGETIQQQRDNGLLLPHGDGGDIRRGQQVAVKESVLPFKRFRTPLGKTVDVLLG
PEMRSTGEVMGFDRDFPHAFAKSQLAAYDGGLPTSGNVFISVNDTDKRQLPLF
>KF630116.1_11916|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDEDFAVEGVDVVH
SIDEALAAVDDEPVAWVIGGGEVYRQFLPYCAEAEVTHNHCTHAVDTYFPDLDADPAWEI
AWRGGVATIASGEGDEGVDYEFVTYRRVEA
>KF630115.1_11919|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTAGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNLEAAAEAAHALDAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEDAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF630107.1_11933|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICRTLIEKGHDAFLLDVFLGLEHAPEHLEDVFTLPGH
GLEIAKNISCEEPDLAAVKASRPDQSDCFLGPNVIELCRLADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGLTKQVFLQAGIDTPAGVTIHKKSKDRSLALTGLSLP
VVIKPCSGGSSIGVYIVSTEEEYAEALEKSFFYEDEVVVEEYIKGREFACGVIDNEALPP
IEIIPKTGFFDYANKYQADATLEVCPADIPEETASRMMEL
>KF630103.1_11943|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAADNNWGIGYQNRLLVSIPSDMKFFRQKTTGNVVVMGRKTLESFPNGLPLKNRVN
IVLTKNKNYQVKDAVIVHSEEELLEELKKYPSEKIYVIGGESIYKMMLPYCDTVYVTKID
REFQADTYFPNLDQMEDWKMTEEGEEQTCFDLEFAFTKYERC
>KF630099.1_11952|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|0
PDDGLDRSEIWIIGGGQLFREAMPFADKAYVTQISMHADADTYAPDVKSLVESGAWKVLE
EGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF630071.1_12015|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
NMDTEKYNVILVGITKEGKWLLVDGVKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTY
KLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGID
QAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAV
KHDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVV
DPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPM
LWKACGLDIPELLDTLIDQAMTRYR
>KF630067.1_12026|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MKLIAAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNERPALH
>KF630059.1_12045|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRQVWEEGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF630057.1_12049|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HPLSEPVDILENGTSTEGELVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITLRKTYIK
SATDELLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMMDQVDRV
IYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGILNQRSQD
VLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERPQYDAPK
FWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF630057.1_12050|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVAHITKVDFEYDADAYFPNLDEKPEWRITGDSEEQTYFDLEFYFLRYEKVK
>KF630053.1_12061|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTASAKRT
AAGRSYATCGY
>KF630052.1_12062|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
AIGLNGGMPWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYR
APGATVVTSLDDALDMARQEAIPDDGLDRSEIWIIGGAQLFAEALPFADKAYVTDLAATV
DADSYAPDMASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF630050.1_12067|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVA
>KF630043.1_12084|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
DNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQS
LSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDDKKEIFIDWM
SNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDAE
YDNKLIADATKIIFDLIS
>KF630042.1_12085|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
KHQYKEGMMDQVDRVLFDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGK
DKLVLNAVLNQRSQDILAANNWNVCQYSLLLMMIAQVCDMEAGELVHVIADCAYL
>KF630030.1_12119|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDSSELVVSLRSAQGLYSFIDKERYNLYIVEMEGHRWEVVLPDGSKTPID
RNDFSFMENGEKKHFDFAYITIHGTPGENGILQGYFDLLGIPYSSCNVLVSAMTFNKFTC
NQYLKGFGIRVAESLILRKGFEITDEEVINKIGLPCFIKPNAGGSSFGVTKVKTKEDIQP
AIEKAFKESDEVMIEAFMRGTEITCGCYKTSDKGVVFPITEVVSANEFFDYGAKYNGESQ
EITPARLPEDTAERVRLLTSAIYDILGCSGLIRIDYIITEGEKVNLLEINTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF630027.1_12130|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VAFKTAVKEMLWIYRDQSNDVTKLQEQNVHIWDEWVDENNTIGRGYGYQIAKFNQIDKLI
ETLKTNPQDRRMLMTMWNIEDLPHMTLQPCCFMTLWDVTDGKLNCMLIQRSGDIPLGVPF
NTSQYAVLVHLIAQVTGLKPGLFTHVINNAHIYENQVEGMKLQLTRANDEYEAPKLWINP
EITNFYDFTADDIKLIDYKYHPAIKMEVSV
>KF630025.1_12135|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MRRRMKIIVAADKNWAIGREGELLCHIPGDLKYFKEKTTGKTVVMGRKTLESLPGGRPLP
NRINIVLTKDKDFEKEGCVIAGSIEEVLRILSDMEGEAMVMGGGLIYRQLLPYCDGCYVT
KIDAAFEADTYFPNLDADGDFRLIWESQPHEENGVTYRFTEYERI
>KF630025.1_12136|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GEMDQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQR
SQDILAANNWNVVQYSVLLHMFAQVSGLRAGELVHVIADAHIYDRHIPVIEELVSRPQYP
APKFRLNPEIKDFYDFTVDDVMIEDYQKNPQILNIPIAI
>KF630017.1_12158|FEATURES|farme|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>KF630017.1_12159|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
VGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMEGEETDKMFRRANCKARVAYLNGSK
AIEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSVYKTLIENHVECLSEPQHF
DFRADGFGESRAFYFRDPDGIILEMMQPL
>KF630008.1_12178|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NIYNFQDLHEMALYPCAYSMTFNVSGHTLNAILNQRSQDMLAANNWNVVQYAVLVHMMAQ
VSGLEAGELVHVIADAHIYDRHVPIVERMLEKEPRPAPRFVMDPSVTDFYRFTRDSFSLE
GYEPHPFEDKIPVAI
>KF630001.1_12196|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTILVLFGGCSTEYEVSLHSAYAVLSHMDPARYTPLAVGITREGQWLCYTGDLSRLEDG
TWQQAADCIPCTPLVEREAHALLLLDGSGRRLLFDAVFPVLHGKNGEDGTVQGLFELAGV
PVIGCGTLSSALCMDKDRAHQLAALAGIRVPRSHVFHSSDDFSRIAQAAEELGYPVFVKP
VRAGSSFGITKVSGPEELPAAMEEAFRHDSAVILEETIPGFEVGCAVMGNEELTVGLVDE
IALSEGFFNYEEKYTLKTSAIHCPARIPPEKAAEIQAAAKTIYRALDCRVFARVDLFLTP
DGEIVFNEVNTIPGFTAHSRYPSMMQGIGISFGELVTRLIELGVAG
>KF629998.1_12201|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDCIVNVTQNWGIGKDGDLLVSIPTDLRRFRALTTGKTVIYGRKTLLTFPHARPLPNREN
WILSATPGFSVPGAAVFPSLAALQEALRTRPADSLCLIGGASVYRALLPWCSRVLLTQTC
ADLPADRFFPDLDRLPNWRCTDTGPLQEDGGHCFRYLTYENDAPLPL
>KF629994.1_12217|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKWIVAADERGGIGKNGGLLVRIPADMKYFREKTLGKTVIMGRATLESFPGGKPLPKRRN
IVLSRTLPEGDAYEVCRSIEELMELTASDNTDDLFVIGGGQIYDQLLPYCNEALVTEIRG
VFDADTRITLPRDLPDWDKAAESDTIEENGVSYVFTVYRRRQ
>KF629992.1_12225|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MSRADALFLQNCRDILDHGVWDTDLPVRPHWEDGTPAHTVKKFGIVNRYDLQEEFPILTL
RRTYWKTAVDELLWIWQKKSYFKTCIDELLWIWQQKSNNIHDLRGHIWDSWADGTGSIGK
AYGYQLAVKHQYPEGEFDQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAFTPRR
LRPALRCVVFHSLPAL
>KF629971.1_12284|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MREGEKMNAIVIVDKNWAIGKNGGLLVHLPGDLKYYRQKTTGNIIVVGRKTLESFPGGKP
LPDRTNIVITSDTDYEKEGCLICHSKEEVMEKLMEYNTEKIFIAGGAQVYEQFMDDCDTF
YVTKIDAEFEADRYFPDLDKLGYTVTWESELQQEKGIFYRFLKYSRP
>KF629967.1_12297|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAADNNWGIGYQNRLLVSIPSDMKFFRQKTTGNVVVMGRKTLESFPNGLPLKNRVN
IVLTKNKNYQVKDAVIVHSEEELLEELKKYPSEKVYVIGGESIYKMMLPYCDTVYVTKID
REFQADTYFPNLDQMEDWKMTEEGEEQTCFDLEFAFTKYERC
>KF629966.1_12299|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FEYLHSGALDPCCYSMTYNVTKERNSEKLALNGVLNQRSQDVLAANNWNVCQYALLLMMV
AQVNDMIPGELVHVIADAHIYDRHVDAVKELIARETYPAPKVSLNPEIKDFYDFTTEDLV
VENYEAGPQIKNIPIAV
>KF629950.1_12344|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
LESGVIETIRSTAQKAYQVLGCSGLARVDFFVRNGSEVLLNELNTLPGFTSISMYPKLME
HEGLSNQELIHRLIQLAVKRMGKGADA
>KF629948.1_12353|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VFHEVQPMLDAAGEDAFVIGGAQVYRLLLPACRRLYVTQIDADGGADVFFPEPAPELWRI
TEQSPWQEEQGLRYRYLTYERKDGTDGI
>KF629947.1_12357|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IADAHIYDRHVPMIEELISREPLPAPQFWLNPEIRDFYQFTRDDVKLIDYQTHDQIKNIP
VAV
>KF629943.1_12366|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKKVLVLFGGVSSEHEVSLVSARSVIQNIPRDRYEVLTLGITKQGEWLLYEGDPEALPED
NWLECGKRTPAVLSPDASHHGLLIFENGAARVEHVDVVFPVLHGKNGEDGTMQGLLQLAQ
LPFVGCGCTASAITMDKAITNAMTDVAGIAQAKWLPLTRDGYQKDAAALRQKAIGRLGFP
IFVKPANAGSSVGVGKARNETELADAIEKAFLHDDKLVLEEGIDGMEVECAVLGNEKPKA
STVGEVVPCNDFYDYEAKYIAADSELHIPARLPADTLEAVRAAACRVFTEMGCSGLARVD
FFVRKSDGAVLLNEPNTIPGFTPISMYPKLWEHTGLPYGELLDRLIQLALKKWEPKD
>KF629942.1_12369|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPQGHIYSNHLEQVKLQLTREPRALPRMEINPDVKSIFDFKFEDFNLTGYDPHPHIKGEV
AV
>KF629941.1_12373|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MICFVACICYKICYNKNVKQNSLKEGVKKMTKGDIYTKEIITRILEEGCWDQDPRPKYAD
GTKAHTLSVNHGMCTYDLAKGEIPLITLRPIATKSSIGELLWIYQDESNDLNVLRDKYGV
TWWDEWDIGNRTIGSVYGETVRRHNLMKNLLQGLKENPDGRRHIINLWQESDFLEPHGLK
PCAFLTEWNVRHGQDGMDYLDMCLVQRSSDFLTAGCINQVQYVVLQYLVARHLNLRPGRF
TWFYNNIQIYDRHLDQAHELLQRDGIECQPKIVLNEEKQNFYDFQVEDVQIVDYPKELIK
KKNPQLKFEIGI
>KF629941.1_12374|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MINLTLIAAIGENYELGKGNQLIWHIPEDMKFFKENTINKPIVMGRKTLESLPRLLPKRK
HLVLTHQSLPTTQDIEVFHELETLLKYLEIQDQEAMVIGGAQVYKQLLPYANKMLLTKIA
SSAKADVYFPKFSEDEWTEEVLSTHTYQEIPYKHLVYYRKKEK
>KF629939.1_12382|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
IQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPAQDFTL
>KF629938.1_12384|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MAKRVTVKELNSYVYEQKRRYKIMKIVVLAGGTSTEREISIVSGTGICGALRQKGHEAIL
VDIFCGVENVDWENPFPAEYDVEKAAEYMSSFNPQIKEMEKKRRSFFGPNVLELCEKCDI
VFLGLHGANGEDGKVQAAFDLMGIRYTGTGYLSSAMAMDKRITKEVFLMNHVPTPGGFTM
TRDNLEKDIAKHGLEFPVVVKTSCGGSSVGVYIVNDQKEYEEALTDACQYGADIVVEEYI
KGREFSVAVVDDKAYPIIEIAPIQGFYDYKNKYQAGSTVETCPAEISPELTAKMQENAVK
AAKALGLTGYSRLDFMMKE
>KF629932.1_12403|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VV
>KF629919.1_12440|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVHMLAQVCDMKVGEFVHVIADAHIYDRHIPLVEELISREPLPAPTFWLNPEVKNFYEFT
PDDVRLDNYETGSQIKNIPIAV
>KF629910.1_12467|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVVVMGRKTLESF
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
ECDVAHITKVDFEYDADAYFPNLDEKPEWQITGDSEEQTYFDLEFYFLRYEKVK
>KF629907.1_12476|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVGITKDGQWKLIDTIAHLEDGSWVNSKTSAYICPDTGSKELLLERGGKTERISIDVVFP
VLHGMNGEDGTVQGLLELAAIPYVGCGVLASACSMDKFYTKVIVDAIGVRQAKFVGVRRH
ELSNMDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELVTALHLAAKHDSKILVEE
TIVGREIECGVLGMNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIR
KDAVAIFKALDCSGLSRVDFFLTKDTNEVVFNEINTLPGFTAISMYPMLWEARGLNKKAL
VQKLIDLAMNRYDV
>KF629903.1_12492|FEATURES|farme|macrolide-lincosamide-streptogramin|VgbA|antibiotic target replacement|0
MRKVVLFIAMSLDGYIADGNGGVAWLNGHGNDNENIDTYTEFTKDIDTVLMGWNTSHQVV
TELSPQEWVYNKFTTYVLTHKECNSSQQIHFTSENPVLLLERLKQEAGKDIWICGGANLV
QQLVSKNMIDKYYISVIPTLLGNGVRLLGNIDREIKLRLCKTQTYNGITDLIYMRR
>KF629898.1_12504|FEATURES|farme|peptide|EdeQ|antibiotic inactivation|0
MEKLMTQSFPSEEYRELEELRKYTDTKTHFYNNIIFHNNTPVGLITYWDFGHFYYIEHFA
IDPAQRNGGYGKSVLNHLCQLLKHPIVLEVEIPEEEMAKRRINFYQRQGFSLWEKPYQQP
PYKTGDNYLPMLIM
>KF629897.1_12510|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTF
NVTQTPGNDKLTLNAILNQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADC
HIYDRHIPLIKELIQRKPYPAPVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF629892.1_12528|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MAHNEIISFADSEERFKMKLIVAADKNWGIGCKNELLVRIPDDMKRFREFTTGNVVIMGR
KTLESFPNAKPLKNRVNIVITGNENYKAEGAVIVHSIDEAVEEAKKYADKDIYVIGGGSI
YRDMLEYCDTAYVTYLDYAYEADTFIPKIGEMAEEWYLAEESEENTYFDLEYYYRTYKRK
>KF629892.1_12529|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
HVIADAHIYDKHVPLIEELISREQHPAPKLWMNPEIKNFYDFTTDDIKLLDYETGPQIKN
IPVAV
>KF629891.1_12531|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIVATDDDLLIGKKDSKNGMPWHNKEDLQHFKKTTLNRTILMGKTTYLAIGRPLPNR
KTIVVTKSGMDDERVEVRNDLIEVIQEYKDKNEDLYITGGASIYKQALPYVDELIISRIP
GKHTGETYFPSFEEYDFHLEKETQLETFVLQIYKKG
>KF629885.1_12551|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
GRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQ
GKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPE
LTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSI
GLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGA
LDAEAYGVKSTIEDMARWVQSNLKPFDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLD
WPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
IVMLANKNYPNPARVAAAWQILNTLQ
>KF629882.1_12560|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VKKKLLVLCGGQSSEHIVSRMSCTSVLNNLDKEKYDLTLVGIDLDGNWYYLDADQQDLAK
DNWLENSQPVDDIYGLLRKQDVAFPVLHGLYGEDGTIQGLFELAKVAYVGCRVFSSSVAM
DKIYTKKILDTVGIPQVKSIYIKKRYDNKLVVVNNNFDEIDDVENYIVKELGMPCFIKAS
RSGSSVGCYRCDSQEELMDRLNEAAKYDRHIVVEECVDCIELETAVLGNDDVIVSRVGQI
MPHGEFYTFESKYEDEESKTCIPALVDQSIQEQIRAYAIKAFKAIDGHGLSRVDFFLDKK
TNKIYLNEINTMPGFTKISMYPQLMDDFGISYSELLDRLIELAVQK
>KF629878.1_12572|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAPK
VTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF629876.1_12578|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVIPSRRPEILHCRLRHGLIRDG
>KF629871.1_12591|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MFKIIDRNNWKRNPYFDHYFDKIPCTYSITVNIDISRVIRFKTEQNTKLYPLLVYALSKA
VNCYDEFRTDINENGEVGVWETLHPCYTVFHKESETFSNIWTEWDKDLNTFLSNYNRDIE
LYGNNTAIDAKPQAPKNVFPISSLPWTTFTGFNLNIKPDTGYLLPIFTFGKYFKQEDKFY
IPLSIQVHHAVCDGFHVSRLVNTIQKICTEI
>KF629869.1_12596|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VSIPADMKMFREETTGKVVVMGRKTLESFPNGLPLKNRTNIVITGNRDYQVKGAVIVHSI
EEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKIDFAYEADAYFPNLDEDPDWEI
TAESEEQTYFDLEYAFVKYERKDR
>KF629864.1_12609|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
VECAVLGGGEKPVQSSGVGEILAAADFYDFDAKYYNEESRTVINPELPGNAAEKVKKAAE
KIFNAVDGYGLARVDFFVTDSGEVIFNEINTMPGFTAISMYPMLWEAAGIPKKQLIDRLI
ELAFER
>KF629859.1_12619|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
KYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAFYDYQAKYIDNKITMDIPAR
VPVEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLNELNTMPGFTQWSMYPLLWE
NMGLSYSDLIKELVALGQEMFEKRESHLI
>KF629858.1_12620|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISIFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNIKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629840.1_12669|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
FPSRSKKVAIIGGGPVGLTMANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAM
KKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKND
TVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFII
QGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGL
DFKDTKSVSESLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIG
DTAHLMPPFAGQGVYIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTK
NEIEMRNPSFTFQQLMNV
>KF629840.1_12670|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDL
HKGSGQEAMKKAGLLQTYYGLSLTNGCKYC
>KF629838.1_12677|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGTKKDDRTGTGTISIFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHIYGYQWRSWPDYNGGFIDQISEVVETIK
HSPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQMRINPDVKSIF
DFKFEDFELVNYDPHPHIAGAVAV
>KF629832.1_12691|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TNLHVTVQDVLAANNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDRHIPIIKELI
GREQHPAPKFTLNPEIKDFYQFTTKDITIEDYVTGPQIKNIPIAV
>KF629827.1_12703|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKIFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNRAYSVPEGVYVFHTVKELLSALPEGENFIIGGEKTYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGKGDPVHRFVTYERVRG
>KF629825.1_12711|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLRRICDEGVVRGDRTGTGTRSVFGHQMRFDLGEGFPLLTTKKVFLKGVIHELL
WFLRGDTNIRYLVENGVHIWDNDAYRYYNELCVRHGVLPVDRETFLSAAGGESPVEGYRF
GDLNHVYGWQWRSWGRPDGSAIDQIARAVDTIRRNPESRRIIVSAWNVAEVDDMALPPCH
VLFQFYVADGRLSCQLYQRSADTFLGVPFNIASYALLTLMMAQVCDLRPGDFVHTLGDTH
LYLNHMEQVAEQLSRTPRKLPSMRLNPAVRSIFDFRYEDFTLEGYDPWPAIKAPMSF
>KF629824.1_12714|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKKNGIGYQGKLLVTIPFDQQLFRKETIGKVVVMGRKTLESLPGGRVLEGRTN
IVLTRNKNYQCKGAVICHSVEAVLEEIKKYRSEDVYIIGGESVYQAFMPYADRIHLTRID
YVYEADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYERKQK
>KF629805.1_12771|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPVTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>KF629802.1_12777|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKDKKIIVLMGGPSKEAEVSRRTGAAIAEALESKGYNAQTLELNPRTVLKDIEDLGGEVV
FNAIHGRYGEDGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTAASESFN
GNLESAEAIIEHIRKDFTIPVVVKSATQGSSIGVTIVRDEAQLEEAVTEALKYDPILVVE
QFLDGREFTVSVLDGKALSVIEIRPHSGEYDYKSKYTVGATEYLVPAPISAEMTAEMQRI
GELVYREVQGSGVIRVDVMTDHADNMYVLEYNTVPGMTATSLVPKAAKEMGIDFPTLCEK
ILLTASIGKF
>KF629790.1_12809|FEATURES|farme|chloramphenicol|GYMC10_3621|antibiotic inactivation|1
MGYQEIDLETWPRKEHYLHFTKQAKCFVSITKDVDVTQLRTAAKTCSRSFYIAFLYVICK
VINRHGEFKLAYLPQEEKLVQWDEVLPSHLVFHEEDETFTCIWSQWEPDFEAFYRGCQED
IAAGKEYRGYRVPGMPENTFCVSCLPWIKYSALDINLCGDGLFLAPMISWGKAELEGGRM
RMPLSFEIHHGAAEGFHIARFYDEVEQEAAALAEYLSAFGGKSVCC
>KF629784.1_12829|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVRATEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTLRRTALKSAMDEILWIWQ
KKSNNIHELHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMMDQVDRVIYDLKNNPFSR
RIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNEKLTLNAILNQRSQDILTANNWNVCQ
YAILLMMIAQVCDMEAGELLHVVADCHIYDRHIPVVKEMIKRKPYLAPIVKLNPEVKDFY
QFTTDDLIVENYETWPQIKNIPVAI
>KF629783.1_12831|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAVETIKHNPDSRRIIVSAWNVG
DLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALLLQMVAQVTGLKA
GDFVHTLGDAHIYLNHLEQVKLQLSREPRALPQMKINPDVKDIFDFKYEDFELINYNPHP
HIAGKVAV
>KF629779.1_12843|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNWNVCQYAVLMHMLAQVCDMQVGELVHVIADAHIYDRHIPLVKELISREPLPAPTFWLN
PEVKDFYRFTRDDVRLDNYQTGPQITNIPIAV
>KF629775.1_12853|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
LIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMIMRVRHEETNSNTITGSDSPVPTHHNG
NEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIVRNWLVRSPTNGIGMSEHGIFHIDLAS
SGPHAMVAGTTGSGKSELLISWCMALAIRHSPQTLHFVFLDFKGGSTFNALERLPHTVGN
VCDLDLAHAVRALNAIEQELARREALVSAERVSRFDQLSHPPARLVVVIDEFHALRDRLP
DYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHADMKANISLSICLRVTDQMQSNELISTK
DAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAFSGTTNPSPLFSAPLA
PHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVIGACGSGKTNLLLCCA
SRLYESGRCTIRFTRKTNSEWTTDDGRISPQHERTIWFVDDADELLSPFAAMPEADKLKT
ALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPSAVLDGFGVDDYAIAG
RGVFIQQARACPVQCAEFQGF
>KF629774.1_12857|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMQGTRWEVQLPDGAKAPVD
RNDFSFMLGTEKIRFDFAYITIHGTPGEDGRLQGYFDMMHIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEDVMEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFEEAQEVLVEAFMEGTELTCGCYKTKDKTVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTNRVQMLTSAIYDILGCSGIIRVDYIVTAGEKINLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF629772.1_12862|FEATURES|farme|chloramphenicol|PMI05_03422|antibiotic inactivation|1
MFVTAEEAMEYQKIRELQDWPRQEAFDHFYHQVVTAVTLTADVDVAPLLQACRERGLRFF
PSFLHLLSRVVNRHDAFKMGHNAEGEPVIWKQVSPSYTVFQEEDSSFYSLSTEYVPEFEA
FYRQVVLDIEQSKPLQGPRWKEEPPNRFYVSCIPWLHYRGFNMQMYGDGKLLCPIFTWGK
FERSGDKTVMPLTIQIHHASADGFHIAQLFQELQWEVDHFSEEQAGA
>KF629767.1_12877|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELG
>KF629764.1_12885|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
IVLTHDHTYKVPGAVVVHDMDELHEELKKYDSQDIYVIGGETIYRQLLDECDVAHITKID
YAYDADAYFPNLDERPEWKITADSEEQTYFDLEYYFYRYERVK
>KF629762.1_12891|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MRIIVLAGGLSTERDVSLSSGAGICRTLREKGHDAFLLDPFLGLPDAGDNLEAAFTRPDA
GLSLASGIRSTEPDLEAVKASREDKSDCFFGANVIELCRLADIVFMGLHGDVGENGKLQA
AFDVLGIRYTGSGSLGCALSMDKEITKVIFEANHIPTPKGTWMKRSTADHSLASTGLPLP
LVVKPCSGGSSIGVYITQTEEEFDKAVKESFRYEDEIIIEEYIKGRELACGVIDGKALPV
IEICPKTGWFDYANKYQDGMTEEMCPARIPEETAKKIQAISEHAFQALKLDVYARADFLL
TEDGNIYCLEYNSLPGMTAASLLPKEAKAAGIEFGELCELLIEKSMDARYCG
>KF629752.1_12920|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGIEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIHELL
WFLKGDTNVKYLQENGVRIWNEWADENGDLGHIYGYQWRSWPDYKGGTIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKSIF
DFQYEDFELVNYDPHPHIAGKVSV
>KF629745.1_12945|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HIYLNHLDQVKLQLSREPRALPQMKINPDVKSIYDFQFEDFELVNYDPHPHIAGIVAV
>KF629739.1_12960|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIAAVDRHMAIGYENKLLFWLPNDLNRFKALTTGNTIIMGRKTFESLPKGALPNRRN
IVLSTRPDTLCPGAEIFPSLEEALKHCEQDEQIYIIGGASVYRQALPLADALCLTEIDAE
APQADAYFPEVAPEIWQEKSRESHPIDEKHPCPYAFVNYIRR
>KF629735.1_12972|FEATURES|farme|quinolone|patB|antibiotic efflux|0
IRKFFDLVSEMPDAISLGVGEPDFDTPWRIREEGIYTLEQGKTFYTSNAGLKDLKIEISK
YLERKIHVEYDPDHEIMVTVGGSEGIDVALRAMLDPGDEVLIPQPSYVSYLPCTILADGN
PVVIPLQEKNEFKLTAEELEAAITPKTKMLVMPFPNNPTGSIMTKEDLEPIAEVVKRHDL
YVLSDEIYSELTYKTEHVSIASLPGMQERTLVINGFSKGFAMTGWRLGYICGPSVIIEQM
LKIHQFAIMCAPTNSQYAAIEGLRHCEDEVQQMRNAYNQRRRYLVNEFAKMKLECFEPFG
AFYIFPSIKEFGMTSEEFAMRFLEEEKVAVVPGSAFGESGEGFLRVSYAYSLEDLKEAIG
RLSRFVERLRSQK
>KF629718.1_13018|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LIQRKVMYMTDRISVAVLFGGVSSEHEISCISAASVLNHIDRDRYDISTIGITKEGNWFL
TGSPVANIGDGSWEKDDSNRRAFIAPDRSVGGIMAETGDGRFEILKVDVVLPMLHGRNGE
DGTIQGLFQIAGIPFVGSGTAASAASMDKVMTKAIINQSGVVAQAGCCVSYRNVYESDRP
AETERIREFFKNTFPLFVKPANAGSSVGITKVKEEENLPAALELAFGEDDKVLVEEAIKG
REIEVAVLGNESPQASCIGEIFAANEFYDYNAKYENSMSRTAIVRDLPPEKEEEIRSKAV
KVYETMGCAGMARIDFFLEESGRVVLNELNTLPGFTSISMYPKLMEHLGMSQEYLVDKLI
EQAMENVART
>KF629715.1_13033|FEATURES|farme|beta_lactam|OCH-5|antibiotic target alteration|0
MKQYLDLLQHVLDHGILKEDRTGTGTISVFGYQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQDNSVRI
>KF629707.1_13055|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRI
>KF629701.1_13072|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
LAGGWSPEREVSLKGGEQIAAALKERGHSVTLCDPAKDFERLMDMAREHDAAFINLHGAP
GEDGLVQAILDRVNCPYQGAGPAGSFLALHKAAARQIFRDAGLNIPDGVFLPRHPGPNWK
PDLQYPMFVKSNTGGSSLHLSRVTNEEELYTALNSLFSMGEEAIVETAVVGREVTCGVLG
EEALAPILVVSKGNYFDYHNKYAPDGAQEICPAPIAPEETAKVQDAALRAHHALGLKGYS
RADFILQDDGTLYILEVNTTPGMTSTSLVPREAAVKGMSFADLVERLLELALER
>KF629700.1_13075|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDVPEGVRVFHSPEVAAEAARALDAPYVIG
>KF629691.1_13103|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MEMPASPIRKLAPLADAAKQRGIHVFHLNIGQPDLPTPEVAIEAIRNIDRKVLEYSPSAG
YRSYREKLVGYYAKYNINLTADDIIITSGGSEAVLFSFLACLNPGDEIIVPEPAYANYMA
FAISAGAKIRTIATTIEEGFSLPKVEKFEELINERTRAILICNPNNPTGYLYTRREMNQI
RDLVKKYDLFLFSDEVYREFIYTGSPYISACHLEGIENNVVLIDSVSKRYSECGIRIGAL
ITKNKEIRDAVMKFCQARLSPPLIGQIAAEASLDADEDYLRDTYDEYVERRKCLIDGLNR
IPGVYSPIPMGAFYTVAKLPVDDSDKFCAWCLSEFEYEGQTVFMAPASGFYTTPGSGRNE
VRIAYVLKKDDLNRALFVLQKALEAYPGRTE
>KF629677.1_13142|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFACNQYLKA
FGVRIAESLLLRQGQSVSDEDVLEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAF
GEAEEVLVEAFMEGTELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVDEITPAR
ISDELTDRVQMLTSAIYDILGCSGIIRVDYIVTAGEKINLLEVNTTPGMTATSFIPQQVR
AAGLEIKDVMTDIIENKFKD
>KF629677.1_13143|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFRKAATGAIPNVPFEVWSQKMRACKTKLEFQ
KTFCYGLLWKLAKEATDGLTLDHTALPDKSAAYTYVSNHRDIILDSGFLSILLVDQGMDT
VEIAIGDNLLIYPWIKKFVRVNKSFIVQRALTMRQMLEASARMSRYMHYTISEKKQSIWI
AQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYDPCDFLKAQEFQ
LKRDIEGYKKTTADDLLNMQTGLFGYKGRVHFQTGACMNDEL
>KF629672.1_13151|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTT
>KF629671.1_13155|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MEFEEIRPYHDEELPQVFEELIADPAFQQVACAVMPGVPFEAIAQKMRASKTKQEFQENL
CYGILHKLAKDTTDGLILESMAVLNKQSAYTYVSNHRDIILDSGFLSVLLVEQGLDTVEI
AIGDNLLIYPWIKKLVRINKCFTVQRALTMRQMLGSSIRMSRYMHYTIAEKKQSIWIAQR
EGRAKD
>KF629667.1_13165|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDCLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF629666.1_13168|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYAILLMMVAQSIDMIPGELLHVI
ADAHIYDRHVDIVRELIERPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPI
AV
>KF629663.1_13173|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VRTESTLLFDKDKYNLYIAIVKRDEWAVILPSGEHTPIDKNDFSFKENGVTRHFDFAYIT
IHGTPGEDGRLQGYFDMIGMPYSSCGMLVSALTFNKYVCNHYLKDFGVKIAASIHLFKGE
TITDEEVVTRLGLPIFVKPNDGGSSFGVTKVKEVSAIQPAIAKAFGEGREVILERFIDGT
EVTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVDEITPARISAELTELIQRKTSR
IYDILGAKGLIRVDYIIPADGEPVLLEINTTPGMTATSFIPQQVRAAGLDIKDVMTDIIE
DELKNRKTK
>KF629659.1_13183|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
LAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRLAAAIATAGEHDWKVLVEQ
GIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFDSKYMDASASHVEVPANLP
VSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEINTMPGFTPISMYPKAWDAT
GVSYTELITRLIEGVLR
>KF629653.1_13196|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLASAAGICKTLLEKGHDAFLLDVFLGLENAPENLEDVFTLPGH
GLEIAKNISETEPDLAAVKASRPDQSDCFFGPNVIELCRLADMTFLGLHGGEGENGKLQA
SFDLLGIRYTGPDSLGCAVAMDKGLTKQIFMEAGVDTPSGVCLYKEDSDCSLESLGLSFP
VVVKPCSGGSSIGVYIVNTEDEYRQALKNSFRYENEVVIETYIKGREFACGVIDGKALPP
IEIIPKSGWFDYANKYQANATEEVCPADISEEIAERMKALTVRAFQALKLNVYSRADFIL
DADGNLYCLEMNTLPGMTSASLLPKEALADGIEYGDLCELIIQKSMEARYQ
>KF629652.1_13198|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKAPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIAESLL
>KF629641.1_13219|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRNIHDLGMEFPVVVKT
CCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYIRGREFSVAVVDGKAYPIIEIAP
KQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKENGD
MYCLEANTLPGMTPTSLIP
>KF629632.1_13240|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKKNGIGYKGKLLVTIPFDQQLFRKETIGKVVVMGRKTLESLPGGRVLEGRTN
IVLTRNKNYKCKGAVICHSVEAVLEEIKKYRSEDVYIIGGESVYQAFMPYADRIHLTRID
YVYEADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYERKQK
>KF629630.1_13248|FEATURES|farme|multidrug|smeS|antibiotic efflux|0
FGLMPAQDATPLSLVLTELITNSVEHGFEGRKEGHITISVGRGGNNLNVVVEDDGTGLAD
EEHDGMARSSGSGLGTQIINTFVTNDFGGTVHWEPRRGGGTRVVLDMKLRAAQDN
>KF629621.1_13267|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MALTEEQLADIRSRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGTISLFGQQMRFD
LSKYFPLLTTKTVFFKGLAYELLWFLKGSSNINWLLEHNVHIWDEWADENGDLGPVYGVQ
WRSWPAPTPEDPNRTIDQISNVLDLIKHHPDSRRMIVSAWNPAEVEKMALPPCHALFQFY
VADDKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWTGGDCHVYDNHI
DQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVDYRHHPTIKAPVAV
>KF629612.1_13294|FEATURES|farme|aminoglycoside|AZ78_1791|antibiotic inactivation|0
MKLVTLVSNNVGVDTYLELRKAVNFKPLSRTQARKALDNSLYIVCAYIDAKIVGMGRLVG
DGAVICYIQDLMIHPDYQHYGIGSAIIEDLIEYVENLCEEGTEIMLDLMCAIGREPFYHK
HEFI
>KF629607.1_13305|FEATURES|farme|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTVNEMPE
FRTALTEKGLGYFSEMHPAYTIFNQEQETFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YAPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHVGRFIELLQKKIIGFDSGCNSAPSDISATVKGRIK
>KF629605.1_13311|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MGGKSSEHDVSLISAKTVIESIDKDRYSVIMVGITKDGQWKLIDTIAHLEDGSWVNSKTS
AYICPDTGSKELLLERGGKTERISIDVVFPVLHGMNGEDGTVQGLLELAAIPYVGCGVLA
SACSMDKFYTKVIVDAIGVRQAKFVGVRRHELSNMDEVVARVEAGVPYPVFVKPSKAGSS
QGVSKAENREELVTALHLAAKHDSKILVEETIVGREIECGVLGMNEPKASGVGEVLSAEE
FYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCSGLSRVDFFLTKDTNEVV
FNEINTLPGFTAISMYPMLWEARGLNKKALVQKLIDLAMNRYDV
>KF629601.1_13319|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|1
SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQ
TLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGL
PLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTR
VFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSN
LKPFDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARP
VKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQIL
NTLQ
>KF629597.1_13330|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNGLPLKNR
TNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESVYRMMLPYCSKVYVTK
IDHAYQADTYFPNLDQLEDWEMTEVSEEHTCFDLEYVFSTYERRQ
>KF629591.1_13354|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VNRYDLSKESPAITLRKTYIRSAIDEILWIWQKKSNNVHDLNSHIWDEWADEDGSIGKAY
GYQLGKKHKYKEGEMDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNV
TGNRLNAILNQRSQDILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIP
IIKELIKRPTYPAPKVTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF629587.1_13361|FEATURES|farme|glycopeptide|VanA|antibiotic target alteration|1
YDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNCEGLARCDFFVEHGTNRVMINE
INTFPGFSPISMYPKLMEHEGIPVPALIDRLIALALERTEKQHG
>KF629585.1_13363|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMQSEDKLCVVVLFGGMSSEHEVSCVSAGTFVDQLDRQRYELLTIGITKEGRWLYTEADS
AQMADGSWEEMADGSWEELPGNMPCVLSPDRADHGLILFTPAGQVEKVHVDVVIPVLHGL
WGEDGTVQGLLELAGIPYVGCGVLASAVCMDKAVANAMFDASGIPHTKWLSATRWEIESD
PDGVCDGVIAKLGWPIFVKPANAGSSVGITKAHDRDELKAAIRLALANDRKVVFEAFVDG
HEVECAVIGSDPAVSTRPGEILAGAEFYTYDDKYKNGVSQVVIPAKLPEEKLDEVKTYAA
MAYTALGCEGLARCDFFVEK
>KF629583.1_13369|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKMFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNKAYSVPEGIYVFHTVKELFSALPEGENFIIGGEKMYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGKGDPVHRFVTYERVRG
>KF629582.1_13371|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADQNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITKNKDYDAKGAIVVHSIEEALEEIKKYPTEDVYCIGGDSIYEQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITAESDEQTYFDLEYQFVKYERKK
>KF629572.1_13396|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKKNGIGYQGKLLVTIPFDQQLFRKETIGKVVVMGRKTLESLPGGRVLEGRTN
IVLTRNKNYKCKGAIICHSVEAVLEEIKKYRSEDVYIIGGESVYQAFMPYADRIHLTRID
YVYDADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYERKQK
>KF629569.1_13406|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
ITRRSLIYVAKEYLGLEAEEREVYFDEVKNFAECGLCGTAAVISPVGKIVDHGKEIYFPS
GMNEMGPITKKLYETLTGIQMGRIQAPEGWLKVIE
>KF629569.1_13407|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTQESFPGGLPLKNRIN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF629564.1_13417|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VVTLPTPGRKADIMKKSVLVVFGGQSSEHIVSCMSAINVIKNIDTERYDVTLIGITEEGK
WLLVDSVEQIEDESWRKNTTTAILSPDATEKSVIVLKDGKAEMIRIDVVFPVLHGLWGED
GTVQGIFELAKIPYVGCGVLASSVSMDKVYTKQIVDHTGVRQAAYELVIRKELEKMDEVV
ARIENRFAYPVFIKPSNAGSSRGVSKASDREELIAGLKEAAHHDRKILVEETIVGREIEC
AVFGNGTEPVIASGVGEILAVADFYDFDAKYYNAESRTVVNPELPGDAAERVRQAARRIF
KAVDGYGLSRVDFFVTKDGEVIFNEINTMPGFTAISMYPMLFEAAGIPKPEMVTKLIEHG
LKRYEA
>KF629562.1_13422|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKVFVAMCQDILENGTSTEGELVRPHWEDGTSAYTIKKFGVVNRYDLSKEFPAITL
RKTYIKSATDELLWIWQKKSNNIHDLKSHVWDEWADEDGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKHTPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQKKGDDRLTLNGIL
NQRSQDVLAANNWNVCQYAVLMHMLAQVCDMRVGELVHVIADAHIYDRHVPIVKELIERP
QYDAPKFWLNPDIKDFYQFTTDDIKITDYVTGEQIKDIPIAV
>KF629554.1_13454|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDKNYKVKDTVIVHSVEEMVEELKKYNSEDVYVIGGESIYRQLLPYCTKAYVTKID
HAYDADTYFPDLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF629553.1_13457|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF629548.1_13470|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
FGKEGADPATAFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVIFMA
LHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGK
DSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALKGAFSYEDEVVVEEYIEGRE
FSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRQMQTYAEAGCKA
LAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMR
KYQK
>KF629540.1_13493|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MGRKTLESFPGGQPLKNRVNVVLTTDKNYKVKDTVIVHSVEEMVEELKKYNSEDVYVIGG
ESIYRQLLPYCTKAYVTKIDHAYDADTYFPDLDADPEWEMTKISDEQTYFDLEYVFVIYE
RR
>KF629523.1_13539|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLN
ADDPAHIALRPSATSLAQVPGKHEHQLIGAQNGQPLPTVDVIFPIVHGTLGEDGSLQGML
RVANLPFVGSDVLASAACMDKDVTKRLLRDAGLNIAPFITLTRANRHNISFAEVESKLGL
PLFVKPANQGSSVGVSKVTSEEQYTIAVDLAFEFDHKVIVEQGIKGREIECAVLGNDNPQ
ASTCGEIVLTSDFYAYDTKYIDEDGAKVVVPAAIAPEINDKIRAIAVQAYQTLGCAGMAR
VDVFLTPENEVVINEINTLPGFTNISMYPKLWQASGLGYTDLITRLIE
>KF629508.1_13585|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LRKTYIRSAIDEILWIWQKKSNNVHDLNSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGE
MDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQ
DILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAP
KVTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNLPIAI
>KF629503.1_13600|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VKELISREPLPAPTFWLNPEVKDFYRFTRDDVRLDNYQTGPQITNIPIAV
>KF629501.1_13604|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIDKENGICRREYHMIGLIVARSKNNCIGKNGKIPWKIKGEQKQFKELTTGNVVVMGRNS
YDEIGHPLPNRETIVISKSKKYVGRNIHTASSVKEAIELAKGKDVYIAGGYGVYKEAIPL
VDVMYITEININIEQGDVFFPEFDENDFDITIEEMSEDNEQFTRKIYRRKVAVKNRNFKE
QRYEYYCTAVSS
>KF629500.1_13606|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQWDKDYLCLCRRILEEGTEVVNRTGTNTIKVPSHNFHFDLSKEFPILTTKQLFIRQAV
LEMLWIYQAQSNDVRWLQERDVKIWNEWEIDDEGYWNASQMLPDENGKLVKTPVHKFFGK
EWAHTIGTAYGYIVNKFQMTQQLIDKIKNHPEDRRMVMTLWQNDYLDTAVLPSCVWSSEW
DVTDGKLNCWVHQRSCDVPLGLPFNVTQYATLLCMLAQVCGLKPGTMDWSIKDAHIYVNQ
IDGIKEQLKRFDEQGDLPAPKLWLNPEIDDFFKFDNSRDCNDVKLIDYKHMGKIKFPISQ
>KF629485.1_13652|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGIHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVTGLQTGDFVHTLGDTHIYTNHLEQVKLQLSREPRPLPQMKINPDIKDIF
SFKYEDFELVNYDPWPHIAGKVSV
>KF629479.1_13669|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIKELKSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVDG
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF629478.1_13676|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSENKLCVVLLFGGMSSEHEVSRVSVGNFVNNIDRTKYEVLAVGITKEGRWLYTEATAA
QMADGSWEELPGNMPCVISPDRADHGMILFTPSGQVEKLHVDVVIPALHGLWGEDGTVQG
LLELAGIPYVGCGVLASAVCMDKAVANALFDAAGIPHTKWLSACRWEIESDLDGVCDGAI
AKLGWPIFVKPANAGSSVGITKAHDRDELKQAIALALENDHKVVFEAFVDGHEVECAVIG
SDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPARLSEEKLDEVKTYAAMAYTALNCE
GLARCDFFVEHGTNRVMINEINTFPGFTPISMYPKLMEHEGTPVPALIDHLIELALERTE
KQHG
>KF629477.1_13678|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPLGPDCHIYDRHIPLVKDMIQRKPYPAPIVKLNPEVKDFYQFTTDDLIVENYETWPQIK
NIPVAI
>KF629472.1_13690|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MLELCVIFGGQSPEHEISRKSVTSVLNNLNKDKYNISTIGITKNGAWYLYTGDYAKIESG
EWEQDTENKKKAILSPDAEDKAIIVFDGDKVMKIHPDVIFPVLHGEFGEDGTIQGLFELS
GIPYVGMGVMASANGTDKTSSKIVFASADIPQADWVVVNKTDNFEDKMDEIENKLGYPCF
VKPARTGSSVGVGKAHDRKELKAALENAAQFDRKILVEENIDGHEVECAVLGNEDVKAAT
VGEIMPTVEFYDFDAKYNDNSTELQIPADLPKETIEQIREYAVRAFKALDGSGLSRVDFF
VKHSDGSVVLNEINTLPGFTNISMYPKLWGAVGIEYSELLDKLIELAEKRVK
>KF629444.1_13760|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKAYGYQMGIKHQYKEGMM
DQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRE
TYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF629433.1_13789|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKIVVLAGGLSPERNVSLSSGSMVCQALRDRGHQVALVDLFFGLEDHKGEPEELFNAPIP
DSFKKVSRQAPDLEQVRASRKWKDASAIGPGVLDLCKKADVVYLGLHGACGEDGRIQAAL
DLLGVPYTGSGYLSSAIAMDKDLTKRLVADKVVTPRWMRVDLTEEQLDGLVEEVSLPAVI
KPVDSGSSIGVFIANDKAELRHALEESVKLGGRVVIEQYIKGREIQVAVLNGKPLPSIEI
TPKEGFYDYENKYQPGAALEVCPAPIPAEWEERIGKAAVAVFETVGLSVYARADFIVTED
GTPYFLEINTLPGMTPTSLVPQEAAAVGMDYGTLCETIIRSSLELRNKEL
>KF629429.1_13799|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
VGPYFKGGAKPITIRVSDFYRAAPNGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDSK
TRTKVEETGGANFLFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGLEAEEREVYFDE
VKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMNEMGPITKKLYETLTGIQMGRIQAP
EGWLKVIE
>KF629421.1_13824|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTNLITMLIEGVLR
>KF629419.1_13829|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MVGRIYHVGLTVSDLERSIAFYRDILGLEFQGEILMEGEETDKMFRKENCKARVAYLNGS
KALEAPPVELIQFVDSKIHKEQSDLFTTSISEVCFYTDNIDSVYKTLIENHVECLSEPQY
FDFRADGFGESRAFYFRDPDGIILEMMQPL
>KF629416.1_13836|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
TGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPCIVKPCSGGSSVG
VSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPIEIAPKSGMYDYA
AKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLDKGGFTYCLEANT
LPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPEEKSDF
>KF629412.1_13847|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
VKSSQLKPDTYSPLRDEFPDQDITISLGELLKYTISKSDNNTCDILIEYVGGIDQVNEYV
KSLGIKDCNLAATETLMHTSGDAYLNWSTPEEVVRLLNIADKQPLFGTQYKDFLQVIMQE
TSTGKDKLKGQLPADVIVGHKTGSSDRTPEGIKIADNDAGFVILPNGQKYYIAVFVMESQ
ETDTDNAAIIASISKIVYDTLNSDIQ
>KF629411.1_13851|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKTRVAVIFGGMSNEHDISLISASNVIAHLDPDKYEIIPVGITKKGRWFFYPGDISGIK
DGSWETNPDCVPAAILPDPLYGGIAKVSDGRMNLVKIDVVFPVLHGKYGEDGTIQGLLDM
AGIPYVGCGCFASAACMDKEYAHCVLQYNGINMAKYRTVKQSDLNNLDAVCEKIAAELKY
PLFVKPACSGSSVGVNKATCFEDLKNAVKLAFTHDKKVIVEEFIKGRELECAVLGTDNPF
ASEVGEILSCNDFYDYDAKYILGTSGLNIPANIPKEASLEIRETAVKAFKALGCFGLSRV
DFFLADNGKVYLNELNTMPGFTSISMYPKLMGNLGIPYGELLDRLIKLAYERN
>KF629408.1_13858|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VCAIRFVYSHILYGKRVKLLVYCSFILLKILFEHSKKCLRSDFLRGKEPFIMKKTVCVIF
GGASSEYEVSLMSSASIIRNLDTEKFDILTLGITKDGRWLLYSGAVENIENNTWMNSETA
RPAFISPDKATNGLVVLNADGSCTVLKVDVLFPVLHGKNGEDGTIQGLFKLSGIPYVGCG
TLASAVCMDKAVTHTLLSAANIEQAHYLWFYADRYFADGEKIRNKIAARLNFPVFVKPAN
AGSSVGVSKVTAPEKLDAAIRLAAENDTKVVVEEGIVGQEVECAVLGNRGKSVASPVGEI
GAGAEFYDYDDKYKNGVAQLFIPARLSEDVAEEVRKTAVRAYNLLGCDGLSRVDFFVTEK
EHKVILNEINTLPGFTSISMYPKLWENAGTPYSELLEKLIDCAFTRAD
>KF629402.1_13875|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTSKTKDTPLDELGYYLP
LVVKPCSNGSSIGVYICHTEEEYYDAIHKSFDVDNTDEVVIEPFIKGREFACGILAGKAL
PLVEIVPKDGLFDYANKYQAGGASEICPPVSLDEETQELIQRAGERAFEALRMDVYSRAD
FIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSELCEAIIQESMKARY
>KF629400.1_13882|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQIFLANCQEILSRGTWDTHLPVRPRWEDGTPAHTVKCFGLVNRYDLREEFPIQTI
RRMYLKSAVEELLWIWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEM
DQVDRVLYDLKHNPSSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGDTLNAILHQRSQD
MLTANGWNVMQYAVLVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPR
LRLDPAVTDFYAFTPDSVQLENYRYHPLKEKIPVAI
>KF629398.1_13890|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PPQSSNSWNVCQYAALLAMIAKASGLKAGELVHVIADAHIYDRHVPIIEKLMEREGYDAP
KLCIQEDVADFYAFNTENVWLEDYQNCGGVGKIPVAV
>KF629396.1_13895|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDWENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPT
>KF629394.1_13901|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VQYAALVHMFAQVCGMQVGELVHVIADAHIYDRHIPLIKELISRETHPAPDFWMNPEIKD
FYDFTPDDFRVENYVTGPQIKNIPIAV
>KF629393.1_13904|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VVLTTDKNYKVKDTVIVHTIEEMVDELKKYDSEDIFVIGGESIYRQLLPYCTKAYITKID
HAYDADTYFPNLDEDPEWEMTKISDEQTYFD
>KF629383.1_13930|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGI
>KF629381.1_13933|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PSYSVTKEPGEERLILNGVLNQRSQDVLAANNWNVCQYAILLMMVAQVNDMIPGELVHVI
ADAHIYDRHVPMIEELISREPLPAPTFWLNPEITDFYDFTPDDVRLDRYETHPQIKNIPI
AV
>KF629375.1_13952|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KNGEDGTVQGLLQLAQIPYVGCDATSSGVCMDKAVANAVADAFGINQAKWCAFTQYDFNK
NRQECIDTAVKKLGFPIFVKPANAGSSVGITKAHDIPELIEAMNVAFNEDTKAVLEEFID
GHEVECAVLGNEEPIAAEVGEIKAAAEFYDFDAKYNNPASELCIPADIDLEKRNEVKAQA
VKAYKALGCEGMSRVDFFVRNSDGAVLLNEINTIPGQTPISMYPKLFEAAGVPYKELIDR
LIGCALSRGGKF
>KF629369.1_13967|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VTRMTCKLSAIVAVCDDWGIGCEGDMVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGR
PLKNRRNIVLTRDESFAAEGVDVVHSIDEALAAVADEPVAWVIGGGEVYLQFLPYCVEAE
VTHNHCVHDVDTYFPDLDADPAWEIARCGGVATIAAGEGDEGLDYEFVTYRRVEA
>KF629359.1_14002|FEATURES|farme|chloramphenicol|PMI05_03422|antibiotic inactivation|1
MFVTAEEAMEYQKIRELQDWPRQEAFDHFYHQVVTAVTLTADVDVAPLLRACRERGLRFF
PSFLHLLSRVVNRHDAFKMGHNAEGEPVIWKQVSPSYTVFQEEDSSFYSLSTEYVPEFEA
FYRQVVLDIEQSKPLQGPRWKEEPPNRFYVSCIPWLHYRGFSMQMYGDGKLLCPIFTWGK
FERSGDKTVMPLTVQIHHASADGFHIAQLFQELQWEVDHFSEEQAGA
>KF629356.1_14010|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
INPIDDNSRSNNNKRLFRRAKEYHHGLNSIATAKAFPSQKSISRLVHMLAQVSGLVAGEL
VHVIADCHIYDRHIPLVEQMLELEPYPAPEFRLDPAVTDFYAFTPDSVQVENYRYHPFSA
KIPVAI
>KF629354.1_14016|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
PDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDRASEFKTDA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASRHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYAFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF629341.1_14060|FEATURES|farme|aminoglycoside|APH(2'')-IVa|antibiotic inactivation|1
MRTYTFDQVEKAIEQLYPDFTINTIEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNE
VNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAA
KDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI
LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEY
GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKI
K
>KF629340.1_14064|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
MMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPT
>KF629339.1_14066|FEATURES|farme|multidrug|MdfA|antibiotic efflux|1
LRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYAAIQESFEEAVCI
KITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIG
EKLSLKELGRDYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIITGEQLSSYEYGLL
QVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWM
>KF629334.1_14081|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GFIDQISEVVDTIKHNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVADGRLSLQLYQR
SADIFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTLGDAHIYLNHLDQVKLQLTREPRP
LPQMKINPDVKSIFDFKYEDFELVNYDPHPHIAGKVSV
>KF629332.1_14088|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKID
FAYEADSHFPNLDEDDEWEITGESDEQTYFDLEYAFVKYERKDR
>KF629324.1_14116|FEATURES|farme|multidrug|sav1866|antibiotic efflux|0
TIPPADRIIVMHHGRIRESGTHQELLKQDGIYKKLYELQLA
>KF629323.1_14117|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTQKQGDDKLTLNAILNQRSQDVLTANNWNVCQYAVLTHMLAQVCDMKVGELVHVI
ADAHIYDRHVELVKELITRQQHPAPKFWLNPEIKDFYQFTPDDIKVTDYVTGPQIKNIPV
AI
>KF629318.1_14131|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
FGKEGADPATAFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVVFMA
LHGANGEDGRVQAYFDLCGIPYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGK
DSMNLADYNMELPVVVKTCCGGSSVGVYITKTPEEYEEALKGAFSYEDEVVVEEYIEGRE
FSVGVVDGKAYPIIEIAPVEGFYDYKNKYSAGATIDTCPAVLTEEQTRQMQTYAEAGCKA
LAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEAAVLGIDYAQLCEKLIEISMR
KYQK
>KF629313.1_14143|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAADKNWAIGKDGELLVRISEDMKNFSAITTGNVIVMGRKTLESFPGGKPLPNRVN
IVLTHEKDYNGKGAIVVHSEEELWEELSKYDTDSIFVTGGESIYRMLLPYCDTAYITRLD
YAYEADTWMPNLDKEEHWSMVEKGEERYCFDLIYHFTTYKNETPALH
>KF629304.1_14170|FEATURES|farme|trimethoprim|dfrA|antibiotic target replacement|0
MVSIIAAVDRNLGIGFQNKLLFWLPNDLK
>KF629302.1_14175|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MSKKVIGIWAQTKNGVIGKDQVMPWHLPAELQHFKQTTTGHAILMGRVTYEGLNKRVLPN
RTNIILSRDDKYDVENEKVLLKTSVEDVLNWYKGQDLSLFIIGGEKVIRLFEPYLEELYQ
TVIDAELEGDTYFPEDFRWDQFQLFDERTIEKDEKNPYDFTIRHFERKED
>KF629291.1_14203|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NLYNFQDLHEMALYPCAYSMTFNVSGDTLNAILNQRSQDMLTANNWNVVQYSVLVHMMAQ
VSGLKAGELVHVIADAHIYDRHVPAVEKLLAQEPQAAPTFHMDEAVTDFYQFTRDSFSLE
GYHPLPFDDEIPVAI
>KF629290.1_14207|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MNKKAPHRISEQHLTVLSWSAPLLAQLIMLIVMCMQRHWLYAAMLAPSLLGSALMLITMI
MRVRHEETNSNTITGSDSPVPTHHNGNEIDHAQLFADMPSISFEHLHGLDNDPLIWRTIV
RNWLVRSPTNGIGMSEHGIFHIDLASSGPHAMVAGTTGSGKSELLISWCMALAIRHSPQT
LHFVFLDFKGGSTFNALERLPHTVGNVCDLDLAHAVRALNAIEQELARREALVSAERVSR
FDQLSHPPARLVVVIDEFHALRDRLPDYMQRLNRLASLGRSLGMHLIVCTQNPMGQVHAD
MKANISLSICLRVTDQMQSNELIGTKDAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDS
LVHAINTASAFSGTTNPSPLFSAPLAPHAGKDDLTAPQREAWHHVPFALSDDGVLISTAF
LDVGHGNIAVIGACGSGKTNLLLCCASRLYESGRCTIRFTRKTNSEWTTDDGRISPQHER
TIWFVDDADELLSPFAAMPEADKLKTALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGE
RATDVMMGIPSAVLDGFGVDDYAIAGRGVFIQQARACPVQCAEFQGF
>KF629287.1_14218|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNAIVVVDQNWGIGREGNLLVHLPGDLKYYKEKTIGNHIIVGRKTLESFPGGKPLPGREN
IVLTRDPGYAKDGCVICHTVEDVQDAVKDYDPETVFVAGGAEIYQEFFSLCDVFYVTKID
ETFEADRYFPDLDEMGLKAAWESELQEEKGITYRFLKYVRENNR
>KF629269.1_14261|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MEFEEIRPYHDEELPQVFEELIADPAFQQVACAVMPGVPFEAIAQKMRASKTKQEFQENL
CYGILHKLAKDTTDGLILESMAVLNKQSAYTYVSNHRDIILDSGFLSVLLVEQGLDTVEI
AIGDNLLIYPWIKKLVRINKCFTVQRALTMRQMLESSIRMSRYMHYTIAEKKQSIWIAQR
EGRAKDSNDVTQDSVLKMLAMGGDGDIITNLQELNIVPLSISYEYDPCDYLKAQEFQLTA
DGPARTTAPPPAPAPRPTASPSQRRHLIPALAVPAGDGHGPFKHLQLQQLGKQRLAF
>KF629265.1_14271|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSHADQLFLQNCREILSHGVWDTDLPVRPRWEDGTPAHTIKKFGIINRYQLQEEFPILTL
RRTYWKSAVDELLWIWQKKSNNIHDLSSHIWDQWADESGSIGKAYGYQLSVKHHYPEGDM
DQVDRVLYDLKHNPASRRILTSLYNFEDLHDMHLYPCAYSMTFNVSGKVLNAILNQRSQD
MLTANNWNVVQYAILVHMFAQVSGLVPGELVHVIADAHIYDRHIPIVERMLERAPAPAPR
LIIDSSVTDFYAFTPDSFRLDGYTPATFEEKIPIAI
>KF629262.1_14278|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MNTLKRDLKIALLLGGPGSEREVSLVSGNSVYDALCRAGFTDVTKVDVHGPDFRLPEGTE
LAYNIIHGTFGEDGTLQAILEERGVPYTGAGSRSSALCFNKSESKKVFLEAGVPTPHAEI
LDCSHGIVMPSLPLPFVIKPPCEGSSVGVHIVRRQEDVLPAMEEAVTHGTTVLVEEFIQG
KELTVGILDGKALPVIHICPRSGFYDLSNKYPWMNMGGGTDYICPADLPEETAANVQEAA
LKAYKAAGVEVYGRVDVLLREEDGAPFVLEINTIPGMTPSSLLPKAAAASGWPYEDLCEK
IAELSLVTPRK
>KF629256.1_14294|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEARG
NADRFFPDIRNMPAWSLEEQGEEREHGGLKYRFNVYKNHSIKEL
>KF629256.1_14295|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSIADRVFIENCRDIISNGVWDTDRPVRPRWEDGSPAHTVKLFGVVNRYDLSQEFPIMTL
RKTGFRNAIDELLWIWQKKSNNIHDLHSHIWDAWADGSGSIGKAYGYQLGVKHHYPEGDM
DQVDRILYDLKHNPGSRRIISNIYNHADLSEMRLYPCAYSMTFNVSGSRLNAILNQRSQD
MLVANNWNVCQYAVLVYMMAQVSGLEAGMLMHVIADAHIYDRHVPLVEELISREPLDAPR
FIIDKSIDDFYKFTVDSFSLEGYESHGSIGKIPVAV
>KF629254.1_14303|FEATURES|farme|kasugamycin|KsgA|antibiotic target alteration|0
HLRGAEFTTALLNDPLIDIKYDLHNAEVLDHLPEGAFATVSNHPIGSIDGIMLIDIFASR
RPDFKVMVNGVLTKIGAMGDNFVSVKPDSNNQGANLKNINGVRISLQQLKEGHPMGFFPA
GGISMYNKKTKKIQDLPWTHSVIRLIRKAKVPVYPVYFDFLNSRFFYWLGRIDWRIRTLR
IPAEAFNKRGRTVDVYIGEPVSPEEIQNIADDKDLAEFLYQRTYAAKK
>KF629245.1_14322|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNIPAEFNEIRPYTPEELPQIYEELIADPAFRTVVESVMPGVPFEGLAMKMRQCKTNLEF
QKAFFYGLLWDLVKKTANGLTFDCSALSDLTRNYTFISNHRDIILDSAFLSILLIDNGMT
TVEIAIGDNLLIYPWIHKLVRVNKSFIVKRGLNMRQKLEASAFMSRYMHFAMKEKHENLW
IAQRQ
>KF629235.1_14347|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VGIAKDGKWYILKQEDNDLSKDTWLDGAEVVEGVFDLLRSQDVAFPVLHGLYGEDGTIQG
LFELAQLPYVGCRVFASSACMDKIFAKKVFESAGIPQVKSVYVKKRNDGRLVVVEKDMEE
TEEVEASIMKELGMPCFIKASRSGSSVGCYRCDKEEDLMAKLEEAAKYDTHIVVEECVDC
IELETAVLGNDDIIVSRVGQIMPHGEFYTFESKYEDAESKTCIPAKVDEEIQEQIRKYAV
RAFKAIDGHGLSRVDFFLDKKTNHVYLNEINTLPGFTSISMYPQLMEDLGYSYSELLDKL
IEIADEN
>KF629228.1_14364|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKKNGIGYQGKLLVTIPFDQQLFRKETIGKVVVMGRKTLESLPGGRVLEGRTN
IVLTRNKNYKCKGAVICHSVEAVLEEIKKYRSEDVYIIGGESVYQAFMPYADRIHLTRID
YVYEADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYERKQK
>KF629223.1_14374|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALKSAMDEILWIWQKKSNNIHDLHSHIWDSWADESGSIGKAYGYQLGVKHQYKEGMM
DQVDRVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAIL
NQRSQDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRK
PYPAPVVKLNPEVKDFYQFTTDDLIVKNYETWPQIKNIPIAV
>KF629222.1_14377|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
EIVISLKSADGIYSFIDKDKYNLYIAIVKRDEWAVILPSGEHTPIDKNDFSFKENGVTRH
FDFAYITIHGTPGEDGRLQGYFDMIGMPYSSCGMLVSALTFNKYVCNHYLKDFGVKIAAS
IHLFKGETITDEEVVTRLGLPIFVKPNDGGSSFGVTKVKEVSAIQPAIAKAFGEGREVIL
ERFIDGTEVTCGCYKVEGKEVVFPLTEVVTNN
>KF629213.1_14402|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPCGPRTGNRLNAILNQRSQDILAANNWNVVQYSVLLMMFAQVCGLEPGELVHVIADAHI
YDRHIPIIRELIARPQFPAPKFELNPEIKDFYDFTVNDIRVTDYQKNEQIKNIPIAI
>KF629212.1_14404|FEATURES|farme|chloramphenicol|CLD_0021|antibiotic inactivation|1
MKMEESPMHFTLIDPNTWERKEYFDHYFSKVPCTYSMTTRLDITKIRKAGMKLYPTMLYA
LTKTVNRHREFRVALDEKGRLGYYDRLLPCYTVFHPDTETFSNLWTDYAEEYSAFCQAYE
EDRRRFGSRQGMTAKPGMPANCFTVSMIPWTSFDGFHLNLQKGYDYLLPIFTLGKFYEEQ
GKCLLPLAVQVHHAVCDGFHVCRFVNELQDWLNG
>KF629209.1_14413|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|0
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPKRAETLRGG
>KF629205.1_14426|FEATURES|farme|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|0
MKNKSSFTVRQEREAEFPAIYELIRTAFATAEVSDGDEQDFANRLRIHGNYIPELALVAE
CQGKLIGHIMLTRTVVTQDDGTPYEALMIAPLSVVLDYRNQGVGSALLKEGLRLAQSRVT
GQLFFAAIRPTTDVSVSKRSENTVSGKPVCRKN
>KF629200.1_14442|FEATURES|farme|multidrug|ACR_trans|antibiotic efflux|1
LAAQYESWTSPEAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVE
FARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVV
FGMALNTLLATVYIPNFYELMQKLQERFSKKQ
>KF629194.1_14453|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVDGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAEADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTNLITMLIEGVLR
>KF629186.1_14477|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADIQYLGIIKNILDAGSLGDNRTGMPAYKLPHQIMQFDLEKEFPILTTKFVAFKTSV
KEILWIWQKQSNDVRLLQQWNCHVWDEWMREDGTIGKAYGYQLGKYHQVDTLLETLKKDP
QSRRMVVDLWNVKDLPDMALYPCAFLTMWDVSDDGRLNCMLVQRSGDMGLGVPFNMAQYA
ALVHMIAQVSGLRVGLFTHVINNAHVYRNHVDAMKTQLARLPKAYDAPVLKLNPDVHNFY
DFKPEDIVLENYKHHEKIAMEVSV
>KF629171.1_14521|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MIKEFRSMKKNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGKWLLVDS
VKDIEDGSWREGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGL
FELSKIPYVGCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLDEAMDRVEKE
IPYPIFVKPSCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDR
TQVKSTCVGEILAAQEAAFYDFDAKYNNAESKTVVDPDMPEESKQKIREDAEAIFKAVDG
FGLSRVDFFLEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELIDILIDQAMTRYR
>KF629168.1_14530|FEATURES|farme|aminoglycoside|rmtB|antibiotic target alteration|1
MSAKKVFNADDVAASILKSPKYRAIAPDAVNRIAAEECQKGGADCEKRARNRLHQIADAF
MNQKEQSMLWDMLERGDLDAALGQHASTRERMATREEYMSLIARHCPPGGIICDAACGLD
PLMLGAAGYAVRGLDIQMTCVDVINAWARRESWDVKAEGADLLGRAELPKSDLTLFMKLL
PVLDAQRAGEGMRLLSLSSSPRVIVSFPTRTLGGRGVGMERNYGERFESALPVEFEICER
MATGNELFYALRRV
>KF629157.1_14555|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
VFEAFVDGHEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKNGVSQVVIPANLPEEKL
DEVKTYAAMAYTALGCEGLARCDFFVEHGTGRVLINEINTLPGFTPISMYPKLMEHEGTP
IPALIDHLIALALERTEKQHG
>KF629148.1_14577|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
TGKVVVMGRKTLESFPNGLPLKNRTNIVITGNRDYQVKGAVIVHSIEEALKEVEKYPAED
VYCIGGDSIYKQMLPYCDTAHVTKIDFAYEADAYFPNLDEDPDWEITAESEEQTYFDLEY
AFVKYERKDR
>KF629147.1_14581|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
VIGVKPADEYMFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHA
IVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYV
AKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVI
QKLYDTLTGIQMGRIQAPEGWLKVIE
>KF629145.1_14584|FEATURES|farme|quinolone|mfd|antibiotic target protection|0
CHGTRLKPEAGYVRVDGKSISELVDLPITELKEFFDHLNLNEHDSNVARRILIEINSRIR
FLIDVGLGYLTLNRLSNSLSGGESQRINLATSLGSSLVGSLYILDEPSIGLHSRDTDRLI
RVLRQLKVNVDTLTMSATPIPRTLQFSLMGARDMSIMRTPPPNRYPIRTGLVTFSSEVIC
DAINFEMSRNGQVYFVCDRISK
>KF629134.1_14610|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MMKRNIAIVAGGDSSEIVISLKSAEGIFSFLDKDKYNVYIAIVKRDEWAVKLPGGEHTPI
DKNDFSFRENGEIRHFDFAYITIHGTPGEDGRLQGYFDMIGMPYSSCGMFVSALTFNKFA
CNHYLKGFGVDIARSIHLFKGQTVTDEEVVSRLGLPVFVKPNDGGSSFGVTKVKEASAIQ
PAIDKAFSEGREVVIESFIDGTEVTCGCYKTSDKEVVFPLTEGVTNNEFFDFDAKYNGQV
QEITPARISAEQTEKVQRETSRIYDILGAKGLIRVDYIIPADGEPKLLEVNTTPGMTATS
FIPQQVRAAGLEMKDVMTDIIENEFN
>KF629132.1_14620|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGLSPERDVSLSSGALIASALSRRGHAVKIIDVYEGICDLPDDITAVFERGKS
YSSPVGEAEPDLDAVRRRNGNRDALVGPGVLEVCAAADVVFLGLHGAIGENGQLQATLDC
AGIKHYTGTGYAGALLSMDKDLTKQLISRAGVPTADWIYFDTATGKKSDITENVGLPCVV
KPTSCGSSVGVTIVRSADELDAALAAAEKYESKLVVEKMIKGRELTVGVLDGKALPPVEI
IPKAGFYDYKNKYQSGMTTELCPAPLTDDETRKVQELAVRTFRALRMEQYGRVDFIYGED
GVFYCLEANALPGMTPTSLLPQEAAAVGIGYDELCDMLADMAKNK
>KF629131.1_14622|FEATURES|farme|beta_lactam|BACSTE_01456|antibiotic inactivation|1
LQQKHSGQDLDISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSET
EDSMHRNPQKAYANWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLL
PSNTVVGHKTGSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEEDAAIIAH
ISRMVYDEMK
>KF629127.1_14634|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VKILVLAGGLSPEREVSLSTGTMVCNALREKGQDAILVDLFYGVEELPGDIESFFADKTP
LPPYTIESAVPDLSRLREESLSRPYGTIGKNVIELCKAADIVFMALHGEPGENGMVQAML
DMLDIKYTGAGYRGSAVAMDKALTKHILVSRGINTAEGVMLKRGEPLPDVPLPCIVKPCS
GGSSIGVRRVLDRADVLPAVEEAFKYEDDILIESFVNGREITCGVLGDTALPPAEVIPKG
GFYDYAHKYQSGLITEICPAELPAEVTAEVQDISLRVFRALGLEVYARMDFIYDGRDFYC
LEANTLPGMTPTSHLPQEAKAMGISYPELCMRIIELSLEKYNK
>KF629121.1_14645|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MLAQVCDMRVGELVHVIADAHIYDRHIPIIKELIQRPTYDAPTFWLNPDVKDFYEFTRND
VRLDNYVTGPQIQDIPIAI
>KF629112.1_14660|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
SAESVLNHIDESKYNLFPVGITKEGDWILYGGKDYSKLVTGEWRSCPENRRATISPVRGQ
GLLSFEGDCVVRERIDVVFPVLHGENGEDGAMQGLLQMAGIPYVGPHIAASAVAMDKSLT
KLVADQAGVPQAAWQLVRAGELENHMENTLDLLENRFRYPMFVKPAGTGSSVGVSKVGDR
DALRSGLRYAGKYDKKILVEEFINGKEIEVAVMGNDNPMASICGEIDSGAEFYDYDAKYL
TETSKAYIPARIPAEVEEVVRETAVKVYNAVGCQGLSRVDFFVTHDENRVVFNEINTLPG
FTSISMYPKLFEASGIPYSQLIDELLRLAVEAFR
>KF629099.1_14695|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KYEIVLIGITKKGEWFQYVGDISKISDGEWENDTKNKKKAFISPDTSTGGIIVIENDTFS
TIKIDAVIPVLHGKNGEDGTIQGLLQLAKIPFVGCNLLSSATCMDKIDTNIILTYAGIKK
AKFAFVTENDFKSDKEKCINYIEKTLPDYPLFVKPSNAGSSVGVSKVLSRDELIKAVEIA
LCEDRRILIEENISGQEVECAVLGNENPIASIVGEIAPANDFYDYEAKYINDNSKLYIPA
RISDEISNKIREIAIKAYKVMGCSGLSRIDFFVEKDSNEIYLNELNTFPGFTSISMYPKL
FENTGIPYSELIDRLINLAFER
>KF629093.1_14709|FEATURES|farme|glycopeptide|VanA|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPFPAEYDVE
KAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKVQATFDLMG
IKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKTC
CGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKALSDHRNCSA
SGIL
>KF629088.1_14728|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>KF629065.1_14786|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNIIVAVDKNWAIGKDNHLLVSIPKDQKLFRDETLGKVVIMGRKTLESLPGGQPLYGRKT
IVLTRDPEFQAKGVTICHNVEEVLDAVKDTDPDDVFVAGGQQVYEALLPYCTVAHVTYID
YAYEADTHFVDLDQDPQWVMDVESDEETYFDLCYTFRRYVKKEQV
>KF629062.1_14791|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VGITKDGQWKLVDRLDHLEDGSWVNSKTSAYICPDTGRKELLLERDGKVDRISIDVVFPV
LHGMNGEDGTVQGLLELAAIPYVGCGVLASACSMDKFYTKIVVDSIGVRQAKFVGVRRHE
LTHMDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELIDALNLAAKHDSKILVEET
IVGREIECGVLGMNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIRK
DAVAIFKALDCSGLSRVDFFLTKDTNEVVFNEINTLPGF
>KF629059.1_14799|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSQADKLFVAMCQEILDHGYSSQGQTVRAKWEDGTPAHTIKQFGIVNRYDLQEEFPALTL
RPTAIKSAVDEMLWIWQKKSNNIKDLSSHIWDEWADENGSIGKAYGYQLGVKYKFPHGEM
DQVDNVLWQLKHTPYSRRIMTNIYKFDDLMEMGLEPCAYSMTFNVTGDRLNAILNQRSQD
ILTANNWNVVQYAVLVHMMAQVSGLKPGQLVHVIADAHIYDRHVDIVREMIQRPQYPAPK
FSLNPEITDFYDFTTDDILIEDYEKNPQIRNIPVAI
>KF629055.1_14811|FEATURES|farme|tetracycline|tet40|antibiotic efflux|0
MAYCILLSFSSVYLLDQGFSNTQIGLLLGLSGLLTALLQPFVGARADHLKVLSLGQFAAL
LILAMLLCTGGLLLLPGQTVQGGLFLSLLILLQLLTSLLYALGMDCVNQGMPLNFGLARG
VGAGSYALASTLCGSAAAAFGPKCIPVLLGGATLLLLAAALSFRPGTPAKQAAPPPASPP
SSPQSFWRRYPRFLPLLAGVVLLYTSHNILMSFPYQIVQYLGGGSGEMGTLLTLQSLMDI
PAMVLFSLLLRRAASWRWVRLAGLSFFLHALLTWLAPSVFFLYGIQIFETTGYALYAVAS
VYWVNDMTAPADRVQGQTYFTMANTLGIVLSSFLGGFLLDAAGTGPTLAFSTVTGGTGMG
ILWIMLR
>KF629048.1_14831|FEATURES|farme|multidrug|RND_transporter|antibiotic efflux|1
LEVLYLSNYAKLNLVDQLTRVPGVGAVNVMGAGDYSMRIWLDPAAMRIRYLSPADVYQAI
QSQNVEVSAGNVGQPIGTDNKNAYQYSLTVKGRLTSPEEFGNIILRTETGGKILRLRDVA
HIDLGSASYSVVSQLDGKPTAAIAIYQQPGSNSLDVSKGVKAKMQELSQNFPAGIQYNVT
LDTTDVIHASIDEVMVTFLETTLLVVLVIFLFLQNWRAVVIPCITIPVSLIGTLAVMSLF
GFSINTLTLFGLILAVAIVVDDAIVVVENSTRLLDTGRYTSRQAVTEAMGEITGPIVGVV
LVLLAVFIPTTLVSGI
>KF629045.1_14837|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLGGGISTERSVSLVTATSVCRALRDAGHKAIFVDMFLGLENYTGRLEDAFDAPDG
FCGSVSISETAPDLEAVKASRKLKSPSHLGVGVLDICALADCVFLGLHGIDGEDGKIQAA
LELLGVPYTGSGPLGSAMAMDKAVAKRIMESAGILTPKWREITYTADDVPALVQELPVPC
VVKAVDGGSSIGVSLPDTREQLEQALYDVLRYGRRIVVEEKIVGREFTQPVLGDDYLSTI
QIVPPEGSTFDYAAKYQSGAAAARELCPAPCTEEEHRLLGETALKLHHALGLSVYSRADF
ILDAEGRPWCLEVNTLPGMTPNSLIPKAAKEAGMTYQELCEKIVSLSLAK
>KF629044.1_14840|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MRIVVLAGGLSTEREVSISSGTLVAEALRSKGHEVVLLDVFMGYEENICDIDALFKQNYS
FTDGNSIGDDVENTITNIKEAKENRLDKTSRYIGRNVIEICAEADITFLALHGGEGENGQ
LQATLDLFGIKYTGSGYLGSALAMNKGLTKSVFMQKNINTPSGELYKNEKDALAWNMFPC
IVKPCSGGSSVGVSKVENADQYKKAVKEALKYEDEIVVEQFVTGREFSVGLIGGKALPPI
EIAPKSGMYDYAAKYQAGATVETCPADIDEETDKKLRDAATEAYEALHLESYARIDFLLD
KGGFTYCLEANTLPGMTPTSLLPQEAAVEGISYPDLCEKIIEISLAKYPEEKSDF
>KF629040.1_14848|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GNFVNNLDRARYEVLTVGITREGRWLCTEATSAQMADGSWEELPGNMPCVISPDRADHGM
ILFTPSGQVEKLHVDVVIPALHGLWGEDGTVQGLLELAGIAYVGCGVLASAVCMDKAVAN
ALFEANGVPHTKWVAANRWEIEKDLEGVCAGVEQKLGWPVFVKPANAGSSVGISKVSSQE
ELKAAIALALENDRKVVFEAFVDGQEVECAVIGSDPAVATRPGEILAGAEFYTYDDKYKN
GVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEGLARCDFFVEKNTGRVLINEINTFPGF
TAISMYPKLMEHEGLPVPQLIDRLIALAVERTEKQHG
>KF629037.1_14857|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKLAVLFGGISSEHDISCLSAASILRNLNKDKYEIYPVGITRDGEWFYCPDCDSDRVESG
AWERMTGKVKVVLAPDRGMHGMVLLREGEIEIVRLDCVFPVLHGENGEDGSIQGLLQLAG
LPYVGCGVAASANTMDKALTKKVVEGTGVRQARYYLALRYDFERNAEAVVAAAAETLGAF
PVFVKPCSQGSSVGVAKANNLLELAEGLTEAFKLDTKVLVEEFIDGHEVECAVLGNLEPQ
ASTVGEIAPTQEFYTFDAKYKDESSRLYIPAHITEEQIATVRQDAVRVYTALGCRGLSRV
DFFVTYEGQEIVFNEINTLPGFTSISMYPKLFEASGIPYSQLIDELLRLAVEAFR
>KF629034.1_14864|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MMNKNDVVAVIMGGPSAEREISLVTGAAIAGALREKGYNVAEIDLEPKKLALQLEECSAK
VVFNAVHGMYGEDGRLQTLLEMLEIPYTGSGMLASALSMDKAASKRIMQAAGIATPKSLI
FVKGETHDFCGEILSAFKKMPVVVKPATQGSSIGVEIVKNDTDINSAMEKAFTYSREVVV
EEFIQGKELTVAIMQDGGMAVALPVINIVPHSGVYDFHSKYTKGETEYLVPAPLDKETTR
HVQELAVATYKVLGCSGVARVDVMLDEAGKGYVLEANTVPGMTATSLVPKAAAAVGISFP
DLCEKILLSASLNDK
>KF629030.1_14877|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
VQKKEEMNMNAIVAADKNWAIGYKNKLLVSIPADMKFFRQMTGGKVVVMGRKTLESFPNG
LPLKNRTNIVLTGNPNYHVKDAVIVHTTEELLEELKKYDEEEIFVIGGESIY
>KF629022.1_14896|FEATURES|farme|chloramphenicol|cat18|antibiotic inactivation|1
MTVNVDITALGAYKLYPAMIWLLTRTVNEIPEFRMALVDGVLGVYDDMHPAYTVFNKESK
TFSGIWTEFDPNYSAFLAAYERDSALYSAAVSYAPKPNTPPNSFNVSMMPWATFTAVNLN
LYNGGTALLPIFTMGKAFFADGRRLLPLAIQAHHAVCDGYHIGRFLAALQGNIDGFEG
>KF629018.1_14906|FEATURES|farme|fosfomycin|fosB|antibiotic inactivation|0
MKVRYTTMIADNMKDSVDFYEKVMGFKVQEVYNLPNGSEITILDGGGAMIELIESSDFET
GLYSMGVEVENLEKTLEDMRAKGVEITMEPVRTLVGRMAFIKDPNEVNIALIEHDR
>KF629015.1_14918|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKQQANKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSG
STEGMRSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTI
QGLLELAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSALLTR
VENRLPYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAA
IGNPDDPAGSAHHPPRRDFDRRRVLYL
>KF629015.1_14919|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
LTGAEFYTYDDKYKNGISKTVIPARLPDQKLDEVKTLAARAYLALGCAGLARCDFFVEHG
TGRVLCNELNTLPGFTSISMYPKLMEHEGLSYAQLVDRLLQLALHRRKGAY
>KF629002.1_14959|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDRLLEKYIAGEPISREKLAREEQRRVQAASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRYEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
LERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRYMFQKIM
>KF628997.1_14977|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
VVFQNPATALNPRMVVREQLLDPMRVHNLGTEAEQEKRVKELLELTGLPSSAAEVLPGQL
SGGQRQRVAIARALSLNPDAIIADEPTSALDVSVRAQILNLLTDLKKELGLAMVFISHDI
QTVRYISDDIIVMNGGKIVEQGEAKQVFQHPRDPYTKMLLGAAPSLLHPKLGE
>KF628982.1_15017|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGVCKALRQKGHQAILVDVFAGLESVKLEAAFEGDYDVE
AAAEYIKSFNERIQELEKQRRDFFGPNVVALCKAADIVFLALHGENGENGKVQAAFDLMK
IKYTGTGHTGSAMAMDKGITKALFQMYQVPTPKGVTMTVKNRRNDLSVHGMDFPVVVKTC
CGGSSIGVYIVQDQEAYVKALDEAFSYEEEV
>KF628979.1_15023|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRRSFFGPNVLELCQAADIVFMGLHGS
NGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTKKIFLMDQVPTPKGVSMLKENCTRN
IHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAIDGAYSYEDEVVVEEYIRGREFSVA
VVDGKAYPIIEIAPKQGFYDYKNKYQAGSTVETCPAEISPELTEKMQHYAEAGAKALRIE
GYARFDFMMKENGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF628977.1_15028|FEATURES|farme|chloramphenicol|cat21|antibiotic inactivation|1
MPFHLIDLKTWKRREFYHHFLKEVVCTYSVTANLDITNLSNCRLYPAIIWLLTKTVNQMP
EFRTALTKEGVGIYDEMHPAYTIFNKENENFSCIWTEFSSDYSLFLSSYEADTEKYSKSE
IFAPKPCRPANSFDISMIPWVKFTSFNINVFDEGKYLLPIFTLGKFFKEKGKRMIPLSIQ
VHHAVCDGYHVGKFIDALQESINKFGK
>KF628975.1_15034|FEATURES|farme|tetracycline|tet32|antibiotic target protection|1
TLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFCWNDYKINIVDTPG
HMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDL
RRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDI
QELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVE
YTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILA
DDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHF
DIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASYTIHIEVP
PNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDC
QICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYND
APKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEP
VFQPRRPNSRLDKIRHMFQKIM
>KF628966.1_15054|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKVLLLAGGWSPEREVSLKGGEQIAAALKERGHSVTLCDPAKDFERLMDMAREHDAAFIN
LHGAPGEDGLVQAILDRVNCPYQGAGPAGSFLALHKAAARQIFRDAGLNIPDGVFLPRHP
GPNWKPDLQYPMFVKSNTGGSSLHLSRVTNEEELYTALNSLFSMGEEAIVETAVVGREVT
CGVLGEEALAPILVVSKGNYFDYHNKYAPDGAQEICPAPIAPEETAKVQDAALRAHHALG
LKGYSRADFILQDDGTLYILEVNTTPGMTSTSLVPREAAVKGMSFADLVERLLELALER
>KF628955.1_15087|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MVAQDTGLKAGDFVHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFKFED
FELVNYDPHPHIAGAVAV
>KF628940.1_15117|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|0
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPCDSDKLEEVFDRPDG
GLEISKGISTSVPDLDALRKSRPDQSPSEIGPNVIELCQMADITFMA
>KF628931.1_15138|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLTSGAGICKTLLENGHQAYLLDLYFGLGNAPANLEDVFTLPGA
GLEIAKNISTKEPDLEVLKKSRPDQSDCMFGPNVIELCRMADITFVALHGSVGENGKLQA
AFDLLGIKYTGCNSFGCALSMNKLVTKQIYKMSGVPTPRGTHLTKETKDLPLSELGYYLP
LVVKPCENGSSIGVYICHTEEEYNNAVRESFEKNPDEELVIEPYIKGREFASAVIAGKAL
PLVEIIPKDGVFNYENKYQAGGAQEICPPVSIDEETQQRMMRAGEEAFAALRMDVYARAD
FIIDDEDGEFYSLEMNALPGMTAASLLPKAAKAAGIEYNELCERIIEESMNARYR
>KF628929.1_15144|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAIVAGGDTSEFHVSLRSAQGIYSFIDKEKYTLYIVEMHGLDWHVQLPDGAKTPVD
RNDFSFVLDGEKVTFDFAYITIHGTPGEDGRLQGYFDMLHIPYSCCGVLAASLTYDKFAC
NQYLKGFGVRIADSLLLRQGQSVSDEDVIGKIGLPCFIKPSLGGSSFGVTKVNVKEQIQP
AIAKAFAEAKEVLVEAFMDGMEITCGCYKTKEKSVVFPITEVVSHNEYFDYKAKYNGESD
EITPARIPDELRDRVQKLTSAIYDILGASGIIRVDYIITEGEKINLLEVNTTPGMTATSF
IPQQVRAANLDIKDVMTDIIENQF
>KF628921.1_15172|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
PCVVKPCCGGSSIGVTIVRDAAEFKKALDEAFHWEDELVIEEYVKGREFSVGVIEGKALP
VIEIAPIQGFYDYKNKYKAGSAVETCPADLPEEVSAQMRKYAEQVAEVIGLDTYSRSDFL
LDENNHMYCLEANTLPGMTPTSLLPQEAAVIGINFNELCEKLIAISMKKYEG
>KF628900.1_15213|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
IGMFVINLYRLGVFDRKIAFFKRRLSGRRTDQRYSNCDIRRRKQMNLIVNADKNWGIGKN
NELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTNIVLTHDKDYDAKGAIV
VGSKEELIDELEEYKDEDIFIIGGESIYRMMLPYCDKAYVTRTDFAYDADTYFPNLDEMP
EWKIVKESEEETYFDIEYQFVVYGK
>KF628889.1_15245|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVS
>KF628888.1_15247|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MKIAVLCGGLSPERNVSISSGTKIAGALQESGHQVVLLDMFFGLEDYTGDIAHVFDDPPA
LGGTRIDESAPDLEAVRAQRKLQSPSLFGEHVLEVCAMADIVFLALHGRTGEDGRVQATL
DLLGIPYTGSGYLGSAIAMDKDLTKRVVAPLGVKTPAWMLVESDGMDIDAVCAQAKLPCV
VKPDDSGSSIGVSIANDEAELRAALKAAANEGSRILIEQYIRGREVQIGILGDKALPSIE
IIPAEGFYDYRNKYQPGAAREITPAEIPAETEQRLADAALTVFHALNLSAYSRADFILDA
EGELWFLEINTLPGMTPTSLVPQEAAAVGISYSELCEQIIADALHK
>KF628846.1_15351|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYASVELLDTAADDFMVTMAT
GGFDVAFIAMHGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPVA
PGLALETGDEVDIDHIVEVCGERCFVKPAVNGSSYGISLVHEPSELPAAIKKAFEYGDKV
LVEKCIEGTELTVGVYGEDDVRALPIVEIRKPEDCEFYDLDVKYVDPTDIHRIPAQISPE
NYARAQELACAAHKALGCLGISRSDFIVSEDGPVILETNTIPGMTDTSLYPDEIRHTDDM
TFPQVCDSLIRMGLRRAGVAC
>KF628843.1_15359|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKQQANKIRVALLFGSCSSEHEVSCVSAAAWADALATMPDRYEVILVGITKQGRWLKYSG
STEGMRSGSWEQDASCVPCVLSPDRSDHGLLVHSANGYELLPVDVVAPILHGKNGEDGTI
QGLLELAAIPYVGCGVLASAACMDKAVANTIMDAYHVPHCHWCSAVRAEAETQRSALLTR
VENRLPYPIFVKPANAGSSVGITKAHNREELNTAIDTALREDDKVVFEEFIDGQEVECAA
IGNPDNPQEVRTTRPGEILAGAEFYTYDDKYKNGISKTVIPAHLPDQKLDEVKTLAARAY
LALGCAGLARCDFFVEHGTGRVLCNELNTLPGFTSIS
>KF628839.1_15368|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
VGITKDGQWKLIDTIAHLEDGSWVNSKTSAYICPDTGSKELLLERGGKTERISIDVVFPV
LHGMNGEDGTVQGLLELAAIPYVGCGVLASACSMDKFYTKVIVDAIGVRQAKFVGVRRHE
LSNMDEVVARVEAGVPYPVFVKPSKAGSSQGVSKAENREELVTALHLAAKHDSKILVEET
IVGREIECGVLGMNWNE
>KF628839.1_15369|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNEPKASGVGEVLSAEEFYSYDAKYNNEESRTVVDPELPEGKAEEIRKDAVAIFKALDCS
GLSRVDFFLTKDTNEVVFNEINTLPGFTAISMYPMLWEARGLNKKALVQKLIDLAMNRYD
V
>KF628837.1_15374|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIAVLCGGRSSERDVSLSTGIQVARALRETGHDVVLVDACVDFPLDCRPEEVFEKALPI
ENHAIGAAAPCVKSFFDRASGFFGKNVLEICKSADIVFNALHGDEGENGKLQAVFDLLNI
CYTGSGAQGCMLAMNKSLSKQLFRTHGIPTPEAVILSESDKCRAAELCEKLGLPCVVKPA
SLGSSVGVSIVRTNDEFFAALDSAFSLEHTVIVEKYIKGREFAVGIVGSRVLPAIEIIPK
HGFYDYKNKYQPGCTVEICPADIDSDTAERMAEATRKVFRVLGLGAYARADFMVDENGIY
CLEANTLPGMTPVSLLPQEAAAGKLDFPALLEAIIKESLLLRATERRH
>KF628830.1_15388|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
ENAIHLAFENDSEVIAEEAIDGFEVGCAVLGVEKLMVGRVDEIELSGGFFDYTEKYTLKT
SKIHMPARIDAATELRIQEAAKTIFKALDCSGFARVDMFLTPAGEIVFNEVNTIPGFTSH
SRYPNMMKGIGLSFSDMLDKLLGLYTKECAKSL
>KF628827.1_15400|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MDNLKAIVAVCDDWGIGANGDMVVSNRADMRHFVSCTKGHTVIMGRKTLESFPGARPLKN
RRNIVLTRDPLFLCRGAEVVHTIEEALAALEPSELAWVVGGGKVYEQLLPYCCEAEVTRN
HCLRNSDTYFPNLDEDPAWVVVSRSKMQQAAEGEGDAGVFYEFTTYRRRDERAGE
>KF628819.1_15421|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEK
>KF628819.1_15422|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFQFEDFELVNYDPHPHIAGKVAV
>KF628815.1_15433|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MTKERDKMNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQ
PLKNRTNIVLTRDENYKVKDAVIVHSVDALMEELKQYDSEEVYVIGGDSVYSALLDYCDT
AYVTKIDFAYEADTWFPNLDERKDWSAAEASEEQTYFDLEYQFVKYKKNGK
>KF628813.1_15439|FEATURES|farme|multidrug|cmeB|antibiotic efflux|1
AAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYI
PNFYELMQKLQERFSKKQ
>KF628807.1_15451|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNLIVNADKNWGIGRENQLLVHIPNDMKMFRQTTTGKVVVMGRKTLESFPNGMPLPKRTN
IVMTTDQDYDGRGAIVVHSEEELFEELKKYADEDIFIIGGESIYRMMLPYCDTAYVTRLD
YAYDADTYFPDLDARKEWEIVKESEEQTYFDLEYVFLKYQRRNDD
>KF628806.1_15453|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VAVIFGGQSSEHIVSCMSAVNVIEHIDSARYNIILVGITQEGHWIKADSLEDVKSGAWRD
GKVGAALLPDATRKCILLMDGDKVEEVRVDIVFPVLHGLYGEDGTIQGLLELARIPYVGC
GVLASAVSMDKLYTKIIVSDLGIRQAGYEPVYREELEDMEQVVDRIEKHFPYPVFIKPSN
AGSSRGISKAGNRQELEAGLLEAARHDRKLLVEETIVGREIECSVFGGGRRGIEASGVGE
ILAAAEFYDFDAKYFNEESRTVTDPELPDGATEKVRQAAMDIFRAVDGYGLARVDFFVKD
DGEVVFNEINTMPGFTAISMYPMLWEARG
>KF628789.1_15496|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKEGDLFMKIIVLAGGLSTERDVSLSSSAGICRTLLEKGHDAFLLDVFLGFPYDADRLEE
VFTLPGHGLEIAKNISTSEPDIDAVKASRPDQSDCFLGPNVIELCRMADITFLGLHGGEG
ENGKLQATFDLLGIKYTGPDSLGCAVAMDKGFTKQVFLQTGIDTPAGVSLHKKEKEKSLE
ALGLTLPVVVKPCSGGSSIGVYIVNSKEEYESALNKSFKYEDEVVIEDYIRGREFACGII
DGKALPPIEIIPKTGFFDYANKYQDGATDEVCPANTSREISDRMMELTVKAYHALKLNVY
SRADFLLDDAGGLYCLEMNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQK
>KF628787.1_15502|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MLALIVAVAHNRVIGKDNTLIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHW
VITRDKGFDAPEGVKIFHNPEAAAEAARALDAAYVIGGAQVYEAFLPYVDTMYITEVDHE
FDGDAFFPEFSEEAFTIESVVDGIVDEKNQYPHRFVTYRRKAAK
>KF628781.1_15518|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
LEVALDYNTGKQILKLLQDTCRQRGVSVVVITHNLALTAMGDKVIKVRNGKIDSITINEH
PLPVERIEY
>KF628780.1_15521|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNTVSKQLIAIWAEAHNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKEVSRDRVVKDDKNAYDFSISRYEKEG
D
>KF628776.1_15531|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNIIVAVDKNWGIGKDNRLLVSIPADMKFFRTTTTGKVVVMGRKTLESFPGGQPLKNRTN
IVLTRDVNYKVKDAVIVHSVEELLEELKKYDSEEVYVIGGDSVYSAMLDHCDTAYVTKID
FAYEADTWFPNLDEREDWSPAEASEEQTYFDLEYQFVKYKKNCV
>KF628763.1_15556|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GVCKALRKKGHNAILVDIFCGLEPVDWDEPFGDKDYEVDSAAEYMRSFDDDIEEIKRTRR
SFFGPNVLELCQAADIVFMGLHGSNGEDGKVQATFDLLGIRYTGTGYLSSALAMDKGLTK
KIFLMDQVPTPKGVSMLKENCTRNIHDLGMEFPVVVKTCCGGSSVGVYIVNNQKEYEDAI
>KF628761.1_15562|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLDRVLTEGIEKGDRTGTGTISVFGHQMRFNLDEGFPCLTTKKLHLKSIIYELL
WFLKGDTNVKYLQDHGVRIWNEWADETGDLGHIYGYQWRSWPTYNGGFIDQISEAVDAIK
HNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFQFEDFELVNYDPHPHIAGKVAV
>KF628759.1_15570|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MNIVVLAGGISTEREISIVSGTKVCEALREKGHRAILLDVFFGNTGLQADCAFTEAYDVN
AAAAYMRSFDSKLEEAVKTQKEFFGPMVLELCKAADVVFLALHGENGENGKVQAAFDLLG
ITYTGSGYLGSALAMDKGISKQLFLENGVPTPKSVMLKKAEGMKQPETIGICLPCVVKTC
CGGSSVGVYIANTREEYEQAVKNAFHYEDEIIIETYVKGREFSIGVVDGEAYPIIEIAPI
QGFYDYKNKYEAGSTIETCPAELAADLTKKMQDYAVMAYHVLRLENYARVDFLMDESNNM
YCLEANTLPGMTPTSLLPQEAGALGMSFADLCEKLIEVSLKK
>KF628748.1_15600|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
LIEKWLSGPEFTVAILGEEILPSIRIQPSGTFYDYEAKYLSDETQYFCPAGLEASQEANL
QALVLKAWTTLGCKGWGRIDVMLDSDGQFYLLEANTSPGMTSHSLVPMAARQAGMSFSQL
VVRILELAD
>KF628738.1_15639|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKEGDLFMKIIVLAGGLSTERDVSLSSSAGICRTLLEKGHDAFLLDVFLGFPYDADRLEE
VFTLPGHGLEIAKNISTSEPDIDAVKASRPDQSDCFLGPNVIELCRMADITFLGLHGGEG
ENGKLQATFDLLGIKYTGPDSLGCAVAMDKGFTKQVFLQTGIDTPAGVSLHKKEKEKSLE
ALGLTLPVVVKPCSGGSSIGVYIVNSKEEYESALNKSFKYEDEVVIEDYIRGREFACGII
DGKALPPIEIIPKTGFFDYANKYQDGATDEECPANISREISDRMMELTVKAYHALKLNVY
SRADFLLDDAGGLYCLEMNTLPGMTAASLLPKEAKAVGIEYGDLCELIIQKSLEARYQK
>KF628731.1_15656|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VITKESRIVVLMGGPSREAEVSRNTGKAILEALTSIGYEAISMEYDPHHVVEQLKEAKAD
AVFIALHGKYGEDGTIQSVLELARIPYTGSGVTSSAITMDKIMSSHFFKQAGLPMAFSKP
YYLKDGKENIEEDIRKSFTLPVVLKPACEGSTIGIEIVKEEKDLKEAIDRVFSVEPRILA
EA
>KF628727.1_15662|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GISSEREISLKSGMSIVENIDKEKYDVESIIIDKKEDIINKVKGIDFALLALHGKFGEDG
TVQSVLQTLGIAYSGCGPLSSAMCMDKDVTKSMLKSAGIRTAPWINLRENDNVDYDEINK
LGYPVVVKPTHGGSSVATFIVKEEKQIEECVAEAFKWDNEVMIEKFIKGDEITCPVFADK
MMPVIAIKPKKGEFFDFTSKYEDGGSEEIVVELEKSLHEEVEKMALETYKALKCEVYSRV
DMIVTSEGTPYILEVNTLPGMTKNSLIPKSAAALNIGF
>KF628719.1_15679|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTKKIVAIWAQDEEGVIGKDNRLPWHLPAELQHFKETTLNHAILMGRVTFDGMGRRLLPK
RETLILTRNPEEKIDGVTTFYDVQSVLDWYQAQDKNLYILGGKQIFQAFESYLDEVIVTH
IHARVEGDTYFP
>KF628703.1_15713|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
IERPQFAAPKVTLNPDVHDFYAFTTDDLIVEGYEHGPQVKNIPIAV
>KF628699.1_15725|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TIKKFGIVNRYDLSKEFPALTLRRTGIKSCVDEMLWIWQKKSNNIHDLNSHIWDSWADED
GSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCA
YSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVH
VIADAHIYDRHIPMIEELIKREPLPAPKFWLN
>KF628696.1_15731|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSRADELFIENCKEILAHGVWDTEQEVRPRWADGAPAHTVKKFGIVNRYDLRAEFPVQTI
RKMAFKSAVDELLWIWQKKSNNIHDLSSHIWDAWADESGSIGKAYGYQLGVKHRYPEGEF
DQVDRVLYDLKHNPASRRILTSLYNHHDLSEMALYPCAWSVTFNVSGRTLNAVLNQRSQD
MLTANGWNVMQYAVLVHFLARASGLEAGELVHVIADAHIYDRHVPVVEELIARTPYEAPR
LWLDPAVTDFYAFTKDSVRLEGYRFHPLEQPIPVAV
>KF628682.1_15785|FEATURES|farme|tetracycline|tetB(P)|antibiotic target protection|1
MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSS
TISFNWNNVKVNIVDTPGHVDFISEVERSLSVLDGAILVISGVEGIQSQTRILFETLKEL
NIPTIIFVNRLDRIGANFNKVFEDIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCMIND
DAIDVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYASEGSLYPVFCGAAAIGLGVEDLLD
GICSYFPFAGDDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKV
KKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISA
IDKEKNPELFKALTLLAEEDPLLELEMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVE
FSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKS
FQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQ
TVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMK
IASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD
>KF628679.1_15792|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
EDGRIVTFRPDLNGERMENSARRLEMPVFSKERFIQAVKETVKANAAYVPPYGSGATLYI
RPYMFGSNPVIGVKPADEYQFRVFTTPVGPYFKGGVKPLTIRVSDFDRAAPNGTGHIKAG
LNYAMSLHAIVDAHNQGFDENMYLDPGTRTKVEETGGANFLFVTKDNTVVTPKSSSILPS
ITRRSLIYVAEHYLGLKVEEREVLLDEVKDFAECGLCGTAAVISPVGKIVDHGREILLPA
GMEQMGPVTQKLYDTLTGIQMGRLEAPEGWIQVIE
>KF628659.1_15842|FEATURES|farme|multidrug|MuxC|antibiotic target alteration|0
GGPVGAVISAAWSLRHTLFKVLIRFICVVVFLILFLILTIPVFFIEWLIGKFNRNARDYS
CLRIVQWGFKAILKVTGVHTTVIGFENIPDEPVLFIGNHRSFFDILLTYSRCPRLTGYVA
KKEMEKIPLLSTWMRFVYCLFLDRENPKEGLKTILQAIDYVKQGISICIFPEGTRNKGEE
LSMLPFKEGAFKIAAKTGRAIVPISMNNTAAIFENQFPRIKKVNVVVEYGTQIYPKDLAP
EDKKHIGAYVQNIIQETINKNAELI
>KF628657.1_15853|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSLADTQYLGIVGNILDHGIYGQNRTGIATYKLPQQIMQFNLQEEFPILTTKFVAFKTAV
KELLWIWQMQSNDVRKLQEMNVHVWDEWMREDGTIGKAYGYQIAKYKQLDKLIKTIKEDP
DSRRMIVTLWNIEDLDDMALQPCAYETLWDVGDGYLNCMLIQRSGDMGLGVPFNTAQYAA
LQCMIAQVTGLKPGKFTHVINNAHIYENHVEALREQLARRNQALPAPKIIVNPEVKDFYD
FTPEDITLDGYEHLGKLSMTVAV
>KF628646.1_15884|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKVGVIMGGISSEREISLKSGNSIVEKIDKTKYEVIPVVIDNKEDIITKVKGLDFALLAL
HGKFGEDGTVQSVLQTLDIPYSGCGPISSGVCMDKDFTKRVLKANDIRTARWINVSSVDE
IDYDKIEEMGYPVFVKPTNGGSSVATFKVKEKSEIRAAVEEGLKWDCEVMIEEFVEGEEI
TCPVFDGEMWPVIAIKPHSDFFDYTQKYAADGADEIVVQLEENLHKEVEKMALDTYKALK
CQVYARVDMIVDKNGIPYILEVNTLPGMTPASLFPKSAAAINISYSGLLDKIIETSMKVK
RSH
>KF628618.1_15960|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSSDYLVAGHVNKMQYVALLMMVARHVGLKPGVFMHVVDNLHIYDRHIEQAKELLSRTPS
EKQPKLILKEGKTNFYDFTLDDFELIDYEPVKPQLKFDLGI
>KF628598.1_16008|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNIIVNVSKNWAIGKNGGLLFHISADMRFFKKHTTGNVIVMGRKTLDSLPGGRALPDRTN
IVLTRS
>KF628596.1_16013|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LDEEKYNVILVGITKDGRWLLVDKLKEIEDGSWRESRVNAIISPDTEDKALVLLAEGTYR
LQPVDVIFPVLHGLNGEDGTIQGLFEMAQIPYVGCGVLASAVSMDKVYTKIIVEDLGIRQ
AQFVHIRRSDLTQMEDALDRAEAKLSYPMFVKPSRAGSSVGVSKAEDREALSKALSKAAE
HDRNILVEETIVGREVECAVLGGKEIKASGVGEILAAADFYDYDAKYNNQESKTLIDPPM
PEETREEIRKSAAEIFKAVDGYGLSRVDFFIAENGEVVFNEINTLPGFTSISMYPMLWAA
QGIKTPALADELIRLAEERFE
>KF628587.1_16043|FEATURES|farme|pleuromutilin|TaeA|antibiotic efflux|1
MKDFRVDHLKKSYGAKSLLEDVSFIINEGEHVGLIGQNGTGKSTLLSILAGVDFAESGDI
TTSNDYRIGYLSQQPELDDEDTIFEALYKGDHPTLKVVHDFEEVVEQLRENPTSESLTKR
YSVLEQKMNEIDGWQVEVQIKTILQKMGLTDIQKKVGTLSGGQKKRVGLAKVLMEEPDLL
LLDEPTNHLDLEAIEWLEGYLANYKGAMMLVTHDRYFLERAVTHMFELVNGRIEAYEGNY
ESYLEQRSQREQIAARMSQKQKRLYLSELEWMRQGAQARSTKQQARIHRFEALEKEVKQT
TSQDKLVMEFDQARIGKRVFQLEDASLSINGQQIVKNLDWIIQSQARIGIAGVNGVGKST
FLNAIAGQIPFDSGQFVIGETVRIAYYKQQDEDIPMDKQLIQYLREEAEEIRRENGEVAS
ISELLETFLFPRHLHGAYIHTLSGGERRRLYLLRLLMTKPNVLLLDEPTNDLDIDTLTVL
EDFLESFNGAVLIVSHDRYFLDKTVDQLFVIRGEGETELFYGSMSEYLEQEKTLAKVVVE
APKVEEPKVETPKVAPSKKMTYQEKKEWETIEGTIQELEERLEFLQEEMSVHAQDFAKLQ
ELQEELDKTEEAASAAYERWEYLAELAGN
>KF628586.1_16047|FEATURES|farme|beta_lactam|LRA-12|antibiotic inactivation|0
VKDWFTVEKIDEDTYAISEYQHWEETHCYLLCGTKRALLIDTGLGVANIKEVVDKLTMLP
IFVVTTHVHWDHIGG
>KF628568.1_16080|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DHGMILFTPDGRVEKMHLDVVIPVLHGLWGEDGTVQGLLELAGIAYVGCGVLASSVCMDK
AVANALFEANGVPHTKWVAANRWEIEKDLEGVCAGVEQKLGWPVFVKPANAGSSVGISKV
SSQEELKAAIALALENDRKVVFEAFVDGQEVECAVIGSDPAVATRPGEILAGAEFYTYDD
KYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCEGLARCDFFVEKNTGRVLINEINT
FPGFTAISMYPKLMEHEGLPVPQLIDRLIALAVERTEKQHG
>KF628567.1_16081|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
DAALIPPAFPGAAYCHDGQRTVPFRCSAVHDIDSLVHAINTASAFSGTTNPSPLFSAPLA
PHAGKDDLTAPQREAWHHVPFALSDDGVLISTAFLDVGHGNIAVIGACGSGKTNLLLCCA
SRLYESGRCTIRFTRKTNSEWTTDDGRTSPQHERTIWFVDDADELLSPFAAMPEADKLKT
ALADPSVTVIAAVEKPQSTLLERCLTRVAFPCGERATDVMMGIPSAVLDGFGVDDYAIAG
RGVFIQQARACPVQCAEFQGF
>KF628551.1_16121|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
LPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSIRLDSIVSIKASQMPPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>KF628545.1_16137|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKRLNIALMAGGDSSEREIALQSAAQIASALDPAKYDITLIDLHGRDWHYTSPDGRQWQV
DKNDFSITIDGDHKTFDYALILIHGTPGENGRLQGYLDMMGIPYSSCSMTSSVVTFDKIT
TKRTVAEFGIPLARGFFFGRDSRIDPQEIVRTLGLPVFVKPNSSGSSFGVTKVKSEADIL
PAVAEAFTESDEILIEECIRGREMGCGMLIAKGREYIFPITEIVSKKEFFDYEAKYTAGC
SDEITPADIAPEIKAELNRLTALAYKACRCRGVVRVDFIVTPEGKPYLIEINSIPGMSGG
SIVPKQVREAGMTLGELYDLIIEDTYDRDRR
>KF628538.1_16153|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GLLELAGIPYVGCGVLASAVCMDKAVANALFEANGVPHTRWLAADRWEIESDLEGVCEGV
EKKLGWPVFVKPANAGSSVGISKVSSRDELKKAIDLALENDRKVVFEAFVDGQEVECAVI
GSDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNC
EGLARCDFFVEKGTGRVLINEINTFPGFTSISMYPKLMEHEGLPVPQLIDRLIALALERK
EKQHG
>KF628536.1_16160|FEATURES|farme|chloramphenicol|catA13|antibiotic inactivation|1
MQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILNR
HEEFRTALDKNGQVGVFSEMLPCYTIFHKKTETFSSIWTEFTADYTEFLQNYQKDIDAYG
ERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIPL
SIQVHHAVCDGFHICRFVNELQELINS
>KF628532.1_16168|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MNLIMKIVVLAGGTSTERDISIMSGTGICKALRQKGHQAVLVDIFCGTENVDWADPFPEE
YDVDQAVEYMKSFNPQIETMKAERRSFFGPNVLELCQAADIAFLGLHGANGEDGKVQAAF
DLMGIKYTGTGYLSSAIAMDKCMTKEFFLANHVPTPKGATLTGENGFDTDLSVLGLEFPV
VVKTSCGGSSVGVYIVNDQKEYEEALKEVSIYGNEAVVEEYIKGREFSVSVVDGKAYPII
EIAPIQGFYDYKNKYQAGSTVETCPAHISQELTDKMQDLAVKAAKALKLEAYSRLDFLMK
ENGDMYCLEANTLPGMTPTSLIPQEAKVLGMDYPQLCEELIRCSMKKYR
>KF628518.1_16209|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADELLQENCRQILSQGTWDTDLPVRPRWEDGTPAHTIKLFGLVNRYDLREEFPIQTI
RRMYLKSAVDELLWIWQKKSNNIYDLNSSIWDAWADETGSIGKAYGYQLGVKHHYPEGDM
DQVDRVLYDLKHNPASRRILTNLYNHHDLSEMALYPCAYSMTFNVTGKTLNAILHQRSQD
MLTANGWNVMQYAVLVRLLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLTRKPYPAPK
LWLDPGVTDFYAFTTDHLRLEGYQCHELGEKIPVAI
>KF628511.1_16226|FEATURES|farme|multidrug|ACR_trans|antibiotic efflux|1
PPLEVYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLA
FVFGVMPLLFATGAGAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF628510.1_16230|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
RVIYDLKNNPFSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTQTPGNDKLTLNAILNQRS
QDILAANNWNVCQYALLLMMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRKPYPA
PVVKLNPEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF628508.1_16239|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
DWGTGGRRPMRQRFQG
>KF628503.1_16251|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRTIAILCGGDTSEFQVSLRSAQGIYSFINKEKYTLYIVEMHGLDWHVQLPDGGKAPID
RNDFSFQMNGRKVTFDFAYITIHGTPGEDGRLQGYFDLLHIPYSCCGVLAAALTYDKFAC
NQYLKVFGVRIAESLVLRQGQSIFDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFDEAQEVLIEAYMEGTEVTCGCYKTKEKSVVFPITEVVTENEFFDYDAKYNGQVS
EITPARLSDDLTHRIQTLTSAIYDILGASGIIRVDYIITAGDKVNLLEVNTTPGMTATSF
IPQQVRAAGLDIKDVMTDIIENQF
>KF628494.1_16277|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGSKTPVD
RNDFSFMNGAEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFVC
NQYLKAFGVRISESLLLRQGQAVSDEDVVEKIGLPCFIKPNLGGSSFGVTKVKTREQIQP
AIAKAFSEAEEVMIEAFMGGTELTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVD
EITPARISEELTRRVQTLTSAIYDILGCSGIIRVDYIITEGEKINLLEVIPHRV
>KF628469.1_16345|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
LTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAG
QGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFT
FQQLMNV
>KF628468.1_16348|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
KRDSHPYTYSPLREARPEGNFKITIGELLKYSVALSDNNACDILIDYLGGTSALQKYVRR
QGIKQMKITATEDRMHKSGDPYLNHTRPSSAVRLLEKFIQQELLSPVYQKFLENTMIATS
TGSDKLKGLLPAETIIGHKTGSSDRDSTGMKAGDNDMGFVYLPHGGDHYTIAVFITDSME
DDKTNAAIIAQISKAVYDYINEISS
>KF628452.1_16387|FEATURES|farme|beta_lactam|HMPREF9445_00715|antibiotic inactivation|1
MFSKLFFCLIFLTALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIAPQTG
>KF628429.1_16447|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDISLILSVGKNNEIGKNNDLVWHFHEDMKFFRETTTGNTVIMGRKTFESLPKVLPNRRN
IVISSDKSLKIDGAEVVHSVDEALETAKNDKIFIIGGGRIYAEFLPLATKLYLTEIDAEC
QEADTFFPQFDK
>KF628428.1_16448|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGISTERTVSLVSGTGVCQALRRKGHQAILVDMFMGLENPPADLNTLFDAPDG
LCPDVKIEVQAPDLDAVRRSRPDQSASRIGPHVLDICRLADVVFLGLHGQDGEDGRIQAA
LDLLGVPYTGAGYLGSAIAMDKIASKQMMDANGIPNPKWQ
>KF628409.1_16486|FEATURES|farme|beta_lactam|blaR1|antibiotic inactivation|1
MKLIRPLPLLLLCALLLAGCGQGGGAPQEQETAQTQTGPTWESRAPSEAFQGIQGCAVLY
DLGTDHYTLYQEDLCRTQVSPCSTFKILSTLMGLHTGVLTGPESTMTYSGIQYPVAAWNG
NLTLAEAFQSSCVWYFRQVIDQVGQASVAQQLAALDYGNQDISQWEGGGQNQSPELNGFW
IDSSLKISPLEQVQVLTKVFEGRSQYTQEEVDTLRTIMLVQDDGTRQVYGKTGSGFGETG
WFVGFQEKAGARTYFAVYLADENRTVSGSQAREVAFALLKETASLA
>KF628402.1_16504|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTN
IVLTHDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVTRTD
FAYDADTYFPNLDEMPEWKLVKESEEETYFDIEFLFIVYS
>KF628395.1_16519|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MELKSGGIKDKHMSMADEIFINMCRDILENGTSTEGEKVRPHWPDGTSAYTIKKFGVVNR
YDLSKEFPLLTLRRTALKSATDEILWIWQQKSNNIHDLHSHIWDEWADEDGSIGKAYGYQ
LGVKHLYKEGLFDQVDRVIYDLKNNPFSRRILTNIYVHQDLHEMNLYPCAYSMTFNVTQK
IGHDKLTLNAVLNQRSQDVLAANNWNVVQYSVLLHMLAQVCDMEVGELVHVIADAHIYDR
HVPIIKELISRTPYPAPKFWLNPEIRDFYQFTRNDVRADDYVTGEQIKDIPIAI
>KF628394.1_16522|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GAYSMTFNVTKEKDSDRLTLNGVLNQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGEL
LHVIADAHIYDRHIPLVKELISRETHPAPKVWLNPEVKDFYAFTVDDLHVEDYVTGPQIK
NIPIAV
>KF628390.1_16532|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MAKENLVVIFGGRSSEHEVSCISVQTVAKGVDLEKYNMTLVGITKDGRWLKADNIESIAD
GSWYDSKVTAVISPDTRRELIVFSDAGVERQKVDVIFPVLHGMYGEDGTIQGLFEMADIP
YVGCGVLASAASMDKFYTKIIVDHIGVSQARFVPVLAEDFSDIDSAMDRVEAELDYPVFV
KPSKAGSSKGVNKATDRASLLYAL
>KF628385.1_16544|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
TTMFQKISERVFDALRLHKYARMDFMMDEAGNAYCLEANTLPGMTPTSLIPQEAAAVGIS
YDELCQKILDMAFED
>KF628377.1_16563|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MDWSIKDAHIYVNQVDGIKEQLRRLDEEGDLPAPKLWLNPEVDDFFKFDNSRDCLDVKLV
DYKHLGKIKFPISQ
>KF628375.1_16571|FEATURES|farme|aminoglycoside|AAC(2')-Ia|antibiotic inactivation|0
PTLEVVRQEREAEFPAIYELIRTAFATAEVSDGDEQDFANRLRIHGNYIPELALVAECQG
KLIGHIMLTRTVVTQDDGTPYEALMIAPLSVVLDYRNQGVGSALLKEGLRLAQSRVTGQL
FFAAIRPTTDVSVSKRSENTVSGKPACRKN
>KF628370.1_16582|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGYSNERDVSLSSGASICKALRERGHQAYLLDAFMGLEYNPGKLEEVFDLPDG
GLGIAAGIQVKEPDLDALWASRPGDSVSYLGPNVLELCSMADITFMALHGSLGENGKLQA
TFDVLGIRYTGPNSLGCALSMDKGVTKEIFKIQGVPTPDGTHLRRSDRHTSLDALGFRLP
VVVKPCSGGSSIGVFIVHTEEEYKDALEQSFQKEDEIVIEPFIDGREYACGIFDGKALPL
VEIVPKDGFFDYVNKYQLGGASEICPAQSLDAVKTAQIQAAGEKAYAALRLDVYSRADFI
VDNNTGEFYCLEVNSLPGMTSASLLPKAAKAAGYEYGEFCELIIQKSMEARYQ
>KF628366.1_16594|FEATURES|farme|aminoglycoside|APH(2'')-Ie|antibiotic inactivation|1
MYSLYEVEQILRNKQVFVCSLAFLGEGEHSEAFLVNRDIVVKLPKHRQASECLKTEMQVV
KGLGTKLNVEIPNVLFQGAFFHEGEEYTYFGSRKLPGHSLNKKQFCALPKPILDKNAEIV
ANFLYRLHSEKNVLPIQREGDVLVHGDFSLNHLLFDQNQMVCSVLDFGDSHVGDFQEDFL
YLLDEEDEEEFGANFGREVLENYKSISSCSLQGEF
>KF628361.1_16612|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MNVGELVHVIADAHIYDRHVDAIKELISREPFPAPKFWLNPEIKDFYQFTPDDVKLEGYQ
TGEQIRDIPIAI
>KF628357.1_16622|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
VIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRINIV
ITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQMLPYCDVAHVTKIDFA
YEADSHFPNLDEDDEWEITGESDEQTYFDLEYQFVKYERKK
>KF628355.1_16625|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target protection|0
AAPHGTGHIKSGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIFVTKDGK
VVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAVISPVGK
IVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF628330.1_16691|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
TSNDPLNQRSQDILAANNWNVCQYSILLMMIAQVCDMEAGELVHVIADCHIYDRHVPVIK
ELISRTPYPAPTVKLNPEIRDFYEFTTDDLIVENYQTWPQIKNIPIAI
>KF628329.1_16694|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MKIALIVAAARNGVIGSGNKMLWRVPEDFAHFKRTTMGHPIVMGRKTWESIGRPLPGRRN
VVVTRNADYRAEGAEVVPSLEEAFRTLADTDTVFVIGGGEIYRQALPSADVVWLTKIDAD
FEGDTTFPELPESEWTTEVLEMLEPTESRSFEVTFCRCERRA
>KF628322.1_16715|FEATURES|farme|trimethoprim|dfrF|antibiotic target replacement|1
MIGLIVARSKNNVIGKNGNIPWKIKGEQKQFRELTTGNVVIMGRKSYEEIGHPLPNRMNI
VVSTTTEYQGDNLVSVKSLEDALLL
>KF628308.1_16750|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DQVDRVLYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDRLTLNGVL
NQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGELLHVIADAHIYDRHIPLVKELISRE
THPAPKVWLNPEVKDFYAFTVDDLHVEDYVTGPQIKNIPIAV
>KF628306.1_16753|FEATURES|farme|glycopeptide|vanF|antibiotic target alteration|1
MKIVVLAGGTSTERDVSIVSGTGICGALRQKGHQAILVDVFCGQEEVDWEDPFPAEYDVE
KAAAYIRGFNLQMAELKKTRKNFFGPNVIDLCKKADFVFLGLHGANGEDGKLQGAFDLMG
IPYTGTGYLSSAMAMDKGVTKAMFQMRGVPDSGR
>KF628303.1_16761|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SITGSFAEYDLSKGEFPITTLRPIAIKSAIKEVFWIYQDQTNSLDVLEDKYNVHYWNDWE
VEGVPANNGDKRSIGQRYGAVVKKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGL
QPCAFQTMFDVRRVGEDVYLDATLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWKVGKF
FYFINNLHIYDNQFEQAEELLKRQPSDCQPRLVLNVPDETNFFDIKPEDFELVDYDPVKP
QLKFDLAI
>KF628302.1_16767|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
PYPTIEIRKADSLFDYQYEDFKVVGYQHHPTIKAPVAV
>KF628298.1_16777|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MEHDSSRSGYHEPEPGHAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFKGGMP
WHLPEDMKRFKELTVSHPVIMGRKTWESLSLKYRPLPNRDNIVVSHDSSYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLFHEAMPFADKAYVTQISMHVDADTYAPDI
KGLVESGAWKVAEEGVWQGTRKGSDDIAGFRFITFERNHEE
>KF628286.1_16812|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MEKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLMGIKYTGTGYLSSALAM
DKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKTCCGGSSVGVYIVNDQA
EYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAPLQGFYDYKNKYQAGST
IETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGDMYCLEANTLPGMTPTS
LIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF628280.1_16830|FEATURES|farme|glycopeptide|vanC|antibiotic target alteration|1
MTRQEYTKALETAFSFEDEVVVEQFIKGREFSIGVIDGKALPIIEIAPIQGFYDYKNKYQ
AGSTIETCPAKLSDSLTAQMQAYAEQVYVALGMQSYARIDFLTDEQENIYCLEANTLPGM
TPTSLLPQEAAVLGMDFNDLCEKLIQVSLEKYENGGKKA
>KF628275.1_16845|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
IVNADKNWGIGKNNELLVHIPNDMKMFRQMTTGKVVVMGRKTLESFPNGMPLPKRTNIVL
THDKDYDAKGAIVVGSKEELLDELEEYKDEDIFIIGGESIYRMMLPYCDTAYVTRTDFAY
DADTYFPDLDEMPEWKLVKESEEETYFDIEYQFLVYQK
>KF628269.1_16860|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VALMTCKLSAIVAVCDDWGIGCEGDMVVSNRVDMRHFVACTKGCPVIMGRKTLLSFPGGR
PLKNRRNIVLTRDEDFAVEGVDVVHSVDEALATVADEPVAWVIGGGDVYRQFLPCCVEAE
VTHNHCVHPVDTYFPNLDADPAWEVSQAGGVATIAAGEGDEGLDYEFVTYRRVEA
>KF628268.1_16862|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
FPNGLPLKNRINIVITSNKEYEVKGAIIVHSIEEALEEIKKYPAEDVYCIGGDSIYAQML
PYCDVAHVTKIDFAYEADSHFPNLDEDDEWEITGESDEQTYFDLEYQFVKYERKK
>KF628267.1_16863|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAKIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTPISMYPKAWDATGVSYTELITRLIEGVLR
>KF628248.1_16908|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
KNVVVIFGGDSSEHDVSCLSATTVIKNMDTEKYNVILVGITKEGRWLLVDSVKDIEDGSW
REGEVKAFISPDTTTRSLVILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYV
GCGVLASAVSMDKVYTKIIVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKP
SCAGSSKGVSKAENRKELEAALYEAVKHDRNILCEETIVGREVECAVLGDRTQVKSTCVG
EILAAEEAAFYDFDAKYNNAESKTVVDPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFF
LEESGRVVFNEINTLPGFTSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF628230.1_16947|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFPGGLPLKNRIN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYERNK
>KF628229.1_16950|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
IWQKKSNNVRALSTGIWDAWADETGSIGKAYGYQMGVKHRYPEGEMDQVDRVLYDLKHNP
SSRRILTNLYNHHDLSEMALYPCAYSMTFNVTGNTLNAILHQRSQDMLTANGWNVMQYAV
LVHMLAQVSGLEAGELVHVIADAHIYDRHVPLVEELLGRTPYPAPRLRLDPAVTDFYAFT
PDSVQLENYRYHPLKEKIPVAI
>KF628223.1_16971|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMDQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKSGHDKLTLNA
ILNQRSQDILAANNWNVVQYAALVYMMAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIK
RETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQAGEQIKDIPIAI
>KF628220.1_16984|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MQVGELVHVIADAHIYDRHIPLIEELISRETHPAPIFKLNPDIKNFYDFTTKDITIENYV
TGPQIKNIPIAV
>KF628212.1_17007|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
IVLTRNRDRVPDGADAVSSIDELKRAIGSDKAFVIGGESIYSMLLDYCERAYVTEVEACG
NADCFFPDIRSMPNWRLAEQGEEREHGGLKYRFNVYKNHSIKEL
>KF628212.1_17008|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LLWIWQKKSNNIHDLHSHIWDAWADGSGSIGKAYGYQLGVKHHYPEGDMDQVDRILYDLK
HNPGSRRIISNIYNHADLSEMRLYPCAYSMTFNVSGNRLNAILNQRSQDMLVANNWNVCQ
YAVLVYMMAQVSGLEAGMLMHVIADAHIYDRHVPLMEELISREPLDAPRFIIDKSIDDFY
KFTVDSFSLEGYESHGSIGKIPVAV
>KF628209.1_17017|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PFNIASYALLTMMIAQECGLRPGDFVHTLGDAHLYLNHADQVAEQLSRTPRPLPTLRLNP
AVRSVFDFRYEDFTLENYDPWPAIKAPMSF
>KF628205.1_17029|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AQVSRSAGELVHVIADAHIYDRHVPIIEKLLEKDERPAPKFIIDKSVTDFYQFTRDSFSL
EGYDPQPFEDKIPVAI
>KF628204.1_17031|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNMIVAADKKNGIGYQGKLLVTIPFDQQLFRKETIGKVVVMGRKTLESLPGGRVLEGRTN
IVLTRNKNYKCKGAVICHSVEAVLEEIKKYRSEDVYIIGGESVYQAFMPYADRIHLTRID
YVYEADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYE
>KF628200.1_17039|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
VTSNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF628190.1_17070|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKVFINMCRDIIDNGTDTRGEKVRPVWEDGTPAYTIKKFGVVNRYDLSKEFPALTL
RRTAIKSCTDELLWIWQQKSNNINDLHSHIWDSWADENGSIGKAYGYQMGVKHQYKEGMF
DQVDRVIYDLKNNPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKKPGHDKLTLNAIL
NQRSNDVLAANNWNVCQYAVLIHMLAQVCDMEVGEFVHVIADAHIYDRHVPMIEELISRK
PLPAPKFWLNPEVKDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF628189.1_17074|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic inactivation|0
AYVPPFGSGATLYIRPYMFGSSAVIGVKPAEEYQFRVFTTPVGPYFKGGAKPITIRVSDY
DRAAPHGTGHIKAGLNYAMSLYPIMEAHRQGFDENMYLDAATRTKVEETGGANFIFVTKD
GKVVTPKSDSILPSITRRSLVAVAKDYLGLEVEEREVCFDEVKDFAECGLCGTAAVISPV
GKINDHGKEICFPSGMEKMGPVTQKLYETLTGIQMGRIQAPEGWIKVVE
>KF628157.1_17158|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
RPLAVEDFSLEGYDPYPAIKAPIAV
>KF628143.1_17199|FEATURES|farme|trimethoprim|dfrA22|antibiotic target replacement|1
MKMIVAVDKNWGIGKNNDLLVSIPADMKMFRTETSGKVVVMGRKTLESFPGGLPLKNRTN
IVLSGNPDYQVKGAIVVHSLQELLEEIKKYPKDQVYCIGGDSVYKMLLPYCDTAQVTKID
FAYEADRYFPNLDEMPQWQVAAESEEQTYFDLEYRFVRYERCK
>KF628141.1_17203|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
IVVVDRNWAIGKNGDLLVHLPGDLRYYKEKTIGNVIVVGRKTLDSFPGGRPLPGRTNIVM
TTDPDFEREDCIICHSKDEVMEKLQAFDTEKVFVAGGANVYEQFMDDCDEFYVTKIDEAY
EADRFFPDLDAKGLHVTWESEPQQEKGISYRFTIYSR
>KF628129.1_17232|FEATURES|farme|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDADKAAREALHGVTGAFMTEREY
KRAMELAAARDWEALLGMHASTRERLPVESMDRVFDQLFEAIGTPARILDLACGLNPVYL
AHRLPNAAITGVDISGQCVNVIRAFGGAETRLGDLLCEIPEDEADAALMFKVLPLLERQR
TGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKQNEDGRFPVRTVRTARFGAREGRRSPETGGQIAPQTSGYREKRADLGGRGDSSVR
LYDRARAERQPSRMGALARCRCAHLLYGADRNCIHMQQDWQADRRVQTPERTRGNAGRGR
IQAHFGIVGVCAEMVAERKRARESELRLLRMYQDGSGRVANLLILQKASAGSWRFDPSAG
>KF628125.1_17245|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MSKIALIAAIAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTSLSWPNVTL
>KF628117.1_17267|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAADENWAIGNKNELLVRIPADQKFFRETTMGKVVVMGRKTLETFPNGLPLMGRTN
IVLTHDKKFRVPGALIVHDMEELHEELEKYNSEDIYVIGGESVYRQLIDECDVAHVTKID
FAYDADAHFPDLDADPAWEITADSEEQTYFDLEYYFYRYERVRK
>KF628110.1_17287|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQD
ILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPK
VTLNPEVKDFYKFTVDDFTIEDYEAGPQIKNIPIAI
>KF628107.1_17293|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKAYVYQLGPHPDARSCDL
RS
>KF628097.1_17316|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
RRKMMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSE
YDVDAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATF
DLMGIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVV
VKTCCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIE
IAPLQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALCIEGYARFDFMMKE
NGDMYCLEANTLPGMTPTSLIPQEAKVLGIDYPDLCEELIRISFKKYSK
>KF628086.1_17342|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
PPRGSYVPPYGSGATLYVRPYMMGTNPVIGVKPADEYMFRVFTTPVGPYFKGGAKPITIR
VSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDENMYLDAATRTKVEETGGANFIF
VTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEEREIYFDEVKDFAECGLCGTAAV
ISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQMGRIQAPEGWLKVIE
>KF628079.1_17362|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDYPKTFSVNLIWGEARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGGKYRPLPNRDNIVVSHDPMYRAPGATVVT
SLDDALDMARQEAIPDDGLDRSEIWILGGAQLFAEALPFADKAYVTDLAATVDADSYAPD
MASLVEAGMWREAEVGEWHTPAKEESGIDSYRFRILAKTK
>KF628074.1_17374|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVHDLKSHVWDEWADEDGSIGKAYGYQMQVKHQYKEGMM
GQVDRVIYDLKNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKNSDKLTLNGIL
NQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHVPMIEELISRE
PLPAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNIPIAV
>KF628059.1_17415|FEATURES|farme|beta_lactam|Ndas_2389|antibiotic target alteration|0
SEYHFRVFTTPVGPYFKGGAKPITIRVSDFDRAAPNGTGHIKAGLNYAMSLHAIVDAHKN
GFDENMYLDSKTRTKVEETGGANFLFVTKDGKVVTPKSDSILPSITRRSLIYVAKEYLGL
EAEEREVYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMNEMGPITKKLYETL
TGIQMGRIQAPEGWLKVIE
>KF628059.1_17416|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFPGGLPLKNRTN
IVLTRNENYKVKDAIIVHSIEELMEELKKYPAEDVYCIGGDTIYKQLLPYCDAAQVTKID
FAYIADSYFPNLDEDPQWHVAAESEEQTYFDLEYKFVRYKRNK
>KF628056.1_17424|FEATURES|farme|macrolide-lincosamide-streptogramin|ABC_transporter|antibiotic efflux|0
VQDHPVSGQVDHIRFGLSDNGITLTDAVVPLDCGNIAIIGPQGRGKTTLLEVIARQVSAM
DGLMLHISGLYRGQRLTTTEHRPRLSAASTRIAPAPPRLIWLVDDADDLLDPLCCDTQAV
RFRQALADSSIIVVFAVRSPRHIRVPDHCSTRIVFPCGDRTADLVAGIPSSLVNTMSQED
LDTPGRAVLIAGASACLVQCAS
>KF628049.1_17442|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MAKKRIVVMYGGKADEHSISCISAASALRALDTDKFEAIPVGITKDGKWIVNGENPLGWS
LDEGLPTVEKTPGAKDVVLEVALGQDGFFAREDDGTLTPFGHVDAVFPVLHGPYGEDGTI
QGLFEMMGVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDARSFDKASEFKANA
DAIMAQVSEAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVYEASHHDWRILVEQG
IDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYMDAAASHVEVPANL
PEETLNLVRETAKKAFVAVDGAGLSRVDTFVTKDGKVMVNEINTMPGFTSISMYPKAWEA
TGVRYTDLITMLIEGVLR
>KF628038.1_17464|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
NLEVNQFEQAEELLKRQPSDCQPRLILTVPDGTNFFDIKPEDFELVDYDPVKPQLKFDLA
I
>KF628036.1_17469|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
DGKVQATFDLLGIPYTGTGYLSSALAMDKSITKQFFRAHHVPTPNGVTLKKGQESEPLSG
FGLELPVVVKPCCGGSSVGVYIAHTNEEYWQAMKDAFSYEPEVVVEEYIEGREFSVGVVD
GKAYPIIEIAPIEGFYDYTNKYKAGSTVETCPAVLTEEQTKEMQKHA
>KF628024.1_17498|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRQVWEDGTSAYTIKKFGIVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQDILAANNWNVV
QYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIVKELIQRPVYPAPKVTLNPEVKDF
YKFTVDDFTIEDYEAGPQIKNIPIAI
>KF627990.1_17586|FEATURES|farme|tetracycline|tet37|antibiotic inactivation|0
PFSFLNKAFAGEYPWRAESMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSH
LRYWGMNPEIIDERDWNQSVRISDALKVHVLPARHFSGRGIKRNQTLWGSFMFVSPEQKV
YYSGDSGYGPHFKAIGEQFGGVDLAIMENGQYDQDWKYIHMHPAETAQASADLNARAVVP
GHNGRFVLAKHTWNDPLIQLAKASKDKNYRLLTPELGEPVRVSDTTQQFREWWE
>KF627984.1_17604|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQVCDMKVGEFVHVI
ADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDGYETHPQIKNIPI
AV
>KF627984.1_17605|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKNNPYSRRIM
TNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAV
LLHMLAQVCVHTA
>KF627978.1_17623|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRHMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCPGAEVFPSLEAALKSCREDEHIYIIGGASIYQQALSLADELCLTEIN
STAPEADAYFPEVSQELWQEKSREAHLADEKHLCSYAFVDYVRK
>KF627976.1_17628|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWMNPEVKDFYEFTPDDVR
LDGYETHPQIKNIPIAV
>KF627968.1_17654|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
FESLPKGALPNRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQAL
PFADELCLTEIDNTAPEADAFFPEISPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>KF627951.1_17696|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|0
LANKNIVVLMGGKSSEHDVSLVSAK
>KF627935.1_17739|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MEPGELVHVIADAHIYDRHIPIIEEMIKRETYPAPKVTLNPEVKDFYEFTTDDFKIEDYQ
AGEQIKDIPIAI
>KF627932.1_17747|FEATURES|farme|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVK
>KF627931.1|FEATURES|farme|aminoglycoside|acyltransferase|antibiotic inactivation|0
MNANVEFDEIRPYHDEELPQVYEELIADAAFRQAVDTVMPGVPFEVWSQKMRACKTKLEF
QKTFCYGLLWKLAKEATDGLTLDHTALPADKSAAYTYISNHRDIILDSGFLSILLVDQGM
DTVEIAIGDNLLVYPWIKKFVRVNKSFIVLRALTMRQMLEASARMSRYMHYTISEKKQSI
WIAQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYD
>KF627924.1_17768|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
FKEYKIMKIIVLAGGLSTERDVSLSSAAGICRTLVEKGHDAFLLDVFMGLENAPENLEDV
FTLPDHGLEIVKNISTEEPDLEAVKASRPDQSDCFFGPNVIELCRLADITFLGLHGGEGE
NGKLQASFDLLGIKYTGPDSLGCAVAMHKGVAKQIFLESGVDTPGGGTIYKNSEDQSYQS
LGLTLPVVVKPCSGGSSIGVYIVNTDEEYAEALKKSFRYEDELVVEPYIKGREFACGIID
GTALPPIEIIPKTGFFDYANKYQDGATSEVCPADIPEEVAERMKELTVKAFNALKLNVYS
RADFLLDAEGNLFCLEMNTLPGMTSASLLPKEAKVYGIEYGDLCELIIKKSMEARY
>KF627916.1_17790|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MSYADKLFIDMCSDIIENGYSTEGEKVRPKWPDGTYAYTIKKFGVVNRYDLSKEFPAITL
RKTYIRSAIDEILWIWQKKSNNVHDLSSHIWDEWADEDGSIGKAYGYQLGKKHKYKEGEM
DQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSM
>KF627914.1_17794|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MVFEAKGVPTPKGMTLEKGECSSYLSDYGMDFPVIVKPCCGGSSVGVCIAHNQQEYGAAL
MEAFSYENQVVVEQFITGREFSVAVVDGKAYPVIEIAPLEGFYDYKNKYSAGSCVETCPA
DLSASLTKEMQMYAEKGYEALNLQAYARLDFLMEEDGSMYCLEANTLPGMTPTSLIPQEA
SVIGMNYPQLCEKLIEVSLKKYQ
>KF627911.1_17804|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKEPGSEKLTLNGILNQRSNDVLAANNWNVCQYAVLLHMMAQVSDMKVGEFVHVI
ADAHIYDRHIPMIEELISRKPLPAPKFWLNPEVKDFYKFTRDDVKLIDYETHEQIKNIPV
AI
>KF627909.1_17807|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDWENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVVEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIKVSMKKYPTQDFTL
>KF627902.1_17827|FEATURES|farme|tetracycline|tetX|antibiotic inactivation|1
MSLLNNKKVAIIGGGPVGLTMANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEA
MKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKN
DTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFI
IQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKG
LDFKDTKSVSEFLANRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLI
GDTAHLMPPVAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADST
KNEIEMRNPSFTFQQLMNV
>KF627892.1_17850|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
NMGSSVGISKAENEAELRAAIDLALKYDSRILIEQGVVAREIEVGILGNTNVKTTDPGEV
VKDVAFYDYQAKYIDNKITMDIPAHVTAEVMTQMRAYAAKAFRALGGCGLARCDFFLAED
GTIYLNELNTMPGFTQWSMYPLLWENMGLSYTDLIKELVALGQEMFEKRESHLI
>KF627889.1_17854|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MMNVIAAVDSNWAIGNKNRLLTSIPADMKFFREKTSGHVVVMGRKTLESFPNGLPLKNRT
NIVLTGNRDYKVKDAVIVHTKDELLEELKKYDSEEIYIIGGESVYRMMLPYCDTAYITKI
DHAYEADTHFPNLDELEDWKMTQVSDEQTCF
>KF627883.1_17865|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
FFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGEFIHTLGDAHI
YLNHLDQVKLQLSREPRALPQMKINPDVKSIYDFQFEDFELVNYDPHPHIAGIVAV
>KF627874.1_17890|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MVLSIIVAAAENNVIGRDNGLIWRPSADLKRFKALTTGHTILMGRKTFESIGRALPNRRN
IVISRNPEFEAAGCEVVHSVEEALELTKNEDEVFVTGGGTIYKKLWDKADRLYLTVVHQE
CEGDTVIPSVDPEVWREVAREVGKADEKNECDYT
>KF627869.1_17903|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
FTNGASAIITDRLIEDDKHVVILVDNTLKALQKMAHYLRKHRKVKVVGITGSVGKTSTRD
MVYSVVKQQYKTLKTEGNYNNNIGLPLTILRLKDEEVMILEMGMNHLNEMEELSRIACPD
ISAITNVGTAHIGELGSRENILKAKLEIVAGMSDGSTLVINGDNDMLSTVRFDNFKVVKV
GVDCAAVFKAEKVILMDDHSEFTINYNGKVYQVVVPVPGNHFVLNALVAIAIGINLEIPM
EKCIQGISQFELTKKRMDVIELKNNITLIDGTYNASEDSMKSSIDVLATYSRRKIAVLAD
MLELGEFSEQLHRSVGKYVAEKQIDVLVAVGREAKFMSDSAALSGMAEIYYCNNNQEVVN
YLKNNLQNDDVVLLKGSNGMKLKDVVTKIEEKIFMKQKLLVLCGGQSSEHIVSRMSCTSV
LNNLDANKYEITLVGIDLDGGWHYLDAKQTDLAKNTWLDNSSMVEDVYGLLKNQDVAFPV
LHGMYGEDGTIQGLFELAKLPYVGCRVMGSSVAMDKIYTKKILDTVGVPQVKSVYVKKRY
DEKLVVVTNTFDEIEEIEDYIVRALGMPCFIKASRSGSSVGCYRCDNQTELIGKLSEAAK
YDRHVVVEECIDCIELETAVLGNDDVIVSRVGQIMPHGEFYTFESKYEDEESKTCIPALV
DEQIQEQIRQYAIKVFKAVDGHGLSRVDFFLDKKTNKIYLNEINTMPGFTKISMYPQLMN
DFGITYPELLDRLIVLALQK
>KF627865.1_17909|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAADENWAIGNKNELLVRIPADQKFFRETTMGKVVVMGRKTLETFPNGLPLMGRTN
IVLTHDKKFRVPGTLIVHDMEELHEELEKYNSEDIYVIGGESVYRQLIDECDVAHVTKID
FAYDADAHFPDLDADPAWEITADSEEQTYFDLEYYFYRYERVRK
>KF627863.1_17913|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VFVIGGAQIYAAALPLARKFSLTRVFRAYEGDTRFPAWDEREWRLVSSESFSGGKDYPWP
FAFELYERR
>KF627858.1_17926|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|1
MKIIVLAGGYSNERDVSLSSGASICKALRERGHQAYLLDAFMGLAYNPDKLEEVFDLPDG
GLGIAAGIQVKEPDLDALWASRPGDSVSYLGPNVLELCSMADITFMALHGSLGENGKLQA
TFDVLGIRYTGPNSLGCALSMDKGVTKEIFKIQGVPTPDGTHLRRSDRHTSLDALGFRLP
VVVKPCSGGSSIGVFIVHTEEEYKDALEQSFQKEDEIVIEPFIDGREYACGIFDGKALPL
VEIVPKDGFL
>KF627857.1_17931|FEATURES|farme|beta_lactam|penPC|antibiotic inactivation|1
MSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDA
EYDNKLIADATKIIFDLIS
>KF627856.1_17934|FEATURES|farme|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWLIDQIIYGYERKDREMLIKGVSELLQTQAE
>KF627848.1_17955|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GPIMTMRRTYYKSCIDELLWIWQKKSNRIAELKSHVWDSWADENGTIGKAYGYQLGVKHQ
YPEGMFDQVDRVLYDLKHHPNSRRILTNIYNFEDLHAMGLYPCAYSMTFNVSGHTLNAIL
NQRSQDMLAANNWNVVQYAVLVHMMAQVSGLQAGELVHVIADCHIYDRHVPLVEKLLKNP
TYDAPRFHMDPAIQDFYQFTADSFTLEGYQYTPFDEKIPIAI
>KF627845.1_17966|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDANWAIGYKNKLLVSIPDDMKFFRQTTTGKVVVMGRKTLESFPNGQPLKNRVN
IVLTSDKNYKVKDAIVVHDLDELHKELEQYNSEDVYVIGGESIYRQLLDECDVAHITKID
YAYDADAYFPNLDEKEEWQ
>KF627843.1_17968|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPASSTIFKENITKIMEEGVWSEQARPKYKDGTTANSKYITGSFAEYDLSKGEFPITTLR
PIAIKSAIKEVLWIYQDQSNSLDVLEDKYNVYYWNDWEVEGVPANNGDKRSIGQRYGAVV
KKHDIINRLLAQLEANPWNRRNVISLWDYEAFEETAGLQPCAFQTMFDVRRVGEDIYLDA
TLTQRSNDMLVAHHINAMQYVALQMMIAKHFGWEVGKFFYFINNLHIYDNQFEQAEELLK
RQPSDCQPRLVLNVPDGTNFFDIKPEDFELVDYDPVKPQLKFDLAI
>KF627843.1_17969|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
LLEWIVNLKRKGNAVSKQIIAIWAEARNHVIGKNHTMPWHLPAELAHFKKTTMGSAILMG
RVTFDGMNRRCLPGRETLILTRDKDFDCEGVTTVTSVEEALAWFEQQDKDLYIAGGAGVY
KAFDGHYDALIKTTIEADLEGDTYFPQLDMTAFKEVSRDHVVKDDKNAYDFSISRYEKEG
D
>KF627835.1_17991|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
VVQLPPASSLERTQAVGKQINKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNW
NERKGKEHTAEAVVQRFNMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATE
MQRAVETLMEHYRNYPALASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMG
EAYVNDYVQFGHIYQVKLGAGDRAQRVIDDVLKLSVPNASGGMVPFSSFTRVEEQLGMDQ
INRYNMYSTAAVTCNVAPGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTT
VVFVMALLVAFLVLAAQYESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILL
VALSAKNGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGA
GAGSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF627827.1_18009|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNAIVAADKNWGIGYKNKLLISIPSDMKFFRQTTMNHVVVMGRKTLESFPNGLPLAKRTN
IVLTRDQDYKVKGAILVHSEEELLEELKKYEEDDIFVIGGGSVYEMMLPYCNTVYVTKID
FAYQADTYFPNLDEMPEWEMTEESEEQTCFDIEFAFTKYERKA
>KF627820.1_18026|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADDVFIKMCQDILENGTSTEGEKVRPVWEDGTPAYTIKKFGVVNRYDLRKEFPAMTL
RRTALRSAMDEILWIWQKKSNNIHELHSHIWDSWADENGSIGKAYGYQMQVKHQYKEGMM
DQVDRVLYDLKENPYSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTKEEGSEQLTLNGIL
NQRSQDVLTANNWNVCQYAVLLHMFAQVCGMKAGELVHVIADAHIYDRHIPLIEELISRE
PLPAPKFWLNPEVKDFYDFTPDDVRLEDYETHPQIKNIPVAI
>KF627819.1_18029|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MMKMARRIALLCGGASGEREVSLLSAAAVEEALEKRYEVIKIDTGVEGWAHTLLDSSVEG
VFICLHGGAGENGSIQGFCESVGLPYTGPGVLSSAIAMDKFVAKLLVESFRIPTPGYIRV
LRGEECNIEDIRTKLGGKLVVKPSTEGSALGVSIVDNGDDLACAIDTALELAPSVLVEQF
ISGRELTVAVLGGEKPRVLPPIEIIPANEFYDYEAKYEQDMAQHICPANLTEAELRQCEE
MALGAHDALGCYGVSRTDCILDERNRLWYLETNTIPGMTGTSLLPDAAKAVGITFDELCW
NIMEDAWSRC
>KF627812.1_18049|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNIIVAVDKNWAIGFQNKLLNSIPEDMKFFRETTTGHVVVMGRKTLESFPNGRPLKNRTN
VVITRQKDYEVPGAVVVHSVEEALEYLKAFKSEDIYVIGGASIYEQMLPYCDVAHVTVMD
YAYQADTWFPNLDKMEDFVVAADSEEKTYFDLEYCFKMYVRKSKLKEIVDFMD
>KF627808.1_18062|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSSAGICKTLVEKGHEAYLLDVFLGLENPPANLEDVFSLPGH
GLEIAKGIRTTEPDIEAIKASRTDKSSCFLGPNVIELCRMADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKDFTKQVFLQAGVDTPAGGCLHKNDTDKSLARFSLTLP
VVVKPCSGGSSIGVYIVHTEKEYEEALNNSFRYEDEILVEPYIKGREFACGIIDGKALPP
IEIIPKTGFFDYANKYQDGASEEVCPADISPEIENKMKELTVKAYRALKLSVYSRADFLL
DEKGNLYCLEMNTLPGMTPASLLPKEAGAVGIDYGSLCELIIQKSLETRYSPQ
>KF627806.1_18067|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKAYLDLLRHIQAHGTVKNDRTGTGTISTFGYQMRFDLSEGFPVLTTKRLHLRSIIHELL
WFLRGDTNIAYLRENGVTIWDEWADADGNLGPVYGSQWRSWPAPDGRHIDQIAQVVDQIE
RNPDSRRLIVSAWNVAEIDRMALPPCHALFQFYVADGRLSCQLYQRSADVFLGVPFNIAS
YALLTMMIAQVTGLVPGEFVHTLGDAHIYLNHREQVALQLTRTPRPLPVMRINPDVRSIF
GFRYEDFSLDGYDPYPSIKAPVAV
>KF627804.1_18073|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MGRKTLESLPGGRVLEGRTNIVLTRNKNYKCKGAIICHSVEAVLEEIKKYRSEDVYIIGG
ESVYQAFMPYADRIHLTRIDYVYDADTFFPEISPNEWSLTDVSDEQTYFDLIYDFRCYER
KQK
>KF627803.1_18075|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGSKTPVDRNDFSFMNGAEKVVFDF
AYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFVCNQYLKAFGVRISESLLL
RQGQAVSDEDVVEKIGLPCFIKPNLGGSSFGVTKVKTREQIQPAIAKAFSEAEEVMIEAF
MDGTELTCGCYKTKEKSVVFPLTEVVTHNEFFDYDAKYNGQVDEITPARISEELTRRVQT
LTSAIYDILGCSGIIRVDYIITEGEKINLLEVNTTPGMTATSFIPQQVRAAGLDIKDVMT
DIIENKF
>KF627795.1_18091|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NGWNVMQYAALVHMLAQVSGLVPGELVHVIADAHIYDRHVPVVEEIIARKPYPAPRLRLD
PAVEDFYRFTPASVKLEGYQFHPLDTPIPVAV
>KF627792.1_18100|FEATURES|farme|beta_lactam|ACT-2|antibiotic inactivation|1
IARGEISLGDPVTKYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQN
WQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEA
HYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQS
RYWRVGAMYQGLGWEMLNWPVDAKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTG
STG
>KF627786.1_18108|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MMAQVSGLEAGMLMHVIADAHIYDRHVPLVEELISREPLDAPRFIIDKSIDDFYKFTVDS
FSLEGYESHGSIGKIPVAV
>KF627786.1_18111|FEATURES|farme|macrolide-lincosamide-streptogramin|GTGU_04410|antibiotic target replacement|0
MAGKMAQAFSGSLTALYVQTPGDADMNAEDTVRLQANMRLAQQFGAEIITTHGEDVATQI
AEYARLSDVTKIVIGRSGVQRRHFWSEPTLTERLITLAPEVDIHIIPDAEVYKSYRR
>KF627785.1_18115|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSKVSIIAAVDRHMAIGFENKLLFWLPNDLKRFKALTTGNTILMGRKTFESLPKGALPNR
RNIVLSSNPDTVCPGAEVFPSLEAALKSCREDEHIYIIGGASIYQQALSLADELCLTEID
STAPEADAYFPEVSQELWQEKSREAHLADEKHLCSYAFVDYVRK
>KF627780.1_18137|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
VTADRHWAIGKDGRPLVTIPADRQMFLKETAGKVVVMGRRTLEGLPGGQPFGNRVNIVLT
HDMQYKVKGAVVCHSLEEALKALKDYDEDDIYIIGGESIYRQFLPYCTTAHVTSI
>KF627780.1_18139|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MNMSYADQIFIQNCNDILEHGVWDTDYDVRPVWEDGTPAHTIKRFGIVNRYDLTREFPVI
TLRRTAFKSAVDELLWIWQKKSNNIHDLNSHIWDSWADENGSIGKAYGYQLGVKHHYKEG
DFDQVDRILYDLKHNPLSRRIMSNIYNHHDLCEMNIYPCAYSMTFNVSGNTLNGILNQRS
QDMLTANSWNVCQYAVLLHMLAQVSGLKPGELVHVIADAHIYDRHVPIIEKLMEREGYAA
PKLCIKEDITDFYAFNTENVWLEDYQNCGGVGKIPVAV
>KF627749.1_18211|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNLIVAVDKNWAIGYGNKLLVSIPQDMKFFRETTSGKVVVMGRKTLESFPGGQPLKKRTN
IVMTGNSNYEVKDAVVVHDIDSLLEELKQYPAEDVYVIGGESVYRALLPYCDKAYVTRID
HAYLADTYFPNLDEDPEWKMTKVSDEQTYFDLEYVFTIYERV
>KF627742.1_18230|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LSNGVWDTDLPVRPRWEDGTSAHTVKKFGIVNRYDLSKEFPILTLRRTYLKSALDELLWI
WQKKSNNIRDLGSHVWDQWADEDGSIGKAYGYQLGVRHRYPEGEFDQVDRILYDLKHNPA
SRRILSNLYNHADLSEMRLYPCAYSMTFNVSGNRLNAILNQRSQDMLTANNWNVCQYAVL
VHMLAQVSGLVAGELMHVIADAHIYDRHVPIVESIIDKEPYDPPVFRLDPAVDDFYQFTR
DSFRLENYEYAPFEDTIPVAI
>KF627742.1_18231|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MECIVNVTPDWGIGRHGELLVAISADLRRFRQLTQGKTVILGRKTLATFPGGRPLKNRRN
LILSHDPAFQVEGAEVVHSLPELFQAIQKVPEEQLCVIGGAAVYEMLLPYCTTAQVTKSY
VTLKADTFFPDLDADSCWSLAEEGKIEEENGVRFQYLKYVNRSPRQWR
>KF627714.1_18319|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSYADQVFISMCEDILENGTSTEGEKVRPHWPDGESAYTIKQFGVVNRYDLSKEFPALTL
RKTYIKSAIDELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMM
DQVDRVIYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAIL
NQRSQDILAANNWNVVQYAALVYMMAQVCDMEPGELVHVIADAHIYDRHILIIREMIKRE
TYPAPKVTLNPEVKDFYGFTTDDFKIEDYQAGEQIKDIPIAI
>KF627712.1_18325|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVTKEKDSDKLTLNGVLNQRSNDVLAANNWNVCQYALLLMMIAQVCDMKAGELLHVI
ADAHIYDRHIPLVKELISRETHPAPKVWLNPEVKDFYAFTVDDLHVEDYVTGPQIKNIPI
AV
>KF627709.1_18330|FEATURES|farme|bacitracin|uppP|antibiotic target protection|0
KDGAWDAGELTTDPNVTLNECAGVFQYAQTVFEGMKAYTTEDGHIVTFRPYLNAERMANS
AKRLEMPVFPEDRFVDAIVQTVKANAAYVPPYGSGATLYVRPYMMGTNPVIGVKPADEYM
FRVFTTPVGPYFKGCAKPITIRVSDFDRAAPHGTGHIKAGLNYAMSLHAIVDAHKNGFDE
NMYLDAATRTKVEETGGANFIFVTKDGKVVTPKSNSILPSITRRSLIYVAKEYLGLEAEE
REIYFDEVKDFAECGLCGTAAVISPVGKIVDHGKEICFPSGMEKMGPVIQKLYDTLTGIQ
MGRIQAPEGWLKVIE
>KF627693.1_18375|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADVLFVNMCEKILEEGFSSEGMQVRARWEDGTAAHTIKTFGVVNRYDLEEEFPALTL
RPTAIKTAVDEVLWIWQKKSNNIKDLKGHIWDEWADENGSIGKAYGYQMGLKYKFAQGEM
DQVDNVLWQLKNTPYSRRILTNIYKFDDLAEMNLEPCAYSMTFNVTGDRLNAVLNQRSQD
ILAANNWNVVQYSVLLHMFAQVSGLRAGRTGSRDRRRPHL
>KF627693.1_18376|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VIADAHIYDRHIPVIEELISRPQYPAPKFRLNPEIKDFYDFTVDDVMIEDYQKNPQILNI
PIAI
>KF627690.1_18384|FEATURES|farme|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEDNKFVLEVSDLHTTFKTDNGDVSAVNGVSFKLEPGKTLGIVGESGSGKSVTAYSIMQI
LAENGAITGGSVKYKGEDITKWNKKKMADFRGKCCSIIFQDPMTSLNPVFTVGYQLEEAV
LLHTDRTKKEAKERAIEMLTLVGVNEPEKRVNQYPHELSGGMRQRVMIAMALACEPDILI
ADEPTTALDVTIQAQILELMQSLQEKLGMAIIMVTHDLGVIASMCDEIIVMYGGRVCERG
TADAIFYSPAHEYTKGLLRSIPTKTNSKTRLVPIGGTPINMLNMPEGCAFCPRCYAAMKI
CLTEKPEEIWVGEDHLASCWMNIKNMMEEGKSNEE
>KF627664.1_18447|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPREYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNG
>KF627656.1_18471|FEATURES|farme|aminoglycoside|AAC(3)-IIa|antibiotic inactivation|0
MDLTEFNEIRPYNDEELPQIFEELIADPAFQKAATGAIPNVPFELLAQKMRACKTKLDFQ
EAFCYGILWKIAADHTAGLTLDHTAIPDKSKAYTYISNHRDIILDSGFLSILLIDQGMDT
VEIAIGDNLLIYPWIKKLVRVNKSFIVQRALTMRQMLESSARMSRYMHYTISEKKQSIWI
AQREGRAKDSNDRTQDSVLKMLAMGGEG
>KF627652.1_18480|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
AQVCDMQVGELVHVIADAHIYDRHIPIIKELIGREQHPAPKFTLNPEIKDFYQFTTKDIT
IEDYVTGPQIKNIPIAV
>KF627649.1_18490|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MSKIALIAAVAEKGAIGQNQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
KNIVLTHNTALSWTNVTVVHTLDEIPIQDTTEDEIFILGGATLYNETIKIADTLYITHIH
HTFDDADTFFPTINPSEWEIANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>KF627647.1_18495|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VEELLGREPLAAPRLKLNPEIKNFYDFRVEDIQLEDYQWHKFPVKIPVAE
>KF627646.1_18498|FEATURES|farme|aminoglycoside|ASD74_10480|antibiotic inactivation|0
MRAGMQMILTGIDYIKKGISICIFPEGTRSKDGKMLPFKEGSMKMATKTGCPIIPIAISN
SAQIWEAHFPKMKPAHVVVEYGAPIYPKELSKEEQKFIGAYTQQKIQEMLDSHQI
>KF627645.1_18503|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LPHRKEGIELNKKTVVVLFGGQSSEHEVSRVSASTIISNINQDKYYVIPVGITKEGQWLI
YNGPVENIKSGEWEKFGTPAVLSPDASHRGILKIVGNKVKTIPVDVVFPALHGLYGEDGT
IQGLLELAKIPYVGCGVLASAVSMDKAFTKIIAKNAKIRQADYLLATKEEIKKKSVLSKI
EKKIGYPCFVKPSNAGSSVGITKAHNYDELVKGLELAAENDRKIIIEKNITGREVECAVL
GWKKARASSVGEIFSAAEFYDYDAKYNNAESKTVVPAEISPEKQDEIRKMAVKVFNAVDG
SGLARVDFFVENETENVIFNELNTLPGFTPISMYSMLWAACGKSTAELLDNLIELALERF
SL
>KF627644.1_18508|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MRETERGENAMNVIVAVDENWGIGKDGDQLVYLSQDLKRFKALTTGHPVILGRKTLATFP
GGRPLKGRRNLILSRDPAFAQEGAEVFRDLEALRSAVSEDAFVIGGASVYEQLLPWCDTA
YVTRIHAAFPADVVFPNLDRDPDWELAEEEPPLEQDGLFFHYVRYRRIR
>KF627635.1_18537|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|0
LKAALAAAPADTFVIGGASVYRQALAYCDTAYVTQIHRAFPAADCYFPNLAADPAWEAVE
TEGPYRYEDLAYTYVTYRRR
>KF627633.1_18545|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|0
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFSDKEKYNLYIVEMEGRRWEV
>KF627617.1_18583|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
EGMMDQVDRVLYDLKHNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLTL
NAILNQRSQDILAANNWNVCQYSILLMMFAQVCDMEAGELVHVISDCHIYDRHIPVIKEL
ISRTPYPAPSVRLNPEIKNFYDFTVDDLIVENYQTWPQIKNIPIAI
>KF627608.1_18608|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MEIMERVTEKIQGRGIVKRLAFGAGDGTKVTHARIITGQGLRKAQITEMKQYLELLDDVL
THGVGREDRTGTGTIGVFGRQSRYDLRDGFPCLTTKKLHLRSIIYELLWFLKGETNIKFL
KDNGVSIWDEWADENGELGPVYGAQWRCWPGEDGRPIDQIARLIDGLKNNPWSRRHIVSA
WNVALVDDMALPPCHSLFQFCVIPAQPGEERHGLSLQLYQRSADLFLGVPFNIASYALLL
LMTAQVCGYEAREFIHTFGDLHLYLNHLDQAREQLSRTPRPLPVMKLNPDVRTIDGFHYE
DFELTGYDPLPHIKAPISV
>KF627595.1_18645|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKTKLLVLFGGRSGEYEVSLISASAVLRNIDAEKYDIIRVGISRDGKWYLFGGDISEIES
GRWCDNAGNRPCAVCPDYGSNALIVFGVKTERLKYDVVFPIIHGTQGEDGTVQGLFELAG
ARVVGCSAETSALCMDKAMTKTVLRAAGIVTAKDVTVLRREWRSPEAKRELIAHIERNLP
YPVFVKPSRAGSSVGVSKAHGRDELCAAFDAAFEWDDKVLCEEYIEGREIECAVFTAPDG
AVTVSEPGEIDPGSDFYDYDTKYKNDNASYYIPARLDSAVTERVRECARLAAAALGITGL
SRIDFFVADGGETVLNEVNTMPGFTPISMYPKLMIHGGMTYSGLIDGLISEALERV
>KF627594.1_18647|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
EKYSIEELDNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLD
GPNGFKQSLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLALNLKEYATGDILSDDK
KEIFIDWMSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLS
KKAEQDAEYDNKLIADATKIIFDLIS
>KF627591.1_18656|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGYSNERDVSLNSGASVCKALRERGHQAYLLDAFMGLDWDSDKLEEVFNQEDG
GLGIAADIQIKEPDLDALWASRPGDSLSYLGPNVLELCSMADITFMALHGSLGENGKLQS
AFDILGIRYTGPNSLGCALSMDKGVTKEIFQAQGVPTPAGTHLFRKDKDCTLDELGFHLP
VVVKPCSGGSSIGVHIVHTDAEYRDAIETSFKKEDEVVIEPFIDGREYACGIVDGKALPL
VEIIPKDGVFDYVNKYQIGGASEICPAQSLNAEQTAQIQAAGEKAFEALRLDVYSRADFI
VDNHTGEFYCLEVNSLPGMTGASLLPKAAKAAGYEYGEFCELIIRKSLETRYQN
>KF627583.1_18673|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MKRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVPVD
RNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMMRIPYSCCGVLAAAITYDKFTC
NQYLKAFGVRIAESLLLRQGQSVSDEEVVEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQP
AIVKAFGEAQEVLVEAFMDGTELTCGCYKTKEKSVIFPPTEVVTHNEFFDYDAKYNGQVD
EITPARISDELTKRVQMLTSAIYDILGCSGIIRVDYIITAGEKLNLLEVNTTPGMTTTSF
IPQQVRAAGLDIKDVMTDIIENKF
>KF627580.1_18679|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
MNLIVAADKNWGIGKDNKLLVSIPSDMKFFRQETMGKVVVMGRKTLESFPNGLPLKNRTN
VVLTSDKNYQVKDAVIVHSIDEVLEELKKYDDDEIYVIGGGKVYEELLPYCDVAHVTKID
FAFEADTHIPNLDEDPEWEITASSDEQTYFDLEYTFVKYERK
>KF627579.1_18683|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
VNNYVDIVEKFRDKGEIMRIVVLAGGTSTERDVSLVTGYRVCESLRRNGHEANMLDIFLG
VDDSEVKTFFTEKNDLGELSDNLKKKTADIPAEVKRRTEARESFFGRNVLELCKEADMVF
MGLHGSNGEDGKVQATFDLLGIRYTGTDYLSSAISMSKELAKKVLVPEGIPMPKGVTLHK
GHKIEYVPFPCVVKPCCGGSSVGVSIAHNEKEFEEALDEAFSYEDTVLVEEFVDGREFSV
AVLDGKALPVIEIEPLEGFYDYKNKYKAGSTKETCPANIPEDIASQMQFWAEKCCQAAGV
TTYARVDELLDKNNNIFCLEINTLPGMTDTSLIPQEAAAVGISYDELTEKIIEISLAKYE
>KF627574.1_18697|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANNDD
QYPLMSVFKFHIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYG
DLINYMVSQSDNDACNWLINFVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNW
STPLSVAQLLRKVYTEKVLSDEHFAFLEKAMLASASGKD
>KF627572.1_18705|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKAIVAADKNWGIGYQNRLLVSIPSDMKFFRETTMGKVVVMGRKTLESFPGGQPLKNRTN
IVITSDSDYKVKDAIVVPSIEAAVEELKKYEEEDIFVIGGESIYRQMLPYCKMAYVTKID
HAYDADTFFPNLDELEDWEMTEEGDEQTCFDLEFAFTRYERR
>KF627570.1_18711|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNAIVVVDQNWGIGREGNLLVHLPGDLKYYKEKTIGNHIIVGRKTLESFPGGKPLPGREN
IVLTRDPGYAKDGCVICHTVEDVQDAVKDYDPETVFVAGGAEIYQEFFSLCDVFYITKID
ETFEADRYFPDLDEMGLKVAWESELQEEKGITYRFLKYVRENNR
>KF627567.1_18724|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MISIIAAVDRKRGIGYQNRLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
VVLSTQKDLICPGTEVFPSLEEALSSCQPDEHVYIIGGASVYRQALPFADTLCLTEVDAE
APQVDAYFPEVAPTVWQEKSRESHPADEKHPCPYAFVDYIRR
>KF627561.1_18740|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
ISIILTRDETYQSDNEKVLIMHSPKEVLDWYHKQNKDLFITGGAEILALFESELELLYRT
VVHEKFKGDTYFPSTFDFGRFKLVSEKFHDKDERNSYTFTIKKYEKVKQP
>KF627552.1_18769|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MIMAKTRVCVIFGGVSSEHDISLMSASSVIQQIPKDKYEIICVGITKKGRWLYFPGDVSM
IANGEWESHPDCTTAIISPDRTHKGLIKIMADGETSILHIDCVFPVLHGKNGEDGTIQGL
FTIAGIPFVGCDTVSSAICMDKAFTHTVLDNAGIKTAKWTAIHRCDISKLDQMIPQMVEK
LGFPMFVKPANAGSSVGINKAANEEQLKDAIKIAFSHDTKVVVEKAISGIEVETAVMGYE
DPKVAEPGEIVPCNEFYDYEAKYIMGTTELHIPARIIEEDTKRLKETAIKAYKALGCGGL
TRIDFFITPDHEIILNEPNTLPGFTSISMYPKLWEYSGVNYSDLIDRLITTAIERAEF
>KF627548.1_18780|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNAIVAADKNWGIGYKNKLLISIPSDMKFFRQTTMNHVVVMGRKTLESFPNGLPLKNRTN
IVLTHDHTYKVLGAVVVHDMDELHEELKKYDSQDIYVIGGETIYRQLLDECDVAHITKID
YAYDADAYFPNLDERPEWKITADSEEQTYFDLEYYFYRYERVK
>KF627548.1|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MSYADQLFIKMCQDIIENGVSTEGEKVRPKWEDGSSAYTIKRFGVVNRYDLSKEFPAITL
RRTALKSAMDEILWIWQKKVQQYS
>KF627541.1_18801|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
QYAVLLHMVAQVSGLEAGELVHVIADAHIYDRHVDAVREIITRQPYDAPRFSLDPAVTDF
YAFTPDSVRLEGYQAHPVPGTIPVAV
>KF627530.1_18828|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTFNVSGRTLNGILNQRSQDMLTANGWNVMQYAVLLHMLAQVSGLEAGELIHVIADAHIY
DRHVPVVEELLEREPYEAPRFILEPSVTDFYSFTPSSVRLEGYQAHALDQKIPVAV
>KF627524.1_18844|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRSKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF627520.1_18860|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MEIIVAVDENYGIGKDGDLLAHLSPDLKRLKAMTVGNIIVMGSKTYMSFPKRPLPDRENL
IITHHPENYPGIKCFTGVGKFLEYSKTADKPIFVLGGGSIYEQLLPYCEKAHITKIIHSF
EADTFFPDLDNNPEWEKENEEEIVTGEKYPFKYVTYVRRKK
>KF627513.1_18884|FEATURES|farme|bacitracin|uppP|antibiotic target alteration|0
MKQYLDLLNRVLTEGTEKGDRTGTGTISIFGHQMRFNLDDGFPCLTTKKLHLKSIIYELL
WFLQGDTNVKYLQEHGVRIWNEWADENGDLGHVVINGVHGPITTVASSTRSAK
>KF627502.1_18908|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NGWNVMQYAVLLHMVAQVSGLEAGELVHVIADAHIYDRHVDAVREIITRQPYDAPRFSLD
PAVTDFYAFTPDSVRLEGYQAHPVPGTIPVAV
>KF627502.1_18909|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MDLIVAVDQNWAIGKDGEQLLYLSQDLKRFKALTLGHAVILGRRTLSTFPGGRPLKGRRN
LILSTTPGFAPEGGEVYPSLDALLAAAPADAFVIGGESGFRALLDRCGTAYVTKILAQYP
ADRYFPDLDADPRWESVEESELLEENGVRFRYVTYRRRQEACPMDRDYIWEGEYGRRSHL
IPVFQQLLREQDASSLQMLSLFVNNNPYNLEFFIAVSYDRPKEEHLDRMFRLLEDAGLRQ
RKDLTALNIMRAMADRRFNSASLLDEDSVPTIMGHLFFFPEIRVLEEKGYRMTPFGREQM
VFLSHSSLDKPEIEEIIPLLNGMDLPVWFDKYSIALGDSITDKVQEGIQQSSIVLFWITE
HFLDSRWCKFEMRAFIKKLIEEDVRVISVLDRGIQISRLPLFLQDIKCLMREERTIYQVA
QQIASALRPS
>KF627483.1_18965|FEATURES|farme|trimethoprim|dfrC|antibiotic target replacement|1
MNLIAAVDLNWAIGRDGDQLCYIPADLKRFQALTTGHPVILGRKTLATFPGGRPLKNRRN
LILSRDPSFAPEGAEVFRSLEALRAAAPANSFVIGGASVYAALLDWCDTAYITKIGRAWE
GADAFFPDLDAGPDWEMAEEEEPQEHAGIPFRYVTYRRRKPHVCG
>KF627482.1_18967|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MQSANKMCVALLFGGMSSEHEVSCVSVGNFVRNIDRSKYEVLTVGITKEGRWLYTEATAE
QMADGSWEELPGNMPCVISPDRADHGMILFTPDGRVEKMHLDVVIPVLHGLWGEDGTVQG
LLELAGIAYVGCGVLASSVCMDKAVANALFEANGVPHTKWVAANRWEIEKDLEGVCAGVE
EKLGWPVFVKPANAGSSVGISKVSSQEELKAAIALALENDRKVVFEAFVDGQEVECAVIG
SDPAVATRPGEILAGAEFYTYDDKYKNGVSQTVIPAHLPEAKLDEVKTYAAMAYTALNCE
GLARCDFFVEKNTGRVLINEINTFPGFTAISMYPKLMEHEGLPVPQLIDRLIALAVERTE
KQHG
>KF627463.1_19020|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MEHKTKMAKQRIVVMYGGKADEHSISCISAAGVLRALDTDKFEAIEVGITKNGEWIVGGE
DPRKWNMSEGLPMVEKTDSSKDVVLDVALGQDGFFAREDDGTLTSLGHVDAVLPVLHGPY
GEDGTIQGLFEMMNVPYVGCGVLASAACMDKHYTKVLLAAAGIPVAPGITLDVRDYDAAS
EFAAAADEMLAAVQQAGLQYPLFVKPSRAGSSFGVTKVEHEGDAAELAAAVFEASHHDWR
VLVEQGIDAREIECAVLCPKAGEAPQASWPGEIVLDKRAEGDDQFYDFDSKYVNSDASHV
EVPASLPEETLNRVRETAKKAFIAVDGAGLSRVDTFVTADGEVMVNEINTMPGFTPISMY
PKAWEATGVSYTNLITMLIEGVLR
>KF627454.1_19047|FEATURES|farme|chloramphenicol|cmlv|antibiotic efflux|1
FDLNSSSSNIVKVAKTLNASHISMLDWSAFPLKHATGNPMSEFIADNRGANAITRPNWSA
VFSVAFCVACLIIVEFLPVSLLTPMAQDLGISEGVAGQSVTVTAFVAMFASLFITQTIQA
TDRRYVVILFAVLLTLSCLLVSFANSFSLLLIGRACLGLALGGFWAMSASLTMRLVPPRT
VPKALSVIFGAVSIALVIAAPLGSFLGELIGWRNVFNAAAAMGVLCIFWIIKSLPSLPGE
PSHQKQNTFRLLQRPGVMAGMIAIFMSFAGQFAFFTYIRPVYMNLAGFGVDGLTLVLLSF
GIASFVGTSLSSFILKRSVKLALAGAPFVLALSALVLTLWGSDKIVATGVAIIWGLTFAL
IPVGWSTWITRSLADQAEKAGSIQVAVIQLANTCGAAIGGYALDNIGLTSPLMLSGTLML
LTALLVTAKVKMKKS
>KF627453.1_19050|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCKDVIENGTSTEGEKVRPVWEDGTPAYTIKRFGVVNRYDLRKEFPALTLRKTALKSAMD
EILWIWQQKSNNIHDLHSHIWDSWADEKGSIGKAYGYQLGVKHQYKEGMMDQVDRVLFDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEPGKDKLVLNAVLNQRSQDILAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEIRDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF627453.1_19051|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVNVVLTTDKNYKVKDTVIVHSVEEMVEE
LKKYNSEDVYVIGGESIYRQLLPYCTKAYVTKIDHAYQADTYFPNLDQLEDWEMTEVSEE
HTCFDLEYVFSTYERRQ
>KF627424.1_19132|FEATURES|farme|macrolide-lincosamide-streptogramin|oleR|antibiotic target alteration|0
MKAYTTEDGHIVTFRPDLNAERMAASAARLEMPVFPKERFIDAVEQVVKANAAWVPPYGS
GATLYLRPYMFGSNAVIGVKPADEYQFRILTTPVGPYFKGGAKPITIRVSDYDRAAPCGT
GNIKAGLNYAMSLHAIVDAHKQGFDENMYLDPKTRTKVEETGGANFIFVTKDGKVVTPKS
DSILPSITRRSLIYVAKEYLGLEAEEREVYFDEVKDFAECGLCGTAAVISPVGKINDHGK
EICFPSGMEKMGPVIQKLYDTLTGIQMGRIEAPKGWIHVIE
>KF627421.1_19136|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCRDIIDNGTSTEGEKVRPVWEDGTSAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNIHDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDL
KNNPYSRRIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAA
NNWNVCQYAVLLHMLAQVCDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLN
PEVKDFYEFTPDDVRLDGYETHPQIKNIPIAV
>KF627420.1_19140|FEATURES|farme|glycopeptide|SCO3595|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERFEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADALAEIEDAGLTYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPAGQLARRNRARSSERRPVL
>KF627420.1_19141|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
VLDHQNDDQFYDFDSKYVNSDASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDT
FVTPDGTVMVNEI
>KF627394.1_19203|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LRDGFPLMTTKKMFLRPIAEELLWFIKGDTNIKYLVDRNVKIWNEWPYEDFKKSPDFNGE
TIEEFVEKIKTDDEFAKKHGDLGPVYGAQWRDFNYEGVDQLAKLVDSLTNNPFSRRHIIC
AWNPAQVDNMALPPCHAFLQFYVSADKNICLVNYINVVRIFF
>KF627393.1_19205|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVANGRLSLQLYQRSADTFLGVPFNIAS
YALLLQMVAQVTGL
>KF627381.1_19251|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRNGYHEPEPGFAGQEKADDWGDDFPKTFSVNLIWAEADDKDGRPGAIGFDGGMP
WHLPEDMKRFKELPVSHPVIMGRRTWESLNVKYRPLPNRDNIVVSHNPQYLALGATVVTD
LDAALDIARQEAIPDDGLDRSEIWVIGGAQVFQEALPFASKAFVTKIQTSVDADTYAPDM
DALVDAGLWEVADPGHWKRTQKDDSGIKRYRFVTYRKIG
>KF627374.1_19269|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MNYDELLAPAAKAMRPSGIRKFFDLAADMPHCISLGVGEPDFKTPWSVRDAGIRSLELGR
TKYTANSGLKELRGEICNYLQRRFDLHYKEENILVTVGGSEAIDLTIRAVVQPGDEVIIP
EPCFVCYEPITQLTGGVPVHIATRAEDQFRLTADQLRAAITPRTKLLIFPYPNNPTGAVM
SAAEMEEIASVLRETNVLVLSDEIYSELTYGLDRHVSIASLPGMAERTIVVNGFSKSYAM
TGWRLGYAAGPAPLVKVMTKIHQSCIMSAPTTSQYAAITALRQCDDQIEMMRDEYNRRRR
YVVKALNDMGLTCFEPRGAFYVFPSIQISGLTSSEFCEQLLREKEVAIIPGSAFGASGEG
YARISYAYSVDHLQTAMKRIREFLTEHGWMKK
>KF627373.1_19272|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VSDKAVSKKGRNMSKETLILLYGGRSAEREVSVLSAESVMRAVNYSRFVVKTYFITKGGE
FIKTQEFTDKPAEEEKLLTNDLAESYPKISPAAIYEKAAVVFPVLHGPMGEDGSIQGFLE
ILRLAYVGPNILSASSTMDKLLAKHVFEAVGVPQVPYVAAFADENQGEIAQEVVEKLEFP
VFVKPANMGSSVGISKVDDLADLQPALSEAYKYDNRVVIEQGVDAREIECAVLGNNSDVS
ATLPGEVVKDVEFYDYNSKYID
>KF627371.1_19275|FEATURES|farme|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>KF627366.1_19290|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MQAIVAADNNWGIGYQNRLLVSIPSDMKFFRQKTTGNVVVMGRKTLESFPNGLPLKNRVN
IVLTKNKNYQVKDAVIVHSEEELLEELKKYPSEKIYVIGGESIYKMMLPYCDTVYVTKID
RKFQADTYFPNLDQMEDWKMMEEGEEQTCFDLEFAFTKYERC
>KF627364.1_19296|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
LSSNHLSKAVEFACGILAGKALPLVEIVPKDGLFDYANKYQAGGASEICPPVSLDAETQE
LIQRAGERAFEALRMDVYSRADFIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEY
SEFCEAIIQESMKARY
>KF627364.1_19297|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPYDSDKLEEVFDRPDG
GLEISKGISTSVPDLGALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTPSG
>KF627355.1_19324|FEATURES|farme|glycopeptide|vanE|antibiotic target alteration|1
MSKQTLILLYGGRSAEREVSVLSAESVMRAVDYNAFEVKTYFITQSGDFIKTQEFIETPG
DDEKLMTNDTVEASQVIKPSDIYEEDAVVFPVLHGPMGEDGSIQGFLETLKLPYVGTNVL
SSSVAMDKIMTKRILEVAGVPQVAYTVYIEGEDLEAAVAETLEKLTFPVFVKPANMGSSV
GISKAENESELRSAIDLALKYDSRILIEQGVVAREIEVGILGNTTVKTTDPGEVVKDVAF
YDYQAKYIDNKITMDIPARVPVEVMTQMRAYAAKAFRALGGCGLARCDFFLTEDGAIYLN
ELNTMPGFTQWSMYPLLWENMGLSYSDLLKELVVLGQEMFDKRESHLI
>KF627350.1_19343|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSRISIIAAVDSRMAIGFQNKLLFRLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNR
RNVVLSSNPAAECPGAEVFTSLEAALESCQAEEKVYIIGGASVYRQAISLADELCLTEVN
DTAPEADAFFPAVDTTIWHEKSREVHPTDEKHLCSYAFVDYVRGID
>KF627350.1_19344|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRILTEGVHKEDRTGTGTISVFGHQMRFNLEEGFPLVTTKKLHLKSIIHELL
WFLQGDTNVKYLQDNGVRIWNEWADANGDLGHIYGYQWRSWPDYNGGFIDQISEAIETIK
HNPDSRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIF
DFQFEDFELVNYDPHPHIAGKVAV
>KF627348.1_19352|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MVVSNRADMRHFVACTKGCPVIMGRKTLLSFPGGRPLKNRRNIVLTRDEDFAVEGGDVVH
SIDEALAAVADEPVAWVISGGEVYRQFLPYCAEAEVTHNHCTHAVGHLLSRFGRRSRVGR
LRGVAVLPRLPRARATRVSIMSS
>KF627346.1_19359|FEATURES|farme|polymyxin|arnA|antibiotic target alteration|0
MCRDIIENGTSTEGEKVRPRWEDGTPAYTIKKFGVVNRYDLSKEFPALTLRRTGIKSCVD
EMLWIWQKKSNNINDLNSHIWDSWADEDGSIGKAYGYQMQVKHQYK
>KF627333.1_19394|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AYSMTFNVTGDRLNAVLNQRSQDILAANNWNVVQYSVLVYMMAQVSGLKPGELVHVIADA
HIYDRHVDIIKELISRPQYPAPKFSLNPDVKDFYDFTVDDIKIEDYQKNPQIKNIPIAI
>KF627331.1_19399|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MELIVAVYDDWGIGRDGTQPVALSADRKFFRTTTRGAMVIAGRRTIEDFPGKQPLPGRVN
VALSRSVTALPGFTVCGSAEKAAALSRTAERCFVIGGGSVYRQMLPFCDTAYVTKVHVTP
ESDTFFPNLDE
>KF627326.1_19414|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
KQINKILDSYPEIKDYIGISGFSVMGGGEQSNAATYFIVLKNWNERKGKEHTAEAVVQRF
NMEVYGIQEAEIFAMVPPAIPGLGATGGLQLQLEDRHNLGATEMQRAVETLMEHYRNYPA
LASVSSQYQANVPQYFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVK
LGAGDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVA
PGSSSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQ
YESWTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIIPLVALSAKNGILIVEFARD
FRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMA
LNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF627324.1_19417|FEATURES|farme|glycopeptide|vanO|antibiotic target alteration|0
MDVSSRADFIVSDADGEFYCLEMNALPGMTAASLLPKAAKAAGYEYSEFCEAIIQESMKA
RY
>KF627324.1_19418|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
MKIIVLAGGLSPERDVSLLSGAGICKTLREMGHQAFLLDVFFGLPYDSDKLEEIFDRPDG
GLEISKGISTSVPDLGALRKSRPDQSPSEIGPNVIELCQMADITFMALHGSIGENGKLQA
TFDNLGIKYTGPNSLGCTLSMNKLVTKQIFKTSGVPTPRGTSLTVKTKDTRLDELGYYLP
LVVKPCSNGSSIGVYICHTEEDYYDAIHKSFDIDNTDEVVTNHLSKAVNLPAVFLPEKHF
RSLKLFQRTDSLIMRTNIRQAVLPKSVLLYHWMQRHKN
>KF627321.1_19426|FEATURES|farme|multidrug|MexF|antibiotic efflux|1
PPRGLSGFSVMGGGEQSNAATYFIVLKNWNERKGKKHTAEAVVQRFNMEVYGIQEAEIFA
MVPPAIPGLGATGGLQLQLEDRHNLGTTEMQRAVETLMEHYRNYPALASVSSQYQANVPQ
YFLNIDRDKVQLMGIPLNSVFTALGYYMGEAYVNDYVQFGHIYQVKLGAGDRAQRVIDDV
LKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGSSSGEGIRQMES
LIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYESWTSPVAAVMGL
PVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRAQGNSIRDAAFQ
AGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRVALGAAVVFGMALNTLLATVYIPNFY
ELMQKLQERFSKKQ
>KF627318.1_19439|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MDQVDRVLFDLKENPFSRRIMTNIYVHEDLHEMNLYPCAYSMTFNVTGNRLNAILNQRSQ
DILAANNWNVVQYAALLMMFAQVSGFEPGELVHVIADAHIYDRHIPIIKELIKRPTYPAP
KVTLNPEVKDFYKFTVDDFMIEDYQAGPQIKNIPIAI
>KF627315.1_19448|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
VKDAVIVHSIDEVLEELKKYDDDEIYVIGGGKVYEELLPYCDVAHVTKIDFAFEADTHFL
NLDENPEWEITASSDEQTYFDLEYTFVKYERK
>KF627304.1_19482|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MRNPLSKRIVEIEPSGIRKFFDIVNEMEDAISLGVGEPDFDTPWHIRDEGIFSLEKGRTF
YTSNAGLKELKQEIAKYIYRKCDVTYDYKKEIMVTVGGSEAIDIAMRAMLDPGDEVLIPQ
PSYVSYEPCAILANGTPVIIELKEENEFRLTKEELEAAITPKTKLLVLPFPNNPTGAVME
RKDLEEIAEVIKEHDIFVLSDEIYAELTYCGEHVSIASLPGMKERTVLINGFSKAYAMTG
WRLGYACAPAEILEQMLKIHQFAIMCAPTTSQYAAISALRNGDDDVMKMREEYNERRRYL
VHRFKEMGLQCFEPFGAFYIFPSIQEFGMTSEEFANRFLREEKVAVVPGTAFGACGEGFL
RISYAYSLDNLKMALERLEHFIAHLREEKKNG
>KF627297.1_19500|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MVIITTREQKGSFMETIKSIVILFGGISSEHEVSCVSAASVLEHIDREKYDIRTIGITKA
GNWFLTDSPASDISDGSWEQDENNRRAFIVPDRGTGGIMAENADGTFEVIRTDVVFPVLH
GKNGEDGTMQGLLQLAGIPFIGSDTAASSASMDKAITKAMIEHRGYVDQARCYVVHQTAY
DRDRNAQLEAVNSFFADTYPLFVKPANAGSSVGISKVKRAEDLEKALYLAFAEDCKVLVE
EAITGREIEVAVLGNEEPQASCIGEIFAANEFYDYNAKYENSKSQTAIVRDLEPEKEQEI
KDKAISVYETMGCSGMSRVDFFLEDGGRVVFNEINTLPGFTSISMYPKLWEASGIPYDEL
IDRLIKLALDKYER
>KF627292.1_19514|FEATURES|farme|beta_lactam|bla(ampc-EC7)|antibiotic inactivation|1
EQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIAR
GEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQP
AWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYA
WGYREGKAVHVSPGALDAEAYGVKSTIEDMACWVQSNLKPFDINEKILQQGIQLAQSRYW
QTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPP
>KF627291.1_19515|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
SFPNGLPLKNRTNIVITSNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQM
LPYCDTAHVTKIDFAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF627289.1_19521|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNVIVAADKNWGIGKNNQLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRIN
IVITSNRDYQVKGAVIVHDEEELMNELGKYDTEQIYIIGGESVYKMMLSYCDKIYVTKVD
RAFQADTYFPNLDEMSEWKMTQESEEQTCFDLEFCFTTYERC
>KF627281.1_19539|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MISIIVAIARNGVIGNGNALIWRIAEDLRRFKALTTGHPVIMGRKTYESIGRPLPNRTNV
VVTRRKDYRPEGCLVAGSLEQAVGLFDQSEEIFIIGGAQIYAQAMPMADRLYLTEIDSDY
EGDTRFPEWKREEWTLLSEERHERGERYDRPFAFRNYIRTKE
>KF627279.1_19544|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MCEDILENGTSTEGEKVRPHWPDGEPAYTIKQFGVVNRYDLSKEFPALTLRKTYIKSAID
ELLWIWQKKSNNVNDLKSHIWDEWADEDGSIGKAYGYQMGVKHQYKEGMMDQVDRVIYDL
KHNPYSRRIMTNIYVHQDLHEMNLYPCAYSVTFNVTKKPGHDKLTLNAILNQRSQDILAA
NNWNVVQYAALVYMMAQVCDMEAGELLHVVADCHIYDRHIPLIKELIQRKPYPAPVVKLN
PEVKDFYQFTTDDLIVENYETWPQIKNIPIAV
>KF627275.1_19556|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
LTPRREQAREEIPRPAHGRLFRPINHERKQQINMEKLNVVALFGGQSSEHVVSCMSVQNV
AANINKEKYNVILVGITEEGRWLKVDSLDEVKNDTWRTSGSRAVLSPDATEKVLWVIRHG
KAEKIPVDVVFPVLHGLYGEDGTVQGILELAQIPYVGCGVLASAVSMDKLSTKLIVKNLG
IRHAEYVPVMKEELEQMDQVAKRVEDAFPYPVFIKPSNAGSSRGVSRADDRKSLENGLKE
AALHDRRILVEEMIVGHEVECAVFGGGKEEVRASGVGEILAAADFYDFDAKYYNSDSRTV
VDPELPGNAAEEIRESAVRIFKAVDGYGLSRVDFFVKEDGEVVFNEINTMPGFTAISMYP
MLWEARGVGKEKLVDDLLEHALKRYER
>KF627274.1_19562|FEATURES|farme|multidrug|YkkC|antibiotic efflux|0
DILVIAGLLEVVWAVGLKYTHGFSRLTPSVITVTAMIVSLALLAWAMKSLPVGTAYAVWT
GIGAVGAAITGIVLLGESANPMRLASLALIVLGIIGLKLSTH
>KF627267.1_19582|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MRISRLFLSKIGRKSLVPADRKEFIMKIVVLAGGISTERDVSLVSGMGIYKALKSKGHQV
MLLDVFLGYEHDDWKDVFEKNVDWAASVGAIKDQNPDIDAVKALRPDWKKNFFGPHVIEI
CQHADVVFMALHGENGENGKIQACFDLNGIRYTGTDYVSSAICMNKAISKD
>KF627251.1_19616|FEATURES|farme|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|0
FYAFPCIKSTGMSSQDFCTKLLEQKHVAIIPGDAFGASGEGYARISYAYSVEHLKEALRR
IREFLQENGIYHGI
>KF627245.1_19636|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MEYQKIRELQDWPRREAFDHFYHQVVTAVTLTADVDVAPLLRASRERELRFFPSFLHLLC
RVVNRHDAFKMGHNAEGEPVIWKQVSPSYTVFQEEDSSFYSLSTEYVPEFEAFYRQVVLD
IEQSKPLQGPRWKEEPPNRFYVSCIPWLHYRGFSMQMYGDGKLLCPIFTWGKFERSGDKT
VMPLTVQIHHASADGFHIAQLFQELQWEVDHFSEEQAGA
>KF627241.1_19647|FEATURES|farme|quinolone|patB|antibiotic efflux|0
VNYDRYINQAIAAVPPSGIRRFFDIAATMKDAISLGVGEPDFVTPYHIRNAAINSIIDGG
TQYTGNRGLPELCREISEYLSERFHTDYDPKTEIMVTVGASEAIDIALRALVGPGDEVLV
PQPSYVSYSPSVIFAGGTPVGVETTADTEFRLTPEALRAAITPRTKCLILPYPNNPTGGI
MEKVDLEKIAQVVRETGILVISDEIYGELTYGDRTHISFASLPDMWQYTITLNGFSKAFA
MTGWRVGYACGPKEILSVMLKIHQYSILCAPRMGQVAALEALQAGRANDYEDVRRMRDSY
DRRRRLMVDSFRKMGLDCFEPLGAFYVFPSIKKTGLDSETFCERLLNEYKIATVPGTAFG
ECGEGHIRCSYATGVEKLNIALERMSEFVDKCGK
>KF627237.1_19661|FEATURES|farme|beta_lactam|CblA-1|antibiotic inactivation|1
MKKKILLICSGLFVLWTFWLIENSLYLKLKLATFGSGSRAGIAVLSGDKVLTVGKGAMPL
MSVFKMFVALNVLEHQEKDKVLIVTEEMINRDTYSPMLKDYPVVPFKISVAELLKYMVSA
SDNNATDILLALGGDIRATQDYVRGLGFPGIVLKVNEQEMHENIRNQYLNRAVPADVVKL
LRVVRESERLTNENKRFFEALMTETATGADKIKKYLPSNVVVGHKTGSSDRLENGIKIAD
NDVGFVRLPDGREYYLGVMIADSPMSDWDNAELIARISKIVYRHFEENRRF
>KF627235.1_19665|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYTEGDFDQMDRVLYDLEHTPYSRRI
MTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYA
ILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRELIERPQFAAPKVTLNPDVHDFYAF
TTDDLIVEGYEHGPQVKSIPIAV
>KF627234.1_19667|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MQNFVAKHIDAVPPSGIRKFFDIASTMKDAISLGVGEPDFITPWNVREAAITSLEKGHTH
YTSNHGMPELREVVDEYLAERYNTHYSIDQTMITVGASEALDLAFRAIIDPGDEILVPAP
SYVSYQPGVAFAGGVPVAMDTLEENNFALTPENIESAITPKTKAIVMPYPNNPTGAIMTK
EQLEEVRKVVEKHNLLVIADEIYSELTYGSRHVSIAEGFEERTVLINGFSKAFAMTGWRL
GYACGPKAIIDAMVKIHQYSMLCAPIMSQYAGLEALKYEMSTGYRQIGEMVSSYNKRRMF
ILDGMREAGLTCFEPKGAFYLFPNITSTGLSSEEFCEKLLAAKKIACVPGSAFGEAGEGY
IRCSYASSMTNIMEAVKRIGEFIQELK
>KF627233.1_19670|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LNHMEQADEQLSREPRPLPVMRLNPDVKSLFDFRYGDFTLEGYDPWPAIKAPMSF
>KF627232.1_19672|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
LPFCTVKLATMALTPEQLADIRTRIPARPETDIPMPYEDLVRKILTEGTLKSDRTGTGTV
SLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWADEN
GDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVENMAL
PPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWTG
GDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFEIVGYQHHPTIKAPVAV
>KF627231.1_19673|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MDYAKIISAAARDMRPSGIRKFFDIAAEMKDCISLGVGEPDFKTPWTVRDAGIRSLEKGR
TWYTSNSGLAELREETCNYLSRRMGLSYTPGETVVTVGGSEAIDMCIRALVNPGDEVIIP
EPCFVCYYPITTLTGGVPVPLPLKAENGFKLTAQELEAAITPRTKLIIFPFPCNPTGAVM
RREDLEPIAALLRDKDIIVLSDEIYAELTYGGERHVSIASLPGMKERTVVVNGFSKAYAM
TGWRLGYACGPEPIIKVMTKIHQSAIMCAPTTSQYAAVTALRRCDADIEAMRSEYDMRRR
FLVSSLNRMGLDCFEPEGAFYAFPSIRKTGLSSEEFCEKLLFGKKVAVVPGNAFGDSGEG
HVRISY
>KF627230.1_19675|FEATURES|farme|beta_lactam|ampC|antibiotic inactivation|0
MNANVEFDEIRPYHDEELPQVYEELIADAAFRQAVDTVMPGVPFEVWSQKMRACKTKLEF
QKTFCYGLLWKLAKEATDGLTLDYTALPADKSAAYTYISNHRDIILDSGFLSILLVDQGM
DTVEIAIGDNLLVYPWIKKFVRVNKSFIVQRALTMRQMLEASARMSRYMHYTISEKKQSI
WIAQREGRAKDSNDRTQDSVLKMLAIGGEGDVIDRLMEMNIAPLAISYEYDPCDFLKAQE
FQLKRDIEGYKKTTADDLLNMQTGLFGYKGRVHFQTGACMNDELAKIDRSLPKPELFARM
SALIDKRIHASYRMYPNN
>KF627224.1_19690|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
RPHVSIATLPYMAERTIVVNGFSKTYAMTGWRLGYACGPAPIIRIMTKIHQSAIMSAPTT
SQYAAITALKECDGEIDRMRDEYNMRRRLVVKAFNDMGLTCFEPRGAFYAFPCIQSTGIT
GMSSQDFCTKLLEQKHVAIIPGDAFGASGEGYARISYAYSVEHLKEALRRIREFLQENGI
YHGI
>KF627223.1_19695|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
MMKIVVLAGGTSTERTVSITSGTGICKALRQKGHQAILVDIFCGIENVDRENPFPSEYDV
DAASEYMSAFNDRIEQMKKERRSFFGPNVLKLCEAADIVFLGLHGANGEDGKVQATFDLM
GIKYTGTGYLSSALAMDKGITKQMFLMNNVPTPRGVSMVKEEMTTDLKALGMEFPVVVKT
CCGGSSVGVYIVNDQAEYEQALKDAYSYENEVVIEEYIKGREFSVAVVDGKAYPIIEIAP
LQGFYDYKNKYQAGSTIETCPAEISPELTEKMQHYAEAGAKALFMEGYCRLDFMMKENGD
MYCLEANTLPGMTPTSLIPQEAKVLGIDYPTLCEKLIEVSMKKYPTQDFTL
>KF627214.1_19719|FEATURES|farme|tetracycline|tet40|antibiotic efflux|0
SHNILMSFPYQIVQYLGGGSGEMGTLLTLQSLMDIPAMVLFSLLLRRAASWRWVRLAGLS
FFLHALLTWLAPSVFFLYGIQIFETTGYALYAVASVYWVNDMTAPADRVQGQTYFTMANT
LGIVLSSFLGGFLLDAAGTGPTLAFSTVTGGTGMGILWIMLR
>KF627204.1_19741|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
VDGTPGEDGRLQGYFDMLRIPYSCCGVLAAAITYDKFACNQYLKAFGVRIAESLLLRQGQ
SVSDEDVIEKIGLPCFIKPSLGGSSFGVTKVKTKEQIQPAIVKAFGEAEEVIVEAFMEGT
ELTCGCYKTKEKSVVFPPTEVVTHNEFFDYDAKYNGQVDEITPARISPELTGRVQKLTSA
IYDILGCSGIIRVDYIVTAGEKLNLLEVNTTPGMTATSFIPQQVRAAGLEIKDVMTDIIE
NKF
>KF627204.1_19742|FEATURES|farme|glycopeptide|vanN|antibiotic target alteration|1
RRMQRNIAIVAGGDTSEIVVSLRSAQGIYSFIDKEKYNLYIVEMEGRRWEVQLPDGNKVP
VDRNDFSFTNGTEKVVFDFAYITIHGTPGEDGRLQGYFDMLRIPYSCCGWHTG
>KF627199.1_19753|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PPSRSRNAIDELLWIWQKKSNNIHDLHSHIWDAWADGSGSIGKAYGYQLGVKHHYPEGDM
DQVDRILYDLKHNPGSRRIISNIYNHADLSKMRLYPCAYSMTFNVSGNRLNAILNQRSQD
MLVANNWNVCQYAVLVYMMAQVSGLEAGMLMHVIADAHIYDRHVPLVEELISREPLDAPR
FIIDKSIDDFYKFTVDSFSLEGYESHGSIGKIPVAV
>KF627189.1_19775|FEATURES|farme|quinolone|patB|antibiotic efflux|0
MEWNNKISENVQAVPFSGIRKFFDLASTMKDVISLGVGEPDYAAPDRVIDACIESLKNKE
TSYTSNWGLLELREEISCLFKKRYGLEYDPMNEIMITVGVSEAITVVMQTILNPGDQVLM
PDPAYLAYPACVRLVGGTPVLVPTFSDDEFRLRVDKLEEKLTTKTKALLIGYPNNPTGTV
MDQAALEEIAAFAQRHDLIVISDEIYCDLTYEGKHTCFASIPGMKERTLVMNGFSKSYAM
TGLRIGYICGPKEVMQSLYKVHQYEILCAASTSQYGAIAALKKCDEDVKVMFDEYKVRRK
IVYDALAKMGLKVFKPKGAFYIFPDISCTGMNDEEFCDRLLMEEKVGVVPGTCFGLQGKN
HIRISYAASRENLTEAMKRMAHFVTKYKK
>KF627187.1_19783|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
VIDYNNFINKKISTVKPSGIRKFFDIANEMDDVISLSIGEPDFQTPWHIREEGINSLKKG
KTWYSPNRGFAELREEIAAYYKRRFGIEYDAKKQTLVTVGGSEAIDLVFRTLLDPGDEVI
IPEPSFVCYEPLTVMADGVPVIINTKNEDNFRLKASDLRAAITPKTKLLVLPFPNNPTGA
IMEREDLEEIAEVIKEHNIFILSDEIYCELTYGNKNHVSIAEIDGMYERTIVVNGFSKSY
AMTGWRLGYALGPVPVIAQMTKLHQYGIMSAPTTAQYAAIEALRNGDRDVEMMRGEYDMR
RRLVVDSFNAMGLTCFEPLGAFYVFPCIKSTGLTSEEFCTRLIVDKHVAVVPGTAFGESG
EGFVRVSYSYSIKNLKIALERIKEFLDELKKG
>KF627179.1_19810|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MKQYLDLLNRVLTEGVEKSDRTGTGTISVFGHQMRFNMDEGFPCLTTKKLHLKSIIYELL
WFLRGDTNVKYLQNNGVRIWNEWANENGDLGHIYGYQWRSWPNYKGGSIDQISEAVETIK
HNPDSRRIIVSAWNVGDLDNMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIAS
YALLLQMMAQVTGLKAGDFIHTLGDAHIYLNHLEQVKLQLSREPRDLPQMRINPDVKNIF
DFKFEDFELINYNPHPHIAGKVSV
>KF627178.1_19813|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MNVIVAADKNWGIGKDNKLLVSIPADMKMFREETSGKVVVMGRKTLESFPNGLPLKNRTN
IVITSNRDYQVKGAVIVHSIEEALKEVEKYPAEDVYCIGGDSIYKQMLPYCDTAHVTKID
FAYEADAYFPNLDEDPDWEITAESEEQTYFDLEYAFVKYERKDR
>KF627170.1_19838|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MNISIIVAIARNHGIGFENKLLYWLPNDLKRLKALTTGHTIIMGRKTFESLPKGALPNRR
NIVLSRREGAVFAGAECFPALEIALSHCKEEEEIFIIGGASLYKEAMHIAQQLYITFIDD
TSKEADAYFPEIKKEEWKETGREDHPTDEKHLYPYSFINYSRIK
>KF627160.1_19866|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MKKNLAVIFGGRSSEHEVSCVSVVTIAKAVDLEKYNMFLIGITKDGEWKLVEDIAGIEDG
SWKESPVSAIISPDTKGGLIISQDDMMKVQPIDVIFPVLHGMYGEDGTIQG
>KF627154.1_19884|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
VIADAHIYDRHIPLVEELIKREPLPAPKFWLNPEVKDFYDFTPDDVKLEGYETHPQIKNI
PIAV
>KF627148.1_19901|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIIVLAGGLSTERDVSLSSSAGICRTLLEKGHDAFLLDVFLGFPYDPDRLEEVFTLPDH
GLGIVKNIDTTEPDIEAVKASRPDQPDCFLGPNVIELCRMADITFLGLHGGEGENGKLQA
TFDLLGIRYTGPDSLGCAVAMDKGFTKQIFLQSGIDTPAGACVHKKAAEKSLQALGLTLP
VVVKPCSGGSSIGVYIVTTESEYEEALSSSFRYEDEVVIEEYIKGREFACGIIDGKALPP
IEIIPRTGFFDYANKYQDGATEEVCPADIDEDTANRMMELTVKAYRALKLNVYSRADFLL
DSRGKSLLP
>KF627139.1_19928|FEATURES|farme|glycopeptide|vanD|antibiotic target alteration|1
MKYRMEIDMSKLKVAVLFGGQSSEHEVSCRSALTIIHNMDKECYEQLLVGITKEGRWLLT
PNAGAIEDGSWRNGSTELILSPDTTHKGFIAMKDGRSEVIAVDVVFPVLHGLYGEDGTVQ
GVLELAKIPYVGCGVVASGVSMDKLFTKIIAATVGVKQAGYEAVRRTELEDMDIVVDRIE
KALPYPVFIKPANAGSSCGVSKAKDRDGLIKGLKLAAQHDRKLLVEETIVGREVECAVLG
GENPEASGVGEVLPAGNAAFYDYEAKYANADSKTDTHPSFPEGKEDEIRSDAVKIFKAVD
GYGLARVDFFLKEDGTVVFNEINTLPGFTSISMYPMLWNERGVNVTDLIDKLIELALKRF
>KF627127.1_19954|FEATURES|farme|glycopeptide|vanL|antibiotic target alteration|1
FVTGGVPTPVGIRLKKGQTPDVKVPYPCVVKACCGGSSVGVVMANNDEEYAKALEEAFKY
DDEVVIEQYIKGREFSVGVVDGKAYPIIEIAPLHGFYDYKNKYQAGSTIETCPAELSEEK
TLSMQAAAELAFKVLRLKNYARMDFMMDEKGDFYCLEANTLPGMTPTSLLPQEAKVLGIE
YEDLCQLLIDISMRDE
>KF627123.1_19962|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
KPSGSVCGMEVGELVHVIADAHIYDRHIPLVKELISRPCYDAPTFWLNPEVKDFYQFTRD
DVRVDNYVTGPQITNIPVAV
>KF627114.1_19987|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SLFGQQMRFDLSEYFPLLTTKTVFFKGLAYELLWFLKGSTNVRWLQERNVHIWDEWADEN
GDLGPVYGAQWRSWPAPTPDDPNRTIDQISNVLDLVENHPDSRRMVVSAWNPAEVENMAL
PPCHALFQFYVADGKLSCQLYQRSCDMFLGVPFNIASYSLLTLMIAQQAGLQPGEFVWTG
GDCHVYDNHIDQVLEQLSRDPYPYPQIRINKADSLFDYDYSDFVIVGYQHHPTIKAPVAV
>KF627111.1_19996|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MPASPIRKLAPLADAAKQRGIHVYHLNIGQPDLPTPRAALDAIRNIDRTVLEYSPSQGYR
SYREKLVGYYKKYDINLSADDIIITTGGSEAVLFAFLSCLNPGDEIIVPEPAYANYMAFA
ISVGAVIRTVTTTIEEGFSLPKVEKFEELINERTKAILICNPNNPTGYLYTRREMNQIRD
MVKKYDLYLFSDEVYREFIYTGSPYISACHLEGIEENVVLIDSVSKRYSECGIRIGALIT
K
>KF627108.1_20004|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|1
MKDKTKLLILFGGVSSEHEVSRVSASSILTHINGGKYEIYTVGITKEGNWFLTSSPAVRI
GDGSWEQDPANKNVALSLDRASRGLVVLEDAEAVKKISIDVVFPVLHGRNGEDGRMQGLL
QIAGLPFVGSDTISSAASMDKAITKVMVEEAGGISQADAVLVYHQRYAKDPYGELLGITS
YFNDTYPLFVKPANAGSSVGISKVKNAEELPKALETAFAEDDKVLVEEAITGREIEVAVL
GNEEPEASCIGEIFAANEFYDYNAKYENDASKTAVVTDLDPKKEQEIKDTAVKIYRIMGC
RGLARVDFFLKDSGRVVFNEINTLPGFTNISMYPQLWEASGIPYPDLIDRLIELALEQ
>KF627106.1_20010|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
LPGFTNISMYPKMWEATGLEYSKLIDRLIELALDSKK
>KF627077.1_20088|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
MAKKRVVVLYGGRADEHSISCISTAGVLGAMDTERLEPIPVGITKDGKWIINGEDPRGWN
LDGGELPTVKITPESRPVMLDPSRGQDGFFIGEPSHINSADSGFGTSFVSMSDPEMHHVL
TSLGHVDAVLPVLHGPYGEDGTVQGLLEMMGVPYVGCGVFASAACMDKHYTKVVLDAAGI
PTAPGVTVDARNFTAADVLAKIEDAGLAYPLFVKPSRAGSSFGVTKVEKADDRETQQDRL
AAAIATAGEHDWKVLVEQGIDGREIECAVLCPKAGDEPEASWPGEIVLDHQNDDQFYDFD
SKYMDASASHVEVPANLPVSVLEDVRDVARRAFKAVDGAGLSRVDTFVTPDGTVMVNEIN
TMPGFTSISMYPKAWEATGVRYTELITRLIEGVLR
>KF627070.1_20107|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
DQISEVMETLKHNPDSRRIIVSAWNVADLNNMNLPPCHAFFQFYVADGRLSLQLYQRSAD
IFLGVPFNIASYALLLQMMAQVTGLKAGDFVHTFGDAHIYLNHLEQVKLQLSREPRPLPQ
MKINPDVKNIFDFKFEDFELVNYDPHPHIAGAVAV
>KF627066.1_20115|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
LINERTKAILICNPNNPTGYLYTRREMNQIRDMVKKYDLYLFSDEVYREFIYTGSPYISA
CHLEGIEENVVLIDSVSKRYSECGIRIGALITKNKEVRNAVMKFCQARLSPPLIGQIAAE
ASLDAPEEYTRETYDEYVERRKCLIDGLNRIPGVYSPIPMGAFYTVAKLPVDDSEKFCAW
CLSEFNYEGETVMMAPAAGFYTTPGAGRNEVRIAYVLKKEDLVRALFVLRKALEAYPGRV
ED
>KF627060.1_20129|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MEKLRVGIVFGGKSAEHEVSLQSAKNIVDAIDKSRFDVVLLGIDKQGQWHVSDASNYLLN
ADDPAHIALRPSATSLAQVPGKHEHQLI
>KF627052.1_20148|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGSAGLSATEEDWGDDFPKTFSVNLIWAQARDKEGRAGAIGLNGGM
PWHCAEDMKHFKELTVSHPVIMGRKTWESLGVKYRPLPNRDNIVISHNPMYRAPGATVVT
GLDDALDLARQEATPDDGLDRSEIWVIGGAQLFFEALPFADKAYVTDLDATVDADAYAPD
VESLVEAGLWHEAEAGEWLTPAKDEPGIAAYRFRILRKTK
>KF627045.1_20163|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MLSIIVAIAENNLIGGDNKLLWHLSEDLKRFKEITMDNTLIMGRKTFESLPGILPGRKHI
VITRDENYKVDSNQVEIVHNIQDVINEYANNSENAFVIGGGEIYNTTFPYCSKLYLTKIK
RSFSGDTYFPDIDFSKWKITYSSGEKKDPKNGIEFEYINLDRQ
>KF627038.1_20186|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MTKKIVAIWAQDEEGVIGKDNRLPWHLPAELQHFKETTLNHAILMGRVTFDGMGRRLLPK
RETLILTRNPEEKIDGVATFYDVQSVLDWYQAQDKNLYILGGKQIFQAFEPYLDEVIVTH
IHARVEVDTYFPEEFDLSLFETVSSKFYSKDEKNPYDFTIQYRKRKEV
>KF627030.1_20211|FEATURES|farme|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTAIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFHKVM
>KF627026.1_20223|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
WAFERYIKSPDYNGPDMTDFGHRCLTDPEFNEEYKKQSKLFCEKILTDDSFAETYGDLGH
IYGYQWRHWETKDGGFIDQIKEVIEAIKKTPDSRRLIVSAWNPEDVPSMALPPCHTMFQF
YVQEGRLSCQLYQRSGDVFLGVPFNIASYALLTHLIAHETGLAVGEFVHTLGDAHLYINH
IEQMKEQLSREIRAFPTLVLNQEKQSVFDFEMEDIQLEGYDPHPAIKAPIAV
>KF627023.1_20230|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MEHDSSRSGYHEPEPGLAGLEDEEDWGDDFPKTFSVNLIWAQACDKEGHDGAIGFEGGMP
WHLPEDMRRLKELTVSHPVIMGRKTWESLSPKYRPLPNRDNIVVSRDPAYTAPGATVVDS
LDDALDLARQEAIPDDGLDRSEIWIIGGGQLYREAMPFADKAYVTQISMHADADTYAPDV
KSLVESGAWKVLEEGVWQNTRKGSGDIAGFRFMTYAKNREE
>KF627019.1_20240|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MIKTNRDSRLLIFSAWNPEDVPSMALPPCHTMFQFYVNEGKLSCQLYQRSADVFLGVPFN
IASYALLTHLIAHETGLEVGEFVHTLGDAHLYQNHVEQMQEQLSREVRSFPTLVLNPDKA
SVFDFDMEDIKVEGYDPHPTIKAPIAV
>KF627010.1_20255|FEATURES|farme|multidrug|mexf|antibiotic efflux|1
GDRAQRVIDDVLKLSVPNASGEMVPFSSFTRVEEQLGMDQINRYNMYSTAAVTCNVAPGS
SSGEGIRQMESLIKEHLGDEFGYEWTSVAYQETQAGTTTTVVFVMALLVAFLVLAAQYES
WTSPVAAVMGLPVALLGAMLGCYVMGTPVSIYTQIGIILLVALSAKNGILIVEFARDFRA
QGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGAGSRIALGAAVVFGMALNT
LLATVYIPNFYELMQKLQEKFSKKQ
>KF626990.1_20292|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
VVSYADQVFMQNIREILDHGVWDTDQNVRPHWEDGTPAHTIKKFGIVNRYDLQKEFPILT
LRRTYWKTAVDELLWIWQKKSNNVHDLNARIWDQWADETGSIGKAYGYQLAVKHHYPEGD
MDQVDRVLYDLKHNPASRRILTNIYNFADLSEMHLYPCAYSMTFNVSGNVLNAILNQRSQ
DMLAANNWNVVQYAVLVYMMAQVSGLVPGELVHVIADAHIYDRHVPIVEKMLTQTPAPAP
KFAIDPSVTDFYAFTRNSFTMEGYTPAPFENKIPIAI
>KF626985.1_20307|FEATURES|farme|quinolone|patB|antibiotic inactivation|0
MIDYNKVLCPAIKEMKPSGIRKFFDIAQQLEGVISLGVGEPDFKTPWLIRQEAISTLEKG
KTCYTANAGLIALREEIAKYFQRTIHTSYDPNKEIIVTVGGSEAIDLTIRCLIQPGDEVL
IVEPSFVCYRPIVSLCGGVPVVIETKEENEFRLTADELREKITDKTKLLVLPYPNNPTGA
IMRREDLEAIAKVLKDTNIMIASDEIYSELTYSGKHCSIAEIEGMRERTIVINGFSKSFA
MTGWRLGFLGGPKEIVSQMLKLHQYAIMSSPTVSQYAAIVAMHSCQKDIDAMRNEYNIRR
RFVVDSFNKLGLKCFAPQGAFYVFPCIKSTGMTSTDFCEKLVYTKKVAVVPGDAFGECGE
GYVRVSYAYSLNHLREAIKRIGEFLEDIKNGNVQ
>KF626983.1_20313|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MNVGELVHVIADAHIYDRHIPLVEELIQRPVHDAPKFALNPEIKDFYDFTPEDVTVTDYV
TGPQIKNIPVAV
>KF626983.1_20314|FEATURES|farme|trimethoprim|dfrA20|antibiotic target replacement|1
MNLIAAVDKNWAIGLKNKLLVSIPADMKFFRETTTGKVVVMGRKTLESFPNQRPLKNRVN
IVLTKDETYQVKDALVVHDMEQLREELAKYPSEDIYVIGGESIYRQLVDECDVAHITKID
YAYEADAYFPNLDEKEEWEITADSEEQTYFDLEYRFLKYEKRSC
>KF626981.1_20319|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
LSATTVIKNMDTEKYNVILVGITKEGKWLLVDGVKDIEDGSWREGEVKAFISPDTTTRSL
VILAEGTYKLQKVDVIFPVLHGMNGEDGTVQGLFELSKIPYVGCGVLASAVSMDKVYTKI
IVDHIGIDQAKFVHVRESDFEHLEEAMDRVEKEIPYPIFVKPSCAGSSKGVSKAENRKEL
EAALYEAVKHDRNILCEETIVGREVECAVLGDRTQVKSTCVGEILAAEEAAFYDFDAKYN
NAESKTVVDPEMPEESKRKIKEDAEAIFRAVDGFGLSRVDFFLEESGRVVFNEINTLPGF
TSISMYPMLWKACGLDIPELLDTLIDQAMTRYR
>KF626979.1_20324|FEATURES|farme|multidrug|mdtK|antibiotic efflux|0
MLYSKKTDYLMESIRLGREMDRREKLNLIVGLSIPSMLAQISTVMMFFIDASMVGHLGAE
ASASIGLIESTTWLIGSLLSAAATGFSVQVAHFIGANDFANARQVFRHALICGVAFSIFV
SLLCVGIHAYLPYWLGGGADIATNSSRYFLIYGLVLPFVFLYHISEMMLKSAGNMHTPSV
MAVLICICDVIFNYLFIYILKLGVVGAALGTAMAYVCISLPNLYLAGFKNKILNLRQDHV
RFRWVRSYVHNACKISIPIAIQNILMSGAQIVSTMIVAPLGNIAIASHSFAITAESLCYM
PGYGIGDAATTLVGQTHGAGRVGLCKNFAYMTVGLGMAVMAVMGVVMYVFAPEMIGVLSP
VESIREMGTICLRIEAFAEPFFAASIVTYCVCVGAGDTRKPAMINLGTMWLVRLTLAYAL
SKSYGLEGVWIAMAIELTFRGILFLIRLFRGSWMKSFHVG
>KF626973.1_20338|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMILNQRSQDILAANNWNVCQYA
ILLMMVAQSVDMIPGELLHVIADAHIYDRHVDIVRGLIERPQFAAPKVTLNPDVHDFYAF
TTDDLIVEGYEHGPQVKNIPIAV
>KF626953.1_20393|FEATURES|farme|glycopeptide|vanA|antibiotic target alteration|0
VDQEGTPWFLEINTLPGMTPTSLVPQEAAAVGIDYASLCQRIIEESLRVRKG
>KF626952.1_20397|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
GIMDIVVLAGGLSTERDVSFVTGNMVSKALRKNGHRVILLDVFMGYSDKKEDISDIFEHT
EEVSVQIEEIPTVAPDLAAVKASRADQSDNFFGPNVIEICQKADVVFMALHGENGENGKI
QAAFDLFGIRYTGTGYLGSALAMDKNIAKQFFVANGIPTPGGIRMKRDEQIRDFAKTGLN
LPCVVKPCCGGSSIGVSIVRTIEEYEAALEEAFRWEEEILIEDYIEGREFSVGVLEGKAL
PIIEIAPVEGFYDYKNKYKAGSAVETCPAQLSEAVTKQMQQYAVEVTKVLGLGAYSRMDF
LLDSREQMYCLEANTLPGMTPTSLLPQEAQAVGVSFEQLCEKLIELSLKKYA
>KF626948.1_20408|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GKAYGYQMGIKYRFAQGEMDQVDNVIWQLKNTPYSRRILTNIYNFRDLSEMNLEPCAYSM
TFNVTGKKLNAILHQRSQDILAANNWNVVQYSVLVHMLAQVSGLVAGELVHVIADAHIYD
RHVPIIKELIERPQYPAPKFSLNPDVRDFYDFTADDIHIEDYQKNPQILNIPIAI
>KF626946.1_20411|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
MNIIVNADKNWAIGKNNSLLVRIPADMKYFRQMTEGNIVVMGRKTLESFPQGRPLANRVN
IVISHNPDYQMKDAIVVHSVEEAIQECKKHKGEVFVIGGESIYRAMLPYCNIAYVTRTDH
VYEADTWFPDLEKDPDWQKTAETDEQTYFDLEYVFAKYERIK
>KF626943.1_20419|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MSQLFFRNPLQIFVNYDKIENEISAPLCVLSDFCERSWHFSCFRQHIGSKSSLPADMMHQ
ASNRPQYCPAAGYQLIKEFRHMAKIRVAVLFGGVSSEHDVSLISAENVIRSIPKDKYEVL
CIGITKKGRWLYFPGDITEISTGAWEQNPDCSAAILSPDPLHGGIIPIENGETYIKKVDV
VFPVLHGRNGEDGRLQGIMEMARIPYVGCGVLSSAVCMDKGMTHTVLDYNGIQTAKWANV
HQRDLNKLDEKCVAIAETLGFPLFVKPANAGSSVGVNKANDLESLKDAVQIAFTHDEKVI
IEEFIDGRELEVAVFGYDAPIASYVGEIEPAAEFYDYDDKYVNGTSKLYIPARITDQESD
RIRETALRAYQALGCKGLSRVDFFLAKDGSVILNEINTLPGFTSISMYPKLMEHLGMSQE
YLVDKLIEQAMENVART
>KF626942.1_20421|FEATURES|farme|glycopeptide|vanG|antibiotic target alteration|1
MKIVVLAGGLSTERDVSLTSGAGICITLRENGHQAFLLDVFLGFPYDSDKLEEVFTLPNA
GLEIADGIKTTEPDLAAIKASREDQSDCFLGPNVIDICRLADIVFMGLHGDVGENGKLQA
TFDILGIKYTGPNYLGSALAMDKGVTKQIFTMAGVPTPLGTNLTKDRKDTALSDLGLTLP
VVVKPCSGGSSIG
>KF626934.1_20440|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SRRIIVSAWNVGDLDHMNLPPCHAFFQFYVANGRLSLQLYQRSADIFLGVPFNIASYALL
LQMMAQVTGLQAGDFIHTLGDAHIYLNHLEQVKLQLSREPRPLPQMKINPDVKNIFDFQF
EDFELVNYDPHPHIAGKVAV
>KF626923.1_20468|FEATURES|farme|chloramphenicol|cat|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTILN
RHEEFRTALDKNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAY
GERKGMFAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHH
>KF626917.1_20484|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
PTRGLQQYLDLLRKIRKDGIVKSDRTGTGTRSIFGYQMRFDLEAGFPLLTTKKVFLKGVI
YELLWFLQGDTNIKYLLDHGVHIWDNDAYRYYNELCVRHGVLPLEREAFLDAVRREEPSS
IDGYRPGDLNHVYGYQWRSWPRPDGGCIDQIRQVIDQIKHSPDSRRMLVSAWNVAEVDDM
ALPPCHVLFQFYVAGGRLSCQLYQRSADTFLGVPFNIASYALLTMMIAQECGLRPGDFVH
TLGDAHLYLNHADQVAEQLSRTPRPLPTLRLNPAVRSVFDFRYEDFTLENYDPWPAIKAP
MSF
>KF626907.1_20509|FEATURES|farme|trimethoprim|dfrE|antibiotic target replacement|0
MAQVCDMEAGELVHVIADAHIYDRHIPIIKEMIKRETYPAPKVTLNPEVKDFYEFTTDDF
KIEDYQAGEQIKDIPIAI
>KF626903.1_20520|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
ILLMMIAQVCDMEAGELVHVIADCHIYDRHVPVIKELISRTPYPAPTVKLNPEIRDFYEF
TTDDLIVENYQTWPQIKNIPIAI
>KF626902.1_20521|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MNNLSIIVAIAKNNGIGKDNQLLYWLPNDLKRLKALTTGHTVIMGRKTFDSLPKGALPNR
RNIVLSRQDGLVCAGAECFTSLEEALAHCNAEEEIFIMGGASVYKEALPLTHRLYITLVH
DTGKQADVFFPEIDEKVWKETGREDHH
>KF626899.1_20528|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSTSTEGEKVRPVWEDGTSAYTIKRFGVVNRYDLRKEFPALTLRRTALKSAMDEILWIWQ
KKSNNIKDLHSHIWDSWADENGSIGKAYGYQLGVKHQYKEGMMDQVDRVLYDLKNNPYSR
RIMTNIYVHQDLHEMNLYPCAYSMTFNVTKEKDSDRLTLNGVLNQRSNDVLAANNWNVCQ
YALLLMMIAQVCDMKAGELLHVIADAHIYDRHIPLVKELISRETHPAPKVWLNPEVKDFY
AFTVDDLHVEDYVTGPQIKNIPIAV
>KF626889.1_20555|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
SIGKAYGYQLGIKYRFPEGEFDQVDRVLYDLKHNPASRRILTSLYNFADLHEMALYPCAY
SMTFHVSGNRLNAILNQRSQDMLTANNWNVVQYAVLVHMLAQVSGLVAGELVHVIADCHI
YDRHIPLVEQMLELEPYPAPEFRLDPAVTDFYAFTPDSVRVENYCYHPFSARIPVAI
>KF626884.1_20564|FEATURES|farme|trimethoprim|dfrA26|antibiotic target replacement|1
MKWIVVADPDGGIGKEGKLLADLPTDMKHFRTKTKGKTVIMGRATLESFPGGKPLPMRRN
IVLSRTLPESEAYEVCRSVDELLELVKDDDPDDLYVIGGGQIYEQLLPYCDEAFVTELET
VFDSDTKIPLLSQTPEWERTEESEPICENGIDYRFVVYRRR
>KF626870.1_20602|FEATURES|farme|glycopeptide|VanD|antibiotic target alteration|1
VQEITPARLPEDTAERVRLLTSAIYDILGCSGIIRIDYIITEGDKVNLLEINTTPGMTAT
SFIPQQVRAAGLDIKDVMTDIIENKF
>KF626866.1_20610|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
AFFQFYVADGRLSLQLYQRSADIFLGVPFNIASYALLLQMMAQVTGLKAGEFIHTLGDAH
IYLNHLDQVKLQLSREPRALPQMKINPDVKSIYDFQFEDFELVNYDPHPHIAGIVAV
>KF626862.1_20624|FEATURES|farme|trimethoprim|dfrA3|antibiotic target replacement|1
MSLSIIVARAANGVIGNDNKLIWHLPDDLKMFKSRTMGRPIIMGRKTFESLPKVLPGRVH
YVLTGNRAYSVPEGVYVFHTVKELLSALPEGENFIIGGEKMYEAMFPYADKMYITEIEKE
YDGDAVFPSFRKEEWKETESVMGKGDPVHRFVTYKRVRG
>KF626853.1_20654|FEATURES|farme|multidrug|sav1866|antibiotic efflux|1
MYDLLPNQQYRTFFIVMGVMMAAFIVRALLYYVISYWGHTFGILVEADIRRDLFTHVQEL
DVSFFDHNRTGQLMSRLTSDLFEITELAHHGPEDLLISTLTIVGALAILFSIEWRLALVV
ACILRVFIAVIMSRRSKMTAASRGEKQKTAAINVGIESSLSGIRTARAFANEEEEIDKFN
AANEEFKVSKRKFHHEMGVFNATMEFFMTLLSAAVITVGGYLIMRGEMNYIDLITFSLYI
ATFINPVRKLANFSEIFARGFAGLERFTALMRVEPALKDAPDAKELEHCRGKIDVDHVSF
SYEGEENEGVLHDVSVHIRPGEMLAVVGPSGGGKSTLCQLIPRFYEVSEGAIRIDGEDVR
SLTQSSLHRAIGIVQQDVFLFADTVRENIRYGRPDATDEEIVEAAKRAEIYDDIVAMPHG
FDTYVGERGTMLSGGQKQRTV
>KF626836.1_20699|FEATURES|farme|trimethoprim|thymidylate_synthase|antibiotic target alteration|0
MCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTLRRTALKSAMD
EILWIYKKKSNTVHDLNSHIWVEWADETGSIGKGYGSQIGQKSHYAEGDFDQMDRVLYDL
KHTPYSRRIMTNTYVFSDLSEMHLYPCWPEEPLCRGRL
>KF626834.1_20706|FEATURES|farme|trimethoprim|dfrG|antibiotic target replacement|1
MQAILSADRNWGIGKDGGLLVRVSEDMKFFRKKTQGHAVVMGRKTFESLPGLLPGRRNII
LSRSGICPPGAEAATGVLELLELLGPEEEQAFVIGGGEIYRQLLPYTE
>KF626832.1_20709|FEATURES|farme|trimethoprim|dfrK|antibiotic target replacement|1
RFSQDMAFFKEKTMGKTVVMGRKTLESFPNAKPLKNRKNVVLTTDKNFKCDGTEIVHGIK
TIVEKYGGDDTFVIGGGEVYKQLLPYCDSAYITKVFSDGNADVFIDNLDENEVWELGNVS
EKHVENGISFVFCTYINKNPQSHFEQKTL
>KF626820.1_20740|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
HIWDSWADEDGSIGKAYGYQMQVKHQYKEGMMDQVDRVIYDLKNNPYSRRIMTNIYVHQD
LHEMNLYPCAYSMTFNVTKEKDSDKLTLNGILNQRSQDVLAANNWNVCQYAVLLHMLAQV
CDMKVGEFVHVIADAHIYDRHIPMIEELIKREPLPAPKFWLNPEVKDFYEFTPDDVRLDG
YETHPQIKNIPIAV
>KF626816.1_20750|FEATURES|farme|multidrug|MexB|antibiotic efflux|1
PPSRSGILIVEFARDFRAQGNSIRDAAFQAGHIRLRPILMTSLAFVFGVMPLLFATGAGA
GSRIALGAAVVFGMALNTLLATVYIPNFYELMQKLQEKFSKKQ
>KF626808.1_20770|FEATURES|farme|trimethoprim|dfrD|antibiotic target replacement|1
EGREQLQADNESGKQKNKNVSDRRIIMNLIVAADKNWGIGKDNKLLVSIPSDMKFFRQET
MGKVVVMGRKTLESFPNGLPLKNRTNVVLTSDKNYQVKDAVIVHSEEELLEELKKYPSEK
IYVIGGESIYKMMLPYCDTVYVTKIDREFQADTYFPNLDQMEDWKMTEEGEEQTCFDLEF
AFTKYERC
>KF626803.1_20781|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
NWNVCQYAVLIHMLAQVCDMEVGEFVHVIADAHIYDRHVPMIEELISREPLPAPQFWLNP
EIRDFYQFTRDDVKLIDYQTHDQIKNIPVAV
>KF626775.1_20852|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
GGHIDQIKEAIDTIQNNPDSRRIIVSAWNVADLPQMNLPPCHAFFQFYVANGKLSLQLYQ
RSADIFLGVPFNIASYALLLMMVAQVTGLEAGDFVHTLGDAHIYNNHIEQVREQLSREPR
DLPKMKLNPDVKSIFDFKYEDFELTDYNPHPHIAGKVAV
>KF626770.1_20865|FEATURES|farme|bacitracin|uppP|antibiotic inactivation|0
MGMQSIVGRGDLLRKVHFPNYIIVASTTMGSMISLGINLCVVLLFGFFAHAHYTWRVLLV
PFNIIQLYCLGLGVALLLASLFVYFRDVAHIWEVVLQAMFYATPIIYPISMVVNNPEFSW
AGKLLMLNPSTQIIMDIRHNLLSPEYVPTVWTMVDNRLLCLLPYVLSVFILCLGIHVFRK
YSSKFAEVL
>KF626712.1_20977|FEATURES|farme|beta_lactam|BAMA_03925|antibiotic inactivation|1
NENVNADYDSLFQELEEKYDATLGIYALDTETNKEISYNADERFAYCSTYKALAAGAILE
KYSIEELDNVIYFEEEDVLSYAPVAKDKVDTGMTIREICDAAVRQSDNTAGNLQFTLLDG
PNGFKQSLSKIGDTVSEPSRIETELNDAVPGDIRDTSTPKQLAFNLKEYVTGDILSDDKK
EIFIDWMSNNATGDELIRAGVPSDWIVADKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSK
KAEQDAEYDNKLIADATKIIFDLIS
>KF626708.1_20984|FEATURES|farme|trimethoprim|dfrE|antibiotic target alteration|0
MSKADQQFVTMCRDILDHGTTTEGQKVRPVWEDGTPAYTIKNFGVTARYDLREEFPALTL
RRTALKSAMDEILWTYQKKSNNVHDLNSHIWDEWADETGSIGKAYGYQIGQKSHYAEGDF
DQMDRVLYDLKHTPYSRRIMTNTYVFSDLSEMHLYPCAYSVTYNVTQRPQDDKPTLNMIL
NQRSQDILAANNWNVCQYAILLMMVAQSVDMIPGELLHVIADAHIYDRHVNIVREL
>AAB17563|FEATURES|argannot|aminoglycoside|AAC(2')-Ic|antibiotic inactivation|1
VHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
HAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSA
RARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDV
W
>CAA39184|FEATURES|argannot|aminoglycoside|AAC(3)-IIIa|antibiotic inactivation|1
MTDLNIPHTHAHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGT
LMMYAGWQDIPDFIDSLPDALKAVYLEQHPPFDPATARAVRENSVLAEFLRTWPCVHRSA
NPEASMVAVGRQAALLTANHALDYGYGVESPLAKLVAIEGYVLMLGAPLDTITLLHHAEY
LAKMRHKNVVRYPCPILRDGRKVWVTVEDYDTGDPHDDYSFEQIARDYVAQGGGTRGKVG
DADAYLFAAQDLTRFAVQWLESRFGDSASYG
>AAA25682|FEATURES|argannot|aminoglycoside|AAC(3)-IIIb|antibiotic inactivation|1
MVHAAVSRVGRLLDGPDTIIAALRDTVGPGGTVLAYADWEARYEDLVDDAGRVPPEWREH
VPPFDPQRSRAIRDNGVLPEFLRTTPGTLRSGNPGASLVALGAKAEWFTADHPLDYGYGE
GSPLAKLVEAGGKVLMLGAPLDTLTLLHHAEHLADIPGKRIKRIEVPFATPTGTQWRMIE
EFDTGDPIVAGLAEDYFAGIVTEFLASGQGRQGLIGAAPSVLVDAAAITAFGVTWLEKRF
GTPSP
>AAA25683|FEATURES|argannot|aminoglycoside|AAC(3)-IIIc|antibiotic inactivation|1
MFSRWSKPLVLAAVTRASLAADLAALGLAAGDAVMVHAAVSKVGRLLDGPDTIIAALSDA
GRPAGTILAYADWEARYEDLVDEDGRVPQEWREHIPPFDPRRSRAIRDNGVLPEFLRTTP
GALRSGNPGASMVGLGARAEWFTADHPLDYGYGEGSPLARLVEAGGKVLMLGAPLDTLTL
LHHAEHLADIPGKRIRRIEVPLATPTGTQWRMIEEFDTGDPIVEGLAEDYFAEIVTAFLA
GGRGRQGLIGTAPSVLVDAAAITAFGVAWLESRFGSPSS
>ABS70978|FEATURES|argannot|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKFGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAQKAAQRSCEPSG
>AAA25334|FEATURES|argannot|aminoglycoside|AAC(3)-IXa|antibiotic inactivation|1
MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDV
VGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRW
PGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMT
LLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIA
RDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR
>CAA33850|FEATURES|argannot|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
QPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPRFEQPRSEIYIYDLAVSGEHRRQ
GIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>AAD46626.1|FEATURES|argannot|aminoglycoside|AAC(6')-IIc|antibiotic inactivation|1
MSANNAAIVLRVMAENDLPMLHAWLNRPHIVEWWGGEDERPTLDEVLEHYSPEVLAKQAV
VPYIAMLDDEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTKLVRS
LVELLFSDPAVTKIQTDPSPSNHRAIRCYEKAGFVQEKNILTPDGPAVYMVQTRQAFESL
RTVQSFKIKGKWS
>AAA98298.1|FEATURES|argannot|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
MNYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKECIESPNLCFGLLIN
NSLVGWIGLRPMYKETWELHPLVVRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDE
YYRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYIVGIIPNANGKNKPDIWMWK
SLIKE
>AAA26549|FEATURES|argannot|aminoglycoside|AAC(6')-Ic|antibiotic inactivation|1
MIVICDHDNLDAWLALRTALWPSGSPEDHRAEMREILASPHHTAFMARGLDGAFVAFAEV
ALRYDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>AAA21889|FEATURES|argannot|aminoglycoside|AAC(6')-Ig|antibiotic inactivation|1
MNIKPASEASLKDWLELRNKLWSDSEASHLQEMHQLLAEKYALQLLAYSDHQAIAMLEAS
IRFEYVNGTETSPVGFLEGIYVLPAHRRSGVATMLIRQAEVWAKQFSCTEFASDAALDNV
ISHAMHRSLGFQETEKVVYFSKKID
>AAK63041|FEATURES|argannot|aminoglycoside|AAC(6')-Ip|antibiotic inactivation|1
MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
IIEYDTIPIGYAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVC
QYLRTEMDADAVILDPRKNNLRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV
>AAD03494|FEATURES|argannot|aminoglycoside|AAC(6')-Iv|antibiotic inactivation|1
MKIMPISESQLSDWLVLRCLLWPDHEEQHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGIATGLVQHVEIWAKQFSCTEFASDAALDN
QITHAMHQALGFQETERVVYFKKNIG
>AAF03531|FEATURES|argannot|aminoglycoside|AAC(6')-Iy|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>AAD52985|FEATURES|argannot|aminoglycoside|AAC(6')-Iz|antibiotic inactivation|1
VIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGETVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>AAN41429|FEATURES|argannot|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
VKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEEPVEVLIARDATGAAVGHVELSIRH
DLEELQGIKTGYIEGLYVAPSHRSTDLVKRFLRESEKWALEQGCSAFASDRSDRVITHRK
FAGSAV
>AAV49321|FEATURES|argannot|aminoglycoside|aadA13|antibiotic inactivation|1
MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDD
TTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWA
GDERNVVLTLSRIWYSAATGKIAPKDVAANWAMEHLPAQHQSVLLEARQAYLGQEEDRSV
LRADKLEEFIHFMKSEITKVLGNDV
>ACF17980.1|FEATURES|argannot|aminoglycoside|aadA16|antibiotic inactivation|1
MSNAVPAEISVQLSQALNVIERHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDE
TVRQALFVDFLEVSASPGQSEALRALEVTIVVYGDVAPWRYLARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNSVPESDLFKALADTLKLWNSQPDWA
GDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLA
SRADQLTAFIYFVKHEAASLLGSTPMMSNSSFKPTPLRGAA
>CAK12750|FEATURES|argannot|aminoglycoside|HMPREF9349_04665|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVIGK
>ADM53774.1|FEATURES|argannot|aminoglycoside|aadA24|antibiotic inactivation|1
VIAEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRR
ALLNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVLLEARQAYLGQEEDRLALHAD
QLEEFVHYVKGESTKVVGK
>AAN34365.1|FEATURES|CARD|aminoglycoside|aadA4|antibiotic inactivation|1
MGEFFPAQISEQLSHARGVIERHLAATLDTIHLFGSALDGGLKPDSNIDLLVTVSAAPND
SLRQALMLDLLKVSSPPGNGGPWRPLEVTVVARSEVVPWRYPARRGLQFGEWLRHDILSG
TFEPAVLDHDLAILLTKARQHSLALLGPSAVTFFEPVPNEHFSKALFDTIAQWNSESDWK
GDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPIICKARAAYLGSEDDDLA
MRVEETAAFVRYAKATIERILR
>AAF17880.1|FEATURES|argannot|aminoglycoside|aadA5|antibiotic inactivation|1
MGEFFPAQVFKQLSHARAVIERHLAATLDTIHLFGSAIDGGLKPDSDIDLLVTVSAAPND
SLRQALMLDLLKVSSPPGDGGTWRPLELTVVARSEVVPWRYPARRELQFGEWLRHDILSG
TFEPAVLDHDLAILLTKARQHSLALLGPSAATFFEPVPKEHFSKALFDTIAQWNAESDWK
GDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPLICKARAAYLGSEDDDLA
MRVEETAAFVRYAKATIERILR
>CAA24595|FEATURES|argannot|bacitracin|uppP|antibiotic inactivation|0
MKERYGTVYKGSQRLIDEESGEVIEVDKLYRKQTSGNFVKAYIVQLISMLDMIGGKKLKI
VNYILDNVHLSNNTMIATVREIAEGTNTSTKTVNTTLKILEEGNIIKRRTGALMLNPELL
MRGDDQKQKYLLLEFGNFEQEDDQKQENALSEYYSFKE
>CAD44606.1|FEATURES|argannot|aminoglycoside|ANT(4')-Ia|antibiotic inactivation|1
MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLR
DSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFF
QRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAML
IGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVA
WAAEHDYVIHSKRIPF
>AAB49832|FEATURES|argannot|aminoglycoside|APH(2'')-IIIa|antibiotic inactivation|1
MKQNKLHYTTMIMTQFPDISIQSVESLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEI
QLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAVFPDDAKDRLALQL
AEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYM
THPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYDYVYLLEDCGE
LFTRQVMAYRGEVDLDTHIRKVSLFVTFDQVSYLLEGLRARDQDWISEGLELLEEDKANN
FGANSA
>ADQ43421|FEATURES|argannot|aminoglycoside|APH(3')-IIc|antibiotic inactivation|1
MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFS
ELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLA
DALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRAT
RPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRC
VAALFQRYGAVPDERRLAFYRLLDEFF
>AAB03856|FEATURES|argannot|aminoglycoside|AC230_04535|antibiotic inactivation|1
MSPPSPVLKNFEAWTMRCVHCGVGIPVVSGLLWRMGPRGLVFIGFGVVGGSCLSRWQLWG
PGWAWVRLSGWCGWRRWGFPYLVLWRVVGTRGSPGWSPKRFRGVRPVRGGRGSSGWTWRW
RSRGSLVRCTALDWERCPFDRSLAVTVPQARAVAEGSVDLEDLTRSGRGGRGSGFSPSWS
GLGLRTRISVCHGDLCPDNVLLDPRTCEVTGLIDWGGSAVRTGTPISRGAGVARAARVGR
GRCNRRKSCVYRLLDEFF
>AAB21326|FEATURES|argannot|aminoglycoside|APH(3')-Vc|antibiotic inactivation|1
MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLT
WLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHEL
PVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVL
CHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRF
LERYGAHHVDENKMAFYQLLDEFF
>EFI05284|FEATURES|argannot|aminoglycoside|APH(4)-Ia|antibiotic inactivation|1
MKSDYSKESITEFLSRKYGEDIRLFPIKEGQESQAYWFSRGGREYVVRINSNMEGFKKDK
YAYEHFRSDRVPIPEVVETGNFDGTHYFCISVKADGITYEDSDEETVVRLLGDITDVTEA
ISRTDISGTSGCGVFDSDTGNAPFYSWREYLAEVFERDWTAVSRSYVNLSLIDELLAAYR
ELISYCPEERALFHGDFGSNNVIVGKKSRISGVIDWDCAAYGDFLYDIATAYFWRTWLMC
MEKTAAYWERKYSHLPRYTERILCYELRIGLTEIYENAVENDTETTEWLQNRCREILREY
RQRKA
>AAD45541|FEATURES|argannot|aminoglycoside|APH(6)-Ib|antibiotic inactivation|1
MDTSKAIEVPEHLAASYSRGFGEEGRAWIAALPTLAAAFLDRWELRRDGAARAGEASLVL
PVLRQDGTRAVLKLQMPREETTAALIGLCTWNGAGTVRLLDHDPHSSTMLLERLDSARTL
ASLEDDDVAMGILAELLARLVSVPAPRELRRLKDIAADMLERVPRAVTALADPADRQLLR
GWAAAVAELIEEPGDQMLHWDLHYDNVLAAEREPWLAIDPEPLAGDPGFDLWPALDSRWD
DIVATGDTRRVVRRRFDLLTGVLGLDRGRAAGWTLGRLLQNELWDIEGGGSALAPSSVAM
AEALQNR
>BAC81971.1|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPE
SLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALY
ERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLE
REQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIG
TELIYLIKKNG
>ABJ53409|FEATURES|argannot|aminoglycoside|rmtD|antibiotic target alteration|1
MSELKEKLLASKKYRDVCPDTIERIWRECSAKFKKEKDVDKAAREALHGVTGAFMTEREY
KRAMEMAAARDWEALLGMHASTRERLPVESMDRVFDQLFEASGTPARILDLACGLNPVYL
AHRLPNAAITGVDISGQCVNVIRAFGGAEARLGDLLCEIPEDEANAALLFKVLPLLERQR
AGAAMDALMRVNAEWIVASFPTRSLGGRNVGMEKHYSEWMEAHVPENRAIAARLTGENEL
FYVLKRK
>ADA63498|FEATURES|argannot|aminoglycoside|rmtB|antibiotic target alteration|1
MNIDEMVAEVLSSKKYTSVDPAVVRRVCMETAPKYPKKKEAIKAVKNELHIIHEVFLQNE
CYKNALSFLSQLSLDFNNAQLIDITMQIMQSHTSTKERLGDIEAVCSFLSTHISKEGSVM
DIGCGFNPFALPLLHEFPATYYAYDICSEGINILNKYFSILKKGEYRAELLDAVSVTPKE
KVDVALLFKLLPLLQQQKKGRGFSILEELDFDKAIVSFPIKSLGGKQKGMETFYSNLFEE
NLPSSLEIIEKQTFSNEMFYVIQNKTKNGGNQS
>AGH19769|FEATURES|argannot|aminoglycoside|rmtH|antibiotic target alteration|1
MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQ
VEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLH
RQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLE
REQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIG
DELLYRIQPNPA
>AAK14791|FEATURES|argannot|beta_lactam|LCR-1|antibiotic inactivation|1
MLKSTLLAFGLFIALSARAENQAIAQLFQRAGVDGTIVIESLTTRQRLVHNDPRAQQRYP
AASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIA
LRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRRVVERKLPFKASS
YDSLKKVMFADENAQYRLYAKTGWATRITPSVGWYVGYVEAQDDVWLFALNLATRDANDL
PLRTQIAKDALKAIGAFHAK
>WP_013544541.1|FEATURES|argannot|aminoglycoside|ampS|antibiotic target alteration|0
MRFDIDEMISPEMLDRLAEVAIKVGLNLQEGQDLVLTAPVKALPLVRRITYYAYKAGAGV
ITPLFGDEALSLIRFENAHSASFDCAPSWLYEGMAKAFENGAARLAIVGDDPLLFSNQDL
DKISRLNKATSMAYQPALNKISNFTINWSIIAYPTPEWAIAMFSDLPLDKAVQKLAEAIF
SASRVTQDNAVYEWHAHNANLKQRSSWLNEQRFAALHFIGPGTNLTVGLADEHEWHGGTS
IAQNGVVCNPNIPTEEVFTTPHAYKVDGFVRSTKPLSYQGTLIDNIEVRFEEGRIINASA
SKGQEVLQRVLQSDEGASRLGEVALVPHSSPISKSGLLFYNTLFDENAACHIALGQCYSK
CFLNGAALTAEDIAMRGGNKSIIHIDWMIGSNEINIDGIMQDGAKIPVFRRGEWV
>ACJ05688|FEATURES|argannot|beta_lactam|ACT-7|antibiotic inactivation|1
MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>CBI75448|FEATURES|argannot|beta_lactam|blaACT-8|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEESHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMANWVMVNMKPDSLQDSSLRKGITLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>BAM34463|FEATURES|argannot|beta_lactam|ACT-16|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEAL
>CAG25815|FEATURES|argannot|beta_lactam|OKP-A-2|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>CAJ19599|FEATURES|argannot|beta_lactam|OKP-A-3|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19607|FEATURES|argannot|beta_lactam|OKP-A-9|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKALLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>CAJ19610|FEATURES|argannot|beta_lactam|OKP-B-2|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAJ19615|FEATURES|argannot|beta_lactam|OKP-B-7|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>CAP12359|FEATURES|argannot|beta_lactam|OKP-B-19|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRMLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>CAP12360|FEATURES|argannot|beta_lactam|OKP-B-20|antibiotic inactivation|1
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMVERNQQIAGIGAALIEHWQR
>AFB82585|FEATURES|argannot|beta_lactam|NDM-4|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AEN03071|FEATURES|argannot|beta_lactam|NDM-5|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>BAO79439|FEATURES|argannot|beta_lactam|NDM-12|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLDDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>BAQ02518|FEATURES|argannot|beta_lactam|NDM-13|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTNDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AKF43458|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASVRAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>AKZ20823|FEATURES|argannot|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTAHMADKLR
>ACJ05687|FEATURES|argannot|beta_lactam|MIR-5|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>ACA30419|FEATURES|argannot|beta_lactam|MOX-3|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWERYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>AGH56079|FEATURES|argannot|beta_lactam|MOX-8|antibiotic inactivation|1
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFNKTGSTSGFGAYVAFVPAKGIGIVML
ANRNYPIPARVKAAHAILTQLAR
>AAN63648|FEATURES|argannot|beta_lactam|TUS-1|antibiotic inactivation|1
MYHYFSSLFVLIFSTLVYPQSDKLKIEPLNDHMYVYTTYQVFQGVEYSSNALYVVTDEGV
ILIDTPWDKDQYAPLVEHIRREHNKEIKWVITTHFHEDRSGGLDYFNKAGAETYTYALTN
EILKQRNEPQATFTFGSTKQFNLGKEKIEVYFLGEGHSKDNTVVWFPEEAILYGGCLIKS
AEATTIGNIVDGNVEAWPTTIKAVKRKFKKAKVIIPGHDAWNQSGHLENTARILSAYQAQ
KLKNNKQL
>ACO57220|FEATURES|argannot|beta_lactam|NmcR|antibiotic inactivation|0
MRSNPPLNALRAFEASARHLSFTRAALELYVTQAAVSQQVRLLEERLGMVLFKRLPRGLE
MTEESRALFAVLTDAFGHIEKAFRQFEGGQFQEVLTVAAVGTFAVGWLLPRLDRFRQEHP
FVKLRLRTNNNVVNLAAEGLDFAIRFGTGLWPSTHNEMLFNAPLTVLCTPATAKRLVTPA
DLLQEDLLRSYRAEEWENWFAAAGLQAVRVNGAIFDSSRLMIESAIHSGGVALAPAKMFV
RELTTAQLVRPFATEINMGSYWLTHLKSKAMTPAMEIFSEWLLKEAAEDNT
>AAK63223|FEATURES|argannot|beta_lactam|Sed1|antibiotic inactivation|1
MLKERFRQTVFIAAAVMPFIFSSTSLHAQATSDVQQVQKKLAALEKQSGGRLGVALINTA
DNSQVLYRADERFAMCSTSKVMTAAAVLKQSETHDGILQQKMTIKKADLTNWNPVTEKYV
GNTMTLAELSAATLQYSDNTAMNKLLAHLGGPGNVTAFARSIGDTTFRLDRKEPELNTAI
PGDERDTTSPLAMAKSLRKLTLGDALAGPQRAQLVDWLKGNTTGGQSIRAGLPAHWVVGD
KTGAGDYGTTNDIAVIWPEDRAPLVLVTYFTQPQQDAKWRKDVLAAAAKIVTEGK
>AAB72007|FEATURES|argannot|beta_lactam|ROB-1|antibiotic inactivation|1
MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>BAP39824|FEATURES|argannot|beta_lactam|blaPER-8|antibiotic inactivation|1
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELK
KLSALSPN
>ACL01102|FEATURES|argannot|beta_lactam|KPC-4|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>ACE62798|FEATURES|argannot|beta_lactam|KPC-7|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAIDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ADH95186|FEATURES|argannot|beta_lactam|KPC-11|antibiotic inactivation|1
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVLWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AKQ06274|FEATURES|argannot|beta_lactam|blaKPC-24|antibiotic inactivation|1
MSLYRPLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>CAA40146|FEATURES|argannot|beta_lactam|LCR-1|antibiotic inactivation|1
MLKSTLLAFGLFIALSARAENQAIAKLFLRAGVDGTIVIESLTTGQRLVHNDPRAQQRYP
AASTFKVLNTLIALEEGAISGENQIFHWNGTQYSIANWNQDQTLDSAFKVSCVWCYQQIA
LRVGALKYPAYIQQTNYGHLLEPFNGTEFWLDGSLTISAEEQVAFLRQVVERKLPFKASS
YDSLKKVMFADENAQYRLYAKTGWATRMTPSVGWYVGYVEAKDDVWLFALNLATRDANDL
PLRTQIAKDALKAIGAFPTK
>AAK96394|FEATURES|argannot|beta_lactam|CARB-1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMEERNDAIVKIGHSIFDVYTSQSR
>AAG29763|FEATURES|argannot|beta_lactam|IND-3|antibiotic inactivation|1
MKKRIQFFMVSMMLSSLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
GVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHVKHTLELLNKK
>AAG29765|FEATURES|argannot|beta_lactam|IND-4|antibiotic inactivation|1
MRKNVRIFTVLSLFLINFFNAQARDFVIEQPFGKQLYLYKTFGVFDGKEYSTNALYLVTK
KGVVLFDVPWQKTQYQSLMDTIKKRHNLPVIAVFATHSHSDRAGDLSFYNKKGIPTYATA
KTNELLKKEGKATSSKLTKIGKKYKIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCL
VKSSAAVDLGYTGEANVEQWPATMKKLQAKYPSTAKVIPGHDEWKGNDHVKHTLELLDQQ
KQ
>CAJ32373|FEATURES|argannot|beta_lactam|IND-6|antibiotic inactivation|1
MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKT
GVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPK
TNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLV
KSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK
>ACZ65152|FEATURES|argannot|beta_lactam|IND-8|antibiotic inactivation|1
MKKSIQFFIVSMLLSPFANSQVKDFVIEPPIKSNLYIYKTFGVFGGKEYSANAAYLKTKK
GVILFDVPWEKVQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATLK
TNEFLKKDGKATSTEIIQTGKPYHIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTMNKLKTKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>ACZ65153|FEATURES|argannot|beta_lactam|IND-9|antibiotic inactivation|1
MKKSIQFFIVSLLLSPFANAQVKDFVIEPPISKNLYIYKTFGVFGGKEYSANAVYLVTKK
GVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNKKGIKTYATAK
TNELLKKEGKAVSSNIINTGKAYHIGGEEFVVDFIGEGHTVDNVVVWFPKYKVLDGGCLV
KSTSATDLGYIKEANVEQWPQTMNTLKSKYSQATLIIPGHDEWKGGGHVEHTLELLNKK
>ADH03007|FEATURES|argannot|beta_lactam|IMP-14|antibiotic inactivation|1
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFNGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>AAK27847|FEATURES|argannot|beta_lactam|IMP-5|antibiotic inactivation|1
MSKLFVFFMFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANVEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
PSKPSN
>AEI54179|FEATURES|argannot|beta_lactam|IMP-24|antibiotic inactivation|1
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>BAP75826|FEATURES|argannot|beta_lactam|IMP-34|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>BAM62794|FEATURES|argannot|beta_lactam|IMP-40|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPSTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AKO63210|FEATURES|argannot|beta_lactam|IMP-18|antibiotic inactivation|1
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVFTKHGLVVLVKN
DAYLIDTPITAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELT
NELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGNASLLQRTWEQAVKGLNESKK
PLQPSS
>AEU10762|FEATURES|argannot|beta_lactam|IMI-2|antibiotic inactivation|1
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKNLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFYSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKNEKEAKHEDKVIAEASRIAIDNLK
>AAL26797|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>AAL26995|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRVDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>CAD60970|FEATURES|argannot|beta_lactam|dsx2_1119|antibiotic inactivation|1
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIAAIGKQLFAGQP
>AAF04458|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFMFICLGLNAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYA
DKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>AAV65595|FEATURES|argannot|beta_lactam|GOB-1|antibiotic inactivation|1
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAEPLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>AEX25999|FEATURES|argannot|beta_lactam|GIM-1|antibiotic inactivation|1
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
AYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTK
KLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSH
EWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKL
MQPTAEASAD
>CAQ53840|FEATURES|argannot|beta_lactam|AIM-1|antibiotic inactivation|1
MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISA
LLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKAT
GAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASP
GHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAA
LDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSG
ARP
>ADZ48685|FEATURES|argannot|beta_lactam|GES-17|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AFK80745|FEATURES|argannot|beta_lactam|GES-21|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVLERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AFU25739|FEATURES|argannot|beta_lactam|GES-22|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPELGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AGT20529|FEATURES|argannot|beta_lactam|GES-23|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGELVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AAG12974|FEATURES|argannot|beta_lactam|FOX-5|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNAPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>CAB61639|FEATURES|argannot|beta_lactam|fonA-3|antibiotic inactivation|1
MVKNILRKTTLMVTTVMPLLFGSAPLWAQTANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>CAB61643|FEATURES|argannot|beta_lactam|fonA-5|antibiotic inactivation|1
MVRNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPQAMAISLQNLTLGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>ADD91577|FEATURES|argannot|beta_lactam|DIM-1|antibiotic inactivation|1
MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKG
NAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTST
NHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRS
LDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNK
SIQPNANASAD
>ADT91161|FEATURES|argannot|beta_lactam|DHA-6|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSTSKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AFV91534|FEATURES|argannot|beta_lactam|NDM-6|antibiotic inactivation|1
MRPLPHSYLKSLVICLLTAFAALTPVVNSGVQAAQPKDVPVTFTAITQGVWMHTSMKHME
NWGHVPSNGLIVEKGDFSILVDTAWDDPQTAQIIEWSKDTLKKPIRWAVFTHAHDDKMGG
VAALRQQGIVTYAAADSNRMAPQNGLTPAEHDLIFDSEHSTSVLHPLVIFDPGPGHTRDN
IVVGLPEQGIVFGGCLIRPSGSTSLGNTADADLAHWKTAVLAVAQRFAEAQQIIPSHGPM
AGRELFELTAQLAEKASIPSTP
>ABK58097|FEATURES|argannot|beta_lactam|blaLAP-1|antibiotic inactivation|1
MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRRE
ERFPMMSTFKVLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELC
NAAITTSDNTAANLLLSTIGGPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTP
AAMAQTLQKLLNGSVLTEKSRKKLISWMQEDKVGGPLFRSVLPAGWMIADKTGAGDHGSR
GIVALLGPGGKPSRIVVLYITNTHSSMNELNEHIAGIGDSVIKNW
>AAP79049|FEATURES|argannot|beta_lactam|blaPLA2a|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
RFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQ
AMARTLRNLLTGRVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLVTHWSADENRP
>ADK47391|FEATURES|argannot|beta_lactam|TLA-2|antibiotic inactivation|1
MKKYFSFCLLGIFIFCFSQQNLKRDITKIIQGKNALVAVSVMNSKGKTEVNINGNKKVPM
LSVFKFHIALAVLDLVDRGILDLEQNIFVKKSELLENTWSPIRDKYPNGNVNIPLREIIE
HTVSQSDNNGCDILLRLIGGVDTVQKFIESKGIKDFAIKYNEEEMNKNGKSIYSNYTTAN
ASSRLLQKFYNGEIISESSRDFLFRIMYETSTGADRLISLLPPDVIVAHKTGTSGIVSGI
QAATNDVGIIILPDDEYYTISVFVINSKENTSTNEKIIADISKTVWDYYFQNK
>AIG20028|FEATURES|argannot|beta_lactam|MIR-5|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQASSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAB76925|FEATURES|argannot|beta_lactam|BL1_ceps|antibiotic inactivation|1
MKQTRSLPLLALGTLLLAPLSLAAPVDPLNAVVDDAIRPMLKQHRIPGMAVAVLKGGQAH
YFNYGLADMAAGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVESVEQMQSYYRQWTPAYQPGSHRQYSNPSIGLFG
HLAASSLQQPFAQLMEQTLLPGLGLHHTYLDVPEAAMASYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKALQQAISLTHQGRYSVGEMTQGLGWESYTYPVSE
QTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNEARISAAHAILSQLAP
>CAA52618|FEATURES|argannot|beta_lactam|CMY-2|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGRDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWAYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDTKVALAAVPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVIVA
NKSYPNPVRVEAAWRILEKLQ
>ACT09140|FEATURES|argannot|beta_lactam|BEL-3|antibiotic inactivation|1
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
CSTFKLPLAALVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSAL
QLSDNAAANLLLKEVGGPPLLTKYFRSLGDKVSRLDRIESTLNTNTPGDERDTTTPMSMA
QTVSKLIFGDTLTYKSKGQLRRLLIGNQTGDKTIRAGLPDSWVTGDKTGSCANGGRNDVA
FFITTAGKKYVLSVYTNAPELQGEERALLIASVAKLARQYVVH
>BAI66131|FEATURES|argannot|beta_lactam|pbp2b|antibiotic target alteration|1
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAMAVLFACLIARGLYLQTVTYNFLKEQ
GDNRIVRTQALPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDV
PVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFAFEKELKRHYPMGSLFAHVIG
FTDIDGKGQEGLELSLEDSLHAGEGAEVVLRDREGNIVDSLDSPRNKAPQNGKDIILSLD
QRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALVNTPAYEPNKPGQADSEQRRNR
AVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIGSATVQXDTHVYPTLDVRGIM
QKSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRWQKIEQATMS
FGYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTE
AGGTGTAGAVDGFDVGAKTGTARKLVNGRYVDYKHVATFIGFAPAKNPRVIVAVTIDEPT
ANGYYSGVVTGPVFKQVMGGSLNILGVSPTKPLTNVAAVKTPS
>AAP97132|FEATURES|argannot|beta_lactam|CEPH-A3|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
WDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFFAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKASPHS
>NP_213666.1|FEATURES|argannot|beta_lactam|cphA2|antibiotic inactivation|1
VGGAVMLKTLFVLLLIISTAFSMTLKKVEENLYMVRGNDGLPSKENKGFISNAYAVLTEE
GWVVIDTLTTPELSEEFLNLLKKVSNKPVIYAIVTHYHLDHWYGAKTFKDKGAKVIAHEK
LKEFYDSGEALQVLEAQKKRFKGVLDSVELVPPDEVVKDKKVLKVGKDVFEIYAMPPAHT
NSDLVIYWKNRKVLFVGDLVYINRIPFMGDRNASSKGWLEVLERLKEFDARMLLGGHNYP
MNKDAIDWTYNYIKFVRDTVKKLKDEGYFIDEIKEAFKGNPYEKVKMYEVFHNTNVWKVY
NELDLEL
>AAP97129|FEATURES|argannot|beta_lactam|cphA8|antibiotic inactivation|1
MMKGWIKCTLAGAVVLMASFWGGSVRAAGMSLMQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVFYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAATHS
>CAA41038|FEATURES|argannot|beta_lactam|TEM-6|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA46344|FEATURES|argannot|beta_lactam|TEM-8|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAA25053|FEATURES|argannot|beta_lactam|TEM-12|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGE11905|FEATURES|argannot|beta_lactam|TEM-34|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA66659|FEATURES|argannot|beta_lactam|TEM-42|antibiotic inactivation|1
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGVRVGYIELDLNSGKILESFRPEER
FPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSA
AITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAA
MATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGSRGI
IAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIK
>CAA71324|FEATURES|argannot|beta_lactam|TEM-49|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGGQATMDERNRQIAEIGASLIKHW
>AAD22539|FEATURES|argannot|beta_lactam|TEM-54|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
LGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF05613|FEATURES|argannot|beta_lactam|TEM-76|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAF05612|FEATURES|argannot|beta_lactam|TEM-78|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>AAL29435|FEATURES|argannot|beta_lactam|TEM-83|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRCEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDEQNRQIAEIGASLIKHW
>AAK14792|FEATURES|argannot|beta_lactam|TEM-88|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTDELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAC67290|FEATURES|argannot|beta_lactam|TEM-95|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGAKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK85243|FEATURES|argannot|beta_lactam|TEM-30|antibiotic inactivation|1
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKLW
>AAM18924|FEATURES|argannot|beta_lactam|TEM-101|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIVEIGASLIKHW
>AAM52207|FEATURES|argannot|beta_lactam|TEM-106|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAN04881|FEATURES|argannot|beta_lactam|TEM-115|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ93490|FEATURES|argannot|beta_lactam|TEM-123|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIALGPDGKPSRIVVIYTTGSQATMDEANRQIAEIGASLIKHW
>AAT45742|FEATURES|argannot|beta_lactam|TEM-126|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERETTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAR89358|FEATURES|argannot|beta_lactam|TEM-127|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDNVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAQ57123|FEATURES|argannot|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGTSLIKHW
>AAS79107|FEATURES|argannot|beta_lactam|TEM-134|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAV83795|FEATURES|argannot|beta_lactam|TEM-136|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGGQATMDERNRQIAEIGASLIKHW
>AAY85632|FEATURES|argannot|beta_lactam|TEM-143|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDCWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAZ14084|FEATURES|argannot|beta_lactam|TEM-146|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLPDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
HGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ32372|FEATURES|argannot|beta_lactam|TEM-148|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMAKTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAJ39390.1|FEATURES|argannot|beta_lactam|TEM-156|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNIGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ACJ04051|FEATURES|argannot|beta_lactam|TEM-167|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW
>ADP20705|FEATURES|argannot|beta_lactam|TEM-182|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRLEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>AGZ20205|FEATURES|argannot|beta_lactam|TEM-205|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGK82336|FEATURES|argannot|beta_lactam|TEM-206|antibiotic inactivation|1
MSIQHFRVTLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGW25367|FEATURES|argannot|beta_lactam|TEM-209|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLDARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CAA63264|FEATURES|argannot|beta_lactam|CMY-1|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPNEARIKAAHAILAQLAG
>CAB50867|FEATURES|argannot|beta_lactam|CMY-5|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKFSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAD50818|FEATURES|argannot|beta_lactam|CMY-8|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>BAB72158|FEATURES|argannot|beta_lactam|CMY-9|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFDIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>AAK59980|FEATURES|argannot|beta_lactam|CMY-11|antibiotic inactivation|1
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGAGVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAPLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLRFVKANIGGVDDKALQQAISLTHQGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVSLEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIEARIKAAHAILAQLAG
>CBX51207|FEATURES|argannot|beta_lactam|CMY-12|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYSNSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>AAQ16660|FEATURES|argannot|beta_lactam|CMY-13|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABR18736|FEATURES|argannot|beta_lactam|CMY-31|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGRLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABN51007|FEATURES|argannot|beta_lactam|CMY-35|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAF36388|FEATURES|argannot|beta_lactam|CMY-37|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWSELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAAIPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPIRVEAAWRILEKLQ
>ACA30422|FEATURES|argannot|beta_lactam|CMY-40|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGT
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGYTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACJ05361|FEATURES|argannot|beta_lactam|CMY-43|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFAA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73431|FEATURES|argannot|beta_lactam|CMY-51|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVQPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AEM97674|FEATURES|argannot|beta_lactam|CMY-62|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFSA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AET07387|FEATURES|argannot|beta_lactam|CMY-63|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ADW84690|FEATURES|argannot|beta_lactam|CMY-64|antibiotic inactivation|1
MMKKSLCCALLLTASLSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAIAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AEZ49855|FEATURES|argannot|beta_lactam|CMY-68|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGIAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AFK73455|FEATURES|argannot|beta_lactam|CMY-84|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPALTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AGC54798|FEATURES|argannot|beta_lactam|CMY-94|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVASAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BAO05497|FEATURES|argannot|beta_lactam|CMY-110|antibiotic inactivation|1
MMKKSICCALLLTASFSKFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWGIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIT76090|FEATURES|argannot|beta_lactam|CMY-112|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AKZ20822|FEATURES|argannot|beta_lactam|blaCMY-132|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKKLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AAD37413|FEATURES|argannot|beta_lactam|SHV-2|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAA66730|FEATURES|argannot|beta_lactam|SHV-2A|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACA09611|FEATURES|argannot|beta_lactam|SHV-28|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACY68243|FEATURES|argannot|beta_lactam|SHV-31|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL68926|FEATURES|argannot|beta_lactam|SHV-35|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDKQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGGRG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL82592|FEATURES|argannot|beta_lactam|SHV-36|antibiotic inactivation|1
MRYVRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAL82593|FEATURES|argannot|beta_lactam|SHV-37|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AAN77730|FEATURES|argannot|beta_lactam|SHV-39|antibiotic inactivation|1
ALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFI
ADKTGASERGARGIVALLGPNNKAERIVVIYLRDS
>AAP03063|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTIGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAS98184|FEATURES|argannot|beta_lactam|UUU_18620|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAQ55480|FEATURES|argannot|beta_lactam|SHV-66|antibiotic inactivation|1
MRYIRLCIIYLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA06586|FEATURES|argannot|beta_lactam|SHV-64|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVLLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47127|FEATURES|argannot|beta_lactam|SHV-72|antibiotic inactivation|1
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADRTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAJ47136|FEATURES|argannot|beta_lactam|SHV-81|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGSPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABA60809|FEATURES|argannot|beta_lactam|SHV-89|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITVSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABH04327|FEATURES|argannot|beta_lactam|SHV-92|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMISTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLAIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABN49112|FEATURES|argannot|beta_lactam|SHV-96|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDARVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABV72593|FEATURES|argannot|beta_lactam|SHV-101|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDGRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACY70943|FEATURES|argannot|beta_lactam|SHV-122|antibiotic inactivation|1
ARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLAT
VGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSA
RSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVSLLGPN
>AEX99752|FEATURES|argannot|beta_lactam|SHV-142|antibiotic inactivation|1
MRYIRLCIISLLAALPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFN88952|FEATURES|argannot|beta_lactam|SHV-145|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGERCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23953|FEATURES|argannot|beta_lactam|SHV-147|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSAFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTSASMAERNQQIAGIGAALIEHWQR
>AFQ23957|FEATURES|argannot|beta_lactam|SHV-151|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQPSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23959|FEATURES|argannot|beta_lactam|SHV-153|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMVERNQQIAGIGAALIEHWQR
>AFQ23960|FEATURES|argannot|beta_lactam|SHV-154|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23962|FEATURES|argannot|beta_lactam|SHV-156|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQPERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23966|FEATURES|argannot|beta_lactam|SHV-160|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSEGQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AFQ23970|FEATURES|argannot|beta_lactam|SHV-165|antibiotic inactivation|1
MRYIRLCIISLLAPLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AHA80962|FEATURES|argannot|beta_lactam|SHV-179|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMNTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CDN33427|FEATURES|argannot|beta_lactam|SHV-183|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIS67769|FEATURES|argannot|beta_lactam|SHV-186|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERCARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAI43415|FEATURES|argannot|beta_lactam|OXY-2-2|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLILVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>CAI43421|FEATURES|argannot|beta_lactam|OXY-6-1|antibiotic inactivation|1
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AET05998.1|FEATURES|argannot|beta_lactam|OXA-4|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AEH57056.1|FEATURES|argannot|beta_lactam|OXA-10|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAA83417|FEATURES|argannot|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKL
>AAA93528|FEATURES|argannot|beta_lactam|blaOXA-10|antibiotic inactivation|1
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
KIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGE
VRMQKYLKKFSYGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVK
EALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPL
RKSIPTKIMESEGIIGG
>AAC23554|FEATURES|argannot|beta_lactam|OXA-20|antibiotic inactivation|1
LIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSFAGHNQDQNLRSAMRNS
TVWVYQLFAKEIGENKARSYLEKLNYGNADPSTKSGDYWIDGNLAISANEQISILKKLYR
NELPFRVEHQRLVKDLMIVEAKRDWILRAKTGWDGQMGWWVGWVEWPTGPVFFALNIDTP
NRMEDLHKREAIARAILQSVNALPPN
>CAB92323|FEATURES|argannot|beta_lactam|OXA-24|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>AAG35607|FEATURES|argannot|beta_lactam|OXA-25|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVEKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKLLENLGII
>CAC35728|FEATURES|argannot|beta_lactam|OXA-29|antibiotic inactivation|1
MKKLSVLLWLTLFYCGTIWAQSTCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGF
DSGILKDTLNPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTRFKNYV
DAFHYGNQDISGDKGQNNGLTHSWLSSSLAISPSEQIQFLQKIVNKKLSVNPKAFTMTKD
ILYIQELAGGWKLYGKTGNGRQLTKDKSQKLSLQHGWFIGWIEKDGRVITFTKHIADSKK
HVTFASFRAKNETLNQLFYLINELEK
>AAK15582|FEATURES|argannot|beta_lactam|OXA-34|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYCIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAIL
>AAP70012|FEATURES|argannot|beta_lactam|OXA-48|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ABD47672|FEATURES|argannot|beta_lactam|OXA-51|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAW57529|FEATURES|argannot|beta_lactam|OXA-58|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGVFHYL
>AAT71317|FEATURES|argannot|beta_lactam|blaOXA-60c|antibiotic inactivation|1
MFSRWSKTFAFGLAACAVALSTATAHAELVVRNDLKRVFDDAGVSGTFVLMDISADRTYV
VDPARAARHIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYKQWEHDMALPEAIR
LSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPQIGWWVGWVERAGRIYAFA
LNIDMPREGDMAKRIPLGKQLMQALAVWPAP
>AAT01092.1|FEATURES|argannot|beta_lactam|OXA-61|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDGQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>AAU88145|FEATURES|argannot|beta_lactam|OXA-63|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKLMAKSFLESWAKDSNLRYAIKNSQV
PAYKELARRIGIKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNE
LQYPIEIQKAISDITITRANLHITLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFAL
NIDNINSDDLAKRINIVKESLKALNLLK
>AAW51373|FEATURES|argannot|beta_lactam|OXA-75|antibiotic inactivation|1
MNIQALLLITSAIFISACSPYIVTANPNYSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGISSSVRKEITYRGLEQLGIL
>ABC26007|FEATURES|argannot|beta_lactam|OXA-83|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABC26006|FEATURES|argannot|beta_lactam|OXA-84|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLAGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABF47914|FEATURES|argannot|beta_lactam|OXA-91|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABI53716|FEATURES|argannot|beta_lactam|OXA-99|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIRQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEMNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31687|FEATURES|argannot|beta_lactam|OXA-107|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABV31690|FEATURES|argannot|beta_lactam|OXA-110|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASALPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABX38721|FEATURES|argannot|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEAGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>ABS71123|FEATURES|argannot|beta_lactam|OXA-115|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACV49885|FEATURES|argannot|beta_lactam|OXA-98|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTEWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAK55330|FEATURES|argannot|beta_lactam|OXA-118|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGKDKARHYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>CCJ32595|FEATURES|argannot|beta_lactam|OXA-120|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84989|FEATURES|argannot|beta_lactam|OXA-131|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNQQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACD84990|FEATURES|argannot|beta_lactam|OXA-132|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEMTYKSLEQLGIL
>ACE63186|FEATURES|argannot|beta_lactam|OXA-133|antibiotic inactivation|1
MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>ACY56711|FEATURES|argannot|beta_lactam|OXA-144|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSILFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACN85419|FEATURES|argannot|beta_lactam|OXA-145|antibiotic inactivation|1
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWEGQLRISAVNQVEFLESLFLNKLSAS
KENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMDI
DNENKLPLRKSIPTKIMASEGIIGG
>ACX31142|FEATURES|argannot|beta_lactam|OXA-150|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKHVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADB28891|FEATURES|argannot|beta_lactam|OXA-160|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTSQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ACZ73269|FEATURES|argannot|beta_lactam|OXA-162|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSARIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>ADI58616|FEATURES|argannot|beta_lactam|OXA-172|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAVPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADM26745|FEATURES|argannot|beta_lactam|OXA-180|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAIKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADM26760|FEATURES|argannot|beta_lactam|OXA-181|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AEB98920|FEATURES|argannot|beta_lactam|OXA-194|antibiotic inactivation|1
MNIKALFLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADT70779|FEATURES|argannot|beta_lactam|OXA-198|antibiotic inactivation|1
MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAK
QRFSTASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCY
QALARQVGAEKYRNYLRKSVYGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPF
SASSYETLRQIMLIEQTPAFTLRAKTGWATRVKPQVGWYVGHVETPTDVWFFATNIEVRD
EKDLPLRQKLTRKALQAKGIIE
>ADX07745|FEATURES|argannot|beta_lactam|OXA-200|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ADX07748|FEATURES|argannot|beta_lactam|OXA-203|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BAL15076|FEATURES|argannot|beta_lactam|OXA-206|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCA94644|FEATURES|argannot|beta_lactam|OXA-208|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEV91550|FEATURES|argannot|beta_lactam|OXA-211|antibiotic inactivation|1
MKTLQLALIALITTFGSACTTIPPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATS
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AEL17179|FEATURES|argannot|beta_lactam|OXA-219|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AEP43731|FEATURES|argannot|beta_lactam|OXA-225|antibiotic inactivation|1
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AFM55000|FEATURES|argannot|beta_lactam|OXA-229|antibiotic inactivation|1
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFDQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDSNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGDDPTERKQLTLSILDKLGLFFYLR
>AFG29918|FEATURES|argannot|beta_lactam|OXA-231|antibiotic inactivation|1
MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKG
KNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMAVTPQVGWLTGWVEKSN
GEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII
>AFH36330|FEATURES|argannot|beta_lactam|OXA-235|antibiotic inactivation|1
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>AFO55202|FEATURES|argannot|beta_lactam|OXA-242|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQR
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AFQ90085|FEATURES|argannot|beta_lactam|OXA-243|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEAGGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>AGC60013|FEATURES|argannot|beta_lactam|OXA-245|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQYFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>AGC70814|FEATURES|argannot|beta_lactam|OXA-247|antibiotic inactivation|1
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGSNTKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>CCJ32596|FEATURES|argannot|beta_lactam|OXA-248|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAMPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCJ32597|FEATURES|argannot|beta_lactam|OXA-249|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIQVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AER57903|FEATURES|argannot|beta_lactam|OXA-251|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVDEVRMQKYLKNFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLTVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AGI65307|FEATURES|argannot|beta_lactam|OXA-278|antibiotic inactivation|1
MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMEQEVRRIQFGNQHIGQQVDNFWLVGPLKITPKQEVEFVS
ALAQEQLAFDPQVQQQVKAMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>AFG25594|FEATURES|argannot|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANFNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYVVLNAIKK
>ALA14809|FEATURES|argannot|beta_lactam|adc74|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>CAC17624|FEATURES|argannot|beta_lactam|OCH-4|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>CAC17627|FEATURES|argannot|beta_lactam|OCH-7|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNSGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPASQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>AAQ54754|FEATURES|argannot|beta_lactam|blaB1|antibiotic inactivation|1
MKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
KGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTK
MTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCI
VKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPYVQYVVAGHDDWKDQTSIQHTLDLISEY
QQKQKASN
>AAK14294|FEATURES|argannot|beta_lactam|VEB-1b|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>ADF48906|FEATURES|argannot|beta_lactam|VIM-3|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATK
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGSEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAS13759|FEATURES|argannot|beta_lactam|VIM-8|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSARRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ACB54703|FEATURES|argannot|beta_lactam|VIM-16|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWLHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>CAO83029|FEATURES|argannot|beta_lactam|VIM-18|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLANEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNL
VVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPG
GLDLLKHTTNVVKAHTNRSVVE
>ACT33323|FEATURES|argannot|beta_lactam|VIM-23|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSSTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>ADL27533|FEATURES|argannot|beta_lactam|VIM-24|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSLTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AFK24647|FEATURES|argannot|beta_lactam|VIM-31|antibiotic inactivation|1
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIHELSRTSAGNVADADLAEWPTSIERIQQRYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AAV37205|FEATURES|argannot|beta_lactam|CfxA4|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGNVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>AAV37206|FEATURES|argannot|beta_lactam|CfxA5|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGCVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>CAA06311|FEATURES|argannot|beta_lactam|CTX-M-6|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYLADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKASDLVNYNPIAEKHVNGTM
TLAELGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKCWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>AAO61597|FEATURES|argannot|beta_lactam|CTX-M-27|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>CAD99182|FEATURES|argannot|beta_lactam|CTX-M-31|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDESFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AAR99493|FEATURES|argannot|beta_lactam|CTX-M-34|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTVDVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
CDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAT70415|FEATURES|argannot|beta_lactam|CTX-M-37|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLHAQTADVQQKLAELEQQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAX54694|FEATURES|argannot|beta_lactam|CTX-M-39|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GDYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAV28215|FEATURES|argannot|beta_lactam|CTX-M-40|antibiotic inactivation|1
MRHRVKRMMLMTTACISLLLGSAPLYAQANDVQQKLAALEKSSGGRLGVALIDTADNAQT
LYRADERFAMCSTSKVMAAAAVLKQSETQKNVLSQKVEIKSSDLINYNPIAEKHVNGTMT
LAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPR
DTTTPLAMAQTLRHLTLGSALGETQRAQLVTWLKGNTTGAASIQAGLPTSWVVGDKTGSG
DYGTTNDIAVIWPEGRAPLILVTYFTQPEQKAESRRDVLAAAAKIVTDGY
>AAY43008|FEATURES|argannot|beta_lactam|CTX-M-41|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTM
TFGELIAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AAY84742|FEATURES|argannot|beta_lactam|CTX-M-42|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAV97955|FEATURES|argannot|beta_lactam|CTX-M-50|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVPLIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ABN48311|FEATURES|argannot|beta_lactam|CTX-M-56|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAENRRDILAAAAKIVTHGF
>ADA62534|FEATURES|argannot|beta_lactam|CTX-M-61|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ABV81082|FEATURES|argannot|beta_lactam|CTX-M-68|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLHAQTVDVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDDTFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACV92002|FEATURES|argannot|beta_lactam|CTX-M-71|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
CGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ACY74743|FEATURES|argannot|beta_lactam|CTX-M-92|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRTQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>CBW46935|FEATURES|argannot|beta_lactam|CTX-M-100|antibiotic inactivation|1
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTM
TFGELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>AEM44649|FEATURES|argannot|beta_lactam|CTX-M-111|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGQGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>BAL72196|FEATURES|argannot|beta_lactam|CTX-M-126|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEATLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AFJ59957|FEATURES|argannot|beta_lactam|CTX-M-130|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRHDVLASAARIIAEGL
>CAG25817|FEATURES|argannot|beta_lactam|LEN-12|antibiotic inactivation|1
ATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLL
CGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGN
LLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTA
QHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKPE
RIVVIYLRDTPASMAERNQHIAG
>ALK01318|FEATURES|argannot|beta_lactam|blaLEN|antibiotic inactivation|1
MRYIRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWHD
>AHF82024|FEATURES|argannot|beta_lactam|blaAQU-3|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVLKGGQAH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFVKANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSE
QTLQVGNSREVSFKGNPVKGFKAPVTFGEARLYNKTGSTNGFGAYVAFVXAKGVGIVMLA
NRNYPIQERVKAAHAILSKLAP
>CBY88906|FEATURES|argannot|beta_lactam|tmb1|antibiotic inactivation|1
MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGK
AFIIDTPWSESDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTN
EILKREGKEQARSSFKGNEFSLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSL
ESSGLGYTGEAKIDQWPQSARNTISKYPEAKIVVPGHGKIGDFELLKHTKVLAEKASNKA
NHGDR
>AAT79355|FEATURES|argannot|quinolone|QnrA2|antibiotic target protection|1
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
YADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYIS
GCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLT
FADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD
>BAG55487|FEATURES|argannot|quinolone|QnrB20|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG
>ADM52194|FEATURES|argannot|quinolone|QnrB30|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AEL00458|FEATURES|argannot|quinolone|QnrB36|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFH88686|FEATURES|argannot|quinolone|QnrB48|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AFD54601|FEATURES|argannot|quinolone|QnrB49|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>ADW54092.1|FEATURES|argannot|quinolone|QnrB46|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG
>AGH08253|FEATURES|argannot|quinolone|QnrVC6|antibiotic target protection|1
MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFS
YADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYIT
GCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLS
HSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD
>ACF70723|FEATURES|argannot|multidrug|qepA|antibiotic efflux|1
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
ILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFGSVLAALADTAALLIAARALLG
LAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFW
LNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASM
AALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYL
QLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQ
GLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
QATAWAGAVLVLVAAGLVARLLRKRPALASG
>EHS19134.1|FEATURES|argannot|fosfomycin|FosB|antibiotic inactivation|1
MLKSINHICFSVRNLNDSIHFYRDILLGKLLLTGKKTAYFELAGLWIALNEEKDIPRNEI
HFSYTHIAFTIDDSEFKYWHQRLKDNNVNILEGRVRDIRDRQSIYFTDPDGHKLELHTGT
LENRLNYYKEAKPHMTFYK
>ACL82959.1|FEATURES|argannot|glycopeptide|vanYM|antibiotic target alteration|1
MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVD
AAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEA
PEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDF
LKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR
>AAF36802.1|FEATURES|argannot|glycopeptide|vanHF|antibiotic target alteration|1
MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEIS
ESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIR
NAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKE
AAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGAL
IKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRA
LYDTVEKTILNCLEFERRETLE
>ABB53369.1|FEATURES|argannot|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPLTSTL
>AAA24786.1|FEATURES|argannot|glycopeptide|vanC|antibiotic target alteration|1
MKKIAVLFGGNSPEYSVSLTSAASVIQAIDPLKYEVMTIGIAPTMDWYWYQGNLANVRND
TWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCH
VAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGS
SKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVD
GFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIY
LNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR
>BAE96113.1|FEATURES|argannot|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGRDALNCIESVELDLAILDIMLPDID
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEVVARVKAQLRQYM
RYKQPCIKQEAERTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>ABX54687.1|FEATURES|argannot|glycopeptide|vanL|antibiotic target alteration|1
MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDI
EYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNI
PYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKP
NEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDE
VSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSD
NNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG
>AAK58490.1|FEATURES|argannot|glycopeptide|VanXYC|antibiotic target alteration|1
MNPYLQLVSKEFPLEKNQEPPHLVLAAFSEDEVYLQPEAAKQWKRLVKALKLEDEICLLD
GYRTEKQQRYLWEYSLKENGLAYTKQFVALPGCSEHQLGLAIDVGLKGSQDDLICPRFRD
SAAADLFTQEMMNYGFILRYPADKQEITGIGYEPWHFRYVGLPHSQIIASQQWTLEEYHQ
YLEQTARQFA
>AAF86641.1|FEATURES|argannot|glycopeptide|vanRC|antibiotic target alteration|0
MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDID
GFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSE
TLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK
>AAY52003.1|FEATURES|argannot|glycopeptide|VanSA|antibiotic target alteration|0
MAIKLKNKNKKTDYSKLKRKLYQYIVVIVMAAVVFVLFLRLFIKGTLGEWIVRFLENSYH
LERQDAMKIYQYTIRNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDILIQNED
KQIELSAEMEFMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSVIGYLS
LLDEAPDMPVEQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKKHIDLYYMLVQ
MTDEFYPQLAANGKQAVIHASEDLTVSGDPDKLARVFNNILKNAAAYSEDNSVIDITAGL
SGDVVSIVFKNAGSIPKDKLAAIFEKFYRLDDARSSDTGGAGLGLAIAKEIIVQHGGQIY
AESNDNYTTFTVELPALPDLVDKRSS
>AAY67970.1|FEATURES|argannot|glycopeptide|vanTC|antibiotic target alteration|0
MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAEL
AVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQSLLVNGILY
HLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAV
FHLLDGTRNGIFFTPLFLCLGVLVRKQSVKRSLSKTALFFLISLIGLLIESAYLHGFSIP
KHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISIL
QNNLINYLVVLILTIGFICLFLRQQHSWFRHKQTTPVKRVVKEFSKTALLHNLQEIQRII
SPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIQLRKNAVKSPILVLGYT
SPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFD
LPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGIL
NYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQT
AVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIP
IESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK
>AAX19285.1|FEATURES|argannot|glycopeptide|vanXA|antibiotic target alteration|1
MKKGFTFLDEILHGVRWDAKYATWDNFTGKPVDGYEVNRIAGTYELADALLKVKELAAAQ
GYGLLLWDGYRPQRAVNCFVQWAAQPEDGLTKERYYPNIDRTEMVSKGYVASKSSHSRGS
AIDLTLYRLDTGELVPMGSGFDFMDERSHHAAKGISGNEAQNRRCLRSIMENSGFEAYSF
EWWHYVLRNEPYPNSYFDFPVK
>ACV60627.1|FEATURES|argannot|glycopeptide|VanYA|antibiotic target alteration|1
MKKWGFLFLLCLGFVFINKALFFQEKVAVEIENYDQNPKDHLDNRGTSESTQTKTITNEQ
IYQGNLLLFNSKYPVRQESVKSDIVNLSKHNELINGYGLLDTNIYMSKGIAQKFSEMVND
ALKEGVSHFIINSGYRDFDEQSVLYQEMGADYALPAGYSEHNSGLSLDVGSSLTKMERAP
EGKWLKENAWKYGFILRYPKDKTDVTGIQYEPWHIRYVGFPHSAIMKEKNFALEEYMDFL
KEQKSITTTIDHQVYKIFYYPISQNTTIHVPANGQYEISGNNMDGVIVTVYSGKRD
>AAO38246|FEATURES|argannot|macrolide-lincosamide-streptogramin|EreA|antibiotic inactivation|1
MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERH
EFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGEL
ETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENS
CLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL
>AAA26779|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmO|antibiotic target alteration|1
MARPTQRARTLSQNFLADRATAERVARLAVPDRGRPPLLLEVGAGNGALTEPLARRSREL
HAYEIDPRLVPGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLT
APGLTDATLLTQLEYARKRTGDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGI
LRIERRPTALLTGAAARRDWADLVELGFSGVGGSLHASLRRAHSRRRVDAAFRAARLDPG
VLVGEVAPDRWLRLHEELTA
>AAB51440|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmV|antibiotic target alteration|1
MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSL
LAYEIDPRLVPVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLR
APHLTDATLLTQLEYARRRTGDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGI
VRIERRRTPLLAPGADAGWRELVDLGFSGAGGSLHASLRRARPRRRVDAAFRAAGLDRDV
LVGEVPPWTWLRLHEVLGS
>AAA98484|FEATURES|argannot|macrolide-lincosamide-streptogramin|ErmX|antibiotic target alteration|1
MSAYGQGRHEHGQNFLTNHKIINSIIDLVKQTSGPIIEIGPGSGALTHPMAHLGRAITAV
EVDAKLAAKITQETSSAAVEVVHDDFLNFRLPATPCVIVGNIPFHLTTAILRKLLHAPAW
TDAVLLMQWEVARRRAGVGATTMMTAQWSPWFTFHLGSRVPRSAFRPQPNVDGGILVIRR
VGDPKIPIEQRKAFQAMVHTVFTARGRGIGEILRRQGCFHHVQKHNHGCAREESTPRPYL
PDCYTNDWIDLFQVTGSSLPHHRPISPSGSSQRPPQRKNRSRRR
>AGI42804|FEATURES|argannot|macrolide-lincosamide-streptogramin|lnuB|antibiotic inactivation|1
MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKDSITSNFDSSNW
LFDVAPYLMLYKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYD
ETGQLENYLSEISGARPNRLTEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQK
NTLQLIRMAEKNADNWLNMSKNLEKEISLENYKKFAKTTARLDKVELFEAYKNSLLLVMD
LQSHLIEQYNLKVTHDILERLLNYISE
>CAA42550.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|LmrA|antibiotic efflux|1
MSVFARATSLFSRAARTRAADEAARSRSRWVTLVFLAVLQLLIAVDVTVVNIALPAIRDS
FHVDTRQLTWVVTGYTVVGGGLLMVGGRIADLFGRRRTLLFGAFLFGASSLAAGLAPNLE
LLVLARFGQGAGEALSLPAAMSLIACSSRTAPFQGVERLASVASVGLVLGFLLSGVITQL
FSWRWIFLINIPLVSLVLVAVLLLVKKDETTARNPVDLPGALLFTAAPLLLIFGVNELGE
DEPRLPLAVGSLLAAAVCAAAFVAVERRTAHPLVPLTFFGNRVRLVANGATVLLSAALST
SFFLLTMHLQEERDLSPIEAGLSFLPLGLSLILACVLVRGLIERIGTTGAAVLGMALAGP
RHRLFALLPSDNSLLTSVFPGMILLLRMATGLVALQNAALHAVTEADAGVASGVQRCADQ
LGGASGIAVYVSIGFSPHLGGDWDPFTVAYSLAGIGLIAAVLAVLALSPDRRLAAPREQE
D
>CAE18145|FEATURES|argannot|multidrug|lsaB|antibiotic target protection|1
MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGK
IISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSN
GEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSV
DHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRV
EASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFE
PVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPI
QYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDI
SHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQT
FQETISTKIIKI
>ACJ63262.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|mefB|antibiotic efflux|1
MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLI
GPFAGVWIDRYNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFH
GPAMQAAIPMFVPADMLTKAGGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAA
FAIVCLLFVIIPDITQTNEKMSVLSDMKQGFIAMKANKPLMAVFSPMLLMTILYMPLGSL
FPLLARSHFMGEAWHNSIVEFVFAGGLLLSSLVIGVWGGMKRRFFMASLAIGLMGLATLI
SGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAPEMMGKVFSLLMTAMTLSMPI
GLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD
>AEG42377.1|FEATURES|argannot|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIQDIQSLAEAHGLLITDKMNFNEMGIDFKVVFALDTKGQQWLLRIPRRDGMREQIKKE
KRILELVKKHLSVEVPDWRISSTELVAYPILKDNPVLNLDAETYEIIWNMDKDSPKYITS
LAKTLFEIHSIPEKEVRENDLKIMKPSDLRPEIANNLQLVKSEIGISEQLETRYRKWLDN
DVLWADFTQFIHGDLYAGHVLASKDGAVSGVIDWSTAHIDDPAIDFAGHVTLFGEESLKT
LIIEYEKLGGKVWNKLYEQTLERAAASPLMYGLFALETQNESLIVGAKAQLGVI
>AAT98415|FEATURES|argannot|macrolide-lincosamide-streptogramin|MsrA|antibiotic target protection|1
MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
TVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNY
SPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRV
FKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIA
PDRLSASKQKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPII
AQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMA
YYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
GQSIHDIT
>AAA50325|FEATURES|argannot|macrolide-lincosamide-streptogramin|oleB|antibiotic target protection|1
MQNAHRSDTGAAALTGTPEKLLPTQPETGSFQVVLDDVVRAPGGRPLLDGVNQSVALGER
VGIIGENGSGKSTLLRMLAGVDRPDGGQVLVRAPGGCGYLPQTPDLPPEDTVQDAIDHAL
AELRSLERGLREAEQALAGAEPEELEGLLGAYGDLLEAFEARDGYAADARVDAAMHGLGL
AGITGDRRLGSLSGGEQARLNLACLLAASPQLMLLDEPTNHLDVGALEWLEERLRAHRGS
VLVVSHDRVFLERVATALWEVDGERRTVNRHGGGYAGYLQAKAAARRRWEQAYQDWLEDL
ARQRELARSAADHLATGPRRNTERSNQRHQRNVEKQISARVRNAKERVRRLEENPVPRPP
QPMRFRARVEGGGTVGRGGALAELYKVTVGTRLDVPSFTVDPGERILITGHNGAGKSTLL
RVLAGDLAPDQGECERPERIGWLPQETEITDRQQSLLAAFAAGLPGIAEEHRGALLGFGL
FRPSALGTAVGDLSTGQLRRLALARLLRDPADLLLLDEPTNHLSPALVEDLEEALAHYRG
ALVVVSHDRMFAQRFTGRRMHMEGGRFVE
>AAB95639|FEATURES|argannot|multidrug|vgaB|antibiotic target protection|1
MLKIDMKNVKKYYADKLILNIKELKIYSGDKIGIVGKNGVGKTTLLKIIKGLIEIDEGNI
IISEKTTIKYISQLEEPHSKIIDGKYASIFQVENKWNDNMSGGEKTRFKLAEGFQDQCSL
MLVDEPTSNLDIEGIELITNTFKEYRDTFLVVSHDRIFLDQVCTKIFEIENGYIREFIGN
YTNYIEQKEMLLRKQQEEYEKYNSKRKQLEQAIKLKENKAQGMIKPPSKTMGTSESRIWK
MQHATKQKKMHRNTKSLETRIDKLNHVEKIKELPSIKMDLPNREQFHGRNVISLKNLSIK
FNNQFLWRDASFVIKGGEKVAIIGNNGVGKTTLLKLILEKVESVIISPSVKIGYVSQNLD
VLQSHKSILENVMSTSIQDETIARIVLARLHFYRNDVHKEINVLSGGEQIKVAFAKLFVS
DCNTLILDEPTNYLDIDAVEALEELLITYEGVVLFASHDKKFIQNLAEQLLIIENNKVKK
FEGTYIEYLKIKDKPKLNTNEKELKEKKMILEMQISSLLSKISMEENEEKNKELDEKYKL
KLKELKSLNKNI
>WP_041823632|FEATURES|argannot|macrolide-lincosamide-streptogramin|carA|antibiotic target protection|1
MPTQITALAVTKAYQGQVVLDSVTCSLTEGERTGIIGENGSGKTTLLRLLAGPEQPDSGE
IVLHATGGVGYFAQDGELPPHVTVAQVVDHALGELRAVEARLRDLEARMADGDTSSLAEY
GDLLTVFELRGGYEADARLERALHGLGLGHLPRDRVVGGLSGGEQARLRLACVLASGPEV
LLLDEPTNHLDASALTWLETYLSTRRGTTVAVSHDRAFLEHVTTTLLEVDADRRQVFRYG
NGYAGYLAEKAAARQRWAQAYDEWRAETDRLRETAATTARRVAPGRAMTDRNKMAYGRAA
GRVQQSVASRVRNAEERLRRLLADPVPAPPEPLRFTAAPRPAGDPQGAVLDAAAITVTGR
LAATDLTVTAGERVLITGANGAGKTTLLRVLAGELAPDGGRVSRRGRIGYLSQEPPPGRP
GETLLAAFARGRAGTAEEHAERLLALGLFTADRFDTPVTRLSTGQRQRLALARLVTAPAD
VLLLDEPTNHLSPALVEELEEALAGFPGALVVVSHDRRLRERWRGSRVELADSGTAALRM
>CAA30695|FEATURES|argannot|chloramphenicol|catIII|antibiotic inactivation|1
MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQ
AVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVME
RYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLL
LPLSVQVHHAVCDGFHVARFINRLQELCNSKLK
>YP_001429534|FEATURES|argannot|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNI
INQNKVFRTGINSEGNLGYWEKLNPLYTVFNKETEKFSNIWTESNVSFNSFYNSYKSDLL
EYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIY
LPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWI
>AAC14737.2|FEATURES|argannot|chloramphenicol|catB2|antibiotic inactivation|1
MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIG
SFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIG
SEAMIMPGIKIGHGAVIGSRALVAKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWD
WPLEQIKEAMPFLCSSGIASLYRRWQGTSA
>AAF61918.1|FEATURES|argannot|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLLPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSRALDAFQRAGDTVIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>ADV91378.1|FEATURES|argannot|chloramphenicol|cmlA5|antibiotic efflux|1
VRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>YP_009080793|FEATURES|argannot|chloramphenicol|cmlA5|antibiotic efflux|1
VRSKDFSWRYSLAATLLLLSPFDLLASLGMDMYLPVVPFMAGALGAGAGTIQLTLTVYLV
LLGAGQLLFGPLSDLLGRRPVLLGGGITYILASFGLAAASSPEVFLSFRILQACGASACL
VSTFATVRDIYSGSEESNVIYGLLGSMLAMVPAIGPLLGALVDAWLGWRAIFGLLGIAMI
GAVTAAWRFWPETRRQRTADLQWSQLLLPVKCLNFWLYTLCYSAGMGSFFVFFSTAPWLM
MGRQALSQLSFSLLFATVAIAMMATARIMGRLIPRWGSLNTLRVGMGCLVVGALLLAVGE
TLIPNSVLGFIAPMWLVGVGIATAASVAPNGALRGFDHIAGTATAVYFCLGGLLLGGIGT
FIIALLPSDTTWPIIAYCLILAIAVLCLSCFNPNRHHPSDDEHDSLATQDIGRSQSGHGH
D
>AAB36568|FEATURES|argannot|chloramphenicol|cmlv|antibiotic inactivation|1
MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVS
IPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFA
SRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGW
ASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGG
VFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISAS
TVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNL
GNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAG
GTTPSEPARGKATSSC
>AEX07579|FEATURES|argannot|multidrug|fexA|antibiotic efflux|1
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQG
AGMSAIPVLSVIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWF
TFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSS
FSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFV
PLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFL
STYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGT
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>AAD09860|FEATURES|argannot|tetracycline|tet(30)|antibiotic efflux|1
MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPI
LGALSDRFGRRPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITD
ITPAEQRAQRFGTVGAVMSLGFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLP
ESRKAGPGKFAFKELNPLAPLVWLWNFKPLLPLVTVSVVFGLVAAIPGTIWVLYGAERFG
WDSVHMGLSLSVFGVSGALAQAFLVGPLSRRFGDLGTLMIGVGFDMLAYMLMAFANQSWM
GYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLASLMSLAGIIGPVLTTAVFFST
KSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA
>AAV80464.1|FEATURES|argannot|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>ACD35503|FEATURES|argannot|tetracycline|tet42|antibiotic efflux|1
MTSPTSLTRRDQNRAWIMLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEA
INGLCAFLVAPFLGRLSDRFGRRPVIIVAAFGAAFSMALFGFGGALWVLVLARVIQGLTA
GDLPALFAYLADITPPEQRAKRFGLLGALSGIGTMIGPAIGGLLAAISIQLPVFLTAAVA
LTIAILSIFLLPESLKPGNRITAIKLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGF
FVNNFSVLALDSIQWGPTQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQM
IGLAALAVVASVFAQPWVFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSL
NAAMGTAAPLIAGALYALVSHAAPYWLGVALMIVAVTVVSRAHIANTAKRPAGETTGDAP
AALVETAG
>CBH51823.1|FEATURES|argannot|tetracycline|tet44|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
TSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMN
IPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVIS
KNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCS
EMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNG
EMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREK
LLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIY
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
INYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYL
SFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQ
AVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN
>AAB24797|FEATURES|argannot|multidrug|mtrR|antibiotic efflux|0
MTKLDKGTVIAAGLELLNEVGMDSLTTRKLAERLKVQQPALYWHFQNKRALLDALPEAML
RERHTRSLPEENEDWRVFLKENALSFRTALLSYRDGARIHAGTRPTEPNFGTAETQIRFL
CAEGFCPKRAVWALRAVSHYVVGSVLEQQASDADERVPDRPDVSEQAPSSFLHVLFHELE
TDGMDAAFNFGLDSLIAGFERLRAAVLATD
>ABP38225.1|FEATURES|argannot|tetracycline|tetH|antibiotic inactivation|0
MPLDNVLAIRRLYIMIKRYYAIGIAVTATLLIPTEALASITPVLQPGNPFDPDSPFARLY
LPQNAPKGKDKVGPAEWTHAYGSPTHNAGFSVSAHAPAWVRRGVQWNFPEARAWPLTDPT
PFGAQVDGVKEALPVQTQFYGNALGVSMVRGVVYAESDDMFAYAINARTGKLIWRTSPVG
NNLMGNPLVIGNRVFLSAGSVSFNFANVVEFKTDPDKAGRGKDISYNGIYCLNSKTGMLE
WYFPTAGDAMPTPAYAYHSLYISTGDGNVYRINASDGKQIWKTHVGGIANMSSPAVWHGR
VYVGMSVVPGLYALNARTGSVDWKGEIPGAVNTGMGDVSPAVAHGIVVMDAVANPKIVDG
KPTMVTLVRGFNAKTGTALWTDNMGRGAKIPAFKGGVPMIHGNVVYVGSPVTSDYDAINL
DTGKVLWTWHVPHPGPAGAARGAPTYYQHMLYISTGPDLYVLNPKNGQEVGHYHVGGRFG
IVNPTIVGGTIYLGNSWDWVNAVPVKDVYSGFNTAKD
>AAA23033|FEATURES|argannot|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREI
LLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>AAA25293|FEATURES|argannot|tetracycline|tetS|antibiotic target protection|1
LKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGITIQTAI
TSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMN
IPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIV
GNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFS
PTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSING
ELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREK
LLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIY
MERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYL
SFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGR
SVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH
>AAB84282|FEATURES|argannot|tetracycline|tetV|antibiotic efflux|1
VRSPRPVAGWRVLAPFRIREYRLLIAAVTLSIFAEGMWSVVMALQVIAIDNDPASLSLVA
TCLGVGLVAFVLVGGITADRINQRTIIIAVEVVNFVTVAVISALALLGVLKIWHMAVAAG
ILGIAAAFFFPAYSAILPRILPPEQLLAANGVEGVVRPVFQRSVGPAVAGMVIGATMPSI
GAVVVAVLFALGLALLVATRPPAQPASEHHERPHVLRDLREGFAFVLKTPWLLWTVLFAS
MFVLVVLGPIEVLLPFIAQDRFADGARAYGFILAFFGIGSAMGALTVSSRRMPRRYLTTM
MLMWGLGSIPLVIVGYTSSFPLMAAATFVIGVTDGAGMVIWGTLLQRRVPTEMLGRVSSL
DFFVSLAFMPLSFAIVGPLSKVVSMEVIFATAGLVPVAIAAVAFTAARMHRDEVANPLL
>AAA92749.1|FEATURES|argannot|trimethoprim|dfrA10|antibiotic target replacement|1
MNISLIFANELITRAFGNQGKLPWQFIKEDMQFFQKTTENSVVVMGLNTWRSLPKMKKLG
RDFIVISSTITEHEVLNNNIQIFKSFESFLEAFRDTTKPINVIGGVGLLSEAIEHASTVY
MSSIHMVKPVHADVYVPVELMNKLYSDFKYPENILWVGDPIDSVYSLSIDKFVRPASLVG
VPNDINT
>AAN85115|FEATURES|argannot|trimethoprim|dfrA10|antibiotic target replacement|1
MTKQAIFAVAENLAFGLGGGLPWDTLKDDLQFFKRLTEGTDLVMGASTYRTLPLLPTNNR
QFIVVSNTEEPSLNVHVVSPEHFKAFLSKTSRNLTIIGGSSLLTVDILSKMDKIIMTTVY
GSFDADVYLPTEVVSYVTGKASNATLFNNSDAKMAVYYG
>AAA68493|FEATURES|argannot|trimethoprim|dfrA8|antibiotic target replacement|1
MIELHAILAATANGCIGKDNALPWPPLKGDLARFKKLTMGKVVIMGRKTYESLPVKLEGR
TCIVMTRQALELPGVRDANGAIFVNNVSDAMRFAQEESVGDVAYVIGGAEIFKRLALMIT
QIELTFVKRLYEGDTYVDLAEMVKDYEQNGMEEHDLHTYFTYRKKELTE
>BAO09635.1|FEATURES|CARD|beta_lactam|OXA-371|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVKPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACM67635.1|FEATURES|CARD|beta_lactam|OXA-226|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYRIEGSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAA26699.1|FEATURES|CARD|aminoglycoside|APH(3')-Va|antibiotic inactivation|1
MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEA
DRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARA
LHELPVEDCPSDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKE
DLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAY
AERFLERYGAHRVDKEKLAFYQLLDEFF
>AAQ08905.1|FEATURES|CARD|beta_lactam|OXA-60|antibiotic inactivation|1
MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYV
VDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIR
LSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRM
ALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFA
LNIDMPREGDMAKRIPLGKQLMRALEVWPAP
>AFU25658.1|FEATURES|CARD|quinolone|QnrB47|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>AFJ11384.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFEKQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>CAH10847.1|FEATURES|CARD|aminoglycoside|aadA23|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>AIT76085.1|FEATURES|CARD|beta_lactam|ACT-29|antibiotic inactivation|1
MMKKSLCCALLLSTSCSVLAAPMSEKQLAEMVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLQDSSLRKGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAB60001.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmE|antibiotic target alteration|1
MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELR
PDLPVLEAGPGEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAE
PPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTW
PLFEWEFVEKVDRRLFKPVPKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNI
QASLLRKYPRRRVEAALDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRT
GGRDHGDRRTGGQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRR
GPSGGGRTGGRPGRRGGPGQR
>AJE60855.1|FEATURES|CARD|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMMLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
EESDYTHYAFSISEADFASFAARLEAAGVAVWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFAE
>YP_002773985.1|FEATURES|CARD|multidrug|clbB|antibiotic target alteration|1
MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPN
VCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATG
TIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDR
HIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSY
RQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE
>AFO53532.1|FEATURES|CARD|rifampin|rgt1438|antibiotic inactivation|0
MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVR
PVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPY
VFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGL
PPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGA
PPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQ
ALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTF
DSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP
>AAB05622.1|FEATURES|CARD|glycopeptide|vanRB|antibiotic target alteration|0
MSIRILLVEDDDHICNTVRAFLAEARYEVDACTDGNEAHTKFYENTYQLVILDIMLPGMN
GHELLREFRAQNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMRILLKRVEALLRRS
GALAKEFRVGRLTLLPEDFRVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWG
YDFDGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL
>BAH66386.1|FEATURES|CARD|aminoglycoside|AAC(6')-Iaf|antibiotic inactivation|1
MDYSICDIAESNELILEAAKILKKSFLDVGNESWGDIKKAIEEVEECIEHPNICLGICLD
DKLIGWTGLRPMYDKTWELHPMVIKTEYQGKDFGKVLLRELETRAKGRGIIGIALGTDDE
YQKTSLSMIDINERNIFDEIENIKNINNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWK
DIS
>BAA03674.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|myrA|antibiotic target alteration|1
MHPDLLPHLRCPVCGQPLHQADAAPPRALRCPAGHSFDIARQGYVNLLTGRAPHVGDTAE
MIAAREEFLAAGHYDPFSAALATAAARAVPRRVRPGDGVGEPVAYPDLVVDAGAGTGRHL
AAVLDAVPTAVGLALDVSKPALRRAARAHPRAGAAVCDTWGRLPLADATVAVLVNVFAPR
NGPEFRRVLRPDGALLVVTPTAEHLVELVDRLGLLRVDPAKDARVADSLTRHFEPAGQST
HRHRLQLTRKEVLTLVGMGPSAWHTDPARLTARVAALSEPVTVTAAVRLARYRPI
>AHL30276.1|FEATURES|CARD|beta_lactam|OXA-376|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAA71915.1|FEATURES|CARD|tetracycline|tet(E)|antibiotic efflux|1
MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPL
LGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIAD
VTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILH
ETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERF
AWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSW
MVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSA
TRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI
>AIT76102.1|FEATURES|CARD|beta_lactam|DHA-19|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPEQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ABM97538.1|FEATURES|CARD|beta_lactam|CTX-M-58|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AHA80101.1|FEATURES|CARD|beta_lactam|CMY-100|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLHFYQNWQPQWASGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>NP_460903.1|FEATURES|CARD|multidrug|sdiA|antibiotic efflux|0
MQENDFFTWRRAMLLRFQEMAAAEDVYTELQYQTQRLEFDYYALCVRHPVPFTRPKISLR
TTYPPAWVTHYQSENYFAIDPVLKPENFRQGHLHWDDVLFHEAKAMWDAAQRFGLRRGVT
QCVMLPNRALGFLSFSRSSLRCSSFTYDEVELRLQLLARESLSALTRFEDDMVMAPEMRF
SKREKEILKWTAEGKTSSEIAIILSISENTVNFHQKNMQKKFNAPNKTQIACYAAATGLI
>AAA98406.1|FEATURES|CARD|beta_lactam|OXA-9|antibiotic inactivation|1
MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSF
KLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSR
LGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPV
SEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVV
FARLEIGKEKSDIPGGSKAREDILVELPVLMGNK
>AAG29757.1|FEATURES|CARD|beta_lactam|IND-2|antibiotic inactivation|1
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
GVVLFDVPWQKEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAK
TNELLKKDGKATSTEIIKTGKPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLV
KSRTATDLGYTGEANVKQWPETMRKLKTKYAQATLVIPGHDEWKGGGHVQHTLDLLDKNK
KPE
>CAA78046.1|FEATURES|CARD|chloramphenicol|cmx|antibiotic efflux|1
MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAI
VSMRWQRRRALLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMV
PADMKGRATSVLLGGVTIACVVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPA
DSPTDSVPNATRELSSLRQRKLQLILVLGALINGATFCSFTYLAPTLTDVAGFDSRWIPL
LLGLFGLGSFIGVSVGGRLADTRPFQLLVAGSAALLVGWIVFAITASHPVVTLVMLFVQG
TLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALGPALGGVAIGIGMGYRAPLWT
SAALVALAIVIGAATWTRWREPRPALDTVPP
>AHJ02283.1|FEATURES|CARD|beta_lactam|CARB-23|antibiotic inactivation|1
MVRVFTRYSLLNIAKVRIKTKERRTPRMKKLFLLVGLMVCSTVSYASKLNLNEDISLIEK
QTSGRIGVSVWDTQTDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATAKIDE
RNIVVWSPVMDKLAGQSTRIEHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKA
TRLDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLKIWMQDNKVSDS
LMRSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIAQ
ISQLILEHYKES
>CEA29751.1|FEATURES|CARD|beta_lactam|SHV-188|antibiotic inactivation|1
MVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELKLNEALPGDARDT
TTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGER
GARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>CAB13167.1|FEATURES|CARD|multidrug|ykkD|antibiotic efflux|0
MLHWISLLCAGCLEMAGVALMNQYAKEKSVKWVLLIIVGFAASFSLLSYAMETTPMGTAY
AVWTGIGTAGGALIGILFYKEQKDAKRIFFIALILCSAVGLKILS
>AFI72872.1|FEATURES|CARD|beta_lactam|CARB-14|antibiotic inactivation|1
MDVRKHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAVHDLETGKRW
EHKSNERFPLSSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGM
SLAELCQATLSTSDNSAANFILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDK
RDTTTPIAMVTTLEKLLIDETLSIKSRQQLESWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPNRKPIVAALYITETDASFEERNAVIAKIGEQIAKIVLMENSRN
>AAU95768.1|FEATURES|CARD|multidrug|mepA|antibiotic efflux|0
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHHMVGLFTTDQAIVEMATFILK
VTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>ACA23185.1|FEATURES|CARD|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLAREEQQRVQDASLFPVYHGSAKNGLGIQPLMDAVTGLFQP
IGEQGGAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALGGREKLKITEMRIPSKG
EIVRTDTAYQGEIVILPSDSVRLNDVLGDQTRLPRKRWREDPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPSVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFILYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGR
SVCLTELKGYQAAVGQPVIQPRRPNSRLDKVRHMFQKVM
>ABA71728.1|FEATURES|CARD|glycopeptide|vanSG|antibiotic target alteration|0
MDSDYTQLQTKILIRTAVVLFGAFALISASLSLLSGHFSRAVVGILEIFYKDYEKALVVY
TYVFRDNKEWFVMIAAFVSFLIVLRLYLKGFTKYFNEINRGINALKEESSEDVVLSSELA
ATEKTINTIKHTLEQQKTAALVAEQRKNDLVVYLAHDLKTPLTSVIGYLTLLRDEKQISD
ELREKYICISLEKAERLENLINEFFEITRFNLSNIILEYSVVNLTRMLEQLVFEFNPMLA
EKKLNCVLKTMPNKMIRCDANKMQRVFDNLLRNAVNYSFENTEISITVTQNENMVHIKFV
NHGNTIPKEKLERIFEQFYRLDTSRSTGNGGAGLGLAIAREIVMLHGGTITARSEDEKIE
FEVTILSS
>ABU55430.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib-Suzhou|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRMDA
>AAR89359.1|FEATURES|CARD|beta_lactam|TEM-128|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGEHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_010550189.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mphE|antibiotic inactivation|1
MRGTGQTAGMTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLD
FRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYP
LLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVR
GVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAV
LDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAY
GLYALETGEEEHRAAAAAALDPPDAD
>BAC67143.1|FEATURES|CARD|tetracycline|tet(B)|antibiotic efflux|1
MNSSTKIALAITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLNNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>AAV85982.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRV
AEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>AAB05624.1|FEATURES|CARD|glycopeptide|vanYB|antibiotic target alteration|1
MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPAT
HTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIR
ISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWV
AVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPW
HYRYVGIEAATKIYHQGLCLEEYLNTEK
>AAQ10694.1|FEATURES|CARD|quinolone|qacB|antibiotic efflux|1
MISFFTKTTDMMTSKKRWAALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQW
LQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVEAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>AAL27443.1|FEATURES|CARD|glycopeptide|vanXYE|antibiotic target alteration|1
MKKNYLRLINENNEIKDSERPSHLVQAPFAQTNILVDPMVAIQLEKLIKTTGLDSQIITI
DGYRSKETQQALWDETIQEKGLEFAHKYVAKPGCSEHEIGLAVDLGLATKENDFIRPSFT
DSPIVDKFLKHMTDFGFILRYQKGKESITNINYEPWHFRYVGTPHSSIMVQQNWVLEEYI
EFIESIRGTAYEA
>YP_001420189.1|FEATURES|CARD|multidrug|clbA|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPDFRMNQIKNAVFQGRINHFNEITVLPKSLRKLLIEEFGES
ILNIAPLKVQHSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCKFCATG
DIGLKRNLTSDEMTDQILYFHLKGHSIDSISFMGMGEALANVQVFDALHVLTNPELFALS
PRRLSISTIGIIPGIKKITQDYPQVNLTFSLHSPFNEQRSKLMPINERYPLLEVMDTLDE
HIRVTSRKVYIAYIMLPGVNDSIDHANEVVNLLRSRYKRGNLFHVNIIRYNPTVSSPMRF
EEVNEKQVVNFYKKLKSAGINVTVRSQFGIDIDAACGQLYGNYQKNKNQ
>AGW16410.1|FEATURES|CARD|beta_lactam|OXA-328|antibiotic inactivation|1
MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
NAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AAB05626.1|FEATURES|CARD|glycopeptide|vanHB|antibiotic target alteration|1
MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEV
SEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAI
RGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSR
KIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGS
LVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTER
VLRDTTEKTIRNCLNFERSLQHE
>AET15272.1|FEATURES|CARD|aminoglycoside|aadA25|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>CAG34107.1|FEATURES|CARD|beta_lactam|OXY-2-5|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTESTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGSG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>AGW83447.1|FEATURES|CARD|beta_lactam|OXA-349|antibiotic inactivation|1
MYKKALIAATSILFLSSCSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRAPTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRVGFGNASIGSKVDNFWLVGPLKITPQQETQF
AYQLALKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWIVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AIT76110.1|FEATURES|CARD|beta_lactam|IMP-48|antibiotic inactivation|1
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPTTAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFNGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>AAL27445.1|FEATURES|CARD|glycopeptide|vanRE|antibiotic target alteration|0
MAKILILDDEKEIVSLLSTLLSNEGYEVYEAMSGKESLEIIENNKIDLAILDVMLPDISG
FDVLQSIREKQFFPVLMLTARGQDMDKITGLSMGADDYIVKPFNPFEVLARVKTQLRRYQ
TYNSQSIDETNEYAKNGLNISVNSRKVFLYDEEIKLTPIEFDILWYLCRNEGRVISSEEL
FEKVWKEDYLENNNTVMAHIAKIREKMHEKPRQPNIIKTVWGVGYTIEK
>ACQ82808.1|FEATURES|CARD|beta_lactam|PDC-3|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAC44793.1|FEATURES|CARD|aminoglycoside|AAC(2')-Ib|antibiotic inactivation|1
MPFQDVSAPVRGGILHTARLVHTSDLDQETREGARRMVIEAFEGDFSDADWEHALGGMHA
FICHHGALIAHAAVVQRRLLYRDTALRCGYVEAVAVREDWRGQGLATAVMDAVEQVLRGA
YQLGALSASDTARGMYLSRGWLPWQGPTSVLQPAGVTRTPEDDEGLFVLPVGLPAGMELD
TTAEITCDWRDGDVW
>AAB41956.1|FEATURES|CARD|multidrug|MexC|antibiotic efflux|1
MADLRAIGRIGALAMAIALAGCGPAEERQEAAEMVLPVEVLTVQAEPLALSSELPGRIEP
VRVAEVRARVAGIVVRKRFEEGADVKAGDLLFQIDPAPLKAAVSRAEGELARNRAVLFEA
QARVRRYEPLVKIQAVSQQDFDTATADLRSAEAATRSAQADLETARLNLGYASVTAPISG
RIGRALVTEGALVGQGEATLMARIQQLDPIYADFTQTAAEALRLRDALKKGTLAAGDSQA
LTLRVEGTPYERQGALQFADVAVDRGTGQIALRGKFANPDGVLLPGMYVRVRTPQGIDNQ
AILVPQRAVHRSSDGSAQVMVVGADERAESRSVGTGVMQGSRWQITEGLEPGDRVIVGGL
AAVQPGVKIVPKPDGAQAQAQSPAPQQ
>AAA26613.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKEFDITLLKSMIKNKGYELYPALIYTIVNI
INQNKVFRTGINSSGNLGFWDKLNPLYTCLINETEKFLNIWIESNVSFSSFYNSYKSDLL
EYKDTNEMFPKKPIPENTGPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKNNKIY
LPVSLQVHHAVCDGYHVSLFMSEFQNIVDSVNEWDLNLK
>AAA16529.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKNKGYELYPALIHAIVSV
INRNKVFRTGINSEGNLGYWDKLEPLYTVFNKETENFSNIWTESNASFTLFYNSYKNDLI
KYKDKNEMFPKKPIPENTVPISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIY
LPFPLQVHHAVCDGYHVSLFMNEFQNIIR
>BAC11901.1|FEATURES|CARD|chloramphenicol|cat|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQKRYKFYPAFVFLVTRV
INSNTAFRTGYNSEGELGYWDKLDPLYTIFDSVSKTFSGIWTPARNDFKEFYDLYLSDVE
KYNGSGKLFPKTPIPENAFSISIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIY
LPLSLQVHHSVCDGYHAGLFMNSIQELADRPNDWLF
>BAE77933.1|FEATURES|CARD|multidrug|CRP|antibiotic efflux|0
MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEM
ILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQ
MARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCS
RETVGRILKMLEDQNLISAHGKTIVVYGTR
>AAA98296.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYGFAKRLLNTKRSFALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>AHL30281.1|FEATURES|CARD|beta_lactam|OXA-383|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AHL30285.1|FEATURES|CARD|beta_lactam|OXA-381|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGFEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKVSAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AAA99505.1|FEATURES|CARD|peptide|bcrB|antibiotic efflux|0
MAKKAKYPDVPIRFSETFSDTNLYIVLLIGVPLYGVITSYLFNREYAESTLKNLLTIPVS
RISLIVSKLVLLLIWIMMLTLIAWVLTLLFGLIGQFEGLSSAVLIEGFKQFMIGGALLFF
LVSPIIFVTLLFKNYVPTIIFTIIISMVSIMVYGTEYSALFPWSAVWVIASGTFFPEYPP
EYSFISVAATTVLGLAATIVYFKKIDIH
>AAO16462.1|FEATURES|CARD|tetracycline|tet(C)|antibiotic efflux|1
MYALVQFLCAPVLGALSDRFGRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITG
ATGAVAGAYIADITDGEDRARHFGLMSACFGVGMVAGPVAGGLLGAISLHAPFLAAAVLN
GLNLLLGCFLMQESHKGERRPMPLRAFNPVSSFRWARGMTIVAALMTVFFIMQLVGQVPA
ALWVIFGE
>AAF27726.1|FEATURES|CARD|chloramphenicol|cmlA4|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFFIAPGLI
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQSAESTSNPNR
>AAZ91706.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|EreA|antibiotic inactivation|1
MTWRTTRTLLQPQNLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERH
DFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKL
QLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGEL
ETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRMMKTFFD
GTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHL
AERVNYRAIAFTHLGPTVPEMHFPSPDSPLGFSVVTTPADAIREDSMEQYVIDACGTENS
CLTLTDAPMEAKRMRSQSASVKTKLSEAFDAIVCVPSAGKDSLVAL
>AAD20273.1|FEATURES|CARD|beta_lactam|IND-1|antibiotic inactivation|1
MKKSIRFFIVSILLSPFASAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSMYLVTKK
GVVLFDVPWEKIQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATAK
TNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLV
KSNSATDLGYIKEANVEQWPKTINKLKAKYSKATLIIPGHDEWKGGGHVEHTLELLNKK
>AGK07369.1|FEATURES|CARD|beta_lactam|OXA-255|antibiotic inactivation|1
MKKFILPIFSISTLLSLSACSTIQNKFEKTSDISDQQHEKAIKSYFDEAQTQGVIIIKEG
KNIRIYGNNLVRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMSIGTQVNNFWLVGPLKITPIQEA
NFADDLANNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVTPQVGWLTGWVEKSN
GEKVPFSLNLEMKQGMSGSIRNEITYKSLENLGII
>BAD11815.1|FEATURES|CARD|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYE
EMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERG
HHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV
>BAP28835.1|FEATURES|CARD|beta_lactam|OXA-420|antibiotic inactivation|1
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
DGQNIKKYGTHLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKD
FTLGEAMQASTVPVYQELARRIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQ
EVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYVGFVEK
ADGQVVAFALNMQMKDGDDIALRKQLSLDVLDKLGVFHYL
>ABF70513.1|FEATURES|CARD|beta_lactam|IMP-30|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFKEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AGW16405.1|FEATURES|CARD|beta_lactam|OXA-323|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQNQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATITEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AGK07368.1|FEATURES|CARD|beta_lactam|OXA-253|antibiotic inactivation|1
MKKFILPIFSISILLSLSACSSIQTKFEDTSDISDQQQGKAIKSYFDEAQTQGVIIIKEG
KNISTYGNNLARAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDLANNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVIPQVGWLTGWVEKSN
GEKVPFSLNLEMKQGMSGSIRNEITYKSLENLGII
>AFO09968.1|FEATURES|CARD|beta_lactam|OXA-184|antibiotic inactivation|1
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>AIT76113.1|FEATURES|CARD|beta_lactam|MIR-9|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQSIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AGW16409.1|FEATURES|CARD|beta_lactam|OXA-327|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGVL
>AAA67509.1|FEATURES|CARD|tetracenomycin|tcmA|antibiotic efflux|1
MSTETHDEPSGVAHTPASGLRGRPWPTLLAVAVGVMMVALDSTIVAIANPAIQQDLHASL
ADVQWITNGYLLALAVSLITAGKLGDRFGHRQTFLVGVAGFAVTSAAIGLSGSVAAIVVF
RVLQGLFGALMQPSALGLLRVTFPPGKLNMAIGIWSGVVGASTAAGPIIGGLLVQHVGWE
AVFFINVPVGLAALVAGLVILTDARAERAPKSFDVSGIVLLSGAMFCLVWGLIKAPAWGW
GDLRTLGFLAAAVLAFAGFTLRESRATEPLMPLAMFRSVPLSAGTVLMVLMAFSFIGGLF
FVTFYLQNVHGMSPVESGVHLLPLTGMMIVGAPVSGIVISRFGPGGPLVVGMLLTAASLW
GMSTLEADSGMGITSLWFVLLGLGLAPVMVGTTDVIVSNAPAELAGVAGGLQQSAMQVGG
SLGTAVLGVLMASRVGDVFPDKWAEANLPRVGPREAAAIEDAAEVGAVPPAGTLPGRHAG
TLSEVVHSSFISGMGLAFTVAGAVALVAAAVALFTRKAEPDERAPEEFPVPASTAGRG
>AAF27727.1|FEATURES|CARD|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>AIT76115.1|FEATURES|CARD|beta_lactam|MIR-13|antibiotic inactivation|1
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLNAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>CAJ32491.1|FEATURES|CARD|aminoglycoside|aadA6/aadA10|antibiotic inactivation|1
MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAARLDE
TVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAG
IFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWE
GDERNVVLTLSRIWYSAATGKIAPKDIVANWAMERLPDQHKPVLLEARQAYLGQGEDCLA
SRADQLAAFVHFVKHEATKLLSAMPVMSKTKLDALST
>AGL43629.1|FEATURES|CARD|quinolone|QnrB68|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>BAB72069.1|FEATURES|CARD|beta_lactam|IMP-10|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>CAA11473.1|FEATURES|CARD|chloramphenicol|catB6|antibiotic inactivation|1
MENYFDSPFKGKLLSEQVTNRNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWVTSFPFFYMQEEPAFSSSTDAFQKAGDTIVGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTRDVEPYTIIGGNPAKQIKKRFSDEEISLLMEMEWWN
WPLDKIKTAMPLLCSSDIFGLHRHWRGIAV
>AAM76670.1|FEATURES|CARD|aminoglycoside|ANT(4')-IIb|antibiotic inactivation|1
MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
GDRLVHISAAVEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPA
AEPEVENTVEALGKIRNAIARGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEA
ILAFPRVPVGFAADWLTCLGLVEERSARSTAAAAERMVRGVLEMLPTDPDLLGEDIARLM
NAGLLEKYVQQ
>NP_417169.1|FEATURES|CARD|multidrug|emrR|antibiotic efflux|0
MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMA
LITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEK
GHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS
>ACV32636.1|FEATURES|CARD|beta_lactam|SHV-126|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGKRGARG
IVALLGPNNKAERTVVIYLRDTPASMAERNQ
>NP_252895.1|FEATURES|CARD|multidrug|mexH|antibiotic efflux|0
MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGV
GELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEI
LHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHL
GQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDP
LIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAH
QDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSS
AAPPVPVAGR
>AGS82587.1|FEATURES|CARD|beta_lactam|IMP-31|antibiotic inactivation|1
MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEKITGWGVITKHGLVVLVNT
DAYIIDTPFTAKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLT
NELLKKNGNAQAENSFSGVSYWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKP
DGLGYLGDANLEAWPKSAETLMSKYGNAKLVVSSHSEIGGASLLKRTWEQAVKGLKESKN
HHSPK
>BAD89844.2|FEATURES|CARD|multidrug|abeM|antibiotic efflux|0
MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPV
MLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFG
VPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIF
MYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRI
LQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIR
VGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLL
WFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVW
LGLIIGLSIACVLLLSRLYLNTKRLSQT
>NP_459346.1|FEATURES|CARD|multidrug|mdsB|antibiotic efflux|1
MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIA
DTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRL
PEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVW
GAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLG
RLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGAN
AIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMF
LQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVER
HISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTI
LSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAV
RRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVV
KQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKL
MHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPE
LANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVM
AQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPA
PGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQ
YNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARA
KEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGML
GVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA
>AHL30283.1|FEATURES|CARD|beta_lactam|OXA-390|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFTEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>YP_490697.1|FEATURES|CARD|aminoglycoside|acrD|antibiotic efflux|1
MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENT
VTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQ
AVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGS
QYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLL
QTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEM
ATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQ
NFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIM
SEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVL
SVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRW
IVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTH
EKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEA
RVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLD
DSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRML
PDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMD
IMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVM
LVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEA
TLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVP
LFFVLVRRRFPLKPRPE
>AAF34333.1|FEATURES|CARD|beta_lactam|SHV-19|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>CEA29752.1|FEATURES|CARD|beta_lactam|MIR-17|antibiotic inactivation|1
MMTKSLSCALLLSVTSAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>AAA26775.1|FEATURES|CARD|beta_lactam|EXO|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRILYTQDD
VEQADGAGPETGKPQNLANAQLTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSL
GDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANT
TSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDG
LVADAARVLAETLG
>AIZ00987.1|FEATURES|CARD|beta_lactam|OXA-421|antibiotic inactivation|1
MTKKTLFFAIGTMFLSACSFNTVEQHQIQSISTNKNSEKIQSLFDQAQTTGVLIIKRGQT
EEVYGNDLKRASTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIDFGNADIGSKIDNFWLVGPLKITPQQEAQF
AYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWFTGWVVQPQGE
IVAFALNLEMKKGIPSSIRKEIAYKGLEQLGIL
>ABX71158.1|FEATURES|CARD|beta_lactam|SHV-104|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSASSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>YP_108403.1|FEATURES|CARD|multidrug|amrA|antibiotic efflux|1
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
DAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHL
AALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPI
DGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQ
QDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDR
AVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVV
VVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>AAF86219.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRKLIL
>CCP46065.1|FEATURES|CARD|multidrug|mtrA|antibiotic efflux|0
MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLP
GMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARL
RRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLE
QVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP
>ABA71733.1|FEATURES|CARD|glycopeptide|vanTG|antibiotic target alteration|0
MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFL
ISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYH
LWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLI
FQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQ
KHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQS
LLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNT
LQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEIL
ILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDK
ILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQ
SSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGES
VGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVT
DIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA
>ABV66096.1|FEATURES|CARD|quinolone|QnrB16|antibiotic target protection|1
MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AHM76777.1|FEATURES|CARD|beta_lactam|ACT-18|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>ACI32877.1|FEATURES|CARD|trimethoprim|dfrA14|antibiotic target replacement|1
MRTLKVSLIAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNR
KYAVVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLST
IDIEPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>AAF34337.1|FEATURES|CARD|beta_lactam|SHV-23|antibiotic inactivation|1
MLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAGTLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>AHA11125.1|FEATURES|CARD|beta_lactam|OXA-362|antibiotic inactivation|1
MKILILLPLLSCLGLTACTSPVSSFPSHITSTQSTQAIAQLFDQAQSSGVLVIQRGQKVQ
VYGNDLSRAGTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVRRIQFGNQQIGQQVDNFWLVGPLKITPKQEVEFVS
ALAREQLAFDPQVQQQVKAMLLLQERKAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG
>AAB41957.1|FEATURES|CARD|multidrug|MexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQ
RDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVER
IMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSI
LFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGR
FMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKS
REAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTV
MAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEA
PQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPE
SVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEM
ERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLI
VPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAI
EAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPIC
FVWLLSLLRSKPAPIEQAASAGE
>AFR46588.1|FEATURES|CARD|quinolone|QnrB57|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>AAC75315.1|FEATURES|CARD|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>NP_252896.1|FEATURES|CARD|multidrug|mexI|antibiotic efflux|1
MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQ
GFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLP
ERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQ
RLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDF
REMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIR
KLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLI
PVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPV
AAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTL
SPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPL
LYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTD
GPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMV
LRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDI
GESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVR
VALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQY
TQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIY
TQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGL
VPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLA
EADLLVNKA
>AAA21532.1|FEATURES|CARD|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>AHA41505.1|FEATURES|CARD|glycopeptide|vanRO|antibiotic target alteration|0
MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGP
SGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDR
RRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLER
AWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG
>AGU69255.1|FEATURES|CARD|beta_lactam|OXA-317|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQEEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AGW83451.1|FEATURES|CARD|beta_lactam|OXA-353|antibiotic inactivation|1
MYKKTLIVTTSILFLSACSSNMVKQHQIHSMSANKNSEEIKSLFDQAQTTGVLVIKRGKT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWKKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEKKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTSSSIRKEIAYKGLEQLGIL
>BAO79518.1|FEATURES|CARD|fosfomycin|FosK|antibiotic inactivation|1
MITGINHITFSVRDLSSSIEFYRDLLGMRLHVTWEAGAYFTAGDTWVCLSVGEPKPANDY
THVAFSVGERELVELHARLKEAGVEEWKQNTSEGNSVYLLDPNGHRIELHCGTLATRLAE
LEKSPYKRLVWC
>BAF95849.1|FEATURES|CARD|beta_lactam|SHV-111|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALSGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIG94927.1|FEATURES|CARD|beta_lactam|OXA-415|antibiotic inactivation|1
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
PVRSKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNS
TVWVYELFAKEIGDDKARRYLKKIDYGNADPSTSNGDYWIEDSLAISAQEQIAFLRKLYR
NELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGSVFFALNIDTP
NRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR
>AAA26683.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|vatA|antibiotic inactivation|1
MNLNNDHGPDPENILPIKGNRNLQFIKPTITNENILVGEYSYYDSKRGESFEDQVLYHYE
VIGDKLIIGRFCSIGPGTTFIMNGANHRMDGSTYPFHLFRMGWEKYMPSLKDLPLKGDIE
IGNDVWIGRDVTIMPGVKIGDGAIIAAEAVVTKNVAPYSIVGGNPLKFIRKRFSDGVIEE
WLALQWWNLDMKIINENLPFIINGDIEMLKRKRKLLDDT
>AHA41500.1|FEATURES|CARD|glycopeptide|vanO|antibiotic target alteration|1
MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWE
NRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYV
GCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFG
VSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGF
FRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGR
VVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR
>AGW16408.1|FEATURES|CARD|beta_lactam|OXA-326|antibiotic inactivation|1
MYKKAFIVATSILFLSACSSNTVKQHQIHSISANKNSEAIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>AIL54055.1|FEATURES|CARD|beta_lactam|CTX-M-115|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHSF
>ADI81040.1|FEATURES|CARD|quinolone|QnrVC3|antibiotic target protection|1
MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFS
YADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYIT
GCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLS
HSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD
>AHL30274.1|FEATURES|CARD|beta_lactam|OXA-374|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPKG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AHL30287.1|FEATURES|CARD|beta_lactam|OXA-389|antibiotic inactivation|1
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPKWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDKVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AHL30279.1|FEATURES|CARD|beta_lactam|OXA-379|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWEWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CCK86741.1|FEATURES|CARD|beta_lactam|ACT-13|antibiotic inactivation|1
MMMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVKDMASWVMVNMKPDSLEESSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>AHC31001.1|FEATURES|CARD|beta_lactam|OXA-246|antibiotic inactivation|1
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKNFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>AAA65954.1|FEATURES|CARD|glycopeptide|vanSA|antibiotic target alteration|0
MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLN
HLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQ
IELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLL
DEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMT
DEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSG
DVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAE
SNDNYTTFRVELPAMPDLVDKRRS
>CBL80435.1|FEATURES|CARD|trimethoprim|dfrK|antibiotic target replacement|1
MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
IILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYE
FEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAS
>AAQ76277.1|FEATURES|CARD|beta_lactam|OXA-50|antibiotic inactivation|1
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>AHL39336.1|FEATURES|CARD|beta_lactam|ACT-24|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIDGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>YP_007503840.1|FEATURES|CARD|tetracycline|tet(A)|antibiotic efflux|1
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
LGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIAD
TTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFR
ETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFG
WNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWL
VFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHS
LPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>AIA58911.1|FEATURES|CARD|beta_lactam|OXA-1|antibiotic inactivation|1
MLAVKIKPFTKPILIMKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFL
LYDASTNAEIAQFNKAKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIW
NSNHTPKTWMQFSVVWVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLE
SSLKISPEEQIQFLRKIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRT
LQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AAC36944.1|FEATURES|CARD|quinolone|blt|antibiotic efflux|1
MKKSINEQKTIFIILLSNIFVAFLGIGLIIPVMPSFMKIMHLSGSTMGYLVAAFAISQLI
TSPFAGRWVDRFGRKKMIILGLLIFSLSELIFGLGTHVSIFYFSRILGGVSAAFIMPAVT
AYVADITTLKERSKAMGYVSAAISTGFIIGPGAGGFIAGFGIRMPFFFASAIALIAAVTS
VFILKESLSIEERHQLSSHTKESNFIKDLKRSIHPVYFIAFIIVFVMAFGLSAYETVFSL
FSDHKFGFTPKDIAAIITISSIVAVVIQVLLFGKLVNKLGEKRMIQLCLITGAILAFVST
VMSGFLTVLLVTCFIFLAFDLLRPALTAHLSNMAGNQQGFVAGMNSTYTSLGNIFGPALG
GILFDLNIHYPFLFAGFVMIVGLGLTMVWKEKKNDAAALN
>BAP18892.1|FEATURES|CARD|fosfomycin|FosA4|antibiotic inactivation|1
MLQGLNHLTLAVSDLASSLAFYQRLPGMRLHARWDSGAYLSCGALWLCLSLDAQRRKTPA
QESDYTHYAFSVAEEHFAEVVAQLAHAGAEVWKDNRSEGASYYFLDPDGHKLELHVGHLA
QRLAACRERPYKGMVFFD
>AEP40502.2|FEATURES|CARD|glycopeptide|vanTN|antibiotic target alteration|0
MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIG
PIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGV
LYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSY
QGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSF
SSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKI
TILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQ
VIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILG
YTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSL
YRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYG
ILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYS
LDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPE
IKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS
>AJA32742.1|FEATURES|CARD|beta_lactam|OXA-424|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AGW16404.1|FEATURES|CARD|beta_lactam|OXA-322|antibiotic inactivation|1
MYKKVLIVATSILFLSACSSNSVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTNYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>ACS44716.1|FEATURES|CARD|trimethoprim|dfrA7|antibiotic target replacement|1
MKISLISATSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHV
EVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>WP_063864673.1|FEATURES|CARD|beta_lactam|SHV-3|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQLQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAC43969.1|FEATURES|CARD|multidrug|opcM|antibiotic efflux|0
MDNMHNTNGLMRFAKVAAASTLLATLLAACAVGPDYQRPDAVVPAAFKEAPTLAAGEQAG
TWKTAEPSDGRTPRRMVKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQW
FPQVGAGFGPTREGLSSASQFQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRAD
QAQSEALFRSVQLALQADVAQNYFELRQLDSDQDLYHRTVELREQALKLVQRRFNEGDIS
ELDVSRAKNELASAQADAVDVARRRAASEHALAILLGKAPADFAFKETPIVPVAVKIPPG
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFRSSISPGRSAISVDARQPVPVVEPYF
LLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQGANYRQQVLVAFREVEDNLADLRLLD
DQIRAQEAAVNASRRAATLSRSEYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVSTV
NLIRALGGGWGNAPAPTAVGDAASGKADVAAR
>CAD12227.1|FEATURES|CARD|tetracycline|tet(33)|antibiotic efflux|1
MSSLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVM
QFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAGITGATNAV
TATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLA
LTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFT
EHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIV
TDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTT
IFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM
>AAC75314.1|FEATURES|CARD|polymyxin|pmrF|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>NP_248848.1|FEATURES|CARD|triclosan|TriC|antibiotic efflux|1
MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATV
DDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKIS
DIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQ
MIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFR
SEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEF
GEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLR
AGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELG
DSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIV
AVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFL
MKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGA
IRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPV
GRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLG
LSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIP
LKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYR
IEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAAL
LPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILL
TAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR
>BAE06009.1|FEATURES|CARD|multidrug|opmE|antibiotic efflux|0
MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPA
LESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQ
QRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQ
GIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAA
TRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATA
RIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAAS
EARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQG
DGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTS
PGVARQRDSRS
>AJP77059|FEATURES|CARD|beta_lactam|PEDO-1|antibiotic inactivation|1
MKIKFIFCLLLFPLFVFSQNVQEPTDTPKEWSAAYAPFRIVGNVYYVGTYDLACYLITTP
KGNILINTGLRSSAAQIKKNVELLGFNFKDIKILLTTQAHYDHLGAMAEIKKLTGAKMMV
DEKDASVMKDGGRTDYALGNGKTTYAPIIPDRLLKDGDQIQLGNTSIVMLHHPGHTKGSC
SFMLKTKDETRDYSVLIANMPSIVTEKKFSEIPAYPQIEKDYAYTLSSLKKLSFDIWLSS
HASQFCLHEKHKPGDKYNPTAFIDRAGYDKVLNSLQLEFDKKIGKK
>BAL43359|FEATURES|CARD|macrolide-lincosamide-streptogramin|mphG|antibiotic inactivation|1
MKNRDIQKLAERNGLILSDEMSFNEMGIDFKVGFATDRDGTKWLLRIPRRTTLGEQIANE
KRILQLVSKYLSVQVPDWRIANEKLVAYPLLDGKPALTYDAETYEVTWNMSKENDLYIPS
LAKALIELHSIPTEEVLRNNLKILTPEQVRNEISERLILVKSELGINAELELRYQKWLDN
DALWPNFTKFIHGDLYAGHTLTHHNGEVCGIIDWSTAQVSDIAQDFSGHVTVFGEESLKN
LIAAYEKQGGEVWDKLFEQAVERAAAAPLAYGYFALETQDEIHLSSAKLQLGVE
>WP_015943580.1|FEATURES|CARD|glycopeptide|vanXI|antibiotic target alteration|1
MKSDFVFVDELVSGIRWDAKYATWDNFTGKPVDGYAANRIVGTRALCAALEKARENAASL
GFGLLLWDGYRPQCAVDCFLRWSKQPEDGRTKQKHYPNIDRSEIIEKGYVAAKSGHSRGS
AIDLTLYHLASGTLVPMGGDFDLMDSVSHHGAHGISQAEARNRQYLCSIMEASGFVSYAC
EWWHYSLKHEPYPNTYFDFLIA
>Q8FW76|FEATURES|CARD|peptide|mprF|antibiotic target alteration|0
MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRH
TSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAG
YAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQ
DVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAG
VVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLG
GKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSA
SIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRL
ERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNW
IATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSI
INRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSL
IALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARV
DLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEK
GFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDAL
FAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKE
KFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK
>CAA53189|FEATURES|CARD|mupirocin|mupA|antibiotic target alteration|0
MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>AAZ42322.1|FEATURES|CARD|quinolone|qacH|antibiotic efflux|0
MKNWIFMAVAIFGEVIATSALKSSHGFTRLVPSVVVVAGYGLAFYFLSLALKSIPVGIAY
AVWAGLGIVLVAAIAWIFHGQKLDFWAFIGMGLIVSGVAVLNLLSKVSAH
>ANK04027.1|FEATURES|CARD|multidrug|gadW|antibiotic efflux|0
MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCH
YLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMF
SHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCF
SKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGT
FS
>WP_063860852|FEATURES|CARD|beta_lactam|MUS-2|antibiotic inactivation|1
MHRILSVITMLICTTLVHAQSDKLKIKQLNDNMYIYTTYQEFQGVTYSSNSMYVLTDEGA
ILIDTPWDKDQYEPLLEYIRSNHNKEVKWVITTHFHEDRSGGLGYFNSIGAQTYTYALTN
EILKERNEPQAQYSFNKEKQFTFGNEKLAVYFLGEGHSLDNTVVWFPKEEVLYGGCLIKS
AEATTIGNIADGNVIAWPKTIEAVKQKFKNAKVIIPGHDEWDMIGHIENTERILSAYNQQ
HSTKND
>NP_415222.1|FEATURES|CARD|aminoglycoside|kdpE|antibiotic efflux|0
MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDG
IEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHS
ATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQV
WGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML
>CDO61516.1|FEATURES|CARD|multidrug|efrB|antibiotic efflux|1
LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHR
FKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQ
PMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPE
KPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDV
RSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINS
EGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIA
HR
>APB03217.1|FEATURES|CARD|chloramphenicol|CatU|antibiotic inactivation|1
MKFHIINVEEWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTR
VVNDRVEFKTSFSPEGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDM
EQYRDTKGLFVKENPPPNTFPISMIPWTSFSGFNLNIVNEADYLLPIITGGKYTEQGGRV
LLPVSLQVHHAVCDGYHASMFFKELQSLADSFEDWLT
>APB03221.1|FEATURES|CARD|kasugamycin|AAC(2')-IIb|antibiotic inactivation|1
MNHRKGNEPTAAALMELHVLAMFTHDGNMQIRTINEPWPGEELAPRFFMGRTIDGSSICR
FRHDVPEGIAGQLRALVEDEPIVTEEVLTRPKHFAAYMNLLRAEHYTSGPCYRIPDQTTQ
AKQTVRITPGNIREYSLTGFEWLTTEIDYDQPCVALIHENRVVSVCRSVRITERAHEAGL
ETSEEFRGRGYAAAVVAGWAIEVQKMGALALYSTLWGNSSSRRVANKLGLSYYGVNFTIS
>APB03223.1|FEATURES|CARD|aminoglycoside|AAC(6')-34|antibiotic inactivation|1
MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVER
VREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEP
DYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQH
EGELRDCWIMEYRAERK
>APB03226.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mphI|antibiotic inactivation|1
MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRK
PRRPDVLDRADNEARVLKLIQSHLSVDVPDWRIYTPELIAYPLLSGQPAASVSMEGYAWN
MDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVS
DALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFV
LYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMA
RNALGLTE
>APB03224.1|FEATURES|CARD|aminoglycoside|cpaA|antibiotic inactivation|0
MPLRITAMTETYADQIMQWSYEPPYDFYNSEPDEEFRKELLECSYYAILDKEGQLFGFCC
TGSSAQIPIAIPLGAYDEDLLDFGLGMKPESTGQCRGKEFLSFVLASIAEFHKRQSFRLT
VAKFNERAIRLYTQLGFSEVATFDYGGTTFITMIKKPGSGL
>APB03215.1|FEATURES|CARD|tetracycline|tetB(48)|antibiotic efflux|0
MSSSMIQPGTERQLKNRTSLGQTVRNSLTMAYRGLLKLRRTPEQLFDVTFQPIIFTLMFT
YIFGGAISGDVASYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAP
LAGALLADTIRYTIATVLTFTMGYIMGYRPEGGLGYVALAGLVVILCSWAISWIFAFCGV
IARSASGVQGISMIVLFPLTFLSNAFVPVDTMPGWLQWFVNMNPISHLVTAVRDLTNAGT
VGWDLTISLVGAAVIVAIFAPITVRAYMRRT
>AET10444.1|FEATURES|CARD|tetracycline|tetA(46)|antibiotic efflux|1
MIRAIWEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQE
EYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYS
FGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMTDLILVYQT
GQMSYKKLKEVIDETDDLEPDGTHYLEQIDSVEFKDYSFSYPGAERKSLSGIDWTIQRGQ
TVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFS
KSIRENIALGKKGASQEDLMEAVAQAAFADDLERMSHGMDTLIGEKGVSVSGGQKQRISL
ARAFLRDADLLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>CAA77936.1|FEATURES|CARD|multidrug|emrE|antibiotic efflux|0
MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAY
AIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLIINLLSRSTPH
>EEL41021.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|mph|antibiotic inactivation|1
MEEIKMNTLKIKQLATKEGLNILEDSIKINESGVDFQVAHAKEQNGDKWILRIPRRPESM
RHVLQEKKALEIIKNHAGFQVPDWSIFTEDLIAYKQLSGVPAATIDIEQQGYIWSFNEKN
APSEYHISLGKVLANLHSLPQQEFNNIGIEILTANELRASMEQRMNRVKEQYYVNQKLWD
RWQAWLTEDSFWPSHVGVTHGDIHPGHILIDKKNNVTGLIDWTEVGIADVSIDFTSHYLL
FGKDGLTKLISSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKEMHEAAVHMLA
TES
>AAN28945|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVL
GAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDA
IGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGA
QGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAA
SFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLET
DVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKS
CRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGY
TDWRGKLERLGAKVLARDAVSVYV
>NP_251217.1|FEATURES|CARD|multidrug|MuxB|antibiotic efflux|1
MNPSRPFILRPVATTLLMVAILLSGLIAYRFLPISALPEVDYPTIQVVTLYPGASPEIMT
SSITAPLENQLGQIPGLNEMSSSSSGGASVITLQFSLQSNLDVAEQEVQAAINAAQSLLP
NDLPNQPVFSKVNPADAPILTLAVMSDGMPLPQIQDLVDTRLAQKISQISGVGLVSISGG
QRPAVRVRANPTALAAAGLSLEDLRSTVTSNNLNGPKGSFDGPTRASTLDANDQLRSADA
YRDLIIAYKNGSPLRIRDVASVEDDAENVRLAAWANNLPAVVLNIQRQPGANVIEVVDRI
KALLPQLQSTLPGNLDVQVLTDRTTTIRASVKDVQFELALAVALVVMVTFLFLRNVYATL
IPSFAVPLSLIGTFGVMYLSGFSINNLTLMALTIATGFVVDDAIVMVENIARYLEQGDSP
LEAALKGSKQIGFTIISLTFSLIAVLIPLLFMGDVAGRLFREFAITLAVAILISGFVSLT
LTPMLSAKLLRHIDEDQQGRFARAAGRVIDGLIAQYAKALRVVLRHQPLTLLVAIATLAL
TALLYLAMPKGFFPVQDTGVIQGVAEAPQSISFQAMSERQRALAEVVLKDPAVASLSSYI
GVDGSNPTLNTGRLLINLKPHSERDVTASEVIQRLQPELDHLPGIKLYMQPVQDLTIEDR
VARTQYQFTLQDADPDVLAEWVPKLVARLQELPQLADVASDWQDKGLQAYLNIDRDTASR
LGVKLSDIDSVLYNAFGQRLISTIFTQATQYRVVLEVAPQFQLGPQALEQLYVPSSDGTQ
VRLSSLAKVEERHTLLAINHIAQFPSATLSFNLAKGYSLGEAVEAIRGVEASLELPLSMQ
GSFRGAALAFEASLSNTLLLILASVVTMYIVLGILYESFIHPVTILSTLPSAGVGALLAL
MLAGQEIGIVAIIGIILLIGIVKKNAIMMIDFALDAERNEGKPPHEAIYQACLLRFRPIL
MTTMAALLGALPLMLAGGAGAELRQPLGITMVGGLLLSQVLTLFTTPVIYLYFDRLARRW
AAWRKQRGLDLNTEAGFDGDAGR
>ENV34035|FEATURES|CARD|aminoglycoside|APH(3')-IX|antibiotic inactivation|1
MINDMKISLPQSLKSFIGNQPLQKDKVGQSPSDVYSFTKNNEKYYLKTTELIYAQTTYSI
IREAKILDWLDGKLNVPELVLMDTDHENEYMISKAVPAKPLQDFTGKSDQFFIDIYTDAL
AQLQSISIKNCPFISNKKFRLAEAEFFIENGLLDELDDDEKDLKLWSSYQNFAEFLDDLK
QQNFQEEYVFSHGDLTDSNVFLSHDAQIYFLDVGRAGIADRFVDIAFIERSLREDCSEDA
ALQFLNHLAEDDSFKRNYFLKLDELN
>EEX02086|FEATURES|CARD|aminoglycoside|ANT(3'')-IIa|antibiotic inactivation|1
MPDFIQLEYLQEKLQQLLAESLFAIYLYGSAVDGGLGPESDLDVLVVVTQPLTSALREQL
AQELLKISQPVGELQRPLEVTILLKDEIQAGNYPLSYEMQFGEWLREELKEGGTLSSQKD
PDISILLRKARFHHTVLFGPALDQWAPEISDQELWQAMSDTYPEIVAHWDEDADERNQIL
ALCRIYFSLVMKDIASKDNAARWVMPQLPPEQKFVLQRLIQEYRGEIGKQNWQEEHYALQ
PIVNFLSSKIEEQFEQKRNLIT
>ENU91137|FEATURES|CARD|aminoglycoside|ANT(3'')-IIb|antibiotic inactivation|1
MSEQFQLQQLQEYLHALFAESLFAIYLYGSAVDGGLGPESDLDLLVVVTQPLTHVQRQQL
AQALLTLSHPIGGLQRALEVTILLKEEVISGRYPLNYELQFGEWLREELVDGGELSAQND
PDISILLKKAHMHHRTLFGPDLTSWLDEIPDQQLWQAMADLYPSIVAHWDEDGDERNQIL
ALCRIYFSLSLGEIVSKSHAAQWVIAQLEEKDQPVLQRMVQEYKGEMTKQDWPSQHQVLQ
PIVNFLSQHIETFFDKKGLKIKQ
>CAH14032.1|FEATURES|CARD|multidrug|LpeA|antibiotic efflux|0
MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSH
NLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSL
SAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGI
IGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQ
KMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVK
KGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS
>CAH14033.1|FEATURES|CARD|multidrug|LpeB|antibiotic efflux|1
MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVE
TAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLP
PEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQ
PYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENL
LIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVI
KGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLI
TIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAA
LKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPL
MCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLI
SHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIV
LPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTP
DHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTI
EVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPA
TLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSM
LFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLIT
LIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHD
AGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE
>KKE03230.1|FEATURES|CARD|fosfomycin|FosA7|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWVCLSYDVSCNYVAP
QECDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLA
SRLAQCREKPYSGMRFGPGK
>WP_063857788.1|FEATURES|CARD|beta_lactam|ADC-13|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857789.1|FEATURES|CARD|beta_lactam|ADC-14|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERFKAAYAVLNAIKK
>WP_063857792.1|FEATURES|CARD|beta_lactam|ADC-17|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDRQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNRENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNTQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_032055358.1|FEATURES|CARD|beta_lactam|ADC-43|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPLKYPKDIQRAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_063857804.1|FEATURES|CARD|beta_lactam|ADC-44|antibiotic inactivation|1
MRFKKISCLLLPPLFIFSTSIYAGNTSKEQEIKKLVDQNFKPLLDKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLSLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_001211216.1|FEATURES|CARD|beta_lactam|ADC-82|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDALAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AKR18016.1|FEATURES|CARD|beta_lactam|PDC-76|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPIAERVKIAYAILSG
LEQQGKVPLKR
>AKR18017.1|FEATURES|CARD|beta_lactam|PDC-77|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPRPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18019.1|FEATURES|CARD|beta_lactam|PDC-79|antibiotic inactivation|1
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALTQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAKGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQGKVPLKR
>AKR18023.1|FEATURES|CARD|beta_lactam|PDC-83|antibiotic inactivation|1
GEAPADRLKALVDAAVQPAMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>AKR18029.1|FEATURES|CARD|beta_lactam|PDC-89|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSALQPHRIARLP
APQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQ
QAKVPLKR
>AKR18030.1|FEATURES|CARD|beta_lactam|PDC-90|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSALQPHRIARLP
APQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQ
QAKVPLKR
>AKR18031.1|FEATURES|CARD|beta_lactam|PDC-91|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSLQPHRIARLPA
PQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQ
AKVPLKR
>AKR18033.1|FEATURES|CARD|beta_lactam|PDC-93|antibiotic inactivation|1
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
EIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQ
FPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLF
PALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANL
HPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMAPQPHRIA
RLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSG
LEQQAKVPLKR
>NP_249115.1|FEATURES|CARD|multidrug|mexR|antibiotic efflux|0
MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQ
MCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELF
APLTPVEQATLVHLLDQCLAAQPLEDI
>NP_253464.1|FEATURES|CARD|polymyxin|basR|antibiotic target alteration|0
MRILLAEDDLLLGDGIRAGLRLEGDTVEWVTDGVAAENALVTDEFDLLVLDIGLPRRSGL
DILRNLRHQGLLTPVLLLTARDKVADRVAGLDSGADDYLTKPFDLDELQARVRALTRRTT
GRALPQLVHGELRLDPATHQVTLSGQAVELAPREYALLRLLLENSGKVLSRNQLEQSLYG
WSGDVESNAIEVHVHHLRRKLGNQLIRTVRGIGYGIDQPAP
>CAC35723.1|FEATURES|CARD|multidrug|acrS|antibiotic efflux|0
MARKTKQQALETRQLILDVALRLFSQQGVSSTSLAAIAKAAGVTRGAIYWHFKNKSDLFN
EIWSLSDASISDLEVEYRAKFPNDPLSVVREILVYILEATVVEERRRLMMEIIFHKCEFV
GEMAVVQQAQRSLWLESYDRIEQTLKDCITAQQLPANLLTRRAAILMRSYLSGLMENWLF
APESFNLHAEARAYVDALIEMYQTCPSLRSSSEVMA
>YP_491362.1|FEATURES|CARD|sulfonamide|sul3|antibiotic target alteration|1
MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGE
STRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSL
SEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKE
KLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIGQLLNVGPSERLSGSL
ACAVIAAMQGAHIIRVHDVKETVEAMRVVEATLSAKENKRYE
>CCP46624.1|FEATURES|CARD|beta_lactam|Sbal223_2079|antibiotic target alteration|0
MTQCASRRKSTPNRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQ
RGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSA
QRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPN
LRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLD
QLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDD
GYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLV
CWLLLSREVLPRLGPAVEASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIE
RSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVS
PMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRR
FGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFA
AVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAM
PKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVA
SMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPL
GGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPA
RVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVL
EYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDW
IAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSA
KKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLEL
GTATRSGLWSPGKIRIGP
>AFK58562.1|FEATURES|CARD|multidrug|evgA|antibiotic target alteration|0
MIKVLLVDDHEMVRLGVSSYLSIQEDIEVIGEAENGRQGYEKAMTLRPDVILMDLVMEEM
DGIESTKAILKDWPEAKIIIVTSFIDDEKVYPAIEAGAAGYLLKTSTAHEIADAIRATQR
GERVLEPEVTTKMMEKMSRRNEPVLHEELTNRENEILMLISEGKSNQEIADELFITLKTV
KTHVSNILAKLEVEDRTQAAIYAFKHGLVK
>CCP44816.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSG
TPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWL
RQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASV
ELVCSS
>ALL09868|FEATURES|CARD|aminoglycoside|HMPREF9710_02755|antibiotic target alteration|0
MVSSIITALYLLNALIALVAILIKPRDVAAIWAWLLVLFALPGVGFVLYLFFGRGLTDKK
KFYLRQSDLKELENFQSFRGDTIEHYDPDMGDKDKQQFVDFFSSLNRMPLTRMNSVTLLT
DGQEKLDSLLQDLKKAKHSIHIEYYAFVTDNIGQQVLHVLEEKAAEGVEVRILYDAFGSH
GTKAKDFNRLIKNGGHVHTFVTSQRALLRFRLNYHDHRKIVVIDGKISYTGGFNIANQYV
NTTKKFGYWRDTHIRIFGAASSLLQLRFLTDWNVSVPEEKKVGYHLNYFFKKADRDESKL
ADTSIQLVSSGPNNEREQIKLSFIKLITSAKKRVWIQTPYLVPDESVIAALKIATASGVD
VKIMIPNKPDHPFIYRATQYYARQLIKENVQILVYENGFLHAKTLIMDDEICMVGSANQD
IRSYRLNFETSAVIYDPEFLEELATQFKEDETHCSSMTTETVKEMSNWLLFKQQISRLFS
PIL
>AFN51820.1|FEATURES|CARD|ethambutol|embA|antibiotic target alteration|0
MPHDGNERSHRIARLAAVVSGIAGLLLCGIVPLLPVNQTTATIFWPQGSTADGNITQITA
PLVSGAPRALDISIPCSAIATLPANGGLVLSTLPAGGVDTGKAGLFVRANQDTVVVAFRD
SVAAVAARSTIAAGGCSALHIWADTGGAGADFMGIPGGAGTLPPEKKPQVGGIFTDLKVG
AQPGLSARVDIDTRFITTPGALKKAVMLLGVLAVLVAMVGLAALDRLSRGRTLRDWLTRY
RPRVRVGFASRLADAAVIATLLLWHVIGATSSDDGYLLTVARVAPKAGYVANYYRYFGTT
EAPFDWYTSVLAQLAAVSTAGVWMRLPATLAGIACWLIVSRFVLRRLGPGPGGLASNRVA
VFTAGAVFLSAWLPFNNGLRPEPLIALGVLVTWVLVERSIALGRLAPAAVAIIVATLTAT
LAPQGLIALAPLLTGARAIAQRIRRRRATDGLLAPLAVLAAALSLITVVVFRDQTLATVA
ESARIKYKVGPTIAWYQDFLRYYFLTVESNVEGSMSRRFAVLVLLFCLFGVLFVLLRRGR
VAGLASGPAWRLIGTTAVGLLLLTFTPTKWAVQFGAFAGLAGVLGAVTAFTFARIGLHSR
RNLTLYVTALLFVLAWATSGINGWFYVGNYGVPWYDIQPVIASHPVTSMFLTLSILTGLL
AAWYHFRMDYAGHTEVKDNRRNRILASTPLLVVAVIMVAGEVGSMAKAAVFRYPLYTTAK
ANLTALSTGLSSCAMADDVLAEPDPNAGMLQPVPGQAFGPDGPLGGISPVGFKPEGVGED
LKSDPVVSKPGLVNSDASPNKPNAAITDSAGTAGGKGPVGINGSHAALPFGLDPARTPVM
GSYGENNLAATATSAWYQLPPRSPDRPLVVVSAAGAIWSYKEDGDFIYGQSLKLQWGVTG
PDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWAPPEADVARIVAYDPNLSPEQWFAFTPPR
VPVLESLQRLIGSATPVLMDIATAANFPCQRPFSEHLGIAELPQYRILPDHKQTAASSNL
WQSSSTGGPFLFTQALLRTSTIATYLRGDWYRDWGSVEQYHRLVPADQAPDAVVEEGVIT
VPGWGRPGPIRALP
>AAA50993.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARG
ITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALE
GDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVG
EEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIK
PHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMV
VTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AAN82549.1|FEATURES|CARD|tetracycline|tetW|antibiotic target alteration|1
MLSPEGESTIVRNIAVSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAAR
AFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILV
VAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPG
DDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRG
TVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKRE
EIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELP
EGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>YP_491222.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVNVRRDGQVYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDETFFDSPRFS
VSRLTHVLKAKAVLCPGVEITFKDEINNTEQRWCYQDGLNDYLAEAVNGLPTLPEKPFIG
NFAGDTEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFILWLNQ
NVQAAELLAEMAISSAQRRMRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVKHFRALVKHGHVYVALPPLYRIDLGKEVYYALT
EEEKEGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTIDDEDDQRTD
AMMDMLLAKKRSEDRRNWLQEKGDMAEIEV
>AAK48336.1|FEATURES|CARD|isoniazid|ethA|antibiotic target alteration|0
MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMY
TLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHI
QSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVV
IGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRW
KNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGD
LFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQ
VDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVE
RPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRF
AKRPAPVGV
>NP_462096.1|FEATURES|CARD|macrolide-lincosamide-streptogramin|macB|antibiotic target alteration|0
MTQTYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVDVILH
ADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVVN
ALSKRVEVTVRRDGQVYNIAFENGEKVQDLQVVGTCGKRNTGTSVHFWPDESFFDSPRFS
VSRLMHVLKAKAVLCPGVEITFKDEVNNSEQRWCYQDGLNDYLGEAVNGLPTLPEKPFIG
NFNGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRNI
LPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLNQ
NVQAAEQLAEMAIASAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEGD
SAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQL
RYGKICILADADSDGLHIATLLCALFVRHFRALVKNGHVYVALPPLYRIDLGKEVYYALT
EEEKAGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLTISDEDDQRTN
AMMDMLLAKKRSEDRRNWLQEKGDLADLDV
>AAO82601.1|FEATURES|CARD|beta_lactam|HMPREF1562_2717|antibiotic target alteration|0
MNNPWRFFIVAEALLFILALWQIVHNPGLAVLLTIGVLLVAYVSRKASKTHFNNFQFVLG
VVFIVIGAMNSTAVWFMLIFGVLFIGLKGFEISGVDIAERAPWRKKQMIMVETAAKEPKN
GKRFKRRWFANERIGNNIYEWDDINIDLISGDTIIDLGNTLLPKEDNIIIIRKGFGRTRI
LVPLGVAILLEHSTFYGTVRFEEEKYQLKNESLKIYSNDYDTNLRRLKIMTNTLVGDVEV
IRV
>NP_251858.1|FEATURES|CARD|beta_lactam|ACT-18|antibiotic target alteration|0
MGELAKEILPVNIEDELKQSYLDYAMSVIVGRALPDARDGLKPVHRRVLYAMSELGNDWN
KPYKKSARVVGDVIGKYHPHGDTAVYDTIVRMAQPFSLRYMLVDGQGNFGSVDGDNAAAM
RYTEVRMAKLAHELLADLEKETVDWVPNYDGTEQIPAVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLGEVIDGCLALMDNPDLTVDELMQYIPGPDFPTAGIINGRAGIIEAYRTGRGRI
YIRARAVVEEMEKGGGREQIIITELPYQLNKARLIEKIAELVKEKKIEGISELRDESDKD
GMRVVIELRRGEVGEVVLNNLYAQTQLQSVFGINVVALVDGQPRTLNLKDMLEVFVRHRR
EVVTRRTVYELRKARERGHILEGQAVALSNIDPVIELIKSSPTPAEAKERLIATAWESSA
VEAMVERAGADACRPEDLDPQYGLRDGKYYLSPEQAQAILELRLHRLTGLEHEKLLSEYQ
EILNLIGELIRILTNPARLMEVIREELEAVKAEFGDARRTEIVASQVDLTIADLITEEDR
VVTISHGGYAKSQPLAAYQAQRRGGKGKSATGMKDEDYIEHLLVANSHATLLLFSSKGKV
YWLRTFEIPEASRTARGRPLVNLLPLDEGERITAMLQIDLEALQQNGGADDDLDEAEGAV
LEGEVVEAAEVEEVEGETAELVAEPTGAYIFMATAFGTVKKTPLVQFSRPRSSGLIALKL
EEGDTLIAAAITDGAKEVMLFSSAGKVIRFAESVVRIMGRNARGVRGMRLGKGQQLISML
IPESGAQILTASERGFGKRTPLSKFPRRGRGGQGVIAMVTNERNGALIAAVQVQEGEEIM
LISDQGTLVRTRVDEVSLSGRNTQGVTLIKLASDEVLVGLERVQEPSGGDDEDLPEGEEA
AESLGESAESESEPAAEAEGNEE
>AJF82049.1|FEATURES|CARD|chloramphenicol|LpxA|antibiotic target alteration|0
MSNHDLIHSTAIIDPSAVIASDVQIGPYCIIGPQVTIGAGTKLHSHVVVGGFTRIGQNNE
IFQFASVGEVCQDLKYKGEETWLEIGNNNLIREHCSLHRGTVQDNALTKIGSHNLLMVNT
HIAHDCIVGDHNIFANNVGVAGHVHIGDHVIVGGNSGIHQFCKIDSYSMIGGASLILKDV
PAYVMASGNPAHAFGINIEGMRRKGWSKNTIQGLREAYKLIFKSGLTSVQAIDQIKSEIL
PSVPEAQLLIDSLEQSERGIVR
>AGQ48857.1|FEATURES|CARD|multidrug|eatAv|antibiotic target protection|1
MSKIEIKNLTFGYDSQGTLLFEQANLNFDTQWKLGLIGRNGRGKTTLLNILQNKLPYQGQ
VIHQQEFAYFPQQTKDKERLTYYVLNDITDFEIWEIERELQLMQTDPEILWREFSTLSGG
EKTKVLLALLFVDDTHFPLIDEPTNHLDISGRKQVAAYLKKKKQGFIVVSHDRGFIDEVV
DHVLAIEKSQLELYQGNFSIYEEQKKLRDEFEMAQNEKLKKEVSRLKKTAAEKAEWSRSR
EGDKTKKQVGFIDTESRRVNKGAVGADAARTMKRSKAIVNRMETQISEKEKLLKDIEYID
SLTMNSQASHHKRLLSVEDLQLGYENLLFEPIHFTIEPHQRVAISGPNGAGKSSIIHYLL
GAFNGKVIGEKYQPKHLSISYASQNYEDNRGTLAEFAEKNQVDYQAFLNNLRKLGMERDV
FHNKIEQMSMGQRKKVELAKSLSQPAELYIWDEPLNYLDVFNQEQLEQLILNVKPAMLLV
EHDQTFLDKVSTEIISLERI
>CAG41169|FEATURES|CARD|fosfomycin|murA|antibiotic target alteration|0
MDKIVIKGGNKLTGEVKVEGAKNAVLPILTASLLASDKPSKLVNVPALSDVETINNVLTT
LNADVTYKKDENAVVVDATKTLNEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCA
IGSRPIEQHIKGFEALGAEIHLENGNIYANAKDGLKGTSIHLDFPSVGATQNIIMAASLA
KGKTLIENAAKEPEIVDLANYINEMGGRITGAGTDTITINGVESLHGVEHAIIPDRIEAG
TLLIAGAITRGDIFVRGAIKEHMASLVYKLEEMGVELEYQEDGIRVRAEGDLQPVDIKTL
PHPGFPTDMQSQMMALLLTANGHKVVTETVFENRFMHVAEFKRMNANINVEGRSAKLEGK
SQLQGAQVKATDLRAAAALILAGLVADGKTSVTELTHLDRGYVDLHGKLKQLGADIERIN
D
>CDJ73208|FEATURES|CARD|fosmidomycin|RosA|antibiotic target alteration|0
MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTY
GLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGS
VSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVAL
FGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKET
ESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQG
FTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFAL
GFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLT
GWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA
>CDJ72593|FEATURES|CARD|multidrug|EmeA|antibiotic target alteration|0
MLSIFKPAPHKARLPAAEIDPTYRRLRWQIFLGIFFGYAAYYLVRKNFALAMPYLVEQGF
SRGDLGFALSGISIAYGFSKFIMGSVSDRSNPRVFLPAGLILAAAVMLFMGFVPWATSSI
AVMFVLLFLCGWFQGMGWPPCGRTMVHWWSQKERGGIVSVWNCAHNVGGGIPPLLFLLGM
AWFNDWHAALYMPAFCAILVALFAFAMMRDTPQSCGLPPIEEYKNDYPDDYNEKAEQELT
AKQIFMQYVLPNKLLWYIAIANVFVYLLRYGILDWSPTYLKEVKHFALDKSSWAYFLYEY
AGIPGTLLCGWMSDKVFRGNRGATGVFFMTLVTIATIVYWMNPAGNPTVDMICMIVIGFL
IYGPVMLIGLHALELAPKKAAGTAAGFTGLFGYLGGSVAASAIVGYTVDFFGWDGGFMVM
IGGSILAVILLIVVMIGEKRRHEQLLQERNGG
>YP_207769.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDSAVYDTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREG
YKTGRGRVVIRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGL
DQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SGASVISNVTEPEAEN
>WP_014065640.1|FEATURES|CARD|beta_lactam|ampC|antibiotic target alteration|0
MTDSIHSSITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLFSMDQSGITA
GKKYVKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDAPAA
MRYTEVRMQKITQALLTDLDKETVNFSPNYDGELMIPDVLPTRIPALLANGSSGIAVGMA
TNIPPHNLNEVLDGCLAYIDNENITIDELMQYIPGPDFPTAALINGRKGIEEAYRTGRGK
VYVRARASVETTDKGKEQIIVTELPYQVNKAKLVEKIAELIKDKKIEGISNIIDLSNKEG
IRIEIDIKRDAVGEVVLNHLYALTQMQVTFGINMVALDHGQPRLFNLKQIIEAFVMHRRE
VVIRRSLFELRKARERTHILEGLAVATSNIDEIIDIIRQSKERKEAAEKLISRPWKLNNE
ILGLLDAAARPAELAAEFGIKGSDYYLSPEQVDAILELRLHRLTGLATEEVINEYKELLV
KIAELLHIINSPERLMEVIREELEQVRAQFADERRTEITAASGDIDLEDLIAQEDVVVTL
SHEGYVKYQPLTDYEAQRRGGKGKSATKMKDEDFIEKLLVANTHDTILCFSSRGRLYWLK
VYQLPQASRGARGRPIVNILPLQENERITAILPISAYEEDKFVIMATAGGIVKKIALTEF
SRPRSSGIIALNLRDEDELIGVDITDGSNEIMLFSSQGRVVRFAESAVRAMGRLATGVRG
IKLALTNDIADDESAVEIEEVSDDNAEETLDLNIDKVVSLVVPKNDGAILTATQNGYGKR
TQLSEYPTKSRNTKGVISIKVSERNGKVVAATQVEETDQIMLITDAGTLVRTRVSEVSIV
GRNTQGVRLIRTAEDEHVVSLERVCDVDDEDEGTEDVTSEE
>AFC91898.1|FEATURES|CARD|beta_lactam|pbp2b|antibiotic target alteration|1
MKWTKRVIRYATKNRKSPAENRRRVGKSLSLLSVFVFAIFLVNFAVIIGTGTRFGTDLAK
EAKKVHQTTRTVPAKRGTIYDRNGVPIAEDATSYNVYAVIDENYKSATGKILYVEKTQFN
KVAEVFHKYLDMEESYVREQLSQPNLKQVSFGAKGNGITYANMMSIKKELETAEVKGIDF
TTSPNRSYPNGQFASSFIGLAQLHENEDGSKSLLGTSGMESSLNSILAGKDGIITYEKDR
LGNVVPGTEQVSQQTVDGKDVYTTISSTLQSFMETQMNAFQEKVKGKYMTATLVSAKTGE
ILATTQRPTFDADTKEGLTKDFVWRDILYQSNYEPGSPMKVMTLAASIDNNTFPGGEYFN
SSELKIADVTIRDWDVNESLTGGGMMTFSQGFAHSSNVGMTLLEQKMGDATWLDYLNRFK
FGVPTRFGLTDEYAGQLPADNIVNIAQSSFGQGISVTQTQMIRAFTAIANDGVMLEPKFI
SAIYDPNDQTARKSQKEVVGNPVSKDAASLTRTNMILVGTDPVYGTMYNHSTGKPTVTVP
GQNVALKSGTAQIADEKNGGYLVGLTNYIFSAVSMNPAENPDFILYVTVQQPEHYSGIQL
GEFANPILERASAMKDSLNLQTTAKALEQVSQQSPYPMPSVKDISPGDLAEELRRNLVQP
IVVGTGTKIKESSVEEGTNLAPNQQVILLSDKVEEIPDMYGWKKETAEAFAKWLDIELEF
EGSGSVVQKQDVRTNTAIKNIKKITLTLGD
>NP_216963.1|FEATURES|CARD|bacitracin|bacA|antibiotic target alteration|0
MNSTNSGPPDSGSATGVVPTPDEIASLLQVEHLLDQRWPETRIDPSLTRISALMDLLGSP
QRSYPSIHIAGTNGKTSVARMVDALVTALHRRTGRTTSPHLQSPVERISIDGKPISPAQY
VATYREIEPLVALIDQQSQASAGKGGPAMSKFEVLTAMAFAAFADAPVDVAVVEVGMGGR
WDATNVINAPVAVITPISIDHVDYLGADIAGIAGEKAGIITRAPDGSPDTVAVIGRQVPK
VMEVLLAESVRADASVAREDSEFAVLRRQIAVGGQVLQLQGLGGVYSDIYLPLHGEHQAH
NAVLALASVEAFFGAGAQRQLDGDAVRAGFAAVTSPGRLERMRSAPTVFIDAAHNPAGAS
ALAQTLAHEFDFRFLVGVLSVLGDKDVDGILAALEPVFDSVVVTHNGSPRALDVEALALA
AGERFGPDRVRTAENLRDAIDVATSLVDDAAADPDVAGDAFSRTGIVITGSVVTAGAART
LFGRDPQ
>AAC75138.1|FEATURES|CARD_deepARG|multidrug|mdtD|antibiotic efflux|1
MTDLPDSTRWQLWIVAFGFFMQSLDTTIVNTALPSMAQSLGESPLHMHMVIVSYVLTVAV
MLPASGWLADKVGVRNIFFTAIVLFTLGSLFCALSGTLNELLLARALQGVGGAMMVPVGR
LTVMKIVPREQYMAAMTFVTLPGQVGPLLGPALGGLLVEYASWHWIFLINIPVGIIGAIA
TLLLMPNYTMQTRRFDLSGFLLLAVGMAVLTLALDGSKGTGLSPLTIAGLVAVGVVALVL
YLLHARNNNRALFSLKLFRTRTFSLGLAGSFAGRIGSGMLPFMTPVFLQIGLGFSPFHAG
LMMIPMVLGSMGMKRIVVQVVNRFGYRRVLVATTLGLSLVTLLFMTTALLGWYYVLPFVL
FLQGMVNSTRFSSMNTLTLKDLPDNLASSGNSLLSMIMQLSMSIGVTIAGLLLGLFGSQH
VSVDSGTTQTVFMYTWLSMALIIALPAFIFARVPNDTHQNVAISRRKRSAQ
>AAC68679.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|desR|antibiotic target alteration|0
MTGKTRIPRVRRGRTTPRAFTLAVVGTLLAGTTVAAAAPGAADTANVQYTSRAAELVAQM
TLDEKISFVHWALDPDRQNVGYLPGVPRLGIPELRAADGPNGIRLVGQTATALPAPVALA
STFDDTMADSYGKVMGRDGRALNQDMVLGPMMNNIRVPHGGRNYETFSEDPLVSSRTAVA
QIKGIQGAGLMTTAKHFAANNQENNRFSVNANVDEQTLREIEFPAFEASSKAGAASFMCA
YNGLNGKPSCGNDELLNNVLRTQWGFQGWVMSDWLATPGTDAITKGLDQEMGVELPGDVP
KGEPSPPAKFFGEALKTAVLNGTVPEAAVTRSAERIVGQMEKFGLLLATPAPRPERDKAG
AQAVSRKVAENGAVLLRNEGQALPLAGDAGKSIAVIGPTAVDPKVTGLGSAHVVPDSAAA
PLDTIKARAGAGATVTYETGEETFGTQIPAGNLSPAFNQGHQLEPGKAGALYDGTLTVPA
DGEYRIAVRATGGYATVQLGSHTIEAGQVYGKVSSPLLKLTKGTHKLTISGFAMSATPLS
LELGWVTPAAADATIAKAVESARKARTAVVFAYDDGTEGVDRPNLSLPGTQDKLISAVAD
ANPNTIVVLNTGSSVLMPWLSKTRAVLDMWYPGQAGAEATAALLYGDVNPSGKLTQSFPA
AENQHAVAGDPTSYPGVDNQQTYREGIHVGYRWFDKENVKPLFPFGHGLSYTSFTQSAPT
VVRTSTGGLKVTVTVRNSGKRAGQEVVQAYLGASPNVTAPQAKKKLVGYTKVSLAAGEAK
TVTVNVDRRQLQTGSSSADLRGSATVNVW
>A0A133N6E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDFLFILKALIIAVVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLSYIFSFIGSKTSSDKRKYEKRLAESKTGFRFGINVIIATI
PAAILGFLFDDEINKYLFSTKTVAVGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLGIPVMVGASGLKLFKF
DYSQMDGTYLIALILGFIVAFIVSLVVIDKFINYLKKKPMRIFAIYRVFAGIVLAILIFT
KVIS
>A0A024P8A8|FEATURES|UNIPROT_deepARG|beta_lactam|temp|antibiotic inactivation|1
MKKIYESKFSMRQVKMFMSLLVLITLAACFDSTNSTNVSSKEGNEVGKTTNASEKFSQLE
NEYNARLGVYAIDTGSNQTIGYRPEERFAFTSTYKALAAAIVLQQSTMKELKEVITYTED
DLVSYSPITEKHVDTGMTLLKLAEAAVRSSDNTAGNLLFKGLGGPDGFEQALRQIGDNTT
QSERYEPDLNEFTPGDNRDTSTPKALTTDLQAFAVGDLLSDDERERFTNWLQGNATGDTL
IRAGAPEGWKVGDKSGAGSYGTRNDIAVVWPPNREPIIISIMSRHYTEEAKYDDALIAQA
AKVALNALK
>A7B8I6|FEATURES|UNIPROT_deepARG|aminoglycoside|mprF|antibiotic target alteration|0
MRDKKKAVFNILFLLLVFGLTVYGVFRGEDLESMMHSIRQAQWQWLVPGVALVLFFIWSE
SIIIWYMMKSYGTRLKKRSCFLFSSVGFFFSCITPSASGGQPMQIYYMKKEKIPIPVSTV
VLMIVTITYKLVLVVIGIGILIFGQGFLHRYLEGILPVYYLGLGLNVFCVVFMTVLVFHP
VLTKEILKKGVHLLEKLRLMKHKEERLEKLDASMDTYRGTAVYLKEHMGVIVVVSGITFV
QRMALFAATWFVYRAFGLSGTSFFDILFLQAVIAVAVDMLPLPGGMGISETLFLNIFRPV
FGSLLLPGMVLSRGLGYYAELLISAAFTVVAQLTIGNEKVREQKKCIKERVEG
>A0A0W1FDU6|FEATURES|UNIPROT_deepARG|aminoglycoside|ATE62_07440|antibiotic inactivation|1
MQVRDAEAADIPAWAAMRAALWPDADAAELAEDLPAALDDETLWNFILVDDAGKAAGFAE
VQLRTMFDGCPVAPYPHIEGIWIDAALRRTGAGRLLLAAIEDRARERGHDRIGSDVELDN
LGSQAWHEANGFAEEVRVILYSKPL
>A0A0D0JYK8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MAEALLQLSGITRSFTAGDREFLALKNIDLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGRETRDLDSEALAELRRDYFGFIFQRYHLLPHLSAMHNVEIPAIYAGTPEL
QRHARARELLARLGLERHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMHILQELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNVPDSDASANDDR
LAPHATAARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVAALNQLYYVDSATPVVGRNL
LLRYRNIDVDAQVNGVSDLYFQVRGIKMAAGIHFSESDARRQAQVVVIDHKTRQRLFGEQ
VDPLGQVILIGNLPCTVIGVAAENKNLFAASKSLNVWVPYETAAGRLLGQRYLDSISVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGAIGISLSYAIGH
LFSLFIKEWEMVFSMASVMTAVFCSTLIGVVFGFVPARNASRLDPIEALARD
>A0A034THR3|FEATURES|UNIPROT_deepARG|beta_lactam|JCM18904_2380|antibiotic inactivation|1
MKKLFLLAGLMVCSTLSYASQLNEDISLLEQQTSSRIGVSVWDTQADERWDYRGDERFPL
MSTFKTLACAKMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRTIGDKATRLDRIEPRLNEATPGDSRDTTTPNAILN
TLRTLVEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLVAQISQLILQKYKDN
>A0A0F0EB81|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTGLQAVILGIVEGLTEFLPISSTGHQIVVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPKERQAQRFTANLLIAFMPAVVLGVLFADLIHEYLFNPITVATALV
IGGVIMLWAERREHVVQVEQVDDMRWTDALKIGFTQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPDDFPVFAIGFVVSFIFAMIAVRGLLRF
IANHSYAMFAWYRIVFGLIILATWQFGVVDWATAHG
>T6HTT1|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENAPPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQISN
>Z9JIR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFELLAALMLGILEGLTEFLPVSSTGHLLIAEHWLGSRSDFFNIVIQTGSILAITLVFRK
RLWSLATGLGKYTNRDYVMKLVAAFLVTAVVGLAVRKAGWQLPETIQPVAWALIIGGIWI
LIAEYVAKHLPERESVTWTVAIAVGLAQVVAGMFPGTSRSASTIFLAMLLGLSKRSAAAE
FSFLVGIPTMFAASSYTFLELFKRGEIRHENWLEVSVAFVAAMVTGFAVVNWLLGYIKAH
SFAPFAYYRITLGLVLLTWLP
>CAA54186|FEATURES|ARDB_deepARG|puromycin|pur8|antibiotic efflux|1
MARKPDISAVPVESAACQGPDPRRWWGLVVILAAQLLVVLDGTVVNIALPSVQRDLGMSD
TSRQWVITAYTLAFGGLLLLGGRVADAFGRRRIFAVGILGFGLASLLGGAAPDPGTLFLA
RALQGVFAAALAPAALALINTLFTEPGERGKAFGVYGAVSGGGAAVGLLAGGLLTEYLDW
RWCLYVNAPVALLALLGCRLLPRDRRTGRAVRLDLPGTLLGCGGLVAIVYAFAEAESGWG
DPLVVRLLVLGVLMLVAFALVERRVQDPLLPPGVVAHRVRGGSFLVVGLPQIGLFGLFLF
LTYYLQGILDYSPVLTGVAFLPLGLGIAVGSSLIAARLLPRTRPRTLIVGALLAAAAGMA
LLTRLEPDTPQVYLTHLLPAQILIGLGIGCMMMPAMHTATARVAPHEAGAAAAVVNSAQQ
VGGALGVALLNTVSTGATAAYLADHGTSPAATVDGTVHGYTVAIAFAVGVLLLTAVLAWV
LIDSRTEAADETGSASVTPARPR
>A0A140QPT5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MQFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQCAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0F5RNZ6|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYQILAGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYGNINLVVSGHG
EVGDRGLLLHTLDLLK
>A0A0P7N222|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>J0MFG8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKTLCLTLLLAASCSSFAAQKELTAPQIEKLVNRTVAPLMKEQAIPGMAVAVIYKGYPL
YFTWGKADVQRNVPVTQQTLFELGSVSKTFTGVLGGDALARGEVSLSDPAQKYWPELNGK
QWKGITLLQLATYTAGGLPLQVPDEVTNSDALLKFYQNWQPKWAPGTQRLYANASIGLFG
ALMVKPSGMSFEQAMLKRVFEPLNLQHTWINVPATEDSHYAWGYRDGKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPDRLGDKTLAQGIQLAQSRYWRVGSMYQGLGWEMLNWPVK
GKTIIDGSDNKIALAPHPATLIEPPAPAVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNTERVKAAYAILEALQ
>L2W0E7|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWMLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPVREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDIAG
APSAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLVMSLSMIPVGMVSNLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYVGGGWLFDLG
KSAQQPELPWIMLGIIGIITFVAMGWQFSQKRATRWLLERDA
>A0A0N9HKT3|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-129|antibiotic inactivation|1
ADIIAAYIILVFFTSAAFSESISENLAWNKEFSSESVHGVFVLCKNSSNSCTTNNAARAS
TAYIPASTFKIPNALIGLETGVIKDERQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEMRMQKYLNSFSYGNANIGGGIDKFWLEGQLRISAVNQVIFLESLYLNKLPV
SKVNQLIVKEALVTETTPEYLVHSKTGFSGLGTESNPGVAWWVGWVEKGTEVYFFAFNMD
IDNESKLPSRKSIPTKIMASEGIIGG
>YP_001338812|FEATURES|ARDB_deepARG|chloramphenicol|cmlA5|antibiotic efflux|1
MLYGSAAKSFVQGDGFVRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNAL
GTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEV
FLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDM
WLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAA
GMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRM
GMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVT
AVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHD
VVALQSAESTSNPNR
>YP_002791392|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MLRSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWG
GEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPG
VRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFE
RQGTVTTPDGPAVYMVQTRQAFERTRSDA
>A0A0R1GL97|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKAAILGIIEGITEFLPISSTGHLYLADEFVKLNESTAFINMFMVVIQLGAIMAVV
VLYFTKLNPWAPSKSVLERRQTWTLWAKVIIAVLPSVIVGLPLNDWMEDHLTSWQVIAAT
LIIYGLLFIVIENYNRTKRPRFTDLNQLPIKLAVFIGIFQILSMVPGTSRSGATILGAIL
IGTSRFVATEFSFFLAIPTMFGASLLKVLKYFLHGNTFTGSQIIVLLTGVIVSFAVAYLA
IKFLLHYIRNNDFKLFGWYRIVLGAVVITYFGLLH
>A0A0M3EY82|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTVGENTFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRKIAPEMIFSFYYRSLLCDEILSVATNGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVNRADAGAIVAQQRVAIGPDDTALELHHKLCAAAQTLLRDTLPTL
LNGSFSEIAQDESKASCFGRRTPEDGRLDWHKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAARPGTVVSASPLIISCGEQSLEIVTGQTDSGLYVQGAQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLRDDNYEIYGLDIGSDAIGRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
AGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGRQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASVRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTIQMEQTIDETLDFFLRTVELSEQAS
>U2IYK3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIILAIVEGLTEFLPVSSTGHMILTEGILGMESTAYLKAFTVMIQFGAILSVVVY
YFRRFLPFPILGLKPDPTTSLGGWRLYGLMIVGCIPAAILGALFNETIDTLLGSTWVVLG
MLFLGGILMIYFDRIFTNKTERPVQVQNAFIIGLFQCLAMIPGVSRSMATIFGGMQQGLT
RRQAAEFSFFLAVPTMFGATLLKGYKLYKELGIEVFQENWQTLLVGNIVAFVVALLAIKF
FIEFVTKYGFRVFGYYRILLSVGVAIALLLGANISLS
>A0A0Q6N2I5|FEATURES|UNIPROT_deepARG|beta_lactam|ASC78_12905|antibiotic inactivation|1
MKSLVHRRTVLLAASALPLASACSAWSAKGPQAASAEAELAALESSVGGRLGVAALDTAT
GARVQHRAAERFPLCSTFKTMLAAAILDRSTRDGSLLERRVSYGKGDILPHSPITEKYLG
QGMTVSAMCAATIQYSDNAAANLLMKILGGPSAVTAYARSIGDQAFRLDRWETELNSAIP
GDPRDTTTPEAMAASLQRLVLGDALGAAKRSQLETWLLGNTTGATRIRAGVPADWKVGDK
TGAGSYGTVNDTGVLWPPVGAPLVLAVYLTFPTQKDAEGRNDVIASAARIAVNALRA
>R8JXH1|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_05617|antibiotic inactivation|1
MLVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTITYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDKGMALKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKAPNK
>YP_001337728|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLVLLVAVGQMAQTIYIPAIADMAVALNVREGAVQSVMAAYLLTYGISQLFYGPLSDRVG
RRPVILVGMSIFMLATLVAITTHSLPVLIAASAMQGMGTGVGGVMARTLPRDLYEGAQLR
HANSLLNMGILVSPLIAPLLGGILDTLWSWRACYAFLLVLCAGVTFSMAKWMPETRPEGA
PRTKLLASYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMAVSILFIL
PIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGLMMWIPGLLGNMTVWTLLVPAALFFF
GAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQTGQGSLGLLMML
MGLLILLCWLPLASRFTHHQQPV
>A0A0W0HHS1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WEFRRKILDVVVGLPTQRNAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGIIMLWAERRQHRTHAESVDEITWKDAIKIGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAALYSGYKYRDLFQPADFPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLLILATWQFGWIDWTAVKP
>A0A0C1YMG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILILKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQAKTFDVVIQFGAILAIC
WEYRAKIGSVVGGLPSRPDARRFATNVIIATIPAVVLGLLLEKKIKAVLFSPVPVSVALI
VGGIVILWAEARQRDRAEPPRVHSVDDLTYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLDRRAATEFSFFLAIPIIFGATLYEMAKYWRSLSVNDLGLFAIGLVAAFVSAFVCVRW
LLRYVASHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>ABB70047|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>YP_001155044|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MVNLDQFCQIFFISSYTYKICPMELILLIKAVILGVVEGLTEFLPISSTGHLILVGDLLD
FNDERGKAFEVIIQFGAILAVCWEFREKLLKVACSLTSNANSRRFFLNLLIASAPAMGLG
FVFGKHIKAILFSPVPVATAFIVGALIIFWAERRQEKIGTTSTHIHTVDDLSYLDALKVG
IAQCAALIPGTSRSGATIIGGMLFGLPRVVATEFSFFLAIPVIGGATAYELLKLWKAPVT
ISGDYGLAIGVGFVAAFISAFICVRWLIHYVAHHNFIPFAWYRIVFGLLVLVTSYSGLIA
WSH
>A0A0U4JL32|FEATURES|UNIPROT_deepARG|beta_lactam|AV650_16790|antibiotic inactivation|1
MLKKSLSCVLLLATSSSVFAAPQTEKQIADIVNRTVAPLIKEQGIPGMAVAVIYQGQPYY
FTWGLADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPASKYWPALSGKQ
WQGITLLHLATYTAGGLPLQIPENVTDEASLQNYYQTWQPQWAPGTKRLYSNASIGLFGA
LMVKPSGMSFEQAMIQRVFQPLKLSQTWINVPQQEDKHYAWGYRDGKAVRVSPGMFDAEA
YGVKSSIEDMASWVQANMAPANVKDASLQKGITFAQSRYWHAGDMYQGLGWEMLNWPVKE
KTVVEGSDNKNALAALSVTKITPPAPLSSASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKNYPNPVRVEAAYRILEALRK
>AAK62562|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCIRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>X5PQC8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFLTALIVVRFLLDY
VSRNGYSLFGWWRLVVGTVGLVALMTWG
>C6WY45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLLKAALLGIVEGATEFLPISSTGHLILAGDLLNFMNHEKRNVFDIAIQLGAILAV
VWEYRARFTNTFAGIGRDPIANRLIINLAIAFLPLAILGLAFGSIIKAHLFKPVPVALAF
IIGAFIILWAEKRTHTITIETVDDIRPADALKLGLAQAVALIPGMSRSGSTIIGGLFFGL
SRKAAAEFSFFLAVPTLGMASIYSMYKDRALLSMDDMGAWAMGFIFSFISAMIAVRALIR
YVSNHDFTIFAWYRLVFGGIVLLTAYTGLVDWTVH
>YP_001451632|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRSVNLLLMLVLLVAVGQMAQTIYIPAIADMARELNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLTVLIAASALQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTVWNWRACYVFLLVLCAGVTFSMA
RWMPETRPAGAPRTRLIASYKTLFGNGAFTCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFATLMWQSVFSCLLAGVMMWVPGLFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQT
GQGSLGFLMTLMGLLILLCWLPLASRVPHQGQTI
>A0A151G1B9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKDTTEKRNTWVLWSKVLLAVIPSVIVGLPLNDWMDEHLMNWAVVSAT
LIIYGVLFIVIENHNKRLTPRFANLQTLPYTTALFIGCFQLLSLIPGTSRSGATILGAIL
IGTSRYVATEFSFFMAIPTMFGASLLKLVKFFAHGGSLAGLQGAVLAVGVIVSFIVAYLS
IRFLLDYIKKNDFKAFGWYRIVLGVLVIGYFTLIH
>A0A085JH61|FEATURES|UNIPROT_deepARG|beta_lactam|blaT-6|antibiotic inactivation|1
MPLKYIYLPLSLLITAFCLPVIASPRLAPEQAKLAEQQLHARAGFAELDLATGALRESYR
SGERFPMMSTYKVLLCGAVLARIDSGREQPERRIMYRQQDLEKYSPVTKQHLNEGMTIAG
LCDAAITMSDNTAANLLLSSIGGPQALTRFLRQTGDPMTRLDRQEPELNEALPGDPRDTT
TPEAMARTLRNLLSGKILTAASQQQLLHWMIADQVAGPLLRKVLPAGWFIADKSGAGEHG
SRGIIAVTGPAGKPSHIVVIYITDNDASMDVLNRQIAGIGAAMFSDLTGRPEKTTKP
>E2D0Y8|FEATURES|UNIPROT_deepARG|aminoglycoside|aph|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDHVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFHKYGIDNPDMNKLQFHLMLDEFF
>J8D5Z8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
HQSYTHIAFSVEQKDFKRILQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A0K6GSK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLAKALLLGIVEGLTEFFPISSTGHLIVVGDLIGFNSDSGKVFEVVIQLGAILAVL
WEYRARFLSAAAGIGRDPQANRFVFNLFVAFLPAALCGFLFIKAIKAHLFNAPSVAMALI
VGGVILLMVERKTWVARVHSVDDMTWKDALKVGIAQIAALVPGTSRSGATIIGGMLSGLD
RRTAAEFSFFLAVPMMFAATVYDVYKNWALFSSADLPVFAVGFAAAFVSAFFAVRGLIRY
VSQHTFEAFGWYRIVFGVLILLTGHFGWVTWQS
>CAD05305|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A0C2IA87|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRPLLELKGITRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETSTLSDDELAELRRDHFGFIFQRYHLLPHLGATHNVEMPAVYAGTGES
KRYSRAQELLARLGLAGHLGHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMKILLELNSAGHTVILVTHDDKVAAHAERIIQMRDGEIVSDRVNANRPEVNEKATQ
RLPSKPKQGNRLMAGLALFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIQAIGSNTIEIFPGSDFGDNKSGSIETLALSDVAALSGLYYIDSASPNIGRN
LLVRYRNLDVTATVSGVSPSYFQVRGTKMGSGVSFTKDDARRQAQVVVIDYNTRIRLFGP
TVDPLGQVILVDNLPCTVIGVTEDKKNIFNTSKNLNIWMPYETAAGRVLGQRFLDSITVR
IKDGQPSKVVEDNVSKLLEKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGITLSFGIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0A2FD26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQSIILAIVEGLTEFLPVSSTGHMVLAEGLMGMESDSYTKAFTVIIQFGAMLSVLVL
YWRRFFDFRSLPGMTQPVLRMLSRFRFYGLLLLGVLPAAILGLLFEKYIDHMLGSVLVVA
LMLLLGGVFMLFVDKMFASSNSSKPTPRSALIIGLYQCLAMVPGVSRSMATIVGGMQQGL
SRKAAAEFSFFLALPTMLGATLLKIYKLYKEGGQEIFMQHMDTLLIGNILAFIVALLAIK
GFVSFLTKYGFRAFGYYRIAMGSLILILMLCGIPLNLQ
>A0A0F9YJY0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLQLYIMNLIQTLILSIVEGITEFLPISSTGHLILFSNLLKITQTEFIKSFEIIIQLGAI
LAVVVIYFKKLIINFNFDLWKKIIIAFIPSIVFGLVFYKLIKGYLIGNSIVVILSLLTGG
VIMILFERFYEQKNQKFYKPKDKVLTNRDYLVIGFFQVFSMIPGVSRAFTTIFGGMLLGM
KRKDATEFSFFLAIPTMFAASTLDLLKTDLSIWTNTNYLVLGIGFMGSFITAYLTIKFLI
KFVQNHNFVNFGIYRIIISIIFAILVLKV
>A0A010KLE1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>R6PFH2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDMLKVIILGIVEGITEWLPISSTGHLILVDEFIKLGASSAFKEMFNVVIQLGAILAVV
VLYFHKLNPFSPKKSRKQKVYTIQLWMKVIVACLPAAVLGILLDDWMEAHLHNYVVVSIT
LILYGILFIVIENWNKDKTPQVTKLHQLSYQTALLIGVFQVLSLVPGTSRSGATIIGALL
LGTSRYVAAEFTFFLAIPVMFGASGIKLLKFIKVGGGFTGMEATMLIVGCLVAFVVSIIA
IKFLMGYIKKNDFKVFGYYRIILGVIVLGYFAASGFLK
>A0A0D5LHK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFTMNVVIATIPAVALALLFEKTIKSVLFAPVPVAVALV
VGGAVILWVEGRQRERGEPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTVFAWYRIVFGLFVLLVGYSGWIEWT
>YP_002384997|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLILLVAVGQMAQTIYIPAIADMARELNVREGAVQSVMGAYLLTYGISQ
LFYGPISDRVGRRPVILIGMSIFMLATLLAATTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYERTQLRHANSLLNMGILVSPLLAPLIGGVLDTLWNWRACYLFLLVLCAGVTFSMA
RWMPETRPADAPRTSLITSYKTLFGNGGFDCYLLMLIGGLAGIAAFEACSGVLMGAVLGL
NSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSAICCLLAGLLMWLPAWFGIMNIW
TLLTPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGALASLSAMLPQT
DQGSLGMLMTLMGVLIVLCWLPLAARMSHQGQAV
>YP_002849300|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYVSEARQLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRDRIAHQIRQGFWLAGSVSVLIMVVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPAMVMGFLGLLVNIPVNYVFIY
GHLGMPELGGVGCGVATAAVYWVMFIAMLSYIKRARSMRDIRNERGFQKPDTAVMKRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGVCMAVVTAIFTVTFREHIALLYNNNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAILMMLRMRFLQRQPSAVILQRAAR
>A0A125S9Y0|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-58|antibiotic inactivation|1
EHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYI
PASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELAR
RIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPLN
>ACC95128|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRILMDGEGVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRALPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAREAATAR
>A0A0U1MI34|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVDVDNNQQRRSKPRRLNLLHVLVGMIPAGILGLLFDN
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNQQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIILVIFIAILYFGFGIGKSI
>A0A058YPS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDSTLHLLKAFFLGIVEGLTEFIPVSSTGHLIVIGDWINFASSSGKVFEVVIQFGSILA
VMWIFRARLWQLIRGTLTGVRQEVNFTRNLLLAFLPAAVIGAIFIKSIKQVFYHPGVVAV
TLVVGGFIMLWVERRAPRTPGDAPGAADDTASDERATAHTLEQISGKQALGVGVAQCVAM
IPGVSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDLYRNIGLLTQHDMSAIA
VGFVAAFLSALVVVRAVLRFVANHTYRVFAWYRIALGLVVAAWIYAK
>A0A0J7Z367|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTQVSIEEHAVADSAAGPYALTTGPDGALWFTLVHSGRIGRLVPGEEPTSHRLDPTCGPT
VITSGPDGALWFTEYRADRIGRITTDGVIDEFGVPTAGCGPFGIAAGPDGALWFTETAAD
RIGRITADGRVTEFPLPVTGAFPSAITAGDDDGMWFTLNQANALGRIGMDGAVTIHPLPT
EAAAPVGIAAGRDGALWFVEIAAGQIGRITSDGQITEFPLPDRTARPHAVTVDSDGTAWF
TEWGGNRVGAITSDGSLSVHDLPTPHSEPHGIATGPDGAVWTALEIGALARIAPIAPADS
AT
>Q07UC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLADIIRAIILGVVEGVTEFLPVSSTGHLLLAERFFNLGEGPFWKSFAVLIQLGAILAIL
ALYFSKLWNIARGMFSDPAAQRFVIGVLVAFLPAAVIGAASGGLIKEYLFNPWVVCFTLI
LGGGILLWVDQLELKPVHHEATEFPLPMYLIIGFAQCIAMFPGVSRSGATIVGAMLLGAD
RRAAAEFSFFLAIPTMLGAFVYDLYKSRADMTMDHGLIVAVGFAVSFITAIIVVKTFLTY
VTRHGFALFAWWRVIVGTLGLIALALGR
>A0A0K8JJF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP3|antibiotic target alteration|0
MSDTVVAVILGIVEGVTEFLPVSSTGHMILAGHMLDFGGEFASVFEVFIQLGAILSILVL
YWDKFVHMLRPRKLSIRRGGLSLQHVIAGILPVLLLGYLLHKPIKEYLFSPFTVILGLIA
GGILMLVAEKAAGRPVVRSVESITIKQAFWVGLFQILSLWPGFSRSGSTISGGLLLGLSR
TAAADFSFIIAVPLMSVACVYDLLKVWNKLNVGDLQMIAIGFIVSFVIAYLSVVWFLRFL
NKSTLASFAYYRFILAAVSYYYFFAR
>A0A0T9LFJ9|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSQPEEINKVSIVIPVYNEQESLPALLERTSAACQLLRQPYEIILVDDGSSDNSAEMLTA
AAEKPNSCIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSMFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKTTEIKVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLSVLLVALRLIFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVESQQTKKTQEEE
>U2EBM8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METMLLVIKSAILGIVEGITEFLPVSSTGHIVIFENLMGFKGTNPNYVEMYTYVIQLGAI
LAVVILYFGKIKDTVVNFFPKKVGYENSGFKFWFMIFIACIPGGILGVLFNDLADEYLFT
PVSVAITLFLGGIWMIYAEKRFRNNNISGKELKVTAKQALIIGLFQCLAIIPGMSRSAST
IIGGWVSGLSTVAAAEFSFFLAIPVMVGMSFLKLLKIGGFAVLSRVELISLIVGFIVSFG
VALIVINSFISYLKRKPMKNFAYYRMIFAVIVLITGFLGIFH
>V9G3G9|FEATURES|UNIPROT_deepARG|aminoglycoside|JCM10914_123|antibiotic inactivation|1
MQTQAILDPFIKLSTEEFGSNLVGIYLHGSMAMGCFNPATSDIDLLLVIQDHLSKETAKR
FGQRLLTFHDRLSNQGGIELSIVLEDSIENMQYPPLFEFHYSNVHREKYRDDPDYICGGF
GDHDLAAHYTVIYHRGVTLYGKPIHQVFKRAVDPSYYRQAIIQDVASAASDIAELPLYFT
LNLCRVLYYLRENIVSSKQEGGEWGLRVLPAPYHGIIRQALLEYGGISDSMDIPEPDLIE
YAQYMLGQIHQASGQTPVY
>J2NR83|FEATURES|UNIPROT_deepARG|beta_lactam|PMI21_04305|antibiotic inactivation|1
MDSVSIMRKKNQKKLISYSAFALLLGASHSFADERIETIVKAAIEPVMQQQKIPGLAVAI
TVHGQPHYFNYGVASKENGKAVTENTLFEIGSVSKTYTATLAAYAQATGKLSLSDNASQV
LPALRGSAFDNISVLQLGTYTAGGLPLQFPSEADHQDKMLGYFKQWKPTYAAGTHRQYSN
PSLGLFGYLAAHSMEAPFDELMEKTLLPKLGLKHSYLKVPQNQMGLYAQGYTKDDKPVRV
EPGALDSEAYGVKTSASDLLRYVEANMNPASLEKPLQQAIAITHTGYYTVGGMTQGLGWE
LYNYPVTLDTLLAGNSSQMAFEAHEVQWLTPPQPQRDAVLINKTGSTGGFGAYVAFIPAK
DIGIVILANKNYPNPERIKIAHKILSALTE
>V9H6E9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMILVLKALILGFIEGLTEFLPISSTGHLIVFGSLLDFHSTGKVFEIAIQLGAVLAVVF
EYRSRFTNVILNFGRDREVNRFVVNLAIAFVPAAVMGLLFSKMIKTYLFNPVSVAMALVI
GGFLILWIEKRTQSRPAKVLTVESMRPRDALMVGLAQVLALIPGTSRSGSTIMGGMLWGL
ERKVATEFSFFLAVPMMIAATFYDIIKHRDLFTMADAGLIGVGFVAAFVAGLVTVRALLR
FVSRKNYVPFAYYRIIFGGIILLTWVMNWVNWSE
>J2NQP8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTEPLLQLTGITRSFTAGDREFLALNNINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGQETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQL
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRTNERDTTHLLSEEP
VAPKAAASRRLVASLGLFKEAFAMAWVALISHRMRTLLTMLGIVIGITSVVSISAVGEGA
KNYVLKDIAAIGSNTIDVYPGSSYGDKRAAAIETLTPADVTALNQLYYVDSATPMIGRSL
LLRYRNIDLDAQVNGVSDQYFKVRGIKMAAGIPFSESDARRQAQVVVIDHNTRQRLFGQD
VDPLGQVILIGNLPCTVIGVAAQDKSLFASGKTLNVWVPYETAAGRVLGQRYLDSISVRM
KDGQPSKVVEEHVTQLLLQRHGTKDFFTNNLDSVLQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSVFIKEWEMVFSLASVLTAVVCSTLIGIVFGFVPARNASRLDPIEALARD
>A0A0B5IFP5|FEATURES|UNIPROT_deepARG|beta_lactam|TE10_12060|antibiotic inactivation|1
MHKMLNGVLALSALSLTAASLAAPKTLTEQQISQVVTQTIEPLLKEQAIPGMAVAVIYQG
QRYYFTWGKADVGSGRPVTTDTLFELGSVSKTFTGVLGADAVARGEIKLSDNASRYWPEL
NGKRWQGITLLDLATYTAGGLPLQVPDNVTDRASLLDFYRRWQPQWAPGSMRVYANSSIG
LFGMLAVKPSGLGFEDAMSQRVLRPLKLNHTWINIPAAEEKNYAWGYRSGQPVHVSPGML
DAESYGVKSTITDMAAWLQANMAPREAGSPTLRKGLEMAQARYWRIGDMYQGLGWEMLNW
PVNGAAIAKGGDNAVALAPHPAAAIEPPVPAVAASWVHKTGSTGGFGAYVAFIPQLQLGI
VMLANKSYPNPARITAGYTILNALQ
>CAL26907|FEATURES|ARDB_deepARG|beta_lactam|TEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIEKQKCLTD
>A0A0A2Y982|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNINLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
TSGSYQITGKETAKLSTDQLSELRQQRFGFIFQRYNLLSTLTAQENVALPAVYTGMAKEQ
RLQRAAQLLEKLGLSNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDHRQSLQITVREITQTT
TNRGWQFYRDQFFEALNMSINAIVAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTS
AAEKNVTALLLSRHGKKDFFILNTDTIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMN
EFTMLFSTFSIVVAVLCSTLIGIIFGYIPAKNAAKLNPITALSQD
>A0A023SF56|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPPSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0W0I094|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNSNVRNFLISALFISSGTCMAATDLRQVVNSSVEPLMQQQGIAGLSVAVVNKGKVQYFN
YGVANKDKQQPVTEDTLFEIGSVSKTFTATLGGYAAASGKLKLSDMASQHLAALKGSAFD
RISLLQLATYTPGGLPLQFPDAADSAGTMLNYFQHWKPTYAPGAQRLYSNPSIGLFGYLS
AQSLGQPFNVAMEKTLLPKLGLTNTHVSVPADKIPTYAQGYDKDQKPVRVGPGALDSEAY
GIKTSTQDLAQYVMLNMHPQTLEKPLQQAIATTHTGYYTVNGMTQGLGWEYYPYPITLQA
LMEGNSTPMAMEPHNVKWLNPAQAQPANVLYNKTGSTRGFGAYVAYVPSKDMGVVILANK
NYPNAERVKVAHAILSALDH
>A0A0B5S431|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A132FJ12|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWTASVDKSSNGEAPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGEQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>L8B2Q9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M2|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>N6YQP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIELLLIALVLGIIEGLTEFLPVSSTGHLIIVGDLLGYNDDTSKVFKIVIQLAAILAVC
WDYRERLIKVAVGLPTQPAAQRFVGMLFIAFLPAAVLGLMFHSTIKGLLFNPLTVATALV
IGGLIILYVEKRAYHPRINDVDEMRWSDALKVGFAQALAMIPGTSRSGATIMGGLVFGLS
RKTAAEFSFFLAIPTMFAATAYDLYKNWALLRLDDVPVFAVGFVASFVAAMWAVKSFIKF
ISNHTFIAFAWYRIAFGLFVLATWYFGWVEWSET
>A0A0S4Q8M6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTACFYSITFLYIFKHIIYYAKIRLSTPSKNIGNKMKLIEIEKLNKYFGSGENTAHVLKD
INLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTASSGVCKIDGKETLNMTSDELSDLRQR
KFGFIFQRYNLLPALTANENVALPAIYAGMDNTSRKARANQLLEKLGLADKTGNRPNQLS
GGQQQRVSIARALMNGGEIILADEPTGALDSKSGETVLEILKDLHKEGHTIIMVTHDANI
AANASRIIEIKDGYIIRDERQQPYSEDLKLTKREYKKPRFFDQLIESFKMAINAITAHKL
RALLTMLGIVIGITSVISVVALGQGSQQQILSNINSLGTNTMTIMNGTGFGDRRANLTKN
LTISDAMMLNKQQFVDSTTPSSNLNGTVIYGNTNVTASINGVGEQFVNVKGLKMISGRFF
DADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILVDKKPLTVIGMAQESNNLNQTSLKMW
MPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKSINELLTAKHGKKDFFVMNSDTIKQT
ITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSVTERTKEIGVRMAIGAKQNNILQQFL
IEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMILSPASVVLAVFCSTLIGVVFGYMPA
KNASKLNPITALAQE
>A0A0D5Y0T0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPISSTGHQIIVADLLDFGGERAMAFNIIIQLGANLAVVWEFRRKIFDVVTGLPTQRNAQ
RFTVNLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALVVGGVIMLWAERRQHEVHASSV
DEINWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVGAAV
YSGYKYRHLFQPDDLPVFAVGFITSFIFAMIAVKGLLKFIANHSYAAFAWYRIVFGLLIL
ATWQFGWVDWTSVHS
>F3B0U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSILEILKVIIIGIVEGITEWLPISSTGHIILVEQLFMLNAGEEFKAMFEVVIQLGAILA
VVVLYFKKLNPFSKGINTKKMYLTIELWKKIIVACIPAAMLGLLIDKWVEEHLRNGFVIS
MALIIYGILFIMIENSNKNRVYSIRSIHSIDYQTALFIGFFQVLALIPGTSRSGATIIGG
MILGATRSVSAEFSFFLSIPIMFGASLLKLVKFGFHYTAVEVLYLIIGMSVAFFVSLFSI
SFLLNWVKKNDFKFFGYYRIGLGIIIVVWYLVSSLMSMK
>C9KPN4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSIADLLKTIILGVVEGLTEWLPVSSTGHMILVDEFIKLDVSKAFMDMFLVVIQLGAI
MAVVVLSFEKLNPFSSWKTRQEKHDTVQLWMKVIVACIPAAVIGLLFNKYMEEHFMTAPV
VATTLIFYGIMFIIVENYNKHRRPVITDLRRLDYKTALIIGIFQVLSLVPGTSRSGATIL
GGLLFGASRTVAAEFTFFLAIPVMFGASALKMVKFGFHYTGAEIIILVVGMVTAFIVSIL
SIKFLMRYIKTNDFKAFGWYRIALGIVVIAYLFMVGDPTAND
>I3BSD7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIHAIILGIVEGITEFLPISSTGHMIVVADWLGIPRESQNTAFEIIIQFAAIFAVIAN
YTDKFHPRHLKLWVKVLIAFLPIAVIGFLFADLIESLFDVKIVAWMFIIGGVIFLLLEHF
YRDSPHRVHDMENMSFQQAAWVGFAQIFALVPGTSRAGATIVGGMLAGLDRKASAEFSFL
LALPVLGASSAYSLLKHYDEFASTSFAPLIVGFVVSFVVAYLTMKIFLGFLEKFTFRTFG
IYRILFGLLLLWWLA
>A0A0A2LKW5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQAIIIAIIEGLTEYLPVSSTGHMIIASSFFGIAGDDFTKLFTIVIQLGAILSVIVL
YFKRFFQTVDFYLKLLVAFMPAVVLGLLLSDFIDSLLESPLTVAISLVIGGVILLKVDDY
FGDSENTEISYATALKIGFFQCIAMIPGVSRSGASIVGGMSQKLSRKAAAEFSFFLAVPT
MFGATAKKSFDYYKAGFELTGDQVNLLIIGNIVAFIVGTLAIKTFINYLSRHGFKVFGYY
RILAGLAVIIIHYFIHPLTII
>A49789|FEATURES|ARDB_deepARG|beta_lactam|CARB-3|antibiotic inactivation|1
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSV
LDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVI
EKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDL
NEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGW
NIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYT
SQSR
>A0A0S4QZV3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIPHHGHALIREMRIAGPDAGPYDLSAEPDGTLWVTMVHAGRIARLTPGGHLDSYQLTPA
SCGPSIITEGPDGAMWFTRNRDHRIGRIARDGATTSFLVPTPDGGPFGITTGPDDALWFT
EMNSDRIGRITTDGTIAEYPLPVTGALPAAITVGADQSVWFTLNQANAIGRITPAGKITL
HLLPTPGAAPVGICRNTDGAIWFVEIAAGQIGRIRTDGRIEEFPLPDREARPHAIIADPL
TGGCWFTTWAAGRIGHITPDGKIDEYELPTSSSEPHGLTVTGDGTVFVALETGGLACLER
TAVVSEN
>R4WAP3|FEATURES|UNIPROT_deepARG|beta_lactam|cphA2|antibiotic inactivation|1
MKGWIKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGTKGV
TVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELI
DHYEELIKAVPQS
>AAB60941|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MKQKNPKNTQNFITSKKHVKEILKYTNINKQDKIIEIGSGKGHFTKELVEMSQRVNAIEI
DEGLCHATKKAVEPFQNIKVIHEDILKFSFPKNTDYKIFGNIPYNISTDIVKKIAFDSQA
KYSYLIVERGFAKRLQNTQRALGLLLMVEMDIKILKKVPRAYFHPKPNVDSVLIVLERHK
PFILKKDYKKYRFFVYKWVNREYHVLFTKNQLRQVLKHANVTDLDKLSNEQFLSVFNSYK
LFQ
>A0A104C1M3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVMSVEALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>D7RFM9|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQSTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAKAGAWRP
>J3GHJ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVATALV
VGGIVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAIGFVTAFVFAMIAVRGLLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWTAVKP
>YP_001348104|FEATURES|ARDB_deepARG|multidrug|mexF|antibiotic efflux|1
MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKL
PEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLF
GLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSATSFQLSINTQ
GRLVNEEEFENIIIRTGANGEITRLRDIARVELGSSQYALRSLLNNKPAVAIPIFQRPGS
NAIEISNLVREKMAELKQSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAIST
VISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGGWLFRPFNRFFDRASHGYVGTV
NRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVI
KQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAAL
NAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIIAKARALPE
LEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQ
VNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGA
PAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLA
AQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFA
KDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSG
MIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA
>A0A0M2NAV3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKKMQSTLKLLSVITCLALTAQGAMASDMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKDYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSDFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHTGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVLLANKNYSIDQRVTVAYKILSELEGK
>A0A0P9JLK8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKVVVFAYHDIGCVGLQALLDADYEIAAVFTHADDPEEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWIERVSKLAPDFIFSFYYRALLSEPLLACAKRGAFNLHGSLLPRYRGRAPVN
WVLVNGETETGVTLHKMVKRADAGPVFAQQRISISATDSALTLHGKLREAAIALLSDALP
SLARDQLSGTPQDESLATCFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGDH
KLIIWAARVEPSNNGAAPGTVISHDPLRIACGEGSLIIHAGQRGNEGLYLSGAQLAREFG
LVQGSQLRDAKMQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPGIDNARQLIGWAPGIALSETIGKTLDFFLREAMAEKA
DQC
>F3M9W5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEVIKAIILGIIEGLTEFLPVSSTGHLILAGNLLNFEGDAAITFKIVIQLGAVMAVLIL
YWKRYLEIGANLIRLDFSQSKGLNVVHMILAMLPALIIYLLFKDTIKSQLFGPTPVLIGL
VAGGLLMIIAARSSRTESADTMDGINYRQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSSDLLNSEDFYLMIIGFTTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIQ
>C8C0I6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDLMLKTTLCTLLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSLSRR
>A0A0A0ZA59|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRRRVMATFLLFIASSAAARAPDEIIEPLMARFAIPGMAVAVLNKGQTTFYSYGVTSTDL
GEPVTPRTLFEIGSLSKTFTATLASYAVQQHKMQLRDSASQWLPALQGSALDRVTLLNLA
THTSGMPLFVPEEVTDSAQLMQWYKAWQPEAEPGTERVYSNLGIGMLGMIAAKSLNMSFM
RAMESMLLPAMGMHRTFLQVPPRAMPDYAQGYDKQNRPVRVTPGPLDAEAYGLKSTSEDL
IRWIGIQMGEVNVVPAWRQAVAATHQGYFRTAAFTQAMMWEYYPLPVTQQQLVAGNSSKI
ILNGMRATPVSPSAPAPLRAWYNKTGSTNGFSAYAVFIPSQRVGLIMLANKWIPNDDRVI
AADEIIRALAK
>C3VJU5|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
SNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVP
YNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAYSDNTANNKIIKEIGGIKK
VKQRLKELGDKVTNPVRYEIELNYYSPNSKKDTSTPAAFGTTLNKLIPNGKLSKENKKFL
LDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYAS
>A0A0T6ZQT4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLFQRDKISHFELPHVFPYIGFDSKKDAVDTVTRGDDPVMRNIRLQTLGALAAASLFCG
ASSQAIASDSPEHIERVVDEAIRPLMKQYDVPGMAVAVAVEGRRYVFNYGVASKESGQKV
GDETLFEIGSISKTFTATLASYAQARGDLSLSDMASQHMPALAGTSFDGISLLDLATYTA
GGLPLQFPASVTDQNEMIAYFKGWRPSYAPGTHRLYSNPSIGLFGYLAAKRMAEPFDDLM
EKTLFPGLGLARTHISVPEQRMGDYAHGYSKAGKPVRVNPGVLDSEAYGVKTTAADLIRF
VEANIDGVALDDTLQRAIAATHTGYFKVGDMTQGLGWEMYPYPVDLKQLLGGNSPEVSFK
PNRVTRLDPPLPPRDDALINKTGSTNGFGAYAAFVPAEHIGIVILANRNYPIPARVKAAY
QILTELQRAAASAP
>A0A0R2XFX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDWIMTVVLGVVEGITEFLPISSTGHLLLMGHLFALQRSELFTIGIQSGALLAVLLIYA
PRLKAMVVGEEGQKGKAYLKKLGAAFMVTAVLGLTASEMGLKLPDSPRPIAWALLVGGVL
IWLAERRLLLHRGKEDLGWWVALVIGASQMLAAVFPGTSRSGATILAGMFCGLSRTAATD
FSFLLGIPTLLAACALSFYRQLKATGVPVQEEWMHLGLGLAVSAITAYFAVKWLLGYVRT
NTLIPFAWYRIGMGLVWLWMVK
>V1W5W5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>A0A0M2ZZ28|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MIASRMLFLLAGLLSYNSSIWAKSLSEQQVKEIVDQQFKPLLDQYKIPGLAVGVTLDGKH
YFINYGLASKSNEQPVSNNTLFELGSVSKTFNATLAGYAQTQGQLLLSDHPAKYFPELKN
TAVNKATILNLGTYTAGGFPLQFPDEVISQQDMVQYFQTWQPKTKVGAARQYSNPSIGLM
GYVTALAMKKPYSELIEKTLLPQLGMTQSYIHVPEQKMSQYAWGYKNNQAIRVSAGMFDA
EAYGVKSSSSDMLKFLDIQIHPQKLKQPLRAAVETTHVGYFKLGAMTQGLGWEQYAYPVS
LETLLQGNSSKMALESHIVTQIKQPKRAPAATLFNKTGSSNGFGAYAAFIPQQKIGIVML
ANTNFPNEARITASYHVMQQLLQKNTAQ
>A0A075M395|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-109|antibiotic inactivation|1
MCSTXKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIA
V
>A0A0K0GDZ5|FEATURES|UNIPROT_deepARG|beta_lactam|WH51_03205|antibiotic inactivation|1
MGKRFEYKFSIHKFTLCILLLMLITLAACADKENSKDASSKEEKEENQTAKIDNQFSQLE
EEFDAELGVYAVDTETNQAIEYQSEERFAFASTYKALAAAIVLQQNSMEELNQVITYTKE
DLVPYSPVTEKHVDSGMTLLNLAEAAVRTSDNTAGNLLFNAIGGPKEFEQTLREIGDNDT
QAERYEPDLNQFSPEDPRDTSTPKALATSLQAFALGDLLPNEKREQFTDWLQGNATGDTL
IRAGAPEGWEVGDKSGAGSYGTRNDIAVVWPPNREPIVIAIMSRHDTEDATYDDALIAQA
AKVALNALN
>A0A0E2GEF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAFSVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>A0A0C1FGQ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNSFQAIVLAIIEGITEFLPVSSTGHMIVASSFMGIASDPFVKLFTIAIQLGAILSVPVL
YFKRFFKSINFYIKLLVAFIPAAVFGLLLSKKIDELLESPMAVGISLLVGGIILLFVDKW
FNKATVDQEENVSYLTALKIGFFQCIAMIPGVSRSGATIVGGMSQKLSRKVAAEFSFFLA
VPTMFAATAKKLYDFYKEGHTITHEQTNLLIIGNVVAFIVALLAIKSFIGYLNKNGFKVF
GWYRIAAGLIIIILLLSGHNLQII
>V5ZEZ1|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPNYRMKQITNAIFPGRINNFNEITVLPKSLRDMLIEEFGES
ILNIVPLKAQQSTQVSKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDALNVLTDPALFALS
PRRLSISTIGIIPNIKKLTQNYPQVNLTFSLHSPFNEQRSELMPINERYPLSDVMDTLDE
HIRVTSKKVYIAYIMLHGVNDSIEHAKEVVNLLRGRYRSGNLYHVNIIRYNPTISSRMRF
EEANEKCLVNFYKELKSAGIKVTIRSQFGIDIDAACGQLYGNYQKTNSQ
>A0A0X1SYF9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKEKTFYGSVAQLCALKGIPVHA
PEDANHPLWVERIAKLSPDFVFSFYYRNLLSEELLSIAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGGILAQNRIAIERCDTALSLHSKLRDSAASLLRDVLP
QLAQGELSETVQDESQASYFGRRTPADGKLVWSKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWAADVVKGNEGRAPGGVISVDPLRIACGEDSLRINAGQRNENGLFLSGPQLASELG
LVEGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDSCNGQVINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVEHRKPSIENAKRLLNWEPSVEMSETIGNTLDFFLREAMLEIA
DQR
>NP_706355|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISRFYPGADAKTVQDT
VTQVIEQNMTGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWLNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSTPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>A0A0R3A6Y9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYRINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGIPES
QRHSRARELLARLGLSGHVTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKANERVDPDLPHEAP
IEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDVDAQVNGVSDRYFKVKGVKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNLFAASKVLNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSLGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>V6MLY1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMPALLELNEVSRLYTNGEEETVVLNKVSLTINAGEMVAIIGASGSGKSTLMNILGCLDK
PSSGEYKVAGQSVAKMEGDQLAALRREHFGFIFQRYHLMSHLSAEQNVEIPAIYADKNAT
QRKERARELLTRLGLGDRIDYRPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQS
GKEVMSILKQLNEQGHTVIIVTHDPLIAAQAERIIEIKDGKIINDNYHQITANKVKKETP
PVLASSYLEQIFGRFTQALDMAWRAMVVNKVRTLLTMLGIIIGIASVVTIIVIGDAAKSM
VLADIKAIGSNTIDIYPGKDFGSDSPEDRQALTLQDVFALKQQSYVQAVTPQVQFSTRLR
RGNQDSPASVTGVSDDYFTVYALKFSQGGSFTADMIQRQAQVVVIDENTRQRFFPTKKEV
IGEQIIIRNIPSTIVGVIAEKKSVFGNGKSLKVWIPYSTLNSRILNQSYLDSITVRSTEG
YDASVAEQQIIRLLTIRHGKKDIFTYNLDSFIKAAESTTQTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARASDVMQQFLIESVLVCLVGGLLGIGLSFGIAMVAS
VMLPDWHFVFQPIALVSAFICSTAIGVIFGFLPARSAAKMNPIDALARE
>A0A143NI30|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWKMLLELPHDRLTRHFVIGILIAFLPAAFIGALAHDFIKTVLFESPRLICIMLI
IGGVVLLVVDRMNLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRKGYSLFGWWRLVVGGVGLVALMIWG
>AAX18273|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLEEITDHVIISGGGEIYKSLISKVDTLHIATVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>A0A109JBF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMLRAVILGIVEGVTEFLPVSSTGHLLLAERFFNLGEGDFWKSFAILIQLGAILAIV
VLYFAKLWRIALGMFSNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEFLFNPWVVCFSLI
VGGAILLWVDQLDLKVYEDDATRFPLLMYFWIGVAQCMAMIPGVSRSGASIVAAMLLGAD
KRSAAEFSFFLAIPTMVGAFAYDFYKNRGDFSTDGLSVIAVGFVVSFITALIVVRAFLNF
VTRRGFTFFAWWRVIIGTLGLIALAMGR
>C2SIN9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSFFKLNYTEKQDSKFSMGGNDMRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRI
GRINATGEINSFPIPTANAGAMSIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTN
AAPFGITEGPDGAIWFTEMNNGRIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQ
NQNNRIGRITTKGEVKEYPIPTPNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEF
VIPTPNARPHAIIPGKNRDLWFTEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDG
DLWFAEECNQIGRLTIIT
>D2SUX6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDNVTL
LNLATHTAGTPLFVPDAVKNTTQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPEAAMDNYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQELDK
>A0A0J6GT81|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAIVFAYHDIGCTGIEALLNAGYEITAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWVERIRKLNADYIFSFYYRHLLGEELLASVSQGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKISIERSDTALSLHAKLRETAARLLAETLP
LLPEGTLKETPQDESKATVFGRRTPADGLLQWARPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVIAGNQGQAPGQVISCDPLRIACGQDSLVITAGQRNDNGLYLSGPQLANELG
LVEGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKFNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVDDGIEALARIIENRDGKCDGQIINIGNPDNEASIRELGQELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSIENARRLIDWTPSIELSETIGKTLDFFLREAMIEIA
EKR
>A0A0J2DXK8|FEATURES|UNIPROT_deepARG|beta_lactam|SK85_04515|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNIIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>A0A127SDT0|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-4|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIVLSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENST
>Q6UIV5|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGK
>I6YPN5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTTDVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A0E2UMW4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLDAGYDIAAVFTHADDPAEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWVERIGKLTPDFIFSFYYRQLLGEPLLTCAKKGALNLHGSLLPHYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLREAASSLLCETLP
LLAQGQLSGTPQDESKATYFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGDN
KLIVWSALVEPRNYHQAPGTVISHDPLRIACGEDSLVISAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTQKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGCDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDIVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRGGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIDWTPGIELSETIGKTLDFFLREAMAEKT
DQC
>A0A0R2M209|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKAVILGIIEGITEFLPISSTGHLYLADAFVKLNEPTAFINMFMVVIQLGAILAVV
VIYFNKLNPWAQRKTNLERHQTWVLWAKVIIAVLPAIIVGLPLNDWMDAHLTSWQVIAGT
LIVYGILFIVIEAYNKTKRPRYADLNQLPITMAVLIGLCQVLAMVPGTSRSGATILGAIL
LGTSRYAATEFSFFLAIPTMLGASSLKVLKYLIHGNHFTGMQLAVLTTGTVVSFLVAYLA
IKFLLSYIRNNDFKVFGWYRIALGTLVIAYFGLLN
>A0A0N9V4V1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGVVEGITEFLPISSTGHLILASELMNFWSKEKSDVFVVAIQIGAIAAV
IYEYWARLWGAATGMFTGEEKGRRLGFGLILASIPIVLVGLTFGQTVKDFLFNNIAVAMG
LIIGGLIIMWIEKHPPQIKAKEVEDLTYKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYHNYKIFTTTEDWVILGFGTLVSFISALVLIRAL
VAYVARRDFMVFAWYRIFSGLLILLFAFTGWKLW
>G3Z6C4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIVEGLTEFLPISSTGHLIVLGDLLNFHSNGKVFEIAIQLGAVLAVIFEYRQRFTSVLS
GLGKDRAANRFVLNLAIAFVPAALMGFLFRKQIKLYLFNPKTVAIMLVLGGLFILWVERR
QSKVKPKVKSVDEMRPIDALVVGCAQVCALVPGTSRSGSTIMGGMLWGIERKAATEFSFF
LAVPMMIAATGYDVFKHYELFTLQDIGLIAVGFIAAFLAGFLAIKSLLKFVSSKNYVPFA
YYRIVFGGLILLTSHMGWVKWTA
>V5ALN5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVQALLDAGFDIAAIFTHADNAQENAFFGSVARLAAERGIPVYAPD
DVNHPLWVDRITELKPEIIFSFYYRNLLGEAILNSARIGAFNLHGSLLPAYRGRAPLNWV
LVNGETQTGVTLHRMISRADAGAIIAQQAVEIADADDALSLHRKLTESARHLLEGALPTL
KSGTFSETAQDESKASYVGRRTPEDGRLEWEKPAQTLHNLVRAVSDPWPGAFSFVGTHKF
IVWKSRVRSDVAPARAGTVISVAPLIIACGEGALEVMTGQTEKGVYMQGAQLAQSLGLVA
GALLSSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDNYEIYGLDIGSDAIGRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKVFDEDNSNLVVGPVSKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVEGGKQKRCFTDI
SDGIEALFRIIENRDGRCDGEIINIGNPDNEASIKELAEMLLESFEQHPLRHRFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPTVAMRQTVDETLDFFLRTVELTDEQ
>A0A0M0X0H2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGLNHFLFSVSNLENSIDFYQNVFDAKLLVKGRSTAYFDLNGMWLALNEERDIPRND
ISHSYTHIAFSIEEDDFEKVYEKLNRLHVHILTGRERDVKDKKSIYFTDPDGHKFEFHTG
TLEDRLTYYQQEKKHMEFFD
>A0A0Q9ZGW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQLGAILAV
IYDYWDRLWQALMGLLTGKAEGMSNPRQLGLSLIVATIPVMIVGFTFADEIKSYLFNPIV
VAIMLIIGGLLIFYVENRPKTIIAQEAEDVGLKTALMIGLLQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIVGAALLDLLKHHDVLTNSEDWLVLGIGTVVSFIVALLC
IRLLVEWVSRRDFKIFAWLRIITGIIVLIAAWGFGYQMAG
>Q5GJ46|FEATURES|UNIPROT_deepARG|beta_lactam|blaORN-6A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARILRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>D7ZGQ5|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9534_03446|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWTPGTQRLYANT
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
QDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>J8ZX71|FEATURES|UNIPROT_deepARG|beta_lactam|iem_04389|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQTNQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDFSNYNPITEKHVDTGMTLKELADASVRYSDSTSHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>F9GWM5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKDLNRYFGEGENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENIALPAIYAGMSQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQ
NVMEILRQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKEAVKSAIENPTKSK
PHFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
KGIGTSTMTIFNGTGFGDRRAEQMQNLTINDATALSQQSYVQSVTPNSSLSGTLIYGNQP
FSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIFPDENPIGKIV
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTIVA
EKGITDLLTMRHGKKRFLYHE
>YP_001808247|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMTAVQLGEYASANVVQALRRVDGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRTQPDGSALHLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVA
TEKRVRATMDKLSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMRQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGWFNGFVARSTQRYATRVGAMLKKPLRWLV
VYGALTAAAALMLTQLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYIRRDEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWKERKAGRDHVQAIVARINERFAGTANTTVFA
MNSPALPDLGSTSGFDFRLQNRGGLDYAAFSAAREQLLAVGGKDRALTDVMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGLHRLDPADV
QKLRVRNAGGEMVPLAAFATLHWTLGPPQLTRYNGYPSFTINGSAAPGHSSGEAMAAIER
IAAKLPAGIGHAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGMITATVLAVFLVPLFFV
MVGRLFDVGPRRRGGAQPATMEGSQ
>M8KG79|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRPTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHSEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0N0BSV6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFWTFIQVLVLGAVEGLTEFLPVSSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTQLKAQRFTLNLLIGFLPAVILGVLFADNIHEYLFNPITVAVALV
VGGVVMLWAEQREHVVHVEHVDDMRWPDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEYSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVTAFIFAMIAVRGLLKF
IASHSYAVFAWYRIGFGLLILATWLFGWVNWTAATAA
>A4KZ60|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDG
EALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFA
SDTQLTNSAGTSAQLAAGFTEVAQVRCFRKPL
>F9Q5J6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQIIEIKNLNRYFGEGENRAHILKDISLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAS
SGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAQENVALPAIYAGFSQQVR
LERAKQLLEKLGLGDKCQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGK
NVMEILRQLHSEGHTIIMVTHDREIAAQANRVIEISDGKIINDSQKKAVSSITNTAINER
KRHFGFSKDQLAESFKMSISAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILEN
IKGIGTNTMTIFNGTGFGDRRAEQMQNLTVSDANVLSQQHYVQSVTPNSYASGTLVYGNK
EFSSTTLKGVGEESFDVEGLKLKQGRLLSHQDVLDSNQVALIDESAKKSIFPNEDPIGKV
VMLNKRPLIIIGVVSDKQMGGASSSLNMYAPYTTVMNRISGSKKIGSITVKIDDSVDTTA
AEKGITELLKMRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQGNILQQFLIEAILICLIGGITGVMISGLIGLIFNLFVKD
FTMAFSAFSIVAAVLFSTLIGVIFGYMPAKRAAQLDPINALARE
>YP_002217186|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRASGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVALI
AIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>N6UDE8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNTHFIPLPKLGIVAGCLAYGVAAHAADGGDQGRLARAVDAAIRPLMKENDIPGLAVAIS
IKGKRYVFNYGVASKEAGQKITDDTIFEVGSVSKTFTAALASYAQVSGKLSFSDKATKYM
PELAGSSFDKISLLDLGTYTAGGLPLQFPKNVTDQDKMVAYYRSWHPSYAPGTYRLYSNP
SIGLFGYLAVRAMGEPFDALMQDKILAGLGLRHTYIHVPATEMRNYAYGYSKQGKPMRVG
PGVLDTQAYGIKTTASDMLSVVEANMDSSGLKGGTLQRAIAATHVGYYTVGNMTQALGWE
TYAYPTTLARLLAGNSSDMALDPHRIEPLDPPQQSKKDVLLNKTGSTNGFGAYVVFIPAR
QIGIVLLANRNYPNPERIKAAYKILTAIESQPSSGAQ
>A0A0K3JYC9|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRSLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGISAWNMLIGI
LIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>Q3KE48|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB2|antibiotic efflux|0
MSEPLLQLTGISRSFTAGDREFLALKNIDLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYRINGRETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAVHNVEMPAIYAGTPEP
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNERDTAALSNEDA
VPKSTAARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGAK
RYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVTALNQLYYVDSATPVVGRNLL
LRYRNIDLDAQVNGVSDLYFQVRGIKMESGIPFSESDARRQAQVVVIDHNTRHRLFGEGV
DPLGQVILIGNLPCTVIGVAAENKNIFSSSKSLNVWVPYETAAGRLLGQRYLDSISVRIK
DGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHL
FSLFIKEWEMVFSLTSVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>G8EX94|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGTKGVTVVGA
TWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEA
L
>A0A127I2Q5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVRNFGALALFLAAGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVIKDGKA
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRG
GKFDHISVLNLGTYTAGGLPLQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQLMEKTLLPKMGLKHTFITVPKSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSASDLLHYVEVNMRPATLDPVLQQAITTTHTGYYTVERMTQGLGWEMYPYPI
KLDALVDGNSTKMAMEPHPVNWLTPAQAPHADTLVNKTGSTNGFGAYVAYVPSKEMGVVI
LANKNYPNGERVKVAHAILSALDH
>R8D0R0|FEATURES|UNIPROT_deepARG|beta_lactam|IG9_02611|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPVTEKHVDTGMTLGQ
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIAEATEVIVKALK
>A0A125S6J9|FEATURES|UNIPROT_deepARG|beta_lactam|IMI-4|antibiotic inactivation|1
MSTTLRKSKPAFLLGSFLMSISLYSYANENGIDEIKNLEKKFNGRIGVYALDTGSGKSFA
YRANERFPLCSSFKGFLAASVLKGSQDKQLNFSEIVNYNTRSLEPNSPITAKYKEQGMPL
GEMAAAALQYSDNAATNIILERYIGGPVGMTKFMRSIGDEEFRLDRYELDLNTAIPGDER
DTSTPEAVGKSLKNLALGNILNDSEKETYQTWLKGNTTGAARIRSSVPREWVVGDKTGTC
GAYGTANDYAVVWPDDRAPLIISVYTTKYEKDAKHEEEFIAEASRIAIKTLN
>F3LVE1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLAKAAVMGIVEGLTEFLPISSTGHLILAGSLLDFTGETAKVFEIAIQTGAMLAVIWE
YRQRLGRTVTGIGHDPLARRFALNVLIAFVPAVVFGLALGKVVKEHLFHPVPVATAFIVG
GIVILLVERRHRRAFGERDLEGARRARVESVDDMTPLDALKVGLVQCLALVPGTSRSGST
IIGAMLFGFSRRCAAEFSFYLGIPTLMGAGAYSVFRQRDALHWGDAPMFLVGSAFAFVSA
LLCIRWLIRYISTHDFTVFAWYRIVFGCVVLLTAWSGVVSWSE
>A0A0S4L608|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEWGPTLAVILGIVEGLTEFLPVSSTGHLILVGHALGFTGDVAANAEISIQLGAILAVI
VFEREKIGRLLSGAWQEQKALRALSANHPPASWSDRVKGSMRNHPNVWFLLGIGIAFLPA
AVLGLLAHGWIKSHLFTPFTVASTSILGGIIILIVEATKRTSQANSLDQVSAVHAFWIGL
AQCASLIPGMSRSGSTIIGGLLAGLDRKVATEYSFFLALPTIIAATVYETWKARGAFTDQ
DYMALGLGMLISFLVAWGVIAAFLTYVQRHTLRVFAYYRIILGIVVMLVVR
>EDK74221|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSEQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIKEDFQPVAKEKAIPTKELFTSV
KYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAG
VMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALL
SKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLI
QFRTLLKVKEI
>W7YUM7|FEATURES|UNIPROT_deepARG|chloramphenicol|JCM16418_2339|antibiotic inactivation|1
MKFSIINRDNWQRKEYFEHYLQQQTTFSMTNEINITVLMKNLKKKGYKLYPAFIFMVTRI
VNSHREFRTCFNSEGNLGYWSEICPCYTIFNNSTHTFSAIWTPNMNNFSKFHFQYEKDVR
KYKDTSSLFPIEPIPDNNIPISMIPWSSFNAFNLNINNGGNFLLPIITGGKYSLVNDELF
LPVALQIHHSVCDGYHASIFMNDLQRLANESEEWV
>AAR29971|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPKYCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGQPVIQPRRPNNRLDKVRHMFQKVM
>A0A0M2QRH4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHELLVRLGLGERADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
ESSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGGGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVALSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0S2C4P3|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-436|antibiotic inactivation|1
MRALALSAVLMVTTMIGMPAVAKEWQENKSWNAHFSEHKTQGVVVLWNENTQQGFTNDLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWIELDDNVWFFATNMD
MPTAEGLGLRQTITKAVLKQEKIIP
>A0A0Q1FWJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIIKSIIFGIVEGITEWLPISSTGHMILLDEFIKMDVSDKFREMYLVVIQLGAIMAVV
LLFWWRIWPFCKEENFKKHYVKHKAAGFLDNFKFIKQDIFIMWFKIVAACVPAIIVEVAF
GDNLEKWFYNYKTVAIMLILIGIVFIIVEEKNKKNIPSVNKIGQITYTTAFWIGMFQLVA
AVFPGTSRSGATIIGGLILGLSRTVAAEFTFYLAIPVMFGASLIKIIKFGLGFSALEAGI
LLTGMITAFIVSLFVIKFLMGYIKKHDFKVFGWYRIILGVLVLGYFALAG
>R8Y404|FEATURES|UNIPROT_deepARG|beta_lactam|F935_01490|antibiotic inactivation|1
MYKKVLIVATTTLFLSACSSKTVKQHQIHSISANQNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRSSTEYVPASTFKILNALIGLEHHKVTTTEVFKWDGQKRLFPDWEKDMTLG
DAMQASAIPVYQKLARRIGLDLMSKEVKRVGFGNADIGSRVDNFWLVGPLKITPLQEAEF
AYELAHKTLPFSKNVQEQVQSLVFIEEKNGRKIYAKSGWALDIDPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSIIRKEITYKGLEQLGIL
>A0A0K2DJA3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MERNCVVSLSLLCASLFFSSVGAKAEEADHSRLKSIVDAAIRPIMKEHAVPGMAVGLTVD
GKHYFFNYGVASKESGRPVTETTLFEVGSVSKLFTGLVGAYGAVTGEVSLTASASSYMPA
LKGSSFDGITLLQLGTYTAGGLPLQFPREVRDEAGMVSYYRNWKPAYAAGAHRVYSNPSI
GLFGHLAAAGMGRPFEDILEDTIFPGLGLTNTYVRVPDARMDDYAFGYTKDGKPIRVNLG
VLGAEAYGVRTGSADLLTFLDANVDMPKDERLRQAIAGTHTGYVRIGAMTQGLGWETYDY
PVPLDVLLAGNSPEISGKPNAAAWIDPPAPPRRDALLNKTGATNGFGAYVAVIPAERLGI
VLLANRAYPIPARIRAAHAILSAVAGGATR
>A0A0Q0B8U1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSVVIPVYNERQSLPELLRRTETACEQLNHRYEIVLVDDGSRDDSAEILQQA
AERASSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVTLAEQGY
DVVGTVRNNRQDSAWRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEVLVDHAEREHGDSRYSPMRLVNLMFDLITCMTTTPLRLLSIIGF
SMAFLGVLFAAVLIVLRLIFGASWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKIARSSSGIAADSIDSSVTPYTNKVAP
>V4N8D5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMNQPLIELKNIVRRYGHGDTETTVLKSINLKIYAGEMVAIVGASGSGKSTLMNILGVLD
QADDGEYLFRGRQISTLSSDELADLRCYHFGFVFQRYHLLPHLTAVENVEIPAIYSAMEK
EKRIERAQKLLCRLGLENQLKHKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQ
SSQEVLSVLKTLNHQGHTVILITHDMQIASHADRIITMKDGEIIADSGVTQNLMKSSVQE
VTPQLSSMHYLATLRRYHAAFLMAMHMMFAHKIRTLLTMLGIIIGIAAVVCVIALGEGAK
NKVLAEFSALGNNTIDIYPGKNWGDPDAIKIQTLNQVDLALLRQQPYLKGATPQISVDLP
LRFLNRTVNASVYGVSDAFFQLRKHRLLSGRWFNAHDMATHQAVSVIDKKSQQVIFGTES
AVGKTVFIGQIPILIVGVVETPPQNIEGQRATIWLPYNTVVSRLYNQSYFQQITVQVKEH
IAPELAEKAIIDLLTIQHGRKDFFTFSSRKFLQSLQRTTQTLTMMISSIAFISLVVGGIG
VMNIMLVSVIERTREIGIRVAVGAKEKDILHQFLIESASVSLLGGMLGVLLSLLLGGLFS
AFTDSIKMQFTFSSFLIAFVCSSMIGMIFGYFPARNAARLKPVVALSQE
>S9SID7|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKPTSKYETIGQILSDFKQPAYRYGQIIDAIFKQKIAEYERITILPKFLREELARTLGPN
VSSVNPVKELTSQQVSKVLFAIDGGERVEAVRLSYKRGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFHLNGHALDSVSFMGMGEALANPHLFDALAILTNPNLFGLG
HRRITISTIGLLPGIERLTREFPQVNLTFSMHSPFDEQRNELMPINKRFPLRGVLNTLDR
HIRHTGRKVYIAYILLRGFNDSAEHAKAVAALLRGRGAWKHLYHVNLIPYNSTEVTPQSY
LPTDPERIETFVRTLKMYGVNVTVRTQFGADINAACGQLYRADSQMNR
>A0A0H0M0M5|FEATURES|UNIPROT_deepARG|beta_lactam|GJ12_25360|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ZP_03030547|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPFEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSIN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>A0A0H3H1L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIVGHLLGFEGDTANTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGKKPEHEGQGSGRL
SLIHILLGMIPAVVLGLIFHDTIKSLFNPINVMYALIVGGVLLIAAEVLKPKQPRAVGID
DMTYRQAFVIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATVL
DMYKSIGFLNAGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
VFF
>YP_001878864|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDVRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGLDPAMRAENISVAQYCQMANYLAENAPLQES
>A0A0G9KEG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVFV
YPSKFTFSHIELWKKIVVAFLPIGIVGFLFSSQIKNLFSIEIIAWMFIIGGIVFLIIEKF
YDENKTHTLDVENVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSFL
LAVPVMCATTGYDLVKHHEELLVGANLLNLAIGFVVSFIVALIVIKLFLKFLERFTFVAF
GIYRIIFGILILLIF
>A0A0A0TVF5|FEATURES|UNIPROT_deepARG|beta_lactam|KS08_06180|antibiotic inactivation|1
MKRKATLKFGICIGLLCVSFTGFNSLFGSTHAEAKSIENTKMTSCITNQKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKQKPIEKLNDVIRYTKEDLVTY
SPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSKRFTKDAEYDNALIAEAAKVAL
DDLK
>C8C146|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MGFLRSGCYPDSCHTDWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCTLLITASCST
FAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQP
LKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPL
DINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ
>I3IH78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTYLEALILAIIEGITEFLPISSTGHMIIASTIMGINENTLVKNFEVVIQFGAILSVVAL
YWQKFFTSFRFYLKLAFAFLPAAVIGVLLGDYIDSLLMNIWVVITTLFLGGIVLIFVDKW
FRHANEAKEQEISWSQGFKIGCFQCIAMIPGVSRSAATIIGGMSTGLNRRTAAEFSFFLA
VPTMLGASAKKLIDSYATIQHHDIKILLFGNIVAFIVAMLAIKAFVGFLKQHGFKWFGYY
RIIVGVVLAIVAVLLKIQM
>A0A0Q4WTF3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKGALAALVLSGLPHVPAPALAVDPSARVATAVEQAYRPLLKAYDVPGIAVAVTREGHS
TVFTFGLADRERQRPVTRDTLFEIGSVSKTFTATLVAYAQGLGRLSLADAPSRFLPELRG
SALDRVSLLDLGTYSAGGLPLQFPDAVADEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAMGGDFAELMETRLFPGLGLKHSFIRVPASESERYAWGYSKDGTPIRVNPGVLDG
EAYGVKSSAADMIRFVEAHLDPTRLDPPMRQAIQGTQIGYFRVGAMVQGLGWEHFPYPIS
LARLQAGNAEPMRFEAQPAARLDPPQRPTGVTLFDKTGSTNGFGSYVAFVPAKRIGLVML
ANRAFPMPARIAAAHAVLEVLAAEEP
>R5DZ54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIEILKAVLFGIVEGITEWLPISSTGHMILVDQFVHLNVSADFYKMFEVVIQLGAIMAV
VVLFWNKLWPFHMKNEKPAWKDGALSMWLKIIVAVIPAAIIGVLFDDKIDELFYHPVPVA
IALIVVGVLFIVVETIMKGKKPSIRNIGQITYKAAVIIGLFQVLAAVFPGTSRSGATIIG
ALLIGVSRATAAEFTFFLAVPVMFGASLLKVIKYIAAGVAMTGSELVILVIGTLVAFIVS
VFVIKFLMSYIKKHDFKVFGWYRIVLGILVLLILR
>A0A127SHS2|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
KKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQ
MLPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGI
DSFNLSETEDDMHSSFEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTET
GANKLKGMLPAKTVVGH
>X2L2G5|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
QITLTATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADE
RFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSA
AALQYSDNV
>ZP_03064700|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMVPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0D9AM76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWIAFQALLLGVVEGITEFLPISSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
WEYRRKIIDVVVGLPSERQAQKFTVNLLVAFLPAVVLGVTFADLIHEYLFNPITVATALV
IGGVVMLWAEKRSHRIQAETVDDMHWSHALKVGCAQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQSGDLPVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIIFGIAILATWQFGLIDWSTAAG
>A0A0R1QCB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGITEFLPISSTGHLVLVDEFIKLQQSKQFIDMFNVVIQLGAIMAVV
IIYFHKLNPWSPKKSRLEKKNTWTLWKKVIIAVIPSVVVGLPLNDWMDEHLMNWQVVSAA
LIIYGILFIIIENHNKDTTPRYADLDTLPYSTAIAIGICQVLSLVPGTSRSGSTILGAIT
IGTSRYVATEFSFFLAIPTMFGASFLKLLKYFMHGGSLAGLPGIVLLVGVVVSFVVAYLS
IRFLLNYIKKNDFKAFGWYRIILGIVVIGYFMLVH
>H0T9C3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTDAIIEVVHLTRIYRVGDIDVKALRDVSLSIERGEFVAIMGSSGSGKSTLMSILGCLDQ
PTSGQYLFEGFDVAHYSESELARIRSQRIGFVFQSFNLLARTSAIENVALPLFYSDVAPS
THRERIARARNALAVLKLGDREENTPGQLSGGQQQRVAIARALINDPAVILADEPTGNLD
TQTSYEIMDTLKSLNRDRGVTVVMVTHEPDIAKYADRTVTMRDGQIVADERRASLPIARN
RRRSSPPMPEAAPVALPAVIGFARMVSAAAVQALARNVTRSVLTMLGVFIGVAALIAMIA
VGQGANDAVRKQIESLGTNLFVVVPGASALGGARAGFGSASTLTKSDAEDIRREASAVGS
VSYLIRQSGQIQYMNRNWTTTIQGVSSNYPPVTNWRIAEGRGIAAEDERSTALVAVIGQS
AFRQLFPDGLSPVGATIQVRSTPLRIIGLLAPKGQTAYGQDQDDVIMVPFATAERKILGV
AAPTQNQTPLNWVYPPYPNPYNLQPRLTGFVNQIYVQANDAGGVSEAVSQVDRVLTRRHN
IRPRQPRDFSIRNLSQIAETAEGSSRTMSILLAAVASISLLVGGIGIMNILLVSVTERTR
EIGLRMAIGARRLHVLLQFLAEAVFLSVTGGMAGIVTGICFSLILPMLTGWQAPISTSAV
LGGFAFAAAVGIFFGYYPAQKAAHLNPIDALRYE
>ZP_03065057|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQASLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELIEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>N9B6N7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILAAELMDFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLWGAATGMFTGEEKGRRLGFGLIMASIPIILIGLAFGQTVKELLFNDVAVAIG
LIIGGFIIMWIEKHPPQVRAHEVEDLTYRDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFQTTEDWTVLSFGIIVSFVSALLLIRAL
VAYVAKRDFMIFAWYRIASGLIILLFAFTGWKLW
>A0ESG8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKTRSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLIGA
LAVKPSGMIFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNITDMASWLKANMSPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVGLAPLPVAEVNPPAPPVKASWIHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>J3GWB5|FEATURES|UNIPROT_deepARG|beta_lactam|PMI32_05060|antibiotic inactivation|1
MHNSTFGKVLSCSAFGLLLSAGYCVAGNQTDAQIEAAVNAAVVPVMQQQNIPGMAVAITV
NGKQHYFNYGVASKETGTPVTESTLFEIGSVSKTFTATLAAYAQASGKLSLSDKASHVLP
ALRDSTFDHVSVLQLGTYTAGGLPLQFPDNADAADKMLGYFKQWKPEYAAGSHRLYSNPS
LGLFGYLAANSMGQPFDELMEKTVLPKLGLQHTFLKVPQDQMALYAQGYNKEDKPVRVEP
GALDSEAYGVKTSASDLLRYVEANIKPSSLEAPMQQAIATTHAGYYTVGDMTQGLGWEFY
HYPITLDKLLAGNSSQMAMETHKVQWLNPPQAQPDNVLINKTGSTGGFGAYVAYVPSKDI
GIVILANKNYPNPERVKIAHAVLSALTQ
>S5U5P1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAANTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPELGLKYSYVNVPKTQIQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BAG79307|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>J2PY73|FEATURES|UNIPROT_deepARG|beta_lactam|PMI05_00160|antibiotic inactivation|1
MRVHHSKMIGFTVKTIFLTLLTLTGCSSPEAPVVKTETPASAMDLKFAALEKKFDARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQIGDSVTTSERYETEL
NEAKPEDIRDTSTPKALATSLRAYTVGDALSAEKQTILIEWLQGNTTGDKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPSNKKPIVIAVLSSRDKQDATYDDALIAEATKVAVDALT
ATKP
>F8ETS2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDSLLTIILLGLLEGLTEFIPVSSTGHLILAERLLGAHGANSASFDIIIQLGAILAVLV
FYADRFWNIIKGLFHRSPSAWHFTRNVFLGFLPALVIGALAYHGVKALLEKPMVVAVALW
VGGIVMLVIERMQPPVESKTVQSIPPYKALLVGLAQCLAMIPGISRSGATIMGALCLGVD
RKTATEYSFFLAIPVMLAATVKELWEQRHSLSSADLGEISLGFAISFFVALIVIKLFLEI
VTRRGFGPFAWYRIIIGFAAMILLLIAP
>D3JX00|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGVKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>C2UW73|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0019_24820|antibiotic inactivation|1
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQQKSIEDLEQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQDYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPREWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDVLKVTNK
>A0A127SWJ0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNSKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDY
>N9LFZ2|FEATURES|UNIPROT_deepARG|aminoglycoside|F904_00426|antibiotic inactivation|1
MNIMPISESQLSDWLALRSLLWPDHDDAHLLEMHQLLKQTDTLQLLAYTDSQQAIAMLEA
SIRHEYVNGTQTSPVAFLEGIYVLPEYRRSGIATQLVQYVEEWAKQFACTEFASDAAIDN
TISHAMHRALGFHETERVVYFKKNIG
>A0A0G8ER34|FEATURES|UNIPROT_deepARG|beta_lactam|B4077_2344|antibiotic inactivation|1
MFVLNKFFTISHYKKIAPVVLLSCVTLIGCSNSNTPSESTKQTKQTNQIKQENNGNDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNKK
>A0A023C9B2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPHSLLSGVRSACALAAFLAAGNCLAATDLQAVVDASVKPLMQQQAIAGLVVGVVQDGKA
RYFNYGVAATDTRQPVSEHTLFEIGSVSKTFTATLAGYAVASGQLKLSAPASHYLPALRG
GKFDHISVLNLGTYTAGGLPLQFPAAFDNTPRMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQLMEHTLLPKLGLKHTYLNVPKSQMNLYAQGYGKDGKPVRVGPGALD
SEAYGIKTSAADLLHYVEVNMHPARQAKPIRQAIALTHTGYYSVDGMTQGLGWEMYPYPI
ELDALIEGNATPMAMAPHKVNWRTPPQALRADTLVNKTGSTNGFGAYVAYVPGKGLGVVI
LANKNYPNAERVKVAHAILSAMDH
>ABB70053|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQFKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0W1B073|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSTELFGQYTANTFKVVIQLGS
ILAVVVIFRNRFIELLGLKRFSRKQSDPVTEQQPQLEKGGHLKLTQVLVGLVPAGVLGVL
FNDYIDEHLFSTSTVLIGLVVGAVLMIIADLFGPKKIQTESVDQITYKQALGVGLVQCFS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLLSLMKNWQYFTIDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIILAAVVYFVFF
>A0A0Y0AFV9|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC|antibiotic inactivation|1
IFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDK
KAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLAT
YTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFD
QVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDM
LSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQI
VMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKKILGLVMLTNKRIPNEERI
>NP_286651|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSC
EQVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFMTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A0N1J631|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAAQALILGIVEGLTEFLPISSTGHQIIVADLLGFGGERAIAFNIIIQLAAILAVV
WEFRQKVFTVVRDLPRERSAQRFTLNLLVAFMPAVILGVLFKEVIATYLFNPITVASALV
VGGVVILWAERREHTVHAETVDEIRWQDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYGFRHQFQMADLPVFAVGFVTSFVFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSTKG
>A8IG40|FEATURES|UNIPROT_deepARG|beta_lactam|AmpC|antibiotic inactivation|1
ASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHP
VTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYT
AGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRFYANSSIGLFGALAVQPSGMSYEEA
MTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARW
VQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVAL
AALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPA
>A0A0P9I3N2|FEATURES|UNIPROT_deepARG|beta_lactam|ALO87_04986|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQIIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVSVPDDKQALYAQGYNTLDEPVRVNPGILAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>ACM47283|FEATURES|ARDB_deepARG|glycopeptide|vanRD|antibiotic target alteration|0
MNEKILVVDDEKELADLVEVYLKNDGYTVYKFYNGKDALKCIESVELDLAILDIMLPDVD
GFQICQKIREKFYFPVIMLTAKVEDGDKIMGLSVADDYITKPFNPLEMVARVKAQLRQYM
RYKQPSLKQEAECTEYDIRGMTISKSSHKCILFGKEIQLTPTEFSILWYLCERQGTVVST
EELFEAVWGERYFDSNNTVMAHIGRLREKMKEPSRNPKFIKTVWGVGYTIEK
>YP_002239313|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSSADTPINWKQNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMSVVMMLMGMAQNIWQFLLLRALLGLLGG
FIPNANALIATQIPRHKSGWALGTLSTGAVSGALLGPLAGGFLADHWGLRTVFFMTAAVL
FICFLFTLFLIRENFVPIAKKEMLSAREVFSSLQNPKLVLSLFVTSLIIQVATGSIAPIL
TLYVRDLAGNVSNIAFISGMIASVPGIAALMSAPRLGRLGDRIGPEKILIVALIISVLLL
IPMSFVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTSQISGRIFSYNQSFRDIGNVT
GPLIGASVSANYGFRAVFLVTAGVVLFNAIYSTLSLRRPAAEASQPDRHSVN
>B4RQE0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFDKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGVAQVFALVPGTSRSGSTVMGGMFWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLK
FVSKKNYIPFAYYRIVFGIVIIILWLSGWISWE
>Q9JVR5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>F0R526|FEATURES|UNIPROT_deepARG|beta_lactam|Bacsa_2220|antibiotic inactivation|1
MATIRKKHIVLLCLALACVAGLTLFFSQPVKGGRAGMSLANVLTDSISRIVSACPGEVGV
ALIVNNSDTVTVNNKSIYPMMSVFKLHQALAICNRFDQDGLSLDTSLTIRREDLDPKTWS
PMLKEHREPLITLPVRDLLRYTLIQSDNNASNLLFERLVSVAETDSFIATLIPRSSFRIA
YTESEMAADHAKAYANCTSPLGAAMLIHRLFTDALVSREKQDFIMKSLGECTTGKDRIAA
PLLGKEGISIAHKTGSGYTENGVLAAHNDVAYICLPNGVSYALAVFIKDFKGNESQASQV
AARISAAVYSLLA
>A0A109RGJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKIIFIGVIEGITEWLPISSTGHMILVEEFISLNVRQEFWDIFLVVIQLGAILAVC
WIYFDRLNPFSSNKSDADRKETWDTWFKVLVGCLPAAIFGLILDDWMEAHLMNWLVVALA
LIIYGIAFIIIEKRNETRQPVVNSMADMSYKTALQIGLFQTLSLVPGTSRSGSSILGATI
LDTSRPVAANFSFFMSIPIMFGASGLKLVKALLTGFRFTGGELILLLVGMIVAYIVSIIT
IRFLLRYIQSNDFKIFGWYRIVLGLIVIIYFGFIR
>D3K2R0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDAAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0T2MU89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFIVLIQLGAILAVIT
VYFARLGMLIRDALTGKAYAWQFALAVVLACLPAVAAGVLLRDFIQGDLWESAALICWTL
LVGGVILLIVDRLKLTPKYDDIYQFPWHLALIVGLFQMLSLVPGVSRSGSTVVGAMLFGA
SKRAAAEFTFFIALPIMIGAFGYDLYKSRDMIDTSLALSVGVGFAAAFIIGALVVRYLLG
FVSKYGFAPFAWWRILVGGAGLIAIYFFGQ
>A0A0B4U293|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
MGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLV
EYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLD
RWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRS
ALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
LIKHW
>AAA26492.1|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmE|antibiotic target alteration|1
MSSSDEQPRPRRRNQDRQHPNQNRPVLGRTERDRNRRQFGQNFLRDRKTIARIAETAELR
PDLPVLEAGPVEGLLTRELADRARQVTSYEIDPRLAKSLREKLSGHPNIEVVNADFLTAE
PPPEPFAFVGAIPYGITSAIVDWCLEAPTIETATMVTQLEFARKRTGDYGRWSRLTVMTW
PLFEWEFVEKVDSAIMRLRRRAEPLLEGAALERYESMVELCFTGVGGNIQASLLRKYPRR
RVEAAFDHAGVGGGAVVAYVRPEQWLRLFERLDQKNEPRGGQPQRGRRTGGRDHGDRRTG
GQDRGDRRTGGRDHRDRQASGHGDRRSSGRNRDDGRTGEREQGDQGGRRGPSGGGRTGGR
PGRRGGPGQR
>Q31EL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIFQAAILGIIEGLTEFLPISSTGHLIVVSDWLGIEQTKQNTAFEVIIQVAAILAIFSH
YKEKFSLQHLRLWNNVLIAFLPIAIIGFIFQDTVKAFFTIETVAWFFIIGGLIFLIMEKL
YVDGKHRTQDIEDLTMRQAFWIGIIQVFALIPGTSRAGASIVGGVMMGLDRKTAAEFSFL
LALPVLMAASGLDLLKHYEDFNNTSWTPLMVGFLMAFLAAWLTIKVFIKFLQTFTFNAFG
VYRIVFGIVLLIWFV
>W4CRW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVIKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLIL
YWKRYLEIGLNMIRMDFSKSKGLNVIHMILAMLPALILYLLFKDTIKSQLFGPTPVLIGL
VVGGVLMIIAARNRRTETADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLSSDDLLLMLIGFATSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIQ
>A0A0F6B1P3|FEATURES|UNIPROT_deepARG|aminoglycoside|STM14_1958|antibiotic inactivation|1
MDIRQMNRTHLDHWRGLRKQLWPGHPDDAHLADGEEILQADHLVSFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>W6WA05|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQALLQLTGITRSFTAGDREFLALKDINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGQETRDLDDQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGIPAP
QRHARARELLARLGLDGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNQRDTGQLPGEEE
VPPKPPATRRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KNYVLKDISAIGSNTIDIYSGSSFGDKRAASIETLVPADVTALNQLYYVDSATPVVGRSM
LLRYRNIDLDAQINGVSDQYFQVRGIKLEAGITFSESDARRQAQVVVIDYNTRHRLFGEG
VDPLGQVILIGNLPCTVIGVAAENKNLFASGKTLNVWVPYETAAGRILGQRFLDSISVRI
KDGQSSKVVENHVTQLMLQRHGIKDFYTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSLFIKEWEMVFSMASVVTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>A0A0U4HZN6|FEATURES|UNIPROT_deepARG|beta_lactam|AV650_28380|antibiotic inactivation|1
MKKNLNTVLAITTLMVSMTPFAAQKSLTAEQISQIVNDTVKPLLEAQSIPGMAVAVLYQG
QPYYFTYGQADINKNLPVTKKTIFELGSVSKTFTGVLGGDIVTRGEMKLSDPVTKYWPQL
TGSQWKGINMLHLATYTAGGLPLQVPDSVTDGASLLNFYQHWQPQWKPGTMRLYANASIG
LFGHLAVKPSNMTFEQTLNQRVFQPLQLTHTWINVPKSAEKEYAWGYSNGQPVRVSSGML
GAESYGVKSTIEDMTVWLKANMTPQHLNDSTLKQGMLLAQSRYWRIGNMYQGLGWEMLNW
PVNADTLINGSDNQVALAPHPSIAIIPPDPADTGSWVHKTGATEGFGAYVAFIPEKQIGI
VMLANKNYPNQERIKASYAILESLQ
>AAK12088|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVQSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSRTFIALAAFE
QEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREDVMHFDIDPSSAT
>F5LRX5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIRGINHLLVSVSDLERSIRFYREVLGARLLVQGRSLAYFDLGGLWLALNTERDIPRNE
IRQSYTHLAFTVDEKDLPALEAKLAACGALLPGRERDSRDKSSLYFEDPDGHKFEFHTGT
LQDRLDYYRAEKGHMRFFGDPTAD
>A0A0S9PWV3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMSIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAILA
VYFGRLLGIAKALPSDPNARRFVFGILLAFLPAAIVGGLFSKYIKYYLFNPWIVCATLVA
GGLVLLVLDETDLEVKKRDVFDFSLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDETGLIVVGFIVAFFSALFVVRTVLDYV
SAHGFRLFAWWRIIVGSLGFFGLIVFG
>A0A0K2FRH1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
SEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGP
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
QLVTWMKGNTTGAASIQLDCLLPGLWG
>P14560|FEATURES|UNIPROT_deepARG|beta_lactam|blaU|antibiotic inactivation|1
MLHTRIRRATLGAVAALSLVPVMACGQESSADAAEPAGSAPSSSAAAHKPGEVEPYAAEL
KALEDEFDVRLGVYAVDTGSGREVAYRDGERFPYNSTFKALECGAVLDKHTDREMDRVVK
YSEDDLVDNSPVTEKHVEDGMTLTALCDAAVRYSDNTAANLLFETVGGPKGLDKTLEGLG
DHVTRMERVEPFLSRWEPGSKRDTSTPRAFAKDLRAYVLGDVLAEGDRKQLTTWLRNNTT
GDGLIRAGVRQGWVVGDKTGTGSYYGARNDMAVVWRPDGRPLVLNVMVHGHTKDAELDSE
LIARATEVVADRLG
>CAB61224|FEATURES|ARDB_deepARG|glycopeptide|vanYA|antibiotic target alteration|1
MKKWFFLLLLLLLIYLGYDYINKALFSQEKVEFQNYDQNPKEHLENSGTSESTQMKTITD
EQVYQGNLLLINSKYPLRQESVKSDIVNLSKHGELITGYGLLDTNIYMSKEIAQKFSEMI
NDAVNGGVSHFIINSGYRDFDEQSVLYQEMGDSYALPAGYSEHNSGLSLDVGSSLTKMER
APEGKWIKENAWKYGFILRYPEDKTDVTGIQYEPWHIRYVGLAHSAIMKEKNFALEEYMD
YLKEEKIISVSVNEEKYEIFYYPVTKNTTIHVPSNLRWEISGNNIDGVIVTVFPEST
>ABG72267|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPFYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIVAVKGQITETRESLRALIGAGASDMPEIKPVALPQVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTLRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
ASPVVEKK
>A0A0Q6BGI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIYLMLKAIIMGLVEGATEFIPVSSTGHLIIAGEWLNFLDKDKRDVFEIMIQLGAVLAV
CVEFRQRLIQTVQRIQTDPDAQHLVRNLVIAFLPAAILGLAFHHQIKEFLFSSFTVGIAL
IVGGILILIIEKFVPPGKVQDIDHISLKQALQIGFAQSLALIPGVSRSGATILGGMCFGL
SRQTATEFSFFLALPIMFAATGYDLLKARDLLSLDDAFIFLIGFVTAFLSALVVIRALIK
FVSQHSFAVFAWYRIVFGILILLFFAH
>E1M8J1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFFEILKSIFFGIVEGITEWLPISSTGHLILAEEFIQYKDQTEAFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKDKVQVRRTWQLWSKVFVATLPLLLVFKFDDWFDTHFHNMVSVA
IMLIVYGIAFIYLEKRNKAQAIEPTVTELDKLPYKTALYIGLFQVLALLPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGEVLSFGQFFLLLVAMVVAFAV
SMVAIRFLTSYVKNTTLRCLVNTVLS
>YP_002181880|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTVGSTSLSKEPGPAPVPPSGLRGHPWLTLFAVAIGVMMVTLDGTIVAVANPAIQK
DLGASLADVQWITNGYLLALAVSLITAGKLGDRFGHRQTFLIGIAGFAVSSAAIGISGSV
ELVIGFRVAQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAAGPIVGGLLV
EHVSWQSVFFINVPVGVIALVFGLVILVDHRAENAPRSFDVLGVLLLSGAMFSLIWALIK
AAEWGWGDSRTALFLALSVLCFGLFALWETRVGEPLIPLGMFRSLPLSAGTVLMVLMAFA
FMGGLFFVTFYLQNVHGMSPVDSGLHLLPLTGMMIVGSPLAGAAITKVGPRVPLVAGMVA
TAVACFGMARLTAGTGTLTMSLWFALLGLGLAPVMVGATEVIVGNAPLELSGVAGGLQQA
AMQVGGSLGTAVLGAVMAGTVSDSFGDNWAGAGLPPLTPEQAELAEKGVQVGIAPVPPQA
PETVVRAITGVAHDTFVSGMSTAFTVAGVVAVLAAIVACFTKRGEHAGPGAGAANI
>A0A135NT09|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKRLPRLLLATALTLASPPLLANNLQTTVDDVIPALMREQGIAGMAVAVYANGQSHYFNY
GLADKASRQPVSRDTLFEVGSVSKTYTATLAALASAEGKLDLQAPASRYQPALAKASIGK
ASVLELGAYSGDCLPLQFPDEVQTPSQTLAWFQHWQPRFAPGTHRCYSNPSLGLFGDLAA
RAQQQPFAKLMTQQVLLRLGLKHTYLEVPASARGLYAQGYDAKDQPVRVNPGPYAEQAYG
IKTSASDLLRYVQLQLQPDTLDPAMRKAIAITQSGYFQVGAMIQGLGWERYPYPVSLDTL
LEYNGAKIIRGENPIQALKPALPADPAAWYNKTGATGGFGAYVAFVPSRQMGIVLLANRN
YPNEERVRAAQRILSSLEP
>N9NNC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTIEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRPHQIVTKEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMLVLAVGIIVAFISALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>C1B3Z2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MILEFAVADEWSGPYAITAGPDQALWLTLVHAGRIARLTVHGEVATYPLDTADCGPTIIT
PGPDGALWFTRFRDHRIGRMTLDGMTESFPTPTAGSGPFGIVTGPDGALWFTEMNTDRIG
RISMDGQITEFPLPTDGGFPSAITAGPDDALWFTLNQANAIGRIDVDGNVAVHALPGSAA
GPVGITRGTDDALWFVEIGAGQIGRISVDGRIDEFPLPDRSARPHAIVADLDDGCWFTEW
GANRIGHIGLDGAITEYDLPTPSSEPHGIVAGPDGAVWVALEIGRVAYGP
>A0A077JIM0|FEATURES|UNIPROT_deepARG|aminoglycoside|aac(6')-Iap|antibiotic inactivation|1
MIVNCDHDNLDAWLALRAALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRHDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LYSQRLHAALGFAETERVVFYRKTLG
>A0A0P9MH58|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGELIAITGASGSGKSTLMNVLGCLDH
AASGSYKVDGRETGTLTEDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTARPIINEKTTE
RLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVTALSSQYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTRMGSGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KADPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQSYLDSITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A0A0B2K4L5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIKTVILGIVEGLTEWLPISSTGHMILVDEFIKLDVSKSFMDMFLVVIQLGAILAVVV
LNFDRLNPFSSHKSSIEKKETYQLWYKVIFACLPAAIIGLMFNKYMEEHFMTAPVVAFTL
IFYGIMFIVVENYNKNRTPAVTDLNKLSYKTAFIIGLFQVLSLVPGTSRSGSTILGGILF
GASRYVAAEFTFFLAIPVMFGASLLKIVKFGIHFSGAELLILVIGMATAFVVSVISIKFL
LRYIKNNDFKPFGYYRIVLGIIVIAYLLVVGDPTQG
>A0A0A3AQ24|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSEIFIAAILGIVEGLTEFLPVSSTGHLIIAAHFLGFTGEKAATFEVIIQLGSILAVVVV
FWRKMFGLIGIHFGVKPDHSQPHLTLLHIILGMVPAVVIGLAFHSTIKSWFNIQNVIYSL
IVGGVLLLIAEKFRPRVTANTVDQISYKQAFAIGLFQCLALSPGFSRSGATISGGLLMGV
GRHAAAEYSFMLAVPMMMGATVLDLYKSWHFLSFADLPMFAVGFVMAFIVAMLAIKWLLA
LIKRISFVPFAIYRFVVAIALYFVFLY
>A0A0A0QXE9|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQ
EGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMIGRAVD
VVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPR
TLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERL
AFYLRLDPLTWG
>CAL37101|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTRHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTK
PEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKN
FINTLAETLVDLHNIPEENITAQHINIKTIQEIKKDFQRRMNKVNETYGVADGLWNRWKQ
WLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDE
GLEQLITAYGKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE
>D3I6H5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLQTIIISIVEGMTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFTFIIQFGAILSVVC
LYWKRFFQIDHTPVPVDETCTFKKIIHPIRFYWLLFIGVLPAVIIGLAAKKSGLLDWLLD
SVWVVAIMLVVGGIFMLYCDKLFNKGKEENQVTEKRAFSIGLFQCLSVIPGTSRSMATIV
GGMANGLTRKRAAEFSFFLAVPTMAGATLLDLLDLLKGDSTWASAHNLIMLAVGCVVSFI
VALLAMKWFVSFLAKYGFKWFGWYRIIVGVIIIIMLLCDIPLNMVD
>A0A024ITP4|FEATURES|UNIPROT_deepARG|aminoglycoside|BN949_01517|antibiotic inactivation|1
MSGQFAIETAGEASLDEWSLLRHRLWPDASPAEHRAELRDVSNNEVGFIAYDPAGMAIGF
AEASLRHDYVNGCDTSPVAFLEGVYVEEAFRGQGVAAALIAEVTRWAISKGVSELASDAD
IANVNSHRMHLALGFEETERVVYFRKIVSSDL
>K8W905|FEATURES|UNIPROT_deepARG|beta_lactam|OOA_14870|antibiotic inactivation|1
MKNFFRQGQLFIALGLAFTSISASALTQKEVDGIIRPLMKQEQIPGMSVAISIDGKQEIY
HYGIQSTQTKVPITDRTLYEIGSLSKTFTATLAAYAQTQGKLDFAKKVSDYLPELKDSAF
DHISIMNLATHTSGLSLFVPKGVVTSTQLMDYFHHWIPEKTIGQYRSYSNLGTGLLGIVA
AKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKNQEEYYAQGYNKQNQPVRVTPDILDAEAY
GLKSNAKDLIRYLEINMQMTKVAKSWQEAVEDTHTGIYLTDSYIQAMMWESYPWPVSLPQ
LLQGNRDDMALQPQKVELIQPPLPPETRALYNKTGSTNGFASYAVFIPEEKIAIVILANK
WYPIPQRVTATYQLLEKIDR
>C4L8T7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDILNSLIMGVVEGITEFLPVSSTGHLIVTKELLKFEGSDTFEIVIQLGGVLAVLWFYF
KTILQQVKSVATDAAVRRFWMAVIVAFLPAACIGLAFHHYITEYLFNSVTVACSLIVGGV
IMWWIEGVAFKPRTLAFEQITLKQALAIGCAQLCALIPGVSRSASTIMGGMLTGLDRSTA
TGFSFFLSIPTLGAASIYSLLKDLNGVGEHGILNISIGLISSFIVSLLSIGWLLRYISKH
NFRGFAVYRIVVGIIILALSYFGFFSPSV
>J2ZMR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHKYLFNPITVATALV
VGGFIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAVKP
>AAN60573|FEATURES|ARDB_deepARG|glycopeptide|vanB|antibiotic target alteration|1
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
ADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVG
CDIQSSAVCMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGV
TKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIF
RIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGI
VLNEVNTLPGFTSYSRYPRMVAAAGITLPALIDSLITLALKR
>A0A0M4QQU5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLSSVSKGGFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGNILAQQRISIERTDTALTLHGKLREAAAQLLAEALP
LLPQGKLQETAQDESKATYFVRRTPADGLLQWTRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWGAEVVAGNQGHAPGQVISCDPLRIACGQDSLVVTAGQRNENGLYLSGPQLARELG
LVEGSRLRGSESGRKARRTRVLILGVNGFIGNHLSERLLQDDQYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIDNKGGKCDGQIINIGNPENEASIRELGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>A0A074VDK6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLLEIKAINRWFGTGENRVQVLKDINLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDVPS
SGSYKIDGVETAAMTADEQAALRRRSFGFIFQRYNLLGTLTARENVALPAVYAGMEYDER
MKRADELLAQLGLAGKEENRPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTGSGK
NVMEILHKLHDAGHTIVMVTHDPTIAANANRVIEISDGRIIADHSKNTDIPPSNIESIEE
HNSWHFYRDQFFESFLMSIQAIMAHKMRSFLTMLGIIIGIASVVSVVALGRGSQEKILEN
INAMGTNTVSVYPGYGYGDRRSSRIKTLTVGDAEVLKQQDYVDSVTPGVNTSGTLTYDNQ
SLSAQLYGVGDQYFDVRGIKLAFGRLFNEDDVTQNSQVVVIDDNTKNKLFADGTNPLGKV
ILFNKRPLRIIGVTEPNNNGFSDSDSLQLFTPYTTLMNRISGSKYITSVTVKVKDNVNSQ
TAEKGIIELLKVRHGTEDFFTRNSDTIKQTIESTTGTMTLLISSIALISLVVGGIGVMNI
MLVSVTERVKEIGIRMAIGARQHNILEQFLIEAVLICLIGGLVGVLFSFAISMLFNLLAT
DFAMSFSTISIVMAVLCSSVIGVLFGFMPAKRASQLNPIDALSRD
>A0A105YNX7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKHRIKRIMAAALFSTCATATVGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
GQTYVFNYGVASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGRLSMSDKTGKYLPN
LQGSPFGNVTLVELGTHTPGGVPLQVPGNIRNEDQLMRYLKDWRPTYSPGAYRTYSNVSI
GTLGLITATSMGQQDFAVPLSRHLLSPLGMTSSYVDVPRSRMADYAQGYTKDGAPTRMTT
DVLSSKTYGIKTTAADLLRFVQANMGEVKLDKPLQQAITDTHTGYFNAGPMTQDLIWEQY
PYPVALKTLTEGNSLSMALNAMPVNEIKPPRAPQQQVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERVTAAYRILTSLGLDGR
>A0A097SRQ8|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
RFALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPM
MSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAIT
MSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMAT
TLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIVDKSGAGERGSRGIIAA
LGPDGKPSRIVVIYTTGSQATMDE
>F4VME6|FEATURES|UNIPROT_deepARG|beta_lactam|ECPG_01411|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGVQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>K7QD66|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENAMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGARVVSTRQTRDLMKSDWAEIVAFTHKGLPEYPDLPLVLPNEVHDGDFTLQEGKVRA
FYAGPAHTPDGIFVYFPEEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKVV
VGGHDSPLHGPEL
>A0A0W2YNB7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAAKEALR
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>ZP_04613685|FEATURES|ARDB_deepARG|beta_lactam|BL2e_y56|antibiotic inactivation|1
MKHSPLRRSLLLAGITLPLVNFALPAWAATLPTSLDKQLAELEQQSQGLLGITVINTGNG
RKIQYRGTQRFPFCSTFKFILAAAVLNKSASQPKLLDKHLHYHERDLLSYAPITRKNLAH
GMSVSQLCAATVQYSDNTAANLLIQELGGVESVNQFARSIGDQTFRLDRLEPELNSALPN
DPRDTTTPSAMAASMNALVLGDALPAAQREQLALWLKGNTTGGETIRAGAPAEWIVGDKT
GTGDYGTTNDIAVLWPTKAAPIVLVIYFTQREKDAKPRRDVLAAATKILLSHLP
>J2SBI8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLNSGYEIAAVFTHPDDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQRVAIERTDTALTLHGKLRLAATDLLRDTLP
ALLQGKVSETPQDESKATVFGRRTPADGKLLWNKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSADIVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDANFDEDSSNLVVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDIESKAFYGTGYQDVSHRKPSIANAKRLLDWAPTVEMTETIGNTLDFFLREAMLEIA
DKKR
>N9DIB1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQNALKKMPIFNLFILLFMHNLELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFQSD
SGRAFEVIIQLGAILAVCWLYRQKIADLLKGFFSGDMHARRFSVNVFLAFLPAVVIGIFA
VDFIKQVLFSPLVVACALIIGGLIIFAVEAKEFKPKTIEATDITFKQAILVGFAQCLAMI
PGTSRSGATIIGGMLSGLSRKAATEFSFFLAMPTMLGAATYDLIRNASVLSSDNMMNIAA
GFAAAFIAALLVVKALVKFVEKHTLRVFAWYRVILGVVLLIVFL
>CAC41338|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILSTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLAGAAVDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARHFGFMSACFGFGMVAGPVLGGLMGGFSPHGPFFAAAALNGLNFLTGCFL
LPESHKGERRPLRGSSHPLASFRWARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRF
HWDATTIGISLAAFGILHSLAQAMITGPVAARLGERRALMLGMIADGTGYILLAFATRGW
MAFPIMVLLASGGIGMPALQAILSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAA
SITTWNGWAWIAGAALYLLCLPALRRGLWRNSSNSRCT
>A0A0F1DC61|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDHSALMLTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEEIHP
>R6JWQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVLFGIVEGITEWLPISSTGHMILLNEIMPLKVSEAFYSMFEVVIQLGAILAVV
ILFWHQLWPFGKKNNKEPLAESGAGAYVKWDIFKLWFHILVSCVPAAIVGILFDEQLEAL
FYNYTTVAIMLIIFGVAFIIVETMHHGKKPKVRNLTGITYKLAFYIGLFQLIAAIFPGTS
RSGATIVGALILGVSRTVAAEYTFFLAVPVMFGASLLKGVKFLMHNSMTSMECTILIVGM
VVAFVVSLVVIKFLMGYIKKHDFKVFGWYRIVLGIIVLICGFAGVIGV
>YP_002030219|FEATURES|ARDB_deepARG|multidrug|smeB|antibiotic efflux|1
MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENA
VTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQ
AVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQ
EYAMRIWLDPEKMRQYALMPSDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRL
HTPEQFAQVVLKADAGGSVVHLGDVATIGLGPESYDSISTFNGKPSASLGIELNAGANAI
AVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIALVVLVMYLFLQ
NWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVM
TFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMIL
SVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVD
GFLGRRALGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMD
RLSAAAVKDDSVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTAAMAS
VPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRY
ASLEDAPVYAVKVDDAKAQAMGVNPQDINDTLNAALGGDFVNNFIYKGRIKKVFIQGTAE
ARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAALQRYNGVSAMEITGQPAAGVSSG
EAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVP
FAVMLAVPVGVFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKS
TREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGM
FFVPLFYLLVRRLFPGRAPADATAAEANP
>E0FFR8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIEKLNKYFGSGENTAHVLKNINLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGVCKIDGKETLNMTSDELSDLRQRKFGFIFQRYNLLPALTANENVALPAIYAGVDNTSR
KARANQLLEKLGLADKTGNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLEILKDLHKEGHTIIMVTHDANIAANASRIIEIKDGYIIRDERQQPYSEDLKLTKREY
KKPRFFDQLIESFKMAINAITAHKLRALLTMLGIVIGITSVISVVALGQGSQQQILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDAMMLNKQQFVDSTTPSSNLSGTVIYGNTNV
TASINGVGEQFVNVKGLKMISGRFFDADEVKLSSQVVVIDGNTKKDLGLTDPVEGKVILV
DKKPLTVIGMAQESNNLNQTSLKMWMPYTTLMQRISGEKFIDSLTVKVKDNVESQTAEKS
INELLTAKHGKKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSV
TERTKEIGVRMAIGAKQNNILQQFLIEAILICLLGGIIGILFAMAIIFSFNTLGTNFKMI
LSPASVVLAVFCSTLIGVVFGYMPAKNASKLNPITALAQE
>A0A086GF70|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAGTHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEATYRIIQALEKR
>A0A0G8F7Q7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHGVIKTYLFQPYTVVIGLVA
GAILMLFAEVKKKEATSYSLDDLTYRQALAIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFVVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>ABG36701|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSPTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCIQSLIVSIVGTL
AVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>A0A127SYH1|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTVNEMPE
FRTALTEKGLGYYSEMHPAYTIFNQEQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDTSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHVGRFIELLQKKIIGFDSGFNSTPSDTSATVKGRMK
>R7L7E4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPKHLKFFIISAVLSILFSISAYAQIELYEVGQNPPAKPGVAKDGCGKEDIGYADALVLG
VVEGVTEYLPVSSTGHLILANALLGLDTDTPLCDSSGAEIYDSDGSPYTMKMAADAYAIV
IQFGAILAVAVIYWQYLLKMLAGLLGRNPEGLRLLRNLIAAFLPAAVVGLILHDFIESQL
FGVKPVIFALAAGAVLMLAMQKYYDKRQYAGKRYPKLEDMKLSKAFLIGALQCVAMWPGT
SRSMMTILGGYLAGLRPSDSAKFSFLLGFVTLSAAAAYKTYKDGAAIAEALSFGPLAMGM
LVAFISAAISVHWMVGFLTRKGLAPFAYYRFILAAVLIAALYFNFI
>A0A0A8GQ57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLEYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
IIFKDKLTQKLDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIVFIIIEL
KHRKKDYAIHSLDEVSYKQAFLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSF
LLAIPTMIIATAYSIYKEPQVLSNMNNFIPLIIGFITAFVVAFVVIKIFLKLISKINFIP
FGIYRIILGFVFLYLFMSGALDISRTGV
>A0A0F2TMK7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MELIDAAPEGAGPYGITVAPGGDVWFTLVHSGEVGRLTADGSVRRYGLGAPDCGPAVITA
GPDGALWFSRMRDHRIGRITAAGEASSFPVRTEGAGPYGIAAGPDGALWFTELGAGRVGR
IGVDGEVEEYPLPLAGAFPSMITAGPDDALWCTLNQADAVARIGLDGEVAVHRLPTEGTA
PVGITAGADGALWYVGIGGGLVGRITVDGQVTEQPLADRAAKPHAIAAGPDGALWFSEWG
AGRIGVLHPDGRLDGYPIPGPGAEPHGIAVGADGVVYAALERGQILRLGA
>A0A0M4FPH5|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0L5XB01|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKEWEILLIDDGSSDSSAELMVK
ASQEADSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEESHQ
>A0A090TTJ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPPHKSPGGREISVPT
VKTVSGWSQFISGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>J3A5B8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHQYLFNPITVATALV
VGGIIMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFVTAFVFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAAKP
>C7HWT2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILDLLKVIILSIVEGVTEFLPVSSTGHLILVNEFVKLEPEKFANAFNVIIQLGAILSVV
VLYFSKLNPWDFEKTKRYFPKNYAKLNGQSKFYYRLTHPYKETIELWKRVIVGVIPAGIL
GFLFDDIIDEYLFNPMVVALMLFVWGIGIILIENRNKKENRQRVDNISLISYKTAFFIGC
FQVLAMIPGTSRSAATIIGAMILGLSRSASAEFSFFLAIPTMLGATLLKVVKNVSGFSGY
EWILILIGMILSFIVAYIVIKKFISYVQKNDFIIFGKYRIVLAVIVFLYFLIIK
>A0A0J6ICK2|FEATURES|UNIPROT_deepARG|glycopeptide|arnD|antibiotic efflux|0
MQAGLRIDVDTYRGTREGVPQLLELLDEAQIKATFFFSVGPDNMGRHLWRLIKPRFFWKM
MRSKAASLYGWDILLAGTAWPGKPIGKDLGHLMRQTLAAGHEVGLHAWDHHGWQANTGRW
SEAQLIEQIRLGVDTLSDITGQAVECSAAAGWRADERVVEAKQRFGFRYNSDCRGHSLFR
PRLADGSLGAPQIPVDLPTFDEVVGPHVSAADFNSYILDRFSPQRLNAYTIHAEVEGILM
ANDFRQLLAQARARDIQFQPLRNLLPADLESVPAGQLSRGVLQGREGWLGVQQP
>N9E7G2|FEATURES|UNIPROT_deepARG|beta_lactam|F934_00954|antibiotic inactivation|1
MLIGLLSCNSSLWAQPLTDLQVKKIVDQQFKPLLERYKIPGLAVAVTLNGKHYFVNYGVA
SQQSKQAVRNNTLFELGSVSKTFNATLAGYAQAQGQLSFSDHPAKYFPELKNTAVNQATI
LNLGTYSAGGFPLQFPDEVVQQQQMIQYFQNWQAKTKVGAARQYSNPSIGLMGYVTALAM
KKPYAELIEKILFPQLDMTQSFINVPTQQLPHYAWGYKNNQAMRVTPGMFDAEAYGVKSS
SSDMLKFLDAQINPSKLKQPLRKAIENTHVGYFKVAAMTQGLGWEQYAYPVKLETLLQGN
SSKMALESHTAIAVKQPKIASAATFFNKTGSSNGFGAYAAFIPQQKIGIVMLANTNFPNE
ERIKASYGMMQQLIQANSTQ
>A0A086DZW8|FEATURES|UNIPROT_deepARG|chloramphenicol|JF66_07460|antibiotic inactivation|1
MGEARAIDVDRWPRREHFEHYLTRVECTYSITVEVDVTEMVAALRESAWKSYIAQIWVIS
SVVNRHAEFRMTLIGEKAPATWDIVHPAFTVFNPERETFASVWSPFHTDFTTFHHDAAVV
LAEHRTATSFQPQSDMPANTFDISSLLWASFTGFSLHMRAGWKHLLPIFTLGKYREVQGR
TMMPVAVQIHHAAADGFHTARLIHELEELLSNPTWLPR
>A0A0K1NDZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAALLLKAAVMGVVEGLTEFLPISSTGHLILAGSLLGFDEAKASVFEMAIQIGAICAVV
LVYWQKIRATLLALPTQRQAQRFAAHVLIGFAPAALLGLLAGKAIKAHLFNAPVVALALV
AGGIVIFWAEGRQRPARVQSVDEMSGLDALKVGLAQCVAMIPGVSRSGATIIGGMLLGLS
RPAATEFSFFLAIPTLIGAGVYSLWSDRALLAWADAPLFAVGLALSFGSALACVRWLLRY
IASHSFVLFAWYRIIFGLLILLTWQMDWVQWSH
>A0A0H1ANC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDPISALLLGIIEGLTEFLPVSSTGHLLIAQHWLGARSDFFNIVIQAGAIVAITLVFRQ
RIWSLTTGLRERANRDYAMKLALAFLVTALVGLPVRMAGWELPETVTPVAWALVIGGVWM
IVAERLAERRPDRTDVTWTVAVLVGLAQVVAGVFPGTSRSAAAIFIAMLAGLSRRSAATE
FVFLVGIPTMFAASAYAFLELWLDQGLGEEAWGDVAIAFVAAMVTGFVVVKWLLGYIKGH
RFTGFAVYRIALGIGLLLLMPSGG
>ZP_03573944|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVLILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLAAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEEEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLGFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGMSARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRRFNKLFHRGAENYGRGVR
GVLSRKAVMLGVYLVLVGATVLVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QQYASIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVSVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GYSSGQAQAAIERIAHETLPRGVRFEWTDLTYQQILAGDSAIWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTHGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVPAPDA
>F4HAL7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRHSLQITARKMTQAA
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
SAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
AAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGIRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>A0A158RHF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHIFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A137RNB2|FEATURES|UNIPROT_deepARG|chloramphenicol|AYK81_08205|antibiotic inactivation|1
MKFHVMDREDWNREQYFEHYLKLKCTFSMTVNVDITMLLKEVYQKGIKFYPVFIYLISRV
VNNHKKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>YP_001310303|FEATURES|ARDB_deepARG|chloramphenicol|catB|antibiotic inactivation|1
MNFNLIDINNWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
VVNNHKEFRICFDHNGSLGYWDSMNPSYTIFHKENETFSSIWTEYNESFLRFYSDYLDDI
KNYGNIMKFTPKSNEPDNTFPVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQGNKI
FIPISIQVHHAICDGYHASRFINEMQELAFSFREWLENK
>J3FE31|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKTVVFAYHDIGCAGIQALLDSGYDIAAVFTHADDPQENAFYASVAQLCANKGIAVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQRVAIERSDTALSLHGKLRIAASDLLRDALP
AMLQGKITETPQDESKATVFGRRTAADGKLVWAQPAEKLFNLVRAVTQPYPGAFCAVGEH
KLIVWSADVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRGPRRTRVLILGVNGFIGNHLSERLLRDERYEVYGLDIGSDAIDRLR
SHPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESRAFYGAGYQDVEHRKPSIANAKRLLDWTPTVEMRETIGNTLDFFLREAMAEIE
SKR
>A0A0U3LL38|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTVSEMSVADKDAGPYGIAAGPDNALWLTFAHSGRIARLTLDGELDEYPLEPPECRPTVI
TPGPDGALWFTRSQDHRIGRITADGETDSFPVPTPGSGPFGITAGPDDAMWFAEMNTDRI
GRITTTGEITEFVLPCTGAYPSAITAGPDGALWFTLNQANAIGRITVHGDIVIHPLPTPS
AAPVGITSDGDALWFVEIVAGQIGRISVDGAIKEFPLPDRAAKPHAIVATSTGDCWFTEW
GANSIGHVTGSGEITEYSLPSPSSEPHGIALGPDGALWAALETGGVARLEP
>A0A090T4G1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKHTEAINFVSIVIPVYNEENCLQELIDRTTKASDSLGKDYELILVDDGSRDRSAEIIEQ
ASEKEGSHVVGVILNRNYGQHNAIMAGFEQVRGDLIITLDADLQNPPEEIPNLVAKAEEG
FDSVGTVRKNRQDSALRRYPSKLINKLVKRSTGVEMNDYGCMLRAYRRHVVDAMLECHER
STFIPVLANGFSRHTTEIDVHHDERADGESKYSFMKLISLMFDLITSMTTAPLRLLSIVG
GGIAAAGIAFGIILMLMRIMFGSEWAGDGLFTLFAILFVFVGAQFVGLGLLGDTLAAYTL
MLERALVSTCKTCWWVKPLSKPVKLMN
>A0A0E1LEY4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>CAJ29561|FEATURES|ARDB_deepARG|beta_lactam|OXA-1|antibiotic inactivation|1
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAEFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>Q65KV1|FEATURES|UNIPROT_deepARG|multidrug|ykkC|antibiotic efflux|0
MRWGSVILAALFEIGWVMGLKHADSALEWICTAAAVVMSFYILVKAGEKLPVGTVYAVFT
GLGTAGTVVCEIALFNEPANIAKLALIGVLLCGVIGLKLVTNEEKGEAS
>A0A0R5RPM8|FEATURES|UNIPROT_deepARG|chloramphenicol|catQ|antibiotic inactivation|1
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTINEMPE
FRTALTEKGLGYFSEMHPAYTIFNQGQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEK
YDPKPERPVNSFDVSMIPWFSFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQV
HHAVCDGYHIGRFIELLQEKINDFDSSFNSTSYEISATAKERMYEMTDKAPWVFSDMSGN
CSNTISLCEATKEDAPFIASVYNQAILAGNCTCDTKTVTSEMREKWICQHAADGYPVYLC
LENGMPVGYGYLTAYRQGREAVNHVAEVSYYLDFSAHGRH
>A0A0Q7YTY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNEIMTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASRWAIFNIAIQPGAILAIVVL
YRKLFWEMFTGFFRRDPVAIAFVRNLALAFVPAVALGLALGDYIEVLLENAVVVAWALII
GGFAILLVERYAKPKESGGVANLSVRQSVLIGLVQCIAMIPGVSRSGATILGAMSLGVDR
KTAAEFSFFLALPTLTGATALQLFKHRDAITTNDLGLIGVGAFVSFIVAWVVIKAFLAVV
TRYGFTPFAWYRIIVGAAALVWLTMR
>A0A0A0CMI5|FEATURES|UNIPROT_deepARG|aminoglycoside|KS18_22820|antibiotic inactivation|1
MVVSNSHNFNEWLYLRNALWPTASEESHCEEMNSILNSDNQIAFMIQSDLGDFCGFAEAS
LRFEYVNGCNSSPVAYLEGIYITPELRRNGLATRLITHIKNWAKDHGCTEMASDAEINNE
ESLALHLSLGFIETERVVFFRKLIK
>I6ZG55|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
DNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTX
RNXTLGKALGDSQRAQLVTWXKXNTTGAAXIQAGLPASWVVGDKTGSGGYGXTNDIAVXW
PKDXAPL
>A0A0F7LKK3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKRFSVLTGGLLLAASLGAQASNTPDQSHLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKENNTPVTKETIFELGSVSKTFTASLISWAQVTGAISLSDKASQHFQPLA
GSAFDNISLLNIATYTAGGLPLQFPDEIDSNSKMVNWYQHWQPKYAPGTYRQYSNPSIGL
AGYIAAQRIGKPYSILVANQILSPLGLHHARFNVPAQDMKNYAWGYSKENKPIRVNPGVL
DEEAYGLKASAQDMISFVDANIDPSRIGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQIAYQANKTTELSPPEPPTEALFINKTGATNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILNALK
>YP_001348105|FEATURES|ARDB_deepARG|multidrug|mexE|antibiotic efflux|1
MEQSSHFFWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLE
APESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQAR
SVNEAQRGERLRASNAISAELADARTTAAQEARAAVAATQAQLDAARLNLSFTRVTAPID
GRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESP
VYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTY
AATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGL
QRVRPGMQVDPQKVEMASTDTLATLARLRQSVGDSEPPKVAATKDNATRNEPRG
>B0N2N2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEESMEIIELIKVIILGIVEGITEWLPISSTGHMILVDEFIKLNVSADFLEMFLVVIQLG
AILAVVVLYWKKLIPFDYKNRWRIKKDTFSMWFKIIFACLPAAVVGLLFDDQLNELFYNP
LTVAIALIVFGVLFIFIENYNKGKETKINSLSEITYNTALIIGIFQLIAAVFPGTSRSGA
TIVGALLIGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAFTTAELLLLVIGMLVAFVV
SMLTIKFLMSYIKKHDFKAFGWYRIILGIIVLIYFMVF
>ZP_02901634|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPECRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>A0A0Q5XUY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPEHSILSALILGLIEGLTEFIPVSSTAHILLAGHFLGFESKGKTFEIIIQLGAILAILT
VYFHRLWSILIALPNDPRARRFVLLIVLAFLPAAVIGFLAHDFIKNVLFETPKLICIMLI
VGGIILYAIDRMPMKPRYHDMMDYTPSLALKIGLFQCLAMIPGTSRSGATIAGSLLMGTD
KRSAAEFSFFLAIPTMLGATVLDLYKNRDVLDFNDASLIAVGFIAAFVSALLVVRSLLAF
VSSRGFAPFAIWRIIVGIAGLIGLTVFG
>X6KJ15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLI
VGGVVLLVVDRMKLQPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAIGFIAAFLTALIVVRFLLDY
VSRNGYSLFGWWRLVVGAVGLVALFIWG
>A0A133Q1F7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLLELIKGIILGIVEGLTEFAPVSSTGHMILMDDMWLKSTDFLGSESAFTFKVVIQLGS
VFAAAWVFRERFFELLHIGKQHQAPISEEFRSKPRRLNLLHVLVGMIPAGILGLMFDDLI
EKYLFSVPTVMIGLFLGAIYMIIADKYSEKVKHPQNVDQINYFQAFVIGISQAIAMWPGF
SRSGSTISTGVLMKMNHKAASDFTFIMSVPIMLAASGLSLIKHYEYIHLAHIPFYLLGFL
AAFIVGLIAIKTFLHLINKIKLVPFAIYRIILVVIIAILYFGFGIGKGIY
>A0A0A2EH72|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWYEAIIIAIVEGLTEFLPISSTGHMIITEHLLGVQTNEFVKAFMVIIQFGAILSVIVL
YYKKFVQIKPIKVFDLPKGEALGLWDRIKHIALRLTDKFDFYWKLFIAFIPAAVLGFIFS
DAIDELLESVQVVAIMLILGGVLMLFVDKIFAKTCENQDITNRKALIIGFCQCVAMIPGV
SRSMATIVGGMSQRLTRKSAAEFSFFLAVPTMFAASAWKLYQLISNPVERQILIDNVDIL
IVGNIIAFVVAMLAIKFFINFLTKHGFKAFGYYRIILGVLLLAMLWMNLY
>M7S3M5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
NVNHPIWVDRIAEFAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARLLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>Q1Q9V1|FEATURES|UNIPROT_deepARG|beta_lactam|Pcryo_1775|antibiotic inactivation|1
MRNPIMKQPFQTFLNQVGFTALVTASLLSGTVQAADNNDHLKSAVDQQAKLLMNEHNISG
MAFGVIIDGKSHFYHYGLADKKAKIPVSENTIFELGSISKTFAATLASYSELNGTLTLED
TADKYIPYLKNSAIGNTKLINLATYSAGGLPLQVPDDVKNNKELLRYYKSWQPVFPVNSK
RLYSNASIGLFGYISALSMDTDYTQLMEEKILPSLNMPNTFINVPSDKMADYAFGYNAAG
DAIRVNPGMLDAETYGIKSTITDMTHFMAANMGLVPLDKNIQQALDNNRKGYYQASTFTQ
GLGWEMYPYPTQLDTLLEGNSMDVVLKPQAIKTDNHPTAVLNNVWVNKTGATNGFGGYIA
YIPAEKSGIVILANKNYPNADRVKAAYTILESAITH
>A0A0W0ZWB0|FEATURES|UNIPROT_deepARG|beta_lactam|Ltuc_1273|antibiotic inactivation|1
MKKKIVFLGLGLLFCTATYAQRTCFLAKENETVLKHEGNDCDQRYAPASTFKIALSLMGF
DAEILKDELHPEWPYKKEYQLSAVNVCKYPHTPRTWLRDSCVWYSQILTKQLGSTRFKNY
VDAFHYGNQDVSGDKGQSNGLTHAWLSSSLAISPKEQILFLQKITHKKLPVSPKALNMTK
DILYLQELAGGWKLYGKTGTGLQLNDKSQKLSLQHGWFVGWIEKNGRVISFASHIADSEE
KTNFASLRAKNNAFIKLFYLINELEQ
>Q8RLU6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0S4IFD0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_3|antibiotic efflux|1
MNMNVQPTAPLCQATGQGEPLLCLEGITRSFQAGERAFLALKGINLQIHRGELVAIIGAS
GSGKSTLMNILGCLDNASTGSYKVDGQQTRDLDVDALAALRRDHFGFIFQRYHLLPHLDA
LHNVEIPAVYAGMDLQWRHQRAQTLLSRLGLGEHLHHRPSQLSGGQQQRVSICRALINGG
QVILADEPTGALDSASGKEVMKILLELHASGHTVILVTHDPHVAAHAERIIEVSDGQIVS
DRRKVADTVPARAVAPTPARKRGHRLLASLGMFREAFKMAWLALVSHRMRTLLTMLGIII
GITSVVSISAIGEGAKGYVLKDIQAIGSNTIDVYSGSNFGDSRARNIETLVPADVAALNA
LYYVDSATPVIGQGTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFSADDARRQAQV
VVIDHNTRERLFGPTTDPLGQVILVGNLPCTVIGVTARNKNLFVASNQLNIWVPYETAAG
RVLGQRHLDSISVRIKDGVPSKRVEEEVSRVLLQRHGSKDFFTNNLDSIMQTVPEDQSIP
DLAAVADRGDLAGGGRHRGDEHHAGVGDRTYP
>A0A011TRZ6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKSTTLLIGFLTTAAIIPNNGALATSKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVLLANRNYPIDERVKAAYRILQALDNKQ
>ZP_03064581|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQASDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>ABO60984|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTTLALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>A0A0X9L5U5|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES-5|antibiotic inactivation|1
MRFIHALFLAGIAHSASASENLTFKTDLEKLEREKAAQIGVAIVDPQGQIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQDRDYAVAVYTTAPKLSAEQRDELVASVGQVITQLILSTDK
>J8DRP5|FEATURES|UNIPROT_deepARG|beta_lactam|IGC_02894|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DVKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDLRIKYTNKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKQPIVLAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNKS
>D4LUY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVLEFIKVVILGIVEGITEWLPISSTGHMILVDEFIKMEMTPEFKEFFLVVIQLGAILA
VVVLYWSKLWPFYIREISPKKRKELNRMNPVSRMALTFVEKFCDKDKWILWFKILVACIP
TIVIALPFNDIIEEKFNNYVVVAIALIVYGVIFILVENYNKRRKPVCTSLEELSFGTAFK
IGIFQVLSVIPGTSRSGSTIIGGILVRTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFAF
TPAEILTLVTGVVVAFFVSIIAIKFLMGYIKKHDFKAFGWYRIVLGILVLGYFAGRKFL
>Q9ZH65|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMKASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>E8YMX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDQHAKTFDVVIQLGAILAVC
WEFRRRIGDVVTGLPSRPEARRFVLNVIIATLPAIVLGLLFEKSIKAALFSPVPVAFALV
VGGVVILWAEARQRGQGAQGQAARVHHVDDMTAMDALKVGLAQCFALIPGTSRSGSTIIG
GMLFGLDRRVATEFSFFLAIPIMFGATAYEMYKDWHTLSVDALGVFALGFVAAFVSAFLC
VRWLLRYIAAHDFTAFAWYRIGFGLLILLVGYSGALSWAD
>R6SA61|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIELIKAFLFGIVEGITEWLPISSTGHMILLDQFVKLDVSKSFYSMFEVVIQVGAIMAV
VVIYWNKIWPFHKSKQTGPLAPTGIWRYVDKDIIIMWIKIVIACLPAGIIGVAFNDTFEK
LFYNPVSVAIALIVFGIAFIWIETVHKNKRAKINSLAELSYYTVILIGFFQLIAAVFPGT
SRSGATIVGALILGVSRTVAAEFTFFLAIPIMFGASLFKLLKFGFVFSSAELLILIVGLI
TAFVSSIIIIKFLMQYIKKHDFKVFGWYRIVLGLLVLLYFLVIK
>J8G2D4|FEATURES|UNIPROT_deepARG|beta_lactam|II5_01596|antibiotic inactivation|1
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
ITSLKFGNTKVETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEW
STSIENVLKRYGNIDSVVPGHGEVGDRGLLLDTLDLLK
>K8ZYI6|FEATURES|UNIPROT_deepARG|beta_lactam|ACINWC141_2773|antibiotic inactivation|1
MRFKKISCLLLPSLFIFNTSIYADNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KNYEMYYGLQSVQDKKAVNGNTIFELGSVSKLFTATAGGYAKTKGKISFEDTPGKYWKEL
KNTPIDRVTLLQLATYTSGNLALQFPDEVQTDQQVLTFFKEWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFVNANLNPQKYPADIQRAINETHKGFYQVGTMHQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0U5B180|FEATURES|UNIPROT_deepARG|bacitracin|uppP_3|antibiotic target alteration|0
MEHYWIAIILGIVEGLTEFLPVSSTGHMILMADLLNFDGDKAKTFEVVIQLGSIAAVVFV
FWRRLLSLIGIGRSRTYGPQLNLLHVIIAVLPAGLMGVLLHDFIKKHLFSPYTVLMALVA
GAILMIVAERFQPRTTAPTIDDITYRQAFGIGLFQCLALWSGFSRSGATIAGGLLLGTSH
KAAAEFTFIVAIPVMIGATGLDLIKSMHFLSASDFGFFATGFVTAFVVAMLAIVSFLKLL
QRISLTPFAIYRLLLAAVFYLFVLR
>D1LFB5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASV
TAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLV
TWLKGTTT
>ABG81258|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSSQNAVRDG
IRYGLEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFIYQPRRPNSRIDKVRHMFHKLA
>A0A0X4EVR3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>N9GNZ1|FEATURES|UNIPROT_deepARG|beta_lactam|F922_01082|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFGQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>A0A097SR23|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MEKVELKTKVIGGATIALACIFASFFATSAYALDTIKLTKVVQAEEETLQARVGMAVFDT
NTGETWQYRGDERFPLNSTHKAFACAALLAKVDGKSLTLDQPVSIRKEMLVPYSPITEKS
LAPQTMTFGEVCHAAVSYSDNTAANVVFDVIGGPTGFTSYMRSIGDEKTRLDRKEPELNE
ATPGDVHDTTTPNAIVNSLRKILLGDVLSVSSRAELTQWMLTDQVAGALLRASLPSDWKI
ADKTGAGGNGSRSIVAVIWPPSKKPLVVGIYVTQTKASMQASNQAIAKIGTALKEAIGQ
>J3GEE7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTTQVSILGLVEGLTEFLPISSTGHQIIAADLLDFGGERAMAFNIIIQLGAILAVV
WEFRHKILEITTGLPTQRNAQRFTLNLLIGFLPAVVLGVMFADKIHEYLFNPITVAVALV
IGGIIMLWAEQREHVVVIDHVDEMRWTDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQSADLPVFALGFVAAFLFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWFLGWIDWNHLSEGA
>A0A0K3MND7|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWQAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0U2BHX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLFIKAVIMGIVEGITEFLPISSTGYMILSADIMNFWDKDKRDLFIVFVQLGAILAV
IYDYWGRLWTAFMGLLTGKADGMTNPRGLGISLIIATIAVMVVGFTLKDFITGTLFHPLV
VATMLIIGALLIIYVEKHPRPIKAQEAEHIDIKTALKIGLCQCLALIPGTSRSGSTIIGA
LWFGASRKAATEFSFFLGIPVIVGAGLLELIEKKDVLQTGEDWAILGVGTAVSFVVALLC
IRLLVVWVSKRDFMIFAYLRIITGVIVLLAYFVFGYQIQG
>Q2XQU6|FEATURES|UNIPROT_deepARG|beta_lactam|pse-1|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFTTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>ZP_03217990|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFFQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LILGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>YP_001871463|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIIMLAGALAIMKLPVAQYPTIAPPAITIAANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNIKDPISRTPGVGDVQLFGS
QYAMRIWMDPHKLNNYKLTPVDVINAIKIQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQILLKVNTDGSQVRLKDVAIVKLGAESYNIIARYNGKPAAGIGIKLATGANAL
NTSAAVKAELAKLQPFFPSGLTVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIALVLSAVFVPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIKKGDHGPKTGFFGWFNNMFEKSTHHYTDSVANILRSTGRY
LVIYLAIVIGMAVLFMRLPSSFLPEEDQGVFLTMVQLPAGATQERTQKVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERKGEQNKVPAIVSRASAAFSKIKDG
MVFAFNLPAIVELGTATGFDFQLIDQGNLGHQQLTDARNQLLGMAAQHPDMLVGVRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIDKWYVRNNMGQMVSFATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAAKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATLRGLENDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLESVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPLFFVVVRRRFSRKTDDIEHSHPVNTPVK
>W3AIQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFIEILKVIVFGLVEGFTEWLPVSSTGHMILVNDIIKLRQPAEYYEVFEVVIQLGAIMA
VVTTFFKQLWPFGRRRQNGGIVLIGSKVELWVKIIVACLPAAVFGLLLDDFLDTYLYNGF
VVALALIIYGVIFILVEKRNEHTDFSIRNLNELDMRTALFIGLFQCLALIPGTSRSGSTI
IGAMILGVSRTTAAEFSFFLSVPVMFGASFLKLLKHGTEFNGVQWFYMVFGMMIAYAVSI
YCINFLMKYIRKNSFVIFGYYRIVIGLIVLIWFAVSQTS
>ACM47285.1|FEATURES|ARDB_deepARG|glycopeptide|vanYD|antibiotic target alteration|0
MWKGVKRNVERQNNNENQYGRNRRKDKRRKLFFYRAACAMLGLLIVSVIFGAVYFLRESK
DPALPSKENTKTSKDYSFLADVQSEDESPVSEPAISNRANTIDLNIIAANAIVVNKDTDA
VLYQKNGTDRIAPASTAKMITALTVLEYCSPEEEMRVGAEIEMIHSDSSTAWLMKGDTLT
VRQLLIALMLPSGNDAAYTLAVNTGKTIAGDNSLSNQQAIKIFMDKVNEKARELGVTDSN
FVVPDGYDAEGQYTTAYDLAIIAKACLENPIISEIVASNTSYEKWPNGREVTYNNSNELL
DPNSPYYRPEVIGLKTGTSSLGGACVVSAAVIDGETYICVAMGSTKESRFQDSVDILDKI
KAQ
>A0A0F5BE86|FEATURES|UNIPROT_deepARG|aminoglycoside|TM63_04555|antibiotic inactivation|1
MDIRQMNRTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>N9KA26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVSVAL
IVGGLIIFWVESKNFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>Q0T4A9|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRYMENID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKAKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPEPAVMKRLIQ
LGLPIALALFLEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRMPSAIILQRASR
>A0A0K0TZZ9|FEATURES|UNIPROT_deepARG|aminoglycoside|XM25_16535|antibiotic inactivation|1
MRRLTQDDRAAWCAQRLLLWPGHSEAELDAEVGQMLASPDTPAFGAFEGKELIGFAEASV
RPYGDGCETAPVAWLEGIYIAPAYRRHGLGRALVEAVAEWARERKLFELGSDAAIYNTTS
HLSHAGWGFEETERIVLFRRKLM
>D4BZ60|FEATURES|UNIPROT_deepARG|aminoglycoside|PROVRETT_07612|antibiotic inactivation|1
MMVTPPQAEQALVILRKHFSDSLIAVYLHGSSVSSGLRPMSDIDLLVVIDSPVTDICREQ
LVRDLMDISGLYPIDPKGRRPLEIVVFLTSELNMLSYPAKCELIYGEWLRTEYEQGVFEG
QTQDPEFTLMLAQASQEAVSLWHKEIYGLPIVGLHDIRRAMLDSLPNLELSLKGDERNVL
LTLARMWYTMETGLFISKDEAAIWAIELMPMELASVLLVAKKAYLTGVSVDWENQQVEVT
LCANYLAERIRVYS
>G9RSF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDYLFAALLGVIEGITEWLPISSTGHLILADEFIHMSTSDAFKEMFDVVIQFGAILAVV
VIFWSKLWPFRINRDACGSGVSSLVDRYCRKDVWDMWFHVLVAIVPSAVIGLPLDDWMTE
HLHNPPVVSAMLILYGVFFVRMESTVGKRRPQVRRIGQINYRMALFIGLFQFLALVPGTS
RSGATILGAMLIGCSRTVAAEFTFFLAVPTMAGASLVKVVKFLADGGGFSGSEVGILLTG
CAVAFAVSMLCIRFLMNYVKKHDFKVFGWYRIGLGALVLAYFYLLKPAL
>A0A0U1MH32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGENNQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSVKVKNPQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>A0A0S4WP34|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
IGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRISDAFKVGLAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFG
IGFVAAFISAFFCVRWLLRFIASHDFRSFAWYRIVFGVIVLVTAYTHLIAWQA
>D1P0T9|FEATURES|UNIPROT_deepARG|beta_lactam|PROVRUST_05757|antibiotic inactivation|1
MDIDMKNIFHHGQTAIALSLAFASFSSAAFTQHDVDSIIKPLMKQQQIPGMSVAISVDGK
HFIYHYGIQSKQTKAPVTDNTLYEIGSLSKTFTATLAAYAQGQGKLDFSQAVSHYVPELK
NTVFDKVTVMNLATHTSGLSIFVPDAVTNSAELISYYQQWSPEKPIGQYRSYSNLGVGLL
GIITAKQLNTTFPDAMENTMLPALGLKHTYLQVPQDQQQNYAQGYNKQHQPVRVTPQILD
NEAYGLKSTAKDLIRFLDINMQVVDVKKPWQEAVEDTHTGVYMTDSFVQDLMWESYPWPV
SLAQLQQGNRDDMALKPQKVEAIQPPMPPESRALYNKTGSTSGFATYAVFIPEEKIGIVL
LSNQWYPIPERINATYQLIEKVKN
>A0A0A6S2E6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFVELLKAIFFGVIEGVTEWLPISSTGHLILVEEFVKLNQSAAFTEMFNVVIQLGAILA
VIVIYFKRLNPFQPGKTDNEIRLTWQLWAKVLIAILPVVVIGLLFDNWFNTHFHNFISVA
LMLIVYGVAFIWVEKRHKNVEPQVTSLAKMSYKTALFIGLFQVLSIVPGTSRSGATILGG
IILGTSRTVATEFTFFLGIPVMFGASLLKVLKFFLKGNVLGFGSLLILIVASLTAFLVSL
VAIKFLTDYVKKHDFTLFGKYRIGLGILLVIYFVFTLIF
>YP_002389784|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MPRFFARHAATLFFPMALILYDFAAYLSTDLIQPGIINVVRDFNADVSLAPAAVSLYLAG
GMALQWLLGPLSDRIGRRPVLITGALIFTLACAATMFTTSMTQFLIARAVQGTSICFIAT
VGYVTVQEAFGQTKGIKLMAIITSIVLIAPIIGPLSGAALMHFVHWKVLFAIIAVMGFIS
FVGLLLAMPETVKRGAVPFSAKSVLRDFRNVFCNRLFLFGAATISLSYIPMMSWVAVSPV
ILIDAGGLTTSQFAWTQVPVFGAVIVANAIVARFVKDPTEPRFIWRAVPIQLVGLALLII
GNLLSPHVWLWSVLGTSLYAFGIGLIFPTLFRFTLFSNNLPKGTVSASLNMVILMVMSVS
VEIGRWLWFNGGRLPFHLLAVVAGVIVVFTLAGLLNRVRQHQAAELAEER
>A0A126RBF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLHRNATSWRFLRNLVIAFIPSAVIGLALHDYIEVLLGAPHVVAWALI
AGGVAILLLERMIKAGRFHGIADIPVARVVGIGLIQCISMIPGVSRSGATIMGALALGVE
RRTAAEFSFFLAIPTMLGATTLELLKKGDQITSSAVGWDSILLGFAVSFIVALLVIRWFV
GLVSRHGFAPFAWYRIIAGVGALAWLWAR
>B9D2A2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIELKNLGKQFRLGDTVFDALKDIDLTIRKGEFIAIIGQSGSGKSTLMNILGCLDNPSCG
EYLLEGNNISNLSGDELARLRRNKFGFIFQRYNLLSTLNTLQNVSLPSVYAGVSKKEREE
RASEILKGLGLGDKLESLPNKLSGGQQQRVSIARALINGGEIILADEPTGALDSQSGMMV
MEILTNLHKEGHTIIIVTHDQNIASYAHRIIEIKDGKILKDSVKKDEIYDIDLKKPKQKN
WLSFYKDQFIESFKMSVNAIFSHKLRSLLTMLGIIIGITSVISVVALGNGSQRQILSSIR
GIGTNTIDIYPGKGFGDMRAGRIKTLSISDAVMLSRQDYLDSVTPNSTTIGTLTFANKSA
SATLRGGGSQSLEVLGHKIKSGRVFSEEEVKDSASVIVIDHNTKNEFFPDTDPLDKTILF
NKRPFKIIGVLAKNDLMDTSMLRTYTTYTAVINKITGDRHITSITAKVKDEVNAQIAERS
LTEILTLKHGARDFFTRNSDSIKKTVEETTQTMTLLISCVALISLVVGGIGVMNIMLVSV
TERTKEIGIRMAIGARQSNILQQFLIEAVLLCVMGGIIGVGLSFVIGSVFDKFVQGFEMV
FSNASIAVALLTSSFIGIAFGYMPARSASKLNPIDALSRE
>B8ZHY8|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKN
>A0A0I9QQQ3|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRVEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A126E3J8|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDRLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGREQLGRRIHYSQSDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>W4QJS6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLEISTEFYKNVFDAKLLLKGRSTAYFDLNGIWLALNEEKHIPRNE
INQSYTHIAFSIEEETYDEMYEKLNRLNVNILSSRPRNQRDKKSIYFTDPDGHKFEFHTG
GLQDRLDYYKQEKTHMEFFD
>CAE46078|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILHNEFLKLNSVRGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIEITEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>AAF72361|FEATURES|ARDB_deepARG|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLTVANGKLT
TMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKV
RNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQV
ALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ
>U3QQQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRARIGNVVRGLGSDPQAQRFAANVVIASVPAILLAFIFGKWIKAHLFNPISVAMAFI
VGGVIILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWRDSLKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRKVATEFSFFLAIPVIFGATVYELYKARSLLNGDDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLATAYSGLVTWHA
>A0A098EWR8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAVKGLNHFLFSVSDLERSIAFYQDALGARLLVKGRSTAYFDLARMWLALNEEKDILRNE
IRASYTHVAFSVDEADFDGMVERLKRLGVEILPGRERDKRSVYFMDPDGHRFEFHTGTLE
DRLDYYREDKGHMEFFE
>H1C4A5|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMLTSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A086YGP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHNTIVALILGVLEGLTEFIPVSSTGHLLLAGHFLNFHSAGRSFEVVIQLGAILALLSV
YAGRLWQVFRSAPHDAGARRTILSVLVAFLPAAVIGVLAHGFIKDVLFETPMLIAIMLIL
GGFVLLWVDRMKVPVRYDDAERLPVHTSLAIGFFQCLAMIPGVSRSGATIVGAMLLGTSK
RAAAEFSFFLSMPTMIGAVVYDLYKNRDVLDSSAWSEIAIGFVAAFVAALIVVRWLLGYV
SRHGYSLFGWWRIIIGSVALIALMIWR
>A0A0F6YIJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWQALLLGIVEGLTEYLPVSSTGHLLVTQRILGIPESDASNAYAIAIQAGAIVAVLAL
YRKRVGQMALGAIGRDPIGAKLAMCVIVAFLPAAIVGFALDDLIESVLFGPWPIVVAWVV
GGVVILWFARTKRSQEGRSLEELGWRAALAIGAVQCIAMWPGVSRSLATILGGVAVGLSL
SAAVEFSFLLGLVTLGAATAYKSLQHGATMLEAYGPLPVAIGFVAAWIAAVVSVRFMVGW
LNERGLGIFAWWRFGAAAIVVAMIAAGML
>A0A156L2L9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGIDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0M2KLF3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTAEQPINKVSVVIPVYNEQESLPELLRRTNDACALLPMDYEILLIDDGSSDNSATMLAA
AAEEEGSHVVAVLLNRNYGQHSAIMAGFSNVSGDLIITLDADLQNPPEEIPRLVATAQEG
YDVVGTVRQNRQDSWFRKKASRLINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAIEIPVMHAEREFGDSKYSLMRLINLMYDLVTCLTTTPLRMLSVVG
SLIALAGFAFSLLLICLRLFLGPHWAADGVFMLFAVLFIFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVINASHPVSTEDDK
>A0A0G3VQR9|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
AVLSRVDAGQEQLDRRIHYSQNDLFEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLL
LTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGEL
LTLASRQQLIDWMEADKVAGPLLRS
>A0A0T8Y508|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEITEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>A0A0W7YCB3|FEATURES|UNIPROT_deepARG|beta_lactam|AMR94_07320|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>J2JAF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLIVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGLILLKVDEW
FNKPNTAETSQEITYLQAFKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQVNLLVIGNVVAFIIALLAIKTFIGFLTKNGFTV
FGYYRIITGIILLVIHFFIHPLTII
>R7LDS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWIEAIIIAIVEGLTEFLPVSSTGHMIITESLLNVEHDAFVKAFTVIIQFGAILSVVCL
YWRKFFYPETMQTKGYTWWQAIWRFYLKLIVGVLPAVVLGLTFNDFIESNLGNVNLVAVM
LIVGGVFMLFCDKIFNKGSENTALTYKRAFIIGCVQCISMIPGVSRSMATIVGGMSQRLT
RKAAAEFSFFLAVPTMFGATCLETYKLISHGEGNILTQGNNLSMLLLGSVVSFIVAIAAI
KYFISYVTKYGFVAFGWYRIIVGAAILLMGAMGMDLAMVD
>C0B2Q3|FEATURES|UNIPROT_deepARG|beta_lactam|PROPEN_03714|antibiotic inactivation|1
MSLKKYNQGRLGVALINTEDNSQITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKN
IAIKKSDLVAYSPITEKHLVTGMSLAQLSAATLQYSDNTAMNKILDYLGGPSSVTQFARS
INDVTYRLDRKEPELNTAIHGDPRDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGN
TTGDHSIKAGLPKHWIVGDKTGSGDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRK
DIIAKATEIVTKEFANSSQ
>A0A0B1Y6A0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYKIDGQSQSINSRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>ZP_04273511|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNEIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>ACA48663|FEATURES|ARDB_deepARG|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLGRMDTTQVTLIHKILAAADERNLP
LWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGD
ELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPV
DWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>A0A038GXS3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFRALSLLATAIFSFGAMSGAAFAADSDTAKIRQTVDETIRPLMALNGIAGMAVGVVVD
GRPYVFDYGVASKATKQPVTRDTLFELGSVSKTFTATLASYAQIEGDLSLNDPVSKHLPS
LDGTAFGKVTLLNLGTHTPGGLPLQVPDEVHDNAQLMQYFRTWRPAQPPGTIRTYANPGI
GTLGLITAKSMNADFDTLMQTRLFPALGLTHSYIDVPASKQRDYAQGYAKDDAPIRMKGG
VLSSEAYGVRSTASDMTRFLQINMNMVHIDPTYQRAVDATHTGYFQAGPMTQDLIWEQYP
YPVALQSLLDGNAAAMIMNATPVTRIDPAQAPRDDVWINKTGSTNGFGTYIAFVPKERVG
IVMLANRNIPNEERVKAAYAIITSLVNGR
>F2X2Y0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHHVKGEITKVVGK
>P62467|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AVLLLYGRRLAADRALWLRIAVAFVPTGVIGFFFYPLIKGVILGNDAVVAFFLFFVGAVL
LFADRLAERAQYQDVKALPLARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLNRQAAA
EFSFLLALPTMFAAVGYDLWKSAPEVPEGGWSLLLLGFLAALATALVTVRWMLAFVARHG
FRPFALYRMALAAVYAFFFLR
>A0A127SYJ5|FEATURES|UNIPROT_deepARG|beta_lactam|CfxA6|antibiotic inactivation|1
MLNYSVAELMNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSIS
QIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVK
INREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFI
AKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNAL
KECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFV
KDFKGNESQASQFVAHISAVVYSLLINTALN
>H6UQL7|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
MRYIRLCIISLLAXLPLXVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITXSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAXXRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>F0R6G5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEGDLNVFQTIIIAIVEGLTEFLPVSSTGHMIITQHVLGVESTEFVKAFTFIIQFGAILS
VVCLYWKRFFRLNHTPAPEGASALKRFLHTYDFYWKLFVAFIPAAVLGLLFSDMIDAMLE
SVIVVAVMLIIGGVFMLFCDKLFGNGSEETKLTEKRAFYIGLFQCISMIPGVSRSMATIV
GGMAQKLTRKAAAEFSFFLAVPTMFAATVYKMFKLFMEGGTEIIVSNMEALIIGNAVAFV
VAMLAIKFFISFVTKYGFAAFGWYRIIVGGVILIMSCLGYNLELV
>A0A0E3V8C3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIHAIALAIIEGLTEFLPVSSTGHMIIYSSLAGIAGNEFTKLYTVDVQFGCILSVLVL
YHRRFMTDTRTGTFVVPSYLKSLPPRLQPMADFYSKILIAFLPAAVIGFLLNDFIDSLLE
SITTVAISLLVGGIVLVFIDRIINRQPKDGDVTVPDAIRIGFFQCIAMIPGVSRSAATII
GGMFQGLSRTQAAEFSFFLAVPTMAAASGYKLLKTYKLLQPADYQTLLIGNVIAFVVGLL
AIRAFVGFLNRYGFKVFGYYRIALGLLLLGLMAAGVKLDVL
>A0A0M0LFI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKALILGLVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGMYSANTFKIVVQLGS
ILAVVVVMWKRLLSLVGLYKIKGQPANRKFNLIHVIVGMLPAVILGFAFKDYIDDYLFGV
KPVIFSLVAGAILMIVADKFGPKRPTVTTLDKISYGQALKIGLVQCLSLWPGFSRSGATI
SGGVLLGLDHKTAADFTFIMAVPIMAGASLVSVMKNWQYMSMDHIGFYAIGFVSAFIFAL
LSIKFFLKLIDKIKLTPFAIYRIILAIVLAIIVF
>A0A0M0P6T4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMVAASAYTFLEMARAGQLGSENWADVGVAFLAAAVTGFVVVKWLMGYIKSH
TFTAFALYRIALGAALLLWLPSGS
>J7VZM6|FEATURES|UNIPROT_deepARG|fosfomycin|fosb|antibiotic inactivation|1
MEQSINHICFSVSNLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QYSYTHIAFTVSNNEFDSLKEILIQNHVNILPGRERDERDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>1708210A|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRCAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGV
ASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQSKLSFKDPASHYLPDVRGSAFDGVS
LLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSL
DQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIKS
NARDLIRYLDANLQQVKDASVARRWPRRTSVITSAGAFTQDLMWENYPYPVKLSRLIEGN
NAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVEMLANKWFPND
DRVEAAYHIIQALEKR
>A0A0F7A5C4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|pseF|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGDLIAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKATE
RMPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSQYYIDSATPNIGRN
MLLRYRNIDVSATVSGVSPSYFQVRGTKMGSGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQSYLDSITVR
VKDGQPSKVVEDNVNKLMQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>M5JLZ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHNHEVYSSVMRKYTTLLIGFLAGSAIIPAGGALAAGTINDEELRRIVDETVRPLMAGQK
IPGMGVAISIDGKSHFFGYGVASKESGQKVDEDTIFEIGSISKTFTATLGGYGLATGAFS
PSDPATRWAPELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFRKWKPDYPA
GTQRRYSNPSIGLFGYLAARSMGQPFDVLMEQKLLPALGLKNTFVHVPESRMKDYAYGYA
KADKPTRVASGTRDAEAYGIKTTAPDLLRFVELNIDSASLAPDFQKAVAATHTGYYRVGA
NNQGLGWEIYTYPVTLKTLLAGNSSDMALKSHKIEKFDPPHAPSADMFINKTGSTKGFGA
YAAFVPAKKTGIVLLANRNYPNDERIKAAYRILQAIDKSE
>A0A0D5VID0|FEATURES|UNIPROT_deepARG|beta_lactam|OI25_4698|antibiotic inactivation|1
MNLRAISVIATALFTCAIATVSRAADDQQSRISQTVSRALQPVMAKDNIAGMAVGIVDGD
KHYVFNYGLASTETKQPVTRDTLFELGSVSKTLTATLASYAQVRGDLSLSDQSDKYLPSL
RNSPFGKVSLLNLGTHTPGGLPLQVPDSIHNNDQLMQYFQQWQPTYAPGTYRTYANPGIG
ALGLITAKSMGQDFGRLMENQLFPALDMKRSYIKVPASALNDYAQGYTKQGAPIRMAPGV
LSEEAYGVRTTAADMIRFVQANMNLIPLDPKFQRAVTETHTGYFKAGPMTQDLIWEQYPY
PVKLQTLLDGNSPAMIFNATPVTAISPPQAPREDVWINKTGSTNGFGAYIAFIPQKRLGI
VILANKNFPIEERVSAAYRILTSLANDQQ
>J3HLE9|FEATURES|UNIPROT_deepARG|beta_lactam|PMI41_04644|antibiotic inactivation|1
MTLKTAAALTASLLVTCSFVTQGHAADDADKIKPVVDAAIRPVMDKNTIPGMAIGVIFEG
KSYIFEYGVASKETGKAITPSTIFEVGSVSKTFVATLASYAQVNGQLSFSDKVEKYLPAL
KGTAFGDVALLHLATHTPGGFPLQVPDEVKTDKQMMAYLKNWKPAYKVGTTRTYANPSIG
MLGVITAKAMKKDFSSLMEGQLFPALGLTSTYINVPKSKMADYAQGYSSKDKPSRVSKAV
LSAEAYGVKTTVTDMVRVMQANMNMVKLDAKLQQAITNTHTGYFKAGVMTQDLLWEQYSY
PVALDALRLGNSSKISLEPVPVDVINPPSAPRDDVLINKTGSTNGFGAYVAFVPEKQLGI
VILANKYYPNTERIEVAHEILTKLDAR
>A0A0L0AW21|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLVIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEDETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRKPDHEGTGKGRLSLIHILLGMFPAVVLGLLLHDMIKSLFNPI
NVMYALVVGGVLLIVAECLKPKKPRAEGVDDITYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSIDFLTVADIPMFAVGFVTAFVVALI
AIKTFLHIIKRISFIPFAIYRFIVAAVVYAVFM
>N8U1I1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTLEKREMFAVSVQIGAIAAV
IYQYWGKLWGALIGALTGDPEGRRLSFNLIVATIPIMLIGLTIGETVKAYLFNAVTVALA
LIVGGLVILWAERRQHIIACQEVDDISFKQAVFIGLIQCLALIPGTSRSGSTIIGSLFMG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHTQDMEVLGVGIVVAFISALVVIRALI
RYVSKHDFSAFAYYRIIFGLFILLTWGTGWVHW
>YP_002028533|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFSLLAVTLAAVLPVAHASAAEAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTENLT
ALLVQTAKGGVLLDGGMPQMASHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAKVAANAESAVLLARGGSDDLHFGDDITYPPASVDRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTREGKPVRIAYADSLSAPGYQLQSNPRYPHLIEDYRRSFATVRALPCD
VLLTPHPGASNWDYASGSKASAKALTCKAYADAAEQKFDAQLAKETARAR
>A0A072D3L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELIRGFFSGDVAARRFAINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGFIIFAVEARKFEPKTIEATDITLKQAILVGFAQCLAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLINISIGFVAAFIAALLVVKALVK
FVEKHTLRVFAWYRVVLGIILLFVFL
>A0A137XL96|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKSTIFLIGFLATAAIIPNSGALAASKVNDDDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVDADTIFEIGSVSKTFTATLSGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDSVTDDSSMLAYFKKWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFVNVPESRMKNYAYGYSKADKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFY
SYPTALKTLLAGNSSDMALKSHKIGKFDQPLQLSADVLVNKTGSTSGFGAYAAFIPAKKT
GIVLLANRNYPIDERVKAAYRILQALDRKQ
>A0A0J8VKD4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELKAIRRSYPSGEEQVEVLKGISLSIEAGEMVAIVGASGSGKSTLMNILGCLDNP
TSGSYRVAGVDVSTLSGDELARLRREHFGFIFQRYHLLSHLTATQNVEVPAIYAGLGRKL
RQQRARELLARLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLRDRGHTVIIVTHDPTVAAQAERVIEIRDGEIISNPSPRKPEARAKALNEA
SRSSGAWQQFVSSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LQDIRSIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTAIAKQPWVRSATPALSQNVRLRY
GNVDVAASANGVSGQYFNVYGMTFSEGNTFNEEQLKGRAQVVVLDQNARRQLFPNKASVT
GEIVLVGNMPATVIGVAEEKQSMFGSSKILRAWLPYDTMAGRMMGQSWLNSITVRVNEGY
DSAQAEQQLTRLLTLRHGKKDFFTMNMDGLLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLQQFLIEAVLVCLVGGALGITLSLLIAFLLQI
FLPGWEIGFSPLALATAFLCSTATGVIFGWLPARNAARLNPVDALARE
>A0A0F0DPS6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHRNAPLALAILPLLFTSLAQAAPPDFDAKVNKLAQQVMREQNIAGLAIGVTDRGEQRFY
NFGVASMESKQPVSSDTLFEIGSVSKTFTATLAGFAQATGKLKLQDSPTRYLKELRGSAL
DQVTLLQLATHVTGGFPLQLPDEVKTPQQLTDYYRTWQPQYPANTQRTYANPSIGLLGIA
TARALDVPFKTAMQRNVFAPLGLSNTHIDVPVTRQGVYAQGYDKDNAPVRVNPDQIADEA
YGVKSSSRDLLRFVQIQLGEVKLGDKLRTAVDATRTGYYQVGPMTQDLVWEQYAYPPKLA
ELQQYNGPSMVLESQPVKALRKPLPPQQDVWVNKTGATGGFGAYVAFVPSKQRGIVILAN
RNYPNELRVKLAWDILSRLN
>A0A0W0AUH0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVIIPVYNEEASLPVLLSRVTAACELLPQDYEVILIDDGSHDGSTEIISEA
AANSDSKLVGVLLNRNYGQHAAIMAGFETAKGDLVISLDADLQNPPEEIPRLVEAAMQGY
DVVGTVRRNRQDSWFRKTASRLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
LVAGLGFTFSILLVLMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQIVRTATPSQQETEQ
>A0A029HBW0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>A8W869|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSQPLLELKGITRSFMAGEREFIALKGIDLSIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQS
QRHSRAGELLARLGLSGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIISDKANDSVGLELPAEAP
VEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVEALNQLYYVDSATPVVGRNL
LLRYGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILIGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0Q9KF48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLINAIIMGIVEGLTEFLPVSSTGHLILTAELLNFTGDRAKTFEVVIQFGAVLAVLVL
YRKRFVKLLNFKIGNGSGLNALHILLAMAPAGIFAVLLHSLIKDYLFRPQTVLIGLIAGG
ILMIIADRVKKKPAAEELDDISYKQAFAIGCFQVLSLWPGFSRSGSTISGGMLFGTSQKA
AAEFTFIVSVPIMAGASGIDLLKSREFLTLSDLPLFLIGLLAAFIVGMIAVVTFINMMKK
IKLSWFAYYRFALAALFSFIIL
>R5AL17|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVTEILKAIFFGIVEGITEWLPISSTGHMILLNEFVKLQVSDEFYKLFEVVIQLGAILAV
ILLFFHKLNPFSPSKSAPQRRNTWRLWFKVVLAVIPSAVIGLPLDDWMDAHFYNYVVVAI
TLIVYGIAFLFVERENSHRRAYANSVYDIDLKTAMLIGCFQCLSLIPGTSRSGSTILGAI
ILGVGRAAGAEFSFFLAIPTMLGASVLKLVKFLLSGVSATGAEWAILAVGCVVSFVVSLL
VIKGLMEYVRKHSFAVFGVYRIILGVLVLGYFAFQTLHA
>A0A101KAA1|FEATURES|UNIPROT_deepARG|aminoglycoside|Cv017_21525|antibiotic inactivation|1
MTPALPDRRVVQADARRLADWLRLRAALWPDCPADDHRADISRQLTQTGRYAAFLALDAG
NAVALLEIALRNDYVNGARSGSPVAFIEGLYVAPRHRRAGLTTMMLAAAKAWALTRGCSE
MASDTSLDNLAAQAAHRALGFEESERVVFYRMAL
>A6U5Q5|FEATURES|UNIPROT_deepARG|aminoglycoside|Smed_0125|antibiotic inactivation|1
MAPESSSPDMESIEIGTIKDVEPWARLRAALWPHHSLEDHRAELGRAFLSGNEEAVAFIA
RNAAHEAIGFAEATLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGIARLLCNAVADWGRSL
GCVEFGSDALLENSASHALHTALGFEETQRVVFFRKPL
>YP_218139|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MMSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILA
VVVMFWRQLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNP
INVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATI
SGGMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSWSFLTAADIPMFAVGFVTAFVVAL
IAIKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>A0A0F0FCU9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTQAPLLLLQHVERSYRAGDQDIPVLRQISLAICAGEMVAIVGASGSGKSTLMHILGCLD
QASAGRYLVAGQDVARLDDDALARLRRERFGFIFQRYHLLARLSAADNVEVPAIYAATDR
AERRARAVRLLARLGLGDRAGHRPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSH
SGQEVLAILRELHALGHTVIIVTHDMGLARNAGRIIEIADGRIVADRANRPAPAPAAGQG
NAPPSPAPEPVANGGGDAPPRRARAWHGFTEAFAMAWGALMAHRMRTALTMLGIIIGIAS
VVSIVAIGEGAKRYVMNDIRAIGANTLEIFPGADFGDDRAAGIRTLVESDIDALHALPYV
DSATPITSKVQRLRHRNTDVNASVHGVGASFFRVRGLGMTQGAPFRPDEVRQHAQVVVID
EKTRRKLFGNVTPVLGKIVLVGSLPCVVIGVAREKKSMFDDNGSNLNIWLPYTTAGSRLF
GRAHFDEVSVRIRDGQPSAAAQHGIERVLTQRHGKKDFFTYNMDSIVKTVERTGHALTLF
LSAVAVISLLVGGIGVMNIMLVSVTERTREIGIRVAVGARQRDVLLQFLTEAVLVCMLGG
AIGTLLAYLIGLVLALLMPQWQMVFSASAVAGAFVCSSLIGVVFGYMPARNAARLQPIEA
LGHE
>R8UA78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDAIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAFL
YHKRLVSLCNIKPLLQKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKPEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTMSGGLLAKVNY
NAASEFSFLIALPVMVGATGLDLLKSWEHLSIDDIPMFAVGFITSFVVAMLAVVTFLKLL
SKIGLKPFAYYRILLAIVFTIFVLL
>J0V796|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LVDLVLGWRDPVNRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELLKTFRDGGAAGEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIA
>J8IJD9|FEATURES|UNIPROT_deepARG|beta_lactam|IIE_01790|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNPIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVLPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>A0A059I423|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MRDIKPINMLSVVIPVYNEQESLPELLQRTCAACDSIKIEYEILLVDDGSSDRSAELIEQ
AATVPGSRITGVLLNRNYGQHSAIMAGFSQVRGDLIITLDADLQNPPEEIPRLVDAARQG
YDVVGTVRQQRQDSWFRRKASRTLNRLIQRVTGKAMGDYGCMLRAYRRHIVEAMLNCHER
STFIPILANTFARHTIELPVIHAERAFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVVG
SLIALSGFAFSLVLIVLRLFFGAAWAGDGVFVLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQRIVHAPEEPSVQDIQS
>YP_002636111|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLTGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
IAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDSIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>B7LLT4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGELDAEAYGVK
STIEDMARWVQSNLNPRNINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>F8S0C3|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA15|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>YP_002045426|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSVAMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>BAC77251|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIIVMLAGVLAIMKLPIAQYPTIAPPAVSISANYPGADAKTVQDT
VTQIIEQNMNGIDNLMYMSSTSDSSGSVTITLTFESGTDPDIAQVQVQNKLSLATPLLPQ
EVQQQGLKVEKSSSSFLMVAGFVSDDPNMTQDDIADYVASNIKDPISRSSGVGEVQLFGA
QYAMRIWLDPNKLNNYQLTTTDVTSAITEQNNQIAAGKLGGLPGGRGQQLNASIIAQTRL
TSPEEFGKILLKVNTDRFQVRLRDVAHIERGRKAMPFTARYNGKPAAGLGIKLATGANAL
NTAKGVKDELAKMTPFFPQGMKVVYPYDTTPFVKISINEVVKTLIEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIPKGDHGVKTGFFGWFNRMFEKSTHHYTDSVGNILRSTGRY
LIIYLLIVVGMGLLFLRLPSLVLPDEDQGILLTMVQARAGATESRTNKVLEECSDYFLNK
EKDNVVSVFTVAGFGFNGNGQNNGLAFVSLKDWGERPGSENKVEAIRGARGAHFSQIKVR
PVFPFKLPAIIELGTATGFDFELIDQGGLGHEKLTEARNQLLGMVAQHPYVLVGVRPNGL
EDTPLFKLIVDQEKAKALGVSITTINSTLSTALGGSYVNDFIDRGRVKKVYVQADAPFRM
LPEDINKWYVRGTSGQMVPFSAFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
NLMEQLASKLPSGIGYDWTGMSYQERLSGNQAPALYAISILVVSLCLAALYESWVVPFSV
MLVLPLGVIGALASTMRGMNNDVYSQVGLLTTIGLFAKNAILIVEFAKDLMEKEGKGLTE
ATLEAVRMRLRPILMTSLAFILGILPLVISSGAGSGAQNAVGTGVMGGMTTATVLAIFFV
PVFFVVVRRRFSKKNEDLEHSHPVEQPLIAQ
>YP_001588793|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQAHARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLAGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>C6J7K1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLIVSIILAIVEGLTEFIPVSSTGHMILTAKLMGYDDQSPEMKTFEIVIQLGAILAMAW
VYRERILNLLGLSKKITVVDLNAPKGRLNLIHILLGIVPALAVGFFFRDFIKGLFSSQTV
LWALVVGGLFMIFAEWFNKNKAEVTAQEMDQLTYKQALLIGLYQCISVLWPGFSRSGSTI
AGGMLSGASYKAAADFSFLIAIPIMCAVSAYEMLDSYRYLTSETIGYFLIGFVVAFVVAY
VVVLAFLKLIQKVQLRHFAYYRFVLAALFWIFIMR
>R9V238|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLCRPAALAAVITLILGHTAAQADDQLQAKVDQIIRPLMQAQGISGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLEAPAKHYHPALAGAP
IGDATVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLAKMGLKNTYLQVPASAQGLYAQGYDDADKPVRVGPGPYADE
AYGIKTSASDLLQYVRLHMQPQGLPPALAKATAITQQGYFQVGTMTQGLGWERYPYPVTL
GTLVDGNSARLIREPQPTKRLQPALPQLPAAWYNKTGATSGFGAYAAFVPSEQLAIVLLA
NRNYPNEARVRAAFEILSGL
>A0A100VPY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIISSIIMGIIEGLTEFLPVSSTGHMILTAHLLGLSEDNESVKTFEVVVQLGAVLAVVV
LYWNKFIDMFRFTGGTRSYSRRLNLGHIFLAMVPAVVIGLVFRDWIKAHLFGPETVLYSL
VIGGILMIVAERWSQKSHRITTHDVDDISYKQAFVVGLFQILALWPGFSRSGSTISGGLF
AGVSRVAAAEFTFLVSVPIMIGATGYDLYKSIDHLNGSDFPIFAIGFIAAFIVAMLAIKT
FLSILKKLSLTVFAVYRFVLAAVFFIILM
>I1V589|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYGDNT
AMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAKSLQNL
TLGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVV
>A0A0N1DIA9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIEALLSSGYDIAAVFTHADDPKENAFYGSVAQLCASKGIAVHA
PEDANHPLWIERISKLNPDYLFSFYYRNLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVAIERNDTALTLHGKLRVAATDLLRDTLP
ALLVGKVSETPQDEAKATVFGRRTPADGKLVWSKPAQELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNEGQAPGRVISVDPLRIACGEDSLLISAGQRNDNGLYLSGPQLASELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDSSNLVVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKP
>A0A0S3N8M6|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDNDTSINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGMLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLILCFFVTLFCIKEKFKPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGSVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTASVVLFNAIYSWNSLRRRRLPQVSN
>A0A076P2L9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYIQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLFSKKIDALLESPVTVAVSLLVGGIILLKVDDW
FNNSSETEITYLKAFKIGLFQCIAMIPGVSRSGASIVGGMSQKLARTSAAEFSFFLAVPT
MLGATLKKCYDYYKDGFILTHDQINILIIGNIVAFLVALLAIKTFIGFLSKNGFKVFGYY
RIVAGIVLLLIHFFIHPLTLI
>R9BUQ4|FEATURES|UNIPROT_deepARG|chloramphenicol|A499_24844|antibiotic inactivation|1
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITHEIDISVLYRNIKLKEYKFYPTFIFLVTSV
LNSNPAFRTGYNSEGELGYWDKLDPLYTIFDSESESFSGIWTTAKDDFKEFYDLYLSDIK
KYNGTGKLFPKTPIPENTVSISMIPWTSFTGFNLNINNNSNYLLPIITAGKFIEKENSIY
LPLSLQVHHSVCDGYHAGMFMNSIQELADSSNDWLL
>NP_348075|FEATURES|ARDB_deepARG|tetracycline|tetPA|antibiotic efflux|1
MVNKPSAYKIYLLFSAITAMGFSLVSTVMIVYHIENVHLNPLQLILVGTTLEAACFLFEI
PTGIVADVYSRKLSIVIGTVLTGLGFILEGSISSFIFVLAAQIVWGLGSTFISGSVEAWI
AEEENTKELNQIYIKGAQVGQIGSVIGIVLSTIIANFSVRLPMIVGGVLFVIFSIFLAIY
MTENNFKPSAPEGLNTFKKMGYTFKSGLDIIKRKAMVMILLSVTLFYGLSSEGYDRLSNA
HFLQDTILPRLWNLKPVTWFGIFGVLGMILSVIAMRLMENKLRNDYKNKNGKLLLYINVF
YILFMLVFAITRNFGLMLIAYLATNTLRTINEPIFSAWLNGHIDDKARATILSINGQINA
LGQILGGPIIGIIATNISISIGIACTSLLLTPVLVLYVISMIMDKKIANKVGGGGNYEEN
N
>A0A0B5FVR5|FEATURES|UNIPROT_deepARG|beta_lactam|cphA4|antibiotic inactivation|1
MKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVG
ATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTWDLMK
SDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFFAGPAHTPDGIFVYFPD
EQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYE
ALIKAAPQS
>N1ZKQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNWGEIFKAFLFGIVEGITEWLPISSTGHMILLQEFVTLKMSAEFMEMFFVVIQLGAILA
VVLLYWNKLFPFSFKKGVQIKIPILQMWFKIIFACIPAAVVGILFDDQLNDWFYNYQTVS
IMLILFGILFLVIENMNHGKRPEIVKLSQITYKTAFLIGLFQLIAAVFPGTSRSGATIIG
GLLIGMSRTVAAEFTFFLAVPVMFGASLLKLMKFGIKFENDEVAVLLVGMIVAFVVSIIA
IKFLMNYIKKNNFKSFGWYRIVLGILVLLYFGIQTLLGFIAA
>J8DP84|FEATURES|UNIPROT_deepARG|beta_lactam|IGC_03027|antibiotic inactivation|1
MKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEQTGPVKHKNHATYKEFSQLEKKF
DARLGVYAIDTGTNRTISYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLV
EYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMAD
RFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEV
IVKALR
>E4LU63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLFDMIKAVLLGIIQGITEWLPVSSTGHMILFNSFFPMSSSLAKPDTPEFAFWGLFLVV
IQLGSILAVCVLYFHKLNPFSSRKSISEKRSTWDLWFHVLVASIPGIIGIFLNDYVEKYM
NNAIVVAIALIVFGIGFIVLESTKHHPKYRRVGEITYQTAFLIGLFQLIAALVPGTSRSG
ATILGASILGCSRFAASEFSFFMAIPAMAGASGLKFLKYFMHYGFSMSGGNIALLVVASI
IAFVVSMFAIRFLMNYIRNHDFKIFGYYRIVVGVAVLICYFLGVLNLSAI
>A0A106BHR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDPTLLLYALILGLVEGVTEFLPISSTGHLILAGQLLGFNGEKEKVFMIAIQLAAIFAV
VWEYRVRLGHVAATLYTEPASRRLATNLMAGFLPAAVLGFLFYKQIKFYLFNPIVVASAL
VIGGVLILWAERRQHTVTAETIDDIGWATALKVGFAQALAMIPGTSRSGATIIGGLFLGL
SRKAAAEFSFFLAIPTMFAATAYDLYKNWQLFNVNDVPLFLVGGAAAFVSALIAVRTLIK
FVSRHDYTLFAWYRIVFGGVVLATAYFGLVDWGLAH
>A0A0Q8LT79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWAKIRSTLVALPTERQAQRFALNVFIAFVPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAERRPPSATRIHSVDAMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPLFATGLVFSFLSAWLCVRWLLR
YISTHSFVPFAYYRIVFGIIVLATAWTGWVQWAD
>Q55926|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-3|antibiotic inactivation|1
MNHRFLLLVSLVVGSAEMLLTSPVSAELSNRLHTPQIAQRPKISNSTTLDNRSLGSVERQ
ERSDWASFFDGAEAQGTIVVLDQRGGAHQLWVYNQERADRAYSPASTFKIPHSLFALDAG
VVRDEFQVFEWDGVERNFAPHNQDQTLRSAMRNSAVWVYEIFAAEIGEAKAREYLTQIDY
GNVDSSTSKGAYWIDGALTISAQEQIHFLQKLYQNELPFRIEHQRLVKDIIIVEAGRNWI
LRAKTGWEGRWGWWVGWVEWPTGPVFFALNIDTPNRLDDLYKREAITRDILQSIDALPAE
EDRK
>H6UQJ9|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-2|antibiotic inactivation|1
TQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQIL
YRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTL
AELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRD
TTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGSGD
YGTTNDIAIIWPENHAPLVLVTYLPNRSRS
>V9GHW6|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKLTSKYEMIQHILTEMKQPAYRFQQIADAIFKQRIGEYERMTILPKRIRQELIKNLGEH
VLNLTPVIQKTSNQVSKVLFAIEGGERIEAVQLSYERGWKSYCISSQCGCGYGCSFCATG
TIGLKRNLTADEITDQLLYFHLNGQTLDSVSFMGMGEALANPNIFDTLKILTDPRIFGLG
HRRITVSTIGILPGIDRLAKEFPQVNLTFSLHSPFDDQRSELMPINNRFPLNDVLNKLDQ
HIRDTGRKVYIAYILLRGENDSNEHAEAIAALLKHRGPWEHLYHVNLIPYNSTDVTPESF
HRSDKDRVQKFVSILKSKGIKITVRTQFGTEIDAACGQLYGHNKQI
>K2SKA5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|syfD|antibiotic efflux|1
MNQKVDIEALHETSINGDQPLLHLQQVSRSFMAGDREFQVLKDIDLAIHTGELVAIIGAS
GSGKSTLMNILDCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQVQRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTTQATQPVPEAQTAKQPGLAPRRLIASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPTDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVIVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0U1YUJ8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLTALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>J8SML2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A0W0VDI8|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1_2|antibiotic inactivation|1
MLNTVNLQIQNQIQESLDLLKIVLGADLLGIYLYGSSIVGGLQKYSDIDLLVVISHSMTL
DERKQIIAHLLKTSGIYMKSIQLPIEMTFVRKAAINPWHYPPQFDFQYGEWLRASFEHGK
VDLWPTQEMPDLALIITQVLLKNHILFGLEPKQLLPKVPYGDFVRAMLHDLGRLTEDLEH
DTRNVLLTYARIWSTLKTNAIRSKPAAADWAIPNLPEAQQVVMRRAKAICVGLESEHWED
IASLIKPCADFMRAQIHQASLLIDLNDSNNHIKLAE
>CAY49157|FEATURES|ARDB_deepARG|multidrug|mexf|antibiotic efflux|1
MNFSKFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDQRYDMLYLSNYALLNVKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVTAIREQNRQVAAGALGAQPAPTATAFQLSVNTQ
GRLVTEEEFENIVIRSGANGEITRLKDIARIELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIEISNEVRGKMDELKKSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALILVVLVVIL
FLQTWRASIIPLVAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLEPFAATEKAMSEVTGPIVATALVLCAVFIPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLRSHDAPKDRFSKVLDKLFGGWLFKPFNRFFDKASHGYVGTV
RRVIRGSGIALFLYAGLMVLTWFGFAHTPTGFVPAQDKQYLVAFAQLPDAASLDRTEDVI
KRMSDIALKQPGVEAAVAFPGLSINGFTNSPNSGIVFVTLKPFDERKDPSMSAGAIAGAL
NGKYSDIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYDELYKEVQNIITKSRTTPE
LFGLFTSYTVNVPQVDAAIDREKAKTHGVAISDIFDTLQIYLGSLYANDFNRFGRTYQVN
VQAEQQFRLDEDQIGQLKVRNNKGEMIPLATFIKVSDTSGPDRVMHYNGFITAEINGNAA
PGYSSGQAQAAIEKLLKEELPNGMTYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIISGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQAEGLDPLAAVLEACRLRLRPILMTSFAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGMI
GVTFFGLLLTPVFYVLIRRYVERSEARKAAKALKLETQQ
>ZP_03282274|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MIEARQLLALAIPVIVAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILFGHGL
LLALTPVIAQLNGSGRRDRVAHQVRQGFWLAGFVSVLIMVVLWNAGHIIRAMQNIDPALA
DKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIYGHFG
MPELGGVGCGVATAAVYWVMFFSMLTFIKRARSMRDIRNDQAFSTPDWHVVTRLIQLGLP
IALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVGFRLG
QGSTLDAQTAARTGLGVGVCMAACTALFTVALREQIALLYNDNPEVVKLASHLMLLAAIY
QLSDSIQVIGSGVLRGYKDTRSIFFITFIAYWVLGLPCGYVLALTDLVVDRMGPAGFWMG
FIIGLTSAAIMMMLRMRFLQRQPSTVILQRAAR
>YP_002245675|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMA
RWMPETRPAAAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQN
GQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>ZP_02901439|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIILMLAGGLAIMNLPIAQYPQIAPPTITISATYPGADAQTVENS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
EVQQQGISVNKSSSSILMVAAFISENGSLNQYDIADYVASNIQDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLIPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANAL
ETARAVKDELNHLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NIRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEDKLPPREATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SIFVAMSLTPALCATILKATPEGGHKPNALFARFNHLFEQSTQHYTDSTRSLLRCTGRYM
VVYLLIGAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGSTMVNTTKVLQQVTDYYLTKE
KKNVESVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSRINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPAMEILGEAAAGKSTGDAMK
FMAELVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVIGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A157SV46|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIRRYLRHALTAALSCSALTALPASARMLCTLVADASDGRILVQQGTQGDCTSRYTPASS
FKLPIALMGFDAGILQDAHTPTWSYESTYPDWGGEEWRKPADPERWIKYSIVWYSQQVAR
RLGQKRFQQYTTAFQYGNEDVSGDAGKHNGLDGAWIVSSLRVSPMEQIGFLRKLVNRRLP
VRPEVYGMVEPLFEIDPSREGWHVYGKTGTGSPGDNGRYDREHAYGWFVGWARKDGRQVV
FARLIQDEKATAPAAGLRARDQMLSQWAGMMAASARP
>A0A0B1K4Z7|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRHTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPASPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0B5S764|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKRMLKIGLCVGILGLSLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKF
DARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLV
EYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMAD
RFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRA
GVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAAEV
IVKALK
>Q7M175|FEATURES|UNIPROT_deepARG|beta_lactam|BL2b_ula|antibiotic inactivation|1
RTQGEPTQVQQKLAALEKQSGGRLGVALINTADLSQTLYRGDEXFAMCSTXKAMATIXTD
LMPDRGYD
>A0A0P9IRV7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
PEDPNHPLWVERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHQMVKRADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLP
LLAQDRLSGTPQDEFRATCFGKRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCTVGDN
KLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLVIRAGQRGDAGLYLSGAQLAREFG
LVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGKGYQDVSHRKPSIANARQLIGWTPGIELSTTIGKTLDFFLREAMIEKA
DQR
>J8K162|FEATURES|UNIPROT_deepARG|beta_lactam|IKG_02331|antibiotic inactivation|1
MKGMMILKNKRMLKIGICFGILGLSLTSLEAFAGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>A0A017HPX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLPEAVTAAALGLLEGATEFIPVSSTGHLLLASHFLGFQSAGQAFEVVIQLGAILAIVV
LYAGKLAWAFGRAPRDPEARRFILTVLVAFLPAAVLGLLLHDFIKTVLFETPRLIAVMLV
LGGIVLLLIDRMALRPRYDQADHLPLRTAFGIGLFQCLALVPGVSRSGATIVGALLLGTT
RRAAAEFSFFLSLPTMGAAVALDLYESRDQLNADDIGLIAIGFAVAFLSGLLVVRWLLAY
LTRHGFAFFGWWRIVVGVVAFALLSLGF
>A0A060KZ42|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNAAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A109W3Z8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPIIEVSAVSKFFGSGENRVQVLHELSFSIEDGEFVAIVGPSGSGKSTLMNILGCLDKAG
SGICRINGQDTADLDPDALSVLRCAHLGFVFQRYNLLSRLSALENVALPAVYAGEGKAER
LQRARALLADLDLNDKLRNLPAELSGGQQQRVSIARALMNGGRIILADEPTGALDSASGD
NVMKILKELHARGHTVIVVTHDLKVAAHAARVIRISDGRIVSDERTRPHAPAALHGATVR
PVLRMTGRLDQLREAVKMSLQAIWAHKLRSCLTMLGIIIGIASVVSVVALGRGSQEKIIA
DISAMGTNTIDIFPGRGFGDQRAAQITTLTVADADILAQQPYIASSTPNASSSGTLLYRN
ISVTAQLNGVGAGYFDVKGLEPASGGFFDENAVRRNESVVVIDENTRRRLFPLGQAEGRI
LLFNSRPLRVVGVVKKKDMGFGPSDTLNIWAPYTTVMYRITGSHSIASITVKVADGVMPL
MAERNITRLLTARHGSKDFSTFNTDSIRQTIESATGTMTLLITGIALIALVVGGIGVMNI
MLVSVTERTREIGLRMAVGARRVNIMEQFLLEAVLICLVGSVAGIALAGLISVAASMLSL
GFSLRFSMDSILLAVACSSFIGTCFGFVPARNASRLNPIEALSRE
>G3ESW2|FEATURES|UNIPROT_deepARG|chloramphenicol|catA1|antibiotic inactivation|1
VKLVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSQDVACYGENLAYFPKGFI
ENMFFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGF
HVGRMLNELQQYCDEWQ
>L2EM69|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRQRIGTVISGLASDVKSQRFAINVIVATVPAIVLALVFGKWIKAHLFNPITVATAFI
IGGVVILLAEWREARRGTVSAPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLSADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIIVLLTAWTGVISWHA
>A0A0H3J7R3|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYEKIKQIVSNLNLPNYRYIQLTKAIFHQRIDNFDDMHILPKALRIALVNKFGN
NVSSVIPVFSQSSKQAQKLLFELTDGERIEAVRLQYKQGWESFCISFQCGCGFGCRFCAT
GNAGFKRNLTADEITDQLLYFYFNEHGLNSISFMGMGEAFANPELFGAVKILTDENLFGL
SQRRITISTIGVIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLHEVMKTLD
EHIIHTGRRVFLAYIMLERINDSKEHAKAVIGLLKNRGSWEHLYHLGLIPYNSTNKTTFK
FQSSSDIKQFCSTLEAGISVTVRTQFGSEISAACGQLYCENEL
>Q0PAR0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRFYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>R8XMA6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDDILQLATAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSRLEWHKPACVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSLTTAAQPGSVISVAPLLIACGYGTLEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQSTCAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLAEKSS
>A0A0B3Y0E0|FEATURES|UNIPROT_deepARG|beta_lactam|RD02_10175|antibiotic inactivation|1
MNMQHFRIALIPFFAAFCLPAFAHPDTLDTVKDAENKLKARVGYTELDLTNGMILEGYRP
EERFPMMSTFKVLLCSAVLSRVDSGKEQLDRRIHFDQSDLVTYSPVTEKHLTDGMTVGEL
CDAAITMSDNTAANLLLSTIGGPQELTIFLRKTGDHVTRLDRWETALNEALPGDERDTTT
PKAMAETLHKLLTGKILTVASQQQLMDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVIIYLTGSQATIEERNKQIAEIGTSLIKHW
>A0A0B2AZM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFVLGAVAAFVSAFVCVRW
LLRYVASHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>H9C532|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
RRITYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFL
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
>A0A0D1L373|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVFDAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEVSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFL
>R5SM85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEYFCALIIGIVEGLTEYIPVSSTGHMIIVGNMINFTGELANVFDVFIQLGAILSVVVV
YRQKFLYILDTHHWFRKKGPSLMNLGIAMLPACVLGYLCHGMIKQYLFGPKTVIIGLVIG
GLFMIFAEKKRKYFLVENIDQITSQQAFKIGLFQCLSLWPGFSRSGSTIAGSLLVGVSRK
AAADFSFIMAVPLMCIACLYDLIKVAKYLSMGDFGILSVGFITSFVVAYVSILWFLKFLA
TSTLTGFAFYRFIVAFVALIYFW
>BAG79901|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDAIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPVVEKK
>A0A0U1LFF8|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MTKITPEYTVVDLSRWARKEHFEVFQGFAQSTFNQTVQLDITVLLKHIKEVGWKFYPAII
SLISHVVNRHPEFRMAMKDNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNIY
AEDVSRYGDNLAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMFTFGKYYNQ
DEKVLLPFAVQVHHSVCDGFHVARMINELQELCDNLPHHSEAPNV
>A0A127SKG2|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHK
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMMPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>S1LGA7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDIHPVKKVSVVIPVYNEQESLPELIRRTTAACELLGKEYEILLVDDGSNDNSAQMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPHLVEKADEG
YDVVGTVRQNRQDTWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGSQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0Q6UP08|FEATURES|UNIPROT_deepARG|beta_lactam|ASC64_11900|antibiotic target replacement|1
MRSLRLGIAVVLVGVGSACSVLGGDEADPASDTVDDLAAALSDLSLGEVPLTDEADRQAF
ADLVEPLDEVPVAVEVAAVEEPQDPDAADAAASATLAWRWDVTETTPWEYDTTVALVRAE
AGWQVDWSPESLAPDLTDGETLGLRTLNPQRGDITGADGQVLVTDRPVLRYGLDKTKVEG
PQVARSARRIARILDVDAASYVERVEAMGPDAFVEAVVLREDDALEVLPAFSEVRGALAV
RDSVPLAPTREFAAALLGRVGPATAELVEESEGRIAAGDEVGLSGLQARYDEQLTGTRGT
AVVARDAEDRLRTLFEVPATDGTDLVTTLDPDLQSKAENALATLGGDAPAAALVAIRPSD
GAILANANGVGAAGADLASTGQYAPGSTFKVVSALALLRSGLAPDAGVSCPPTTVVDGRS
FKNYDDYPSSSLGDITLAQAVAQSCNTAFIGNAGRLEPGDLTAAAQALGLGTDHDLGFPV
YFGQVPPPETETGAAADLIGQGTVLASPFAMATVAASVAAGRAVLPVLLPAHEVQQTPPD
RPLTPTEAGTLRGFMRAVVTTGSGRFLADLPGEVGAKTGTAEYGEPDAAGELPTHAWMIA
TRGDLAVAVFVGTGVSGSQTAGPVLEAFLR
>L2VIP2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRARGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>Q5GJ48|FEATURES|UNIPROT_deepARG|beta_lactam|blaORN-4A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLNVGELCA
AAITLSDNTAANLLLTTLGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>W7P8I7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MMKKSLSCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPKWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAITARVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLQDTSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVDAAYRILDALQ
>F3JTT8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPAIQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYNRNPLRVFELDFEENLKIV
RYCVKYTKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>J2VC92|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRCVSIVIPIYNEQDSLPELLRRTEAACQQLHQDYEIVLVDDGSRDNSAQILEDA
ANRECSPVVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRSNRQDSALRRWPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVTHAEREHGESKYSPMRLISLMFDLITCMTTTPLRLLSIVGF
GMAGIGLLFAVMLIVLRLVFGAEWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSTPSVSAPVVIVDGLTSTSSDQVLS
>A0A068NDJ0|FEATURES|UNIPROT_deepARG|chloramphenicol|BcrFT9_01917|antibiotic inactivation|1
MKFHVMDREDWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLISRV
VNNHKKFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMR
CYANVHGLFTKENIPPNVFPISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFPRGFTGIN
>J8NIX2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHISRNEI
HQSYTHIAFSVEQEDFKCLIQRLEENDVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A0E2UP82|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLVCTGLLLVSSAAFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQRRLFPALGLNSTYVSVPDEKQALYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPTRL
DMLLAGNASAMLNTQKAEAIEPPLEAQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>A0A109FQ88|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNAPLQKLLICALLLGAGSCMAATDMRQVVDSSVQPLMQQQGIAGVSVAVVNKGQVQYFN
YGMASRETQKPVTEDTLFEVGSVSKTFTATLGGYAQATGKLKLSDKASEHLSALTGSAFD
GISLLQLATYTAGGLPLQFPDAADSAATMLNYFQHWKPTYAPGTQRLYSNPSIGLFGYLT
AQSLGQPFNAAMEKTLLPKLGLKNTYVSVPAARAGDYAQGYDSAQKPVRVGPGALDSEAY
GIKTSSQDLARYVIANLHPQTLGKPLQQAIATTQTGYYTVNGMTQGLGWESYPYPITLQA
LIDGNSTPMAMEPHKVQWLSTPRVQPANVLFNKTGSTRGFGAYVAYVPSKDIGVVILANK
NYPNAERVKVAHAILSAMDQ
>ACA23192|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMLLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYKSRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFSKIT
>U1BQ45|FEATURES|UNIPROT_deepARG|beta_lactam|O166_21360|antibiotic inactivation|1
MAWGKIIGAACVLPFWAVSAAHAFDADGLKKAVQAEEKTLRARIGVAALDGGGGEAWSYR
GDERFPINSTFKAFACAALLAKVDRKEAALEQTASIDQSMLAGWSPITEKRLAPQRMTLD
EVCQAAVSYSDNTAANVVLEAIGSPAGFTAFMRRIGDEQTRLDRTEPDLNEGTPGDPRDT
TTPNAVVASLRKVMLGDALSAASREKLGRWMREDRVADELLRSSLPAGWEIADKTGAGGY
GSRNIIAVIWPPGRAPWLLGVYVTQTEASMPMRNQAIARIGAALTQAIGR
>A0A077D1U6|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-109|antibiotic inactivation|1
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVHYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIA
>G7ZTT3|FEATURES|UNIPROT_deepARG|aminoglycoside|aphA|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEANGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>YP_001175338|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNTRVHQGHLARKRFGQNFLNDQFVIESIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
EMTVIELDRDLAARLKTHPFLGPKLTIYQQDAMTMNFAELSEKLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQIIPVLEVPPTA
FTPAPKVESAVVRLVPHAVMPHPVKELRVLSRITTEAFNQRRKTIRNSLGNTFTVDVLTE
LGIDPAMRAENISVEQYCKLANYISDNAPPKES
>A0A0B2Y5J3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSADGEVCTYPVGEGSRPSIIAAG
PDGALWFTRSGDDRIGRITTAGGLTSFELPDGSAPFGITPGPDEAMWFTTMSAGEIGRIG
TDGEITTAATVGGMPSMITEGPDGAMWFTLNESGAVGRLTIDGALTIRELPTAAAGPVGI
AATHDDAVWFTEIRADKIGRIPVNDAIQELDLPGKPHAVVADPTDGVWVSLWGADQIARI
SGDGEVVTIDLPSGSEPHGLAIGPDGACWVALECGFVLKMPT
>A0A0J1PU01|FEATURES|UNIPROT_deepARG|beta_lactam|SK35_01966|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A077MSF5|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MQSLKFFRSIEIVTFEKIKKVSVIIPVYNEEESLPQLLERTIAACQQLEQKYELILVDDG
SRDSSADILTQAAETPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEE
IPRLVKTAEEGYDVVGTRRANRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRH
IVHAMLQCHERSTFIPILANTFARRTTEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLT
TAPLRLLSVVGSIIAVTGFLLAVLLIALRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMG
LLGEYVGRIYNDVRARPRYFIQKVVGVRKINDNQEKS
>AAF61485|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHP
DARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPAL
YPDIAEADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLI
LDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASL
AAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>A0A0P9P4K2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGRRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>E2DP59|FEATURES|UNIPROT_deepARG|aminoglycoside|kanR|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVLSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFYVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>A0A0E1HTH4|FEATURES|UNIPROT_deepARG|aminoglycoside|DM57_06980|antibiotic inactivation|1
MRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPGILAPVGFAE
VAVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCAAFASDAPLE
NAASHALHRALGFDETERVVFFRKPLAR
>YP_001438116|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYFVEARQLLALAIPVIFAQIAQTSMGVVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRDRIAHQVQQGFVLAGLVSVLIMLVLWNAGYIIHAMHNID
PVLANKAVNYLRALLWGAPGYLFFQVMRNQCEGLAKTTPGMAMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATASVYWVMFFCMRFWVKRAGSMRDIRPEPASRRFDWPVIRRLAQ
IGMPVALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSMSAAVTIRVG
FRLGQGSTLEAQTSARTGIIVGICLAVLTALFTVVFREPIALLYNDNPEVVTLASHLMLL
AAIYQISDSIQVIGSGVLRGYKDTRSIFFITFIAYWVLGLPSGYILGLTDWVVEPMGPAG
FWFGFILGLTSAAIMMMWRMRYLQRQPSETILARAAR
>NP_733568|FEATURES|ARDB_deepARG|tetracenomycin|tcmA|antibiotic efflux|1
MTSQTTINKPGPGDGSPAGSAPAKGWRGHPWVTLVTVAVGVMMVALDGTIVAIANPAIQD
DLDASLADVQWITNAYFLALAVALITAGKLGDRFGHRQTFLIGVAGFAASSGAIGLSGSI
AAVIVFRVFQGLFGALLMPAALGLLRATFPAEKLNMAIGIWGMVIGASTAGGPILGGVLV
EHVNWQSVFFINVPVGIVAVVLGVMILLDHRAANAPRSFDVVGIVLLSASMFALVWALIK
APEWGWGSGQTWVYIGGSVVGFVLFSVWETKVKEPLIPLAMFRSVPLSAGVVLMVLMAIA
FMGGLFFVTFYLQNVHGMSPVDAGLHLLPLTGMMIVASPLAGAMITKVGPRIPLAGGMVC
TAVAMFGISTLETDTGSGLMSIWFGLLGLGLAPVMVGATEVIVGNAPMELSGVAGGLQQA
AMQIGGSLGTAVLGAVMASKVDSDLAGNWKDAGLPELTPQQADQASEAVRVGVPPVAPGT
PAEVAGKITDVAHDTFISGMSLASLVAAGVAVVAVFVAFLTKRGENAEAGAGVGHI
>U2SNA1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFRPRLAVLAAAITLAFGHTSAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLQAPAKRYHPALAGAP
IGDATVLELGAYSADCLPLQFPESVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMNEGLLTKMGLKNTYLQVPASAQGLYAQGYDAADKPVRMGPGPYADE
AYGIKTSASDLLRYVRLHMQPQGLPPALVKATAITQQGYFQVGAMTQGLGWERYPYPVTL
RTLIDGNSSLLIREPQATTRLQPALPALPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNQARVQAAFDILSGL
>A0A102CSP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDNLWLKSKEIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFV
VALFVVRFFLKLINKIKLVPFAIYRIILGVILFILFM
>K7Q9V9|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRA
FYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>A0A0K9GUX5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSVKGLNHFLFSVSDLENSIKFYQNVFDVKLLVKGRSTAYFDLNGIWLALNEEKDIPRNE
ISQSYTHAAFSIEEAEFDRMYEKLKELDVCILSGRSRDERDKKSIYFIDPDGHKFEFHTG
TLQERLNYYKQEKTHMKFYD
>P33369|FEATURES|UNIPROT_deepARG|multidrug|mdtQ|antibiotic efflux|0
MNRDSFYPAIACFPLLLMLAGCAPMHETRQALSQQTPAAQVDTALPTALKMVGQTXQWWL
EYHDNQLTSLINNALQNAPDMQVAEQRIQLAEAQAKAVATQDGPQIDFSADMERQKMSAE
GLMGPFALNDPAAGTTGPWYTNGTFGLTAGWHLDIWGKNRAEVTARLGTVKARAAEREQT
RQLLAGSVARLYWEWQTQAALNTVLQQIEKEQNTIIATDRQLYQNGITSSVEGVETDINA
SKTRQQLNDVAGKMKIIEARLSALTNNQTKSLKLKPVALPKVASQLPDELGYSLLARRAD
LQAAHWYVESSLSTIDAAKAAFYPDINLMAFLQQDALHLSDLFRHSAQQMGVTAGLTLPI
FDSGRLNANLDIAKAESNLSIASYNKAVVEAVNDVARAASQVQTLAEKNQHQAQIERDAL
RVVGLAQARFNAGIIAGSRVSEARIPALRERANGLLLQGQWLDASIQLTGALGGGYKR
>E2IJX3|FEATURES|UNIPROT_deepARG|beta_lactam|CMY-86|antibiotic inactivation|1
MMKKSLCCALLLTAPFSTFDAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGMPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEVAWHILEKLQ
>J9S1G1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA114|antibiotic inactivation|1
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
LTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRMLVN
QQLPIKATAYELADNLFEVGQADGWRL
>N9F791|FEATURES|UNIPROT_deepARG|aminoglycoside|F933_03220|antibiotic inactivation|1
MKILSVSEPLLADWLRLRILLWPNTEDAHLIEMRQLLAEKQTLQLMAYSNNQAVAMLEAS
IRHEYVNGTETSPVAYLEGIYVCSEFRRLGVATNLIRQAEQWATQFACTEFASDTAVDNL
VGQAMHKALGFQETERVIYFSKKIK
>A0A127E5U6|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
ETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCA
TGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFA
LSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVMNIL
DEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTISAPE
MYGEANEGQVEAFYKVLKSAGIHVTIRRQFGIDIDAACGQLYGNYQNSQ
>C4NV14|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MFDVMEQQRLISTRLDIMSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLK
PYSDIDLLVTVAARLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPA
RRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLF
EALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPV
ILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>L3BPM2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNIDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>J9SZS8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA114|antibiotic inactivation|1
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
LTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVN
RQLPVKAAAYELADNLFEAGQADGWRL
>T6HKU4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFMNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>Q849R2|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELIAAALQYSDNTAMNKMI
>A0A0Q9V649|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQGINHMCFSVSNLEQSITFYQKVLGAELLVKGKSTAYFNLNGLWLALNEEKNVPRSEI
QYSYTHLAFSIAIESFDEAKELLKEHNVTILPGRSRDERDKKSLYFTDPDGHKFEFHTGT
LQDRLAYYQDEKPHMKFYSLKE
>A0A0M7PRH0|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRIMFQQGTRQDCTQRYTPASTF
KLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARA
LGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPV
KAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFA
RLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK
>D5VPS8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPDWLIALILGLIEGLTEFIPVSSTGHLLLVGHFLGFHSPGNTFQVLIQLGAILAITSVY
FGRLWGLLTTLPTDPGSRRFVIGILLAFLPAVFVGVAAHDFIKTVLYETPALVCATLIVG
GFILLALDRMKFEPRYTDVADYPLKTAFIIGLFQCLALVPGVSRSGATIAGALLLKCDKR
SAAEFSFFLAMPTMAGAFAYDLYKNIDQLSTNDLGLIGVGFVAALVSGVFVVKTVLNFIT
RHGFAPFAYWRIAVGVVGLALLYIPR
>A0A127SJH0|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDINSWTRHEYFEHYFTNIPCTYSMTVKLDITQIKKKQMKLYPAMLYYLATIVNR
HPEFRTAINQAGELGIYDEMIPSYTVFHKDTETFSNLWTEYMPNIEAFSRAYENDIQLYG
SNHGMTGKPDVPENVFTVSMIPWSTFDSFNLNLQKGYSYLIPIFTLGKYYGEDGRIMLPL
AIQVHHAVCDGFHICRFVNELQELINS
>YP_002706076|FEATURES|ARDB_deepARG|multidrug|smeD|antibiotic efflux|1
MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFL
VAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARL
SAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRI
GKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVS
ILMEDGSTFEHKGTLEFSEVSVDPATGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDA
VLVPMQGIARDPKGDTTAMVVDKDNKVEVRPVKVSRTVGDKWLVDDGLKAGDKVIVEGLQ
KIGPGMPVKATEKGAAPAKPAAAAQPAAPAGDAK
>A0A024QFV2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MRIKGINHLLFSVSDLEVSIDFYQHVFDAKLLVKGKSTAYFDLNGLWLALNEEKNVPREE
IQESYTHIAFSIEEKDFQQMYDRLGSLNVSILQGRQRDVRDKQSIYFTDPDGHKFEFHTG
TLADRLDYYKQAKKHMTFYD
>A0A097AR05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
YKGKIFASLKNLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEHLFSPFTVAIALIVG
AIMMIVIEDTFGKRYKIDNMDKVDTKKSFWIGIAQVMSLFPGMSRSASTIMGGMLVGLSV
KAAAEFSFFLAIPTMLAATGFELIKSFTAMSLLEWEALTVGFIMSFITALFVVDKFLSYL
TKHPLKPFAYYRLIVGLLMLLLISEKIVK
>A0A127T046|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSPLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>A0A081R8V4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRREPTSWRFLRNLLVAFIPAAMIGLALHDYIEALLGAPKVVAWALI
VGGVAILGIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGVSRSGATIMGALMLGVE
RRTAAEFSFFLAIPTMLGATALELLKNGDKLTSATVGWDSIALGFIVSFIVALLVIKWFV
GLVSRHGFTPFAWYRIIAGITALAWLSLR
>ZP_01994501|FEATURES|ARDB_deepARG|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
MRSEKEVYDIVLNFAKTDKRIRMVTLEGSRTNTNIPPDDFQDFDITFFVTDMDSFTSDDK
WLDIFGERLILQKPEDMELFPAVEKGFSYLMLFTDDVKIDLTLLPLELIDEYFTWDKLVK
LLLDKDNRIVKPPIPTDIDYHLQKPTQRMFDDCCNEFWNTTTYVVKGLCRKEILFAIDHM
NDIVRKELLRMISWLIGIKQGFHFSLGKNYKFMKQYAPEELWERLMSTYNMDSYPHMWES
FEQCMALFREVSSEVACQLDYQYPLYDEKISNYVIRQKKKYGIEDDNK
>A0A023E8T8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVIIPVYNEEASLPVLLSRVTAACELLPQDYEVILIDDGSHDGSTEIISEA
AANSDSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTVRRNRQDSWFRKTASRLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
LVAGLGFTFSILLVLMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQIVRTATPSQQETEQ
>A0A0W0YZ55|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MISTNEIQQQLSDCLGLLKNVFGRDLLGAYLYGSYLVGGLQKYSDIDLFVVTNRSSTTEE
KIELTTQLLHISGIYMKGIKPPIEMTVVEKAAVNPWQYPPLFDFQYGEWLRQSYEMGNFE
SWQSQEMPDLALIITQILLKSHTLAGENPEQLLAPVPYYDFMKAMLNDLDRLTDDLEDDT
RNVLLTLARIWSTLETNMIRSKPDAADWVIRRLTSKHQPVMDRAKSICIGHEEEYWDDLN
ESIKSCVQYMIRRINEQKLSINLKDPSNKITLA
>J7JZQ0|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEVGQADGWRLFGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A0R2BVG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIIKAIILGIIEGITEFLPISSTGHLYLADEFIKLSESKAFINMFMVVIQLGAILAVVL
IYFHKLNPFSPKKAQREKGQTWQLWFKVLVAVIPSIIVGLPLNDWMDAHLNTWPVISATL
IIYGILFIVIERWNKGRTSHFNDLNTLPYSIALGIGMFQLLSLIPGTSRSGATILGAIII
GTSRFVATEFSFFMAIPTMFGASLLKIVKFLAHNSFSGDQVAVLLVGMIVSFVVAYLSIR
FLLNYIKKNDFQAFGWYRIVLGIIVIAYFGLKAIF
>YP_002217166|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTY
QTDQQTLILNTANAYFKVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEELRQVTGNYYPELASLNVEHFKTDKPKAVNALLKEAEN
RNLSLLQARLSQDLAREQIRQAQDGHLPTLNLTASTGISDTSYSGSKTNAAQYDDSNMGQ
NKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASISSI
NAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARYTYLINQLNIK
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPDQDAAADGYNAHSAAPAVQPTAARAN
SNNGNPFRH
>A0A0W0ZMJ0|FEATURES|UNIPROT_deepARG|beta_lactam|Lste_0698|antibiotic inactivation|1
MKKNILLIGMGLLLCTTIWAQGTCFLAYENQTVLKHEGNECNQRYSPASTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKDPHNPRTWIRDSCVWYSQVLTQQLGMNRFKNYV
KAFHYGNQDVSGDKGKNNGLTHAWLSSSLAISPAEQIKFLQKIVYNKLPVSKKSLSMTKD
ILYIQELAGGWKLYGKTGTGRQLTRDKSHQLPLQHGWFVGWIEKNGRLVTFVNHIADSKE
KTTFASFRAKNEVLIKLHYLINELEK
>A9VGR9|FEATURES|UNIPROT_deepARG|beta_lactam|BcerKBAB4_2421|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYNSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKNPIILAILSNHAKEDAKYDDKLIADATKI
VLDNLKVTNK
>A0A088MYT3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHWLVIALILGLVEGVTEFLPISSTGHMILVSNLLGLNDDKTKTFEIMIQLGPILAV
VVIFWRRLFSLIGINFNSVSSDRRLHLNHIILGIVPSVVFGLMFHKKIKSLFEPKYVMYA
LVVGSLLLLAGQWLNPRKPRATSIDDISYRQAFFIGCFQCFALWPGFSRSGATISGGLLV
GVSRDAAFEFSFILAVPMILGATILDVYKSLPCLFWQDWPMFIVGLFTAFIVALITIQFF
WHIIKSISLVPFVLYRFLLVTLFYWVLIY
>A0A0B2F3R7|FEATURES|UNIPROT_deepARG|aminoglycoside|QW71_31235|antibiotic inactivation|1
MEVLAYLDQAVELFKDELGTNLSGIYLHGSLAMGCFHQDRSDIDLLIVVHDKLPVEVSRK
LATKVIAYHDSLPNRRGVELTIVLKKYLKNFVHPTPFEFHFSDFHLDRYRNDEHYLCGGF
EDADLAAHFAVVYQRGIILYGEPIREAFLPVDRQYYLDSILGDIGDAPQNIMNLPVYYTL
NLCRVLYYLQEGYISSKKEGGIWGLQHLPAKYHGLLKQCLDEYSGGISRGGYDQALLIDY
AEYMAGEIRQHQAKV
>K0WEQ2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLQLTGITRSFTAGDREFLALKNINLTINAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGQETRDLDDQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGIPAP
QRHARARELLARLGLDGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNQRDTGQLPGEDV
PPKPPATRRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGAK
NYVLKDISAIGSNTIDIYSGTSFGDKRAASIETLVPADVTALNQLYYVDSATPVVGRSML
LRYRNIDLDAQINGVSEQYFQVRGIKLEAGITFSESDARRQAQVVVIDYNTRHRLFAEGV
DPLGQVILIGNLPCTVIGVAAENKNLFASGKTLNVWVPYETAAGRLLGQRFLDSISVRIK
DGQSSKVVENHVTQLMLQRHGIKDFYTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHL
FSLFIKEWEMVFSMASVVTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>ACQ53948|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLLILKAIIIGIVEGITEFLPVSSTGHLIIVGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
AVVVLYWDKIMSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGMPFNDKIEEKLFY
PLPVTIALIVGAIWMIYAENRYRNNSKTTSIDDINAKQAIIIGLFQCLALWPGMSRSAST
IIGAWIAGLSTVAGAEFSFFLAIPIMIGASGVSLIKHNVFSTCSSIELIALAIGFIVSFV
VALVVIDKFIAFLKKKPMKVFAVYRIALGIVLMVLIYSNIISWH
>E6LNW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILEILKVIIIGIVEGITEWLPISSTGHIIFIEQLFNFNVSENFKDMFDVVIQLGAILA
VAVVYFKKLNPFNKGRNKKKMYLTIELWKKIIVACLPAAMLGLLINDWVKEHLLNGFVIS
MALIIYGILFIMIENSNKNRAYSIKSVYSINYQTALFIGFFQVLALIPGTSRSGATIIGA
MILGVSRSVSVEFSFFLSIPIMFGASLLKLVKFGLHYSMAEIVYLLLGMTVAFFVSVFSI
GFLLNWIKKNNFKFFGYYRIVFGLIILVWYFTSSLPK
>D1LFF3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASV
TAFARQLGDETFRLDRTEPTLNTAIPGDPHDTTSPRAMAQTLRNLTLGKALGDSQRAQLV
TWMKGNTTGAASIQAGLPASWV
>A0A0M1NFD7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDLWLNSKELFGSEVANAFKVVIQLGS
ILAVVVLFWGRFMDLLGLRKLKGTSAVNGQKLNLLQIIVGLLPAGVLGLLFEDYIDDNLF
TMKTVIVGLFLGAFLMIAADKFRPKLTAETVDQITYKQAFGVGLIQCLSLWPGFSRSGST
ISGGVLLGMSYRAASDFTFIMAVPIMAGASLLKIVKYWDSFTPEVLPFFIAGFISAFIFA
LFCIRFFLILINKVKLTPFAIYRIVLAVVLLFIIW
>A0A060KTW2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFATCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>H6SKH2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSEFKPLDAFLMAALLGIVEGLTEFLPISSTGHLVLLVDLLHFPAPPGKTFEIVIQLGAI
LAVCVVYARRLGRAAVGLWSDRRERAFVRTLFLAFLPALFIGAVAYPFVKKLLDTPLVVA
VALLVGGVAILAIERLVRRPRVFAIEDFSPSLATRIGFFQVIAMIPGVSRSGATIMGALL
MGVERKTAAEFSFFLAIPTMVAATVYSLYKNRDVLSFDDLGLIATGFSLAFVTALVVVKA
AVAFIGRYGFAPFAWYRIVLGSVMIGVLLL
>A0A132PF12|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAALLRAVGAVLVAAIALVSTASQAAGSPDAVQAAVDRAFRPLLEQYDVPGMAVAVTVDG
RRYFVDYGLAANPGGPAVSRHTLFEIGSVSKAFTATLASYAQATGALSLDAHPSAYLPEL
RGSAVDAATLRDLGTYTAGGLPLQFPDTVTDDAGMLAYFREWSPTAAPGEIRRYSNPSIG
LLGHLTSRAMRGDFADLMQAQVFSRLGLSSTYIHVPDSAMDRYAWGYDKANEPTRVSPGV
FDAEAYGIKTSAADLIGFIEANIAPHRFDQSLQRAIEGTHVGYSRVRDMVQGLGWERYPY
PVSLDVLLAGNSSTMAMEPQPALPIAPGRLPDGPALFNKTGSTDGFGSYALFVPDRQIGI
VMLANKNFPIPARVTAAHAVLQELEARR
>D2D0D5|FEATURES|UNIPROT_deepARG|beta_lactam|blaTER-2|antibiotic inactivation|1
MRHSLFAPILLLALFALPAWAHEATVNQVKAAERQLEARVGYAELDLASGRLLASYRPDE
RFPMMSTFKVPLCAAVLARVDAGEEKLDRRVRYRQQDLVEYSPVTEKHLADGMTVAELCA
AAITLSDNTAANLLLASVGGPQGLTAFLRRSGDQTSRLDRWETELNEALPGDARDTTTPQ
AMAKTLRNLLTGSVLSAASRQQLRSWMVDDKVAGPLLRSALPHGWFIADKTGAGNRGSRG
IIAALGPDGQPARIVIIYLTGTEASMDERNRQIAEIGETLVKHW
>A0A0N0FBV5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKVVVFAYHDIGCVGLQALLDADYEIAAVFTHADDPEEKTFFGSVAQLCARHDIPVHA
PEDPNHPLWIERVSKLAPDFIFSFYYRALLSEPLLACAKRGAFNLHGSLLPRYRGRAPVN
WVLVNGETETGVTLHKMVKRADAGPVFAQQRISISATDSALTLHGKLREAAIALLSDALP
SLARDQLSGTPQDESLATCFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGDH
KLIIWAARVEPSNNGAAPGTVISHDPLRIACGEGSLIIHAGQRGNEGLYLSGAQLAREFG
LVQGSQLRDAKMQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
AKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDIESQSFYGKGYQDVSHRKPGIDNARQLIGWAPGIALSETIGKTLDFFLREAMAEKA
DQC
>I4K6I3|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVRAESVDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>A0A0N0VLX6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQTIVQALLLGVLEGLTEFIPVSSTGHILLAGHFLGFDSTGKTFEVLIQVGAILAILS
VYAARLWKIATDLPSDPKTQRFVAGILLAFLPAAVIGGLAHGFIKTILFESPMTICIALL
VGGVILLWIDKLPLKPKYEDVMDYPPSLCFKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMAGAFALDLYKNYDVLTANDVTLIVAGFISAFISAVIVVRYLLDY
VSKHGFALFAWWRIFVGSAGLIGLWLIG
>A0A098FJ97|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MGIKMDEYELLDKDSGPYGITAGKDGALWFTQHKANQIGRMTVNGEVTPFVVPTPNAGVL
SITSTTQGDIWFTENRANKIGKLTGTGEIIEYTLPSPNSAPFGITEGHNGDIWFTEMNGN
RIGRILSSGEMIQYDLPSPGCYPSFIVAGTDGAIWFTENQSNQIGRITMLGEMTNYTLPT
KHAGPVGITSGPDGALWFVEINGNKIGRITTSGTICEYTIPTPDARPHAIVTGPDRALWF
TEWGSNQIGRITMQGEITEYPIPTQNAEPHGIASGPDGAIWFAEECNKIGRLSLL
>G2S3I9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALSPDVIFSFYYRNLLSDDILSLAPKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGNIVAQQKVAIEADETALQLHHKLCGAAQNLLRDVLPSI
QQGSFKETSQDESKASCFGRRNPEDGRLDWAKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLVVSCGEQALEILTGQTDNGVYVQGAQLAQSLGLVA
GAIITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLTNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCNGEIINIGNPENEASIRELAEMLLASFERHPLRDQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPEVKMEQTIDETLDFFLRTVELSEQTS
>A0A089LBH9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQDSIMKTYEIVIQLGAILAIAI
VYRQRILNLLGIGRSGRSRGGVMPASRLNLIHVLLGIVPALAVAFFARDFIKGLFGASTV
LWALVAGGILMIVAEWVNKRKIRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTNDTIWYFAIGFVISFVVAY
VVVVLFMRMIQKIRPTHFAIYRFILAAVFWLFIMR
>H8GKI9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHVLWDALILGIVEGLTEFLPVSSTGHLILAGQLLGFNDEKGKVFEIAIQFAAILAV
VWEYRSRLWHTLTGIRTEPVSQRLAINMIVAFLPAAILGFLFLKQIKTYLFNPFVVASAF
IVGGFLILWAERREHKINAETIDDMTWRDALKVGFAQAVAMVPGTSRSGATIIGGLFFGL
SRRAATEFSFFLAIPTMFAATFYDVYKHRALFSASDLDLFAVGGTVSFISAFLAVRGLLR
FISRHDFSVFAYYRIAFGVLVLLSAQMGWVDWSGG
>CAA76542|FEATURES|ARDB_deepARG|qa_compound|Qac|antibiotic efflux|0
MHYLYLFISIATEIIGTSFLKTSEGFTKLWPTLGTLLSFGICFYFLSLTIKFLPLNITYA
TWAGLGLVLTTIISVIVFKENVNLISIISIGLIVIGVVLLNVFGESH
>Q83Z49|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPERDLFEALRETLKLWNSQPDWA
GDERNVVLTLFRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQEEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0R5RPN8|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MFKIIDRNNWKRNPYFDHYFDKIPCTYSITVNIDISRVIRLKTEQNTKLYPLLVYALSKA
VNCYDEFRTDINENTVFHKESETFSNIWTEWDKDLNTFLSNYNQDIKLYGNNTDIDAKPQ
TPKNVFPISSLPWTTFTGFNLNIKPDTGYLLPIFTFGKYFKQADKFYIPLSIQVHHAVCD
GFHVP
>C5AQS5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAQNDGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFS
>A0A0H4IRB8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-125|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARSEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>I4E7J8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>V2V7W8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDSEARHFAFSVLIAFFPAVIIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFTGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFVAAFFSALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>BAD95814|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Va|antibiotic inactivation|1
MDDSTLRRKYPHHEWHAVNEGDSGAFVYQLTGGPEPQPELYAKIAPRAPENSAFDLSGEA
DRLEWLHRHGIPVPRVVERGADDTAAWLVTEAVPGVAAAEEWPEHQRFAVVEAMAELARA
LHELPVEDCPFDRRLDAAVAEARRNVAEGLVDLDDLQEERAGWTGDQLLAELDRTRPEKE
DLVVCHGDLCPNNVLLDPGTCRVTGVIDVGRLGVADRHADIALAARELEIDEDPWFGPAY
AERFLERYGAHRVDKEKLAFYQLLDEFF
>A0A127SPU7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELKNRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISLSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVY
DAMR
>W0HLB2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPMKIDKVSIVIPVYNEQESLPELMRRSVAACERLDAAYEILLVDDGSSDDSAAVLTA
AAEAPGSHIVVVLLNRNYGQHSAIMAGFSHVSGDLVVTLDADLQNPPEEIPRLVEVAAQG
YDVVGTVRQNRQDSWFRKRASRMINALIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKTIEIPVMHSEREFGDSKYSLMKLVNLMYDLITCLTTTPLRMLSVIG
SIIALLGFAFSLLLITLRLFLGAHWAAEGVFMLFAVLFIFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQRVVSQNPLSSQQETQ
>R6MIM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVLIAVILGIVEGITEWLPISSTGHMILVEQFLHMSTSHEFNSMFRVVIQLGAIMAVV
VLYFNKLNPFSKRKSAKQKRNTINLWCKIVVACLPAAVIGLLFDDILDKYLYNYVVVALM
LIIYGIFFILIEKKNEHTRPQVTKLTELTYQMALIIGGFQVLALIPGTSRSGATILGALL
IGTSRYVATEFTFYLAIPVMFGASILKVIKFGFHYTAIEVVILLVGCLVAFFVSVFAIKF
LMGYIKKHDFKAFGYYRIVLGVLVLLYFLIFG
>E7MZL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKTVILGIVEGLTEWLPISSTGHMILVDEFIQLNVTKAFMDMFLVVIQLGAILAVVV
LNAGKLNPFLRRKSNAERRETFDLWGKVIFACIPAGAIGLALNKYMEEHFMNAPVVASML
ILYGVLFIIVERWNRVRTPRIENLSQLDYRTAFIIGVFQVLSLVPGTSRSGATILGGILF
GASRYVATEFTFFLAIPVMFGASFLKLVKFGFHYTGAELVILAVGMVTAFIVSILSIRFL
LRYIKRNDFTAFGWYRIALGVVVLAYLFAVGDPT
>ZP_04073068|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQKVIKNEKGTISISQLNK
KVWVHTELGYFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVETL
HPGKGHTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDRGLLLHTLDLLK
>A0A0R1LDY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKNQTWSIWFKVLVAIIPSVVIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKNKRPQVEDLDQLSYKTAFTIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIGKYFWNGHTFTGDQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIVLAIIVIAYFGIKSFA
>ZP_02465588|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAAALAVVVIAGLGTFGAIRVNASAPEKSAAPLPEVDVATVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAADAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNQDGALVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIAGGLAAGDRI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRAQAAQGNARA
>M6F258|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGESLEFDDLFDIFIQSGAILSV
LFLYREKFRSQIVSSFRYVLKQNSDSEGFNFLIQICIGAFPILIAGFMAKKFLDTIKARP
DLLEILSGAWIFGGVLILIAEWYFHQKGTEKKKPIHFKDSILIGIFQCMALVPGMSRSAA
TIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLL
CTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>YP_002366165|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A031JUM3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTLTAILLGIVEGLTEFLPVSSTGHLILATRLFGYDSSQWATFNIVIQLGAILAVIVQ
FWRTFWAVGMGLLKLNPTSIRFVRNVLLAFIPSAVLGLLFNNYIEGLLGEPAVVAWALII
GGIAILGIEKVAKPGPLTGVSELPAVKCIGVGFAQCLAMVPGVSRSGATIMGALSMGIER
RTAAEFSFFLAVPTMVGATTLELLKHHKELMAGAGPVGWNEIAVGFVVSFIVALVVIKAF
MAFVSKSGFAPFAWYRIVAGALALFLLSRI
>A0A0D8LBI5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSFNEIKKVSVVIPVYNEEESLPQLLERTIKACQSLKQAYEIVLVDDGSRDRSAEILTQA
AEIPENHVVSVLLNRNYGQHSAIMAGFRQADGDLVITMDADLQNPPEEIPRLVEKAEEGY
DVVGTRRANRQDSWFRKTASKMINKMIIAATGSAMGDYGCMLRAYRRHIIDAMLQCHERS
TFIPILANTFARKTIEIDVRHAEREFGDSKYSFLKLINLMYDLLTCLTTAPLRLLSIVGS
IIAASGFLLALLLIILRVAFGALWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGAQAKETSETETQEKTNESNRICLP
>J8WN93|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A060KTP3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRALLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>D1PVQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLFQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVQPGDPFVHAFTFIIQFGAILSVVC
LYWKRFFQMRNAEELSDKLKFYGLLIVGVLPAVVVGLAAKKSGLLAWLLDSVTVVAIMLV
VGGVFMLFCDKIFNGGRDENRVTCKRAFLIGCFQCLAVVPGVSRSMATIVGGMQQKLTRK
HAAEFSFFLAVPTMAGATLLDLIEMFGEDATWATPHNITMLIVGSVVAFIVAMLAMKWFV
GFITKFGFKAFGWYRIIVGGIILVMLLSGQSLVMVD
>YP_695835|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
ILAVVVLYWRKISSSVVEFLCYIFSFIGLKTSGDKRKYEKRLAESETGFRFGINVIIGTI
PAAILGLLFHDEIKEYLFSTKTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYG
QSLLVGCFQCLSLWPGMSRSASTIMGGWISGLSTTVATEFTFFLAIPAMVGASGLDLFKF
DYSQMNATNWISLILGFIVAFIVSLVVIDKFINYLKKKPMRVFAIYRVFAGIVLAILIFT
KVIS
>A0A0B1R8P9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKEPHEGTGTGKLTLIHILLGMVPAVVIGLVLHDQIKSLFNPIN
VMYALVVGGVLLLVAEYFKPKQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDLYKSMGFLTMQDFPMFAVGFVTAFIVALLA
IKVFLELIKRISFVSFAIYRFIVAAAVYAIFM
>A0A0H4JBK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIFFIQAVVLGVIEGLTEFLPISSTGHLIIGAHLINANHPNIEVFEIFIQLGAILAII
YEYRIQLLNKTLHLSDQKSKTFFSNIFLAFLPAAIVGLAFHDVIKKFLFNPIVVSCALII
GGILILLIEKKTNIGSTKTVDHISHKQSLGIGLFQCLALIPGTSRSGATIMGGLLLKLDR
KTATEFSFFLAIPIMFAASFYDLLKNLHSLSSDDLWFFLIGLSTAFISALIVVRFLIKFV
AHNDFKIFAYYRILIGIIFLILFY
>R8CGN5|FEATURES|UNIPROT_deepARG|beta_lactam|IGA_06067|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTIQFVSVISPVQAERTVEKKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLKRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>A0A080SJ45|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHELLVRLGLGERADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIVEIRDGEIVRNPPASRQGGGLRARPQA
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVALSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0A6TJG6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWGLATGLGERANRDYVLKVGVAFLVTAVVGLVVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSKRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWTDVAVAFVAATITGFVVVKWLLGYIKKH
RFTVFAVYRMLLGAALLLWLPAAAG
>YP_688360|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLAILLAQNIEQFTLLRFLQGISFC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAAL
AAISFFGLQRAMPETAMRIGEKLSLKELGRDYKLVLKNGRFVAGALGFVSLPLLAWIAQS
PIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPIMIGLLVA
AAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASDMSKGTVSAAMGMLQMLIFT
VGIEISKHAWLNGGNGLFNLFNLVNGILWLSLMVIFLKDKQMGNSHGG
>A0A157TLN3|FEATURES|UNIPROT_deepARG|polymyxin|arnC_1|antibiotic target alteration|0
MTTQPASLPRSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYE
ILLVDDGSSDNSARMLTDAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMY
DLITCLTTTPLRLLSVFGSVIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFTFIG
AQFIGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHLASQEENHP
>F1DI10|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
GMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPN
DERDTTMPAAMATTLRKLLTGELVTLASRQLLIDWMEADKVAGPLLRSALPAGWFIADKS
GAGERGSRGMIAALGPDGKPSRIVVINTTGSQATMDERNR
>S3I4V9|FEATURES|UNIPROT_deepARG|beta_lactam|ica_05539|antibiotic inactivation|1
MLVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGSQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0M5ILT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASKWAVFNIAIQPGAILAIVVLY
RHLFWDMFVGFFRRDPVAIAFVRNLLLAFFPAVVLGLAFGDQIELLLENAVVVAWALVIG
GFAILLVERFAKPRESGGVAALTTRQSILVGLVQCLAMIPGVSRSGATIMGAMSLGVDRK
TAAEFSFFLALPTLSGATVLQLFKHRDAITSGDLGLIGVGALVSFIVAWAVIKAFLAVVT
RYGFAPFAWYRIIVGGAALLWLALR
>A0A0C3MTP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLLFKALILGVVEGLTEFLPISSTGHLILVSDLLDFNDEKGKVFAIVIQLGAILAVC
WEYRIKIGGVVMNIGSSEDANRFVLNLFIAFLPAAILGLLFIKTIKQYLFHPVPVAMAFI
IGGILILWAERRKHVIEVDRVENMDWKHALKVGLMQCLALIPGTSRSGATIIGGLFFGLS
RKAATEFSFFLAIPIMFAATFYDVYKHRDILQFDDIGVFVVGFVASFISALLAVRGLLRF
ISHHDFTVFAWYRIGFGIIVLLTAYSGVVKWSAA
>A0A0J1VU37|FEATURES|UNIPROT_deepARG|chloramphenicol|SP99_00894|antibiotic inactivation|1
MKNTVPEYTPVDLSRWARKEHFEVFQSFAECTINQTVLIDITVLRKHIKTVGWKFYPTII
FLLSKIMNRHPEFRMAMKDNELVVWNEIHPSYTIFHPETETFSSLWSHYDGNMQHFQNTY
AEDTARYGNNLSYWPKEESRENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPMAVQVHHSVCDGFHVARMFNELQEMCDGLPELSEEHNA
>A0A060L035|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDSL
>A0A0B9AE02|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNNEVIKNEADEIKKVSIVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDD
SAEILTQAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRL
VATAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHVSVEQQEEE
>A0A104L769|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLLVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQHAIPGMAIGVVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAARYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDGIRDDAGLIRYLRAWRPEYAPGTHRKYSNVSI
GMLGWLTAKAMHQDFATLMEQRLFPALGMTHTYIDVPAARMADYAQGYTKDGKPVRMTEG
MLWQPAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVGLPTLLAGNAPKMLFDAVPASAIQPPLAPSAATWINKTGSTAGFSTYVAFVPAKRIA
IVMLANGNVPIEDRVKVAYRILGVLGDGR
>A0A0H1RJJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGIAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>BAH64410|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTLKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQYNVPDGSAQMTLSTYILGFAL
GQLLYGPMADSLGRKPVILGGTLVFAAAAVACALSQTVDMLIVMRFFHGLAAAAASVVIN
ALMRDIYPKDEFSRMMSFVMLVTTIAPLVAPMVGGAVLVWFSWHAIFWILALVALLASLM
IGLFVRETLPAERRQPFHLRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
ININHVAPQHFGYYFALNIVFLFLMTMFNSRFVRRVGALRMFRAGLWIQFAMAVWMVVCA
LLDVGFWSLVIGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIIGAL
LSMATFTTAWPMLISIAFCATCSIFFSLYASRRRKIAR
>B2ZTR5|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
LFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQ
DKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPINQVNLLQL
ATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKFVALSMNKP
FDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLP
DMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSE
QIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIK
>N8R940|FEATURES|UNIPROT_deepARG|aminoglycoside|F991_01542|antibiotic inactivation|1
MNIKPASEASLKDWLKLRIKLWNDLEESHLQEMHQLLAEKHALQLLVYSDDHAVAMLEAS
IRYEYVNGTETSPVAFLEGIYVLPEYRRLGVATLLVRQVEAWAKQFSCTEFASDAALDNV
ISHAMHRALGFQETERVVYFSKKID
>B4DBG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPIWLLAIILGFVEGLTEFLPVSSTGHLLIAEHLLKIDPSSFLRSDMFNVVIQAGAVLAV
IPLFKDRLKMLSRLHEPASQQFLAKIIVAFVITGVGGFIMEKKHFKLPEEVQPVAIALII
GGIVFIAVEALLRNKQLSEEISWTVAITVGLAQLIAAGFPGASRSGSTIMLAMIVGAGRA
RATEFSFLVSIPTMLAASGYKIFKTLHHPAIDAIPTDWSSLIIASVVAIIVSFIAVKWLL
RYVQTHTFIGFGIYRIIAGAALLLFIR
>A0A123UV96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNRGIEPRVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>A0A0A0Q9K4|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-17|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>B2VCS9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MEPIISLRHLYREFNAGMETVPVLTDISLTIAAGEMVAIVGASGSGKSTLMNIIGCLDKP
TSGEVFINGTPVHEADSQHLAELRSRHLGFIFQRYHLMPYLTAEENIAIPALYTAMPEKE
RNRRTQMLARKLGLESRLHHRPAQLSGGQQQRVSICRALINGAHIILADEPTGALDSVSG
QALMDVLHQLHAAGHTVIIVTHDRHIARQAQRTVEISDGRIISDVRHRALRSQLTLPEQD
NGRASPGRSVHQSVRMAWRSLLGHRMRAFLSMLGIIIGISSVVSSMAVGEGARQAIMSEI
GKLGNTTLEIRPGTGWNSQRPDMERALSMDDVSSLQKLPWVSGVSPVVSSMSLAVRKGGD
SSMMISGVSQDYFALQGLRFVQGNGFTARDVDDGEPVLILDETGRDTLFPGGEDPLGKIV
QIAGAPWRVIGVASKPGPKVVAGFMAAWMPYTSLQQRITGEKPLEAITLRFSAALTPAEA
TRKAVRHLIREHGKQDFFTQTDDRLANALQKTSDSMSLLITAMAAISLLVGGVGVMNIML
VSVTERTHEIGIRLSVGARPSDIMNQFLIEAVTICTCGGVIGILGSWIFGSVFSLISNAF
SMVFTPLPLLLACGFSALIGLTFGYFPARSAARLNPTEALARE
>A0A0E2M791|FEATURES|UNIPROT_deepARG|beta_lactam|L360_00404|antibiotic inactivation|1
MLNLTVCQAQSNPTDYACLMGPDTPLTRYYGRLLMMKKSLCCALLLGLSCSALAAPVSEK
QLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHYYTFGKADIAANKPVTPQTLFELGSIS
KTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVT
DNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLKPLKLDH
TWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADA
SLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAP
PVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILEALQ
>L0LI82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEQIIIALVLGLVEGLTEFIPVSSTGHLILLGHFLGFKSAGTFEVLIQLGAILAILLVY
FNRLVQIAKALPVSVKARHFVLAVLFGFLPAAVIGALAHDFIKTVLFDSPKVICISLILG
GIVLLVIDRIEFKPKYTSAYEFSWPMAVKIGFFQCLAMIPGTSRSGSTIVGALLLGADKR
SAAEFSFFLAMPTMVGAFTLDLWKSRHDLSFADGQLIVIGFFMAFISALLVVRALLDFVS
RRGYAPFAWWRIAVGTIGLIGLYFG
>U7R1N7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVAGFICATCFGDLFNGVRSLYMTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLL
GFTGDKAETFEVIIQLGSILAVVVVFWRRLFGLIGLHFGEVPHEGKTNGKLKLSHILLAM
LPAVTLGLLFHDTIKSLFNPQSVMYALIIGGVLLITAEILKPKTPRAEGLDDITYRQAFM
IGCFQCLALWPGFSRSGATISGGMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFL
TASDIPMFAVGFITAFIVALIAIKTFLALIKRMSFIPFAIYRFIIAAAVYCVFM
>B1W5S0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAVSEMSVADKDAGPYGIAAGPDSALWLTFSRSGHVARLTLDGELDEYSLEAPECRPAVI
APGPDGAMWFTRSQDHRIGRVTADGETESFAVPTSGSGPFGITAGPDGAMWFTEMNTDRI
GRITSMGEITEFVLPRTGACPSAITGGPDGALWFTLNQANAIGRVTVRGDIAIHRLPTPN
AAPVGITSDGAALWFVEIAAGQIGRITVDGAIEEFPLPDRTAKPHAIVAASTGDCWFTEW
GANSIGHITGSGEITEYGLPSPSSEPHGITLGPDGALWAALETGGVARLEP
>A7Y413|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
RKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYDFGYNQENQPIRVNPGP
LDALAAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYAVLNAIKK
>A0A0D6FBV2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRQAAELGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDSTYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRMCPDAQGALPGSVISVSPLRVACADGALEIITGQAGDDITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A089NKW8|FEATURES|UNIPROT_deepARG|beta_lactam|blacep04|antibiotic inactivation|1
MTDTLNPGRLKMLAVCAALLAAGQSLAQDRLESIVSDAVRPVMHAQGIAGMAVAVTVNGK
PQYFNYGVASKETGKPVTQDTLFEIGSVSKTYTATLIAYAQATGKLALTDNASAVLPALR
GSAFDHISVLQLATYSAGGLPLQFPAEADSADKMLGYYQQWKPVYPVGSQRLYSNPSIGL
SGYLAAQAMGQPFDDAMENTLLPKLGLKHTWLKVPQEQMALYAQGYDKADKPVRVGPGAL
DAEAYGVKTSAADLIGFVQANLKPASLDKPLQQAIALTHTGYYSVGDMTQGLGWEMYRYP
VTLDGLLAGNSTAMAMQSHQVQWLNPPQAPSGNVLLNKTGSTGGFGAYVAYVPSKDMGVV
ILANKNYPNAERVKIAHQILSALAL
>A6VP08|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MNIIEIKGLNRYFGEGENRVHILKNISLDIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKIDGKETVELSSDQLSDLRSQKFGFIFQRYNLLSALTAQENVALPAIYAGKSQAER
LAHAEELLEKLGLDGKEQNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSASGE
NVIQILRQLHDEGHTIIMVTHDRNIAASANRVIEIKDGEIIGDNRKSSVKSAVKNVRVSK
SRFGFSKDQLIEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILSNI
NGLGTNTMTIFNGTGFGDRRADQMQNLTVNDANALAKQSYVQSVTPNSSSSGLLIYGNQS
FTSTNLRGIGEQYFDVEGMRLVMGRSITQQEVSENAQVALLDESSKKSIFPDEDPLGKTV
MFAKRPFRIIGVVTDRQMGAASSSLSIYAPYTTVMNKVTGGTKIGSITVKIADNVNTTVA
EKSLTDYLTVRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARKSNILQQFLIEAILICMIGGISGILLSLIIGGLFNVFMTDF
TMSFSTFSIVAAVLFSTLIGVIFGYMPAKKAAQLDPITALARE
>A0A080M614|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MDLLLLLKALILGLVEGLTEFLPVSSTGHLILAGDLLDFNDERGKLFEIVIQSGAILAVC
WEYRAKLSQVLLGLASERAAQRFALNLLVAFLPLAIIGLLFGKTIKAHLFNAPVVALAFI
AGGFLILWAERREHRIRVESVDDLSLTDAFKLGCAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAIPTLIIATLYQLYRERALLSFDDLGMWVVGFLAAFISAFWAVRGLLRY
ISTHDFSIFAWYRIVFGIVVLLTWHYNWVSWTY
>A0A0K4JSY0|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLTGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASIFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGVAVLMLSLFILKE
TRPAAPATSNKPQENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLLMEIMGFKRGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMIASQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGVGAWNMLIGI
LIACSIVSLLLIMLVAPGRTVAAHEEIHHHA
>G4L895|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNVIKAIILGIIEGITEWLPISSTGHLILADEFVRLEASEAFMSMFNVVIQLGAILA
VVVLYFNKLNPFASNKNTTQKNATWQLWFRVIVAIIPSGIIGIFLDDWLDAHLHKFLPVA
IVLIIYGVAFILVEKRNQNRTPKIAQLNEITYKFALIVGMFQVLSLVPGTSRSGATILGA
ILIGGSRFVSTEFSFFLGIPTMFGASFIKILKFLGTGNSFDFTGTIILLIGTVISFIVSI
LAIKFLLNYLKKNDFTAFGWYRIVLGIVLIIYWMVAM
>A0A0T9QV03|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MSQNEQIKKVSIVIPVYNEQESLPVLLKRTSAACKLLTQPYEIILVDDGSSDSSAEILTV
AANEPDSGIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGVEQTENNQDVEK
>A0A127SPR3|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
EISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIKKLGINDFNLSETEDSMHRNPQK
AYSNWSTPSEMVRLLKMADEKDLFAPVYRDFFWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEVK
>ABG71589|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNTLFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAELPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>AAZ98836|FEATURES|ARDB_deepARG|glycopeptide|VanSD|antibiotic target alteration|0
MKNRKKTKYEDDYLLFKNRLSIKMLLMMVCSLLIIAGVYLFILKGNFANAVVSILEHFVY
HDRDEAAVVYLKTFKRYEFWLFLLAILGVFFVIFRMFVGNVSKYFKEINRGIDSLVHEDA
EDIALPAELASTERKINSIRHTLAKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLT
LLRDEGQISDELRERYLSISLDKAERLEDLINEFFEITRFNLSHITLVYGKINLTRMLEQ
LAYEFKPMLAGKNLKLEFEIQPDISISCDANKMQRVFDNLLRNAVSYCNADTSIKITAEQ
MEDHVIIKVINEGNTIPQERLERIFEQFYRLDVSRSSATGGAGLGLAIAKEIVELHHGQI
TAHSADGLTCFEVSLPLVGKS
>ABG71881|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>A0A0R0ATA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFGQRGNRDYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMARDGKLGSENWTEVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAVYRIALGAALLLWLPSGS
>A4YJM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLSRVAIGALTNPDDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLMMYLWIGVAQCLAMIPGVSRSGSTIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTSDHLGLIAIGFVVSFITAMIVVKAFLGY
VTRHGFVLFAWWRVIVGTLGLIALALGK
>E5WF18|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGINHFLFSVSNLEASIEFYKNVFGAKLLVKGRSTAYFDLNGIWLALNEEKDIPRTE
ICQSYTHIAFSIEEAEFDNMYRKLKELKVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRLNFYKKEKTHMEFYN
>A0A0A1VEF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLAKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDAKAKVFDIAIQTGAIFAVILVYW
QRIRDTLVALPTQRQAQRFALNVLIGFVPAVVLGLLLGKAIKAHLFTPVVVASTFIVGGF
IILWAERRQQTAVRIQSVDDMGPMDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKA
ATDYSFFLAIPTLIGAGVYSLYKERALLSAADVPLFAVGLVFSFISAWLCVRWLLRYISS
HSFVPFAYYRIVFGVVVLLTAWSGVVTWAD
>A0A0Q4MD40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVTEGHQLLIALILGIVEGLTEFLPVSSTGHLIIAGHLMGFTDDKSKVFEVIIQLGSILA
VVVVFWRRLFGLIGIHFGKKVEHEGVGKGHLTLLHILLGMIPAVVIGLLFSHNIKALFEP
KYVMYALVVGGIYILVAEWVKPKFPKAVGIDDITYLQAFMIGCFQCLALWPGFSRSGATI
GGGLLMGVSRYAASEYSFLLAVPMMLGASTLDLYKNHSILSWSDLPMFAVGFVTAFIVAL
IAIKTFLSLIKRISFVPFAIYRFVVAALVYWVFIS
>I0GSW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLSIAELLKVVVLGIVEGLTEWLPVSSTGHMILVDEFIKLDVSKDFMDMFLVVIQLGAI
LAVVALNFEKLNPWSDWKTRQEKRDTVSLWFKVIIACVPAAVIGLAFNDYMEEHFMTAPV
VAATLIFYGAMFIWIENYNKHRRPRINDLARLDYRTAFIIGMFQVLSLVPGTSRSGATII
GGILFGTSRIVAAEFTFFLAIPVMFGASLLKMVKFGLHYTGAEIVIMIVGMVTAFIVSII
SIKFLLSYIKTNDFKAFGWYRIVLGIVVIAYLFLIGDPTADNH
>A0A010SUD7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFIAKPCAALLLLASTVSVGNLAMANAQRSDIDNVVQDAAQAVMQQYNIPGLAIAVTAN
GKQHFYNFGVASRETQQKVTSDTLFEIGSISKTFTVTLAAYAEVNGQLSLTDHPGKYLPE
LAGSPFDKATLINLATHTAGGFPLQVPDQVQNNQQLMDYFKAWQPTYAPGAQRTYANPSI
GALGMITAISMKMPFAVALEQRLFPALGMPNSFINIPASKLSLYAQGYNKQDVPVRLNPG
VLGDEAYSVKTSSTDLIRFVEANLGVAKVEAKLGRALMETHKGYFQVGPMTQDLIWEQYA
YPVQLSALVEGNADKMIYDSHVVTALNPPLAPQEAVWVNKTGSTGGFSAYVAFVPEKKFG
IVVLANKSYPNEPRVRLAHRILSELDCCSLAED
>A0A0M7C6G3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEQTIYLLKALFLGIVEGITEFIPVSSTAHLLILGSWIDFSSGDAKVFEVVIQFGSILA
VVWIFRARLIQLIMGTLRGDRTEMMFTRNLLIAFLPAAVIGALTIQYVKALFHHQIVFVF
TLVLGGLLMLWVERKPQYAKHTADSDQGETATSQKATAFALEEITWKQALVVGFAQCVAM
VPGTSRSGATIIGGMLAGIQRKTATEFSFFLAMPTMLAATVYDLYRNGASLSSDQSTAII
VGFVAAFFSALFLVKAVLRFVSSRTYRPFAWYRIALGGVLFVWLMT
>K0DBU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLIKSIIIGIVEGITEFLPVSSTGHIILVSSLMNIPGGAVWTKSFTAVFDYTIQLGAI
FAVIQLYFHKLNPFSSTKTPRERFQTWRLWIKVAVGFLPALIFGFLLNDFMDAHLLNVWV
VSAMLILYGILFIVIENRQKGIAPKVTDLNKMTYQLALFIGLFQVLSLVPGTSRSGATIL
GAILLGASRFVAAEFSFFLSIPVMFGVTVLKVGSFLAHGGRFTIMQSLVMLIGFVVSWIV
AWFAIKVMMRYIQNNDFKIFGWYRIVVGVLFLLLAVFGVITIA
>A0A0M0W3I0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVVKAIILGIIEGLTEFLPVSSTGHLILAGDLLNFDGEAAITFKIVIQLGAVMAVLIL
YWKRYMEIGANLVRMDFAQSKGLNVIHMILAMLPALILYLLIKDTIKSQLFGPAPVLIGL
IAGGLLMILAARSKRTKTADTMDDMNYRQALGIGLFQCLALWPGFSRSGTTISAGLLLGA
SQKAAADFTFLISVPVMFGASLLDLYDSRNLLNADDLILMVIGFITSFLVALIAVATFIK
LIKRLRLEWFALYRFALAALFYFIVLR
>A0A087LDZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWIELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGFRGRHPGGHPRLTLLHVIVGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKRAARAQTVDEITYKQAFLVGLVQCLSLWPGFSRSGSTIA
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFLSAFVFALL
AIRFLLQLINRIRLVPFAVYRIVLAVVISLLYF
>A0A085VHJ3|FEATURES|UNIPROT_deepARG|beta_lactam|IV01_13870|antibiotic inactivation|1
MTCSFSFPLLASATQPTPNIEAKARAAAEQVMQEYKVPGMAIAVTANGHQFFYNFGVTSR
EAPKQVSDDTLFEVGSISKTLTATLATYAQANGQLSLNDHPGQYLPALKGTAFDKVTLLN
LATHTAGGFPLQVPDEVQSNEQLLTYLKNWQPEYAPGTARTYANPSIGMLGMITAKAMNM
PFVEAMQQQLYPKLRLTNSYLNVPADKLPLYAQGYDKKDAPVRLNGGVLGDEAYGMKTSS
KDLIHFVEANINPAKLDTALARAVADTQVAYFKAGAITQDLVWEQYAYPVKLETLLEGNS
AKMVLETHPAQAITTPLAAQQNTWINKTGSTNGFGGYIAFIPQKKLGIVILANKNYPNEA
RVKLAYQILSELD
>F4Y5N7|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MCSTSKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAAL
QYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMA
ESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIA
VIWPENHAPLVLVTYFTQ
>A0A0M2YNL6|FEATURES|UNIPROT_deepARG|beta_lactam|XB02_00865|antibiotic inactivation|1
MKSFLTALLIAFTASAQAADLSSQTIAERVKSVIDPLMAQQGIPGMSVGVLYKGRPQYIN
FGVADTASDRRVTENTLFELGSVSKTFTGVLAGVLIRNGALRLNDPVSRYWPALNGPQWQ
SRRMVHLATYSAGGLPLHLPDEVTSQDELLAYAQHWQPDAAPGTQRHYSHVSIGLLGYLM
VKGEFEEAMQKDVITPLRLTRTFYTVPPSMMFDYARGYQDGKPVRVSPGMLSAETSGVKS
TARDMMAFMQANANPNGLSSGNTALRNGILTAQSRYLRAGELYQGLGWEIYPWPIDSQTI
VAASDSQAALSTQPATILSPTQPMDRASWVHKTGSTKGFGAYIAFVPQQNSGVILLANKN
YPNPERIKAAVAIMAMLASD
>BAG06200|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MMKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGE
VEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKE
DGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVS
KKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLRDFAKKFHLTTNETE
SRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRV
TIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLA
LVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTL
DDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKF
EKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALE
NNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSG
TAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYEN
GNKKYDIDE
>C5AZA1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKRVLAALVLSGLPHVTAPALAADPSARVAAAVEQAYRPLLKAYDVPGIAVAVTREGHS
TVFTFGLADRQRQRPVTRDTLFEIGSVSKTFTATLVSYAQGLGRLSLDDAPSRFLPELRG
SALDRVSLLDLGTYSAGGLPLQFPDAVADEAAMIAYFRRWQPSAPPGTQRLYSNPSLGLF
GAAAAAAMGGDFAELMETRLFPGLGLKHSFIRVPASESERYAWGYGKDGTPIRVNPGVLD
GEAYGVKSSAADMIRFVEAHLDPTRLDPPMRQAVQGTQVGYFRVGAMVQGLGWEQFPYPV
SLERLQSGNAEPMRFEAQPAARLDPPRTPTGVTLFDKTGSTNGFGAYVAFVPAKRIGLVM
LANRAFPMPARIAAAHAVLEALAAEEP
>A0A0R0BIE2|FEATURES|UNIPROT_deepARG|aminoglycoside|ARC02_10620|antibiotic inactivation|1
MEAPNPFTDGLPLPWAWREALANARIERQSIGVSRADVARVHRPGQPDAFVKSEVIDAFS
ELGDEIARLRWLQAQGQPAPTVIATTEEAGRRWLLMSALPGHDLASSPELAPQELVELLA
DALRGLHALPVVACPFDQRLASRLQAAQARVEAGLVDADDFDDERLGQSAQQVFAELCST
RPDHEDLVVSHGDACLPNLMVVEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A0A2WPN4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVSWPLVSAWEAILLGVVEGLTEYLPVSSTGHLTLLAHALGLDLEHDPFLKSFVIAIQLG
AILAVLLLYWRRFARDLEAWKRILAAFLPTALVGFLLYRLIKDVILGKDWIVVLALFLVG
LLLLFADRALAGRARYQDLDELPLKDAFWVGVFQSLAAVFPGTSRSGITIFGGLLLGLRR
KAAAEMSFLLAVPTMLAATGYDLLRSARDLPQEGYGLLALGFLAALLTALATVRLMLALV
ERLGFAPFAYYRMALALVYALVFLR
>YP_001587496|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>V8C5L6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIILGIVQGITEWLPISSTGHLILVEELIKLQQNDAFKNMFNVVIQFGSIMAVV
VIYFHKLNPFSPTKTQKQKMMTIQLWIKVIIGTLPAMIVGLLLNDWIEAKMSNAYVVAFM
LILYGILFIIIENINAKREPRVTKLSQLSVPTVLLIGVFQMMAMIPGTSRSGATIVGALA
LGVSRGVAAEFTFFLAIPVMFGASALKLFKFGLAFTPKQVFLLLLGMLVSFGVSIIAIKF
LMKYIRNNDFKVFGYYRIVLGIIVFLYFGISALL
>A0A0Q6WY66|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDITLALQALIMGLVEGFTEFLPISSTGHLILAGSLLNFVGEKVKVFEIVIQTGAIIAVM
WEYRVRLASVLSGMFSDPKAQRFIANLVIGFLPAAVLGFLFNKAIKAHLFSPVPVAAAFI
VGGFVILWVEKRAKVNPAAVRVQSVDDMSALDALKVGCAQAFALIPGTSRSGATIIGGMM
FGLSRKAATEFSFFLAIPLLLSATVYSLYKERALLSAADLPMFGVGMVAAFVSAFLCVRW
LLRYISSHDFTIFAWYRIIFGLVVIATDYSGLVVWAD
>A0A0R0CHF1|FEATURES|UNIPROT_deepARG|aminoglycoside|ABB26_03985|antibiotic inactivation|1
MSEGRFQVRRAQVDDWSDWATLRLELWPDSETDMVDLLELIEGEGNTCLLAFDAAGQAVG
LAEASLRHDYVNGTSTSPVGFLEGWYVRDVARNQGIGRGLIEAVARWAKACGCTELASDT
AQDNRAAQDAHRACGFTETERVVYYCMPLPTEPA
>A0A127T1U8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
AGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIY
QGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWP
ELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSS
IGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPG
ALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEML
DWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKEL
GIVMLANKNYPNPARVTAAWQILNALQ
>G9WH86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFEILKAIVLGIVEGVTEFLPISSTGHLILVDEFVKISSDKAFTTTFEYVIQLGAIIAV
VLLYWRRLWPFGNDKTEKQRFNIWATWVKVVVGVIPSVIIGFLLNDWMDQHLMTWQVVSV
ALIFYGIAFILIENFQKSRKPRVSTVSHLTLGDVIKIGLFQVLSIIPGTSRSGATILGGL
SIGVSREAAAEFSFFLSIPTMLGVSVLKIGSYLHDHGMFSVEQIVVLLVGMVISFLVAYV
VIKWLLRFIQTHDFKAFGWYRIILGVVVIIFGFLGVIH
>A0A106HXS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>A0A0D5CAG8|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
AMWQTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDRTG
>YP_002398143|FEATURES|ARDB_deepARG|multidrug|EmrE|antibiotic efflux|0
MLIGRVNSFVSLGFLLIIIVPAFISCHARAPWIHIHQDENGELCSNCSTILSSMNRKEYA
MNPYIYLGGAILAEVIGTTLMKFSEGFTRLWPSVGTIICYCASFWLLAQTLAYIPTGIAY
AIWSGVGIVLISLLSWGFFGQRLDLPAIIGMMLICAGVLVINLLSRSAPH
>YP_001589293|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPAALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>K0NTN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPASFINMFMVVIQLGAILSVI
VIYFNKLNPFAPSKSRREKGQTWQIWFKVIVACLPSIIIGLPLNDWLEANMTTWQVIATT
LIVYGILFIILESYYAKRNPSLTDLNKMTYKTAFLIGCFQVLSMIPGTSRSGATILGAML
IGSSRFVATEFSFFLAIPTMFGASLLKIVKFFKNGHVFVGNQLAVLLVGMLVSFIVAYLA
IKFLLKYVQSHDFKPFGWYRIILGVIVIICGLVFA
>U1S9F1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGLEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWVERIAKLNPDYIFSFYYRNLLSEPLLATARNGAFNLHGSLLPKYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQQKVVIDRTDTGLTLHAKLRDAASNLLRDALP
QLAQGKLAETAQDESQATYFGRRTAADGKLEWKKPAEALFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNDGQAPGRVISVNPLRIACGEDSLVIKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKK
>W1DFI2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTEAAEAEGSHVVA
VLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNR
QDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTF
ARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFG
LLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQ
RVVRQPETASKEEDRS
>YP_001389621|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MNKFGPNPNSIYPNENIKSICYIKNVIKNPNIQVGDYTYYDDINGAEKFEEHVTHHYEFI
GDKLIIGKFCAIAKGIEFVMNGANHRMKSITTYPFNIMGGGWEKAMPTLEDLPLKGDTVV
DNDVWIGQNVTVMPGVHIGDGSIIAANSLVTKDVPPYHIAGGNPCKIIKKRFDDELIDYL
LNLKWWDWSEEKIFKNLEVLCSPDLDKIKSIK
>A0A0J6IKS3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYDIAAVFTHADDPKENNFYASVAQLCARKGIPVHA
PEDANHPLWIERIRKLNAQYMFSFYYRHLLGEELLASVSHGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGDILAQQRVSIERSDTALSLHAKLRDSAAKLLAEALP
LLPEGKLKETPQDESKATYFGRRTAADGLLQWSRPAEELFNLVRAVTQPYPGAFCAVGEH
QLIVWASEVMPGNNGMAPGHVISCDPLRIACGKDSLIINAGQRNADGLYLSGPQLARELG
LVDGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGFKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFT
DVADGIEALARIIENRDGKCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSIENARRLIDWTPTIELSETIGKTLDFFLREAMVEIA
EKR
>A0A0M3F2F1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPPQHEGEGKGRLTLIHILLGMAPAVVLGLIFHDTIKSLFNPI
NVMYALVVGGVLLIAAELLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSFHFLTVGDIPMFAVGFVTAFLVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>ZP_03063004|FEATURES|ARDB_deepARG|aminoglycoside|aadA|antibiotic inactivation|1
MACYDCFFGVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLNIMREAVIAEVS
TQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDL
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDID
LAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTL
SRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFV
HYVKGEITKVVGK
>A0A127SZK6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKAGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>I6YE83|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVMAVAAVLKKNESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A8URP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIKDAFILGVVEGLTEFLPVSSTGHLILTAHVLGLPHDEFTKSFEIAIQLGSILAVVFI
YFERFIKDYETWKRVILAFIPTGLIGFALYKLIKGYLIGNDLVVVINLFLGGIVLILADR
FCERFCYLKDIDELPVKKAPIIGLFQALAVVPGVSRSGATIIGGMLMGLSRRSAAEFSFI
LAVPTMLMATAYDLFKTGGQFESSQWELLGVGFITAFFTAMVSVKLFLKFLNSHGFTIFG
VYRMIVAILYAAAFLL
>A0A0D6WYW4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHLPDPLSVEEIPVGDEKDGPYGIASGADGALWLTFAGSGRIARLTPGGGLRTYALDPPG
CRPTVITPGPDGALWFTRYGDHRIGRVTVDGDSTSFPLPTPDSGPFGITAGPDGALWFTE
TQTDRVGRITVEGEVTEFGLPGAAPGAFPSAITAGPDGALWFTLNQADAIGRVTVDGEVA
TYPLSTSGAAPVGITSDGTALWFTEIGAGRIGRISVDGAIEEFPLPDPAARPHAVVATTA
GECWFTEWGADRVGRVTAGGEITEYGLPTPSSEPHGIAVGPDGALWAALETGGVARVGP
>A0A0M1NF31|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLDSSIEFYQKVFDAKLLVKGRTTAYFNLNGMWIALNAEKDIPRNE
ISQSYTHIAFSIEEADFMNMYEKLIGLNVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLQDRIDYYKQEKAHMEFFD
>A0A0K9Z0Q9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEIFVAFVLGLVEGLTEFAPVSSTGHMIIVDDMWLHSKEMFTKEFANTFKVVIQLGS
ILAAVIVFKDRFLSLLGLKKLSPDGNGPGHKLRLTQVIVGLVPAAVLGLLFNNYIDEYLF
SINTVLIGLVAGALLMIAADWFRPGRPKVSTVDQISYKQALVIGLFQCIALWPGFSRSGS
TISGGVLLGLSHRAASDFTFIMAVPVMAGASFLSLLKHWQYITIESLPFFIVGFISAFVF
ALLSIRFFLKLINKIKLVPFALYRIALAAIIYFFMM
>1CIA|FEATURES|ARDB_deepARG|chloramphenicol|catIII|antibiotic inactivation|1
MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQ
AVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVME
RYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLL
LPLSVQVHQAVCDGFHVARFINRLQELCNSKLK
>A0A0X8K5X5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILIFKAIIMGMVEGITEFLPISSTGHLILADSLLNFWTKDKADLFIVVIQLGAISAV
IYLYWGRLWRALMGLITGKDPERKNPRQLGISLIISTIPIMLIGLMFDKALKAALFNPTV
VAISLIVGGLIIFWAERQQHKHTVKYAEAEDIDIKTAIIIGLIQCLALIPGTSRSGSTII
GSLFLGVSRKASAEYSFFLGIPVLVGAGLLDLTKNHHILTTTEDWTIMAVGVVVSFIFAM
IFIKWLVNWVSTRDFTLFAWWRIVVGVLVLIAGMLGYI
>ZP_00051658|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
AYFGRLWGIATALPSDPKARRFVLAVLVAFLPAAIIGGLFSKYIKFYLFNPWIVCATLVA
GGLVLLVVDDTVGEPKAAPHDGPTESPRKTDVFEFSLPMALKIGIFQCLAMIPGVSRSGA
TIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVAAFVS
ALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAALIIFG
>A0A0I9QQ20|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNHGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AAS61092|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLFGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKSIAIPGAIAQIAVATLLGMGLSHFLGWDLITGLVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETT
NLNQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAY
GAVELFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILVN
EPLAVIASLAIIIFGKSAIAFALVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGL
LSGHGRNLVLASAILSIMLNPLLFTLLDRYLAKTETMEDLILEEAVEEEKQIPVDLCNHV
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVFGNAANADVMALGRLD
CARWLLLTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIA
NSMLNMLKIETLTEEDKMPVCPI
>J1JZ32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIAQWVQSFILGLIEGVTEFIPVSSTGHLVLAGHFMGFHSTNNTFEILIQLGAILAILT
VYCAKLMRIIKALPFDPSARRFVIGVLLAFLPAVIIGILAHGFIKSVLLDSPKLICISLI
IGGIILIIVDCLPIKPRYTDATHYPLSVYFKIGLCQCVAMIPGVSRSGSTIVGALLMGAD
KRSAAEFSFFLAMPTMVGAFAYDLMKNYKVLTWNDGVSIFIGFFVAFIAGVFVVRRLLDY
VSNHGYRLFGYWRLIVGILGLLALTFWG
>K0N9G9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYTVNIENWRVIMFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFISMFE
YVIQFGAILAVVLLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSAVVGLPLNSWMDE
HLHTPIVVATTLIVYGILFIILENYLKNKSAHITTLADITYQTALLIGLFQVLSIVPGTS
RSGATILGALLIGTSRYVATEFSFFLAIPTMVGVSIIKIGKYLWQGNGFSGEQWAVLMTG
SIVSFLVAIVAIKWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>D4E5A5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLIKRLALLSLCLTTLPAFADASDTQAVDQIVQPLMQKYAVPGMAIAVSVDGKTHFYNYG
VASKQNKQPITNQTLFEIGSLSKTFTATLAAYAQNAGKFTLADPASRYLPQLRGSAFDRV
TLQNLATHTSGLPLFVPDNVTNTAQLMDYYKNWTPTQTVGSYRIYSNLGIGMLGMIAANS
LNQPFADAMEQRLLAGLGMKHSFVNVPPRAMADYAQGYNKEDQPVRVTPGPLDAESYGLK
SSSGDLIRYLNANMGLGKVDPSWQQALNDSHKGYYHASEFTQNMMWESYPYPVTLEKLLA
GNDGKVILNGVPAKAITPPQPPVQQAWYNKTGSTNGFSTYAVFIPAQKIAVVMLANKSFP
NEQRVTAVYNIVQTLKK
>NP_645462|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGDNNQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNPQTVDQINYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQITDIPFYILG
FLAAFTVGLIAIKTFLHLINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>B6I9E2|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGCSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>D0EJY2|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-11|antibiotic inactivation|1
MRDTRFSCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>Q3ATR5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELVDVQRSYTIGESEVAALRGVSLTIERGEFVAIMGASGSGKSSLLHILGLLDTP
DKGSYRIAGSDVATLSDDARASLRNHVAGFVFQQFHLLRRMSIEDNVRLPMLYSGVERSS
NLQAEAIRRLEMVGLAHRLHHTPSQLSGGEQQRVAIARALIRQPAIIFADEPTGNLDTRN
SLEIMKILQGLHEEGKTIVMVTHEPDIAAYADRIITMRDGVIISDERKATATVLPSSDSP
FVLPTTAIAAWWHYKRLSGFVAQAMQAILANKMRSLLSMLGILVGVASVIAMMALGEGAR
VAMQEELKAMGSNMLSVRGGSAKIRGTSQGAGAVTRFTVKDVEAIAALRPLVRNASGVVN
GSARVVYGNRNWSSSLLGAGYDYGTMRAALPTVGRWFTAEELQRRDKVAIIGVTVARELF
GESNPLGKTIKINRINFTVIGLAPAKGFVGPQDEDDIVMIPLSTAMYRVLGRDYLSGIFV
EVAEAHRVDEARQRIAAFIRQRHRLPVDDDSFYIRDMTEIQKMLSSTTRTMSLLLGAIAA
ISLVVGGIGIMNIMLVSVTERTREIGLRKALGARNSDIMLQFLVESAGMTLLGGVLGLLV
GIGVALGLTLVAGWAVKISLFSVLLATLFSAVTGLFFGLWPAQKAAALKPVEALRYE
>A0A0P8YMK7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPPRQALLSLRGIGRSFPSGETRVQVLEDVNLDIGHGEMLAIVGASGSGKSTLMNILG
CLDRPSSGSYTVSGHDVGTLDSDALAELRREHFGFIFQRYHLMQHLTATGNVEVPAVYAG
TDGAAREARARQLLARLGLDDRGDHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGAL
DSRSGQEVIAILRELHAQGHTIIIVTHDMQVASCTERIIEIADGRIVGDRPNVPTVAAPE
ATGAAEAPQPVTRPATGGRLSTGWSRFAEAFRMAWRSMMSHRMRTALTMLGIVIGITSVV
SIVAIGEGAKRFVLSDIRAIGTNTLDIYPGRDFGDDKAQSIRTLVPADLQAIAAQPFVHS
VTPATMRSLRLRYRSIDINGNVNGVSDNYFAVRDVQMASGIAFNANDVRHQSQVVVIDQN
TRRKLFPEGVDPLGKIILVGSLPCTVIGVAQEKKSMFGENKQLNIWLPYSTAASRLFGQQ
HFDGITVRIRDEQPTKAAEDGIVKLLTLRHGGKDFFTFNMDSIVKTAERTSQSLTLLLSL
IAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDVLQQFLTEAVLVCLVGGLIG
VLLSYGISFLFSLFVKQWQMIFSLGAVLSAFFCASLIGVLFGYLPARNAARLDPIEALAR
E
>A0A0N1DW81|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSVGIRILSAILLSAGAATSAFAADETKLKAITDAAIKPIIEKYAIPGVAVAITADGQD
HIFNYGVESKDTGRPVAPTTLFELGSISKTFTVTLASYAEANGQLSLSDKVGKYLPAMKG
KPFGDIALMNLGTHTAGGFPLQLPDEIKTEKQLLGYFETWQPSYAAGAQRSYANPSIGML
GYIVAKAMHADFAALMQGKLFAGLGLKSTYIDVPKARLADYAQGYKRSGEPARMTPAVLS
AEAYGVKSTAGDMIRFVGANMGLVKLDEKLQQAITSTHIGYFKAGAMTQDLIWEQYAYPA
ALNDLLEGNSPAMLKTMPVSELRPPMKPRGDVWINKTGSTNGFGAYVAFIPKQRLGIVIL
ANKNYPNEDRVAAAYQILTALSAD
>A0A0D1XH08|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MLRINATTKYGKIKQFLKSMKQPDYRFKQIIHAIFQQRVGYFEQMDVLPKTLREQLINEF
GENILNINPVLEHTSQQVKKVLFRLPDSNKIEAVGMKYHAGWESFCISSQCGCNLDCKFC
ATGAIGLRRNLTADEITDQALYFYLDGHSLDSIAFMGMGEALANGNIFAALDIFTNPALF
ALSPRRITVSTVGIIPTIRRMTRDYPQVNLTFSLHSPFNEQRSSFMPVNDRFPLVEVMNA
LDDHIQVTGRKIYIAYIMLPGVNDSLDHAKAVIELLKGRVKSGRLYHVNIIRYNPTMDAP
VHYGESDEKKVNAFFKKLASAGIHVTVRQQFGIDINAACGQLYGQYQKKAYNNN
>I2KA75|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFQAIIIGIIEGFTEFLPISSTGHMIVASKFLGVSQDALTKAYEVIIQFAAIMAVMLI
YKEKITFKKVALWQKLFVAFLPLAIVGFIFKDQIKTLFTVEVVAWMFIIGGLIFLLLEYF
YKEKEWHISEVEAVTYKQALWVGIAQIFSLIPGTSRAGATIVGGLLVGMDRKASAEFSFL
LAIPVMAAVTGYDLLKHYQDFTDANWGAFIVGFITAFIVAYLTIKLFLAFIQRFTFVAFG
IYRIVFGVILLIYI
>J3GLK0|FEATURES|UNIPROT_deepARG|beta_lactam|PMI31_05012|antibiotic inactivation|1
MDTLKTIAACMALLASGQCAAQDQIETVVNAAVQPVMQAEGIQGMAVAVTVNGQAHYFNY
GVASKETGNPVTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQILPALHGSAFDH
ISVLQLGTYSAGGLPLQFPAEYDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
HSMGQPFDELMEKTLLPKLGLQHTYVHVPQDQMALYAQGYNKDGKPVRVSPGALDSEAYG
VKTSASDLLAYVDANMKPASLEKPLQQGIALTHSGYYTVGNMIQGLGWEMYRYPITLDHL
LDGNATPMAMEAHTVQWLNPPQTQPENVLINKTGSTGGFGAYVAFVPSKDIGIVILANKN
YPNAERVKIAHQILSALPQ
>A0A0R3CBL4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIERSYTGLSLHAKLREAATALLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQADVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNENGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNGVCDGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPSVQMSETIGNTLDFFLREAMLEIA
DKK
>A0A0Q7C1W3|FEATURES|UNIPROT_deepARG|beta_lactam|ASC92_22490|antibiotic inactivation|1
MNPPVQRRSLLLAASVLPLAGACTAWSRTGSPSSAEAQLAELERASGGRLGVAGFHTGSA
ARIQHRAHERFPLCSTFKLMLAAAVLEHSAKDASLLARRIGYGKADLVSWSPITEKHMAD
GMTVAELCAATVQYSDNGAANLLLKMLGGPATVTAFARGIGDQAFRLDRTEPELNTAIPG
DLRDTTTPAAMSDSVQRLALGDALGTAQREQLKDWLLGNTTSTERFLAGVPAGWKVGDKT
GSGSYGSTNDVGVLWPPAGAPLVLSVYLTFPQKDAKGRSDVIASATRIVVAALAG
>NP_756458|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>C4G9Y3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFQILKAILFGIVEGVTEWLPVSSTGHMILLNEFVKLDVSNEFWKMFLVVIQFGAILAVI
LLYWKTIWPVRRSKKTGRHYVSRKTIALWIKVIAACIPAAVVGLVLDDWLDEHLYNWWVV
AIMLILVGLVFLLVEKRNADRQPLVTSLEELTMKDALIIGIFQLLAAVFPGTSRSGATIV
GALSIGVSRKIAAEFTFILAIPVMLGASLLKIVKYLVGGAYFSGMEAAILLTGMLVAFFV
SLVIIRFLMDYIRKHDFKPFGMYRIVLGFAVILYFALLH
>ZP_03079543|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSQIDKVRYMFNKIT
>A0A0X8SEP6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLAQPYEIILVDDGSSDNSADMLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVRVAEEG
YDVVGTVRANRQDSWFRKSASRIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHER
STFIPILANTFARRTTEIDVLHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFVLAVLLIALRLIMGPEWAGGGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQPNHNTQEEE
>Q84EZ9|FEATURES|UNIPROT_deepARG|beta_lactam|AmpC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQEISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMGFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNRETVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVSP
EVLINGSDNKVALAATPVTAVKPPAPPVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNTERVKAAYHILQALQ
>K7ZXK5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGETDVEVLKGVSLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVATLNNDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTGRAA
RQVRARELLTRLGLEARVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVIATLKQLRDRGHTVIIVTHDPHVAAQAERIIEIRDGEIVSNPPAVEKRSGAGLTTQP
HEAAALGQFINSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVL
EDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQRQPWVSSATPAVSQNLRLRYG
NVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQLFPNKASVVG
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSVTVRVKDGYD
SGEAEQQLIRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLV
LPGWEIGFSPVALLTAFLCSSVTGVLFGWLPARNAARLNPVDALARE
>G8B4G1|FEATURES|UNIPROT_deepARG|beta_lactam|IMP-13|antibiotic inactivation|1
MKKLFVLCVCFFCSITAAGAALPDLKIEKLEEGVFVHTSLEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYEIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFIKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLMKRTWEQALKGLKESKK
TSSPSN
>ABD46710|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MRTLKVSLIAAKAKNGVIGCGPDISWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNR
KYAVVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLST
IDIEPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>A7H3S6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYIF
NEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNAQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKGKAQEKLTLKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSVLTMLGIIIGIASVVCVVALGLGSQAKVLESITRLG
TNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGINNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKNTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTMGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVIFGFFPARNAANLNPISALSKE
>BAF36555|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MLRSRVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATAGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGELRSAIAFSETLAKFRSRDARDRGLDHA
>R8HAV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKEVLFGPGPVVISLVAG
GILMIAAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFVTAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>Q2T8C6|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLLQDGDCSRRASPASTFKIAIS
LMGYDAGFLRNEHDPVLPYRDTYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQR
FARYAKAFDYGNADVSGDPGKNNGLDRSWIGSSLQISPLEQLRFLSKMLNRKLPVSPNAV
DMTERIVEATTLADGTVVHGKTGAAYPLLADGTRDWAHGFGWFVGWITRGNQTLVFARLM
QDERKQPVSTGIRTREAFLRDLPRLLATR
>A0A0P6S8Q9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTEPLLQLTGITRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGQETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQL
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDPAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRANERDTTHLLSDEP
VAPKAAASRRLVASLGLFKEAFSMAWVALISHRMRTLLTMLGIVIGITSVVSISAVGEGA
KNYVLKDIAAIGSNTIDVYPGTSYGDKRAAAIETLTPADVTALSQLYYVDSATPMIGRSL
LLRYRNIDLDAQVNGVSDQYFKVRGIKMAAGIAFSESDARRQAQVVVIDHNTRQRLFGQD
VDPLGQVILIGNLPCTVIGVAAQDKSLFASGKTLNVWVPYETAAGRVLGQRYLDSISVRM
KDGQPSKVVEEHVTQLLLQRHGSKDFFTNNLDSVLQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSLFIKEWEMVFSLTSVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>A0A127SIK7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCPLLITASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>R9UV61|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-78|antibiotic inactivation|1
FCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMXSTFKVLLCG
AVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLL
LTTIGGPKELTAFLHNMGDHVTRLDRXEPELNEAIPNDERDTTMPAAMATTLRKLLTGEL
LTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRI
VVIYTTGSQATMDERDRQIAEIGASLIKHW
>A0A140H9G7|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
GAMLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANL
LLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKL
>W1SMW5|FEATURES|UNIPROT_deepARG|chloramphenicol|BAVI_12359|antibiotic inactivation|1
MKFNLIDRENWDRDQYFEYYLNEKCTFSISANIDITALLEHLRNKGIKLYPSFIYMVSKI
VNSHPEFRTCFNDERVLGYWDQMIPSYTIFHDDNKTFSCIWTEFSNEFSVFYENYQEDIK
QYADVKGLFTKENEPKNSFPISSIPWVSFTGFNLNINNEGDFLLPIITGGKYFNLEDRTL
LPISLQVHHAVCDGYHASTFLDELQHLANNCHKWLT
>U6A745|FEATURES|UNIPROT_deepARG|beta_lactam|blaFONA-1|antibiotic inactivation|1
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
MNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDERDTSSPLAMAKSLQNLT
LGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWIVGD
>YP_773413|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVIALFIMLGGAFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTALIEREMNGAPGLLYTSATSSAGAASLYLTFKQGVNADLAAVEVQNRLKTVEARLPEP
VRRDGIQVEKAADNIQLVVSLTSDDGRMSAVQLGEYASANVVQALRRVDGVGKVQFWGAE
YAMRIWPDPVKLAGHGLTASDIASAVRAHNARVTVGDIGRSAVPDSAPIAATVFADAPLK
TPADFGAIALRAQPDGSALHLRDVARIEFGGNDYNYPSYVNGKVATGMGIKLAPGSNAVS
TEKRVRATMDELSAYFPPGVKYQIPYETSSFVRVSMNKVVTTLIEAGVLVFLVMFLFMQN
LRATLIPTLVVPVALAGTFGVMYAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEGLAPYDATVKAMRQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALSLAVSIGFS
AFLALSLTPALCATLLKPVSGDHHEKRGFFGWFNGFVARSTQRYATRVGAMLKKPLRWLV
VYGALTAAAALMLTQLPSAFLPDEDQGNFMVMVIRPQGTPLAETMQSVREVESYIRRDEP
AAYTFALGGFNLYGEGPNGGMIFVTLKNWKERKAARDHVQAIVARINERFAGTANTTVFA
MNSPALPDLGSTSGFDFRLQNRGGLDYAAFSAAREQLLAAGGKDPALTDVMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINTTLAVMFGSDYIGDFMHGTQVRRVIVQADGLHRLDPADV
QKLRVRNAGGEMVPLAAFATLHWTLGPPQLTRYNGFPSFTINGSAAPGHSSGEAMAAIER
LAAKLPAGIGHAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVLGVTLRAMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLVDAALEA
ARLRLRPIVMTSLAFGVGVLPLAFASGAASGAQMAIGTGVLGGMITATVLAVFLVPLFFV
IVGRLFDVGPRRRGGAQPAAMEGSQ
>F0JF91|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAPWYVAIILGIVEGLTEFLPISSTGHLIIAGHLLNFTGPKADTFEIVIQLGAILAVVVL
YWDRFVGLIFPDKSRKFSGVYGLWLLFLTSLPASVLGLLTHHYIKEYLFSPFTVAISLAV
GAVLIFVVEALDLKKTTLTLDEITPKTALGIGLFQCLALWPGFSRSASTIMGGMLLGTKR
TVAAEYSFIAAVPIMFAATGYDFLKNYALFESGDLVFLLIGFVVSFIAAWLAVKGFIVLL
GRLTLRPFAVYRLVLAALILLFL
>A0A0D0MIY4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSIKAVVFAYHDIGCVGLQALLESGYHIAAVFTHADDPSEKTFFGSVAQLCAQHDIPVHA
PEDPNHPLWIERVGKLDPDFIFSFYYRRLLSEPLLACASKGAFNLHGSLLPRYRGRAPAN
WVLVNGERETGVTLHQMVKRADAGPIMAQQRVPISALDTALTLHGKLRKAAANLLSDALP
LLARGRLPGTPQDESQATYFGRRTAADGLIDWARPAAQLNNLVRAVTQPYPGAFCPVGEH
KLIVWSARVEEADHGLAPGTVIDCDPLRIACGEGALVIGAGQRGADGLYLSGVQLAREFG
LVQGSRLQGQNQSRPTRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFSEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVVDGIEALARIIENRGERCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFREVESQSFYGKGYQDVSHRKPCVDNAKRLLDWTPTIELSETIGKTLDFFLREAMAEKA
DQR
>CAL13103|FEATURES|ARDB_deepARG|polymyxin|rosB|antibiotic efflux|0
MHHSTPLITTIVGGLVLAFLLGSLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
AEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVF
GLCLSTASTVVLLRALEERQLIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETT
SLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAY
GAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLR
EPLAVLASLAIIIFGKSAAAFILVRMFGHSKRTALTISVSLAQIGEFAFILAGLGISLGL
MSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPVDLCNHA
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLD
CARWLLLTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIA
NSMLNMLKIETLTEEDKRPLCPI
>M5QSH2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARKGIPVHAPE
DANHPLWIERIRKLNADYIFSFYYRNLLGEELLASVSQGAFNLHGSLLPRYRGRAPANWV
LVKGETETGVTLHRMVKRADAGDILAQQRISIERTDTALTLHGKLRETAAQLLAEALPLL
PQGKLKETPQDESKATYFGRRTPADGLLQWARPAEELFNLVRAVTQPYPGAFCAVGEHKL
IVWGAEVVAGNQGHAPGQVISCDPLRIACGQDSLVVTAGQRNENGLYLSGPQLARELGLV
EGSRLRGSESGRKARRTRVLILGVNGFIGNHLSERLLQDDQYEVYGLDIGSDAIERLRSH
PNFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLVRY
CVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAYGQ
KGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGEQKRCFTDV
ADGIEALARIIDNKGGKCDGQIINIGNPENEASIRELGEELLRQFEAHPLRDNFPPFAGF
RDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIAEK
R
>A0A0Q6L611|FEATURES|UNIPROT_deepARG|beta_lactam|ASG66_02340|antibiotic inactivation|1
MYYRRKEVMTVKKKMMIVIMSLVALLVLSACMKPEKSSESSPEKKKSTVSDETFANIEDK
YDARVGIYAIDTGSDRTIDYRSEERFAFTSTYKALAAALVLKQNTMEELEEVITYTEDDL
VSYSPITEKHVETGMTLAELSEAAVRTSDNTAGNLLFEELGGPEQFKQSLREIGDDVTQA
DRYETALNEFTPGDPRDTSTPEALATSLQGFAVGDLLSDDKRKILIDWMKGNATGDTLIR
AGAPEGWTVADKSGAGRYGTRNDIAVVWPPDREPIIMAIMTRHDTEDADYDDALIAEVAE
VTLEALK
>YP_002401592|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQSGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A127SML6|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DILLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPK
AYSNWSTPSEMVRLLKMADEKNLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVVITPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>W7YVE3|FEATURES|UNIPROT_deepARG|chloramphenicol|JCM19045_309|antibiotic inactivation|1
MTFEKIDLANWKRKETFEHYYQQQTSFSITTEIDLTKLKQALDQHGIKLYPALIFLLTEV
VNSNSVFRTSFNQDGDLGIWKKLNPMYTLFHQTSKTFSAIWTDSSTDFRQFHRNYQADVA
QYGSSETLFPKKPIPENTVSISMIPWTSFTGFNLNINTNKNHLLPIITAGKFEMKDEALL
LPLSLQVHHAVCDGYHASLFMNAVQERADKQSIGLCSSKKQSFNQKVARLISISGGSLPR
RNG
>A0A0Q4XVQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDATSIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAILA
VYFGRLLGIARALPSDPNARRFVLGILLAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVA
GGLVLLVLDETDLEVKKRDVFDFSLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSRDDTGLIVIGFIVAFFSALFVVRTVLDYV
SAHGFRLFAWWRIIVGSLGFFGLIVFG
>ZP_02357857|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLAGMIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
EAVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRNLTADDVVRAIREQNVQVAAGVIGASPTLPGTPLQLSVNAR
GRLQSEDEFGDIVVKTAPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLAISDEVRKTMAELKQDFPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLLFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIENGLTARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGEKEDWLTRLMNRVLGGFFRGFNKVFHRGAERYGRGVR
GVLSRKAVMLGVYLALVGATVMISKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGAIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFDQRHGKALSAGAIAGALN
QQYSAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVNVTDVFDTMQIYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNAAGEMVPLSSLVTVSPTFGPEMVVRYNAYTAADVNGGPAP
GYSSGQAQAAIERIAAQTLPRGVKFEWTDLTYQQILAGDSAIWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGKTPFEAAVQASRLRLRPILMTSIAFIMGVVPLVLSTGAGAEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAQKDSAGYGLPAPDA
>R6V082|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKVIFLGIVEGITEWLPVSSTGHLILVEEFIKLNVSEAFWEMFMVVIQLGAIMA
VVVLYFKKLWPFQNQKKAKGALERYVKTDKMIMWFKIVVSCIPSIVIGLPFNDFIEEHFN
NYLVVSIMLIVYGIFFILIENYNKKRTASINSVVEIGWKTAFLIGVFQLLAVIPGTSRSG
ATIIGGILLGTSRTVAAEYTFFLAIPTMFGASLLKLVKFGLNFTGTEAIILIVGTLVSFV
VSILAIKFLMGYIKKHDFKVFGWYRIALGIVVLLFFSLFR
>W8QQ89|FEATURES|UNIPROT_deepARG|beta_lactam|blaMIR-7|antibiotic inactivation|1
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>V3PSX2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDAIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPAI
LNGTFSETAQDESKASSFGRRTPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVTCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSDQAS
>R9J3R3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKAVVYGIVEGITEWLPVSSTGHMILLEEIMPMKVSEEFWNMFLVVVQLGAILAVV
LLFWNRIFPLQRNRRRQIRIDWNIMSLWGKILVACIPAAIVGVLFDDWLEEHLYNFWVVA
VMLIAVGIIFILVENRNRGVRPMIRTTDELDYKVVLLIGLFQLVAAVFPGTSRSGATIIG
ALMIGVSRTVAAEFTFYLAIPVMFGASFLKLLKFGFTFTGIEIGILLTGMVVSFLVSIVV
IRFLMGYIKKHDFKVFGWYRIALGAMVLLYFGVIAA
>A0A0S4HMB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQPSARRFTANLLIAFMPAVVLGVIFSDLIHHYLFNPITVATALV
VGGVIMLWAEKRQHQVHAETVDEITWQDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGFKYRHLFVPADFPVFAIGFVTAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSAAKP
>A0A108F6U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSIDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWRAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0R1IRK2|FEATURES|UNIPROT_deepARG|chloramphenicol|FC68_GL001087|antibiotic inactivation|1
MEFTKIDLDTWTRKEVFNHFIEQKTTYSMTSNLSITKAVKFAKDNNYDFYPLFIYSIVRV
INSNYLYRMDFNEQGELGYYDNSVPFYSIFDSRTELTSHIDTPDAYTFAEFDRDYLSDVK
KYRGTGKLFPKQLVPKNVVNISMIPWVNYTEFNLNNNSNGNYLLPTVTAGRFERTGSEIK
LPVTFQIHHAVCDGYHTSQFFIKLQDILNNVDEL
>L2E810|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLQIIILACVQGLAELLPVSSSAHVILAEKWLGLDPTSPDMTLMLVMLHTGTMFAVIA
YFWRSWQQTYFSSTKALWNNGVLLAVATAATGVVGLALLYIIKHAVMGGADSFEVEHLFG
NTRLMAVSLAVAGVLIIVSSRRSSTATEDLTGQRALWVGAVQGLCLPFRGLSRSGATISC
GMLLGVERRRAEEFSFALAVVLTPAVIAKEGYRFFKAHAGATDGLLHLLAPSLLGMVFSF
IAGLVALRWLSRWLEQGRWYLFGCYCLVASVVVWTFAG
>I6D187|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLSGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A081J418|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
LVYWQKIRSTVVDLPTSRHAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFI
LGGFVILWAERRPASAMRVQTVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSVDDIPMFAVGLVFSFISAWLCVRWLLR
YISTNSFVPFAWYRIAFGIIVLVTAFTGLVNWSGG
>A0A0A0Q7X8|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-7|antibiotic inactivation|1
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>J7Y272|FEATURES|UNIPROT_deepARG|beta_lactam|IEI_02607|antibiotic inactivation|1
MIVLNKFFNILHYKKAVPVVFLSCATLIGCSDSNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPEHFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKKNTTG
DSLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDTLKTTNK
>A0A0T5XGI7|FEATURES|UNIPROT_deepARG|chloramphenicol|AOX65_09745|antibiotic inactivation|1
MTKITPEYTVVDLSRWARKEHFEVFQGFAQSTFNQTVQLDITVLLKHIKEVGWKFYPAII
SLISHVVNRHPEFRMAIKDDELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVY
AEDVSRYGDNLAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMFTFGKYYNQ
DEKVLLPFAVQVHHSVCDGFHVARMINELQELCDNLPHHSEAPNV
>H6UQN1|FEATURES|UNIPROT_deepARG|beta_lactam|DHA-1|antibiotic inactivation|1
ALLAFSAPXFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQ
PVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATY
TAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQ
LLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLR
WAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVA
LQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAA
QAILSAL
>F1T3S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPAMIELLKALLFGIVEGITEWLPISSTGHMLLLEKFVVLDVSPAFWHMFLVVIQLGAIL
AVCVSFFKELNPFGFSLTKLQRNTIWTLWAKIIVACIPAAVIGIPLDDWMDEHLSSPFVI
AAALVVYGVVFLCLRDSQSNLAMHKGKHAKAVQSEQRRHTFLDKRITTHAIDNLSWKQTI
GIGCFQVLSIIPGTSRSGSTIIGALLMGCSRSVAAQFTFYLAVPVMVGASGLRLVKFFIK
GNTFSTMEAATLAVGCLVAFLVSMAVVKFLMRYIKRHDFSIFGWYRIALGIAVATYFWLI
>ZP_03003683|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITAS
VLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDVGN
VTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A089JJZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLSIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSTELFGQYTANTFKVVIQLGS
ILAVVVIFRNRFIELLGLKHFSRKQLDPVTEEQPPLEKGGHLKLTQVLVGLVPAGVLGVL
FNDYIDEHLFSTSTVLIGLVVGAVLMIIADLFGPKKIQTESVDQITYKQALGVGLVQCFS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLLSLMKNWQYFTIDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIILAAVVYFVFF
>C5VU45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESLLFIIKVIIIGIVEGITEFLPVSSTGHMIIIEDLIKFKEGVEPISLYTKQYKDAFTM
IIQLGAILAIVVLYWDKIKKSFQNFSPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSKINE
KLFNPESVTAALIVGAVWMIFAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGVSTVAAAEFSFFLALPVMFGVTLKSLKDINVFDLSSMHIIGLTVGFIV
SFVVALIVVDKFINFLKKKPMRVFAIYRILLGIVLIVLFLFNVIQL
>A0A0U3EIS7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPVPCSHGFLSVFGAAVLALLGHQAAVADDAARVRSALEPIIGPLMSQYAVPGMAVAISL
HGQAHVLNFGVASKASGQAVTDATIFEVGSISKTLTATLGAYAEATGKLSLSDHPGKYIP
ELRGKAIDRATLLHFGTYTAGGLPLQFPEAVVGQKAMLAYYADWRPAAPPASIREYSNPS
LGLFGLAASHALGTSFASAMETLVFPAFGMTSTFIHVPERAAANYAWGYRGEQAVRVNPG
PMDEQTYGVKTTASDLLRFVQANLDPATLSGAMKRAVQSTQVGRFRAGPLVQGLGWEQYG
YPTSREWLLGGNAEEVIFDPQPVQKVLAGQQQGPRLFNKTGSTGGFGAYVLFVPAAQFGL
VILANKNYPIPARVEAAHAILTALVGERPEGK
>A0A0R1TUE4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVIELLKAFLFGVVEGITEWLPISSTGHMILLDQFVKLDVSKDFYSMFEVVIQLGAILAV
VLIYWSKIWPFHTPQHSAKNATGIWRYVDKDIMIMWVKIFIACLPAGIIGVAFNDTFERL
FYNPTCVALALIIFGIAFIWIEDIHKNHQPKITSIAELSYYTVVLIGFFQLIAAVFPGTS
RSGATIVGALLLGVSRTVATEFTFFLAIPVMFGAALFKLLKFGLAFTPMELWILAVGMIT
AFVTSIIAIKFLMQYIKKHTFKAFGWYRIILGILVILYFWIIK
>L9PHQ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MDIVLALKALIMGLVEGFTEFLPISSTGHLILAEHLLGFHGLEEKMKVFEIVIQAGAIFA
VCWEYRARIAAVLTGLGDPKQQRFALNVLIAFLPAAVLGVLFSKAIKAKLFAPVPVALAF
IVGGFVILWVEKREKDNPAMARINSVDDITPKDALKIGLAQAFALIPGTSRSGATIMGSM
IFGFSRKVATEFSFFLAIPTLLGATVYSLYKERALLSAADLPLFSIGTVAAFVSAFLCVR
WLLRYISSHTFTAFAWYRIAFGLMVLVTGYTGVIVWAD
>F8LZ56|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKQYSDIDLLLTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0D0HFP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFDDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILLAEARQRERGEAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>F3L7I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFEILKAIFFGIIEGITEWLPISSTGHLILVEEFVKLRENAAFLEMFNVVIQLGAIIA
VVVIYFKRLNPFQPGKSAAEIRLTWQLWLKVVIAILPVVIIGMPLDNWFNKHFYNFITVA
LMLIVYGFAFIWIEKRNKTVEPQVTSLARMSYKTALFIGLFQVLSIIPGTSRSGATILGG
ILMGTSRTVATEFTFFLGIPVMFGASLLKVVKFFLKGNVLGFGQLLILLAASLTAFVVSL
YVIKFLTDYVKKHDFTVFGKYRIILGSLLIIYFFVNLFI
>A0A0P4RDX3|FEATURES|UNIPROT_deepARG|aminoglycoside|TPA0598_07_06890|antibiotic inactivation|1
MPQAGYTELVRVAAMSDRPGPWTVSPVLLGVDDGDWLPVTSGESGAAVFRSADATRYAKC
VPAADAAGLKAERDRVAWLNDQGVPGPQVLDWHSGEAGACLVTRAVSGIPADQVSTDDLR
GAWERIADAVRRLHEVPVSQCPFRRGLDAMVAVARDVVARGAVNPEFLPVEQQNTPAAEL
LDRITLQVPRRREQEAADTVVCHGDLCLPNIILDPRTLDVSGFIDLGRLGLADRYADLAL
LLANARETWTDEERGRAADMAFAEKYGIDLDHDRLRFYLHLDPLTWG
>ZP_03048355|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYTELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>A0A0M1RAV7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACETLGKAYEILLVDDGSSDNSALMLTE
AAQAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIALAGFTLSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKVSQEEKHP
>A0A086MER0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSQIIEALFLGLIEGLTEFLPVSSTGHLLLVGHFLGFESTGKTFEVLIQLGAILAILSVY
FNKLWSIAKALPHDPMARHFVIGMLVAFLPAALIGAVLHGFIKEVLFDPWIVCVTLIVGG
FVLLAIDRMPLEATKTDATQFPLSMYFKIGLIQCVAMVPGVSRSGATIVGAMLMGASKRA
AAEFSFFLAMPTMAGAFTYDLLKNYKILSANDAAIIVAGFISAFVAALVVVKMLLDYVSR
HGFTPFAYWRILVGAAGLAGLMVYG
>A0A0R2RYU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLIDVIILAIIEGITEFLPVSSTGHMIIASSFMGIETEDFTKLFTIVIQLGAILSVVVL
YWKRFFQSLDFYFKLMVAFIPAAVLGFLLNDVIDQLLESPITVAISLLIGGFILLKVDSW
FKGNEDFDPKNPTAHTEISYLTALKIGFFQCLGMIPGVSRSGASIVGGMTQKINRKTAAE
FSFFLAVPTMLGATVKKSYDYYTQGWVLSGDQVNYLIIGNIIAFIVAFLAIKSFISFLSK
KGFKLFGYYRIILAITLLVIHFFIHPLSVI
>YP_002040674|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSVVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLGAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>A0A127SB31|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
TTLRALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYAD
IAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLL
HLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSG
LSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTI
EDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGS
GNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNP
ARVTAAWQILNALQ
>CAA90431|FEATURES|ARDB_deepARG|fusidic_acid|fusH|antibiotic inactivation|0
MATLIPKKGSTLLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAF
TARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGI
VEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGE
FRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRT
GAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRV
MSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWG
RFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWK
DLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLE
FGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL
>F9VLI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEILLLLKAVVIAIIEGITEFLPVSSTGHMIIASDIINFIETAGVDFVQMYEVVIQLGAI
LAIMVLYRNKIIDSIVHLKEYGFKMWFYIFIAFLPSALIGILINDIIKSKLFNTFSVSFG
LIIGGIILLFVEKYFSNRNVDKQTKDIGDVTLKQALGIGCFQVLSLWPGMSRSSSTISGA
WIFGCSTKLAAEFSFFLAIPTMIGASVYELFGMDYSSFTSGHAIALVVGFSVAFLVAILV
VDTFIKFLRKYPMKYFAYYRIIIAILLIILVNLNIIKV
>C0C6G0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MCIRREKRMLDIIKVIILGIVEGITEWLPVSSTGHLILVGDVLKPSMSAGFMEMFNVVIQ
LGAIMAVVVLYFHKLNPFSPKKTGKQKMLTWQMWIKVVIASVPAGVIGILFNDILDELFY
KPFPVAVMLILYGALFIIIENRNAHRKPSVNRISDLTVPMLLWIGFFQMLALIPGTSRSG
ATIVGALIIGVSREIAAEFTFFLAIPAMFGASLIKLIKFGFHFTGAEFGLLMLGCVVSFG
LSIVAIRFLMGYIKKHDFKVFGWYRIALGGIIVIYTGVQILLG
>A2TJ33|FEATURES|UNIPROT_deepARG|aminoglycoside|AADA2|antibiotic inactivation|1
MREAVTIEISTKLSEVLRVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLWEAKQDYLGQKEDHLA
SRADHLEEFISFGKARSSSQLVNDV
>C3BTF1|FEATURES|UNIPROT_deepARG|beta_lactam|bpmyx0001_49550|antibiotic inactivation|1
MIVLNKFFNISHYKKVVPVLFLSCVTLIGCSNSNTQSEPPKQTKQENTVNHSFTKLEKEF
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGVLLQKKSIEDLDERIVYTSEDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLRAIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRELLIDWMKRNTTGGNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VIDALKATNK
>A0A0U1XY27|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
GMPAVAKEWQENKSWNAHFTEHKSQGVVALWNENKQQGFTNNLKRANQAFLPASTFKIPN
SLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMS
KMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRIVKQAML
TEANGDYIIRAKTGYSTRIEPKIGWWVGW
>Q0PH70|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-77|antibiotic inactivation|1
FAMCSTSKVMAAAAVLKQSESDKTLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAA
ALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLA
MAQTLRNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPTSWVVGDKTGSGDYGTTN
>A0A0U1YWJ1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGSEDISGNVDSFWPDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0P9NXA8|FEATURES|UNIPROT_deepARG|beta_lactam|ALO74_00598|antibiotic inactivation|1
MPWNKTQLCAALALNASLACAQDPAPDLDAVVQQAAQQVMQENNIAGMSIAITCNGTQQF
YNYGVASKANRQPVSSDTMFELGSISKTFTATLATWAQANGQLSLTDSIDTYLPQLNDTR
LGKIPVFHLGTHTAGGFPLQVPEKVQNTRQLMDYFKAWQPDYLPGTHRTYANPSVGLLGL
VAARSMKLPYEKALQQRLFPALNLSNTYVNVPNEKQKLYAQGYNKLDEPVRVNPGPLASE
AYGVKSSARDMIRFVEANLGPGQYDAPLQRALSDTRISYFKVGGMTQDLIWEQYPMPVGL
GQLLEGNASAMLNTLKTEVIEPPQAAQSAVWVNKTGSTNGFGGYVAFIPEKQLGIVILAN
KNYPNEERVRLAYRILGESGCCSKP
>W1Q4B8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNGIIELVKVIILGIVEGITEWLPISSTGHMRLVDAFMPLQLNKAFTDMFFVVIQLGAIL
AVMVVFFHKLNPLSPSKSAAEKKNTWVLWSKVIVATMPAFVLGFLLDDLMDQYFDKPWVY
AITFTVYGLAFIWVESGKRKAKASRINSLEAISYKDAALMGLWQCLALVPGTSRSGATII
GALLMGTKRYVATEFSFFMSIPVMFGASFLKLVKFGFHYTAAEATYLILGMLIAFGVSLL
VINFLLGYIKKHDFKVFGYYRVALGILVAVLYFLGVFKGK
>J0UYY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLYDSAILGVVEGITEYLPVSSTAHLVLTSQLLDLEQNEFMTSFQIIIQIAPIFSVMLL
FWSRLIASFDLWIKLGIAFVPTGFVGLFFHEQIEALFTSDLTILFMFLTGIAFLIFEFFI
KEERFKFHREEQISFFGALGVGIFQVFALIPGVSRSGSTILGAMIFGFSRELAMRFSFLL
AIPTMGIASAYTFFKSESVVLNNLELLGVGFIVSFLFGIIAIKGFLHVVSNYKFIPFGIY
LIVSAGIFYFFL
>A0A060KTD7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRLDVLASAAKIVTDGL
>A0A0Q6BX31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFVQIAKALVLAVVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAVLAILF
VYFGKLWGIATSLPNDPKARRFVLAVLIAFLPAAIVGGLFSKYIKYYLFNPWIICATLVA
GGLVLLVIDDMVGEPKATPTDESHTDTVETPRKTDVFEFSLPMALKIGLFQCLAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSDDAALIVIGFVA
AFVSALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLIIFG
>A0A0S6V7I1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLAQPYEIILVDDGSSDNSADMLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVRVAEEG
YDVVGTVRANRQDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHER
STFIPILANTFARRTTEIDVLHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFLLAVLLIALRLIMGPEWAGGGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFVQKVVGEQPNHNTQEEE
>YP_001925041|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLVLIAKAIVLAVAEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
AYFGKLWSIATALPNDPRARRFVLAVLIAFLPAAIIGGLFSKYIKFYLFNPWIVCATLVA
GGLVLLVIDDTVGEPKAAQNEGTGDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLIIFG
>A0A0E2BK87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIQFDDLFDIFIQSGAIL
SVLFLYREKFGSQIRSSLRYVTKQNPDPQGFYFLVRIAIGALPILVAGFIAKNFLDTIKT
RSDLLSILAGAWIFGGVLILVAEWFFQKRRGVEEKKPVGFRDAILIGIFQCAALIPGVSR
SAATIVTARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNEVTIPVLTFGFLIS
FLFCTLVIRLFLRYLQKHSFGVFGIYRILLGVGVLVFTKFIR
>A0A086F144|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLICLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLATTLRDEEE
>A0A0F6TV91|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGVQAVLDAGYDIAAIFTHADNPGENAFFGSVSRLAADAGIPVYAPD
DVNHPIWAERISQLAPDVIFSFYYRHLLSDAILALAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGAIVEQQRVAISPDDTALTLHHKLCQTARLVLEQALPSI
KRQETHDVQQNESEATYFGRRTPEDSFLTWNRPATTLHNMVRAVAAPWPGAFSYSGTQKF
TIWSSRVHAQNQNVQPGTVISVSPLLIACSEGALEVVTGQAGNGITVQGAQLAQILGLVA
GSRLNNPSLAASKRRTRVLILGVNGFIGNHLTERLLREDHYEIYGLDIGSDAIGRFLNHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENAGGRCDGEIINIGNPENEASIKELAEMLLESFDKHPLRNHFPPFAGL
RVVESSSYYGKGYQDVEHRKPNIRNAKRCLDWEPTIDMRETVDETLDFFLRSVDLTEHSS
>YP_404705|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLNNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLLEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>YP_002434803|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MHDIFSAVLLGIVEGLTEFLPVSSTGHLIIAGDLLGFTGPKAATFEVVIQLGAILAVVVL
YWDRFWGLLRPKPYVRFAGMRGIVMLGITSLPASLLGLATHHYIKENLFSPATVALALGV
GAVAMLLVERRTHRPVYTGLDDMTPTLALGIGLFQCLALWPGFSRSAATIMGGMLLGARR
GLAAEYSFIAAVPIMFAATGYDLLKSHALFTMADLPFFATGFLVSFLSAWVAVKVFIGLM
GRVTLVPFAWYRLAVAPLVFWFMVN
>A0A0N1CQC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNFIKAILFGIIEGITEWLPISSTGHLILADEFIGLDVTPEFMTMFNVVIQLGAILA
VVYLYFHKLNPFSPQKNALEKRNTWTLWFKVVVAVLPSVIIGLPLDDWLDAHFYNFLSVS
IVLIIYGIGFIVVEKRNKNQTPKCTDLNQFTYKAALIVGMFQVLALIPGTSRSGATILGG
ILIGASRFVAAEFSFFLGIPTMFGASALKIFKFLKDGNAFDLQGTVILLTGTIVSFIVSV
IAIRFLMNYIKRNDFTVFGWYRIVLGVILIGYWLTQL
>ZP_03030251|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVHTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0U1YWH6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVSKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A0J7DK56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFNDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGVGKVTEGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFIVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>A0A060KQ62|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNAAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGW
>A0A0J6BK29|FEATURES|UNIPROT_deepARG|beta_lactam|AB432_03435|antibiotic inactivation|1
MKAHYSKRIGFTVKTILLTLFTLTGCSSPEAPVQKTETQASAMDLKFAALEKKFNARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYSKDDLVTYSPIT
EKHVATGMTLREVADAAVRFSDNTAGNLLFKELGGPKGFESALRQIGDSVTTSERYETEL
NEAKPEDIRDTSTPKALATSLRAYTVGDVLSSDKQTILIEWLQGNTTGDKLIRADVPKDW
KVGDKTGAASYGTRNDIGVIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKVAVDALT
AAKS
>ZP_04299687|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>A0A0K8J584|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKAIILGIVEGITEWLPISSTGHMILVNEFIPLNVSEEFMEMFQVVIQLGAILAVV
ILYFHKLNPFSPKKSKEEKKDTMSIWYKVIIGVMPAGIMGVLFDDWFDQHFYNYITVAIM
LIFYGVLFILIENKNKDKGAEIESFNELSYKTALLIGIFQVLSLIPGTSRSGVTILGAII
LGTSRFVAAEYSFFLSIPVMFGASALKLIKFGFDFTGKEIAILITGMAVAFIVSIIAIKF
LISYIKKNDFKSFGWYRIVLGILVLGYFMVIA
>A0A127SN39|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSIWKRNEYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATVVNR
HSEFRMTINQAGELGIYDEMLPSYTIFHEDTETFSNLWTEYVPNIEEFSRAYENDIRLYG
SNHGMIGKPDVPENVFTVSMIPWSTFESFNLNLQKGYRYLIPIFTLGKYYMEDGRIMLPL
AIQVHHAVCDGFHICRFVNELQELINS
>A0A0M2ZWN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTLEKREMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAVTVAIA
LIVGGFVILWAERRQHKIISPEVEDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAILVVGIIVAFVSALIVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>B2VBI9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDIGCTGIRALAEAGYEIAAIFTHADNAAENHFFASVARTAAELGVPVYAPE
DANHPLWVDRIRGMKPDAIFSFHYRHMLNDDIINSASLGAFNLHASLLPKYRGRAPLNWV
LVNGEQETGVTLHRMVKRADAGAIIAQNTVAIADRDDALTLHRKVCAAAGELLAEALPAI
KIGEFSEHQQDESQASYVGRRTPEDGRIDWHLPAQRVYNLVRAVTDPWPGAFGYVGTGKF
IVWQSKIHYDRAAAKPGTVLSVAPFVVACAEGALEIVTGQSESGVYMQGSQLAQTLGLVA
GARLYNHPAAVAKRRTRVLILGVNGFIGNHLTERLLVDDNFEVFGLDIGSDAIGRFIGHE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDASFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDI
HDGIEALFLIIENKQKNCDGQIINIGNPENEASIKQLAEQLLESFERHPLRDRFPPFAGF
REVESSTYYGKGYQDVEHRKPSIRNAKQLLNWQPTIAMDKTIDDTLDFFLQSVEPGDAEE
>F5LIJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEVFAAFILGLVEGLTEFAPVSSTGHMIIVDDAWFQTKDLFTPQAANTFKVVIQLGS
ILAVVVLMRDRFMNLLGLKKLPGQDEGGPRLNLLQVIVGLIPFGVLGVLFEDYIDEYLFS
TRTVVIGLVLGAVLMLVAEWRRPVVPKTDTVDRLTYKQALGMGLFQCLAMWPGFSRSGST
ISGGVLLGLSHRAAADFTFIMAVPIMAGASFLKLLKSWDSIPAEAIPFFAVGFVSAFVFG
LISIRFFLKLINRIKLVPFAIYRLVLAAVIYMVLL
>YP_001345921|FEATURES|ARDB_deepARG|multidrug|mexB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDT
VVQVIEQQMNGIDNLRYISSESNSDGSMTITVTFEQGTDPDIAQVQVQNKLQLATPLLPQ
EVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGS
QYSMRIWLDPAKLNSYQLTPGDVSAAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRL
QTAEQFEKILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANAL
DTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMAL
SVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAP
YLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSTAERTQVVVDSMREYLLE
KESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKD
AMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLASQNPALQRVRPNGM
SDEPQYKLEIDDEKASALGVSLADINSTISIAWGSSYVNDFIDRGRVKRVYLQGRPDARM
NPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAM
AAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVE
AAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWV
PLFYVAVSTLFKDEASKQQAEAEKGQ
>YP_039790|FEATURES|ARDB_deepARG|multidrug|mepA|antibiotic efflux|0
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
VFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVALPFSDQ
IAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNI
ILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEI
FKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPL
IAYNFMSNKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHHMVGLFTTDQAIVEMATFILK
VTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGVVIIPVLFIMNALFGLTGVIWSLL
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>A0A0R1WAZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESKAFINMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNHREKSQTWSIWFKVLVAILPSVIIGLPLNDWMDAHLTSWQVISA
TLLIYGILFIVVENWLKDKRPQTADLESLSYKTALEIGLFQVLSLVPGTSRSGATILGGM
TVGTSRFVATEFSFFLAIPTMFGASLLKIVKYFMKGNVFTGSQTIILLVGTLVSFIVAYA
SIKFLLDYIKRNDFKAFGWYRIILAIIVIAYFGIKAMVA
>Q9LAR7|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-21|antibiotic inactivation|1
LLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKV
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEFCAAAITMSDNSA
ANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEAFPGDARDTTTPASMAATLRKLL
TSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASERGARGIVALLGPNNK
AERIVVIYLRDTPASMAERN
>A0A0Q5D274|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSKFSCLVAFSIAVLASCGSVAKADEFAEKAQASFEPVIKEYGIPGLVVGVTRNGKHEFY
AVGLASRADNRPATPDTLFELGSISKIFNVTLAALAEERGKLSLSDTVAHHVCVDACSIG
DKLTLMDLATHHSGGLPLQVPDNVSNVDGLVSWLKDWNPPQPGTRSYSNVSIGMLGYISG
KAMGSNYKQALQDVLFPAFGLHHTWIDVPKSDMNRYAFGYDRKTNAPIRVSSGVLDSEAY
GVKSSVRDMLTVLDVELGHGKAPDELRNAIERTHEGQYKTAFFTQDMIWEQYPWPADLQT
MTSGNGYDFIMKPQPAEKISPSLAPQKNVILNKTGSTNGFGGYIALLPSEDIGVVVLANK
NYPNEARVRATYSLIQALLAN
>ZP_03064101|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNDYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>A0A127SS60|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-11|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWVIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0M1ULT3|FEATURES|UNIPROT_deepARG|chloramphenicol|ABED_0729|antibiotic inactivation|1
MEYKKFDINSWNRKEHFEHYRNLQCSFSLTSEIEITKFLQYLKENKYKFYSSIIYLITKL
VNLTFEFKISIKNNEIVTWDVLHPSYTIFHQKEETFSSIWSEYSDDKTIFFNEFEKDCTN
YENNKSLFPKFNIPENHFNISCLPWIKYSGFNLNLPYLNDYFQPIITIGKYDKNENKIVL
PITIQIHHAVCDGFHVAKFINKLQEWCNEPEKHL
>W4BKL0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIVKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLTSQEFLGKYTANSFKVVIQLGS
ILAVVIIFRNRFIDLLGFGKLSRKDLAVVPEGQRQAPAEGRLKLTHILVGLLPAGIFGFL
LEDYIDEHLFSTFTVLIGLVVGALFMICADRFAPANARTESVDQITYRQALSVGLIQCIS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFVFALVSMRFFLKLINRIKLLPFAIYRIVLAGVVYLIWF
>A0A071MGT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVMSVDALTPLDAFKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0A8RF76|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDLNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETHTGETLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTRADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEL
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGPQMRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNVASIRQLGEELLRQFEAHPLRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>BAE92844|FEATURES|ARDB_deepARG|beta_lactam|PC1|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>I6ZRK9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-135|antibiotic inactivation|1
PFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNXGKILESFRPEERFPMMSTFK
VLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNT
AANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPAAMATTLRKL
LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDG
KPSRIVVIYTTGSQATMDERNRQI
>YP_001451669|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MTRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADQSGRKPVAIAGAVIFIIASMLCSRATDGSLFLTGRFIQGIGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIVPVLAPVLGHLIMLKFPWQSLFYTMIAMGIAVCLLSVFILKE
TRPATCSSTSRPQQNAESLLNRFFLSRLAITTLSVSVILTFVNTSPVLLMEMMGFDRGEY
ATTMALTAGISMAVSFSTPFALSVFKPRTLMLTSQGLFLAAGIVLSLSSSHAVTLFGLTL
ICAGFSVGFGVAMSQALGPFSLRAGVASSVLGIAQVCGSSLWIWLAAVIGFNALNMLIGI
LIGCSMVCILLLMTIQPAAHYEKIHHQSRS
>A0A0M4GA36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLWEFFVALILGIVEGLTEFAPVSSTGHMIIVDDLLLQSKELFNEPVANTFKVVIQLGS
ILAVVIVFKDRILNLLGLTKKDIGTTEAKDQLGLKKLFVGILPAGLLGVLFEDYIDEYLF
SVNTVVIGLVLGAILMIVADYMRPKTPKVNTVDEITYLQALAIGSFQCLGLWPGFSRSGS
TIAGGVLLGMSHRAASDFTFIMAIPIMAGASGLSLLKNWEYFSIDVLPFMATGFIAAFIV
ALISIRFFLKLINRIKLVPFAIYRIVLAGLIYMLYF
>A6F242|FEATURES|UNIPROT_deepARG|beta_lactam|MDG|antibiotic inactivation|0
MNLQPIFSQAGAALLALFVLSLGSVAQADDWSPTLQKEIERIDRTFSGDLGVYIRHLGTG
QKVSHNIDQDWYLASTVKIPLAIVLMQRAENEGLDLEQKLTLRAADYVDGTGDLLWVDPG
ARYSLEELNRRSIVDSDSTATDMLIRFLGEKSFGEDVARLVPEGLGPITTILQVRYDAYR
EVHPSVSVLTNRDFIDLKTARTYQARYDMLLEKLNITAREADAKGVREAFERYYQRGINS
GSLEAFGALLEQLVRGELLNDAHTDQLLGYLSEITTGDHRIAGGLPAGTHFAHKTGTQVA
RSCDIGLLNPQAPDEAVIVAVCARDYAALSEAERAYQAIGNALHESGLTRTVD
>ZP_04233793|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MKGMMILKNKRMLKIGMCVGILGLSVTSLETFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIASNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIVILSSKDEKEATYDNQLI
AEATEVIVKSLK
>D5V6L4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQIIDSVILGIIEGFTEFLPISSTGHLIVASEFLGLKQDSMNKAYEVIIQFAAILAVILN
YPDKFSIKKIELWKKLILAFIPIGAIGFLFSHQIKAMFSIEIVATMFIIGGIVFLIVEKF
YDEKKSHITDVEQVSYKQALYIGIAQIFALIPGTSRAGSTIIGAMLVGLNRKASAEFSFL
LAFPVMCATTGYDILKHYKDFTDANLMILAIGFVVAFIVAFLTIKLFLKFLQNFTFVAFG
IYRIIFGVILLLIFT
>A0A0N2CX29|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MANIIEIKQLNRSFGEGENCVHILKNISLSIKKGDFIAIMGQSGSGKSTLMNIIGCLDAP
TSGSYKIHNNETVELSQNQLSDLRSQTFGFIFQHYNLLSSLTAAENVALPAIYAGMPQTQ
RLTRAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSG
ENVMKILRQLHSEGHTIIMVTHDRDIAASANRVIEIKDGEIIGDTQPHPVKSAVKNSGVF
KGRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILEN
IKGIGTNTMTIFNGTGFGDRRAEQMQNLTVNDSNALSNQSYVQSVTPNSASSGTLIYGNQ
TFSSTSLKGVGEQYFDVEGLTLKLGSTFTQEDIRENHSVALIDESTKKSIFPHENPLGKI
VMFNKRPLRIIGVVSDRQIGGASSSLNIYAPYSTVMNKISGSKKIASITVKVSDSVNSAV
AEKGITELLQMRHGKKDFFIMNSDTIKQTIESTTSTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLIGGVTGILLSGVIGLLFNTFMSD
FAMAFSSASIIAAVAFSTLIGVVFGYMPAKRAAQLDPITALARE
>A0A0A8XHJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESKQFEHKTDDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTADNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSA
>D4YXJ5|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVGMGLLRREPASWRFLRNLLVAFIPAAVIGLALHNYIEELLGAPRVVAWALI
AGGIAILGIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGISRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKNGDKLTSATVGWGSIVLGFIVSFIVALLVIKWFV
GLVSRHGFAPFAWYRIVAGIAALAWLSLR
>N9LBM9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTPEKSAVFVVLIQIGAIAAV
IYEYWSRLWNAATGMVTGEEKGRRLGFSLIFASIPIVLVGLTFGQVIKEVLFNDLVVALG
LIIGGLIIIWVEKNPPRINAAEVENITFKQAIWIGLIQVLALIPGTSRSGATIIGAMYLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYHVLDGFDDWIVLAVGLIVSFISALLLIRAL
VAYVAKRDFMVFAWYRIASGLLILLLFFTGWKLW
>AAK38457|FEATURES|ARDB_deepARG|quinolone|qacB|antibiotic efflux|1
MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIV
DIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIA
GALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLIN
VPFTIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIP
WVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQW
LQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFF
GHPLSYSTMALALILVGAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAV
LGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFND
AFVATALVGGIIMIIISIVVYLLIPKSLDITKQK
>K2PVD6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLQAIILAIIEGLTEYLPVSSTGHMIITSSFFGIADDEFTKLFTIVIQLGTILSVVVL
YFKRFFQSVDFYLKLLAGFIPAVVLGLLFSDLIDTLLESPLVVAISLLIGGIVLIKVDDW
FGDEQGTEISYKTAFKIGLFQCLAMIPGVSRSAASIIGGMSQKLSRTAAAEFSFFLAVPT
MLGATAKKGFDYFNDGLTLNSEQIELLIIGNIVGFIVALFAIKTFIGYLSKHGFKIFGYY
RIFVGILLLVIHYFISPLSI
>A0A0G8EQ15|FEATURES|UNIPROT_deepARG|beta_lactam|B4077_2467|antibiotic inactivation|1
MIVLNKFFNILHYKKIVPVLFLSCATLIGCSISNTPSEPPKQTKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDAHDTSTPKALATSLQAFTLGEVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWKVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>A0A0N9WQJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAVQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGEREKAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTVNLLIAFMPAVVLGVIFANMIHKYLFNPITVATALV
VGGVIMLWAERREHSVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFQAMPTMVGAAVYSGYKYRDLFQAADLPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIVFGLLILATWQFGWVDWAAATS
>W4RXH8|FEATURES|UNIPROT_deepARG|aminoglycoside|XPU_0115|antibiotic inactivation|1
MLIRAATLADAAMWATLRTQLWSGTTYFNNWAEALLILEEADDERAIFVVIDEQDRVCGF
VEASLLYKQVKGGSAPPVAYIDGLYVQEVRRREGLGAYLMIAIQTWARERGCTEISSDGA
FGDVRSEMFHAALGFEETERVVHYRKKL
>R5R8C3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIEILKVIFFGIVEGITEWLPISSTGHLILVDNFVKLNVSEAFWQLFLVMIQLGAVLA
VVLLDFEKLWPFHKKDPERESNWKYISENKKLAEVQKFTDHYVDMNKIVLWLKILVSCVP
AIIIALPFNDWIEEHLEHDVVIATTLIVYGILFIVIENYNKKRTPTRKKLSDITFKDALF
IGVFQLLAVIPGTSRSGATIIGGILLGTSRKLAAEYTFFLAIPTMLGASLLKLVKFGLGF
TGTEIIILLLGMAVAFVVSILAIKFLMGYIKKHDFKVFGWYRIVLGAVILGYYFL
>A0A0F4IE16|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRTRPSPKGPHLTPRATAHLLSSHAVTAGAGPYALAAGPDGAVWCTLVHAGRIARLAPDG
RIDEFPLDSSDCGPSLITAGPDGALWFTRNRDHRIGRITTDGRARSHALPGAAPGPYGVA
AGPDGALWYTTLHTHSIGRLTPDGEVTEYPLPGTGSFPSFLVAAPDGALWCTLNQAHALA
RITVTGDVRLFPLPTDGAAPVGLAAGPDGSLWFAEIGAGRIGRLDPSGPGAAVTEYPLPD
AQCRPHAVAVAPDGACWFTAWATGRIGRVTTDGQVTEATLTDPGCEPHGLAFGADGTLYV
AQESGDITRWDVTGPTEA
>A0A151AN96|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLIFIFKAIIIGIVEGITEFLPVSSTGHMIIVGHLIGFKEGMLPKELYTKQYIDAFTM
IIQLGAILAIVVLYWNKISSTFQNFSPKKTKSGFKFWLNVCIACIPAAFLGVVLGLDDII
EEKLFNPVTVTVALLVGAIWMLYAEKRYRGKFTTKSIDDVNVKQAFIIGAFQCLAMWPGM
SRSASTIIGAWIAGLSTVAAAEFSFFLALPVMIGVSIIKLIKINILALHSMQIIALTVGF
VVSFVVALIVVDKFISFLQKKPMRVFAIYRIFIGIILLGLILLNVL
>A0A127SSQ5|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYTGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYANWSTPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>A0A098YME1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIIEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIVSGEPQGRRLGIGLILASIPIILIGLTLGQTVKQLLFNDIAIAIG
LIVGGLIIIWIEKNPPQVRVHEVEELSIRDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVLNTTEDWTVIGVGLLVSFISALILIRAL
VAYVAKRDFMIFAWYRIASGLLILLFAYTGWKLW
>U3BFD9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MCVRKLTINAIALAMLFAPVVNAAGVGEKLKNEVDKQAQALMQNYHIPGMAFGVVIEGKA
YFYNYGVADKAQNQPVSEATIFELGSVSKTFAATLASYAQVKGQLSLTDTAEQHMPELKG
STIGARTLQELGTYLAGGLPLQFPDAVKNNQDMVQYYRNWGEVYPRNTKRLYSNPSIGLF
GYIAALSLKEDYASVMEKNVFPALSMSNTYINVPDNKMKEYAFGYNANGEAVRVNPGVLD
AEAYGVKSSSSDMVQYIKANLGLAVVAPDMQQALVNNRTGFYQSRTFTQGLAWEMYPYPS
ILNALLEGNSTDVVIKPQPIQINMPPTPPTNEVWVNKTGSTGGFGAYVVYIPSKEAGIVI
LANKNYPNQERVKAAFHILQAGLEQ
>A0A0H5IYS0|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIIDVVTGLPAQREARRFTMNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEGRQRERSEPARVQSIDALTPFDALKVGLAQCCALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRLAFGLFVLLVGYSGWIEWT
>A0A0A1A709|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>U2LZF7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELSDIRRSYQSGDQTLEVLKSVSLRIEAGEMVAIIGASGSGKSTLMNILGCLDKP
NSGIYRVAGQDVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGMNNSA
RHARAAALLQRLGLGERIAYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
KEVMTILKQLCEQGHTVIIVTHDPAVAQQAERIIEIHDGEIIGDSRPQGQGKAQAKSLEL
ATPAPSWQQMADRFREALSMAWWAMAANKMRTLLTMLGIVIGIASVISILVIGDAVQQQV
LAEIKSIGTNTVDVYPGKDFGDDDPTLRQALKYDDLSALHAQPYISALSPMTRSSMRLRF
GNIDVAANVAGVSEQFFRVYGMEFSQGAAIDVRQVESQTQTVVIDTNTQRRLFPQQKNVL
GEVILIGNMPATVVGVAKEKQTMFGSSKMLSVWVPYTTMANRLMGNDYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLILVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIESVLVCLVGGILGIALSFTIGLLVQL
AMPGWQINFPPVALLSAFLCSTGIGVVFGYLPARSAARLDPIDALARE
>E0LV98|FEATURES|UNIPROT_deepARG|beta_lactam|PanABDRAFT_1092|antibiotic inactivation|1
MKKSVFYFALLSLSASCVAADLSSQQVTSLVKAAIEPLMEQQAIPGMSVAVLYKGRAQFV
NLGVADLASGRQVTENTLFELGSVSKTFTGTLAGILIRNGDIRLNDPVQKYWPQLTGEQW
RPVRMLHLATYTAGGLPLQLPDEVTDQASLLRFYQEWQPKASPGTLRQYSNASIGLFGSL
MVKGDYEQAMARNVFQPLRLTRTYITVPPSMMLDYAWGYKKGQPVRVSPGMLDAEAYGVK
STARDMLTFMQANVDPNRLSSGNTVLRNAIRTAQSRYFKIGSFWQGLGWEIYDLPATADT
IISDSDNGVALQPRPATLLNPVGPSLNASWVHKTGATNGFGAYIAFIPEQNSGIVMLANK
NYPNPLRIKAAWQILQALHQGTP
>A0A0K0N4E3|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
SVFXXPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVL
SRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTT
IGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTL
ASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVI
YTTGSQA
>J9C608|FEATURES|UNIPROT_deepARG|beta_lactam|IGE_02454|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
NLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELAAASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>V5NA29|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
PNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPAS
VTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQL
VTWMKGNTTGAASIQAGLPASWVVGNKTGSGGYGTTNDIAVI
>YP_878662|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
IIQLGAILAIVVLYWDKIKRSFENFAPSKPKSGFKFWLNIAVSAVPAGVLGLKFHSKINE
KLFNPGSVTAALIVGAIWMIFAEKRYRGKFTTKDIDNVTIKQAFIIGCFQCLALWPGMSR
SASTIIGAWIVGLSTVAAAEFSFFLALPVMAGVTYKSLKDINVFALGSMHIVGLTVGFIV
SFIVALIVVDKFITFLKKKPMRVFAMYRILLGIVLIILSLFNVISM
>A0A104NLF8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNFGIKRALAAALFSACAVATTGYAANDRSDTVKGAADSVILPIMTKYGIPGMAVGIVAD
GRSYVFNYGVASRQDQRPVTRDTLFEIGSVSKTLTATLASWAQATGQLSLSDKTEKYLPN
LQGSPFGHVTLLELGTHTPGGMPLQVPDNVRNEAQLMRYLKAWQPAYPPGTRRTYSNVSI
GMLGLITAKSMGQQDFAVPLSRHLLSPLGMNNTYIEVPKARMADYAQGYAKDGAPVTTDG
DVLSSKTYGIKTTAADLLRFVQAHMGDVKLDKPLQQAITDTHTGYFKAGPMTQDLIWEQY
PYPVALKTLFAGNSPSLTFNATPVSKITPPQAPQAPVWINKTGSTDGFGAYVAFVPARHM
GIVILANRHYPNEERIAAAYRILTSLGLAAR
>A0A0H5EUX2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIINTLIFTSIATFPLYTLAQTKLTELQVATIVNNTLTPLLEKQGIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAGNDKLKEAIIASQSRYFQAGDMFQGLGWEM
YSWPINPQGVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>N9Q137|FEATURES|UNIPROT_deepARG|aminoglycoside|F892_02745|antibiotic inactivation|1
MKIMPVTEPLLADWLQLRILLWPDDEDAHLLEMRQLLEQPHTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGVATTLVQQVEDWAKQFSCTEFASDAAIDN
TISHAMHRALGFQETERVVYFKKKIS
>A0A072BXY4|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPANRDYAAKLTVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKQITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDLTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIA
>A0A0P9B448|FEATURES|UNIPROT_deepARG|beta_lactam|AN402_4634|antibiotic inactivation|1
MIVSKKVFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSEPSKQTKQENTSRHSFVKLEKEY
DAKLGIYALDTDTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVGTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPK
RFEPELNEVQPGDTRDTSTPMALATSLQTYALSDILPTEKRNFLIDLMKRNTTGDNLIRA
GVPEEWEVADKTGSGAYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLNALKITNK
>D2K8A8|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLICGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A085P284|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFIEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>Q8VQB9|FEATURES|UNIPROT_deepARG|aminoglycoside|ant(3'')-1b|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLVVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEQFFDPVPEQDVFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>AAM15533.1|FEATURES|CARD_deepARG|aminoglycoside|PvrR|resistance by absence|0
MSWKSYRVLVVEDQPFQREYLLNLFRERGVQYLVGAGDGAEALRCLKQDRFDLILSDLMM
PGMDGIQMILQLPYLKHRPKLALMSSSSQRMMLSASRVAQSLGLSVIDLLPKPTLPKAIG
QLLEHLERCLRQKLEPETDETPHGRTALLDALHNEQLVTWFQAKKSLHTGRIVGAEALIR
WSHPQHGLLLPSCFMSDVDATGLHEALLWRVLEQTLNAQESWRRAGYEIPVSVNLPPHLL
DNQELPDRLYEYVGARGACTSSLCFELTESSVTTLSSNYYAGACRLRMKGFGLAQDDFGQ
GYSSFYNLVTTPFTELKIDRSLVQGCVEDNGLNAAVISCIELGHRLNLDVVAEGVETCEE
LNLLRRLGCDRAQGFLISKAVSAREFERQLREDGPSLLV
>A0A0A2EFR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLLESVILAVVEGLTEFLPVSSTGHMILTEGLLGMESTPYLRAFIVMIQFGAILSVVVL
YWKRFFNFRKPSAGERDSRYAGLTGWNLYLLMIIGLIPAAVMGLLFESYIDRLLGSMWVT
VAMLFVGGVFMLFMDTFFIQEKKPVVTPKKALIVGFFQCIAMIPGVSRSMATIVGGMQQR
LTRKQAAEFSFFLAVPTMFGATVLKGYKLYKEFGIQIFYDNMLTLITGNVVAFIVAMFAI
KFFIGYVTRKGFKIFGYYRIVISLLFMMLLLTGVVTA
>E8LDY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLNLIAVIVGIVEGLTEFLPVSSTGHMIIVGHVLGFEGQLADVFDVFVQLGAILSVVFI
YKERFARFFTKDGWDINKGLSVWHVAAGIVPVMLVAFFLYHYIKEYLFSPFTVAIGLFLG
GLLLMFAEYRTKGREAELVDDVDKISIRQAVWVGIYQFLSLWPGFSRSGSTIAGGLLVGL
TRSAAANYTFVIAVPLMFVACIYDLLRNLQYLSAGDMQVLAIGFVVSFIVAYISVLWFLK
FLQNSKLTSFAVYRILLAGVTYWYFYM
>A0A0A0E3R5|FEATURES|UNIPROT_deepARG|beta_lactam|NP83_07915|antibiotic inactivation|1
MRKTHNIFSMNNFIHALLVLVVAIVSLGGWSATNKLSGKPEKAVTKTLAPHIHREFGELE
SKFDARLGVYAIDTGTNQTVSYRSHERFAYASTYKALAAGALLQQYSIDQLEELVTYNSE
DIVSYSPVTELHVDTGMTLGEVIEAAVRYSDNTAGNLLLEKLGGPEGFETALRQIGDKVT
EADRYETDLNSAIPGDTRDTSTPKSLATSLKAFAVSDLLPTEKRKILTDWMRGNATGDAL
IRSGAPTGWEVADKSGAGSYGTRNDIAIVWPPNRAPIVIAVLSSRDTQNATYNNTLIAEA
AKVALNALK
>AAP97133|FEATURES|ARDB_deepARG|beta_lactam|cphA7|antibiotic inactivation|1
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINNNYHTDRAGGNAYWKSIGAKVVSTRQT
RELMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAATHS
>A0A0P7KUT7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MTIQSINHLLFSVSDLEKSIAFYENVFDAKLLVKGNNTAYFDVNGLWLALNVEKDIPRND
IIHSYTHIAFTISEDEFDKMYDHLVQLKVNILDGRQRDEKDKQSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKLHMEFFDN
>B9KCF3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIRLENIQKKINNTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DAYEVTNLNKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKHERSQKAKE
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTVVLVTHDREIAARAKRVIEIKDGKIISDNGAKKADEIKAKLMPKEKKSFNL
LKNQLFESLKMSVASIIAHKLRSLLTMLGIIIGIASVVCVVALGLGAQQNILASISSIGT
NTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEADVGKIGVVTYKNNSLQARIY
GVGPNHLRLRGFVMVDGRFINNEDIKDNTNICIIDENALRILFDNISAKDVLGKSVIFNK
QPLTIVGVLKKERDNKGFRADENTIKIYTPYTTLMNKITGDKQIRAIVTKVKDEVNPTLA
EEAMVKILEIKRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIML
VSVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAIFGVMLSFIIIEVFNSLNFGF
TMILSLNSVFLGLLSSVLIGVVFGFFPAKNAANLNPISALSKE
>NP_460125|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGDVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>K0WHJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTFIQVLILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRPKIFDIVKGLPTQRNAQRFTLNLLIAFLPAVVLGVLFADKIHQYLFNPITVAMALV
VGGIVMLWAEQRNHVVSVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQASDLPVFALGFVIAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWVFGWVNWTEVAA
>H9UUK0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASLRKTSAAPSFPTVCGL
SRCRK
>A0A140IK99|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIRLDCL
>A0A0U1I593|FEATURES|UNIPROT_deepARG|beta_lactam|ampC_2|antibiotic inactivation|1
MMKKSIITTLVLTAIAAAPLSTSAQTKLTEQQVAAIVNDTLKPLIEKQDIPGMAVAIFYD
GKPQFFNYGVADIKAGTPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTDYAPE
LTGSQWKAVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPEWAPGEMRNYSNASI
GLFGALAVKRSQLTFEEYMTKNVFQPLKLNHTFITVPESMLPNYAWGYKEGQPMRVTLGM
LGEEAYGVKSTTKDMVRFMQANMNPESLPVENDKLKQALIAAQSRYFQAGEIFQGLGWEM
YNWPIDPQRVIADSGNDIALKPRKAKELLPPPPAVRASWVHKTGATNGFGAYIVFIPEQN
IGIVMLANKNYPNPVRVQAAYNILQALR
>A0A0M9B0C3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSKKAVVFAYHDIGCAGIDALLGAGFEIAAVFTHADDPKENAFYGSVAQLCANKGIPVHA
PEDANHPLWIERISKLNPDYIFSFYYRNLLSEPLLATASKGAFNLHGSLLPLYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAIIAQQKVGIERSDTALSLHAKLRDAASSLLRDTLP
ALLQGKVSETPQDESKATVFGRRTPADGKLVWKKPAEELFNLVRAVTQPYPGAFCDVGEH
KLIVWGAQVAKGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDARFDEDTSNLVLGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIDNAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>K1J515|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFDGPKAATFEVVIQMGSILAV
VAVFWRRLFGLIGIHFGQKPAQGHATLSLVHIILGMLPAVVIGLAIHSWIKAHLFGPQTV
MYALVAGGILLIIAEKFRPAVRSETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRQAAAEFSFILAVPMMVAASGLDLYKSRDFLSMADFPMFAVGFVTAFVVAMIAIK
TFLALIRRLDFIPFAIYRFVVAFAVYLVFVA
>F5N5A5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERDIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEIFQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDFVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A157L627|FEATURES|UNIPROT_deepARG|chloramphenicol|cat|antibiotic inactivation|1
MEKITPEYTSVDLSRWARKEHFEIFQGFAQSTFNQTVLIDITALLKHIKAVGWKFYPTII
FLISKIVNSHPEFRMAMRDNKLIIWNEVHPNYTIFHNETETFSSLWSHYDGNIQHFQKTY
AEDIARYGNNFSYWPKEESRENIFFISGIPWVSFTSFNVNVAHMKNFFAPMFTLGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARLYNELQEMIDALPQSGA
>B7CB15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDIIKTIFLGIIQGITEWLPISSTGHLILFSSIWPLEPAKFFEVFKVVIQFGSILAVLV
LYEQKLNPFDSRKSAKKKKQTLQLWSKVIVGVIPCAIIGLLLDNIIEDYLSKNIVIAITL
ILYGMIFIFVEKHPKKEKIQTIERLDYKSALKIGCFQCLALIPGTSRSGATILGGLYCGC
SRTVASEFSFFLAIPVMFGASLLKVIKYLMKVGLFSFGQLFLLVLGTFVAFVVSLFAIKA
LLNYVKNHDFTVFGWYRIILGIFVILFFYIL
>ZP_04625767|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MLAGTLAIMKLPVAQYPTIAPPAITISANYPGADATTVQNTVTQVIEQNMNGIDNLLYMS
SSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMV
AGFISEDGTMQQEDIADYVGSNVKDPISRTAGVGDVQLFGSQYAMRIWMDPHKLNNYGLT
PVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRLTNAEEFSQIMLKVNTDGSQ
VRLKDVAIVQLGAESYNIIARYNGKPAAGIGIKLATGANALNTSAAVKAELAKLQPFFPA
GLKVVYPYDTTPFVKNSINEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGT
FAILSAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMQEEGLPPKEATKKSMEQIQ
GALVGIALVLSAVFVPMAFFGGATGAIYRQFSITIVSAMVLSVLVALILTPALCATMLKP
IAKGDHGPKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRYLVIYLAIVIGMGVLFLRLP
SSFLPEEDQGVFLTMVQMPAGATQERTQKVLNQVTDYYLDKEKDVVNSVFTVNGFGFSGQ
GQNTGLAFVSLKNWDERPGEQNKVPAIVGRASAAFSQIKDGLVFAFNLPAIVELGTATGF
DFQLIDQGNVGHQKLTEARNQLLGMAAQHPDMLVGMRPNGLEDTPQFKIEVDQEKAQALG
VAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRMLPGDIDKWYVRNNAGQMVS
FATFSTAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMDLMQELAAKLPSGVGYDWT
GMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVVGALLAASLRG
LENDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLVESTLEAVRMRLRPILMTSL
AFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFFVPVFFVVVRRRFSRKNEDV
EHAHAVDHKVK
>A0A0Z8UZL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFLTFLF
>A0A0C1Q469|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHKAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLADLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAMSVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>Q9X5C1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKITLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWTPGTQRLYANTSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMQDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>G8LJX7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLEAGYEIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDAIFSFYYRNLICDEILSLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVHRADAGAIIAQQRVAIDADETALQLHQKLCTVAQSLLRDVLPAI
LNGTFSETAQDESKASCFGRRRPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSASPLIVSCGEQALEIVTGQTDNGVYVQGAQLAQSLGLVT
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
AGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKEGRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMDQTIDETLDFFLRTVELSEQVS
>A0A0M9GI66|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNPKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCALKGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATAKNGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQNRVAIERSDTALSLHAKLRDSAASLLRDALP
QLAQGKLSETAQDESKATYFGRRTAADGKLVWSKPAEELFNLIRAVTKPYPGAFCAVGEH
KLIVWGAEVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNENGLFLSGPQLANELG
LVDGSLLRGAEAARKKRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPISKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDCCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVEHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLKEAMLEIA
EKR
>W1F212|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFYSRKRAGYRDAG
>A0A0A2HQI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVLYWEKIKESVVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFTQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFVVAFI
VSIIVINKFVSYLKKKPMKVFAIYRVLAGLLLAALVFTKIIVLTV
>W3V3F5|FEATURES|UNIPROT_deepARG|beta_lactam|PTE_04072|antibiotic inactivation|1
MTKRFSVLTGGLLLAASLGAQASNTPDQSHLTNTVDKTIHSLMQEYDIPGMAIAVTFRGQ
HFFYQYGDASKENNTPVTKETIFELGSVSKTFTASLISWAQVTGAISLSDKASQHFQPLA
GSAFDNISLLNIATYTAGGLPLQFPDEIDSNSKMVNWYQHWQPKYAPGTYRQYSNPSIGL
AGYIAAQRLGKPYSMLVTNQILSPLGLHHARFNVPEQDMKNYAWGYSKENKPIRVTPGVL
DEEAYGLKASVQDMISFVDANIDPSRIGDSKLAQAIRATHTGYYRVGEMTQGLGWELYHW
PVTLEQVLSGNSAQIAYQANKTTELSPPEPPTEALFINKTGATNGFGAYVAFVPQEQMGI
VLLANKNYPNEARIKAAWQILNTLK
>J7WBS6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MIQSINHICFSVINLEKAIEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEV
QYSYTHIAFTVTNNEFDSLKEILIQNHVNILPGRERDDRDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>U7V589|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFLLVIILGIVEGMTEFVPVSSTGHMILVERFINSPLVSKSFMDNFLVIIQFGAILSV
VAYFWKDLTPFVKTKEEFKEKFSLWTKIIVGVLPAGVIGLLADDYISEFFMDNTTVVASM
LILYGIIFILVERKNLKGKVTSIKQMSYKLAFTIGFFQCLAMIPGTSRSGATIVGSLLLG
VSRAAAAEYSFFLAIPTMAGATLLKLLKNGLNFTTLEWQLLIVGSVVSFVVAYVVINWFM
GYIKKRTFVAFGVYRIIIGILVLLLMK
>YP_002286768|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLL
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>Q6QWR0|FEATURES|UNIPROT_deepARG|aminoglycoside|aada2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVMLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0Q4TDE5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRPSLRPLLVTLGLCLGSQSAFAELNQAVDAAVKPMMQTYAIPGMAIAISHKGQQHFFEY
GVASHESGQAVDRHTLFELGSISKLFTATLGAYAEARGTLNLSDNASQYLPELRGTAFDH
ISLLDLATYTPGGLPLQFPDAVSSERQMLDYYRNWQAVYAPGMQRLYSNPSIGLFGHLAA
ASMAKPFQQLMEKDLLPQLGMQESYVQIPAEQMTRYAWGYRDDKAVRVSPGALDAEAYGL
KSTAADMLRFIDANLHPDKLPAPLLQAVSSTHRGYYQVGDMTQALGWERYAYPISLAKLQ
AGNSAEMALQPQPVERFSVPKPAEGDLLLNKTGSTNGFGAYILLLPARDIGLVILANRNY
PNAERVRLALQLLESLEP
>V9W5Y1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYDYWVAIIIGIVEGLTEFLPVSSTGHMILTQALLNINESDQMMKVFEIVIQLGAILAVV
LIYWRRIIDLLGPKRLKEAYQIVRRGFRSTDKQKGQKMNVIHILVGIVPVMLLAFLLNDF
IDEYLFSPVTVLIGLVLGGILLIAGEKQDNSKMIQDLDGITYKQAFVIGLYQILSLWPGF
SRSGSTIAGGMLSGVSRKASADFTFIMAIPIMFAATGYSLLKHLQHFSGDVIGFFAVGFV
VSFIVALLAVVTFIKLVQSMKLTYFAYYRFLLALVFGIYLWFR
>R5GAW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIEMLKVILLGIVEGITEWLPISSTGHMILVDEFIKLNVSKAFMEMFLVVIQLGAILAV
CVIYFHKLNPFSPKKSAREKRETFDIWGKVIVGCLPAAVIGLAFNDKIDALFYNAQTVAF
TLILYGILFIVVENHNKNKESQVKELSDLTYKIALIIGCFQVLALIPGTSRSGATIIGAM
LLGTSRFVAAEYSFFLSIPVMFGASFLKLVKYGFHYTGNEVAILVVGMVVAFIVSILAIK
FLLGYIKNNDFKAFGVYRIILGIIVAVYFFIK
>A0A095RUU6|FEATURES|UNIPROT_deepARG|aminoglycoside|DP49_2125|antibiotic inactivation|1
MTHPAALFKIRAVQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
ILAPVGFAEVAVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCA
EFASDAPLENAASHALHRALGFDETERVVFFRKPLAR
>R7IS63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILKSILFGIVEGITEWLPVSSTGHMILLEQFVKFQNVSENFFDMFEVVIQLGAILAVV
VLYFKDIWPFTDDPDRGYAKTGVLSKIDRHIMVLWFKILAACIPAAIVGIAFDDFLTEHL
YNPYVIGVALIVFGIAFIVVENHNKDMKPTTLKASQITYKQAFIIGLFQLIAAIFPGTSR
SGATIIGALMIGISRKAAADFTFYLAIPVMFGASLLKVFKFIKAGSGFMTMEAAVLLVGM
IVAFVVSLVVIKMLLGYIRKHDFKVFGWYRIILGIIVLAYFMLG
>CAD02604|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
GQLIYGPMADSLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLVAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVM
IFALIKETLPVERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVPPQDFGYYFALNIVFLFVMTIINSRFVRRVGALNMFRAGLWIQFAMAVWMVFSA
LMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIALCAACSILFYLYASRPKKR
>K1JST2|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1171_00331|antibiotic inactivation|1
MKQRKTILWGAVATLMWTGLAHAEATSPADPLRSVVDASIQPLLKEQRIPGMAVAVLKDG
KAHYFNYGVAELATGKKVSEQTLFEVGSVSKPLTATLGAYAVIKGAMKLDDKASRHAPWL
KDSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIG
LFGYLAASSLQQPFAQLMEQTLLPGLGMHHSYINVPKQAMANYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANVNGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYP
VSEQTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKRVGIVML
ANRNYPIQERVKAAHAILSKLAP
>A0A062Y7A1|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSYLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLTDARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRTARRLLERDA
>A0A127SQ59|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MTVKLDISKLKKDGKKLYPTLLYVVTTILNRHEEFRTSLDKNGQVGVFSEMLPCYTIFHK
ETETFSSIWTEFTADYTEFLQNYQKDIDAYGERKGMFAKPNPPENTFPVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRNDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>C9PTB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIQTIIVAIVEGLTEFLPVSSTGHMIITQALLGIESDEFVKAFDVIIQFGAILAVVVL
YWKRFFRLDHSTPPEGLTPFQRTLRKWDFYYKLLIAFIPAMVIGGLCNKFIDALLGNVMV
VAVMLVVGGVFMLFCDKLFGNGSPETKLTPRRAFAIGLFQCLAMIPGVSRSMATIVGGMA
QKLTRKDAAEFSFFLAVPTMFAATCLDLLKLFLHMHKIGDYSMLASHAGTLLLGSAVAFV
VALIAIKAFIAYLTKYGFRAFGVYRIIVGGAILAWMLAGNSLAMVD
>R8P8R8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLINGFNHLCFSVSDLERSIQFYETVLEGKLLVKGRKLAYFDICGVWVALNEEAGIARNE
IHQSYTHLAFSVKQEDFGRLLKRLEENKVHILQGRERDVRDCQSIYFIDPDGHKFEFHSG
TLQDRLKYYKEAKSHMKFY
>G3LSZ7|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
PMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHI
A
>A0A090ZFG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDFLHLIKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLRTEQLLGSKYVANTFKVVVQL
GSILAVVVVFWNRFMELLGLSRFMGKKGSASAWSDEMIVAEDGSYRPRQLKHGGGSRLKL
TQVIVGLIPAGVLGVLLEDFIDEHLFSTATVLIGLVVGALLMIAADRFAPKGAKVETVDQ
ITYKQAFAIGLFQCLSIWPGFSRSGSTISGGVLLGLSHKAAADFTFIMAVPIMAGASALS
LVKNLQYFTPDVLPFFIAGFISAFVFALLSIRFFLKLINRVKLVPFAVYRILLAIVIYFA
FFF
>A0A127SII5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-183|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWVYC
>A0A0S3BQ49|FEATURES|UNIPROT_deepARG|beta_lactam|AS145_22975|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLSKMVSGKLPVSAQTLQYT
ANILKVSEINGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAREEVLAALPAKLKTL
>Q307S9|FEATURES|UNIPROT_deepARG|beta_lactam|blaP1b|antibiotic inactivation|1
MKFLLAFSLLIPSVVFASTSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPKTSTFKTIACAKLLYDAEQGKVNPNTTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVCGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLLSVLPAGWNIANRSGAGAFGARSI
TAVVWSEHPAPIMGSPYLAQTQPPMAEGNDAIVKIGHSIFDVYSSQAP
>A0A029PQV9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEILDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>E3G3A0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGRPPVHEGEGNGRLSLIHVLLAMFPAVVLGLVLHDAIKSLFNPI
NVMYALVVGGVLLIAAEVLKPKVPRAKGLDDMTWGQAFLIGCFQCLALWPGFSRSGATIA
GGMLLGVSRYAAAEFSFLLAVPMMMGATALDLYKSMGFLTAADVPMFAVGFITAFIVALL
AIKTFLHIIKRITFIPFAIYRFIVAAVVYAVFM
>A0A0X1TJN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLDFIEILKVIFLGIVEGITEWLPISSTGHMILVDEFITLNMSEAFKEMFFVVIQLGAI
LAVVVMFWNKMFPFQFKNKAQSIVKKDTFSLWFKVAVACVPSAIMGILFDDYLDAYLQTP
IVISIMLIFYGLLFILIENWNKKRTPTTMALSDISYKTAILIGAFQVLSLIPGTSRSGAT
IIGALLIGVSRVAAAEFTFFLAVPTMLGASAFKLLKFGFEFTSAELLALVLGMAVAFAVS
VLVIKFLMNFIKKHDFKVFGWYRIVLGILVVLIKS
>A0A0G1K506|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFQAIILSIVEGLTEFLPVSSTGHLLLTQQYLSVASSEFSKTFDIVIQFAAILAVVWL
YRKNLFSSIRIWRQSLIAFIPTGIIGILLYKLIRTVLLERPIITVYALFWGGLALLAVDR
IKKLRLGQKESLSLSVGRLFSIGLFQSISVIPGVSRSAASIIGGLVSGLSRSQAVEFSFF
LAIPTMLAATGYDLLKSGLYFSPQEYLILLTGCLFSFLSATVAVKTFIRFVKDHDFTYFA
IYRIILAFIVWITLKP
>J3G6G7|FEATURES|UNIPROT_deepARG|beta_lactam|PMI28_03401|antibiotic inactivation|1
MDRLKTIAAGMAIFAAGQCVAQDQIETVVNAAVQPVMQAEGIHGMAVAVTVNGQPHYFNY
GVASKETGNPVTQDTLFEIGSVSKTFTATLAAYAQASGTLSLSDKASHVLPALRGSAFDH
ISVLQLGTYSAGGLPLQFPAESDSADKMLDYYKQWKPLYTPGSHRLYSNPSLGLFGYLAA
HSMGQPFDDVMQNTLLPKLGLEHTYLRVPQDQMALYAQGYNKDDKPVRVGPGALDSEAYG
VKTSAADLMAYVEANMKPSRLEKPLQQAIALTHTGYYTVGDMTQGLGWELYRYPITLDQL
LAGNSTPMAMEPHKVQWLIPSQPQPENLLINKTGSTGGFGAYVAFVPSKDIGVVILANKN
YPNAERVRIAHQILSALPQ
>W8Y1B7|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQALLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILSLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQTVAIGPDDAALTLHRKLCAAATELLSQALPAI
LAGTTDERPQDHSQATYVGRRTPEDGRLDWEQPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRSDLPAAKPGTVISVAPLIVACQEGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVVAVKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDCP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDAKH
P
>A0A0F1A7W6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYEILLVDDGSSDNSALMMTE
AAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHKASQEENHP
>C1M2W2|FEATURES|UNIPROT_deepARG|beta_lactam|cfxA6|antibiotic inactivation|1
DSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALAL
CNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASN
LMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFT
EGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVA
YICLPNNVSYTLAVFVKDFKGNESQASQYVAHISAVVY
>A0A099SQH1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQIIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVNVPDDKQALYAQGYNTLDEPVRVNPGVLAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A096KQA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIELLKSAFMGLVEGITEWLPVSSTGHMILVDEFVKMNVSETFWNMFLVVIQLGAILA
VCVLFFHELNPFSPSKGKEGRRDTWVLWGKIVLGCIPAAAIGLPLNDWMEEHFYNAPVVA
LALIVYGVLFIVIENWRANKREEMAVAGSFGSRAVVSGGRPAGAHFAAPAAATAEDEDDD
ENLDFGSIATLEDLSWKTALGIGCFQVLSLVPGTSRSGSTIIGGLLLGCTRSVASKFTFF
LAIPVMFGASALKLVKYFIKGGTFGANEVAILGVGCVVAFVVSLIAIKWLMGFVRRHDFK
CFGVYRIILGIVVLAYFFVLEPMLGL
>A0A127T3Z1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
KTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYA
DIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITL
LHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPS
GLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKST
IEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIING
SGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPN
PARVAAAWQILNALQ
>A0A093S879|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDVKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSAELLTDAA
SDPGNHIIAVLLNRNYGQHSAIMAGFQQAVGDVIITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVLHAQREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRMFLGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLATTLRDEEE
>S4CNP8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFTNFIKAILFGIIEGITEWLPISSTGHLILADEFIGLNVTPEFMTMFNVVIQLGAILA
VVYLYFHKLNPFSPQKNEIEKKDTWTLWFKVIVAVLPSVIIGLPLDDWLDAHFYNFFSVS
IVLIVYGIGFIVVEKRNKNKAPKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGA
IMIGASRYVAAEFSFFLGIPTMFGASALKIFKFLKDGNAFDLQGTVILLTGTIVSFIVSI
IAIRFLMNYIKRNDFTVFGWYRIVLGIILIGYWLIQL
>G0A279|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIEILIKSLILGVVEGLTEFLPISSTGHLILAGDLLDFNDEKAKLFSIVIQVGAILAIC
WEYRAKIVSVLSGLTSDRQAQKFVLNLAIAFIPLASLGLLFGKHIKALLFKPIPVALAFI
VGAFVIIWAEKREHKIRVHSVDDLSMLDAFKLGIAQAFALIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAIPTLIIASLYDLYKHRDLLHVESDVASFAVGLIAAFISALFAVKGLLR
YISHHDFIPFAWYRIAFGLIVIGTAYSGMVQWTVD
>A0A0R1T5W2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQAIILGVIEGITEFLPVSSTGHLYLANAFIHLHEPVAFINLFMVVIQLGAIMAVVVLYF
HKLNPIAPGKTTTERHATWVLWVKVVVAMLPSLVVGPFVDDFMDAHLTTWPVITTTLIVY
GVLFIVVEQINANRRPKTTALNRLSLPLAFTIGLCQLLSLVPGTSRSGATILGAMVLGTS
RFVATEFSFFLAIPTMVGASALKVLKFTLHGNHLTGPESFVLAVGVIVSFVVAYAAIKFL
MRFIQYHDFKIFGWYRIALGLIIFGYFGLQQLIK
>B5YBN3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFWVIILSIVQGITEFLPISSTAHLILIPYLVKIPDFGLSFNVGLHLGTLLAVFFYFIK
DWWEFLVSIFIGGEKRRILGLIILATLPAGVLGVFLDPLVEKISQPQVYSFSIWIILLGV
ISFGIVFLILEKISKKNLEIKDMDVKRALIIGFWQVFSLFPGVSRSGSTISGGMFTGLRR
DEATKFSFYLSLPIIGGAVFFKLLHVIKGENPGNLYLILWGAFWAFIVGILTIHLLLNYV
KKSSLKVFSYYRFILALSILFAYFGLQIPSLIIFGVAIIYLIFSMAKAEG
>A0A0R1YQB1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSESQQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPKKTSDERRLTWILWSKVIVAVLPSVVIGLLLNDWMDAHLMNWAVVSAM
LLVYGILFIVIENWNAKRTPQFTDLNRLSYSTAFIIGLFQLLSLVPGTSRSGATILGGIL
IGTSRFVATEFSFFLAIPTMFGASLLKLYKYFHHGGVFTGMQTAVLLTGMIVSFIVAYLA
IRFLLNYIKHNNFKVFGWYRIILAVIVIGYFGLVAK
>YP_002414661|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGTLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>A0A0E1KZP6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKATIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWKKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGIIGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSIAFTQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTSTLWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAALVFTKIIVLTV
>A0A098EGC0|FEATURES|UNIPROT_deepARG|bacitracin|uppP_1|antibiotic target alteration|0
MGLWEFFVAIVLGIVEGLTEFAPVSSTGHMIIVDDIWLNSKELFSEPVANTFKVVIQLGS
ILAVVIIFRDRFKDLLGLDRSKTAEKKQRLSLTKVIVGLIPAGVFGLAFEDYIDEYLFSV
ETVIIGLVLGAVLMLIADYFTKKKPHIDTVDQMTYKQALGMGLFQCLGLWPGFSRSGSTI
AGGVLLKMSHKSAADFTFIMAVPIMLGASGLSLLKNWQYITVDALPFFVVGFISAFVVAL
VVVKFFLKLIDKIKLVPFAIYRIVLAALIFVIYL
>A0A0A1H309|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHILILALVQGAAELLPVSSSAHVIVAEKLMGLDPTAPAMTMLLVMLHTGTMFAVIV
YFWQSWRKTYFSSMAEFRRQAWYIVIATAATGVVGLTLQEAIKRGFAHNAPDFEIEQLFG
NARLMAAALLAAAVLIIGSARLPQSGSRSLTARRAVWIGAVQGLCLPFRGFSRSGATIST
GLALRIDRRQAEEFSFALAVALTPAVLVKELHRLFKTGAAGAIQHPNGWLHALAPDLAGM
VFSFLAGLAALRWLSGWLERGHWHYFGIYCVFAAAVVLWVG
>E5CAL9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMSQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILVNNMPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>A0A101KPN7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAMVLGVIEGITEFLPISSTGHLLIAEHWAGERSDTFNIVIQAGAILAVTIIYWRR
LASLVVGWRQPENRAYAGKLIVAFLITAILGLIAKKLGFALSENVTPIAWALIIGGFWII
AAEWIAAKQRDRVKISWTVAIVVGLAQIVAGIFPGTSRSAATIFAAMLAGTSNRAAATEF
AFLVGIPTMFAASAYQLYGEIKQGGGHEDWTALGIAFVVSTFTAFIAVKWLLGYIQSHRF
TVFAIYRIIFGAALLGMAALGWVS
>ZP_04196507|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFVM
>R2QCD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAAILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFAPSKSSNEKKDTWVLWSKVLVACVPAAIIGLLLDDWLDAHFYKFLPVA
IALIVYGIGFIIVEKRNKNKTPRWSNLNDLTFQAAILIGAFQVLALIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLADGNSFQMEETVILLVGTVVSFIVSI
FAIKFLINYLKRNDFTVFGWYRIILGIILIGYWFIAM
>A0A0S4RGD0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MIKLQDIKKKFITGGVETEVLKGINLSINRGEFVAIIGQSGSGKSTLMNILGCLDTPSSG
KYLLEGQDISKFDRDALSNLRLKTFGFIFQRYNLLSSNDVKNNVALPGVYAGMGKKDRLN
FAKELLSKLGLESKFDTYPNQLSGGQQQRVSIARALMNGGDILLCDEPTGALDSTSGVMV
MEILKDLHKSGHTIIVVTHDKDIASWADRIIEIKDGNILSDNKKQNNIYEFKKVSEGIKK
GFKASLDRFLESFSMSVGAIKAHKLRSFLTMLGIIIGIASVVCVVALAKGSQEKILNEIN
KVGTSTIMLNPGKAPGDPNRNKIKKFTLDDAELLSKLEFVDYATPTVSQSGLLVYANQNA
NANLRAGSENYLKITGVKVVLGRDFSSDDIKNSESVIIIDTDVKSSFFGQNDPIGKTILF
NKKPFKIIGVAKKDEGAFGSENLTVYMPYSTAVNKITGDRNLRSITVKLKSNVNAQLAES
TIKEVMSVKRGDSDFYTRNSDTIMQTIKSTTDAMSLLISGIALISLMVGGIGVMNIMLVS
VFERTKEIGIRMAIGAKSKDIMIQFLIEAILLCAIGGAIGVGLAYLIGYLFNMFGASFKM
IFSTSSIFIALGVSSLIGIIFGYMPARNAAKLNPIDALSRE
>N9YR04|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMFFHKLNPFSPSKSSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVA
AALIVYGVLFIVLENSSVCTNPRFNKVGQISAKTAFLIGMVQLLALIPGTSRSGSTILGA
MVLGCSRAAAAEFSFFLGIPVMFGASLLKIVKYFLAGNVFTGPQIFYTILGMLIAFVVSI
YSIQFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>A0A023V8E2|FEATURES|UNIPROT_deepARG|beta_lactam|CFNIH1_08415|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLNLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMTKRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSLVDMTRWIQANMDASQVQEKTLRQGIEIAQARYWHIGDMYQGLGWEMLNWPVNA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>D7N879|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLKVIILGIIEGITEFLPISSTGHLILASDFISLTPKEFENAFEVIIQLGAILSVLVI
YFDTLNPFSKNKMSKQLVENQSRLTISQKWFLRDKKTMRLIAKIIVGFLPAAVLGFLFDD
LIDKYLFNKVTVSLALVFYGAVIILMENRGKKIKFKYEKLDSITIKTAFFIGVFQCLAMV
PGTSRSAATIIGAMILGCSRTAAAEFSFFLAIPTMLGATSLKILKMGIGFSLHQWILILV
GGLVSFLVAYAVIIKFMGYIKKHDFKIFGIYRIILGAVVLISMLIFK
>U5DDY1|FEATURES|UNIPROT_deepARG|beta_lactam|KR51_00036950|antibiotic inactivation|1
MNLRKKGFFASIFLGLMISIGFALVTYSSNAGENDLIAAVQQIEARLNARIGIAVIDKET
DRNWRYHAGDRFPINSTYKTIACAALLSRVDSGQEQLDRIVIFDESQLADYSPVTETRVG
APGMSLGELCQATIATSDNSAANFVMQAIGGPQAVTQFMRSIGDRTSRLDRWSPELSESV
PGDQRDTTSPNAMAMMLEQLVLKGTLSFESRQTLESWLKGNEISGDLIRAAVPSDWDVID
KTGSGGYGSRSIAAVMWPPQREPVIAAIYITETEVSFAERNAAIAEIGEAIVGAVMAQ
>E7T2Q7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYQILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0U3I8B3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLWGAATGIFSGEPQGRRLGIGLILASIPIVLIGLTFGQTVKELLFNDIAIAIG
LIVGGLIIIWIEKHPPQERVHEVEDLSVKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSAHVFDGQQDWIVLATGIIVSFISALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWKLW
>A0A0D7K978|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVALPTERQAQRFALNVLIGFVPAVVLGLLFGKAIKAHLFTPVVVATTFI
VGGFIILWAERRAPVATRIESVDDMGPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSLADAPMFLTGLVFSFISAWLCVRWLLR
YISTHSFVVFAYYRIVFGVVVLATAWLGWVQWAE
>A0A0J0YU28|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGDNRVHVLKNINLNIEKGDFVAIIGQSGSGKSTLMNILGCLDVAS
SGSYKVNGIETSAMTADELAGLRRKRFGFIFQRYNLLSSLNARENVALPAVYAGLDYEER
SRRADGLLSDLGLAGKENNKPSELSGGQQQRVSIARALMNGGEIILADEPTGALDTESGA
NVMEIIHQLHAQGHTVILVTHDPNIAANANRVIEIRDGEIISDISKNTDITAIAVQSVHE
NRSWSFYKDQFAESFRMSVQAILAHKMRSLLTMLGIIIGIASVVSVVALGRGSQEKILKD
INAMGTNTITIYPGKGFGDRRSSRVKTLTVSDANVISKQSYIESATPMTSGGGTLTYRNI
ALTAQLYGAGEQYFNVQGIKLKEGRFYDLADVKGSNQVVVIDENTQKQLFRSGESALGKT
ILFKKRPLRVIGVAMNEDSSFGSNDQLQLWAPYTTVMQQITGARHISSISVKVKDNVNSK
AAEKSLKELLTARHGKEDFFMNNIDSIKQTIESTTNTLTLLISSIALISLLVGGIGVMNI
MLVSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLIGGLAGILFSVLISIVFNHFTT
NFAMSFSTVSIIAAVTCSTVIGIIFGFMPAKRASQLNPIDALAHD
>A0A0R3BEX0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MNSKAVVFAYHDIGCAGIEALLTAGYDIAAVFTHADDPKENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAILAQQKVAIERSDTGLTLHAKLRDAASSLLRDALP
QLAAGKLAETAQDESKATYFGRRTPADGKLEWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVQGNEGLAPGRVISVNPLRIACGEDSLVIKFGQRNDNGLYLTGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIS
DKR
>BAG79306|FEATURES|ARDB_deepARG|multidrug|mdtE|antibiotic efflux|1
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
VAEIRPQVGGIIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARI
TFNRQASLLKTNYVSRQDYDTARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVS
GKSSVTVGALVTANQADSLVTVQRLDPIYVDLTQSVQDFLRMKEEVASGQIKQVQGSTPV
QLNLENGKRYSQTGTLKFSDPTVDETTGSVTLRAIFPNPNGDLLPGMYVTALVDEGSRQN
VLLVSQEGVTHNAQGKATALILDKDDVVQLREIEASKAIGDQWVVTSGLQAGDRVIVSGL
QRIRPGIKARAISSSQENASTESKQ
>A0A132GEH2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRPAALAAVIALVLGHTGAQADDQLQAKVDQIIRPLMQEQGISGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDATVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPHAEPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMTEGLLAKMGLKNTYLHVPASAQGLYAQGYDAADKPVRVGPGPYADE
AYGIKTSASDLLQYVRLHMQPQGLPPALAKATTITRQGYFQVGSMTQGLGWERYPYPVTL
GTLVDGNSARMIREPHATTRLQPALPPLPAAWYNKTGATNGFGAYAAFVPSEKLAVVLLA
NRNYPNEERVRAAFKILSGL
>A0A0C6EXR3|FEATURES|UNIPROT_deepARG|aminoglycoside|ant1|antibiotic inactivation|1
MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQ
LTRKKLTERLMTISGKIGNTDSVRPLEVTLINRSEVVPWQYPPKREFIYGEWLRGEFENG
QIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGD
ERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGL
YSKVKALVKYMKNSIETSLN
>YP_001453825|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNLSQTGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVIWFIVTCLATLLAQNIEQFTLLRFLQGVSLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEEMFVLFAVL
AAIAFVGLQRAMPETATRLGEKLSLKELGRDYKLVLKNVRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRALIIMGGWPIVAGLL
IAAAATVVSSHAYLWMTAGLSVYAFGIGVANAGLVRLTLFASDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAYLSGGNGLFSLFNLANGILWLLLMVIFLKDKRVGDSREG
>B9AYU4|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCGD1_3867|antibiotic inactivation|1
MTHSSQRRILLLAAATAPLALSLGACAARDAAVSDAAFPVGASPASFAALERAAGGRLGV
CAIDTATGRRALYRADERFPFCSTFKAMLAAAVLAQSVAHPGLLQQRVTYGRSDLVNYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPPAQRAQLIEWLRGNKVGDKRIRAGVPT
GWRVGDKTGTGDYGTTNDAGVLWPPSRAPIVLAVYYTQARADAKAKDDVIAAATRIAIAT
LG
>V6T664|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWELFVAFILGLVEGLTEFAPVSSTGHMIIVDDLLLHSKQLFTEPVANTFKVVIQLGS
ILAVVIVFKERFINLLALKKGVSIGDSKGRLSLPKVIVGLIPAGLTGVLFEDYIDEYLFS
VETVIIGLVVGAFLLILADRFQPKQLKTEDVDQISYKQALGVGLFQCLGLWPGFSRSGST
IAGGVILGMSHRAASDFTFIMAVPIMLGASGISLLKNWGYFTMDALPFFTVGFLSAFVFA
LIFIKFFLRLINKIKLVPFAIYRIILAALIYFIFL
>B9CL36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSVLTLCAMMYKQNERGVVEVFNLIVSAVYGIVEGITEWLPISSTGHMLLLNRFVPLSVS
ADFWDMFVVVIQFGAILAVCAIFFHKLNPFSPHKTKEERRCTWKLWAKVVVCCIPAAAVG
IPLDNFIEERLGSPYVIASTLILYGLIFILLEAHREKVAKAAPVVQPHGKHMRLSEDTVV
KRRSADEQARVVDIDALDWKTAFGIGLFQVLSIIPGTSRSGATIIGGLVLGCSRSVAAEF
TFFLAIPTMVGASGLRLVKFFLKGNSFTSPEIAILAVGCVVAFVVSLGVVRALMGYVRKH
DFKPFGVYRIILGIAVIAYFALFA
>A0A0P9E468|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLTSKYETIRRMLSDFKQPEYRYAQIMDAIFKQNVGEYERMTILPKFLRDELTRMLGPN
VCSIVPVKEFTSKQVSKVLFAIAGDERVEAVRLTYEQGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAITILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLKALDH
HIRHTGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGPGEHLYHVNLIPFNSTEVTPDSY
QQSDPDRIKAFVRILKSKGISVTVRTQFGSDINAACGQLYRSE
>A0A0F4XGC3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLFADLIHHYLFNPITVAAALV
VGGLVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAQS
>ZP_03222019|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MANFFIRRPIFAWVLAIILMMAGALAIMQLPVAQYPTIAPPAVSISATYPGADAQTVQDT
VTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQ
EVQQQGISVEKSSSSFLMVAGFVSDNPNTTQDDISDYVASNIKDSISRLNGVGDVQLFGA
QYAMRIWLDANLLNKYQLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRL
KDPQEFGKVTLRVNTDGSVVHLKDVARIELGGENYNVVARINGKPASGLGIKLATGANAL
DTATAIKAKLAELQPFFPQGMKVVYPYDTTPFVKISIHEVVKTLFEAIILVFLVMYLFLQ
NIRATLIPTIAVPVVLLGTFAVLAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
MEDNLSPREATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATLLKPVSAEHHEKKSGFFGWFNTRFDHSVNHYTNSVSGIVRNTGRY
LIIYLLIVVGMAVLFLRLPTSFLPEEDQGVFLTMIQLPSGATQERTQKVLDQVTHYYLNN
EKANVESVFTVNGFSFSGQGQNSGMAFVSLKPWEERNGEENSVEAVIARATRAFSQIRDG
LVFPFNMPAIVELGTATGFDFELIDQGGLGHDALTKARNQLLGMVAKHPDLLVRVRPNGL
EDTPQFKLDVDQEKAQALGVSLSDINETISAALGGYYVNDFIDRGRVKKVYVQADAQFRM
LPGDINNLYVRSANGEMVPFSTFSSARWIYGSPRLERYNGMPSMELLGEAAPGRSTGEAM
SLMENLASQLPNGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGRGLI
EATLEASRMRLRPILMTSLAFILGVMPLVISRGAGSGAQNAVGTGVMGGMLTATLLAIFF
VPVFFVVVKRRFNRHHD
>D3V1W5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLERTIAACQQLEQKYELILVDDGSRDSSADILTQA
AETPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIPRLVKTAEEGY
DVVGTRRANRQDSWFRKTASKIINVMITKATGRSMGDYGCMLRAYRRHIVHAMLQCHERS
TFIPILANTFARRTTEIDVTHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGS
IIAVTGFLLAVLLITLRLIFGSIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYVGRIYND
VRARPRYFIQKVVGVRKINDNQEKS
>R6B270|FEATURES|UNIPROT_deepARG|beta_lactam|BN477_01630|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HDNEMHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPQK
AYANWSTPSEMVRLLKMADEKDLFAPVYRDFLWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGIVIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEMK
>A0A0C2UUN2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MQLGGINHLLFSVSDLDESIRFYTTVLNAKLLVKGRSLAYFDLNGLWLALNVEKDIPRNE
IQHSYTHIAFSLKDEEFDSAEERLKRLNVNILPGRTRDERDKRSIYFTDPDGHKFEFHTG
SLQDRMDYYRTEKPHMQFFE
>A0A090FHQ6|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFGKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGALGHDFIKNYLFESPKLICSMLI
IGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIISVGFIAAFVAALIVVRFLLDY
VSKNGYALFGWWRLLVGVAGLAALMVWG
>A0A088NML9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSALEDQPLLRLDGVSRSFMAGDREFLALKGIDLEIHAGELVAIIGASGSGKSTLMNILG
CLDHASAGSYQVSGKETRDLDDDALAALRRDHFGFIFQRYHLLPHLDALRNVEIPAVYAG
VAQAGRHARARELLGRLGLGGHLAHRPSQLSGGQQQRVSICRALMNGGEVILADEPTGAL
DTASGKEVMNILLELHGAGHTVILVTHDPKVAAHAERIIEVSDGQIVSDRRTGAEPPAPI
AEAAPAREQAPRRLVASLGLFREAFKMAWIALVSHRMRTLLTMLGIIIGITSVVSISAIG
EGAKGYVLKDIQAIGSNTIDIYSGTSFGDSRAKAIETLVPADVIALNELYYVDSATPVIG
QSSLVRYRNIDADVQLNGVSEQYFQVRNIPLAAGIVFSADDARRQAQVVVIDHNTRKRLF
GDGVNPLGQVILVGNLPCTVIGVTAENKNLFVAGNTLNVWMPYETAAGRVLGQRHLDSIS
VRIKDGMPSKRVEEEVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLTLLLSLIAVISL
VVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSYG
IGYLFALFVKQWEMVFSLGSVVTAFVCSTLIGIVFGFVPARNAARLDPIEALARD
>A0A0G3XEA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLTLTAILLGILEGLTEFLPVSSTGHLILAQAFFGYDPAQWRQFNIVIQLGAILAVVVT
YWKTFWTMGLGFLKLESEALHFARNILLGFIPAAIIGLLAKDAIDIMLGTPLVVAVALVI
GGIAILVLERTIPAREDVGVAGLSWKTAIAVGFAQCLAMIPGTSRSAATILGALAMGVGR
KTAAEFSFFLAVPTMLGAATVKIFDEPALLAGEAAVGWTEIALGFVASFLVALVVIRAFV
AYVSRHGFAPFGWYRIALGLFALGWFTLG
>YP_791281|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQRQAQRFTANLLIAFFPAVVLGVLFADLIHEWLFNPITVALALV
VGGVVMLWAERRKHVIHAEHVDDMTWKDALKIGCAQCLAMVPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFRPEDLPVFAVGFVTSFVFAMVAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGEM
>R5L9U7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFIKMNVSSDFKEMFFVVIQLGAIL
AVVVMFWNKMWPFKRKDTEDGINKKGSILKKDIWSLWFKVVVACIPGAVVTIAFDDFIEA
HLHTPTVIAITLIFYGIAFIIVERWNKTRTPKINTLSDITYKTAFIIGLFQVLSIIPGTS
RSGSTIIGSLLIGVSRVAAAEFTFFLAVPVMFGLSFIKLLKFGLLFTVSELSILLVGMAV
AFFVSLLVIKFLMGYIKKHDFQIFGWYRIILGAVVLVYFLFR
>D7PIM2|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-2|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRHVSLKKSDLVNYNPITEKHLN
TGMTVGELAAAALQYSDNTAMNKLIGQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVALGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>A0A0X8JU25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFSIIKVFILSLVEGLTEFVPVSSTGHMIIVDQFLKLSNNKVFVDAFEIIIQLGAILSV
VVYYWKKIFPFAKGHAKQESMDIITMWIKIVIAVIPATILGLKFNKVIKEKFFNPVTVSI
MLVFYGILLIWIETRKKKEEKIKSIKEMTIPVALGVGLFQCLAMIPGTSRSAATIIGGVL
LGLNRVLATEFSFFLAIPTMFGATLLEIVKIGHVLTMEEWFLIGLGFVLSFIFAYAVIKV
FMDYIKKHDFKVFGYYRIILGIIILVLFFTGVIK
>A0A0G4QB59|FEATURES|UNIPROT_deepARG|beta_lactam|blaB|antibiotic inactivation|1
MFKKTFRQTAAISVSLISLLASSTLWANTNNTIEAQLSELEKYNQGRLGVALINTEDNSE
ITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNIAIKKSDLVAYSPITEKHLVTGM
SLAQLSAATLQYSDNTAMNKILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRKDIIAKAAEIVTKEFANSSQIK
>R8DWT6|FEATURES|UNIPROT_deepARG|beta_lactam|ICC_02134|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEKKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKCVTDVIITHAHAD
RIGGITALKERGIKVHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVEAFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>A0A068QRQ0|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPRLLERTLAACQTLEQQYEVILVDDGSRDSSTEILTQA
AELPENHVIAILLNRNYGQHSAIMAGFHQADGDLVITLDADLQNPPEEIPRLVKKAEEGY
DVVGTRRAHRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVRAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLSVAGS
IIAITGFLLAVLLIALRLIFGSMWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVEKTNDNQEESE
>YP_454364|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MSKYFIDRPIFAWVIAIIIMLAGALSILKLPIEQYPAIAPPTIRITATYPGADASTLQDS
VTQIVEQNMNGIDHLMYMASDSDSSGTATITLTFESGADPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVQVQKSSASFLMVAGFISDDKNMTQEDIADYVGSSLKDPISRTNGVGEVQLFGA
QYAMRIWLDPNKLNNFQLTPVDVISALEVQNNQIAAGQLGGSPPVKGQQLNTSIIVQTRL
KTTDEFGKIQLKVNPDGSQVRLKDVATIALGGESYDIIARINGQPATGLGIKLATGANAL
DTANAVKAELGRLQANFPAGLKVVYPYDTTPFVKISITEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILGAFGYTINTLTMFACVLAIGLLVDDAIVVVENVERVM
AEEGLSPIEATRKSMGQIQGALVGIALVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMIL
SVIVALVLTPALCATLLKPIKKGDHGKTTGFFGWFNKKFDQSTHHYTDSIGHILNSTGRY
LLIYLLIVVGMALLFIRLPTSFLPDEDQGVFLTMTLLPAGATQERTQHVLDEVTQYYLNN
EKDNVRSVFTVNGFGFAGRGQNSGIVFVSLKDWGERSGAENKVPAITARANQAFSKIKDG
IVLAFNLPAIVELGTATGFDFELIDENNLGHEQLTAARNQLLGMVAQHPDVLQGVRPNGL
EDTPEYKLDVDHEKAEVLGVSLSDINTTIGAALGGSYVNDFIDRGRVKKVYVQGDAPYRM
LPQDINNWYVRGSDNQMVPLSAVTTARWQYGSPRLERYNGLPSMEIQGEAAPGKSTGEAM
ALMEQLAGKLPAGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLAISTGTGSGSQNAVGTGVMGGMVTATLLAIFF
VPVFFVVVRRRFGKKGHQDELEQGHPVENPPPRP
>A0A073HBJ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>R7C049|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQWIEALQAAFLGVVEGLTEFLPVSSTGHLIIAGDLIGFHTGPSADTFYIAIQAGAIVAV
CWHYRERIFAILRNLFVPGKEQRLAVNTVIAFIPAAFLGVLLSSTIKAYLFNPAAVAAAL
IVGGILILWIERAHEKSGKAPRVASMDDMTWKDAVGVGLMQCFALIPGTSRSGATIIGGL
VLGLSRKAATEFSFFLAIPTIFGATVYDLYKSREVLSVDVLPSVAIGFVVSFFSAILVVR
WLLRFVSTNDFRVFGWYRIVFGIVVLALCAAGLADF
>A0A127SBW3|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
FNQKYFFQASFITMVIGFGMNLNASEVSQNEKNIEKVVTQSFKPLIDEYGVAGMAIGVIY
NGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKYVP
ALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSNPS
IGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRVNP
GPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALGWE
MFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEGFG
LVMLMNKKIPNVDRIKASYNVFETLKDN
>A0A0W1QFF4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTLLVAILLGIVEGVTEFLPVSSTGHLILASELMGYDSARWAMFNVVIQLGAILAVVVL
YWRTFWAVMEGLLKLNPVSIRFVRNLLIAFIPAAVIGLVLHRHIEALLGAPKVVAWALIV
GGVAILIIERLVKSATIHGIAEIPLLRVIGIGFVQCLAMVPGVSRSGATIMGALSLGVER
RTAAEFSFFLAIPTMLGATALELLKNHEMLVTSGVGWGEIGIGFVVSFVVALAVIKWFVG
IVSKHGFTPFAWYRIVAGATALIWLSVR
>A0A0L6XS43|FEATURES|UNIPROT_deepARG|aminoglycoside|AKG99_27275|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNLDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A0H1RD98|FEATURES|UNIPROT_deepARG|aminoglycoside|AA309_10385|antibiotic inactivation|1
MQIIPSDLQSLNAWAALRKELWPDTDLAEHTLEAEAILHNPQQAVAFLAYDAKAAAIAFA
EVALRRDYVNGCTTSPVAFLEGIYVRPAYRKRGIARLLCKAVEDWARGLGCQELASDVEI
HNEISQSMHVAVGFEETERVVYYRKPLRSR
>A0A0K1ETE2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQVELDEFTVCGPEAGPYAITTGPDGALWFTLVHHGKIGRFTAKEEPRLFALPRSDGRPS
ILVNGPDGALWFTQTAANSIGRISVAGEVTEFALPTPGAQPFGIALGHDGALWFTEMGTH
RIGRITVAGEIAAFPLPLEGGFPSAIVAGPDGAMWFTLNQAHAVGRMDAQGVTTLHPLAQ
GAAPVGMAVGSDGALWFVQIGDGQIGRLTVDGQSTEFPLPDRAARPHAIAADPAGGLWFT
EWGANGVGHVSLEGEITRVALPTPGSEPHGLTVAPDGGVWVALEIGKLLRLRRAR
>A0A0N1JGN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERRVHTVRTETVDDMTWRDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASANA
>Q8KT50|FEATURES|UNIPROT_deepARG|beta_lactam|cfxa2|antibiotic inactivation|1
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATFIPRSRFQI
AYTEEEMRADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>A0A029PJ98|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREYGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A127SFT5|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLAFPATINRLDGGG
>A0A0X8GPZ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLFKSLIMGMVEGITEFLPISSTGHLILTGDLLNFMSKEKRDVYEIFIQLGAMLAV
VWEYRAKITQTLTGAGKPGSERNLLLAVVIAFIPAAIFGLLFNKVIKAHLFQPVPVAMAF
IIGGLIILWAEKRQLNKTPVVETVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGMFL
GISRKAATEFSFFLGIPTLGAASIYSLLKHRHELDIGDSGVFAVGFIASFIFAFIAIRAL
IKFVSTHTFVGFAYYRIAFGLIVLATAYSGMVSWTV
>D9SST6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
METVFFILKSMVLGIVEGVTEFLPVSSTGHLIIFQSFLGFDVGQSKEYIDMYTYVIQLGA
ILAVIVLFWKKIMNTLVKLFPSEKRDISYRESGLRFWLIIVAACIPGAIVQLGFGDFFDE
YLMNPTAVSIALVVGGILMILIENKYRKRRNGTKSELDVTIKQALIIGAFQCLAVFPGMS
RSASTIMGGWIAGLTTIAAAEFSFFLAIPVMAGMSLLKIVKIGGFAAMTSAQVISLGVGF
LVAFIVALIVVDRFIAFLKKKPMRIFAVYRFVFAVFVFIAGYLGFFNV
>A0A0Q4MQK2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|ASE93_02570|antibiotic efflux|1
MITTQSSPPSQQPLLYLHNICRHFSTGAEEITVLNNISLSIKAGEMVAIVGPSGSGKSTL
MNVIGCLDTPTSGVYQVAGQNVQRLSSDDRALLRRQRFGFIFQRYHLIPALTVLENVEVP
ARYAHQTRMQRQNKARELLAQLGLGEFETRNVARLSGGQQQRVGIARALVNGGEVILADE
PTGALDSRHGREVMQLLQHLHRQGHTVIIITHDPQVADYADRIITLSDGKIVSDVQHTLP
DREVRLSSTPLFVKSDLAAQPSWRSRWEASCDLLWSACRTLLAHRMRSGLTLLGIVIGIV
SVVSLNAAGEGAKKYVLNTLSTLGANVITLYPGKGFGDNPSSNLRALGRRDLKLLSEQRW
ITAVAPKISSTLPVRWRRTDTSANVNGVSAEFLKTNNLVPVIGRSLISLDVTRQSSVVVI
DENLQRKLFPAGTQPLGQIILVGTLPCRVVGVMRSTSAYAGNALNLWLPWSTANSRLLGQ
DWFDSLSVSLNEHVSSDAAKRSIQKLLTRLHGRQDFFMQDSAAFVSSIEKTSFALTLFLS
IIALISLLVGGIGVMNIMLVSVSERTRETGVRMAVGARQRDIQRQFLTEAVLLCLAGAAV
GVTVSLAIGTLLSLFIHPWKLVFSPSAILTAVGCAVLVGVLSGWLPAWKAARLDPAEALA
RE
>V6Q381|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWYNLIKAIILGIVEGVTEWLPISSTGHLILVQEFMKLDARPEFIEMFNVVVQLGAIIA
VILIYFNKLNPFSPKKTATEKKDTWNLWFKVLVGCLPAAVLGLMFDDFLDEHFHKFLPIA
LMLIIYGVLFIIVENRNKDREPSITSFQDFTYKAALIIGFFQVLALMPGTSRSGATIIGA
LLIGTSRFVATEFSFFLSIPVMIGASGYKMLKFLKIGGAFTGDELMILIVGSVVAFVVSL
IVIKFLLNYIKTNDFKPFGWYRIILGVILIGYWTMTHL
>A0A140AQ53|FEATURES|UNIPROT_deepARG|beta_lactam|blaVEB|antibiotic inactivation|1
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWDYYLNK
>YP_001563294|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
LVYWQKIRSTVVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFI
LGGFVILWAERRPASATRVQTVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPMFAVGLVFSFISAWLCVRWLLR
YISTNSFVPFAWYRIAFGIIVLVTAFTGLVNWSGG
>A0A095XQ32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAVFLGIVQGITEWLPVSSTGHMILVDQFLHLAGSKKFIDTFLVVIQFGSILAVL
ILYFNKLNPFSSRKSPKAKKATWDLWIKVLIAVLPSGIIGVLFEDQIDQIFFKPSVVAGA
LIIYGVIMIWIENRHKRPQITKFSQVSYKTALLIGLFQCLALVPGTSRSGSTIIGATLIG
TSRFIAAEFSFFLAIPTMLGASLLKLLKAGFAFTGFEWFVMFVGSLVAFIVSVIVIKFFM
SYIKKHDFKAFGVYRIILGIIVFLYFAILG
>A0A0F3LEL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFESAGKTFEIVIQLGALLAIVSVY
FKKLWTLATRWPFDAEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPQVVCIALIVG
GVILLLLDRMDKKPRWLDAEAYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDIGLIAVGFVVAFISALAVVRFLLDFVS
KRGFGVFAWWRIVVGVVGLALLQAGF
>F9EK81|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DKATSGKYYIDGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVD
HDSRMERAKKLLEKLELSNKLKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDS
KSGIMVMKILNQLHEEGHTIILVTHDKGIASQANRIIEIKDGEIFNDTRQREIKKELQED
KKSINNLKKNKFQVAKDQFFESFNMSVSAIIAHKMRSLLTMLGIIIGIASIVCVVAIGNG
SQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTDVDILEKQSYVDSVTPNSTSS
GTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALIDENTQKSLFGE
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
VKDDIDSQVAQKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVV
GGIGVMNIMLVSVTERTKEIGIRMAIGAKEKIYYNNFYWKQF
>A0A0H7XFB1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLP
LQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRV
FQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNL
TPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPV
KAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAACQILN
ALQ
>YP_063446|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREI
LLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0A1YUV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLLDFTGDRFNAFNIIIQLGAILAVV
WEFRGKIFEVVSGLPTQRKAQRFTVNLLIAFMPAVVLGVIFADLIHHYLFNPITVATALV
VGGVIMLWAERREHEVHAETVDDITWKDALKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>E6MJJ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNIVKSIIFGIVEGVTEWLPISSTGHMILLNAICKLNVRQSFLAMYLVVIQLGAILAVV
VLYWRKLWPLRRRRTTKDPEGQLIVDRETIAMWLKIIVATIPAAVIGVPFDDFFESLFYN
YWTVAAMLILFGIAFILIENRNRGARPAKTDIAQFTYRDAIIIGLFQLIAAVFPGTSRSG
ATIVGALLIGISRTAAAEFTFFLAIPAMFGGSLIKLLKFHHFASGELGILLVGMIVAFAV
SIFAIRFLMQYIKQHDFKAFGWYRIVLGIIVLGFFLIAG
>A8SXG3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALSFIEILKVVFLGIVEGITEWLPISSTGHMLLVDEFITLDASDRFKDMFFVIIQLGAI
LAVVTIFWNKMWPFQMKDKTQSVFKKDTWSMWFKTVVACIPGAVVTLLFDDFIEAHLHTA
VVISIALIFYGVAFIVIENWNKTRTPKVETLNDITYKTAFFIGMFQVLSIIPGTSRSGAT
IIGALLLGVSRVAAAEFTFFLAVPVMFGLSALKLIKFGLSFTSAEFAILIIGCVVAYLVS
IVVIKFLMGYIKKHDFKIFGWYRIVLGVIVLLYFAFFA
>E2YUY5|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPNYRMKQITNAIFPGRINNFNEITVLPKSLRDMLIEEFGES
ILNIVPLKAQQSTQVSKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDALNVLTDPALFALS
PRRLSISTIGIIPNIKKLTQNYPQVNLTFSLHSPFNEQRSELMPINERYPLSDVMDTLDE
HIRVTSRKVYIAYIMLHGVNDSIEHAKEVVNLLRGRYRSGNLYHVNIIRYNPTVSSRMRF
EEANEKCLVNFYKELKSAGIKVTIRSQFGIDIDAACGQLYGNYQKTNSQ
>YP_001031495|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MKNKKSMMNLAISNLFLVFLGAGLVIPVLPTLKEQMHFSGTTMGMMISIFAIAQLIASPI
AGALSDKIGRKKLIAIGMIIFSFSELLFGLAQAKTGFYISRALGGVAAAMLMPSVTAYVA
DMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAHFGIRVPFYVAAILAFIGFILTITIL
KEPERTMEANHETEKVSFLDILKNPLFGSLFIIILISSFGLQAFESIYSIMASINFGFSM
GEIALVITVSGILALFFQLFLFDTIVNKIGELGLIQLTFFASAIFIAIIAFTKTNLVVAL
STFVVFLAFDLFRPAVTTYLSKHAGNRQGAINGLNSAFTSFGNILGPMAAGYMFDINHLF
PYYISAIILLGTGFLSLFLNRKNLSKA
>A0A142E0Z0|FEATURES|UNIPROT_deepARG|beta_lactam|AMS64_05195|antibiotic inactivation|1
MKGWMKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEELIKTAPQS
>F4QVR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLTAILLGLVEGLTEFIPVSSTGHLLLLGHFLGFESTGKTFEIVIQLGALLAIISVY
FKRLWTLATRWPFDPEARRFLIGLLVAFLPAAAIGYFAYEFIKTVLFETPLVICVALIIG
GVLLLWLDRMSKVPAYLDADRYPFRVYFLIGLFQCLAMIPGVSRSGATIAGGLLLGTDKR
SAAEFSFFLALPTMGAAVFYDLFKNRDVLDFSDLGLIAIGFIAAFVSALAVVRFLLDFVS
KRGFGPFAWWRIVVGVVGIIGLGVTGAL
>ACJ22953|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGERLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>ZP_04323456|FEATURES|ARDB_deepARG|beta_lactam|BLA1|antibiotic inactivation|1
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKRLLKIGICVGILGLSLTSLEAFTGGPLQVE
AKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGN
ALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPI
IIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>A0A0S1Y232|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENTLYLLKAVFLGIIEGLTEFIPVSSTGHLILFGDWINFQSSSGKVFEVVIQFGSILA
VMWIFRERLWQLIRGTFTGVRSEMLFTRNLLVAFLPAAVIGAIFIHAIKELFYHPAVVAT
TLVLGGFVMLFVERHTKAATPGPHSAADDSASEVRASAHRLEEITWKQALGVGFAQCLAM
VPGVSRSGSTIIGGMIAGIQRKTATEFSFFLAMPTMLGASVYDSYKNMGLLSQHDVTAIV
VGFIAAFLSALVVVRAVLRFVANHTYRVFAWYRIALGIVVGLVLFLR
>A0A0M8R2P9|FEATURES|UNIPROT_deepARG|beta_lactam|ADK43_05615|antibiotic inactivation|1
MRKPTSSLTRRSVIGAGLGLGGALALGSTTASAASAGTTPSGNPAAVRRLRALEREHQAR
IGVFALNLATGASLLHRAHERFPMCSVFKTLAAAAVLRDLDHDGSQLSRVIRYTEADVTK
SGHAPVTKDHIGTGMTIRDLCDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRL
DRWEPELNSGEPDRRTDTTSPYAIARTYQRLVLGNALNRPDRALLTDWLLRNTTTLTTFR
TGLPKGWTVADKSGGGDTYGTRNEAAIAWTPDGAPVLLTALTHKPTLPTAPGDTPLIIKL
ATVLSEAVAPA
>YP_859822|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MGFLRSGCYPDSCHTDWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCTLLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQP
LKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPF
DINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ
>CAA67864|FEATURES|ARDB_deepARG|multidrug|mexF|antibiotic efflux|1
MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKL
PEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLF
GLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPNDTIFQLSINTQ
GRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGS
NAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVIL
FLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAIST
VISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTV
NRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVI
KQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAAL
NAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPE
LEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQ
VNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGA
PAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLA
AQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFA
KDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSG
MIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA
>A0A0A8FHP3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSAAHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHHKLRDVASQLLKDSLPAI
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARALYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGNDALEIVTGQGDNGIYLQGAQLAQGLGLVS
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLDNP
HFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPENEASIRQLAEMLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGQFSQ
DGE
>A0A0D0IBM8|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSESPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYNDKLIADA
TKVVLDTLKVTNKN
>G5MI78|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEGIV_2167|antibiotic inactivation|1
MDIRHMNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFIAMADGVATGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>A0A101WLQ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDFLSALILGIVEGITEFLPISSTGHLIIVNQFVGFTEQFAKMFDVVIQLGAILSVVVY
FRKRLIPSGRNYLSENQRIFDLWKKTIVGVIPALGIGFLAGKYIEERLFNTTVVALALIV
GGIILIYIENRKPLNRISTVEQLTYSTAFLIGLIQCLAMIPGTSRSAATIIGAMFLGASR
VVAAEFSFFLAIPTMVAASGYTLLKSGMLLTSHEFLVVACGFIVSFVVAWLVIAGFMNYI
SKRDFKPFAYYRIVLGIIVLAYFTFLKF
>W8F197|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYWHAFLLAIVEGLTEFLPVSSTGHMIIVANLLGIGQLPFTDTFITSIQFGAILSVVVL
YWRRFLQSFDFYLKLAAAFIPFGILGFLLKDVIEALLKNVAVVAWSLMLGGVVLVFIDKL
FTSERKQVTTPSFAQAVKIGLFQCVALIPGVSRSAATIVGGLAQGFDRRSAADFSFLLAV
PTMAVITAYQLYKTFKVAAPGTDDIKILLFGNVVAFIVALLAVKSFVDFVSRFGFRAFGL
YRIAVGMIILIMLALGIPLQII
>A0A0M1NJ38|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITSIILGIVEGLTEFIPVSSTGHMILTTKVLGYDDQTPMMKTFEIVIQLGAILAIAI
VYWNRILNLLGWSRSEPLNKKESRKRLNLIHILLGIAPALLVAYYARDFIKSLFHVQTVL
FALVAGGIFMIFAEWFNKHKVQVTSQELDDMTYKQALQIGIYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFIIAIPIMCAASGYELLDSYRYFTSETVGVFLTGFIVSFVVAYF
VVLAFRKLIQKIRLTHFAIYRFVLAAIFWLFIMQ
>A0A133H8B3|FEATURES|UNIPROT_deepARG|aminoglycoside|WS72_29690|antibiotic inactivation|1
MTHSLAHFTIRAAEASDDDAWRRLRRALWPHADDAAHARDIARQLGAPDRHACFIASAAD
GAALGFAEVAVRRDYVNGCDTSPVLFLEGIFVAPAARRRGVARALCSAAAAWGAARGCAE
FASDAPLENAASHALHRALGFAETERAVFFRKALQRRRGGLSG
>A0A0P4RDM3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTRRTASFQQIPVSDADAGPYALTTGPDGALWCTLVHAGQIARLTPDGQLDRFALDSADC
GPSVITSGPDGALWFTRSRDHRIGRITVTGEVSSFPLPTPGSGPFGMVSAPDGALWFTQL
HGDRIGRITTDGRVTEFPLPLSGAFPSALTTGPDDALWFTLNQAHAIGRISFDGDITLHP
LPTENAAPVGITCGRDGALWFVEIGAGRIGRITTDGRIDEFPLPDPSSRPHAIAAGPAGD
CWFTEWGANRVGSITPDGRIEEYDLPIASSEPHGLAFGPDGALYVALEVGVVARLVL
>A0A0C3IFS2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRKMLAANCGLIMTGSLLLNGSAWASGTPESADIEALVNDTIAPLMAEHRIPGMAVALSL
NGQQHYFNYGLANQEAGIPVTDETLFELGSVSKIFTAALAGYAQTSGALSLSDPASRYLP
ELEGSAFDEITLLELGTYTAGELPLQFPESVQSEETMIDYYRQWQPESAPGSHRLYSNPS
LGLFGYLAAQSLGQPFEMAMEEALFTPLGLEHSYFQVPEAQQANYAYGYSKEDEPIRVNP
GMLDAQAYGLKSTAADVLTLVEANMSGAELNEPLSQALAATRTGYFEVGNMTQGLGWESY
AYPVALDQLLVGNSLEMILQPNPANRLTPPLAPRQEALYNKTGATNGFGGYVAFVPSEQI
GIVLLANRNYPNQARIEAAHHILTKLTEAP
>A0A080ERT6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>F5MWD3|FEATURES|UNIPROT_deepARG|beta_lactam|SFVA6_0091|antibiotic inactivation|1
MAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSD
PATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQ
RLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGK
AVHVSPGALDAEAYGVKSTIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQ
GLGWEMLDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVA
FIPEKELGIVMLANKNYPNPERVAAACQILNALQ
>G3F057|FEATURES|UNIPROT_deepARG|beta_lactam|blaKPC-2|antibiotic inactivation|1
RLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERF
PLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAA
VQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAV
TESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTAND
YAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALDDA
>A0A0D7KKA2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFYVIVAIVLGIVEGLTEFIPVSSTGHMILTTKLMGIEEQANWLKTFEIVIQLGATLAMT
VVYWDRILEMLGLRKRTVQQGHVICPRLNLLHVIIGIAPALAVAYVAKDHIKQLFDSTET
VLWALVVGGAFMWFAEWYGSRRQPSANTIDEISYKQAFSIGLFQILSVLWPGFSRSGSTM
SGGMLSGVSYRASADFSFLIAIPIMCAASGYELLQNYKMFTLDILAFFVLGFLVSFVVAY
VIVVAFLKHIQRIKLRHFAIYRFVLAALFWYFMM
>B9BP96|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCGD2_6517|antibiotic inactivation|1
MRITVTRVVATLLVATAAIATTGRAAELTQARVRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMAKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPVSVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPAARRADYAQGYTADGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGAIDIAPRLRRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGDR
>D7R515|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPRSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>Q19RM0|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER-1|antibiotic inactivation|1
TSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLH
QVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLL
FELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQ
LSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPD
GRPLLVAVFVKDSAESSRTNEAIMRR
>J0JS84|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg5DRAFT_2875|antibiotic inactivation|1
MTRDWIGILSAALVSTCISTSGFAADELKLKAISDAAIKPIMDKYGIPGMAVAITADGQN
HIFNYGVESKDTNRPVTPATMFELGSISKTFTVTLTSYADVTGRLSLSDKASRYLPSMKG
RPFGDVVLMDLGTHTAGGFPLQVPDDVKTEKQLMEYLATWKPSYAAGTHRTYANPSIGAL
GYITAKSMGKDFAALMEDQLFPSLGLTSTYINVPKSRMADYAQGYKRSGEPARMTPATLS
SEAYGVKSTAGDMIRFIDANMGLVELDDKLQQAITNTHTGYFDVGAMTQDLIWEQYSYPA
TLTTLIDNNSSAMLKTIPVKQLMPAMKPRDDVWINKTGSTNGFGAYVAFVPKERVGIVIL
ANKNYPNEDRVSAAYQILTDIISAR
>J7SI64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQFIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNSLTGGQVAILLVASVTAF
VVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLLYGAVKLIFG
>A0A0Q6HWC5|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGLNHFLFSVSDLDKSTEFYEAVFGAKLLVKGNSTAYLDLNGMWIALNLEKDISRNE
IKDSYTHVAFSIDEKDFDEIYEKLESLQVNILTGRERNERDKRSIYFTDLDGHKFEFHTG
TLQERLDYYKQEKSHMTFYL
>B0UFD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLAGIGKAVILALVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAIVS
VYFRTLLDLALRAPRDPKARRFILAILLAFLPAAIIGGIFSKTIKLYLFNPWIVCSTLVA
GGLVLLVIDETELDQKYDDVHQFSLGMALKIGLFQCLAMIPGVSRSGATIVGAMLMGAGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKYLSRDDVGLIAIGFVVAFLSALFVVRRLLDYV
SRHGFGLFAWWRILVGAAGFAGLIVFG
>CAA67866|FEATURES|ARDB_deepARG|multidrug|mexE|antibiotic efflux|1
MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLE
APESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQAR
SVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPID
GRVSRAEVTAGNLVNSGETCSPPLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESP
VYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTY
AATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGL
QRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG
>W0PCY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQVWYLFKAVVLGVVEGITEFLPISSTAHLLILGDWIGFDSGQFKVYEIVIQLGSILAV
MWLYRQRLREVIVGTFTGNRTEQRFTMNLIIAFLPAAVIGLLLINQINQLLDGKFMVYAF
TLVLGGIIMLWVERRPSMAKHTTLQEHELAHQTRNLEDITWKQALVVGFAQCLAMIPGTS
RSGATIISGMMAGIHRKTATEFSFFLAMPTMIAATCLSLYKHGGELSQSNLLAVVLGFIA
AYVSALVVVRALMRFLSNASYRPFGWYRIVFGIIVALWAWNQVA
>A0A0A5GJR8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKITGLNHLLFSVSDLKRSIQFYQEVFDAELLVVGEKTAYFDLAGMWLALNEERDIPRHD
IHHSYTHIAFSVPEEEIESERERLEQIGVHILPGRERSNRDRESVYFTDPDGHKFEFHTG
TLKERLHYYREEKPHMKFNESGY
>A0A127SKM5|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
KLYPAMLYYLTTIVNRHSEFRTAINQAGELGIYDEMIPSYTIFHEETETFSNLWTVYMPD
FEAFSMAYENDIQRYGSNHGIIGKPDVPENVFTVSMIPWSTFEGFNLNLQKGYNYLIPIF
TMGKCYKEDEKIMLPLAIQVHHAVCDGFHICRFANELQELINN
>B6BVY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIFFIQAVILGVIEGLTEFLPISSTGHLIIGAHLINANHPNIEVFEIFIQLGAILAII
YEYRTQLLNKTLHLSDQKSKTFFSNIFLAFLPAAIVGLAFHDVIKIFLFNPIVVSCALIT
GGILILLIEKKTNIGSTKTVDNISYKQSLGIGLFQCLALIPGTSRSGATIMGGLLLQLDR
KTATEFSFFLAIPIMFAASFYDLFKNLHSLSSDDFWFFLIGFSTAFISALIVVRFLIKFV
AHNDFKIFAYYRILIGIIFLILFY
>M6UGM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENFEFDDLFDIFIQSGAILSV
LFLYQEKFRLQIVSSFRYVLKQSSDSEGFNFLIQIGMGAVPILIAGFVAKKFLDTIKTRP
DLLDILSGAWIFGGVLILIAEWYFHKKQGNVEKKPINFKDSILIGIFQCMALVPGMSRSA
ATIITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGDTIPVLMFGFLVSFL
LCTLVIRWFLRYLQKHSFSVFGVYRILLGVGVLVLTKLI
>B1IEX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKAIIIAVVEGLTEFIPVSSTGHMILIGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENIFRKKEHAVQDIDSITFTQALKVGLLQILSVWPGMSRSAS
TIMGGWTAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFIVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAVLVFTKIIVLTV
>C0DSN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLLLAFKALFLGIIEGLTEFLPISSTGHLIVAGSLIGFDAESHAVFNIAIQLGAILAVV
YEYRARFTHVITHIGKDRLANRFVLNLAIAFIPAAAIGLLLNDFIEKVLFNPVSVAAALV
VGGFLILWIEKRQSRVPPKVRSVDDMRPRDALAVGLFQILALIPGTSRSGSTIMGSMVWG
LDRKTATEFSFFLAVPIMVAASGYSILKNLSAFSSQELGLIAIGFAAAFASGLIAVKALL
RFVSSKNFVPFAYYRIIFGGIILLTWLCGWVNW
>A0A0G5X728|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGLDQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELARDGQLGSENWTEVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFALYRIALGAALLLWLPSGS
>Q8CWZ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFEIIKAIIFGIVEGITEWLPISSTGHLILVEEFIHFNNANAAFTNMFNVVIQLGAIL
AVVVIYFDRLNPFKSGKTAREVQITWQLWAKVILSALPAAVIGLIFDDWLDAHFQNFFSV
ALMLILYGIAFIYVERRHQGVEPQVTHLVSLPYKTAFFIGLFQVLSLIPGTSRSGATILG
GILLGTSRQVATEFTFFLGIPIMFGASLVKVLKFIVSGTILTGSQLFILLVAMLVAFAVS
LYVIRFLTDYVKNHDFTFFGKYRIGLGILLLFYGLMKVLFG
>ZP_03837411|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPPHKPSTGRDISEPT
VKTVSGWSQFISGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPTKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0M7D654|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MPLRLPLRALGAALSLFALAGAPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
FKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVF
ARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ
>B1C475|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIEILKAIVLGIVEGITEWLPISSTGHMILVDEFIKLDVSAEFLEMFLVVIQLGAILA
VVFIYWKKLFPFDYKNHWKVKRNIVTMWFKILVACIPAAVIGLLFDDVLNELFYNPLTVS
IALIVFGILFIIIENYNKNRSAKINSLREITYTTALIIGIFQLIAAVFPGTSRSGATIVG
ALLIGVNRRIAAEFTFFLAIPVMFGASLLKIVKFGLVFSAFEFVLLVVGMLVAFIVSMIT
IVFLMDYIKKHDFKVFGWYRIILGVIVIAYFMFLN
>J1QMF9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTLPLVEKVSVVIPVYNEQESLPELIRRTTASCNLLGVDYEILLVDDGSSDDSAQMLTA
AAEEPGSRVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQHRQDSLFRKMASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRAVEIPVQHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALAGFSLAVLLVVLRLAFGPQWAGEGVFMLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQESDDSQEEKKQ
>B0VCG7|FEATURES|UNIPROT_deepARG|aminoglycoside|aphE|antibiotic inactivation|1
MMSNSKLKEPPLNRTYIFLGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELA
GERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQL
GAVHSLSVDQCPFERRLSRMIGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPV
RLDQERTDMVVCHGDPCMPNFMVDPRTLQCTGLIDLGRLGTADRYADLALMIANAEENWA
APDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0B5E3C6|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
CRRMGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIH
YSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>J9S0D8|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-119|antibiotic inactivation|1
MHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFGQERAAKRYSPASTFKLPH
TLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNSAVWVYELFAKEIGEDKAR
RYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYRNQLPFQVEHQRLVKDLMI
TEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTPNRTDDLFKREAIARAILR
SIDALPPN
>A0A0R2MWL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKAIVIGIVEGLTEFLPISSTGHIDLVNSVIKLDQSKEFVAMFEYVIQFGAILAVI
FLYFNRLNPLSPSKTKQEQHDIWQLWFKVIVAVIPSVVIGLPLNNWMDEHLHTPLVVATT
LIIYGILFIVIENYFKNRPAKFSSLNDLTYQMALMIGIFQVLSIVPGTSRSGATILGAII
LGTSRYVATEFSFFMAIPTMVGVSILKIGKFLLQGGTFGGEQWAILLTGSVVSFIVAWIS
IKWLLKFVQTHDFKPFGWYRIILGIIVIAVMIF
>A8HNT0|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-28|antibiotic inactivation|1
SVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAA
VLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLI
AHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKAL
GDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLIL
VTNFTQPQ
>W0MS42|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKDVTRRFVAGEKDFIALNNINLTINAGELIAITGASGSGKSTLMNVLGCLDH
AASGSYKVDGRETGTLTEDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
IRVERAQKLLERLGLPGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKNTE
RLPSKPAQGNRLMANLGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVTALSSQYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKMGSGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQSYLDSITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIA
YVFSLFVKEWQMVFSLGSIITAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>H9AZ20|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_III2|antibiotic inactivation|1
MKLSFSTLKLKKAAAVLLFSCVALAGCANNQSNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVAYQPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNTAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PALNEVNPGETQDTSTARALATSLRAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
DGWEVADKTGAGSYGTRNDIAVIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVIK
ALNKNGK
>A0A156SM20|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAKMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKASVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0P0DK20|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASRWAIFNIAIQPGAILAIVVL
YRKLFWDMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTKDVGGVANMSTRQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLSGATALQLFKHRDAITSNDLGLIGLGAFVSFIVAWVVIKAFLAVV
TRYGFAPFAWYRIIVGAAALVWLTMR
>J3CX56|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALLIKAAIMGIVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIRATVVALPTEKQAQQFVLNVLVAFVPAVVLGLLFGKAIKAHLFTPVVVASTFI
IGGFIILWAEKRQQNNPAAARIQEVDAMTVMDAVKVGLVQCLAMIPGTSRSGATIIGGML
LGLSRKAATDFSFFLAMPTLIGAGAYSLYKERALLSMADLPMFGVGLVFSFLSAWLCVRW
LLRYISSNSFVPFAWYRIAFGIVVLATAWSGLVVWAE
>H1CZB3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYEYFCALVVGIVEGLTEYIPVSSTGHMIIVGHMLGFEGTLADLFDVFIQLGAILSVLVV
YHEKFTYILNTHHWFRRKGPSVFNICIAMFPACLMGLLFHGFIKHRLFSPTTVIIGLVLG
GIFMIVAEKARKGKEFAVTDVDKISTKQSFIIGLFQCLSLWPGFSRSGSTIAGSLLLGIS
RKAGADFTFIMAVPLMFLACFYDLLKVIGSLSVSDLGVLAVGFVTAFVVAYASILWFLKF
LNTSTLTGFAIYRFFVAAFALVYFW
>YP_002214869|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRCEHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALVRE
>A0A0C1Q0N6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEITIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIVDVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>A0A0Q4IJA1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
YWRTFWAVGMGLLKREPKSWLFLRNLVVAFIPAAVIGLALHKYIEALLGNAEVVAIALIV
GGFAILAVERFAPRSDISGVADIPLKTVIGIGFLQCLAMVPGVSRSGATILGALALGVER
RTAAEFSFFLAIPTMLGASALELLKNRDAIASGGGVGLGAIAIGAAVSFIVALLVVKWFV
GIVTKHGFVPFAWYRVAAGSAALVWLLSK
>A0A0D7QH37|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMVRAVILGIVEGVTEFLPVSSTGHLLLAERFFDLGEGNFWKSFAILIQLGAILAIV
VLYFAKLWRVALGMFSNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEYLFNPWVVCFSLI
VGGAVLMWVDQLDLHPHEDEATRFPLLMYFWIGLAQCLAMIPGVSRSGASIVAAMLLGAE
KRAAAEFSFFLAIPTMIGAFAYDFYKNRGDFTTDNLGLIAVGFVVSFITALIVVRAFLNF
VTRRGFTFFAWWRVVVGTLGLIALAMGK
>A0A037Z1Q5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIFLLKAIIIAIVEGITEFIPVSSTGHMILFGWAIDFRGKFAEMFEVVIQLGAIMAVV
ILYWQKIRESIIEFFKFIFTKGREGRKGFKFGINVIMASIPMGVIGILFYSKIKSKFIPE
AVIVGFIVGGLLLLIVENRFRNRNYKVRSVDNITPMQAFKVGLLQILSVWPGMSRSASTI
MGGWIAGLSTPIAAEFSFFVAIPAMVGATGKDLFEFDYSIMTPMLWISLIVGFIVALIVA
LIVMKKFINYLKKKPMRGFAVYRIIAGIFLGVLVLTKVITLTT
>A0A0R5RP94|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LGWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>YP_001460870|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASTMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>M4R2V5|FEATURES|UNIPROT_deepARG|beta_lactam|WQG_950|antibiotic inactivation|1
MFNKLKIGTLLLLTLTACSLNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQAR
IGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYS
PETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLE
PDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATP
TSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFH
TLQLN
>YP_002773891|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MPQLQGLNHLLFSVSDLEKSFCFYRDVLHAKPLVRGRKLAYFDLNGYWLALNEEPDIPRN
EIAHSYTHMAFTITEESFDEWYAHLEKHGVTILHGRDRSERDKRSIYFIDPDGHKFELHT
GTLQDRLAYYRDEKHHMTFFE
>A0A133QUD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLELLKALILGIVEGLTEFAPVSSTGHMILVDDIWLKSTSFLGSESAFTFKIVIQLGS
VFAAAWVFRNRYFEMFRLGKYKHTAPSTEHTEGETLSRTAQSKHKRLTIWHVLVGMIPAG
VLGLLFDDLIETYLFSVPTVMIGLLLGAFYMIFAQKFSRRYAHREHLDQITYVQAFIIGL
SQAVAMWPGFSRSGSTISTGVLMKLNYKAASDFTFIMAVPVMLAASGLSLVKHMEYIHLN
HIPFYLIGFIAAFLFGLLSIRLFLNLINRIKLVPFAIYRIILVIFIAILYFGFGIGKGI
>I1V585|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNT
AMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPGDTTTPRAMAQTLRQL
TLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTV
>R6FQE1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSYMGDLTIWEAIVIAIVEGLTEFLPVSSTGHMIITQNMLGVESTEFVKAFTVIIQFGAI
LSVVCLYWKRFFRLNHTPAPQGASSLRRLLHKFDFYWKLLVAFIPAALLGFLFSDKIDAL
LESVVVVAVMLVIGGIFMLFCDRIFSKGSEQTELTEKRAFLIGLFQCIAMIPGVSRSMAT
IVGGMAQKLTRKAAAEFSFFLAVPTMFAATAYKVLKLFLEGGTEIVVNNLPALLVGNVVA
FVVALLAIKFFISFVTKYGFKAFGWYRIVVGGGILVMLLCGYSLEVL
>N4W9P2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MFVKGLNHFLFSVSDLETSITFYQDVFNATLLVKGNTTAYFDLNGMWLALNEEKDIPRHE
ISQSYTHIAFSIEESDYETIYQKLEELGVNILSGRSRDDRDRKSIYFTDPDSHKFEFHTG
TLKDRLDYYKQEKPHMKFYR
>R9UDV6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLFSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLKKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVAKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>B2CD70|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
SPKGRFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVR
ELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDT
TMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDHLSSY
>P52700|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAVALPAAHTSAAEVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLT
ALLVQTPDGAVLLDGGMPQMASHLLDNMKARGVTPRDLRLILLSHAHADHAGPVAELKRR
TGAKVAANAESAVLLARGGSDDLHFGDGITYPPANADRIVMDGEVITVGGIVFTAHFMAG
HTPGSTAWTWTDTRNGKPVRIAYADSLSAPGYQLQGNPRYPHLIEDYRRSFATVRALPCD
VLLTPHPGASNWDYAAGARAGAKALTCKAYADAAEQKFDGQLAKETAGAR
>ZP_04345284|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHRSVNLLLMLVLLVAVGQMAQTIYIPAIADMARELNVREGAVQSVMAAYLLTYGLSQ
LFYGPLSDRVGRRPVILAGMSIFMLATLVAITTHSLTVLIIASAIQGMGTGVGGVMARTL
PRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGMLDTLWNWRACYIFLLILCAGVTFSMA
RWMPETRPAGAPRPRLIASYKTLFGNSSFTCYVLMLIGGLAGVAVFEVCSGVLLGAGLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLVAGLMMWIPGLFDVMNVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWFSAMLPQT
GQASLGLLMTLMGLLIFVCWLPLASRVSHQGQAV
>H0HJC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENQTIVEALLLGMLEGLTEFIPVSSTGHILLAGHFLGFESTGKTFEVLIQLGAILAILT
VYSARLWRMAGDLPHDPKTRHFVLGILVAFLPAAVIGALGHSFIKTVLFETPKLICIMLI
LGGFVLLWVDRLTLKPKYHDVKQFPLSLCFKIGLVQCLSMIPGTSRSGATIVGSLLMGAD
KRSAAEFSFFLAMPTMAGAFAYDLFKNRDILSLADLPVIVAGFIAAFIMAVVVVRSLLDY
VSSHGYALFGWWRLIVGSAGLAALYLVG
>A0A0D6BRK3|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MIRIQSGALSEQSDWLQLRRELWPDCPPQEHQAEIRQMLAEPQRYGCWLAYGADGVAAGL
AEAALRHDYVNGTESSPVVFLEGIYVAPESRRQGIAQRLIEQVAAWGRQQGCVELASDTS
LDNLPSQTLHHALGFEETERVVYFKKRL
>A0A0S1RU88|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQ
PTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPFEQVDFLRKLVNRQLPVKAAAYDLAENLFEVGEADG
>N9SYS4|FEATURES|UNIPROT_deepARG|beta_lactam|F885_03600|antibiotic inactivation|1
MNQPKAFSMTLKKLYLLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAAYAQAQGQLSLSDHPAK
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDEVLQQQDMIKYFQTWQAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIRVPEQHMSQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRQAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>A0A0J6V6T8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAASIGKAVVLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVG
VYFRQLVDLLLRAPRDPNARRFILAILIAFLPAAIIGGLFSKYIKFYLFNPWIICSTLVA
GGLVLLVIDETEIEQKYDDVHQFSLPMALKIGLFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSKDDVGLIAIGFVVAFLSALFVVRKLLNYV
SRHGFSLFAWWRILVGAAGFAGLIVFG
>A0A0J7D1I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHGVIKTYLFQPYTVVIGLVA
GAILMLFAELKKKEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVNDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0Q7AMW0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILLFKAAVMGVVEGLTEFLPISSTGHLILAGSLLGFNDDKMKVFDIAIQTGAIVAVI
IVYWQRLRETMAGLGSDAKAQRFAINVAIGFVPAVVLGLLFGKAIKAHLFTPIVVASTFI
IGGFIILWAERRTAVATRVETVDDMTRLDALKVGLVQCLAMIPGTSRSGATIIGGMLLGL
SRKCATDYSFFLAIPTLVGAGLYSLYKERALLSAADIPLFGVGLLFSFLSAWVCVRWLLR
YISTHTFVVFAWYRIAFGIVVLITAYSGLVTWAD
>A0A0H4W1A9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDSTLYLLKAFFLGIIEGLTEFIPVSSTGHLILFGDWIQFESSSGKVFEVVIQLGSILA
VMWIFRARLWQLIRGTLAGERQELMFTRNLLLAFLPAAVIGAVFIKAIKQTFYHPGVVAV
TLVLGGLIMLWVERRAPHTPGDAPGAADDTASDERATARRLEDISWKQALGVGAAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNLDVLTSHDLSGIA
VGFVAAFLSALVVVRAVLRFVANHTYRGFAWYRIALGLVVAAWLFAK
>AAO42740|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDALLEKYIAGEPISQEKLAREEQRRVQEASLFPVYHGSAKKGLGIQPLMDAVTGLFQP
IGEQGSATLCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWREAPLPMLRTTIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0ESJ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIDGSDSKVALASLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>D8ECB6|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKE
TRPASPAASAKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>E7RPV0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVLQTIILAIVEGLTEFLPVSSTGHMIITQGLLGIESTPFVKAFTIIIQFGAILSVVCL
YWRRFFRLDHTPVPPNSSVFKAFIHKWNFYWKLLVAFVPAMVIGFVGKMSGLIDRFLESV
EVVAIMLVVGGIFMIFCDKLFNKGKEETVLTERRAFNIGLFQCIAMIPGVSRSMATIVGG
MSQRLTRRAAAEFSFFLAVPTMAAATALDVWEVFFGSDANTSWATPDNLAMLALGCVVAF
VVALLAMKWFVAFLTKYGFKSFGVYRIIVGGFILLWLLLGHNLSMVS
>A0A0A0QAW6|FEATURES|UNIPROT_deepARG|beta_lactam|MIR-5|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASLGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0M0G6E8|FEATURES|UNIPROT_deepARG|beta_lactam|AF332_00150|antibiotic inactivation|1
MKKLYYSISGKHTLKAVRLISMALLLILAGCANANKASEPNMDEASKKTSVNTDQKFKQL
ERDFDARLGVYAYDTGSKKTIAYRSNERFAYASTFKPLAAAILLEKKSLEEMDEIITYKS
DDLVTYSPVTEKHVKTGMTLRELCEAAIRFSDNTAGNLMLEELGGPEGFETALKEMGDSV
TKPSRFETDLNEAEPGDIRDTSTPKELAASLQKSLMGDLLPEEKQSILTDWMRGNATGDP
LIRAGVPSGWEVADKSGAGGYGTRNDIAIVWPPNREPIIMAILSSRDSKDAEYDNALIAE
AAEMTIKALD
>A0A0Q6GUI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
VYFQRLLSIALALPSSAKARGFVLSVLIAFLPAAVIGAIAHDFIKTVLFETPMLICIVLI
IGGIILYAIDRMPLKPIYRDVMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRDALDFNDVTVIAVGFLAAFVSALFVVRSLLNF
VSNRGFAPFAIWRIIVGTAGLIGLWLFG
>G5K5A8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFEIVKAIFFGIVEGVTEWLPISSTGHLILVQEFINLNQDKAFMEMFNIVIQLGAIIA
VIVIYFQRLNPFQPGKSALDVRLTWQLWLKVFIACIPSIVIAVPLDNWFEAHFYNIIAIA
VALIVYGIAFIWIEKRNEKVSPNVTQLSRMSYKTAFLIGCFQVLSIVPGTSRSGATILGA
IILGTSRTVAADFTFFLAIPTMFGYSGLKALKFFLDGNSLIFSQVLILLAASLTAFVVSL
YVIKFLTDYVKKHDFTVFGHYRIVLGSLLIVYALFKAMF
>ZP_03945515|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MRSPFKVVGAQGGYAVLEILKAVILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFID
MFNVVIQLGAIMAVVVLYFHKLNPWSPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLND
WMDAHLMNWLVVSIALIVYGVLFIVIENHNQNLRPRFDSLNTLPYKVAILIGCFQILSLI
PGTSRSGATILGAILIGTSRYVAAEFSFFLAIPTMFGASLLKLYKFFAHGGTLAGNQGLI
LAVGVIVSFVVAYASIRFLLNYIKTKDFKAFGWYRIILGVIVIAYFALLAH
>A0A087FTY0|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKAVVFAYHDMGCTGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
DVNHPLWIERIREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGDIVAQQTVAIGPDDAALTLHRKLCAAATELLGQALPAI
LEGKTAERPQDHSQATYVGRRTPEDGRLDWEQPAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLPAAKPGTVISVAPLIVACQDGALEIVTGQTERGVYMQGAQLAQALGLVS
GAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLESP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
YDLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPENEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWEPKVEMEETVEHTLDFFLRTVELVDDKN
P
>K5E470|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLHGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSGLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVAEDVRQRASTVDRSRLANS
RAEPLREPASAWSLPATWNAIVVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTSGRQRPIQIIPDDVVAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCILGKTVAHELFD
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQVLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRGAILRQFLIEATVLCVVGGFIGIFAGHMWSVLVGRVIGWPTAMSIWAPIVAVTVAATV
GIVFGYYPARTASRLNPIDALRYE
>Q0BHM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIVSIVTGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSIDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRFVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0H3DPR3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MDMTMSDFKTIQFVSVVIPVYNEQESLPELLKRTIAACDATGKQYEIVLVDDGSSDRSAE
ILREAAQRPGSRVVAVLLNRNYGQHSAIMAGFSHIKGDLVITLDADLQNPPEEIPRLVET
ADQGYDVVGTIRQNRQDSWFRKRASRMINGLIQRTTGKSMSDYGCMLRAYRSSIIKAMLH
CHERSTFIPILANSFARRTIEIPVKHAEREHGESKYGLMKLINLMYDLVTCLTTTPLRAL
SIFGSVIALLGFAFAVLLILMRLTLGPQWAAEGVFTLFAVLFIFIGAQFVGMGLLGEYIG
RIYNDVRARPRYFIQNVVRANPPDEEQEK
>ZP_03015699|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGNIPYNISTNIIRKIVFESSA
TISYLIVEYGFAKSLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSVLIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKYARIYDINNISFEQFVSLFNSYK
IFNG
>S3TSF9|FEATURES|UNIPROT_deepARG|beta_lactam|F907_00233|antibiotic inactivation|1
MSKKLKCLALLTPLILILPLTACQSSSQKKQQVVSLNEQQRVANLFQQAQTIGVLVIYDG
KQIQTYGNATRRADQRFIPASTFKILNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDLS
LAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEV
RFVYALAKQKLPFDQSTQQQVKGMLLVDEHQGTKIYAKSGWGMDVTPQVGWWTGWIEQPN
GKIIAFSLNMQMSQPEHADARKVIVYQALQELGLLAN
>Q13NG8|FEATURES|UNIPROT_deepARG|beta_lactam|Bxe_B1593|antibiotic inactivation|1
MKFKAQSLTATVVFALCATASMSRAADATQDGIQRTVDAAIRPLMAKDGIHGMAVGIVAG
GKAYVYNYGVASAETGKPVTRDTLFELGSISKTFTATLASYAQVSGNLSLSDTTGKYLPV
LQGSQFGNVKLINLGTHTPGGLPLQVPDEIHDNDELMQYFKAWRPSCVPGACRTYTNPGI
GTLGLITAKSMGEDFTPLMEQRMFPALGLKNSYIDVPEARIPDYAQGYKKDGAPIRMAPG
VLSAEAYGVKSTAADMTRFMQANMNLLPLDAKLQRAIMQTHTGYFKAGVLTQDLIWEQYA
YPVALKTLLAGNSSAMALKATPAVEIKPPLAPRQDVWINKTGSTNGFGAYVAFVPEKQLG
IVMLANKNFPNDERVSVAYKILTALAGAGVQ
>NP_456105|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNEKGFGKPDSVVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>A0A0Q3TU96|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIKGLNHFLFSVSNLEQSIKFYQDVFDARLLVKGKSTAYFDLSGMWLALNEEKNVPRNE
INESYTHIAFTIEEADFENTHVRLMELGVNILVGRERDKRDKKSIYFTDLDGHKFEFHTG
TLQDRMEYYRLEKQHMEFND
>A0A103TNX0|FEATURES|UNIPROT_deepARG|beta_lactam|WS86_20025|antibiotic inactivation|1
MNHSPLRRSLLAAAVSVPLVGACAPLRGDSNGVTAAERQLRELESTFDGRLGFVALDTAT
GTRIAYRADERFPFCSTFKTMLSAAILARSAGDAELLQRRVRYTKRDLVNYSPITEKHVG
KGMTIAELCAATLQYSDNTAANLLIALLGGPQAVTAYARSIGDTTFRLDRRETELNTAIP
GDERDTTTPAAMAASVRRLLVGDALGAAQRAQLDAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTGNDIGVAYPPNRAPIVFVVYTTMREKNAQARSDVIASAARIAARAFA
>A0A073CXR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIMFILKAIIIAVVEGLTEFIPVSSTGHMILVGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENMFRKKEHAVQDIDSITFAQALKVGLLQILSVWPGMSRSAS
TIMGGWIAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPILWSALILGFVVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRILAGLLLAVLVFTKIIVLTV
>AAS45561|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A060KZ56|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKRVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDILASAAKIVTDGL
>A0A0A2UG02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGSGGELVDIIIGLILGIVEGLTEFAPVSSTGHLILVGHLLGFEGTVRASTFEIVIQLGS
ILAVAFLFWKRILSILGIHVGEDRKATKAKEKLTLIHIIIGVIPFGVGGVFFYDYIKEVL
FSAQTVVVTLILGGILMIAAEMFKPKKPAAETLDQVTYRQALIVGLFQCLALVPGFSRMG
ATLSGGLLAGMSHKTASEFTFIMALPIMFGASLKDLYESWDYLSVDDLPLFITGFVTAFI
VAMIAVKFFLKLINRIKLIPFAIYRFVLAAAFWIFLLR
>ZP_03947551|FEATURES|ARDB_deepARG|glycopeptide|vanWB|antibiotic target alteration|1
MRKGCYIMDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETD
CALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHADKDTPYKDGLT
VTNGKLTTMSGGGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISE
GWIDLKVRNDTDCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYA
QVKRMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>A0A117V4K8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSMNLTAIVLGIVEGLTEFLPVSSTGHLVLATDLFGYDLKDWEVFNIVIQLPAILAVVV
VYWRTFVEVGTGALRRDRESLHFIRNVLIAFIPAAVLGVLLKKKIDFLLESPLVVAVALI
VGGFAIIVIERAVRHRDYEPVSALPVKRSFLIGLVQCIAMIPGVSRSGATIMGALAMGEN
RKTAAEFSFFLAVPTMIGATVKQLWDNRHALAAHSGPVGFVQIAIGSVVSFVVALVVIRL
FLGYISKHGFIPFAIYRIVIGTAALIWLLKI
>A0A0Q9QYU5|FEATURES|UNIPROT_deepARG|beta_lactam|ASH00_00180|antibiotic target replacement|1
MGKTNITSVLTVAALALTLTSCSQDGPTAEDAATRLAEGLASGDLSSVAFAAVSGEDATA
QLEEITAALDAVSPKVSVAGVESTGEDTATAQLNHVWDLDDSDKDWAYTTTAELTLVDDQ
WQAGWDPSVAVDGLSAEASLAVSRTPAERAEVLGAGGEVLVTDRPVIRVGIDKTRIEASG
LESSSAALADLVGIDPAAYTEQVLSAGEQAFVEAIVLRDNEDRPVSDEEIDAIPGASGIP
DTMSLAPTRTFARELLGSVGPVTAELVEQSAGRLEPGDVAGLSGLQLQYDEQLGGTPGMV
IEAVTGEGEARTSEVLFDKAPVPGEPLELTLDPALQTLAENVLAEEPSASSIVAIRPSTG
EILTVANGPGSEGLQTALLGQYPPGSTFKVATSLALLKNGFTPQSPTSCPEELVVEGRAF
NNVPGYPAQFTGEIPLLQAVAQSCNTGFISQRDVVSQEALASAAADLGIGIDVPIGTPAF
FGSVPTEADGTAHAASMIGQGEVLVSPLSLAIMAASVSAGERVAPTLLAGTAAPEEAPSS
SASTEPATDQTAEAETQPAPTPSSLTAAEAADLREMMGAVVTVGGAQLLADIPGEPVLAK
TGTAEFGTEDPPRTHAWVVALQGDLAVAVFVEEGERGSISGGPLMEEFLRGAGQ
>A0A0S7AQ25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGVTIFEALILGILEGLTEFLPISSTGHLTLAAHLLQLDIENDPFIKSFIVVIQLGAILA
VLALYFQRFLRDIEVWKRIIVAFIPTGILGFLLADVIENVFLGNDLIVVINLVGVGILLL
FVDRWLQHHKRYDDVNQMPVPHAVLIGLSQALAMMPGVSRSGATIVGGMALGLSRRAAAE
FSFILAVPTMLSATGFSLVRHMDQFRADSWGLLVVGFLAAFISALLTVRWLLDFVSRNSF
VPFAIYRILIGVVYGVFFLR
>K6CB68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTILKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLQSEQFLTKYVANTFKVVIQLGS
ILAVVVVFKDRFIEMLGLGKRGRQALHEKGHLKLTHVIVGLIPAGILGVLLEDMIDEHLF
TTGTVLIGLVLGAILMIIADKFTKNKPMVQTVDQITYKQAFTIGCIQCLSLWPGFSRSGA
TISGGVLVGLSHRAAADFTFIMAVPIMAGASGISFLKNLEYFSFDALPFFILGFISAFVF
ALISIRFFLKLINRIKLVPFAIYRIVLAAVIYVVYF
>A0A0G8F0L4|FEATURES|UNIPROT_deepARG|beta_lactam|B4077_0876|antibiotic inactivation|1
MIVLNKFYNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQTKQENTVNHSFSKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALASSLQAFALGDVLSTEKRSLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>G4QAV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSDFIFLLKAAILGVVEGVTEFLPISSTAHLLILGDWLNFDAGQDKVYEIVIQLGSILA
IVWLYRSELLKIAAGSMRARKPDLLFVRNILLAFLPAAVIGLIFIKQIKKLLDDQFIVYA
ITLVLGGLIMLWVESRPEFSKRVRDDENIMVKSKTLSIEEISIMQALAVGFAQCLAMIPG
TSRSGASIIAGMMAGIERKVATEFSFFLAIPTMMGATALSIYKYGHLLSESNIIAVVIGF
VTAFFSALFVVKGLLRFVAKHSYVPFAWYRIIFGAIVALWVWNIL
>A0A0N1B354|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLIEAAILGIVEGLTEFLPVSSTGHLLLLGHFLGFESNGKSFEVLIQLGAILAITSVY
FRRLLDIALRIPTDPAARRFVIGVLVAFLPAALIGAVLHGFIKGVLFNPFIVCCALIAGG
LILLVVDDLELQEKHTDATTFPLSMYLKIGLFQCLAMIPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKSYKTLTFDDVTLIAVGFVTAFFAALIVVRSFLDFVSK
RGFALFAWWRIVVGLFGLAGLWIVG
>A0A0W0MLP2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLSIQAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLADEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQA
QRHSRAQELLTRLGLAGHISHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKANQSVGLEVPSEAP
IEPKRSGARHLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFNVKGLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPT
VDPLGQVILVGKLPCTVIGVAAENKNMFAANKSLNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGSKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGMIGISLSFAIGY
LFSLFVKEWEMVFSLGSIVTAFACSTMIGIVFGFVPARNAARLDPIEALARD
>BAH02344|FEATURES|ARDB_deepARG|glycopeptide|vanXB|antibiotic target alteration|1
MENGFLFLDEMLHGVRWDAKYATWDNFTGKPVDGYEVNRIIGTKAVAFALREAQIHAAAL
GYGLLLWDGYRPRTAVDCFLRWAAQPEDKLTKEKFYPNIERAELITKGYVASQSSHSRGS
AIDLTLYHLDTGELVSMGSNFDFMDERSHHTAKGIGDAEAQNRRCLRKIMESSGFQSYRF
EWWHYKLIDEPYPDTYFNFPVS
>ZP_04677690|FEATURES|ARDB_deepARG|multidrug|NorA|antibiotic efflux|1
MRKQLFTLYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGILVASFALAQMIISPFGGG
LADKLGKKLIICIGLVLFSISEFMFAVGHSFTILVISRVLGGFSAGMVMPGVTGLIADIS
PSQDKAKNFGYMSAIINSGFILGPGFGGFLAEVSHRLPFYFAGGLGIIAFIMSLIVIHNP
KKMTTAGFPQYDPELLTKINWKVFLTPVILTLVLAFGLSAFETLFSLYTSDKAGYTPKDI
SIAITGGGIFGALFQVFFFDKFMKFTTELNFIAWSLLYSAIVLVMLIIAQGYWTIMLISF
IVFIGFDMIRPAITNYFSNIAGNRQGFAGGLNSTFTSMGNFIGPLVAGTLFDVNIEFPLY
MAIAVSLSGIVIIFIEKMIRTRLNRIAQ
>U2K512|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEYLFFVEIIKTFIIAVVEGITEWLPVSSSGHMLLVDAFLPLKSSAEFKSLFFIVIQLAA
VCAVIVLFWNDMFPFRFGEKNIKQKTVVQKDIFALWFKTIIACIPGATAVFFFGDYIEAH
LQTPVVISCALIFYGILFIVVERINEKRSARIEQLSAIDYKTAFIIGLFQVLSIIPGTSR
SGATIIGALLIGVSRTAAAGFTFFLAVPVMLGSSLLKLLKYGGSLSANEAFLLLTGCTVS
FAVSLAAVKFLMNYIKKHDFKVFGWYRIALGFTVLLALKIM
>A0A0M4FGF6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-1|antibiotic inactivation|1
NFAIFLINANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNKAKCATQM
APDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEIT
QKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNL
PVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSGHKYVFVS
ALTGNLGSNLTSSLKA
>A0A0M7K6E6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSGDGKVFEVVIQLGSILA
VMWVFRARLMQLIRGALTGVPSEVAFARNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVV
TLVLGGLIMLYVERKTHHTPGDQPGAADDTASDERASAYTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVFDMYKNFGALTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIVFGAVVAAWIFTR
>A0A095Z9L0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFDLFKVLILGIVEGLTEFLPISSTGHLILFGKFIELSPKEFSNAFFVIIQLGAILSVL
YLYFNDLNPIGKYKIQEKVGDKYKSLSLKDKWELRDMPTMRLLAKIIIGFLPAAVLGFLF
DDLIDKYLFNEVTVAIALIFYGIIIILMEKKNKDSNFKYNDLDDISLKTAFFIGVFQCLA
MVPGTSRSAATIIGAMLLGCSRTSAAKFSFYLAIPTMLGATALKVIKIGISFSLWQWFLI
IVGGIVSYILALIVIKKFLSYIRNNDFTYFGIYRIILGILVLFIRFI
>C0L015|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
KPTDRVILVFDHVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQ
DQDLRSQCGILLSGFMTICKKSGKKRVDAIFNIWETTFPKRKKIFF
>A0A0F0C7F1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPTKSSRQKDATWALWIKIVIACVPAAVLGLLLDDWMEAHLFNAYVVA
AALIIYGVLFIVLENSSVCSNPQINKVGQISAKTAFMIGMVQLLALIPGTSRSGSTILGA
MVLGCSRGAAAEFSFFLGIPVMFGASLLKLVKYFVAGNVFTGPQIFYTVLGMLIAFVVSI
YSIQFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>YP_001116031|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIGLDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASIIPLIAVPVSIVGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIESGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRALGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSRIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QKYGAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDRGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAIERIAHETLPRGVRFEWTDLTYQQILAGDSAMYVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGGPAHGVPASDA
>A0A0M4G455|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXY|antibiotic inactivation|1
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A127SCA3|FEATURES|UNIPROT_deepARG|beta_lactam|OCH-8|antibiotic inactivation|1
AVTAGGKTYFFGYGVASKESGQKVTEDTIFEIGSVSKTFTATLGGLGLAEGAFKPGDTAT
KYAPKLAGSSFDNVSMLDLGTYTAGGLPLQFPDSVTDHKTMIDYFKNWKPDYPAGTQRRY
SNPSIGLFGYLAAQSMGEPFDKVMETRLIPAFGLKHTFIQVPESQMKNYAYGYSKANKPI
RVSPGAFDAQAYGIKTTAPDLIRFVQLNMDSTSLGQPMQKAVAATHTGYYKVGDMTQSLG
WERYAYPLSLKTLLGGNTSDMAMKSHKIEKLAPPLQPSDDMLLNKTGSTGGFGAYVAFVP
GKKIGIVMLANR
>A0A066UPA5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLFIKAVIMGIVEGITEFLPISSTGYMILSADIMNFWDKDKRDLFIVFVQLGAILAV
IYDYWGRLWTAFMGLLTGKADGMTNPRGLGISLIIATIAVMVVGFTLKDFITGTLFHPLV
VATMLIIGALLIIYVEKHPRPIKAQEAEHIDIKTALKIGLCQCLALIPGTSRSGSTIIGA
LWFGASRKAATEFSFFLGIPVIVGAGLLELIEKKDVLQTGEDWAILGVGTAVSFVIALLC
IRLLVAWVSKRDFMIFAYLRIITGVIVLLAYFMFGYQIQG
>R5TEN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLTMIEVLKAILFGVVEGITEWLPISSTGHMILLDEFVKLNVSKEFLDLFLVVIQLGAIL
AVVVIYWNKLIPLSTKHGLHISRRKCKMWVKIIVASIPAGVVGILWDDVFTKYFYNYQTV
AIMLILVGVVFIIIERSNKNKIAKIDSIDDISYGQAFLIGVFQMIAAIFPGTSRSGSTIV
GSLMLGISRTAAAEFTFFLAVPAMFGGSAIKILKYNGGFNSAEVALLAIGMIVAFVLSII
AIKFLMSYIKKHDFKVFGWYRIILGIAVIGYFLAAR
>V9VXS6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFFTAAAITLLSLPAALTAAPWTDAQMQELAESSFAAVIEEYNVPGLVVGVTHRGQTYY
YAAGLASREDNTAVSPDTLFELGSVSKLFNVSLAALAEARGDMDLNEQVSERLPDLDGTA
FGDLSLMDLATHNSGGLPLQVPETVASSEGLVEWLADWQPSDTGSRSYSNISIGLLGHIT
ANVLSMGYADTVEQDLFQEMGLQSTWVNVPEKSLERYAYGYDRKTDLPIRVNPGVLDAEA
YGVKSSARDMVRFLELNIGHADASDDLNAALKRTRQGLAQTDAYVQNMIWEQYPWPVSVE
QMIKGNSYAYILKPQPMETLDPPLPPQKNVILNKTGATNGFGAYVALLPGEELGVAVLAN
RNIPNEARIRATYAFIQRVLADQE
>N9AW82|FEATURES|UNIPROT_deepARG|beta_lactam|F948_02950|antibiotic inactivation|1
MQTKYELKVKRLMMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPL
LEEYKIPGLAVAVTLDGQHYFVNYGVASLQSKSKQVVSNSTLFELGSVSKTFNATLASYA
QAQGRLSLSDHPAKYFPELKNAAVNQATLLNLGTYSAGGFPLQFPDEVVTQQDMVQYFQN
WKTKTKIGEARQYSNPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTQSYIHVPEQKMS
QYAWGYKNNQAIRVSAGIFDAEAYGVKSSSSDMLKFLDAQINSAQLDQPIRQAVENTHIG
YFKVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALESHAVTLIKHPKIASQSTYFNKTGS
TNGFGAYAAFVPQHKIGMVMLANTNFPNEARIKATYQAMQQILKEKATR
>Q9KVZ1|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLS
SRADQLEEFVHYVKGEITKVVGK
>A0A0M9D329|FEATURES|UNIPROT_deepARG|aminoglycoside|AM629_00230|antibiotic inactivation|1
MNRKHQQPPYIQSKNDLYQIVISNSYNFNDWLYLRSALWPAASEEEHSEEMNSILDSDNQ
VAFMIQSGTGDFCGFAEASLRFEYVNGCNSSPVAYLEGIYITPEFRRKGLATQLVTHINR
WANAHGCTEMASDTDINNQQSQNLHLSLGFMETERVVFFRKSIK
>Q8L1L5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEDAQMKKSLCCALLLSASFSTLAAPVTDKQLADIVNRTIAPLMQEQAIPGMAVAVIYQG
KPHFFTWGKADITANRPVTQQTLFELGSVSKTFTGVLGGDAIARGEIRLSDPVTKYWPEL
TGKQWQHINLLHLATYTAGGLPLQVPDEVTDRAALLKFYQDWQPQWAPGEKRLYANASIG
LFGSLAVKPSGMSFEQAMTTRVLQPLKLNHTWLTVPESEQQHYAWGYRDGKAVHVSPGQL
DAEAYGVKTTIEDMASWVQANMNPTTVSDQKLQQGITLAQSRYWQIGEMYQGLGWEMLNW
PVKAKTVVTDSDNKVALAPVTAVEINPPAPAVKASWVHKTGSTGGFGSYVAFIPEKDLGI
VMLANKSYPNPARVDAAFRILDALR
>BAH65216|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSAMSQAENLLQVYQQARISNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYTNGYRDSNGVNSNVTSGSLQLTQVLFDMSKWRALTLQEKTAGIQDV
TYQTDQQTLILNTATAYFKVLAAIDTLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDAVLANEVTARNDLDNAVEGLRQVTGNYYPELASLNVNGFKTNKPQAVNALLKEA
ENRNLSLLQARLSQDLAREQIRQAQDGHLPTLNLSASTGVSNTRYNGSKTNTPLAYNDSD
NGQNQIGLNFSLPLYQGGAVTSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNVNASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSNARYNYLINEL
NIKSALGTLNEQDLVALNNTLGKPISTSADSVAPENPQQDATADGYGNTTAAVKPASART
TQSSGSNPFRQ
>W0L4E4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELSGIRRSYQSGDQTLEVLKNVSLRIAAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGTYRVAGQDVAALDGDALAELRREHFGFIFQRYHLLPHLSAVHNVEVPAIYAGLGSQV
RRERAAALLTRLGLGERITYHPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMSILKQLCEQGHTVILVTHDPAVARQAERVIEIRDGAIMSDSRPLSKTGSPAKTLAL
TSQSPSWQQMTDRFREAMMMAWWAMAANKMRTLLTMLGIIIGIASVISILVIGDAAKLSV
LAEIKSIGTNTVDIYPGKDFGDDDPTFRQALKYDDLSALREQPYVSVLSPTIRNSMRLRF
GNIDVAANVSGISEQYFRVYGMAFSQGAGIDIGQLQSGAQVVVIDTNTQRRLFPLRKNAI
GEVILVGNMPATVVGVAEQKQSMFGSSKMLNVWVPYTTMANRLTGNDYFDSITVRIRDGY
NSQEAEQQLTRLLTLRHGKKDFFTYNMDNLVQTAEKTTRTMQLFLALVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGIALSLAIGQLVQW
AMPGWQISFPPTALWGAFLCSTGIGIVFGYLPARSAARLDPIDSLARE
>ABF20240|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGVKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPMLCSSNIVGLHKYWLEFAV
>D7PIH4|FEATURES|UNIPROT_deepARG|beta_lactam|blaRAHN-1|antibiotic inactivation|1
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVGLKKSDLVNYNPITEKHLN
EGMTIGELAAAALQYSDNTAMNKLIEHLGGPNKVTDYARTLGDNTFRLDRTEPTLNTAIP
GDERDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDK
TGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKS
>P18330|FEATURES|UNIPROT_deepARG|mupirocin|ileS1|antibiotic target alteration|0
MTDYKATLNLPDTAFPMKAGLPQREPQILQRWNSIGLYGKLREIGKDRPKFVLHDGPPYA
NGTIHIGHALNKILKDMILRSKTLSGFDAPYVPGWDCHGLPIEHKVEVTYGKNLGADKTR
ELCRAYATEQIEGQKSEFIRLGVLGEWDNPYKTMNFKNEAGEIRALAEIVKGGFVFKGLK
PVNWCFDCGSALAEAEVEYEDKKSSTIDVAFPIADDAKLAEAFGLASLAKPAAIVIWTTT
PWTIPANQALNVHPEFTYALVDVGDRLLVLAEEMVESCLARYELQGSVIATATGSALELI
NFRHPFYDRLSPVYLADYVELGSGTGIVHCSPAYGVDDFVICKKYGMVNDDIINPVQSNG
VYVPSLEFFGGQFIFKADQPIIEKLREVGALMQTAAIQHSYMHCWRHKTPLIYRATAQWF
IGMDKEPTSGDTLRVRSLKAIEDTKFVPSWGQARLHSMIANRPDWCISRQRNWGVPIPFF
LNKESGELHPRTVELMEVVAQRVEQQGIEAWFKLDAAELLGDEAPLYDKISDTLDVWFDS
GTTHWHVLRGSHPMGHETGPRADLYLEGSDQHRGWFHSSLLTGCAIDNHAPYRELLTHGF
TVDETGRKMSKSLKNVIEPKKINDTLGADIMRLWVASTDYSGEIAVSDQILARSADAYRR
IRNTARFMLSNLTGFNPASDLLPAEDMLALDRWAVDRTLLLQRELQEHYGEYRFWNVYSK
IHNFCVQELGGFYLDIIKDRQYTTGANSKARRSAQTALYHISEALVRWIAPILAFTADEL
WEYLPGERNESVMLNTWYEGLTELPADFELGREYWEGVMAVKVAVNKELEVQRAAKAVGG
NLQAEVTLFAEDGLTADLAKLSNELRFVLITSTASLAPFTQAPADAVATEVPGLKLKVVK
SAFPKCARCWHCREDVGVNPEHPEICGRCVDNISGEGEVRHYA
>A0A0A2XHB7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
SSGSYQIAGKETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQ
RLQRAAQLLEKLGLGNKIDNKPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSG
ETVMQILQQLHQEGHTIILVTHDKHIAQFANRIIEIKDGEIIQDQRQSLQITARKMTQTT
TNRGWQFYRDQFFEALNMSINAIIAHKLRSLLTMLGIIIGITSVVCVVALGNGSQQKVLQ
NINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQPYIESVTPNSSVSGTLTYRN
NAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRIFQDRNPLGQI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTS
TAEKNVTALLLSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNI
MLVSVTERTKEIGVRMAIGAKQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMS
EFTMLFSTFSIVVAVLCSTLIGIIFGYVPAKNAAKLNPITALSQE
>D9RYG0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPLLLKAVIMGIVEGLTEFLPVSSTGHLIIAGDLIGFKGSPFHIMFDIVIQLGAILAVVF
YYRKRIASSLRQLSPGQKGFRFWLNILIAFFPSAIAGVLLNDYIEEYLFSSFTVAIALIA
GGFLMILAENVFGRYGINDVDDMDAGKSLIVGIAQCLSLFPGMSRSASTIMGGMAAGLSV
KAAAEFSFFLAIPTMLGATAFSLMKGFSAVTPAEWQALGVGFVVSFLVALLAVDRFLAYL
TKHSLKSFAYYRIVAGVIMLILVYTGLVG
>J7K4F8|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRLSSTALGAALSLSALAGAPAQAAVLCTMVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
VKAAAYDLAENLFEVGEAGGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>K8A201|FEATURES|UNIPROT_deepARG|beta_lactam|BN137_2547|antibiotic inactivation|1
MKRQARVLLTMMMVAGSAQAATVAPPDDVIKPLMAHYQIPGMAVAVSVNGEAHYWHYGVA
SKATRTPVDENTLFEIGSLSKTFTATLAAYAHEEGKLDFSAPANHYLPELKGSALDGVSL
LNLATHTSGMPLFVPDTVKNTPQLMAWYRAWQPAQPVGTVRVYSNLGIGLLGMIAANALD
KPFSELMEQGLLADFGMTHSYVNVPAAAMKDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEREVSPRWRAALDATHQGYYRSGEFTQGMMWEYYPWPSSPETLLAGN
SSQRIMKGLSATVITPPQNAPQAAWYNKTGSTNGFSAYAVFIPEKRIALIMLANKWFPND
DRVKAAYQIVQELEHARP
>A0A027U534|FEATURES|UNIPROT_deepARG|beta_lactam|BY96_00445|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A8D242|FEATURES|UNIPROT_deepARG|beta_lactam|bla-oxa-58|antibiotic inactivation|1
PASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELAR
RIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQ
QQVKEMLYVERRGENRLYAKSGWGMAVDPQVGWYGGF
>A0A127SK35|FEATURES|UNIPROT_deepARG|beta_lactam|OXY-2-7|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAICSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A0K9K427|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILVIC
WEYRAKIATVVTGLPTRPDARRFTLNVIIATIPAIVFGLLLEKHIKAVLFSPVPVPVSVA
LIVGGIVILWAEARQRDRNSAPRVHSVDDLSPADAFKVGLAQCFALIPGTSRSGATIIGG
MLFGLDRRVATEFSFFLAIPIIFGATIYEMAKYWKTLTVNDIGLFAIGLVAAFVSAFVCV
RWLLRYVASHDFSAFAWYRIGFGLLILIVGYSGGLSWVD
>ZP_01364091|FEATURES|ARDB_deepARG|chloramphenicol|catB7|antibiotic inactivation|1
MGNYFESPFRGKLLSEQVSNPNIRVGRYSYYSGYYHGHSFDDCARYLMPDRDDVDKLVIG
SFCSIGSGAAFIMAGNQGHRAEWASTFPFHFMHEEPAFAGAVNGYQPAGDTLIGHDVWIG
TEAMFMPGVRVGHGAIIGSRALVTGDVEPYAIVGGNPARTIRKRFSDGDIQNLLEMAWWD
WPLADIEAAMPLLCTGDIPALYRHWKQRQATA
>A0A0Q9GH75|FEATURES|UNIPROT_deepARG|beta_lactam|ASE51_07330|antibiotic inactivation|1
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGTLLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLREIADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALATSLQKYVLGQALPEDKRALLTDWMKRNTTGDALIRE
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>R9A7K7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFGNLKIDHESFEDLFDIFIQTGAI
LSVVVLYFQLLWKHTKAATLYLVKKSTDKTGFDFYRNLIVGILPIIILGFVFKNSLDQIK
MRADLLLILGLSWFVGGLVMVFVEMKHYDESEGRVIGMKESILVGFFQCFALIPGVSRSA
ATIITARIMGVSKKDSAEFSFFLAIPVLTLAGIYKLYKHRAILNSETIGLLLFGSIVSFV
ICYFIIRLFMAFIRRRSFLSFGIYRILLGSLVILYFVRG
>A0A060PA45|FEATURES|UNIPROT_deepARG|beta_lactam|BRPE67_DCDS05660|antibiotic inactivation|1
MKCRALSVLAAAIFSFGAMSGAAFSHDAASIRSTVDETIRPLMALHGIAGMAVGVVVDGQ
PYVFDYGVASKATHAPVTRDTLFEIGSVSKTFTATLASYAQTQGDLSLTDPVSKYLPALG
GSAFGKVTLLNLGTHTPGGLPLQVPDDIHDNAQLMRYFSAWRPMQPPGTIRTYANPGIGT
LGLITAKSMRQDFDALMQTRLFPTLGLKHSYMQVPATKQRDYAQGYAKNDTPIRMKGGVL
SSEAYGVRTTAADMTRFLQINMNMVHIDPAFQRAVDATHTGYFQAGPMTQDLIWEQYPYP
VALQALLDGNAQAMIMNATPVTRIDPPQPPRDDVWINKTGSTNGFGTYIAFVPKARVGIV
MLANRNIPNEERVKAAYAIITSLTGSR
>D6IH93|FEATURES|UNIPROT_deepARG|beta_lactam|ECDG_02574|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>B0NS79|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNLLGIESTEFVKAFTVIIQFGAILSV
VWLYWKRFFRLNHTPVPADTSALKRFLHKFDFYWKLLVAFVPAAVLGFLFSDKVDEMLES
VTVVAVMLVIGGVFMLFCDKIFSKNSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKMTRKAAAEFSFFLAVPTMFAATVYKMLKLFLDGGTEIIMNNLPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGIILLLLLTGHNLEVV
>G4HC00|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKVMIHEYIVKTQDSGPYGITRGKDGAMWFTEQRGNRIGRINDAGEITSFPLPTESAGVM
SIISDRTGDLWFTEYQANKIGRMSLDGYFTEYELPVVNSAPFGITEDREGAIWFTEMNSG
RIGRLTASGEMTEFELPNSDTFPSFIVPGSDGALWFTQNQGNSIGRITTEGDVTEFPIPT
PNSGPVGITSGPDGALWFVQIMSNKIGRMTTSGEVTEYMIPTSNAKPHAIISGENGDLWF
TEWGGNQIGRITVQGKITEYPIPTNHAEPHGIAIGTKGDIWFAEECNQIGRLIISP
>ACF08831|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKSTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSDLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNVCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNNIT
>ABY55286|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGERLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>A0A147J953|FEATURES|UNIPROT_deepARG|aminoglycoside|NS258_08635|antibiotic inactivation|1
MIVTPAAPEHSQGWLALRAMLWGEEAGDPAEIAERLAQGGGFVALENAQVIGFAEAAIRH
DYVNGCDTSPVLFLEGLCVDPAHRRHGVAGALVAAVADWGRAQGCTEFASDAELDNIDSH
AMHRALGFVETERVVYFRRML
>A0A0W0YH08|FEATURES|UNIPROT_deepARG|beta_lactam|Lsai_2249|antibiotic inactivation|1
MKKLSALLGMTLLFCASAWAQKSCFLARENQTLLKHEGDDCDQRYAPQSTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKYPHNPYTWMRDSCVWYSQVLTQQLGMKRFKEYV
DAFHYGNEDVSGDKGQNNGLTHAWLSSSLAISPTEQMQFLQKIVTKKLPVSRRAFEMTKD
ILYIQELAGGWKLYGKTGTGEQLEKDKKQKLRLRQGWFVGWIEKDNRKVAFVKHITACKE
SFAGLKARNEALIQLFYLINELEK
>A0A0M1R2F1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELTDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLARAQALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAQKEALP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>ZP_04612557|FEATURES|ARDB_deepARG|polymyxin|RosB|antibiotic efflux|0
MGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKD
LLAVKAIAIPGAIAQIAVATVLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQ
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
TLMIVVGRRLVPWILAKTASTGSRELFTLAVLALALGIAYGAVGLFDVSFALGAFFAGMV
LNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILIHEPLAVLASLAIIIFGKSAAA
YLLVRLFGHSKRTALTISVSLAQIGEFAFILAGLGISLGLMSEHGRNLVLAGAILSIMLN
PLLFTLLDRYLTKNETMEDQILEEAVEEEKQIPVDLCNHALLVGYGRVGSLLGAKLHAEG
VPLVVIESSRPRVEALREQGIHAVLGNAASADTMSLARLDCARWLLLTIPNGYEAGEIVA
AARIRRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKIDKLSEEDTRQG
CPI
>U6ZE16|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTAACDQMNRDYEILLVDDGSSDNSAALLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVDTADQG
YDVVGTIRENRQDSWFRKSASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRTTEIMVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIALSGFSLALLLILLRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRSSEQDNEE
>A0A087FTY1|FEATURES|UNIPROT_deepARG|polymyxin|yfbF|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDTACATLGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSIFRKSASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFG
SVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASKEEDRS
>M1L6G3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MKFLDMDQFLVLIKVCFLGIIEGLTEFIPVSSTAHLIFIGKLINFNSCNGMVFEVFIQVG
AIFSALFLFRSYIFDILFGVFRLEYKYLLFSTKVLCSILPSIIIGALLIRHIKKLFICPN
VIALSLIIGGLVIIIVEYRRNISSSEKLSYYSDLYSISIKQSLCVGFAQCIAMIPGVSRF
GATVIGGMISGLNRSIATKYSFIIAIPTMLGAALFDLWSNINDLSYIDFSNILIGSVSAF
ISAFFIVKYVVRFVETNTYVVFALYRIVVGFAILFLC
>ZP_03747370|FEATURES|ARDB_deepARG|beta_lactam|pbp2b|antibiotic target alteration|1
MRNTGSANIIYENFKMLIKNEYKPRMLPKVEKIKKPVTSDGRIRIVLGCMALAFTALLGR
GIYLQTTQHEFLKNQGDQRFVRTLTLPASRGMITDRNGATLALSAPTESLYAMPSGMEEM
PTAEQLTKLAAIVDLPVETLQDKLAKKDKDFIYLKRQLSQEKAEEIKALGIKGLAFQKEL
KRHYPMGNLFAHVIGFTNIDGKGQEGLELSREDSLHGADGAKVVLRDNKGNIVDSLDSPR
NSDPKNGQDMVLSLDQRIQTLAYDELNKAVAYHKAKAGTVVVLDAQTGEILALVNSPAYD
PNQPGSADSEQRRNRAVTDMIEPGSAMKPFTIAKALDSGKVGVADRFNTMPYKIGPATVR
DTHVYPTLDVRGIMQKSSNVGTSKLSAKFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLR
SWRRWQPIEQATMSFGYGLQLSLLQLARAYTMLTHDGELLPVSFEKQAVAPKGKRVIKAS
TAREVRDLMVSVTEPGGTGTAGAVDGFDVGAKTGTARKLVNGRYVDNKHVATFIGFAPAK
NPRVIVAVTIDEPTANGYYGGVVAGPVFKQVMGGSLNILGVSPTKPLTNVAAVKTPS
>J8F2Y4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNQIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>E5WW15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTMGDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNLLGIESTEFVKAFTVIIQFGAIL
SVVWLYWKRFFRLNHTPVPAGTSALKRFLHKFDFYWKLLVAFVPAAILGFLFSDKIDEML
ESVTVVAVMLVIGGVFMLFCDKIFSKGSEDTVLTERKAFNIGLFQCIAMIPGVSRSMATI
VGGMAQKMTRKAAAEFSFFLAVPTMFAATMYKMLKLFLDGGTEIIMNNMPALIIGNVVAF
VVALLAIKFFISFVTKYGFKAFGWYRIIVGGIILLLLLTGHNLEVV
>V5M6J9|FEATURES|UNIPROT_deepARG|beta_lactam|YBT1518_05635|antibiotic inactivation|1
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSLAVGALLRKNSLEALDQRITYTH
EELSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREVGDTV
TTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTGDK
LIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAD
ATKVVLNTLKATE
>E2XT42|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MGSQHVLTLVFLMTGARYHRLSKGRTLPRFASFAKTLVIGPSLIWKPDCMYEKSFINART
VLFSALLLGAGSCVAATDLRAVVDNNVEPLMQQQGIAGLSVAVMNKGQVQYFNYGVASRD
TRHPVSQDTLFEIGSVSKTFTATLGGYAQATGKLKLSDKASEHLAALKGSAFDQISLLQL
ATYTPGGLTLQFPDSADSADRMLNYFQHWKPTYAPGAQRLYSNPSIGLFGYLAAQSMGQP
FRVAMEKTLLPRLGLKSTYVSVPADKAGLYAQGYDKHQKPVRVSPGALDSEAYGLKTSAQ
DLAHYVMVNMHPDTLEKPLQQAIDTTHTGHYTVNDMTQALGWEYYPYPITLQALTDGNST
PMAMEPHKASWLAKPQVQPANVLFNKTGSTGGFGAYVAYVPSKDIGVVILANKNYPNAER
VKVAHAILSALDQ
>U2M054|FEATURES|UNIPROT_deepARG|beta_lactam|L580_0112|antibiotic inactivation|1
MVKNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKNSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPMAMAKSLQNLTLGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTAGL
>A0A060L007|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQRLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0G4Q1G0|FEATURES|UNIPROT_deepARG|chloramphenicol|cmlA|antibiotic inactivation|1
MNYKKIDLEQWYRKEHFLHYRHNLQCGFSLTTKIDITALKAILTKNNLKFYPAMVYLIAK
TVNYYPESRMAIKNDELVIWDYTNPAYTIFHPETETFSELWSEYVEDFDTFLQGYNQDFQ
QYKNNLNLSAKPNFPENHFCISMIPWISFDGFNLNIANVKDYYPPIFTMGKFIQQNDKFL
LPISIQVHHATCDGFHIARMVNKLQELCDDFSV
>A0A060KTB2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADGRFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALRYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RGTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0B6AB97|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MLPVFALSCAAVVGFSSSEVHAETVKCQRQETKSDREFAKLEEKYDANLGVFALDTGTNK
TVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLVNYNPITEKHVDTGMT
LRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPERFEPDLNEVNPGETH
DTSTPRALAASLQKYVLGQALPEDKRALLTDLMKRNTTGDALIRAGVPKSWEVADKTGAG
SYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQAVKTLKVTRK
>A0A0B2FCG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQDSIMKTYEIVIQLGAILAIAI
VYRQRILNLLGIGRSGRSRGGVMPASRLNLIHVLLGIVPALAVAFFARDFIKGLFGASTV
LWALVAGGILMIIAEWVNKRKIRVTAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTNDTIWYFAIGFVISFVVAY
VVVVLFMRMIQKIRPTHFAIYRFILAAVFWLFIMR
>C2LJK0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELNNVSRLYTNGEEDTVVLDQISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
SSGEYKVTGQCVADMESDQLAALRREHFGFIFQRYHLMAHLTAEQNVEIPAIYAGKSTEQ
RKERARALLTRLGLAERIHYRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILKQLNQQGHTVIIVTHDPLIAQQADRIIEIKDGQIISDNNNHHSAPVKKAPPAI
QTASYFHQVIGRFTQALNMAWRAMVVNKIRTLLTMLGIIIGIASVVTIIVIGDAAKDRVL
ADIKAIGANTIDIYPGKELGSDSPEDKQSLTIQDVDALKQQSYIQSVTPQIYFSSRLRRG
NQDAPATVSGVNEDYFSVYALKFAQGSTFTPDMIHRQAQVVVIDENTRHRFFPNKQAVIG
EQIIIRNIPSTIIGVVAEQKSTFGDNKSLRVWVPYSTLSSRIYNRSYLDNITVKVKEGYD
ASVAEQQILRLLTIRHGKKDIFTYNIDSFIKAAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVMQQFLIESVLVCLVGGLLGISLSFAIAMFASMM
LPNWHFVFQPTALISAFACSTAIGVIFGFLPARNAAKMNPIDALARE
>E8UCJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSSDFLYLLKAALLGIVEGVTEFLPISSTAHLLILGDWINFDAGQDKVYEIVIQLGSILA
IIWLYREKLCSIASGCVCARKPDLLFTRNILLSFLPAAVIGVIFIKQIKRLLNDQFIVYS
ITLILGGLIMMWVESRPQYSKRIKSEDNLNSLQTQSIEEISIAQALIVGFAQCLAMIPGT
SRSGASIIAGMLAGIERKVATEFSFFLAIPTMLGATALSIYKYGHLLSQSNIVAVIIGFV
TAFFSALFVVRGLLRFVSKHSYIPFAWYRLVLGAIVAMWVWNIL
>Q2FC36|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQ
>L1QIT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLTAILLGLVEGLTEFIPVSSTGHMLLLGHFLGFQSTGKTFEVVIQLGALLAIISVY
FKRLWALATRWPFDAEARRFLIGLLIAFAPAVVIGFLAYGFIKTVLFETPLVICIALIVG
GVLLLWLDRMKKIPAYLDADRYPFRVYFLIGLFQCLAMIPGVSRSGATIAGGLLLGTDKR
SAAEFSFFLALPTMGAAVAYDLFKNRDVLDFSDLGLIAIGFVAAFISALAVVRFLLDFVS
KRGFGPFAWWRIAVGVVGIIGLAATGAL
>P13955|FEATURES|UNIPROT_deepARG|trimethoprim|dfrA|antibiotic target replacement|1
MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHIKQLTTGNTLVMARKTFNSIGKPLPNRRN
VVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLYEAMIDQVDDMYITVIDGKFQG
DTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK
>A0A0H3W1A1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-130|antibiotic inactivation|1
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQELAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>A0A033UR43|FEATURES|UNIPROT_deepARG|beta_lactam|V070_01895|antibiotic inactivation|1
MKKLILIIASILLLSACSTADATTQDLKKVEDKYDANVGVYALNTATDEEITFNEDKRFA
YASTFKAVSSAMLLEKTPHNELNKKVHVSKEDIVPYSPVLEKFINKDITIKKLIEATMLY
SDNTANNMIIEELGGYKEVNKRLKSLDDKTTKPSRMEPELNNYDPKSNKDTSTPKAFGKT
LNKLINDGRLSKENKAFLIDLMINSKSGDTLIKKGAPKNFKVADKSGQAITYASRNDIAF
VYPKGESKPIVLVIFTNKEGKTDKPNDKVVSETAKVVLEKFNDK
>ZP_02508655|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAAAFAVVFIAGLGTFGAIRVNAGAPEKSAAPLPEVDVATVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRRGVIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIVGGLAASERI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPRAAQGNARA
>R5P4N5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTIIISIVEGLTEFLPVSSTGHMIIAENLLGVDIKATFVNAFTVIIQFGAILSVIC
LYWKRFFYPETVKNGEKTYWKAMFDFYARLIVGTLPAVVLGLAFKDFIESNLGNVQLVGW
MLIIGGVFMLFCDKIFNKGTEQTQLTYKRALTIGFIQCIAMIPGVSRSMSTIVGGMSQRL
TRKAAAEFSFFLAVPTMFGATCLEVYKLISHGGGSLLTQGNNLSTLILGSVVAFIVAILA
IKFFINYVTKYGFAAFGWYRIVVGLIIIICELCGVNMRMVD
>F1YSC7|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MTMFQDGGFLLFRRATLADVPVYARLRRELWNDDTLADHEQQIIDLLQKPETQSLILLAF
STNAACCGFAEASMRYDYVNGCTSSPVAFLEGIYVVPAERQRGVARGLVEQITHWARQNG
CTELASDAELTNTDSLAMHRALGFDETERVIFFSKGLI
>A0A0A0Q7Y3|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-1|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTSAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQTLEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>C8SZL3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYYLVTCLTTTPLRLLSIFG
SVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASKEEDRS
>D5RFI1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPISSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAIFSV
VVYFWKDISPFVKTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNILIVAIT
LIAYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIIVIVLLY
>A0A139T6S6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEILKVILFGIVEGITEWLPISSTGHMILLDEFIKLDVSSEFYSMFQVVIQLGAILAVV
VLFWNDFFPFGRKNNKQPMTTTGILSYVKMDKIILWFKILVACVPAAIVGILFDEQLEAL
FYNYQTVAIALIVFGIAFIIIENRNKGSYSKINTLTDITFNTAFLIGIFQLIAAIFPGTS
RSGATIVGALLLGVSRTVAAEFTFFLAIPVMFGASLLKLVKFGLVFTAQEAILLIIGMIV
AFVVSILVIQFLMGYIKKHDFKVFGWYRIVLGILVLAYFMFIG
>A0A0I9QPS5|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKDWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>H1PRQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPFLIVIILGIVEGMTEFLPVSSTGHMILVEKFINSSFFSKNFMDSFLIIVQLGAILAV
VIYFWKDINPFVREKEVFVQRFRLWAKVVVGVFPAAVIGLLLDDYISEYFMGNVVVVAMT
LIFYGIILIVVEKCYTGTAHIDSFQKLGYKTAFTVGLFQCLAMIPGTSRSGATIIGSLLL
GLSRGVATEFSFFLAIPTMFGATLLKLMKNGLKFSPVEWQLLGVGSVVSFVVAYLVIRWF
MQYIKKRDFVSFGIYRIVLGIVVLFFIFM
>I7APH4|FEATURES|UNIPROT_deepARG|beta_lactam|TEM32|antibiotic inactivation|1
PFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMISTFK
VLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNT
AANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPAAMATTLRKL
LTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDG
KPSRIVVIYTTGSQATMDERNRQI
>A0A0T9NSH2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MTVLLELNGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SAGVYCVAGQDVAVLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKSE
RRERANMLLTRLGLGDRVGYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKTVHAVAASEAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSEQYFRVFGMKLEQGTAITHEQVERQSQVAVIDRNTQRRLFPHMKDV
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRAYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLVVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A077PTY1|FEATURES|UNIPROT_deepARG|beta_lactam|XBKB1_170008|antibiotic inactivation|1
MPFSSLRLTRISATIFPLLGTLITFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSIITYRGHERFPLCSTSKMMAVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAELSAATIQYSDNTAMNLLLGQLGGAHSVTRFARSIGDNTFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRAYLVEWLKGNTTGGTSIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPSDKDAKAHNDVLAAAARIMTQEK
>E9L096|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRKLQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTSSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAEQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>YP_001434323|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGSSDLVARNEARSRNVHILTIGAIALLGIALIIAVPAAGDWWKVVILGVVEGLTEFLPI
SSTGHLLIVSSLLDFEGSLGGTFEIFIQLGAVLAVVGYYAVDLLHQARQAPRDPQTRRFW
LAIVLAFIPAAVTGLALHDWIKAVLFSPTVIGIALITGGVVLIIVERLPRGAATIHDATH
LSLRQALGIGIAQALALTPGVSRSAASIIGGMLVGLDRRAATTFSFYLAIPTLGAATVVD
LLTSLDQVTPSDVGRLFLGLVVSLIVAWLSIGWLLRYVANHSFVAFGIYRIVAGLIVLAL
VALGRL
>CAL69903|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYTSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELQQEESIRFHNCSLFPVYYGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A0U7KVF1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_2|antibiotic efflux|0
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAA
RRERAEALLRRLGLGERVNYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILKQLCAQGHTVILVTHDPAVARQAERIIEIRDGEIIADSRPAPPEDTQAKPLAL
AAAAPSWRQMGGRFREALVMAWRAMAANKMRTALTMLGIIIGIASVVSILVIGDAAKQMV
LADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALREQPYISALSPSISSSMRLRL
GNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQRRLFPHQKNVV
GEVILVGNMPATVVGVAKEKQSMFGSSKTLNVWVPYSTMANRLMGNNYFDSITVRIRDGY
DSKEAEQQLSRLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQL
VLPGWQISFPPAALLSAFLCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A0H4PLV9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-2|antibiotic inactivation|1
QIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVS
KTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVR
DKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAH
TWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEK
TLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAP
AVKASWVHKTGSTGGLQ
>A0A0E2HDL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
VVVMYFHKLNPFSPTKTSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVA
AALIVYGVLFIVLENSSVCTNPRFNKVGQISAKTAFLIGMVQLLALIPGTSRSGSTILGA
MVLGCSRAAAAEFSFFLGIPVMFGASLLKIVKYFLAGNAFTGPQIFYTILGMLIAFVVSI
YSIRFLMSYVRKHDFKFFGYYRIILGVIVLAYFGITALAS
>A0A0U2T6D5|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQSVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>A0A0Q7E2T5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGIIEGLTEFLPVSSTAHILLAGHFLGFNSPGRVFEVLIQLGAILAIL
VVYFQRLLSIAKDAIARKPGALRFILGVILASFPAAIAGVLLHDFIKTVIYETPVVFCVS
LIVGGIILLYVDQLKLTPKYTDIYNYPPLLCLYIGLFQVLALIPGVSRSGSTIVGALLLG
TDKRSAAEFTFFIAMPIMGGAFAYDLYKSRDFITAELGAAVIIGFAAAFVTAFFVVRYLL
DFISKNGFAVFAYWRIFVGAIGLWGILLFG
>A0A029LAY4|FEATURES|UNIPROT_deepARG|multidrug|mdtl|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPAASDKSRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLTVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPAAAHEEIHHHA
>F2JR40|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLFALKAAILGVVEGLTEFLPVSSTGHLIIFSNLLKFSDNTAFANMFTMVIQLGAILA
VLVLYRKKIWDTIVHLFPSKNVSFEKSGLYFWLMIVISCVPAAAIGIPFDDLIEEKLFNP
LVVACALFVGGLWMMYAESKLRGNQTTSLSTTKITAKMAIIVGLFQVLSIVPGMSRSAST
IIGGWVAGFSTVAAAEYSFFLAIPVMFGQALLNILKAQGTLLASEWIALGIGFVVSFIVA
LAVIGSFISYLQKKPMKVFAIYRIIFAFVVLGVGMLGLF
>YP_492693|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmC|antibiotic target alteration|1
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
DHKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIA
DEIYLIVEYEFAKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKK
SRISHKDKQKYNYFVMKWVNKEYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYK
LFNK
>A0A0P0MFA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSMLLAKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVI
LVYWEKIRSTLKALRYQVEAQRFVLNVFIGFLPAVILGLLFGKLIKAHLFTPWVVATTFI
VGGFIILWAERRPPSSVRIRAVEDMRGRDALMVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSMEDIPLFATGLVVSFISAWICVRWLLK
YIASHSFEIFAWYRIAFGLVVLGTAWTGVVTWAP
>ZP_04417104|FEATURES|ARDB_deepARG|chloramphenicol|catB9|antibiotic inactivation|1
MNFFTSPFSGSPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCARYLHPERDDVDKLVIGS
FCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTE
AMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWP
ESWLKESMQSLCSSDIEELYLYWQSKART
>H3N452|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARIAAEQGIPVWAPE
DVNHPLWIERIREIKPDVLFSFYYRNLLCDDILNIAPQGAFNLHGSLLPKYRGRAPLNWV
LVNGESETGVTLHRMVNRADAGNIVAQKSVAIGADDAALALHRKLCAAASDLLAQALPAI
RDGKTEERVQDESQATYVGRRTPEDGRLDWEHSAQTLHNLVRAVSDPWPGAFGYAGANKF
IVWKSRVRHDLAAAKAGTVLSVAPLVVACQEGALEIVTGQTERGVYMQGTQLAQALGLVA
GAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDNYEIYGLDIGSDAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
NGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGQIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGF
REVESSDYYGKGYQDVEHRKPSIRNAKRCLNWVPTVEMEETVEHTLDFFLRTVELTDSGK
S
>A0A127AX88|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-142|antibiotic inactivation|1
EADWVGIDNTADNSQILXRADERFAMGSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDL
VNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARHLGDQTFRL
DRTEPTLNTAIPGDPRDTTSPRAMAQTLPNLTLGKALGDSQRAQLVTWMKGNTTGAASIQ
AGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTLLHPSP
>Q7N4A3|FEATURES|UNIPROT_deepARG|chloramphenicol|cat3|antibiotic inactivation|1
MNYSKVDIDLWDRKEHFLHYRNVVQCGFSLTAKIDITHLLSSLVEKQYKFYPTMIYLIST
VVNSYSEFRMAIKDEELIVWDGVNPAYTIFHKETETFSAIWTEFNSDLAEFMKNYSADYE
TYKDDLCFFSKPELPENHFHISSVPWVSFDGFNLNMASVMDYFPPIFTMGKFYQNGNQTQ
LPLAIQVHHATCDGFHVGRVINNLQELCNDFI
>BAH62098|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAISITAMYPGADAETVQNT
VTQVIEQNMNGIDHLMYMSSNGDSTGTATITLTFESGTDPDIAQVQVQNKLALATPLLPQ
EVQQQGISVEKASSSFLMVVGVINTNGTMNQDDISDYVAANMKDPISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVISALKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TNTEEFGNILLKVNQDGSQVRLRDVAKIELGGESYDVVAKFNGQPASGLGIKLATGANAL
DTANAIRAELAKMEPFFPSGMKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGSHGATTGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LVLYLIIVVGMAWLFVRLPSSFLPDEDQGVFLSMAQLPAGATQERTQKVLDEMTNYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSQRPGEENKVEAITARAMGYFSQIKDA
MVFAFNLPAIVELGTATGFDFELIDQGGLGHEKLTQARNQLFGMVAQHPDVLTGVRPNGL
EDTPQFKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYIMSEAKYRM
LPEDIGKWYVRGSDGQMVPFSAFSTSRWEYGSPRLERYNGLPSLEILGQAAPGKSTGEAM
ALMEELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMVTATILAIFF
VPVFFVVVRRRFSKKSEDIEHSHQVEHH
>S3AFA4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYFFEILKAIFFGIVEGITEWLPISSTGHLILAQEFIQFKDQNETFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKDKVQVRRTWQLWSKVFVATLPLLAVFKFDDWFETHFYNKVSVA
IMLIVYGVAFIYLEKRNKAQAIEPTVTDLDKLPYKTALYIGLFQVLALLPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGEVLSFGQFFLLLVAMVVAFAV
SMVAIRFLTGYVKKHDFTVFGKYRIVLGSVLLLYSFVRLFV
>CAG74079|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVLAIMVMLTGLLAIVKLPIAQYPTIAPPAIEITANYPGADASTLQDS
VTQVIEQNMNGIDNLMYMSSSSDSSGTVQITLTFEASTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVNVQKSSSSFLMVAAFISEDGKMSQEDIADYVAANVKDPISRTSGVGDAQLFGS
QYAMRIWLDPNKLNNYQLTSGDVSAAIRVQNNQIAAGQLGGAPPVPGQQLNASIIAQTRL
NSAEEFSKILLKVNADGSQVRLKDVARVELGAEGYDVIARFNGKPAAGIGIKLATGANAL
DTANAVKDALTKAEEFFPSGLKVVYPYDTTPFVKISINEVVKTLVEAIVLVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATKRSMEQIQGALVGIALVLSAVFVPMAFTGGSTGAIYRQFSITIVSAMVL
SVLVALILTPALCATLLKPIAKGDHGEKKGFFGWFNRLFEKSTQHYTDSVANILRSTGRY
LVIYLLIVVGLALLFLRLPTSFLPDEDQGVLLNIVQLPSGATQENTQKIMDRMTQYYLDN
EKGNVKSVFTVTGFGFSGRGQNAGLAFASLNDWSERSGAENKVMAIAGRANAAFSQYKEA
MVFAVNLPAIIELGTATGFDFQLIDQANLGHAKLTEARNQLLGMAAQRPDTLVQVRPNGM
EDTPQFRLDIDQEKAQALGVSLSDISSTLATTLGGSYVNDFIDRGRVKKVYVQADAPFRM
LPDDIKNWYIRGSNGQMVPFSAFTQSHWEYGSPRLERYNGQPSMQIQGEAAPGKSSGDAM
ALMEEFVTKLPQGIGYQWTGMSYQERLSGNQAPAIYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGIIGALIAANMTGLENDVYFKVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLDAVRMRLRPILMTSLAFILGVMPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSKKVDDTTAH
>A0A0G4K5L0|FEATURES|UNIPROT_deepARG|chloramphenicol|catP|antibiotic inactivation|1
MFNKIDLNNYNRKEHYEMYMNNIPCTYSITVPLNITKFKKTVKDKNIKFYASVIYLISKV
VNKYKEFKMALNDNKELGYYDIISPSYTIFHNDTKTFSSIHTEYNEKFDLFYKNYISDME
TYGENKTFLAKPCNIKNIFNISSLPLSTFTSFNLNLPNSFEYLAPIFTIGKYYTDDKNNI
MMPLCLQIHHSVCDGYHVGIFFEDLQHEFDEFYLLY
>A0A0A1RQI8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYDIAAIFTHADNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERIGQLAPDMIFSFYYRHLLSDEILRLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRITISPDDVALTLHHKLCQSAREVLAQALPAI
KAGDFQEYPQQEADATCFGRRTPEDSFLDWNNPCAQLHNMVRAVSDPWPGAFSYAGTQKF
TIWSSRQSANTSAALPGTVISVSPLLIACADGALEIITGQAGDGITMQGSQLAQVLGLVA
GSRLNSQPVSASKRRTRVLILGVNGFIGNHLTERLLREDNYEIYGLDIGSDAIERFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKDFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALFRIIENEGGRCDGEIINIGNPDNEASIQELAEMLLSCFEKHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>R7AE09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIEIIKAIIFGIVEGITEWLPISSTGHLILFEKIFAFKNVSEGFWSMFEVVIQLGAILAV
VVLFWNSIFPFTNKNGRGFKESGILSHLDKEITTLWFKIIVACIPAVIFVVLGLDDVCEA
MFYNYFCVAIALIVFGVAFIVVENWNKNRTSKISSLGEITYQTALMIGLFQLIAAVFPGT
SRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASLLKIVKFGFNFTAMEAALLIIGMA
AAFVVSLFVIRFLMGYIKKHDFKVFGWYRIILGAIVLLLRP
>A0A0Y2BCG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIIEFIKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSSQFLGSHSAFTFKIVIQLGS
VFAAAWVFRERYFEMLHIGKYKHVAHSEGMRSKPRRLNLLHVLIGMIPAGILGVLFDDFI
EEHLFSVPTVMIGLFIGAIYMIIADKYSTKVKHPQTVDQINYLQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLNHKSASDFTFIMAVPIMLAASALSLLKNYQYIDLAHVPFYIIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIFIAILYFGFGIGKGI
>N8V2W5|FEATURES|UNIPROT_deepARG|aminoglycoside|F971_00085|antibiotic inactivation|1
MKIMPVTEPLLADWLQLRILLCPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAIAMLEA
SIRYEYVNGTQTSPVAFLEGIYVLPEYRRSGVASTLVQQVEDWAKQFSCTEFASDAAIDN
TISHAMHRALGFQETERVVYFKKKIS
>A0A0F6ILE3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKKFLDTIKARP
DLLEILSGAWIFGGVLILIAEWYFHQRPEEKKSIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLFAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSIFGVYRILLGVGVLVLTKLI
>C6B3C0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWRDPVNRDYAAKLIVAFLITAILGLIVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARRPPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASAYELLKTFRDGGAAGEDWTALGIAFVVSTVVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMAATGLIA
>A0A0Q4E9Y1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
WAFRRKILDVVIGLPTQPKAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALV
VGGVIMLWAERRQHAVHAETVDEITWKDALKVGVAQCLAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVKALLKF
IASHSYAAFAWYRIAFGLVILATWQFGWIDWTAVKP
>R5ULA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELIEVLKAVLFGIVEGVTEWLPISSTGHLILLNEVVKLKVSDEFYSMFEVVIQLGAIL
AVVVLFWSQIWPFGRKNNVAPLTKRGPGAWIKTDIFKLWFHILVSTIPAAVIGVLADDWV
EEHFYNYQMVSVMLILFGIAFILIENSHKGKNSRINSLADIGYDTALFIGLFQLIAAIFP
GTSRSGATIVGALLIGVSRTVAAEYTFFLAIPVMFGASILKIAKFGLDFSTSEVVILFVG
CVIAFAVSLIVIRFLMGYIKKHDFKVFGYYRIILGVFVLACGFLGALHA
>R8V8H5|FEATURES|UNIPROT_deepARG|beta_lactam|KQ1_03079|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDALKTTNK
>AAR04097|FEATURES|ARDB_deepARG|beta_lactam|CcrA|antibiotic inactivation|1
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVRSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVN
QYIESTSKP
>C0Q069|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGVLPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNEGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRSYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>S3YK71|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|HMPREF9309_01063|antibiotic efflux|1
MLKLENINKNFNLGKVQVLNDINLEIKKGEFVAIIGQSGSGKSTLMNIIGCLDTQSSGKY
YVDDKDVSKFSSDEKASLRRKKFGFVFQRYNLISNLTALENVCLPGIYEGLEDRKTKGLN
LLDKLDIKEKAYSKPNQLSGGQQQRVSIARALINGGEVILADEPTGALDSKSGIMVMEIL
SNLHKNGHTIILVTHDKNVANYANRIIEIKDGKIINDETKKNEKFITQNLDKNKNKSSFG
YKFLEALKMAISSIFSHKLRSFLTMLGIIIGIASVICVVALGEGSQEKILSSIRAIGTNT
INIYPGKNFGDLRAGKVKSLSVDDSRILGMQNYLDYSTPNTSTSGVITYKNLSLNANLRG
GGVNSLAVNGIEIQTGRSFEVSDIANSSSVVIIDQNTKNSFFKDGDPLGKNIFFNQKPLK
IIGIAKEDENAFGGSDNLRLYAPFSTVINKITGDRHIHSITVKVKDDTNAQLAEEAIVSI
LTQKHGKKDFFTRNSDTIKKTVESTMATMRLLISSIALISLIVGGIGVMNIMLVSVSERT
KEIGIRMAIGAKESDILIQFLIEAIILCIIGGIIGLLTAYSFGYLFNSISGNFYMKFSTM
PAIIALMSSCLVGTIFGYLPAKNASKLNPIDALLQE
>YP_001570871|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFQPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLQRRRLATE
>C6W614|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWQAIILAIVEGITEFLPVSSTGHMIIASSFMGISHLEFTKMFTVNIQFGAILSVLVL
YWKRFFQTTDFYFKLFVAFLPAAVIGFLLNDFIDALLENVWVVAISLLLGGIVLIFIDRI
ANDTREKVITFPTAFKIGFFQCIAMIPGVSRSASTIIGGMLNGLSRKQAAEFSFFLAVPT
MAAAGGYKLLKTYDTIQKEDIQTLLIGNAVAFVVAMLAIKFFISFLTKYGFKVFGYYRII
LGLVLLGLLASGYKLDVV
>F4T7V3|FEATURES|UNIPROT_deepARG|beta_lactam|ECIG_03089|antibiotic inactivation|1
MGFLRSGCYPDSCHTDWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCTLLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQP
LKLNHTWINVPSAEEKNYAWGYREGKAVHVSPRALDAEAYGVKSTIEDMARWVQSNLKPL
DINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNTLQ
>C3HIP8|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0012_23150|antibiotic inactivation|1
MKGMIILKNKKMLKIGICVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>YP_002806354|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKTTLCALLITASCST
FAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPR
DINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAARPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNALQ
>G4C020|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKKMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLGWGSAGD
>K6CKQ2|FEATURES|UNIPROT_deepARG|beta_lactam|BABA_00315|antibiotic inactivation|1
MRKTHDIFSMKIFIHALLVLVVAIVPLGGWSTTNKLSDKPEKAVTKTPAPHIHREFAELE
SKFDARLGVYAIDTGTNQTVSYRPNERFAYASTYKALAAGALLQHYSIDQLEELVTYNSE
DIVSYSPVTELHVDTGMTLREVIEAAVRYSDNTAGNLLLEKLGGPEGFETALKQIGDKVT
EVNRYEPDLNSAIPGDKRDTSTPKSLATSLQAFAVSDLLPTEKRKILTDWMRGNATGDAL
IRAGAPTGWEVADKSGAGSYGTRNDIAIVRPSNRAPIIIAVLSSRDTQNATYDNTLIAEA
AKVALNALK
>A0A0H3CL06|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELTDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSRLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLARAQALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRASRAAAPKEALP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQIFL
PGWEIGFSPVAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>CAI29522|FEATURES|ARDB_deepARG|chloramphenicol|cmlA4|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVTGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLI
MGRQGVSQLGFSLLFATVAIAMVLRLVLWALIPKWGSPSVLRMGMGCLIAGAVLLAITEI
WASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVAGTVTAVYFCLGGVLLGSIGTL
IISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQSAESTSNPNR
>C8S5D2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHTTLVSALLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGKTFEIVIQMGAVLALMAL
YAGRLWQVFSTAHRDPAALRFVVSVLLAFLPAVVVGVLAHDFIKSVLFETPMLIAVMLIL
GGVVLLFVDRLAPVVQHDEAMQLPFRKALLIGIFQCLAMVPGVSRSGATIVGALMLGVSK
RAAAEFSFFLSMPTMAAAVGYDLLKNRDVLDWTAWHQIAVGFGVAFLAGLIVVKWVLGYI
SRHGYALFGWWRIIVGSLALVGLLLGY
>J7VNM0|FEATURES|UNIPROT_deepARG|beta_lactam|IC1_02470|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEAT
EVIVKALR
>ZP_04661877|FEATURES|ARDB_deepARG|multidrug|AdeA|antibiotic efflux|1
MQKHLLLPLFLSIGLVIQGCSSEEAKQPEVPPAKVSVLSLKPQSVNFSENLPARVQAFRT
AEIRPQVGGIIEKVLFTQGSEVKAGQALYKINAETFQADVNSNKASLNKAEAEVARLKVQ
LERYEQLLPSNAISKQEVSNAQAEYRQALADVAQMKALLARQNLNLQYATVRAPISGRIG
QSFVTEGALVSQGDTNTLATIQQIDKVYVDVKQSIGEYERLQTALQNGELSANSDKTVRI
SNSHGQFYNVSAKMLFEDINVDPETGDVTIRIVVNNPERKLLPGMYVRVNIDRASVPQAL
LVPSQAIQRNNNGDPQVYVINAKGLADIRPIELGQQYEQFYLVNKGLKVGDKVIVEGIDR
IQPNQKLEISKWKAPITQGAQ
>E6L3V2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTIFDSILLGIIEGFTEFLPISSTGHLIVLSEILGLEQNNVNKAFEIIIQFAAIMALVF
VYPSKFTFSHIELWKKIVVAFLPIGTVGFLFSSQIKNLFSIEIIAWMFIIGGVVFLIIEK
FYDENKTHTLDVENVSYKQAIFIGVMQIFALIPGTSRAGASIIGAMMAGLNRKTSAEFSF
LLAVPVMCATTGYDLVKHHEELLVGANLLNLTIGFIVSFIVALIVIKLFLKFLERFTFVA
FGIYRIIFGILILLIF
>J7WJH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASALDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>N9KH26|FEATURES|UNIPROT_deepARG|beta_lactam|F909_00850|antibiotic inactivation|1
MNQPNTFSMTLKKLCLLTGLVSSSSALWAGTLTEQQVQKIVDQQFKPLLAQYKIPGIAVA
VTLNGKHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAGYAQAQGQLSLSDHPAK
YFPELKNTAVNRATILNLGTYNAGGFPLQFPDDVIQQQDMVKYFQTWQAKTKVGSARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIQVPEQQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDVQINPQQLKQPLRKAIENTHVGYFKVGGMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITPIKQPKLATPATFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>D4F978|FEATURES|UNIPROT_deepARG|beta_lactam|EDWATA_03336|antibiotic inactivation|1
MIIQRFSCALALCAVSFSPFTQAAQPATEAQRVAVAVEQTIVPLLQQQQIPGMAVAVVYR
GKSYYYNYGVADQATQRAVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDRAATLWPA
LSGTQWHNITLQQLATYTAGGLPLQVPESVGDKAQLLDFYQRWQPQWAAGTTRYYSNASI
GLFGMLAVQPSGLSFSQAMARWILQPLALRHTYLNVPAAAMANYAWGYRDGHPLRVTPGA
LDEEAYGIKSTSQDMASWLQANMDPAQVKDKTLRQALDFAQSRYYQAGALYQGLGWEMLN
WPLNAQTLIADSANSVALQPRVVRLITPPSAPQAASWVHKTGSTNGFGAYIAFIPQAQLG
IVMLANKNYPNPQRVQAAYTILQHLQ
>ZP_01722744|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MTIQSINHLLFSVSDLEQSIAFYENVFDAKLLVKGNSTAYFDVNGLWLALNIEKDIPRND
IQYSYTHIAFTISEDEFDKMYDKLVQLKVHILDGRQRDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKLHMEFFNH
>ZP_03078078|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSD
RVGRRPVILVGMSIFMVATLIAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGT
QLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRP
AGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSIL
FILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAAL
FFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLL
MTLMGLLILACWLPLASRISHQGQTV
>J7VE82|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLDFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKEATAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAVGFITSFTVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A0A0G3IX29|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKSASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLNWEPKIDMLETIDETLDFFLRTVDLTDKPS
>A0A0R1K6P7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIEIIKTVILGIIEGFTEFLPISSTGHLYLADEFVKLNETPAFIHMFMVVIQFGAILAV
ILIYFHKLNPFSPKKNRREKRLTWDIWFKVLVAIIPSVVIGLPLNDWMDKNLTSWQVIAA
TLLIYGILFIIVENYFKNKRPQVTDLDNLSYGTAFKIGLFQVLSLVPGTSRSGATILGGI
SIGTSRFVATEFSFFLAIPTMFGASLLKIVKYFAGGNTFSGSELTILLIGTFVSFIVAYA
SIKFLLNYIRSNDFKAFGWYRIILAILVILYFGFIKGMIA
>A0A072ND65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFYAIIYGIVEGITEFLPVSSTGHLILTGNLMGVPWSKEVKDAFEVVIQGGAILSVLV
YYWRDFLKIRHIGRDREQQTLWTGVLVATIPAVVLGLLFGDLIQANLFNPTVVAWALIVG
GVLMWLIESRRTPPQVSGTEHIGVRRSFFIGVLQCLALLWPGFSRSASSILGGMVLGLDR
PTATKFSFYLGVPTLGGAALLNLVQDREVIFGEIGLLNVLLGAATSFVVAYLAIGWLLKF
VSTNNFKGFAVYRVVVGVVILLLVGAGRL
>N9RLG8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESKNFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMMNIAVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A095ANX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
YRKLFWEMFTGFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALII
GGFAILLVERFAKTTDVGGVANVSARQSMLVGLVQCIAMIPGVSRSGATILGAMSFGVDR
KTAAEFSFFLALPTLTGATVLQLFKHRDAITSNDLGLIAVGSLVSFVVAWAVIKAFLAVV
TRYGFAPFAWYRIIAGVAALIWLGMR
>A0A0H5AJZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVQRADAGAILAQQKVIIERSDTGLTLHAKLRDAASNLLRDALP
QLAAGKLAETAQDDSQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVLKGNEGLAPGRVISVNPLRIACGEDSLVIKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDACNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKH
>ACB18310|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMRQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>NP_706986|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSASAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A060KZA9|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MAKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A081RU83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVAGFICATCFGDLFNGVRSLYMTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLL
GFTGDKAETFEVIIQLGSILAVVVVFWRRLFGLIGLHFGEVPHEGKTNGKLKLSHILLAM
LPAVTLGLLFHDTIKSLFNPQSVMYALIIGGVLLITAEILKPKTPRAEGLDDITYRQAFM
IGCFQCLALWPGFSRSGATISGGMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFL
TASDIPMFAVGFITAFIVALIAIKTFLALIKRMSFIPFAIYRFIIAAAVYWVFM
>A0A0B1PTR3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRTPFSARRCLLMASSLLFSGAAWALEEPHEADLQALLDSTITPLMEQYRIPGMAVALSI
QGQPYYFNYGLANLETEEPVTDETLFELGSISKVFTAALAGYAQASGALSLSDPASGYWP
ALEGSAFDEITLLELGTYTAGELPLQFPDSVQSEEQMIDYYRQWQPESAPGAQRLYSNPS
IGLLGYLTAQRLGSPFETLMEKALFIPLGLEHTHFQVPDAQRAHYAYGYSKEDEPIRVNP
GVLDAQAYGLKANAADVLTFLEANMRDPAHASGTTERLDDALATTRTGYFDVGPMTQGLG
WEHYHYPVTLETLLEGNSLEMILAPNPAHRLTPPQAPRQAAYYNKTGSTNGFGGYVVFVP
SEQIAMVMLANRNYPNQARIETAHHILSALTDTP
>U1IP33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMTDMLRAVILGIVEGVTEFLPVSSTGHLLLAERFFNLGEGNFWKSFAILIQLGAILAIL
VLYFGRLWRVALGMFSNPDDRRFVIGVLVAFLPAVVIGLLAGKYIKEFLFNPWVVCFTLI
VGGAVLLWVDQLDLKVYEDDATRFPLLMYFWIGVAQCLAMIPGVSRSGASIVAAMLLGAD
KRSAAEFSFFLAIPTMVGAFVYDFYKNRADFTSDNLSVIAVGFVVSFVVAMVVVKTFLNY
VTRHGFTFFAWWRVIVGTLGLIALAMGR
>A0A0G0EZ47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESIKLLALAITQGLSELLPISSSAHLILLGQVINIPTSTLLLSSLHIGTTIAILAFFWK
KLFSNFFTKKKWTFYIKILLSVIPSAILGVLFESKIESVLHDNWIIAVSLIFWGILMILA
QNKKDDDCGVTDMENVTWQQSLIMGFAQAIALIPGTSRSGVTTLSGIALGLNKYTAFEYS
LILGLPILIGAPIWEILKMTQDTGIPTITTLTMANYIDLGIILLVPFIVGCISLIALKKI
SRDKWLSAFGIYRIILGVAILVFGYLL
>A0A132BRB2|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSDLLTSIEFYQNVFDAKLLVKGRSTAYFDLNGIWLALNEERDIPRND
INASYTHIAFTIEESEFEQMSAKLKNLHVTMLPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLQYYKQAKTHMDFYD
>A0A0D6SXC4|FEATURES|UNIPROT_deepARG|beta_lactam|SZ39_2149|antibiotic inactivation|1
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQPEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVNTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0Q4Y799|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLAKAAVMGIVEGLTEFLPVSSTGHLILAGALLGLDDEKGKVFDIAIQTGAILAVI
LVYWHKIRDTVMALPRQTKARRFALNVLVGFLPAVVLGLAFGALIKAYLFTPLVVATTFI
LGGFIILWAEHRPPGSVRVEHVDDLTPLDALKVGLVQCFAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLVGAGGYSLIKQRALLSWADLPMFAVGLLFSFISAWFCVRWLLR
YISSNSFVPFAWYRIAFGLVVLWTWYAGWIAWNG
>Q1PBU4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
FNRTITPLMKEQAIPGMAVAVIYQGKPYYFTWGKADIANNRPITQNTLFELGSVSKTFNG
VLGGDAIARGEIKLSDPVTRYWPELTGKQWQNISLLHLATYTAGGLPLQIPDEVTNKTAL
LRFYQNWQPQWAPGAKRLYANSSIGLFGVLAVKPSGMSYEGAMIRRVLQPLKLTHTWITV
PQNEQRDYAWGYRDGKPVHVSPGQLDAEAYGVKSSIMDMARWVQANMDASHVQEKTLQQG
IGLAQSRYWRIGEMYQGLGWEMLNWPVKADTIINGSDSKIALAALPAVEVNPPAPAVEAS
WVHKTGSTGGFGSYVAFIPEKNLGIVMLANKS
>A0A089N7Q0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFAIIKAIVLGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLRRFSRKAMEPDRIIAGGAAVQKRTEGGGHLTLGQVIVGLIPA
GILGFLFEDYIDNYLFSTATVLIGLVVGAIFMIIADRFSARRKPRTENVDQITYGQALGM
GLIQCFSLWPGFSRSGSTISGGIMLGMSHRAAADFTFIMAVPIMAGASLISLMKNWQYFT
MDALPFFIAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRILLAGLVYIIFF
>A0A0A8H9W7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MICLENIQKKINHTTILENINLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSSGKYFL
DQYEVTKLDKDEKARIRREKIGFIFQRYNLLSLLNAKDNVALPAVYAGKNKQDRLEKAKK
LLSFLELDHKELSKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEIL
NKLNEQGHTIVLVTHDREIAVKAKRVIEIKDGKIISDSGAKKAEKFQARVMPKEKKNFVL
FKNQLFESLKMSIASIVAHKLRSLLTMLGIIIGIASVVCVVALGLGAQERILASINSIGT
NTIEIVSGRDLGDIRSGRTTLNLSDLKTLNSLPYLEAVEAEIGRVGVVTYKNNSLQARIR
GVGPNHLKLSGSVMVDGRFINDEDIKDNANICIVDENTLRILFDNISTKDVLGKSIIFNK
QPLIVVGVSKKVDKDDFGADENTVKIFTPYSTLMNKITGDKRIRVIVTKVKDEVEPSLAE
EAIVKILEIKRGKKDFFTVNLDKIKQKIKENTATLTLLISSIAVVSLIVGGIGVMNIMLV
SVSERTREIGVRMAIGARKEDILMQFLIEAVLICSLGAILGVMLSFVVIEVFNSLKIGFT
MILSLDSVFLGLLSSVVIGIIFGFFPARNAANLNPINALSKE
>ZP_02365020|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAATLAVVVIAGLGAFGAIRVNASAPDKSAAPLPEVDVANVLSKTITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQSDWQRAQRLIGDNAIAKRDYDEKQNAAREAFANLKAADAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNQDGALVPGLYARVKVG
GSAPHPALLIDDAAVNTDQDKKFVFVVDQQGRVSYREVQLGSQHGNQRVIVGGLSAGDRI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPQTTQGNARA
>A0A0J1ESC6|FEATURES|UNIPROT_deepARG|chloramphenicol|EL84_16660|antibiotic inactivation|1
MFNSIVLDQWDRKPYFDHYLNQVRCTYSITANLDITLLINELKLKGLKFYPALIHMISTV
VNAHREFRTCFDAEGRLGYWDEMSPSYTIFHEDNKSFSTIWTAFHEDFETFHIRYLEDMK
NYKDHKKFVAKPNEPPNTFPVSSIPWVNFTGFNLNIYNEGTYLLPIFTMGKYVQQNDKVY
LPLSVQLHHAVCDGYHAGVVFNELQSLADRCQDWC
>A0A064DT52|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPSHKPSGGRDIVEPT
VKAASGWGQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRRQLFPNKAKVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
DSAQAEQQLTRLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>Q8GM01|FEATURES|UNIPROT_deepARG|beta_lactam|oxa|antibiotic inactivation|1
MPSPLLSTALAVSLLCALPASAAGCFLWADGHGNPIEQEGGCDRRLPPASTFKIPLALMG
YESGYLTDEEHPALPYQPQYDGWLPAWRETTTPRRWETYSVVWYSQRLTEWLGMQRFQRY
VDRFDYGNRDLSGNPGKQDGLTQAWLSASLAISPQEQARFLGRMLDGRLGLAPETLRHSA
NILKVAEIDGWQIHGKTGMGYPKRADGSLDKGQQIGWFVGWASKGSQHRIFVRTRIQPPG
KQFASVQAKEEVMAALPARLGKE
>A0A0M4R4E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTQPQARRFTVNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALV
IGGVIMLWAERRQHVIRAETVDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFAIGFVTSFIFAMIAVRALLKF
ISNHSYAAFAWYRIAFGLLILATWQFGWINWSAAAA
>V5R1L5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDEKTLFEIGSLSKTFTATLASGAQHEGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTAGTPLFVPDAVKNTAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLKGFGMTHTFINVPDAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGMMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIQQLDK
>A0A0Q7PR46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAIIAILL
VYFQKLVSIAMAMPTSAKARRFVLAVAVAFLPAAVIGALAHDFIKTVLFETPILICIVLV
IGGVILLAVDRMPLKPRYTDIMDYPPSLAFKIGLFQCLAMVPGTSRSGATIVGALLMGTD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDALSFDDSALIAVGFIAAFVSGLFVVRSLLDF
VSRRGFAPFAWWRIVIGSLGLAALLLYR
>I2IT25|FEATURES|UNIPROT_deepARG|beta_lactam|BCh11DRAFT_01667|antibiotic inactivation|1
MKFKALSLTATVVFALCATASMSRAADVTQDSIQRTVDAAIRPLMAKDGIHGMAVGIVAG
GKAYVYNYGVASTETGKPVTGDTLFELGSISKTFTATLASYAQVSGNLSLSDTTGKYLPV
LQGSQFGNVKLINLGTHTPGGLPLQVPDEIHDNDELMQYFKAWRPSCAPGTCRTYANPGI
GTLGLITAKSMGQDFTPLMEQRMFPALGLKNSYIDVPEARMPDYAQGYKKDGAPIRMAPG
VLSDEAYGVKSTAADMTRFMQANMNLLPLDAKLQRAITQTHTGYFKAGVLTQDLIWEQYA
YPVALKTLLAGNSSTMALKATPAVEIKPPLAPRQDVWINKTGSTNGFGAYVAFVPEKQLG
IVMLANKNFPNDDRVSVAYKILTALADAAR
>A0A094JU64|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHIIELIKALILGLVEGATEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
VLAAVVVFKDKFFELLYLRKGEVRKGQRLTLMHIFVGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADRFGKRTVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISG
GVLVGMSHRAAADFTFIMAVPIMAGASAISLLKNWQYITFDALPFFIVGFISAFVFALLA
IRFFLRLINRVRLVPFAIYRIVLAAVIYIIYFA
>N1W930|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDNTLNAFLRGIIEAATEFLPVSSTGHLFLFSYFFPFENLKIDHESFEDLFDIFIQTGAI
LSVVVLYFQLLWTHTKAATLYLVKKTTDKSGFDFYRNLIVGILPIIILGFVFKNSLDQIK
MRPDLLLIIGLSWFVGGLVMVFVEMKNYDESDGRTIGMKESILVGFFQCFALIPGISRSA
ATIITARILGVSKKDSAEFSFFLAIPVLTLAGIYKLYKHRAILNSETIGLLLFGSIVSFV
ICYFIIRLFMAFIRRRSFLSFGIYRIFLGILVILYFLRG
>Q06650|FEATURES|ARDB_deepARG|beta_lactam|BL2a_kcc|antibiotic inactivation|1
MRKPTSSLTRRSVLGAGLGLGGALALGSTTASAASAGTTPSENPAAVRRLRALEREHQAR
IGVFALNLATGASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLARVIRYTEADVTK
SGHAPVTKDHIDTGMTIRDLCDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRL
DRWEPELNSGEPDRRTDTTSPYAIARTYQRLVLGNALNRPDRALLTDWLLRNTTTLTTFR
TGLPKGWTVADKSGGGDTYGTRNEAAIAWTPDGAPVLLTALTHKPSLPTAPGDTPLIIKL
ATVLSEAVAPA
>YP_691420|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIVELAVTDNQAVKQGDLLFRID
PRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAAKQATDTLRRT
EPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIA
LTKLHLEMTTVRAPFDGRIISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETDLKNIR
SGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKI
MVDKPDPEMFRIGASAVANLEPQ
>A0A0L0JA17|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILIFKAIIMGMVEGITEFLPISSTGHLILADSLLNFWTKDKADLFIVVIQLGAISAV
IYLYWGRLWRALMGLITGKDPERNNPRQLGISLIISTIPIMLIGLLFDKALKAALFNPTV
VAISLIVGGLIIFWAERQQHKHTVKYAEAEDIDIKTAIIIGLIQCLALIPGTSRSGSTII
GSLFLGVSRKASAEYSFFLGIPVLVGAGLLDLTKNHHILTTTEDWTIMAVGVVVSFIFAM
IFIKWLVNWVSTRDFTIFAWWRIVVGVLVLIAGMLGYI
>YP_274481|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVEGMLYMSSQATADGKLTLTITFALGTELDNAQVQVQNRVTRTEPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDQRYDMLYLSNYAVLNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVNAIREQNRQVAAGQLGSPPSPNATSFQMSINTQ
GRLVTEEEFENVVVRAGADGEITRLKDVARIELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIDISNDVRARMAELKKSFPEGMDYSIVYDPTIFVRGSIEAVIHTLFEALILVVLVVIL
FLQTWRASIIPLVAVPVSLIGTFAVMHMFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLEPVQATHKAMAEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKGHDAPKDRFSRFLDRILGGWLFRPFNRFFEKASHGYVGTV
ARVIRSSGIALLVYAGLMVLTWLGFASTPTGFVPSQDKQYLVAFAQLPDAASLDRTEDVI
KRMSELALKQPGVENAIAFPGLSINGFTNSPNNGVVFVALKPFEERKDPSLSANAIAGAL
NGQFASIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYDELYKETQNIIAKSRSVPE
LAGLFTSYTVNVPQVDAAIDREKAKTHGVAVSDIFDTLQVYLGSLYANDFNRFGRTYQVN
VQAEQQFRQDADQIGQLKVRNNLGEMIPLATFVKVSDTAGPDRVMHYNGFITAEINGAAG
PGFSSGQAQAAVEKLLREELPNGMVYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAIAGVMIAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQAEGMSPLDAVLEACRLRLRPILMTSFAFIMGVVPLVLSSGAGAEMRHAMGVAVFSGML
GVTFFGLLLTPVFYVLIRNYVERQEARKAAKAQRLQNLPAEMH
>F4N5L3|FEATURES|UNIPROT_deepARG|beta_lactam|AMPC|antibiotic inactivation|1
MMKKSIINTLIFTSIATFPLYTLAQSKLTELQVATIVNNTLTPLLEKQGIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAGNDKLKEAIIASQSRYFQAGDMFQGLGWEM
YSWPINPQGVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>I7ABV1|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15like|antibiotic inactivation|1
SLRQFTLMATATVTLLLRSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYR
ADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAE
LSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTT
SPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYG
TTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIV
>A0A0B6FVX2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSECKEIKKVSIVIPVYNEQESLPALIERTLAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVSAEQTENNQEVEK
>AAK53982|FEATURES|ARDB_deepARG|glycopeptide|VanSC|antibiotic target alteration|0
MLIIIPFAVRFVAGMRVWYGYEPIYQILRLFVDYWLLCLAIGALLIWVSTTIYYMSKAIS
YLNETIQATNQLIAEPTKRIVLSSNMIDVQEVLNQLREKNLQDQRAAKEAEQRKNDLIVY
LAHDLRTPLTSVIGYLTLLEEEPQLSTELRARYTKIALQKAQRLELLISEFFEITRFNLT
TIALQTETTDLSLMLEQLTFEFLPLLEEKNLHWQLQLQKKVFATVDTEKMERVFDNLIRN
AINYSYPNSPLRLAISESDDILIRLTNQGKTIPAEKIGLIFEPFYRMDASRATATGGTGL
GLPIAKEIVEALGGKIWAESRDETIVFSIRLPKAAMEKNEQLSKPHPSEPTA
>A0A0J8SUR3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWIRLWGAATGIVSGEPQGRRLGIGLILASIPIILIGLTFGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPQVRAQEVEDLTIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSYDVFSGTQDWVVLTVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>A0A0Q8PNZ4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MPRRPTVSIAEIPVSDRAAGPYGITAGPDGALWFTMVHHGRIGRVTADGEVSSHQLEPAT
GGPSVITAGPDGALWFTEFRGHRIGRITTTGDVTFFPVPTPDAGPFGIVTGPDGALWFTE
ANVDRIGRITPDGHVTEFPLALSGAFPSAIAAGSDGRMWFTLNQANAIGAIGTDGDVTVY
PIPTPASAPVGITAGADGAMWFVEIGAGQIGRITPDGRIDEFALPDRAARPHAIVAGADG
ACWFTEWGANRIGRITPDGRIDEHDLPSSSSEPHGIAQGPDGAIWTALEIGSVARLAAL
>A0A068Z998|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLQLNGIRRSYQSGDQTVDVLKDVSLSIESGEMVAIIGASGSGKSTLMNILGCLDKP
SAGVYRVAGQDVAMLNDDALAQLRREHFGFIFQRYHLLPHMSAAHNVEVPAVYAGLGKAE
RRERAEALLRRLGLGERVSYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
DEVMNILKQLRAQGHTVVIVTHDPAVAQQAERIIEIRDGEIIADSRNNQKGNQKVKSFGL
DAIVPSWQQMVGRLREALVMAWRAMTANKMRTALTMLGIIIGIASVVSILVIGDAAKQRV
LADIKSIGTNTIDIYPGKDFGDDNPTFRQSLKYEDLDALREQPYVSVLSPTIGSSTRLRL
GNVDVAANVSGVNEQYFRVYGMTFTQGAGIDVMQVQSQSQTVVIDANTQRRLFPHQKQVV
GEVILVGNMPATVVGVAKQKQSMFGSSKTLNIWVPYSTMANRLMGNTYFDSITVRIRDGY
SSHEVEQQLTRLLTLRHGKKDFFTYNMDSFVQAAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARSGDVLQQFLIEAILVCLVGGALGITLSFAIGLLVQL
LLPGWQISFPPTALLSAFVCSTGIGVVFGYLPARNAARLNPIDALARE
>A0A0M0G5Q0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MAIQGLNHFLFSVSNLDRSIAFYQEVFHAELLVKGRSTAYFDLSGMWLALNEEKDIPRQD
IHQSYTHIAFSVKEEEMGTMYDRLVKSGACILGGRERDSRDKESIYFTDPDGHKFEFHTG
TLEDRLSYYREEKKHMEFYDDRKKP
>G5RI44|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
NVNHPIWVDRIAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWV
LVNGESETGVTLHRMVKRADAGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTM
KCGDIPSVPQRESDATYYGRRRPEDGLIDWHKPVSTVHNLVRAVAAPWPGAFSYNGSQKF
TIWSSRICPDAQGALPGSVISVSPLRVACADGALEIITGQAGDGITVQGSQLAQTLGLVA
GARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEENYEVYGMDIGSNAISRFLLHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDI
RDGIEALFRIIVNDGDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGF
QVVESRGYYGKGYQDVAHRKPSIDNARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>AAA26700|FEATURES|ARDB_deepARG|aminoglycoside|APH(3'')-Ia|antibiotic inactivation|1
MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADPAGLEAERDR
IAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHE
VPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLAPPAELLARLTGELARRRDQE
AADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERA
RFADAAFAERYGIAPDPERLRFYLHLDPLTWG
>CAA90688|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MKVSLIAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQCLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>E6XLA9|FEATURES|UNIPROT_deepARG|beta_lactam|Sput200_1981|antibiotic inactivation|1
MQQHTLLVSMSLLSSVLLSVTLFSNVSAAQALNAKEMQSLVDSAVKPLMTEYHIPGAVIG
LTIDGKKYFYRYGVSSKTSGQSVTEHTLFEIGSISKTFTATLANYAQLKGKLTLTDMASD
YVPALKGSHFDGISLINLATHTAGDLPMQVPDKVTNNAELMAYLKQWQPSFAPGTHRNYA
NPSIGLLGMIAAQSLNQTFQQALEQTIFPQLGMTSSYVKVPSDKMADYAQGYNKQDMPVR
VNPGVLADEAYGVKTTATDLLQFVEANMQMHPLAKPLQTAIDETHRGYFDVGVMTQDMIW
EHYSYPIELDKLLMGHTQEVVLGSTPVNPIVPPLEPQQNVWINKTGSTGGFTAYVAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>Q2NWE3|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADMHEWVIAFILGGVEGLTEFLPVSSTGHMILVGSLLGFTDDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGQVPHEGIGSGRLRLGHILLGMIPAVVLGLVFHEQIKAIFAPIY
VMYALVVGGVLLLAGEWLKPKVPRAAGIDDLTYLQAFLIGCFQCLALWPGFSRSGATISG
GLLVGVSRYAASEFSFILAVPMMLGATVLDLYKSLPFLSWQDLPMFAIGFVTAFVVALLA
IKFFLQIIKRISFVPFAIYRFILAVVVYWILIG
>A0A0B2YFV3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSADGEVCTFPVGEGSRPSIIAAG
PDGALWFTRSGDDRIGRITTAGGLTSFELPDGSAPFGITPGPDEAMWFTTMSAGEIGRIG
TDGEITTAATVGGMPSMITEGPDGAMWFTLNESGAVGRLTIDGALTIRELPTAAAGPVGI
AATHDDAVWFTEIRADKIGRIPVNDAIQELDLPGKPHAVVADPTDGVWVSLWGADQIARI
SGDGEVVTIDLPSGSEPHGLAIGPDGACWVALECGFVLKMPT
>G5F3I4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLVEFLKAALFGLVEGVTEWLPVSSTGHMLLLQQFVSLDVSVDFWNMFLVVIQLGAILA
VCVLYFGELSPFSREKDAARRRATWSLWAKIVVACLPAAVIGIPLNDWMEEHLGGPFVIA
GALIVYGIAFIVIESGRERRAAALAAAGGAGAVMLAARRAGTAEGPRHLAARAEGPETDG
PSALADAGARVRDIDSLDWPTAIGIGVFQVLSMVPGTSRSGSTIIGGLILGCSRKVAAEF
TFYLAIPVMFGASALRLVKFFLKGNGFAPNEAMVLAVGCVVAFVVSLAVIRFLMGYIRRH
DFRPFGWYRIALGAAVIAYFLLA
>F3FGE5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDLAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>J9YLG9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDILKSIIIGIVEGITEFLPVSSTGHIILAEALIGIPSGNVWTNSFTAVFDYAIQLGAI
FAVIQLYFNRLNPFSQQKTPKERFQTWRLWIKVVVGVIPAVIFGFLFNDFMDAHLLNFWV
VSATLIIYGIAFILIENRQKNIAPKITNLNKITFKLALFIGLFQVLSLVPGTSRSGATIL
GAVILGASRFVAAEFSFFLSIPVMFGVTILKVGTFLLHGGRFTGMQSIVMLVGFVISWIV
ALFAIKIMMRYIQNNDFKIFGWYRIAIGVIFLLLGFVGFVK
>YP_002113107|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
KLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMNFGELSTQLGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPYPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVETLTE
MGIDPAMRAENISVAQYCQMANYLSENAPLKES
>H1AFJ1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VQQPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLAR
VDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVRELCAAAITMSDNSAANLLLATVG
GPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARS
QRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVILS
CGIRPASMAERNQQIAGDRRGANQKGKTYN
>S2FGT5|FEATURES|UNIPROT_deepARG|beta_lactam|PG5_32970|antibiotic inactivation|1
MTDTLNPGRLKMLAVCAAMLAAGQSLAQDHLESIVSDAVRPVMHAQGIAGMAVAVTVNGK
QQYFNYGIASKETGKPVTQDTLFEIGSVSKTYTATLIAYAQATGKLALTDKASKVLPALR
GSAFDHISVLQLATYTAGGLPLQFPAEADSADKMLGYYQQWKPVYPVGSQRLYSNPSIGL
SGYLAAQAMGQPFDDAMENTLLPQLGLKHIWTKVPQDQMALYAQGYDKADKPVRVGPGAL
DAEAYGVKTSAADLIGFVQANLKPASLDKPLQQAIALTHTGYYSVGDMTQGLGWEMYRYP
ITLDRLLAGNSTPMAMQAHQVQWLNPPQAPSGNLLLNKTGSTGGFGAYVAYVPSKDMGVV
ILANKNYPNAERVKIAHQILSALAL
>A0A0J6J1M0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEALLNAGYDIAAVFTHADDPSENNFYGSVAQLCARKGIPVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLASSSKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGDIVAQERISIERSDTALSLHAKLRETAAKLLAETLP
VLPEGKLKETPQDESKATYFGRRTAADGLLQWNRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWASEVVAGNEGQAPGNVISCDPLRIACGKDSLVITAGQRNDNGLYLSGPQLARELG
LVDGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GTKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENKDGKCDGQIINIGNPENEASIRELGHELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>A0A147GCW0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MICSRSVALAVALTLGAPWLPAYANDPLRIKVDTVIGPLMQAQGISGMAVALYAHGHAHY
FSYGVASRESGVPVSRDTLFEIGSLSKTFTATLVAVANAEGQLALDAPAKRYHPALAGTA
MGDATVLDLGTYSADCLPLQFPDTVDTPQQVVTFLRQWQPKGTPGAQRCYSNPSLGLFGD
LAARAQHQPFATLLEHNVLEPMGLHSTYLEVPSDARSLYAQGYDASDKPVRVNPGPYAQQ
AYGIKTSASDLLRYVRLNMQPDGLPAPLARATLITRSGYAQIGEMTQCLGWERYAYPVAL
RTLIAGNGPQMIQGPQPAQRLQPPAAPLAGAWYNKTGSTNGFGAYAAFVPSEGLAIVLLA
NRNYPNEARVRAAYEILSGL
>A0A0A0TPV0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MNIKGINHLLFSVSHLEKSIEFYENVFHAQLLVKGQKTAYLDLNGLWLALNLEVDIPRNE
IHKSYTHMAFTIEAKDFDAIHQKLKSLNVNILNGRARDKQDQKSIYFTDPDGHKFEFHTG
TLQDRLAYYKKDKPHMKFYI
>YP_001439344|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTMDFGELSQKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYFCQVIPVLEVPPTA
FTPPPKVDSAVVRLVPHATPPHPVKELRLLSRLTTEAFNQRRKTIRNSLGNVFSPEVLTS
LGIDPAMRAENISVAQYCQMANYLADNPPSKES
>A0A0M3RBW1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKIKGLNHFLFSVSNLEQSIKFYQDVFDARLLVKGKSTAYFDLSGMWLALNEEKNVPRNE
INKSYTHIAFTIEEADFENTHVRLMELGVNILVGRERDKRDKKSIYFTDLDGHKFEFHTG
TLQDRMEYYRLEKKHMEFND
>C4VLQ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLINIIKAIILGIIEGITEFLPISSTGHLYLANYVVKLQENQSFIDMFMVVIQLGAILSI
IVIYFNKLNPFSLSKTKLQRENTWKLWIKVVVAVLPSVIIGLPLNDWLDEHMTNWQVISA
TLIIYGVLFILLENYYRNRDSKLTDLNKISFQMAFLIGCFQVLSLIPGTSRSGATILGAM
LLGASRYVSAEFSFFLAIPTMFGASLLKIVKYVHAGHTFVGDQLAVLLVGMIVSFVVAYL
AVKFLLKFIQTHDFKSFGWYRIALGIIVILIGVFVK
>A0A089PVQ3|FEATURES|UNIPROT_deepARG|beta_lactam|blacep05|antibiotic inactivation|1
MIISSAPRTGLTAAALSLFLAAPAQAADANAPLRAIVDQAVRPVIAEYDLPGVAVAVTVD
GKASFFNYGLASREYQTPVSENTLFELGSISKTFTATLASYAQVTGKLSLEDHPGKYMPE
LKGSAIDKASVLNLGTYTAGGLPLQFPDDVSDDGMLAYFKQWKADAAPGTQRRYSNPSLG
LFGHVAALSMGSGFAEAMEGRILPGLGMKHTHVRVPAGAMGDYAWGYDEANRPGRVNPGP
LAAETYGIRSSAADMIRYLQANIDPSRLEAPLRRAVEGTHVGYFKIDGMVQGLGWEQYPY
PVALAQLEAGNSQKMIREANPASALTPPQTPPPATLFNKTGSTSRFGAYAAFVPAQKIGV
VILANKNYPIAARVKAAHEILINLETRRAD
>F6AFK8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDSWLAFQALILGIVEGLTEFLPISSTGHLIVVGDLLDFNGERATAFKIIIQLGAILAVM
WEFRQRILSVVSGLGSDPMARRFTVNLMIAFFPAVVLGLLFADLIEHWLFNPITVSAALV
IGGVVMLWAEKRQHRIVAETVDDMDWKLALKVGFAQCLALIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVAATVYSLYKYREILQWSDLPVFAIGFVTTFIVAMITVRALLVF
IANHSYAVFAWYRIAFGLLILATWQFGWIDWSTAEG
>Q9KJD2|FEATURES|UNIPROT_deepARG|beta_lactam|acc-1c|antibiotic inactivation|1
MRKKMQNTLKLLSVITCLAATAQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVT
VNGKNYIYNYGLAAKQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYV
PELRGSSFDHVSVLNVGTHTSGLQLFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIG
TGLLGMIAAKSLGVSYEDAIEKTLLPQLGMHHSYLKVPADQMENYAWGYNKKDEPVHVNM
EILGNEAYGIKTTSSDLLRYVQANMGQLKLDANAKMQQALTATHTGYFKSGEITQGLMWE
QLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSSLEGNK
>M5SYP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPELIRVLILAVVQGIAEFLPISSSGHLVILDNLLGDLGESATLVIILHAGTLGSILVVY
WRRILNLLTSDRRVIGLLVVGTLPAVVVGLTIKRGFPWLTESPVLAAAMLIVTGVLLVVL
GKIKPTVGQYTQMGWLGAFIVGCFQAVAILPGISRSGSTILGGRLMGLSNEDSVTFSFLL
AIPAILGATTLAVKDLLDGTEAASDLPVATLLIGATCAFVVGIFALKWLIRWSREARLHW
FAYWCIPFGISMLIFYVSR
>N9C0T7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHLEAFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIVDLIKGFFSGDAEARHFCISVLIAFFPAVIIGVMAVDFIKSVLFSPLVVAIAL
IVGGLIIFWAESIKFDHKTTEATQITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIRNANILTADNMTNIALGFITAFLAALFVVKALVR
FVEKHTLRVFAWYRIALGLIIMFVML
>A0A0S1AVK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLYALPVIRPSMLMSDPISALLLGILEGLTEFLPVSSTGHLLIAERWLGHRSDFFNIVIQ
AGAILSVALVFRQRLWSLATGLHEPGNRDYVLKLATAFLVTAAVGLPVRMAGWQLPETVT
PIAWALVFGGVWMLLAERFAARLPDRDTVTWKVAVGVGLAQVVAGVFPGTSRSAAAIFLA
MLLGLSRRSSAAEFVFLVGIPTMFAASGYAFFELARHGQLAHEAWSDVGIAFAAAVVTGF
VVVKWLLGYIKHHRFTGFAVYRMALGAALLLFLPAGH
>C7S9Q3|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQ
LGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTA
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDW
MEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATM
DG
>X6CGR6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQPFVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFRRLWQMLIDLPHDRLTRHFAIGVLIAFLPAAIIGALAHDFIKAVLFESPRMICIMLI
IGGFVLLAVDRMNLKPFYRDVERFPTRLYLQIGLFQCLSLVPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFVAAFVTALIVVRFLLDY
VSRNGYSLFGWWRLVVGGVGLAALMIWG
>A0A142NCL5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MCSFNPSKVFSHSAFALFFGSVACHAATPTDAQLQALVSQAVTPVMQQNNIPGLTVAITL
NGQAHYFNYGVAAKDTGQKVSENTLFEVGSVSKTFTATLAGYAQATGKLDLSSKASQLWP
ELKGSAFNNISVLQLGTYSAGGLPLQFPAEADSSDKMLGYYQQWKPQFPAGSHRLYSNPS
LGLFGYLTAKSLGQPFEQAMTQTLLPKLGLQHTFLSVPPAQSKLYAQGYDSADQPVRVSP
GALDAEAYGIKTSAADLLRYVQAQLKPASLAPDLHQAIANTHIGYYRVGDMTQGLGWERY
AYPITLEKLQNGNSTPMAMEPHKVEWLTPPQAEPANVLFNKSGSTRGFGAYVAFVPSRDM
GIVILANKNYPNAERVKIAHTVFAALAD
>G2LME2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MLHLNQVIASIIIGVIEGITEFLPISSTGHMIIASHLLKIENNNTKILEIFIEFGSALSI
LYFFHKKILKIIKFNINEKKIKTKNMHILISIFPTIFFGLIFYKKIKLLFNTYDVMYSLI
LGGFFLLVAEIFKPKKHKISNIHDISLFQSAVIGLFQIFCLYPGFSRSGVTIATGILLGI
KRSVAIEFSFIISIPLIMGASFFDFINNISNIKASDFPIFFLGTIISFTISMLCIKQLLK
IINKTSLIFFGIYRFIIAGFIYFIN
>YP_348389|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSQFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIG
ETVAAPLEQAITGVENMLYMSSQSTADGKITLTITFALGTDLDNAQVQVQNRVTRTEPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDKRYDMLYLSNYAILNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVTAIREQNRQVAAGQLGAPPAPTAQSFQLSINTQ
GRLVTEEEFENIVIRAGEDGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGS
NAIDISNDVRAKMEELKKGFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALILVVLVVIL
FLQTWRASIIPLVAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLNPFDATKKAMGEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKGHDAPKDRFSRVLDKIFGGWLFRPFNRFFDRASHSYVGTV
RRVIRGSGIALFLYAGLMVLTFFGFSSTPTGFVPGQDKQYLVAFAQLPDAASLDRTEDVI
KRMSDLALKQPGVESAVAFPGLSINGFTNSPNAGIVFVTLKPFDERKDPSMSAGAIAGAL
NGQYAGIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEELYKETMNIIAKSHNVPE
LANLFTSYTVNVPQVDAAIDREKAKTHGVAVSDIFDTLQIYLGSLYANDFNRFGRTYQVN
VQAEQQFRLESDQIGQLKVRNNKGEMIPLATFIKVSDTSGPDRVMHYNGFITAEINGAAA
PGYSSGQAEKAIEKLLKDELPNGMTYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAITGVIISGGDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQQEGLDPLAAVLEACRLRLRPILMTSFAFIMGVVPLVFSSGAGAEMRHAMGVAVFSGML
GVTFFGLLLTPVFYVLIRNFVERSEARKAAKAQNLQKPLEAHP
>A0A075JMS8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MHITGLNHFLFSVSNLERSIAFYESVFNAKLLVKGKNTAYFDLHGMWLALNVEKDIPRHE
ISQSYTHIAFSIEEADVERVYRKLVDLNVTILSGRPRDKKDKQSIYFTDPDGHKFEFHTG
TLQDRIAYYKQEKPYMEFYD
>A0A0K4LM41|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKR
RLARAQELLQRLGLEERVDYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPATENMNVVAGTESI
VKMSSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQRQPWVASATPAVSQNLRLRY
SNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNSRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFALQL
FLPGWEIGFSPLALLLAFLCSTVTGVLFGWLPARNAARLDPVDALARE
>A0A0J5W1J3|FEATURES|UNIPROT_deepARG|beta_lactam|VL14_10265|antibiotic inactivation|1
MRKQNHSIFSVKMLEKVGLFSVVLLLALTGCANGNSQSDASAAEKKKETSVNTNQKFKQL
EKEFDARLGVYAYDTGTKKTIAYRSNERFAYASTFKPLAAAILLKRKSLEEMDEIITYTS
DDLVTYSPVTEKHVKTGMTLRELCEAAIRHSDNTAGNLILEELGGPDGFEAALKEMGDTV
TKPERFETDLNEAEPGDIRDTSTPKALAASLQKVLMGDFLPEEKRNVLTDWMRGNVTGDP
LIRAGVPSGWEVADKSGAAGYGTRNDIAIVWPPNREPIIMTILSSRDSKDAEYDNSLIAK
TAEMTIKALD
>E7GNB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIEVIKAVILGIIQGITEWLPISSTGHLILFDNIWPMASSPEFFEVFKVVIQFGSILA
VLVLFFDKLNPFSPKKGYRDKKETFDLWKKVVAGCIPIVIVGLPLDMILEDYLSGVYVVA
ATLILYGIAFIVIESRASVPSMNTLQDLTYKTAFFIGCFQVLAAIPGTSRSGATILGAVL
LGCSRYVASEFSFFLAVPVMAGASGLKLLKYFLKEGMFSGPEWFLLIIGTLVSFIVSIFA
IRLLLGYIRNHDFKVFGVYRIILGIVVIIYFTFLA
>I1V594|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
VMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNV
AMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSLRAMAQTLRNL
TLGKALGDSQRAQLVTWMKGNTTGAASILTGLPASWVV
>A0A0E2Q403|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
AILAVMVIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNF
FVVAIMLVVYGIAFIWIEDRNRRVEPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGAT
ILGGIIVGTSRSVAADFTFFLAIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAF
LVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>E6U569|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MANLLLLLKALILGIVEGITEFLPISSTGHMILVGAFMGTDSGPYAKFFTLFEIVIQFGA
ILAVVVLFRKRILDVFRNFKPGQYGLRLALAIIASLVPTVIVAVLFYKKIGKLLMYPLPV
ALSLVVGGIALIYFERAFGHKGKVRRMEDVGIKEGFMVGVFQCLSFLWPGFSRSASTIIG
GWVVGLTTVAAADYTFFLAIPTMFGASAYSLLDAKMKLSGIEVAALVLGFVVAFIVALIV
VKKFIGFLKKKPLRVFGYYRIAVGIVMLICVAAGVLH
>Q97LQ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MEHIEILKAIFLGIVEGITEWLPISSTGHMILVNEFIRLNVTEAFKQVFLVVIQLGAILS
VVLLYFNKLIPFSLNGGFYLKKDVVSMWIKIIISCIPATIVGIPFDDKIDALFYNYQTVS
ITLISFGILFIMIENHNKGKHPRITSISEITYTTAVLIGIFQLIAAVFPGTSRSGATIVG
ALLIGVSRTVAAEYTFFLAIPVMFGASLLKLFKFGLHFTSTEITILFIGMLSAFIVSILA
IKFLMIYIKRHDFKAFGWYRIILGCAVLVYFLIV
>P14511|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant2Ia|antibiotic inactivation|1
MSNVRHHEGSVTIEISNQLSEVLSVIERHSGINVAGRAFVRSAVDGGLKPYSDIDLLVTV
AVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQR
NDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWN
SQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQ
KEDHLASRADHLEEFIRFVKGEIIKSVGK
>H8KNH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIQAIILAIVEGLTEFLPVSSTGHMIIASWLMKVPNGDFTKFFTVGIQFGTILSVVVL
YFKRFFQTLDFYFKLFVGFIPAVVFGVLFSHQIDALLESVLTVGIMLLVGGVIFILLDNW
FKASENNPDKEIKYNNAFVIGLFQCIAMIPGVSRSASTIIGGLTQKLNRKQAAEFSFFLA
VPTMFAATAKKMYDFYKDGGINLSGEEWKLFGIGNLVGFIVAIIAIRAFIGYLTKHGFKV
FGWYRIVVGAVIIIFYFLGYNLQLI
>W6W1T0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACRQLQHDFEIVLVDDGSRDESANMLEEA
AGRENSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAEAEKGY
DVVGTVRGNRQDSALRRYPSKLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERS
TFIPILANSFARHTTEIVVAHAEREHGDSKYSPMRLINLMFDLVTCMTTTPLRLLSIVGF
AMAGLGVLFAVALIVLRLAFGAGWAGDGMFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRSQPAAPAPAVTVDGLSSTATSSTSDQVLS
>D1PGN1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIQTIIISIVEGLTEFLPVSSTGHMIIAENLLGVDIQDKFVNAFTVIIQFGAILSVIC
LYWKRFFYPEAVKTGEKTYLKAMFDFYARLVVGTVPAVILGLAFNDFIESNLGNVQLVGW
MLVIGGIFMLFCDKIFNKGSEQTKLTYKRALIIGFIQCIAMIPGVSRSMSTIVGGMSQRL
TRKAAAEFSFFLAVPTMFGATCLEVYKLISHGGGSLLTQGNNLFTLILGSVVAFIVAILA
IKFFINYVTKYGFAAFGWYRIVVGLIIIICGLCGVDMQMVD
>ZP_03063464|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MIMKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
SQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMAR
TLLRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFS
MARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVL
GLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMN
VWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLP
QTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>R2SG57|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAIILGIIEGITEWLPISSTGHLILVDEFIKLKMSPEFMSMFNVVIQLGAILA
VIVLYFHKLNPFAPSKSSQEKKDTWSLWFKVIVAIIPSGILGILLDDWLDANLHKFLPVA
IVLIVYGVAFIWVEKRNRGVKPVYTSLQGFTYRASLIVGFFQVLSLVPGTSRSGATILGG
ILIGASRFVATEFSFFMGIPTMLGASGYKILKFIKQGNSFDFETSVILLVGTVVSFVVSI
IAIKFLLSYIKKNDFTAFGWYRIILGAILIGYWLIAM
>Q2FC74|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFG
>D2N0K2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGVIEGLTEFLPVSSTGHMILSTTILGIDIDKFWKSFLIIIQLGSILAVIFV
FWRKLFQGLDIWFKLAVGFFPTGVIGLFVAKYLNALFNGWVVVFMLIFGGVVFILIELAH
KNKQYCINSLEEISFKQAFCIGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLL
AIPTMIIATAYSIYKEPELLSNANSLVPLSIGFITAFIVAVLVVKFFLKFISKFNFIPFG
VYRIILGLIFFYLYYSEILNAGSEFKL
>A0A0M8PW40|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPNFRMSQITNAIFQGRINNFNEITVLPKSLREMLIKEFGES
ILNIATLKAQHSEQVTKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATG
DLGLKRNLTSDEITDQILYFHLKGHSIDSISFMGMGEALANVQVFDALNVLTNPELFALS
PRRLSISTIGIIPGIKKMTQNYPQVNLTFSLHSPFNEQRSGLMPINERYPLLDVMDTLDE
HIRVTSRKVYIAYIMLPGVNDSIEHAKEVVNLLRGRYKRGNLYHVNIIRYNPTVSSPMRF
EEVNENQVVNFYKELKSAGINVTIRSQFGIDIDAACGQLYGNYQKTITNK
>A0A0E2MPK1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAAKEALP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A060KQF6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLTATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSGLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>YP_312012|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDISMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>U5MNS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP2|antibiotic target alteration|0
MGLDILFILKAIIIAIVEGLTEFIPVSSTGHMILVSNVINFKGEFVDMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFIYIFTGGKKGKTGFNFGINVLIGSIPAGIVGMLFYKKIKSLFK
PEDVIVAFIVGGILLIIIENIFRKNKKHATKSIDDITPMQSIKVGLFQVLSMWPGMSRSA
STIMGGWVSGLSTPIAAEFSFFLAIPAMVGSSAKDLSEFDFSSMNMTLWIALIIGFIVAF
IVSIVVMDKFVAYLKKKPMRVFAVYRVGAGIVLAILTFFGFVKL
>ZP_02346204|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFCHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKKPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQPGQAP
>J7V052|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIAFTLFVLL
>R9VRW8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFNLPPVEKVSVVIPVYNEQESLPELIRRTTESCDVLGIDYEILLVDDGSSDNSALMLSE
AAEQPGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQNRQDSLFRKMASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRAVEIPVQHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIAVLGFSLAVLLVVLRLAFGPQWAGEGVFMLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQENDVSQEEKNQ
>ABD04054|FEATURES|ARDB_deepARG|chloramphenicol|catB8|antibiotic inactivation|1
MKNYFDSPFKGELLSEQVKNQNIRVGRYSYYSGYYHGHSFDDCARYLRPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTAIGNDVWIG
SEAMIMPGIKIGDGAVIGSRSLVTKDVEPYAIIGGNPAKQIKKRFSDEEISLLMEMEWWS
WPLDKIKTAMPLLCSSNIFGLHKYWREFAV
>A0A0G8C803|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRISRINANGEMNSFPIPTANAGAM
SIISDQTGDLWFTEYNSNKIGKMTMNGLFEEYVLPTTNAAPFGITEGPDGALWFTEMNSG
RIGRITKSGEIIEFELPNSKSFPSFITLGSDGALWFTQNQNNTIGRITTKGEVTEYPIPT
PNSGPVGITSGPDGAIWFVQIMGNKIGRITLKGEFKEFVIPTPNARPHAIIPGKNGDLWF
SEWGGNQIGRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A085GCF3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTKPEVIHKVTVVIPVYNEQESLPELIRRTTAACETLGKDYEILLVDDGSTDNSAEMLSD
AAEAPGSHIVAVLLNRNYGQHNAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDTWFRKRASRVINRLIQSTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKAVEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSVFG
SIIAVLGFALSVLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFIQRVVSRSSVSTSEENQQ
>ZP_04084549|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYVIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>F3BKN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIINAIILGIIEGITEFLPISSTGHLIVASKWLGIESTDTNLAFEVIIQLAAILAVLAN
YKDKFSPKHFNLWIKVAIAFIPLGIIGFIFSDVIKTLFSVPVVGVMFIVGGVIFLLLERS
YKEAHCTTTDVTQVTYKQALWIGVAQVFALIPGTSRAGSSIVGAILCGLNRKTSAEFSFL
LGLPILAAASGYDLLKHYQLFSLDDLTALAVGFFTSFIVAYFTIKLFIRFLENFTFVSFG
LYRIVFGVILLTNLNSG
>A0A0Q9VDC4|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGLNHFLFSVSDLDSSIEFYQKVFDAKLLVKGRTTAYFDLNGMWIALNEEKDIPRNE
ISESYTHIAFSIEEADLMNMYEKMIGLNVNILSGRPRDEKDKKSIYFTDPDGHKFEFHTG
TLKNRIDYYKQEKAHMEFFH
>D4HV90|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADMHQLWVAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGNKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHCGEVKHEGIGQGRLSLIHIMLGMVPAVVIGLLLHDRIKMLFNPVN
VMYALVVGGVLLIAAELLKPRQPKSPGVDDITYRQAFIIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMVGATGLDLYKSMGFLTMADFPMFAVGFVSAFIVALIA
IKSFLHIIKRISFIPFAIYRFIVAAAVYALFVL
>YP_001966009|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTNWVNTAFML
TFSIGTALYGKLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFPILILARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTII
TVPFLIKLLKKEVRIKGHFDIVGIILMSVGIVFFMLFTTSYNISFLIISILSFLIFVKHI
RKVTEPFVEPALGKNISFIIGVLCGGLIFGTVAGFISMVPYMMKDVHQLSTAAIGSVIIF
PGAMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIAAFFLEVTPWLLTIILVFVFG
GLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGIGIAIVGGLLSVRLLNQKLLPM
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>A0A0P8WEJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADIPLFATGFITAFVVAMLAIVSFLKLLG
RVKLTPFAYYRFILAAVFYFFIM
>Q8L1L6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGVSCTTFAAPMSEKQLADVVERTITPLMKAQAVPGMAVAVIYQGKPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLSDKATKYWPELTGKQ
WQCISLLDLATYTAGGLPLQVPDDVTDNASLLHFYQTWQPQYHPGSTRLYANASIGLFGA
LAVKPSGMSFEQAMTERVFKPLKLAHTWINVPPQETQHYAWGYRDGKAVHVSPGMLDAQA
YGVKTNVEDMASWVIANMTPDSVQDASLKQGITLAQSRYWRIGSMYQGLGWEMLNWPVDA
KTVVNGSDNKVALAALPVKEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKDLGIVMLA
NKSYPNPARVEAAYRILSALQP
>A0A066ZZC6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQAAILGIIEGLTEFLPISSTGHLIVVSDWLGLQQTDQNKAFEVIIQFAAILAVISH
YKEKFTPGHSRLWGNVIIAFIPIGIVGLLFHHQIKEIFTIQIVAWMFIIGGIIFLILERL
YTEGTHRTKDIEDLSIRQAFWIGIAQVFALIPGTSRAGASIVGGMIVGLDRKASAEFSFL
LALPVLAAASGLDFVRHYSEFANTSWMPLIVGFVVAYIVAYLTMTVFIRFLERFTFNAFG
IYRILFGIILLIAFS
>G2HZB5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLFDSLILGIIEGITEFLPISSTGHLIVASEFLGLEQTNINKAFEVIIQFAAILAVILS
YPSKFTFSHINLWTKVLIAFLPIAIIGFIFSKQVKELFSIEIVAWMFIIGGIVFLIVEKF
YDEKATHTLDVENITYKQATWIGFAQIFALIPGTSRAGSSIIGAMLVGLNRKTSAEFSFL
LAFPVMCATTAYDLLKHHDEILVGGNFLNLATGFVVSFIIAFLAIKLFLKFLENFTFVAF
GIYRIVFGILLLIIF
>A0A0B3TNC3|FEATURES|UNIPROT_deepARG|aminoglycoside|PJ20_20795|antibiotic inactivation|1
MGPDDIPAWRTLRHCLWPQASADEHDREMAEILSSPERYATFIAFSTAKAALGFAEASIR
HDYVNGCDTSPVLFLEGIYVVPEARRQGVAKALFEYAEQWGALHACEEFASDTDVRNDGV
QALHRALGFEETERVVFFRKRTSKAALG
>V7UXE4|FEATURES|UNIPROT_deepARG|aminoglycoside|CFSAN001590_08465|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQADYLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGLAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>CAA63057|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLRSSLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>CAJ31231|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-124|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPDQKAESRRDVLAAAAKIVTHGF
>A0A103BM88|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATAAAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAVGIVAG
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVAKYLPE
VQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLDAWRPDYAPGTQRKYSNVAI
GMLGWLTAKAMHQDFATLMEQRLFPALGMTHTYIDVPDARMADYAQGYTKDGKPTRMTQG
MLWQQAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVVLPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINKTGSTGGFSTYVAFVPAKRIA
IVMLANGSVPIEDRVKVAYRILGSLGDGR
>A0A0B1QZ89|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQLPKTLSILALIMSSNSFAQTPAPDTIIKPLMQQYQIPGMAVAILHNGKTEFYNYGVAS
KETQQPITQQTLFEIGSLSKTFTATLASYAAQQKKLQFSDKASTWLPELKGSAFDRVSLL
NLATHTSGTPLFVPDAVTNQQQLMDWYKHWQPDAKPGTVRVYSNLGIGMLGMIAAKSLQQ
PFISAMEKQLLPAMGMHHSYVQVPASAMGQYAQGYNKQDKPVRVTPGPLDAESYGLKSTS
SDLIRWLSIQLDEQKVAPDWQQAIARTHQGYYQTDAFTQAMMWEYYPLPVTAQQLVEGNS
GQRIMKGMSATLISPPQPAPQQAWFNKTGSTNGFSTYAVFIPSQKIAVIMLANKWFPNDD
RVIAADKIIKQLNK
>D4QLM1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFFANIIKAVILGIIEGITEWLPISSTGHLILADEFIKLDASSQFMSMFNVVIQLGAILA
VVVLYFHKLNPFSPSKSTIEKKDTWTLWFKVIVSCIPAIIIGLPLDDWLEANFHKFLPVA
IVLIVYGIAFIIVEKRNKNKTPRWTSLNDFTYQAALLVGLFQVLALVPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASGLKIVKYLAEGNSFKMEETVVLLVGTFVSFVVSV
LAIKFLLSYLKKNDFTAFGWYRIILGIILIGYWFIAM
>F3MIM4|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MKHLSKYEKIRKILSALNQPNYRYSQITESIFKNKIGNFEAMNNLPKPLRNELIKELGNN
VLSITPKMEQKSNQVSKILFAVPGDEYIESVRLSYQTGWESYCISSQCGCGFGCTFCATG
TLGLKRNLTTDEITDQLLYFTLNNHPLDSVSFMGMGEALANPYVFDALHVLTDPKLFGLG
HRRITVSTIGLIPGVKKLTKEFPQINLTFSLHSPFHDQRSELMPINNHFPLEEVMTVLDE
HIQQTKRKVYIAYILLRGINDSTKHAEAVADLLRGRGPWEHLYHVNLIPYNSTDATSQSF
VESDQNSINMFLRILKSKGIHVTVRTQFGSDINAACGQLYGSNGNI
>A0A0M0WNG1|FEATURES|UNIPROT_deepARG|beta_lactam|AMS61_14265|antibiotic inactivation|1
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALATSLQTYVLGQALPENKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>N8VCJ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIIDLLKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTEATMITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIAVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGVILLFIFL
>A0A0K1M535|FEATURES|UNIPROT_deepARG|aminoglycoside|AKJ12_12675|antibiotic inactivation|1
MSAQAGWRVRAAVGADAQALLALRLALWPDADDGVAELQAALAQADASHLLVVDDADAAL
GFAEVSVRHDYVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVEWTREQGCTELASD
ARLDDSGAQAAHAACGFEPTERVVYYRLQLA
>A0A0F4AXB6|FEATURES|UNIPROT_deepARG|beta_lactam|SG71_24560|antibiotic inactivation|1
MVMRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTT
PASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASRRGA
RGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>F5SNY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIVEGITEFLPISSTGYLILSADIMGFWTKEKADLFIVVIQLGAILAVIYEYWGRLWGA
LMGLITGKSEGPNALKNPRQLGLSLIVATIPVMIVGFTMADQIKEYLFNPYTVAIMLILG
GLLIFYVERKPIPVVAEEAEDVSLKHALLIGLFQCLALIPGTSRSGSTIIGALWLGVSRK
AAAEFSFFLGIPVIVGAGLLDMIKHKDVLASSEDWVVLAVGVVVSFIVALLCIRWLVDWV
SRRDFTIFAWLRIVTGVMVLLAAWVFGYNIQG
>YP_001143321|FEATURES|ARDB_deepARG|beta_lactam|cphA5|antibiotic inactivation|1
MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTIVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFNLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQALIKAAPQA
>A0A140GPI4|FEATURES|UNIPROT_deepARG|beta_lactam|blaFOX|antibiotic inactivation|1
MQQRRAFALLTLGSLLLAPCTYAGGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVNEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHGPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYQSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAAVKSAIALTHTGFYSVGEMTQGLGWESYAYPVTE
QTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLNE
>J8JV93|FEATURES|UNIPROT_deepARG|beta_lactam|IIM_01640|antibiotic inactivation|1
MEQTCYLECLLYVRIKTGVQMGFSVLNLIFIFSIKNLKGMIFLKNKRMLKIGICAGILGL
GLSSLEIFTGGSLQVEAKEKTGQVKHKNHATYQEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVDYSPVTEKHVDTGMTLGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTGWEVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVIVNALR
>A0A0F7PPP7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNESTIVGAFLGLIEGLTEFVPVSSTAHLLLAGHFLGFKSPGNSFEVLVQLGAILAILSV
YFARLWKLAMDLPSSATARRFVGAILLAFLPAAVIGAFAHGFIKSVLFESTALICWVLIG
GGVILLMIDRMKLTPKYTNVMDYPLPLAFKIGLFQCLAMIPGTSRSGATIAGALLMGADK
RSAAEFSFFLAMPTMVGAFTLDLYKNYDKLAYDDVVTIVVGFIMAFIAGVIVVRGLLDFV
SRHGFAVFAWWRIVVGTLGLIGLWLLG
>A0A0J6TFT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVS
VYFRQILDLLRRAPSDPNARRFILAILIAFLPAAIVGGLFSKHIKFYLFNPWIICSTLVA
GGLVLLVIDETEIEQKYDDVHQYSLPMALKIGLFQCLAMIPGVSRSGATIVGAMLMGSGK
RAATEFSFYLAMPTMAGAFAKDLLDNYKNLSKDDVGLIAIGFVVAFLSALFVVRKLLDYV
SRHGFALFAWWRILVGAAGFAGLIVFG
>Q11WJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTWLESIILAIVEGVTEFLPVSSTGHMIITSALMGIKSDPFTKVFEVAIQFGAILSVVVL
YFKRFFKSCDFYFKLFVAFIPTAIVGLLLKKHIDTWLENVWVVASTLLVGGIVLLFVDKW
FQKNETEGEEEVSYQTGFLIGCFQCLAMIPGVSRSAATIIGGLTQKLTRKAAAEFSFFLA
VPTMFAATAKSLYDEKELILESTDKIPLLLLGNVVAFIVAMLAIKFFINILTKYGFKAFG
YYRIALGALLLILLAMHVDLQVV
>C9LGX9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDMTWWQALVIAIVEGLTEFLPVSSTGHMIITEGAMGMQSTPFVKAFTVIIQFGAILSV
ILLYWRRFFYPESIRTKGYTWWQAIWRFYLRLIVGVLPAVVFGLAFNDLIEENLGSVRLV
AVMLIVGGIFMLFADKLFGNGWKKEPSYKNAFLIGLFQCLAMIPGVSRSMATIVGGMQQR
LTRKSAAEYSFFLAVPTMAGATLLETYKLLKHDSGMLLSGDHLWLLLLGSGVAFVVALLA
IRFFIAYVSKYGFKAFGWYRIVAGSVILLLMACGVELNMAG
>F8T8X2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA2|antibiotic inactivation|1
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDFMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEEFIRFVKGEIIKSVGK
>A0A0T9T9C2|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSPLRRSLLLAGLTLPLVTLTSPVWAAALSASLDNQLAELERTANGRLGVALINTANG
SKVQYRGGQRFPFCSTFKLMLTAAVLGQSQSLLGLLDKHIRYHESDLLSYAPITRKNLAQ
GMTVSQLCAATIQYSDNTAANLLIKELGGLEAINQFARSIGDQTFRLDRWEPELNTALPN
DPRDTTTPAAMAASIHKLVLGEALKTPQREQLVVWLKGNTTGDATIRAGVPTDWIVGDKT
GSGDYGTTNDVAVIWPSQGAPLVLVLYFTQRQKDAESRRDVLASATKIVLSHLS
>A0A0U3BVS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLFIKAVIMGIVEGITEFLPISSTGYMILSADIMNFWDKDKRDLFIVFVQLGAILAV
IYDYWGRLWTAFMGLLTGKADGMTNPRGLGISLIIATISVMVVGFTLKDFITGMLFHPLV
VATMLIIGALLIIYVEKHPRPIKAQEAEHIDFKMALKIGLCQCLALIPGTSRSGATIIGA
LWFGASRKAATEFSFFLGIPVIIGAGLLELIEKKDVLQTGQDWAILGVGTAVSFVVALLC
IRLLVAWVSKRDFMIFAYLRIITGVIVLLAYFVFGYQIQG
>A0A088G9R0|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-1|antibiotic inactivation|1
IGLDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYS
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWE
PELNEAIP
>A0A0H3H486|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTE
AAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHER
STFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSIFG
SVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQPETASKEEDRS
>E2XSZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTVNLLIAFLPAVALGVIFADLIHHYLFNPITVATALV
VGGIVMLWAERRAHEVHAETVDDITWKDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFITSFIFAMIAVKGLLKF
IASHSYAAFAWYRIGFGLLILATWQFGWIDWSAAKA
>D0EJY4|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-13|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRLWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPTAERVKIAYTILSGLEQQGKVPLKR
>A0A127SPH1|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
LYYLATIVNRHPEFRTAINQAGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSM
AYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYY
RDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>Q104Y5|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC16)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGCGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>B1K805|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIGAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
DRHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEALAEVGV
GAAATTETAADTRSAPASGDAPPPANNDTAADPAPRARRFAAGTGRFAEACRMAWIALVS
HRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSIGTNTISLYPGSDWGDSRADT
IQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYFQTRGMRFALG
VPFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSAFGSV
KSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNM
DSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSD
ILQQFLVEAVLVCLLGGTIGIALSFGLGALFSVFVAQWKMVFSAGAIVTAFVCSTLTGVI
FGFMPARNASRLDPIDALARD
>A0A0B2FFT5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIVKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKKFSRKELTVVPEGQPQAPAEGRLKLAQVIVGLIPAGIFGFL
FEDYIDEHLFSTSTVLIGLVVGAIFMICADRFAPKTIKTESVDQITYRQALSVGLIQCVS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLLKNWQYFTLDALPFF
IAGFISAFLFALLSMRFFLKLINRIKLLPFAIYRIILAGVVYLVWF
>A0A0F7N3A2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHPSAAPAIREIPVADRDAGPYGIATGPDGALWLTFAHSGRIARLTLDGELDEYALDSSE
CRPAVITPGPDEALWFTRSRDHRIGRITVDGETESFPVPTPDSGPFGIAAGPDGAMWFTE
MNTDRIGRITCEGEITEFALPRTGAYPSAISAGPDGALWFTLNQANAIGRITVDGDFATH
PLPTPGAAPVGIASDGAALWFVEIAAGQIGRIPVDGEIEEFPLPDRTAKPHAIVAAATGD
CWFTEWGANRIGRITDGGEIAEYALPSPSSEPHGITVGSDGALWVALETGGVARLEP
>A0A0T7E2Z2|FEATURES|UNIPROT_deepARG|beta_lactam|carB|antibiotic inactivation|1
MKKLFLLAGLMVCSTLSYASQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRVEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRTIGDKATRLDRLEPRLNEATPGDNRDTTTPNSMVN
TLRTLIEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLIAQISQLILQKYKDN
>N6YWR4|FEATURES|UNIPROT_deepARG|beta_lactam|C667_02293|antibiotic inactivation|1
MAIRFLTILLSTFFLTSFVHAQEHVVVRSDWKKFFSDLQAEGAIVIADERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDAGAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDNARRYLKQIDYGNADPSTIKGNYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKYLMITEAGRNWILRAKTGWEGRFGWWIGWVEWPTGSVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>J2LDB2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYISSIILGIIEGITEFLPISSTGHLIIAEQWLGARSDTFNIVIQAGAILAVTIIYWRR
LLDLLLGWRDPQNRDYALKLIVAFLITAVLGLLVKRMGYELPETATPVAWALIIGGIWMI
FAEWAAARRPPSTHITWLVAILVGIAQVVAGVFPGTSRSGATIFVAMLAGTANRAAATEF
AFLVGIPTMYAASAFSLLKTFKDGGAANEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTVFAIYRIILGVVLLGMAMAGMIS
>Q9KIG2|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA7|antibiotic inactivation|1
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLND
AVRQALLVDLLXVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG
IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA
GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP
ARADQVAALIKFVKYEAVKLLGASQ
>A0A017IGK2|FEATURES|UNIPROT_deepARG|multidrug|mdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAQEPWLLWFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAF
NAWLLPAWKLSTVRTPIREGMARVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSERRFRLEHRLMAGLLIMSLSMMPVGMVSSLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>A0A0U1YUK6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGCSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>T2H763|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPLSRPAALAAVIALVLGHTGAQADDQLQAKVDQIIRPLMQEQGISGMAVAIYARDHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDATVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPHAEPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMTEGLLAKMGLKNTYLHVPASAQGLYAQGYDAADKPVRVGPGPYADE
AYGIKTSASDLLQYVRLHMQPQGLPPALAKATAITGQGYFQVGSMTQGLGWERYPYPVTL
GTLVDGNSARMIREPHATTRLQPALPPLPAAWYNKTGATNGFGAYAAFVPSEKLAVVLLA
NRNYPNEERVRAAFKILSGL
>B3WCK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFISMFEYVIQFGAILAVV
LLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSAVVGLPLNSWMDEHLHTPIVVATTL
IVYGILFIILENYLKNKSAHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVLIIKIGKYLWQGNGFSGEQWAVLMTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>A0A026RZ68|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKE
TRPAAPTTSDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLATGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPIAAHEEIHHHA
>A0A0F0EJ87|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEPCPMMPKTIKAKPGILAAVGFFLFTSQTLASPLSDAEVASTVNAAVRPLMQQHAIPGM
AVAISVKGKQHYLNYGVASIQTGQAVNADTLFEIGSVSKTFTATLAGFAQASGKLSLSDP
ASKHWPALAKTPFDGITLLNLGTYSAGGLPLQFPDQVKDQDDMLRYYAHWKPAYAPGTQR
LYSNPSLGLFGYLAARSMGTPFTELMQQQLLPQLGLQHTYLQVPATQMDRYAQGYNKDNQ
PLRVGPGALDAEAYGVKTSAADLLHYLDVNMQPQRLSAPLQRAIATTQTGYYRVGAMTQG
LGWEMYDYPISLDQLLAGNSSSMTLEPHPTTWLKPAQPLHANTLLNKTGSTNGFGAYVLF
VPSRQIGIVLLANKNYPNTERVKVAHAILTALDQ
>A0A0K9YMM5|FEATURES|UNIPROT_deepARG|chloramphenicol|ADS79_29250|antibiotic inactivation|1
MKFHRIDLDSWNRKPYFDHYLNQVRCTFSMTANIDLTELLPLLREKKVKLYPAFLYMVTQ
AVNAHREFRTTYDAEGHLGYWEKMIPSYTFFHQDDQTFSSIWTDFIDDFYLFYENYTADM
KMYGDNKGIVAKAMEPPYTFPVSCIPWVSFTGFNLNIFGDGQYLLPIITSGKYFEQEGKT
LLPVSLQVHHAVCDGYHASLFMNDLQKWASGGKSWLLMP
>A0A0P9Q6S3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWVSAKA
>YP_001881802|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGINSNATSASLQLAQSIFDMSKWRALTLQEKAAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQN
ARAQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEA
EKRNLSLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDD
SNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSIVQTVRSSFNNINA
SISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLIN
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
SARTTTSNGHNPFRN
>J3H3Q0|FEATURES|UNIPROT_deepARG|beta_lactam|PMI34_04648|antibiotic inactivation|1
MDRLKTIAACMAIFAAGQCVAQDQIEAVVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
GVASKETGTPVTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQILPALRGSPFDH
ISVLQLGTYSAGGLPLQFPAEYDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
QSMGQPFDELMEKTLLPKLGLKHTYVHVPQDQMALYAQGYNKDDKPVRVTPGALDSEAYG
VKTSASDLLAYVGVNMKPAPLEKPLQQAIALTHSAYYTVGDMTQGLGWEMYRYPITLDRL
LDGNSTPMAMQAHEVRWLNPPQAQPENVLINKTGSTGGFGAYVAYVPSKDIGIVMLANKN
YPNAERVRIAHRILSAMTQ
>A0A0F7VU84|FEATURES|UNIPROT_deepARG|aminoglycoside|sle_16300|antibiotic inactivation|1
MSDHPGPPTVSPALFGMGSGDWLPVTAGESGAFVFRSADAARYAKCVPAAEAAGLEAERD
RVEWLNGRGVPGPRVLDWYSGEAGVCLVTSAVSGVPADQVSAEELRLSWGRIADAVRRLH
EVPVAECPFGRELDAMLALARDVVARGAVNPEFLPVEQQHLPPAELLARLTGQVPRRREQ
EAADTVVCHGDLCLPNIILDPRTLDVSGFIDLGRLGRADRHADLALLLANARETWPDEEW
ARAADAAFAERYGIAVDPDRLRFYLHLDPLTWG
>A0A0M2EHM4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTPDMLPFFIVGFVSAFV
VALFVVRFFLKLINKIKLVPFAIYRIILGVILFILFM
>ZP_03592168|FEATURES|ARDB_deepARG|multidrug|Bmr|antibiotic efflux|1
MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPI
AGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAAFIMPGVTAFIA
DITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTL
REPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTA
SDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILL
VTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNY
PFYFATVTLAIGIALTIAWKAPAHLKAST
>G4Q6C2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMLSALILGIVEGLTEFLPVSSTGHMIIVGHMIGFDGNLAKIFDVVIQLGAILSVLVL
YRGRFARFFTKEGWQLGKGLSAYHVLAGCIPTMAFALLVHSFIKKYLFSPFTVAIGLVLG
ALLMMAAERKIRGHEAELVQDVDHISLKQALYIGFYQFLSLWPGFSRSGSTIGGALLVGV
SRKAGADFTFIMALPIMVAACLYELLKNLSALSSGDFAVLGLGFAVAFAVAYFSILWFIG
FLNRSTLKSFAVYRILLALFTLWYFYC
>A0A127SMT0|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
HNNEVHYPLLSVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDL
DISLGELLQYSISLSDNNACDILIEYAGGIGHIHQYIKKLGINDFNLSETEDSMHRNPQK
AYSNWSTPSEMVRLLKMADEKDLFAPVYRDFFWKTMTETATGSNKLKGLLPSNTVVGHKT
GSSDRNLKGVKMADNDAGVLIMPGGKKYYIAVFVTDSSETDEENAAIIAHISRMVYDEVK
>A0A0B5E9H0|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
RTARGMGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
IHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHN
MGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>A0A0S9F309|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVLLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIRETLVALPTERQAQRFALNVFIGFLPAVVLGLLFGKMIKAHLFTPVVVASTFI
LGGFIILWAERRSPAATRIQTVDEMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPMFAVGLVFSFISAWLCVRWLLR
YISSHSFVPFAYYRIVFGIIVLVTAWTGWVQWAD
>C8W9M4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESAILWIEALKSALFGVVEGITEWLPISSTGHMLLLNQFLPLNVSEDFWNMFLVVIQLG
AILAVCVGFFHKLNPFSPKKSKEEKRSTWKLWAKVVVSCVPAAAIGLPLNDFIEEHLGSP
FVIAATLIFYGIIFILLELHREKVAATVKVEAPRGKHMRPDAGASLKASSADDLARVKDI
DNLDWKTALGIGVFQVLAIVPGTSRSGATILGGLALGCSRAVAAEFTFFLAIPTMAGASA
LRLVRYFMKGNTFTTPEALILSVGCLVAFIVSLIMVRALMGYVRKHDFKPFGVYRIILGI
AVIAYFLLVK
>H2IUH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIVESHSLLVAAILGVVEGLTEFLPVSSTGHLIIVGNLLGFTGDTSKSFEVVIQLGSILA
VVVMFWRRLFSMIGLHFGKPPVHEGTGTRRLNLLHIILGMIPATVIGLVFHSQIKSLFEP
KFVMYSLVVGGVLLIAAELLKPKKPRAEGLDDISYLQAFMIGVFQCLALWPGFSRSGATI
SGGMLMGISRFAASEFSFLLAVPMMMGATALDLYKSYSFLTLADLPMFVTGFVSAFIVAL
IAIKTFLAVIKRISFIPFAIYRFFVAIAVYYVFIA
>R6SMI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIELLKVIFLGIVEGITEWLPISSTGHLILVEEFVKLDVSKEFWEMFMVVIQLGAILA
VVVLYWNKIWPFQNKKKQRVNVTKIEKTAGVLCRFVNIEKMVMWFKIMVSCLPAILIGLP
FDDFIEKTFNNWFVVAVMLIVYGVLFLMVEDYNAKRTVKVNSIADISWKMALYIGIFQVL
ALIPGTSRSGATIIGGILLGASRTVAAEYTFFLAIPVMFGASLLKIVKFGFHFTQWEAVI
LGVGTVVSFLVSILAIKFLMGYIKKHDFKAFGWYRIALGVVVMLFFTIFR
>AAF71281|FEATURES|ARDB_deepARG|glycopeptide|vanG|antibiotic target alteration|1
MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKIL
NNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGENGTLQGIFE
LAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPL
FIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVG
RVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDM
FYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE
>YP_410369|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRIS
ESEAVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDYIRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSCSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>A0A0B5NNS5|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLV
DYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKRATYDNQLIAEAAEV
IVNAFR
>ZP_03615711|FEATURES|ARDB_deepARG|tetracycline|tet37|antibiotic inactivation|1
MFPRNSEKKRRRNYKNIKDMTEITNKIYYVGVNDRNKHRFEGLWPLPNGVSYNSYIIDDE
KVALVDTVEVDFFTQFLENIHEVIGDREIDYLIINHMEPDHSGSIALIKKYYPNIKIVGN
KKTLGMLEGFYGVTDDVVEVKNGETLSLGNHELSFVLIPMVHWPETMVTLDAKNKVLFSG
DAFGCFGALNGGIIDTEINCETFWLEMVRYYSNIVGKYGIPVQNALKKLAGVELDYICST
HGPVWHEHIEKVIGMYDKMSKYETEPGLVICYGTMYGNTERMAEIIARAASKAGVKNIVM
YNISKTHHSYILRDIFRYKGLIVGAPTYNAGLYHEMEVLLSELANKDVKNHLLGWYGSHC
WASKAVAKIQEWNETKLHYEPVGEPVDMKQAITPEVKAQCEALGKAMAEKLLAE
>A0A0H0DGG0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGATRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDISSWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>A0A078KR89|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAFIIWMLFKSVLMGIVEGITEFLPISSTGHMIIVDQLIGFSGKNGFSSEFTALFEVVIQ
LGAILAIIVLYRKKILNSLKTLKPGGFGFKLWTGLIIAMIPAGIIGILDKKVFDDVIERY
MMKPIPVSLALVVGAIWMLYAEWRYRKNHTCKRLEDVSYKQAFAIGVFQCLAIVWTGFSR
SASTIIGGWIMGLSSPVAAEFSFFLAIPAMICASGADLITSDLQLSGLEISSLIVGFVVS
FIVALIVVKKFMDFIKHKPMKGFAYYRLAVGILLIILAIFRVIR
>A0A0C5K8Q3|FEATURES|UNIPROT_deepARG|beta_lactam|UC34_00370|antibiotic inactivation|1
MNKPYFTFVAALAATAAIGWMAISARSYAAEANPQDQTNPRQAEIKSLVDKTIGPLMARQ
EIPGMAVGIVFDGQSYLFDYGLADKAANKPVTNDTLFEIGSVSKTFTATLTAYAQAAGAL
ALTDKTSRIAPEFAGTPFGDVKLLNLATHTTGGMPLQVPDNVENTDEITQYLKAWKPAKP
TGTVRTYSNVSIGALGWLTARAMHGDFATLMSDHVFKPLDLTHTYLRVPEDQQANYAWGY
KDGKPVRVSPGVFEQEAYGVKTTAGDLLRFVRANLGETVHDRRLRHAIYATRSSYFFDAP
MTQDLVWEQYPYPVAVDTLLEGNSSHMAYEPTPAREFAPPMAPSPVSWVNKTGSTNGFGT
YVAFVPSKQMGIVLLANKNYAMDERIRAAHLILTTLDGARATPAPTSTPTK
>A0A0S3C5I0|FEATURES|UNIPROT_deepARG|beta_lactam|ATN06_12195|antibiotic inactivation|1
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKRMLKIGICVGILGLSLASLEAFTGGSLQVE
AKEKKGQIKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKAL
AAGVLLQQYSTEKLNDVITYTKEDLVDYSPVTEKHVDTGMTIGQIAEAAVRYSDNTAGNI
LFHQIGGPKGYENALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKTIATNLKAFTVGN
ALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPI
IIAILSSKDEKGATYDNQLIAEAAEVVVNAF
>A0A0R2YP19|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDDSAQLLEDA
AAEEGSHVVAVILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGVLFAFALIIMRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSSSSDQVQS
>A0A0R2TPJ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAETSTIVAALLGLLEGLTEFIPVSSTGHLLLAGHFLDFESAGKTFEVVIQLGAVLAVLT
VYAAKLLGVVTAAPNDPQARRFIGAVLIAFLPAVVIGVAAHDFIKSVLFETPILIASTLI
LGGIVLLFADRLAARPVHDQAMRFSPMMAFKIGVIQCLAMVPGVSRSGATIVGALMLGAS
RRAAAEFSFFLSMPTMAGAFAYDLYKNRTLLDASALSDIAVGFVMAFVAGVLVVKWLLNF
VSNHGFSLFGWWRIAIGSLALVTLLLGF
>A0A0B5S8D6|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNK
>A0A0F4V8I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
WEFRRKIIDVVTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHQYLFNPITVATALV
VGGIIMLWAEKRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVAAAVYSGYKYRHLFVPSDFPVFAIGFVTAFIFAMIAVKGLLKF
IASHSYAAFAWYRIAFGLVILATWQFGWVDWTAVKP
>ZP_02686031|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADYYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>YP_002387665|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFYLYASRPKKR
>C5URB4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFTYIFTGGKKGEVGFKFGINVLIGSIPAGVVGILYYSKIKTLFK
PQAVVVGFIVGGILLLVIENIFRKKRHSVKNIDRITPMQSIKVGLFQVLSMWPGMSRSAS
TIMGGWVAGLSTPIAAEFSFFLAIPAMIGSSAKDLFEFDFALMNATNWVALIVGFIVAFI
VSLIVMEGFVAYLKKKPMRVFAIYRVVAGIVFAILMYKGIVTPHL
>ZP_03283887|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKKQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAKELNVREGAVQSVMAAYLLTYGVSQ
LFYGPLSDRVGRRPVILVGMSIFMVATVIAISTSSLTVLIAASALQGVGTGVGGVMARTL
PRDMYQGTQLRHANSLLNMGILVSPLMAPLIGGLLDTLWSWRACYAFLLVLCVIVTFSMA
RWMPETRPVDAPRTKLLTSYKTLFGNGAFTCYLLMLIGGLAGIAVFEACSGVLLGAGLGL
SSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVISCLLAGLMMWIPGLFGVMTVW
TLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGALAWLSAMMPQT
GQSSLGLLMTLMGLLILLCWLPLASRVPHHEQPV
>A0A127SBT8|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_sm|antibiotic inactivation|1
MMMRCNKNVLSVVLLGALTLSAGSAFGQLSRADVDAVIRPLMSQYQIPGMAVALSVDGQH
TFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQFNELASHYLPSLKG
SAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQTWQPTSPIGSQRVYSNLGIGMLG
LITAQSLQKPFSEAMEQDLLTPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPLDA
EAYGLKSSSADLLRWLDLNMAISPLSPAWQHAIAESHKGYYQTGEFTQALMWEYYPWPTT
KEKLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILL
ANKWYPNDARIEVAYELIERLKK
>YP_371056|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDDRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDVARIKLDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIESGMNARAATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYARLADATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAIERIAHETLPRGVRFEWTDLTYQQILAGDSAMYVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGVPSQHVPASDA
>N9LL80|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>L0LWY4|FEATURES|UNIPROT_deepARG|beta_lactam|RTCIAT899_PC04360|antibiotic inactivation|1
MNIRTNSLQKLGIVAGCLFYGVGAHAADGNDQDRLERAVNEVVRPLMKENDVPGMAIALT
VKGKRYVFNYGVASKESGQKVTNDTIFELGSISKTFTATLGSYAQINGKLSFSDKATKYM
PELAGSGFDRISLLDLATYSAGGLPLQFPNGVTDQDKMVAYYRNWHPSFAPGAYRQYSNP
SIGLFGYLAAQAVGEPFDTLMQDKILPGLGLRHTYVRVPPAEMANYAYGYSKQGKPIRVN
GGVFDTQAYGIKTTSSDMLAFLEANMGEAKLDDKLQQAIDATHVGYYRVDNTTQALGWEI
YAYPTTLARLLAGNSSEMAFEPHKVTRLAPPQQPRKDVLLNKTGSTNGFGAYAAFIPAKQ
IGIVLLANRNFPIPARVAAAYKILTAVEDMQGSNAVQ
>K2QH39|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEDQSIISALVLGLIEGLTEFVPVSSTAHVLLAGHFLGFESPGNTFAVLIQLGAILAILS
VYFAKLLGIALSLPTSAESRRFVGAVLLGFLPAAVIGVVAHDFIKTVLFETPMLICVVLI
LGGFVLLWIDRLPLKPKYHDVTEYPLSLALKIGFCQCLAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFTLDLYKNRNALTVDDTMIIAIGFVAAFVSALFVVRGLLNF
ISKRGYAPFAWWRIAIGTLGILGLLLVG
>EAL17042|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNILLKLGVCVSLLGTTQFVSTISSVQASQKVEQKVMKNEAGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAALAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
GDNIVVWLPQYNILAGGCLVKSADAKDLGNVADAYVNEWSTSIENVLKRYRNINLVVPGH
GEVGDRGLLLHTLDLLK
>AAN41408|FEATURES|ARDB_deepARG|trimethoprim|dfrA5|antibiotic target replacement|1
MKVSLTAAKAKNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSAWTADNDNVIVFPSIEEAMYGLAELTDHVIVSGGGEIYRETLPMASTLHISTIDI
EPEGDVFFPNIPNTFEVVFEQHFSSNINYCYQIWQKG
>A0A0A8P3D2|FEATURES|UNIPROT_deepARG|beta_lactam|blaMIR-18|antibiotic inactivation|1
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWLIANMKPDSLEAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>D4E721|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRVELIKKVSVVIPVFNEQESLPALLARTDAACKQLSQPYEIILVDDGSNDDSAELLTA
AAEQPGSCVIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEQG
YDVVGTVRANRRDSWFRKSASRVINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEIQVTHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVVALSGFLLAVILIVMRLLLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGKQHDHNTQEEE
>W4E3T5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTEAIKAIILGIIEGLTEFLPVSSTGHLILAGDLLKFEGEAAVTFKIVIQLGAVMAVLLL
YWKKYVNIGINMLKLDFSKSKGLNAIHMLLAMVPALVVYLLFKDTIKSQLFGPKPVLIGL
IAGGLLMIFAARSRRSVTSETVDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLSTDTLTLMLIGFVTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAGLFYVIVIL
>A0A081P4A8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDWWVAVIIGIVEGLTEFLPVSSTGHMILTSTLLGIPDTDELIKTFEIVIQLGAILAGV
VVYWKRILRLFGLSKEKPKAGKGMNLLHIMLAIVPTLAIAYLTKGFIKAHLFSPSTVLIG
LILGGVLLIVGEKFQPEVTAHDVDELTYQQAFFIGLWQIISIWPGFSRSGSTIAGGMLAG
ASRKAAADFTFIIAIPVMVAATGYELLKNLDTFSSGDVGFFAIGFIVSFVVALLAVVTFI
KFVQKFSMSYFAYYRFAAAALFWIFVLR
>A0A0W0HJP0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPES
QRHSRAHDLLTRLGLAGHTTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKANDSVGLELPSEAP
IEPKRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVEALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSYAIGY
LFSLFVKEWEMVFSVGSIVTAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A083UJ51|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLAVCAAMLAAGQSLAQDHLESIVSDAVRPVMHAQGIAGMAVAVTVNGKQQYFNYGIASK
ETGKPVTQDTLFEIGSVSKTYTATLIAYAQATGKLALTDKASKVLPALRGSAFDHISVLQ
LATYTAGGLPLQFPAEADSADKMLGYYQQWKPVYPVGSQRLYSNPSIGLSGYLAAQAMGQ
PFDDAMENTLLPKLGLKHTWLKVPQEQMALYAQGYDKADKPVRVGPGALDAEAYGVKTSA
ADLIGFVQANLQPASLDTPLQQAIALTHTGYYSVGDMTQGLGWEMYRYPVTLDRLLAGNS
TAIAMQAHPVQWLKPPQSQPKDVLLNKTGSTGGFGAYVAYVPSKDMGIVILANKNYPNEE
RVRIAHQILSAMAL
>A0A0B4SDI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIITPEAANTFKVVIQLGS
ILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYL
FDVRTVAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSG
STIAGGVILGLNHRAAADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFV
VALFVVRFFLKLINKIKLVPFAIYRIILGVILFILFM
>V0Y3L9|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1608_01663|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTPAWQILNTLQ
>A0A0S2EAE6|FEATURES|UNIPROT_deepARG|beta_lactam|blaGES|antibiotic inactivation|1
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEQEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>R4WAP2|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMVELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFMKANISGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>A0A0F7FBH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLAIIKAIVLGLVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
ILAVVVIFRNRFIDLLGLKRFSKGSLEPVPDDQPQVETGGRLKLGQVIAGLIPAGLLGML
FEDYIDEYLFSTSTVLIGLVIGALFMICADLFAPKRARTQSVDQITYGQALAVGLIQCVS
LWPGFSRSGSTISGGVLLGLSHRAAADFTFIMAVPIMAGASLISLYKNWQYFTLDALPFF
IAGFISAFVFALLSMRFFLKLINRIKLLPFAIYRIVLAAVVYIIFF
>N9BQ39|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLFHVFILAVIQGLAELLPVSSSAHVILAEKMMGFDPSAPQMTFLLVMLHTGTMFAVIV
YFWRSWKRTYFSNWDDFKQRFFYVLIATAITGVLGLLLQALIKHVFFGGASNFEIEHLFS
NSKLMAAALAAAGVLIILSSRFDRGQQGDIGLSSAIVIGAVQALCLPFRGFSRSGATIST
ALFLGISRQKAEEFSFALAVVLTPAVIAKELLRLVHAQQASVGASHLAIGSLLLPSLFGM
VFSFLTGLLALKWLSAWLEHGRWYLFGIYCLVFSGVVLMLS
>R5X3M6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIEIIKAIILGIIEGITEWLPVSSTGHMILVDEFLQLNMSPAFKEMFFVVIQLGAIMA
VVVLYWKKIFPFSFKKKPFVQKSIIIMWIKVIIACLPAAVIGLLFDDKVNELFYNFQTVA
IMLILFGIFFIVVENYNKGKNPIANDMDQLTFKMAVIIGLFQVIAAVFPGTSRSGATILG
ALLIGVSREVATEFTFFLAIPVMFGASLLKLVKFGFVFTGFEMIILSVGSIVAFIVSILA
IKFLVGYIKKNDFKVFGWYRIILGIILLGYYFFLR
>F0RWI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAEMLKSLVLGIVQGITEWLPISSTGHLLLLDEVLHLRLGENAKELFMVIIQLASILAVV
VLYFSTLNPFSAKKSKQERSATYLLWVKVLIATIPAGIAGVLLDDFMDEHLYRWPVIAIA
LFSYGVLYLFLEKSSIGRAQKRVKNLSSLTHKDALFLGLFQMLALVPGTSRSGSTILGGI
IIGLERQVAAQFSFFMAIPIMAGASLLKLLKLGFSYTREEYILLIIGFVSSFLVSLVCIK
ALIAYVRKHDFSVFGLYRIVLAVVVSVYFLTIGA
>ZP_04309403|FEATURES|ARDB_deepARG|glycopeptide|vanRA|antibiotic target alteration|0
MSKSENLFCVTDCVYIQQYDFTWCNRYDRLVIQKRFQLKKKHIHRGGLVTMSDKVLIVED
EREIADLVELYLKNENYTVFKYYTAKEALECIDKNVLDLAILDIMLPDVSGLTICQKIRD
KHTYPIIMLTAKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKYNGVTAQN
ENVIVHSGLVINISTHECSLNEKPLSLTPTEFSILRILCENKGNVVSSEQLFHEIWGDEY
FSKSNNTITVHIRHLREKMNDTVDNPKYIKTVWGIGYKIEK
>A0A0B4UA24|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVIIYTTGSQATMDERNRQIAEIGASLIKHW
>J7LKU2|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKEMNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLIN
NFGETVLNIKLLAEQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCK
FCATGDIGLKKNLTVDEITDQVLYFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPN
LFALSPRRLSISTIGIIPSIKKITQEYPQVNLTFSLHSPYSEERSKLMPINDRYPIDEVM
NILDEHIRLTSRKVYIAYIMLPGVNDSLEHANEVVSLLKSRYKSGKLYHVNLIRYNPTIS
APEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIXAACGQLYGNYQNSQ
>CAF21854|FEATURES|ARDB_deepARG|multidrug|norA|antibiotic efflux|1
MKKQLFILYFNIFLIFLGIGLVIPVLPVYLKDLGLKGSDLGMLVAAFALSQMIISPFGGT
LADKLGKKLIICIGLIFFAVSESMLAAGRSFTILIISRVLSGFSAGMVMPGVTSVIANIS
PGADKAKNFGYMSAIINACFILGPGLGGFLSEISHRLPFYVAGTLSVGAFIMSVLLIHNP
HKATTDGFHQYQPELFTKINWKVFITPVILTLVLAFGLSAFETLFSLYTADKVNYTPKDI
SIAIIGGGVFGALFQVFFFDKFMKYMSELNFIAWSLLYSAIVLVMLVLANGYWTIMIISF
VVFIGFDMIRPALTNYFSNIAGKRQGFAGGLNSTFTSMGNFIGPLVAGALFDVNLEFPLY
MAIAVSLSGIIIIFIEKGLKSRRKEAN
>YP_002742650|FEATURES|ARDB_deepARG|quinolone|PmrA|antibiotic efflux|1
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSEQVAFYAGLAISVSAISA
ALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNA
TALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAI
LTICFIKEVFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVR
DLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANA
SSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGS
AVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>J8JHT5|FEATURES|UNIPROT_deepARG|beta_lactam|IIK_02331|antibiotic inactivation|1
MEQIYFSDCLLYVSKKSVKNLKGMMILKNKMLLKIGICVGILGLSITSLEAFTGGPLQVE
AKEKKGKIKHKNQATHKEFSQLEKKYDARLGVYAIDTGTNQTIAYRPNERFAFASTYKAL
AAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNI
LFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGN
ALPHQKHNILTDWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPI
IIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>A0A096CAA3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9302_06045|antibiotic inactivation|1
MTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGIS
LDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVA
QTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQS
FIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISY
TLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>A0A0D9LKI0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTNSSGTLTYRNT
DLSASLYGVGEQYFDVRGLKLESGRLFDEGDVKEDAQVVVIDQNTKEKLFGTDVNPLGKT
VLFNKRPLTVIGVMQKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVESTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNQFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>A0A014BUD3|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-10|antibiotic inactivation|1
MRFKKISYLLLPSLFIFNTSIYAGNISKDQEIKQLVDQNFKPLLEKYNVPGMAVGIIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLTLQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYINVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKDNIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0E2M3X8|FEATURES|UNIPROT_deepARG|aminoglycoside|L360_04877|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLASRADQ
LEEFVHYVKGEITKVVGK
>A0A080FIZ4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDSDALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAGGIGVMNIMLV
SVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWE
IGFSPLALLLAFLCSTATGILFGWLPARNAARLDPVDALARE
>D6AZL5|FEATURES|UNIPROT_deepARG|beta_lactam|SSHG_03556|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRILYTQDD
VEQADGAPETGKPQNLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSLGD
RVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLANTTS
GDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDDGLV
ADAARVLAETLG
>CAJ00301|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYS
STYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>J1H864|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVVEILKAVFLGIVEGITEWLPISSTGHLILVDQFLKLNASAEFKELFFVVIQLGAILA
VIVFYWKKLWPFSNEGRLHIESDTISLWMKIIAACIPAAVIGLLFDDPINALFYNYQTVS
FTLVLYGILFIVIENRHRDSSAKIRDVSQMNYKTAFLIGLFQVLALIPGTSRSGATIIGA
MLLGTSRVAATEFTFYLAIPVMFGASLLKMVKYGLPATSLEMAVLLVGTLVAFLVSLLAI
RFLTVYIKRHDFKVFGWYRIVLGILVILTFVFR
>A0A0Q5RC35|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLIIVLLGIVEGVTEFLPVSSTGHLILAGALLGLPQADATFDIVIQLGAILAVVVLFW
GRFMKVRRGLLARDAAAIRFTRNVLLGFLPSAVVGAIAYKAIKAVLEAPTIGPMVVAIAL
IVGGVLILIIERMSKRIVTRSVEDMPWRTALTIGVVQCLSMIPGVSRSGATIMGALTLGV
DRETAAEYSFFLAIPTMMGATALALFKSRHELGDAHLTAIAIGFVVSFLVALAVIRWFVA
FVARHGFAPFAWYRIGAGVIALIALNYR
>M1LRD4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLDSSLYFIQTAILGIIEGISEFMPISSTAHLIFFGNLMGFTSEKSRIFEVFIQSGAVL
ALVIFFRRKLSNLFFGVVNFDKTQLLLFRNLIVSILPSIIVGFFFVKTIKQIFDYYIIIS
MSLILGGFILLIVEYKYNNFKERRNLNEISFTQALFIGLLQCLAMIPGVSRSGATIVAGI
VVGLDRRSATEFSFMMAIPTMLGAAIYDLYSNFKVLSNNDILGISIGFLCAFFSAILVIE
CVMNFISNNTYKIFALYRIFFGGVMFLLYFNWH
>A0A0T2Q827|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLTLTAILLGIVEGLTEFIPVSSTGHLILASELLGYDAAEWAQFNVIIQLGAILAVVVQ
YWRTFWDAGIGVLKLEAHGLRFARNILVAFLPSALLGLALKDYIDILLGSPSVVGWALIL
GGLAILGIERVAKPGPDTSVADLPLKQVFGVGLAQCVSMIPGVSRSGATIMGALAMGINR
KTAAEFSFFLAVPTMIGASTLELLDSGLAVHGNVGWDEIAIGFVVSFVVALAVIKAFVAY
VSRYGFAPFAWYRIVAGVVAIVWLWSR
>A0A0L8PRE3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MAMSEIPVADEDAGPYGITTGPDGALWLTFVHSGRIARLTPDGELDTFPLESAECGPTVI
APGPDGALWFTRFRDHRIGRITTAGETESFPLPTPDSGPFGITAGPDGAMWFTEMNTDRI
GRITGTGEITEYALPRTGSYPSAITAGPDSALWFTLNQANAIGRITVHGDIAVHPLPTPG
AAPVGIASDGVALWFVEIAAGQIGRISVDGAIEEFPLPDRTAKPHAIVAAAPGDCWFTEW
GANSIGHITRSGQITEYGLPSPSSEPHGITVGPDAAVWAALETGAVARLAR
>YP_001570088|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVIVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPNDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLSGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTASQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
VMRKILDHLFDPQADTTQPGQAP
>J9C1S8|FEATURES|UNIPROT_deepARG|beta_lactam|IG3_02100|antibiotic inactivation|1
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>A0A0L8AF53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGLNQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSENWADVGVAFLAAAVTGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>A0A0M3GNY5|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPENRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAAGEDWTALAIAFIVSTIVAFIAVKWLLAYIRSNR
FTLFAIYRIILGVLLLGMATSGLIA
>A0A062IIM3|FEATURES|UNIPROT_deepARG|aminoglycoside|J635_4357|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RGVACPEGINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>F3KPS9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDALLLLKAALMGIVEGLTEFLPISSTGHLILAGSLLGFHDEKAKVFDIAIQTGAIFAVI
LVYWQKIRATLVELPTQARARRFALNVLIAFFPAVLLGLLAGKAIQAHLFTPEVVATTFI
VGGFIILWAERRQARLAAQPLARGAHAPLVQDVDDMRWQDALKVGLVQCLAMVPGTSRSG
ATIIGGMLLGLSRKAATDFSFYLAMPTLIGAGAYSLYKERALLSLADLPMFGVGLLFSFI
SAWLCVRWLLRFIATHSFVGFAWYRIVFGLIVLGTAWSGLVEWRAA
>ACO79044|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MELWLAAQAFILGVVEGLTEFLPISSTGHQIIIADLIGFGGDRAKAFNIIIQLGAILAVV
WEFREKVFGVILGLPREPQAQRFTVNLLIAFLPAVVLGVAFADLIEHWLFNPITVASALV
VGGLVMLWAERRQHVIEVHAVDEMNWRHALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAAYSGYKHRALFENGGDLPVFALGFVVSFIFAMLAVRGLLR
FIASHSYALFAWYRIGFGLLILLTWQLGVVDWSTAQG
>A7GA76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIDIIFILKSIIIAVVEGLTEFIPVSSTGHMILIGSAINFNGDFAKMFEVVIQLGAILA
VVVRYWEKIKESIVEFFKFIFTKGKEGKTGFKFGVNVIVGSIPIGITGLLFYHKIKSLFR
PEAVIIGFIVGGILLLIIENIFRKKEHAVQDIDSINFTQALKVGLLQILSVWPGMSRSAS
TIMGGWTAGISTPIAAEFSFFLAIPAMIGTSLKDLFEFDYSIMTPTLWSALILGFIVAFI
VSIIVMNKFVSYLKKKPMKVFAIYRVLAGLLLAVLVFTKIIVLTV
>A0A0Y6HB47|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIDFHSNHKVFEIAIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIVDVDALRPIDALMIGVAQVFALVPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>A0A0A8TFH8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFELFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
WLYRQKIIELVRGFFSGDVHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFAL
IIGGLIIFAVEARKFEPKTIEATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGL
SRKAATEFSFFLAMPTMLGAATYDLIRNADVLTSDNLMNISVGFVAAFIAAILVVKALVK
FVEKHTLRVFAWYRVVLGIILLIVFL
>YP_001572039|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRILQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELAAEK
>A0A0B2DAR9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALLLGIVEGLTEFLPISSTGHQIIVADLIGFGGERARAFNIIIQLGAILAVV
WEYRRKILDVVVGLPRQRSAQSFTFNLLLAFLPAAVIGVIFSDLIHEFLFNPITVAAALV
VGGVVMLWAERRPHAVQAETVDDMRWSQALKVGCAQCLALIPGTSRSASTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFALGFVVSFIFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFGWIDWSTAQG
>A0A0C5VS36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPLHEGKTQGHLTLGHIILAMIPAVVMGLVFHDAIKTLFAPRT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSVADLPMFAVGFVTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYVVFL
>ZP_04271500|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLIQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKGAAAYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>W8U2Y4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSESEEIKKVSIVIPVYNEQESLPALIERTSAACKLLSQSYEIILVDDGSSDNSAEMLTA
AANAPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAQEG
YDVVGTVRANRQDSMFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVGAEPSENNQEVEK
>V4NI11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLIAVLLGVVEGLTEFLPVSSTGHLLLLSHFLKFETTGKTFEVLIQLGAVLALLTLYF
QRLWDVVVTLPTEPRSRGFVISVLVAFLPAMVLGVLLHDFIKTVLFESPRLICFSLIVGG
IALWAVDKWAPKPQHDDAMALDWKTALTIGLFQCLAMIPGMSRSGSTLIGAMLCKVDKKA
SAEFSFFLAMPTMAGAFAYDVFKTYKQMDFSDVWLIGLGFMSAFVTAVLVVKALLAYVSR
HGYGVFAIWRICVGVLGLVLLQMGF
>A0A0A0TTZ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILNLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVILGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSPDMIPFFLVGFICAFVV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>T0QQF8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEKATTRSLLVLSTLLLSPLSHAKEAEPLTAVVDGAIQPLLKEHRVPGMAVAVLKEGKAH
YFNYGVADRESGARVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGVSMAELATYSAGGLPLQFPDGVDSTDKMHAYYRQWTPAYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVSPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAAVTSAIALTHTGFHSVGGMTQGLGWESYAYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPNEARIKAAHAILEALAAE
>A0A099UAD2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFINAVTLGIIEGLTEFLPISSTGHLILTSKLLGIPEDSFHRVFEIVIQLGSILAVVFV
FWEKLYKNSLDLWLKLIIGFLPVGILGFLFYNVIKSLFNPLIVAIMLIIGGIVFIVVEIF
YKEKDHYIQAIWQISYKQALWIGCFQALALIPGTSRSGATIIGGLLLGCNRRVATEFSFL
LALPAMMAASGYSLYKNYELLNKDNLLLLLIGFVVAFFAALIAVKLFLGFIARFNFIPFG
IYRILLGVACLFYLDIF
>C4SA85|FEATURES|UNIPROT_deepARG|aminoglycoside|ymoll0001_20050|antibiotic inactivation|1
MEIKKLSSANINLWIALREQLWPHHPENKTDGENIILSDGLASFIAIDNLGQGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPSSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRKASLS
>A0A0D6B6M1|FEATURES|UNIPROT_deepARG|beta_lactam|NHU_03651|antibiotic inactivation|1
MRFPASVLSRVAAGLSLGLCLASASLAQTPLETLADTVERVESRLGARVGVSLVDTGSGL
SWTHRENERFLMNSTMKVPLCGAVLARRDAGDLSLQAELPVRKSDLLAYAPVTEKRAGGE
MTIAELCLAAIDMSDNTAANLLIAHLGGPQAVTRFFRSAGDTISRLDRNEPELNTFNAAD
LRDNTTPAAMTETLRGLLLGDILSRSSRGQLAEWMSHGGVTGNLLRAEAPEGWVILDKSG
SGTHTRNLVALVTPVDGSPWIVTIFVSDVDADSQTRNRALQDVGRAAMAVMRD
>A0A093VF45|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLHSLLTAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGEVAHEGHTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYALVVGGFLLLAAEWLKPKKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFIVALIA
IKTFLKIIKRISFVPFAIYRFIVAGVVYMVFM
>ZP_04103077|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSAQASQKVEQIVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGITALKERGIKAHSTALTAELAKNSGYEEPLGDLQTITSLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>ZP_03837591|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDTPGEKAFFGSVSRLAASAGIPVYAPD
DVNHPLWIERISQLAPDVIFSFYYRHLLSEEILSLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIIAQQRVAISPDDVALTLHHKLCQAARQLLEQALPAI
KTEDYAERPQQEADATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCTNDLAAQPGTVISVAPLLIACIDGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTSKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAIGRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPDNEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RNVESSTYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>G5K942|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFEILKAIFFGIIEGITEWLPISSTGHLILVEEFVKLRENAAFLEMFNVVIQLGAIIA
VVVIYFKRLNPFQPGKSATEIRLTWQLWLKVVIAILPVVIIGMPLDNWFNKHFYNFITVA
LMLIIYGIAFIWIEKRHKTVEPQVTSLARMSYKTALFIGLFQVLSIIPGTSRSGATILGG
ILMGTSRTVATEFTFFLGIPVMFGASLLKVVKFFLKGNVLGFGQLLILLVASLTAFVVSL
YVIKFLTDYVKKHDFTVFGKYRIILGSLLIVYFFVSLFI
>B8XTS1|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC80-8652)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIAPAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>C5AA98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFNADQAKTFDVVIQFGAILAVC
WEYRRRIGTVVAGLPSRPEARRFALNVVIATLPAVVLALLLEKAIKRALFSPVPVAFALV
AGGAVILWAEARQRERRAPARVISIDALTPLDALKVGLAQCCALIPGVSRSGATIIGGML
AGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFSADSVGLFAIGLAAAFVSAFACVRW
LLRYVASHDFTVFAWYRIVFGLVVLLVGYSGWLNWN
>A0A0Q5M169|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFESAGKTFEIVIQLGALLAIVSVY
FKKLWILATRWPFDAEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPQVVCIALIVG
GVILLLLDRMDKTPKWLDAEAYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKR
SAAEFSFFLALPTMGAAVAYDLLKNHKTLDFSDIGLIVVGFVVAFISALAVVRFLLDFVS
KRGFGIFAWWRIVVGVVGLALLQAGF
>V5R1F4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKATRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDNVTL
LNLATHTAGTPLFVPDAVKNTTQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPEAAMDNYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPGWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYTIIQELDK
>A0A127SJC1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGVFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A140NM13|FEATURES|UNIPROT_deepARG|beta_lactam|S70_09140|antibiotic inactivation|1
MKNIFRQRRLFIALSLAMTSISAFALTQQEVDDIIKPLMKQEQIPGMSVAISVNGKQAIY
HYGVQSKQTQIPVSDRTLYEIGSLSKTFTATLATYAQIQGKLDFSQSVSHYLPELKGSAF
DNVSVMNLATHTSGLSLFVPSDIKTNDQLMAYYQKWLPDNEVGQYRSYSNLGVGLLGIVT
AKQLNMPFSQAMEKLMLPSLGLKHTYIHVPKSQEKYYAQGYNKQNQPVRLNLAILGPEAY
GLKSNAKDLIRYLEINMQSIKVAKTWQEAIENTHTGVYLTDSFVQDMMWESYPWPVSLSQ
LLQGNRDDMALKPQKVELIKPAMAPEVRAYYNKTGSSNGFATYAIFIPEEKIAIVMLSNK
WIPIPQRITATYQLLEKIER
>W2E0F9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPQLSLSGVRNFGALALFLATGHCLAADDLRAEVDASVKPLMQQQSIPGLVVGVIKDGKA
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRG
GKFDHISVLNLGTYTAGGLPLQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQLMEKTLLPKMGLKHTFITVPKSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSASDLLHYVEVNMRPATLDPVLQQAITTTHTGYYTVERMTQGLGWEMYPYPI
KLDALVDGNSTKMAMEPHPVNWLTPAQAPHADTLVNKTGSTNGFGAYVAYVPSKEMGVVI
LANKNYPNGERVKVAHAILSALDH
>Q0AAG2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MALWIAALLGVIQGIFMFLPVSSTAHMVLTEHWLIARGETLPPPESAEMILFALVVHVGT
LVSIAVVFWPSLWRFSLNALGGAWEWAGRGGRGGLPLYWRLFWLGMFSVLCTGVLGLTLK
ATFEHVFASPLMIAGTLTLTGILLWWTDRLAPRRRGLKGINLKVAGVIGLAQGFALMPGL
SRSAMTIVFALFTGLKRRWAAEYSFFLAIPTICAATLLQAIEVYRLGLPNTVGFSALAVG
FVVAAIVGIISLKLVIYFLYRARLKVFSFYVWALALGIATGLIDLAPALG
>A0A0C5XNF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRKEPTSWRFLRNLLVAFIPAAVIGLALHNHIEELLGAPRVVAWALI
VGGVAILAIERMVKENRFHGIADIPFVRVVGIGFIQCLAMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASALELLKNGDKITSGAVGWDSIALGFVVSFIVAVLVIKWFV
GLVSRHGFAPFAWYRIVAGIAALLWLSMR
>A0A090GHZ2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFGKLWQMLIKLPSDPQTRHFVIGILIAFLPAAVIGAVGHDFIKNYLFESPKLICSMLI
IGGVVLLVVDRINFKPVHHDVERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIISVGFIAAFVAALMVVRFLLDY
VSRKGYALFGWWRLVVGIVGLAGLMVWG
>ABS72056|FEATURES|ARDB_deepARG|glycopeptide|VanYD|antibiotic target alteration|0
MMEYQNNNGNYDKRNRRKAKKRKLLFYRAACVTLCLLIVSVIFGVVHFLGESKDPGLLSK
ENTKTDKNYSWLTDDQNEAVPSVPEPAISDQANKISVNIAAANAIVMNKDTNEVLYQKKS
TAKIAPASTAKMIMALTALDYCSPEDEMKVGAEIEMIQSDSSTAWLMKGDTLTVRQLLIA
LMLPSGNDAAYTLAVNTGKKIAGDKSLTHQQAIEVFMDKVNEKAVNLGATNSKFVAPDGY
DAEGQYTTAYDLAIIAKACLDNPIISEIVASYSSYEKWPNGREVTYSNSNELLDPNSPYY
RPEVIGLKTGTSSLGGACIVSAAVIDGETYICVVMGSTKESRFQDSVDILDKIKAQ
>A0A0F0DSS5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRHKIIDVIKGLPNDPRQQRFAINVIVATIPAITLALIFGKAIKAHLFNPIVVASAFI
LGGFVILWAEWRERHRGETHDPRANALLEAAKAGAPRIETLDDLRISDAIKVGFAQCFAL
IPGTSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKSRALLSADDLSIFA
VGFVAAFISAFFCVRWLLKFIATHDFRGFAWYRIIFGVIVLVTAYTHLIAWQA
>J8FAW8|FEATURES|UNIPROT_deepARG|beta_lactam|II5_02520|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDTRVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALLAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEAT
EVIVKALR
>A0A009SFJ7|FEATURES|UNIPROT_deepARG|beta_lactam|J529_1700|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNN
KKYEMYYGLQSVQDKKALNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQCRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>YP_001350570|FEATURES|ARDB_deepARG|multidrug|OprJ|antibiotic efflux|0
MRKPAFGVSALLIALALGGCTMAPTYERPVAPVADRWSGPAAQRQGVAVDQLDWKGFIVD
AELRRLVSVALDNNRSLRQALLDIEQARAQYRIQRADRVPGLDASASGSRQRQPADLSAG
NRSAVASSYQVGLALPEYELDLFGRVKSLSDAALQQYLASEEAARAARIALVAEVSQAYL
SYDGAQRRLALTRQTLASRESSLALIGQRRAAGTATALDYQEALGLVEQARAERERNLRQ
KRQAFNALVLLLGSADAAQTIPRAPGEQPKLLQDIAPGTPSGLIERRPDILAAEHRLRAR
NADIGAARAAFFPRISLTGNFGTSSAEMSGLFDGGSRSWSFLPTLTLPIFDGGRNRANLS
LAEARKDSALAAYEGAIQGAFREVADALAASDTLRREEKALRALADTSNEALKLARARYE
SGVDSHLRYLDAQRRSFFDESAFIDGSTQRQIALVDLFRALGGGWGQARVALAQR
>AAB17875|FEATURES|ARDB_deepARG|thiostrepton|tsnr|antibiotic target alteration|0
MTEPAIITNASDPAVQRIIDVTKHSRASIKTTLIEDTEPLMECIRAGVQFIEVYGSSGTP
LDPALLDLCRQREIPVRLIDVSIVNQLFKAERKAKVFGIARVPRPARLADIAERGGDVVV
LDGVKIVGNIGAIVRTSLALGAAGIVLVDSDLATIADRRLLRASRGYVFSLPVVLADREE
AVSFLRDNDIALMVLDTDGDLGVKDLGDRADRMALVFGSEKGGPSGLFQEASAGTVSIPM
LSSTESLNVSVSVGIALHERSARNFAVRRAAAQA
>A0A0J6NMP9|FEATURES|UNIPROT_deepARG|chloramphenicol|VK91_10900|antibiotic inactivation|1
MKFNKIDINNWERKEIFNHFLNQQTSFSITRNIDITELYKITKDKGYKFYPVFIFLITHV
ANSNKHFRMNFNSAGEFGYWDKVVPMYTIFDKTSELFSAIYTNTDEGFKKFYENYISDTE
KYNGTGKLFPKTPIPENVVNISMIPWTSFTGFNLNVNNSPNYCLPIITAGRFINKTSNIY
LPLSLQVHHSVCDGYHAALFMDRFQTLLENKLEFLI
>A9QKP6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTVLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRAD
QLEEFVHYVKGEITKVVGK
>JQ1201|FEATURES|ARDB_deepARG|chloramphenicol|cmlA1|antibiotic efflux|1
MSSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKSLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>A0A0N0LXR7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLTLTAILLGIVEGLTEFLPVSSTGHLILATQLFGYDASQWATFNIVIQLGAILAVIVQ
FWRTFWAVGVGLLRLDPVSIRFVRNVLLAFIPSAVLGLILKDHIEGLLGEPSVVAWALIV
GGIAILAIEKVAKPGPLTGVAELPMVKCIGVGIAQCLAMVPGVSRSGATIMGALAMGVER
RTAAEFSFFLAVPTMMGASTLELLGAREQLMAGTGPVGWGEIGIGFAVSFVVALVVIKAF
MAFVSRSGFAPFAWYRIVAGALALFLLSRV
>A0A0Q9V2L7|FEATURES|UNIPROT_deepARG|chloramphenicol|ASG97_23120|antibiotic inactivation|1
MKFNIIDRENWVRKEYFEHYLQQQTTFSITNEMNITVLMENLKKKNYKLYPAFIFMVTKI
VNSHREFRTSFNKEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNESRFSEFHSQYEKDVE
EYNGTGGLFPKTPIPDNHIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYTQIKDEWF
LPVSLQIHHAVCDGYHASVFMNDLQRFADESADWL
>A0A127SHK9|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITSSCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKAGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0U1YUH4|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHVFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A126QPG1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAPWYVAIILGIVEGLTEFLPVSSTGHLIITGYLLDFTGPKAETFEIVIQLGAILAVVAL
YWDRFIGLLATDPERKFSGVYGLWLLFLTSLPASVVGLLAHGYIKEHLFSPGTVAVALAV
GAVLIFVVEGMNKRIEMESLDEITPKLALGIGLFQCLALWPGFSRSASTIMGGMLLGAGR
TVAAEYSFIAAVPIMFAATGYDFLKNYELFEHGDMLFLLLGFLVSFIAAWIAVKGFIILL
GRLTLRPFAVYRLGLAVLILLFL
>A0A158M5D7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDSTLYLLKAFFLGIIEGLTEFIPVSSTGHLILFGDWIQFESGSGKVFEVVIQLGSILA
VMWIFRARLWQLVRGTLCGERQELLFTRNLLLAFLPAAVIGAIFIKSIKQTFYHPGVVAV
TLVLGGLIMLWVEWRAPKTPGDAPGAADDTASDERATARRLEDISWKQALGVGVAQCLAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNMDVLTSHDLSGIA
VGFVAAFLSALVVVRAVLRFVANHTYRGFAWYRIALGIVVAIWLLSK
>A0A0Q9VJE3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRIKIEEFELPQIDSGPYGITRGKDGALWFTQHKANQIGRMTVDGKVTHIDLPTVNAGVL
SITSTDQGDIWFTENRANKIGKLTVTGEITEYTLPNSDSGPFGITQGHNGDIWFTEMNGN
RIGRILSSGEIIEYSLPVPDSYPSFIVAGSDYALWFTQNQSNQIGRITIGGEVTTYKLPT
KQAGPVGITNGPDGALWFVEINGNKIGRITTSGTISEFTIPTPNARPHAIVTGPDRALWF
TEWGSNQIGRITINGEIMEYPIPTKNAEPHGXVVGPDKALWFAEECNKLGRLSFV
>A0A0S3MY07|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLDKEYEILLIDDGSSDNSAQMLVD
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKEMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKEIK
>A0A0H5GRY1|FEATURES|UNIPROT_deepARG|beta_lactam|blaA|antibiotic inactivation|1
MKHSSLRRSLLLAGITLPLVSFALPAWANALPASVDKQLAELERNANGRLGVAMINTGNG
TKILYRAAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTARPN
DPRDTTTPAAMAASMNKMAERKYHWGCHNSCGCPY
>A0A0V8CXI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLLLNDWLDKHFYHFV
PVAFMLIIYGGAFIVIECRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLIGVSREVAAEFTFFLGIPVMFGASFVKILGFIKGGNSLSFEQFGILLVACIVAF
GVSMGTIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFKAFLG
>A0A0J1KC59|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSNIRRSYPSGEGQVEVLKDVSLRIQAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQ
RLARAQELLQRLGLGDRVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDSQVAAQAERVIEIRDGEIVRNPPPQKPTAGRDIDEPT
VTTASGWSQFVSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLVAIQKQPWVSSVTPAVSKNLRLRY
GNIDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDSNTRRQLFPSKAKVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAQAEQQLTRLLSLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQL
FLPGWEIGFSPVALLTAFLCSTATGILFGWLPARNAARLDPVDALARE
>A0A0M1I997|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSTYLHRIASFTFTGCMAGLISCTAVAQPLSAQQVQHQIDQHFQPLIDQYQIPGMSVAV
TMHGRHYYRHYGVASVQTQQAVSEQTLFELGSVSKLFTATLTGYAQAQGNLKLSDHPAQY
FPELKQSAVNQATLLNLGTYTAGGFPLQFPEQVTSQSDMVKYFQQWQPKAAPDRIREYSN
PSIGLMGELTARAMKAPYTTLMERNLLVALGMRHTYIQVPTAQMPHYAWGYKAKQAIRVS
PGMFDAQAYGLKSTSADMLKFLDAELNPQRLKPALQQAVESTQIAYFKVGPMQQGLGWEQ
YAYPVALDTLLAGNSTQMALNAQPAQPIAHPVKAPAQTWLNKTGATNGFAAYVVFIPSEQ
IGLVMLANRNFPNEARIRAAYATLTQLIQSNHNK
>AAD42183|FEATURES|ARDB_deepARG|glycopeptide|VanHD|antibiotic target alteration|1
MEKIIDITVFGCEPDEMEVFQKISYELGVTATLIKDSISESNAGLANGCRCVSVSHKAEL
SEPILLALKNAGVKYISTRSIGFNHIDIQAAGLLGMVVGTVEYSPGSVADYTVMLMLMLM
RGTKSILRETQRQNYCLNDLRGKELRDMTVGVLGTGRIGQAVMERLEGFGCKVLAYDRNQ
KAGADYVSFHELLKKSDIVTLHIPLAEDTRHMIGYEELEMMKEEALLINTGRGALVDTAA
LVEALKGQKIGGALDVLEGEEGIFYHDCTQRRIEHPFLSVLQGMPNVIVTPHTAYHTERV
LVDTVRNTIRNCLNFERSLGNV
>A0A0M2N9P5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|XK97_10945|antibiotic efflux|1
MNPIIELRHVYREFVAGNQTHVVLNDITLTIAQGEMVAIIGASGSGKSTLMNIIGCLDKS
TRGEVLINGISVNETDSDRLAELRSCYLGFIFQRYHLMPYLTAEENIAIPALYTAMPESE
RKARIQMLGQKLGLKSRLGYRPAQLSGGQQQRVSICRALINGAQVILADEPTGALDSVSG
KALMGVLHQLHADGHTVIIVTHDHGVAKQAQRIVEISDGRIIADEINQSCPEERLAQHIP
VVRDNGRASLWRSIHESMRMAWRSLLGHRMRTFLSMLGIIIGISSVVSSMAVGEGARQTI
MNEIGKLGNTTLEIRSGTGWGSKRPDMERALSLNDVASLQKQPWAEGVSPQVSSMATAVR
KGYDSSMMLSGVSQDFFALQGIRFIQGNGFTARDVAEGEPVLVLDETSRDTLFQDGEDPL
GQIVQIAGASWRVVGVAVKPGPKVVGGFMSGWLPYTSLQQRISGDKPLEAIVLRFQESLT
PQDAMQTVEHLLTREHGKKDFFSQTDDQLTKAMQKTSDSMSLLITAIAAISLLVGGVGVM
NIMLVSVTERTHEIGIRLSVGARPSDIMHQFLIEAVMICTLGGLVGVGGSWIAAQIFALI
TDEFSMAFTWLPVAIACAFSALIGLTFGYFPARSAAKLNPTEALARE
>T2D0V9|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
KPLLEKYNVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAY
AKNTGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFK
DWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEKTIFPDFGLKHSYVNVPKTQM
QNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETH
QGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
NGFGTYAVFIPKENIGLVI
>J2DCS5|FEATURES|UNIPROT_deepARG|beta_lactam|PMI03_00629|antibiotic inactivation|1
MRNLFLPTFGMIAVASLFHGSSACAADGGEQARLERAVNDAIRPVMKENDIPGMAVAVTV
NGKRYVFNYGVASRENGQKVTEDTIFELGSISKTFTATLASYAQLRGTLSFSDKASKYLP
ALAGSSFDTISLLDLGTYTAGGLPLQFPDDVTGQDKMIGYYRSWKPAYAPGTRRLYSNPS
IGLFGYLAAASMGESFDDLMEQKIFPGLGLTHTYIRVPQDQMGNYAYGYSKSNKPIRVGP
GALDSEAYGVKTTAADMIHFLEVNMDSSKQDETLQSAIATTHTGYYRIGDMTQGLGWEMY
AYPTSLERLQAGNSNEMSRNPNKANKLVPPQPPRRDVLINKTGSTNGFGAYVAFVPAKGI
GIVMLANRNYPIPARVKAAYRILTALDKESGMR
>A0A0U7CJ84|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS381446_03540|antibiotic inactivation|1
MIVNCDHDNLDAWLALRTALWPSSSPEDHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>NP_706356|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAQLTVNRYQKLLGTQYISKQGYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPI
SGRIGKSNVTEGALVQNGQATVLATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENG
KAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
LNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVV
ISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>A0A0R3ACX7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMLAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPES
QRHSRARELLQRLGLASHVTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAVGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKVNDSVGPLLPGEAP
IEPRRSGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIQTLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDVDAQVNGVSDRYFKVKSLKLEAGIAFSESDARRQAQVVVIDHNTRQRLFGPN
IDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGIIGISLSYAIGY
LFSLFVKEWEMVFSVGSIITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>ACA23187|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDELLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFQKVM
>A0A117I0P0|FEATURES|UNIPROT_deepARG|chloramphenicol|PAHA3_0954|antibiotic inactivation|1
MFNPIELDQWDRKPYFDHYLNQVRCTYSITANVDITLLIAELKLKGMKFYPTLIHMISKV
VNTHREFRTCFDAEGRLGYWDVMSPSYTIFHEDDKSFSTIWTAFHEDCQTFHSRYMEDMK
NYKDLKQFVAKPNEPPNTFPVSSIPWVSFTGFNLNIYNEGTYLLPIFTMGKYVQQNDRVY
LPLSVQLHHAVCDGYHAGVLFNELQSLADRCHEWC
>A0A095ZMY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAWFNVFILGIVEGITEFLPVSSTGHLILFHRWFQLSPENFQNAFDVCIQLGAILAVVVL
YFRKLNPLASVDQNGQAMTPKKRRKIVELWAKVLVGVLPAMVLGLLFDDLIDKYLFSEKV
VAVTLVLWGIVIILMEKRVRPAKFQSLEEVPYSYALGIGFFQCLAMIPGTSRSAATIIGA
MTLGLKRVDAAEFSFFLAIPTMLGATLLKVVKNVHGFDPSQWIMILFGGLVSFITAYLVI
RVFMNFIKKHDFVPFGIYRIIVGILVFILFL
>K9NFK1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MDRLKTIAAGMAIFAAGHCVAQDQIETLVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
GVASQETGSPVTKDTLFEIGSVSKTFTATLAAYAQTSGKLSLSDKASQVLPALRGSAFDN
ISVLQLGTYSAGGLPLQFPAEYDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAA
HSMGQPFDDLMEKTLLPKLGLKHTYVHVPQDQMALYAQGYNKDGKPVRVTPGALDSEAYG
VKTSAADLLAYVDANMKPAPLEKPLQQAIALTHSAYYSVGDMTQGLGWEMYRYPITLDRL
LDGNSTPMAMQAHKVQWLNPPQAQPQNVLINKTGSTGGFGAYVMYVPSKEIGIVMLANKN
FPNAQRVRIAHQILSALAR
>E1YL33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIKEVLMDLLLLFKALVMGIVEGVTEFLPISSTGHLIITGDILDFLQKEQRDVFEIVIQL
GAIVAVCWEYRYKLIHLLAGLGRDRHARRFACNIIVAFIPAAVLGLLFGKNIKAYLFFPE
PVAIAFIVGGLIIMWAERRKHSIQVHEMYDMSLKDALKVGLAQCFALIPGVSRSGSTIIG
GLLSGLSRKATTEFSFMLAIPTLTAAALYDLYRHREMLNANMTGLVAVGFIMSFISALLA
VRGLLRYISRHDFSAFAWYRIAFGAIVLVTAYWGVVNWSR
>C5BDQ6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVQSLIDAGYEIAAIVTHQDAPGENLFFGSVARLAAQHNIPVFAPD
DVNHPLWVERLRALQPQVIFSFYYRHLLNDEILALAPQGAFNLHGSLLPAYRGRAPLNWV
LVNGETESGVTLHRMEKRADAGNIIAQHRIAIAEEDTALTLHHKLCQCARVLLAEALPQI
RSGSYAEFPQDESAATYVGRRTPADGRLEWSKPARELYNLVRAVTEPWPGAFSYAGNRQF
TVWQARVRRDLPAARPGTVLLASPLTIACGEGALEIVAGQPQDGLYMQGSQLAESLGLVE
GAILNSSLNFGARRATRVLILGVNGFIGNHLTERLLAEDNYEIYGLDIGSDAISRFIGHP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYKKRIIFPSTSEVYGMCSDPQFDEDSSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAK
DELRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KEGVEALFRIIENKDNLCDGQIINIGNPDNEASIRELAEQLLVCFEQHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAQRLLGWQPVIPMESTIEDTLDFFLQTFDGTEQE
>J0M616|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGEEQVEVLKGISLTIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGSYKVAGVDVSGLDNDALATLRREHFGFIFQRYHLLSHLNASQNVEVPAVYAGTTRAQ
RQRRAHELLGRLGLKERVEYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLRERGHTVIIVTHDPAVAAQAQRIIEIRDGEIISNPPPVHQPAARMVENQT
LRSGSSIQQVISSFREALGMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LEDIRSIGTNTIDVYPGKDFGDDNPQFQQALKYDDLLAIGQQPWVSSATPSISSNLRLRY
GNVDAAASVNGVSGDYFDVYGMTMSQGASFNDEQMKGRAQVVVLDANSKRQLFPNKSDVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKVLRVWLPYNTMAGRVMGQSWLNSITVRVKEGY
DSHEAEQQLNRLLSLRHGKKDFFTYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLVIAFTLQL
VLPGWQIGFSPVALLTAFGCSTATGVLFGWLPARNAARLNPIDALARE
>A0A0B5Z9A3|FEATURES|UNIPROT_deepARG|beta_lactam|penPC|antibiotic inactivation|1
MKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKEFSKLEQKF
DARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLV
DYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGFEKALRKMGDRVTMSD
RFETELNEAIPGDIRDTSTAKAIARNLKDFTIGNALPHQKRNILTDWMKGNATGDKLIRA
GVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEV
VIDAIK
>A0A0E2M4N3|FEATURES|UNIPROT_deepARG|aminoglycoside|L360_04906|antibiotic inactivation|1
MLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASA
FPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILL
TKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWY
SAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKG
RDHQVSW
>U2NM87|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVPHEGQTAGQLKLGHILLAMIPAVALGLLLHDMIKSLFEP
KNVMYALVVGGLLLLAAEWLKPKKPSAVGLDDITYRQAFLIGCFQCLALWPGFSRSGSTI
SGGMLVGVSRFAASEFSFILAVPMMIGASGLDLYKSLHFLTLSDLPMFAVGFATAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAAAVYMVFIH
>A0A143GHL7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHCVSIVIPVYNEQESLPELLRRTMAACKQLAYEYEIILVDDGSRDNSAQLLEDA
AALEGSNVVAVILNRNYGQHAAIMAGFEHCRGDVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVHHAEREHGESKYSPMRLISLMFDLLTCMTTTPLRLLSIVGF
SMAALGMLFAFALIILRLAFGAGWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAETFTVDGLTSSHTSTSPSDQVSS
>B3PI58|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLVIKAIIMGIVEGITELLPISSTGHLILAADVMNFLSHDKRVVFEIFIQMGAMLAI
VWEYRVKIFSSLAGAVRPGIERNLFINVAIAFFPAALVGFLFSDFIRTVLFSPYVVAGGF
IVGGVIIMWVEKYAYAPRLDDMDRISYADAFNVGLCQCLALIPGTSRSGATIIGGMYFGL
SRRASTEFSFFLAIPMIGAASLYALWEAREQMEIEDMGILAIGFITSFFVTFAVMRALLR
FVSKHTYMAFAWYRIAFGLLVLATAYTGVINWSV
>H9XQ08|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
FCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCG
AVLSRXDAGQEQLGRRIHYSQNDLVEYSPVTXKHLTDGMTV
>AAC32186.1|FEATURES|ARDB_deepARG|trimethoprim|dfrA16|antibiotic target replacement|1
MKLSLMAAKSKNGIIGNGPDIPWSAKGQQLLFRAIIYNQWLLVGRKTFESMGALPNRKYA
VVTRSNFSTNDEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDI
ERDGDIVFPEIPDTFKLVFEQDFESNINYCYQIWQKS
>A0A0J5Z947|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRSDARRFTLNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVVSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>CAA76069|FEATURES|ARDB_deepARG|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLGVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTTPKAVISTP
>A0A0P6WRA6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVVILIKAFILGMVEGLTEFAPVSSTGHMIVVDDLWIKSKEVLGKYPANTFKVLIQLGS
ILAVVIVFRERFKDLLGMDSRKEKRSPKLKLSHILVGLLPAVILGLLFEDYIDEHLFSLN
TVLAGLAIGAFLMIAADVFRPKVQAVETVDGITHKKALMIGLIQCLSLWPGFSRSGSTIS
GGVLLGLSYRAASDFTFIMAVPIMLGASVLSLMKNWMYFNAEFMPFLLVGFISAFLFAYF
SIRFFLKVINKVKLIPFAIYRLILVCIILLIFL
>YP_002009763|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCV
GRVFDVVPRRRGGAQAALEAK
>A0A0R5RPG2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0P9WM06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIISGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A158AJN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIGTVITGLPVRADARRFTLNVIIATIPAVVLGLLLEKHIKAVLFSPVPVSVALI
VGGIVILWAESRQRERGVITRVHSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGML
FGLERRVATEFSFFLAIPIIFGATLYEMAKYWRTLTVDDFGLFAIGMVAAFVSAFACVRW
LLRYVATHDFTAFAWYRIGFGLLILIVGYSGGLSWAD
>A0A060KTK6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
VLYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>F8F7Y8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLWKAVIMGIVEGLTEFLPVSSTGHMILTGHLLEFEGDKASTFKVVIQFGAVLAVLVL
YWRRFIGLLQISPRMLERPGLNLLHVGAALVPFLVAGLTIYGYMKKHLFGPTPVLIGLVA
GGVLMIAADRFRGRVTAETMDDITYKQAFGIGLFQCLAIWPGFSRSGSTISGGMLLGTSQ
KAAAEFTFIISVPIMFAASAYDLYKSREFLSAGDLPLFLTGLGTAFLVAMLAIVTFLNLI
KRLSLSWFAVYRFVLALVFVIILYL
>A0A0S2SHE7|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MPSPLLSTALAVSLLCALPASAAGCFLWADGHGNPIEQEGGCDRRLPPASTFKIPLALMG
YESGYLTDEEHPALPYQPQYDGWLPAWRETTTPRRWETYSVVWYSQRLTEWLGMQRFQRY
VDRFDYGNRDLSGNPGKQDGLTQAWLSASLAISPQEQARFLGRMLDGRLGLAPETLRHSA
NILRVAEIDGWQIHGKTGMGYPKRADGSLDKGQQIGWFVGWASKGSQHRIFVRTRIQPPG
KQFASVQAKEEVLAALPARLGKE
>A0A0J7DJ89|FEATURES|UNIPROT_deepARG|beta_lactam|TU62_02400|antibiotic inactivation|1
MIVLNKFFSMLHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDAHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDALKAKNK
>A0A099SC28|FEATURES|UNIPROT_deepARG|chloramphenicol|DP68_01695|antibiotic inactivation|1
MKFNLIDTEHWNRKPYFEHYLNSVRCTYSITANIEITNLLHDIKQKKLKLYPTFIYIIAT
VVNTHKEFRTCFDESGNLGYWDSMSPSYTIFHKDNETFSSIWTEYDKSFSCFYSKYLHDI
KNYGDIMSFTPKLNEPANTFPISCIPWVSFTGFNLNIYNDGTYLVPIFTIGKYFKQADKI
LIPISIQVHHAVCDGYHTSRFINEVQELILNYQTWLKHK
>A0A0H4KJS0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKMRYKEYNLSLENSSPYGITAGTDGELWFTQHKANSIGRITLDGQLTYTKVPTADAGVL
LITSSYNDELWFTENKGNKIGRLTSEGEIKEYPLPHEDSAPFGITKGPDGDVWFTETKGN
RIGKIASSGEITEYSLPAGAAFPSYIVYGADGALWFTLNQSNQIGRITVAGNITLFNLPT
ENAGPVGITGGPDDALWFVEINANQIGRITLDGEISEYKIPTSHARPHGIATGPDDALWF
TEWGRDQIGRITTEGEFKEYQLPTKSAEPHGIILGSDGALWFAQECNKIGRLSF
>A0A0Q4SSY7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWVAFQALILGIVEGLTEFLPISSTGHLIVVGDLLGFNGEKATAFKIIIQLGAILAVI
WEFRAKVLGVVVGLPSDPNAQRFTFNLLLAFIPAVIFGLAFADLIEHWLFNPITVAMALI
IGGIIMLWAEKREHAIKAETVDDMTWKLALKVGLAQCLALIPGTSRSGATIIGGLVFGLS
RKAATEFSFFLAMPTMVAATVYSLVKYRDILQMSDLPIFAIGFVSTFIVAMITVRALLKF
ITSHSYAVFAWYRIAFGLVILATWQLHLIDWSTAQP
>A0A157ZSG7|FEATURES|UNIPROT_deepARG|beta_lactam|AWB76_01197|antibiotic inactivation|1
MKFRALSLLATAIFSFGAMPGVARASDAASVKATVDKTIKPLMALHGIHGMAVGVVVDGK
PYVFDYGVASKATKQPVTRDTLFELGSISKTFTATLASYAQIEGDLSLSDPVSKYLPSLD
GTDFGKVTLLNLGTHTPGGLPLQVPDEVHDNEQLIQYFSTWRPAGPPGTIRTYANPGIGT
LGLITAKSMKQDFDALMQTRLFPALGLKHSYIDVPASKQRDYAQGYTKDDTPIRMKGGVL
ASEAYGVRTTAADMARFLQINMNMVRIDPAYQRAVDATHTGYFQAGPMTQDLIWEQYPYP
SAMQPLLDGNASSMILNATPVTRIDPPQGPRDDVWINKTGSTNGFGAYIAFVPKARVGIV
MLANRNIPNEERVKAAYAIITSLTSGR
>R7CVK1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDLTLLETIVIAIVEGLTEFLPVSSTGHMIITQGVLGVESTPFVKAFTVIIQFGAILSV
VCLYWKRFFRLNPKPVPAGSTPVRRFLHKFDFYWKLLVAFIPAAIFGFLFSDKIDELLES
VTVVAVMLILGGIFMLFTDRIFRDEAGRKTELTEAKAFRIGLFQCIAMIPGVSRSMATIV
GGMAQKLSRKDAAEFSFFLAVPTMFAATAYKMLKLFLDEGGADVLRENLTALLVGNAVAF
VVALVAIKFFIAFVTKYGFKAFGWYRIIVGALILILLLAGHSLTL
>A0A0Q4S3E2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAVSLLIGGLILLKVDEW
FNKPDSAETSQEITYLQAFKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATAKKCYDYYKAGFELSHDQINLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRIIAGIVLLLIHFFIHPLTII
>N9ML49|FEATURES|UNIPROT_deepARG|beta_lactam|F898_01135|antibiotic inactivation|1
MLNSKRLSGPVKQLLVLAGLLSGSAPLWAQQLSEQQVQAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKHSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNRVVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAHINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHTSAQ
>A0A0M3F048|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFSAPTIQKVSVVIPVYNEQESLPELLRRTTAACETLGKAYEILLVDDGSSDDSAHMLTD
AANEPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSLLRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFG
SVIALAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHEASQEEKHP
>R4PVT8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQTVVMGLVQGATEFIPVSSSGHLVIAQHFMKIAPDHLFLEYINIGTLLALITYYRR
EWRQLVKDIFEQKKYSLAVNIVLTSLPAGLIGFFLADFIDGSSFFVSVYVVLVTLPTIGV
VMIILERLPRARSVMRMEELSWHSALTIGFAQVLALIPGVSRSGSTIIAGRLVGLTSSEA
ARYSFMASLPIMLAVSVKLFLKSSDRLYFIDHMPAIVISNVVAFVAGVSAISFLMRYLSG
HSLALFGWYRIILSIAVLSMLLIL
>A0A0F6J018|FEATURES|UNIPROT_deepARG|beta_lactam|BTCBT_005890|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHDKEDAKYDDKLI
AEATKIALGVLKAKNK
>S9UA13|FEATURES|UNIPROT_deepARG|chloramphenicol|PAALTS15_11084|antibiotic inactivation|1
MKFHLIDVDMWNRKPYYTHFLNEARCTFNLTANIDITVLLDNLRDKNKKLYPALIHMTAK
IVNAYPEFRTSYDEDGKLGYWESMNPSFTIFHPEDNTFSSLWTPYTEEFHAFHESYLADV
GQYGKVKGLIGKKDQPANTFPISCIPWVSFTGFNLNVFNEGTYLLPIITFGKYFEQTGRV
LLPVSLQLHHAVCDGYHAGLFVGELQRFADHSKEWVDDPK
>AAG05347|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
WEFRGKIFQVVRDLPSQRQAQRFTANLLIAFFPAVVLGVLFADLIHEWLFNPITVALALV
VGGVVMLWAERRKHVIRAEHVDDMTWKDALKIGCAQCLAMIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYVYRDLFRPEDLPVFAVGFVTSFVFAMLAVRALLKF
IGNHSYAAFAWYRIAFGLLILATWQFHLIDWSTAGEV
>A0A0P9WG31|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIKFVSVVIPVYNERQSLPELLRRTETACEQLNHRYEIVLVDDGSRDDSAEILQQA
ADRAGSPFVAVILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVMLAEQGY
DVVGTVRNNRQDSAWRRWPSKFINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEVLVDHAEREHGDSRYSPMRLVNLMFDLITCMTTTPLRLLSIIGF
SMAFLGVLFAAVLIVLRLIFGASWAGDGTFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKIVRSSSGIAADSIDSSVTPYTNKVAP
>A0A0C6P5V4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQVEMTEFPVGKPQEALYGVASTPDGALWFTLAKGNAIGRLSPDGAVSRFPLPHADGQP
TTITCGPDGRPWFTLSSANAIGRLAPDGALRMFELPRPASRPFGIAGGHDGCLWFAEMAG
DRIGRITIDGDIEEYDLPVKGGYPSCMAAGRDGLMWFTLNQAGAVGSISATAAPRIFPLG
AADAAPVGIASDAQGALWIAQAGNGAIARFDAGGRITEFPLHSRAARPHAIAADAAGNLW
FTEWGANRIGRISEAGDLAGYELAAPGSEPHGIAIDPHGCVWAALETGRLVRLQASPRD
>A0A0N0M595|FEATURES|UNIPROT_deepARG|beta_lactam|AFL42_15675|antibiotic inactivation|1
MGKRFEYKFSIHKFTLCILLLMLITLAACADKENSKDASSKEEKEENQTAKIDNQFSQLE
EEFDAELGVYAVDTETNQAIEYQSEERFAFASTYKALAAAIVLQQNSMEELNQVITYTKE
DLVPYSPVTEKHVDSGMTLLNLAEAAVRTSDNTAGNLLFNAIGGPKEFEQTLREIGDNDT
QAERYEPDLNQFSPEDPRDTSTPKALATSLQAFALGDLLPNEKREQFTDWLQGNATGDTL
IRAGAPEGWEVGDKSGAGSYGTRNDIAVVWPPNREPIVIAIMSRHDTEDATYDDALIAEA
VKIALNALK
>YP_002092118|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MAFSFDHFGVGPRMDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTF
DVVIQFGAILAVCWEYRQRIVSVVSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKA
VLFSPVPVAFALVVGGAIILWAEARQRERSEPPRVMSVDALTPLDALKVGIAQCFALVPG
MSRSGSTIIGGMLFGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGL
VAAFVSAFVCVRWLLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A142IQX6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRLTITALALLLIGQTALAQPNKLRATVDAAVQPAIEQYRIPGLAVAIVHKGERHFFNYG
VASRESSQAVNEHSLFELGSVSKLFTATLGAYAQAEGKLRLDDPASQHLPALRGSVFERI
SLLDLATYTPGGLPLQFPDAVRSERQMLDYYRAWQPAHPAGSQRLYSNPSIGLFGHLAAA
SLGKPFDQLLESQLFPQLGMTDSHVHVPQSQMARYAWGYSDDQAIRVQPGTLDAEAYGVK
STAADMLRFIEANLDPSQLPAPLRQAIATTHQGYYRVGDMTQGLGWERYAYPITLERLQT
GNSPQMALQPHAVERFATPQPAEGDLLLNKTGSTNGFGAYVLLLPARDTGLVILANRNYP
NAERVRIALEILEALEH
>D4BVQ1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALIDLQGITRRYGEGENQVTVLKNVSLQINAGEMVAIIGASGSGKSTLMNIIGCLDKP
TEGNYCIDGQSVATLDNDQLAELRREHFGFIFQRYHLLSHLSAEQNVEVPAVYAGAGKNQ
RRERAAQLLQRLGLGERVDYRPSQLSGGQQQRVSIARALMNGGQIILADEPTGALDSHSG
EEVMNILKDLCAQGHTVIIVTHDPEIAQQAERIIEIKDGEILNDSGSKATKRTNSLPKAP
PRKFSLAQAYGRFSEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVSIMVIGDAAQGMVL
NDIKSIGTNTISIYPGEDFGYDDAKNRQSLRASDIDALAKQPYVYAISGELNHSTRLRKG
NVDASAQLTGVGRDYFNVYASKFSEGMSFTQDMVDKRAQVVVIDANTKRRFFPKQEHVIG
ETLLIGNMPVTIIGVLEEKKSTFGSSKSLSVWLPDTTVNSKILNRPYYESFVVRVKDGYD
AKTVEQQLTRLLTLRHGKKDIFTYNLDTFVKTAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLMGGLMGIGLSYGISLLAQMA
LPGWTFSFDPVALVSAFVCSTAIGIIFGFLPARNAARLNPIDALARE
>ZP_02904980|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVEDML
YMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTL
TMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQ
RGLSAEDVVQSIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTP
DGGVTHLRDIARIELDASEYGLRALLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQ
DMPAGIDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVS
IIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIESGMNARQATYKAMQ
EVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAIL
LKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVG
ATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAF
PGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALNQQYGAIKDSFVAVFPPPP
VLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDL
DRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKT
RNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIAHET
LPRGVRFEWTDLTYQQILAGDSAMYVFPISVLLVFLVLAALYESLTLPLAVILIVPMSIL
SALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLR
LRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLMLTPVFYVVLRT
LAGGKIHVAGKDSAGYGVSPSGVPASDA
>D2J684|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MIYKNYNCNIGGFILKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTK
SGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGK
DITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPK
SKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKS
GQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ZP_01072284|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYPSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKPEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A127T1F6|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTIGKYYEEDREILLPLAVQVH
HAVCDGFHICRFVNELQELINS
>ZP_02344978|FEATURES|ARDB_deepARG|multidrug|MdtM|antibiotic efflux|1
MQRIIQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LAGGMALQWLLGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLAARFVQGTSICF
IATVGYVTVQEAFGQTKAIKLMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMG
LLALCGLLLAMPETVQRGAVPFSAVSVLRDFRNVFRNPIFLTGAATLSLSYIPMMSWVAV
SPVILIDAGGMSTSQFAWAQVPVFGAVIVANMIVVRLVKDPTRPRFIWRAVPIQLSGLAT
LLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFSNNLPKGTVSASLNMVILTVM
AVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELVAEK
>Q9CDM7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIRAIILGVIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
LYFHKLNPFNKLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFV
PVAFMLIIYGVAFIVIERRWVPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGAT
IVGALLVGVSREVAAEFTFFLGIPVMFGASFIKILHFFKNGNSLSFEQFGVLLVACIVAF
GVSMVAIKFLTDYVKKHDFTFFGKYRIVLGIILLIYAMFRAFLG
>ZP_04318513|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKERVDDMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETF
YPGKGHTEDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNI
NAVVPGHGEVGDKGLLLHTLDLLK
>BAC67151|FEATURES|ARDB_deepARG|tetracycline|tetG|antibiotic efflux|1
MRSSAIIALLIVGLDAMGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPV
LGQLSDSYGRRPVLLASLAGAAVDYAIMASAPVLWVLYIGRLVSGITGATGAVAASTIAD
STGEGSRARWFGYMGACYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLR
ETRRGHGKTGKPVRIQPFVLFRLDDVLRGLTALFAVFFIIQLIGQVPAALWVIYGEDRFQ
WNTATVGLSLAAFGATHAIFQAFVTGPLSSRLGERRTLLFGMAADATGFVLLAFATQGWM
VFPILLLLAAGGVGMPALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSAT
AGAWNGWVWIVGAILYLICLPILRRPFATSL
>A0A0H5RLE5|FEATURES|UNIPROT_deepARG|beta_lactam|BN2156_01817|antibiotic inactivation|1
MAAVAVGAGVGTSAPAFAAPIDDQIAELERRHNALIGLYAVNLDSGRTLTHRPDEMFAMC
STFKGYAAARVLQMVGRRQISLENRVFVEPAAIVPNSPVTETHAGAEMTLAELCQAALQR
SDNTAGNLLLKTIDGPAGITAFARSIGDDRTRLDRWEVELNSAIPGDPRDTSTPAALAGG
YRAVLAGDALSPPQRRQLEDWMRANQTSSMRAGLPDGWTTADKTGSGDYGSTNDVGIAYG
PDGQRLLLAMMTRSQADDPKADNLRPLIGELTALVLPSLL
>E1L2U8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAAAISLVELIKAALYGVIEGVTEWLPISSTGHMLLFEKFVQLQVSAQFWHMFLVVIQLG
AILAVCVTFCKQLNFLAPSLTPSARKNTLVLWAKIIVACIPAAAVGIPLDDWMDEHLSSP
YIIAAALIVYGVAFIVVEKIFTARERALGARAATELAAAPAMPAGAETLPHHAPKHMAVA
AHDACAYTDAAHAGARVGTDAAAETSRITTLEALNWKTTIGIGIFQVLSIVPGTSRSGST
ILGARMLGCSRSVAAQFTFLLAVPVMVGASALRLVKYILKKNIPTSNEAAILAVGCIVAF
VVSLCVIHGLMRYIKRHDFQVFGWYRIVLGIITIAYFALV
>K9AE09|FEATURES|UNIPROT_deepARG|beta_lactam|C273_11186|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKNV
>E0J047|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITSSCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPRALDAKTYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0Q7SFH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVILLIKAAVMGIVEGLTEFLPISSTGHLILAGSLLNFVGEKAKVFEIAVQTGAMFAVV
WEYRERLARTVKGITHEPQAQRFALNVLIAFLPAVVLGLAFGKFIKAHLFHPVPVALAFI
IGGFIILWVEGRNRRLHDGGHQPRVQTVDDMGPLDALKVGLLQCLAMIPGTSRSGATIIG
GLVLGMSRKAATEFSFYLGIPTLMGAGAYSVLKQRDALAWEDAPMFAVGLVFAFISALLC
IRWLIRYVSSHDFKVFAWYRIAFGVIVLATAYMGMDIWKD
>K4L088|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MATIQFILQSIILGIVEGITEFLPVSSTGHLIIFQNLINFQGTNPHYVEMYTYVIQLGAI
LAVIVLYWKKIKQTLVDFFPSKVGYQESGLKFWLMIVLACIPGATIGILFDDTAEKYLFS
PIPVAITLFLGAILMIYAENRLRKNAPVGRDLNVSPRQAVMIGLFQCLAVIPGMSRSAST
IIGGWVAGLPTVAATEFSFFLAIPVMIGMSLLKVVKIGGLAILTSQEILSLAVGFIVSFL
VAVIVIQKFISYLQRKPMRIFAIYRMIFAAFVLAAGVAGLF
>D4E1G2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFIAEDYGVSAHMADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTF
EVIIQLGSILAVVVMFWRRLFGLIGIHFGGKPVAHEGHTAGRLKLGHILLAMVPAVVLGL
VFHDVIKSLFEPKNVMYALVVGGFLLLAAEWLKPKKPRAVGLDDITYRQAFMIGCFQCLA
LWPGFSRSGSTISGGMLVGVSRYAASEFSFILAVPMMIGASGLDLYKSLHFLTLADLPMF
AVGFVTAFVVALIAIKTFLTLIKRISFIPFAIYRFIVAAVVYMVFM
>L4J574|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>R5Z9C9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVLEFFKAIIFGIVEGITEWLPVSSTGHLILVEEFIKFTKVSDNFFSVFEVVIQLGAILA
VVLIYFKDIWPFTNKPEKAFTKKGLLSHLDKNITNLWGKILVACVPAAIIGLLFDDKFEA
LFYNPTCVSIALIVFGIAFIVVENWHKGRKSRINSVPAITYKDAIIIGVFQLIAAIFPGV
SRSGATIIGALLIGVSRKVSAEFTFYLAVPVMFGASLLKIVKYGLNFTGTEIALLILGMV
VAFIVSLWIIKFLMNYIKKHDFKVFGWYRIILGTLLILYFGIMR
>T0NUX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADKFAKRAARAQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTAADIPFFIAGFLSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAIVIYFLYF
>D0EJY8|FEATURES|UNIPROT_deepARG|beta_lactam|pdc-17|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDDRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A085BUA4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKFPNLALAVVLSVPFALPASLFAQGATSEQIVDIAGASFAPVIEQYRIPGLVVGITWQG
QHSFYATGVAARKGNVAATPDTIFELGSISKIFTATLAALAEDRGMLDLDAPVSDSIPQL
EGAAFGAIRLVDLSTHVTGGLPLQVPGEVGNVPELIRWLEGWQPPQPGTRSYSNVSIGLL
GHITAQTMQMSFAQAAEDVLFPAMGLGSTYVDVPDDAMDRYAFGYDRKTDAPIRVNPGVL
ADEAYGVKSTARDMLRLLDLELGRGGADPALTAALERTRQGQAETAYYTQDMIWEQYPWP
VDVAKMEAGNGYDFILSPQPATRLTPPLPPQRDVILNKTGATNGFGGYVALLPGQDLGIV
VLANRNYPNEARVRATHALITDLLATQD
>A0A124EZV1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
YFWASWRKTYFSSITNFKKQAGFIILATAITSILGLTLQALIKHVFFAGANHFEIEQLFS
NSKLMAAALVSAGILIILSARLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATIST
GLFLGVARQKAEEFSFALAVVLTPAVIVKEFYRLMHAENFQNMHLTQLLFPSVLGMVFSF
IAGLAALKWLSSWLEHGRWQLFGFYCIGFAGIVLALG
>AAN79805|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MLIFYFPGGEMSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGI
ALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSG
LGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATG
AVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLM
LPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMP
VGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGY
IGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0A7HID4|FEATURES|UNIPROT_deepARG|beta_lactam|bla-TEM|antibiotic inactivation|1
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDTGQEQLGRRIH
YSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMG
DHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKV
AGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
IAE
>ZP_04464540|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLRTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GAEILLASGEKMTLSTNAMHWTGRSNPVKVGEQIWIRQRANGEWQLGQIPSANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNMIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGESALKPTDDSTNGEELDQQPETVPELPELQSNFTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLPLPPKIVEKSIDTLTGLLSPNGGRKEYFIVGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A6MFN9|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
KLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYA
STSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKVITLKALIEASMTYSD
NTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVY
PKGQSEPIVLVIFTNKDNKSDKPNDK
>M0Q6R9|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGVQSLIDAGYEIAAIITHQDAPGENVFFASVARLAAQHTIPVFAPD
DVNHPLWIERLRELQPQVIFSFYYRHLLSDEILALAPQGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMEARADAGNIIAQQRIAIADDDTALTLHHKLCQCAKTLLAEALPQI
RSGNYSEYPQDESAATYVGRRTPADGRIEWNKPARTLYNLVRAVSEPWPGAFSYAGNRQF
TLWQARVRHDLPAARPGTVLSTAPLVVACGQDALEIVAGQPQDGLYMQGSQLAESLGLVE
GAILNSSLNFGARRATRVLILGVNGFIGNHLTERLLAEENYEVYGLDIGSDAISRFIGHP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDC
VKYQKRIIFPSTSEVYGMCSDPQFDEDHSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAK
DGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KEGVEALFRIIENKDNRCDGQIINIGNPDNEASIRELAEQLLVCFEQHPLRDRFPPFAGF
REVESSTYYGKGYQDVEHRKPSIRNAQRLLGWQPVIPMEQTIEDTLDFFLRTFDGTEQE
>A0A0K4KN76|FEATURES|UNIPROT_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDNDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGITGHSALNMWSGIVF
SITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLL
GGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITAS
VLILCFFVTLFCIKEKFKPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAP
ILTLYVRELAGSVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVL
LLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGN
VTGPLMGAAISANYGFRAVFLVTASVVLFNAIYSWNSLRRRRLPQVSN
>P0C070|FEATURES|UNIPROT_deepARG|multidrug|mepB|antibiotic efflux|1
MSKFFIDRPIFAWVIALVIMLVGALSILKLPINQYPSIAPPAIAIAVTYPGASAQTVQDT
VVQVIEQQLNGIDNLRYVSSESNSDGSMTITATFEQGTNPDTAQVQVQNKLNLATPLLPQ
EVQQQGIRVTKAVKNFLLVIGLVSEDGSMTKDDLANYIVSNMQDPISRTAGVGDFQVFGA
QYAMRIWLDPAKLNKFQLTPVDVKTAVAAQNVQVSSGQLGGLPALPGTQLNATIIGKTRL
QTAEQFESILLKVNKDGSQVRLGDVAQVGLGGENYAVSAQFNGKPASGLAVKLATGANAL
DTAKALRETIKGLEPFFPPGVKAVFPYDTTPVVTESISGVIHTLIEAVVLVFLVMYLFLQ
NFRATIITTMTVPVVLLGTFGILAAAGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEEGLPPKEATKRSMEQIQGALVGIALVLSAVLLPMAFFGGSTGVIYRQFSITIVSAMGL
SVLVALIFTPALCATMLKPLKKGEHHTAKGGFFGWFNRNFDRSVNGYERSVGAILRNKVP
FLLAYALIVVGMIWLFARIPTAFLPEEDQGVLFAQVQTPAGSSAERTQVVVDQMREYLLK
DEADTVSSVFTVNGFNFAGRGQSSGMAFIMLKPWDERSKENSVFALAQRAQQHFFTFRDA
MVFAFAPPAVLELGNATGFDVFLQDRGGVGHEKLMEARNQFLAKAAQSKILSAVRPNGLN
DEPQYQLTIDDERASALGVTIADINNTLSIALGASYVNDFIDRGRVKKVYIQGEPSARMS
PEDLQKWYVRNGAGEMVPFSSFAKGEWTYGSPKLSRYNGVEAMEILGAPAPGYSTGEAMA
EVERIAGELPSGIGFSWTGMSYEEKLSGSQMPALFALSVLFVFLCLAALYESWSIPIAVV
LVVPLGIIGALIATSLRGLSNDVYFLVGLLTTIGLAAKNAILIVEFAKELHEQGRSLYDA
AIEACRMRLRPIIMTSLAFILGVVPLTIASGAGAGSQHAIGTGVIGGMISATVLAIFWVP
LFFVAVSSLFGSKEPEKDVTPENPRYEAGQ
>D2C0D7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDFGCVGLRALVAAGYTVEAVFTHADNPAENQFFGSVARTAAELGIPVFAPE
DVNHPLWVERIAAMSPDVIFSFYYRHLLSDAILQSAAHGAYNLHGSLLPRYRGRAPLNWA
LVNGETETGVTLHRMVARADAGNIVAQQRVAIDESDTALSLHHKLRDVASQLLKDSLPAI
AAGKANDIPQDESQATYVGRRTPEDGRIEWQKPARALYNLVRAVTEPWPGAFSFVGTTKF
IIWQAKVRTDFAAAKPGTVLSTSPLVVACGNDALEIVTGQGDNGIYLQGAQLAQSLGLVT
GAILNNSPVVSVKRRTRVLILGVNGFIGNHLTERLLQEDNYEVFGLDISSDAIERFLGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKTIRDC
VKYKKRIIFPSTSEVYGMCTDPVFDEDNSNLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDI
KDGIEALFRIIENKDGVCDGQIINIGNPENEASIRQLAEMLLESFEKHPLRNQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRLLHWQPTIEMEKTVAETLDFFLQTVETGQFSR
DGE
>Q1MQW6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSWLTIGVILGLVQGITEFLPVSSTGHLIIVAKFLHFTGSKASVFEVAVQLGSIMAVVV
IYWNRFIGLIRPEKNKKFTGLYGIWLLFLTTLPPGIIGFLFHSYIKTLFTIPSVIAALTT
GSIFMLISEQLCRNISQRIVTLDELTPKTALGIGFFECLALWPGFSRSAATIMGGMLLGA
KRHLAAEYSFIAAVPVMFAATGYDLLKNWDLFTANDLPLFITGMICAFLAAWITIKVFIL
LISKISLRPFAYYRLLLAFIVYLCIK
>YP_581244|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLMGFWTKEKVDLFVVVVQFGAILAV
IYDYWGRLWQALMGLLTGKAEGMSNPRQLGLSLIVATIPVMIVGFTFADEIKAYLFNPIV
VAIMLIIGGLLIFYVENRPKAIIAEEAEDVSLKTALMIGLLQCLALIPGTSRSGATIIGA
LWLGVSRKASAEFSFFLGIPVIIGAALLDFIKHRDVLTSSEDWLVLGIGTVVSFIIALLC
IRLLVAWVSRRDFKIFAWLRIITGVLVLIAAWGFGYQMAG
>ZP_03265942|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVVGSLLDFSGEHAKNFYVVIQLGAILAVC
WEFRRRIGNVIVGLPSRPDARRFALNVIIATIPAVVLGLLFEKSIKEALFSPVPVAFALV
AGGVVILWAEARQRARGDAAVRVRSIDDLSPLDALKVGLAQCFALIPGTSRSGSTIIGGM
LFGIERRAATEFSFFLAIPIIFGATAYELYKDWHLLTTDALGSFALGFAAAFVSAFICIR
WLLRYVASHDFTVFAWYRIGFGLLILLIGYSGGLSWAD
>A0A0H3CDQ7|FEATURES|UNIPROT_deepARG|aminoglycoside|CCNA_03676|antibiotic inactivation|1
MIIRLATRRDLAAWADLRAALWPDGSVEEHRAEAEDALNQPDGLVAYVAETPDGVIAGFA
EAALRRDYVNGCDSSPVAFVEGLYVRPEHRKADIARRLCAAVADWGRTQGCTELASDAEI
HNLESHAFHQAIGFEETERVVYFRMTL
>R4WAP4|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSGLLGAGLLFSLPASAATGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGFLVDEEHPALPFKPGYDDWLPAWRETTTPRRWETYSVVWFSQQITEWLGMDRFQQ
YVDRFDYGNRDLSGKPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAKLKTL
>A0A0K0U236|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNVDQGLFVPLLLGIIEGLTEFLPVSSTGHLLLVEHFLGFDSPGRVFEVLIQLGAILAIV
VIYFWRLVGIARDVFLRKPYALRFALCVILACLPAAIAGVLLHDFIKTVIYESPILICVM
LIVGGVVLLFVDQLKLKPKYTEIYSYPPLMCFYIGLFQMLALIPGVSRSGATIVGSLLLG
TDKRSAAEFSFFVALPLMVGAFGYDFYKNRELIGPELGLNIAIGFAAAFIVGTLVVKYLL
DFVSRHGFSFFAYWRIFVGAIGLWGLLLFK
>F3GUL3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
VGGVIMLWAERREHTVRTETVDDMSWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRGLLKF
IVTHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>YP_776582|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLAAEDVVRSIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGIDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLGFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIESGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFKRFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKIVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QQYGAIKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGIAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSAGYGASGSGVPATGVPASDA
>J8N2N6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEREDFECLIQRLEENDVHILQGRERDIRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>A0A059V142|FEATURES|UNIPROT_deepARG|beta_lactam|DW66_2804|antibiotic inactivation|1
MPLSRLAALAAAITLNLGYSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
FSYGVASKADNVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAP
IGDASVLELGAYSADCLPLQFPDAVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGD
LAARAQHQPFSTLMSEGLLKQMGLRNTYLQVPASAQGLYAQGYDSADKPVRVGPGPYADE
AYGIKTSASDLLRYVRLHMQPEGLPPALAQATAITQRGYFQVGAMTQGLGWERYPYPVTL
ATLVDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTNGFGAYAAFVPAEQLAVVLLA
NRNYPNEARVRAAFDILSGL
>S2KV99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRRKILDVVFGLTSQPTARHFTANLLLAFMPAVVLGVLFADLIHRYLFNPITVATALV
IGGVIMLWAERRSHRVEVDHVDDMRWTHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAVGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWSTAQG
>YP_002848751|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLSSGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLTGVIWFIVTCLATLLAQNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAISFFGLQRAMPETATRLGEKLSIKELGKDYKLVLRNVRFVAGALALGFVSLPLLAWIA
QSPIIIISGEHLSSYEYGLLQVPIFGALIAGNLVLARLTSRKTVRSLIIMGGWPIAVGLI
IAAAATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIELSKHAYLLGGNGLFSLFNLASGVLWLILMVIFLKDKRVGNSREG
>A0A0U1YUE6|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A5EYB8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALIKVQKLCKYFGSGETKTCVLREIDLEITAGEMVAIVGQSGSGKSTLMHILGCLDRP
SSGDYWLDGNHIDTLTAGAQARLRREYIGFIFQRYHLLNDLSARENVAIPALYAGVDRVT
RLLRADQLLERLGLGARKHHKPQQLSGGQQQRVSIARALINGGKIILADEPTGALDSESG
AEVMNILRELHQQGHTIILVTHDAHIAEQADRIIELKDGVILSDTVRNVRPFQAPELPQK
SVQKNRFSLKTLASAFSMAIRAILGHKLRSFLTMLGIIIGIASVVSMVALGQGSQQQVLS
RIQTLGSNTIQVFSGAFGDPNAWRVQTLSADDATLLAQQSFVDSATPILSLDGAVRTSDR
TLTAIVTGIGRHYFQVQNMPIIRGAALAENDIRELKAVAYIDEKSAQQLFPHSDPLGAVM
VLGNVAVTIIGVVDTQNHRQFRNTNAINLFMPYTSVMSRLLGSSRVSQIMVRIRDGVEST
VAEDAISRILIRRHGSKDFTLFNNDSLRQVITQTSKTLSLLIAAIAVISLIVGGIGVMNI
MLVSVTERTQEIGIRMAVGARRQDILQQFLIEAVLLCLFGGIIGIGLAFGIGQLIALSGA
FTMIYSLTSVVIAFGCASGIGILFGYLPAKNAAKLDPVQALAHD
>M5QD83|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPVPRKLSGLTLVLVGLCAFSTAALAQDLVPGLDAAVTEGATQLMQTYGVPGLSIAVSVN
GKQHFYNFGVASRDTRVPISSDTLFEVGSISKTLTATLATYAQINGQLSLDAPVSRYVPE
LQGTAFGKVQLTHLATHTAGGFPLQVPDAVQNEQQLMDYLKAWKPVYPAGTQRSYANPSI
GMLGLITARSMNQPFAQAMENTLFPALGLHSTYIDVPKSKMALYAQGYDKQDQPVRLNSG
MLGNEAYGVKTSSRDLIHFAQLNALPGKPSTKIQQAIGDTHTGYFRIGPMTQDLIWEQYA
YPVTLKNLLLGNSDKMAYENNDAIALHPPLAPQEAVWINKTGSTGGFGGYVALIPVKKQA
VVILANKNYPNSARIELAYKILNALD
>L3Q3I7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLTVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0G0AGB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELHILEIIKAIILGVVEGLTEFLPISSTGHLILINELIYFDEDFTVLFDIVIQFGAIIA
VLVYFIKKLWPFTKDEIKNKETLNIWYKTIVAILPAIFFGALFADFIKEKLFNPWVVAIS
LLVGGLIILFIENKKETIKVFSIEDLSFKTAFFIGLIQCLSMIPGVSRSASTIMGGIVLG
ASRVVSTEFSFFLAIPTMFAASAYSLLKYEGALNLNQIFILLIGFIVSFFVALAIVKFLI
NFVQKHNFKIFGYYRIILGIIILLYFLIK
>A0A132TX83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDVIKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLIL
YWRRYLAIGANLIRMDFSKSKGLNVIHMILAMLPALILYLLFKDIIKSRLFGPTPVLIGL
VAGGLLMILAARSRKTNTADTIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGT
SQKAAADFTFLISVPVMFGASLLDLYDSRDLLNSDDLILMLIGFTTSFLVAMIAVVTFIK
LIKRLRLEWFALYRFVLAALFYLIVIL
>A0A085EMY8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLQAIVLAIIEGITEFLPISSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVLVL
YFKRFFQSFDFYFKLLVAFIPAVVFGLLFSKKIDALLENPVTVAVSLLIGGIILLKVDQW
FNKPDVSDNAQDISYGQAFKIGLFQCLAMIPGVSRSGASIVGGMSQKLSRTSAAEFSFFL
AVPTMLGATVKKCYDYYKDGFVLNDDQINFLIIGNIVAFIVALLAIKSFIGFLTKNGFKV
FGYYRIIAGLILLAIHYFIHPLTVL
>BAD60926|FEATURES|ARDB_deepARG|glycopeptide|vanD|antibiotic target alteration|1
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
NYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYV
VCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFG
VNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGF
FKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGS
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR
>V5C0F7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIVSVVSGLPSRTDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRECSEPPRVMSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>U2M0P3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSRAEPISKVSVVIPVYNEQESLPALLARTTAACKQLLQPYEIILIDDGSSDNSAAMLTA
AAEQPDSCIIAVLLNRNYGQHSAIIAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSWFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEIEVRHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSVVG
SVIALSGFVLAVLLIVLRLVLGPEWAAGGVFTLFAVLFTFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGAKPTQNNQEEE
>A0A0J1IK83|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDKLWDLIVAFILGIVEGLTEFAPVSSTGHMILVDDLWLKSGEIFSPEVANTFKVVIQL
GSILAVVIIFKDRFLNILGLKKTINGEKVVGHKLSLVQVLIGLIPAGVLGLLFDDYIDEH
LFNFETVAYALIVGAVLMIIADFTQKKKKPTTTSLDQITNKQAFFIGLFQCIALWPGFSR
SGSTISGGVLMGLSHRVAADFTFIMAVPIMAGASFISLLNNWEYITSAALPFFIVGFISA
FIFALISIRFFLKLIDRIKLTPFAIYRIVLAIIIIVVFI
>A0A0R0DG76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSNTLSALLLGILEGLTEFLPISSTGHLLIAERWLGARSDFFNIVIQAGAILAVLLVFRQ
RLWSLATGLDERENRDYVMKLGVAFLVTALVGLPVRLAGWELPETVTPVAWALLLGGVWM
LVAERFAGRLPDSQAVTWKVAIAVGLAQVVAGVFPGTSRSAAAIFLAMLLGLTRRAAATE
FVFLVGIPTMFAASGYAFLEQLRHGGLGHENWGEVGLAFAAAVVTGFVVVKWLLGYIKHR
RFTGFALYRLALGAALLLFLPAGN
>A0A0I1ZTY4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MEQEAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLS
DPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGT
QRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREG
KAVHVSPGALDAEAYGVKSTIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMY
QGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYV
AFIPEKELGIVMLANKNYPNPARVAAACQILNALQ
>A0A0G3J9A1|FEATURES|UNIPROT_deepARG|beta_lactam|APECO2_00290|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDPMFKMTLCALLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVKPSGLSFEQAMQTRVFQP
LKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPL
DITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKAI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAACQILNALQ
>A0A125VAL2|FEATURES|UNIPROT_deepARG|bacitracin|bacA2|antibiotic target alteration|0
MSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFN
LQSVIIGFIVGGILLLVVETLFRKKNHSTDNIDKITPIQVLKVGTLQVLSAWPGMSRSAS
TIMGGWIAGLNSPTAAEFSFFLAVPAMVASSGKDLFEFDYSIMTPTLWIALVVGFIVAFI
VSIIVMEKFVNFLKKKPMRVFAVYRIIMGVVLAVLAFTNIISV
>R5FRD0|FEATURES|UNIPROT_deepARG|beta_lactam|BN812_02170|antibiotic inactivation|1
MCIVLVCIFTLVFSLFCKSATKDSAISPLTDILTDSISQIVSACPGEIGVAVIINNTDTV
KVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRGKLNLKTWSPMIKDYSEPI
ISLTVRDLLRYTLTQSDNNASNFMFKDIVNVAQTDSFIATLIPRSSFQIAYTEEEMSADH
NKAYSNYTSPLGAAMLMNRLFTEGLIGDEKQSFIKNTLKECKTGVDRIAAPLLDKKGVTI
AHKTGSGYVNENGLLSAHNDVAFICLPNNTCYTLAVFVKDFKGNESQASQYVAHISAVVY
SLLMQTSLNT
>L0M044|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
VVMFWRRLFSLIGIHFGRPVHEGEGKGRLSLIHILLGMIPAVVLGLVFHDTIKSLFNPVN
VMYALVVGGFLLIAAECLKPKQPRAVGVDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWHFLTLADLPMFAVGFVMAFVVALIA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A154ASU4|FEATURES|UNIPROT_deepARG|chloramphenicol|A3782_09770|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNIFPISSIPWTSFTGFNLNNDADFLLPIITCGKYFNEENKVMLP
VSLQVHHSVCDGYHASRFIEDLQELSNSCNEWLK
>A0A0Q0TYZ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDFLFILKAIIIAIVEGLTEFIPVSSTGHMILASSIIGFNDPKVFVDMFEVVIQLGAI
LAVVVLYWKKIKDSVIEFFTYIFTKGKKGKTGFQFGINVLIGCIPMGVIGIVFYRQIKML
FNPKIVVAGLIVGGILLIIIENKFRKNRKYSTKNIDSITPLQSLKVGVFQVLAVWPGMSR
SASTIMGGWVAGLSTPIAAEFSFFLAVPAMIGSTAKDIFEFDFSMMNMTLWITLIVGFIV
AFIVSLVVMEKFVAYLKKRPMRVFAVYRVGIGIIFAILMMLGMNLNM
>A0A0R2ZCW6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPRFIPSVTALALLIGASHCLAATDLRAVVDASVKPLMQQQAIPGLVVGVLQDGKAQYFS
YGVADKQSGQPVSENTLFEVGSVSKTFTATLAGYAVAAGKLTLDQPASHYLPALAGGRFD
HISVLNLGTYTAGGLPLQFPQEADNSQRMISYYQQWQPAFAPGTQRLYSNPSLGLFGYLA
ARSLGQPFDQLMEKTLLPTLGLTHTFLKVPLNQMNLYAQGYDKEGKPVRVGAGAMDSEAY
GIKTSAADLLHYVEVNMNPASQQKLIRSALTLTHTGYYTVDGMTQGLGWEMYPYPIPLDA
LIDGNSTQMAVEPHKVNWLTPPQPPHADTLVNKTGSTNGFGAYVAYVPSKRRGVVILANR
NYPNSERIKLAHTVFARIDHRDGQP
>J1QR26|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTVLLELKDIRRSYPSGDEQVEVLKGITLSINAGEMVAIVGTSGSGKSTLMNILGCLDKP
SSGTYRVAGTDVSTLGGDALEQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSDRKA
RLIRARELLTRLGLGERTDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGELISNPPARERAVTAGNRDAV
SVQVGGWRQFISRFHEALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDEPQYQQALKYDDLLAIQKQPWVRSATPSVSQNLRLRN
DNIDVAASANGVSGQYFNVYGMTFSEGASFNAEQEKGRAQVVVLDSNIRRQLFPNKVSVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKDGY
SSEQAEQQLTRLLNLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLSQFLIEAVFVCLVGGALGVTLSMLIAFTLQL
FLPGWEIGFSPVALITAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>ZP_02422325|FEATURES|ARDB_deepARG|glycopeptide|VanRG|antibiotic target alteration|0
MNESILIVDDEKEIADLIEVYLENDGYTVHKFYNGMDALKCIESQNLDLAILDVMLPDID
GFRICQKIREQYYYPIIMLTAKVEDTDKIMGLTIGADDYITKPFNPLEVVARVKTQLRRY
VRYNNAANTEEKDAPIAEHDVRGLIINKNTHKCTLYGKEVTLTPIEFSILWYLCENRGKV
ISSEELFENIWGEKFLDNNNTVMAHIGRLREKLNEPAKKPKFIKTVWGVGYTIEK
>E1IDN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSITVGVLLLISLGMTVPFDPSWWQVCVLGIVQGLTEFLPISSTAHLLLVGDLIGFEGSI
GGTFEIAIQLGTVIAVLGFYIQDLFGQFQAILGAKSAEAKAAAQRLWIAVVIAFVPAAAV
GLIFRKQIKYYLYDSPSMIAGALIVGGIIFLLIELLPHRPARTSELGKISWRQALGVGVA
QIFALVPGTSRSGSSIVGGLLAGLDRRTATAFSFYLSIPTLGAATIFDLLGSLDQIHAAD
WGRLFLGSVVAMIVGWLSIGWLLRYVARNNFVAFGIYRIIAGLLILALVMIGYL
>A0A0B8WDM0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNYLHAIILGIVEGITEFLPISSTGHMVIASSVMGIHDDQFVKNFEVIIQFGAILSVLVL
YWKRFLPDWNFYKKLFVAFLPTGIIGFLVKDLVDQMLGSVQVVAWALIIGGGILVWSDRI
FAHLTAMGRKTDDLSYGDSVKLGLFQALAMIPGVSRSAATIMGGLTLGMNKKEAAEFSFF
LAVPTMAAATGYKLLKVYKTIEAGQLGVLAVGCVVAFFVAMLAIKFFINIVARYGFRGFG
YYRIVLGIIILIMIYTGHNLQLT
>A0A0L6FNW8|FEATURES|UNIPROT_deepARG|aminoglycoside|DA83_06175|antibiotic inactivation|1
MIHPCTDPSSPVWLHLRSALWPDSTATDHLAEMADIAGSPATFVALLAYDEQGRVHGLAE
ASVRHDYVNGSNTSAVAYLEGIFVEQASRGQGVARQLIAAVERWAAGKGCRELASDAALD
NLGSQRMHAALGFAETERVVYFLKQVAPLN
>A0A126RRT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDSSTWAMFNVIIQLGAILAVVV
LYWRTFWAVGMGLLRNDPTSWRFLRNLLVAFIPAAVIGLALHKYIEQLLGAPKVVAWALI
VGGIAILAIERMVKENRFHGIADIPFVRVIGIGLIQCLAMIPGISRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGATTLELLKNGDKLTSATVGWDSIALGFIVSFIVAVLVIKWFV
GLVSRHGFTPFAWYRIIAGITALVWLSLR
>A0A0M0VTU5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLRSEEFLTKYVANTFKVVIQLGS
ILAVIVVFKDRFLDLLWLKRKKPEAGAPAGTGRLKLSQVIVGLIPAGVLGLLFEDFIDDH
LFSTATVLIGLVIGAVFMIFADKVSSKKEPKVVTVDQITYRQAFSVGLIQCLSLWPGFSR
SGSTISGGVMLGMSHRAAADFTFIMAVPIMFGASFLSLLKNWEYFTLDALPFFIAGFVAA
FVFALISIRFFLKLINRIKLVPFAIYRIVLAAVIALVLYL
>AAC15775|FEATURES|ARDB_deepARG|tetracycline|otrB|antibiotic efflux|1
MSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIY
GRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRER
GRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALN
LPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVE
LRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVI
PFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWL
GVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLAD
LLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSF
AHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA
>A0A157ZNE8|FEATURES|UNIPROT_deepARG|beta_lactam|AWB79_01201|antibiotic inactivation|1
MKFRALGLLATTIFSFGALSTAAHADDTANIKATVDKTIKPLMALHGIAGMAVGVVVNGK
PYVFDYGVASKETKQPVTRDTLFELGSVSKTFTATLTTHAQGQGDLSLNDPVSKYLPTLD
GSEFGKVTLLNLGTHTPGGLPLQVPDEVRNNDELMQYFKTWRPTQPPGTIRTYANPGIGT
LGLITAKSMRQDFDSLMQKRLFPALGLAHTYIDVPAAKQRDYAQGYAKNDAPIRMKGGVL
SSEAYGVRSTAADMTRYMQINMNLVRVDAPFQRAVDATHTAYFQAGPMTQDLIWEQYPYP
VALQSLVEGNSQSMILNATAVTKIEPPQAPRDDVWINKTGSTNGFGAYIAFVPKARTGIV
MLANRNIPNEERVKAAYAIITSLTGGQ
>A0A0L0QLK3|FEATURES|UNIPROT_deepARG|aminoglycoside|AFK71_11355|antibiotic inactivation|1
MGKLINEEIPKEAVQALKITMELQGQTVIGVYMFGSAVIGGLRINSDVDILVVVNHRLSE
EMRRKLTERLMLISGKVGNTKSVRPLEVTVINHSDVVPWRYPPRNEFLYGEWLRSEFEAG
QIPEPTCNPDLAIVLAKTRKNSVSLYGPDASDILDPVPKTDIRRAIKDSLPDLIEGMKGD
ERNVILTMARMWQTVADGEISPKDVAADWAIPRLPQEYANLLDLARKGYLGEYADNWEGL
ESEVRALVNYMKNSIASYVSI
>CAP45560|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-27|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVTAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNDTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0U3LST2|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDTLLALKALIMGIVEGLTEFLPISSTGHLILTNSLLQFTGPDFSKEKADVFEIVIQAGA
ILAVCWEYRVRIATVLTGMFSDRKAQRLVINLIVAFLPAAILGFLFSRRIKDVLFNPVSV
AIAFIVGGLIILWVERRNKDRMSMASARVETVDDMTPLDALKVGIAQAFALIPGTSRSGA
TIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKERALLSAADVPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTIFAWYRIVFGIIVLVTAYTGTVAWVD
>CAS09877|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
GQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAM
IFFLIKETLPPERRQPFHIRTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IEINHVAPENFGYYFALNILFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMVISA
LLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGAL
LSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>L1NPG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDILKAALFGIVEGITEWLPVSSTGHMILLDEFVRLDVSPEFWKMFLVVIQLGAIAAVA
VLYFDKLWPFARGLRLKREAVPLWSKILLACVPAAVVGLSLNDWIDSHFYNPWTVAVMLI
VFGIAFIVVENRNKHHRPKTVDLTGISYTQALWVGLFQVIAAVLPGTSRSGATILGGIAV
GLSREVAAEFTFFLAVPVMFGASLLKIAKHGLSFTAHEAGVLACGMIVSFVVSILAIKFL
MAYIKRHDFKIFGWYRIVLGALVLLYFAALK
>A0A085GKZ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MIKRTLCSALVLSVSCATFAAPKTLTEQQIGKTVAQTITPLLKAQDIPGMAVAVVYQGKP
YYFTYGKADIEQNIPVTKQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPALSG
SQWKDITLLHLATYTAGGLPLQVPDEVTHQAALLNFYQTWQPQGAPGEKRLYSNASIGLF
GALAVKPSGKTFEEAMKQRVFQPLKLAHTWIKVPASEEKQYAHGYRNGKPVRVSPGMLDA
EAYGVKSSIEDMASWVQYNISPELVADKTLRQGIELAQSRYWRAGSMYQGLGWEMLNWPL
QANTVIDGSDNKVALALTPVTAINPPVAAVKASWVHKTGSTGGFGNYVAFIPEQQLGIVM
LANKSYPNPERVKAAYTILNALQ
>A0A0M3H8L1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGEVDVLKGITLSIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYQVAGVDVVHLSGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGKERRI
RLERARDLLTRLGLGERAEYFPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIIELRDGEIVRNPPPSSPEKGGVLRAES
RAEPSVWRQFSSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVSSATPAVSKSLRLRA
NNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKAKVV
GEVILVGNMPATIVGVADEKQSMFGSSKILRVWLPYSTMAGRVMGQSWLNSITVRVQEGY
DSATAEQQLVRLLELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARARDVLQQFLIEAVLVCLVGGAIGVSLSLMIAFILQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0U5HUT0|FEATURES|UNIPROT_deepARG|aminoglycoside|BN1263320037|antibiotic inactivation|1
MIASAPTIRQATPADAAAWAQLRLGLWPDADDPLEELTQSLADAEGAVFLACAADGEAVG
FAEVRLRHDYVNGTESSPVGFLEGWYVQPQWQGRGVGRALLTAVQAWTRDAGCRELASDS
RVEDVQAHAAHRACGFEETERVVYFRMPLEPSA
>N2IVE7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>R3TQ88|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLSNLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMEMFNVVIQLGAIMA
VVVLYFHKLNPFSPQKNEVEKQDTWILWSKVVVACAPAAIIGIPLDDWLEAKFHNFFTVA
LMLIVYGIAFVVIEKRNRDRKPKCTDLRDFTYKAAAVVGFFQVLSLIPGTSRSGATILGA
ILIGASRFVATEFSFFLGIPVMFGASFLKIVKFVMKGNSFGFTETFILLVGSIVAFVVSI
IVIKFLLNYLKRNDFTAFGWYRIVLGVLLISYWLFS
>A0A0S2FM19|FEATURES|UNIPROT_deepARG|aminoglycoside|LC55x_1285|antibiotic inactivation|1
MKAGWRVRRAEAADLAAWSLLREALWPQEDASRHADDIGQMLSRPHNAAAFLAVDADGVA
RGFAEATLRSDYVNGTDGSPVGFLEGWYVQPEFQREGVGRALIEAVERWTVQCGCSELAS
DALLDNLDSHRAHEACGLRETERVVYFRKRLRDGG
>AAL92527.1|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSNLRHNQILIWLCILSFFSVLNEMVLNVSLPDIANDFNKPPASTNWVNTAFML
TFSIGTAVYGKLSDQLGIKRLLLFGIIINCFGSLIGFVGHSFFSLLIMARFIQGAGAAAF
PALVMVVVARYIPKENRGKAFGLIGSIVAMGEGVGPAIGGMIAHYIHWSYLLLIPMITII
TVPFLMKLLKKEVRIKGHFDIKGIILMSVGIVFFMLFTTSYSISFLIVSVLSFLIFVKHI
RKVTDPFVDPGLGKNIPFMIGVLCGGIIFGTVAGFVSMVPYMMKDVHQLSTAEIGSVIIF
PGTMSVIIFGYIGGILVDRRGPLYVLNIGVTFLSVSFLTASFLLETTSWFMTIIIVFVLG
GLSFTKTVISTIVSSSLKQQEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIPLLDQRLLPM
EVDQSTYLYSNLLLLFSGIIVISWLVTLNVYKHSQRDF
>A0A0F7FBJ9|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKSTSKYERIQHLLSDLKQPAYRFQQIADAIFKQRIGEYDQMTIIPKAIRNELIQNFGEN
VLNLTPVMQKTSNQVNKVLFAIEGNEHVEAVQLSYERGWKSYCISSQCGCGYGCRFCATG
TIGLKRNLTADEITDQLLYFHFNGQALDSVSFMGMGEALANPYIFDTLKILTDSRTFGLG
HRRITVSTIGIIPGIDRLTKEFPQVNLTFSLHSPFDEQRSELMPINNRFPLNDVLNKLDQ
HISDTGRKVYIAYILLRGENDSNEHAEAIAALLKNRGPWEHLYHVNLIPYNSTDATPDSF
HQSDKEQVQRFAHILKSKGIKVTVRTQFGTDIDAACGQLYGHNN
>A0A127SMZ7|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MFFEKIDKNSWKRNEYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINN
>YP_001639853|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
VYFGRLWSIATALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVA
GGIVLLIIDDTVGEPKAAPNEGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVS
RSGATIVGAMLMGASKRSATEFSFYLAMPTMAGAFAKDLLDNYKNLSSNDALLIVIGFVA
AFISALIVVRTVLDYVSRHGFWLFAWWRIIVGSLGFAGLILFG
>ZP_03552050|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDDKAKVFDIAIQTGAIFAVI
LVYWQKIHSTVVALPRQAKARRLALNVVIGFLPAVVLGLLFGKMIKAHLFIPVVVASTFI
IGGFIILWAEKRPPGSVRIEHVDDMTMWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGAYSLYKERALLSVADIPLFSVGLVFSFISAWLCVRWLLK
YISTHDFIPFAWYRIAFGIVVLATAWTGTVVWAE
>A0A0D7F945|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWSALQALILGIVEGITEFLPISSTGHQIVVADLIGFGGERAIAFNIIIQLAAILAVV
WEYRFKVFEIVTDLPRKSYAQRFTGNLIIAFLPAAVLGVILGDLIHEYLFNPITVAFALV
IGGVIMIWAEKRTHRIRVEEVDDMRWHDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGATVYSVYKYRHLFTASDVLVFGVGFVTSFLFAMLAVKALLKF
IGNHSYEVFGWYRIVFGLLILATWQFGGIDWHAAKAAG
>A0A0J6QK25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPILLFHSLIMGLVEGITEFLPISSTGHLILTGDLLGFLDKEKRDVYEIFIQLGAMLAV
VWEYRRKIGHTVAGAVRPGGERNLLLGIVIAFIPAAVAGLLFSKQIKAVLFNPVCVAIAF
IVGGLIILWAEKREHKVAVETVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGLFLGL
SRKAATEFSFFLGIPTLGAASLYSLIKHRDALSADDIGVFAVGFAASFVFAFLAIRALLR
FISTHSFAVFAWYRIAFGLIVLGTWWSGLVEWSA
>A0A0G0A1G9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLFQTLLLSIVEGTTEFLPISSTGHLILVANLFKIPQTEFVKSFEIIIQLGAILAVVAI
YFRKIITNLDAKLWKNIIVAFLPSAIFGLIFYKYIKLYLIGNSTVVIWSLLIGGVAMLLF
ERFHKFSSIRYTLSPIRYLVIGLFQVLSMIPGVSRAFATIFGGMVVGLNRKEAVEFSFFL
AIPTMFGATVLDIYKTKIWLNPTPDVGLLIIGFFASFLTAYFVIKWFIKFVESHNFTIFG
WYRIILALIFLFYL
>X0QML4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILLIQAVIMGIVEGITEFLPISSTGYLILSADLLGFWTKEKVDLFVVVVQLGAILAV
IYDYWDRLWQALMGLLTGKAEGMSNPRQLGLSLIVATIPVMIVGFTFADEIKSYLFNPIV
VAIMLIIGGLLIFYVENRPKTIIAQEAEDVNLKTALMIGLLQCLALIPGTSRSGATIIGA
LWLGVSRKLPLNFLSFGIPVIVGAALLDLLKHHDVLTNSEDWLVLGIGTVVSFIVALLCI
RLLVEWVSRRDFKIFAWLRIITGIIVLIAAWGFGYQMAG
>Q2NRV7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVIFAYHDMGCVGVTALINAGYTIEAIITHPDAPSEKTFFGSVARIAAEHNIPVFVPD
DVNHPLWIARIKALAPDVIFSFYYRQLLCQDILSLPTVGAFNLHGSLLPRYRGRSPLNWV
LVNGEQETGVTLHRMTARADAGAILAQRSVAITLQDDALTLHRKLCEAAAGVLEKVLPAI
REQRCTETPQDESIASYVGHRTPEDGRIDWGQPAATLANLVRAVTDPWPGAFSYAGGEKF
IIWKAQVRPNSADAQPGTVLSIDPLVIACGSDALEVQTGQSQQGVYMQGGQLAHALGLVK
GALLNPRPLVSHKRRTRVLILGVNGFIGNHLTERLLRDGNYEIYGLDIGTDAISRFMVNP
LFHFVEGDISIHSEWIEYHIKKCDIVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRHC
VKYQKRIIFPSTSEVYGMCTDPVFDEDDSSLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSHIKLVDGGAQKRCFTDI
SDGIEALFRIIENKDNNCDGQIINIGNPDNEASIRQLAELLLASFERHPLRQHFPPFAGF
RDVESSSYYGKGYQDVEHRKPSIRNAKRLLGWAPSVPMAQTIDETLDFFLQTVDLPDAAQ
>A0A0G3YN16|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARELLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDPAVARHAKRIIEISDGEIVADRPNRHYAEALAEVSV
GAAEAAEAIEAEAGALPADDRHDTPPPAPVDTDAHPDTGTRTRRFAAGSGRFAEACRMAW
IALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINLYPGTDWGD
SRADAIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVNALVSGVGDRFFQARGM
RFAQGVAFDEDAVRRQVQVAVIDQNTRRKLFGATRNPIGEVILVDNVPCVVIGVTADKKS
AFGSVKSLNVWVPYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLMTQRHGRKDF
FTYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVG
ARQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSAGAIVTAFICST
LTGVIFGFMPARNASRLDPIDALARD
>A0A142FK27|FEATURES|UNIPROT_deepARG|aminoglycoside|aph(3')-VIk|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIA
IIDCPFISNIDHRLKESKFFIDNQLLDDIDQDNFDAELWGEHKTYLSLWNELTETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASEETAKIFLQH
LKNDRPDKRNYFLKLDELN
>B6XC59|FEATURES|UNIPROT_deepARG|aminoglycoside|PROVALCAL_00921|antibiotic inactivation|1
MTKVCTSELITEWLALRLALWSTSDESSHLSEIKDILNNPNLSAFFAFDDNQQIVAFAET
SIRVDYVNDCSSSPVAYLEGIYTAPHARKRGYAKDLINHVKQLAIKNTCKELASDTNLDN
EISQKLHQSLGFIETERIVFYKQQLSD
>V5PXA7|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTKPHLTLFASLVATAAIGWMAFSARSFAAEPDDATTRTNPRQEEIRSLVDKTIRPLMAR
QDIPGMAVGILFDGHTYVFDYGVADKAANKPVTADTLFEIGSVSKTFTATLAAYAQADGA
LSLTDKASRFAPEFAGTPFGDVKLVNLGTHTSGGMPLQLPDNVRTTDQIADYLKAWKPAK
PTGTVRTYSNVSIGALGWLTARAMQGDFATLMAEHVFKPLDLRHTFIRVPESEQANYAWG
YKDGKPVRVTPALLEPEAYGVKTTAADLLRFVNANLGQPVPDRKLRHAIYATRTGYYFDA
PMTQDLVWEQYPYPVTLDALLEGNSSHMALNPTPVRELSPPMAPTPVAWVNKTGSTNGFG
AYVAFVPSKQMGIVLLANRNYAMDERIRAAHLILTTLDGARP
>A0A0J1MTW1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFVVAAAVYVVFF
>CAC86407|FEATURES|ARDB_deepARG|aminoglycoside|APH(6)-Id|antibiotic inactivation|1
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTSAIVKGLKPIEDIADELRGADYLV
WRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMANCMPASEDPCL
LPFSRSGIALQLCFSGRANDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMF
SSRGWLVKDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLL
EQAYAYGCLSAAWNADGEEEQRSLAIAAAIKQVRQTSY
>A0A0M0W260|FEATURES|UNIPROT_deepARG|chloramphenicol|AMS62_24270|antibiotic inactivation|1
MKFHIINVEQWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTR
VVNDRVEFKTSYSPKGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDM
ERYRDAKGIFVKENPPPNTFPISMIPWASFSGFNLNIVSEADYLLPIITGGKYNEQGGRI
LLPVSLQVHHAVCDGYHASMFFQDLQSLADSCEDWLT
>YP_584847|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRQRIGTVISGLASDVKSQRFAVNVIVATIPAIVLALVFGKWIKAHLFNPITVATAFI
IGGVVILLAEWREARRGTVSAPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLSADDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIIVLLTAWTGVISWHA
>A0A060L057|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTSNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A062X695|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAFLFGVVEGITEWLPISSTGHMILLDQFVQLGVSEDFYSMFEVVIQLGAILAV
VVIYWHKIWPFHQADKSAHAQGIWRYVDKDIMVMWLKIFIACLPAGIIGVAFNDTFERLF
YNPTCVAIALIVFGIAFILIEDIHKNKQPKITSIAELSYYTVVLIGFFQLIAAVFPGTSR
SGATIVGALILGVSRTVATEFTFFLAIPVMFGAALFKLVKFGFSFTPLEIWILVVGLVTA
FITSIIAIKFLMQYIKKHTFKAFGWYRIILGLLVIAYFWFVK
>A0A023REU1|FEATURES|UNIPROT_deepARG|beta_lactam|B224_1061|antibiotic inactivation|1
MQQQVRMTLLMASTLLWAGLAQATADTQADPLRPLVDASIRPVLKEHRVPGMAVAVLKDG
KAHYFNYGVANRESGARVSEQTLFEIGSVSKTLTATLGAYAVVKGALKLDDKVSQHGPWL
KGSAFDGITMAELATYSAGGLPLQFPYEVDSIDKMRAYYRQWTPAYRAGSHRQYSNPSIG
LFGHLAAQSLGQPFEQLMSQTLLPGLGLEHTYLKVPAEAMANYAYGYSKEDKPIRVNPGV
LADEAYGIKTSSADLLTFVGANMTGTGDEAMQQAIALTHKGVYSVGAMTQGLGWESYTYP
VTEETLLAGNSAKVILEANPTTPAPNETGSQVLFNKTGSTGGFGAYVAFVPAKGIGIVML
ANRNYPIQARVETAHAILSQLAE
>A0A084U5Q5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQTIAQALVLGILEGLTEFIPVSSTGHILLAGHFLGFESTGKAFEVLIQLGAILAILS
VYAARLWRILIDFPKDENTRRFVFGVLLAFLPAAVIGVLAYKIIKTVLFETPMLICIMLI
LGGFVLLWVDRWARSPRYHDITKFPLSMYFKIGLFQCLSMIPGTSRSGSTIVGGLLLGAD
KRAAAEFSFFLAMPTMAGAFVYDLYKNHEILSAADVKIIGVGFVAAFFAAVLVVRWLLGY
VSRRGYSLFGWWRIIVGTLGMIGLLVLG
>J8P4W0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGITSGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A0A8X2Z8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGINHLLFSVSDLEKSIDFYKHVFDARLLVKGKTTAYLDLNGIWLALNVEKDIPRQE
INQSYTHIAFSIDEVEFEPMYNRLKDLEVNLLAGRLRNEKDKMSIYFTDPDGHKFEFHTG
TLQDRIDYYKNEKGHMRFYD
>A0A112LPK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLIVLKALMMGLVEGFAEFLPISSTGHLIVFGNLIDFHSNHKVFEITIQLGAVLAVVF
EYRQRFSNVLHGVGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIVDVDALRPIDALMIGVAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFVAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>L9PX76|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLQTIIIAIVEGLTEFLPVSSTGHMIITQHLLGVEQGNPFVHAFTFIIQFGAILSVVC
LYWKKFFSFTSDMWRLYKLLVIGVLPAVVVGLAAKKSGLLDWLLDSIWVVAITLVLGGIF
MLFCDNIFNKGREENEVTPKRAFLIGLFQCLSVIPGMSRSMSTIVGGMANKLTRKKAAEF
SFFLAVPTMAGATILDVYDMMKGDVKWATSDNLFLLGVGCVVSFAVAIFAMKWFVSFLTK
YGFKAFGWYRIIVGVILLAMLFSGMSLNMVD
>A0A0J1VUB3|FEATURES|UNIPROT_deepARG|beta_lactam|SP99_00382|antibiotic inactivation|1
MMKKSLSCALLLTVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSDMSFEEAMTKRVFKPLRLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVMANMAPDALQDSSLKQGIALAQSRYWCVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>G0K314|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAVQNRAHQTGAPVTRRTRLVQQGSSILSTFFLPPRVHAPSMSDLLSALLLGILEGLTEF
LPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQRLLRLATGFNQRENREYVF
KLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWMLLVEAYTARLPDRDQVTWT
VAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFL
EMAKAGQLGSENWTDVGVAFVAAAVTGFVVVKWLMGYIKSHRFTAFAIYRIALGAALLLW
LPSGS
>A0A0C2EI94|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTESLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>ZP_04300309|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MVKGINHLCFSVSNLEKSITFYEKVLEGELLVKGKKLAYFNICGVWVALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREDKPHMTFY
>A0A0F4VB15|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIESLLSSGFDIAAVFTHADDPKENAFYGSVAQLCARKGIPVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQKTVAIERSDTALSLHGKLRLAASDLLHDTLP
ALLAGKVSETPQDESQATVFGRRTPADGKLVWQKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWNAEVAKGNEGQAPGRVISVDPLRIACGEDSLVITAGQRNDNGLYLSGPQLANELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNDNDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
DKR
>M9KB82|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPSGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>C3JA72|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILESIVLAIIEGLTEFLPISSTGHMIFTQGLLGMQSTDYSRAFTVMIQFGAILSVVVL
YWRRFFVPGAQQMGASGDKSTRWKDFFLFYLKLAVGCLPAAVLGLLLEKQIDALLGSVWV
VATMLLLGGVLMVFVDRIFSKSQGEKITFGNALWIGFFQCIAMIPGVSRSMATIVGGQQQ
GLSRRTAAEFSFFLAVPTMFGATLLKAYKLYKGFGSAIFAENWQTLLIGNVVAFLLALVA
IRFFINFLTRYGFKVFGYYRIVVGILILTLLACGVELTID
>R8F1Z6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EKIGLKPFAYYRILLAIVFTLFVLL
>A0A0U0XQL0|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVMAVLTVPEDPASTKGKPTIAAATRIVLRAFGA
>A0A132HML6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKIFASYRLRTVTAALALCTASAHAAGDGVPVGEDRLARLVADTVRPVMAQYEVPGMAVA
VTVRGKSQVFNFGLASKADATPVTEHTLFEIGSVSKTFTATLASYAAQRGAISFSDKASQ
YLPGLAGSSLDAISLLELGTYTAGGLPLQFPDAVTTSDQMLAYFKEWKPTYAAGTHRQYS
NPSIGLFGYLAARSLGEPFDNLMEHRIFPGLGLKHSFIRVPQSRMGDYAYGYKDGKPIRV
NPGMFDSEAYGVKTTAADMIRFVEANMDGARLEPTLQRAVTGTHTGYFRVGPMTQGLGWE
MYTWPTSLEDLLTGNAAGMLEPKEVARLAPPQPPRADVLINKTGSTNGFGAYVVFVPARQ
IGVVMLANRNLPIPERVRAAYQILKALDAQ
>A0A0K2J3V2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTILQAIVLAIVEGLTEFLPVSSTGHMIIAEGIMGVESTSFVRAFTVMIQFGAILSVLVL
YRKRFFCFPVAPRALGQGKGKEFMSRFDLYWKLLIALVPAVILGFLFEDWVDRMLGSVWV
VAVVLFLGGIFMLFVDKLFASSDRGEITYPKAFVIGLFQCLAIFLPGLSRSMATIVGGQQ
QKLSRKAAAEFSFFLAVPTMLGATLLKAYKLYKEGGIEIFREHMTVLLVGNIVAFIVALA
AIKFFIGFLTRYGFKAFGYYRILVGGLLIVLMLSGVSLAV
>A0A0D5L6X1|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MNHSPLRRSLLVAAVSAPLAGACAPLRGNSKNVAAERQLRELESTFDGRLGFVALDTATG
ARIAHRADERFPFCSTFKMMLSAAVLARSADDAALLQRRIPYAKRDLVRYSPITERHVGA
GMTVAELCAATLQYSDNTAANLLIDLLGGPQAVTAYARSIGDATFRLDRRETELNTAIPG
DERDTTTPAAMAASVRRLLAGDALGAAQRAQLNAWMLGNKTGDARLRAGVPAGWRVADKT
GTGDYGTGNDIGVAYPPDRAPIVFVVYTTMRSQNAPVRDDVIAAAARIAARAFA
>Q8D341|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKVIVFAYHEIGYIGLSCLIKLGFKVLSVITHIDDHASEKIFFSSVKKKSLKHKIPVFYP
KNINNLKWIDYLSKLKPDIIFSFYYRKILSEDILKIPKLGSFNLHGSLLPKYRGCSPLNW
VLINGEKTTGVTLHRMTKKIDHGSILSQYSIKIEEKDTSKSLYKKLCYASMYILNKTLPM
ILKNKINEIDCTDDFSSYFHKRYPKDGLIDWNQSANNIYNLIRALTKPWPGAFSYLFDKK
IIIWKSKISFESYKTPGTILNFNPLIISCKKKSLEILSAQYTECNILNKRNIENISRIKG
KKLIIKNIKSFKNLKKILILGVNGFIGYHITNLLLKYNNYKIYGIDIKNNLVKSFIGNEK
FCFIKGDIKQYYNWVKKKIKKCDIILPLIAIARPMQYIKNPLKVFKIDFEENLKIIRYCV
KYKKRIIFPSTSEVYGMCKDDYFDEENSNLVTGAIKNQRWIYSSSKQLLDRIIWAYGVKN
NLNFTIFRPFNWIGPGLDDFKIAEKQNARVTTQIIFNLINGLPVTIVNNGNQKRCFTDID
DGIEALFEIIKNKNNKCNKKIINIGNPHNEYTIMQLTKIIINIIYSNNRNYNFPKFSGFN
MLSGTNYYGEGYQDIDRRKPNIDIAKKLLNWTPKTKIRITLRKIINFFINNNTS
>A0A0S2DDB2|FEATURES|UNIPROT_deepARG|aminoglycoside|GLE_1155|antibiotic inactivation|1
MTQPWRVRAAAPADRAAWATLRAQLWPEQPLAELAADLDGWFEDARLAAFIAEDGEGVCG
FAEASLRSDYVNGTESSPVAFLEGWYVAPSHRGRGVGRALVATVEAWGRERGCRELASDA
LLDNLDSHRAHAACGFEETERVVYFRRRLDAQ
>A0A0W0SH12|FEATURES|UNIPROT_deepARG|beta_lactam|Lche_0322|antibiotic inactivation|1
MKKNIVFLCMGLFFCTPIWAQGTCFLAYENQTVLKHEGDECNQRYAPESTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQHLGMKRFKNYV
TAFHYGNQDVTGDKGQDNGLTHAWLSSSLAISPTEQNKFLQKIVYKKLPVSKKAFTMTKD
ILYIQELAGGWKLYGKTGTGRQLSADKSKKLPLQHGWFVGWIEKDGRVVTFVNHIADSKE
KATFASFRARNDALIKLHYLINELEK
>A0A0M1I2K3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAVIQGLAELLPVSSSAHVILAEKLMGFDPSASNMTFLLVMLHTGTMFAVIV
YFWHSWKKTYFSDWASFKQRAWYVLLATAMTGALGLLLQSLIKHVFFGGASSFEIEHLFS
NAKLMAAALAAAGVLIILSSRLDRGQQGDVRLPSAIIIGAVQALCLPFRGFSRSGATIST
GLFLGISRQKAEEFSFALAVVLTPAVIAKELLRLLHAQQTTTGTAHLTLSSLFLPSLFGM
VFSFLTGLLALKWLSAWLEHGRWYLFGIYCLAFSGVVLALA
>J8RSI0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKKESTTFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSADDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>W4QIQ0|FEATURES|UNIPROT_deepARG|beta_lactam|JCM9152_3453|antibiotic inactivation|1
MKITKMTCSILLGTLLFFGCSSDQEQDQTSSDQPEFERPTPTVEDTFSQLEEEYDARLGI
YALDTGTGKTVTYRSDERFIYASAHKPLAVGVLLQQKSMEELDEHITYSRDDLVNYNPIT
EHHVDSGLTLKELSDASIRYSDNTAANLIFHAIGGPEGFKEGLRAIGDNVTEPERIEPDL
NDVEPGEIQDTSTPEALAKSLQQFTLGDALSEDKQELLIDWLKRNTTGDDLIRAGVPEGW
EVGDKTGSGSYGTRNDIGILWPPGRDPIILSVLTSKEEQDADHDDTLIARATEEVINILF
GTE
>A0A0M4G0X0|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-457|antibiotic inactivation|1
MTVRLFSTALGAALSLSALAGAPAQAAILCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
VKAAAYDLAENLFEVGEASGWHLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>S1M5Q7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGISVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDEILQLAPTGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCYAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSVLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHASTAQPGSVISAAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVE
GSRLNSQPVCTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCNDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALFRIIENTGNRCDGEIINIGNPDNEASIEELSQMLLASFEKHPLRHHFPPFAGF
RIVESSSYYGKGYQDVAHRKPGIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDK
>A0A0M0T2Q7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIELLKALLLGFVEGMTEFAPVSSTGHMIIVDDMWLQTTDFLGKYSANTFKIVIQLGS
ILAVVVVFWKRLFSLIGLYKIEGEHDASGTHKLKLRHVLIGLLPAGILGLLFEDFIDENL
FSIETVIIGLAVGALLMIAADKFGPKEPKTTSLDQITYRQAALVGLFQCISLWPGFSRSG
STISGGVFLGMNHRTAADFTFIMAVPIMFGASFLSLVKNWSDIQPNHFAFYAVGFVASFV
FALLSIRFFLKLINKIKLVPFAIYRLVLAAVLAVIVYM
>A0A031GJ92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFLQLFILSIVQGFAELLPVSSSAHVIMAEKLMGLDPTSPELTMLLVMLHTGTMFAVIV
YFWASWRATYFSSTSAFRSNVLLLAASTALTGIVGFGLLKVITHVMSKDAPGFEIEHLFG
NAKLMAAALAAAGVLIIVSSRQQARQHGTLSIGKAMVIGAVQGLCLPFRGFSRSGATISA
GIAMGVPQRRAEEFSFALAVVLTPAVLAKEGWRFYQAVTNGSLDHLEHGNSLLHLLGPSL
LGMLLSFLVGLLALRWLSRWLEQGRWHFFGAYCLLASLVVLYVG
>B8ZHY3|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWRKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDGKN
>A0A0F6MXY3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|pseF|antibiotic efflux|0
MSRPLLELKGVSRSFMAGEKDFKALKDINLTINAGEIVAITGASGSGKSTLMNVLGCLDH
ASSGSYKVDGRETSAMDDRELAVLRRDHFGFIFQRYHLLPHLSALHNVEMPAIYAGVAET
QRHNRAGELLARLGLDGHLLNRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMKILLELNAAGHTVIIVTHDEKVAANAKRIIEIQDGEIVSDRVNLDRPVEDLPVQD
ERPPKVKQANRLVAGLGLFSEAFNMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIAAIGSSTIEIFPGTDWGDSRASAIETLVLSDVTALSDQYYIDSATPNVGRN
LLLRYENIDVTATVNGVSESYFQVRGIKLGEGVVFGKDDARRQSQVVVIDHNTRVRMFGP
NVDPLGKVILVDNLPCTVIGVTEDKKSVFNTSKALNVWMPYETAAGRLLGQRYLDSITVR
MKDGQPSKVVEDNIIKLMEQRHGVKDFFTYNLDSIMQTVQKTSQSMALLLSLIAVISLVV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLVGGTIGIALSFGIG
FIFSLLVKEWQMVFSMGSIIMAFVCSTLIGIVFGFVPARNAARLDPIEALARD
>ZP_03838598|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MQMKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYSNGYRDANGVNSNATSASLQLTQSIFDMSKWRALTLQEKSAGIQDV
TYQTDQQTLILNTATAYFNVLNAIDVLSYTQAQKDAVYRQLDQTTQRFNVGLVAITDVQN
ARSQYDTVLANEVTARNNLDNAVEQLRQVTGNYYPELASLNVDGFKTNKPQAVNALLKEA
ENRNLTLLQARLSQDLAREQIRQAQDGHLPTLDLTASTGVSDTSYNGSKTNNNAQYDDSN
MGQNKIGLTFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLANARYTYLINQL
NVKSALGTLNEQDLVALNNTLGKPVSTTPDTIAPQNAQQDAAADGYTSNSPAPAAQPTAA
RTTSSNGTNPFRN
>A0A0V9DWZ5|FEATURES|UNIPROT_deepARG|beta_lactam|APT89_22520|antibiotic inactivation|1
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
FTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0P0R3M8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILTLKALILGVVEGLTEFLPVSSTGHLIVAGSVLNFDVPQEKTFDVVIQLGAILAVC
WEFRQRIVDVVSGLGTRPEARRFTLNVIIATIPAIVLGLLFEKSIKAVLFSPVPVALALV
VGGVLILWVESRQRNRADVQARVHSMDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLDRRVATEFSFFLAIPIIFGATVYELHKGWHELSTDALGLFSIGFLAAFVSAFACVR
WLLRYIAAHDFSAFAWYRIGFGLLILLIGYSGGLSWAD
>CAQ52800|FEATURES|ARDB_deepARG|trimethoprim|dfrB1|antibiotic target replacement|1
MQRVVGPHRTPRSSQERSEMERSSNEVSNPVAGNFVFPSNATFGIGDRVRKKSGAAWQGQ
IVGWYCTNLTPEGYAVESEAHPGSVQIYPVAALERIN
>A0A098M8V6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTANLLGFAEQEPIMKTFEIVIQLGAILAIAL
VYRQRVLSLFGLGRSPSERGGVMPRARLNLLHIFLGIAPALGVAFFARDFIKGLFGATTV
LWALVAGGILMIVAEWVNKRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYRASADFSFLIAIPIMCAASGYELLDSYTYFTSETIGYFVIGFLISFVVAY
LVVIVFMKLIQKIRLTHFAIYRFILAAVFWLFIMR
>K7QD65|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
VKENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
KSIGAKVVATRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLHA
FYAGPAHTPDGIFIYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTV
VGGHDSPLHGPE
>AAF34177|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
VVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDI
EPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>YP_492684|FEATURES|ARDB_deepARG|tetracycline|tetK|antibiotic efflux|1
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
TFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAF
PSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIV
TIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHI
SRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIF
PGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMG
GLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLE
FINYSSGVYSNILVAMAILIILCCLLTIIVFKRSKKQFE
>A0A0G3LU90|FEATURES|UNIPROT_deepARG|aminoglycoside|FD63_13310|antibiotic inactivation|1
MSDGYSIRAAVAADLRAWAALRVALWPDERDAFGGVVEALQREDAANFLAFASDGHAIGF
ADVTLRQDYVNGTDSSPVGFLEGWYVVPEWRGRGVGRALLRQVQEWTCAQGCSQLASDAL
LDDAAAQAAHRACGFEESERVVYFRMPVAD
>A0A0M2F112|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
SDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVIITLDADLQNPPEEIPRLVEYAAQGYD
VVGTVRANRKDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLATTLRDEEE
>A0A126PIK5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCAGTLALLDAGYDIAAIFTHPDAAGENHFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQRVAIDADETALELHHKLCTAAQSLLRDALPAI
LNGTFSETEQDESKASCFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLVVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAISRFLNNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDASSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPENEASIRELAEMLLASFERHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>Q7X5K5|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV-12|antibiotic inactivation|1
MRYIRLLFISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTHYPG
QHGRDPAQAADQPASERPFATAAAAVDGGRRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>YP_855286|FEATURES|ARDB_deepARG|beta_lactam|imiS|antibiotic inactivation|1
MKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVISTRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYLGPAHTPDGIFV
YFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELI
DHYEALIKAASQS
>U2XPN4|FEATURES|UNIPROT_deepARG|chloramphenicol|MTS1_02191|antibiotic inactivation|1
MHDAAPIDLDTWPRRRHFDHYLRTVRCTYSMTVEIDVTDFVAAVRSSGRRTYVAQIWAIA
SIVNRHPEFRMTLTADGAPAVWPEVQPSFTVFHPETETFSSVSVAFDRDFAAFHDAAARV
IADHAGSTELFPQGPPPPNSFDVSSLPWTDFTGFNLNVEGVEAHLAPIFTLGRYVERDGR
MLLPMAVQVHHAAADGFHTARLVNDLRELFADVAWLAA
>A0A0M4GY09|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGMFTGEPKGRRLGFSLIMASIPIVLIGLTLGQSIKELLFNDIAVAIG
LIIGGLIIIWIEKNPPVVKAQEVENISYKEAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSYDVFKTNQDWLVLATGTLVSFISALILIRVL
VAYVAKRDFMIFAWYRIASGLLILLFALTGWKLW
>A7ZP73|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>CCQ20328.1|FEATURES|CARD_deepARG|macrolide-lincosamide-streptogramin|msrA|antibiotic target protection|1
MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGSV
TTQGKLAYIKQLSTDTSTKSGGEKTRKAQHAMRQNPSVLLADEPTSLMLKASNI
>S3IJ03|FEATURES|UNIPROT_deepARG|beta_lactam|ICA_01678|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLKAKNK
>A0A0R3AZU3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRHLTALAMFLGAGQCLAATDLQAVVDASVKPLMQQQAIPGLAVAVVQNGKVQYFNYGMA
SKEAQQPVNQNTLFEIGSVSKTFTATLGGYAQAIGKLTLSDKASQYWPALAGSAFDRISL
LQLATYTPGGLPLQFPDAADNADAMLGYFQRWKPSYAPGAQRLYSNPSIGLFGYLAARSL
GQPFNVAMEHTLLPKLGLSNTHLSVPTAQSGEYAQGYDKQQKPVRVSPGALDSEAYGIKT
STHDLARYVIANLHPQTLEKPLQQAIASTHAGYYRVNGMTQGLGWEYYPYPIALQALIDG
NSTPMAMEPHRPDWLATPQAQPANVLYNKTGSTAGFGAYVAYVPSKDMGVVILANKNYPN
AERVKVAHAILSALDH
>A0A135NT80|FEATURES|UNIPROT_deepARG|aminoglycoside|AXZ07_12315|antibiotic inactivation|1
MAMIQPCTDPGSPAWLHLRRALWPDSAATDHLAEMVDIAGRPATFVALLAYDEQGRAQGL
AEASVRHDYVNGSNTSPVAYLEGVFVEQASRGQGVARQLIAAVERWADGKGCRELASDAA
LDNLGSQRMHAALGFAETERVVYFLKPVAPLD
>A4WAM4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTKVEAIHKVSVVIPVYNEQESLPELIRRTTAACELLGKDYEILLVDDGSSDESASMLSD
AAEEPGSHIVAVLLNRNYGQHNAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDTWFRKRASRLINRLIQSTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARKAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSVFG
SIIAVLGFTLSVLLVVLRIAFGPQWAADGVFMLFAVLFMFIGAQFVAMGLLGEYIGRIYT
DVRARPRYFIQRVVSRGSVSTSKENQQ
>F3K1G2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
LGGVIMLWAERREHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A148HST5|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF3040_03041|antibiotic inactivation|1
MAGRFVWKPDPMFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>Q704Y9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>D8IXD7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDTLLALKALIMGIVEGLTEFLPISSTGHLILANSLLQFTGPDLSKEKADVFEIVIQAGA
ILAVCWEYRVRIATVLTGMFTDRKAQRLVVNLIIAFLPAAILGFLFSRRIKEVLFNPVSV
AIAFIVGGLIILWVERRNKDRMSMASARVETVDDMTPLDALKVGIAQAFALIPGTSRSGA
TIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYSLYKERALLSAADVPLFTVGTVAAFVS
AFLCVRWLLRYISSHDFTIFAWYRIIFGIIVLVTAYTGVVAWVE
>M3J8M9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|H740_10307|antibiotic efflux|1
MKNLIELKNLSKKFKLGDNVFDALKDVNLTIKKGEFIAIIGQSGSGKSTLMNILGCLDNP
SGGQYLLEERDISKFEGDELARLRREKFGFIFQRYNLLSTLTTLQNVALPSVYAGVSKKD
REKKAGELLEGLGLGEKLQNLPSKLSGGQQQRVSIARALINGGEIILADEPTGALDSKSG
LMVMEILTNLHKQGHTIIIVTHDPNIAAYANRVIEIKDGKILSDTVKSEEIFASEKPAPK
QKNIFSFYKDQFIESFKMSINAILSHKLRSALTMLGIIIGITSVICVVALGQGSQEQILS
DIRGIGTNTIDILNGKGFGDMRSERVRNLTVSDAAMLSKQDYLDSVTPNASASGTLTYGN
KSASATIKGGSEESLNVMGYKVEAGRVFTAQEVAESASVIVIDQPTREQFFADEDPLGKT
VLFNKRPFKIIGVVAKNDNMFADSSTLRTFSTYTAVINKLTGDRHLSSITVKVKDNVNAQ
IAEQSLTEILTAKHGKKDFFTRNSDTIKKTIEETTRTMTLLISCIAFISLLVGGIGVMNI
MLVSVTERTKEIGIRMAIGARQGNILEQFLIEAVLLCLIGG
>C6CR01|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTTACEQLSQDYEILLVDDGSSDNSAAMLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVAGDLVITLDADLQNPPEEIPRLVSTAEQG
YDVVGTIRENRQDSWFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARRTTEILVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIAISGFTLALLLILLRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRIVGNDPRFSEQDNEE
>J6HWM5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGNIEVLKGITLNIAAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKA
RLARAHELLVRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMGILHQLKAQGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPALSPAQGGVLRQRT
AAEPSAWRQFSSGFREALIMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRA
DNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKARVV
GEVILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
DSAVAEQQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A8SKZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MWLLDIIKVIILGIVEGITEWFPVSSTGHMILVDEFLKLNQSAEFKEMFLVVIQLGAILA
VVIMFFNKLNPFSKKKTKEQQKDTINIWLKVIVGVIPAGVLGVLFDKTLEKYFYNFPTVA
FTLVLYGILFIVVENNPKFKKQNVKRFEDLSYSLAFYIGCFQVLSLIPGTSRSGATILGA
LILGLSRSLAAEFSFFMSIPVMFGASLLKLRKFGFAFSLFQFFILILGMFVAFVVSVMAI
KMLMRYIKKHDFKVFGYYRIVLGVILILYYILH
>K8FK42|FEATURES|UNIPROT_deepARG|beta_lactam|bla-oxa|antibiotic inactivation|1
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTF
KLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARA
LGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLHISPFEQVDFLRKFVNRQLPV
KAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFA
RLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK
>A0A0J1FP32|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MSLIIKAIILGIVEGITEFLPVSSTGHLIIVNEFINFTGSFAKMFDVIIQLGAILSVVVY
FWHKLFPFGRHKSRLEKAEIWDIWKKTIIGVLPALFIGALLGKRIEDKLFTPVVVALALL
IGGIILIIIENKNAGGKISSIKQLSYKTALSIGFIQCLAMIPGTSRSAATIIGAMLLGSS
RLVAAEFSFFLAIPTMVAASGYSLLKIGLGMTAYQLLLLAIGFVVSFIVALFVISGFMNY
ISKRDFKLFGYYRIVLGILVLLYFNFLK
>A0A101HJY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLIEAIIIAVVEGLTEFLPVSSTGHMIITQSLLGMESSAFVKAYTVIIQFGAILSVVVL
YWKRFFRLNRVEKIAVEPLKALSKKQRILLAGRNFLHKYDFYWKLVIALLPAGIIGLLLG
DLIDSMLESVTVVTAMLVIGGIFMLYVDRWFNRPTADQSMGWQRALKIGFFQCIAMIPGV
SRSMATIVGGMGTGLNRRNAAEFSFFLAVPTMAAAAGYKLYQLMRDPLQLDMLADHLLLL
IIGNLVAFLVAMAAIRFFIDFLTKYGFRAFGFYRIIVGGILLILILAGVDVTI
>K1UZ74|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MHLPDPPSVEEIPVGDEKDGPYGIASGADGALWLTFAGSGRIARLAPGGGLRTYALDPPG
CRPTVITPGPDGALWFTRHGDQRIGRVTVDGDSTSFPLPTQDSGPFGITAGPDGALWFTE
TRTDRVGRITVAGEVTEFGLPGTAPGALPSAITAGPDGALWCTLNQADAIGRVTVDGEVT
TYPLPTSGAAPVGITSDGTALWFVEIGAGRIGRISVDGVIEEFPLPDPAARPHAVVAAVP
GECWFTEWGANRVGRLTGDGEITEYELPTPASEPHGITSGPDGALWAALETGGVARIVP
>A0A0B3T7A7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLAFKAVILGVVEGLTEFLPISSTGHLILAGSLLDFNDEKGKVFEIVIQFGAILAVC
WEFRVKISQVVAGLGSDAKARRFAVNVIVACLPAIVLGLLLGKHIKAALFNPSVVATAFI
VGGVIILLVERHNRRNAEAGKLPRVNSIDDLSVVDALKVGCAQCLALVPGTSRSGATIIG
GMMFGLERKVATEFSFFLAIPILFGATLYELYKARATLSVDDFSLFGIGFIAAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGLVVLATGYSGLVVWAD
>ZP_03060956|FEATURES|ARDB_deepARG|multidrug|MdtH|antibiotic efflux|0
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
GLGIFGGAIADRFGAKPMIVTGMLMRATGFATMGIAHEPWLLLFSCLLSGLGGTLFDPPR
SALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAF
NAWLLPAWKLSTVHTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAG
APSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQL
FTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLG
KSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>A0A0Q0C353|FEATURES|UNIPROT_deepARG|beta_lactam|ALO94_201046|antibiotic inactivation|1
MQRNGTLLCTGLLLVSSVAFAEDNSAALDTLVQTEARKVMQENNITGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGRLSLTQSIDSYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPEKVQNTRQLMDYFKAWQPEYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVSVPDDKQALYAQGYNTLDEPVRVNPGVLAAE
AYGVKSSSRDLIRFVEANIGLGQYDAPLQRALSDTRIGYFKVGGMTQDLAWEQYPTPIHL
DVLLAGNASAMLNTQKADAIEPPLAAQPTAWVNKTGSTNGFGGYVAFIAQKQLGIVILAN
KNYPNEERVKLAYRILQHAEPLN
>A0A0G4BZP5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A132EI25|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNVTRFVATLLVAGCAAATAGRAAAVTPDEVRQAVNRTVAPLMKQYEIPGMAIGVIAD
GRPYVFDYGVMSTQTGQPVAADTLFEIGSVSKTLTATLAADAQERGELSMTDPVSRYVPA
LQRSPFGRVTLVELGTHTAGGLPLQVPDAIRDEAGLMRYLDAWQPAYAPGTRRTYSNVSV
GMLGWIAAKAAGGDFSALMTQRLFAPLGMTHTYIDLPDARKADYAQGYTKDGKPVRMTGG
ALWREAYGVRTTAADLLRFVQANLGLLDTPLQLRRAIERTHAGYVRAAPLTQDLIWEQYP
YPVALPTLLEGNGMKMIVDATPASELKPPQPPRQDVWINKTGSTNGFGTYVAFIPAKRVG
IVMLANRSFPNDARVEAAYRILASLTDGR
>F1AW47|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
FSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWET
ELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPA
GWFIADKTGAGERGARGIVALLGPNNKAERIVVIYAG
>A1T6B0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIPRVTSTAQTDLTEGADPYGICAADDGALWVTLVHSGAVVRLSADGGRRDYPIGAQARP
SVVTVGRDGTAWFTRTGDDRITALDRTGAMTTFELASGSGPFGICVGADGAVWFTESTGD
RLGRIDPDATVSYVALPEGCFPAFVAAGADGAVWATLNHADAVVRILPSADPEVIDIPTP
GAAPVGITWGGDAVWFVEIATGRIGRIGDDRLVTEFALPDPACRPHAITAGPDGCWFTEW
ATDRVGHIGRDGTVEEYDLPSSVSEPHGITVAPDGAVWVAAESGSVVRLG
>A8A2C2|FEATURES|ARDB_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A026UIR1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A127T7A0|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNA
>Q57QK4|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FILNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIRENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGNVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>ACR56331|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-3|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLALGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>N8WS53|FEATURES|UNIPROT_deepARG|beta_lactam|F964_04530|antibiotic inactivation|1
MVVLNKTKMIFCVLIGSMSLTSYVNANDIPATSIKVETAMNTAFQPLMKTYAVPGMAIGV
LYNGKSYEKYYGVQSLANAKAVNKNTLFELGSVSKIFTATAGTYTENLGKISLQDHPGKY
IPALKNSDINQVTLLELATYTSGNLPLQFPDQIKTDAQTLQYFQDWKVKNPIGQFRQYSN
PSIGLFGEATAKAMNMPFSALLEQVIFPKLELQHTYVQVPKAQQGNYAFGYDQNNHPLRV
TAGAFDAQAYGVKSSLPDMLHFLNLNLNPDQAKAAIKPAILATHTGYFKMGGMTQALGWE
SFSYPATLNTLLESNSDRVVMQSNPVEKTLMKTGSRVFHKTGSTNGFGTYVIYIPQENFG
LVMLMNKKIPNAERIKAAYEVLNSLKQKSNP
>G9QNU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEVIKAIVLGCVEGLTEFLPISSTGHLILVGHFLSFTGDKAKTFEIVIQLGSILAVVVL
YFKRFLSLFNFKKRSGLNLLHIIIGMIPASVLGFLFHDVIKNVLFSPFTVGIGLFLGAFL
MIYAEKKSKTESTQDLDHLSYKQAFIIGLYQCLSLWPGFSRAGSTISGGLLAGANHKTAA
EYSFLLAVPMMVAASGLDLLKSYQYLSIHDLNYFATGFITAFIVAMLAIVFFLKILSKVK
LIPFAIYRIIIGIIVIAYFI
>ZP_03835678|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MGFKPLINLKSDTRGLHMNKNRGLTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPEVGVV
TLKTEPLQITTELPGRTSAFRIAEVRPQVSGIILKRNFTEGGDIEAGVSLYQIDPATYQA
AYESAKGDLAKAQAAANIAQLTVKRYQKLLGTKYISQQDYDSALADAQQANAAVVAAKAA
VETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDF
LRLKQELANGTLKQENGKAKVELVTSDGIKFPQAGTLEFSDVTVDQTTGSITLRAIFPNP
DHTLLPGMFVRARLEEGTNPTALLVPQQGVTRTPRGDASALVIGADNKVETRQIVASQAI
GDKWLVTDGLKPGDRVIVSGLQKVRPGAQVKAQEITADNNQQAASGSQPEQSKS
>A0A0B7GBH5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRA
RLARAHDLLVRLGLGDRADYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSG
EEVMAILHQLKAQGHTVIIVTHDPQVAAQAERIIEIRDGEIVRNPPGSRQGGGLRARQQP
EPSAWRQFTSGFREALVMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQPWVRSATPAVSKSLRLRANN
IDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQLFPNKAKVVGE
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
ETAEKQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFL
PGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0U7V8L8|FEATURES|UNIPROT_deepARG|aminoglycoside|ERS381432_03028|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEI
ALRYDYVNGCESSPVAFLEGIYTAERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>A0A0F0GDZ6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIQGWNHICFSVSNLEKSIQFYQNVLDGKLLVKGRKLAYLDCLGMWLALNVEEDIPRNE
IHHSYTHIAFSVAEADFESMLNKLKTLNVPILPGRERNEQDKRSVYFTDPDGHKFEFHTG
QLQDRLEYYKNDKKHMTFYE
>YP_002044935|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAEEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQLWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNDVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A023VG13|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKEYEILLIDDGSSDHSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>J3DX05|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTTTQVSILGLVEGLTEFLPISSTGHQIIAADLLDFGGERAMAFNIIIQLGAILAVV
WEFRHKILEITTGLPTQRNAQRFTLNLLIGFLPAVVLGVMFADKIHEYLFNPITVAVALV
IGGIIMLWAEQREHVVVIDHVDEMRWTDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFQSADLPVFALGFVAAFLFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWFLGWIDWNHLSEVA
>BAH65866|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MKRHKNFNLLLMLVLLVAVGQMAQTIYIPAIADMAVALNVREGAVQSVMAAYLLTYGISQ
LFYGPLSDRVGRRPVILVGMSIFMLATLVAITTHSLPVLIAASAMQGMGTGVGGVMARTL
PRDLYEGAQLRHANSLLNMGILVSPLIAPLLGGILDTLWSWRACYAFLLVLCAGVTFSMA
KWMPETRPEGAPRTKLLASYKTLFGTGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGL
SSMAVSILFILPIPAAFFGAWFAGRPNKRFPTLMWQSVICCLLAGLMMWIPGLLGIMTVW
TLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMMPQT
GQGSLGLLMMLMGLLILLCWLPLASRFTHHQQPV
>CAC47934|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFEN
LENFLGGSIVLQFEPTQKLFSRKLYNPYTVFCHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKIKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRTISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>A0A0D7LFD5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
EVNHPLWIERISQLAPDVIFSFYYRHLLSDEILSIAPKGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQQRVAISPDDVALTLHHKLCQAARQLLEEALPAI
KTGDYAEHPQQEAEATCFGRRTPEDSFLDWNKPAAELHNQVRAVSDPWPGAFSYVGTQKF
TVWSSRVCKNDRAAQPGTVISVSPLLIACADGALEIITGQAGDGIAMQGSQLAQVLGLVP
GSRLNSQSVTTAKRRTRVLILGVNGFIGNHLTERLLQEDNYEVYGLDIGSDAISRFLQHP
RFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRYC
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
RDGIEALYRIIENEGGRCDGEIINIGNPENEASIQELAEMLLTCFEKHPLRNHFPPFAGF
RDVESSSYYGKGYQDVEHRKPNIRNAKRCLNWEPTIEMQETVEETLDFFLRSVDITEHTS
>U3N6P8|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-114u|antibiotic inactivation|1
MTVRRLSCALGAAISLSALGGGPVQAAVLCTVVADAADGRILFQQGTRQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIQYSVVWYSQLIAK
ALGQDRFQRYASAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRRLVNRELP
VKAAAYELADNLFEVGQADGWRLYGKTGTGSPGGNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDEHATRPNAGLRARDELMRDWPAMAGAWRP
>A0A0Q7YPI5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHISRLAPVTLAVAFTSAPFAQADDLKAKAAAAFQPVVKQYDIPGLIVGITRNGTHEFYA
TGLASKADRRDVTPETLFELGSISKLFNVTLAALAEQRGTLKLEDKVAHHLCADKCRIGD
DLTLMDLATHHTGGMPLQVPDSVSDVNGLVDWMKDWKPTNPGARSYSNVSIGMLGHISAK
AMGMPYAKAAEGTLFPALGLKNTFVTVPKSEMKLYAYGYNKANEPIRVGKGVLDAEAYGV
KSSASDMLAFLDAELGTRSVSGELQKAFERTRTGQFKTAYFSQAMVWEEYPWPVKLDQMV
AGNSPDFILKPQPVEKIAEPAKPGESTILNKTGSTNGFGGYVAMIPEKKLGIVVLANRNY
PNEARIRATYALIKSLGE
>L0IKM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLVKAFILGIVEGLTEFLPVSSTGHLIIVGDLLNFKGAYATMFEVVIQLGAILAIVYY
YREKIWDSLKNLAPNKWGFRLWFKIVVAFIPSAILGLLLNDYIDKHLFSSFTVSIALIIG
AIMMLIVENAFSNYKIDDMDKVSIKKSFWIGVAQCMSLFPGMSRSASTIMGGMMAGLSVK
AAAEFSFFLAIPTMLGATVVSLHKGIATMTALEWEALAVGFIMSFIVALIVVDKFLSYLK
SHPLRPFAYYRLIVGIIMIGLVLTKIVK
>A0A0G2YFE2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphAH5|antibiotic inactivation|1
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPDYPDLPLVLPNVVHEGDFTLQGGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>A0A085F647|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQNLIEAMVLGIVEGLTEFLPVSSTGHLLLLGHFLGFESNGKTFEVLIQLGAILAILLVY
FRRLLDIALRLQKDPAARRFVIGVLVAFLPAALIGALLHGFIKGVLFNPFLVCCALIAGG
LVLLVVDELELEVKHTDATAFPLPMYLKIGVIQCLAMIPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKILTFDDTMLIVVGFVAAFFAALLVVKTFLDYVSR
RGFALFAWWRIIIGAAGLVGLWVFG
>T0GF92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
LYWRTFWAVATGLLRREPVSWRFLRNLLVAFLPSAVIGLALHSYIEVLLGAPQVVAWALI
AGGIAILLIERMVKKAQYHGIADIPLPQVIGIGFIQCIAMIPGVSRSGATIMGALTLGVE
RRTAAEFSFFLAIPTMLGASTLELLKKGDQITGGSVGWGSIALGFAVSFVVALLVIKWFV
GLVSRRGFAPFAWYRIVAGAAALIWLAAR
>ACB17069|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPS
RAITQMHQALNDRLDDAISHLTNSLTPLPETRIEREALALQKLNVFCLADDADWRTQSAW
WQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAIAEGQCWQSDWRIT
ESQAMAARECNLENICQTLLQLGQMDPNTPPTPATKPPSMVADAFTNPDYMRYAVKTLLA
CLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVM
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
DRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQ
IRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQA
LDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLF
ARLPDWTAPALTPATEQAQGATQ
>C2XNJ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>N9LAH1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILTGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIIGGFIILWAERRPHQIVTQEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLG
VSRKAAAEFSFFLGIPVLMGAGLLDMYKMRHELHSNDMAVLAVGIIVAFVSALVVIRALI
RYVSKHDFTAFAYYRIVFGLFILATWWTGWVHW
>BAG79903|FEATURES|ARDB_deepARG|multidrug|MdtN|antibiotic efflux|0
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
ELAVTDNQAVKQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSIN
ATVEKARAAAKQATDTLRRTEPLLKEGFVSAEDVDRARTAQRAAEADLNAVLLQAQSAAS
AVSGVDALVAQRAAVEADIALTKLHLEMATVRAPFDGRVISLKTSVGQFASAMRPIFTLI
DTRHWYVIANFRETDLKNIRSGTPATIRLMSDSGKTFEGKVDSIGYGVLPDDGGLVLGGL
PKVSRSINWVRVAQRFPVKIMVDKPDPEMFRIGASAVANLEPQ
>A0A0M4NX00|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
LFLYREKFKSQIVSSFRYILKQNSDSEGLYFLIQICIGAFPILIAGFIAKKFLDTIKARP
DLLEILSGAWIFGGVLILVAEWYFHQRPEEKKSIGFKDSILIGIFQCMALIPGMSRSAAT
IITARFLGKDTKSSAEFSFFLAVPVLLAAGIYKLIKYRSILNGNTIPVLMFGFLVSFLLC
TLVIRWFLRYIQKHSFSVFGVYRILLGVGVLVLTKLI
>R6CIL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIVEIIKVIVLGIVEGITEWLPVSSTGHLILVDEFMKLKASEDFKEMFDVVIQLGAILA
VVVLYWHQLFPFGKKDNKYPLSDHGAGSYIKTDIFKMWFKVLAACVPAAVIGLLFDDLFH
AMFYNWQTVAVMLILFGIAFIVIEKHNKGKKPTINSIEQMPYCVAVMIGAFQLIAAVFPG
TSRSGATIVGALLIGVSRTVAAEFTFYLAVPVMFGASLLKLVKFGLAFQTAELVYLILGM
AVSFIVSIVVIRFLMGYIKKHDFTVFGWYRIILGVLVILYFGLVR
>C2ZG46|FEATURES|UNIPROT_deepARG|beta_lactam|bcere0029_52090|antibiotic inactivation|1
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKTSIEDLDQIIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYNDKLIANATKI
VLDSLKVTNKS
>A0A0J6MF57|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVRRADAGAIVAQQKVVIDADDTALQLHQKLNATAQTLLRDALPAI
LNGTFSETAQDESKASSFGRRAPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQVS
>A0A0D8KFT1|FEATURES|UNIPROT_deepARG|aminoglycoside|RS75_08215|antibiotic inactivation|1
MSGQFVIKIAGEASLDDWSSLRFRLWPDASSAEHRAELLAFSDTEVGFIAHDPAGTAIGF
AEASLRQDYVNGCDTSPVAFLEGIYVEQAFRGQGVAAALIAEVTRWAISKGVSELASDAD
ISNVDSHRMHAALGFEETERVVYFRKIVSSK
>K9D1W8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLKVVVLGIVEGLTEWLPVSSTGHMILIDEFIQLNVTKAFMDMFLVVIQLGAILAVVV
LNAGKLNPFLKRKSAQERRETFDLWGKVLVACLPAAVIGLAFNKYMEEHFMNAPVVASTL
IFYGILFILVERWNKTRTPRVEHLAQLDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIF
GASRYVATEFTFFLAIPVMFGASFLKLVKFGWHYTGAELVILALGMATAFIVSILSIRFL
LRYIKRNDFTAFGWYRIALGIVVLGYLFLVGDPT
>D2C0D6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDMEAINKVSVVIPVFNEQESLPELIRRTTTACEQLSQDYEILLVDDGSSDNSAAMLTE
AAQAPGSHVVAVILNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVSTAEQG
YDVVGTIRENRQDSWFRKTASRMINHLIQRTTGKAMNDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRTTEILVRHSEREFGDSKYSFMKLINLMYDLVTCLTTTPLRLLSVVG
SVIAISGFALALLLILMRLFFGAAWAADGVFTLFAVLFSFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQHIVGNDPRFSEQDNEE
>A0A0S3NCP6|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMVPAVVLGLLFHDTIKSLFNPV
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVATAVYVVFF
>A0A103B6Q9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSQPLLKLAAVTRRFPAGDKDVVVLNNVSLSIDAGEIVAIVGASGSGKSTLMNILGCLDH
PSEGTYTVGGRDTQMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRA
ERHARARALLARLGLADRAHHRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKS
GQDVIRILHELNALGHTIVIVTHDKAVARHARRIIEISDGEIVADRPNRHYAEALAESGV
GPAATAETAPDGRSAPASGDAPPAGDADADADTDTAPAPRARRFAAGTGRFGEACRMAWI
ALVSHRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLDEIGSIGTNTISLYPGTDWGDS
RADTIQTLVPDDVAALAEQPYVDSATPETSRTLLLRYRNINVNALVSGVGDRYFQARGMR
FALGVAFDDDAVRRQAQVVVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSA
FGSVKSLNVWVPYTTASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFF
TYNMDSVVKTVEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGA
RQSDILQQFLVEAVLVCLLGGTIGIALSFGLGALFSMFVAQWKMVFSAGAIATAFVCSTL
TGVIFGFMPARNASRLDPIDALARD
>E3GGW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLEFLKAAFFGVVQGITEWLPVSSTGHMILFEQFIHMNVSKDFWDMFVVVIQFGSILAV
VLLYFHKLNPFSPSKSPIQKKRTWSLWGKVLVGIIPLGLIGLPFDDLVTGKLYGYVTVAI
ALIVYGIAFIVVENRNCAKTPAIRSFEQLSYKTALFIGLFQVLSIVPGTSRSGSTILGAS
LLGCSRHIAAEFSFFMAVPVMLGASLLKIVKFFVKTGVGFTGMEIGILLIGMAVAFVVSV
FAIKFLMGYIRRHDFKAFGWYRIVLGIIVILYAVIFA
>A7B510|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIILGIVEGITEWLPISSTGHLILVEEFVKLNFSQSYLDMFNVVIQLGAIMAVV
VIYFHRLNPFSPKKTEKQKKMTLQLWVKVVIASIPAGVVGILFNDFIEEKFNNSYVVATM
LIVVGVLFIVIENRHKGRKPQITKISQMGVPVLIWIGVFQMLAMIPGTSRSGATIIGALA
LGVSRTAAADFTFFLAIPAMAGASLVKLRHFGFDFTGTELGLLLLGCVVSFVVSILAIKF
LLKYIQNHDFKAFGYYRIVLGIIVFLYFGIHALLA
>A6P145|FEATURES|UNIPROT_deepARG|chloramphenicol|BACCAP_04212|antibiotic inactivation|1
MLMPLAIQVHHAVCDGFHVGRMLNELQQYCDEWQGGA
>A0A0A0YZV7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLALWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>AAQ75792|FEATURES|ARDB_deepARG|beta_lactam|mecC|antibiotic target replacement|1
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>ZP_04156234|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVTQGPSLNLLHIIIGMIPAGVLGVLFHSKIKEVLFGPGPVVISLIVG
GILMIVAEKFSRPSTAKTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDVLSSADITLFVTGFITAFLVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYYFFIM
>A0A0M1JIP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYILLLKALILGIVEGLTEFLPISSTGHLILSGHLLNFNDAKGKVFEIAIQLAAILAVV
WEYRVSISEIIIELPYSRKAQRFAVNIILAFLPAAILGLLFIKVIKAYLFNPISVATAFI
IGGVLILWAERREHRIRVRNLNDIPWIDALKIGFAQSLALIPGTSRSGATILGGLFVGLE
RKVATEFSFFLAIPTMFAATLYDVIKNRHLLDSSDIPMFLVGGIASFIAAFLAVRGLLRY
ISRHDFTIFAWYRIAFGIIVLLTAYTGLISWTESG
>D3SLI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEAYQAVLLGVVEGLTEFLPISSTGHLILTSHIMGIPQDSFTKSFEISIQMGAIMAVLFL
YWRRIVKNPQLWKRIIVAFFPTGVLGFLLYKLVKNYLIGNDLVTSLALIGGGLFLLVADR
VCSKFCYIRNVEDLPLLRAFAIGVFQALAMVPGVSRSGATIIGGMLMGLNRKAATEFSFL
LAIPTMMAATSYDLYKSHHNFQWQEWHLLLLGFVSAFLSALLAVKVFLRFVSSHSFVPFG
VYRILVGALYLSIFYL
>AAA26081|FEATURES|ARDB_deepARG|trimethoprim|dfrA1|antibiotic target replacement|1
MVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGD
VYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>A0A0N1UZ94|FEATURES|UNIPROT_deepARG|aminoglycoside|SMDB11_3538|antibiotic inactivation|1
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEI
ALRYDYVNGCESSPVAFLEGIYTVERARRQGWAARLIAQVQEWAKQQGCSELASDTDIAN
LDSQRLHAALGFAETERVVFYRKTLG
>A0A0B2TCZ3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MIDDIKNVSVVIPVYNEEESLPVLIERALVACRKIGKPWEIILVDDGSSDRSAELLTEAA
RDPEKHIIAVLLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYD
VVGTVRANRQDSLFRKLASKTINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERST
FIPILANTFARKTIEIDVMHAEREFGTSKYSFLKLINLMYDLLTCLTTTPLRILSLIGSV
VALSGFLLALLLIGLRLFFGAEWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYTDV
RARPRYFVQKTVSAATPLTTSLRDEEE
>Q21C73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLSDILRAVILGIVEGVTEFLPVSSTGHLLLAERFFDLGDTNFWKSFTILIQLGAILAIL
ALYFAKLWRIALGMFSDPAAQRFVIGVLVAFLPAAVIGALAGGYIKSYLFNPWVVCFSLI
VGGAILLWVDQLDLQPTQDEATAFPLPMYLYIGCAQCLAMIPGVSRSGATIVGAMLLGAD
KRAAAEFSFFLAIPTMVGAFVYDLYKNRADMTMDHSLIVAIGFAVSFVTAIIVVKSFLAY
VTRHGFTLFAWWRVIVGTLGLIALALGK
>N9PPI6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDAESRHFTFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAFAL
IIGGLIIFWVESKNFDHKTTEATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIGVGFVAAFFSALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>ZP_04621517|FEATURES|ARDB_deepARG|fosmidomycin|RosA|antibiotic efflux|0
MTDRSDTGFEAPVKTTIKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQAEFSLSFAQI
GLITLTYQLTASLLQPLIGLYTDKHPQPYSLPMGMGFTLSGILLLAVATTFPVVLLAAAL
VGTGSSVFHPESSRVARMASGGRHGLAQSVFQVGGNFGSALGPLLAAILIAPYGKGNVGW
FSLAALLAIVVLLQVSKWYQQQQRAIHGKPVKILSAKVLPRKTIISTLAILMVLIFSKYF
YLASISSYYTFYLMHKFGISVQNAQIHLFVFLFAVAAGTIIGGPLGDRIGRKHVIWGSIL
GVAPFTLVLPYASLYWTGVLTVIIGVILASAFSAILVYAQELIPGKVGMVSGLFFGFAFG
MGGIGAAILGYVADLTSIELVYQICAFLPLLGIFTALLPNIDDK
>A0A0Q9ES00|FEATURES|UNIPROT_deepARG|aminoglycoside|ASE45_04665|antibiotic inactivation|1
MNDGWRVRPATEADLAAWAQLRRALWPDDEGETPSGHGDDMHGLLSRPDRNVCLLAFDER
GQACGFAEASLRTDYVNGTDGSPVGFLEGWYVVPELRGNGVGRVLIAAVEAWTKQRGCAE
LASDSLLDNRDAHRAHAACGFEETERVVYFRKSLR
>G3LSZ6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
AMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAA
LQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAM
AQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNHI
A
>A0A0F5XYW8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGSGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPIN
VMYALVVGGVLLLAAEYLKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDMYKSIGFLTMADFPMFAVGFVTAFVVALIA
IKAFLELIKRISFVSFAIYRFIVAAAVYMVFM
>A0A0N1LPE6|FEATURES|UNIPROT_deepARG|aminoglycoside|IP83_02945|antibiotic inactivation|1
MVPATEEHLDGWAALRHALWDELTAAEHRAEAQEQLGEPERLLNLVALDGDKVVGFAEAA
LRHDYVNGCETSPVVFLEGIYVDASARGQGLARRLCDAVADWGRAHECSEFASDALEDDA
DSHAFHRAAGFAETERVVYFRREL
>ABM73648|FEATURES|ARDB_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLAGSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGRSM
SLSELSAAALQYSDNVAMNKLIAQLGGPQGVTAFARKIGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDAQRAQLVTWMKGNTTGTASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLVLVTYFTQPQPEAESRRDVLASAAKIVTEGL
>H3SCK9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLNLWESFVAFVLGLVEGLTEFAPVSSTGHMIIVDDFLFQSKELFSPAVANTFKIVIQL
GSILAVVVVMWGRFMSLLGLNRRKERSPFEPRLNLLQVIVGLIPAGVLGVLFNDYIDEYL
FSTKTVVVGLVLGAILMIAADWFRPRRPRAETVDQITYGQAFAVGLIQCLSLWPGFSRSG
STISGGVLAGMSHRAAADFTFIMAVPIMAGASFLSLLKSWDSITMEAVPFFIIGFISAFV
FALISIRFFLKLINRIKLVPFAIYRLVLAAVIFFVFL
>E0WSG2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MMPLLELKSIHRSYPSGEQSVEVLKDISLKINAGEMVAIMGASGSGKSTLMNILGCLDQP
TTGTYLVNGQDVASLDNDGLAILRREHFGFIFQRYHLLPHLNAAHNVEIPAIYAGWSNNK
RHERASMLLTRLGLSTRANYRPNQLSGGQQQRVSIARALINGGQIILADEPTGALDRHST
VEVITILKQLQQQGHTVIIVTHDAQVAAQAERIIEISDGSIIADSGFKPSPNKLPTKSLS
PKADIPSWQQTVFRLREALLMAWCAMMTSKMRTGLTMLGIIIGIASVVFILVIGEAAQKK
VLADIRAIGTNTIHIYPGEDYGDDEPSHLRSLTANDLEALTAQPYIDVISPLIASSMRLR
SRNVDVAGHVFGVNGQYFHVFGMTMAQGSVISQYQVDQQSQVVVIDNNTQRLLFPHLENV
VGQVILIGNMPATVIGVVRKKPSMFNNSQTLQVWVPYRTMSKRLNGKFYFDSITVRIKDG
YDSKDVEQKLVRLLTLRHGKKDIYTYNMDTLLQTAEKTTRTMQLFLTLVAVISLIVGGIG
VMNIMLVSVTERTREIGIRMAVGARPGDIMQQFLIEAILLCLVGGTLGVMLSLSVGLVMS
ILLPSWPIVFSPMAMLSAFLCSTVIGIVFGYLPARNAARLSPIEALARE
>A0A150EQV6|FEATURES|UNIPROT_deepARG|beta_lactam|AT272_02940|antibiotic inactivation|1
MILKNKRMLKIGICVGILGISLTSLEVFKGETLQVEAKEKTGKVKHKNQATHKEFSQLEK
KFDAQLGVYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKED
LVDYSPITEKHIDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAIYDNQLIKEAA
EVVIDAIK
>A0A0A8UTA7|FEATURES|UNIPROT_deepARG|aminoglycoside|LHA_1702|antibiotic inactivation|1
MERKTNLKALKLDDETEKQIDQCLNLVKEIFGQDLLGVYLYGSSVLGGLQKYSDIDLLVV
SDRSTTYAEKTKLSTNLLQISGVYMKSTKLPIELTIVKKAEINPWHYPPHFDFQYGDWFR
TQFESGIIEPWPTKEMPDLALLITQILLASKTLLGANPNQLLCKVPYNDFMSATTDALQN
LTSELNSDTRNVLLTFARIWSTVETDAIRSKPAAANWAIERLPEEYCSIIKRARAICTGE
EKEDWDDVRELIKPCADFIIDQINNKVIEIKLSNNTTKSINLADLDI
>1BUL|FEATURES|ARDB_deepARG|beta_lactam|NmcA|antibiotic inactivation|1
NTKGIDEIKNLETDFNGRIGVYALDTGSGKSFSYRANERFPLCSSFKGFLAAAVLKGSQD
NRLNLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERYIGGP
EGMTKFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVAKSLKTLALGNILSEHEKE
TYQTWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTT
KNEKEAKHEDKVIAEASRIAIDNLK
>F3F0G8|FEATURES|UNIPROT_deepARG|polymyxin|PSYMO_20503|antibiotic target alteration|0
YVGLQALLGAGYEIAAVFTRADDPKEKTFFGPVAQLCARHGIPAHAPEDPNHPLWVERIG
KLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPANWVLVNGESETGVTL
HQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAAGLLSETLPLLALGQLSGTPQDE
TLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGENKLIVWAASAEAGNN
GEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGVQLAREFGLVEGSQLLDKEKRR
PARRTRVLILGVNGFIGNHLSERLLQDDRYDIYGMDIGSDAIERLRTKPNFHFIEGDISI
HTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRYCVKYNKRVIFPS
TSEVYGMCQDASFKEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAYGQKGLQFTLFRPFN
WMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALARIIE
NRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESQSFYGKG
YQDISHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKADMR
>A0A0S1Z227|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFAQPQPKAESRRDVLASAAKIVTDGL
>A0A0B5HVB6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNRVTQVSIEERTVADPTAGPYALTTGPDHALWFTLVHGGRIGRLVPGGEPTSHRLDPDC
GPTVITPGPDGALWFTEYRADRIGRITTDGTVTEFALPTPGCGPFGIAAGPDGALWFTET
AADRIGRITVDGRVTEFPLPVTGAFPSAITAGDDGGMWFTLNQANAIGRIGMDGEIVLHP
LPTEEAAPVGIAAGHDGALWFTEIAAGQIGRITPGGRITEFPLPDRTARPHAVTVDGDGT
VWFTEWGGNRVGALTPDGSLTVHDLPTPRSEPHGIAIGPDGALWTALETGALARVTT
>A0A0S3BW17|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLEDSITFYERVLEGELLVRGRKLAYFNICGVWIALNEEIHISRNEI
HQSYTHIAFSVEQKDFECLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLTYYKEDKPHMTFY
>Q8RKB1|FEATURES|UNIPROT_deepARG|beta_lactam|kluA-6|antibiotic inactivation|1
MMTQSIRRSMLTVMATLPLLFSRATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPANHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>A0A150EJH5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFEDERAKVFEVVIQLGSILAVVVV
FWKRLWSLVGIGKVKEGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAATGLDLIKSWDVLSSADVTLFATGFVTAFVVAMLAIVSFLKLLA
RVKLTPFAYYRFILAAVFYFFIM
>A0A0W0JR71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIVVADLIGFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMRWNDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>J8FDB8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAFLMIFAEAKKAEVTAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAIGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>A4VLM0|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLWVAIQALILGVVEGITEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVI
WEYRRKIIDVVVGLPEERQAQKFTVNLLIAFMPAVVLGVAFADLIHEYLFNPITVAAALV
IGGIVMLWAERRDHAIRAETVDDMTWTLALKVGFAQCLALVPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFAVFAIGFVTSFIFAMLAVRALLKF
IGNHSYAAFAWYRIGFGLLILATWQLGMIDWSTAIG
>Q08325|FEATURES|UNIPROT_deepARG|aminoglycoside|fmrO|antibiotic target alteration|1
MLAAAKYRNLDPAFVERLAQEAAERFRDRGQAVKYAKRKLHQAFGAFVAGTPAQAVAACV
AKIAAGAEPKEAGREAMRAHASSAERVDWLEPFYERVAQWCGPASSVIDLACGLNPLAVP
WMALAPGATYACYDVDRTMAEALRALGTVYPVRVNAAAVDLVAAVPAAGVDVALVLKTLT
TVEQQRGGRRVAEYRRELTAVQHHSDGARSLSGRRGYADDPDAIVQRAVHGTGYEVVDEA
AFGTEALYHLVPLAGTAGRPAPAEGAAEPGATRPVVDVPATARPDADRVDPTG
>A0A0D6BHX0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSNKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENTFYGSVAQLCARKGIAVHA
PEDANHPLWIERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAIIAQERVAIERSDTALTLHHKLRDAAASLLRDTLP
ALAQGKITETAQDESKASYYGRRTAADGKIEWKRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGEDSLVITSGQRNANGLYLGGPQLANELG
LVDGSLLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDKYDVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIVDNENDCCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGAGYQDVEHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DRSKEEAR
>F5LRP0|FEATURES|UNIPROT_deepARG|multidrug|rlmN|antibiotic target alteration|1
MRLPSKYETIRQILSDLKQPEYRYAQIMDAIFKHNVGEYERMTMLPQFLRDELTRMLGPN
VCSIVPVKELTSKQVNKVLFAIAGDERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHVLDSVSFMGMGEALANPYVFDAVTILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPLYDVLKALDR
HIEHTGRKVYIAYILLRGVNDSAAHAEAVAELLRGRGPVEHLYHVNLIPFNSTEVTPDNY
QQSEPNRIKAFVRILKSKGISVTVRTQFGSDINAACGQLYRSE
>AAK73751|FEATURES|ARDB_deepARG|trimethoprim|dfrA14|antibiotic target replacement|1
MKVSLIAAKAKNGVIGCGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYA
VVTRSGWTSNDDNVVVFQSIEEAMDRLAEFTGHVIVSGGGEIYRETLPMASTLHLSTIDI
EPEGDVFFPSIPNTFEVVFEQHFTSNINYCYQIWKKG
>A0A0F1AFK7|FEATURES|UNIPROT_deepARG|beta_lactam|SS37_21665|antibiotic inactivation|1
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVETAYRILDALQ
>A0A089M471|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQSPIMKTYEIVIQLGAILAIAL
VYRQRILNLLGIGRSRSGRGGVMPASRLNLIHVILGIVPALAVAFFARDFIKGLFGASTV
LWALVAGGVLMIVAEWVNRRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYQYFTKDTIMDFAIGFVISFIVAY
AVVVAFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>G9W5E1|FEATURES|UNIPROT_deepARG|aminoglycoside|LTSEBAI_2519|antibiotic inactivation|1
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHLALGFEETERVIFYRKRC
>B7WTS7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHAELVLKTLMMGVVEGITEFLPVSSTGHLILAGNALSFLAKEKRDVFEVFIQFGAMLAV
IWEYRARLANVVVSARADQGARRFLVNLAIAFMPAAVLGLLIGSHVQRLLFSPGPVAVAL
VIGGIAILWAERRPVHVKAERAEEISRIDALKIGFVQCLALWPGTSRSGATIIGGLWFGA
SRQAATEFSFFLGIPVLGAASGYNLFKHWNALSSDDIGVFVMGLLASFVFALLAIRLLMR
YLTGHGFGVFAWYRIALGTLILAVLVT
>A0A0E1JJ81|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCTGTQALLDAGFDITAIFTHPDVAGENHFFGSVARIAAEHGIPVYAPD
DVNHPLWVDRIQKLAPDVIFSFYYRNLLCDDILSVATKGAFNLHGSLLPAYRGRAPLNWA
LVNGEMETGVTLHKMVRRADAGGIVAQLKVGIGADETALELHHKLCIAAQSLLRDALPTI
RQGTFTETAQDESKASSFGRRTPEDGRLDWAKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRMREDIPAAKPGTVISVSPLIVSCGEQALEIVTGQTDNGLYVQGAQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLEDDNYEIYGLDIGSDAIGRFLTNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSEQAS
>G7GCN8|FEATURES|UNIPROT_deepARG|beta_lactam|ACT4_020_00170|antibiotic inactivation|1
MTKPKHLSMNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNNTAVNRATILNLGTYTAGGFPLQFPDEVVTQQDMVKYFQKWQPKTKISAARQYS
NPSIGLMGYVTALAMKKPYSELMEKTLFPELGLKQSFIRVPESQMKNYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>YP_002269113|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MTNLKSDTRGLHMNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTE
PLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSA
KGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETAR
INLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQ
ELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLL
PGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWL
VTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS
>C3I0Z5|FEATURES|UNIPROT_deepARG|beta_lactam|bthur0013_24150|antibiotic inactivation|1
MYVLNKFFTYKKIIPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFVKLE
KEYNAKLGIYALDTGTNQTVTYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITYTRE
DLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTGKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADA
TKVVLDTLKVTNKN
>A0A0R2D2J4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAIILGIVEGVTEFLPISSTGHLVLVDQFIKLEQSSQFIDMFNVVIQLGAIMAVV
VIYFHKLNPWSPQKNTLEKKNTWTLWKKVIIAVLPSAIIGLPLNDWMDEHLMNWFVVSMA
LIVYGVLFILIENRNRNIEPKYADLNTLSYKTAIAIGLFQILSLVPGTSRSGSTILGGIT
IGTSRYVATEFSFFLAIPTMFGASLLKLYKFFKHGGSLAGLPGLVLAVGVIVSFVVAYIS
IRFLLNYVKKNDFKAFGWYRIILGIIVIGYFALVH
>A0A0Q7TDI6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSILIRAVASSVIAIAALCLPAAARAADDTARIAAAVDQTYRPLMKKYDIPGMAVAVTVG
GRQHFFNFGVASKEAKSPVTNHTLFEIGSVSKTFTATLAAYAVASGAMTLNAHPSAYMPA
LRGAAIDKASLLNLGTYTAGGLPLQLPATVSSDAAMTAYFKAFKPAAAPGQQRQYSNPSL
GLFGHVTALAMKRDFADLMEKEIFPRLGLKHSYIRVPAAAMDRYAWGYKADKPVRVSPAV
FANETYGVKTTSSDLLHFVEVNMAPEALDEPMRRAVAATHVGYFSIGAMVQGLGWEQYRY
PVTLDALRDGNSAAMIFKPNVAAQLTPPRTPEGEILFNKTGSTTGFGSYVAFVPAKKIGI
VMLANRNFPISDRIVAAHVVLEALAGMQ
>A0A0S1YF07|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
DLVNYNPITEKHVNGTMTLAELSAAALQYSDNTAMNKLIAHLGGPDKVTAFARAIGDNTF
RLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGSALGETQRAQLVTWLKGNTT
>A0A0N7LIT6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
PEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPAN
WVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLP
LLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQ
KLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELG
LVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKA
DPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIVR
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
QQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTD
VDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPMRAQFPPFAG
FREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREA
QA
>A0A0Q6N7I8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVYWQKIHSTVVALPRQAKARRLALNVIIGFIPAVLLGLIFGKMIKEQLFTPVVVASTFI
IGGFIILWAEKRPPGSIRIEHVDDMTMWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGAYSLYKERALLSMADVPMFSVGLVFSFVSAWLCVRWLLK
YISTHDFIPFAWYRIAFGIVVLATAWTGTVVWAE
>X4ZWI8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTRLLGFEEQDNLMKTFEIVIQLGAILAIAL
IYWRRILNLLGIGRKKERAGVMPRSRLNLIHVLLGIVPALAVAFFARDFIKSLFGASTVL
WALVAGGILMIVAEWVNKRKVRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKDITGDTIGIFAIGFLVSFVVAYL
VVILFMRLIQKIRLTHFAIYRFLLAAFFWLFVMR
>R7CB85|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIFDVFVAVIWGIVEGITEWLPVSSTGHMILVEEFLKFQDEQFSQMFLVVVQLGAILAV
VLLFWSRIWPFRFTKRERGESIIDWKIMQMWFKIIVACLPAAIVGILFDDWIDEVFYNAY
VVAGALIVYGILFIIVENWNKGRKPAITSVTEIGYDTALIIGIFQLLAAVVPGTSRSGAT
IIGALLLGVARGAAAEFTFYLAIPVMFGASVLKIIKSGLSFGAMGYVTLLVGMLVAFVVS
LFVIRYLMSYIRKHDFKAFGYYRIVLGVVVLVYFFLFK
>A0A0Q0DRT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAV
VWEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVILGVIFADLIHHYLFNPITVATAL
VIGGVIMLWAERREHVVRAETVDDMKWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAGYSGYKYRDMFRPDDVAVFAIGFVTSFIFAMIAVRGLLK
FIATHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0A6FGT3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MPSIQSSKVISCAAFGLFLGATSSFAAAPDAVQLQALVNDAVTPVMQQQNVPGLTVALTV
NGKAHYFNYGVASKDTGEKVSENTLFEIGSVSKTFTATLAGYAHATDKLDLSTKASQLWP
ELKGSAFDTISVLQLGTYSAGGLPLQFPDNADSSDKMLGYFQQWKPVYPAGSHRQYSNPS
LGLFGYLAAKSLGQPFDQAMTQTLLPKLGLQHTYLSVPAAQMDLYAQGYDKNGKPVRVTP
GALDSQAYGVKTSAVDMLRYVQANLKPETLEAVLQKTIANTHTGYYTVGDMTQGLGWEMY
RYPISLERLLAGNSTEMAMQAHKVQWLNPPRPQPDDVLINKTGSTGGFGTYVAFVPSKDI
GIVIMANKNFPIPERVKIAHTILSAVAD
>A0A0G1PD14|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLHAYPRKRYAVLMSLSEVIILGLVQGLTEFLPVSSSGHLVAVRVLINLSDIEGNAVDAF
LHLGTLLAVLVYYRRVWWGMVRSVITNDEEGKDKRELAAKLALATVPAAVVGYLFQDQVA
GYFRDPSSVAASFLATAVILVVADWLAGQQISIKRASFLDAVMIGLAQVIALLPGVSRSG
MTIAAGRWRGLGRKQATNFSFLMSAPIIAGASLTSLASLLNAGALSWGQMALGLLVSFCA
GLTAIFLLLKVVERISLRPFAIYLVVIAGLLLFVS
>E7GR10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSFVEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLEVSEAYREVFMVVIQLGAILA
VLILYFHKLNPFSSRKSDAQKRGTLRLWGKILVACIPAAVIGLPLDNFMNKLMNGYVVSA
MLIIYGVFFILLENRNRNSKFPIERVTQISFQTAAVIGCFQVLALIPGTSRSGATILGAM
LIGCSRGAAAEFSFFLGIPVMFGASLLKIIKFFIEGGAFKGYEVFYLLLGMAVAFAVSVY
SIKFLMGYIRKHDFKFFGYYRIVLGIIVLSYFGISALVA
>BAA32077|FEATURES|ARDB_deepARG|beta_lactam|ACT-28|antibiotic inactivation|1
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNITDMASWLKANMNPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWIHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>I6VDW2|FEATURES|UNIPROT_deepARG|beta_lactam|blaSHV|antibiotic inactivation|1
IRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIGMDLASGRTLTAWRADERFP
MMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAI
TMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMA
ATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVA
LLGPNNKAERIVVIYLRDTPAEYG
>K1LM59|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEQLIDLVELLKIIILSVVQGITEWLPISSTGHMIILEDFLTLNLRPEFVEFFFVAVQLG
SILAVVILYFSKLNPFSLRKTPAQQKNTWMLWFKVAFASIPVAILGVALNDYMDEYFYNI
FVVAIALIAYGIIFILIENRQTGRHQRQIRYFNELSFSRAFKIGIYQALSIIPGTSRSGS
TIIGGLLEGTSRSLATEFSFFLSIPAMFGATAYKFLKLSIALTLSEVIYLAVGLLVAFVI
SIISIKFLLNYIKHNDFKSFGIYRIVLGIILIAYQMFFK
>A0A108T6L6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLSTLEVIIIAIVEGLTEFLPVSSTGHMIITQNLLGIESTEFVKAFTVIIQFGAILSV
VWLYWKRFFRLNHTPVPAGTSALKRFLHKFDFYWKLLVAFVPAAVLGFLFSDKVDEMLES
VTVVAVMLVIGGVFMLFCDKIFSKNSEDTVLTEKKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKMTRKAAAEFSFFLAVPTMFAATVYKMLKLFLDGGTEIIMNNLPALIIGNVVAFVV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGIILLLLLTGHNLEVV
>D7GV06|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSNFIEFLKIVVFGVVEGFTEWLPISSTGHLILVENIVHLNVSEEFMNVFRVVIQLGAIL
AVLVLYFRRLNPFDPGKKPAQKRATWHLWFKIIIACLPAAVVGILLDEVLDKYLYNPYVV
AAMLIIYGVIFIAFENRNQHAEFRIKKVSQISYQTAFYIGLFQLLALIPGTSRSGATILG
AMMLGCSRTAASEFTFFLGIPVMFGASLLKILHYGLAFSAMELFFMAAAMVIAFVVSMYS
IQFLLGYVKKHDFKFFGYYRIVLGVIVLIYFGLTAILTK
>A0A077FB62|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTGLQAVILGVIEGLTEFLPISSTGHQIIVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPKEQQAQRFTANLLIAFMPAVVLGVLFADLIHHYLFNPITVAAALV
VGGVIMLWAERRQHVIKVDQVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDFPVFAIGFVVSFIFAMIAVRGLLRF
IANHSYAMFAWYRIVFGLIILATWQFGWVDWATAQG
>A0A0S8Z5H1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVASALV
VGGVIMLWAERRQHQVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRDLFVPADFPVFAVGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLLILATWQFGWVDWTAAKP
>H0SXT0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
ALYFFKLSRVAIGALTNPDDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLI
VGGAILLWVDQIDLKPREHDATRYPLMMYLWIGVAQCLAMIPGVSRSGSTIVAAMLLGGD
KRSAAEFSFFLAIPTMVGAFVYDFYKSRAEMTSDHLGLIAIGFVVSFITAMIVVKAFLGY
VTRHGFVMFAWWRVIVGTLGLIALALGK
>G7UUY3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSELFAALLLGILEGLTEFLPISSTGHLLIAERWLGHRSDLFNIGIQAGAILAVVLIYRQ
RLWQLLAGFLKPDQAALPSIDGDSPRGYSLKLALAFLVTAVLGLVVKKLGFALPETVTPI
AWALIIGGVWMIAAEYFAERRALTLGERARITWTVAILVGIAQVVAGVFPGTSRSAATIF
MALLAGTTKRASATEFAFLIGIPTMFAASGYQLMEVVRSGQAAQEDWGLFAAAFIASAVT
AFIAVKWLLGYIQSHRFTVFAVYRMLLGAALLLFLPSGA
>A0A0D5VF71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLMACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDDHAKTFDVVIQLGAILAVC
WEFRRRIGSVVAGLPSRPDARRFTLNVIIATIPAVVLGLLFEKSIKAALFSPVPVAFALV
AGGVVILWAEARQRARGDAAARVQHVDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGM
LFGLERRVATEFSFFLAIPIIFGATAYELYKDWHLLSVDALGSFALGFVAAFISAFACVR
WLLRYISAHDFTVFAWYRIGFGLLILLVGYSGALSWAD
>A0A0H3N5Y7|FEATURES|UNIPROT_deepARG|bacitracin|bacA1|antibiotic target alteration|0
MYWRYFDLETFSLLEIFKAVILGIVQGITEWLPVSSTGHMILINEFIKLNFSNTFINTFL
VVIQFGSILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDID
RVFFNSTVVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSR
SGSTIIGAVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVA
FVVSIVVIKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>J8PAL2|FEATURES|UNIPROT_deepARG|chloramphenicol|IKO_01764|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTSIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>ZP_02901234|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
VADRSGRKPVAIPGAALFIIASIFCSLAETSTLFIAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMTIMGVAVLMLSLFILKE
TRPAAPATSNKPQENTESLLNRFFLSRVLITTLSVSVILTFVNTSPVLLMEIMGFKRGEY
ATIMALTAGVSMTVSFSTPFALGILKPRTLMIASQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGVGAWNMLIGI
LIACSIVSLLLIMLVAPGRTVAAHEEIHHHA
>A0A098M926|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQDFLGKYTANTFKVVIQLGS
ILAVVIIFRNRFIDLLGLKRFSRKQLQVEAEGQPSVETMGRLKLTQVIVGLIPAGLLGLL
FEDYIDEHLFSTSTVLIGLVIGALFMIAADLFAPKKVTVQSVDQITYRQALTVGFIQCFS
LWPGFSRSGSTISGGVLLGMSHRAAADFTFIMAVPIMAGASLISLIKNWQYFTVDALPFF
IAGFISAFLFALLSMRFFLKLINKIKLLPFAIYRIVLAGVLYLVIF
>A0A060KQE6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVPKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRTQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AAA25007|FEATURES|ARDB_deepARG|beta_lactam|pbp1a|antibiotic target alteration|0
MRIAKLILNTLLTLCILGLVAGGMLYFHLKSELPSVETLKTVELQQPMQIYTADGKLIGE
VGEQRRIPVKLADVPQRLIDAFLATEDSRFYDHHGLDPIGIARALFVAVSNGGASQGAST
ITQQLARNFFLTSEKTIIRKAREAVLAVEIENTLNKQEILELYLNKIFLGYRSYGVAAAA
QTYFGKSLNELTLSEMAIIAGLPKAPSTMNPLYSLKRSEERRNVVLSRMLDEKYISKEEY
DAALKEPIVASYHGAKFEFRADYVTEMVRQEMVRRFGEENAYTSGYKVFTTVLSKDQAEA
QKAVRNNLIDYDMRHGYRGGAPLWQKNEAAWDNDRIVGFLRKLPDSEPFIPAAVIGIVKG
GADILLASGEKMTLSTNAMRWTGRSNPVKVGEQIWIHQRANGEWQLGQIPAANSALVSLN
SDNGAIEAVVGGFSYEQSKFNRATQSLVQVGSSIKPFIYAAALEKGLTLSSVLQDSPISI
QKPGQKMWQPKNSPDRYDGPMRLRVGLGQSKNIIAIRAIQTAGIDFTAEFLQRFGFKRDQ
YFASEALALGAASFTPLEMARAYAVFDNGGFLIEPYIIEKIQDNTGKDLFIANPKIACIE
CNDIPVIYGETKDKINGFANIPLGENALKPTDDSTNGEELDQQPETVPELPELQSNMTAL
KEDAIDLMAAAKNASSKIEYAPRVISGELAFLIRSALNTAIYGEQGLDWKGTSWRIAQSI
KRSDIGGKTGTTNSSKVAWYAGFGANLVTTTYVGFDDNKRVLGRGEAGAKTAMPAWITYM
KTALSDKPERKLSLPPKIVEKNIDTLTGLLSPNGGRKEYFIAGTEPTRTYLSEMQERGYY
VPTELQQRLNNEGNTPATQPQELF
>A0A026RSM3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNATGGTEPV
VNTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>A0A118Q2C0|FEATURES|UNIPROT_deepARG|beta_lactam|WJ63_05905|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLVLTLNACASSQAGAPSVASATSFDALERAAGGRLGVCAIDT
ATGRRVQYRADERFPFCSTFKAMLIAAVLAQSVTRPALLAQRVTYRQADLVRYSPVTEQH
VGAGMTVGELCEATAQYSDNSAANLLMKVLGGPSAVTAFARTIGDDTFRLDRWETELNTA
LPGDPRDTTTPAAMAASLRVLALGGALPAPQRAQFAAWLRGNKTGDKRIRAGVPAGWQVG
DKTGTGDYGTTNDVGVLWPPAGGPVALAVYYTQARADAQAKDDVIAAATRIAIAALG
>A0A0U5HC78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAVVLVFRQ
RLLQLATGFGQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVLAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLELAKEGNLGSENWTDVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>A0A127SJL2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLITATCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>YP_543006|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTIYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>X2KPW5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
LSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKP
VTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYT
AGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQA
MTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGTLDAQAYGVKTNVQDMANW
VMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVAL
APLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIG
>G2H3V2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHDILSAVILGIVEGLTEFLPVSSTGHLIIVGDLLGLSGPKVATFEVAIQLGAILAVVVL
YWDRFWGLLRPKPYVRFAGVRGIVLLGITSLPASLLGLVAHGYIKEHLFSPATVAVALVV
GAAAMLLVERRKMRPAYMGLDDMTPALALGIGLFQCLALWPGFSRSAATIMGGMLLGARR
GLAAEYSFIAAVPIMFAATGYDLLKSHALFTTADIPFFATGFVVSFLSAWVAVKVFIGLM
GRVTLAPFAWYRLAVAPLVFWFMVN
>B8ZHZ0|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MLKSSWRRSALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKS
>YP_002394083|FEATURES|ARDB_deepARG|multidrug|MdtP|antibiotic efflux|0
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
WKQLNDPQLDALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVS
ANGFLSPYAMDAPALGMDGPYYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETA
AVELSLTTGVAQLYYSMQASYQMLDLLEQTRDVIDYAVKAHQSKVAHGLEAQVPFHGARA
QILAVDKQIAAVKGQITETRESLRALIGAGASDMPEIKPVALPRVQTGIPATLSYELLAR
RPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSIHLDTLFKKTSRQFNFIPGLK
LPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLNDEREMQAERVE
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
AAPIVEKK
>A5YVY0|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGKWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGRIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>A0A0Q6KR60|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLIEAIILGVVEGLTEFLPVSSTGHLLLLGHFLGFESNGKSFEVLVQLGAILAIMLVY
FRRLLDIAMRLGSDPQARRFVLGVLVAFLPAALIGALAHGFIKTVLFNPVLVCTSLIAGG
LVLMVVDELELEVKHEDATRFPLSMYLKIGLVQCLAMIPGVSRSGSTIVGAMLLGASKRA
AAEFSFFLAMPTMAGAFAYDLLKNYKTLTFDDTILIVVGFIAAFCSALLVVRLFLDYVSK
RGFALFAWWRIIVGMVGLAGLWIVG
>A0A127SMZ2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGA
>A0A0P0H9J6|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-204|antibiotic inactivation|1
MSIKHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>W8TK75|FEATURES|UNIPROT_deepARG|bacitracin|uppP1|antibiotic target alteration|0
MHDILKSFILSLVEGVTEFLPISSTGHLILVNKWVQFSGSFSNSFNVIIQFGAILSVIVL
YWHKLYPFSAKKSGLERKASFDIWKKVIVGFIPAMVLGFLFGDFIEEKLFNPTTVAIMLI
IGGIAILLLEKRSDSFKINSFDELTYKNAFIIGTIQCLAMIPGTSRSASTIIGGMLRGTS
REIAAEYSFFLAIPTMAGATAYSLLKNGLSISSGEWTTLLSGIFFSFLIAMAVISFFMNY
IKKHDFKIFAYYRIVLGILVLLLF
>G4H883|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMDFLTSIILGIVEGFTEFIPVSSTGHMILTAKMLGYDDQTPIMKTFEVVIQLGAILAI
AIVYWNRILTLLGWSRSEPIAKAAPKRLNLIHVLLGIAPALLVAYFARDFIKSLFHAQTV
LFALVAGGVFMIFAEWYNKHKARLTAENVDDMTYKQAFLIGLYQIISVLWPGFSRSGSTI
AGGMISGVSYKASADFSFLIAIPIMCAASGYELLDSYRNFTSDTIGVFIAGFIVSFVVAY
FVVLAFMKLIQKIRLTHFAIYRFVLAAVFWLFIMH
>A0A0F3U782|FEATURES|UNIPROT_deepARG|beta_lactam|UN91_24910|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFIWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLHQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVHASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0G3CTV4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MDDLQKISKVSVVIPVYNEQESLPTLLSRTIAACKQLKQQYEIILVDDGSTDASGDMLTA
AAEEPDSHVIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVEVAEQG
YDVVGTVRGNRQDSWFRKTASKIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHER
STFIPILANTFARHTTEIEVRHAEREFGDSKYSLMKLINLMYDLLTCLTTTPLRLLSVLG
SIVALSGFTLAVVLIVLRLIFGPTWAAEGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYT
DVRARPRYFIQKIVGEQNQINNQEENE
>Q9AM98|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-12|antibiotic inactivation|1
PRFMSIQRRNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVLYLGE
>A0A0H5M090|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSIINTLVFTAFAATPLYISAQTILTPKQVATIVNDAIAPLVEKQDIPGMAVAVFYDG
KPQFFNYGVADKKTGRPVTENTLFELGSVSKTFTGIAGEYAAQTGIMNLNDPVTKYAPEL
TGNQWKDVKMLHLATYTAGGLPLQLPDSVIDQTTLWQFYQQWQPQWAPGVMRNYSNASIG
LFGALAVKRSQLTFENYMTQHVFHPLKLDHTFITVPEAMQSNYAWGYKDGQPVRVTLGML
GEEAYGVKSSSHDMVKFLQANMNPNSLPAGNDVLKKAITASQSRYFQAGEMFQGLGWEMY
NWPINPQHVVADSGNDIALKPRKVDVLVPPVNAMPASWVHKTGATNGFGAYIVFIPEENI
GIVMLANKNYPNPVRVQAAYNILQALR
>S4ZKC2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFINMFEYVIQFGAILAVI
LLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSVVVGLPLNNWMDEHLHTPLVVATTL
IIYGVLFIILENYLKNKNAHITSLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLWQGNGFSGEQWAVLMTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>B4STJ7|FEATURES|UNIPROT_deepARG|aminoglycoside|Smal_1717|antibiotic inactivation|1
MQATHASSDGMPLPSAWREALAGARIERQSIGVSRADVARVHRPGQADAFLKSEVIDPFS
ELGDEIARLRWLQAQGQPVPTVIATAEDAGRRWLLMSALPGRDLASSPELVPQRLVEVLA
DALRGLHALPVAACPFDQRLASRVQAAVARAEAGLVDADDFDDERLGQSAQQVLAELLAS
QPAHEDLVVSHGDACLPNLMVAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A0J1LFF2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPIKKVSVVIPVFNEQESLPELIRRTSDACEKLGKDYEILLIDDGSSDRSAQLMMD
ASQAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SVIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>I4CC02|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELWIAAVLGIVEGITEFIPVSSTGHLILAGHFLGFSGEKAACFDVFIQLGAICAVVFLY
YQRFLGLVPVNGFRSYSEQGFSGIRGLVLLALTTLPALVVGAVAHKAIKAYLFGPMTVIL
ALAVGGIALIVVERVKPEGNVRTLDGLTYGQALTVGCFQILAMWPGVSRSAATIVGGMIS
GLNRYVAAEYSFLAAVPVMIAATGYDLYKEWQWLEMSDLGFFAIGFIVSFISAALAVKTF
ISLVQRWSLAPYAWYRIAVALVVYLVLVK
>AAD51059|FEATURES|ARDB_deepARG|glycopeptide|VanHD|antibiotic target alteration|1
MEKIIDITVFGCEPDEMEVFQKISYELGVTATLIKDSISESNAGLANGCRCVSVSHKAEL
SEPILLALKNAGVKYISTRSIGFNHIDIQAAGLLGMVVGTVEYSPGSVADYTVMLMLMLM
RGTKSILRETQRQNYCLNDLRGKELRDMTVGVLGTGRIGQAVMERLEGFGCKVLAYDRNQ
KAGADYVSFHELLKKSDIVTLHIPLAEDTRHMIGYEELEMMKQEALLINTGRGALVDTAA
LVEALKGQKIGGAALDVLEGEEGIFYHDCTQRRIEHPFLSVLQGMPNVIVTPHTAYHTER
VLVDTVRNTIRNCLNFERSLGNV
>A0A024Q8U8|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MNLGNKLFKLIKWKKTGLVLFVSFAALIGCTDDEASSESHREEPKPEIKDRFQSLEDEFD
ATLGVYALDMGTNESIAYRSDERFAYTSTHKVLAVGALLQQKSIAELDERITYTNDDLVN
YNPITEKHVDTGMTLKELSDASLRYSDNTAANLIFNQIGGPSGLKKVLRNIGDDVTDPQR
IEPALNDFTPGEPADTSTPKALVNSLQAFTLGDALPKEKRLLLMDWMKRNTTGDHLIRAG
VPDDWEVADKTGAGSYGTRNDIAIIWPPEGDPIVLAILSKRDQKDAEYDDKLIAETTKAV
IDHIQSDDE
>L8PXG0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MKFEQQEINILHSDSGPYGIAVSHEGMVWFTQHKANKISCIDKKGQIQEYTVPTPDAGVM
CLAMSSKGDIWFTENRANKIGKLTTKGQFIEYPLPHPNSAPYGITEGPNGDIWFTEMNGN
RIGKLTSEGKIHEYELLNEGSYPSFITLGSDQSLWFTENQNNAIGKITESGELTEYPIPT
PASGPIGITKGHDDALWFVEIMGNKVGKITVSGEITEYDIPTPNARPHAIAAGVKSDLWF
TEWGANKIGRLTSDQTIEEYTINTPNAEPHGIGCDNDGIVWFALECNKLGKLKLTK
>A0A085UEX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFFELLKALVLGIVEGLTEFAPVSSTGHMILVDDMWLKSTQFLGSESAFTFKVVIQLGS
VFAAAWVFRHKYFEMLHIGKYAPEVQEGRRSKPRRLKITHILVGMIPAGILGVLFDDFIE
KHLFSVPTVLIGLFLGAIYMIIADKYSRGVRNPKNVDEINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMDHKSASDFTFMMAVPIMMAASGLSLIKNFSYIHLTHIPFYILGFLA
AFIFGLLSIKLFLSLIKRVKLLPFAIYRIVLVVVIAVVYYGIIK
>AAN60217|FEATURES|ARDB_deepARG|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMDRRL
VHGETADLAPTGFGQQVREAMDQRREHHIEQRDATRNRDGRIFYRRNLLATLREREVARA
GAEMAEGKALPFRAAKDGESVSGKFTGTVHLSSGKFAVVEKSHEFTLVPWRPIIDRQLGR
EVMGIVQGGSVSWQLGRQRGLER
>ABG72340|FEATURES|ARDB_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MGFLRSGCYPDSCHADWCRYNLTHRQCKSGPPMAGRFVWKPDLMLKTTLCTLLITASCST
FAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFE
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
PDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQP
LKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPL
DINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>G5CK56|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEYQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNGAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGI
>A0A075SKB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNSGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWILLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>R6ETJ0|FEATURES|UNIPROT_deepARG|beta_lactam|BN487_00430|antibiotic inactivation|1
MCVVAACAVVVAFWIFPNSAPKGKAQSSLATILTDSLSRIASACPGEMGVAVIVNDTETI
TVNNQSVYPMMSVFKVHQALALCDDFDKRGLSLDTLIRINRSELDPKTWSPMMKDHPERI
LSLTIRDLLRYTLTQSDNNASNLLFKRLVDVAKTDSFVATIIPRPSFRIVYTEEEMAVDH
DRAYSNYTSPLGAAMLMNRLFTDKLVSDGKQDFIKNTLKECETGTDRIVAPLLEEPDAVI
AHKTGSGYVDENGVLVAHNDVAYICLPHNNISYALAVFVKDFKGNEAQASRYIARASAVV
YSLLTQNLSYACLDSQ
>E5G504|FEATURES|UNIPROT_deepARG|aminoglycoside|aacA7|antibiotic inactivation|1
MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVTRPAAVLIAVAPDG
EALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFA
SDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL
>S6FJF9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
ILAVAIVFKDRILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLF
SVRTVAYGLIAGAVLMLIADWINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGS
TIAGGVIVGLNHRAAADFTFIMAIPIMAGASLLKLVKYWSSLSYDMIPFFLVGFICAFIV
ALLVVKFFLRLINRIKLVPFAIYRVILGIILIMLVR
>H5XSQ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLVIEIIKAIILGIVEGITEWLPISSTGHMILVDEFIKLNMSEAFKEMFFVVIQLGAIAA
VVVLYWEKLLPLSSKGKLAINNETMSLWFKILTACVPAAIIGLAFDDQIDAQFYNYQTVA
VTLILYGVLFIIIENRNRNLRPRINNLSQITYKTAMIIGLFQVLSLIPGTSRSGATILGA
ILIGTSRTVAAEFTFFLAIPVMFGASLIKILKFGLVFTSSELIILIIGMVVAFVVSLLAI
KFLVGYIKTNDFKAFGWYRIGLGIIVAIYFFMQSAI
>A0A0M3G7R4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKDLNRYFGEGENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKINGKETIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYVGMSQEKR
LSRAKQLLEKLGLGDKWQNKPSQLSGGQQQRVSIARALINGGEIILADEPTGALDSQSGQ
NVMEILRQLHAEGHTIIMVTHDREIAASANRVIEIKDGEIIGDTQKEAVKSAVENPTKSK
PHFGFSKDQFVEAFRMSVSAIIAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILANI
KGIGTSTMTIFNGTGFGDRRAEQMQNLTINDATALNQQSYVQSVTPNSSSSGTLIYGNQT
FSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIFPDENPIGKIV
MFNKRPLRIIGVVSDKRMGGASSSLNLYAPYTTVMNRISGSKKIASITVKVDGSVNTTVA
EKGITELLTMRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQFNILQQFLIEAVLICLIGGVTGILLSGLIGLLFNVFMTDF
TMAFSTGSIVAAVVFSTLIGVIFGYMPAKRAAQLDPITALARE
>A0A072T2D6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
LVYWQKIRSTVVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFI
LGGFVILWAERRPASATRVQTVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSAADIPMFAVGLVFSFISAWLCVRWLLR
YVSTNSFVPFAWYRIAFGIIVLVTAFTGLVNWSGG
>Q2FC31|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEI
>AAT45018|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKKVQRMMFAAAACIPLLLSSAPLYAQTSAVQQKLATLEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIRPTDLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>A0A0E2REI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLGAILAVM
VIYFKRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNFFVVAIM
LVVYGIAFIWIEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGATILGGII
VGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAFLVSLFV
IRFLMNYIKKHDFTVFGKYRIVLGIIVLFYGAVKLIFG
>Q2FC76|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLILLIAIALVLSACNSTSSHTKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANKKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
FK
>R9VQV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRQPHEGTGTGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPLN
VTYALVVGGFLLIAAEVLKPKVPRAQGVDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATVLDLYKSMGFLTVGDIPMFAVGFITAFIVALIA
IKTFLELIKHISFIPFAIYRFVVAAAVYLVFF
>A0A125Y7E5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGQKPTPGHATLSLVHVILGMLPAVLVGLAIHSWIKANLFGPETV
MYALVAGGILLIIAEKFRPAVTAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMIAASGLDLYKSRDFLSMADFPMFAVGFVTAFVVAMVAIK
TFLALIRRLDFIPFAIYRFLLAFVVYLVFVA
>A0A0E1FMZ4|FEATURES|UNIPROT_deepARG|beta_lactam|IX87_08585|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYKQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLTPQKYPTDIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>YP_691421|FEATURES|ARDB_deepARG|multidrug|MdtO|antibiotic efflux|0
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQIVQLWVGCLLVILISMTFEIPFVALSLA
VLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLM
RTHRLGLVFFAVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPNRAI
TQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQSAWWQS
CVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESE
AVAARECNLENICQTLLQLGQMNPNTPPTPAAKPPSMVADAFTNPDYIRYAVKTLLACLI
CYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWL
DNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRA
LGIIIGTVVSAMIYTFVWPESEARTLPQKLAGALGMLSKVMRIPRQQEVTALRTYLQIRI
GLHAAFNACEEMCQRVVLERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDN
ALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARL
PDWTAPALTPATEQAQGATQ
>J8GPN4|FEATURES|UNIPROT_deepARG|beta_lactam|IIA_02962|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLRAIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>A0A125SQ26|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTLRAGRLFAAIVFSCMVSSVVQAADNTIQSEVDGVIQPLMKQYAIAGVAVGVIADGKPH
VFNYGLASVRPRRLVTGNTLFELGSVSKTFTATLAAKAQIDGDLSLSDRTSKYLPSLQNT
PFGDVTLLNLGTHTPGGLPLQVPDNVNNIDELMQYFRQWKPAYAAGTYRTYTNPGIGTLG
LITAKSLGQDFDTLMTQGLFPALGLQHSYINVPAARMKDYAQGYTKDDAPIRMKPGVLSS
EAYGIKTTAADMLHFLQANMNLVKLDPKLQRAITDTHTGYFDAGPMTQDLIWEQYPYPVA
LENLLEGNAPAMIMNATPVTQLKPPQPPRDDVWINKTGSTNGFGTYVAFIPEKRLGIVIL
ANKNIPNGARVTAAYRILESLADKAQTQ
>A0A0A0Q9I9|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-7|antibiotic inactivation|1
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>E7DK52|FEATURES|UNIPROT_deepARG|beta_lactam|KPC-2|antibiotic inactivation|1
ALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARS
QQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGG
PAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQR
QQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPMCWPSTP
GRLTRMTSTARPSSPLRLDSRS
>A0A060KZ63|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGAM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_001337075|FEATURES|ARDB_deepARG|multidrug|TolC|antibiotic efflux|0
MQMKKLLPILIGLSLTGFSAMSQAENLLQVYQQARISNPDLRKSAADRDAAFEKINEARS
PLLPQLGLGADYTYNNGYRDSNGINSNVTSGSLQLTQVLFDMSKWRALTLQEKTAGIQDV
TYQTDQQTLILNTATAYFKVLAAIDTLSYTEAQKQAIYRQLDQTTQRFNVGLVAITDVQN
ARSQYDAVLANEVTARNDLDNAVEELRQVTGNYYPELASLNVNGFKTNKPQAVNALLKEA
ENRNLSLLQARLNQDLAREQIRQAQDGHLPTLSLSASSGISNTSYSGSKTHNNPQQYQDN
DAGQNQIGLNFSLPLYQGGAVTSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNVNAS
ISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQQLSNARYNYLINE
LNIKSALGTLNEQDLVALNNTLGKPISTSADSVAPENPQQDATADGYGNTTAAVKPASAR
TTQSSGSNPFRQ
>ABY66120|FEATURES|ARDB_deepARG|beta_lactam|CTX-M-14|antibiotic inactivation|1
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFSQPQQNAESRRDVLASAARIIAEGL
>A0A0N0XVN5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNEINESHDTGSVREFTVSDADAGPYALTEGPDGALWFTLVHRGAVARRGPDDGLVTVHP
VGDGPTVITAGPDGALWFTEYRAHRIGRLTPEGDYASFAPRTPGGGPFGITAGPDGAMWF
TLSSADRVGRVTVDGEVTEYPAPGAFPSALTTGSDGALWCTLNQGNAVGRLTTDGHGTAY
PLPTEGAGPVGIAAGPDGALWFTEIGAGRIGRITVDGAVTEYPLPDPAARPHAVTAGPDG
ALWFTEWGGGRVGRITVDGDITSYALSRTDCEPHGITAHDGALWCALETGSLARIEVRP
>A0A0R1JCS7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEVGMMLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTDMFNVVIQLGA
IMAVVVLYFHKLNPLSPKKTHVEQHQTWVLWFKVIVAVLPSVVIGLLFNDWMDAHLMNWQ
VVSAMLLIYGVLFILIENRNANRQPLFSDLNTLSYRTAFIIGMFQLLSLVPGTSRSGATI
LGGILIGTSRYVATEFSFFLAIPTMFGASLLKVYKYFSHGGAFTGMQTAVLLTGMLVSFV
VAYFAIRFLLNYIQHNNFKIFGWYRIILSLIVIGYFGFLAH
>F6BKJ8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLIKAFILGIVEGLTEFLPVSSTGHLIIVGDLLNFKGAYATMFEVVIQLGAILAIVYY
YREKIWNSLKNLAPNKWGFRLWLKIVIAFIPSAILGLLLNDFIDKHLFSPFTVSIALVIG
AIMMLIVENAFSNYKIDDMDKVTPKKSFWIGVAQCMSLFPGMSRSASTIMGGMMAGLSVK
AAAEFSFFLAIPTMFGATVVSLHKGIATMTSIEWEALAVGFIMSFIVALIVVDKFLSYLK
SHPLRPFAYYRLIVGIIMIGLVLTNIVK
>A0A127SHB1|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLGALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>F8UWR8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
CALLLSTSCSALAGPLSEKQLAEVVEQTVTPLMKAQAIPGMAVAVIYEGQPHYFTFGKAD
VAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQWQGIRML
DLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVQPSG
MSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNV
QDMASWVMVNMKPEALQDTSLGQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGS
DNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANK
>YP_001879172|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AIVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>AAM13572|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVMSLELPEVKGIGRFGYVPYVGYKCINHVSISSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYAQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>A0A0W0BD74|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVIIPVYNEEASLPVLLSRVTAACELLPQDYEVILIDDGSHDGSTEIISEA
AANSDGKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTVRRNRQDSWFRKTASRLINKSVQKATGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTTTPLRLLSIVGS
LVAGLGFTFSILLVLMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHQIVRTATPSQQETEQ
>ACO52881|FEATURES|ARDB_deepARG|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEEDFEPLSQRLEQAGVTIWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVFTSDEA
>A0A064DGM2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPV
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTAADIPMFAVGFVTAFVVALV
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>H5UX53|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELTGIHRRYLSGGEPVDVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGNYKVAGVDVATLNSDELAKLRREHFGFIFQRYHLLSHLTAAQNVEIPAIYAGVARKA
RQQRARELLDRLGLAARVDYSPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLRDRGHTVIIVTHDPAIAAQAERVIEIRDGEIISNPPARSGRAAAKVERTP
ADGGWQQLTSGFREAFSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLE
DIRSIGTNTIDIYPGTDFGDDDPQYQQALKYDDLVAIQKQPWVRSATPALSSNLRVRYGN
KDVAASANGVSEQYFNVYGMTFSEGNTFNQAQHQGRAQVVVIDENTRRQLFPDKRNVVGE
VILVGNMPATIIGVAQEKQSMFGSSKILRVWLPYSTMSGRVMGQSWLNSITVRVKDGYNS
QEAEQQLTRLMSLRHGKKDFFTWNMDGFLQTAERTTRTLQLFLTLVAVISLLVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFTLQLFL
PGWQIGFSGLALLTAFVCSTATGILFGWLPARNAARLNPVDALARE
>A0A023V486|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLVFHDTIKSLFNPIN
VMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLSASDIPMFAVGFVTAFIVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A089NF48|FEATURES|UNIPROT_deepARG|beta_lactam|blacep02|antibiotic inactivation|1
MIVLNKFFNILHYKKAVPVVFLSCATLIGCSDSNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEGLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPEHFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKKNTTG
DSLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDTLKTTNK
>D3DFC7|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MNIHQAIILGIVEGLTEFLPVSSTGHLILTAHLMGLENDNFTKSFEISIQMGAILAVLFL
YTKRFLRDYQVWKRILVAFFPTGLLGFLLYKFIKNYLVGNDKVVVASLFLGGVFLLFADR
VCERFCYMEDASKLSLRKAFMIGIFQSLAMIPGVSRSASTIIGGMLMGLNRKASAEFSFL
LAVPTMLIATSYDVYKSHTTFTNAQWYLLFVGFLSAFLTALITVKVFIGFISRHSFLPFG
IYRILISFAYGFYFL
>A6LZF4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNIKINEYYIPTSLSGPYGITAGIDEALWFTENKANKIGRITVKGEIEEYLVPSQDAGLS
IIVSGTNGDLWFSEYNANKIGKITIKGEIVEYSIPTADSGPFGITEGPDGAIWFTELTGN
KIGRISNLGEVIEYKLPNDSSYPSSIVCGSDGVLWFTENQGNKIGKITMLGEITEYTIPT
IGSGPVGITSGPDGALWFVEINGNRIGRITTEGIINEYDLKTVKARPHAIITGSDGALWF
TQWGSNQIGRITTSGEVSEYEIPTANSEPHGIAVGPDKAIWFAEECNKIGQLILL
>A0A060KZ60|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAERHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A127SAI3|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MTVKLDITQIKKKQMKLYPAILYYLTTIVNHHSEFRTAINQAGELGTYDEMIPSYTIFHE
DTETFSNLWTEYMPNIEEFSRAYENDIQRYGSNHGMIGKPDVPENVFNVSMIPWSTFDSF
NLNLQKGYDYLIPIFTMGKYYKEYKKTILPLAIQVHHAVCDGFHICRFVNELQELINS
>BAA02945|FEATURES|ARDB_deepARG|tunicamycin|tmrB|reduced permeability to antibiotic|0
MAMIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLW
RAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKR
LRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRG
SLRRFADRLMVKLNHIRIK
>H8G416|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTTPAITDHWVAGERGSGTGPYGVTVGPDGAVWFTMARSGCVGRWVPGEEPTLHRLAPDC
QPTVIVTGPDGALWFTETQGHRIGRLTTDGELTEFATPTGESGPYGLTVGPDGAMWFTEL
NADRIGRITSTGEITEYPLTRAGAFPSAIATGADDALWFTMNQANAVGRLAMDGTVTVYD
LPTEAAGPVGLTAGDDGALWFVEIMAGQLGRITTTGEITEYPLPDRNAKPHAITAGGDGR
CWFTEWGSGRVGSITSEGVIDVYDLPVPASEPHGIAVGPDGVVWAALEVGALARIDTRRR
DG
>A0A021XDU6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIVSALILGLIEGLTEFIPVSSTGHILLAGHFLGFKSPGNTFAVLIQLGAILAILS
VYAAKLLKIAFALPSSPEARRFVISVLIAFLPAAVIGALAHDFIKTVLFETPMLICIVLI
VGGVILYVIDRLPLQPRYTDAMQYPPSLAFKIGLCQCLAMIPGTSRSGATIAGALLMGTD
KRSAAEFSFFLAMPTMVGAFTLDLYKNRDALSSDDLLVIGVGFAAAFVAGLFVVRSLLDF
VSRRGFTLFAIWRIVVGTLGLIGLLIFG
>A0A0S1RS98|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRMLVNRQLPIEAAAYELADNLFEVGQADGWRLYG
>A0A0M1NVA7|FEATURES|UNIPROT_deepARG|beta_lactam|AM233_18505|antibiotic inactivation|1
MNKRWFYQILAPMGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENITAKETTIKKFEQ
LEKEYDARLGVYAIDTGTKETVEFHENERFAFTSTHKALAVGALLQQKSIEDLNQRITYT
SEDLVNYNPITEKHVDTGMTLKELSDASLRYSDNTAGNLILEQLGGPAGFKKVLEGIGDN
VTNPERIEPDLNVVNPGETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGD
ALIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKEADYNDELIA
EATEEVIKALKVKDK
>A0A0C5E4Z3|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSQKAVVFAYHDIGCAGIEALLNAGYDIAAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
PEDANHPLWVERIAKLNPDFIFSFYYRNLLSEALLATAAKGAFNLHGSLLPNYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAILAQQRVAIERSDTALSLHGKLRDAAASLLRDTLP
ALAQGKVNETAQDESKASYYGRRTAADGKLLWSQPAERLFNLVRAVTKPYPGAFCAVGEH
KLIVWSAEVVKGNEGQAPGRVISVDPLRIACGEDSLVINAGQRNDNGLYLSGPQLANELG
LVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDKYEVYGLDIGSDAIERLR
SHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GSKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGAQKRCFT
DIADGIEALARIVDNENDVCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESKAFYGAGYQDVEHRKPSIANAKRLLNWEPSIEMKETIGNTLDFFLREAMLEIA
DKR
>A0A127SSP7|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHVHFPLLSVFKFHVALAVLDKMDKQ
SISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLRELMQYSISQSDNNACDILIEYAG
GIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNWSTPSAMAQLLRTADEKELFSNKE
LKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRK
YYIAAFVMDSYETDEDNADIIARISRMVYDAMR
>B2ZTR4|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
TSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAV
NSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTS
GNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPLDQVL
EKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSF
IHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMK
PNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVMLTNKR
>A0A0Q6SXN4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIELERVSRHYASGGAQVRALDDVSLRIEAGEMVAIMGASGSGKSTLMNLLGCLDKPS
SGRLCVDGHNLPELSPDQTATLRRETFGFIFQRYHLLPHLDAVGNVELPAIYAGYNGRER
HRRAISLLQRLGLGERLSHKPAALSGGQQQRVSIARALMNGGRIILADEPTGALDSASGA
ELLALLGELNAMGHTVILVTHDAEVASHARRIIELRDGRVVRDAAMTTAPRAATPGEEPA
RLSTARGPAHWLAPWREALAMSLAALSGNRMRSALSMLGISIGIAAVISINALGEAARSG
VRHSAQEASASKLDISQGNRKLLPGAVTQPLTLRDVMALRSLPGVTAVVPHYASGATARH
GRRDDSVTVNGIAVGDIGLGNQTITQGRDIGAQDQQNAAQVAVLDRVARDVLFAPGEPVL
GQTVMVGPLPLTVIGLAEPLHAQDSPFTLPFRVPGNVYVPQSTYTSKFDTHLETDRLSVH
FATPFPTETFRAQVRQRLLALHGGTEDFTLETNDALTGIFTVLLTQLTGLLRAIAAISLL
VGGVGVMNIMLVSVAERTREIGIRMAVGARQRDVRRQFLIESVLLCCLGGLAGVSLPWLA
TQVIRLAFPDLPLVVSWDALALALGTCTAIGLLFGNLPARNAAMLSPVVALARD
>A0A0N0ERL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRAGLLAFRALQGLADEFRPAAGSSYVQACRGIVATIFYTTTLNSEPAASLHGGMMDLWT
AAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVVWEFRR
KILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVVGGVI
ILWAERRVHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAAT
EFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKFIATHS
YAVFAWYRIAFGLLILATWQFGWIDWASAKA
>ZP_04324291|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MEKMKNTLLKLGVCVSLLGTIPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVH
TELGYFSGEAVPSNGLVLITSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAH
ADRIGGMKTLKERGIKAHSTALTAELAKKNRYEEPLGDLQSVTNLKFGNMKVETFYPGKG
HTEDNIVVWLPQYQILAGGCLVKSASSKDLGNVADAYVNEWSTSIENVLKRYGNINLVVP
GHGEVGDRGLLLHTLDLLK
>R6WEB9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDALKVIILGIVEGITEWLPVSSTGHLILVGDLLAPGLSDEFMEMFNVVIQLGAIMAVV
VLYFHKLNPFSPKKTKKQKLLTWQMWIKVAIASVPAAIVGLLFNDILDKIFYKPFPVAVM
LIVYGVLFIVIENRNAGRRPSVNKIADLSMSMLLWIGFFQMLALIPGTSRSGATIVGALI
IGVSREIAAEFTFFLAIPVMFGASLLKLIKFGFAFTAGEFGYLMLGCVVSFAVSIFAIKF
LMSYIKKNDFKVFGYYRIVLGGLIVVVSLVQMVLA
>A0A0A8DXE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGIIEGLTEFLPISSTGHLLIAERWLGHRSDFFNIVIQAGAILATTLVFRQ
RLWDLATGLGDRANRDYAFKLGAAFLVTAVVGLIVRKAGWQLPDSVQPVAWALVIGGVWM
LVAEYFAARMPERETVTWTVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAE
FAFLVGIPTMFAASAYSFLELYKDGGLGSENWGDVALAFVASMVTGFVVVKWLLGYIKSH
RFTAFAVYRIVLGAALLLWLPAA
>A0A0R2KVV4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEILKSILFGIVEGITEWLPISSTGHMILLDQFVKLDVSRDFYSMFEVVIQLGAILAVV
ILYWSKIWPFHKKQTLTPNFNSQAKIWNYMDKDIFIMWVKIVIACIPAGVVGVLFNETFE
KLFYKPIPVALALIVFGVAFIWVETVHKNKTPKINTINDLTYFTVIMIGFFQLIAAVFPG
TSRSGATIVGALILGVSRTVAAEFTFFLAIPVMFGASFFKLYKFGFHFTGMETLILAIGM
ITAFITSIIVIKLLMNYIKKHDFKIFGWYRIVLGIIVILYFTLH
>A4SDL5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MMPLLELVDVHRSYKIGESTVHALRGVSLKIRRGEFVAVMGSSGSGKSSLLHILGLLDNP
DSGEYRIFGRNVNDLSGDEQAGLRNHMAGFVFQQFHLLKRMSVVDNVRLPHIYSGEQGDF
RQEALRRLEEVGLGHRTDHTPNQLSGGEQQRVAIARALIGDPGIIFADEPTGNLDSVNSA
EIMKILQNLHREGRTIIMVTHEHDIAAYAGRVLTMRDGLVVSDEQRDVVDGPTEIPNDYE
KAGESMRHASRPISLWKDGRFIGFMQQAFQAIFANKVRSFLSVLGILVGVASVIALMALG
EGAKSAMQEELKSMGSNLLSVRGGSSKVRGSARAAGAIAPFTFTDVKDIAAMRPMIRNAA
GTVSGSARIVYGNKNWSASLDGVGYEFGIMRAAVPSIGRWFTREEIQKRDKVAILGMTVV
RELFGNANPLGRTVKINRINFRVIGVAPPKGFSGPRDGDDVVMIPVTTAMYRVLGKDYLS
YIYVEVRHAAEIKKAKKAISALIMKNHRLREADEAFYIRDMTEIQEMLSSTTQTMSLLLG
SIAAISLLVGGIGIMNIMLVSVTERTREIGLRKAIGARRGDILLQFLVESVGLTLSGGIM
GVASGTGIAFFLALFAGWSVKASLLSVVLATCFSALIGIFFGLWPARKAADLKPVEALRY
E
>A0A0Z8AB33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
MTIYFKKLNPFQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAI
ALIVYGIAFIWIENRNRGVEPQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAI
ILGTSRSVAADFTFFLGIPTMFGYSGLKAVKYFLDGNSLNMEQVWLLLVASVTAYLVSLV
VIRFLTDFVKKHDFTVFGYYRIILGAILLVYAFITFLF
>A0A127T6E6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
MEKYFMMKTSLTGVLLLGASFSTFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYH
GKPYYFSWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQ
LTGQQWQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASI
GLFGALAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYA
>YP_002214831|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAAL
AAIAFFGLQRAMPETATRRGETLSFKALGRDYRLVIKNRRFVAGALALGFVSLPLLAWIA
QSPIIIISGEQLSSYEYGLLQVPVFGALIAGNLVLARLTSRRTVRSLIVMGGWPIVAGLI
IAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLFSSDMSKGTVSAAMGMLQMLI
FTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNSQTV
>A0A0E1NGG2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_4|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SSGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKITQEVVSSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSDQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0H3WY38|FEATURES|UNIPROT_deepARG|aminoglycoside|AB870_05350|antibiotic inactivation|1
MHPVESRDVARWGSLRHRLWPHASPTEHEREIMEMLSEPNRYAAFIAISQEGRTVGFAEA
SIRRDYVNGCDTSPVLFLEGVYVAPDARRRGIAKALFKRVEHWGTLRGCEEFASDTDVAN
TDVQALHRALGFEETERVVFFRKRTLKSTSA
>G7Z3Q6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MMIDQYLDATLMGLVEGLTEFLPVSSTGHLIMLDELLGFQGPPGKVFEVVIQLGAILAIC
VVYFQRLWQVATGLKDDPGARRFVMAVLIAFLPAMVLGAGLHGVIKTLLFNPTVVSIALI
VGGIAILLVERLVPVARYHRIENFSAPLALKIGFCQCLALVPGVSRSGASILGALLMGVD
RKAAAEFSFFLAVPTMAGATAYDLYKNWSVMSLDSGLLILVGFVTAFIAAALVVKTLVDF
VGRYGFTPFGWYRIAIGTGMLAFLYL
>A0A0K6L4W6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MEIKGINHLLFSVSHLDTSIDFYQKVFDAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
IKLSYTHIAFTIEDHEFEEVSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTG
TLQDRLRYYKQEKTHMHFYDETAF
>A0A127ST84|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MVFEKIDRSIWKRNEYFEHYFTNIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQRYG
SNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKIILPL
AIQVHHAVCDGFHICRFVNELQELINS
>H6D9D5|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MSIQRFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGEPLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0B2JTT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIINAIILGIIEGITEFLPISSTGHLIVASKWLGIESTDTNLAFEVIIQLAAILAVLAN
YKDKFSPKHFNLWVKVAIAFIPLGIIGFIFSDVIKTLFSVPVVGVMFIVGGVIFLLLERS
YKETHCTTTDVTQVTYKQALWIGVAQVFALIPGTSRAGSSIVGAMLCGLNRKASAEFSFL
LGLPVLAAASGYDLLKHYQLFSLDDLTALAVGFLTSFIVAYFTIKLFIRFLENFTFVSFG
LYRIVFGVILLTNLNSG
>A0A060KTF0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGMALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>D7RNT5|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-114a|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAM
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATQPNAGLRARDELVRDWPAMAGAWRP
>I3E3M3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYGANTFKVVIQLGS
ILAVVVVMKDRFFDLLRLRRRSKDGVAGQGRLKITHVIVGLIPAGILGVLFENYIDEYLF
STATVLIGLVIGAVLMIIADVFGGKNPKVHTVDQITYKQALIIGLIQCLSLWPGFSRSGA
TISAGVLAGLSYRAAADFTFLMAVPIMAGASGISLLKNLEYISIDDLPFFIAGFISAFVF
ALISIKFFLRLIDKIKLVPFAIYRILLALIIYIVYF
>ACI76096|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VIYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A127SR90|FEATURES|UNIPROT_deepARG|chloramphenicol|catA13|antibiotic inactivation|1
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYGVTTIIN
RHEEFRTALDENGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAF
GERTGMSAKPNPPENTFPVSMIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYYIP
LSIQVHHAVCDGFHVCRFLDELQDLLNK
>E6KXH1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEMKNINRYFGAGENRVHILKDISLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
SGSYKIDEKETIELTADQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMPHNQR
LERAKQLLEKLGLSDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGE
NVLEILRQLHQEGHTIIMVTHDKHIAASANRMIEIKDGEIISDTQTQPVKSAVKNSNVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTITIFNGTGFGDRRAEQMQNLTVNDANALRQQTYVQSVTPNSASSGTLIYANKA
FSTTSLKGVSEESFDVEGLKLKQGRLLSAQDVAENAQVALIDESAKKAIFPYENPLGKVV
IFNKRPLRIIGVVSDRQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVAEDVNTTAA
EKGITELLTLRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIML
VSVTERTKEIGVRMAIGARQSNILQQFLIEAVLICLIGGVTGILLSGAIGVLFNTFMTDF
TMAFSGGSIIAAVAFSSLIGVVFGYTPAKRAAQLDPITALARE
>YP_002146111|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPNPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLSGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLNEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>A0A0U1HPI9|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_1|antibiotic target alteration|0
MLQNEPIKKVSIVIPVFNEQESLPALIERTTAACKLLTQSYEIILVDDGSTDNSAELLTA
AANVPENCIIAVLLNRNYGQHSAIMAGFNQLSGDLVITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALFGFTFAVLLVVLRLVFGPEWAGGGVFTLFAVLFMFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQKVVCAEQTENNQDVEK
>A0A142FK25|FEATURES|UNIPROT_deepARG|aminoglycoside|aph(3')-VIj|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSVA
IIDCPFISNIDHRLKESKFFIDNQLLDEIDQDDFEAELWGDHKTYLSLWNELNETRVEER
LVFSHGDITDSNIFIDKSGEIYFLDLGRAGLADEFVDISFVERCLREDVSEETAKIFLKH
LKNDMPDKRNYFLKLDELN
>A0A059VDC5|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA24|antibiotic inactivation|1
MIAEISTQLLEVLSVIERHLEPTLLAVHLYGSAVNGGLKPYSDIDLLVTVTVRLNETTRR
ALLNDLLEVSTFPGESEALRAIEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLKLWNSQPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVLLEARQAYLGQEEDRLALHAD
QLEEFVHYVKGESTKVVGK
>A0A0M2PQ51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILTILKAVILGLVEGLTEFAPVSSTGHMIIVDDMWLQSEEFLGKYVANTFKIVIQLGS
ILAVVVVFRNRFIDLLGLGRLNKESVSEGQNRLKLSQVIVGLIPAGVLGVLFEDFIDEHL
FSIETVLIGLVAGAILMILADIFGPKQPKTETVDQITYKQAFTVGLIQCLSLWPGFSRSG
STISGGVLLGMNHRTASDFTFIMAVPIMAGASFLSLLKNWEYFTLDAMPFFIAGFISAFV
FALISIRFFLKLINKIKLVPFAIYRILLVVVIYLVYF
>W4V298|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELGVGLIKVIILGIIEGITEWLPISSTGHMILVEELIKMNMSDEFMEMFRVVIQLGAIM
AVVVLYWNKLFPFSFKDGVQIKKDTFSLWIKVLAATLPAALIGIPFDDKIDSLFYNYTTV
AITLIVYGILFIIMENRNKSKISLISTFDELGYKAVLLIGVFQVLALIPGTSRSGATILG
AIMIGCSREIAAEFSFYLAIPVMFGASLLKLVKFGFAFSQLELIILFTGMIVAFAISIFA
IKFLMGYIKRNDFKAFGYYRIILGLIVVLYFLAVR
>F6DIC4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AVLLLYGRRLAADRALWLRIAVAFVPTGVIGFLFYPLIKGVILGNDAVVAFFLFFVGAVL
LFADRLAERAQHQDVKALPLARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLNRQAAA
EFSFLLALPTMFAAVGYDLWKSAPEVPEGGWSLLLLGFLAALATALVTVRWMLAFVARHG
FRPFALYRMALAAVYAFFFLR
>E1HQ00|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF9543_03168|antibiotic inactivation|1
AGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIY
QGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWP
ELTAKQWNGITLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSS
IGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPG
ALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEML
DWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKEL
GIVMLANKNYPNPARVTAAWQILNALQ
>A0A0E4H9G8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILEILKAIFYGIVEGISEWLPISSTGHLILVQEFVKFSNVSDDFMSMFNVVIQLGAILA
VMVIYFERLNPFQRGKSEKQVRLTWQLWAKVLVAALPAAVLGLFLDDWLDATFYNFITVA
LMLIAYGFAFLYVEKRNENLEPSVSSLSRLPYKTALFIGFFQVLALIPGTSRSGATILGG
ILLGTSRQVATEFTFFLGIPIMFGASFLKLVKILASGVSVTGGQWLLLILAMVTAFGVSI
LAIRFLTDYVKKHDFTIFGKYRIGLGAVLMAYYLAKLIFKW
>A0A139DSW7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEVRRINRFFGKGDSRFHVLKDINFDINRGDFVAVIGQSGSGKSTLMNILGCLDTPT
SGSYRLDGIETSGLSANAHAWVRGRKIGFIFQRYNLLASLNSLDNVALPAIYTGLSHQVR
TDRAAELLERLGVADKFRNKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
IVMDILRVLHQSGRTIILVTHNHTIAAHAHRVIELKDGFIVANSRRLPARRIDYQNPVDS
FVSPVTFHCDQFIEAFKISIQAITTHKLRSLLTMLGIIIGIASVVSVVALGRGSQERIIN
NINSMGTNTINIYPGSGFGDRQNARVRTLTVSDSAMLAGLSYLDSSTPNTSVSGLLVYGN
QSFTASLSGVGDQFFDVRGLSIELGRFFTRRDIQEVASVVVIDPNTRDKLFPGGENPVGC
TIIFRRQPLTIIGVTKSKNNVFDAVDSLSLWAPYTTVMSKITGDYYINSIIVKVNNLVNS
QLVEKNLIDLLTIKHDGRKDFFTQNTDSIKKTIEDTTRTMTLLISSIAFISLVVGGIGIM
NIMLVSVAERTKEIGVRMAVGAKRFNIMEQFLLEAIVLCLVGGVLGIALSGSFRFFFNAV
SKNFTISFSIASIFLALGCSTFIGVLFGFIPAWNAAHLNPIDALAYE
>G8EXA3|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGAKGVTVVGA
TWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEA
L
>A0A0A8TML0|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MALLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKNTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDQIKTDAQTLKYFQDWKINQPVSQFRQYSNP
SIGLFGEATAKAMNMPFSTLLEQVIFPQLQLQHSYVNVPKAQQTNYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLNLNLNPDQAKASIRPAIQGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKQTSHP
>NP_706007|FEATURES|ARDB_deepARG|kasugamycin|KsgA|antibiotic target alteration|1
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
QLTVIELDRDLAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNIST
PLMFHLFSYTDAIADMHFMLQKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSA
FTPPPKVDSAVVRLVPHATMPHPVKDIRVLSRITTEAFNQRRKTIRNSLGNLFSVEVLTG
MGIDPAMRAENISVAQYCQMANYLAENAPLQES
>YP_349555|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLLTLFKVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTQSNAQRFTRNLLIAFFPAVILGVLFADTIHEYLFNPITVAVALV
VGGIVMLWAEQRDHVVSVDHVDDMKWADALKIGCVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQSSDLPVFALGFVVAFIFAMIAVRGLLKF
IANHSYATFAWYRIAFGLLILATWQFGWVNWTAAAAA
>E9XN76|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVAMLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
INTASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>B8ZI26|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKN
>V4IXJ6|FEATURES|UNIPROT_deepARG|beta_lactam|B590_12618|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSDGRGRGRGSGSASDAERRLARLER
ASGARLGVYAYDTGSGRAVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQ
DDVDRAGGAPETGKAENLANGMTVEELCEVSITASDNCAANLMLRELGGPTAVTRFARSL
GDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLALGDALNPRHRRLLTSWLLANT
TSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRPPIVLTVLTAKTGEDAVRDDG
LVADAARVLAETLG
>A0ESJ6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVTVIYQGKPHY
YTVGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVAGASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>ZP_04627600|FEATURES|ARDB_deepARG|multidrug|AcrB|antibiotic efflux|1
MAKFFIDRPIFAWVIAIILMLAGALAIMKLPVAQYPTIAPPAITISANYPGADATTVQNT
VTQVIEQNMNGIDNLLYMSSSSDSSGNVQLTLTFNSGTDPDIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVAGFISEDGTMQQEDIADYVGSNVKDPISRTAGVGDVQLFGS
QYAMRIWMDPHKLNNYNLTPVDVINAIKVQNNQVAAGQLGGTPPVPGQELNSSIIAQTRL
TNAEEFSQILLKVNTDGSQVRLKDVAIVQLGAESYNIIARYNGKPAAGIGIKLATGANAL
DTSAAVKAELAKLQPFFPAGLKVVYPYDTTPFVKISINEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILSAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
QEEGLPPKEATKKSMEQIQGALVGIAMVLSAVFIPMAFFGGATGAIYRQFSITIVSAMVL
SVLVALILTPALCATMLKPIAKGEHGPKTGFFGWFNRMFEKSTHHYTDSVANILRSTGRY
LVIYLVIVIGMGVLFLRLPTSFLPEEDQGVFLTMVQMPAGATQERTQKVLNQVTDYYLDK
EKDVVNSVFTVNGFGFSGQGQNTGLAFVSLKNWDERPGEQNKVPAIVARASAAFSQIKDG
LVFAFNLPAIVELGTATGFDFQLIDQGNVGHQKLTEARNELLGMAAQHPDMLVGMRPNGL
EDTPQFKVEVDQEKAQALGVAISDINTTLGSAMGGSYVNDFIDRGRVKKVYVQADAPFRM
LPGDIDKWYVRNSAGQMVSFATFSSAKWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAM
DLMQELAGKLPSGIGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVVGALLAASLRGLNNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLV
ESTLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKSEDIEHAHAVEHKAK
>E8KHA0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MKLIEIENLNKYFGSGENKAHILKNVNLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
SGICCIDGKETLQMNSDELSDLRQRKFGFIFQRYNLLSALTANENVALPAIYAGMDSHSR
KARADQLLDKLGLSDKTLNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGE
TVLQILQDLHKEGHTIIMVTHDPNIAATASRVIEIKDGQIIRDERQQPYSEELKLAKREH
KSPRFFDQLIESFKMATSAIMAPKLRALLTMLGIVIGITSVISVVALGQGSQERILSNIN
SLGTNTMTIMNGTGFGDRRANLTKNLTISDATMLNKQAYIDSTTPSGSWLSRAA
>ZP_03215830|FEATURES|ARDB_deepARG|multidrug|EmrD|antibiotic efflux|1
MLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSD
RVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGT
QLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRP
AGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSIL
FILPIPAAFFGAWFAGRPNKRFSALMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAAL
FFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLAWLSAMLPQTGQGSLGLL
MTLMGLLILACWLPLASRISHQGQTV
>A0A0E1SHW3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHPEQAKTFDVVIQFGAILAVC
WEYRRRIIDVVTGLPAQREARRFTMNVVIATVPAVALALLFEKTIKSVLFAPVPVAVALV
VGGAAILWVEGRQRERSEPARVQSIDALTPFGALKVGLAQCCALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPVIFGATLYETAKDWRAFNVDSVGLFAIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>A0A078Q5N5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTTFETIIIAIVEGLTEFLPVSSTGHMIITQNILGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLNHTPAPAGASALKCFLHKFDFYWKLLVAFIPAAILGFLFSDKIDEMLES
VAIVAVMLVIGGIFMLFCDKIFSKGSEDTVLTERKAFNIGLFQCIAMIPGVSRSMATIVG
GMAQKLTRKDAAEFSFFLAVPTMFAATGYKVLKLFLDGGTEILVNNMPALIIGNVVAFIV
ALLAIKFFISFVTKYGFKAFGWYRIIVGGTILVMLLLGYNLEIG
>Q0K1N3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC1|antibiotic inactivation|1
MKRIPVARIATIAMACSLFAANASAADSVGQRQIERAVNDAIRPLMAAHGVPGMAVAVTA
GGKRYVFNYGVAAKEGRRKVDGDTLFEIGSVSKTFTATLASYGQARGTLSLADPAGKYLP
ALAGSSLGATSLLDLGTYAAGGLPLQFPDAVTDTRTMVDYFRGWRPRYAAGSHRQYSNPS
IGLFGYLAASSMGQPFDDLMEKTLFPALGLAHTYIRVPKARMGDYAYGYSKDGKPVRVTP
GVLDAEAYGVKTTAADMIRFVEANIDSAGLDDKLRRAIAGTHTGYFKVGDMVQGLGWEMY
AWPTRVDSVLAGSSPQVVLEANQVSRLEPPLSSPADVLVNKTGSTNGFGAYVVFVPAKRI
GIVMLANKNFPVPERVKAAFRILAALDGAPGRADTP
>ZP_03916453|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MIINLIKVLILSLVEGITEFLPVSSTGHLILVNQFVKLEPEGFSNAFNVIIQLGAILSVV
VIYFEKLNPWAKSKQELPKKYKDLNAQSKAYYLATHPDKTTINLWLKVIVGVLPAMVLGL
LFDDLIDAYLFNPITVAAMLLLWGIIIIFIEKKNKTIKYDSLKDVPYTTIIMIGLFQCLA
MVPGTSRSAATIIGAMILGLSRPAAAEFSFFLAIPTMLGATLLKLIKNLGDFTGTEWTLI
LLGMILSFIVAFIVIKQFLAYVKKHDFIPFGIYRIILAVIVFVYFLLINR
>YP_001416709|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTRRQGPQRLRSWTHDCTCEGDGTGCAILTAFRMTSLMTLGAMLEALVLGLVEGLTEFIP
VSSTAHILLLGHFLRFESAGHTFEVLIQLGAVLAILTVYFQRFLRVAQQLPSNPGARRFV
IGILVAFLPAAVIGALAHGFIKSVLFETPALICVTLILGGIVLLFIDKVVPEPRYNNAMG
LPLLLALKIGFFQCLAMIPGMSRSGSTIVGAMLMGVDKRAAAEFSFFLALPTMAGAFAYD
LFKNRNNLSFDDGLLIVIGFIAAFCAAVLVVRTLLDFVAKHGYAPFGWWRIIVGVAGLIG
LAVVG
>N1M224|FEATURES|UNIPROT_deepARG|beta_lactam|EBGED10_60890|antibiotic inactivation|1
MKKNTLLKVGVCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGGKGLLLHTLDLLK
>A0A0D6IV06|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb_1|antibiotic inactivation|1
MSKALKVGLDGGPYALAAGPDGAMWVTLAHSGEIARVTETGEVAVYPVAPQARPSIIAAG
PDGAMWFTRAGDDRIGRITVDGELAEFELAEGSAPFGIAAGPDDALWFTAMTSGEVCRIS
TDGEVTSVAVVGGMPSMITAGPDGAMWFTINQGNAIGRLETDGTLTVRELPTPAAGPVGI
TATHDDAVWFTEIGADQLGRIPLDEAIQELELPGKPHAVVADPDDGVWVSLWGADQLARV
SGDGEVVTIDLPSGSEPHGLAIGPDGAAWVALECGFVLRMPN
>A0A0E3UYH3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSTWQAIILAIVEGLTEFLPVSSTGHMIIASSLMGINELPITKIFEVNIQFGAILSVVVL
YWRRFLQSFDFYKKLLLAFIPAAVIGFALNDVIDAMLESVVITAIMLVLGGVVLLFVDKW
FRNAEKDEVSYKNALAIGVFQCIAMIPGVSRSAASIIGGMSQGVNRKAAAEFSFFLAVPT
MLAAATYKLITDLLQLELSDLIKFDIVKIQNSFEVIQPEDLQLLLVGNVVAFFVAMAAIS
FFISFLTKYGFKLFGYYRIALGVVLLALLAMGVDLKV
>A0A085VA76|FEATURES|UNIPROT_deepARG|aminoglycoside|IV02_07790|antibiotic inactivation|1
MIKCCTLLDHNGWLPLRTALWPDSAADSDHDKQTILREPERYLVLVFKDENDNALGFAEA
SIRTDYVNGTHSSPVAFLEGLYVQPASRGQSIARQLVAGVEQWALEMGCTELASDALVEN
RVSHSMHEALGFEETERVVYFLKSLGVDREQ
>A0A0J6EJ15|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNIWDIIVAVILGIVEGLTEYAPVSSTGHMIIVDDLWLKSKELLTPEAANTFKVVIQLGS
ILAVAIVFKDRILNLLGMKKNITEAQKEGSRLTIAQIAVGLVPAAVLGFLFEDYIDEHLF
SVKTVAFGLIAGAVLMLAADWINKRKPATDSVDRITYKQAFGIGLFQCLALWPGFSRSGS
TISGGVIFGLNHRAASDFTFIMAMPIMAGASLLSLVKNWEYLSTDLLPFFIAGFISAFIV
ALFVVRFFLKLINKIKLVPFAIYRIILGIVLFALFL
>A0A127SFF6|FEATURES|UNIPROT_deepARG|beta_lactam|VEB-1a|antibiotic inactivation|1
FFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINNDFHFPMQSVMKFPI
ALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSESDNI
GCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDT
YNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDV
GVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>A0A0S1RSL2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQ
PTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPFEQVDFLRKSVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGT
>I2B7L3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFMTPPINKISVVIPVFNEQESLPALIRRTQAACQQTGKDFEILLIDDGSSDDSASMITM
AAETQDSPIVAILLNRNYGQHSAIMAGFSNVTGDLIITLDADLQNPPEEIPRLVAAAEHG
YDVVGSVRQQRQDSWFRKSASRLINRLIQRTTGKAMGDYGCMLRAYRRHIVEAMLNCHER
STFIPILANTFARRTTEIPVAHAEREFGTSKYSMMRLINLMYDLITCLTTTPLRLLSILG
SIVALCGFGVAILLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQRVIRQNSNTSKTGEQEHKS
>A0A0K0Q868|FEATURES|UNIPROT_deepARG|beta_lactam|AC241_04730|antibiotic inactivation|1
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>K8QF18|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVDQVVKLSQGRQFMNMFEYVIQFGAILAVI
LLYFNKLNPFSKPTVQAQKDTWQLWAKVIIAVLPSVVVGLPLNDWMDKHLHTPLVVATTL
ILYGVLFIVLENYLKNKQAHITSLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSILKIGKYLLQGNGFTGEQWIVLLTGSVVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIILGAIVLLVMFL
>A0A0Q7LKN8|FEATURES|UNIPROT_deepARG|aminoglycoside|ASD41_25500|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPAADHRAEVESSLAEGDRYASFLCEDEAGVAAGFA
EASIRHDYVNGCETSPVGFLEGIYVLPAYRRRGVARALITAVERWATSRGCQELASDSAT
DNLRSQSLHMALGFEETERVVYFRKELAPAVADN
>K8W9H0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSHADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQSYELILVDDGSSDRSAQM
LTEAAENPDNHVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTA
MQGYDVVGTRRANRQDSWFRKTASKMINAMITKATGRSMGDYGCMLRAYRRHIIQAMLQC
HERSTFIPILANTFARRTIEIDVAHAEREFGDSKYSFMKLINLMYDLLTCLTTAPLRLLS
VVGSIIAAGGFLLAVLLIALRLIFGAEWAADGVFTLFAVLFMFIGAQFVAMGLLGEYIGR
IYNDVRARPRYFIQKVVGADAKSDKNQEED
>N8YSP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
IYEYWGKLWGAAIGLFSGEPKGRHLGVSIIAASIPIMIVGLTCGDIVKELLFNDISVAIG
LIVGGLIIWWVEKNPPKVNAVEVDNITIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLG
VSRKAATEFSFFLGIPVIVGAGLLDLFKNYHIYETTQDWTVFFVGLIVSFVSALILIRVL
VAYVSKRDFMIFAWYRIASGLIILLFALTGWKLW
>A0A0Q7H1P0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDDKAKVFDIAIQTGAIFAVI
LVYWHKIKSTVVALPRQPKAQRLALNIFIGFLPAVVLGLLFGKAIKAHLFIPTVVASTFI
IGGFIILWAEKRPPGSVRVEHVDDMSPWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRQAATDFSFFLAIPTLIGAGVYSLYKERALLSVADLPLFAVGLVFSFISAWLCVRWLLK
YISTHNFIPFAWYRIAFGIVVLATAWSGAVVWAE
>B2CD69|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM|antibiotic inactivation|1
PRRSFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
LCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTT
MPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVQDH
>W0XA62|FEATURES|UNIPROT_deepARG|aminoglycoside|aphA3|antibiotic inactivation|1
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVERE
KDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDLRELYDFLKTEKP
EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>K0FPJ7|FEATURES|UNIPROT_deepARG|beta_lactam|MC28_1922|antibiotic inactivation|1
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLEQRIKYTSKDLV
NYNPITEKYIDTGMTLKELMDASIRYSDNTAQNLILTQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIENRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDVLKVTNK
>V9QVM6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVTGLPTQRNAQRFTLNLLIAFLPAVVLGVIFANLIHHYLFNPITVATALV
VGGIVMLWAERRQHEVHAETVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPADLPVFAIGFVTSFIFAMIAVKGLLKF
IASHSYAVFAWYRIAFGLLILATWQFGWIDWAAAKA
>A0A0P7L443|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYNIEGQSQSINRRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVIYALVAGAILMIVADKFAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>M5FEF1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MESQTIVQALLLGLLEGLTEFLPVSSTGHILLAGHFLGFRSTGKAFEILIQLGAILAILS
VYFRRLWQMLLDLPHDRLTRHFALGILIAFLPAAVIGALAHDFIKTILFESPRLICIMLI
IGGVVLLLVDRMKLKPVYRDVERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAIPTMVGAFAFDLFKNRNVLSSADLPIIAVGFIAAFVTALIVVRFLLEY
VSRNGYALFGWWRLVVGGVGLVALMIWG
>W1IQZ8|FEATURES|UNIPROT_deepARG|polymyxin|pbgP|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLERTVAACQKIGQRYEIILVDDGSRDRSADILTQA
AEIPENHVIAILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEISRLVKAAEEGY
DVVGTRRANRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVHAMLQCHERS
TFIPILANTFARKTIEIDVAHAEREFGDSKYSFMKLVNLMYDLLTCLTTAPLRLLSVVGS
VIAMTGFLLAVLLIALRLIFGAIWAAEGVFTLFAILFMFIGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVKKTNDNQEKS
>T0PEU1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGLHFGEVPHEGKTNGKLKLSHILLAMLPAVTLGLLFHDTIKSLFNPQS
VMYALIIGGVLLITAEILKPKTPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLTASDIPMFAVGFITAFIVALIA
IKTFLALIKRMSFIPFAIYRFIIAAAVYCVFM
>A0A158BP48|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTLLLVKAALMGIVEGLTEFLPISSTGHLILAGSLLHFTSEKAKVFDIAIQTGAIFAVI
LFYWRRLVDTTAALGDSSRARRFVSNVLIAFLPAVVIGLLAGKAVKAHLFTPTVVATSFI
AGAVVILWAERRPKSVVRVFTVDDMSPFDALKVGLLQCLALVPGVSRSGSTIIGGMLVGL
SRNAATEFSFFLAIPTLIGAGAYSLFKERHLLSAADAPLFAVGLIFSFLSAWVCVRWLLR
YVATHDFVPFAWYRIAFGIAVLVTAHFGWVNWAD
>YP_001061519|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIAAAAFAVVFIAGLGTFGAIRVNAGAPEKSAAPLPEVDVATVLSKMITDW
QSYSGRLEAVEKVDVRPLVSGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
GAQARNGYAQSDWQRAQRLIGDNAIARRDYDEKQNAAREASANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYIGGAKD
GRKVPVELGLANESGYSRQGVIDSVDNRLDTSSGTIRVRARFDNADGALVPGLYARVKVG
GSAPHPALLIDDAAINTDQDKKFVFVVDQQGRVSYREVQLGAQHGNQRVIVGGLAASERI
VVNGTQRVRPGEQVKPHLVPMTGGDDAAAATPVAGGVQRPRAAQGNARA
>A0A0L0AMH3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELTGIRRSYSSGEGSVDVLKGVSLRIEAGEMVAIVGASGSGKSTLMNIIGCLDKP
TGGTYRVAGTDIATLDGDALARLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGTERAV
RLKRARALLERLGLAERADYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHQLRDRGHTVIIVTHDPDVAAQAERIIEIRDGEIISNPPAKTTASAPLNQIHQ
GPVSGWRQFCSSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKELVL
ADIRAIGTNTIDVYPGKDYGDDDPQYQQSLKYDDLAAIQKQPWVKSATPAVSQSLRLRYN
NLDMAASANGVSGQYFNVYGMTFSEGTTFNDEQLKGRAQVAVLDSNTRRQLFPNKTHVVG
EIILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTMAGRIMGQSWLNSITVRVNDGYE
SAQAEQQLTRLLTLRHGRKDFFTWNMDSVLKTAEKTTRTLQMFLTLVAVISLLVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVSLSMLIAFTLQLF
LPGWEIGFSPVALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0M3AJV8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLVKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIAL
IVGGLIIFWVESKNFDHKTTEATRITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIGVGFVAAFISALLVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>NP_833174|FEATURES|ARDB_deepARG|beta_lactam|BL2a_1|antibiotic inactivation|1
MKERVDNMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
NVWVHTELGYFNGEAVPSNGLVLNTAKGLVLVDSSWDNKLTKELIEMVEKKFQKRRTDVI
ITHAHADRIGGIKTLKERGIKAHSTALTAELAKNSGYEEPLGDLQIITSLKFGNTKVETF
YPGKGHTEDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNI
NSVVPGHGEVGDKGLLLHTLDLLK
>S0TI75|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLISDDILQLATAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSRLEWHKPACVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSLTTAAQPGSVISVAPLLIACGYGTLEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPVCTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVAHRKPSIRNARRCLGWEPKIDMQETIDETLDFFLRTVDLAEKSS
>Q98GG1|FEATURES|UNIPROT_deepARG|fosfomycin|fosX|antibiotic inactivation|1
MIEGLSHMTFIVRDLERMTRILEGVFDAREVYASDTEQFSLSREKFFLIGDIWVAIMQGE
KLAERSYNHIAFKIDDADFDRYAERVGKLGLDMRPPRPRVEGEGRSIYFYDDDNHMFELH
TGTLTERLARKAKGLEAAQ
>A0A062YE23|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVAILDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQKLLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTAPV
VKMASGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>P33733|FEATURES|ARDB_deepARG|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPADEKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQ
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>ABD97469|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGIGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYAQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>D2MX27|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIAENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DQYEVTKLDNDEKARLRREKIGFIFQRYNLLTLLSAKENVSLPAVYAGKNIQERNQNAKK
LLNDLELAHKLESKPNELSGGQQQRVSIARALMNGGELILADEPTGALDSKSGIMVLEIL
QKLNAQGHTIVLVTHDPKIAAQTKRIIEIKDGEILSDTKKEKIQEKHTLKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSVLTMLGIIIGIASVVCVVALGLGSQAKVLESIARLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAYSNTSGVATYTNISLSARA
EGVGANNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPAEKSENILGRVVLFN
SQPFKIIGVLQKNTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDEVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFIIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVIFGFFPARNAANLNPISALSKE
>XP_001893601|FEATURES|ARDB_deepARG|aminoglycoside|APH(3')-Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKTAFSKIWY
>S3JWW8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
DVNHPLWVDRIKEAQPEVIFSFYYRNLLSEEIINSASVGAFNLHGSLLPKFRGRAPLNWV
LVKGETETGVTLHRMVKRADAGDIVAQERVAIAAEDTALTLHHKLCETAKSLLASALPVI
KTGHFPQTAQDDSQATYFGGRSPKDGAISWEGSAAEANNLVRAVTEPWPGAFSYVGGSKF
IVWKSRVLDSNNGAKAGTVLSVSPLVIACGTGALEIVTGQAENGVYMQGSQLAQSLGLVN
GAILSSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDNFEIFGLDIGSDAISRFIGNE
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCTDASFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
GDGIEALFRIIENKNSNCDGQIINIGNPDNEASIKQLAEMLLESFERHPLRSQFPPFAGF
REVESSAYYGKGYQDVEHRKPSIRNAQRLLSWTPEVHMEKTIDETLDFFLKTVELTDPAS
>S3MXP2|FEATURES|UNIPROT_deepARG|beta_lactam|F945_02224|antibiotic inactivation|1
MIFIQKKMGQAAIMTMISCLGMQLHANETGQNEKSIESAITQSFKPLMDQYGVAGMAIGV
IYNGKKYEQYYGIQSEKANKSVNHQTLFELGSLSKTFTAISGTYANNLGKISLNDHPSKY
MPELKNSEIDQVSLLELLTYTSGNLPLQFPDHVKTDQQILTYFKNWKMKNPPGTYREYSN
PSIGLFGHLTAKAMNRSFSSLLEQVIFPQLNLKNTYVNVPAEQKINYAFGYDKNNQPIRV
NPGPFSDEAYGVKSTLPDMLKFVSLNLNVNLNNPAMKTAILDTHQGFFKVADSGMTQALG
WEMFSYPTTSKTLQMSNSEQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPQEG
FGLVMLMNKKIPNVDRIKAAYNVFETLKDNPHSTN
>A8W907|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
NVLWSSSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTP
IDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGK
VVALSMNNPFD
>A0A0S1RIY1|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA|antibiotic inactivation|1
RILVQQGTQQACAERYTPASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQ
PTDPARWIKYSVVWYSQLTAKALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISS
LRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEVGQADGWRLYGK
>A0A0S2SLM8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MNNTDIKLVSVVIPVYNEEASLPVLLSRVTAACDQLSQDYEVILIDDGSHDGSTELISEA
AAREGSKLVGVLLNRNYGQHAAIMAGFETAKGDLVITLDADLQNPPEEIPRLVEAAMQGY
DVVGTMRRNRQDSWFRKTASKLINKSVQKTTGVHMSDYGCMLRAYRRHIIDAMLCCQERS
TFIPILANSFARRTIELEVGHAERAHGESKYGLMHLINLMYDLVTCMTITPLRLLSIVGS
VVAGIGFTFSILLILMRLVMGADWAADGVFTLFAILFTFVGVQLLGMGLLGEYIGRMYTD
VRARPRYFIHRIVRTATTPSQQEAEQ
>K8WNU8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALIDLQGITRRYGEGENQVTVLKNVSLQINAGEMVAIIGASGSGKSTLMNIIGCLDKP
TEGNYCIDGQSVATLDNDQLAELRREHFGFIFQRYHLLSHLSAEQNVEVPAVYAGAGKNQ
RRERAAQLLQRLGLGERIEYRPSQLSGGQQQRVSIARALMNGGQIILADEPTGALDSHSG
EEVMSILKDLCAQGHTVIIVTHDPEIAQQAERIVEIKDGEILKDSGSKASIRANSLPKAP
ARKLTLNQMYGRFSEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVSIMVIGDAAQGMVL
NDIKSIGTNTISIYPGKDFGSDDAENRQSLKSLDIDAIAKQPYVHAVSGELNSSTRLRKG
NLDASAQLSGVGRDYFNVYAWKFSEGMGFTQDMADRRAQVVVIDANTKRRFFPKQEHVIG
ETLLIGNMPATVIGVLEEKKSAFGSNKSLSIWLPDTTVNSKVLNRPYYDSITVRVKEGYD
AKTAEQQLIRLLTLRHGKKDIFTYNLDTFIKTAEKTTQTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARTSDVMQQFLIEAVLVCLMGGLMGIGLSYGISLLAQMA
LPGWTFSFDPVALISAFVCSTAIGIIFGFLPARNAARLNPIDALARE
>A0A127SUD9|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRTQQMSELENRIDSLLNGKNATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNW
STPSAMAQLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVYDAMR
>I6AR92|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTFFRSRLRLATAFLATSCAALATPDDAAASDPATPARTEIVRASDPPDALDAIVLGIVE
GVTEYLPVSSTGHLVIANHFLDLESTVPLYDGEGQMLWAKKPSPKHPEGEPLTIKAAADA
YAVIIQAGAIAAVGLIYWRRLLQIARGLFGNSPDGVRLLRNIVLACIPPGLAGLLLGDFI
DSHLFSIRTVAWALVAGSVLMVAAEWWRKRQPRRIVEYTGEDLKAGQALFIGFAQCLALW
PGMSRSMVTMVAGYFTGMRPARSAEFSFLAGFALLSAAALYKSWKAGPAVIEVFGWSNTL
LGMLVATIAAVIAIKGFVGYLSRHGLGIFAIYRLALAAVLFVWFV
>A0A0Q9UHR5|FEATURES|UNIPROT_deepARG|chloramphenicol|ASG99_13090|antibiotic inactivation|1
MKFNIIDRENWYRKEYFEHYLQQQTTFSITNEINITVLMKNLKKKNYKLYPAFIFMVTKI
VNSHREFRTSFNPEGNLGYWSEILPSYTIFDKKTYTFSSIWSPNVSRFSEFHSQYEKDVE
EYNGTGSLFPKTPIPDNNIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQIKHELF
LPVSLQIHHAVCDGYHASVFMNDLQWFADESADWL
>D4B7D5|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEATPIKKVSVVIPVFNEQESLPELIRRTGAACEKLGKDYEILLIDDGSSDRSAQLMMD
ASLAPNSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEG
FDVVGTVRQNRQDSVFRKTASRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SAIAATGFTLSVLLVVLRLTLGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0B5ECR8|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
ATEAASVITRGDYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGR
RIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLH
NMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEA
D
>S1L6C8|FEATURES|UNIPROT_deepARG|beta_lactam|A31E_04029|antibiotic inactivation|1
MLKMTLCALLITASCSALAAPQQLNDIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDTIARGEINLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPDWTPGTQRLYANSSIGLFGSLAVK
PSGLSFEQAMDTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNIDPRNINDKTLQQGIQLAQSRYWKIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>A0A143SP07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAMQAIILGIVEGLTEFLPISSTGHQIVVADLLGFTGERAIAFNIIIQLAAILAVV
WEFRRKIFDVVVGLPTQRGAQRFTVNLMVAFFPAVVLGIAFADLIHHYLFNPITVASALV
VGGVAILWAEKRAHRIQAETVDEMNWTHALKVGFAQCLALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFLLGSVVSFIFAMIAVRGLLKF
IGTHSYAAFAWYRIGFGLLILLTWQLGVIDWSTAQG
>ZP_01813310|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSNKFVITWDNMQTYCRQLAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
SSYDHDHQRDMTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPSGAH
LLDEYIVDIAQDTWIEQPWDTSLSYVEPVNRKSK
>A0A071LPV2|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSTIQKVSVVIPVYNEQESLPELIQRTTAACQQLPCDWEILLVDDGSSDDSVRLMTEAAQ
QPGSHLVAVLLNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVAKASEGYDV
VGTVRQNRQDSLFRKTASRMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHERSTF
IPILANTFARKTAEIPVQHAEREHGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFGSVI
ALLGFLFAVLLVALRLVFGPAWGAEGVFTLFAVLFMFIGAQFIGMGLLGEYIGRIYNDVR
ARPRYFIQQVVSSNHQESQEGEEE
>A0A0Q0WW56|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSLKAVVFAYHDIGCTGIEGLLNAGYEIAAVFTHADDPSENNFYGSVAQLCARKGIAVHA
PEDANHPLWIERIRKLNADYIFSFYYRNLLGEELLNSVSKGAFNLHGSLLPRYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGDIVAQERISIERSDTALSLHAKLRDTAAKLLAETLP
VLPEGTLKETAQDESKATYFGRRTPADGLLQWARPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSSEVVAGNEGQAPGNVISCDPLRIACGKDSLVITAGQRNENGLYLSGPQLARELG
LVEGSRLRGSESGRPARRTRVLILGVNGFIGNHLSERLLQDDRYEVYGLDIGSDAIDRLR
SHPNFHFVEGDISIHTEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GTKGLKFTLFRPFNWMGPRLDRLDSARVGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIDNKDGKCDGQIINIGNPENEASIRELGEELLRQFEAHPLRDNFPPFA
GFRDVESQSFYGTGYQDVSHRKPSVENARRLIDWTPTTELSETIGKTLDFFLREAMVEIA
EKR
>ACP19236|FEATURES|ARDB_deepARG|glycopeptide|vanA|antibiotic target alteration|1
MNRIKVAILFGGCSEEHDVSLKSAIEIAANINKEKYEPLYIGITKSGVWKMCEKPCAEWE
NDNCYSAVLSPDKKMHGLLVKKNHEYEINHVDVAFSALHGKSGEDGSIQGLFELSGIPFV
GCDIQSSAICMDKSLTYIVAKNAGIATPAFWVINKDDRPVAATFTYPVFVKPARSGSSFG
VKKVNSADELDYAIESARQYDSKILIEQAVSGCEVGCAVLGNSAALVVGEVDQIRLQYGI
FRIHQEVEPEKGSENAVITVPADLSAEERGRIQETAKKIYKALGCRGLARVDMFLQDNGR
IVLNEVNTLPGFTSYSRYPRMMAAAGIALPELIDRLIVLALKG
>A0A0Q4NLQ7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MAHYEPIRKVSVVIPVYNEEESLPALLTRTQAACQQLTQQYEIILVDDGSADSSGDMLAA
AAEQPDSHIIAVLLNRNYGQHSAIMAGFSHVTGDLVITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRANRRDSWFRKTASKMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARKTVEIPVQHSEREFGDSKYSLMKLINLMYDLITCLTTTPLRMLSVVG
SAIAIFGFVLAIFLILMRLIHGPAWAADGVFTLFALLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFVQKVVGVRSEENSQEEE
>A0A0M2NZ44|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTQFLGSESAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYRSEPIDGIGQKPKRLNLLHIIVGMIPAGILGLMFDDVIE
KYLFSVPTVMIGLFVGAIYMIIADIYSKKVTNPQTVDQINYFQAFIIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKSASDFTFIMAVPVMLAASGLSLVKNFEYIQLNHIGFYFLGFIT
AFIVGLIAIKTFLFLINKIKLIPFAIYRIVLVIIITILYFGFGIGQGISGQ
>K2RVF1|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MQWNGTLFCTGLLLVSSVAFADNNSAALDTLVQTEARKVMQENNIAGLSIAITRHGKQQF
YNYGVASKATGQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYMPQLRDTR
LGKIPVFHLGTHTAGGFPIQVPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGV
IAARSMNMPFQEAMQQRLFPALGLNSTYVSVPDDKQVLYAQGYNKLDEPVRVSPGILAAE
AYGVKSSSRDLIRFVEANIGLGQHDAPLQRALSDTRIGYFKVGGMTQDLVWEQYPTPIRL
DMLLAGNASAMLNTQKAEAIEAPLAEQPTAWVNKTGSTNGFGGYVAFIAERQIGIVILAN
KNYPNEERVKLAYRILQHAAPFN
>A0A0G0Z2D8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTNLQTIILAVVEGLTEFLPVSSTGHLILTQKLLGITTTEFTKSFDIFIQLSAILAVVVL
YWKKIIGSRHLWRQLIVAFIPTGVLGLIFYKYVKGFLLDNVFVTVLALLIGGFILLIIDR
LPKLALGSKKISELNSRSLLSVGLFQSLSMIPGVSRSAASIIGGLFSSLSRVEAVEFSFL
LAIPTMIAASGYDLLKTGFSFTSREFFLLALGSLFSFLASILAVRSFTSFVAKHNFTVFA
IYRIVFAFIVLWLLNP
>A0A0A1AWR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFDGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGHLTLIHILLGMVPAVVIGLLLHDQIKSLFNPIN
VMYALIVGGVLLLAAEFLKPKQPKAPGIDDITYLQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSRGFLTMADFPMFAVGFVTAFIVALLA
IKLFLHIIKRISFVPFAIYRFIVAAAVYMVFM
>A0A0H3NWI6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
SSGVYRVAGQDVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNE
RRERANMLLTRLGLGERVSYQPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERVIEIKDGRIMADSGSKITQEAVSSDAIS
LTPPAPSWQQLAGRFREALLMAWRAMSANKMRTALTMLGIIIGIASVVSILVVGDAAKQL
VLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTALKAQSYVSAVSPTIAGSMRLR
YGNIDVAASVSGVSDQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQRRLFPHIKDV
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
YSSKEAEQQLVRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVE
MFLPNWQIAFPPVALFSAFLCSTVIGVVFGYLPARSAARLNPIDALARE
>A0A0N1C480|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTIVTAILLGIVEGLTEFLPVSSTGHLILATELFGYDSHQWAMFNVMIQLGAILAVVVQ
YWRTFWAVGMGLLRLEPISLRFLRNLLAAFIPSAILGLLLKDQIDVMLGSPMVVCWALIL
GGVAILVIEKHAKTGELTGIGQLPLRQALGVGLAQCVSMIPGVSRSGATIMGALAMGIER
RTAAEFSFFLAIPTMLGATTLELIDNREAVMASTLGVGWAEIAVGFAVSFVVALAVIRFF
VAYVSRSGFKPFAWYRIVAGAAAIIWLSLR
>D5DGB7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MIVKIKEYELSHVDSGPYGITSGKDGALWFTQYKTNKIGRMTVEGKMKHFNVPTIDAGAL
SITSTTQGDIWFTENKANKIGKLTITGDIMEYVLPTPDSAPFGITEGHNGDIWFTEMNGN
RIGRILPSGEIIEYDLPHPGSYPSFIVVGSDNALWFTLNQSNQIGRITLEGRVTTYLLPT
AQAGPVGITNGPDDALWFVEINGNKIGRITTSGVINEYSIPTPNARPHAIVTGPDNALWF
TEWGSNQIGRITVNGEITEYPIPTANAEPHGIVVGSDQALWFAEECNKLGRLSFVQKP
>ABI18324|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVAVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>A0A0P9VBA5|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIPVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLP
LLALGQLSGTPQDETLASCFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCAVGEN
KLIVWAASAEAGNNGEAPGTVISHDPLRIACGEGSLVINAGQRGDNGLYLSGAQLAREFG
LVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQEDRYDIYGMDIGSDAIERLR
TKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIV
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFT
DVADGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFA
GFREVESQSFYGKGYQDVSHRKPSIDNARQLIGWTPGIELSETIGKTLDFFLREAMAEKA
DMR
>A0A0A7XFQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAFSVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMINIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIVLGVIILIAAMFFNLSV
>G5CK58|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFWLPAFAHPETLVKAKDADYQLGARVGYIELDLNSGEILESFRP
QQRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGP
>C5QR38|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIFLIVIALVLSACNSNSSHTKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>R6M7V1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFLEMIKSIVLGIVEGISEWLPISSTGHMILVNELINNTEGFTASDLYLYVIQLGAILAV
VTLYFHKLNPFSPKKTNVEKENTWKMWFKVIIACVPAAVIGLVLDNFMSAWENWQVVSAM
LILYGVAFIVVESLHKETKIKSMDDMTYKTALLIGLFQVLSIVPGTSRSGATILGAMLIG
CSRSVAAEFSFFLAIPVMFGVSLLKVLKYGLAMPMQDVIVLLTGMVVAYIVSMLAIKFLM
NYVRKHNFKSFGYYRIILGILVILYFSFIH
>J0YIS0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MYFFEILKAIFFGIVEGITEWLPISSTGHLILAQEFIQFKDQNETFMSMFNVVIQLGAIL
AVMVIYFNKLNPFKPGKDKVQVRRTWQLWSKVFVATLPLLAVFKFDDWFETHFYNKVSVA
IMLIVYGVAFIYLEKRNKAQAIEPTVTELDKLPYKTALYIGLFQVLALLPGTSRSGATIV
GGLLNGTSRSVVTEFTFYLGIPVMFGASALKIFKFIKAGEVLSFGQFFLLLVAMVVAFAV
SMVAIRFLTSYVKKHDFTVFGKYRIVLGSVLLLYSFIRLFV
>A0A089PTA0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTPETIKKVSVVIPVYNEQDSLPELLRRTTEACQKLNRDYEILLIDDGSSDDSAAMLTR
AAEEPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIVTLDADLQNPPEEIPRLVEKADEG
YDVVGTVRQNRQDSWFRKRASKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHER
STFIPILANTFARRAVEIPVHHDERQFGDSKYSFMRLINLMYDLITCLTTTPLRLLSVVG
SIIALSGFALAVLLVVLRLALGPQWAADGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVSSETALSSEENQ
>A0A0D5CAH1|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-15|antibiotic inactivation|1
MAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
MNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLT
LGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGA
>A0A077PCE2|FEATURES|UNIPROT_deepARG|beta_lactam|XBKQ1_120029|antibiotic inactivation|1
MLFSSLRLTRISATIFPLLGALITFPIHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSTITYRAHERFPLCSTSKMMAVSALLKKSETDEGLLNQRIHYQQSDIVEYSPITEKHLQ
DGMTLAELSAATIQYSDNTAMNLLIDQLGGTHDVTRFARSIGDNSFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRTQLVEWLKGNTTGGASIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPWILVTYFTQPNDKDAEAHPDVLAAAARIMTQER
>A0A0P0G9C0|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM1|antibiotic inactivation|1
RFRMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCS
AAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPA
AMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRG
IIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLI
>ZP_02197344|FEATURES|ARDB_deepARG|tetracycline|tet34|antibiotic target alteration|1
MSKKFIITWDAMQSYCRELAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRYVDTICI
SSYDHDHQRDMTVLKAPEGDGEGYLIIEDLVDSGDTARQLREMYPKAKLIAVCAKPSGKE
LLDDYVVDIAQDTWIEQPWDMSIQYAEPVNRKQK
>D0Z6U7|FEATURES|UNIPROT_deepARG|aminoglycoside|Aph3Ia|antibiotic inactivation|1
MSHIQRETSCSRPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMDKLQFHLMLDEFF
>A0A059I590|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCVGINALLSAGYEITAIFTHNDVATENHFFGSVARLAAEHGIPVYAPD
EANHPIWLDRIRTMAPEMIFSFYYRHLLSDEILQCAQKGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVKRADAGNILAQQKVAIEDQDNALTLHRKLTQAAEQLLGDVLPRL
REGEVSEWPQDESQATRVDRRTAEDGRIDWNQPAQTIHNLVRAVTDPWPGAFAFAGSVKF
IVWKSRVHPQQHQAKPGTVLSKQPFLIACGEGALEIQTGQSEHGVYMNGSQLAQSLGIVP
GALLYSKPQSALQRRTRVLILGVNGFIGNHLTERLLQDEHFEVYGLDISSDAISRFLDHP
RFHFVEGDIAIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYQKRIIFPSTSEVYGMCTDDSFDEDCSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
QDGVEALFRIIENKQLNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRSQFPPFAGF
REVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPTVTMDVTIDNTLDFFLRTVEPQADK
>A0A154IEP3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNRSWIKTLSAALVSTCISTSGFAADEMKLKAISDASVKPIMDKYGIPGMVVAITADGQN
HIFNYGVESKDTNRPVNPATMFELGSISKTFTVTLTSYADVTGRLSLSNKASKYLPSMKG
RPFGDVALTNLGTHTAGGFPLQVPDEVKTEKQLMEYLATWKPSYAAGTHRTYANPSIGVL
GYITAKSMGKDFAALMEDQLFPSLGLTSTYINVPKSKMADYAQGYKRSGEPARMTPATLS
SEAYGVKSTAGDMIRFIDANMGLVELDDKLQQAITNTHTGYFDVGAMTQDLIWEQYSYPA
TLTTLMDNNSGAMLKTIPVKQLTPAMEPRDDVWINKTGSTNGFGAYVAFVPKERVGIVIL
ANKNYPNEDRISAAYQILTDIISAR
>A0A0W2H9B0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVGNPPPRESRAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AMAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0H4IUK8|FEATURES|UNIPROT_deepARG|beta_lactam|blaKPC-18|antibiotic inactivation|1
MSLYRRLILLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>A0A0K0QMB7|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MGQSINHICFSVSNLEQSTEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
QHSYTHIAFTVTNNEFDSLKEILIQNHVKILPGRERDERDKRSIYFTDPDGHKFEFHTGT
LQDRLQYYKEDKKHMTFY
>A0A127SGW4|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MLYYLATIVNRHSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSNLWTPYIPDFEAFS
MAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKY
YRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>A1ABK4|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMQNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATAAVYWVMFLAMVSYIKRARSMRDIRNEKGTAKPDPAVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQIALLYNDNPEVVTLAAHLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTDLVVEPMGPAG
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRAAR
>L9HX59|FEATURES|UNIPROT_deepARG|beta_lactam|EC34880_4995|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKLYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A094TLJ9|FEATURES|UNIPROT_deepARG|aminoglycoside|DR95_1104|antibiotic inactivation|1
MDAPFQIQQVVNVLKKILRTKLNTIYLHGSSVSGGLRPNSDIDLLVIIKSPLTKEEKNLL
NTDLLSISGHYPYDKFGRKPLEIVMFVSHLLHNLQYPARCEFIYGEWLRDTLEQGLSDNS
SEDPEYTLMLAQAQKEVKLLWGEYVILPKINNQQIRKALLDSLPNIISSIEGDERNVLLT
LARMWFTMSTGQFISKDTAADWAINRMPNKFIEVMTVARDAYLYGNNVEWTKYKELLPLI
IEYFSIQIKNVYLIKNDLVTD
>A0A127T2C5|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLCALLVTASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0A1A3I5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVSNPPAIEKVNVAGGTEPV
VNTASGWRQFASGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>Q53698|FEATURES|UNIPROT_deepARG|beta_lactam|BL2a_pc|antibiotic inactivation|1
MKKLIFLIVMALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKAIT
>A0A0K0N4U2|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M-14|antibiotic inactivation|1
HRSXQSXFKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVT
AFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVT
WLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQ
>A0A0D1W4D1|FEATURES|UNIPROT_deepARG|chloramphenicol|AF333_29570|antibiotic inactivation|1
MNFYRIDMDRWSRKPYFEHYMKESKCSYSITANLNVTTLLDRLQNKKVKFYPAFIYMVSR
VVNSHTEFRTTFNDKGQLGYWDHMIPNYTIFHKEDKTFSAMWTEYSNDFLLFYKNYQCDM
EQFGDKKGLWAKENVPVNTFSISSLPWVSFTGFNLNLYNGEYLLPIITGGKYFSDGKEIL
LPVSLQVHHAVCDGYHVSIFINDLQKLADSCEEWVV
>D8EAD9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ
RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPV
VNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSFGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLRLRY
NNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQL
FLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>J2XQI3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTEPLLQLTGITRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYKINGQETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQL
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTAS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRANERDTTHLLSDEP
VAPRATASRRLVASLGLFKEAFSMAWVALISHRMRTLLTMLGIVIGITSVVSISAVGEGA
KNYVLKDIAAIGSNTIDVYPGSSYGDKRAAAIETLTPADVTALNQLYYVDSATPMIGRSL
LLRYRNIDLDAQVNGVSDQYFKVRGIKMAAGIPFSESDARRQAQVVVIDHNTRQRLFGQD
VDPLGQVILIGNLPCTVIGVAAQDKSLFASGKTLNVWVPYETAAGRVLGQRYLDSISVRM
KEGQPSKVVEEHVTQLLLQRHGSKDFFTNNLDSVLQTVQKTSRSLALLLSLIAVISLVVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGH
LFSLFIKEWEMVFSLTSVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>A0A0B7G5U6|FEATURES|UNIPROT_deepARG|beta_lactam|KVR801_180132|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPVVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTHLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>A0A0G0M313|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLGIIEGLTEFLPISSTGHLILTARLLNIPQTEFVKTFEIAIQSGAILSVLVLYGKTILS
RPGLVKRVVVAFIPTALVGFVFYRFIKQYLLGNTEVVLISLFAGGIVLILIELFFKNKPR
DAQANQNQDFSTLSYEKAMIIGIFQAISVVPGVSRAAATIIGGMLLGLPRTSAVEFSFLL
AIPTMFAATFLDLKKTSINLTGQEWLLLLVGFMVSFLVATAAIKWLLFYVKKNTFVPFGI
YRIAISIILFLIIR
>A0A0U1QT36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQLFIAVILGAVEGLTEFAPVSSTGHLILAADLLNFKGETAKTFEVIIQLGSIMAVVVLY
WKRLWSLFGLYRNEPKTGPENLNLIHIIVAGIPAGILGFLLRDFIKNVLFSPQSVLIALV
VGGILMIIAEKIAANRGGRGTKELSYAQAFVIGLFQCLSLWSGFSRSGSTIAGGIIAGVE
RKTAAEFSFILAVPMMIGASGLDFYKSLDFLSASDIPLFVVGFLTAFVVAMLAILFFMKL
LRRYTLVPFAVYRFILAAVFALFIIF
>A0A0H3WTX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLNFNDEKGKVFDIVIQFGAILAVC
WEFRAKIAQVVLGLGSEAKARRFALNVIVACVPAIVLGLLFGKHIKAVLFNPLVVATAFI
VGGVIILLVERHNRANEAAGKLPRVTSIDDLSALDALKVGFAQCLALVPGTSRSGATIIG
GMMFGLERRVATEFSFFLAIPILFGATVYELYKSRSTLAVEDFGLFGVGFVFAFISAFIC
VRWLLRYIASHDFTAFAWYRIVFGLIVLASAYSGLVVWAD
>A0A060KQ33|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIATDGL
>A0A0N1F3H8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENWIEAAVLGIVEGLTEFLPVSSTGHLLLLGHFLGFESNGKSFEVLVQLGAILAITLVY
FRRLLDIARRIPTDPAARRFVLGVLVAFLPAALIGAVLHGFIKGVLFNPFIVCCALIAGG
LILLVVDDLELEEKYQDATTFPLPMYFKIGLIQCLAMIPGVSRSGSTIVGAMLLGSSKRA
AAEFSFFLAMPTMVGAFAYDLLKSYKTLSFDDMTLIVIGFVCAFFAALVVVRSFLDFVSK
RGFAVFAWWRIVVGLFGLAGLWIVG
>R5Y1S1|FEATURES|UNIPROT_deepARG|chloramphenicol|BN488_01641|antibiotic inactivation|1
MVFEKIDRSSWKRNEYFEHYFADIPCTYSMTVKLDITQIKKKRMKLYPAMLYYLATIVNR
HSEFRTAINQEGELGIYDEMIPSYTIFHEDTETFSDLWTEYMPNIEEFSRAYENDIQRYG
SNHGMTGKPNVPENVFTVSMLPWSTFESFNLNLQKGYSYLIPIFTLGKYYEEDERILLPL
AVQVHHAVCDGFHICRFVNELQELINS
>J3GWY2|FEATURES|UNIPROT_deepARG|aminoglycoside|PMI32_04857|antibiotic inactivation|1
MFRIQHCQSGEQAGWLPLRQALWPDASEQEHRDEIAEQLRQPQRYINFVAYDAGEQPVGL
AEASLRHDYVNGTDSSPVVFLEGIYVVPQQRRHGVAARLIEHVAHWGRERGCVEMASDTD
VDNLPSQETHKALGFEETERVVFFRRQL
>S9SUL0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFYVIVAIVLGIVEGLTEFIPVSSTGHMILTTKLMGIEEQANWLKTFEIVIQLGATLAMT
VVYWDRILEMLGLRKRTVQQGHVICPRLNLLHVIIGIAPALAVAYVARDHIKQLFDSTET
VLWALVVGGAFMWFAEWYGSRRQPSANTIDEISYKQAFSIGLFQILSVLWPGFSRSGSTM
SGGMLSGVSYRASADFSFLIAIPIMCAASGYELLQNYKMFTLDILAFFVLGFLVSFVVAY
VIVVAFLKHIQRIKLRHFAIYRFVLAALFWYFMM
>A0A127SHH7|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MFKTTLYALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>I7AP07|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-1|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKXLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAXXRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAG
>J8GY01|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEEHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERNVRDCESIYFVDPDGHKFEFHSGT
LQDRLNFYREEKPHMTFY
>A0A127SP34|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLRNGRKAPVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMVRLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>R7PDW7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDMTWLQTVIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESTDFVKAFDVIIQFGAILSVI
ILYWRRFFYPDSAKKEGHTWWGAIWRFYLKLIVGIIPAVILGTAFSDAIDEALGSVTLVA
VMLVVGGIFMLYCDRIFNKGSENTPLTYKRAFIIGCIQCIAMIPGVSRSMSTIVGGMSQR
LTRRAAAEFSFFLAVPTMLGATCKKVYDLISNGGGNLLTEGNNLTVLLVGSAVAFVVAIA
AIKFFINYVSRYGFRAFGWYRIIVGVVILVCLACGIDLKMA
>V6M8V4|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MRLTSKYETIRRILSDFKQPEYRYAQIMDAIFKQNISQYERMTILPKFLRDELTRMLGPN
VCSIVPVKELTSKQVSKVLFAIAGDERVEAVRLTYERGWKSYCISTQCGCGFGCRFCATG
TIGLKRNLTADEITDQLLHFRLNGHALDSVSFMGMGEALANPHIFDAVRILTDPHLFGLG
HRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPIPDVLEALDR
HIRQTGRKVYIAYILLRGVNDSAAHAEAVAELLRGRGPGEHLYHVNLIPFNSTEVTPDSY
RQSDPDRIKAFVRILKSKGIKITVRTQFGSDINAACGQLYRSE
>J7GKY1|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPASAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEF
SYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLV
MLTNKRIPNEERIKAAYVVLNAIKK
>E6LBU2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIKMDDFWRSFLIIIQLGSILAVLFV
FWRKLLQSFVLWLKLAFAFLPTGLIGLFVAKHLELLFNGYVVVFMLILGGVVFIGIELWH
RGKSYAVNSLDEVSFKQAFCIGLIQSLAMIPGTSRSGASIIGGLLLGLNRKVAAEFSFLL
AVPTMMIATAYSIYKEPSILSSASSFTPLFIGFVVAFVVAVLVIKFFLKFIAKFDFIPFG
IYRVVLGILFFYLYASGILDAGSEFEL
>ZP_02360222|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSIYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLYLTFKQGVSADLAAVDVQNRLKTVEARLPEP
VRRDGISVEKAADNIQLVVSLTSEDGRMSAVQLGEYASANVVQALRRVEGVGKVQFWGAE
YAMRIWPDPVKLAALNLTASDIATAVRAHNARVTIGDIGRSAVPDSAPIAATVLADAPLS
TPDAFGAIALRARADGSTLYLRDVAKIEFGGNDYNYPSFVNGKTATGMGIKLAAGSNAVA
TEKRVRATMDDLSKFFPPGVTYQIPYETSSFVRVSMQKVVTTLIEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFALALAVSIGFS
AFLALSLTPALCATLLKPVADDHHEKRGFFGWFNRFVARATNRYTRRVGQVLKRPLRWLV
VYGALTAGAALLLTKLPTAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRKKEP
SAYTFALGGFNLYGEGPNGGMIFVTLKDWKERKRTHDQVQAIVARINEHFAGTPNTTVFA
MNSPALPDLGSTGGFDFRLQDRGGLGYAALVAAREKLLAEGHANAVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMDEINATLAVMFGSDYIGDFMHGAQVRRVIVQADGLHRLDPGDV
TKLRVHNAKGEMVPLSAFATLHWTMGPPQLTRYNGFPSFTINGSAAAGHSSGEAMAAIER
IASTLPAGVGYAWSGQSFEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQVAIGTGVLGGVVSATLFAIFLVPLFFV
CVGRVFDVGPRRRGGAHAALEIK
>A0A0J6ZMN3|FEATURES|UNIPROT_deepARG|beta_lactam|TQ94_07605|antibiotic inactivation|1
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETNGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLKAKNK
>ZP_03225116|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MLNEWIIAIILGILEGLTEFLPVSSTGHLILAANLLEFHGETAKTFEVVIQLGAVLAVLI
LYWKRFVSFLSTEQFEGNQLNLVHIALAMLPAVVVGLLLHSFIKAYLFGPETVLVGLVVG
GIFMIVAEKLKKAPKASNLDEITYRQAFGIGMFQCFALWPGFSRSGSTIAGGILLGVNHR
SAAEFTFLVSVPIMMAATGLDIVKSLDTLVAEDFALFGVGFLTSFIVAMIAIKTFLHLLK
KLSLSVFAYYRFVLAAVYFFIVL
>F5SYA3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILQSIILGFVEGLTEFLPISSTGHLIVVSDWLGLAQTDSNKAFEVIIQLAAILAVIAS
YKERFSPKYVGLWTKVALSFVPVGLVGLLFHDQIKALFSVQIVAVMFIVGGIIFLLTEKF
IGEKPPQVDDINEVSYTQSLIIGIAQVFALIPGTSRAGSTIIGALLVGLSRKASAEFSFL
LALPVMAAASGLDLISHYQDFANTSFLPLIVGFVVAFITAYLVIKLFIRFLANFTFVAFG
WYRIVFGVLLLVLY
>B2VBJ0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTEQSIKKVSVVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAAMLVAA
AEAPDSHIVAVLLNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVETAQQGY
DVVGTVRQNRQDSGFRKIASRAINHLIQRATGKAMGDYGCMLRAYRRHIVDAMLNCHERS
TFIPILANTFARQATEIPVLHAEREFGDSKYSLMSLINLMYDLITCLTTTPLRLLSVIGS
VIALMGFAFSLLLIALRLFLGAEWAGDGVFMLFAVLFIFIGAQFVGMGLLGEYIGRIYND
VRARPRYFIQRVVSRDADSTKDKKS
>Q9K3E0|FEATURES|UNIPROT_deepARG|aminoglycoside|ant|antibiotic inactivation|1
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFESATIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDYLA
SRADHLEEFIRFVKGEIIKSVGK
>ABO60989|FEATURES|ARDB_deepARG|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGIAYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGTR
>F5NXK4|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRPIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0M9CYQ9|FEATURES|UNIPROT_deepARG|chloramphenicol|AM629_13400|antibiotic inactivation|1
MSYSKVDIDLWNRKAHFLHFRNVVQCGFSLTTKIDITHLLSSLVEKQYKFYPTMIYLISK
VVNSYSEFRVAIKDEELVVWDSVNPAYTIFHNETETFSAIWTEFNCDLPEFMKNYSADYE
TYKDDLCFFSKPELPENHFHISSVPWVSFDGFNLNVANFTDYFPPIFTMGKFYKNGNQTQ
LPLAIQVHHATCDGFHVGRAINKLQELCDDFI
>A0A060KQC0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTPLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MLYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>YP_002090520|FEATURES|ARDB_deepARG|multidrug|mexD|antibiotic efflux|1
MSEFFIKRPNFAWVVALFISLAGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDS
VTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQ
AVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFF
SSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKG
TLDDPQEFGQVVLRANEDGSLVRLADVARLELGKESYNISSRLNGTPTVDGAIQLSPGAN
AIQTATLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLF
LQNVRYTLIPSIVVPVCLLGTLMVMYLLGVLGEHDDHVSGMVPGDRASWVDDAHRGGGRN
VERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLA
VSILFSGFLALTFTPALCATLLKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVAR
AGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERF
LKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSAAAEIAALNEHFALPDD
GTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGL
AEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRM
TPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAM
AEMERLAAQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSV
MLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRD
AAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFV
PICFVWLLSLLRSKPAPIEQAASAGE
>ZP_04220669|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATSYSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWTHLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTVFVLL
>A0A011RLF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDPLLLLKALILGIVEGITEFLPVSSTGHLILAGDLLDFNDERGKLFEIVIQSGAMLAVC
WEYRAKIGSVVRGLPSEPAAQRFALNILVAFLPLAVIGLLFGKAIKAHLFNAPVVAAAFI
IGGLVILWAERREHRIRIESIDDLSLSDALKLGLAQALALIPGTSRSGATIIGGLFFGLS
RRAATEFSFFLAMPTLIGASIYQLYKERALLSVDDLGMWVVGFIASFISAFWAVRGLLRY
ISTHDFSIFAWYRIAFGIVVLLTWHYDLIAWTAG
>A0A136ACK8|FEATURES|UNIPROT_deepARG|chloramphenicol|ADL13_06810|antibiotic inactivation|1
MFKQIDENYPRKEHFHHYMKLTRCSYSLVIDLDITTLHSILKEKKLKVYPVQIYLLARAV
QKIPEFRMDLVNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYKSCVADIETY
SESNKLFPKPNMPENMFNISSLPWIDFTSFNLNVSTDETYLLPIFTFGQFKMKGEKIILP
VAIQVHHAVCDGYHVGQYVEYLRWLIEHCEEWLSDSLYT
>A0A0J6GKG5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAVQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVVGLPTQPQARRFTVNLIIAVLPAVVLGVIFADMIHEYLFNPITVATALV
IGGVIMLWAERRQHVIRTETVDEMNWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPDDLPVFAIGFVTSFIFAMIAVRGLLKF
ISNHSYALFAWYRIGFGLLILATWQFGWIDWTAAAA
>A0A024E6Y8|FEATURES|UNIPROT_deepARG|beta_lactam|OU5_1307|antibiotic inactivation|1
MFKFQLPRLASLSAFALFLGASHCMAATKSDDQLDALVKAAIGPVMQQQNIPGVAVAITL
KGQQHYFNYGMASKEDGKPVSKDTLFEIGSVSKTFATTLTAYAQASGKLSLSDRASQVWP
DLRGSAFDTISVLQLATYTAGGLPLQFPDEADHPDKMLAYFKQWKPVYAAGTHRQYSNPS
LGLSGYLAAKSMGQSFDELMEKNLLPKLGLKHTYLKVPQDQMGLYAQGYGKDGKPVRVSP
GALDSEAYGVKTSAADLLRYVEANLKPATLEKPLQQAIALTHSGYYTVGEMTQGLGWEHY
HYPASLETLLSGNSTEMAMVAHKVQWLNPPQPAQDAAWFNKTGSTGGFGAYVAFVPSEDI
GIVILANKNYPNAERIKIAHNILSALTE
>A0A085H6A3|FEATURES|UNIPROT_deepARG|chloramphenicol|GLAD_03289|antibiotic inactivation|1
MKATTPAYTVVDLSRWARKEHFEVFQSFAQSTFNQTVQLDITALLKHIKAVGWKFYPTMI
FLIAHVVNRHTEFRMAMKNNELVIWDEVHPSYTIFHNETETFSSIWSPYDGNIQHFQNVY
SEDVARHGNNLAYWPKGQSPDNIFFVSAIPWVSFTSFDINVAHMQNFFSPMFTFGKYYEQ
DGKVLLPFALQVHHSVCDGFHAARLINELQAMCDDIQHYSEELRG
>A0A0Q5TD38|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIWQAIILAIVEGITEFLPVSSTGHMIIASSFMGISHLEFTKMFTVNIQFGAILSVLVL
YWKRFFQTTDFYIKLFVAFLPAAVIGFLLNDFIDALLENVVVVAVSLLVGGIILIFIDRI
ANDTSSEKEITLPTALKIGFFQCIAMIPGVSRSASTIIGGMLQGLSRKQAAEFSFFLAVP
TMAAAGGYKLLKTYDTIKAEDIQTLLIGNVVAFVVAMLAIKFFISFLTKYGFKVFGYYRI
ILGLILLGLLASGYKLDVV
>A0A0M9D1W2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGEVPREGKTNGKLKLSHIILAMLPAVTLGLLFHDTIKSLFNPQS
VMYALVIGGVLLITAEILKPKTPTAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLTVSDIPMFAVGFVTAFIVALIA
IKTFLTLIKRISFIPFAIYRFIVAAAVYWVFM
>J0H3K9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYINAVLLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
LLDLVLGWREPANRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMI
FAEWAAARKAPHKEITWLVAILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEF
AFLVGIPTMYAASGYELLKTFKDGGAANEDWTALGIAFVVSTIVAFIAVKWLLAYIRSNR
FTLFAVYRIILGVLLLGMAATGLIG
>ZP_03984017|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MYFAFISERNGDMLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEM
FNVVIQLGAIMAVVILYFHKLNPFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDY
LDAHFYNFLTVSIMLIVYGIAFIIIEKRNKNVAPKCTNLKDFTYKAALIVGAFQVLALIP
GTSRSGATILGAILIGASRFVATEFSFFLGIPVMFGASFLKIFKFLAKGNTFGSEEIIIL
ITGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILIGYWLFS
>A0A0I1Q4H0|FEATURES|UNIPROT_deepARG|polymyxin|arnA_1|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPAEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTFPAI
KHGNILEIAQRENEATCFGHRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTXXXXXXXXXXKFMGCVAINTSMRTILI
>F0PTL4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
FWKRLWSLVGIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAG
GILMIVAEKFSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHT
AAAEYTFILAVPMMVAASGLDLIKSWDILSAADLPLFATGFITAFVVAMLAIVSFLKLLS
RVKLTPFAYYRFILAAVFYFFIM
>T5HRY1|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MENNKILGINHLLFSVSDLSVSISFYEKVFDAKWLVKAEKTAYFDLNGIWLAFNEEKDIK
RQEIHDSYTHIAFSIQQEDLPFWEKKLHDLGVNVLKGRKRNEGDRDSIYFSDPDGHKFEL
HTGSVFDRLQYYQNEKPHLSFHEGHIKALYDRNK
>A0A0A0YZZ7|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFGPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>B9B621|FEATURES|UNIPROT_deepARG|beta_lactam|BURMUCGD1_6280|antibiotic inactivation|1
MRITATRVVAMLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGDLSLSDPVARYVPA
LNGKPAGALTLRELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGAIDAAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASTMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGER
>A0A0H3L780|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADLHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGRLTLIHILLGMIPAVVVGLALHDQIKTLFNPIN
VMYALVVGGLLLLAAEFLKPKQPKSPGIDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDIYKSLGFLTMADFPMFAVGFITAFVVALLA
IKVFLELIKRISFVSFAIYRFIVAGAVYMIFM
>A0A0J5Z426|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MEFKLKEMALASKKTGPYGIAVSDKGEVWFTQHKANKISCIGLDGVISQYPLPTPDAKVM
CVMVSSKGEVWFTENAANRIGRITKEGTIKEYPLPNPDSAPYGITEGRNGDIWFTEMNGN
RIGRIKDDGSITEYNLPAQGSYPAFITLGSDDALWFTENQNNAIGRITENGEVTEFKIPT
PASGPVGITKGNDGALWFVEIIGNKIGRISAAGEITEFEIPTANARPHAITAGAGNDLWF
TEWGANKIGRITDNGMIEEYPIETPNAEPHGISSSDGKNIWFALECDRIGKITLIE
>A0A0A3INE8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MSIKGINHFLFSVSNLDVSIEFYEKVLDAKLLVKGRNTAYFDLNGMWLALNVEEDIPRNE
IKQSYTHIAFSIEEEKVDELYEKLERLNVNILSGRERDERDKKSIYFTDPDGHKFEFHTG
TLQDRLDYYKKEKTHMEFFE
>CAJ32498|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQHQPDSDYLGNLLRSKTFIALAAFD
QEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQGIATALINLLKHEANALGAYVIY
VQADYGDDPAVALYTKLGIREDVMHFDIDPSTAT
>A0A0G4Q215|FEATURES|UNIPROT_deepARG|beta_lactam|blaB|antibiotic inactivation|1
MFKTTCRQTAVIAVSLISLLASPMLWAKTNSTIEEQLTTLEKNSQGRLGVALINTKDNSQ
VTYRGDERFAMASTSKVMAVAAVLKESEKQSGLLDNPITIKKTDLVPYSPITEKHLATGM
TLAQLSVATLQYSDNTAMNKILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEQNAKYRKDIIAKAAEIVTKEFSNLSQTK
>A0A143PAZ9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLLELLKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSPEFLGSQSAFTFKIVIQLGS
VFAAAWVFRKRYFEMLYIGKYQPAATETESVNSEIGKRAKPKRLTLWHVLVGMIPAGILG
LLFDDVIEKYLFSVPTVMIGLLLGAFYMIFAQKFSERYAHRENIDQITFFQAFVIGLSQA
VAMWPGFSRSGSTISTGVLMKMNYKAASDFTFIMAVPIMLAASGLSLIKHIGYIHLNHIP
FYIIGFLAAFIFGLLSIRLFLNLINRVKLVPFAIYRIILVIFIAILYFGFGIGKGI
>A0A112M000|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
SGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKER
SARAEKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVMEIIHKLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIRE
KASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILED
ISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTI
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
AEKGLTDLLKARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIM
LVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTD
FPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD
>A0A0T7G9D9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALILGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYARKLLQIAADLPTSPKARRFVITVLIAFLPAAVIGALAHGFIKAVLFETPMLICVMLI
LGGFVLLVVDRIKFQPKYHDVMDYPPSLAFKIGLFQCVAMIPGTSRSGATIVGALLLGAD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRNALSLDDGALIAVGFVAAFVTAIVVVRSLLDF
VSSRGYAPFAYWRIVVGAAGLIALLLGA
>YP_039604|FEATURES|ARDB_deepARG|tetracycline|tet38|antibiotic efflux|1
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
GAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLY
VIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPF
LFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNA
QRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYI
VAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFAL
MYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSH
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>A0A0E0WZ03|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELRDIRRSYPSGDGNVEVLKGITLNVAAGEMVAIVGASGSGKSTLMNILGCLDKP
TGGTYRVAGTDVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKA
RLARAHELLVRLGLGDRAEYQPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSG
EEVMGILHQLKAQGHTVIIVTHDPQVAAQAERVIEIHDGEIVRNPPALSPAQGGVLRQRT
AAEPSAWRQFSSGFREALIMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQKQPWVSSATPAVSKSLRLRA
DNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARRQLFPHKARVV
GEVILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
DSAVAEQQLLRLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQL
FLPGWEIGFSPLALLTAFLCSTLTGVLFGWLPARNAARLDPVDALARE
>A0A0R1R681|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIFKAIIIGIVEGLTEFLPVSSTGHIDLVSQVVKIQQNADFMAMFEYVIQFGAILAVI
LLYFNKLNPFAPSKSHAEKSATWVLWFKVIIACIPSIVIGLPLNDWMDAHLHTPQVVATT
LILYGILFIVIENMFKNRAPKIANLANLSYQTALFIGLFQALSIVPGTSRSGATILGAII
LGASRYVATEFSFFLAIPTMVGVSILKIGKFLMNGNTFTGEQWVILLTGTVVSFIVAFIS
IKWLLKFVQTHDFKPFGWYRIALGIVVILVLFLA
>A0A0K2PDB0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKARVLLMMMLMGGSAQAATDWTPDAVVKPLMAQYQIPGMAVAVSVNGETHFWHYGVA
SKETRKPVDDHTLFEIGSLSKTFTAALASYAQQEGKLDFSAPASRYLPTLKGSAFDGVTL
QNLATHTSGMPLFVPDEVKTTAQLMDWYRAWQPKQPAGTERVYSNLGIGMLGLITAKALD
KPFSEAMEQGLLAEFGMKQSFVNVPAAAMRDYAQGYNKDDKPVRVTPGPLDAESYGLKSS
SADLLRYLQIQLGEREVSPRWRASLDATHNGYYRSGEFTQGLMWEYYPWPSSLSTLLEGN
SSQRIMKGLTATAIVPPQQAPQAAWYNKTGSTNGFSTYAVFIPGKRIALIMLANKWFPND
DRVKAAYQIVEHFDK
>B6R156|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTTDSIVGALVLGIIEGLTEFIPVSSTGHLLLIGHFIGFKSEGRAFEVMIQLGAIAAILS
VYFTRLTRIAVALPTSAKARHFTIGVLLAFLPAAAIGALAYDFIKAVLFETPALVCVTLI
FGGIIMLLVDKMPLQARYTNVEDYPLSLYIKIGFAQCMAMIPGVSRSGATIVASLLMGTD
KRSAAEFSFFLAMPTMVGAFVFDFLKNKDALGQDDWTLIIIGLVSSFIAGFFVVRSLLDY
VSKHGFALFGWWRIIVGGLGLLGLILTQS
>A0A0F0FX51|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRRRITTVVGGLATDEKAQRFAINVIVATVPAIVLALVFGKWIKDHLFNPITVATAFI
VGGVVILWAEWRESHRGRVSHPQGNALLKAAQAGAPRIESVDDLNWRDAIKVGLAQCCAL
IPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKSRALLSADDLGIFG
IGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIIFGIIVLVTAYSGLIAWHA
>A0A0A0Q8P6|FEATURES|UNIPROT_deepARG|beta_lactam|PDC-3|antibiotic inactivation|1
MRNTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>R6J1U9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIIEILKAIVLGVVEGITEWLPISSTGHMILVDEFLHLNVTPQFKEMFLVVIQLGAIL
AVVVLYWHKLWPFGIENKRIVPKKDIWQMWFKVLVSCVPAAVVGVLFDDKLNALFYNWQT
VAIMLILFGIFFLVVETWNKGKTAKIHSIGELTYTSALIIGAFQLIAAVFPGTSRSGATI
LGAILIGVSRTVAAEYTFFLAVPVMFGASALKLVKFGFHFTSAEAILLAVGMIVAFVVSI
LTIKFLMGYIKKHDFKAFGWYRIVLGAAVILYFVLAR
>A0A0A8C296|FEATURES|UNIPROT_deepARG|beta_lactam|RO07_08790|antibiotic inactivation|1
MTATAAVVWMGLSARSYAAQPESDPRLAEIRSLVDKTVEPLMAQQQIPGMAVGVDFDGKT
YVFDYGVADKAGNRPVTHETLFEIGSVSKTFTATLATYAQGAGALSLTDKTRRFMPEVAG
TPFGEVSLVNLGTHTTGGMPLQVPDDVTNDEQLLRYLKAWKPAQPTGTVRTYSNVSIGML
GKIVARAMRGDFATLMTEHVFKPLELEHTFIRVPADQMKHYAWGYDKTGKPVRVSPALMG
EEAYGVKTTASDLLRFVSANLGKPVFNYRLRHAIYATRTGYFFDKPMTQDLVWEQYPYPV
SVDTLLEGNSAKMAYEPTPVREFSPPMAPTPVAWVNKTGSMQGFGTYVAFVPSKQMGIVM
LANKNYPIKERVRAAHHILTVLDGIPRTAVVPQQ
>J5I236|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEITLMELLKTVILGIVEGLTEWLPISSTGHMILVDEFIQLNVTKAFMDMFLVVIQLGAI
LAVVVLNAGKLNPFLRRKSNAERRETFDLWGKVIFACIPAGAIGLALNKYMEEHFMNAPV
VASMLILYGVLFIIVERWNRVRTPRIEDLSQLDYRTAFIIGVFQVLSLVPGTSRSGATIL
GGILFGASRYVATEFTFFLAIPVMFGASFLKLVKFGFHYTGAELVILAVGMVTAFIVSIL
SIRFLLRYIKRNDFTAFGWYRIALGVVVLAYLFAVGDPT
>A0A127SZJ3|FEATURES|UNIPROT_deepARG|beta_lactam|BL2be_ctxm|antibiotic inactivation|1
MVKKSLRQFALLAATVFPLLAGSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIYRSTGWPAGGYRVCP
>EEB58431|FEATURES|ARDB_deepARG|multidrug|MexF|antibiotic efflux|1
MNFSKFFISRPIFAAVLSLLILIAGAISLFQLPISEYPEVVPPTVVVRASFPGANPKVIG
ETVASPLEQAITGVEGMLYMSSQATADGKLTLTITFALGTELDNAQVQVQNRVTRTEPKL
PEEVTRIGITVDKASPDLTMVVHLTSPDQRYDMLYLSNYAVLNIKDELARLGGVGDVQLF
GMGDYSLRVWLDPNKTASRNLTATDVVNAIREQNRQVAAGQLGSPPSPNATSFQMSINTQ
GRLVSEEEFENVVVRAGPDGEITRLKDVARIELGSSQYALRSLLNNQPAVAMPIFQRPGS
NAIDISNDVRARMAELKKGFPEGMDYSIVYDPTIFVRGSIEAVIHTLFEALILVVLVVVL
FLQTWRASIIPLVAVPVSLIGTFAVMHMFGFSLNALSLFGLVLAIGIVVDDAIVVVENVE
RNIELGLEPVEATHKAMAEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAIST
VISAFNSLTLSPALAAVLLKAHDAPKDRFSRFLDKILGGWLFRPFNRFFEKASHGYVGTV
ARVIRSSGIALLVYAGLMVLTWLGFASTPTGFVPSQDKQYLVAFAQLPDAASLDRTEDVI
KRMSELALKQPGVENAIAFPGLSINGFTNSPNNGVVFVALKPFDERKDPSLSANAIAGAL
NGQFASIQEAYMAIFPPPPVQGLGTIGGFRLQIEDRGNLGYDELYKETQNIITKSRSVPE
LAGLFTSYTVNVPQVDAAIDREKAKTHGVAVSDIFDTLQVYLGSLYANDFNRFGRTYQVN
VQAEQQFRQDADQIGQLKVRNNLGEMIPLATFVKVSDTAGPDRVMHYNGFITAEINGAAA
PGFSSGQAQTAVEKLLREELPNGMVYEWTDLTYQQILSGNTALFVFPLCVLLAFLVLAAQ
YESWSLPLAVILIVPMTLLSAIAGVIIAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKD
KQAEGMSPLDAVLEACRLRLRPILMTSFAFIMGVVPLVLSSGAGAEMRHAMGVAVLSGML
GVTFFGLLLTPVFYVLIRNYVGRQEARKAAKAKKLQNLPAEMH
>A0A084CG84|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAIQAIILGVVEGLTEFLPISSTGHQIIVADLIGFDGERAIAFNIIIQLAAILAVV
WEFRRKILDVVFGLTSQPSARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRAHRVEVDHVDEMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPSDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIAFGLLILATWQFGWVDWSTAHS
>A0A0H3MNF3|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>F9MPZ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MQDAITAVLLGIVEGLTEYIPVSSTGHMILVGDWVGFTGVRAGVFEVFIQLGAILSVLLI
YKDTFLRMFTRYDCLYLYKRKNWFRRDTGLTLAHIVAGIVPVMIIGLLAHHAIKTYLFSA
GTVIIGLIVGGIFMLVAEKLHVHTVCRDVEQMTIGQAFFVGLFQVFALWPGFSRSGSTLA
GGLLLGVSRKAAADFSFIIAVPVMLAACFFDLYKNWSLLSSDDILMIAIGFIVAFGVAYV
SVLWFLRFLHKSTLASFAYYRFFIALISWVYFFLLH
>A0A0E2UY14|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEYEVTKLNNDEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKK
LLNDLELAHKLDSKPNELSGGQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEIL
QKLNEQGHTIVLVTHDPKIAAQAKRVIEIKDGEILSDTKKEKAQEKLILKTMPKEKKTLT
LLKNQAFECFKIAYSSILAHKLRSILTMLGIIIGIASVVCVVALGLGSQAKVLESIVRLG
TNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVDAHSNTSGVATYTNISLSARA
EGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSENILGRVVLFN
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
AIIRILEIKRGQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVS
VSERTREIGIRMAIGARREDIMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPM
ILNAYSVLLGLLSSMFIGVVFGFFPARNAANLNPISALSKE
>G1V499|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFSTGLIMGAVQGLTEFLPVSSSGHLVIAGDLLGFTGPKASTFEVAIQLGSIFAVLLV
YWDRFMGLLLPGRVQTSAPKPFAGVRGIWLLFLTTLPPSVLGLLLHSYIKQLFTPFSVSL
SLAVGGLLMLFVESYCAKRPPKYSSIDEVTPKLALGIGLCQCMALWPGFSRSGSTIMGGM
LLGEKRALAAEYSFVAAVPIMFAATGYDLLKTWSLFTVDDIPLFATGLFFAFLFGWLAIK
TFIALVGRITLRPFAVYRLLLAPIVYFFMVNMG
>A0A023CG80|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLKAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWIERIAKLNPDFIFSFYYRNLLSEALLATTSKGAFNLHGSLLPKYRGRAPAN
WVLVKGETETGVTLHRMVKRADAGAILAQQKVVIERSDTGLTLHTKLRDAAASLLRDALP
QLAAGKLTETAQDESQATYFGRRTAADGKLEWKKPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLAPGRVISVNPLRIACGEDSLVVKFGQRNDNGLYLAGPSLANELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVFGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GAKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDVCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIENAKRLLNWEPTVEMSETIGNTLDFFLREAMLEIA
DKR
>F5MDI0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MLELKDIRRSYPAGDEQVEVLKGITLDIYVGEMVAIVGASGSGKSTLMNILGCLDKATSG
TYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLL
RAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEV
MAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNT
VSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLAD
IRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNLCLRYNNV
DVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHKADVVGEV
ILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGFDSA
EAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNI
MLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLP
GWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE
>B4SRU3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFGQRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSENWTEVGVAFLAAAVTGFVVVKWLMGYIKSH
KFTAFALYRIALGAALLLWLPSGS
>A0A0D7XME7|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MQQKNKYIRIQEFLKQNKFPDFRMNQIKNAVFQGRINHFNEITVLPKSLRKLLIEEFGES
ILNIAPLKVQHSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCKFCATG
DIGLKRNLTSDEMTDQILYFHLKGHSIDSISFMGMGEALANVQVFDALHVLTNPELFALS
PRRLSISTIGIIPGIKKITQDYPQVNLTFSLHSPFNEQRSKLMPINERFPLLEVMDTLDE
HIRVTSRKVYIAYIMLPGVNDSIDHANEVVNLLRSRYKRGNLFHVNIIRYNPTVSSPMRF
EEVNEKQVVNFYKKLKSAGINVTVRSQFGIDIDAACGQLYGNYQKNKNQ
>E1LAL5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDQYVIALILGVIEGITECIPVSSTGHMIIIGHMLNFEGTHADVFEVFIQIGAILAIYTH
YRRTFNGFLKRKNWIKTRGVSLLHISAGMLPVLMAGYLLQYIIKEYLFGPIPVIVGLIIG
AIFMIYAEKRTVSGRLVDSVNNLTIYQCFQIGLYQMLCLWPGFSRSGATIAGGMLIGCTR
RAAADFSFIMAVPVMIIVCVYDLVRVIHALGLNDIIMFIIGTVVSYIVGYITVKGFLWYL
NRSSLASFGYYRIIVAILAIIYLYM
>ZP_03836960|FEATURES|ARDB_deepARG|quinolone|QnrB12|antibiotic target protection|1
MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAI
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSE
LGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG
>A0A073K847|FEATURES|UNIPROT_deepARG|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKKKMMLKVGLCVSLLGVSQFASATFPAQAVGNEERNVIKNQEGTISISQLNSYVWVHTE
VGYFNGETVPSNGLILNTSKGLVLIESSWDDKLTKELIEMIEKKFHKPITDAIITHAHAD
RIGGIKTLKEKGVKVHSTALTATLAKKYGYEEPIADLKEITNMKFGNMKVEAFYPGKGHT
EDNITVWLPQYKILFGGCLVKSADAKDLGNVADAYVDEWSHSVGKVMSRYKNIKSVVPGH
GEVGDSRLLSHTLDLLKSK
>BAB05497|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MRIQGINHLLFSVKCLERSIEFYKKALGAKLLVKGRTTAYFDLQGIWLALNEEPDIPRNE
IHQSYTHIAFTVGEEEMEEAYERLAGLGVNILKGRPRDPRDRQSIYFTDPDGHKFEFHCG
TLNDRLDYYREAKPHMTFFDD
>A0A0M0GL17|FEATURES|UNIPROT_deepARG|chloramphenicol|AF332_27215|antibiotic inactivation|1
MKFNKIDLENWKRKEIFNHYLNQQTTFCITTEIDISELHRVTKQKGYKFYPVFIFIVTSV
VNSNKVFRTNFNSEGELGYWDKLDPMYTVFDHKTESFSGIWTHAKGNFKEFYDMYLSDVK
TYTGTGKLFPKTPIPENTVSISMVPWTSFTGFNLNINNNTNYLLPIITGGKFINKGGSIY
LPISMQVHHSVCDGYHAGIFMNSVQKLAENTADWLL
>S9PJF0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MQAVSSSIMTEHPLSNPAAGPYGIVGGPDGALWFTEIHSGRIGRLRVDGELASFPLPTPD
AGPSLIVAGPDGALWFTEYKANRIGRITTEGAVTEYALPTPNAGPFGLTVGPDGALWFTE
STANRLGRITLDGTVTEFPLPSPDVFPSTLTTGPDGALWFTENKANRIGRMTTEGHVTEY
ALPTANAGPVGITVGPDGALWFVEILVDRIGRMTTEGHVTEFPLPRAGARPHAIVTGSDG
ALWFTQWGSNHIGRMTTQGAVTEYAIPTPQAEPHGITSGPDGALWFAEEAGKIGRLAPG
>A0A089JH31|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFAEQDSIMKTYEIVIQLGAILAIAL
VYRKRVLNLLGIGRSSSGRGGVMPAARLNLIHVILGIAPALAVAFFARDFIKSLFGASTV
LWALVAGGILMIVAEWVNRRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYKNFTSETIGYFVIGFLISFVVAY
LVVILFMKWIQKIRLTHFAIYRFILAAVFWLFIMR
>G5D8T5|FEATURES|UNIPROT_deepARG|beta_lactam|blaTEM-195|antibiotic inactivation|1
YYPVLNAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLL
TTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELL
TLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIR
>R7DHG7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEELNWFQTIIIAIVEGLTEFLPVSSTGHMIIAQNMLGVPSSDFVKAFTVIIQFGAILSV
VVLYWKRFFKLNPCKIFDSEAVSGKTGSARWVEYGRRFLYKYDFYWKLLVAFIPAAFFGL
LFSDKIDEMLESVTVVAVMLVIGGVVMLFVDKWFNKTTPDQTMTLKRAFNVGLFQCIAMI
PGVSRSMATIVGGMAQKMTRKNAAEFSFFLAVPTMFAATAYKLLKLLTSENGMQVLQDNL
LTLIVGNVVAFIVALLAIKFFISFVTKYGFKAFGYYRIIVGGIIIVLMLLGYNLEIS
>A9DZU2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENSTTLIAAFLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGRTFEVVIQLGAVLAILT
VYSARLWAVFSAAPHDPQARRFIWSVLLAFLPAVVIGVMAHDFIKTVLFETPLLIAIMLV
LGGVVLLVVDRIAPAPTYSDATKFPLSMAFKIGVIQCLAMVPGTSRSGATIVGALMLGAS
KRAAAEFSFFLSMPTMAGAFAYDIYKNRDVLDASAMGEIAVGFAMAFISAVFVVRWVLDY
VSRYGYALFGWWRILVGSVVIVALWAGY
>A0A0Q0EPQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRAGLLAFRALQGLADEFRPAAGSSYVQACRGIVATIFYTTTLNSEPAASLHGGMMDLWT
AAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVVWEFRR
KILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVVGGVI
MLWAERRVHTVRTETVDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAAT
EFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFITSFVFAMIAVRALLKFIATHS
YAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0D7KG51|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKVQGLNHLCFSVSDLERSIAFYEHILEAKLVVKGRKLAYFDLHGLWIALNEEQDVPRNE
IHPAYTHIAFTVSEHDIDEIKTKLVQYGVQILSGRERDERDKRSIYFTDPDGHRFEFHSG
QLADRLDYYKETMPHMTFLE
>A0A127SVP9|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLIAASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKAGATGGFGSYVAFIPEKE
LGIVMLANKNHPNPARVAAAWQILNALQ
>A0A0X1U7I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MSLEFIEILKVIFIGIVEGITEWLPISSTGHMLLVDQFIALNMSIPFKEMFFVVIQLGAI
LAVVVIFWKKMFPFQFGNKAQSIIKKETFSLWFKVVIACVPGAIVTILFDDYIEANLHTP
MVIALALIFYGVAFIVIELWNKKRLPTTTRLNDITYKTAFIIGLFQVLSIIPGTSRSGAT
IIGALLIGISRVVAAEFTFFLAVPVMFGLSALKILKFGFSFTSAELLILGIGMVVAFVVS
VIVIKFLLGYIKKHDFKVFGWYRIILGIIVIAYFAIL
>N8YMB1|FEATURES|UNIPROT_deepARG|beta_lactam|F963_03263|antibiotic inactivation|1
MGFLNKSKTTLCVLISGMGLTTYVNANQQVTTAQVENAMSQAFQPLMQKYAVPGMAIGVL
YQGKNYQKYYGVQSLADKKSVNKNTLFELGSVSKLFTATAGSYAQSLSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPIGQFRQYSNP
SIGLFGEATAKAMNMPFSTLLERVIFPQLQLQHSYVNVPKAQQTNYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLNLNLNPDQAKAAIRPAIQGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIKAAYEVMNTLKQTSHP
>A0A0T9R513|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MLKKSVINTLVFTAIATSPFYTSAQTILTEQQVAAIVNNTLKPLIKQQNIPGMAVAVFYD
GKPQFFNYGVADIKADIPVTENTLFELGSVSKTFTGIAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWQDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMHNYSNASI
GLFGALAVKRSQLTFEDYMKKYVFQPLKLTHTFITVPESMQSSYAWGYKDGQPVRVTLGM
LDEEAYGVKTTTKDMVRYMQANMDPDSLPAENDKLKKAIIAAQSRYFQAGEMFQGLGWEM
YNWPIDPQRVIADSGNDIALKPRKVDELLPPHPATRASWVHKTGATNGFGAYIVFIPEEN
IGIVMLANKNYPNPVRVQAAYNILQALR
>A0A0E3Y8T6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIDCHELLIIFILGIVEGLTEFLPVSSAGHMILIGYLLEFNSDRAKIFEVVVQFGTILSV
IVKFWRKLFSVVGIRFNQEILDKEKNSCLSLWHILLGVLPIIVLGFLFYNQIKFFFELIY
VMNALLVGSLLLLVAEYFAYCSSSRKISITELSYMQAFFIGCFQCFALCPGFSRSGATVS
GGLLMGVSRHSSFEFSFFLAVPVIFGASILDLYKNISLFTHHDVLLFFVGFCTSFVVGLC
SIKYFLQMVKNISLIPFVVYRFILAGIIYWLVYNP
>A0A096LNB7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIEALKAFLIGIVEGITEWLPISSTGHMILVDEFVKLQVSDEFLALFLVVIQLGAIMAV
LILYFHKLNPFSPKKDAVEKKSTWRLWGMVAIGCIPAAIIGLAFDDLVNEYFYNKVTVAA
MLILYGVVFIVLERRNRRRLREAEAALEAPRGRHARVAYGDAADEAEASLFKITDVDEID
WKTALKIGCFQVLAIIPGTSRSGATIIGGMLAGCSRTAAAEFTFFLAIPIMFGWGLVKCL
KFFAAGIAMTSTEVLVLVVGIITAFAMSVVAIKFLMGYIKKNDFTAFGWYRIVVGVLVLG
YFVFESMGMLP
>N8VK46|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFNSLLHLFMDNLALLKALFLGLIEGLTEFLPISSTGHLILFGHLIDFKSDSGRVFEV
VIQFGAILAVCWLYRQKIIALIRGFFSGEVHARRFAINVFVAFLPAVVIGVLAVDFIKQV
LFSPLVVAFALIIGGLIIFAVEAREYKPKTIEATDISFKQSILVGFAQCVAMVPGTSRSG
ATIIGGMLLGLSRKAATEFSFFLAMPTMLGAATYDLFRNANVLTSDNLVNISVGFMAAFV
AALLVIKALVKFVEKHSLRVFAWYRIGLTHYHL
>ZP_02903696|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|0
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGVERKR
RLARARELLQRLGLEERVDYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPATENMNVVAGTESI
VKMSSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQRQPWVASATPAVSQNLRLRY
SNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNSRRQLFPHKANVV
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRIMGQSWLNSITVRVKEGF
DSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFALQL
FLPGWEIGFSPLALLLAFLCSTVTGVLFGWLPARNAARLDPVDALARE
>A0A0N7AFF6|FEATURES|UNIPROT_deepARG|beta_lactam|blaCphA|antibiotic inactivation|1
YYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNA
YWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQGGKV
RAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIK
TVIGGHDSPLHGPELIDHYE
>X2L3X0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
ALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHYYTFGKADIAANKPVTPQ
TLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGL
PLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTR
VLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMAN
MAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLP
VAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANTSY
>ACI02996|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEAIRKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKVLLLGAPLNSVTALHYAEAVADIPN
KRWVTYEMPMLGRNGEVAWKTASEYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGATPIVPAHEAAQRSCEPSG
>A0A0I2CF58|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANISARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A060NNL1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLLKAAVMGLVQGITEFLPISSTGHLILTSALLGLYGEKVRLFEVVIQVGALLAIV
SVYLERLLATARGLPRGDAVAWRFTSNLVIGCLPAVLLGVLFFDFITGVLFNPLVVASTF
ISGGLVILWVEARQARQPPQRIQEVDEVGWRDSLTVGLIQCLALVPGVSRSGATIIGAMA
FGFSRRSATEFSFFLSIPMLVGAAGYDLFRNSDLLTRADLPFFAVGLIVTWLSAWACVRW
LLRYVAQHTFVPFAWYRIAFGLLVLLTAYMGWVDWTR
>A0A0K0HCA5|FEATURES|UNIPROT_deepARG|polymyxin|pmrF|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIKRTTAACENLGKAWELILIDDGSSDRSAELLVN
ASKEAGSHIITVLLNRNYGQHAAIMAGFSHVNGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRHIIDAMLSCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLVVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQQVIYPENTPFTEENHQ
>A0A127SVN2|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNHPNPARVAAAWQILNALQ
>I7AP36|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15like|antibiotic inactivation|1
LLLGSVPLYAQTADVQQKLAELERQSGSRLGVALINTADNSQILYRADERFAMCSTSKVM
AAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
NKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTL
GKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRA
PLILVTYFTQPQPKAES
>W9ABK6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MKLGKINHLLFSVSNLERSISFYEKVFDATLLVKGRSTAYFDLDGLWVALNVEDIPRSEI
QQSYTHIAFTIEDEEYEVLYNRLRELKVNILSGRQRDERDKKSIYFADPDGHKFEFHTGT
LEDRMDYYREEKSHMEFF
>A0A127KWT6|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTLPPVEKVSVVIPVFNEEESLPELIRRTTGSCDSLGIDYEILLVDDGSSDNSAQILTT
AAEQPGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQHRQDSLFRKLASRTVNRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARKAVEIPVQHAEREFGDSKYSFLRLINLMYDLVTCLTTTPLRLLSVVG
SVIALAGFSLAVLLVVLRLTFGPQWAGEGVFMLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQEHDAPQEENNQ
>A0A024CJN5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTTQPLLELQGITRRFSAGAKDFIALDNINLTINEGELVAIIGASGSGKSTLMNVLGCLD
HADAGSYKVSGRETYALTDDELAALRRDHFGFIFQRYHLLGHLSAVNNVEMPAIYAGVGE
SARNDRAQELLSRLGLGEHLSNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDTA
SGKEVMKILLELNAAGRTVILVTHDEKVAAHAQRVIEISDGKIVSDRINPDRQSLQDQEQ
DRLPTKNRKGNRLVASFELFREAFTMAWVALISHRMRTLLTMLGIVIGITSVVSIVAVGE
GAKRYVLNDIAAIGSTTIEIFPGTDWGDSRSAAIETLSLGDVAALGEQYYIDSATPNVGR
NLLLRYQNLDVTATVNGVGDNYFRVRGIKMGEGVGFSKEDSIRQAQVVVIDHNTRTRLFG
PKTDPLGQVILVDNLPCIVIGVTEDKKSVFNTSKNLNVWMPYETASGRLLGQRYLDSITV
RVKDGQPSKLVEENLTKLIEKRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIAVISLV
VGGIGVMNIMLVSVTERTREIGIRMAVGARPSDIRQQFLVEAVMVCLLGGLIGIGLSFAI
GYVFSLLVKEWQMVFSLGSIITAFVCSTLIGIVFGFVPARNAARLDPIEALARD
>D5ZUR9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSRSPAPAVREIRVTDEKAGPYGITAGPDGALWLTLVGSGRIARLTLDGEFREYPLDSPA
CRPTVIAPGPDGALWFTRYQDHRIGRITTDGAVDSFPLPTPGSGPFGITSGPDGAVWFTE
MNTDRVGRITGEGEVTEFVLPVTGGFPSAITTGPDGALWFTLNQANAIGRITTDGDTAVH
PLPTPDAGPVGITGDGTALWFVEIAAGQIGRISVDGGIREFPLPDRTAGPHAIVAASTGD
CWFTAWGAGRVGHITGDGEITEYDLPSPSSEPHGIALGPDGALWVALEAGGVARVEPERR
QPDPAGG
>G5LRD0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVKASQEADSHIIS
ILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEGFDVVGTVRQNR
QDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHERSTFIPILANIF
ARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLGSVIAIGGFSLS
VLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYNDVRARPRYFVQ
QVIYPESTSFTEESHQ
>A0A0K2P2I9|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKSKACALVMMMSLGGSAQAATGWTPDDVVKPLMAHYQIPGMAVAVSVNGETHFWHYGVA
SKETRKPVDEKTLFEVGSLSKTFTAALASYAQQEGKLDFSAPASRYLPELKGSAFDGVTL
QNLATHTSGMPLFVPDDVKNTAQLMDWYRAWQPKQPVGSERVYSNLGIGMLGLITAKALD
KPFSEAMEQGLLAEFGMTQSFVNVPAAAMGDYAQGYNKDDKPVRVTPGPLDAESYGLKSS
SADLLRYLQIQFGERAVSPRWRASLDATHNGYYRSGEFTQAMMWEFYPWPSSPEKLREGN
SSQRIMQGLKAQAIVPPQKAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYQIIEHLDK
>A0A009HTU0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
WLYRQKIINLIKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIAL
IVGALIIFWVESRQFEHKTLDATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAATFDLIKNADVLTSDNMVNIGVGFVAAFIAALFVVKALVL
FVERHTLRVFAWYRIALGVIILIAAMFFNLSA
>A0A100WXC0|FEATURES|UNIPROT_deepARG|aminoglycoside|RMCFA_6206|antibiotic inactivation|1
MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDW
RVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDML
ARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRRQEAADRVVCHGDLCLPNI
LVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADAVPGFTEEATAGLAAGYPAQVDPE
RLRFYLALDPLTWG
>NP_459471|FEATURES|ARDB_deepARG|multidrug|acrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
VAYRIAEVRPQVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAAN
IAELTVKRYQKLLGTQYISKQEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSSVTEGALVQNGQASALATVQQLDPIYVDVTQSSNDFLRLKQELANGSLKQENG
KAKVDLVTSDGIKFPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLQEG
TKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVASQAIGDKWLVTDGLKAGDRVV
VSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>ABV66095|FEATURES|ARDB_deepARG|quinolone|QnrB6|antibiotic target protection|1
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
ESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTR
TWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA
ANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG
>A0A0P0RA78|FEATURES|UNIPROT_deepARG|beta_lactam|K788_0004543|antibiotic inactivation|1
MLCAMWMTSGAAYAAEAAQDKLKRAVDAAIQPLMTKDQVPGMAVGVIVDGRAVVFNYGVA
STETGKPVTDATLFELGSVSKTFTATLTSWAQVDKQLSLTDSVAKHLPALRGTQFGNVSL
LNLGTHTPGGLPLQVPDDIGNDAQMIRWFAAWRPAHAPGTVRTYANPGIGALGMITAKSM
GQDFTALIERRLFPALGLKNSFIDVPGDRAPDYAQGYTKTGQPIRMAGGEFAPEAYGVKS
TATDMLRFIEANMKQVKLDAQLQRAITDTHTGYFQAGPMTQDLIWEQYPYPVSLNSLMEG
NAPAMALDATPVTKIEPPDAPKDDVWINKTGSTNGFGSYVAFVPSRRMGIVILGNRNFPI
ADRVAAAHRILTSLDGGGQ
>C2PF27|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0006_22160|antibiotic inactivation|1
MKFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISRV
VNNHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSNDFHIFYKNYEEDMR
CYANVHGLFTKENVPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVI
LPVSLQVHHSVCDGYHASRFIQDLQELSNSCNEWLK
>D3EDH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFITSIILGIVEGLTEFIPVSSTGHMILTAKVLGYDDQTPIMKTFEVVIQLGAILAIAI
VYWNRILNLLGWSRSEPLTRKVPRRRLNLMHIFLGIAPALLVAFFARDFIKSLFHAQTVL
FALVAGGIFMIFAEWYNKHKVQVTSHDMDDLTYKQAFLIGIYQIISVLWPGFSRSGSTIS
GGMLSGVSYKASADFSFIIAIPIMCAASGYELLDSYRYFTLDTIGVFLAGFIVSFVVAYF
VVLAFMKLIQKIRLTHFAIYRFGLAAVFWLFIMH
>A0A0P6WI71|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLTLTAILLGIVEGLTEFVPVSSTGHLILATELFGYDAHQWAMFNVVIQLGAILAVVVQ
YWPTFWSAGIGMLRMERGSLLFVRNILAAFLPSAVLGLLLKDYIDVLLGSPSVVAWALIL
GGIAILAIEKNAHPGPEQGVAALPLKQALGVGFAQCLAMVPGVSRSGATIMGALAMGIGR
KTAAELSFFLAVPTMIGASTLELAGGHEEIASGVATVGWGEIAIGFVVSFVVALIVIRAF
IAYVSRHGFSPFGWYRILLGGAAVAWLALR
>A0A0E1PRG7|FEATURES|UNIPROT_deepARG|beta_lactam|blaADC-30|antibiotic inactivation|1
MSYLFLSCTEELIMRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKY
DVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKI
SFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNS
IGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGY
NQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVN
TMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYV
VFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>W7RML7|FEATURES|UNIPROT_deepARG|chloramphenicol|M769_0109450|antibiotic inactivation|1
MNFQTIELDTWYRKSYFDHYMKEAKCSFSITANVNVTNLLAVLKKKKLKLYPAFIYIVSR
VIHSRPEFRTTFDDKGQLGYWEQMHPCYTIFHQDDQTFSALWTEYSDDFSRFYRQYLLDA
ERFGDTRGLWAKPDIPPNTFSVSSIPWVRFTNFNLNLDNSEHLLPIITNGKYFSEGGETL
LPVSLQVHHAVCDGYHAGAFMNELERLAADCEEWLV
>YP_608499|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDFWSALQAIILGVVEGLTEFLPISSTGHQIIVADLINFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQAPARRFTANLLIAFFPAVVLGVLFADLIHEYLFNPITVAAALV
VGGVIMLWAERRQHRIEVDHVDEMSWHHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFALGFVVSFIFAMIAVRGLLKF
IANHSYAVFAWYRIAFGLLILATWEFGWVDWSTAHG
>A0A0Q7JIM7|FEATURES|UNIPROT_deepARG|beta_lactam|ASD06_10205|antibiotic inactivation|1
MTSATARLTAAGAALLLPLLAGCSPESSAPTGSSSQPTAEASASPSSSRAGVEGQAAAQL
EAQFTALERRRGGRLGVYALDTGSDRSLSHRGDERFAMASTVKVLAVAALLDRLSAADLG
RRLRWTSGDLVAHSPVTERFVDRGMTIRQLIDASLTRSDNTAANLLFEQVGGPTTVGDFV
AAAGDDITSVDRREPALNDWAPGETRDTSTPRALGGTLATLVRGDVLEPADRLVLERAMR
DSVTGAGLVRAGVPDGFVVEDKSGTARYGVRNDVAIVRPPGGRAPWILAVMTSHETADAE
PDDELVAAATRIVVQALRSPG
>A0A0E2TKS5|FEATURES|UNIPROT_deepARG|beta_lactam|BX52_14575|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLLLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0C1ZK75|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSEPLLQLTGISRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
ATAGSYRINGRETRDLDSQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPEP
QRHARARELLARLGLEGHLTHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTS
GKEVMRILLELHAAGHTVILVTHDPKVAANAERIIEVSDGEILSDRRNERDSTALSNEDA
VPKSTGARRLVASLGLFKEAFNMAWVALISHRMRTLLTMLGIVIGITSVVSISAIGEGAK
RYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVTALNQLYYVDSATPVVGRNLL
LRYRNIDLDAQVNGVSDLYFQVRGIKMESGIAFSENDARRQAQVVVIDHNTRQRLFGEGV
DPLGQVILIGNLPCTVIGVAAEKKNIFSSSKSLNVWVPYETAAGRLLGQRYLDSISVRIK
DGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGG
IGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHL
FSLFIKEWEMVFSLSSVLTAVICSTLIGIVFGFVPARNASRLDPIEALARD
>AAS16363|FEATURES|ARDB_deepARG|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYVV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIAGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>A0A0R2YED9|FEATURES|UNIPROT_deepARG|beta_lactam|TU73_12825|antibiotic inactivation|1
MKLINILSAISLACITSQVFANQSDLTLIHFKGPLYIVEDKEYVQENSMVYIGEQHITVI
GATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWRKLGASIVSTQMTYDLE
KSQWRSIVDFTRQGMEHYPVLEQSLPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFP
EERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLISSGELPVEAIIAGHNSPIQSVEL
IDHYLNLLEHGEQ
>A0A0R1N0X1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNILKAVILGIIEGVTEFLPISSTGHLYLANEFVKLDESPAFITMFMVVIQLGAILAVV
VLYFHRLNPFSPKKTHAEKSDTWRLWFKVILAVIPSMIVGLLLNDWMDAHLNTWPVISAT
LIIYGVLFIVVERWNAHRTPRETDLNAVSPATGFKIGLFQLLSLVPGTSRSGATILGGIT
IGASRFVATEFSFFLAIPTMVGASGLKLAKYLLKGNTFTGDELMVLLVGTFVSFIVAYIS
IRFLLNFIKRNDFQGFGWYRIILGILVIAWFSFH
>A0A0L1K9Z0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDYITAIFLGIVEGLTEFIPVSSTGHLILATELSGADPNEWAMFNVVIQLGAILAVVYQ
YWGTFWSAGIGVLRREREGLMFARNILLGFLPSAVIGFALYESFEAMLGNPGIVPWALIA
GGVAIIVIERAANPRDEGRGVAELPLAKVLGVGFAQCLAMVPGVSRSGATIMGALAMGIN
RKTAAEFSFFLAVPTMVGATTLEVATKYDEMMAGATRVGWDHIALGFAVSFIVALFVIRA
FVAYVSRSGFTPFAWYRIIAGSAALAWLTFA
>NP_417969.1|FEATURES|CARD_deepARG|multidrug|gadE|antibiotic efflux|0
MIFLMTKDSFLLQGFWQLKDNHEMIKINSLSEIKKVGNKPFKVIIDTYHNHILDEEAIKF
LEKLDAERIIVLAPYHISKLKAKAPIYFVSRKESIKNLLEITYGKHLPHKNSQLCFSHNQ
FKIMQLILKNKNESNITSTLNISQQTLKIQKFNIMYKLKLRRMSDIVTLGITSYF
>T4VN53|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEIFKAIILGIVQGITEWLPVSSTGHLILVEQFVKFDLSQVFVSTFMVVIQLGSILAVL
TLYFKKLNPLDSSKTEKEKKDTINLWIKVIIAVIPSGILGVLFDDAIDSLFFNPTTVSIT
LIVYGVIMILIENRNKKPKVNDFSQLTYKLALGIGLFQCLALIPGTSRSGSTIIGAALLG
TSRYVAAEFSFFLAIPTMFGASALKLVKTGAAFSGFEWLVLGAGFVTAFIVSVFAIKFLM
DYIKKHDFKAFGYYRIVLGIIVFAYFTFLI
>A0A0A3YUK4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCIGIHALVKAGYEIEAIFTHADSATENHFFASVARTAAELGIPVFAPE
DVNHPLWVDRIKTMAPEVIFSFYYRNLLSNEILGCAAQGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMLARADAGAIVAQERVSIEPEDNALTLHRKLNSAAEHLLADCLPAL
KNGNAVAHPQDDSQATCFGRRTPEDGRIDWSLSAESVNNLVRAVTDPWPGAFGYVGAAKF
IIWKGKVRHDRPAAKAGTVLSVSPLIIACGEGALEVITGQSETGVYMQGSQLAQTLGLVS
GALLTNKPVSAVKRRTRVLILGVNGFIGNHLTERLLQDDNFDIFGLDIGSDAIGRFVGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCEDPNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIRLMDGGNQKRCFTDI
SDGVEALFRIIENKNNNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRQQFPPFAGF
RDVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPEVRMDKTIDATLDFFLRTVDGVDDRK
>J0C989|FEATURES|UNIPROT_deepARG|aminoglycoside|Rleg10DRAFT_4261|antibiotic inactivation|1
MEAIIEAGTIKDVEPWAQLRLALWPHHSLEDHRAELGRAFLSESGEAVAFIARNAANEAV
GFAEATLRHDYVNGCSSSPVLFLEGIYVRPVDRRKGIARLLCNSVADWGKSLGCVEFGSD
ALLENSASHALHTALGFEETQRVVFFRKPL
>C9YV49|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSIQEFPVSDVEAGPYGIAAGPDGALWFTLVHAGRVGRLTPDGETTSYALPSASGGPSVI
TAGPDGALWFTEFKGHRIGRITTAGEVTSFALPTPDAGPFGIAAGPDDALWFTEAGAGRI
GRITTEGEVVEFPLPVAGAFPSAIAAGPDGRLWFTMNQANAIGAVTPEGEVTVHPLPTPG
AAPVGIAAGGDGALWFVEIGAGQIGRITPDGKTDEFPLPDRGSRPHAIVADTDGGCWFTE
WGANRVGRITYDGHHHEIQEHTLPTPASEPHGIALGPDGSVWTALETGSVARLRAVADAG
>A0A144KKE7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVDRIRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWA
LVNGETETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNTTAQTLLRDALPAI
LSGTFSETAQDESKASSFGRRKPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVTCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGSDAIGRFIGNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
ESLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMELTIDETLDFFLRTVELSEQDS
>A0A0A1HZ86|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGIVEGLTEFLPISSTGHQIVVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLFADLIHEYLFNPITVAAALV
VGGFIMLWAEQRQHEVHADTVDDITWKDAIKVGLAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRALFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IANHSYAVFAWYRIVFGLLILATWQFGWVDWTSARP
>D3EDX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLTILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYVANTFKVVIQLGS
ILAVIVVFKDRFLDLLGLKRKKPEAGVPAGTGRLRLSQVIVGLIPAGVLGVLFEDLIDEH
LFSTETVLIGLVIGAIFMIVADKVSSKKEPKVVTVDQITYRQAFSVGLIQCLSLWPGFSR
SGSTISGGVMLGMSHRAAADFTFIMAVPIMFGASFLSLLKNWEYFTLEALPFFIAGFVAA
FVFALISIRFFLKLINRIKLVPFAIYRIVLAAIIALVLYL
>N9NK62|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWTRLSGAATGIVSGEPQGRRLGIGLILASIPIILIGLTFGQTVKELLFNNIAIAIG
LIVGGLIIIWIEKNPPQVRAQEVEDLTIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIVGAGLLDLYQSYDVFSGTQDWVVLTVGLLVSFISALLLIRAL
VAYVAKRDFMIFAWYRIVSGLLILLFAYTGWTLW
>A0A0Q6MVV9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFVLLLKAAVMGVVEGLTEFLPVSSTGHLILAGSLMHFNDARGKLFEIVIQSAAILAVV
WEFRGRIGGVLGGLGHDPKARRLLLNVGIAFLPLAVLGLLFGKMLKANLFNAPTVATTFI
VGGLIILWAERRQHSVRVHSVDEMTPLDALKVGIAQAFALIPGTSRSGATIIGGMLFGLS
RQVATEFTFYLAIPTLGVASVYSLYKERALLSVDDLGMWVVGMVAAFISAFFCVRWLLRY
ISTHTFVPFAWYRIVFGIVVLVTAWSGVVTWAD
>E0SDP1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MADLHSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFEGDTAKTFEVIIQLGSILAV
VVVFWRRMFGLIGIHFGQPPQHEGRGKGHLTLVHIVLAMIPAVVLGLVLHDFIKSLFNPV
TVTYALVAGGVLLLLAEWFKPKKPKAEGLDDISYVQAFLIGCFQCLALWPGFSRSGATIS
GGMLVGVNRYAASEFSFILAVPIMLGASGLDLYKSWHFLSLSDLPMFATGFVTAFVVAMI
AIKTFLQLIKRISFVPFAIYRFIVAAVVWLVLM
>A0A076W4S8|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MINGFNHLCFSVSDLERSIQFYETVLEGKLLVKGRKLAYFDICGVWVALNEEADIARNEI
HQSYTHLAFSVKQEDFGRLLKRLEENKVHILQGRERDVRDCQSIYFIDPDGHKFEFHSGT
LQDRLKYYKEAKPHMKFY
>A0A0A0Q801|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-20|antibiotic inactivation|1
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
YTFGKADIAANKPVTPQTLFELGSISKTFTSVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>A0A100HQS1|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTTLHIIILACVQGLAELLPVSSSAHVILAEKWLGLDPTSPDMTLMLVMLHTGTMFAVIV
YFWRSWRQTYFSSTRALWNNGVQLAVATVATGVVGLTLLYVIKHAFMGGADSFEVEHLFG
NTKLMAVSLAVAGVLIIVSSRHANTATGELTGWRALWIGAVQGLCLPFRGLSRSGATISA
GMLVGVQRRRAEEFSFALAVVLTPAVIVKEGYRFYKAYAGTADSMLHMLAPSLLGMVFSF
IAGLVALRWLSRWLEQGRWYLFGCYCLVASVVVWMFGG
>W1F0U1|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAHLAPEVIFSFYYRHLICDAILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPTI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKM
>BAB71966|FEATURES|ARDB_deepARG|tetracycline|tetPA|antibiotic efflux|1
MVNKLSAYKTYLLFSAITAMCFSLVATVMIVYHIETVHLNPLQLILVGTTLEVACFIFEI
PTGIVADVYSRKLSIVIGVVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSVEAWI
AEEEKDKDLDKIYIKGAQAGQIGSVIGIVLSTVIANLSVRLPIIVSGVLFIILALFLWLY
MPENNFKSSAPEDLNTFKKMGYTFKSGLKFIKNKPIIIILLSVTLFYGLSSEGYDRLSNM
HFLQDTMLPKLGNLKPVTWFGIFGIAGMILSAIVMHFMEKKLKDDDKNKNGKLLLCINIF
YISFMFIFAITKRFNLMLIAYLATSTFRTINEPIFSAWLNGHIDDKARSTVLSINGQINS
LGQILGGPIIGIIATNISVSMGIACTSLLVTPVLVLYIVAMIMDKKVVDRVGGIDYEENN
>F0YTN8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKVIVLGIVEGITEWLPISSTGHLILVEEFVKLKMTDDFMSMFNVVIQLGAILAVV
VIYFHKLNPFSDTKTHKQKMLTLQLWVKVLIASVPAAIIGLLFDDFIDAHLMNYVVVAIT
LILYGVAFIVVEKRHEHVKPAVKRLSDLTIPMVLIIGCFQVLALIPGTSRSGATIIGGLL
IGAARGVAAEFTFFLAIPVMFGASFLKIIKFGFHFTGMEVFLLLLGCVISFVVSIFAIKF
LMQYIKNHDFKVFGYYRIVLGIIVLLYFGMTALFA
>G2ZFY4|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFDP
ATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDER
NVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEDRLASRADQ
LEEFVHYVKGEITKVVGK
>ZP_03000297|FEATURES|ARDB_deepARG|multidrug|MdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGVALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKE
TRPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>P23835|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTINLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLLLGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>Q705J0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRTGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>A0A0Q9IAX8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENAFEAALLGVVEGLTEFLPVSSTGHLLLLGHFLGFESNGKSFEILIQLGAILAILLVY
FRRLLDIALRVPSDPAARRFVIGVVVAFLPAALIGAVLHGFIKGVLFNPFIVCISLIVGG
LILLVVDDLELEVKHQDATTFPLPMYLKIGFIQCLAMIPGVSRSGSTIVGAMLLGSSKRA
AAEFSFFLAMPTMAGAFAYDLLKSYKTLTVDDVTLIAIGFVTAFISALIVVRSFLDFVTK
RGFAPFAWWRIVVGLFGLAGLWIYG
>R8DA28|FEATURES|UNIPROT_deepARG|beta_lactam|IGA_01699|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITFTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVIVKALR
>A0A099F2J9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDRNTLVAAALGLLEGLTEFIPVSSTGHVLLAGYFLGFDSPGRAFEVLIQLGAIMAILGV
YATRLWTIFASAPRDPRARRFIAAVLLAFLPAAVIGVLAHRVIKEILFETPVLIASMLIL
GGVVLLFVDRMATRPRYHAAEDFPLPMALGIGLIQTLAMIPGVSRSGATIVGALLLGANK
RSAAEFSFFLSMPTMLGAFVYDLYKNRDILDVAAVGNIAVGFACAFVAAVIVVRWLLNYV
SAHGYALFAWWRIIVGSVVLLALWVGR
>A0A0M0GES5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIMILKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLNTKEFLTKYEANTFKVVIQLGS
ILAVVIIFKDRFIELLGLGGRGKNSEEKQSRLKLSQVIVGLIPAGVLGVLFEDYIDEHLF
STETVLIGLVIGAFLMIFADIFGGKNPKTVSVDQITYKQALSIGLIQCFSLWPGFSRSGS
TISGGVLLGLSHRAAADFTFIMAVPIMAGASFLSLIKNLEYFSVDALPFFIAGFISAFVF
ALISIRFFLKIIGKIKLIPFAIYRIVLAGVIYFIFL
>ABO42026|FEATURES|ARDB_deepARG|aminoglycoside|AAC(3)-Ia|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
QPDSDYLGNLLRSKTFIALAAFDQEAVVGALAAYVLPKFEQARSEIYIYDLAVSGEHRRQ
GIATALINLLKHEANALGAYVIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>A0A0X4EP06|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCMGTLALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
DVNHPLWVERIRALAPDMIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWV
LVNGEAETGVTLHRMVRRADAGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPSI
LSGTFSEAAQDESKASCFGRRTPEDGRLDWNKPARQLHNLVRAVTDPWPGAYSFAGVSKF
IVWKSRVRDDIPAAKPGTVVSVSPLIVSCGEQALEIVTGQTDNGLYVQGTQLAQSLGLVA
GALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDNYEIYGLDIGADAISRFLDNP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDNRCNGEIINIGNPENEASIRELAEMLLASFERHPLRDKFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLNWTPTVKMEQTIDETLDFFLRTVELSDQAS
>Q3LG62|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>N9LEC7|FEATURES|UNIPROT_deepARG|aminoglycoside|F903_02786|antibiotic inactivation|1
MNIKPASEASFKDWLKLRIKLWNDLEESHLQEMHQLLAEKHALQLLAYSDDHAVAMLEAS
IRYEYVNGTETSPVAFLEGIYVLPEYRRLGVATLLVRQVEAWAKQFSCTEFASDAALDNV
ISHAMHRALGFQETESVVYFSKKID
>CAA38136|FEATURES|ARDB_deepARG|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILGADILVEGETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>NP_863005|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MLRSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWW
GGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDP
GVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGF
ERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>BAE96115.1|FEATURES|ARDB_deepARG|glycopeptide|vanYD|antibiotic target alteration|0
MERQNNNENQYGRNRRKDKRKKLFFYRAACAMLGLLIVCVIFGAVYFLRESKDPVLPSKE
NTKTGKDYSFLADGQSEDESPISEPAISNRANAIDLNIIAANAIVMNKDTDALLYQKNGT
DRIAPASTAKMITALTVLEYCSPEEEMRVGAEIEMIHSDSSTAWLMKGDTLTVRQLLIAL
MLPSGNDAAYTLAVNTGKVIAGDNSLSNQQAIQIFMDKVNEKARAIGVTDSNFVVPDGYD
AEGQYTTAYDLAIIAKACLEDPIISEIVASNTSYEKWPNGREVTYNNSNELLDPNSPYYR
PEVIGLKTGTSSLGGACVVSAAVIDGETYICVVMGSTKESRFQDSVAILDKIKAQ
>NP_708846|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNALLKEAEK
RNLSLLQARLSQDLEREQIRQAQDGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>S7TJZ6|FEATURES|UNIPROT_deepARG|beta_lactam|dsx2_1119|antibiotic inactivation|1
MRIRILLRLAVACLCLGLCLGLGAVLPAARAFALESTASADTMDTARLAEAVQNEEAALH
ARIGMAVSDTNGGDVWQYRGDERFPLNSTHKVFACAALLARVDAGVLAPDRRVSITESML
VVYSPITKKHLAPETMTLSEVCRASVSYSDNTAGNVVVDAAGGPAAVTAFMRSIGDGVTR
LDRAEPELNEAAPGDPRDTTTPAAAAASLARVVLGDALAPSSRAALTDWMLHDQVADGLL
RAALPPDWRIADKTGSGGHGSRSILAVVWPPKRSPLVVAIYITQTEASVQDANLAIARIG
RVLREAVGR
>ACD03314|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SEAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAMPILCSSNIVGLHKYWLEFAV
>A0A066T8W8|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHVLVE
ASQAEGSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0S8B9T3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDASLLSALILGIVEGLTEFLPISSTGHLILVGDLLGFNDERGKVFNVVIQTGAMLAIIW
EYRRRFGHALVSVLRERAAQRFWLHLAVAFAPAAVLGLAFGGAIKRLLFKPVPVALAFIV
GGLVILWVERRAHRAQPPRVDAVDQMTWRDALLVGIAQSFALIPGTSRSGSTIIGGMIFG
LSRRAATEFSFFLAVPTLVAAGAYDFYKNRALFVADDLGLFAVGSAAAFVSAFTVVRWLI
RYVANHDFRPFAWYRIAFGAIVLATAYSGWVDWSLG
>A0A100YR32|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNDYMIAVILGIVEGFTEYLPVSSTGHMILVGDWLGFDGPRASVFEVFIQLGAILSVLII
YKEKFIRMLYQYRCWNLFRRENWFRTDTGLTLAHVAAGIVPVMGIGYLAHHAIKTYLFSA
GTVIIGLIIGGLFMLAAEKAHMKVRCKDVEKMTIVQAFLVGAFQMLALWPGFSRSGSTIA
GGLFLGMSRKAAADFSFIIAVPVMIVACFYDLLKSLSYLSGNDLVMIAIGFVTAFIVAYV
SVLWFLKFLNKSTLASFAYYRFVVALVSFLHFFVLN
>J2X3Y0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSLALSPHCASCQDVDMLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEIL
LIDDGSSDDSARMLTEAAEAEGSHVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQ
NPPEEIPRLVAKADEGYDVVGTVRQNRQDSIFRKTASKMINRLIQRTTGKAMGDYGCMLR
AYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPVMHAEREFGDSKYSFMRLINLMYDL
VTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGVFMLFAVLFMFIGAQ
FVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>L3BYC1|FEATURES|UNIPROT_deepARG|beta_lactam|A13W_03460|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNH
PNPARVAAAWQILNALQ
>A0A127SJG4|FEATURES|UNIPROT_deepARG|beta_lactam|CblA-1|antibiotic inactivation|1
MPLKEIEVMKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGD
MLRYNDHVHFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPD
QDFTITLRELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSS
FEAVYRNWSTPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVV
GHKTGSSDRNAD
>A0A0U4DBJ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVAIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERRELPRVMSVDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0K8PAQ6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYITEIIKAIVFGIVEGITEWLPISSTGHMILLNELVHLNMSDAFQEMFLVVIQLGAILA
VIITFFKKLNPFSSNRNGNHKKETFQLWLKIFLACIPAGLIGFLFEDQIDKLFFNFKTVA
ATLIIYGILFILIERRNKTRNSSINELSQLNYAAAVMIGIFQMLSLIPGTSRSGATILGA
ILIGTSRSVAAEFSFFLSIPIMLGASGLKLLKFGFSFSNIEIAVLFAGMITAFLVSAAAI
KFLMGYIKKHDFTLFGYYRIFLGILVLLFFSLLR
>K9NIX5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVATALV
VGGIVMLWAERRQHEVHAESVDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAVGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGLIILATWQFGWVDWSAVKP
>H6LJ25|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGFLEILKAILLGVVEGVTEWLPISSTGHMILVDGFIKLNMSDAFIEMFLYVIQLGAILA
VVYIYWHKLVPFAIKDKKIMIRKNTMILWSKIVVACIPGIIAYFLLDKLFNTYFMNSVTV
SVMLIFYGILFIVIENYNKKRTPEVIKLSQLTYKKALQIGAFQALSIVPGTSRSGVTILG
GMILGTSRTVAAEFTFFMAVPVMFGISFLKLIKFGLAFSLWEGVILLVGMITAFITSIVA
IKFLMSYIKKHDFKVFGWYRIVLGIIVLLYFFITGN
>A0A0C5JVF7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
YFWKSWRERYFSSKHDFVHNAKQVIIATAFTGVIGLALMFFIEKVLMRGSAHAEIEHLFG
NLYIISAGLAMAGILILISGTRRPPMGDRPMRGTDSAWIGAVQGVCLPFRGFSRSGSTIS
TGMLRGLDKVRVEEFSFALAVVLTPPVIVKEAYRLYKSGGAQTLSGHFMSVLTPSLVGMA
FSFLAGLVALRWLSRWLEHGRWYLFGIYCLVASAVVLAASQYL
>J8I1D0|FEATURES|UNIPROT_deepARG|chloramphenicol|IIG_02558|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
INKHTEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYANVHGFFTKENIPPNIFPISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRIM
LPVSLQVHHAVCDGYHASRFIEDLQELANTCNEWLK
>A0A117XR52|FEATURES|UNIPROT_deepARG|beta_lactam|WI38_29595|antibiotic inactivation|1
MTYSSQRRTLLLAAATAPLALTLSACASPRANASSVGSATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFAQRVTYRQADLLEWSPVTEKH
VDTGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDETFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQYAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTINDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>K0DSI7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDQHAKTFDVVIQLGAILAVC
WEFRRRIGDVVTGLPSRPEARRFVLNVIIATIPAIVLGLLFEKSIKAALFSPVPVAFALV
VGGVVILWAEARQRGQGAQGQAARVHHVDDMTAMDALKVGLAQCFALIPGTSRSGSTIIG
GMLFGLDRRVATEFSFFLAIPIMFGATAYEIYKDWHTLSVDALGVFCFGFRGGVCQRVFV
RALAASLYCRARFHGVRVVSHRLWIADSAGRL
>AAU01314|FEATURES|ARDB_deepARG|rifampin|rif|antibiotic inactivation|0
MNNTIINSLIGGDDFIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
QYITALNHLVLSLELPEVKGMGRFGYVPYVGYKCINNVSVSSCNGVIWEIEGEELYNNCI
NNTIALKHSGYSSELNDISIGLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITV
TVTFNPVSDIVIRDSSFDFETFNKEFVYVPELSFIGYMVKNVQIKPSFIEKPRRVIGQIN
QPTATVTEVHAATSLSVYTKPYYGNTDNKFISYPGYSQDEKDYIDAYVSRLLDDLVIVSD
GPPTGYPESAEIVEVPEDGVVSIQDADVYVKIDNVPDNMSVYLHTNLLMFGTRKNSFIYN
ISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSIWTSQRNVYNGDNRSAESKAKD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
FTPKIFFRPTTITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQG
VSITKIMGDNN
>V3PMZ0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNNIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDGDALARLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>D8MPI7|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCIGINALVNAGYEIEAIFTHADSSNENHFFASVARTAAEQGIPVYAPE
DVNHPLWVDRIRTMAPEVIFSFYYRNLLSDQLLSIATKGAFNLHGSLLPKYRGRAPLNWA
LVNGETETGVTLHRMVARADAGAIIAQDKVSISADDNALTLHRKLNAAAEHLLADCLPAL
RNGQISERAQDNTQVTVVGRRTPDDGRIDWSQPAEVVNNLVRAVTDPWPGAFGYVGAAKF
IIWKGKVRHDLPAAKAGTVLSVNPLVVACGEGALEVMTGQSENGVYMQGSQLAQTLGLVN
QALLTNKPVSAVKRRTRVLILGVNGFIGNHLTERLLQDDNFDIFGLDIGSDAISRFIGHP
RFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYKKRIIFPSTSEVYGMCDDPNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVLWAYGDK
EGLRFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLMDGGKQKRCFTDI
SDGVEALFRIIENKDNNCDGQIINIGNPDNEASIKELAEQLLASFERHPLRDRFPPFAGF
RDVESSSYYGKGYQDVEHRKPAIRNARRLLGWTPEVTMDKTIDATLDFFLRTVELDVPEE
KK
>ZP_04198378|FEATURES|ARDB_deepARG|beta_lactam|BcII|antibiotic inactivation|1
MKKNTLLKVGLCVSLLGTIQFVSVISPVQAERTVEKKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLLQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLKRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>D5RK68|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFASLLSALLMGVVEGVTEFLPISSTGHLILLGEAIGFQGPPGKTFEISIQLGAILAVI
WLFRATIWRIATGMWRIGSHEYYFALNLLLAFLPALVLGATLYRTVTELLYTPFVVALAL
IGGGLVILAIERWRPAPQIHSVPEIGPLAALLIGFGQALAMIPGTSRSGATIISALLVGV
DRRTAAEFSFLLAIPTMVAATVFSLWKNRADLDFSGAGLIAVGFAAAFLVSLVVVRWLMS
VISRIGFTPFAWYRIGLGLIILAWLALR
>U7UGI4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIKAIILGIIEGFTEFLPISSTGHLILAGNFFNLSNKEFQNAFNVIIQLGAILAIVVI
YFNSLNPLGKNKLERKLKRPLEGLTFKEKLALADKKTLRLWTKIIIGFLPAAVLGFLFDD
LIDKYLFNNITVAISLIFYGIVIILIEKKDKSGKYTSIDRLPIKTVILIGLFQCLAMIPG
TSRSAATIIGGVLLGADRITAAEFSFYLAIPTMLGATFLKIIKIGVSLSLSQWIIILVGF
IVSFLVALIVVKKFLAYIKKHDFKVFGIYRIILGILVIALEIFTK
>A0A0W0H7A7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
ATAGSYKINGIETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPET
TRHSRARELLARLGLAGHTSHRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHS
GKEVMRILAELHAAGHTVIIVTHDPKVAANAQRIVEVCDGEIVSDKSNDSVGLELPGETP
IEPKRSGARRLVASLGLFKEAFNMAWVALVSHRMRTLLTMLGIVIGITSVVSISAIGEGA
KRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDVDALNQLYYVDSATPVVGRNL
LLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDHNTRHRLFGPN
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
KDGQPSKVVEDNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVG
GIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGF
LFSLFVKEWEMVFSLGSVITAFACSTLIGIVFGFVPARNAARLDPIEALARD
>A0A130W9W7|FEATURES|UNIPROT_deepARG|beta_lactam|bla_2|antibiotic inactivation|1
MKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLSISPAEQIQFLQKIIYKKLPVSQKAYTMTKN
IMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHITDSKE
NTTFASFRAKNDTLIQLFNLINELEK
>J7M689|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAF
GKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRND
VAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A085I1S9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELSGIRRSYPSGDGSVDVLKGISLQINAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGVDVATLDSDALAALRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGMERKA
RLERARQLLQRLGLADRVDYAPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDTRSG
EEVMAILHQLKEQGHTVIIVTHDPQVAAQAERVIEIRDGEIIRNPPARQTAAAAREPAAQ
DASGWRQFSNSFREALSMAWRAMVANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMVLA
DIRAIGTNTIDVYPGKDFG
>BAA22228|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MILETTAKASQQYKVMPIMISLLLAGFIGMFSETALNIALTDLMKELNITAATVQWLTTG
YLLVLGILVPVSGLLLQWFTTRQLFTVSLIFSILGTFIAALAPSFSFLLAARIVQALGTG
LLLPLMFNTILVIFPPHKRGAAMGTIGLVIMFAPAIGPTFSGLVLEHLNWHWIFWISLPF
LVLALVFGIAYMQNVSETTKPKIDVLSIILSTIGFGGIVFGFSNAGEGSGGWSSPTVIVS
LIVGVVGLILFSIRQLTMKQPMMNLRAFKYPMFILGVIMVFICMMVILSSMLLLPMYLQG
GLVLTAFASGLVLLPGGILNGFMSPVTGRLFDKYGPKWLVIPGFVIVTVVLWFFSNVTTT
STAVLIIILHTCLMIGISMIMMPAQTNGLNQLPREFYPDGTAIMNTLQQMAGAIGTAVAV
SIMAAGQHDYMSTVKNPADPAVIPQALTAGVQHAFVFAMIVAIIGLIGAFFMKRVKVDH
>D6NSM8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>A0A127SCP7|FEATURES|UNIPROT_deepARG|beta_lactam|TLA-3|antibiotic inactivation|1
MKKHLVVIVFCALFASASAFAAKGTDSLKSSIEKYLKDKKAKVGVAILGIEDNFKLNVNE
KHHYPMQSTYKFHLALAVLVKLDKENISVDKKLFVKKSDLLPDTWSPLRDKYPNGNLELS
FSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYT
YWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSS
DTNDKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLIKGG
K
>J9AID0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSDLKKSIMFYEKVLEGKLLAKGRKLAYFNICGIWIALNEEAHIPRNEI
HQSYTHIAFTVEQEDFNCLLKRLEENGVHILKGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYKDEKPHMTFY
>A0A0W3BER0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIIIEFIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGPHSAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYRNTSINEEFRSKPRRLNLLHVLVGMIPAGILGVLFDDFI
EAHLFSVPTVMIGLFLGAIYMIIADKYSKKVQNPKSVDQINYVQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLDHKSASDFTFIMAVPIMLAASALSLVKNYQYIELAHIPFYLIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIIIAILYFGFGIGQGISG
>A0A127SQ54|FEATURES|UNIPROT_deepARG|chloramphenicol|catD|antibiotic inactivation|1
MKRIVFEVIDINGWRRREHFEHYFTNVPCTYSMTVKVDITQIKKKRMKLYPAMLYYLATI
VNRHSEFRTAFNQAGELGIYDEMLPSYTIFHEDTETFSNLWTPYIPDFEAFSMAYANDMQ
RYGSNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYRDDEKII
LPLAIQVHHAVCDGFHICRFVNELQELINS
>NP_755652|FEATURES|ARDB_deepARG|multidrug|tolC|antibiotic efflux|0
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
LPQLGLGADYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTY
QTDQQTLILNTATAYFNVLNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNAR
AQYDTVLANEVTARNNLDNAVEQLRQITGNYYPELAALNVENFKTDKPQPVNTLLKEAEK
RNLSLLQARLSQDLAREQIRQAQGGHLPTLDLTASTGISDTSYSGSKTRGAAGTQYDDSN
MGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLESAHRSVVQTVRSSFNNINASI
SSINAYKQAVVSAQSSLXAMEAGYSVGTRTIVDVLDATTTLYNAKQELANARYNYLINQL
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
RTTTSNGHNPFRN
>Q7M8Z9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIFHAIILGIVEGLTEFLPVSSTGHLILVSELLGIKQDDFHKTFEISIQLGSILAVLAL
FRERLFSGVDIWLKLAVAFIPTGALGFLLYKHVKALFAPSTVAYALILGGIVFLVLEWLH
KDKEYKINSVESIGYKEALAIGFFQALAMIPGTSRSGSTIVGGLILGLNRKVAAEFSFLL
ALPTMFIATGYDLYKNSHTLSIENLSALGVGFVVAFIFAMIAVKGFLKFISRFNFVPFGI
YRIILGIIFLFYLDLI
>AAK15701|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>A0A0M1KMT4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
RLWTLATGLGERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWM
LVAEHVAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAAD
FVFMVGIPTMFAASGYALLEMYKEGGFGTENWADVAVAFVAATITGFVVVKWLLSYIKKH
RFTVFAVYRIVLGAALLLWLPAAAG
>A0A024E4S0|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSAKAVVFAYHDIGCAGIETLLEAGFEIAAVFTHADDPKENAFYASVAQLCARKGIPVHA
PEDANHPLWIERISKLKPDYLFSFYYRQLLSEPLLATARKGAFNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHRMVKRADAGAIIAQQRVAIERSDTALSLHGKLRVAAIDLLRDALP
ALRQGTVSETPQDESKATVFGRRTPADGKLVWKRPAEELFNLVRAVTQPYPGAFCAVGEH
KLIVWSAEVAKGNAGLAPGRVISVDPLRIACGEDSLVITSGQRNDNGLYLSGPQLASELG
LVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIDRLR
SHPRFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAY
GQKGLNFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGVEALARIIDNENDACNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFA
GFRDVESKAFYGTGYQDVSHRKPSIANAKRLLDWTPTVEMSETIGNTLDFFLREAMLEIA
EHSKEESC
>Q7ULB5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLYGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSSLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVAEDVRQRASTVDRSRLANS
RAEPLREPASAWSLPATWNAIVVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTSGRQRPIQIIPDDVVAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCILGKTVAHELFD
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQVLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRSAILRQFLIEATVLCVVGGFIGIFAGHMWSVLVGRVIGWPTAMSIWAPIVAVTVAATV
GIVFGYYPARTASRLNPIDALRYE
>A0A0N0WBX3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQTTQPAPEAQPAKQPGLAPRRLIASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPSTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>A0A0E9EN84|FEATURES|UNIPROT_deepARG|bacitracin|uppP_3|antibiotic target alteration|0
MSLLETIILAIVEGLTEFLPVSSTGHMIITRDLLGMQANDPFINAFIVIIQFGAILSVVT
LYWKRFFRLDNTPVPEGTPAVKAFIHRWNFYWKLLVAFIPAAVIGLLANHLIEKMLGSVI
VVAVMLVVGGIFMLFCDRIFNHGQESTSLTDKKAFMIGVFQCIAMIPGVSRSMATIVGGM
AQGLTRKRAAEFSFFLAVPTMFAATCLDVFKLIKNGGVDALSSHVPTLLLGSAVAFVVAL
LAMKWFVNFLTKYGFKVFGVYRIIVGGFILIWLMMGHSLAMVD
>A0A0Q5VLS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADWLAAIILGLVEGLTEFIPVSSTGHLLLTQHLLGLNDPRWSSFVVLIQLGAILAVVAL
YFQRLWGVLIRLPTDPKARHFAISVLVAFIPSLLAGAFLYDFIKAFLFESLATICVSLIV
GGFVLLALERFAPKPHTGDAMALSWRQSVLVGLFQCLSLVPGVSRSGATIAGGLVLGLEK
PAAAEFSFFLAIPTMVGAFTYDLIKDGGAIDMNFAWIIAIGFVVSFLSGLLVIRWMLGFV
ARHGFTPFAWWRIAVGLAGLAALYGGVLA
>A0A0B1FYN9|FEATURES|UNIPROT_deepARG|beta_lactam|PU33_13870|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVILANKNY
PNPARVAAAWQILNALQ
>A0A0D7XB10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIIEGLTEFLPVSSTGHMILTADLLGLNTENDTVKTFEVIVQLGAVLAVVVLYWRRFLS
LFDFRRRISTQPRLNLLHIILAMIPAGVIGVLFRDVIKQYLFGPQTVLYSLVIGGLLMIA
AEKFHPPIKSHTVDDITYKQAFTIGLFQVLALWPGFSRSGSTMSGGLFARVSHTAAAEFT
FLVSVPVMLGASGIDMIKSMDHLSMSDFPVFAAGFITAFIVGMLAIKTFLGLLKRLSLTS
FAIYRFVLAAVFFFIIL
>L0FSL3|FEATURES|UNIPROT_deepARG|beta_lactam|B479_27189|antibiotic inactivation|1
MLACVVASFIPTPVFALDTTKLIQAVQAEESALQARVGMTVFDENTGTTWNYRGDERFPL
NSTHKTFSCAALLAKVDGKSLSLSQSVSISKEMLVTYSPITEKSLSPETVTLGRICQAAV
SYSDNTAANVVSNAIGGATGFNAYMRSIGDEQTRLDRKEPELNEGTPGDVRDTTTPNAIV
NSLRKILLGDGLSVSSRSELTQWMLDDQVAGALLRASLPSDWKIADKTGAGGYGSRSIVA
VIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKDAVAP
>G8GMB7|FEATURES|UNIPROT_deepARG|beta_lactam|IMP|antibiotic inactivation|1
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEK
LVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSF
GGVSYWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPK
SAKLLMSKYGKAIS
>A0A0W0HL79|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNHSLQKFLFSALLISSGSCVAATDLRTVVDAGVKPLMQQQGIPGLSIAVVNQGKVQYFN
YGVASKETKQAVNQDTLFEIGSISKTFTATLGGYAQATGKLKLSDTASQHLPALAGGVFD
HISLLQLATYTAGGLPLQFPQSADTAQAMLGYFQHWTPTYAPGEQRLYSNPSIGLFGYLA
AQSLGQPFNLAMEKTLLPKLGLTNTHVSVPASKTAQYAQGYDKNLKPIRVSPGALDSEAY
GIKTSTQDLARYVIANLHPETLEKPLQQAIATTHAGYYTVNGMTQGLGWERYPYPIKLQA
LLDGNSTEMAMQPHKVNWLTPAQPQPANVLYNKTGSTGGFGGYVAYVPSKDMGVVILANR
NYPNAERVKLAYAILSAMDH
>A0A0N9YDV7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDLLKSLVIGIVEGLTEFLPVSSTGHIIIAESFMNIPGGAVWTKSFTAMFDYAIQLGAI
FAVIQLYFKKLNPFSPSKSSLEKRQTWTLWFKVIVGVLPAVIAGLALNDYMDAHWLNAWV
VAAMLIVYGVPFIVVERYLANKNAILTDLNAMSYKMALFIGLFQVLSIVPGTSRSGSTIL
GALILGASRFVAAEFSFFMSIPVMFGVTILKVGKYLLDGGGFTGAQTGVMVVGFIVSWIV
AYFAIKVMMNYIKNNDFKVFGYYRIVVGIVVLALGAAGMLHMH
>A0A0R2ZBF8|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSSKAVVFAYHDIGCAGIEALLATGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
PEDANHPLWVERIAKLNPDYIFSFYYRNLLSEALLATAKNGAFNLHGSLLPKYRGRAPAN
WVLVNGETETGVTLHRMVKRADAGAILAQQKVTIDRSDTGLTLHAKLRDAATSLLRDALP
QLAQGKLTETAQDESQATCFGRRTAADGKLDWKKPAEQLFNLVRAVTQPYPGAFCAVGEH
KLIVWQAEVVKGNEGLTPGRVISVNPLRIACGEDSLVIKFGQRNATGLYLAGPSLADELG
LVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLRDDRYEVYGLDIGSDAIERLR
SHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKLV
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
GDKGLKFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFT
DIADGIEALARIIDNDNDNCNGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFA
GFRDVESKAFYGTGYQDVAHRKPSIDNAKRLLNWAPTVEMSETIGNTLDFFLREAMLEIA
DKK
>D0GPX4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFDILKVVILSLVEGLTEFIPVSSTGHMIIVEKFIKLSENKSFVNAFEIIIQLGAILAV
VVYFWHKLWPFSKNLSKAQSRGIILKWIKIIIAVLPAVVLGLLFDDIIDKYLFKVTVVAG
TLIFYGVVLIWIESGKRKGGEISKVKDIPISKVIGIGLFQCLAMVPGTSRSAVTIIGGVL
LGLNRVLATEFSFFLAIPTMMGATLLKVIKMGTKMTGYEWFLIGLGFVLSFVFAYGVIKV
FMDYIKKHDFKVFGYYRIILGIIVFALYFTGVIK
>A0A0T5XPV4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAAKEALP
VSTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTRVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0M2RTV4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTSPRIREIPLTGAGSGPYGITIGPDGACWLTLAGSGGVVRLDADGTVRTYRDDPAESRP
LIITTGPDGALWYTRSGDDHLGRITVDGATSSVALPAGTAPCGLAVGPDDALWYAGMGDD
TVGRVTVDGAVSTFPLPVAKGFPSMLAAGPDGALWLTLNQANAIARVAVDGQVTLHPLPT
GAAGPVGITLGGDGALWFVEIAAGQLGRITPDGSISEIPLPDRAARPHAIVADPAGGCWF
TEWGANRIGHVDASGRITAHDLPTPHSEPHGLTVAPDHSVWIALETGAAAHLTPDPAGVR
RRRE
>A0A0J8Q3R3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MVQQGSSILSTFFLPPRVHAPSMSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGAR
SDFFNIVIQAGAIVAVVLVFRQRLLQLATGFNQRENREYVFKLGAAFLVTAVVGLVVRKA
GWSLPETVSPVAWALIIGGVWMLLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTS
RSASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFLEMAKAGQLGSENWTDVGVA
FVAAAITGFVVVKWLMGYIKSHRFTAFAIYRIALGAALLLWLPSGS
>K1JNX4|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1168_01600|antibiotic inactivation|1
MKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPELI
DHYEELIKAVPQS
>A0A0K3EGB6|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKSFYGSVARLAAERGIPVYATD
DVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>BAC59742|FEATURES|ARDB_deepARG|multidrug|norM|antibiotic efflux|0
MHRYKEEASSLIKLATPVLIASVAQTGMGFVDTVMAGGVSATDMAAVSVASSIWLPSILF
GIGLLMALVPVVAQLNGSARREKIPFEIQQGVVLALLISIPIIGVLLQTQFILQLMDVEA
VMAGKTVGYIHAVIFAVPAFLLFQTLRSFTDGMSLTKPAMVIGFIGLLLNIPLNWIFVYG
KFGAPELGGVGCGVATTIVYWVMFALLLAYVMTSSRLKSINVFGEYHKPQWKAQVRLFKL
GFPVAAALFFEVTLFAVVALLVSPLGPIIVAAHQVAINFSSLVFMLPMSVGAAVSIRVGH
RLGEENVDGARVASRVGIMVGLALATITAIITVLSRELIAELYTNNPEVISLAMQLLLFA
AVYQCTDAVQVIAAGALRGYKDMRAIFNRTFIAYWILGLPTGYILGRTDWIVEPMGAQGF
WLGFIIGLTAAALMLGVRLRWMHRQEPDVQLNFSLQ
>YP_001882200|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPDQVTGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIG
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>A0A0M8Q5S8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVVVVMWKRMLSLVGLYNIDGQPKSVKGRFNLAHVIVGMLPATVIGFAFKDFIDDHLF
KVEHVIYALVAGAILMIAADKLAPRKPKVDSLDDISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGISHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYLSFYVVGFISSFVF
ALLSIKFFLALISKVKLMPFAIYRLVLAAILSIIIFM
>J9GTK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLILELIKGLILGIVEGLTEFAPVSSTGHMILIDDMWLKSSEFLGSESAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYKASSIDGVGQKPNRLNLLHIIVGMIPAGILGLLFDDVIQ
KYLFSVPTVMIGLFVGAIYMIIADIYSKKVANPQSVDQINYIQAFVIGLSQAVAMWPGFS
RSGSTISTGVLMKMDHKSASDFTFIMAVPVMLAASGLSLVKNFEYIHLDHFGFYALGFIA
AFVVGLIAIKTFLYLISKVKLIPFAIYRIVLVIIIAILYFGFGIGQGISGE
>A0A0N8SV40|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIAVHA
PEDPNHPLWVERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPAN
WVLVNGESETGVTLHQMVKRADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLP
LLAAQGQLPATPQDESRATYFGRRTPADGLIDWSLPATQLYNLIRAVTQPYPGAFCPVGD
NKLIVWAASVDTSSNGEEPGTVISHEPLRIACGEGSLVITAGQRGDNGLYLSGEQLAREF
GLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLQQDDRYEIYGMDIGSDAIERL
RAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKI
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
YGQKGLQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCF
TDVVDGIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPF
AGFREVESQSFYGKGYQDVSHRTPSIDNAKKLIGWTPGIELSETIGKTLDFFLREAMAEK
ADQC
>Q1GY95|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILLLLKAFILGIIEGATEFLPISSTGHLIIVGDLLDFNDDKGKVFEIVIQLGAILAVC
WEYRSRLISVATTLHTNTSQRFILNLFVAFLPAAIFGLLLHGFIKEHLFSSITVACALIV
GGFAILLVENLYAHDKAPAAKASNLNEITPWQALKVGCAQSLAIMPGVSRSGATILGGMI
FGLNRKTATEFSFFLAIPVMLAATFYDVYKNFSLFVFEDLAMFAVGFITAFLAALVAIKT
LIRYVANHDFKGFAYYRIVLGIIVLAYYW
>A0A0F7HEC5|FEATURES|UNIPROT_deepARG|beta_lactam|WN53_20975|antibiotic inactivation|1
MLKKSLSCVLLLATSCSVFAAPQTEKQIADIVNRTVAPLIKEQGIPGMAVAVIYQGQPYY
FTWGLADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLGDPASKYWPALSGKQ
WQGITLLHLATYAAGGLPLQIPDNVTDEASLQNYYQTWQPQWAPGTKRLYSNASIGLFGA
LMVKPSGMSFEQAMSKRVFQPLKLSQTWINVPQQEDKHYAWGYRDGKAVRVSPGMFDAEA
YGVKSSIEDMASWVQANMAPANVKDGSLQKGITLAQSRYWHAGDMYQGLGWEMLNWPVKE
KTVVEGSDNKNALAALSVTKITPPAPPSSASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKNYPNPVRVEAAYRILEALQK
>F5J3I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSIIEAIIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESNEFVKAFTVIIQFGAILSVIVL
YWKRFFRFREVPESENTGFLKYVFYKYEFYWKLLMGFIPAAILGFIFNDMIDELLESVLV
VSIMLVLGGILMLFVDKWFNRPEEGEQEITYKNAFIIGCYQCIAMIPGVSRSMATIVGGM
SRGLSRKNAAEFSFFLAVPTMAAATGYKLLKLIMSDTGFELLKDNMGVLVIGNVVAFIVA
LLAIKFFIGFVTKYGFKLFGWYRIIVGGILLALLLSGHELTII
>Q104Y9|FEATURES|UNIPROT_deepARG|beta_lactam|bla(ampc-EC11)|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWIRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A084GPY9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLWEIFVAVVLGIVEGLTEFAPVSSTGHMIIFDDLLFQSKELYGQQVANTFKIVIQLGS
ILAVVIIFRERFISLLGLKKETAKEKQTKLKLSQVFVGLLPAGIFGLLFEDYIDEHLFSI
NTVLIGLVVGAFLMIAADFVQKKRTVTTETVDKITYKQALMVGLIQCLSLWPGFSRSGST
ISGGVMLGMNHRTASDFTFIMAVPIMAGASGLSLLKNWEYFTLDALPFFIAGFISAFVVA
LISIKFFLALINKVKLVPFAIYRIVLAAVIYFVFL
>A0T1W6|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
TVTPLMKAQSIPGMAVAVIYQGQPHYFTFGKADVAANTPVTAQTLFELGSISKTFTGVLG
GDAIARGEISLGDPVTKYWPELTGKQWQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRF
YQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKA
EEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQGMAL
AQSRYWRTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVH
KTGSTGGFGSYV
>A0A0D0J8Z5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNAQRFTLNLLIAFLPAVILGVLFADAIHEYLFNPITVAVALV
VGGIVMLWAEQRSHVVSVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLLILATWVFGWVNWTAAAAA
>H1HVJ2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MRIIEILKVIVLGMVEGFTEWLPISSTGHLILINKLIQLDVSPEFMEMFRVVIQLGAILA
VVMLYFDRLNPLSRSKRGDQRRVALILWSKIIVACVPAAILGKLLDDWMDAHLYNGLVVS
IMLVIYGILFILIENRNQTSKPQITKMWQLNYQTALYIGMFQVLALIPGTSRSGVTILGA
VILGCSRAVGAEFSFFVGIPVMFGASLLKFAKFVKFGFRFSNAEILYLVLGMLVAFLVSV
YSIRFLMSWVKKNDFKVFGYYRIVLGVIVLIWYIMSTLMGRSMGAA
>A0A063XQM1|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFTLPLVEKVSVVIPVYNEQESLPELIRRTTASCNLLGIDYEILLVDDGSSDDSAQMLTA
AAEEPGSRVVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKANEG
YDVVGTVRQHRQDSLFRKMASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANTFARRAVEIPVQHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSVFG
SVIALAGFSLAVLLVVLRLAFGPQWAGEGVFMLFAILFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFIQRVVRQESDDSQEEKKQ
>A0A0J7AVW6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSITFYEKVLEGELLVKGRKLAYFHVCGVWIALNEEAHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRINYYKEDKPHMTFY
>W0DFE2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEVKHAIILGFVEGLTEFLPVSSTGHLILVAHLLGLDHSEFTKSFEISIQLGAILAVAVL
YFWTLLRDLETWKRIIVAFLPTGLLGFSLYRFIKGYLIGNDLVVVVSLVLGGVFLLFADR
FCERFCYLQSIRELPLKKAFVIGLFQSLAMVPGVSRSASTIIGGMLMGLNRKQSAEFSFL
LAVPTMLIATSYDLYKSHSQFTTQEFHLLALGFITSFLTALLSVKLFLKFISTHSFLPFG
VYRILVGLAYAYFFLL
>A0A0A0Q7Y9|FEATURES|UNIPROT_deepARG|beta_lactam|ACT-12|antibiotic inactivation|1
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMALAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>E0XCT4|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
STSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSD
NTANNKIIKEIGGIKKVKQRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLN
KLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKS
>YP_001588124|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNID
PALADKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIY
GHFGMPELGGIGCGVATAAVYWVMFIAMLSYIKHARSMRDIRNETGFGKPDSVVMKRLIQ
LGLPIALALFFEVTLFAVVALLVSPLGIVDVAGHQIALNFSSLMFVLPMSLAAAVTIRVG
YRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHIALLYNDNPEVVALAAQLMLL
AAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTDLVVDRMGPAG
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>A0A0N1M6A0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIVKGLPTERNAQRFTLNLLIAFLPAVILGVLFADAIHEYLFNPITVAVALV
VGGIVMLWAEQRSHVVSVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIGFGLLILATWVFGWVNWTAAAAV
>W7NNQ9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTTQPVSLPHSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYE
ILLVDDGSSDNSALMLTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDAD
LQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCM
LRAYRRHIVDAMLHCHERSTFIPILANTFARKATEIPVLHAEREHGESKYSFMRLINLMY
DLITCLTTTPLRLLSVFGSIIAVAGFALSVLLVVLRLVFGPQWAAEGVFMLFAVLFMFIG
AQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQEEIHP
>ABG21123|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSDEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFHNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGPSELCGNVFKIEYTKKRQRLAYIRLYSGVLHLRDSVRVSEKEKIKVTEMYTSING
ELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIENPHPLLQTTVEPSKPEQREM
LLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVEIELKEPTVIY
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>ABS72729|FEATURES|ARDB_deepARG|multidrug|Mdr|antibiotic efflux|1
MEQTAAKDASTKFVVIGLLLGILMSAMDNTIVATAMGNIVADLGSFDKFAWVTASYMVAV
MAGMPIYGKLSDMYGRKRFFLFGLILFLIGSALCGIAQTMDQLIIYRVIQGIGGGALMPI
AFTIIFDLFPPEKRGKMSGMFGAVFGLSSVLGPLLGALITDSISWHWVFYINVPIGILSL
FFILRYYKESLEHKKQKIDWAGAITLVVSIVGLMFALELGGKTYDWNSVQIIGLFAVFAV
FFIAFFIVERKAEEPIISFWMFKNRLFATAQILAFLYGATFVILAVFIPIFVQAVYGSTA
TSAGFILTPMMIGSVIGSMIGGIFQTKVRFRTLMLISVVAFFIGMLLLSNMTPDTARTML
TVFMLISGFGVGFNFSLLPAASMNDLEPRYRGSANSTNSFLRSFGMTLGVTIFGTIQTNV
FTNKLTDSFSGMKGAGGAMQNIGNPQEIFQAGTRAHIPPHILDRIIDAMSQSITYVFTLA
LAPIVIAAVTILFMGKARVKTSQEMVKKAN
>A0A0F4BRX0|FEATURES|UNIPROT_deepARG|chloramphenicol|SG71_02085|antibiotic inactivation|1
MKNAVPEYTPVDLSRWARKEHFEVFQSFAECTINQTVLIDITALRKHIKEVGWKFYPTII
FLLSEIMNRHSEFRMAMKDNELVIWNEIHPSYTIFHPETETFSSLWSHYDGNIHHFQKTY
AEDTARYGNNLSYWPKGESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARMFNELQAMCDGLSELSDEPGA
>A0A0E3WH39|FEATURES|UNIPROT_deepARG|bacitracin|uppP3|antibiotic target alteration|0
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGFDEQSPIMKTYEIVIQLGAILAIAL
VYRQRILNLLGIGRSRTGRGGVVPASRLNLIHVILGIVPALAVAFFARDFIKGLFGASTV
LWALVAGGVLMIVAEWVNRRKIRITAHELDDLSYGQALAIGLYQIISVLWPGFSRSGSTI
SGGMLSGVSYKASADFSFLIAIPIMCAASGYELLDSYQYFTKDTIMDFAIGFVISFIVAY
LVVVAFMKLIQKIRPTHFAIYRFILAAVFWLFIMR
>S7XSJ7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILSGQLLDFWTVEKRDMFAVAVQIGAIAAV
IYEYWGKLWGALIGAMKGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIA
LIVGGFIILWAERRKHLVVSSEVDDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLG
ISRKAAAEFSFFLGIPVLMGAGLLDMYKMRNDLHSNDLAVLAVGIVVAFISALIVIRALI
RYVSKHDFTAFAYYRIGFGVFILATWWTGWVHW
>W1WXP4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPEDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHSHAPAAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPQIDMQETIDETLDFFLRTVDLTDKPS
>A0A0G3YQQ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
WEYRQRIASIVSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERSEPPRVVSVDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWQAFTVDSLGLFALGLVAAFVSAFVCVRW
LLRYVATHDFTVFAWYRIAFGLFVLLVGYSGWLNWA
>A0A0J8V1Y4|FEATURES|UNIPROT_deepARG|beta_lactam|APD06_15965|antibiotic inactivation|1
MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPINQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKFVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>A0A147GTT9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIVLLAKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDGKAKVFDIAIQTGAIFAVI
LVYWQKIKSTVVALPRQRKAQRFALNVFIGFLPAVVLGLLFGKAIKAHLFIPTVVASTFI
IGGFIILWAEKRPPGAVRVEHVDDMTPLDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGL
SRKAATDFSFFLAIPTLIGAGVYSLYKERALLSVADIPMFAVGLVFSFISAWLCVRWLLR
YISTHSFIPFAWYRIVFGLIVLGTAWSGLVVWAD
>W1S2J1|FEATURES|UNIPROT_deepARG|aminoglycoside|C100_12680|antibiotic inactivation|1
MTTGAFCVFRAGASHVERWALMRAALWPDTALADHRDEILGLLGQPDGKSAAFLVSDDQD
EAVGFAEATLRHDHVNGCETTPVAFLEGIFVEPITRRTGAARALTEAVLAWGRNHGCKEL
ASDADIFNYASHDFHAALGFTETERVVYFRRPID
>N8S9W0|FEATURES|UNIPROT_deepARG|beta_lactam|F985_01857|antibiotic inactivation|1
MRFNKISCLLLFPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFEDKPSKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVSLSMNQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQHYAFGYNQQNQPIRVNPGP
LDGPAYGVKSTLPDMLGFVHANLNPQQYPADIQRAINETHQGFYQVDTMYQALGWEEFSY
PATLQTLLDSNSDQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0M0ACI3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEVVIQLGAILA
VVVLYWKKIKDSVIEFFAYIFTGGKKGEVGFRFGINVLIGSIPAGVIGILFYSKIKTLFK
PQAVVVGFIVGGILLLVIENIFRKKRHSVKSIDRITPMQSIKVGLFQVLSMWPGMSRSAS
TIMGGWIAGLSTPIAAEFSFFLAIPAMVGSSAKDLFEFDFALMNLTTWVALIVGFIVAFI
VSLVVMEGFVAYLKKKPMRVFAIYRIIAGIIFAILMYMGIVTPHL
>A0A0A6FJX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIFEIIKGLPTERNAQRFTLNLLIAFLPAVVLGVLFADAIHEYLFNPITVAVALV
VGGIIMLWAEQRSHVISVEHVDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRVAFGLLILATWLFGWVNWTAAAAA
>G8NB65|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSAWEALLLGFVEGLTEFLPVSSTGHLTLLFHLLGLPVESDDFLKTFLIAIQLGAILAVL
LLYGRRFAVDRALWLRLGVAFLPTAAMGFLLYPFIKGVVLGQDGIVVFFLFFVGLALLFA
DRLAERARYGDVLELPLARVAWIGFFQGLAALFPGTSRSGATILGGLLLGLKRRAAAEFS
FLLALPTMLAAVGYDLLKSAPSIPPGGWSLLLLGFASALLTALLTVRGMLFLVERLGFRP
FAYYRMALALAYAYFFLR
>A0A0D8WGI6|FEATURES|UNIPROT_deepARG|beta_lactam|UC41_03510|antibiotic inactivation|1
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPAPKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>YP_002040143|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RQARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0S4I2Z3|FEATURES|UNIPROT_deepARG|polymyxin|arnC_3|antibiotic target alteration|0
MKPYPIRCVSVVIPVYNEQDSLPELLRRTEAACAQLHHEYEIVLVDDGSRDNSAQILEEA
ASREGSPVVAVILNRNYGQHAAIMAGFEHCKGDVVITLDADLQNPPEEIPRLVAQAELGY
DVVATVRNNRQDSALRRWPSKLINMAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERS
TFIPILANSFARHTTEILVMHAEREHGESKYSPMRLVNLMFDLITCMTTTPLRLLSIVGF
AMAGLGVLFAMTLIFLRLVFGAEWAGDGSFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFVEKVLRSQPAAPAPVVTVDGLTSTSDQVLS
>YP_185622|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
VFAAAWVFRERFLEILHIGKHKHVEGDNDQQRRSKPRRLNLLHVLVGMVPAGILGLLFDD
FIEEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKNPQTVDQISYFQAFVIGISQAVAMWP
GFSRSGSTISTGVLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILG
FLAAFTVGLIAIKTFLHQINKIKLIPFAIYRIVLVIFIAILYFGFGIGKGI
>A0A089W1X3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGEEQVEVLKGVSLTIEAGEMVAIVGASGSGKSTLMNILGCLDKP
SGGSYKVAGVDVSGLDNDALATLRREHFGFIFQRYHLLSHLNASQNVEVPAVYAGTTRAQ
RQQRAHELLGRLGLKERVEYLPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMATLKQLCERGHTVIIVTHDPAVAAQAQRIIEIRDGEIISNPPPVHQPAARKIENQA
LRSGSSIQQLISSFREALGMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LEDIRSIGTNTIDVYPGKDFGDDNPQFQQALKYDDLLAIGQQPWVSSATPSISSNLRLRY
GNVDAAASVNGVSGDYFDVYGMTMSQGASFNDEQMKGRAQVVVLDANSKRQLFPNKSDVV
GEVVLVGNMPATVIGVAEEKQSMFGSSKVLRVWLPYNTMAGRVMGQSWLNSITVRVKEGY
DSHEAEQQLNRLLSLRHGKKDFFTYNMDGLLKTAEKTTRTLQMFLTLVAVISLLVGGIGV
MNIMLVSVTERTKEIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLVIAFTLQL
VLPGWQIGFSPVALLTAFGCSTATGVLFGWLPARNAARLNPIDALARE
>A0A0F5FVV3|FEATURES|UNIPROT_deepARG|aminoglycoside|VE25_06015|antibiotic inactivation|1
MSGIHVSPACAADDADWLAMRNALWPRSRDDEHRADIEAYDETARSPICLIARDEAGVAL
GFAEAALRHDYVNGCKTSPVAFLEGIYVRPQARGRGVARKLVVEVEAWALGLGCTEFASD
AALDNVESHAMHKALGFTETQRVVYFRKLLSS
>A0A0Q3M9A2|FEATURES|UNIPROT_deepARG|aminoglycoside|ARD30_01020|antibiotic inactivation|1
MTISIERAERRHLVAWAELRAALWPDQGADAHRDELAEDLLSADVRSFACLAVTAAGEAV
GFAEAALRSDYVNGCETSPVVFLEGIFVRADHRRGGVARHLCRAVEDWGRSLGCSEFASD
AVIDNHASLAFHRALGFVETERVVFFRKAVAADETKAG
>A0A0Q4N7X4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MAESHSLLVAVIMGVVEGLTEFLPVSSTGHMIIVGNLLGFTGDKAKSFEVIIQLGSILAV
VVMFWRRLFGMIGLHFGKPPVHEGTGTRRLNLLHILLGMIPATVLGLLLHSQIKSLFEPK
NVMYALVVGGFLLIAAELFKPKKPRAEGLDDMTYAQAFLIGVFQCLALWPGFSRSGATIG
GGMLLGVSRFAASEFSFLLAVPMMLGATVLDVYKSYGFLSMADLPMFATGFVTAFIVALF
AIKTFLAVIKRISFIPFAIYRFFVALAVYFVFIA
>A0A0N0Z967|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MAGLLELKGITRCYPAGDSTITVLKDISLSINAGEMIAIIGQSGSGKSTLMNILGCLDKP
TIGEYWVNGQNTAALDSDQLAALRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGTAKDQ
RRQRAISLLNKLGLESRIAYRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSQSG
EEVMKILKDLCAQGYTVIIVTHDPKIAAQTQRIIEIKDGEIINDPGHAPTDHHVILPTPI
QNKTTISQIFGRFNEALLMAWRAMVVNKMRSLLTMLGIIIGIASVVSIMVIGDAAKGMVL
NDIKAIGTNTISVFPGEDFGSDDPENKQALKPADVLALEQQPYVQAVSGVTEGAARLRHG
NLDASGRIQGISRNFFAVYAEKFSEGMNFTPDMMKRQAQVVIIDANVKRRFFAHQKNVVG
ETLLIGNMPATIIGVLAEKKSIFGAANSLEVWLPDTTFRSRITNRPYIDNIVVRVKDGYD
VKSAEQQLIRILTLRHGKKDIFTYNIDTFIKTAEKTTRTMQLFLTLVAVISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARASDVMQQFLIEAVLVCLIGGVLGIGLSYGIALLAQLA
LPSWQLTFDPMALITAFICSTAIGIIFGFLPARNAAKLNPIDALARE
>J1YWG2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAVVFAYHDMGCVGTQALLDAGFEIAAIFTHPDNANENHFFGSVARIAAERGIPVYAPE
DVNHPLWVDRIRDLNADVIFSFYYRNLLCGNILNTARFGAFNLHGSLLPAYRGRAPLNWV
LVNGETETGVTLHRMVARADAGAIIAQQRVAIEENDEALSLHRKLSEAAKAMLSSVLPDI
KAQRFSETAQDESKASYVGRRTPEDGRLDWEKPAQTLQNLVRAVSDPWPGAYSFAGTHKF
IVWKSRVRTDLSPARAGTVLSVAPLVVACGEGALEILTGQADNGVYMQGAQLAQSLGLVA
GALLTSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDNYEIYGLDIGSDAISRFLGSP
RFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIIRDC
VKYNKRIIFPSTSEVYGMCTDKNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
HGLKFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDI
SDGIEALFRIIENKDGRCDGEIINIGNPDNEASIKELAEMLLASFEKHPLRDRFPPFAGF
REVESSSYYGKGYQDVEHRKPSIRNAKRCLHWEPTVDMRQTIDETLDFFLRTVELTDEK
>C2NHL6|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0004_21800|antibiotic inactivation|1
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHEKGIKFYPTFIYIISRI
INKHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMR
CYASVHGLFTKENIPPNVFPISSIPWTSFTGFNLNLNNDADFLLPIITCGKYFNEENKIM
LPVSLQVHHSICDGYHASRFIEDLQELSNSCNEWLK
>A0A0M8UJR9|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTTRAPAYLIGSHTVPTAGAGPYALAAGPDGAVWCTLVHAGRIARLAPDGRIDEFPLDSP
DCGPSLITAGPDGALWFTRNRDHRIGRITTDGRTRSYALPGAEPGPYGIAAGPDGALWYT
ALNTHSIGRLTPDGEVTEYPLPGTGTFPSFLVTAPDGALWCTLNQAHAVARITVTGDVRL
FPLPTDGAAPVGLAAGPDGSLWFAEIGAGRIGRLDPSGPDGAVTEYPLPDAQCRPHAVAV
APDGACWFTAWATGRIGRVTKDGRVTEVALADPGCEPHGLAFAADGTLYVAQESGDITRW
DVTAATEG
>A0A0G3B301|FEATURES|UNIPROT_deepARG|aminoglycoside|Ant2Ia|antibiotic inactivation|1
MTIXISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEP
AMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDER
NVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRAD
HLEEFIRFVKGEIIKSVGK
>A0A0Q0AR98|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKIIDVVTGLPKQRQAQRFTVNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALV
VGGVIMLWAERRQHTVRTETVDDMTWSDALKVGMVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDVAVFAIGFITSFIFAMIAVRALLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0T9UL33|FEATURES|UNIPROT_deepARG|polymyxin|pmrF_2|antibiotic target alteration|0
MSESEKIKKVSIVIPVYNEQESLPALIERTSAACKLLTQPYEIILVDDGSSDNSAELLTA
AANEPESHIIAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVSVAEEG
YDVVGTVRANRQDSLFRKTASRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHER
STFIPILANTFARRTTEITVHHAEREFGDSKYSLMKLINLMYDLITCLTTTPLRLLSLVG
SVIALSGFTLAVLLVALRLVFGPEWAGGGVFTLFAVLFMFIGAQFVGMGLLGEYIGRIYN
DVRARPRYFIQKVVSAEQTENNQEVEK
>R6UKJ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDISAIIEYLKAALFGVVEGITEWLPISSTGHMILLNEFIPLKVSAEFWNMFEVVIQLGA
ILAVVVIFWKQIWPFTLNNGSGSTGIKKLVKTDILSLWGKILVACIPAAIVGLLLNDFLE
TYLYNYVVVAIALIVFGVAFIVVENWNKSRTPKVTGLNDLTYKLVIIIGLFQLLAAVFPG
VSRSGATIVGALLIGVSRTVAAEFTFFLAIPVMAGASLLKLVKFGFNFTAQELIILVIGF
VVAFLVSIVVIKFLLKYIKRHDFKVFGWYRIVLGVAVLLYFALAVH
>ZP_03838614|FEATURES|ARDB_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLIFHDTIKSLFNPIN
VMYALVVGGVLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWSFLTASDIPMFAVGFVTAFVVALVA
IKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>P18251|FEATURES|UNIPROT_deepARG|beta_lactam|SHV-14|antibiotic inactivation|1
MRYFRLCIISLLATLPLRVHAGPQPLEQIKLSESQLSGSVGMIEMDLARPGTLTAWRADE
RFPMMSTFKVVLCGAGLARVDAGDEQLERKIHYRRQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLPAVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTAR
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGRLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIAGALIEHWQR
>T2D1I8|FEATURES|UNIPROT_deepARG|beta_lactam|ADC-2|antibiotic inactivation|1
PLLDKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKSVSSSTIFELGSVSKLFTATAGGYA
KNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKE
WKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQ
NYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANINPQKYPKDTQRAINETHQ
GFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTN
GFGSYVVFIPKENIG
>NP_745006|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MMDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAV
VWEFRSKIFEVVFGLTNQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAAL
VVGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGL
SRKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFALGFVTSFIFAMIAVRALLK
FIANHSYAAFAWYRIVFGLFILATWQFGWVDWSTAHG
>ZP_02655873|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|MacB|antibiotic efflux|1
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
TSGTYRVAGRDVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKK
RHARARELLLRLGLSDRVDYPPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILRQLRDRGHTVIIVTHDPLIAAQAERIIEIHDGKIVHNPPAQEKKREQGVDAAV
VNTAPGWRQFASSFREALSMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQMV
LADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQKQPWVNSATPSVSKSLRLRY
GNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRRQLFPNKANVV
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
DSDQAEQQLTRLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQL
FLPGWEIGFSLTALASAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A9VRT9|FEATURES|ARDB_deepARG|fosfomycin|FosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRKEI
HQSYTHLAFSVEQKDFERLLHRLEENNVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYRDEKPHMTFY
>F0JR85|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDAIKSLFNPI
NVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATIS
GGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTTGDIPMFAVGFITAFVVALI
AIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>A0A0J7ESY0|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLRGINHICFSVSNLENSIMFYEKVLGGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
HQSYTHIAFSVEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRINYYREDKPHMTFY
>A0A128EF41|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFLHAIILGVVEGLTEFLPVSSTGHMILTSELLGLEQTNTLKCFEVVIQLGSILAVVFM
FFDKLRQDINLWIKLAVGFVPTAAIGFLLYKHIKALFNPSTVAYMLIIGGIVFIAIELLR
RKKPVQNEVATLDDISFKQAFIVGFSQCFAMIPGTSRSGATIIAGLLCGLSRKVAAEFSF
LLAIPTMFAATFYDAYKNIDIFKENLNHAFIFLLGGAVAFVVALLAVKLFIKFVSKFDYI
PFGIYRIAVGLLFLICIL
>A0A0U1YUC2|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
GEARMSKMLHAFDYGNEDISGNLDTFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRI
VKQAMLTEANADYIIRAKTGYSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLR
QAITKEVL
>A0A124EE99|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEAKKAEATAFSLDDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KAASEFSFLIAIPVMAGATGLDLLKSWKYLSVDDIPMFAVGFITSFLVAMLAVVTFLKLL
EQIGLKPFAYYRILLAIVFTLFVLL
>A0A0F5K2S9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDVILVLKAIVMGVVEGLTEFLPISSTGHLILVGNLLNFDDARAKLFDVVIQFGAILAVC
WEFRKKIGTTVGGLTRRDDVHSRRFAWNVVIACLPAVVLGLLFGGLIKEYLFSPVPVALA
AVIGGFVILWVERRARRNGPLAMTAENGIRVDHIVATPGGSAHEAAHHGSARVHSLEALR
WTDALKVGFAQCLALIPGTSRSGATIIGGMLFGLERKVATEFSFFLAIPIIFGASAHDLY
KARHSLQADDLGLLLIGLIAALVSALVCVRWLLRFISNHDFTVFAYYRIVFGLVILVAAY
GFGEWQIA
>CAJ77891|FEATURES|ARDB_deepARG|trimethoprim|dfrA5|antibiotic target replacement|1
MAAKAKNGVIGCGPHIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGALPNRKYAVVTRS
AWTADNDNVIVFPSIEEAMYGLAELTDHVIVSGGGEIYRETLPMASTLHISTIDIEPEGD
VFFPNIPNTFEVVFEQHFSSNINYCYQIWQKG
>YP_002385941|FEATURES|ARDB_deepARG|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGS
QYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSTEEFGKILLKVNQDGSRVLLRDVAKIELGVENYDIIAEFNGQPASGLGIKLATGANAL
DTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGR
YLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLT
KEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKD
AMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNG
LEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYR
MLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEA
MELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFS
VMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGL
IEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIF
FVPVFFVVVRRRFSRKNEDIEHSHTVDHH
>D4F3Y0|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSDSKPIKFVSVVIPVYNEQESLPELLRRTLAACDAMGKPYEVVLVDDGSSDDSAAMLCE
AAERPGSPVVAVLLNRNYGQHSAIMAGFSHVKGDLVITLDADLQNPPEEIPRLVETAEQG
GYDVVGTIRQNRQDSWFRKRASRMINSLIQHTTGKSMSDYGCMLRAYRSNIIKAMLHCHE
RSTFIPILANSFARRTIEIPVKHAEREHGESKYGLMKLINLMYDLVTCLTTTPLRALSIF
GSVIALLGFAFAVLLILMRLTLGPQWGAEGVFTLFAILFIFIGAQFVGMGLLGEYIGRIY
NDVRARPRYFIQKVVQTTSSNEEQEK
>CAR56417|FEATURES|ARDB_deepARG|multidrug|CeoA|antibiotic efflux|1
MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDW
QSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLA
AAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREANANLKAAEAALETARINLGY
TRITAPVSGRVSRAEITLGNVVSAGASAAPLTTLVSVSPIYASFDADEQTYLQYINGARS
GRKVPVELGLANETGYSRSGEIDSVDNRLDTSSGTIRVRARFDNADGTLVPGLYARVKVG
GSAPHEALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQQGMQHGNRRVIVSGLSAGDRV
VVNGTQRVRPGEQVKPHMVPMTGGDAPSAPLASTAKPAAPAKADS
>A6YRS6|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_cmy2|antibiotic inactivation|1
TASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNH
PVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATY
TAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEE
AMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMAR
WVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVA
LAALPAVEVNPPAPAVKASWVHKTGSTGGLGSYVAFVP
>ZP_04209720|FEATURES|ARDB_deepARG|beta_lactam|BcI|antibiotic inactivation|1
MNLLLVFSIENLKGMMILKNKRMLKIGICVGILGLSVTSLEAFTRGSLQVEAKEKTGQVK
HKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQN
SIDTLNEVIKFTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPK
GYEKALRQIGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKI
LTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKD
EKEATYDNQLIAEATEVLVKALR
>R5PBR5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNTLETIIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESTPFVKAFTVIIQFGAILSVICL
YWKKFFYPTAERSGVSYWRAMYDFYARLVVGVLPAVVLGLAFNDFIESNLGNVTLVAVML
IIGGVFMLFCDRIFNKGSEDTRLTYRRAFTVGLIQCISMIPGVSRSMATIVGGMSQRLTR
KAAAEFSFFLAVPTMLGATCLETYKLISHGGGSLLTQGNNLETLLLGSAVAFVVAILAIK
FFINYVTKYGFAAFGWYRIIVGIVIIACALCGIELKMVD
>A0A150B9E0|FEATURES|UNIPROT_deepARG|beta_lactam|AT267_09870|antibiotic inactivation|1
MRWYIRFKYYKSTCFYRRGGQVEAKEKTVPVKHNNHGTYKEFSQLEKKFDARLGVYAIDT
GTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKEDLVDYSPITEKHID
TGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMSDRVTMSDRFETELNEAIP
GDIRDTSTAKAIATNLKAFTVGNALSDHKRNILTEWMKGNATGDKLIRAGVPTDWEVGDK
SGAGSYGTRNDIAIVWPPNRAPIIVAILSNKDEKEAIYDNQLIAEAAEVIVKALR
>AAF71279|FEATURES|ARDB_deepARG|glycopeptide|vanYG1|antibiotic target alteration|1
MNHMNMKHRRRKRRRNQSFLFTGILLLVVVSASANLWYGFGNAAKKDSVIEEMPFTITQD
GMQAKEEIKKTVLETSYGGKQQVAEENHGNTQNAGTDEAWNLMLVNRDNAIPDNYKVNLA
SKGGERVNHRIYEPLMEMLNAAREENWGELPMVVSGYRTQEKQQSLYDEKIAKFKKEGYS
DSEAVRQAEQWVAVPGHSEHQLGFAVDINGATYDVYLWLQENSYKYTALSSDTRQKTDIT
GTAEEVWHYRYVGVEAATEMYENGLCLEEYLEKKQSEN
>A0A0P9Z8B5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELNGVTRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
PNSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKG
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPVINEKTTE
RLPTKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIQAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSEYYIDSATPNIGRN
LLVRYRNIDVSATVSGVSPSYFQVRGTKMGLGVGFNKDDARRQAQVVVIDHNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
VKDGQPSKVVEDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFVIG
YVFSLLVKEWQMVFSLSSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A0A060KZY0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFATCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>U5N8G8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MDLVVLFQAVVLGVVEGLTEFLPISSTGHLILVGALLGFDDAKAKVFDIAIQTGAIAAVV
MVYWPKISHVTTTFYRDRHARRFVGNVLVAFAPAVVFGLLLGKTIQTYLFTPAVVATTFI
LGGFVILWAERLHDRHPALVDVHDIDDMHWRDALKVGLVQCLALIPGTSRSGATIIGGML
LGLSRKAATEFSFFLAIPTLIGAGVYSLYKERALLSVADFPLFLVGMGVSFLSAWLCIRW
LLRYVSSHSFVGFAWYRIAFGVVVILTAWTGVVDWTTP
>A0A0Q5W995|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MPEHSIFSALLLGLIEGLTEFIPVSSTAHILLVGHFLGFESKGKTFEIIIQLGAILAILT
VYFQRLWSILVALPSDPRARRFVLLILLAFLPAAIIGFLAHDFIKNVLFETPKLICIMLI
VGGIILYAIDRMPMKPRYHDMMDFTPALALKIGLFQCLAMIPGTSRSGATIAGSLLMGTD
KRSAAEFSFFLAIPTMLGATVLDLYKNRDVLDFNDASLIAVGFIAAFVSALVVVRSLLAF
VSSRGFAPFAIWRIIVGTVGLIGLTVYG
>A0A127SEL6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-12|antibiotic inactivation|1
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGRQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKQ
CKQFASIKAKEEVLAALPAQLKKQ
>A0A088WZ63|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALALGIVEGLTEFLPVSSTGHLIVAGSFLRFHAEQAKTFDVVIQFGAILAVC
WEYRRRIVDVVTGLPAQREARRFVMNVVIATLPAISLALLFEKTIKSVLFAPVPVAVALV
VGGVVILWVEGRQRERGAPARVQSIDALTPLDALKVGLAQCFALIPGMSRSGSTIIGGIL
FGLDRRVATEFSFFLAIPVIFGATLYETAKDWRTFDADSIGLFSIGLVAAFVSAFACVRW
LLRYVASHDFTAFAWYRIAFGLFVLLVGYSGWIEWT
>F7JPC5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLEALKIIFLGIVEGITEWLPISSTGHLILVEEFVHLELSDAFVEMFNVVIQFGAILAVI
LLYFHKLNPFSPKKTEKQKLMTIQLWVKVVIATIPAMVFGLLFDDYVDEHFMNAYVVAAM
LIIYGILFIVVEKKHEGVPPKAAKLSQLTIPMILAIGGFQVLAMIPGTSRSGATILGGLL
IGASRSVAAEFTFFLAIPVMFGWSFLKMLKFGFAFTGQEFFMLLLGCAVSFGVSVFAIKF
LMKYIKNHDFKVFGYYRIVLGVIVLLYFGVTALMA
>H8GYX8|FEATURES|UNIPROT_deepARG|bacitracin|upk|antibiotic target alteration|0
MDWFYAIVYGIVEGITEFLPISSTGHLILAGNLMGVPWPKEVKDTFEVVIQGGAILAVLA
YYWRDFLKIRHIGSDRGQQRLWLGVVVACIPAVVLGLLFGDVIKANLFRPSVVAWALIVG
GVIMWLVESRRATPKVHDIETIGVGRSLLIGAVQCLALLWPGFSRSASSILGGMVLGLDR
PTATKFSFYLGVPTLGGAALLDFIKSREILGQIGIVNVVLGAAVSFVVAYLAIGWLLRFV
STNNFKGFAVYRVVVGALILLLIATGVMTNGSLA
>BAH62099|FEATURES|ARDB_deepARG|multidrug|AcrA|antibiotic efflux|1
MNKNRGLTPLAVVLMLSGSLALTGCDDKPAQQGAQHMPEVGIVTLKSAPLQITTELPGRT
SAYRIAEVRPQVSGIILKRNFVEGSDIQAGVSLYQIDPATYQASYDSAKGDLAKAQAAAN
MDQLTVKRYQKLLGTKYISQQDYDTAVATAQQSNAAVVAAKAAVETARINLAYTKVTSPI
SGRIGKSAVTEGALVQNGQTTALATVQQLDPIYVDVTQSSNDFLRLKQELADGRLKQENG
KAKVELVTNDGLKYPQSGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEG
INPDALLVPQQGVTRTPRGDASVMVVGEGDKVEVRQVTASQAIGDKWLVTDGLKSGDRVI
VTGLQKIKPGVQVKAQEVASDDKQQAAGNAPSEQTKS
>A0A0C2UIN6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWFDSIILGIVEGLTEFLPVSSTGHMILTNKLLGYGDNIPEQLKTFEIVIQFAAILAIA
IVYRDKIFQVLGFGRKETVKGLSVDALPTRRLNLIHVLLGIVPPLVAAFLFRDYIKGGGF
NYVPVLWALVVGGIYMWISEVLYDSGKIKRTAETMDDITYKQALIIGFIQCVSALWPGFS
RSGSTIAGGMLTGLSYRASADFSFFIAIPIMTAATGYELLTNIDQFRSGAIDVGFLVTGF
IVSFVVAWIVVVAFLKVLQKVKLKYFAWYRFALAAIFYLFILR
>A0A0Q3TKD2|FEATURES|UNIPROT_deepARG|chloramphenicol|AN964_13675|antibiotic inactivation|1
MKFHPIDRENWDRKIYFEHYLHQKCNYSISTNIDITMLLEQLRNKGLKLYPAFIYMVSKT
VNSYKEFRTCFNEDGVLGYWDQMVPSYTIFHQDNKTFSSIWTDFNDEFPTFYNNYQIDLE
CYGDLKGLDTKENISENTFHISSIPWISFTGFNLNVHHDNDYLLPIITGGKYFYQKDKIW
LPVSLQLHHAVCDGYHAGLFFMELQQLSYQSKEWLS
>A0A136DDZ0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLRKENKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVA
GAILMIFAEVKKQEATACSLDDLTYHQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMVGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAVLFTLFVLL
>K9L6R0|FEATURES|UNIPROT_deepARG|beta_lactam|blaCMY-6|antibiotic inactivation|1
MSTRCKSNTLIASDGPGHLFAFNYGTDFMMKKSLCCALLLTASFSTFAAAKTEQQIADIV
NRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGV
LGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALL
HFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVP
QNEQKDYALGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGI
ALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASW
VHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>F0S1U4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNILDAIILGIVEGITEFLPISSTGHMILVSYLLGLKQNSFEKTFEIAIQLGAILAVVSI
YREKLTRNIELWKKLIAAFIPTGIIGLALHHYVEELFNPFVVSIALIFWGAVFIVIELLY
KEKEHHISEPEKISYLKAVMLGVFQSLAMIPGTSRSGATIIGGLLLGMKRVAATEFSFLL
AIPTMFAATGFEIVKNFKDFTPEGGIALIVGFVTAFVFAYISVKWLLNFIKTHTFIPFGI
YRIVVGFLFLKLFLL
>A0A0E9B678|FEATURES|UNIPROT_deepARG|beta_lactam|BN1182_AZ_01360|antibiotic inactivation|1
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPAGWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAVARKDVLAGAAKIVASGYNK
>A0A0B5S7H4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGIAVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
SIISDQTGDIWFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHGITFCPDGDLWFAEECNQIGRLTIIT
>A0A0D0P6P8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIVVADLLDFGGERSMAFNIIIQLGAILAVV
WEFRQKIFDVVLGLPTQPSARRFTANLLIAFLPAVVLGVLLADWIHHYLFNPITVAAALV
VGGLVMLWAEKRQHRVHAETVDDITWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKALLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWSAAQP
>F3WK55|FEATURES|UNIPROT_deepARG|polymyxin|SB521682_2635|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVYPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQMLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTECLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSE
>A0A0R0ANN2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPVSSTGHLLIAEHWLGRRSDFFNIVIQAGAILATTLVLRK
RLWFMATHLHERDNRDYVAKLAVAFLVTALVGLPVRLAGWELPETIVPVAWALVIGGVWM
IVAESWASRLPPRDEVTWKVAIAVGLAQVVAGVFPGTSRSASAIFIAMLLGLSRRSAAAE
FVFLVGIPTMFAASAYAFLELVRHGGIGNENWLDVGVAFAAAVVTGFAVVKWLLGYIKTH
RFTAFAVYRIVLGVALLLWLPAA
>J7IUA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLLIEILKAVILGIVEGVTEWLPISSTGHMILVDQFIQLNMSEAFKEMFFVVIQLGAILS
VVVLYWKKLIPVSFTKKASIKYDTIILWLKILTACLPAAIIGLLFDDQIDAQFYNYQTVA
VTLILYGILFVVIENRNSNFRPRINNLSQITYKTAMIIGVFQVLALIPGTSRSGATILGA
ILIGTSRTVAAEFTFFLAIPIMFGASLLKILKFGLVFTNAELVILLTGMVVAYMVSILSI
KFLVGYIKKNDFKAFGWYRIILGIIVLLYFLIVS
>A0A0B2XLA0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDYGGISIVLTLNMIKTIILGIVEGFTEWLPISSTGHLVLVGSVLKLDESKAFIDMFNYV
IQFGAIMAVVILYFHKLNPFSPRKNQLEQKQTWTLWFKVIVAVIPSVIIGFPLNDWMDEH
LMKNWIVASMLILYGVLFIVIENRNKHTTPKFADLNTLPWLTAFWIGCFQALSIIPGTSR
SGATILGAIILGTSRFVGAEFSFFMAIPTMVGVAILKIGKFLYQGNTFTGDQSIILLVGM
LVSFIVSIISIKFLMDYIKKHDFKVFGWYRIILGLLVLGAMLFA
>A0A0K3Q3D4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>R7MXX2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDYIIAVILGIVEGMTEYLPVSSTGHMILVGDMLGFTGPRASVFEVFIQLGAILSVIII
YKEKFIRMLHQYRCWDLFRRENWFRTDTGLTLAHIAAGIVPVMGIGYLAHHAIKTYLFSA
GTVIIGLIIGGIFMLVAEKSHTKTVCNDVEKMTIAQAFLTGMFQVLALWPGFSRSGSTIA
GGLFLGLSRKAAADFSFIIAVPVMIVACFYDLLKSLSDLSGNDLVMIIIGFITAFIVAYI
SVLWFLKFMNKSTLASFAYYRFVVAVISFVYFFIL
>U2LZR0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFVAFVLGIVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGGKPVPHEGQTAGQLKLGHILLAMIPAVALGLLLHDMIKSLFEP
KNVMYALVVGGLLLLAAEWLKPKKPSAVGLDDITYRQAFLIGCFQCLALWPGFSRSGSTI
SGGMLVGVSRFAASEFSFILAVPMMIGASGLDLYKSLHFLTLSDLPMFAVGFATAFVVAL
IAIKTFLQLIKRISFVPFAIYRFIVAAAVYMVFIH
>A0A0D9A423|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MHTSSLSKTLACSAFGLLLATTHCIAAAPSDQQIEATVKAAVTPVMQQQNIAGMAVAVTY
KGQAHYFNFGAASRETGKAVTENTLFEIGSISKTFTATLAAYAQASGKLSLSTKASQILP
ALQGSAFDNISVLQLGTYTAGGLPLQFPENADSPDKMIGYFQQWKPTYDAGSHRLYSNPS
LGLFGYLAAQSMGAPFDQLMEQTLLPKLGLSHTWLKVPQAEMALYAQGYNKEDKPVRVGP
GALDSEAYGVKTSAVDMLRYVEANMRPTKLEAPMQQAIATTHTGYYTVANMTQGLGWELY
SYPITLDQLLAGNSTEMAMQAHEVKWLNPPQPQPQNVLINKTGSTGGFGAYAAFVPSKEI
GIVILANKNFPIPDRVKIAHSVLSVLAH
>A0A125WFP0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFMIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVF
EYRQRFAGVLHGLGKDKKANRFVLNLAVAFMPAAVMGLLFGKQIKEYLFNPLSVAVMLVL
GGFFILWVEKRQSRAEPKIADVDALRPIDALMIGIAQVFALIPGTSRSGSTIMGGMLWGI
ERKTATEFSFFLAVPMMVAATAYDVLKHYRFFTLHDVGLILIGFIAAFVSGLVAVKALLR
FVSKKNYIPFAYYRIVFGIAIIILWLSGWISWE
>AAK64454|FEATURES|ARDB_deepARG|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQYYPLG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
TVLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATTITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>YP_002029848|FEATURES|ARDB_deepARG|multidrug|smeF|antibiotic efflux|0
MKSASLFLSIAAALALAGCSTLVPKNTAVAPAIPAQWPAEAAQGEVADVAAVGWRDFFTD
ARLQQVIDQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDAGVTEQ
FTAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYGADAQR
LKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQDRNAL
ALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANANIGAAR
AAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIANADRDI
ALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGLDSFVT
LLDARRTAYNAQQTQLQAQLAQQSNRITLYKVLGGGWHERG
>C3WB37|FEATURES|UNIPROT_deepARG|chloramphenicol|FMAG_00636|antibiotic inactivation|1
MKFNYIDIENWKRKAHYRHYLDDIPCTYSMTTKLDVTKIVTEQKKIYPTMLYHITKIVNR
YEEFRTVLDSEGKVGYFDEMLPCYTVFYKESETFSNIWTEYSEDYEVFCKNYRDDIEKYG
KNLEMEGKPNTPINSFPISMIPWESFEGFNLNLQKGYGYLLPIFTLGKYFKDGEKYLMPI
SIQVHHSVCDGFHFCRFLDSLRKSLGE
>M4MPN0|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MTHFSATKFVMAAAALLCCGAGAHAADRGEEGELARLVDETIRPLMREHGVPGMAIAVTV
RGKKYIFNYGLASRESGQKVTDETMFEIGSVSKTFTAMLASYAEARGDLTLSDPAGKYLP
ALAGTRFDDISLLNLGTYTAGGLPLQFPDSVTDQESMIDYYRDWRPTYAAGTHRLYSNPS
IGLFGYLAAKSMGEPFADLMEKSIFPAFGLTSTFIAVPQDRADDYAYGYSKAGKPIRVTR
GVLDSEAYGVKTTAADLIRFVEANIDGTGLDEPIRRAIAATHTGYFKVGAMTQGLGWEMY
PYPTKLDDLLAGNSSRMALEPHKVSKLVPPAAPQENLWINKTGSTNGFGAYAAFVPAERI
GIVMLANRNYPIPARVKAAYQILSTLESGPGSADAR
>A0A0M2UCK7|FEATURES|UNIPROT_deepARG|bacitracin|V520_22670|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRGKIFDVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVF
>R7LW43|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLIQSILMGIVQGLSEFLPVSSSAHLVFTSNFYKVFKNIPIQAQSNEEVFFDIMLHLGT
LIAVLIYFRKDIWEILKALIVACKNRDFSEHKAKLALYIIAGTVITIALALPFNGFAEHL
VFHPALVGALLIGTGGVLFYSEYLSKKCSEKSESVSLKQAILIGLAQGVAVLPGFSRSGW
TIATGLFAGLDRATSARYSFLLSIPIILGASMVYPLIKIDVAEAVQYNWLAISVGTVVSG
IIGYLCIKYFMKFISKFSLNIFGYYCVIMGLFTLVFFNIFK
>A0A0C1XS73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSLVQSIILAIIEGVTEFLPVSSTGHMIIASSVMGIEANPFVKLFTVAIQLGAILSVVVL
YWKRFFKSFDFYLKIGVAFIPSVVAGLFFKEYVDALLERVDVVGYTLLIGGVFFLFMDKI
FNSESHPDQQISYPRAFKIGLFQVIAMIPGVSRSAATIIGGLSQKLTRKNAAEFSFFLAV
PTMFAATVLSGYSYYSDGYSLTSDEVSILIVGNIAAFIVAMIAIKSFINFLTKHGFRLFG
YYRIVVGVIILALYYFGAGLSIL
>J3I929|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRPKIINIVKGLPTERNAQRFTLNLLIAFLPAVVLGVLFADTIHEYLFNPITVAVALV
VGGIIMLWAEQRNHVISVDHVDDMRWSDALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPNDLPVFALGFVTAFIFAMIAVRGLLKF
IANHSYAAFAWYRIAFGLLILATWVFGWVNWTAAAAA
>A0A0Q6ZAS3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLFDLLKALVLGIVEGVTEFLPVSSTGHLLLVERFFQLDQDNFWKTFAVMIQLGAILAIL
AIYFNRLWRIALGMFSDPAARRFVIGVLLAFFPAVVLGLLFGGFIKDVLFNPWVVCFSLI
AGGAVLLWVDQQDLKPRYHDATGFSLPMYLGIGVAQCAAMIPGVSRSGASIVAAMLFGAD
KRAAAEFSFFLAIPTMVGAFVYDFYKSRADMTMDHGLVIAVGFIVSFITAIIVVKTFLDY
VTRHGFVLFAWWRVIVGTLGLIALALGM
>A0A0N9HNT3|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-21|antibiotic inactivation|1
MLGVKEKLMTIRIFAIFFSTLIFATFAHAQEGTLERSDWKKFFDDYQAKGTIVVADERQA
DRILSVFDQARATKRYSPASTFKIPHTLFALDVGAVRDEFQVFRWDGIKRSFAGHNQDQN
LRSAMRNSTVWVYELFAREIGEEKAKRYLKQIGYGNADPSTSKGDYWIDGTLEISAYEQI
SFLRKLYRNELPFRVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGAVF
FALNIDTPNRMDDLFKREAIVRAILHSIDALPPN
>I6FF29|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSD
PATKYWPELTAKQWNGITLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQ
RLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGK
AVHVSPGALDAEAYGVKSTIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQ
GLGWEMLDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVA
FIPEKELGIVMLANKNYPNPARVAACQILNALQ
>A0A0W1AKG3|FEATURES|UNIPROT_deepARG|beta_lactam|Lwor_0132|antibiotic inactivation|1
MKKSSVLLCMTLLYCSTTWAQSTCFLVQENQTVLKHEGRDCNQRFSPESTFKIALSLMGF
DSGILKDKLHPEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTLFKNYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLAISPSEQIQFLQKIVNKKLPVSPKALTMTKD
ILYIQELAGGWKLYGKTGNGRQLTKDKSQKLPLQHGWFVGWIEKDGRVITFTKHIADSKK
HATFASFRAKNEALNQLFYLINELEQ
>A0A0Q6ZX28|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
WEFRRKIFDVVLGLPTQPSDRRFTANLLIAFLPAVVLGVLFADLIHHYLFNPITVAAALV
VGGLVMLWAEKRQHQVHAETVDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRELFVPADFPVFAIGFVTAFIFAMIAVKGLLRF
IASHSYAVFAWYRIAFGLLILATWQFGWVDWTAAKP
>A0A095WHQ4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADQSIISALVLGLIEGLTEFLPVSSTAHVLLAGHFLGFQSPGNTFAVLIQLGAILAILL
VYAGKLLEIAMDIPTSRKARHFVVTVLIAFLPAAVIGALAHDFIKTVLFETPMLICIVLI
LGGFVLLAVDRMKFQPKYHDIMDYPWPLALKIGFFQCLAMVPGTSRSGATIVGALLMGAD
KRSAAEFSFFLAMPTMLGAFVLDLYKNRDILSFDDGAVIAIGFVAAFVTAIFVVRSLLDF
VSSRGYAFFAYWRIIIGAIGLLALVMLG
>E2ZEJ1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGIVEGITEWLPISSTGHMILLEQIIKFNASEEFMSMFRVVIQLGAIMAVVVLFWGKLWP
FGMKQGRVISKPSVWNLWFKVVAATIPVLIISPLDDWMEAHFYNYITVAAMLILYGALFF
VVENRRAAPHVSRLEQITYRDAIIIGLWQCLAIIPGTSRSGATIVGGLLLGLSRACVAEF
TFYLAIPVMAGASLLKVVKFVVGGSVMTGTEVAVLAVGCVVAFGMSLAAIRFLMDYVKRH
DFKFFGAYRIVLGIIVLAVAAATAIF
>Q5GJ47|FEATURES|UNIPROT_deepARG|beta_lactam|blaORN-5A|antibiotic inactivation|1
MRQYRFALLPLLAALALPGWAHEATVTTVKQAESQLQGRVGYAELDLASGQLLSGYRAGE
RFPMMSTFKVLLCGAVLSRVDTGEEQLDRRIHYRQQDLVEYSPVTEKHLADGLTVGELCA
AAITLSDNTAANLLLTTIGGPQGLTTFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPE
AMARTLRNLLTGRVLSPASQQQLQRWMVEDKVAGPLLRSALPAGWFIADKTGAGNRGSRG
IIAALGPDGKAARIVVIYLTATPASMDERNKQIAAIGETLVRHWSKDDKRP
>A0A0X7AFQ9|FEATURES|UNIPROT_deepARG|aminoglycoside|L901_16330|antibiotic inactivation|1
MSAQFAIETAGEASLGEWSLLRHRLWPDASPAEHRAELQDVSDNEVGFIAYDPAGMAIGF
AEASLRHDYVNGCDTSPVAFLEGVYVEEAFRKQGVAAALIAEVTHWATSKGVSELASDAD
ISNVDSHRMHAALGFEETQRVVYFRKSLPLGS
>A0A0U5JIF5|FEATURES|UNIPROT_deepARG|multidrug|cfr|antibiotic target alteration|1
MKQTKTKYIKMIQIVSELKLPDYRYEQITNAIFHQGIDQFDNMQILPKALRKALANEFGN
RVSSVKPVFIQDSKQAEKLLFELADGEKIEAVGLKYKQGWESFCISTQCGCGFGCRFCAT
GSAGLKRNLTADEITDQLLYFLFNNHRLSSVSFMGMGEAFANPELFDAIKILTDQKLFGL
GQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFDKQRSDLMPVNKRFPLNEVMKVLD
EHIIHTGRRVFIAYIMLEGINDSKDHAEAVAGLLKSRGSWGHLYHIDLIPYNSTDKTTIR
FQSSNAIRQFCSTLKKAGISVTIRTQFGSEISAACGQLYYDNEV
>U3N7T6|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-10|antibiotic inactivation|1
LCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
QYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMA
QTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAG
>ZP_04055482|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmF|antibiotic target alteration|1
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
IENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFES
LGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALL
NIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQI
VCLSPSQWLNCFLEMLEVVPEKFHPS
>A0A0J5L9R5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MTALLELSDIRRSYPSGDGSVEVLKGISLRINAGEMVAIVGASGSGKSTLMNIIGCLDKA
SSGTYRVAGTDVATLDADALARLRREHFGFIFQRYHLLSHLSATQNVEIPAVYAGTERRR
RLERARALLAQLGLEARRDYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSG
EEVMAILHELRAQGHTVIIVTHDPAVAAQAERIVEIRDGEIVSNPPPKAAGAGARSTPAG
TAGAWQQFTGGFREALAMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLLAIQQQPWVSSATPAVSKSLRLRYNN
IDVSASAEGIGTQYFSVYGMSFSEGNTFNAVQQADRAQVVVIDGNTRRQLFPDKASAVGE
VILVGNIPVTVIGVAAEKQSMFGSSKNLRVWLPYTTMAGRVMGQSWLNSITVRINEGYDS
ALAEQQLTRLLTLRHGKKDVFTMNMDSILKTAERTTHTLQLFLTLVAVISLLVGGIGVMN
IMLVSVTERTREIGIRMAVGARAADVLLQFLIEAVLVCLVGGALGVGLSLMIALVLQLFL
PDWSIGFSPLALLMAFICSTLTGVLFGWLPARSAARLDPVEALARE
>AAB51122.1|FEATURES|ARDB_deepARG|tetracycline|tetQ|antibiotic target protection|1
MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITD
SMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEG
IQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVY
PICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAM
FNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRI
NDSEKFIKIKNLKTIYQGRKINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQH
PALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLL
EERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESD
ISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYV
FRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPY
NTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKILFMFQKSNVIKIME
RSGNFYKAIQ
>J8QXS0|FEATURES|UNIPROT_deepARG|beta_lactam|ICE_01755|antibiotic inactivation|1
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKATATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEAT
EVIVKALK
>YP_001335662|FEATURES|ARDB_deepARG|multidrug|MdtK|antibiotic efflux|0
MQKYFVEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
GHGLLLALTPVVAQLNGSGRRERIAPQVRQGFWLAGFVSVLIMVVLWNAGYIISSMHNID
PLLAEKAVGYLRALLWGAPGYLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIY
GHFGMPELGGVGCGVATASVYWVMFASMLWWVRRARTMRDIRCAERFSGPDFAVLLRLVQ
LGLPIALALFFEVTLFAVVALLVSPLGIIDVAGHQIALNFSSLMFVLPLSLAAAVTIRVG
FRLGQGSTIDAQVSARTGVGVGVCLAVFTAIFTVLMRKQIALLYNDNPEVVTLASHLMLL
AAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTDMIVPRMGPAG
FWCGFIIGLTSAAIMMMLRMRFLQRQPSSIILQRAAR
>A0A0M3EQR6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSALLELRNIYRRYPSGDSSVTVLDDVSLTISAGEMVAIVGQSGSGKSTLMNILGCLDTP
SDGQYFVAGKNTAELSGDELAALRREHFGFIFQRYHLLSHLSAEQNVEMPAIYAGLSARE
RRERAAELLQRLGLGERLIYRPGQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSG
KEVMAILHQLCEQGHTVIIVTHDPVIAAQAARIIEIKDGHILSDSGAVINPQAKTPAAKP
RLKSSAFSRFFGRFNEALLMAWRAMVVNKMRTLLTMLGIIIGIASVVTILVIGDAAKALV
LSDIKSIGTNTIFIYPGKDFGSDPGQDLQSLKPGDVDVIRRQPYVYAASAEIGSNARLRR
GNIDSAARITGIGPDFFTVYDMRFGEGRAFPPEMYERRSQVVIIDMNTKRKLFPHQKNVV
GETLLVGNMPATVVGVIADRKSMFGNSQTLQVWMPYTTLTGRLMQRNYLDMISVRIRDGY
NTNNTEEQLVRLMTLRHGKQDTFTYNLDSVVKTVDKTTTTMQLFLTLVAVISLVVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVMQQFLIEAVLVCLMGGAIGLGLSYSIAFAAQM
ALPDWEFVFRPAAIVSAVLCSTAIGVIFGFLPARNAAKLDPIDALARE
>AAU18978|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MGAVEGLTEFLPVSSTGHMILTGHLIGFDDDRAKVFEVVIQLGSILAVVVIFWKRLWSLV
GIGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAGGILMIVAEK
FSKPSTARTLDEITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFIL
AVPMMVAASGLDLIKSWDILSTADIPLFATGFITAFVVAMLAIVSFLKLLSRVKLTPFAY
YRFILAAVFYFFIM
>H2J1V6|FEATURES|UNIPROT_deepARG|beta_lactam|Rahaq2_4834|antibiotic inactivation|1
MMKNTLRKTVLMAAAVVPMLAFSAASWAQTATKMTSVQQQLAALEKDSGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRHVSLKKSDLVNYNPITEKHL
NTGMTVGELAAAALQYSDNTAMNKLIGQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVALGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKSRRDVLASAAKIVTQGY
>G3Z4X3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
SGSYQIDGIETAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKER
STRAEKLLQDLGLEGKEGNKPSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGK
NVIEIIQKLHKEGHTVIMVTHDPGIAAIANRIIEIRDGEIISDSSKNPEIPESKIERIKE
KSSWLFYYDQFVEAFKMSVQAIMAHKMRSLLTMLGIIIGIASVVSVVALGNGSEKKILAD
ISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQSYVASATPQTTSGGTLTYRNT
DLTASLYGVGEQYFDVRGLKLESGRLFDEGDVKEDAQVVVIDQNTKEKLFGTDVDPLGKT
VLFNKRPLTVIGVMQKEENSFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
VAEKGLTELLKTRHGTEDFFMNNSDSIKQMVESTTGTMKLLISSIALISLVVGGIGVMNI
MLVSVTERTKEIGVRMAIGARRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNQFVT
EFPMEISIGSVIGAVVCSTAIGVAFGFMPANKASKLNPIDALSKD
>A0A0G0T6U9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIIHALILSVVEGITEFLPISSTGHLILASQLLKIEQTEFVKSFEIYIQLGAIMSVLFL
YLKQIRRKEVLLPTIIAFLPTALVGLLLYGSIKNVLLGNSLVTVAALFWGGILIILVELL
FKEKDHHVNDIGKISLKNAFIIGLFQSISVVPGVSRAAATIIGARLMGVKRKTAAEFSFI
LALPTMLAATGLDLLKSDFSFGTSEVILLVVGFLGSFLVASLAIKFLLSYIQNHSFIAFG
VYRIILAILFYLLILRNA
>G8EXA4|FEATURES|UNIPROT_deepARG|beta_lactam|cphA|antibiotic inactivation|1
KCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGARGVTVVGA
TWTPDTARELHKLIKRVSRRPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKS
DWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDE
QVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEE
L
>C3VJV0|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
SNSSHAKELNDLEKKYNAHIGVYALDAKSGKEVKFNSDKRFAYASTSKAINSAILLEQVP
YNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKK
VKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFL
LDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYAS
>A0A0R3ABH5|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MNHQPKYLVSALLLLSGSCMAATDMRQVVDSNVKPLMQQQDIPGLSVAVINQGKVQYFNY
GVAAKDTQAAVSQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDKASPYLPSLAGSAFDR
ISLLQLATYTAGGLPLQFPQASDSATTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTA
QSLGQPFNVAMEKTLLPKLGLTNTYVSVRTDKASQYAQGYDKQQKPVHVSPGALDSEAYG
LKTTSQDLARYVIANMHPQTLEQPVQQAIAAAHAGYYTVNGMTQGLGWERYPYPITLQAL
IDGNSTPMAMEPHKVTWLNPPQAQPANVLYNKTGSTGGFGAYVAYVPSKDMGVVILANKN
YPNAERVKVAHAILSAMDQ
>C0L620|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M-15|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYGDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0S4IFQ5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFTGERAMAFNIIIQLAAILAVM
WEFRGKIIDVVRGLPNQRRAQRFTGNLLLAFLPALVLGVLFADLIHEYLFNAVTVAAALV
LGGVIMLWAERRQHAVEVTHVDEMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RTAATEFSFFLAMPTMVGAAVYSGYKYRHLFQPDDLPVFALGFVTSFIFAMIAVRGLLKF
IANHSYAAFAWYRIVFGMLILASWLFGWVDWTVAHG
>A0A125U6I2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MFDIIKAVIIGIVEGLTEFLPISSTGHIDLVNHVIKLSQSQDFISMFEYVIQFGAILAVV
LLYFNKLNPFSKPTAKARNATWQLWAKVIIAVLPSAVVGLPLNSWMDEHLHTPIVVATTL
IVYGILFIILENYLKNKSAHITTLADITYQTALLIGLFQVLSIVPGTSRSGATILGALLI
GTSRYVATEFSFFLAIPTMVGVSIIKIGKYLWQGNGFSGEQWAVLMTGSIVSFLVAIVAI
KWLLKFVQTHDFKPFGWYRIALGAIVLLVMFI
>A0A062YA94|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPCEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KDGNILEIAQRENEATCFGRRTPEDSFLKWHKPAAVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHTSAAQPGSVISVAPLLIACGDGVLEIVTGQAGDGITMQGSQLAQSLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNARRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0Q8BZ36|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTENSLYLIKAFILGILEGLTEFIPVSSTGHLILVGDWLNFDSGDGKVFEVVIQLGSILA
VMWVFRARLLQLIRGTLTGVPSEVAFTRNLILAFLPAAVIGAIFIKTIKSVFYHPAVVVV
TLVLGGLIMLYVERRTRHTPGDAPGAADDTASDERASAHTLEQITWKQALGVGVAQCFAM
IPGTSRSGATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAAYDMYKNFGLLTQHDLSGIA
VGFIAAFLSAMVVVRAVLRFVANHTYRVFAWYRIIFGAIVAAWIFTR
>A0A0C4YHK8|FEATURES|UNIPROT_deepARG|beta_lactam|RR42_s0522|antibiotic inactivation|1
MTHSPVRRTLLLAAATVPFAAACTSWAGRTEGSVAAQDRLAALELAAGGRLGIAALNTAN
GARLSHRANERFALCSTFKVIAASAVLQRSATQAGLLQRRITYKKDELVAYSPITEKHVG
GGLTVAELCAAALQYSDNTAANLLMKLLGGPAAVAAFARTIGDDQFRLDRWETELNTALP
GDPRDTSTPAAMAASLQRLTLGDALGGVEREQLVAWMRGNTTGATRIRAGVPVDWQVADK
TGTGDYGTANDIGVAWPPGKPPIVLAIYFTQPGKDTAYRNDVLASAARIAAEALS
>A0A0Q5Z550|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAVGIAKAVVLGVVEGATEFIPVSSTGHQLLVGHFIGFKSPNNTFEVLIQLGAILAILT
VYFRRLLGVALAFPNDPRARRFVFGILIAFLPAAIIGGLLSKYIKYFLFNPWIVCATLVA
GGLVLLVIDETDLEVEKRDVFDFPLVMDLKIGLFQCLAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAMPTMAGAFAKDLLDNYKNLTVDDTGLIVIGFITAFISALIVVRTVLDYV
SAHGFRLFAWWRIIVGSLGFAGLIVFG
>A0A0M0G503|FEATURES|UNIPROT_deepARG|beta_lactam|AF331_13055|antibiotic inactivation|1
MVLNKKILMVTMFILLVLMTLSACMKPEKSAESSPEKKKSTVSDETFANIEDKYDARVGI
YAIDTGSDRTIDYRSEERFAFTSTYKALAAALVLKQNSMDELEEVITYTEDDLVSYSPIT
EKHVETGMTLAELSEAAVRTSDNTAGNLLFEELGGPEQFQQSLREIGDDVTQSDRYETAL
NEFTPGNTRDTSTPAALATSLQGFAVGGLLPDDKREILIDWMKGNATGDTLIRAGAPDGW
TVADKSGAGRYGTRNDIAVVWAPDREPIIMAIMTRHDTEDADYDDALIAEVAEVTLEALK
>A0A0U1BIA7|FEATURES|UNIPROT_deepARG|beta_lactam|penP|antibiotic inactivation|1
MISRRALLVGGVSAAGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGSAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA
>A0A068E9Y7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLILELIKGIILGIVEGLTEFAPVSSTGHMILIDDMWLKSSEFLGSESAFTFKIVIQLGS
VFAGAWVFRERYFEMLHIGKYRAEPIDGIGQKPKRLNLLHIIVGMIPAGVLGLLFDDVIE
KYLFSVPTVMIGLFIGAIYMIIADIYSKRVTNPQTVDQINYFQAFVIGLSQAIAMWPGFS
RSGSTISTGVLMKMNHKAASDFTFIMAVPVMLAASGLSLVKNLEYIQLNHIGFYILGFIA
AFIVGLIAIKTFLYLISKIKLIPFAIYRIILVIIIAILYFGFGIGQGITGE
>R6DIS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLNYLISFFFGIIEGITEWLPVSSTGHMILFDEFVKLSMSDDFKEMFLIVIQLGAILAVV
VLFFWDIWPFTTPQKGLIKKDKFSMWFKIAVACIPAVILELCLGDKIDAMFYNFQTVAIM
LITVGVLFIIVENWNKGRSASVTTIDEISYKYAFYIGMFQLVAALLPGTSRSGATIIGGL
VLGLSRTVAAEFTFYLAIPVMFGASFIKMLGFGLHFTGTEIGVLLTGTITAFVVSVFVIK
FLMGFIKKHDFKVFGWYRIILGLIVLAYYFLH
>E2GM24|FEATURES|UNIPROT_deepARG|beta_lactam|bla|antibiotic inactivation|1
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
FKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAK
ALGQDRFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLP
VKAAAYELAENLFEVGQADGWRLYGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVY
ARLLQDERATRPNAGLRARDELVRDWPAMAGAWRP
>A0A127STY2|FEATURES|UNIPROT_deepARG|chloramphenicol|catS|antibiotic inactivation|1
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRYSEFRTAINQEGELGIYDEMIPSYTIFHE
DTETFSNLWTPYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGF
NLNLQKGYDYLIPIFTMGKYYRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>A0A145UXX4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRQSRAAAPKEPLP
AATGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKTNVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
GLAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>A0A0J5ZN31|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MRFNATRFAATLFVAACATATAGRAAAVTQDDIHATVTRHVAPLMKQYAIPGMAIGVVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLSDPAGKYLPA
MQGKPFGALTLLQLGTHTPGGMPLQVPDSIHDEAGLMRYLDAWRPAYTPGTRRTYSNVAI
GMLGWLTAKAMNRDFAVLMEQRLFPALGMTHTYINVPDARKTDYAQGYTQDGKPIRMTGG
MLWQQAYGVRTTAADLLRFVQANMGLVDTAPRLQRAIERTHTGYFRSAPLTQDLIWEQYP
YPVALPTLLEGNAPKMLFNATPASAITPPLAPSPNMWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRNYPIEDRVKVAYQILGSLGDGR
>Q0K7S4|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
WEFRARIGNVVRGLRAEPLAQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFI
VGGVVILLAEWRDARRGTVSHPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGATVYELYKARALLNGDDLGIFA
VGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIAFGIVVLLTAYSGLVSWHA
>R8Y164|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
YFWKSWKKTYFSSWESFKKQAFYIILATLITGVLGLALQSMIKHVFFGGASSFEIEYLFS
NSKLMAAALISAGVLIILSSRLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATIST
GLFLGVSRQKAEEFSFALAVVLTPAVILKELYRLVHAQGLQTVAHGQVFHSMVPSLLGMC
FSFGAGLLALKWLSSWLEHGRWHLFGMYCIGFAVVVLCVN
>C3X6Q0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIELRGINKVYGTGDNQVRVLKDVNLDIEAGDFVAIIGQSGSGKSTLMNILGCLDTAS
SGNYKIAGENVAGMTPDQLATLRSQYLGFIFQRYNLLSTLNAEENVELPAIYSGLKHQER
QTRAEALLSNLDLGNRIDHLPSELSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGE
NVMAILKTLNDQGHTIILVTHDKNVANYANRIIEIKDGVIISDERKKPNKNSAQDYHPKD
DNRNSFAYLKDQFTEAFKMSIQAIKAHKMRSVLTMLGIIIGIASVVSVVALGKGSQEKIL
ADINSMGTNTIVIMPGHGFGDRNSSKYKTLTVHDSDLLARQSYVDSATPAVSSSGTLTWQ
NISVTAQLQGVGEQYFDVKGLKSEEGRFFNREDVKKGSAVVVIDQNTKNKLFPNGGDIVG
STIIFNRQPLKIIGISEKQNANFGPSDTLTMWSPYTAVMNRITGDRNISSITVKVKDDVS
MTAAEKNIIRFLTVKHGKEDFFTVNTDSIRQTIESTTGTMRLLISCIALISLVVGGIGVM
NIMLVSVTERTREIGIRMAVGARRSSVLQQFLIEAVLICIIGGFIGVLFAFGIGLFFSLF
VKTFTLSYSAASIFLALACSTLIGVIFGYIPARNASRLNPVDALCD
>B0A7L2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEFIEIIKAIILGIIEGITEWLPVSSTGHMILVDEFLQLNMSPAFKEMFFVVIQLGAIMA
VVVLYWKKIFPFSFKKKPFVQKSIIIMWIKVIIACLPAAVIGLLFDDKVNELFYNFQTVA
IMLILFGIFFIVVENYNKGKNPIANDMDQLTFKMAIIIGLFQVIAAVFPGTSRSGATILG
ALLIGVSREVAAEFTFFLAIPVMFGASLLKLVKFGFVFTGFEMIILSVGSIVAFIVSILA
IKFLVGYIKKHDFKVFGWYRIILGIILLGYYFFLR
>I7CAW9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
WEFRSKIFEVVFGLTHQPKARRFTGNLLLAFMPAVVLGVLFADLIHEYLFNPVTVAAALV
VGGVIMLWAERREHRVEVDHVDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDLFQPGDLPVFALGFVTSFIFAMIAVRALLKF
IANHSYAAFAWYRIVFGLFILATWQFGWVDWSTAHG
>A0A127SCJ5|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
PLIEQQKIPGMAVGVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDA
IARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQN
WQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEK
NYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQS
RYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTG
ATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ
>A0A143HHY9|FEATURES|UNIPROT_deepARG|beta_lactam|ATY39_14210|antibiotic inactivation|1
MLTGCTNATNSSAASAEHKTTKEKGTHTEEAFKQLESEFDARLGVYAIDTKTKKSVSYQS
DERFAFASTYKALATGTMLKQQSIKDLDKIITYTKDDLVTYSPITEKHVDTGMSLKDIAT
AAIRYSDNTAGNLLFNEIGGPRGFEKALRKMGDKVTKSNRLEPELNLTLPGDLRDTSTPR
ALATSLQKYVIGDVLTTKKKALLTDLLVGNATGDTLIRAGVPKDWVVGDKSGAGSYGTRN
DIAVVWPPYRKPIVIAILSSRNTKDATYDDALIAKAAKVVVNALK
>A0A137RPY5|FEATURES|UNIPROT_deepARG|beta_lactam|AYK81_08635|antibiotic inactivation|1
MILKNKRMLKIGMCVGILGISLTGLETFKGGTLQVEAKEKTGQVKHKNQATHKEFSKLEQ
KFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKED
LVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATGDKLI
RAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSNKDEKGATYDNQLIAEAA
EVVVNAFK
>A0A0S3BFZ2|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MKQTRFLPLLALGTLLLAPLSLAAPVDPLNAVVDDAIRPMLKQHRIPGMAVAVLKGGQAH
YFNYGLADMAAGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVESVEQMQSYYRQWTPAYQPGSHRQYSNPSIGLFG
HLAASSLQQPFAQLMEQTLLPGLGLHHTYLDVPKQAMASYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKALQQAISLTHQGRYSVGEMTQGLGWESYAYPVSE
QTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNEARVSAAHAILSQLAP
>A0A158C4J2|FEATURES|UNIPROT_deepARG|beta_lactam|AWB83_03995|antibiotic inactivation|1
MKFRTLSFLAAAIFSFGAISVAAHAADADDARIRKTVDDTIKPMMALHGIAGMAVGVVVQ
GRPYVFDYGVASKETKQPVTRDTLFELGSISKTFTATLASYAQLEGDLSLNDPVSRHLPS
LAGSEFGKVTLLNLGTHTPGGLPLQVPDDVHDNDQLLRYFKSWRPAQPPGTIRTYANPGI
GALGLITAKSMRQDFDALMQTRLFPALGLKHSYVDVPAAKQRDYAQGYGKDDAPIRMKGG
VLSSEAYGVRSTADDMTRFMQINMNMVRIDPPFQRAVIATHTGYFHAGPLTQDLIWEQYP
YPVALQSLLDGNSQSMILNATPVTAIEPPQAPRDDVWINKTGSTNGFGAYVAFVPKERVG
IVMLANRNIPNDERVKAAYAIITSLVGGR
>A0A0D9H2D4|FEATURES|UNIPROT_deepARG|chloramphenicol|LI62_10805|antibiotic inactivation|1
MTKIMPEYTVVDLSRWARKEHFEVFQGFAQSTFNQTVQLDITVLLKHIKEVGWKFYPAII
SLISDVVNRHPEFRMAMKDDELVIWNEVHPSYTLFHKETETFSSLWSHYDGNIHHFQRVY
AEDVARYGNILAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMFTFGKYYNQ
DGKVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHHSEALNV
>D2J6J5|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
MAFLLLHNYTDFIEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELG
DKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKS
GDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPND
KLISETAKSVMKEF
>H6Q5F2|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIIFAYHDIGCIGLLSLIKSGYKILSVITHNDQKNEKIFFSSVKSIALKKNIPVFTSE
TINSFIWIEYFKKLEPDVIFSFYYRNILCSEILKIPKFGSFNLHGSLLPKYRGCCPLNWS
IIRGEYQTGVTLHRMTTKIDHGPIISQVKININKLDNAISLHKKICYAAYNMLNKIAPVI
LKKNFCETPQNCHNTSYFGKRSPEDGLIDWNQSAKKIYNLIRGLTKPWPGAFSYLNNKKI
IFWKSKIIKKKYDIDPGLIIKINPLIISCKIQALNIISAQYTKHTFNNKTNIYHLSMIKN
KKYVIYPNSTSKPILKKILILGINGFIGYHITKRLLKSNSYKIYGLDLKKNLIEKFINNS
KIKFLQKNIKSCSHWVKEKVKKCDIILPLIAIARPMQYVQEPIKTFELDFEENLKIIRYC
VKYKKRLIFPSTSEVYGMCTDKEFHETNSNFVTGSVRNQRWIYASSKQLLDRIIWAYGKS
NNLLFTIFRPFNWVGSRLDDFKIAQMNHARVITQMIFNIAHGLPINLVNCGKQKRCFTDI
YDGIEALFRIIENKKNNCNQEIINIGNPKNEYSILELAKIVVHTFQKFTSSNTFPKFSGF
RNLRGDEYYGFGYQDIEYRKPNIGIAQKLLDWKPKIQINNTINYMIKFFLQL
>J2L727|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGETAETFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGEVKHEGVGTGKLTLIHILLGMVPAVVIGLLLHDQIKTLFNPIN
VMYALVVGGVLLLVAEYFKPKQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMIGATGLDLYKSLGFLTIQDLPMFAVGFVTAFIVALLA
IKVFLELIKRISFVSFAIYRFIVAAVVYAIFM
>A0A0V0PYF0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHNTLVAVALGLLEGLTEFIPVSSTGHVLLAGHFLGFDSPGRAFEVLIQLGAIMAILGV
YSGRLWRIFTSAPHDPRARRFILAVLLAFLPAVVIGVLAHRIIKEVLFETPALIATMLIV
GGVVLLFVDRMANRPRHFSAEDFPLPMALKIGFIQCLAMIPGVSRSGATIVGALLLGADK
RSAAEFSFFLSMPTMLGAFVYDLYKNRDILDAAAAGNIVIGFVCAFLAAVVVVRGLLNYV
STYGYGFFAWWRIVVGAVVLLALQAGW
>A0A0G8BC38|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLAFHDFIKSLFAP
KNVMYALVVGGLLLLAAEWLKPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTI
AGGMLVGVNRYAASEFSFILAVPMMIGASGLDLYKSLHFLTWGDLPMFAVGFVTAFVVAL
VAIKTFLSLIKRISFVPFAIYRFIVAAVVYMVFL
>ZP_02091679|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFQKVM
>R5DYH7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNFVEWLKVVLLGIVEGITEWLPISSTGHLILVDEFVKLNQSESFMKMFNVVIQLGAILA
VVVLYWDKLWPFHTKKNAPRRSWFANQADHGVMKGFQTFCNNYCYMDKIVLWVKIVFACI
PAMVIGIPFDDWMEAHFHNATVVSLALIAYGVIFIVIENYNKTRTPRMNTLSELSFKNAF
LIGVFQVLSLIPGTSRSGSTIIGGILIGASRELAAEFTFFLAIPVMFGASLIKLLKFGLA
FTGTELAVLIVGMLVAFGVSILAIKFLMSYIKKHDFKVFGWYRIVLGLLVLLYFYVIR
>E5UH07|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDILILFKALILGIIEGLTEFLPISSTGHLIVFGDLMNFQSNGKVFEIAIQLGAVLAVVF
EYRQRFTHIIKGLGKEQTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLIL
GGFFILWVEKRQTTAKPKVNHVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGL
ERKTATEFSFFLAVPMMIAATGYDILKNYKLFTLQDVGQIAIGFIAAFIAGLLAVKALLK
FVSSKNYVPFAYYRIVFGGLILLTWMLGIVSWSE
>Q5YEX8|FEATURES|UNIPROT_deepARG|beta_lactam|blaampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARFAAAWQILNALQ
>A0A0J7MJU7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILMIKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
WEYRAKIASVVTGLPTRPAARRFTINVIIATIPAVVLGLALEKHIKAVLFSPVPVSVALI
GGGIVILWAEARQHDRNTAPHVHSVDDLSPADALKVGLAQCFALIPGTSRSGATIIGGML
FGLDRRVATEFSFFFAIPIIFGATLYEMAKYWKTLSVNDLGLFAIGLVAAFISAFVCVRW
LLCYVVSHDFSAFAWYRIGFGLLILIVSYSGGLSWAE
>D9TPY6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILLVKAFILGIVEGLTEFLPVSSTGHLIIVGDLLNFKGAYATMFEVVIQLGAILAIVYY
YREKIWDSLKNLAPNKWGFRLWFKIVVAFIPSAILGLLLNDYIDKHLFSSFTVSIALIIG
AIMMLIVENAFSNYKIDDMDKVSTKKSFWIGVAQCMSLFPGMSRSASTIMGGMMVGLSVK
AAAEFSFFLAIPTMLGATVVSLHKGIASMTALEWEALAVGFIMSFIVALIVVDKFLSYLK
SHPLRPFAYYRLIVGIIMIGLVLTKIVK
>A0A099BUH4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIIQTIILAIVEGLTEFLPVSSTGHMIITQGLLGIESTPFVKAFTIIIQFGAILSVVCL
YWNRFFRLDHSPAAAGSTPLQKFLHKWDFYWKLLVAFVPAVVIGLIGKKTGLIDRFLESV
EVVAIMLVVGGIFMLFCDRIFNQGSEENQITEKRAFNIGLFQCIAMIPGVSRSMATIVGG
MAQKLTRRAAAEFSFFLAVPTMAAATVLDVYELFFSSDAATAGWATTDNLMMLGLGSVVA
FVVALLAMKWFVAFLTKYGFRAFGIYRIIVGGFILFWLLSGHSLAMVG
>B2FHB6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
RLLQLATGFNQRGNREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWM
LLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAE
FVFLVGIPTMFAASAYTFLEMAKAGQLGSEDWADVGVAFLAAAITGFVVVKWLMGYIKSH
RFTAFAIYRIALGAALLLWLPSGS
>A0A081NXV0|FEATURES|UNIPROT_deepARG|chloramphenicol|ET33_18140|antibiotic inactivation|1
MNFTVLDMNKWERRAYFEHYLHAARCTFSITANLNVTKLLPTLRAKGLKFYPAFLYMVTK
TVNEHREFRVCFNNEGELGYWEKLLPSFTFFHKDDKTFSTMWTDFSTDFDVFYQNYLDDM
NRYGEVKGLSAKGNEPPNTVNVSCIPWVSFTGFNLNIYTDGRSLLPITTCGKYFEQAGEI
LLPVSLQVHHAVCDGYHAGVFINELQELANNCEQWLLPDPAAT
>V3DI00|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKK
RLERAQMLLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPREYRAAAPKEVLP
ASTGWGQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRVGN
VDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AMAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPVAIITAFLCSTFTGILFGWLPARNAARLDPVDALARE
>G5CK57|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-116|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPIDKRDSTL
PV
>A0A0J1GAX3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIILALKAIIMGLVEGFTEFLPISSTGHLILAGSLINFTGEVAKVFEIAIQAGAILAVM
WEYRARIGTVLGGLGSDPRQRKFVLNLIVAFLPAAVLGLLFSKAIKAHLFAPVPVALAFI
VGAFVILWAERRHKMLPGAHRVDTVDDMSMLDAFKVGCAQCFALVPGTSRSGATIIGGML
FGLSRKAATEFSFFLAIPTLLAATVYSVFKARHDLHASDLPLFLIGGVAAFVSAFLCVRW
LLRFISTHDFTGFAWYRIVFGILILVTAHFGWVIWAD
>N9BDM5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
IYEYWARLWGAATGIFSGEPQGRRLGIGLILASIPIVLIGLTFGQTVKELLFNDIAIAIG
LIVGGLIIIWIEKHPPQERVHEVEDLSIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLG
VSRKAATEFSFFLGIPVIIGAGLLDLYQSAHVFDGQQDWIVLATGIIVSFVSALLLIRAL
VAYVAKRDFMIFAWYRIASGLVILLFAFTGWTLW
>YP_001068559|FEATURES|ARDB_deepARG|aminoglycoside|Aac2I|antibiotic inactivation|1
MAGTPRWYNDGVLPQLSSEVRGHGVIHTARLVHTADLDNETREGARRMVSEAFRGDFTDD
DWEHALGGMHALICSHGVLIAHAAVVQRRLLYRDAALRCGYIEAVAVREDCRGQGLGSAV
MDACEQVLRGAYQLGALATSTMARPMYRARGWVPWRGPTSVLSPGGRISTPEDDGSVFVY
PVGSALGSTDLDTTAELTCDWRHGDVW
>V0VGU3|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1604_00910|antibiotic inactivation|1
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSP
GALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVSASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVAAAWQILNALQ
>A0A127DCR8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNMWEIFVAVVLGLVEGLTEFAPVSSTGHMIIVDDLWLKSNELFGSEVANVFKVVIQLGS
ILAVVVLFWGRFMDLLGLRKMKDPSAVKGQKLNLLQIIVGLLPATVLGLLFEDYIDENLF
TMKTVIVGLILGAFLMIAADKFRPKLTTETVDQITYKQALGVGLIQCLALWPGFSRSGST
ISGGVLLGMSYRAASDFTFIMAVPIMAGASLLKIVKYWDYFTPEVLPFIIAGFISAFIFA
LFCIRFFLILINKVKLTPFAIYRIVLAVVLLFIIW
>A0A0J7EIZ0|FEATURES|UNIPROT_deepARG|chloramphenicol|TU65_24405|antibiotic inactivation|1
MKFYIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISRV
INNHKEFRTCFNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
LYTNVHGLFTKENIPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFLEDLQQLISNCNKGLK
>A0A0M1NET5|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MGIKMDEYELLDKDSGPYGITAGKDGALWFTQHKANQIGRMTVNGEVTPFVVPTPNAGVL
SITSTTQGDVWFTENRANKIGKLTGTGEIIEYTLPSPNSAPFGITEGHNGDIWFTEMNGN
RIGRILSSGEIIQYDLPSPGCYPSFIVAGTDGAIWFTENQSNQIGRITMLGEVTNYTLPT
KHAGPVGITSGPDGALWFVEISGNKIGRITTSGTLCEYTIPTAGARPHAIVTGPDRALWF
TEWGSNQIGRITMQGEITEYPIPTQNAEPHGIASGPDGAIWFAEECNKIGRLSIL
>C7G7S8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNLSFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFLQLNASDSFKEMFFIIIQLGAI
LAVVVLYWNRMFPFQFKDKAKPVIRKDIFSLWFKVVVACIPGAAVTILFDDYIEAHLHTP
VVIAIALIFYGVAFILIENWNKTREPKIKTLADISYQTAFMIGLFQVLSIIPGTSRSGAT
IIGGLIIGVSRVAVAEFTFYLAVPVMLGMSLLKLLKFGFAFTGAEFVILGVGTVVAFLVS
IVVIHFLMSYIRKHDFKVFGWYRIVLGALVLVYFAFR
>R4WAL9|FEATURES|UNIPROT_deepARG|beta_lactam|AQU-1|antibiotic inactivation|1
SPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNY
GVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDG
ITMVELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAA
SSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLADEAYG
IKTSSADLLAFMKANISGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSEQTLL
AGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPI
QE
>YP_001785579|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|VatB|antibiotic inactivation|1
MNKFGPNPNSIYPNENINSVCYIKNVIKNPNIQVGDYTYYDDINGAEKFEEHVTHHYEFI
GDKLIIGKFCAIAKGIEFVMNGANHRMKSITTYPFNIMGGGWEKAMPTLEDLPLKGDTVV
DNDVWIGQNVTVMPGVHIGDGSIIAANSVVAKDVPPYHIAGGNPCKIIKKRFDDELIDYL
LNLKWWNWSEEKIFKNLEVLCSPDLDKIKSIK
>C2YRM4|FEATURES|UNIPROT_deepARG|chloramphenicol|bcere0028_21910|antibiotic inactivation|1
MRFHIIDRENWNREQYFKHYLKLKCTFSVTVNVDITRLLKELHQKGIKFYPVFIYLISRV
INNHKEFRTCLNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMR
CYTNVHGLFTKENMPPNVFPISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVM
LPVSLQVHHSVCDGYHASRFIEDLQKLSNSCNEWLN
>CAG34251|FEATURES|ARDB_deepARG|multidrug|smeF|antibiotic efflux|0
MEVIPMKSASLFLSIAAALALAGCSTLVPKNTAVAPAIPAQWPAEATQGQVADVAAVGWR
DFFTDARLQQVIDQSLQNNRDLRVAVLNVERARGQYRVQRADRVPGVAVTGQMDRRGTDA
GVTEQFTAGVGVAEFELDLFGRVRNLSEAALQQYFAVAANRRNAQLSLVAETATAWLTYG
ADAQRLKIADATLKTYEDSLRLAEARHERGGSSALELTQTRTLVETARTDAARLRGQLAQ
DRNALALLAGGQLDPALLPDSIEPQLLALAPPPAGLPSDVLLQRPDIMAAEHQLLAANAN
IGAARAAFFPSISLTGSIGSGSSELSNLFDSGTRVWSFLPKITLPIFQGGKLRANLAIAN
ADRDIALAQYEKSIQVGFRETADALALNVSLDEQVSSQQRLVEAAEQANRLSQARYDAGL
DSFVTLLDARRTAYNAQQTQLQAQLAQQANRITLYKVLGGGWHERG
>CAD89787|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSA
PISYLIVEYGFAKMLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKYARIYDINNISFEQFVSLFNSYK
IFNG
>ZP_04623137|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MTSVPQPVNWKRNLFVTWLGCFLTGAAFSLIMPFLPLYVEQLGVSGHQSLNMWSGLVFSI
TFLFSAIAAPFWGSLADRKGRKIMLLRSALGMGIVMVLMGMAQNIWQFLALRALLGLLGG
FIPNANALIATQVPRNKSGWALGTLSTGGVSGALIGPLIGGLLADNYGLRPVFFITAGVL
FACFAMTWLYVREQFAPVLKKDMLNGRQVFNSLKNPKLILSLFVTTMIIQIATGSIAPIL
TLYVRELAGDIHNLAFVSGMIASVPGVAALISAPRLGKLGDKIGPERILIAMLALSILIL
IPMAFVQTPMQLGILRFLLGATDGALLPAVQTLLIYNCTNQVAGRIFSYNQSFRDVGNVS
GPLLGAAVSASYGFRAVFCVTAVVVLFNALYSYWCLQRQPLKAQRREVQQQQDH
>B5B4Y9|FEATURES|UNIPROT_deepARG|beta_lactam|blaPER|antibiotic inactivation|1
LILFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQF
SVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQPSETSPALLWKWMVESSTGPERFKGLLPFGTESHIKL
VFPVSEP
>CAG76487|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
VVMFWRRLFGLIGIHFGKVPHEGKTSGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQN
VMYSLVIGGFLLLAAEWFKPKEPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFILAVPMMMGATVLDLYKSWHFLSLADVPMFAVGFVTAFVVALIA
IKTFLKIIKRISFIPFAIYRFIVAGVVYMVFM
>A0A0G1HTC1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTIFQAIILSIVEGLTEFLPISSTGHLILVQKYLIITTSEFTKTFDIVIQLSAIMAVVWF
YRKILFSQVMIWKQSLIAFVPTGFIGFLLYKLIRNTLLGNPLVTVYALFFGGIILLVVDK
SRRLNFGQKKHSDLSLKQLFSIGFFQSISVIPGVSRSAAAIVGGLGTGMSRAQAVEFSFF
LAIPTMLAATGYDLLKSGLVFSGQEYSLLLIGCFFSFFSAIIAVKFFIEYVQKNNFTPFA
IYRIVLALVVLLTMKA
>K1ITR1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTDTYSLLVAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQLGSILAV
VAVFWRRLFGLIGIHFGQKPSRDHATLSLVHVILGMLPAIVVGLAIHSWIKANLFGPQTV
MYALVAGGILLIIAEKFRPTVTAETLDDISYKQAFGIGLFQCLALWPGFSRSGATISGGM
LMGISRHAAAEFSFIMAVPMMVAASGLDLYKSRDFLSMADFPMFAVGFITAFVVAMFAIK
TFLTLIRRIDFIPFAIYRFVVAFAVYLVFVA
>YP_236080|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALV
IGGVIMLWAERREHTVRTETVDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRDMFRPDDFAVFAIGFVTSFIFAMIAVRGLLKF
IATHSYAVFAWYRIAFGLLILATWQFGWIDWASAKA
>A0A0Q7M8C9|FEATURES|UNIPROT_deepARG|beta_lactam|ASD16_16550|antibiotic target replacement|0
MTFAGERAAHARRLLVGGIALVTVAAGLTACSAEPPDPESATKALASALASGNFAKAPFA
GGAADASAATAARTAAYEGLAPWEPQVAVVSTTIDEQDEDLATVTLGYTWDIDESDADWT
YETHAKLARDDEDVWHATWSPSLLAPDLVAGEVLTVARARADRANVLGAGGAVIVEPRRV
HRLGIDKTRVAAADQDAAARALARELGIDADAYATRVAEAGEKAFVEAITIREGDLGYDL
ARLRALAGVNDVTDTLPLAPSRYFARPILGTVGPATAEIIEKSDGAVAAGDLAGLSGLQR
QYDAQLRGLPGVTITASQPDGAAPRQLYTVAPTPGTPLTTTLDVGLQQAAESVVATVAPA
SAVVAIRPSTGDVLAAASGLGGEGMSTATLGQFAPGSTFKVVSALALLRSGMTADSDTTC
PATVSVDGRSFTNFPEYPTDKLGTIPLRTAFANSCNTAFISARDTADQDALIDAAGSLGL
APDATLAFPAFLGDVPADSDGTDHAASMIGQGRVLASPLGMATVAASVAHGATVVPRLVV
PADGAATPEPTDDDTASSAEPTDAPRPIDPLTADEAATLHQLMRGVVTDGGATFLLDLPG
DEVAAKTGTAQFGEAGNLQNHVWMIAIQGDLAVAVFVDVGEYGSTTAGPLLEQFLRAAQG
>A0A157QTX3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELKDIRRSYPSGDGPVEVLKGISLSVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDISTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAKALLTRLGLAERVEYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAERIIEIHDGELVSNPPPRESRAAAPKEALP
ASTGWAQFSSGFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLA
DIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQLFPNKANVVGE
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
ALAEQQLERLLTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFL
PGWEIGFSPMAILTAFLCSTFTGILFGWLPARNAARLDPVDALARE
>ABC18245|FEATURES|ARDB_deepARG|tetracycline|tetW|antibiotic target protection|1
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
TSFQWHRCKVNIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWREDPLPMLRTSIAPKTAAQRER
LLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLETVVKEPTVIY
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
IRYGLEQGLFGWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYL
SFTLYAPREYLSRAYHDAPKYCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQ
SVCLTELKGYQAAVGKPVIQPRRPNSRLDKVRHMFQKVM
>AAG45719|FEATURES|ARDB_deepARG|chloramphenicol|cmlA5|antibiotic efflux|1
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLV
MIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACL
VSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLRLGMI
AASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLM
MGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAITE
IWASQSVLGFIAPMWLVGIGVATAVSVSPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGT
LIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSRGQGEHDVVALQSAESTSNPNR
>K1IK00|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF1170_03745|antibiotic inactivation|1
MKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTR
DLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDAPLHGPELI
DHYEELIKAAPQS
>C9YGN0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSGRVVLDIVLLIKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDEKAKVFDIAIQTG
AIFAVILVYWQKIRDTLVALPTDKAAQRFALNVLIGFFPAVILGLLFGKAIKAHLFTPAV
VATTFIVGGFIILWAERRQSAGGNAVRVHSVDDMTALDALKVGLVQCLAMIPGTSRSGST
IIGGMLLGLSRKAATDFSFFLAIPTLIGAGAYSLYKERALLSMADAPMFLVGLVFSFISA
WLCVRWLLKFISTHSFVGFAYYRIVFGCVVLVTAWTGLVVWAE
>R2XNF3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLIANIFKAIILGIVEGITEWLPISSTGHLILADEFIRLNMSPAFIEMFNVVIQLGAILA
VVVLFFSKLNPFAPSKNHKERQETWTLWFKVIIACLPAAVIGLPLDDFLDEHFHKFLPVA
IMLIVYGIAFIVVERMNKNKTPKCTNLNDFTYKAALIVGGFQLLSLIPGTSRSGATILGA
IIIGSSRYVATEFSFFLGIPVMFGASGLKIVKFLMHGNTFGASEIIVLLVGMVTAFVVSI
IAIKFLLDYIKRNDFTVFGWYRIVLGIILIGYWLIAM
>AAY21388|FEATURES|ARDB_deepARG|multidrug|EmeA|antibiotic efflux|1
MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPI
AGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAPALLMPSVTAFVA
DMTTISERPKAMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVL
KEPEKRILAAVEAKKGSFMDILRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTT
SEIAIVITVSGILALICQLFFFDAIVQKIGEMGLIQLTFFASAIFIAVIAFTKNNLVVVF
STFIVFLAFDLFRPAVTTYLSKHAGDQQGTINGLNSTFTSFGNILGPMAAGALFDINHFF
PYYVSAVILLGTGFLSLFLNRNKM
>A0A060L031|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCNTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
CDTTSPRAMAQTLRNLTLGKALGDSQRAQLATWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAPAAKIVTDGL
>L7ZUS6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIMVDDLWLKSTEFLGKYAANTFKVVIQLGS
ILAAVVVFKDRFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTK
TVLIGLVLGALLMIAADQFAKKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTIS
GGVLVGMSHRAAADFTFIMAVPIMAGASGLSLLKNWQYVTTADIPFFIAGFLSAFVFALL
AIRFFLELINRIRLVPFAVYRIVLAIVIYFLYF
>E8U924|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MENWLIAIIQGIVEGVTEFLPISSTGHLIVTGDLLKPDWSKAAGDTFEVVIQGGAILAVL
VYYARDLLGQARVIGHDQPTQRLWAGVVAACLPALMLGVLFSSKIKEVLFRPTVVAWALI
VGGILMYLIELRPRQARVRELKEIGVGKAFLIGAAQCLALLWPGFSRSASSILGGMLMGL
DRPTATKFSFYLGIPTLGGAALVDFIRNRDVLGEIGMGSVAIGFITSFVVAYFAIGWLLQ
YVSKHDFKGFAIYRIIAGAVILALIATGVIHDTIRV
>A0A0G9I870|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDMFSALLLGILEGLTEFLPVSSTGHLLIAEQWLGRRSDFFNIVIQAGAILATTLVFRQ
KLWSLATGLGDRGNRDYVLKLGTAFLVTAVVGLAVRKAGWQLPETVQPVAWALVIGGVWM
LVAEHFAAKLPERELVTWKVAIAVGLAQVVAGVFPGTSRSAATIFLAMLLGLSKRSAAAD
FAFLVGIPTMFAASGYSFLELYKDGAVGSEDWGDVAIAFAAAVVTGFVVVKWLLGYIKSH
RFTAFAVYRIVLGAALLLWLPAA
>A0A0U4KAY1|FEATURES|UNIPROT_deepARG|polymyxin|yfbG|antibiotic target alteration|0
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
NVNHPLWVERIAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFTYVGNQKF
TVWSSRVHPHASKAQPGSVISIAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLLIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A103ESZ8|FEATURES|UNIPROT_deepARG|aminoglycoside|WS70_17400|antibiotic inactivation|1
MTHPASLFTIRAATASDAPAWRQLRRALWPHADDAEHARDVAQQLDAPNRHACFIAWTPD
DAPLGFAEVAVRRDYVNGCNTSPALFLEGIFVDPAARRRGVARALCSAAAVWGATCGCAE
FASDAPLGNAASHALHRALGFDETERVVFFRKTLAR
>A0A0R1S8G0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDVIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQSTQFTDMFNVVIQLGAIMAVV
VLYFHKLNPLSPRKTAIEKNRTWVLWFKVIVAVLPSVVLGLLLNDWMDAHLMNWAVVAAM
LLVYGVLFIVIENWNANRRPRFTDLNTLPYQTALIIGMFQLLSLVPGTSRSGATILGAIL
IGASRYVATEFSFFLAIPTMFGASLLKVYKYFAHGGVFTGLQTMILATGMIVSFVVAYLA
IRFLLNYIKNNNFKVFGWYRIVLSLIVIVYFGFMSK
>A0A0M3SV33|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDIAIALKALILGIVEGLTEFLPISSTGHLILAGELLNFNDEKGKIFEIVIQFGAILAVC
WEFRRRIVDVVGGLATEPRAQRFAINVIIATVPAIVLAFLLGKWIKAYLFNPITVATAFI
VGGLVILLAEWRESRRGQVSHPQGNALLEAAKASAPRIESVDDMNWRDALKVGIAQCFAL
VPGTSRSGATIIGGMLFGLSRQVATEFSFFLAIPVIFGASVYELYKARDLLSADDIGVFA
IGFVFAFLSAFLCVRWLLRFVATHDFKPFAWYRIVFGVLVLATAQLGIVAWHG
>YP_001696597|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
ILAVIVVMWKRMLSLVGLYKIDGQSQSINRRFNLLHVIVGMLPAVVLGFAFKDFIDDHLF
KVEHVVYALVAGAILMIAADKLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGA
TISGGVLFGMSHRVAADFTFIMAVPIMAGASLVSVLKNWDTLSMDYFGFYAVGFISSFIF
ALLSIKFFLALISKVKLMPFAIYRLVLAAVLCVIIFM
>A0A0P7CV73|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAIAFNIIIQLAAILAVV
WEFRGKILEVVFGLTSQPTARRFTGNLLLAFLPAVVLGVLFADLIHHYLFNPITVATALV
VGGVIMFWAERRTHRVAVDHVDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLS
RKAATEFSFFLAMPTMVGAAVYSGYKYRELFQPGDLPVFAIGFVTSFIFAMIAVRALLKF
IANHSYATFAWYRIAFGLLILATWQFGWIDWSTAQG
>ZP_03822933|FEATURES|ARDB_deepARG|aminoglycoside|AAC(6')-Ig|antibiotic inactivation|1
MNIKPASEASLKDWLELRNKLWSDSESSHLQEMHQLLTEKYALQLLAYSDHQAIAMLEAS
IRFEYVNGTETSPVGFLEGIYVLPEQRRSGVATMLIRQAEVWAKQFSCTEFASDAALDNV
ISHAMHRSLGFQETEKVVYFSKKID
>A0A0B5SBV6|FEATURES|UNIPROT_deepARG|fosfomycin|fosB|antibiotic inactivation|1
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
HQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESIYFVDPDGHKFEFHSGT
LQDRLNYYREEKPHMTFY
>A8U5A9|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MIFIELLKAVFLGVVEGITEWLPISSTGHMILVEEFIQLDASAAFKEMFFVVIQLGAILA
VVLLYFNKLNPFSPKKSTQEKKDTMSIWYKVVVGVLPAAVLGFLFDDWLNDHLYNYWTVA
IMLIVYGILFIIIENRNKGKESSINSFQDLTYKTAFLIGMFQVLSLIPGTSRSGATILGA
ILIGTSRFVATEYSFFLSIPIMFGASFLKLFKFGFAFTGMEVAILLTGMIVAFVVSVIAI
KFLMGYIKNNDFKAFGWYRIILGILVIGYFIFFG
>A0A149SUX4|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFPAKADSFSEQAREVLRPMMKKYDIPGLVVGITRNGKHEFYAAGVASRADNRAVTPDTL
FELGSISKIFNVTLAALAEERGELSLNETVAHYVCVDACSIGNRLTLMDLATHHSGGLPL
QVPGSITDVDGLVAWLKNWHPSEPGARSYSNISIGMLGYITGKAMGSDYKQVVQDVLIPM
FRLQHTWIDIPESEMGQYAWGYDRKTNAPIRMSPGVLADEAYGIKSNARDMLKVLDVEMG
QGAASEELRKAVKKTHDGQYKTAFFTQDMIWEQYSWPTNLHTMTLGNGSDFIMKPQSEQK
LSPPLPPQKNVLLNKTGSTNGFGGYIVILPGENIGVVVLANKNYPNEARVKAVYSLIEGL
HSKQ
>V4QZX7|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MHYLLAALLGLIEGLTEFLPVSSTAHLLIAEKLMAFSDPGGNFAVMIQLGAILAVVVLYF
QRLFKAVISIPTSADSRRFAISVLVAFFPAVVIGVVVKKSGLLSDFFENVPLICSALIVG
GIALWAVDKFAPKPVYHDSSALDVKTSLLIGLFQCMAIIPGMSRSGSTLIGAMVCKVDKK
AGAEFSFFLAIPTMLGAFAVEFADSHKLLTADQYGLIAIGFVVAFLSALLVIKPFIGFVQ
KRGYGLFALWRILVGVGGLVWWFGFAHAG
>AAY63943|FEATURES|ARDB_deepARG|tetracycline|tetM|antibiotic target protection|1
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
TSFQWENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMG
IPTIFFINKIDQNGIDLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIE
GNDDLLEKYMSGKSLEALELEQEESIRFQNCSLFPVYHGSAKNNIGIDNLIEVITNKFYS
STHRGQSELCGKVFKIEYSEKRQRLAYIRLYSGVLHLRDSVRISEKEKIKITEMYTSING
ELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREM
LLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVEIEIKEPTVIY
MERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQNAVMEG
IRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYL
SFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGR
SVCLTELKGYHVTTGEPVCQPRRPNSRIDKVRYMFNKIT
>A0A127SU79|FEATURES|UNIPROT_deepARG|beta_lactam|BL1_ec|antibiotic inactivation|1
MAGRFVWKPDPMFKTTLCALLITSSCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
YQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYW
PELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANS
SIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSP
GALDAETYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEM
LDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKE
LGIVMLANKNYPNPARVTAAWQILNALQ
>V1H410|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTAACESLGKAWEILLIDDGSSDSSAELMVK
ASQEAGSHIISILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEG
FDVVGTVRQNRQDSLFRKSASKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHER
STFIPILANIFARRATEIPVHHAEREFGDSKYSFMRLINLMYDLVTCLTTTPLRLLSLLG
SVIAIGGFSLSVLLIVLRLALGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYN
DVRARPRYFVQQVIYPESTPFTEENHQ
>YP_002847014|FEATURES|ARDB_deepARG|beta_lactam|CMY-59|antibiotic inactivation|1
MSTRCKSNTLIASDGPGHPFAFNYGTDFMMKKSLCCALLLTASFSTFASAKTEQQIADIV
NRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGV
LGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALL
RFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVP
QNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSNVTDMARWVQVNMDASRVQEKTLQQGI
ALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASW
VHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>I5ARK4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MILNIFKTIILGMVEGITEWLPVSSTGHLILVNSIMKLDMSHAFVEMFDVVVQLGAILAV
VVIYFKKLWPFRMKGETAVKSQFAHVQTEGAGARFQKFADRYLYMDKVVMWLKILVSVIP
AIVIGFPLDDWLDEHLYNAMVVALMLILYGIFFILIENRNRGQKPRVDRLRKITMKDALI
IGLFQCLAMIPGTSRSGATIIGGILIGMSRTVAAEYTFYLAIPTMFGASALKLLKFIKNG
GGFGGGELLILAIGMAVAFAVSIFTIKFLMDYIRKHDFKVFGWYRIGLGALVLILGFANL
I
>A0A0U1XY91|FEATURES|UNIPROT_deepARG|beta_lactam|blaOXA-48-like|antibiotic inactivation|1
QGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLI
TAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIEQISF
LRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRIEPKIGWWVGWVELDDNV
WFFAMNMDMP
>A0A124ESD6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MSLVREIGGGPYALAAGPDGAMWVTLVHDGAIARVGADGDVERFPVAAGSRPSLITAGPD
GALWFTRNGDDRIGRITTEGALTAFPLAEGSAPFGICVGADGALWFTEMGSGGIGRITVD
GEVSGWASVGGTPSMITRGPDDAVWFTLNQGNAIGRLHPGDGVTARELPTRGAGPVGITA
THDDAIWFTEFLADKLGRMPLDGALQEIDLPGKPHAVVADPAGGVWVSLWGADRLARVGA
DGDVETYDLPPGSEPHGLAFGPDGALWVALESGFVLRMPD
>CAP74085|FEATURES|ARDB_deepARG|chloramphenicol|catB3|antibiotic inactivation|1
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
SFCSIGSGASFIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIG
SGAMVMPGIKIGHGAVIGSRSLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWN
WSLEKIKAAVPMLCSSNIVGLHKYWLEFAV
>G8B4F8|FEATURES|UNIPROT_deepARG|beta_lactam|IMP-10|antibiotic inactivation|1
MSKLSVFLIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ABW78937|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLTIVALYMELPVWIAMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLDPNFIREMKEGIVVMRQNKGLFALLLLGTLYTFVYMPINA
LYPLISMEYFNGTPMHISITEIAFASGMLAGGLILGRLGSYEKRVPLITGSFFMMGASLA
IAGLLPPSGFFIFVVCCAIMGLSVPFYSGVQTALFQQKIKPEYLGRVFSFTGSIMSLAMP
LGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMMTEVRKLDLK
>A0A0I9QPR9|FEATURES|UNIPROT_deepARG|beta_lactam|CARB-17|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLTGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0F3IH11|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MELIIILKAFILGVVEGFTEFLPVSSTGHLILTGDLLNFNDEKGKVFEIVIQMGAIMAVC
FEYRTKIAQVIVGLPNQKSAQKFTLNLAIAFIPLAVLGLLFGDFITDVLFKPVPVALAFI
IGAFVIIWAEKRNHTIRIHEVDDLSAIDALKLGLAQAFALIPGTSRSGATIIGGLLFGLS
RKAATEFSFFLAIPTLTIASLYKLYKHRELLSLATDSVYFAVGLTAAFISALLAIKALLQ
YISRHDFIVFAWYRIAFGIVVLATAYSGVVDWTVD
>D0S1V7|FEATURES|UNIPROT_deepARG|beta_lactam|HMPREF0012_00293|antibiotic inactivation|1
MFDELIMRFKKISYLILPSLFIFNTSIYAGNTSKEHDIKKVVDQNFKPLLEKYDVPGMAV
GVIQNNKKYEMYYGLQSVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKEKISFDDTPG
KYWKELKNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQY
SNPSIGLFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPI
RVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALG
WEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKEN
IGLVMLTNKRIPNEERIKAAYAVLNAIKK
>K5UZS7|FEATURES|UNIPROT_deepARG|beta_lactam|pse4|antibiotic inactivation|1
MKKLFLLLGLLACSSATYAAKINEDLAAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
MSTFKTLACATMLNDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSVGGPRGVTMFLRTIGDKATRLDRFEPRLNEAKPGDKQDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAM
VWKENHKPVYISIYITGTDLSLQARDQVIAQISQLVLDEYKNI
>A0A0T6YU28|FEATURES|UNIPROT_deepARG|aminoglycoside|N182_21955|antibiotic inactivation|1
MRVLLMDGETIGRWVEMRLALWPDTPAADHRAEVESSLAEGDRYASFLCEDEAGVAAGFA
EASIRHDYVNGCETSPVGFLEGIYVLPAYRRRGVARALITAVERWATSRGCQELASDTAT
DNLRSQSLHMALGFEETERVVYFRKELAPAVADN
>A0A142G2V3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKQLNRYFGEGENRVHVLKDISLSIEKGDFVAIMGQSGSGKSTLMNIIGCLDTAT
GGSYKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLTAAENVALPAIYAGMPQNQR
LERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKHQVKSAVKNPSVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPNTSSSGILVVGNKS
FTSANLYGISEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKKAIFANENPLGKTV
IFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRIGSITVKISDDVNSTV
AEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGARQINILQQFLIEAVLICLIGGVAGILLSVLIGVLFNSFITD
FSMDFSTASIVTAVLFSTLIGVLFGYMPAKKAAELNPITALAQE
>W1WWS7|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
ASQAETSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEG
YDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHER
STFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLG
SIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYT
DVRARPRYFVQQVIRPSSKENE
>A0A0J6M651|FEATURES|UNIPROT_deepARG|chloramphenicol|VK95_20590|antibiotic inactivation|1
MKKTPPEYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKAVGWKFYPTII
FLLSNIMNRHPEFRMAMKDNELVIWNEVHPSYTIFHPETETFSSLWSHYDGNIHHFQNTY
AEDTARYGNSLSYWPKEESRENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQ
DGKVLLPLAVQVHHSVCDGFHVARMFNELQEMCDGLPELSEEPGA
>A0A063XVN3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTVLLELKDIRRSYPSGDEQVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
SSGTYRVAGTDVSTLGGDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSDRKA
RLIRARELLTRLGLGERTEYQPSQLSGGQQQRVSIARALMNGGQVILADEPAGALDSHSG
EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGELISNPPARERAVTAGNRDAV
SVQVGGWRQFISRFHEALTMAWRAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLV
LADIRSIGTNTIDVYPGKDFGDDEPQYQQALKYDDLLAIQKQPWVRSATPSVSQNLRLRN
DNIDVAASANGVSGQYFNVYGMTFSEGASFNAEQEKGRAQVVVLDSNTRRQLFPNKVSVV
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKDGY
SSEQAEQQLTRLLNLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGV
MNIMLVSVTERTREIGIRMAVGARAGDVLSQFLIEAVFVCLVGGALGVTLSMLIAFTLQL
FLPGWEIGFSPVALITAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>ABS19068|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MKPNRPLIVILCTVALDAVGIGLIMPVLPGLLRDLVHSNDVTAHYGILLALYALMQFACA
PVLGALSDRFGRRPVLLVSLSGAAIDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYI
ADITDGDERARYFGFMSACFGFGMVAGPVLGGLMSSFSPHAPFFAAAALNGLNFLMGIFL
LPESHKGERRPLRREALNPLASFRWVRGMTVIAALMAVFFIMQLVGQAPATLWVIFGEDR
FHWDTSLIGISLAAFGILHSLAQAMITGPVTTRLGERRALMLGMIADGAGYILLALATRG
WMAFPIMVLLASGGIGMPALQAVLSRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYA
ASITTWNGWAWIAGAALYLLCLPALRRGFWSGVGQRADR
>F2AKF1|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MIQLYGLRKDYRVGDHDLPVLRGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
DYHLAGIDVSSLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRREC
IEDATKLLESVGLGGRLDHMPNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQ
EILALFRQLNQEHGITLVVVTHDAEVAHEADRVVRMKDGLVAEDVRQRASTVDRSRLANS
RAEPLREPASAGSLPATWNAVVVAVLALRRNALRTVLTMLGVIIGVASVISTMELSAGAS
TAIEETVASMGASMLTISPGKASSTSGRQRPIQIIPDDVVAVAEQCSAVKVAAPLVYSQV
QLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCILGKTVAHELFD
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
TFADQMPPMQLASTRRSTQREEIHQIYVEAESPDHVELARQQITQVLSRRHNVEPAGAYR
INDITEVSKVVGQVVGGVSALGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGA
NRSAILRQFLIEATVLCVVGGFIGIFAGHMWSVLVGRVIGWPTAMSIWAPIVAVTVAATV
GIVFGYYPARTASRLNPIDALRYE
>ZP_01172287|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MMKEMIVALILGIVEGLTEFAPVSSTGHMIIVDDILLKSKELFSKEVANTFKVVIQLGSI
LAVVIVFKDRFIQLLGLGKGGKEQSDGPRLKLTQVIAGLLPAAVLGLLFEDYIDKYLFSV
NTVVIGLVAGALLMIAADYYSKRKPAIETVDKITYRQAILIGLFQCIALWPGFSRSGSTI
SGGVLLGLSHRAASDFTFIMAVPVMLGASGLSLLKNWEYFTPDAIPFFIVGFISAFVFAL
ASIRFFLALINRIKLVPFAIYRIILAAVIYFVFL
>B1TFK7|FEATURES|UNIPROT_deepARG|beta_lactam|BamMEX5DRAFT_6573|antibiotic inactivation|1
MRFNAIRIAATLFVAACAAVTAGRAAAATPDEIHDTVTRNVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLSDPAAKYLPA
LQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDDAGLMRYLDAWRPAYTPGTRRTYSNVAI
GMLGQLTAKAMNRDFAALMEQRLFPALGMTHTYINVPAARQGDYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLVDTAPRLQRALERTHTGYFRAGPFTQDLIWEQYP
YPVALPTLLEGNGPPMLHDATPTTELKPPLAPRPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRNFPIEDRVKAAYLIVEALDGKP
>A0A085GXL6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
VMFWRRLFGLIGIHFGQPPVHEGKTQGHLTLGHILLAMIPAVVLGLVFHDAIKTLFAPRT
VVYALVVGGFLLLAAEWLKPKQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVSRFAASEFSFILAVPMMMGATALELYKSLPFLSMADLPMFAVGFVTAFIVALIA
IKTFLSVIKRISFVPFAIYRFIVAAVVYMVFL
>A0A0U2VPX1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDILIAIIMGIVEGLTEFLPVSSTGHMILTAHLLGFEGEKAKTFEIVIQLGAVLAVFVL
YWRRFLGMLHFKPGYMQERRANIVHVALAMAPAVVIGLALHSLIKTYLFGPETVLVGLVA
GGILMIVAEKSRRKVTAETMDDISYKQAFGIGVFQCLALWPGFSRSGSTISGGMLLGTSQ
KAAAEFTFIVSVPIMFAATILDLYKSREYLSVEDMGLFITGLVSAFVVAMIAVVTFLNLI
KRLKLSWFAYYRFVLAAIFIYVLFM
>CAR59037|FEATURES|ARDB_deepARG|beta_lactam|pbp2|antibiotic target alteration|1
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
APTRGIIYDRNGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALK
SSSRYRPVVLKNALTDVEIARFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKIND
NDLKALDKKGLAENYAADHNIGKQGIERYYENDLHGKTGYQEVEVDNHGRIVRLLKDVPP
IAGKNIHLTLDLHLQEYIESLLAGQRAAVLVEDPHDGSVLAMVSMPSYDPTPFVKGISYQ
DYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCGIITPQTTFFGAPTWTLPGTQ
RHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYGKPTGIDLSEE
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
LNEESGKTVVPYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNRTGYKFFHTAPYGIAA
KSGTSQVFSLKENQTYNAKMIPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAP
IMRKILDHLFDPQADTTQSGQAP
>BAA05208|FEATURES|ARDB_deepARG|tetracycline|tetL|antibiotic efflux|1
MNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
TFSIGTALYGKLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAF
PALVMVVVARYIPKENRGKAFGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATII
TVPFLIKLLKKEERIRGHIDMAGIILMSAGIVFFMLFTTSYRFSFLIISILAFFIFVQHI
RKAQDPFVDPELGKNVFFVIGTLCGGLIFGTVAGFVSMVPYMMKDVHHLSTAAIGSGIIF
PGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIAAFFIDAAPWIMTIIVIFVFG
GLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIGFLDHRLLPI
DVDHSTYLYSNMLILFAGIIVICWLVILNVYKRSRRHG
>R9R9J8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKFIGGEYLSPNFINSFLIIIQLGAIFSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLNNVLIVAIT
LITYGVIFIGIEIVYKLKNIKPKVKRFSGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYIVI
KWFMDFIKKRSFASFGLYRIILGIVVIILLH
>CAG34024|FEATURES|ARDB_deepARG|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MDERELIERADGPVTRCRLVRDLKELGVGPGDTVMVHTRMSAVGYVVGGTQTLIGALLNA
VGDTGTLMAYCGWNDAPPYDLADWPPEWRDAARAAWPAYDTRFSEADHGVGRVPEALRHW
PGAVRSRHPDASFVAVGPAAHRLMDDHPWDDPHGPDSPLGRLTRDGGRVLLLGAPLDALT
LLHHAEALAEAPGKRYVEYEQPITVDGRRVWRRFRDVDTQTEAFPYGRVVPEGVWPFTVM
AEEMLAAGIGRTGRVGAAPSHLFEAPDVVRFGVEWIESRLGEAADGS
>ABX79411|FEATURES|ARDB_deepARG|glycopeptide|VanRC|antibiotic target alteration|0
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
GFQLLQNIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRY
QRYNQSAVPQKIEEYEKEGLLLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASE
TLFEAVWKEKYLDNNNTVMAHIARLREKLNEQPRKPKLIKTVWGVGYIIEK
>W4V0G2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MGDLTLIETIIIAIVEGLTEFLPVSSTGHMIIAQNMLGVESTEFVKAFTVIIQFGAILSV
VCLYWKRFFRLRPICIFAPEATVGKSIPAKLGIWLKRFLQKFDFYWKLLVAFIPAAFIGL
LFSDKIDEMLESVTVVAVMLVIGGIFMLFCDRIFTKSEEGMELTEKKAFNIGLFQCIAMI
PGVSRSMATIVGGMAQKMTRKDAAEFSFFLAVPTMFAATGYKLLKLFLNGGVDVLVDNMA
ALIIGNVVAFIVALLAIKFFINFVTKYGFKAFGWYRILVGGAILIMLMLGYNLEIA
>CAG30567|FEATURES|ARDB_deepARG|tetracycline|tetO|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK
IPTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM
GNDELLEKYMSGKPFKMSELEQEENRKFQTGTLFPVYHGSAKNNLGIRQLKKGIASKFYS
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQVKNDEVILKGEIPARCIQEYRNDLTYFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>A0A0H3NSH2|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPNLNQSKILLQLDNVSRWFISGEERVRVLKNINLTVHSGEMVAIVGASGSGKSTLMNIL
GCLDKPSSGEYLVAGRIPQHLDSNELAELRREHFGFIFQRYHLLNDLSAQENVEIPAIYA
GVNREERRLRAASLLSRLGLVDRLDYRPSQLSGGQQQRVSIARALMNGGEVILADEPTGA
LDTHSGTEVLNILKGLHQQGHTVVIVTHDMSIAEHAQRIIALRDGEVISDRQMPQPELPA
KISTIETPDIAHKPPLTSWKA
>CAQ51492|FEATURES|ARDB_deepARG|tetracycline|tetH|antibiotic efflux|1
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
LGRLSDKYGRKPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSD
VTPAKNRTRYFGFLGGAFGVGLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFR
ETQKREALVANRTPENQTASNTVTVFFKKSLYFWLATYFIIQLIGQIPATIWVLFTQYRF
DWNTTSIGMSLAVLGVLHIFFQAIVAGKLAQKWGEKTTIMISMSIDMMGCLLLAWIGHVW
VILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLVSLTNITGIIGPLLFAFIYSY
SVAYWDGLLWLMGAILYAMLLITAYFHQRKTTP
>A0A127SFJ6|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-198|antibiotic inactivation|1
MIKIQIVISALLWSMPALAEDPALTELFSQQGVQGTIVMSSLNGGKTFIHNDLRAGQRFS
PASTFKIPNTLIALEEKALAGKDDIFKWDGQIHDVATWNHDQTLTSAFKVSCVWCFQELA
RRVGAEKYQQYLRALNYGEWREPFVATTFWLDGSLQISALEQVNFLRRVYRRELPLSDHA
YETLKHIMLVEQGNTYTLWAKTGWAARVTPPVGWYVGYVETPTDVWVFATNIELRDEKDL
ELRQKLTRSALQVKGVIH
>R8JZD6|FEATURES|UNIPROT_deepARG|beta_lactam|ICS_05495|antibiotic inactivation|1
MFVLNKFFTISHYKKIVPVVLLSCVTLIGCSNSNTSSESPKQTKQTNQIKPENTGNDSFA
KLEKEYDAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDEKITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTALPKEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNKK
>A0A0T9KE13|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB_1|antibiotic efflux|1
MAALLELKGIRRSYQSGEQTVDVLQDVSLEINAGELVAIIGASGSGKSTLMNILGCLDKP
SEGIYRVAGQDVDSMDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKQE
RRERAKMLLTRLGLGERINYRPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSS
VEVMAILKQLQQQGHTVIIVTHDPTVAAQAERIIEIKDGRIMADSGSKMPPKTAEPDTLI
LTPPAPSWQQLAGRFREALLMAWRAMASNKMRTALTMLGIIIGIASVVSILVVGDAAKQM
VLADIRAIGTNTIDIYPGKDFGDDDPSNRQALVYDDMAALKAQSYVNAVSPVISGSMRLR
FGNIDVAGSVSGVSAQYFRVYGMGIEQGTAITQDQVVRQAQAVVIDRNTQRRLFPHMKDV
VGQVMLIGNMPATIVGVVEEKQSMFGSSKSLRVWIPYTTMANRLMGKSYFDSITVRINDG
YNSKEAEQQLVRLLTLRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIG
VMNIMLVSVTERTREIGIRMAVGARSSDVMQQFLIEAVLVCLVGGALGITLSFAIGLAVE
MVLPNWQVSFPPVALASAFLCSTIIGVVFGYLPARSAAKLNPIDALARE
>A0A0P7LEY6|FEATURES|UNIPROT_deepARG|beta_lactam|ACU57_19250|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWIRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NSSGNKIALAARPVKAITPPTPAVRASWVHKAGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>H9TK08|FEATURES|UNIPROT_deepARG|aminoglycoside|strA|antibiotic inactivation|1
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
RRCGLPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQC
PFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVV
CHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAV
LFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0D0J707|FEATURES|UNIPROT_deepARG|beta_lactam|SN10_19300|antibiotic inactivation|1
MKKLFLLLGLLVCSSATYAAKLNEDISAIEQHIAGRIGVAIWDTQSNEHWDYRGDERFPM
MSTFKTLACATMLNQMDTGKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTLFLRSLGDKATRLDRFEPRLNEAKPGDKQDTTTPNAMVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDPLIRSVLPKGWSIADRSGAGGFGSRGVTAM
IWKENHKPIYVSIYITETDLSLQARNQVIAQISQLIVDQYQTY
>A0A0V8HGH0|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLYTLIKAVILGLVEGLTEFAPISSTGHMIIVDDLWLQSKEFLGKYPANTFKVVIQLGS
ILAVIVIFRERFMDMLDFKSRRTAVKSSGDKLKLSHIIVGLLPAGVLGVLFEDVIDEYLF
SIETVLIGLFVGAVFMIIADMISSKYNSVKVESVDMITHKQALIVGLIQCLALWPGFSRS
GSTISGGVLLGMNHRTAADFTFIMAVPIMLGASVLSLAKNWQYFTIDAFPFMAAGFISAF
IFALVSIKFFLKLINKVKLIPFALYRILLVLVIYVLYF
>A0A0S1Z261|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLTELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A0S7C543|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MTVIEAIIIAIVEGITEFLPVSSTGHMIITQELLGMKIDDFVKAFTVNIQFGAILSVVVL
YWKRFFQSLQFYYKLFVAFIPAAVIGFLAGDFIDSMLESVVVVAVMLVLGGVVLVFVDKW
FNKPAADQTVTYPTAFKIGLFQCIAMIPGVSRSAATIIGGMTQKLDRKTAAEFSFFLAVP
TMFAAAGYKLMQNYQTITAENIDILLIGNAVAFVVAMIAIKSFISFLTKYGFRVFGYYRI
LVGLAILIMIALGYDLNIA
>D0UXZ6|FEATURES|UNIPROT_deepARG|aminoglycoside|aadA1|antibiotic inactivation|1
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
TTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPSDWA
GDERNVVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLA
SRADQLEEFVHYVKGEITKVVGK
>R8X793|FEATURES|UNIPROT_deepARG|beta_lactam|WC7_00171|antibiotic inactivation|1
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMSKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQHGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>R8QJ89|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
SIISDQTGDLWFTEYNSSKIGKMSMNGLFGEYVLPTTNAAPFGITEGPDGAIWFTEMNNG
RIGRITKSGEITEFELPNSKSFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPT
PNSGPVGIASGPDGAIWFVQIIGNKIGRITFEGEIKEFVIPTPNARPHAIIPGKNRDLWF
TEWGGNQISRITVEGVITEYTIPTNNAEPHDITFCPDGDLWFAEECNQIGRLTIIT
>A0A063XMF6|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDLHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
VVMFWRRLFGLIGIHFGKQPHEGTGTGRLSLIHIILGMIPAVVMGLVFHDTIKSLFNPLN
VTYALVVGGFLLIAAEVLKPKVPRAQGVDDMTYRQAFIIGCFQCLALWPGFSRSGATISG
GMLMGVSRYAASEFSFLLAVPMMLGATALDLYKSMGFLTTGDIPMFAVGFITAFIVALIA
IKTFLELIKRISFIPFAIYRFIVAAAVYLVFF
>A0A0F3WWG5|FEATURES|UNIPROT_deepARG|beta_lactam|SG66_19445|antibiotic inactivation|1
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVMVNMKPDSLEESSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>G9Y2P3|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MSNNEVIKNEADEIKKVSIVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDD
SAEILTRAAEIPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRL
VATAEQGYDVVGTVRAKRKDTWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEA
MLHCHERSTFIPILANTFARRTIEIDVRHDEREFGESKYSFLKLINLMYDLVTCLTTTPL
RLLSIVGSVIALSGFTLAVLLIAMRLIFGPTWAAEGVFTLFAVLFTFIGAQFVGLGLLGE
YIGRIYNDVRARPRYFVQKIVSADALKTHVSVEQQEEE
>YP_195816|FEATURES|ARDB_deepARG|tetracycline|tetA|antibiotic efflux|1
MNCEFKLIYCILKIRKVKIEKSEMNSSTKIALVITLFDAMGIGLIMPVLPTLLREFIASE
DIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWML
YLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISP
HSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIY
FSAQLIGQIPTTVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTA
VLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGL
LVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQ
ETSA
>F2BVL8|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MYQYFCAVIIGIVEGMTEYLPVSSTGHMIIVSSMLNFTGDLAKFFEVFIQLGAILSVLVV
YKEKFIFMLDTHHWFRKKGPSCFNIIISMIPACVMGLLFHGMIKKYLFGPETVIIGLIIG
GIFMIYGENKVKRKNVSVKNVEDINTKQAFKIGLFQCLSLWPGFSRSGSTIAGGLLLGVS
RKAAADFSFIMAVPLMFLATLYDLLKNIKYLHFSDIGVLLTGFIVSFIVAYLSIVWFLKF
LNKYNLTGFALYRFLVAIVAFLFVI
>Q0VTS6|FEATURES|UNIPROT_deepARG|beta_lactam|adc-19|antibiotic inactivation|1
MRFKKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVAVSMNKPFDQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0P9IUS7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MSRALLELKGVTRRFVAGEKDFIALNDINLTINAGDLIAITGASGSGKSTLMNVLGCLDH
ANSGSYKVDGRETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKS
MRVERAQKLLERLGLSGHLEHRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVS
GKEVMNILLELNSAGHTVILVTHDEKVAAHAERIIEMRDGEIIADRVNTDRPIINEKATE
RLPSKPRQGNRLMANIGLFQEAFVMAWVALISHRMRTLLTMLGIIIGITSVVSIVAIGEG
AKRYVLKDIEAIGSNTIEVFPGSDFGDTKSMDIQTLALSDVAALSSQYYIDSATPNIGRN
MLLRYRNIDVSATVSGVSPSYFQVRGTKMGSGVGFNKDDARRQAQVVVIDYNTRIRLFGP
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQSYLDSITVR
VKDGQPSKVVEDNVNKLMQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAV
GGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSFVIG
YVFSLLVKEWQMVFSVGSIVTAFICSTLIGIVFGFVPARNAAQLDPIEALARD
>A0A0M0T5Z9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MTFEKIKKVSVVIPVYNEEESLPQLLERTLAACQKLEQKYELILVDDGSHDSSVEILTQT
AESPENHVIAILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEIPRLVKTAEEGY
DVVGTRRLHRQDSWFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIVQAMLQCHERS
TFIPILANTFARRTIEIDVAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVAGS
IIAITGFLLAVLLIVLRLIFGSMWAAEGVFTLFAILFMFLGAQFVAMGLLGEYIGRIYND
VRARPRYFIQKVVGVKKTNDNQEES
>CAE16345|FEATURES|ARDB_deepARG|bacitracin|BacA|antibiotic target alteration|0
MTDLSTLFHAAILGVVEGLTEFLPVSSTGHMIIVGHMLGFTGDKAETFEVIIQLGSILAV
VVVFWRRLFGLIGIHFGEVPHEGKTNGKLKLSHIILAMLPAVTLGLMFHDVIKSLFNPQS
VMYALVIGGVLLITAEILKPKTPKAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISG
GMLMGVNRYTASEFSFILAVPMMMGASGLDLYKSLHFLSASDIPMFAVGFVTAFVVALVA
IKTFLALIKRISFIPFAIYRFIVAAAVYWVFM
>K9BKU8|FEATURES|UNIPROT_deepARG|bacitracin|uppP_2|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIFDLIKGFFSGDAEARHFAFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFDHKTTDATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGL
SRKAATEFSFFLAMPTMLGAAVFDLARNADVLTQDNMLNIAVGFVAAFISALFVVSALVK
FVERHTLRVFAWYRIVLGIILLFVFL
>A0A0N0X3R3|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
GSGKSTLMNILGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDA
VRNVEIPAIYAGTAQTTRHERAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGG
QVILADEPTGALDTASGKEVMRTLLELHAAGHTVILVTHDPKVAANAERIIEVSDGEIIS
DRRTAQTTQPAPEAQPATPPGPAPRRLLASLGLFREAFNMAWIALISHRMRTLLTMLGII
IGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANFGDSRAKSIETLLPSDVAALN
QLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITFSDQDARRQAQ
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
GRVLGQRHLDSISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRS
LTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVC
LMGGVIGIGLSYAIGYLFTLFVQQWEMVFSLASVVTAFACSTLIGVLFGFVPARNAARLD
PIEALARD
>ZP_02374815|FEATURES|ARDB_deepARG|multidrug|AmrB|antibiotic efflux|1
MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEES
VTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKTVEARLPEP
VRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAE
YAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLT
TPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVA
TEKRVRATMDELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQN
FRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMV
EEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFS
AFLALSLTPALCATLLKPVAGDHHEKDGFFGWFNRFVARSTHRYTQRVGRVLKRPLRWLV
VYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSP
SAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRAQDQVQAIIAGINAHFAGTPNTMVFA
INMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLADGRKDSVLTDLMFAGTQDAPQ
LKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGQHRLDPGDV
TKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIER
IASALPEGIGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVP
LGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQGMSLADAALEA
ARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFV
CVGRVVDIVPRRRGGARAALEIK
>G4A7M4|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MNIIEIKQLNRYFGEGENRVHVLKDISLSIEKGDFVAIMGQSGSGKSTLMNIIGCLDTTT
GGSYKIDGKETIELTNDQLSDLRSQKFGFIFQRYNLLSSLNAAENVALPAIYAGMPQSQR
LERAKQLLEKLGLGDKWQNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSHSGE
NVMEILRQLHEEGHTIIMVTHDKHIAASANRIIEIKDGEIISDTQKHQVKSAVKNPSVFK
GRFGFSKDQLMEAFRMSVSAIVAHKMRSLLTMLGIIIGITSVVSVVALGNGSQQKILENI
RGIGTNTMTIFNGNGFGDRRSRHIQNLKISDANTLSKQSYIQSVTPNTSSGGILVVGNKS
FTSANLYGIGEQYFDVEGLKLKQGRLLTEDDVDQSNQVVVLDESAKKAIFANENPLGKTV
IFNKRPFRVIGVVSDQQLGGFPGNSLNLYSPYSTVLNKITGGSRISSITVKISDDVNSTV
AEKSLTELLKSLHGKKDFFIMNSDTIKQTIENTTGTMKLLISSIAFISLIVGGIGVMNIM
LVSVTERTKEIGVRMAIGAHQINILQQFLIEAVLICLIGGVAGILLSVLIGVLFNSFITD
FSMDFSTASIVTAVVFSTLIGVLFGYMPAKKAAELNPITALAQE
>N8RPL8|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
WLYRQKIIDLLKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAVAL
IVGGLIIFWVESIKFEHKTTEATRITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGL
SRKAATEFSFFLAMPTMLGAATFDLIRNADVLTQDNMLNIAVGFVAAFIAALLVVSALVK
FVERHTLRVFAWYRIVLGVILLFIFL
>A0A142FK22|FEATURES|UNIPROT_deepARG|aminoglycoside|aph(3')-VIg|antibiotic inactivation|1
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
LSWLSEKLKVPELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNAVA
IIDCPFISNIDYRLKESKFFIDNHLLDEIDQDDFEAELWGDHKTYISLWNELNETRVEER
LVFSHGDITDSNIFIDKFNEIYFLDLGRAGLADEFVDISFVERCLREDASKETAKIFLKH
LKNDRPDKRNYFLKLDELN
>A0A0L0LBU0|FEATURES|UNIPROT_deepARG|bacitracin|bacA|antibiotic target alteration|0
MTWLDSVILGIVEGITEFLPVSSTGHLILASELLGLPSTEFLKSFEIAIQLGAILAVVIL
YWKSFLDVSILKKIAAAFIPTAVIGLALHGVAKTYLLGNIQVVLWALALGGAALIVFELL
HMEKDSAAGEVHDITYKQAIIVGLFQSIAIIPGVSRSAATIVGGLIAGIRRVAILEFSFL
LAVPVMAAATGLDLLKSAGTFSSADFGNLAIGFIVSFIVAFFSIRFLLQYVRKHTFIPFG
IYRIFIALVFFLFVVS
>M5CYY1|FEATURES|UNIPROT_deepARG|aminoglycoside|butA|antibiotic inactivation|1
MQATPASSDGMPLPSAWREALAGARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
ELGHEIARLRWLQAQGQPAPTVIATAEDAGRRWLLMSALPGRDLASSPELVPQRLVEVLA
DALRGLHALPVAACPFDQRLASRVQAAVARAEAGLVDADDFDDERLGQSAQQVLAELLAS
QPAHEDLVVSHGDACLPNLMVAEGRFSGFIDCGRLGVADRYQDLALAARSLVHNFGDTRW
VAPLFQRYGAVADERRLAFYRLLDEFF
>A0A127SDG9|FEATURES|UNIPROT_deepARG|beta_lactam|OXA-10|antibiotic inactivation|1
MNVSHQEGAMKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSC
ATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGA
IQVSAVPVFQQIAREVGEVRMQKYLKKISYGNQNISGGIDKFWLEGQLRISAVNQVEFLE
SLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETE
VYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>A0A0F5QAY4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNADQGLFVPLILGIIEGLTEFLPVSSTGHLLLAGHFFGLTQPATFIVLIQLGAILAIVT
VYFVKLGVLIRDALTGKAYAWHFALAVVIACLPAVVAGVLLRDFIQGDLWESTLLICLSL
LIGGVILLIVDRMPKQEKYDDIYQFPWHLALIIGLFQVISLIPGVSRSGSTVVGAMLFGA
TKRAAAEFTFFIALPIMVGAFGYDLYKSRDLIDMSVGINIAIGFAAAFVAGAIVVRYLLD
FVSKHGFAPFAYWRIAVGGAGLIALLVMR
>W4B7H8|FEATURES|UNIPROT_deepARG|chloramphenicol|C169_09248|antibiotic inactivation|1
MNFNVIDIKQWPRKPYFEHYTSVHECTYSMTLNVDVSLLLQSLRARGLKFYPAFIYMVTR
VVNERVEFRTSYHPKPLLGYWDSMTPSYTYFHHDDQTFSCVWTEFSDDFSRFHNRYEQDM
ERYRDVKGIFVKENPPPNTFFISMIPWASFSGFNLNMTNGNTDFRPIITGGKFAEQGGRM
LLPIALQVHHAVCDGYHASLFFQDLQTLADSCNEWL
>X6FM54|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MESQTIVEALLLGMIEGMTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
VYFHRLWQMLVDLPRDRVTRHFVLGILVAFLPAAVIGALAHGFIKTVLFESPRLICVMLI
IGGLVLLWVDRFKPKPLYHDVERFPLRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVD
KRAAAEFSFFLAMPTMVGAFAFDLFKNRNVLTSADLPIIAAGFIAAFVAALIVVRFLLNY
VSRHGYSLFGWWRLVIGTVGLAALFVRG
>A0A0M9X977|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MTDVSIEEHPVAGGGPYAITTGPDGALWYTLVHSGGIGRMVPGAEPVNHRLDPDCGPTII
TSGPDGALWFTEYRAHRIGRITTDGTVAEFPLPTPDCGPFGIAAGPDGALWFTETAADRI
GRITTGGAVTEFPLPATGAFPSAITAGPDGGMWFTMNQADAIGRITADGTVTVHPLPTAG
SAPVGIAPGPDGALWYVAIAAGLIGRITTEGGIREFPLPDRAGRPHAIAPGADGALWFTE
WGGNRVGSITVEGVIEVHDLPTSGSEPHGITLGPDGAVWTALETGALARLAPKPLPRPGR
EPHP
>J0VWZ3|FEATURES|UNIPROT_deepARG|beta_lactam|Rleg10DRAFT_6104|antibiotic inactivation|1
MKSIGISILSASMLMACAATSGFAADETKIKTITDAAIKPIIEKYAIPGVAVAITADGQD
HIFNYGVESKDTGRPVAPTTLFELGSISKTFTVTLASYAEASGQLSLSDKVGKFLPAMKG
KPFGDVTLMTLGTHTAGGFPLQLPDEVKTEKQLFGYFEAWQPSYAAGTQRSYANPSIGML
GYVVAKAMHGDFAALMEGKLFAALGLKSTYIDVPKARLADYAQGYKRSGEPARMTPAMLS
AEAYGVKSTAGDMIRFVGANMGLVKLDEKFQQAITNTHIGYFKAGAMTQDLIWEQYAYPP
SLNGLLQGNSPAMLETMPVSELQPPMKPRADAWINKTGSTNGFGAYVAFIPKQRLGIVIL
ANKNYPNEDRVAAAYQILTALSAD
>A0A0N0GC36|FEATURES|UNIPROT_deepARG|polymyxin|ABJ99_5169|antibiotic target alteration|0
MVVFAYHDIGCVGLQALLDADYEIAAVITHVDDPEEKTFFGSVAQLCARHDIPVHAPEDP
NHPLWIDRVSKLAPDFIFSFYYRALLSEPLLACAKRGAFNLHGSLLPRYRGRAPVNWVLV
NGETETGVTLHKMVKCADAGPVFAQQRISISATDTALTLHGKLREAAIALLSDALPLLAR
DQLSGTPQDESLATCFGRRTPADGLIDWSLPAARLYDLIRAVTQPYPGAFCPVGEHKLLI
WAARVEPSNNGVAPGTVISHNPLRIACGEGALIIRAGQRGDEGLYLSGTQLAREFGLVQG
SQLRDAKKQRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIGSDAIERLRAKPN
FHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRYCV
KYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQKG
LQFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVAD
GIEALARIIENRDGRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFAGFRD
VESQSFYGKGYQDVSHRKPGIDNARQLIGWAPGIALSETIGKTLDFFLREAMAEKADQC
>J8P410|FEATURES|UNIPROT_deepARG|beta_lactam|IKO_01882|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEVFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPITEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEATEVIVKALK
>A0A0Q4TN50|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDAMSIVKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFQSPNNTFEVLIQLGAILAILA
VYFRRLLGIAVAFPSDPNARRFVLGILLAFLPAAIIGGLFSKAIKFYLFNPWIVCATLVA
GGLVLLVLDETDLEVKKRDVFDFTLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADK
RSATEFSFYLAIPTMAGAFAKDLLDNYKNLSQDDAGLIVIGFVVAFLSAFVVVRTVLDYV
SSHGFRLFAWWRIIVGSLGFAGLILFG
>K8WPA4|FEATURES|UNIPROT_deepARG|polymyxin|arnA|antibiotic target alteration|0
MKAIVFAYHDIGCVGLKALKKAGYDIQAVFTHTDDPNENHFYSSVARVSADMELPVYAPE
NVNHPLWIERIRELKPDVIFSFYYRDMLSEEILSLAPKGAFNLHGSLLPKYRGRAPINWA
LLNGETETGVTLHKMVAKADAGDIVAQEKVAISDTDTALTLHAKVREAAEVLLDKTLPLI
EAGSYTSVPQDESQASYFGRRSEKDGLIDWNRSAKEIDCLIRAVTEPYPGAFTYLGARKM
IIWRARVLDDNQGKRAGTVLSNDPLRIACGEGAIEIVSGQGDSGLYMQGNRLANEMGIVT
DVRVGSKPTAQIKRRTRVLILGVNGFIGNHLTERLLQDDNYDIYGMDISSSAIDRFIGNP
RFHFIEGDVSIHTEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLKVVRYC
VKYNKRIIFPSTSEVYGMCDDKEFDEDESRLIVGPINKQRWIYSVSKQLLDRVIWAYGAK
ENLKFTLFRPFNWMGPRLDSLNSARIGSSRAITQLILNLVEGSPIKLVDGGEQKRCFTDI
KDGIEALFRIIENKDGKCDGQIINIGNPTNEASIRQLAEMLLESFENHPLRGNFPPFAGF
REIESSSYYGKGYQDVEHRKPSIENARRLLEWEPSIDMKDTIEETLDFFLQGAVEELGKN
>YP_637442|FEATURES|ARDB_deepARG|aminoglycoside|Aac2I|antibiotic inactivation|1
MAGTPRWYNDGVLPQLSSEVRGHGVIHTARLVHTADLDNETREGARRMVSEAFRGDFTDD
DWEHALGGMHALICSHGVLIAHAAVVQRRLLYRDAALRCGYIEAVAVREDCRGQGLGSAV
MDACEQVLRGAYQLGALATSTMARPMYRARGWVPWRGPTSVLSPGGRISTPGDDGSVFVY
PVGSALGSTDLDTTAELTCDWRHGDVW
>W0MTM8|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MSRNGTLLCTGLVLVSSIAFAEDKPATFDAFVQAEASKVMQENHIAGLSIAITRNGKQQF
YNYGVASKTTGQPVTSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPHLQATR
LGKVPVFHLGTHTAGGFPLQVPDQVQNTRQLMAYFKAWQPEYLPGTHRTYANPSVGLLGM
VAARSMRQPYEDALQQRLFPALGLNNTYVRVPDEKQAFYAQGYNKLDEPIRVSPGPLAAE
AYGVKSSSRDLIRFIEANMGLGQYDAPLRRALSDTRTGYFKIGDMTQDLIWEQYSMPVRL
PQLFDGNASAMLQTLKAEAIEPPLAPQPAAWVNKTGSTNGFGGYVAFIPEKQLGITILAN
RNYPNEQRVALAYRILEQSGCCSTP
>A7ZV23|FEATURES|UNIPROT_deepARG|beta_lactam|ampC|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGVLDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A127SSB7|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-95|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLARV
>E5WMG4|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDFIMILKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLNTKEFLSKYEANTFKVVIQLGS
ILAVVIIFKERFMEMLGLGGRSKNSEEKQSRLKLSQVIVGLIPAGILGVLFEDYIDEHLF
STETVLIGLVIGAFLMIFADIFGGKDPKTVSVDQITYKQALSIGLIQCFSLWPGFSRSGS
TISGGVLLGLSHRAAADFTFIMAVPIMAGASFLSLIKNLEYFSVDALPFFIAGFISAFVF
ALISIRFFLKMINKVKLIPFAIYRIVLAGVIYFIFL
>A0A0X8FFP1|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MLDIIKVFIMGIVEGITEWLPISSTGHLILVEEFISMDFRPEFWNIFVYVIQLGAILAVV
WIYFDRLNPFSNQKSAEEKKQTWETWFKVVVGCIPAGVIGLLFNDFAEEHFQNWVVVSAA
LIIYGIAFIVVENRNKNRPVTVHSTQELSYKKAFQIGLFQALSVIPGTSRSGSSILGATI
LGTSRPTAADFSFFMSIPIMFGMTFLKLTKGFLDGFRFSTEEGFLLILGMVIAYIVSILT
IRFLLRYVQKNDFKAFGWYRIALGIIVIIFFAIFQ
>ZP_03644637|FEATURES|ARDB_deepARG|macrolide-lincosamide-streptogramin|ErmG|antibiotic target alteration|1
MNKVNIKDSQNFITSKYHIEKIMNCISLDEKDNIFEIGAGKGHFTAELVKRCNFVTAIEI
DSKLCEVTRNKLLNYPNYQIVNDDILKFTFPSHNPYKIFGSIPYNISTNIIRKIVFESSA
TISYLIVEYGFAKGLLDTNRSLALLLMAEVDISILAKIPRYYFHPKPKVDSALIVLKRKP
AKMAFKERKKYETFVMKWVNKEYEKLFTKNQFNKALKHARIYDINNISFEQFVSLFNSYK
IFNG
>I6YE63|FEATURES|UNIPROT_deepARG|beta_lactam|CTX-M|antibiotic inactivation|1
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
FAMCSTSKVTAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAA
ALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTASPRA
MAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTND
IAVIWPKDRAPLILVTYFTQPQPKAESRRDVLAS
>A0A105ZE26|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRRRIASVVAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALV
VGGVIILLAEARQRERADAPRVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGML
FGLDRRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDSIGLFALGLAASFVSAFACVRW
LLRYVASHDFTAFAWYRIVFGLFVLLVGYSGWLNWA
>L1NZU8|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|HMPREF9120_00664|antibiotic efflux|1
GRLKAFQTALNLSNHALSGNTMSLIECKNINRYFGSGENRVHVLKNVSLSIEKGDFVAII
GQSGSGKSTLMNILGCLDTATSGSYQIDGIETSKMNPDELAGLRRERFGFIFQRYNLLGS
LTARDNVALPAVYMGAAHKERSERAEKLLHDLGLQSKENNKPNELSGGQQQRVSIARALM
NGGEIIFADEPTGALDTASGKNVMEIIHKLHQDGHTVIMVTHDPGIAANANRVIEIRDGE
IISDTVKNPDIPPSSVERVKENASWSFYYDQFMEAFKMSVQAITAHKMRSLLTMLGIIIG
IASVVSVVALGNGSQQKILQDINSMGTNTVSIFPGRGFGDRRSSRIKTLTIADAQAIAKQ
GYVASVTPQTSSSGTLTYRNTDLTAMLYGVGDQYFDVRGLKLASGRLFDEDDIKQDAQVA
VVDDNVKTKLFGDGVDPLGKTILFKKRPLTVIGVLQKEENNFGSSDSLMVWSPYTTVMHQ
ITGETYASSITVKIKDDVSSQVAEKSLTELLKARHGTEDFFMNNSDSIKQMVEKTTGTMK
LLISSIAVISLVVGGIGVMNIMLVSVTERTKEIGVRMAIGARRSNILQQFLIEAVLICLI
GGLIGVGISLAIGVLFNQFVTDFPMTFSTLSIVGAVVCSTAIGVAFGFMPANRASKLNPI
DALAQD
>A0A060KT79|FEATURES|UNIPROT_deepARG|beta_lactam|blaCTX-M|antibiotic inactivation|1
MVKKSLRQFTLMATATVTLLLGSVPLYAQTAGVQRKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ZP_02903427|FEATURES|ARDB_deepARG|multidrug|MdfA|antibiotic efflux|1
MQNRLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYRAGIDWVPTSMTA
YLAGGMFLQWLLGPLSDRIGRRPVMLAGVAWFIVTCLAILLAQNIEQFTVLRFLQGISLC
FIGAVGYAAIQESFEEAVCIKITALMANVALIAPLLGPLVGAAWIHMLPWEGMFVLFAVL
AAISFFGLQRAMPETATRIGEKLSLKDLGRDYKLVLKNGRFVAGALALGFVSLPLLAWIA
QSPIIIITGEQLSSYEYGLLQVPIFGALIAGNLLLARLTSRRTVRSLIIMGGWPILIGLV
VAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLFASEMSKGTVSAAMGMLQMLI
FTVGIEISKHAYLNGGNGLFNLFNLANGILWLLLMVIFLKDKRVGNSREG
>YP_001437159|FEATURES|ARDB_deepARG|multidrug|Bcr|antibiotic efflux|1
MTTRQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIASEFGVEAGSAQMTLSTYILGFAI
GQLFYGPMADSLGRKPVILGGTLIFAAAAIACALAQSIDQLIYMRFLHGLSAAAASVVIN
ALMRDIYPKEEFSRMMSFVMLVTTIAPLLAPMAGGAVLVWFNWHVIFWILAVLALLACAM
IFFLIRETLPVERRQKFHFRTTLGNFATLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVY
IELNHVSPQHFGYYFALNIVFLFVMTIINSRFVRRVGALKMFRAGLFIQFAMAVWLVISA
QFDIGFWSLVLGVAAFVGCVSLVASNAMAVILDEFPHMAGTASSLAGTFRFGIGAIMGAL
LSMATFNSAWPMLLSIFFCATCSILFYLYASRPRRRAV
>A0A066PSE7|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MPGAVPGAVIELRGVSRTYRSGDVEVQALREVDLVIGPGEFVAIMGSSGSGKSTLMAILG
CLDRPSRGEYRFESVDVARLEEPELARVRSARIGFVFQSFNLLARTSALDNVALPLFYAS
DGPVKGGSRTARALRALGQMGLAGREGNTPSQLSGGQQQRVAIARALINAPRLLLADEPT
GNLDTRTSHEIMETLAALNRERGTTILVVTHEPDIAAYADRVLTMRDGRIVGDERREKAR
GEAAPAVAEAAPDAAPNETPDAAPTRRRAGIAWAFGAMIVGAAVQALARNRLRSALTMLG
VFIGVAALITMVAVGQGANQAIRKQIESLGTNLLVVLPGATTAGGARAGFGSASTITVDD
ARAILREDPAVSRIGYLIRAAGQVRYASQNWTTAIAGVSIDYPAMTNWRVAEGRPIGAQD
ERNGALVGLIGQTVRQQLFAPGEDPVGATILVKGTPIRVIGVLAGKGQTAFGTDQDDIVM
LPFSTAEQRVLGTATPSRQDAPLNWAYPAWPNPYGLQLRLTGYVNQLFAQAVSPDAVAEA
MEQISGTLSVRHRIQPNGLKDFSVRNLSQIAAAAQGSSRIMSLLLAIVASISLLVGGIGI
MNILLVSVTERTREIGLRMAIGARRLHVLLQFLAESVFLSVTGGLGGIVLGVALSGGITL
FAGWPAPVSLLAVAGGFLFSVAVGVAFGFYPARKAARLDPIEALRYE
>A0A031J2E9|FEATURES|UNIPROT_deepARG|polymyxin|arnC|antibiotic target alteration|0
MKPYPIHRVSIVIPVYNEEESLPELLRRTTAACRQLAYEYEIILVDDGSRDNSAQLLEDA
AAEDGSNVVAVILNRNYGQHAAIMAGFEQCQGEVVITLDADLQNPPEEIPRLVEQAALGY
DVVATVRNNRQDSAFRRWPSRLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERS
TFIPILANGFARHTTEILVHHAEREHGESKYSAMRLISLMFDLLTCMTTTPLRLLSIVGF
SLAALGMLFAFALIVLRLAFGADWAGDGLFVLFAVLFVFTGGQFIGMGLLGEYLGRMYSD
VRARPRFFIEKVLRNQPAAPAPVVVVDGLVSSHTSTSADQVQS
>Q47308|FEATURES|UNIPROT_deepARG|aminoglycoside|aph|antibiotic inactivation|1
MSHIQRETSCSRQRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
VANDVTDEMVRLNWLTEFMLLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENI
VDALAAFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK
EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADRYQDLAILWNCLGEFS
PSLQKRLFQKYGIDNPDMNKLQFHLMLDEFF
>A0A070K8G2|FEATURES|UNIPROT_deepARG|multidrug|mdtL|antibiotic efflux|1
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
VADRSGRKPVAIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTL
DDRRRAKVLSLLNGITCIIPVLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKE
THPAAPAASDKPRENSESLLNRFFLSRVVITTLSVSVILTFVNTSPVLLMEIMGFERGEY
ATIMALTAGVSMTVSFSTPFALGIFKPRTLMITSQVLFLAAGITLAVSPSHAVSLFGITL
ICSGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSSLWIWLAAVVGIGAWNMLIGI
LIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>K0WG10|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
WEFRRKILDVVIGLPTQPSARRFTANLLIAFLPAVVLGVIFANLIHQYLFNPITVATALV
VGGVIMLWAERRQHEVHAETVDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLS
RKTATEFSFFLAMPTMVGAAVYSGYKYRHLFVPADFPVFAIGFITAFIFAMIAVRGLLKF
IASHSYAAFAWYRIVFGLVILATWQFGWVDWSAAKA
>A0A142EGV9|FEATURES|UNIPROT_deepARG|beta_lactam|TEM-163|antibiotic inactivation|1
FAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSR
IDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIG
GPKELTAFLHNMGDHVTRLDRWEPELNEAIP
>A0A0H3W0X3|FEATURES|UNIPROT_deepARG|beta_lactam|blaZ|antibiotic inactivation|1
VIALVLSACNSNSSHTQELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAI
NSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNK
IIKEIGGIKKVKQHLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANG
KLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSE
PIVLVIFTNKDNKSDKPNDK
>J8PYK5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
YHKRLVSLCNIKPLLQKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLVA
GAILMIFAEEKKKEAVAYSLDDLTYSQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNY
KTASEFSFLIALPVMIGATGLDLLKSWKYLSVDDIPMFAVGFITSFIVAMLAVVTFLKLL
EKIGLKPFAYYRILLAILFTLFVLL
>B9BAV5|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
WEYRQRIASVVTGLPSRPDARRFALNVVIATIPAIALGLLLEKKIKAVLFSPVPVAFALV
VGGAIILWAEARQRERREPPRVQSIDELTPLDALKVGVAQCFALIPGMSRSGSTIIGGML
FGLERRVATEFSFFLAIPIIFGATLYETVKDWHAFTVDALGLFVLGLVSAFVSAFVCVRW
LLRYVATHDFTVFAWYRIVFGLFVLLVGYSGWLNWA
>YP_001778539|FEATURES|ARDB_deepARG|multidrug|ceoB|antibiotic efflux|1
MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIA
ETVASPLEEQINGVEDMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRL
PEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLW
GSGDYAMRVWLDPQKVAQRGLSAEDVVQSIREQNVQVAAGVIGASPSLPGTPLQLSVNAR
GRLQTEDEFGDIVVKTTPDGGVTHLRDIARIELDASEYGLRSLLDNKPAVAMAINQSPGA
NSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIV
FLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVE
RNIEGGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAIST
VISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVR
GVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIR
DMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFSERHGKALSAGAIAGALN
QKYSAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPEL
GPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRV
QADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAP
GFSSGQAQAAVERIAHETLPRGVRFEWTDLTYQQILAGDSAMYVFPISVLLVFLVLAALY
ESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFAREL
EHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLG
VTLFGLMLTPVFYVVLRTLAGGKIHVAGKDSTGYGVPAPDA
>A0A085H3X0|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|1
MTALLELIDIRRSYPSGDGPVEVLKGITLQVEAGEMVAIVGASGSGKSTLMNILGCLDKP
TSGTYRVAGTDVATLDSDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKK
RLERAQALLTRLGLGERVDYQPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG
EEVMAILHQLRDQGHTVIIVTHDPQVAAQAGRILEIHDGELVSNPPATLNATRRQEVALP
PPSGWRQFASSFREALTMAWLAMAANKMRTLLTMLGIIIGIASVVSIVVVGDAAKQLVLS
DIRSIGTNTIDIYPGKDFGDDEPQYQQALKYDDLAAIQKQPWVNSATPAVSQNLRLRYGN
IDVAASANGVSGDYFNVYGMTFSEGGTFNAEQLAGRAQVVVLDANSRRQLFPNKSKVVGE
IVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
AQAEQQLERLMTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAIISLLVGGIGVMN
IMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQLFL
PGWEIGFSPMALLTAFLCSTFTGVLFGWLPARNAARLDPVDALARE
>A0A126Y456|FEATURES|UNIPROT_deepARG|beta_lactam|Salbus254_2618|antibiotic inactivation|1
MHPSTSRPSRRTLLTATAGAALAAATFVPGTAHASSGGRGHGSGSVSDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRPDELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQDD
VDRADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPDAVTRFVRSLGD
RVTRLDRWEPELNSAEPGRVTDTTSPRAMTRTYGRLVLGDALNPRDRRLLTSWLLANTTS
GDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTTKTEQDAARDDGLV
ADAARVLAETLG
>A0A026V160|FEATURES|UNIPROT_deepARG|beta_lactam|BW70_08010|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGAQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>R8DPN5|FEATURES|UNIPROT_deepARG|beta_lactam|ICC_04623|antibiotic inactivation|1
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAAGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>I4N3A2|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
WEFRQKIIEIVTGLPTRPQARRFTANLLIAFLPAVVLGVIFADAIHEYLFNPITVAVALV
AGGIVMLWAEEREHVVRVEHVDDMTWKDALTIGFAQCLAMIPGTSRSGSTIIGGLVFGLS
RKAATEFSFFLAMPTMVGAAVYSGFKYRHLFQASDLPVFALGFVTAFVFAMIAVKALLKF
IANHTYDLFAWYRIGFGMLILATWWFGWIDWDHVQP
>D5Q5Y3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MYWRYFGLETFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFL
VVIQFGSILAVLVIFFRKLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDID
RLFFNSTVVAIALIVYGIIMIGLEKRNKRPKYKDFSQVTYKLALCIGLFQCLALIPGTSR
SGSTIIGAVLLGTSRYVAAEFSFFLAIPTMLGASALKLLKAGFGFTGFEWLILGVGSVVA
FVVSIVVIKFFMDYIKKHDFKVFGYYRIVLGIVVLAYFFLL
>D6BIZ3|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
VVYFWKDISPFVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAIT
LITYGVIFIGIEVVYKLKNIKPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGA
LLLGLSRPLAAEFSFYLAIPTMFGATALKLFKNGLAFTEMEWSYLALGSAIAFVVAYMVI
KWFMDFIKKRSFASFGLYRIILGIVVIILLLY
>A0A0P8WH96|FEATURES|UNIPROT_deepARG|beta_lactam|AN402_1544|antibiotic inactivation|1
MEQTCFLDGLLCVRIKTDVENLKGMMILKNKRMLKIGICVGILGLSLTSLEAFKGGPLQV
EAKEKTGQVKHKHQATYKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKA
LAAGVLLQQNSTEKLNEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRNSDNTAGN
ILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVG
NVLPVHKRNILTGWMKGNATGDKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAP
IIIAILSSKDEKEATYDNQLIAEAAEVIVKALR
>YP_002400010|FEATURES|ARDB_deepARG|multidrug|mdtF|antibiotic efflux|1
MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITISATYPGADAQTVEDS
VTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPE
AVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGS
EYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRL
QTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLATGANAL
DTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIKISIQEVFKTLVEAIILVFLVMYLFLQ
NFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVI
AEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLL
SVFVAMSLTPALCATILKAAPEGGHKPNTLFARFNTLFEKSTQHYTDSTRSLLRCTGRYM
VVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKE
KNNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAV
VFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVIGVRPNGLE
DTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRML
PDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMK
FMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVM
LVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPVE
AIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAAGTGVMGGMFAATVLAIYFV
PVFFVVVEHLFARFKKA
>Q7WCA6|FEATURES|UNIPROT_deepARG|macrolide-lincosamide-streptogramin|vgb|antibiotic inactivation|1
MNQVEMTEFPVGKPQEALYGVASTPDGALWFTLAKGNAIGRLSPDGAVSRFPLPHTDGQP
TTITCGPDGRPWFTLSSANAIGRLAPDGALRMFELPRPASRPFGIAGGHDGCLWFAEMAG
DRIGRITIDGDIEEYDLPVKGGYPSCMAAGRDGLMWFTLNQAGAVGSISATAAPRIFPLG
AADAAPVGIASDAQGALWIAQAGNGAIVRFDAGGRITEFPLHSRAARPHAIAADAAGNLW
FTEWGANRIGRISEAGDLAGYELAAPGSEPHGIAIDPHGCVWAALETGRLVRLQASPRD
>YP_002215984|FEATURES|ARDB_deepARG|multidrug|mdtG|antibiotic efflux|0
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
TFLFSAIASPFWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGG
FIPNANALIATQVPRHKSGWALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVL
FICFLLTFFFIHENFLPVSKKEMLHVREVVASLKNPRLVLSLFVTTLIIQVATGSIAPIL
TLYVRELAGDVSNIAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILIVALIISVLLL
IPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTNQIAGRIFSYNQSFRDIGNVT
GPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>C8PW78|FEATURES|UNIPROT_deepARG|bacitracin|uppP|antibiotic target alteration|0
MDLILIFKAIIMGMVEGITEFLPISSTGHLILADSLLNFWTKDKADLFIVVIQLGAISAV
IYLYWGRLWRALMGLITGKDPERNNPRQLGISLIISTIPIMLIGLMFDKALKAALFNPTV
VAISLIVGGLIIFWAERQQHKHTVKYAEAEDIDIKTAIIIGLIQCLALIPGTSRSGSTII
GSLFLGVSRKASAEYSFFLGIPVLVGAGLLDLTKNHHILTTTEDWTIMAVGVVVSFIFAM
IFIKWLVNWVSTRDFTIFAWWRIVVGVLVLIAGMLGYI
>ADU82030.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MAKEKFNRTKPHVNIGTIGHVDHGKTTLSAAISAVLSLKGLAEMKDYDNIDNAPEEKERG
ITIATSHIEYETENRHYAHVDCPGHADYVKNMITGAAQMDGAILVVSAADGPMPQTREHI
LLSRQVGVPHIVVFLNKQDMVDDQELLELVEMEVRELLSAYEFPGDDTPIVAGSALRALE
EAKAGNVGEWGEKVLKLMAEVDSYIPTPERDTEKTFLMPVEDVFSIAGRGTVVTGRIERG
VVKVGDEVEIVGIRATQKTTVTGVEMFRKELEKGEAGDNVGVLLRGTKKEEVERGMVLCK
PGSITPHKKFEGEIYVLSKEEGGRHTPFFTNYRPQFYVRTTDVTGSITLPEGVEMVMPGD
NVKITVELISPVALELGTKFAIREGGRTVGAGVVSNIIE
>AAB05462.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDTAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>ABX45066.1|FEATURES|megares|beta_lactam|OXA-82|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWQVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CAB45461.1|FEATURES|megares|glycopeptide|vanHO|antibiotic target alteration|1
MTFSSTSSAPPPSPLLPATRITVYGCGRDEAALFRRTAPRFGVEATLTEAAVSEENAEMA
AGNQCISIDHKTPVTPATLRALHRAGVTYISTRSIGYNHIDVTYAAGVGISVENVTYSPA
GVADYTLMLMLMAVRNAKSTVRRAELHDYRLNEIRGKELRDLTVGVIGTGRIGAAVVDRL
RGFGSRVLAYGKRPTIAADYVSLDELLRSSDIVSLHVPLTPDTHHLLDQSRIRRMKSGAF
VINTGRGPLIDTEALVPALESGRLSGAALDVIEGEEGIFYADCRNRTIESTWLPRLQKMP
NVLISPHTAYYTDHALMDTVENSIINCLNFGSRKQHG
>AAL10704.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MLRSRVTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
SPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIA
EADCRLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGM
GFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATAGLPVKDLGPASLAAELH
AIGNGADYVRTHAPGELRSAIAFSETLAKFRSRDARDRGLDHA
>AAF89155.1|FEATURES|megares|beta_lactam|BD94_2866|antibiotic inactivation|1
MLKKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIINIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQTSIQHTLDLISE
YQQKQKASN
>NP_273190.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MNYSFTEKKRIRKSFAKRENVLEVPFLLATQIDSYAKFLQLENAFDKRTDDGLQAAFNSI
FPIVSHNGYARLEFVHYTLGEPLFDIPECQLRGITYAAPLRARIRLVILDKEASKPTVKE
VRENEVYMGEIPLMTPSGSFVINGTERVIVSQLHRSPGVFFEHDKGKTHSSGKLLFSARI
IPYRGSWLDFEFDPKDLLYFRIDRRRKMPVTILLKALGYNNEQILDIFYDKETFYLSSNG
VQTDLVADRLKGETAKVDILDKEGNVLVAKGKRITAKNIRDITNAGLTRLDVEPESLLGK
ALAADLIDSETGEVLASANDEITEELLAKFDINGVKEITTLYINELDQGAYISNTLRTDE
TAGRQAARVAIYRMMRPGEPPTEEAVEQLFNRLFFSEDSYDLSRVGRMKFNTRTYEQKLS
EAQQNSWYGRLLNETFAGAADKGGYVLSVEDIVASIATLVELRNGHGEVDDIDHLGNRRV
RSVGELTENQFRSGLARVERAVKERLNQAESENLMPHDLINAKPVSAAIKEFFGSSQLSQ
FMDQTNPLSEVTHKRRVSALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLIN
SLSVYARTNDYGFLETPYRRVIDGKVTEEIDYLSAIEEGRYVIAQANADLDSDGNLIGDL
VTCREKGETIMATPDRVQYMDVATGQVVSVAASLIPFLEHDDANRALMGANMQRQAVPCL
RPEKPMVGTGIERSVAVDSATAIVARRGGVVEYVDANRVVIRVHDDEATAGEVGVDIYNL
VKFTRSNQSTNINQRPAVKAGDVLQRGDLVADGASTDFGELALGQNMTIAFMPWNGYNYE
DSILISEKVAADDRYTSIHIEELNVVARDTKLGAEDITRDIPNLSERMQNRLDESGIVYI
GAEVEAGDVLVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDTSLRMPTGMSGTVIDVQV
FTREGIQRDKRAQSIIDSELKRYRLDLNDQLRIFDNDAFDRIERMIVGQKANGGPMKLAK
GSEITTEYLAGLPSRHDWFDIRLTDEDLAKQLELIKVSLQQKREEADELYEIKKKKLTQG
DELQPGVQKMVKVFIAIKRRLQAGDKMAGRHGNKGVVSRILPVEDMPYMADGRPVDIVLN
PLGVPSRMNIGQILEVHLGWAAKGIGERIDRMLKEQRKAGELREFLNRLYNGSGKKEDLD
ALTDEEIIELASNLRKGASFASPVFDGAKESEIREMLNLAYPSDDPEVEKLGFNDSKTQI
TLYDGRSGEAFDRKVTVGVMHYLKLHHLVDEKMHARSTGPYSLVTQQPLGGKAQFGGQRF
GEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYENIVKGEHKIDAGMPESFNVLVKEI
RSLGLDIDLERY
>YP_002344015.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MKFFKINPNTDFNLLCSFINPHKMGQKIMSEKTKIHFIFIKDISTPAANILKQDALRVGA
ELITHKEVITAKITHSNALLMASKEQIQKLVVKEKLQDFGLKNLALFLQKDFLKPKKAEL
MAVINVNEDSFNAKSRVSEEDFEKRLNDFLALKPEYIDIGAVSSRPGSEYCGKEEEFKRL
KKVLDLIYEKNYYEQAIFSLDSFDEYCLEYALNKGFKLINDITSLRNLNLAKLASKYGAK
YCLMHMQNNPNNMQDNPFYEDLLDEMTLFFKEKLELLESFGVKESILDVGIGFGKSAGHN
MILIKHLEHFLQFNKPLLIGASRKSVINAYFQSEIKDRLAGTLYLHLKAFENGASIIRVH
DLYEHKQLFALAQAMDNIGV
>EGF60091.1|FEATURES|megares|fosfomycin|FosA5|antibiotic inactivation|1
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
DESDYTHYAFSISEADFASFAVRLEAAGVAMWKLNRSEGASHYFLDPDGHKLELHVGSLA
QRLAACREQPYKGMVFFDQ
>AFK60084.1|FEATURES|megares|multidrug|adeC|antibiotic efflux|0
MGGTPLETTLRKYIEVASKKKPADLVIKHAKIVNVFTKEIMEKDVAICEGMIVGIGEYEG
KSVHNANGQYLVPGFIDGHVHIESSLLSPSEFSKVSLLHGVTTVVTDPHEIGNIAGSTGL
EFMIEDARQTLMNIFFMLPSCVPVTPFETNGANLNAKKLAPFLQKPEVLGLAEVMNYQAV
ANNETDILEKIQLMHQHKKKIDGHAAGIGMEELNVYPAAGIRTDHEATTAKEAKERLDLG
MYLMVREGTVAKDLASLLPAITPENSRRCFFVTDDKLINDLVKEGSIDHIVRQAIALGID
PLQAIQMATLNAAECFDLKTLGAIAPGYQADFFLTDDLTKLPIHEVFYKGTLVVQSGQLQ
DHLFADHSNSYTCCLPKLNAQPLNPHSLELLLSSSQAHVIEIIPNSLVTKDLVEKVDRQG
ERFIPSIEKDQLKIAVIERHHQTGNIGLGIVKGFQLKQGAIATTIAHDSHNLVVVGTNDE
DMLYAANLLIQKGGGMTVVNKQQEIACVSLPIGGIMTQEPFSIVYEQLNELITKAHQLGA
AKTFDPFLTLSFLTLSVIPELKITDKGLFSFSRFQLIPPCGKTDEINTF
>WP_000331899.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAYSYTEKKRIRKNFGKLPQVMDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSV
FPIESYSGNAALEFVEYSLGKPEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVR
EQEVYMGEIPLMTENGTFVINGTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIP
YRGSWLDFEFDAKDLVYVRIDRRRKLLATVVLRALGYNNEQILNLFYEKVPVYLDMGSYQ
IDLVPERLRGEMAQFDITDNEGKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERIT
AEDITLRDGEVIAANTLLSHEVMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDR
EEALVEIYKVMRPGEPPTKEAAENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQ
KSREVEGILSHEDIIDVLRTLVEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRV
ERAVKERLSQAETDNLSPQDLINAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVS
ALGPGGLTRERAGFEVRDVHQTHYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPY
RKVVDGRVTDDVEYLSAIEEVGTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVT
HMDVSAQQVVSVAASLIPFLEHDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARD
SGVCVIANRGGVIEYVDASRIVIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIV
NLGDKVARGDILADGPSTDMGELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSI
HIQELSCVARDTKLGAEEITADIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKG
ETQLTPEEKLLRAIFGEKAADVKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKA
QLDSYRKDLKEEYKIFEEAARERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLE
IQPADEAIAERLTQIQVFLKEKSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRR
IQPGDKMAGRHGNKGVVSNILPVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGM
AAKGLGDKIEKMLKEQRTVLELREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVP
LATPVFDGAEESQIKDLLELADISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDD
KMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGR
TRIYKNIVDGNHYMDPGMPESFNVLTKEIRSLGINIELKNGD
>WP_015891554.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MKETETQQTLTYTEEDIQVLEGLIAVRKRPGMYIGSTGSRGLHHLLWEIVDNAKDEALAG
VNDSIIVTLYKDGSVSVEDHGRGIPTGMHKTGRPVPEVIFTTLHAGGKFGGGGYKKSGGL
HGVGSSVVVALSKWLEVEIHREGKIHKQRFEYVVDANGTEHVGKPVTGLEITGNTKRTGT
TVRFLPDDAVFGNARFDYETIRDRFRETAFLLKKLRMVLIDERGPEKKREEFYFEDGLKS
YVSYLNEGKNSLHPIVYFEGEKDNIYVELAFQYNDGYAETLVSYVNSIVTTDGGTHVTGF
RNGTTRIFNEFARKKGYLKEKDPNLTGNDLREGFLGVLSLQMADVQFESQTKDKLGNEEA
RAIVEQIVSEKLGFFLEENPEIGKLLIDKAVRSAEIREELRKQREALRGDKKGKTAKKRK
SISEKFTPPQYRDSKRNELFLVEGDSAGGSAKQARNSEFQALFSLRGKPLNTEKAKLSEV
LANEEFRTILEVLETDIGEEFSIENCAFDKVIIMSDADVDGSHIQTLLLTFFFRYMRPMI
AAGHLYIAQPPLYQVKKQSKGKQTEAIYCWSDYELEQALKKVGRGAEVQRYKGLGEMNAD
QLWETTMDPETRKLIKVELEDLAHCEKLVTVLMGDKVPPRREWIENHVTFEVGEDE
>WP_023356657.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEQNTPQVREVNISQEMRTSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMNDLGMTS
DKPYKKSARIVGEVIGKYHPHGDSAVYESMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKIAMEILRDITKDTIDYQDNYDGAEREPVVMPSRFPNLLVNGAAGIAVGMA
TNIPPHQLGEVIEGVLAVSENPEITNQELMEYIPGPDFPTAGQILGRSGIRKAYESGRGS
ITIRAKAEIEETSSGKERIIVTELPYQVNKARLIEKIADLVRDKKIEGITDLRDESDRNG
MRIVIEIRRDANAHVILNNLYKQTALQTSFGINLLALVDGQPKVLSLKQCLEHYLDHQKV
VIRRRTAYELRKAEARAHILEGLRIALDHLDAVISLIRNSQTAEIARTGLIEQFSLTEKQ
AQAILDMRLQRLTGLEREKIEEEYQSLVALIAELKDILANEARVLEIIREELNEIKERFN
DERRTEIVTSGLETIEDEDLIERENIVITLTHNGYVKRLPASTYRSQKRGGKGVQGMGTN
EDDFVEHLISTSTHDTILFFSNKGKVYRSKGYEIPEYGRTAKGIPIINLLEVEKGEWINA
IIPVSTFDEEQYLFFTTKQGVSKRTALSQFANIRNNGLIALGLREDDELMAVRLTDGKKQ
IIIGTKNGLLIRFPEEDVRQMGRTAAGVKGITLTDDDVVVGMEILEEDSHVLIVTENGYG
KRTPASEYRVQSRGGKGLKTCKITDSNGPLVTVKATKGEEDLMIITASGVLIRMDINDIS
TTGRVTQGVRLIRMSDQEHVATVALVEKNEEEPEETEEV
>BAM98943.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSTDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSDA
>CAH14961.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MSENYTAEAIEVLSGLEPVQRRPGMYTDTTRPNHLAQEVIDNSVDEVLAGFASRIIVTLH
EDGSIEVEDDGRGMPVDLHPQLGLSGVEVIMTRLHAGGKFSDKNYSFSGGLHGVGVSVVN
ALSERLDVTIKRNGIIYQMTFANGDKLCELNETGVTKKRETGTVIRFWPNGKYFDTTKIS
VKHLTHVLRAKAVLCSGLSMTFINKITNEEMNWCYEQGLTDYLRQTLPEDYLPEEPFAGA
FKSDEATVDWALAWSDSANGNLNESYVNLIPTIQGGTHVNGLRSGLFEAMSEFCELRNLL
PRGVKLTADDLWESCQYVLSIKMKEPQFAGQTKERLSSRQTSGLVSNVIKDAFAIWLNQH
RNQGEAIAALAIERAQKRLKQAKQVARKRVSQGPALPGKLADCLQTDLGQAELFLVEGDS
AGGSAKQARNKDYQAILPLRGKILNSWEVDSSQVLASQEIHDISVAIGVDPGSSDLEGLR
YGKICILADADSDGAHIATLICALFLRHFKPLVKAGHVFVAMPPLYRIDAGKLIHYALDD
EEKNRIVQHLSQTTKSKVNVQRFKGLGEMNPIQLRETTMDPNTRRLVQLTLDDEEQTEAI
MDMMLNKKRASDRKLWLETKGNLAEI
>AAK21274.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFDGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYQRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>WP_001289589.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDYSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIE
VYEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>AAC43480.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>CBA31120.1|FEATURES|megares|fosfomycin|FosA4|antibiotic inactivation|1
MLSGLNHLTLAVRDVARSLAFYQSLPGLRLHARWDGGAYLSCGSLWLCLSLDENAGSPAA
DYTHYAFTVSEADFPQVVETLTAAGVTPWKTNRSEGDSWYFLDPDGHQLELHVGSLATRL
AACRAAPYKGMRFYD
>AEG42370.1|FEATURES|megares|aminoglycoside|ANT(2'')-Ia|antibiotic inactivation|1
MNKSIIIILLITVLAATMLRSRAVALKQRLGRMDTTQVTLIHKILAAADERNLPLWIGGG
WAIDARLGRVTRKHDDIDLTFPGERRGELEAIVEMLGGRVMEELDYGFLAEIGDELLDCE
PAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIWDYFYYADEVPPVDWPTKH
IESYRLACTSLGAEKVEVLRAAFRSRYAA
>AAK21275.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALQVAGAAYAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVDGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFGGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGYQKQNGEGFGTSVTYDIWDGISAGFAYSSSKRTDEQNSVNTRYTDSNGVSR
RVLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGIIGFANKAQNFEVVAQYQFDF
GLRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNVSTYVDYKINLLDDNCFTKDA
SISTDNVVALGLVYQF
>AAO04716.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVSRALPDVRDGLKPVHRRILYGLNEQGMTP
DKPYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLVNGAAGIAVGMA
TNIPPHNLTEVIDGVLSLSKNPDITINELMEDIQGPDFPTAGLVLGKSGIRRAYETGRGS
IQMRSRAEIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALIHYLEHQK
TVVRRRTEYNLKKARDRAHILEGLRIALDHIDEIITTIRESDTDKIAMASLQERFKLTER
QAQAILDMRLRRLTGLERDKIESEYNELLEYIKELEEILADEEVLLQLVRDELTEIKERF
GDERRTEIQLGGLEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRSQNRGGRGIQGMNT
LDEDFVSQLVTMSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPIINAIELENDETIS
TMIAVKDLESEEDYLVFATKQGIVKRSSLSNFSRINKNGKIAINFKEDDELIAVRLTTGN
EDILIGTAHASLIRFSESTLRPLGRTAAGVKGISLREGDTVVGLDVADSESEDEVLVVTE
NGYGKRTPVSEYRLSNRGGKGIKTATITERNGNIVCITTVTGEEDLMVVTNAGVIIRLDV
HDISQNGRAAQGVRLMKLGDGQFVSTVAKVNEEDDNEENADEAQQSTTTETADVEEVVDD
QTPGNAIHTEGDAEMESVESPENDDRIDIRQDFMDRVNEDIESASDNEEDSDE
>CBO78207.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIERIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIR
>AFK58692.1|FEATURES|megares|peptide|cls|antibiotic target alteration|0
MLLYVRRNIFVVSSIITALYLLNALIALVAILIKPRDVAAIWAWLLVLFALPGVGFVLYL
FFGRGLTDKKKFYLRQSDLKELENFQSFRGDTIEHYDPDMGDKDKQQFVDFFSSLNRMPL
TRMNSVTLLTDGQEKLDSLLQDLKKAKHSIHIEYYAFVTDNIGQQVLHVLEEKAAEGVEV
RILYDAFGSHGTKAKDFNRLIKNGGHVHTFVTSQRALLRFRLNYHDHRKIVVIDGKISYT
GGFNIANQYVNTTKKFGYWRDTHIRIFGAASSLLQLRFLTDWNVSVPEEKKVGYHLNYFF
KKADRDESKLADTSIQLVSSGPNNEREQIKLSFIKLITSAKKRVWIQTPYLVPDESVIAA
LKIATASGVDVKIMIPNKPDHPFIYRATQYYARQLIKENVQILVYENGFLHAKTLIMDDE
ICMVGSANQDIRSYRLNFETSAVIYDPEFLEELATQFKEDETHCSSMTTETVKEMSNWLL
FKQQISRLFSPIL
>CAJ14963.1|FEATURES|megares|nitroimidazole|nimE|antibiotic inactivation|1
MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYFYADGKIYFHCAKIG
HKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMAMTLLVNKY
SFGEPGLSDEIAKSINHLLMVKIDI
>WP_000819066.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFENLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEE
>AAO82906.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MKSLAGHVVKYGKHRERRSFARISEVLELPNLIEIQTDSYQWFLDEGLREMFEDILPIDD
FQGNLSLEFVDYELKEPKYTVEEARAHDANYSAPLHVTLRLTNRETGEIKSQEVFFGDFP
LMTEMGTFIINGAERVIVSQLVRSPGVYFHGKVDKNGKEGFGSTVIPNRGAWLEMETDAK
DISYVRIDRTRKIPLTVLVRALGFGSDDTIFEIFGDSESLRNTIEKDLHKNASDSRTEEG
LKDIYERLRPGEPKTADSSRSLLTARFFDPKRYDLANVGRYKVNKKLDLKTRLLNLTLAE
TLVDPETGEIIVEKGTVLTHQIMETLGEYIDNGLNSVTYYPSEDAVVTEPMTIQVIQVLS
PKDPERIVNVIGNGYPDDSVKTVRPADIVASMSYFFNLMEDIGNVDDIDHLGNRRIRSVG
ELLQNQFRIGLARMERVVRERMSIQDTETLTPQQLINIRPVVASIKEFFGSSQLSQFMDQ
TNPLGELTHKRRLSALGPGGLTRDRAGYEVRDVHYSHYGRMCPIETPEGPNIGLINSLSS
YAKVNKFGFIETPYRRVDRATGRVTDQVDYLTADIEDHYIVAQANSLLNEDGTFANDVVM
ARLQSENLEVAVDKVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLIQP
RSPWVGTGMEYKSAHDSGAALLCKHDGVVEFVDAKEIRVRRDNGALDKYMVTKFRRSNSG
TSYNQRPIVHLGEKVEKGDTLADGPSMEEGEMALGQNVLVAFMTWEGYNYEDAIIMSRRL
VKDDVYTSVHIEEYESEARDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVQDGDL
LVGKVTPKGVTELSAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKIFTREAGDEL
SPGVNMLVRVYIVQKRKIHEGDKMAGRHGNKGVVSRIMPEEDMPFLPDGTPVDIMLNPLG
VPSRMNIGQVLELHLGMAARQLGIHVATPVFDGATDEDVWETVREAGMASDAKTVLYDGR
TGEPFDNRISVGVMYMIKLAHMVDDKLHARSIGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTYKSDDVVGRVKTYEAIVKGEPIPKPGVPESFRVLVKELQSLGLD
MRVLDIEEAEIELRDMDDDDDDLITVDALTKFAEQQSAKQLEKEAESVVKEEAQDVVQEI
ETAEDRD
>ABG77966.1|FEATURES|megares|multidrug|acrB|antibiotic efflux|1
MPNFFIDRPIFAWVIAIIIMLAGGLSILKLPVAQYPTIAPPAVTISATYPGADAKTVQDT
VTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQ
EVQQQGVSVEKSSSSFLMVVGVINTNGTMTQEDISDYVGANMKDAISRTSGVGDVQLFGS
QYAMRIWMDPNKLNNFQLTPVDVINAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRL
TSADEFSKILLKVNQDGSQVRLRDVAKVELGGENYDIIAKFNGKPASGLGIKLATGANAL
DTATAIRAELKKMEPYFPSGLKIVYPYDTTPFVKISIHEVVKTLAEAIILVFLVMYLFLQ
NFRATLIPTIAVPVVLLGTFAILAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVM
AEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMAL
SVLVALILTPALCATMLKPIQKGGHGEHKGFFGWFNRMFDKSTHHYTDSVGNILRSTGRY
LLLYIIIVAGMAILFVRLPSSFLPDEDQGVFLTMAQLPAGASQERTQKVLDEVTDYYLTK
EKDNVESVFAVNGFGFAGRGQNTGIAFVSLKDWSERPGKENKVEAITGRAMGTFSQIKDA
MVFAFNLPAIVELGTATGFDFQLIDQGGLGHEKLTQARNQLFGEVAKHPDLLVGVRPNGL
EDTPQYKIDIDQEKAQALGVSISDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAQYRM
LPNDINSWFVRGSNGQMVPFSAFSTSRWEYGSPRLERYNGLPSMEILGQAAPGRSTGEAM
NLMEELASKLPSGVGYDWTGMSYQERLSGNQAPALYAISLIVVFLCLAALYESWSIPFSV
MLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGLI
EATLEAVRMRLRPILMTSLAFILGVLPLVISSGAGSGAQNAVGTGVMGGMITATVLAIFF
VPVFFVVVRRRFSRKNEDVEHAHSVEPH
>AAB24796.2|FEATURES|megares|tetracycline|tetG|antibiotic efflux|1
MGLGLIMPVLPTLLRELVPAEQVAGHYGALLSLYALMQVVFAPMLGQLSDSYGRRPVLLA
SLAGAAVDYTIMASAPVLWVLYIGRLVSGVTGATGAVAASTIADSTGEGSRARWFGYMGA
CYGAGMIAGPALGGMLGGISAHAPFIAAALLNGFAFLLACIFLKETHHSHGGTGKPVRIK
PFVLLRLDDALRGLGALFAVFFIIQLIGQVPAALWVIYGEDRFQWNTATVGLSLAAFGAT
HAIFQAFVTGPLSSRLGERRTLLFGMAADGTGFVLLAFATQGWMVFPILLLLAAGGVGMP
ALQAMLSNNVSSNKQGALQGTLTSLTNLSSIAGPLGFTALYSATAGAWNGWVWIVGAILY
LICLPILRRPFATSLVI
>AAK21277.1|FEATURES|megares|multidrug|omp36|reduced permeability to antibiotic|0
MKVKVLSLLVPALLVAGAANAAEIYNKDGNKLDLYGKIDGLHYFSSDDSVYGDQTYMRIG
VKGETQINDQLTGYGQWEYNVQANNTESSSDQAWTRLAFAGLKFGDAGSFDYGRNYGVVY
DVTSWTDVLPEFDGDTYGSDNFLQSRANGVATYRNSDFFGLVDGLNFALQYQGKNGSVSG
EDQTNNGRGFQKQNGEGFGTSVTYEIWDGISAGFAYSSSKRTDEQNNSTYFSKSYRRTYG
VLGEGDHAETYTGGLKYDANNIYLATQYTQTYNATRTGDIGFANKAQNFEVVAQYQFDFG
LRPSVAYLQSKGKDMGRYGDQDILKYVDLGATYYFNKNMSTYVDYKINLLDDNKFTKDAS
ISTDNVVALGLVYQF
>BAH76607.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAQLTKNFGKIVKTLTIPHLLNLQIDSYELFLQKDIPPTSREDAGLEGVFRSVFPIEDFN
RTASLEYVSYEIGEPKYDVPECIAKGLTFEAPLRIKVRLVVYDVDEETENRTIRDIKEQI
IYFGTVPLMTEKGTFIINGTERVIVNQLQRSPGIIFEHDSGKSHTSRKVLYSCRIIPMRG
SWLDFDYDHKDILYVRIDRRRKMPATILFKAMGMSRADILRYFYEVEHFTFEPHHVFRQV
LPDFYRKEKAYSEIRDSEGKVIVAVDKPITKRAWRLMLEAGIEKVEVDPATLLGLFLAED
LADPATGEVMAEAGDELNADLIEKLKDAGIVELSLLHTRGVDTSSSIRDTLALDKTIDTI
TAQVEIYRRLRPSSPPTPEIAANFFENLFRNPDYYDLSPVGRYKINARLKVDQPLDFRTL
ANDDILKAVKHLTFLKDSHGPADDIDHLGNRRVRPVGELVENQYRIGLVRMERAIKERMS
LQEVATLMPHDLINPKPVAAVLKEFFGTSQLSQFMDQTNPLSEVTHKRRLSALGPGGLTR
ERAGFEVRDVHTSHYGRICPIETPEGPNIGLIVSLTTHSKVNDFGFIETPYKVVKDGQLT
GETIYLDATREIDEVIAGANAPLDENKAFINSMVGARIRGDQVVIPREQVTLMDISPSQI
VSVSAALIPFLEHDDANRALMGSNMQRQAVPLLRCEQPLVGTGMEGAVAKDSGSCILAEG
EGFVHYADAERIIVCYDDPAVGTDTGSAKTYELLKHHKSNQNTCFGQVPRVLVGQRVVKG
DVLADGPGIRDGELALGKNLLVAFMPWCGYNYEDSILISENAVKDDTFTSVHIEEFEVVA
RDTKLGPEEITRDIPNVGEEMLKDLDDCGIIRIGARVAPDDILVGKITPKGETQLTPEEK
LLRAIFGDKARDVKNTSLKVPPGIEGTVIDVRVFNRRSGEKDDRTRQIEDFELARLDTKE
GQHAAAIAANVRRRLWPVVSGKTVFQTIKGVKKGEVLLEANHPMTQEVLEALPVKKLSGL
FTSKETNEAVAEVLDEYDRHIQFIKGLYDQKREKTTEGDDLPPGVIKMVKVYVAVKRKLN
VGDKMAGRHGNKGVVSCILPIEDMPFFSHGRPVDIVLNPLGVPSRMNIGQILETHLGWAG
MELGRQLAEMVDSGKAMEGVRDRAKAVFDTEETTALIDGMSDDDLRDALRALKNGIVAKT
PVFDGATEDELWSWLKLAGLPEDGKVTLYDGRTGEAFHRPVTVGCMYILKLHHLVDEKIH
ARSTGPYSLVTQQPLGGKAQFGGQRLGEMEVWALEAYGASYLLQEFLTVKSDDVGGRVKM
YEKIVKGDNFLEAGLPESFNVLVKELMSLGLDVDLIQDEKKIAKAPPRR
>AAG21808.1|FEATURES|megares|multidrug|floR|antibiotic efflux|1
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
MLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAML
VATFATVRDVYANRPEGVVIYGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAM
LALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAVMGTFFVFFSTAPRVLI
GQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGEL
YGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTL
AVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>ABW76137.1|FEATURES|megares|beta_lactam|OXA-136|antibiotic inactivation|1
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAISDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>AFU25737.1|FEATURES|megares|trimethoprim|dfrA7|antibiotic target replacement|1
MGVLPNRKYAVVSRKGISSSNENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKA
DIIHLSTVHVEVEGDINFPKIPENFNLVFEQFFLSNINYTYQIWKKG
>AJG01376.1|FEATURES|megares|beta_lactam|OXA-69|antibiotic inactivation|1
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALISLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACH50230.1|FEATURES|megares|multidrug|ramR|antibiotic efflux|0
MARPKSEDKKQALLEAATQAIAQSGIAASTAVIARNAGVAEGTLFRYFATKDELINTLYL
HLKQDLCQSMIMELDRSITDAKMMTRFIWNSYISWGLNHPARHRAIRQLAVSEKLTKETE
QRADDMFPELRDLCHRSVLMVFMSDEYRAFGDGLFLALAETTMDFAARDPARAGEYIALG
FEAMWRALTREEQ
>AAK52604.1|FEATURES|megares|chloramphenicol|cmlA5|antibiotic efflux|1
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAY
VVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLA
IVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLP
VKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFM
GRVIPKWGSPSVLRMGMGCLIAGAVLLAITEIWALQSVLGFIAPMWLVGIGVATAVSVAP
NGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLS
CVSRVKGSRGQGEHDVVALQSAESTSNPNR
>AEE66656.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDSNQPGLFDGGATDPHEAITLGRYAEQAYLDYAVSVVRGRALPDVGDGQKPVQRRILY
AMQAMGLAAGAKPVKSARVVGDVLGKYHPHGDQAAYDAMVRMAQDFSLRYPLIDGHGNFG
SRDGDNAAAMRYTEARLTPFSKLLLDELEEGTVDFVPNYDGSQQEPAMLPARLPVMLLNG
ASGIAVGMATEIPSHNLREVAQACVALIRNPKLPQEELLALVPGPDFAGGGQIITPAADI
AQIYATGRGSLKARARWQFEEMARGQWQLVVTELPPGTSGQKVLEEIEEITNPKVRAGKK
SLSAEQQQAKAVMLSLLDAVRDESGKDAAVRLVFEPKTSRVDRDEFVNTLLAQTSMESNV
PVNVVCIGTDGRPRQKSLRDVLEEWVAFRTDTVVRRTRHRLDKVLDRIHVLEGRMVVYLN
VDEVIQTIREAEEPRAALMARFGLTERQAEDILEMRLRQLARLEGIKIEQELAGKREEQL
RLQDLLDNPGSLKRLLIKEIEGDAKQYGDDRRTLIETAERAVLETKVVDEPVTVIVSQKG
WLRARQGHGHDAGQFSFKQGDDLYGAFECRTTDTLIAVGDNGRVYSVAVSGLPSARGDGQ
PVTTMIDLEAGTRIVHTIAAAPDSRWLLATRRGFGFAARLSDMSSRQRAGKQFITLEKGD
ELLRPVPLFEGATQLALLSAKGKFLVFDLDEVKSLSGGGRGTILMGLDTADKLDQTVPIG
AAGLRAAGIYRNKQTEDILAGAALAPYVGKRARKGRQLNVRPRQPVLSPVF
>ACL31576.1|FEATURES|megares|aminoglycoside|rmtB|antibiotic target alteration|1
YGTIHDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTP
ESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLAL
YERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLL
EREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTI
GTELIYLIKKNG
>AAD25064.1|FEATURES|megares|tetracycline|tetR|antibiotic target alteration|0
MTHHRKRLDRTSVLLGARQVLDETGLDGFTTRALAAHLQVQQPGLYWHFRTKAELLAALA
SDVLDREHHASFPESDEKWDAFLLRNARSFRHALHAVRDGARLHAEHHRRPSGDDTDEGA
EASGQQVGLLVSQGFDEQTAISMLIAVSRYTVGVVLEEQTAEVGNASVPERDREFDFGLT
ALIDGFSHSRTASLTSSES
>AAN41428.1|FEATURES|megares|aminoglycoside|AAC(6')-29b|antibiotic inactivation|1
MKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEEPVEVLIARDATGAAVGHVELSIRH
DLEELQGIKTGYIEGLYVAPSHRSTDLVKRFLRESEKWALEQGCSAFASDRSDRVITHRK
FAGSAV
>AHH83942.1|FEATURES|megares|glycopeptide|vanWB|antibiotic target alteration|1
MDRKRLTQRFPFLLPMRRAQRKMCFYAGMRFDGCRYAQTIGEKSLSHLLFETDCALYNHN
TGFDMIYQENKVFNLKLAAKTLNGLLIRPGETFSFWWLVRHAAYKDGLTVTNGKLTTMSG
GGMCQMSNLLFWMFLHTPLTIIQRRGHEVKEFPEPNSDEIKGVDATISEGWIDLKVRNDT
DCTYQIWVTLDDEKIIGQVSADKEPQALYKITNGSIQYVRESGGIYEYAQVKRMQVALGT
GEIIDCKLLYTNKCKICYPLPESVDIQEENQ
>YP_001085750.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MDAPYLLSIQVDSYRTFLQDGKSPKNREDIGLQAAFRSVFPIESYSGNAALEFVEYSLGK
PEFDVRECILRGSTYAAPMRVKIRLIIKDRETKSIKDVREQEVYMGEIPLMTENGTFVIN
GTERVIVSQLHRSPGVFFDHDKGKTHSSGKVLYSARIIPYRGSWLDFEFDAKDLVYVRID
RRRKLLATVVLRALGYNNEQILNLFYEKVPVYLDMGSYQIDLVPERLRGEMAQFDITDNE
GKVIVEQGKRINARHVRQMEAAGLTKLSVPDEYLYERITAEDITLRDGEVIAANTLLSHE
VMVKLAEGGVKQFNILFTNDIDRGSFVADTLRADLTRDREEALVEIYKVMRPGEPPTKEA
AENLFNNLFFSSERYDLSPVGRMKFNRRLGRPYEVGTDQKSREVEGILSHEDIIDVLRTL
VEIRNGKGEVDDIDHLGNRRVRSVGEMTENQFRVGLVRVERAVKERLSQAETDNLSPQDL
INAKPVAAAIKEFFGSSQLSQFMDQNNPLSEITHKRRVSALGPGGLTRERAGFEVRDVHQ
THYGRVCPIETPEGPNIGLINSLSVYAKANDFGFLETPYRKVIDGRVTDDVEYLSAIEEV
GTVIAQADSAVDKDGNLTEEFVSVRHQGEFVRMPPEKVTHMDVSAQQVVSVAASLIPFLE
HDDANRALMGSNMQRQAVPTLRADKPLVGTGMEANVARDSGVCVIANRGGVIEYVDASRI
VIRVNEDEMVAGEAGVDIYNLIKYTRSNQNTCINQNVIVNLGDKVARGDILADGPSTDMG
ELALGQNMRVAFMTWNGYNYEDSILLSERVLQEDRLTSIHIQELSCVARDTKLGAEEITA
DIPNVGEAALSKLDESGIVYIGAEVTAGDILVGKVTPKGETQLTPEEKLLRAIFGEKAAD
VKDSSLRVPSGTKGTVIDVQVFTRDGLEKDDRALAIEKAQLDSYRKDLKEEYKIFEEAAR
ERVIRLLKGQESNGGGSTKRGDKLSEDLLSGLELVDLLEIQPADEAIAERLTQIQVFLKE
KSAEIDEKFAEKKRKLATGDELTTGVLKVVKVYLAVKRRIQPGDKMAGRHGNKGVVSNIL
PVEDMPHDANGVPVDIVLNPLGVPSRMNVGQILETHLGMAAKGLGDKIEKMLKEQRTVLE
LREFLDKIYNKVGGEQEDLDSLTDEEILALAGNLRAGVPLATPVFDGAEESQIKDLLELA
DISRTGQTVLFDGRTGEQFDRPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLGGK
AQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVEGRTRIYKNIVDGNHYMDPGMPES
FNVLTKEIRSLGINID
>AAD22147.1|FEATURES|megares|chloramphenicol|cmlB|antibiotic efflux|1
MDMYLPAVPFMPHALGTTAGTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLAGGAAY
VAASIGLVVTSSAGVFLGFRILQACGASACLVATFATVRDIYAGRKESNVIYGLLGSMLA
MVPAIGPLLGAVIDTWFGWRAIFAFLGLGMIAALTAAWRLWPETRVQRPAALQWSQLLLP
IKHLNFWLYTVCYAAGMGSFFVFFSIAPGLMMGRQGMSQFGFSLLFATVAIAMMLAARFM
GRVIAKWGSLSALRMGMGCLIAGAVLLVITELWIPQSVLGFIAPMWLVGVGVATAVSVAP
NGALRGFDHIAGAVTAVYFCLGGLLLGSVGTLIISLLPRDTAWPVIAYCLVLATIVLGLS
CVSRARDLRGHGEYDAVART
>AFA38016.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPAPALYPDIADADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFL
SPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>AAO81398.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MAKKINNEYNDASIQVLEGLEAVRKRPGMYIGSTDSRGLHHLVYEIVDNAVDEALSGYGN
EINVTIQKDNSICVADSGRGMPTGMHASGIPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSKWLEVHIVRDGVEYMERFEDGGKPVGTLKKIGKTKKRNGTSVTFLPDDTIF
STTNFSYEILAERLRESAFLLKGVKITLTDERGEEPKEEVFHYEEGIKEFVAYLNEEKDT
LTPVVYFSGAKEGIEVELAYQYNDGYSENVLSFVNNVRTKDGGTHEVGMKTSMTKAYNEY
ARKVGLLKEKDKNLEGSDFREGLAAVLSIRVPENLLQFEGQTKGKLGTPLARTVVDNVVG
EQMGFYLQENSEMSQSLIRKAIKAREAREAARKAREESRNGKKRKKGESLLSGKLTPAQS
RNPKKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVINTEKAKMQDILKNEEINTMIY
TIGAGVGPEFSIEDCNYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEAGKVYIALPP
LYKVSKGTGKKSVIEYAWTDGELAEVIDKVGKGYMLQRYKGLGEMNAEQLWETTMDPETR
TLIRVRIDDAAQAERRVTTLMGDKVEPRRKWIEQHVQFTLEEDGSILDRSEEDTSAPTGE
SLLDAEKTKEAEQTDDTEISLFDIE
>YP_001706419.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDSAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEGNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTSGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFLENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSADSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIETVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>AAZ06275.1|FEATURES|megares|tetracycline|tet33|antibiotic efflux|1
LIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAG
ITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAA
LLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAP
GATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDAL
GLVGLA
>AAK45502.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MRSTPPASAGRSTPPALAGHSTPPALAGHSTLCGRPVAGDRALIMAIVNRTPDSFYDKGA
TFSDAAARDAVHRAVADGADVIDVGGVKAGPGERVDVDTEITRLVPFIEWLRGAYPDQLI
SVDTWRAQVAKAACAAGADLINDTWGGVDPAMPEVAAEFGAGLVCAHTGGALPRTRPFRV
SYGTTTRGVVDAVISQVTAAAERAVAAGVAREKVLIDPAHDFGKNTFHGLLLLRHVADLV
MTGWPVLMALSNKDVVGETLGVDLTERLEGTLAATALAAAAGARMFRVHEVAATRRVLEM
VASIQGVRPPTRTVRGLA
>AEP40321.1|FEATURES|megares|beta_lactam|NDM-1|antibiotic inactivation|1
ALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLI
VRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIAT
YANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGID
GTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAI
T
>AAC74213.1|FEATURES|megares|multidrug|phoQ|antibiotic target alteration|0
MKKLLRLFFPLSLRVRFLLATAAVVLVLSLAYGMVALIGYSVSFDKTTFRLLRGESNLFY
TLAKWENNKLHVELPENIDKQSPTMTLIYDENGQLLWAQRDVPWLMKMIQPDWLKSNGFH
EIEADVNDTSLLLSGDHSIQQQLQEVREDDDDAEMTHSVAVNVYPATSRMPKLTIVVVDT
IPVELKSSYMVWSWFIYVLSANLLLVIPLLWVAAWWSLRPIEALAKEVRELEEHNRELLN
PATTRELTSLVRNLNRLLKSERERYDKYRTTLTDLTHSLKTPLAVLQSTLRSLRSEKMSV
SDAEPVMLEQISRISQQIGYYLHRASMRGGTLLSRELHPVAPLLDNLTSALNKVYQRKGV
NISLDISPEISFVGEQNDFVEVMGNVLDNACKYCLEFVEISARQTDEHLYIVVEDDGPGI
PLSKREVIFDRGQRVDTLRPGQGVGLAVAREITEQYEGKIVAGESMLGGARMEVIFGRQH
SAPKDE
>CAB11783.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSEQNTPQVREINISQEMRTSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMNDLGMTS
DKPYKKSARIVGEVIGKYHPHGDSAVYESMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKISMEILRDITKDTIDYQDNYDGSEREPVVMPSRFPNLLVNGAAGIAVGMA
TNIPPHQLGEIIDGVLAVSENPDITIPELMEVIPGPDFPTAGQILGRSGIRKAYESGRGS
ITIRAKAEIEQTSSGKERIIVTELPYQVNKAKLIEKIADLVRDKKIEGITDLRDESDRTG
MRIVIEIRRDANANVILNNLYKQTALQTSFGINLLALVDGQPKVLTLKQCLEHYLDHQKV
VIRRRTAYELRKAEARAHILEGLRVALDHLDAVISLIRNSQTAEIARTGLIEQFSLTEKQ
AQAILDMRLQRLTGLEREKIEEEYQSLVKLIAELKDILANEYKVLEIIREELTEIKERFN
DERRTEIVTSGLETIEDEDLIERENIVVTLTHNGYVKRLPASTYRSQKRGGKGVQGMGTN
EDDFVEHLISTSTHDTILFFSNKGKVYRAKGYEIPEYGRTAKGIPIINLLEVEKGEWINA
IIPVTEFNAELYLFFTTKHGVSKRTSLSQFANIRNNGLIALSLREDDELMGVRLTDGTKQ
IIIGTKNGLLIRFPETDVREMGRTAAGVKGITLTDDDVVVGMEILEEESHVLIVTEKGYG
KRTPAEEYRTQSRGGKGLKTAKITENNGQLVAVKATKGEEDLMIITASGVLIRMDINDIS
ITGRVTQGVRLIRMAEEEHVATVALVEKNEEDENEEEQEEV
>AAN65247.1|FEATURES|megares|aminocoumarin|gyrB|antibiotic target alteration|0
MSKSSCTPVPNAEMSAWISWLCRILSIRAFSTLRILPRIGRIAWYCGLRPDLAEPPAESP
STTKISDIAGSFD
>ABR78840.1|FEATURES|megares|aminocoumarin|parE|antibiotic target alteration|0
MTQSSYNADAIEVLTGLEPVRRRPGMYTDTTRPNHLGQEVIDNSVDEALAGHAKRVEVIL
HADQSLEVIDDGRGMPVDIHPEEGVPAVELILCRLHAGGKFSNKNYQFSGGLHGVGISVV
NALSKRVEVNVRRDGQVYSIAFENGEKVEDLHVTGTCGKRNTGTSVHFWPDESFFDSPRF
SVSRLTHLLKAKAVLCPGVEIVFRDQVNNSEQSWCYADGLNDYLSEAVNGLPLLPEKPFV
GAFSGETEAVDWALLWLPEGGELLTESYVNLIPTMQGGTHVNGLRQGLLDAMREFCEYRN
ILPRGVKLSAEDIWDRCAYVLSVKMQDPQFAGQTKERLSSRQCAAFVSGVVKDAFSLWLN
QNVQAAELLAEMAISSAQRRLRAAKKVVRKKLTSGPALPGKLADCTAQDLNRTELFLVEG
DSAGGSAKQARDREYQAIMPLKGKILNTWEVSSDEVLASQEVHDISVAIGIDPDSDDLSQ
LRYGKICILADADSDGLHIATLLCALFVRHFRTLVKEGHVYVALPPLYRIDLGKEVYYAL
TEEEKTGVLEQLKRKKGKPNVQRFKGLGEMNPMQLRETTLDPNTRRLVQLVISDEDEQQT
TAIMDMLLAKKRSEDRRNWLQEKGDMADLEV
>BAM98940.1|FEATURES|megares|aminoglycoside|AAC(6')-Ib10|antibiotic inactivation|1
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
GYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVT
KIQTDPSPSNLRAIRCYEKAGFEKQGTVTTPDGPAVYMVQTRQAFERTRSDA
>YP_003610761.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MVYSYTEKKRIRKDFGKRPQVLDIPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQ
SYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQ
EVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYR
GSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQME
LVPERLRGETASFDIEADGKVYVEKGRRITARHIRQLEKDDIKHIEVPVEYIAGKVAAKD
YVDESTGELICPANMELSLDLLAKLSQAGHKRIETLFTNDLDHGPYISETVRVDPTNDRL
SALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLRDEIEGSGIL
SKDDIIEVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLS
LGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTR
ERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVT
DEIHYLSAIEEGNYVIAQANSNLDDEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQV
VSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKR
GGTVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERG
DVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVS
RDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEK
LLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDL
SEELQILEAGLFSRIYAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDE
LKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRQIQPGDKMAGRHGNKGVISKIN
PIEDMPHDANGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAK
LREFIQRAYDLGTDVRQKVDLNTFSDEEVLRLAENLRKGMPIATPVFDGAKEAEIKELLQ
LGGLPTSGQITLFDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLG
GKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMP
ESFNVLLKEIRSLGINIELEDE
>ABS43700.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MKFFKINPNTDFNLLCSLINPHKMGQKIMSEKTKTHYIFIKDISTPAANILKQDALRVGA
ELITHKEVITAKITHSNALLMASKEQIQKLIAKEKLQDFGLKNLALFLQKDFLKPKKAEL
MAVINVNEDSFNAKSRVSEKDFEKRLNDFLALKPEYIDIGAVSSRPGSEYCGKEEEFKRL
KKILDLIHEKNYHEKAIFSLDSFDEYCLEYALNKGFKLINDITSLRNLNLAKLASKYEAK
YCLMHMQNNPNNMQDNPFYEDLLDEMTLFFKEKLELLESFGVKESILDVGIGFGKSAEHN
MILIKHLEHFLQFNKPLLIGASRKSVINAYFQSEIKDRLAGTLYLHLKAFENGASIIRVH
DLYEHKQLFALVQAMDNIGV
>CAU08345.1|FEATURES|megares|rifampin|arr-3|antibiotic inactivation|1
MSSDWTPISHENCQQVRGPFYHGTKAHLSIGDLITTGHLSHFEDGRALKHVYFSALMEPA
IWGAELAMSLSRLDGRGYIYIVEPTGPFEDDPNLTNKRFPGNPTKSYRTCDPLRIVGSVE
DWQGHPADVLQQMLESLEDLKRRGLAIIED
>WP_000819067.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>CAD12205.1|FEATURES|megares|tetracycline|tet33|antibiotic efflux|1
MGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVS
LAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSAC
YGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHR
GRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVL
VQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQ
TLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPC
VILIMRGTAASPKFGSWASGDSM
>WP_001289562.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MYSSGNTHDKNFRKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGS
IDNDPPAAMRYTEAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGS
TGISAGYATDIPPHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKK
AYESGKGRIIVRSKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEV
RDETDRTGLRIAIELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIID
SYLNHQIEVVANRTKFELDNAEKRMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIE
VFEFTEEQAEAIVMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEEL
NEIKKKFKSERLSLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVED
IGLKDGDSLLKHQEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDE
VVINVFNEKDFNTDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDDLISVMRF
EKDQLITVITNKGMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMAT
QRGSLKRISFKILQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHG
LINDIHKSEQYTNGSFIVDTDDFGEVIDMYIS
>BAP39825.1|FEATURES|megares|fosfomycin|fosA|antibiotic efflux|0
MQLLGSVASPFVRRLRLVLAGQPYQFVALNIFESEGRSVLVQHNPARKVPVLVDGEQVIF
DSGVIYRYLASKLKFKPLSWDQENGLTTINACTDSLVELLLCKRSGFDVTEDKLFFNLQH
ERIQATLEALEQQIRAGHFGDWDYPGISLFTLIDWILFRDLVDLKPFPVLLQFRNAHLNR
PMVAETDPRLS
>WP_001289560.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSEIIQDLSLEDVLGDRFGRYSKYIIQERALPDVRDGLKPVQRRILYAMYSSGNTHDKNF
RKSAKTVGDVIGQYHPHGDSSVYEAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSLLAEELLRDINKETVSFIPNYDDTTLEPMVLPSRFPNLLVNGSTGISAGYATDIP
PHNLAEVIQATLKYIDNPDITVNQLMKYIKGPDFPTGGIIQGIDGIKKAYESGKGRIIVR
SKVEEETLRNGRKQLIITEIPYEVNKSSLVKRIDELRADKKVDGIVEVRDETDRTGLRIA
IELKKDVNSESIKNYLYKNSDLQISYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKFELDNAEKHMHIVEGLIKALSILDKVIELIRSSKNKRDAKENLIEVYEFTEEQAEAI
VMLQLYRLTNTDIVALEGEHKELEALIKQLRHILDNHDALLNVIKEELNEIKKKFKSERL
SLIEAEIEEIKIDKEVMVPSEEVILSMTRHGYIKRTSIRSFNASGVEDIGLKDGDSLLKH
QEVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPIEEDEVVINVFNEKDFN
TDAFYVFATQNGMIKKSTVPLFKTTRFNKPLIATKVKENDNLISVMRFEKDQLITIITNK
GMSLTYNTSELSDTGLRAAGVKSINLKAEDFVVMTEGVSENDTILMATQRGSLKRISFKI
LQVAKRAQRGITLLKELKKNPHRIVAAHVVTGEHSQYTLYSKSNEEHGLINDIHKSEQYT
NGSFIVDTDDFGEVIDMYIS
>ABO64442.1|FEATURES|megares|beta_lactam|TEM-162|antibiotic inactivation|1
MLHNIRKRRKSMSIQHFRVALIPFFAAFCLPVFAHPKTLVKVKDAENQLGARVGYIELDL
NSGKILESFRPEKRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDVVEYSPVTEK
HLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNE
AIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFI
ADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_000202262.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MTSLAHHATENRSVAEFTEQAYLNYAMYVIMDRALPHISDGLKPVQRRIVYAMSELGLKS
SGKPKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIEGQGNWGSPDDPKSFA
AMRYTEAKLSAYSELLLSELGQGTSEWQDNFDGSLKEPITLPARVPNILLNGTTGIAVGM
ATDIPPHNLREVVKGTIALIRNPQTSDEKLAEYIPAPDLPTKAEIITPPEELLKIQTTGR
GSYRMRAVYTIEKNEIVITELPYQVSGSKVITQIADQMQAKKLPLVVDVRDESDHENPTR
LVIVLRSNRIDAEAVMSHLFATTDLESSYRVNLNMIGEDGRPQVKSIRRILLEWIEIRKK
TVTRRLQYHLNRIEKRLHILAGLLIAYLDIDTVIRIIREEDQPKPVLMEHFNIDEIQAEA
ILELKLRHLAKLEEMEIRHEQDELSAKAAIIREQLENPESLKNLIISELKEDAKKFGDER
RSPIVARAEAVQIKEQDLMPAETVTVVLSEAGWVRAAKGADVDAENLNYRAGDQYLSHAV
GKTNQRVYFLDETGRSYALPISNLPSARGLGDPLSSKLSPASGVSFIQVYLDDDESELIA
ASSAGYGFKTQTKQLDTNAKAGKTFLTVPDKAKALPLISAQNMTHLAVLSSAGRLLILDL
AELPNLNKGKGNKLIQLEGKEQILSMTTLNLDEIIQVVAGQQHLKLKGDDLQKYMGKRAS
KGQLLPRGYQKANKLLIQR
>AGS60938.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSELTHDGVERQPLHLFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNS
SAKFKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLIDGQGNWGAPDDPKSFA
AMRYTESRLSKYSQILLSELGHGTVDWIPNFDGTLQEPKMLPARLPNILLNGTTGIAVGM
ATDIPPHNAREIGQALTMLLDNPDAGLSDVMQYVQGPDYPTEAEVITAPEDIKKIYKTGR
GSIRMRAVWQKEEGCAVITALPHQVSGAKVLEQIAALMRAKKLPLVDDLRDESDHENPTR
LVIVPRSNRVDLEQVMYYLFVNTDLEKSYRVNLNMIGLDNRPAVKGLLTILNEWLVYRRQ
TVTNRLNHRLEKVLRRLEILKGLLIAYLNIDEVIEIIRYEDEPKAELMRRFALSDIQAEA
ILELRLRHLAKLEEIKLQAESDELEKERDSIEKLLNSPRRLNTLLKKEIEADAKEFGDER
RSPIRPQEEAKVVNEQDMLPSEPVTIVLSEMGWVRSAKGHEIDPSTMSYRAGDSYHSAVR
GMSNQPVLFLDSTGRSYSLSPNDMPSGRSQGEPLTGKLTFPPDASVKYMLAGAAKQEYLL
ATKEGYGSVLSYEEMETKNKTGKGLLTVSDETELLAPFLVDAEKKNNQHWLVIITDKTRI
LAISAEHLNEMNKKGRGTRLVTLGKEQSDVIEQIVLIAKNEALTFTVDGQQQTLKAEEIS
YFSGDVGDEPIPLKHLHPEAVTVIMSEKGLIRCQKGHNIDAKSVGFKTGDDYFDAVEGMS
NQAVHLIDTTGQSYTVDVDALPSGRSKGDDLTGRLKVQKGAQLRHVVMGESSDKILMASD
AGYGFICSIDDLTSKNRAGKSLLTLPENALPLPPQRLNDELSDLIMIITQGGRMLIFEAS
ELPTMVKGKGNQMVSIPASQAASGEDKVAWLRVLPENASVTLHFGKRKLTMSMNELQTFK
AKRGRRGTSLPRGAQSIDHIDIETH
>WP_000907145.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MAGHDVQYGKHRTRRSFSRIKEVLDLPNLIEIQTDSFKAFLDHGLKEVFEDVLPISNFTD
TMELEFVGYEIKEPKYTLEEARIHDASYSAPIFVTFRLINKETGEIKTQEVFFGDFPIMT
EMGTFIINGGERIIVSQLVRSPGVYFNDKVDKNGKVGYGSTVIPNRGAWLELESDSKDIT
YTRIDRTRKIPFTTLVRALGFSGDDEIFDIFGDSELVRNTVEKDIHKNPMDSRTDEALKE
IYERLRPGEPKTAESSRSLLVARFFDPRRYDLAAVGRYKINKKLNVKTRLLNQTIAEPLV
DPETGEILVEAGTIMTRSVIESIESHLDGDLNKIVYIPNDAAVVTEPVVLQKFKVVAPTD
PDRVVTIIGNANPDDKVRTVTPADILAEMSYFLNLAEGLGRVDDIDHLGNRRIRAVGELL
ANQVRLGLSRMERNVRERMSVQDNEVLTPQQIINIRPVTAAVKEFFGSSQLSQFMDQHNP
LSELSHKRRLSALGPGGLTRDRAGYEVRDVHYTHYGRMCPIETPEGPNIGLINNLSSYGH
LNKYGFVQTPYRKVDRETGVVTNEIVWLTADEEDEYTVAQANSRLNEDGTFAEKIVMGRH
QGVNQEYPANIVDYMDVSPKQVVAVATACIPFLENDDSNRALMGANMQRQAVPLINPQAP
YVGTGMEYQAAHDSGAAVIAQYDGKVTYADADKVEVRREDGSLDVYHIQKFRRSNSGTAY
NQRTLVKVGDVVEKGDFIADGPSMENGEMALGQNPIVAYMTWEGYNFEDAVIMSERLVKD
DVYTSVHLEEYESETRDTKLGPEEITREIPNVGEDALKDLDEMGIIRIGAEVKEGDILVG
KVTPKGEKDLSAEERLLHAIFGDKSREVRDTSLRVPHGADGVVRDVKIFTRVNGDELQSG
VNMLVRVYIAQKRKIKVGDKMAGRHGNKGVVSRIVPVEDMPYLPDGTPVDIMLNPLGVPS
RMNIGQVMELHLGMAARTLGIHIATPVFDGASSEDLWSTVKEAGMDSDAKTILYDGRTGE
PFDNRVSVGVMYMIKLHHMVDDKLHARSVGPYSTVTQQPLGGKAQFGGQRFGEMEVWALE
AYGASNVLQEILTYKSDDINGRLKAYEAITKGKPIPKPGVPESFRVLVKELQSLGLDMRV
LDEDDQEVELRDLDEGMDEDVIHVDDLEKAREKAAQEAKAAFEAEEAEKATKAEATEEAA
EQE
>WP_000819068.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDLSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMKSLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELETILADEEVLLQLVRDELTEIRDRF
GDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAV
VNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>AAO38185.1|FEATURES|megares|tetracycline|tetA|antibiotic efflux|1
MPVLPGLLRDLVHSNDVTAHYGILLALYALVQFACAPVLGALSDRFGRRPILLVSLAGAT
VDYAIMATAPFLWVLYIGRIVAGITGATGAVAGAYIADITDGDERARHFGFMSACFGFGM
VAGPVLGGLMGGFSPHAPFFAAAALNGLNFLTGCFLLPESHKGERRPLRREALNPLASFR
WARGMTVVAALMAVFFIMQLVGQVPAALWVIFGEDRFHWDATTIGISLAAFGILHSLAQA
MITGPVAARLGERRALMLGMIADGTGYILLAFATRGWMAFPIMVLLASGGIGMPALQAML
SRQVDEERQGQLQGSLAALTSLTSIVGPLLFTAIYAASITTWNGWAWIAGAALYLLCLPA
LRRGLWSGAGQRADR
>AAA25527.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MKKNIKYSQNFLTNEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRSLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>ACN39575.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIRYQKTEGTSIESN
>ACD03449.1|FEATURES|megares|tetracycline|tet39|antibiotic efflux|1
PSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGV
LGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMA
PLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKR
FGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMSRGIS
>WP_000116442.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDLAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSIYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSADSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>AKL59536.1|FEATURES|megares|beta_lactam|OXA-24|antibiotic inactivation|1
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMGVTPQVGWLTGWVEQAN
GKKISFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ABR78833.1|FEATURES|megares|quinolone|parC|antibiotic target alteration|0
MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKF
KKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRY
TESRLSKYAELLLSELGQGTVDWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDI
PPHNLREVAKAAITLIEQPKTTLDELLDIVQGPDFPTEAEIITSRAEIRKIYQNGRGSVR
MRAVWSKEDGAVVISALPHQVSGAKVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIV
PRSNRVDMEQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRR
RLNHRLEKVLKRLHILEGLLVAFLNIDEVIEIIRTEDEPKPALMSRFGISETQAEAILEL
KLRHLAKLEEMKIRGEQSELEKERDQLQAILASERKMNNLLKKELQADADAFGDDRRSPL
HEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAQGLSYKAGDSWKASAKGKSN
QPVVFIDTTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVEHMLMESDDQKLLMASDA
GYGFVCTFNDLVARNRAGKALITLPDNAHVMPPLVIEDESDMLLAITAAGRMLMFPVSDL
PQLSKGKGNKIISIPAAEAAAGQDGLAHLFVLPPQSTLTIHVGKRKIKLRPEELQKVTGE
RGRRGSLMRGLQKIDRVEIDSPRRAAAGDSEE
>ABR78980.1|FEATURES|megares|sulfonamide|folp|antibiotic target alteration|1
MKLVAQGSTLDLSHPHVMGILNVTPDSFSDGGAHNSLIEAVKHANLMINAGATIIDIGGE
STRPGAAEVSVEEELARVIPVVEAIAQRFEVWISVDTSKAEVIRQSARAGAHIINDIRSL
TEPGALQAAAETGLPVCLMHMQGQPKTMQEAPKYEDVFADVERFFNEHIVRCEQAGIAKE
KLLLDPGFGFGKNLSHNYQLLARLGEFHHFGLPLLVGMSRKSMVGQLLNVGPSERLNGSL
ACAVIAAMQGAQIIRVHDVKETVEALRVVEATLAAKGKKRYE
>AAK44229.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDTTLPPDDSLDRIEPVDIQQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAMF
DSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDTLVRMAQPWSLRYPLVDGQGNFGSPG
NDPPAAMRYTEARLTPLAMEMLREIDEETVDFIPNYDGRVQEPTVLPSRFPNLLANGSGG
IAVGMATNIPPHNLRELADAVFWALENHDADEEETLAAVMGRVKGPDFPTAGLIVGSQGT
ADAYKTGRGSIRMRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRDGKLAGIS
NIEDQSSDRVGLRIVIEIKRDAVAKVVINNLYKHTQLQTSFGANMLAIVDGVPRTLRLDQ
LIRYYVDHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVIALIRASETVDIARAG
LIELLDIDEIQAQAILDMQLRRLAALERQRIIDDLAKIEAEIADLEDILAKPERQRGIVR
DELAEIVDRHGDDRRTRIIAADGDVSDEDLIAREDVVVTITETGYAKRTKTDLYRSQKRG
GKGVQGAGLKQDDIVAHFFVCSTHDLILFFTTQGRVYRAKAYDLPEASRTARGQHVANLL
AFQPEERIAQVIQIRGYTDAPYLVLATRNGLVKKSKLTDFDSNRSGGIVAVNLRDNDELV
GAVLCSADDDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNIDDRLLSLNVVREG
TYLLVATSGGYAKRTAIEEYPVQGRGGKGVLTVMYDRRRGRLVGALIVDDDSELYAVTSG
GGVIRTAARQVRKAGRQTKGVRLMNLGEGDTLLAIARNAEESGDDNAVDANGADQTGN
>AGJ50602.1|FEATURES|megares|beta_lactam|pbp2|antibiotic target replacement|1
LSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQK
DASWGNYNITRFKVVNGNIDLKQAIX
>BAB43879.1|FEATURES|megares|beta_lactam|BLAZ|antibiotic inactivation|1
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>ADM92620.1|FEATURES|megares|sulfonamide|sul2|antibiotic target replacement|1
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
SDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAK
SSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFF
LGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTVRGPGDVGAATLAAELAAAA
GGADFIRTHEPRPLRDGLAVLAALKETARIRYQKTEGTSIESN
>CAJ68894.1|FEATURES|megares|macrolide-lincosamide-streptogramin|ErmB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYHLSTQIIKKVVFESRAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIKQLLKLPAECFHPKPKVNSALIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_000819100.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTP
DKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMA
TNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGS
IQMRSRAVIEERGGRRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRT
GVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQK
TVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEK
QAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRF
GDERRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVIS
TMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQ
EDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTE
NGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDV
ADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDADEVNEDEQSTVSEDGTEQQREAVVND
ETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSSDEDEE
>AAF71282.1|FEATURES|megares|glycopeptide|vanWG|antibiotic target alteration|1
MKFDGNRYAKKTSEKLLPNTVFETSSLMLNENSGFDMKYQINKVHNLKLAAKTINKVIIE
PKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSYGGGLCQLSNMLFWLFLHTPLVIVER
HGHAVESFPSTTEEMPRRNEATINEGWLDLKPRKKTNILSRLRLVLMTTLVWCNFVAKLV
NIDIRFLFVCFLFQAREKVYQIASVCRTEKDKMTGSQTEKELYVNQCKIAYKLPDGVKIE
ERGV
>AAZ98828.1|FEATURES|megares|beta_lactam|SHV|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLTSGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAR21615.1|FEATURES|megares|aminoglycoside|AAC(3)-Id|antibiotic inactivation|1
MFGEAFNDQDSYARNKPSSSYLQKLLSTSSFIALAAVDEQKVIGAIAAYELQKFEQQRSE
IYIYDLAVAATRRREGIATALIKKLKAIGAARGAYVIYVQADKGVEDQPAIELYKKLGTI
EDVFHFDIAVEQSKNHA
>WP_003156440.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLEFIDYSLGDPKYPVEESKERDVTYSAPLRVKVRLINKETGEVKDQDVFMGDFPIMT
DTGTFIINGAERVIVSQLVRSPSVYFSGKVDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEILDLIGENEYLRNTLDKDNTENSDKALLEIYERL
RPGEPPTVENAKSLLDSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EILAEKGQILDRRTLDKVLPYLENGIGFRKLYPNGGVVEDEVMLQSIKIYAPTDAEGEQT
INVIGNAYIEEAIKNITPADIISSISYFFNLLHGVGDTDDIDHLGNRRLRSVGELLQNQF
RIGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAEL
THKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSFAKVNRF
GFIETPYRRVDPETGKVTPRIDYLTADEEDNYVVAQANAKLSDDGSFLDDSIVARFRGEN
TVVARNRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPIVGT
GMEYVSGKDSGAAVICKHPGIVERVEAKNVWVRRYEEIDGQKVKGNLDKYSLLKFVRSNQ
GTCYNQRPIVSVGDEVVKGEILADGPSMELGELALGRNVMVGFMTWDGYNYEDAIIMSER
LVKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVNDGD
LLVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIIHDVKVFNREDGDE
LPPGVNQLVRVYIVQKRKISEGDKMAGRHGNKGVISKILPEEDMPYLPDGTPIDIMLNPL
GVPSRMNIGQVLELHMGMAARYLGIHIASPVFDGAREEDVWETLEEAGMSRDAKTVLYDG
RTGEPFDNRVSVGIMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGDNVPEPGVPESFKVLIKELQSLGM
DVKILSGDEEEIEMRDLEDEEDAKQADGLALSGDEAPEETASPDVERDAVTKE
>WP_012503694.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MTDATIRHDHKFALETLPVSLEDEMRKSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAM
HELKNNWNAAYKKSARIVGDVIGKYHPHGDFAVYGTIVRMAQNFAMRYVLIDGQGNFGSV
DGLAAAAMRYTEIRMAKISHEMLADIEEETVNFGPNYDGSEHEPLVLPTRFPTLLVNGSS
GIAVGMATNIPPHNLTDTINACLRLLDEPKTEIDELIDIIQAPDFPTGATIYGLGGVREG
YKTGRGRVVMRGKTHIEPIGKNGEREAIVIDEIPYQVNKAKLVEKIGDLVREKTLEGISE
LRDESDKSGMRVVIELKRNENAEVVLNQLYKLTPLQDSFGINMVVLVDGQPRLLNLKQIL
SEFLRHRREVVTRRTLFRLKKARHEGHIAEGKAVALSNIDEIIKLIKESPNAAEAKEKLL
ARPWRSSLVEEMLTRSGLDLEMMRPEGLAANIGLKKQGYYLSEIQADAILRMSLRNLTGL
DQKEIIESYKNLMGKIIDFVDILSKPERITQIIRDELEEIKTNYGDERRSEINPFGGDIA
DEDLIPQREMVVTLTHGGYIKTQPTTDYQAQRRGGRGKQAAATKDEDFIETLFVANTHDY
LMCFTNLGKCHWIKVYKLPEGGRNSRGRPINNVIQLEEGEKVSAILAVREFPEDQYVFFA
TAQGMVKKVQLSAFKNVRAQGIKAIALKEGDYLVGAAQTGGADDIMLFSNLGKAIRFNEY
WEKSGNDEAEDADIETEISDDLEDETADNENTLPSGKNGVRPSGRGSGGLRGMRLPADGK
IVSLITFAPETEESGLQVLTATANGYGKRTPIADYSRKNKGGQGSIAINTGERNGDLVAA
TLVGETDDLMLITSGGVLIRTKVEQIRETGRAAAGVKLINLDEGETLVSLERVAEDESEL
SGASVISNVTEPEAEN
>ACJ05192.1|FEATURES|megares|beta_lactam|OXA-20|antibiotic inactivation|1
LIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYN
ESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSX
>NZ_AEXB01000013|FEATURES|megares|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSDLQKSVTFWHELLGLALYARWNTGAYLTCGDLWVCLSYDEARQYVPP
QESDYTHYAFTVAEEDFEPFSQRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGSLA
ARLAACREKPYAGMVFTSDEA
>CAA26631.1|FEATURES|megares|chloramphenicol|cat|antibiotic inactivation|1
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEV
VNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLF
EYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIY
IPVALQLHHAVCDGYHASLFINEFQDIINKVDDWI
>AAP93923.1|FEATURES|megares|tetracycline|tetR|antibiotic efflux|0
MSEKNTAARLTRETVLRGALALLDDIGIDALSTRRLAQHLGVQSPTLYWHFKNKAELLKA
MAETIMLDHREEVPADMPWQAWVTANAINFRRALLAYRDGARLHAGTRPQEPQFAIIEAK
VALLCRAGFTPEHAVNLLFAVGRFVVGWVLEEQQMQPDDALNEADRRRYPLLCGGWEKLQ
DKGADALFEAGLRLLVDGAEAALTNANNHGAQS
>WP_000116444.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSVSEIRPIAIEDELKHSYLDYAMSVIVSRALPDVRDGLKPVHRRVLYAMHELGNDYNKA
YKKSARVVGDVIGKYHPHGDLAVYETIVRMAQDFSLRYLLVDGQGNFGSIDGDSAAAMRY
TEVRMTKLAHELLADLEKDTVDWEDNYDGSERIPEVLPTRVPNLLINGAAGIAVGMATNM
APHNMTEVVNACLAYADNPNISIEGLMEYITGPDFPTGGIIYGKSGIVDAYRTGKGRLHI
RGKYHFEEDEKTGRTTIVFTEIPYQVNKARVIERIAELVKEKKLEGISELRDESDKEGMR
IAIDLKRGENAEVVVNNLFLNTQLENSFSINMVCLDNGQPKLMNLKDIIAAFIRHRQEVV
TRRTMFELRKARERGHILEGLTVALANIDEIIETIKTSANPAEARERLLAGEWAGGGVVA
LLEKAGAISVRPDEIEGEDPNRPFGLSDSFYRLSPTQVGAILELRLHRLTGLEQDKLHAE
YTEILGQIAELTAILNDFNLLMGVIREELAQVLQQYGDARRTEIVESRVDFCREDLIPEE
QVVLTVSQTGYAKTQPLSDYQAQRRGGRGKSATSMKDDDFIQHLIVASNHATVLCFTNVG
KVYRLKVFEVPQASRGAKGRPIVNLLPLDATETVTAILPLTEFPENHYVFMATASGTVKR
VELEQFANIRSNGLRAIELNEEDTLIGVAITDGNQQIMLFSNEGKAIRFAETDVRAMGRT
AKGVRGMRVSFASSTLSEEDADVENDDSDDNDDSTDSSLVSRIVSLVVVPETGEVLCASA
NGYGKRTPVNDFPTKKRGGKGVIAIKTSERNGELVGAVSIDETKELLLISDGGTLVRTRA
AEVAMTGRNAQGVRLIRLSEEETLVGVVSIEAVEDEEELLEGEVDTTETDSEEAVSNNED
TSEE
>CAI29521.1|FEATURES|megares|trimethoprim|dfrA15|antibiotic target replacement|1
MAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRS
SFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDIEPEGD
VYFPEIPGSFRPVFSKDFVSNINYSYQIWQKG
>CAJ29622.1|FEATURES|megares|sulfonamide|sul1|antibiotic target replacement|1
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
EIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADC
RLVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRVILDPGMGFFL
RPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGN
GADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CBA32359.1|FEATURES|megares|quinolone|gyrA|antibiotic target alteration|0
MSDLAREITPVNIEEELKNSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWN
KAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYTLVDGQGNFGSIDGDSAAAM
RYTEIRLAKIAHELMADLDKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMAT
NIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTSAIINGRRGIEEAYRTGRGKI
YIRARAEVEVDPKNGRETIIVHEIPYQVNKARLIEKIAELVKDKRVEGISALRDESDKDG
MRIVIEIKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMALKEILAAFVRHRRE
VVTRRTIFELRKARERAHILEGLAIALANIDPIIELIRRAPNPSEAKAGLIAQAWELGTV
SAMLERAGDDAARPEWLEPEFGIRDGKYWLTEQQAQAILDLRLQKLTGLEHEKLLDEYKE
LLEQIAELLHILGSADRLMEVIREELELIRDQFGDERRTEITANSADINIEDLINQEDVV
VTLSHQGYVKYQPLTDYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDTILCFSSRGRLY
WMKVYQLPEASRGARGRPIVNLLPLEANERITAILPVREYEEGVNVFMATASGTVKKTAL
TEFSRPRTAGIIAVNLNEGDELIGVDLTAGKDEVMLFSAQGKVVRFKEDAVRPMGRTATG
VRGIRLGEGDSVVSLIVPRGEGAILTATQNGYGKRTAVEEYPTKSRATKGVISIKVTDRN
GPVVGAVQVDDADQIMMITDAGTLVRTRVSEISVVGRNTQGVILIRTAEDENVVGLQRVA
EPVDDEELDSIDGSVAEGDDEIAPETDVDDDAADDADE
>YP_002343912.1|FEATURES|megares|rifampin|rpoB|antibiotic target alteration|0
MCDMLDNKLGNRLRVDFSNISKQIEIPNLLQLQKKSFDYFLNLDNGESGIEKVFKSIFPI
HDPQNRLSLEYVSSEIGKPKYTIRECMERGLTYSVNLKMKIRLTLHEKDEKTGEKVGVKD
IKEQEIYIREIPLMTDRVSFIINGVERVVVNQLHRSPGVIFKEEESSTVANKLVYTAQII
PDRGSWLYFEYDAKDVLYVRINKRRKVPVTMLFRALGYKKQDIIKLFYPIQTIHVKKDKF
LTEFNPNDFMDRIEYDIKDEKGKIVHQAGKRLTKKKAEQLIKDGLKWIEYPVEILLNRYL
ANPIIDKESGEVLFDSLTLLDESKLAKIKEQKSFDIANDLANGVDAAIINSFAQDGETLK
LLKQSENIDDENDLAAIRIYKVMRPGEPVVKDAAKAFVNDLFFNPERYDLTKVGRMKMNH
KLGLEVPEYVTVLTNEDIIKTAKYLIKVKNGKGHIDDRDHLGNRRIRSIGELLANELHLG
LAKMQKAIRDKFTSLNADLDKVMPYDLINPKMITTTIIEFFTGGQLSQFMDQTNPLSEVT
HKRRLSALGEGGLVKERAGFEVRDVHATHYGRICPVETPEGQNIGLINTLSTYAKVNELG
FVEAPYRKVVNGKVTNEVVYLTATQEEGLFIAPASTKVDAKGNIVEEFVEARQDGETILA
RREEVQLIDLCSGMVVGVAASLIPFLEHDDANRALMGSNMQRQAVPLLTASAPIVGTGME
QIIARDAWEAVKAKRGGVVEKVDNKSIFILGEDDKGPFIDHYTMEKNLRTNQNTNYIQHP
IVKKGDIVKAGQIIADGPSMDQGELAIGKNALIAFMPWNGYNYEDAIVVSERIIREDTFT
SVHIYEKEIEARELKDGIEEITKDIPNVKEEDVAHLDESGIAKIGTHIKPGMILVGKVSP
KGEVKPTPEERLLRAIFGEKAGHVVNKSLYATASLEGVVVDVKIFTKKGYEKDDRAIKSY
DKEKMALEKEHHDRLLMMDREEMLRVCALLSKASLNSDQKIGDKNYKKGQTADISELEKI
NRFTLTTLIKAYSKEIQKEYDDLKNHFQNEKKKLKAEHDEKLEILEKDDILPSGVIKLVK
VYIATKRKLKVGDKMAGRHGNKGIVSTIVPEVDMPYLPNGKSVDIALNPLGVPSRMNIGQ
ILESHLGLVGLRLGDQIQEIFDRKQKDFLKELRAKILEICSIPRLANEKEFIKSLSDEEL
LNYARDWSKGVKFSTPVFEGVNIEEFSKLFKMAKIDMDGKTELYDGRTGEKIAERVHVGC
MYMLKLHHLVDEKVHARSTGPYSLVTQQPVGGKALFGGQRFGEMEVWALEAYGAAHTLRE
MLTIKSDDVEGRFSAYKALTKGENVPATGIPETFFVLTNELKSLALDVEIFDKDEDNE
>WP_002592615.1|FEATURES|NCBI|aminoglycoside|APH(2'')-IIa|antibiotic inactivation|1
MIDLDVEIYQHLNEQIKINKLCYLSSGDDSDTFLCNEQYVVKVPKRDSVRFAQKREFELY
RFLENCNLSYQTPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKEL
HSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAV
LFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGR
KVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKGVSELLQTQAEMFIF
>NZ_KQ236707.1|FEATURES|NCBI|trimethoprim|dfr|antibiotic target replacement|1
MNKEIQFSMIVARGVNGEIGQDGDLPWHVEGVRLKEDLKRFKAITMGKTLVMGRKTFESI
PNGLPGRNVIVLTREPYDKADITERGDGTFVAWGNSCHLFEVAEHLGVTEIIVAGGAEIY
NLHKDVITKVFETKVLRAYPAADTHVDVFWESPGYDTEGRQWRVTSRGHIIENGSFTIAT
TYER
>WP_058515178.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLKKTIQDQQLIALLNNHYGFDIHRIQLILGGADMNAFGYKADSESSSYFVKLKYGHHDE
INLSIIRLLHDAGIKEIIFPIHTLETQLFQQLDYFKIIVYPFIHAPNGFTQNLTEKQWKQ
LGKVLRQIHETSVPTPIQQQLRKEMYSTKWREMVRSFYSKTEFDNSDDKITADFKSFFNQ
NIDSIQQLVNASEKLSKKIKPGLDNYVLCHSDIHAGNILVVNEEFIYIIDWDEPILAPKE
RDLMFIGAGVGNVWNKPSEIHYFYEGYGETKVDKTILSYYRYERIVEDMAVYGQDLLSRE
QNDQSRLESFKHFKEMFDPSNVVEIAFATG
>WP_027224994.1|FEATURES|NCBI|aminoglycoside|APH(9)-Ia|antibiotic inactivation|1
MLRNNIPDQQLIELLKVYYGIDIHTLQLLVGGADMNAFGYKADSESNSYFVKLKYGHHDE
INLSIIRLLHDSGVKEIVFPINTLEANLFQQVDHVKIIVYPFIDAPNGFTKNLTEKQWKQ
LGKILRQIHETSVPTPIQQRLRKETYSPKWREMVRSFYSQIGFDKSDDQITTDFKSFFNK
NIDLIHQLVNSSEELSKKIQPDFEKYVLCHSDIHAGNVLVIDEESIYIIDWDEPMFAPKE
RDLMFIGGGIGNVWNKPHQIDYFYEGYGKTSVDKTILSYYRHERIVEDIAVYGHDLLSRD
QNAQSRLESFKHFKSMFDPNDVIEIAFASD
>WP_053258911.1|FEATURES|NCBI|aminoglycoside|SeKA_A1070|antibiotic inactivation|1
MDIRHMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_048348829.1|FEATURES|NCBI|aminoglycoside|SEET0819_14790|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
SIRHDYVNGCDNSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>WP_000354863.1|FEATURES|NCBI|aminoglycoside|LFZ48_07285|antibiotic inactivation|1
MDIRQMNKTNLEHWRGLRKQLWPGHPDDGHLADGEEILQADHLVSFVAIEDGVAIGFADA
SIRHDYVNGCDSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPEN
TISQKVHQALGFEETERVIFYRKRC
>NP_627790.1|FEATURES|NCBI|glycopeptide|ddlA|antibiotic target alteration|1
MARLKVGIVFGGSSEEHAVSVKSAQEVARNLDTEKYQPFFVGITKDGAWRLCDGPGQDWE
NGDCRPVVLSPDRSVHGLLVLEQGQYRSVRLDVVLPVLHGTLGEDGATQGLLELSGIPYV
GCDVQSSALCMDKSLAYVVARSAGIATPDFWTVTGDETIDPGRLTYPVFVKPARSGSSFG
VSKVCRPEDLATAVESARRYDTKVLIEAAVVGSEVGCAILGNDPDLIVGEVDRIALSHGF
FRIHQEEQPENGSENSTPVVPADIPTEKRSLVQETAKAVYRALGCRGLSRVDMFLKEDGE
VVLNEVNTLPGMTSYSRYPRMMAAAGLPLSEVIDRTLSLALT
>WP_023042300.1.|FEATURES|NCBI|glycopeptide|VanD|antibiotic target alteration|1
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
NYAGYPAVISPDRRTHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYV
GCDIQSSVTCMDKSLAYMVVKNAGIEVPGFRVLQKGDSLKAETLSYPVFVKPARSGSSFG
VNKVCRAEELQAAVTEAGKYDCKILVEEAVSGSEVGCAILGNENALMAGEVDQIELRHGF
FKIHQEAQPEKGSENAVIRVPAVLPDEVRERIQKTAMKIYRILGCRGLARIDLFLREDGC
IVLNEVNTMPGFTSYSRYPRMMTAAGFTLTEILDRLIELSLR
>WP_043911783.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGAEVVLRPVAAGDEEVLDRIVREPEVAAWWSPPDDFQRMLAVVLQGEVIGAIQYQEE
TDPEFRHAGLDVFLTARHHGKGLGTDAVRTLARWLVHDRGHHRLTIDPAAANTAAIRSYR
KVGFKPVGIMRSYWRDHRTGTWQDGLLMDLLAEELT
>WP_046928126.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGTDVLLRPVQDTDIATLDRIVREPAVAAWWSPPDDYADMLAITHSGKVIGAIQFSEE
TDPDFRHAGIDIFLTTSHHGKGLGTDAVRTLAHWLIHERGHHRLTIDPAAANTAAIASYR
KVGFKPVGIMRAYGRDYRTGGWADGLLMDLLADELT
>WP_026328431.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib-SK|antibiotic inactivation|1
ELHGEKVVLRPVEDSETETLDRIVREPEVAAWWSPPNDYRNTFAVFLDDEIIGAVQFTEE
SDPEYRHAGIDVFLTARRTGAGLGTDTVRTLARWLLDDRGHHRLTIDPAAENAPAIASYR
KVGFQPVGVLRRYWRDHQTGEWRDGLLMDLLADELA
>WP_047467383.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGERVLLRSTVPADTPVLDAIVREPEVARWWPPPEAYAAMLAVVVDGEVIGAIQFSEE
SDPEFRHAGIDLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTHAIRSYR
KVGFAPVGIMRAYWRNHRTGAWEDGLLMDLLAAELT
>WP_053927904.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELRGTDILLRPVQDTDTATLDRIVREPAVAAWWSPPDDYADMLAITHSGKVIGAIQFSEE
TDPEFRHAGIDIFLTTSHHGQGLGTDAVRTLAHWLIHERGHHRLTIDPAAANTAAIASYR
KVGFKPVGIMRAYGRDYRTGGWADGLLMDLLADELT
>WP_018088143.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Isa|antibiotic inactivation|1
ELHGAAVVLRPTTDTDIPTLDRIIREPEVAAWWSVPDDYRDMLAILCHDEVIGAIQFSEE
TDPEFRHASIDIFLTARRHGQGLGTDAVRTLAHWLTHARGHHRLTIDPAAANTPAIRSYR
KVGFQPVGIMRAYGRDHRTGGWADGLLMDLLADELT
>ADC58623.1|FEATURES|NCBI|beta_lactam|blaLEN-13|antibiotic inactivation|1
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>WP_017724236.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphC|antibiotic inactivation|1
MTQHNEIIKCAEKHQLHIQPRTISLNESGLDFQVAFGKDEHGIEWVLRLPRRSDVYKRTK
PEKQVVDFLQSNVSFEIPKWKVHAKDLIAYPKLTGNPAATIDPEIQDYVWEIEHKPVPEN
FVNTLAEALVDLHNIPEENITAQHIKIKTIQEVKNDFQRRMNKVKETYGVVYELWNRWKQ
WLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRIFGEE
GLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMKSGESAFEKMALKELGMEE
>WP_006261873.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILAEAHGLLLTEKMKFNEMGIDFKVGFAIDRSGQQWLLRIPRRNDMGEQIEKE
KRILELVKKHLSIEVPDWQISSPELVAYPMLKYNPVLTFNAETYEVSWHMDKDSPKYITS
LAKTLVEIHSIPEIEVLGNDLKIMKSSNLRPEIASHLQLVKSEIGISEQLETRYRKWLDN
DALWADFTQFIHGDLYAGHVLASKEGIVSGIIDWSTAHIGDPAIDFSGHATVFGEESLKG
LIMEYEKQGGKVWDKLYEQTLERAAAAPLAYGFFALETQDESHIAGAKVQLGV
>CDS98980.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mphD|antibiotic inactivation|1
MTIKDIQILAEEHGLLLTENIRFNEMGIDFRVGFAIDNKGQRWLLRIPRRNDMSEQIDKE
KRILHLVKKHLSVKVPDWKITSPKLIAYPLIKEKPALTVDAETYGMVWNMDKDSPNYIQS
LAKSLVELHDITEEEVIKNHLKIMKPSDLRPEIDNQLKTVKSEIGISSELELRYKKWLDN
DKLWPDFTQFIHGDLYAGHILTSQDGIVAGIIDWSTAHLGDPANDFSGHVTIFGEASLRK
LITAYENQGGRTWGQLYEQAIERASASALAYGYFALETNDENHIMGAKVQLGV
>WP_002485790.1|FEATURES|NCBI|beta_lactam|mecI|antibiotic target replacement|0
MDNKTYEISSAEWEVMNIIWMKKYASANNIIEEIQMQKDWSPKTIRTLITRLYKKGFIDR
KKDNKNFQYYSLVEESDIKYKTSKNFINKVYKGGFNSLVLNFVEKEDLSQDEIEELRNIL
NKK
>WP_027625762.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_005816151.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPIWMVMVVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVI
ASITVAIVRIPKLGDQVQSLKPNFIREMKEGMAVLRQNKGLFALLLVGTLYMFVYMPINA
LYPLITMEYFNGTPMHISITEIAYASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLT
ISGLLPQSGFFIFVVCCAIMGLSGPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIDVNHWFLLSGILIICIAIVCPMITEIRKLDAK
>WP_024410015.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWIVMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKPVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALYQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCPMITEVRRLDLK
>WP_023918145.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVTALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_000417521.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASTTVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMP
IGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>ACG58972.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTERTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYMELPVWMVMVVLFIRSVGTAFHT
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVI
ASITVAIVRIPKLGDRVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMDYFNGTPVHISITEISFASGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLA
VSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIACPMITEVRKLDLK
>AAQ62544.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|mefA|antibiotic efflux|1
MEKYNNWKFKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
GPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVALYTELSVWMVMVVLFIRSIGTAFHS
PALNAVTPLLVPEEQLTKCAGYSQSLQSISYIISPAAAALLYSVWKLNAIIAIDILGAMI
ASITVAIVSIPKLGDQVQSLKPNFLREMKEGIVALRQNKGLFALLLLGTLYTFVYMPINA
LFPLISMEYFNGTPVHISITEIAFASGMLVGGLLLGRLGNFEKRVLLITGSFFIMGASLA
VSGLLPPSGFVIFVACCAVMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSFAMP
IGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK
>WP_002449603.1|FEATURES|NCBI|mupirocin|ileS|antibiotic target alteration|0
MTKKYLNTQNEISVFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKD
LVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFN
YEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQ
TALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSK
IRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFV
TNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEII
KLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPS
HIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDED
IELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPAD
FIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELI
NKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNN
EITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIRRSRGRFW
EQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFIN
QALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELN
IKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSL
SSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKK
KNLPINQRIDIYIGVTGELLESIKTNKNMFKENLLIKNIHLNVIDEYENTIHFNNKEIKI
SLLY
>WP_063854490.1|FEATURES|NCBI|nitroimidazole|nimB|antibiotic inactivation|1
MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKG
HKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKY
SYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEA
>WP_023289605.1|FEATURES|NCBI|beta_lactam|OKP-A-4|antibiotic inactivation|1
MRYVRLCLFSLIAALPLAVFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>WP_026056097.1|FEATURES|NCBI|beta_lactam|OXA-348|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGRT
EEIYGNDLKRASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLS
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_017389475.1|FEATURES|NCBI|beta_lactam|OXA-332|antibiotic inactivation|1
MYKKALIVATSILFLSACSSNSVKQHQIHSISANKSSEEIKSLFDQAQTTGVLVIKRGQT
QEIYGNDIKRASTAYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPDWDKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQF
AYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_010890145.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIVSGVVVLN
>CAG34239.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGAVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>CAF18335.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGCLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>T45122|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KGWLFLVIAIVGEVIATSALKSSEGFAKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_032164557.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KAWLFLVIAIVGEVIATSALKSSEGFTKLAPSAVVIIGYGIAFYFLSLVLKSIPVGVAYA
VWSGLGVVIITAIAWLLHGQKLDAWGFVGMGLIIAAFLLAR
>WP_000259018.1|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGADVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>WP_007929940.1.|FEATURES|NCBI|sulfonamide|sul|antibiotic target replacement|1
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
IRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCR
LVVMHSAQRDGIATRTGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLS
PAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASLAAELHAIGNG
ADYVRTHAPGDLRSAITFSETLAKFRSRNARDRGLDHA
>NG_047751.1|FEATURES|NCBI|trimethoprim|dfrB|antibiotic target replacement|1
MDQGSNEVGNPVAGQFSFPSNAAFSMGDRVRKKSGAAWQGQIVGWYCTKLTPEGYAVESE
AHPGSVQIYPVAALERIN
>WP_015741374.1|FEATURES|NCBI|fosfomycin|FosA4|antibiotic inactivation|1
LSGLNHLTLAVRDVARSLAFYQSLPGLRLHARWDGGAYLSCGSLWLCLSLDENAGSPAAD
YTHYAFTVSEADFPQVVETLTAAGVTPWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRAAPYKGMRFYD
>WP_038883625.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
LSGLNHLTLAVRDVARSVAFYHTLLGLRRHAVWDGGAYLSCGDLWLCLSLDDGAGAPPAD
YTHYAFTVSEADFPRMVETLTRAGVQTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLA
ACRARPYQGMTFFE
>WP_038862786.1|FEATURES|NCBI|fosfomycin|FosA3|antibiotic inactivation|1
LNGLNHLTLAVRDVARSVAFYHTLLGLRLHAVWDGGAYLSCGELWLCLSLDDAAGTPPAD
YTHYAFSVSEADFPRLVEKLTLAGVQTWKTNRSEGDSWYFLDPDGHPLELHVGSLATRLA
ACRARPYRGMRFFD
>WP_003975347.1|FEATURES|NCBI|glycopeptide|vanJ|antibiotic target alteration|0
MVLRSAARPELWKRAPVLTVSALLLGLVMMLHAEIPNRFGSIGSLVETFLPWFGLFVPVL
AAGALWRRSAAAVTALVLPVTVWLSLFGGLLGDKSGAGGEFTMASHNVGAENPDPAGTAR
DLAASGVDVLALEEITAQDREVYEKGLAREYPYHTVQGTVGLWSKLPLSGTRPVDIATDY
GPLADTKPADVTMAGNRALRTTVATEKGPLVVYVTHLGSVRLNPRAGFWTDSRDRNAWAL
GEALAADRSERIALLGDLNGTVDDRALAGITSQLHSVQEAAGNGFGFTWPAKFPVARIDQ
ILVRGVEPTGSWTLPATGSDHLPVAAGVSW
>WP_048759255.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LDPAQPLSSAPPYSLFEQWAQPVAPFQIFPQLYYVGTRNLSSVLFSTPEGLILIDAGLDA
SAPVIKSHIEALGFNIKDLRFILNSHARLDQAGGIARLKAWSGAKVVASAANAQQLARGG
KQDFALGDALGFPPVKVDIIVGQGDSVTLGGLKFTALMTPGHLPGATSWTTTLRQSGKTY
RLVYADSLATPDYYLVDNKNYPSLVQDIRSSFRLLAQQHADIFIANKGTRFDLENKMARL
QAGDRDAFVDRLGLQQYVQQSQRSFETQLK
>WP_005030815.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
LNSQQALTEAPPMSLFELWNAPIEPFKIFHHVYYVGTENLSSVLFDTGAGLVLIDSGIDQ
SAVQIKSNIEKLGFKITDVKYLLNSHARLDQAGGFAKLKQWSGAKLIASAENAEMLANGA
STDFALGNQLPFPPVKADLIFKDGEQLKLGEQVFTAHATPGHLPGATSWTTEVQYHFKHY
QIIYADSLFTGGYHLLNNKNYPHIVTDMQKTFQTLNAIHADIFLANKADRFNMKQKLIRL
KAGDQNAFIDPDGLQNYVAKGKAEFEQQLQ
>AIG22448.1|FEATURES|NCBI|beta_lactam|blaOXA-372|antibiotic inactivation|1
MMHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFAS
ASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDIPDWNRDQTLESAFKVSCVWCYQEIAK
QVGEETYRRYLTLARYGVLTNVADTTTFWLDGSFTVSAVEQIALLEKIYLRELPFRDEAY
DALKQVMLAEQTDSYKLYAKTGWAARMNPQIGWYVGYVETSDDVWFFAINLTLRSELDLG
LRQKITKAALRAERIIP
>ABP68837|FEATURES|NCBI|quinolone|qnrB6|antibiotic target protection|1
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG
>WP_033648215.1|FEATURES|NCBI|beta_lactam|SRT-2|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>WP_049201909.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAVYHIIQALEKR
>CAL34450|FEATURES|NCBI|beta_lactam|blaOXA-193|antibiotic inactivation|1
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKK
>WP_044403015.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADKAEAAFDAQLKKQRGG
>WP_031743169.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|Erm(37)|antibiotic target alteration|1
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
ELHPRRAGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLV
AADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR
>WP_031576412.1|FEATURES|NCBI|tetracycline|tetA(46)|antibiotic efflux|1
MIRAILEYIRERKWRYVKIAMVLILYDYTLLIPTQVIQRLVDHLSQQTLTQSNFVWDMVL
LVGSAILNYLTAFYWQLRLFQSSVHFKATLQGQAFRKLVAMRRPFFEKFRSGDLLTRFTT
DVDGMADMAGYGMMVLLFGGGLFAFIIPTMFFISWQLTLISFIPMIFLVVSTYFLSRKQE
EYVEQNREAVAQLNDEVLESIEGIRVMRAYSRRDQQVKQFQKKTASLSKTGDKIASIQYS
FGPLALLFIGFSTVLLLLFGGQSLASGQLSLGKLLALQLYLVFLIEPMWMMADLILVYQT
GQMSYKKLKEVIDETDDLEPDGPHYLEQIDLVQFKDYSFSYPGVERKSLSGIDWTIQKGQ
TVGIVGRTGAGKTTLVRQFLRQYPVGEGEFLVNQQPIVDYNRHSIEEKIGYVSQEHILFS
KSIRENIALGKKGASQDDLVEAVAQAAFADDLERMSQAMDTLIGEKGVSVSGGQKQRISL
ARAFLRDAELLLLDDSLSAVDAKTEQAIIDTIQKERKDKTTIIVSHRLSAVHQADWIIVL
DQGQIVEEGRASDLLAQEGWYYEQYQRQQKQEGE
>ACG60763.1|FEATURES|NCBI|bleomycin|Turpa_2231|antibiotic inactivation|0
MAVLLSGVPVLAALDVSTTQKFWIEVLGFTEEFLTEDFGGVSRDGVELFICSVEDQVVPD
NTQAWLRVRDIDALHAEWSARVSSDYADASHPAMTAIREVPWGREFGLRDPAGNLVHFSE
LSEAAETTRTVR
>AAB00461.1|FEATURES|NCBI|aminoglycoside|AAC(6')-34|antibiotic inactivation|0
MTEHPRAHTAHLRTARLELTPLDPAADARHLHHAYGDEEVMRWWTRPACADPAETERYLT
SCAAAPGARLWTIRAPDGTVPGMAGLLGGTDVPGLTWLLRRDSWGHGYATEAAAAVVGHA
LEDGGLDRVEAWIEAGNRRSLAVAARVGLTERARLAQHYPHRPGPHEMVVLGKARAEEPL
TTLAVITELPVRDVAATLRLVEAALGARTAFAIGDPPEFAEAALTPWSAGPRFRLAAVPG
PGPVEPVRLHLDAAGTADSLHRRAVDAGARVDGPPVRRPWGRSEFVITLPEGHELTVSAP
V
>BAQ33930.1|FEATURES|NCBI|fusidic_acid|fusD|antibiotic inactivation|1
MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIE
KLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYI
GWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQ
YTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS
>WP_009821475.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
DNLMPAAPRYLVPQSALEQVRNPKEIEEETGGRLGVALVDRQGALLLGFNRDERFAMCST
FKAPLAAAVLTGADGGKFGLEGTIPFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVS
DNSAANLLLPMLGGPEGLTAFMRVHGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLM
ARLFFRDLKAESADRLRAWFNASSTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSP
TGEEYILAIYLDRPTIDAKKAEAAIAEAARAALNFVGQARKSGLE
>WP_015345560.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|EreB|antibiotic inactivation|1
MKNIKPLTFPFNSENNTSIKQSLFRFREYFDSSTIVGLGENSHFIKEFFTFRHQVIEFLV
TECDFDTLAFEFGFSEGLEVDKWIKSQIPFDDLDKLLSHFYYPNEFKDTLLWLRRYNQDN
NNQITFLGVDIPKNGGSYFPNFRIVSDYLQRLSIVSSDVLQKILNLAEKFDFYSTSQLAL
NLSLFDEAEHNELKALLLKVYIRLVTLQPKLESLEFQSILHQVKGLIYMNYNADAMESFI
TEKGIEGDMGAKDQYMAESIDWFLKNSLGKKIILVAHNAHIQKTPVDFDGFISCYPMGQR
LSMTFGEKYKAFAITNLRGETAALYPDNDYQFGFRVDKFPLDSPESDSVEFFMQELSGKE
CCLIINKSKELKNCSKIRFDSIYLKTEIVDSFDGIFLIEKSTVSEIVD
>WP_012704143.1|FEATURES|NCBI|beta_lactam|III_02866|antibiotic inactivation|1
MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGV
KLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSY
APVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARI
EPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGA
PKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFIAILSSKNDKDAKYDDKTISEASKIVF
DYFINTRK
>ENW94121.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQEREQQQITSLFQNAQTSGVLVIYD
GKKIQKFGNDVHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLVDEVHGTKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKITAFSLNMEMSRPEHTEARKAIVYQALQQLDLLAN
>ABV63006.2|FEATURES|NCBI|beta_lactam|OXA-247|antibiotic inactivation|1
MKKKYIKRLFSCIMLMAFCISQPSSTEARSIAWSVDEFFKNREGTFVIQEVKEKSPWVYN
KKRAKERFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNRDHTLGSGMRDS
VVWYYQAMARDIGEERMNHWVKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYE
ETLPFDLKNMRTVKRMMVQEEEKHATLYGKTGSGSDIGWYVGFIKHEHKTYILATNIKGT
GIEAKDITYRILKKYHLMEASV
>WP_045900075.1|FEATURES|NCBI|aminoglycoside|aadA7|antibiotic inactivation|1
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
AQRATLMQELLALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQG
IYEPAQQDWDIVLLITQILETSIPLKGERAERLFTPAPAAQLLKALRYSLDLWQSTADVQ
GDEYHIVLTLARIWYTLSTGRFTSKDAAADWLLPQLPEEYAATLLAAQREYLGLEQQDWH
ILLPAVVRFVDFAKAYIPTQFT
>WP_044185010.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIDEIARHAGYSKWHLQRLFLQYKGQSLGRYIRERKLS
LAAQDLLNTDQKVYDICLKYGFDSQQTFTRIFTRTFHQPPGAYRKENH
>WP_049839937.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEEIARHSGYSKWHLQRLFLQYKGESLGRYIRERKLL
LAARDLRDTDQRVYDICLKYGYESQQTFTRVFTRTFNQPPGAYRRENH
>WP_061708302.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVEWIDDNLHQPLRIEDIARHAGYSRWHLQRLFMQYKGESLGRYIRKRKLQ
LAARDLRESDEKVYEICLRYGFDSQQTFTRIFTRTFNQPPGAYRRENH
>WP_064561429.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
TISAQVIDTIVQWIDDNLHQPLRIDDIALHAGYSKWHLQRLFMQYKGESLGKYIRDRKLL
LAARDLRDTDNKVYDISLKYGFDSQQTFTRIFTRTFNQPPGRYRRENH
>WP_062777133.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVVDTLVEWIDNNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRKRKLD
LAADELCTTDQKVYDICLKYGFESQQTFTRIFTRTFNQPPGAYRKENH
>WP_035891756.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELATQVVDTLVEWIDDNLHQPLRIDEIARRAGYSKWHLQRIFLQHKGESLGRYIRHRKLH
LAADELCTTNQKVYDICLKYGFDSQQTFTRIFTRTFHQSPGAYRKENH
>WP_031520556.1|FEATURES|NCBI|multidrug|ramA|antibiotic efflux|0
ELPAQVIETIADWIDDNLHKPLRIDDVARHAGYSKWHLQRLFHHHKGESLGRYIREKKLK
LAAQDLCATNDRVLDISMKYGFDSQQTFTRLFTRRFSMSPGNYRRQGG
>CAF05908.1|FEATURES|NCBI|beta_lactam|blaGIM-1|antibiotic inactivation|1
LEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDR
GYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLG
NGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNI
VSKKYPIQMVVPGHGKVGSSDILDHTIDLAES
>ABC88434.1|FEATURES|NCBI|beta_lactam|blaIMP-22|antibiotic inactivation|1
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVILVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NDLLKQNGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVVAWPHSAEILMSRYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLKESKK
PSEPS
>ALT07696.1|FEATURES|NCBI|beta_lactam|blaIMP-55|antibiotic inactivation|1
MSKLSVFFIFLICSIATAAESLPDLKIEKLEEGVYVHTSFKEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKIFFGGCFIKP
YGLGKLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPS
>BAM37538.1|FEATURES|NCBI|beta_lactam|blaIMP-34|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPS
>WP_025518018.1|FEATURES|NCBI|quinolone|QnrC|antibiotic target protection|1
MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFI
YADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSEANFVSHVSNKMYFCSAYIT
GCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGGDLT
HSELNGLEPRKVDLTGVKICSWQQEQLLAQLGVIVIPDKLL
>WP_006255810.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRAGVNLERLYLDIKTNLSQDVLFMQTVVDGSVYLVCSQTYIKEEYKEFV
CNHDDDILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIY
QGREINVDEVGANDIAIVEDMEDFRIGDYLGAKPCLIQGLSRQHPALKSSVRPDRPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTIEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQVASSKAITDLQKMMSEIEDIICNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSM
>WP_063856408|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQ
IPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFV
CNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFI
LPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIY
QGRKINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPYNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGDYSDNIRMNEKDKILFMFQKSN
>WP_016278665.1|FEATURES|NCBI|tetracycline|tetQ|antibiotic target protection|1
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
TSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLHKLQ
IPTIIFINKIDRAGVNLERLYLDIKANLSQDVLFMQTVTDGSVYPVCSQTYIKEEYKEFV
CNHDDDILERYLSDSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELMDAITSFI
LPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKSIKIKNLKTIY
QGREINFDEVGANDIAIVEDMEDFRIGDYLGVKPCLIQGLSHQHPALKSSVRPDKPEERS
KVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTI
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
GIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPM
LCFELQIPQEASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKG
LGVFMVKPCGYQITKGGYSDNIRMNEKDKLLFMFQKSM
>AKG19864.1|FEATURES|NCBI|aminoglycoside|adenylyltransferase|antibiotic inactivation|1
ESIADQLSDTLSILENHLGETIQAVHLFGSAVDGGLKPFSDIDLLITVSTPLGESTRVAL
MSDLLLVSAFPGTDAKRRALEVTILAQKDVVPWRYPARRQMQFGEWLRHDINAGIFEPAM
TDHDLAILLTKVRLHSLALYGPAAQEFFDEIPAIDVQRSLLETLALWTTEADWEGDERNI
VLALVRIWYTAMTGDIASKDAAADWALQRLPSEHKHIVIAARDGYLGLGTVDLAAYPQER
AELLNYIRSSVTTKLQ
>AAN60064.1|FEATURES|NCBI|aminoglycoside|aadA11|antibiotic inactivation|1
AEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQAL
VVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPAT
TDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNV
VLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGQGEDCLASRADQL
AAFVHFVKHEATKLLG
>WP_054171716.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTTAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAALPPLLEQCRSLAEGLLQEEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATQPERFAARLEQVSALAGLERTRLLRWIAASAG
LSAVWFRDDGDPAEVDETVARMALEALAEA
>WP_049446763.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTAAGEPAMLKISSETEEQNSHRLLRWWEGDG
AARLLAHEGPAILIERAGGDSLRQRSIGGDDDACTTILCQVLQRLHRPRSAPPAELVCLR
RWFADLLQPRAVLPPLLEQCRSLAEALLQEEREIRPLHGDLHHDNVLDFGARGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLEQVSVLAGVERTRLLRWIAASAG
LSAVWFRDDGDPAEVDEAVARMALEALAEA
>WP_014647081.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTADGEPAMLKVSSETEEQNGHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDACTTILCQVLRQLHRPRSAPPAELVCLR
TWFADLLQPRAALPPLLEQCRSLAERVLQEEREIRPLHGDLHHDNVLDFGTRGWLAIDPK
RLLGDRAFDYTTMFSNPDLCGPGIHVATRPERFAARLQQVSALAGLERTRLLRWIAASAG
LSAVWFRGDGDPAEVDEAVARMALEALAEA
>WP_008265677.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGKAIETPRAQLWPVLTAAGEPAMLKVSSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERARGDSLRQRSIDGDDDACTTILCQVLQRLHQPRSTPPAELVCLR
TWFADLLQPRAALPPLMEQCRSLAEELLQDEQEIRPLHGDLHHDNVMDFGPRGWLAIDPK
RLLGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARLEQVSTLAGLERGRLLRWIAASMG
LSAVWFRDDGDPADVDEAVARMALEALAEG
>WP_012510997.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGAAIETPHAQLWPVLTIAGQPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGDSLRQRSIEGDDDTCTTILCQVLQRLHRPRSAPPAELVCLR
TWFADLLQPRAALPSLLEQCGSLAAALLQEEQEIRPLHGDLHHDNVLDFGARGWLAIDPK
RLIGDRAFDYTTLFSNPDLCGPDIHVATQPERFAARVEQVTALAGIERHRLLRWIAASAG
LSAVWFRDDGDTADIDDAVARMALEALAEG
>WP_053517941.1|FEATURES|NCBI|aminoglycoside|APH(6)-Ic|antibiotic inactivation|1
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTADDLPAMLKISSETEEQNSHRLLRWWDGDG
AARLLAHEGPAILIERAGGQSLRERSIGGDDSTCTTILCQVLQRLHRPRSAPPAELVCLP
TWFADLLQPRGSLPPLLEQCRSLAVALLEAEQEVRPLHGDLHHDNVLDFGTRGWLAIDPK
RLIGDRAFDYTTLFSNPDLCGPGIHVATRPERFAARVTEVSALADLDRTRLLRWIAASAG
LSAVWFRNDGDPADIDETVAAMALEALAEG
>WP_010529130.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NKIPTISESEWEVLKVLWEKAPQTANDIISSLQAQTNWKPKTVRTLLDRLTKKEVVGVHK
NQRVYTFYPFYSQDECQRAKTDSFVKRFYDGTLKSMLVQFIQDEDLSEEDIKELRSILDK
K
>WP_026568830.1|FEATURES|NCBI|beta_lactam|blaI|antibiotic inactivation|0
NEIPSISESEWEVLKVLWHKAPQTANDIISSLPAQTTWKPKTVRTLLDRLTKKQVIGVNK
DQRVYTFYPLYSQNECQRAKTASFVKRFYDGTFKSMIVQFMEDEELSDEDIKELQSILES
K
>WP_064206686.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MPYLYLVISIITEIIGTSFLKTAEGFTKLWPTLGTLISFGICFYFLSVTMKYLPLNVSYA
TWAGLGLVLTTIVSVVIFKESVNLISIFSIILIIIGVVLLNVFGSSH
>WP_063855882.1|FEATURES|NCBI|tetracycline|tet42|antibiotic efflux|1
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAINGLCAFLVAPFLGRLS
DRFGRRPVIIVAAFGAAFSMALFGFGGALWVLVLARVIQGLTAGDLPALFAYLADITPPE
QRAKRFGLLGALSGIGTMIGPAIGGLLAAISIQLPVFLTAAVALTIAILSIFLLPESLKP
GNRITAIKLRDVQPFAVFKEAFGRKELRGLMIGFGLLALPFGFFVNNFSVLALDSIQWGP
TQIGLLTAAVGIIDILIQGVLLGILLPRIGERGVIVSGIVAQMIGLAALAVVASVFAQPW
VFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGATQSLNAAMGTAAPLIAGALYA
LVSHAAPYWLGVALMIVAVTVVSRAHIANTAKRPAGETTGDAPAALVETAG
>AAL75558.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPL
LGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVAD
STAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFK
PAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWD
SAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVY
PVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQH
SADGTVWLIGTALYGLLLAICLLIRKPAPVAATC
>WP_060557577.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLGGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSATVFIKKSLYFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYCGLLVASYFKQKSPILKKFPL
>WP_063108606.1|FEATURES|NCBI|tetracycline|tetJ|antibiotic efflux|1
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
LGKLSDKYGRKPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTD
VTHPHERTRYFGFLSGAFGVGLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQ
ETQTTKISTEISALNQDTAPHSTTGFIKKSLCFWLIAYFIIQLIGQIPATIWVLFTQVRF
AWHTTEVGLSLAFLGVLHIFFQAVLAGKLAQKWGERNTVIISMSIDAFGCLLLAWISHVW
VMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLVSLTNITGIVGPLLFSFIYSY
SVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>AAC74604.2|FEATURES|NCBI|multidrug|marA|antibiotic efflux|0
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
RKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLH
PLNH
>BAU88433.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKEKDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNNSSEKLKLNIRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQTLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQCHQAMKHAKVNNLSTVTYEQVLSIFNSYLL
FNGRK
>WP_041152457.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYNLSTQIIKKVVFESRAS
DIYLTVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTT
DVPDKYWKLYKYFVSKWVNREYRQLFTKNQFRQAMKHAKVNNLSTITYEQVLSIFNSYLL
FNGRK
>WP_032495453.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ermB|antibiotic target alteration|1
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
SHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESHAS
DIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFYPKPKVNSVLIKLTRHTT
DVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKYAKVNDLSTVTYEQVLSIFNSYLL
FNGRK
>WP_002360844.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNQKNPKDTQNFITSKKHVKEILNHTNINKQDNVIEIGSGKGHFTKELVKMSRWVDSIEI
DEDLCQVTQKVVKPFQNIKVIHTDILKFNFPKNKDYKIFGNIPFNISTDIVKKIAFESNS
KYSYLIVENGFAKRLQNTKRALGLLLMVELDIRVLKKVPRAYFHPKPNVDSVLIVLERHQ
PLILKKDYKEYQSFVYKWVNREYRVLFTKNQFRQALKHANVTNINKLSKEQFLSIFNSYK
LFQ
>WP_041902801.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNRKNPKDTQNFITSKKHVKEILDRTNICKRDHVIEIGSGKGHFTKELVKMSRSVTAIEI
DEDLCRSTQNAVYPFENIKVIHTDILKYAFPKRTNYKIFGSIPYNISTDIVKKITFESQA
KYSYLIVEKGFAKRLQNLQRALGLLLMVEMNVNILKKVPRAYFHPKPSVDSVLILLERHE
PLILKKDYKKYQAFVYRWVNKEYHTLFTKNQFRQALKHANVTTLNKLSKEQFISIFNSYK
LFH
>WP_018930853.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|ErmA|antibiotic target alteration|1
MNEKNPKDTQNFITSKKHVKEILNHTNINKQDNVIEIGAGKGHFTKELVEMSQSVTAIEI
EEDLCRATQKAVELFQNIKVIHTDILKFAFPKNAGYKIYGNIPFNISTDIVKKIAFESRS
KYSYLLVEEGFAKRLQNTQRALGLLLMVEIDIKILKKVPREYFHPKPSVDSVLIVLERHK
PLILKKDYKKYQSFVYKWVNREYHLLFTKNQFRQALKHANVTNFNKISKEQFISIFNSYK
LFT
>WP_024531368.1|FEATURES|NCBI|beta_lactam|Sfh-1|antibiotic inactivation|1
MILNIKYLFTAVTFLLIACESMASEKNLTLTHFKGPLYIVEDKEYVQENSMVYIGTDGIT
IIGATWTPETAETLYKEIRKVSPLPINEVINTNYHTDRAGGNAYWKTLGAKIVATQMTYD
LQKSQWGSIVNFTRQGNNKYPNLEKSLPDTVFPGDFNLQNGSIRAMYLGEAHTKDGIFVY
FPAERVLYGNCILKENLGNMSFANRTEYPKTLEKLKGLIEQGELKVDSIIAGHDTPIHDV
GLIDHYLTLLEKAPK
>WP_004721352.1|FEATURES|NCBI|multidrug|adeS|antibiotic efflux|0
KNNIGISRQLIITMAKVSLLTTCFSLIFGYLTYFVAIEFKLVSLEQLNSEDWSFNFVDLT
WILLVTLCGSLTSVYLGLKLAQRFIAPLNSLAIAAREISLGNLSVRAQLDNPSSVAEITK
MINDFNRMAEKLEISVNNASIWNAAIAHELRTPVTILQGRLQGVLDDIFTPDKALLKNLL
NQVEQLSFLIEDLRTLSLADNQQLRLNLESVCLSDVITQSVNLLQDRFDQAKLVIETNLS
DQACFFDRQRLEQILIALFENEIRYAQAGILRISTQKKSEGLVLTIEDQGPGIADQHIPF
IFDAFYRLEESRGKKNGGSGLGLSVVNAIMIAHEGRIEYSKSQALGGSCFSILFKP
>WP_064580700.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFERFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLV
SRLAQCREKPYSGMRFGLGK
>WP_064757576.1|FEATURES|NCBI|fosfomycin|FosA2|antibiotic inactivation|1
MLLSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
QESDYTHYAFSIAPEDFEPFSYKLKQAGVTVWKDNKSEGKSFYFLDPDGYKLELHVGDLA
SRLAQCREKPYSGMRFGSGK
>WP_033450617.1|FEATURES|NCBI|aminoglycoside|ASF14_19185|antibiotic inactivation|1
YREVNCVAMPVPAGLSEEVKGYSWARNNVGESGGVVYRLYGKAGAPDLFLKHGRDTVAND
LVDEMVRLRWMANHIAVPTVTHFVSTTDEAWLLMTALAGETAYQALEARPEERTTIVDAL
ADFLRTLHAIPISECPFTSDHSYRLGLARKRIDAGLVEEDDFDEEREGWTAEQVWQEMHR
HLPFMADQVVTHGDFSLDNLLMVDGVVIGCIDAGRVGIADRYQDLAILWNCLGEFDEALQ
DRFFARYGVPKPDPSKLLFHLMLDELF
>WP_056433730.1|FEATURES|NCBI|aminoglycoside|ASF14_19185|antibiotic inactivation|1
DREEACAAISVPESMSAPLVGYEWARDNVGESGGAVYRLHGKLDAPDLFLKHGRSSVAAD
VIDEMVRLRWLARHIPVPAVEGFVAMQDEAWLLMTALPGQTAYQLLEAQPDAHVGIVDAL
AAFLRRLHAIPVNECPFNSDHAYRLARARERIHAGLVEEDDFDDEREGWTAEQVWEAMQR
LLPMPSDPVVTHGDFSLDNILMVDGEVVGCIDAGRVGVADRYQDLAILWNCLGEFDALLQ
NRLLEQYGIADVDERKLQFHLMLDEMF
>WP_048216288.1|FEATURES|NCBI|aminoglycoside|SK35_04809|antibiotic inactivation|1
HRESTCARLQLNSSLDHELDGYKWARDHVGQSGAAIYRLYDKVDAPELYLKQGNGSVAND
ITDEMVRLIWLKDYIPLPNVKHFSRTPDVALLVTTAIPGKTAFQMLEEHPDMSNDIVDAL
ATFLRRLHAIPVNSCPFNSNHQFRLTLAQNRMKNNLVDAEDFDDERNGCSVEQVWEKMHT
LLPFSSVPVVTHGDFSLDNIIFCNDEIVGCLDVGRVGIADQYQDLAILWNCLGEFSHSLQ
NRLFQQYGIPQPDEKKLQFHLMLDEFF
>AHF51365.1|FEATURES|NCBI|aminoglycoside|APH(3')-IIIa|antibiotic inactivation|1
MAKMRISPELKKLIGKYRCVKDTEGVSPAKVYKLVGENENLYLKMTDSRYKGTTYDVGRE
KDMMLWLEGKLPVPKALHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIR
LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP
EEELVLSHGDLGDSNIFVKDGKVSGFIDLGRSGRADKWYDIAFCVRSIREDIGEEQYVEL
FFDLLGIKPDWEKIKYYILLDELF
>WP_042227921.1|FEATURES|NCBI|aminoglycoside|butA|antibiotic inactivation|1
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYKGAPAFLKIAPSIWWRTLQPE
IEALAWLDGKLPVPKILYTAEHGGMDYLLMEALPGKDGSHETIQAKPEFFVKLYAEGLRN
IHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPTDIKEEYDCTPEELYQQLIAKKPATED
PVFAHGDYCAPNLIIAGEKLTGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLE
LYGLDGLDEDKVKYYIWLDEFF
>WP_063840319.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ib|antibiotic inactivation|1
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
TPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANAAQLGKGLGTKLVRA
LVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERT
RSVA
>WP_049443010.1|FEATURES|NCBI|aminoglycoside|STRNTR1_0556|antibiotic inactivation|1
VPTIRQATPADVAAWAQLRLGLWPDADDPLEELAESLADAEGAVFLACLAGGEAVGFAEV
RLRHDYVNGTESSPVGFLEGWYVQPQWQGHAVGRALLAAVQAWTRTAGCSELASDSRVED
VQAHAAHRACGFEETERVVYFRMVLDAE
>WP_053518652.1|FEATURES|NCBI|aminoglycoside|STRNTR1_0556|antibiotic inactivation|1
AATIRQATPADAAAWSQLRVGLWPDADDPLEELAQSLADPEGAVFLACAADGEAVGFAEV
RLRHDHVNGTGSSPVGFLEGWYVTPQWQGRAVGRALLAEVQAWTRDAGCSELASDSRLED
VEAHAAHRACGFEETERVVYFRMPLDAA
>WP_049677835.1|FEATURES|NCBI|aminoglycoside|ERS008437_00710|antibiotic inactivation|1
IKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFADAS
IRNDYVNGCIHSPVAFLEGIFIVPSSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNV
LSQQVHEALGFKETERVVYYRK
>ACT99625.1|FEATURES|NCBI|aminoglycoside|AAC(6')-33|antibiotic inactivation|1
AYEFCEIGESNEYIILAARILTKSFLDIGNNSWPDMKSATKEVEECIEKPNICLGIHENE
KLLGWIGLRPMYKLTWELHPLVISTQYQNKGIGRLLINELEKKAKQIGIIGIVLGTDDEY
FKTSLSAVDLYGENILDEIRTIKNIKNHPYEFYQKCGYSIVGVIPDANGKRKPDIWMWKK
I
>WP_036761389.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MRGKATITADLRRLGLQPGDLVMVHASLKALGPVEGGAAGVAQALMDAVGRGGTVMGYAS
WDRSPYEETLNGARMDEDLRRAWPAFDPRTAGTYRGFGLLNQLLAELPAARRSAHPDASM
VAVGPLAQTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAIADIPG
KRRVSYKMPVLGPDGRTVWEAATDFDSNGILDCFAVEGQPDAVETIARAYVQTGRHREGV
VGAAHCHLFDARDIVAFGVDWLERQFGS
>WP_024844582.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MRGKATIAADLRRLGLRPGDLVMVHASLKALGPVEGGGAGVAQALMDAVGPDGTVMGYAS
WDRSPYEETLNGARMDEALRRDWPAFDPRTAGTYRGFGLLNRFLAALPDARRSAHPDASM
VAVGRLAGTLVEPHRLGQALGEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPG
KRRVSYEMPVRGPDGRTVWEAATDFDSNGILDCFAVEGRPDAVETIARAYVETGRHCEGV
VGAARCHLFDAQDIVAFGVGWLERQFGS
>WP_006473458.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIc|antibiotic inactivation|1
MHTRKAITEALQKLGVQSGDLLMVHASLKAIGPVKGGAETVVAALRAAVGPTGTVMGYAS
WDRSPYEETLNGARLDDKARRTWPPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASM
VAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKVLLLGAPLNSVTALHYAEAVADIPD
KRRVTYEMPMLGSDGEVTWEAASDYDSNGILDCFAIEGTPDAVETIANAYVKFGRHQEGV
VGFAQCYLFDAQDIVTFGVTYLEKHFGG
>WP_058323800.1|FEATURES|NCBI|aminoglycoside|AAC(3)-IIb|antibiotic inactivation|1
MKTRIEIAADLQRLGIQPGDLVMVHASLKAIGGVELGAATVVGALLDAIGPTGTVMGYAS
WDRSPYEETLNGAKMDEELRRNWPPFDSATSATYRGFGMLNRFLVQNRGARRSAHPDASM
VAIGPLAETLTEPHCLGQALGKGSPLERFVRLGGKVLLLGAPLASVTALHYAEAIANIPG
KRRVTYEMPLLGPDGQTIWELTEDFDSNGILDCFAVDGQPDAVETIARAYIALERHQIGR
VGDACSYLFDAQDIVSFGVTYLESRFRE
>WP_035417850.1|FEATURES|NCBI|aminoglycoside|str|antibiotic inactivation|1
RTERQMMACVDEFIKSEDLIRVAVVEGSRTNKQIERDWFQDYDLSFFVTDMEVYKGDESW
LDHFGKRRMMQKPEAMELYPAEIGNGFSYLIYFDDGIKMDLTLYPLEDLHDYFNQSDGLV
ELLCDKDQRIHKAIEPTDQAYWLMKPSSRMFDDCCNEFWCLASYVAKGLYRQEIFFALDH
LNQLLRPELLRMISWRIGAEKGFSFSIGKHGKFLDKQLQEDELQKLLETYNCGGIKETWQ
AFERCCTLFRSYSRQVAASFNYQYPDYDQQMTAFIYESYA
>AHJ80331.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RKEKEMINLFEYIVMNDDGIRLSVLEGSRTNKNITKDYFQDYDISFFVTDIDSYKKDDCW
LEVFGDLTFMQKPEDMELFPSELGNWFSYIMYFNDGVKIDLTMIPLNEIDDYLSDSDGLV
EVLIDKDNRINEKIVPSDKKYWIKRPSEREFDDCCNEFWNVSAYVAKGLFRKELLFALDH
FNQILRPELLRMISWEVGLRKGFNFSVGKNYKFIDQYLPEKEFDKLTKTFSLSGYRESWE
SFELCCQMFRTYSKKVASSLGYKYPEYDQKMTRFIRNVYE
>WP_057982850.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEAKMMEMLMGFAKNDKRIRLIMLEGSRTNPSITRDAFQDFDLSFFVTELESFKRSDDW
LDIFGKRLIMQKPEDMELFPPELGNWFSYLMLFEDGNKVDLTLIPLQEVEEYFFKSDGLV
EVLLDKDSLVKKELQANDRQYWLKRPTAREFDDCCNEFWMVATYVVKGLARKEILFAIDH
LHEIARPNLLRMMSWQIGLEHGYTFSVGKNYKFIQQYLPKEDWEAFLSTYSQASESKMWQ
SLFTCYRLFRQYAKLVASELGFLYPDYDVAITAYTERVYH
>WP_024714945.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMMDIFLDFALNDERIRLVTLEGSRTNKNIPPDPFQDYDISYFVTDMESFKGNDRW
LEFFGTRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIHEAEAYFAESDGLV
EVLLDKDTFIKHKVIPNDRQYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
VNEIVRPNVLRMVAWHIASQQGYTCSMGKNYKFMNRYLSNKEWEELMATYSVNGYQEMWK
SLFNCYALFRKYSKAVSESLGYQYPDYDEGITKYTKRIYE
>WP_026043025.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RTVQEMMSMLIDFARKDDRIRLVTLEGSRTNKNIPADPFQDYDISYFVTEMDSFKENDQW
LDVFGNRIMMQKPEDMELFPSELGNWFSYLMLFEDGNKVDLTLIPIDETEQYFADSDGLV
EVLLDKDELIKHEVVASDRQYWTRKPTSREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGCEKGFTFSVGKNYKFIDHYLPTEDWEALRSTYHENGYTQMWE
SLFTCYELFRKYAKAVAESLGYPYPDYDEAITKYAKNIYH
>WP_063207627.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQEMLDMLVKFAMNDERIRLVTLEGSRTNFNILPDSFQDYDISYFVTDMDSFRESDQW
LHVFGNRLMMQKPEDMELFPSELGNWFSYIILFDDGNKLDLTLIPMNEVEDYFTNSDGLV
EVLLDKDALIQEEVIANDRQYWIKKPTAREFDDCCNEFWMVSTYIVKGLARKEILFAIDH
LNEIARPNLLRMMAWKIGSEQGYTFSVGKNYKFINQYLPNEDWESLLSTYSENGYREMWQ
SLLTCYALFRTYAKAVASSLKYEYPDYDEAITRYTENIYN
>WP_028608516.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
RSEQDMMNIIVDFAVHDDRIRLVTLEGSRTNKNIPPDRFQDYDISYFVADMDSFKENDQW
LTLFGSRVMMQKPEDMELFPSDLGNWFSYLMLFDDGNKLDLTLIPLNEADDYFTNSDGLV
EVLLDKDNRVKNDVIADDRHYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDH
LNEIARPNLLRMMAWQIGSEHGYTFSVGKNYKFINRYLPNEDWETLLSTYSENGYPEMRR
SLLTCYELFRKYSRAVAERLGYTYPKYDEAVTTYTENIFN
>ANW86196.1|FEATURES|NCBI|glycopeptide|vanSB|antibiotic target alteration|0
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
RLDIQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVA
QSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVP
PPLERKDELGALAHDMHSMYVRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIA
ATSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKIISEILELVSLNDGRIVPIAEPLDI
GRTVAELLPDFQTLAEANNRRFVTDIPAGQIVLSDPKLLQKALSNVILNAVQNTPQGGEV
RIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLD
AMSLQYALENTSDGVLFWLDLPPTSTL
>WP_000781800.1|FEATURES|NCBI|beta_lactam|ICG_02197|antibiotic inactivation|1
MHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNKNVWVHTELG
YFNGVAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRI
GGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTITNLKFGNMKVETFYPGKGHTED
NIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNININSVVPGH
GEVGDRGLLLHTLDLLK
>WP_033671989.1|FEATURES|NCBI|beta_lactam|II9_03025|antibiotic inactivation|1
ILKNKMLLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKTGKVKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIR
AGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAE
VVIDAIK
>WP_029438368.1|FEATURES|NCBI|beta_lactam|AT270_13635|antibiotic inactivation|1
ILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKNGQIKHKNQATHKEFSQLEKK
FDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDL
VDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAVATNLKDLTVGNALPHQKRNILTDWMKGNATGDKLIR
AGVPTDWVVADKSGAGSYGTRNDVAIVWPPNRSPIIIAILSSKDEKEAAYDNQLIAEAAE
VVVNAFK
>WP_041184610.1|FEATURES|NCBI|beta_lactam|B4079_5004|antibiotic inactivation|1
ILKNKRMLKIGVCVGILGLSITSLHAFKGEILQVEAKEKTGKVKHKNQATHKEFSQLEKK
FDAQLGVYAIDTGTNETIAYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKFTKEDL
VDYSPITEKHIDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMS
DRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPDDKRKVLTDWMKGNATGDKLIR
AGVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLIAEAAE
VVVNAFK
>WP_008770854.1|FEATURES|NCBI|beta_lactam|BL2e_cfxa|antibiotic inactivation|1
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGDVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSA
>WP_032597912.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLREIYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_032582677.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHENLEFCYQNW
TTPLAAAKLLEIFRNKNLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPGGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_068801164.1|FEATURES|NCBI|beta_lactam|KS04_10900|antibiotic inactivation|1
KRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTDK
GVMVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKM
TDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIV
KSGDSKDLGYIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQ
QKQKASN
>WP_063842622.1|FEATURES|NCBI|beta_lactam|BlaB|antibiotic inactivation|1
KKIKISLILALGLTSLQAFGQENPDVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVTDK
GVVVIDCPWGEDKFKSFTDEIYKKHGKKVIINIATHSHDDRAGGLEYFGKIGAKTYSTKM
TDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCII
KSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQTSIQHTLDLISEYQ
QKQKASN
>WP_061544131.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYSNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_062912850.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYXKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTSFFNKNILSHSFNGKKSLLKNRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>WP_064134774.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLITSVVSFCFIFLLLVFFKYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFK
FLKSLLYLKYLKKQSLYLNENEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIVMSYNPLIHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNIPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLIPIFICIFTFLLIVIQSQFLMGQSITDYNYKKPLQNDHQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKNYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>WP_049385819.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFHIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKNEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
GNLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLAMFGLDRHIISDKNSRMSWNHKHYP
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYIAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQKNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKEMGVLNGQ
>WP_061649395.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSFFKF
NNLNNQEPTVESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLNSLLYLKYLKKQSLYLNEKEKDKINKILFNHQYKRNIVIRKAESIHSPITFWYGKYII
LIPSLYFKSINDKKLKYIILHEYAHAKNRDTLHLIIFHIFSIAMSYNPLIQIVKRKMIHD
NEVEADRFVLNNINKYEFKSYAEAIMDSVLKTSFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDKSKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHNHYP
FDSWNKDQDLNTAIQNSVNWYFERISNQLSKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
KISNLEQVIVLKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFSTHLSDEKASGENAKLINEKILKEMGVLNGQ
>WP_064125810.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDAMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_061824589.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQGKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI
>WP_064131164.1|FEATURES|NCBI|beta_lactam|mecR1|antibiotic target replacement|1
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKG
FDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQ
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
SLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEAN
GWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISEHILKEMELI
>BAD10974.1|FEATURES|NCBI|bacitracin|BacA|antibiotic inactivation|0
MKEKVVVDKAISLYTESFGDPAHEPIILIMGAMSSAVWWPDEFCSQLAKMGRYVIRYDHR
DTGKSTSYEPGQAPYSVEELADDVVRVIDGYGLEAAHLVGMSLGGFLSQLVALKYPKRVK
SLTLIASEWLADADPDMPAFDPAIIEYHQRAESLDWSDKDAVVAYQVGSWRINSSTAHAF
DAEKIQNIAELNFDRTPNILTTFNHTTLGGGERWLGRLNEIAVPTLIIHGTEDPVLPYVH
GLALKEAIRGSKMLTLEGTGHELHHEDWPRIIQAIKGQTS
>AEQ26262.1|FEATURES|NCBI|aminoglycoside|aadA1bp|antibiotic inactivation|1
IAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRA
LINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPA
TIGIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERN
VVLTLSRIWYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLATRADQ
LEEFVHYVKGEITKVVGK
>WP_058576636.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKSWLFLTVAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVLKSIPIGVAY
AIWSGLGVVLVTAVAWGLYGQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>AGY30885.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
MKSWLFLTIAILGEVVATSALKSSEGFTKLVPSFIVIVGYGIAFYFLSLVFKSIPVGVAY
AVWSGLGVVLVTAVAWGLYVQKIDAWGFVGISLIVCGVLVLNLLSKASVH
>ACN22630.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
KNWLFLATAIISEVIATSALKSSEGFTRLVPSFIVVAGYAAAFYFLSLTLKSIPVGIAYA
VWSGLGIVLVTAIAWVLHGRKLDMWGFVGVGFIINGVAVLNLLSKASVH
>WP_022951155.1|FEATURES|NCBI|quinolone|qacH|antibiotic efflux|0
NHWLLLLVAIVGEVVATSALKSSEGFTKLFPSMIVVVGYGLAFYFLSVALKTIPVGIAYA
VWAGLGIVLVAFIAYIMHGQKLDFWAFVGISLIVSGVAVLNLLSKTSTH
>WP_069996661.1|FEATURES|NCBI|beta_lactam|blaZ|antibiotic inactivation|1
MKKLIILVMLALILSACNTKHSTNNDIEKLEKKYGANIGMYALNTQNGEELSFNENKRFA
YASTLKAISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITIKKLIEATMLF
SDNTANNKIIDELGGYEHVKNRLTDLGDTTTHPSRKEPDLNFYSPKDKRDTTTPIAYGKT
LNKLIVDGKLSKANKDFLLDLMFKNKSGDTLIRDGASSNFKVMDKSGQALTYGSRNDVAL
VYPDGQNKPIILVIFTNKDKKDGKPNDKIVSEVAKIVLKSINE
>WP_032036997.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVNAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKIQIQQ
AKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNYRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIRPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMQLNNQIELYKVLGGGTSKV
>WP_000045117.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSAIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKTIAEKSYKEFIS
DPKLVQVIEISLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVMGSAVRQVNPSINPN
NPASTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNITQVWLNYA
FAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGHPVPQNLLPDHVIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKSGNFAWSIGPSIDLPIFDWGTRKTNIKIAE
TDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYRAGV
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKV
>WP_042077412.1|FEATURES|NCBI|multidrug|AdeC|antibiotic efflux|0
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
DPKLAQVIEITLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPN
NPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYA
FAQANLNLAEQTLKTQLDSYHLNKKRFEVGIDSEGPLKQAQISVETARNDVATYKTQIQQ
AKNLLDLLAGYPVPQNLLPDHSIQNITFEKTFAAGLPSDLLNHRPDLKAAEYELRAAGAN
IGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPTIDLPIFDWETRKANIKIAE
TDQKIALVKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATDATYKLSMTRYRAGV
DSYFTVLDAQRSAYAAQQGLLTLEQMKLNNQIEIYKALGGGISKS
>AGU13987.1|FEATURES|NCBI|aminoglycoside|AAC(6')-Ia|antibiotic inactivation|1
MNIQILNLAECTEFQESAARVLLDGFREVGKIAWATYEEAMVEVQECTEIPNIAICAVDN
NKVVGWVGIRPMYDYVWELHPMIVTKKYQKKGIGTKLLKEIEQIAKEKGLLGLALGTDDE
TDSTSLSKCDFSRDNILIEIANIKSSMSHPYAFYEKNGYFIVGVIPNANGKRKPDIWMWK
ELES
>WP_034051940.1|FEATURES|NCBI|beta_lactam|BL1_sm|antibiotic inactivation|1
RCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFY
NYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAF
DRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLIT
AQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAY
GLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKET
LLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANK
WYPNDARIEAAYELVQRLKK
>WP_057463840.1|FEATURES|NCBI|beta_lactam|CARB-10|antibiotic inactivation|1
RRFACALAFTLSLPLVSEAGPLMDTVSQLETEVGGRIGVVLRHTGSDWAVEHRADERFPM
ASTFKALLCGAVLSRVDRGEESLGDLVTYKATELVPYSPVTENHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARRGDPRDTTSPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKDWRIADKSGAGYNGSRGIIAV
LWPETGKPYLAAAYMSGSDASFKQRNAVIAEIGKAMIEEIKQR
>KZK95120.1|FEATURES|NCBI|beta_lactam|LEN-22|antibiotic inactivation|1
RRFACALAFTLSLPLASEAGPLMDTVSQLETEVGGRIGVVLRHTGSDWAVEHRADERFPM
ASTFKALLCGAVLSRVDRGEESLGDLVTYKATELVSYSPVTENHVASGMSVGQLCEATVT
MSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARHGDPRDTTSPSAVLK
TLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKGWRIADKSGGGQNGSRGIISV
IWPDAGAPYLASVYMMGSDASFRQRNAVIAEIGKAMIEEIKQR
>WP_019710657.1|FEATURES|NCBI|aminoglycoside|Aac3VIII|antibiotic inactivation|1
MDEKELIERAGGPVTRGRLVRDLRALGVCGGDTVMVHTRMSAVGYVVGGTQTLIGALLDT
VGDAGTLMAYCGWNDAPPYDLADWPLGWREAARAEWPAYDPLFSEADHSVGRVPEALRHW
PGAVRSRHPDASFVAVGPAAHRLMDDHPWEDPHGPDSPLARLARDGGRVLLLGAPLDALT
LLHHAEALAEAPGKRYVEYEQPVIVDGRREWRRFRDIDTENEAFPYGRVVPEGVWPFTVI
AEDMLVAGIGRTGRVGAAPSHLFEAPDVVQFGVEWIEGRLGEAADD
>WP_002785795.1|FEATURES|NCBI|aminoglycoside|aadK|antibiotic inactivation|1
MQNQDKFLKQFKKLALLDKNIRLVTLEGSRVNKKAKKDKYQDYDISFFVPLDKMKDFLGL
NEKQNFNECKNLPKCILELEKSSYFKKILMLQMPECMEFYPPDLPQNWISFLVLFESGVR
LDLTIIPLEDLKNYYEFEPLSQALLDKNGLFTHTIPKAPFSITHLSQRSFDDVCNEFYFL
YSCLKKALLRKQFILSNHLLNSLRKALFDLLSFKIGLNFGFEIWLGKEYTNILEFLEEKE
VKIILKSFNTATLEHIKKARKKLEILFHKNAKFVAKKSDFKLFPYRKNVKRYCKILGKL
>AMX05089.1|FEATURES|NCBI|quinolone|QnrB|antibiotic target protection|1
MALIFEGEKIGRTRFTGEKIENAIFRNCDFSGTDLTSTEFIGCQFYDRESQQGGKFTRAQ
LKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGTSFMNMITTRTWFCSAYITKSN
LSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFPSFDWRAANFTHCDLTNSE
LGELDVRGIDLQGVKLDSYQIAQLMERLGIVVLG
>APY23862.1|FEATURES|NCBI|beta_lactam|PC1|antibiotic inactivation|1
MKKFFTIFVLLCVCFAYTTASASAQDLTKLEHKNDATVGVYGINTATGKTYSHNADTRFA
YASTFKAITSGLLLQQSSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNVIMEQLGGLDQISSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHS
LQQLLTTDAVAPQQRKFLQNLMFNNETGDSLIKKGVPDSYKVGDKSGQGTTYGTRNDVAL
IYPKHQTKPIVLVVFTKHKQQDAKPQDALVAQAARQAIQQLD
>WP_034682171.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQIINWAKENPDIRTVLLTSSLVNPYAPVDDFSDLDVELVFEGMKPYESDKKW
IECFGTPISMVEEDETFFDGKHAMKMVLYEDHVKVDFKLYEKSEFIKEVDGETLPEDWDV
GYKVLIDKDDLTKELKPPTHQSIMIKKPTEQRFQQLINDFWWDTTYVAKCLKRDDIFYAK
FMMEDVIRTDYLVPMLEWYIASEKEWNNITTNKHGRLFKKYLSPELWKQVEATFSGSSIE
DNWNALFACADLVHEVGTFLAKKIGSPYPLEMENKVRKYLNEIKE
>WP_080778132.1|FEATURES|NCBI|aminoglycoside|ANT(6)-Ib|antibiotic inactivation|1
KAREEKLKQVISWAENNTDIRCVLLTSSLVNPYAPVDDFSDLDIELVFEDRERYEQDKSW
IFLFGETVSMVEEDTTCFDGKHAMKMVLYTDHVKIDFKLYQKSEFVKEVQGEDLPEDWDV
GYKVLVDKDNLTRDLKAPTYQSIMITKPTEKEFGQLMNDFWWDTTYVAKCLKRGDLFYAK
FMSENVIRTDYLVPLIEWYIASFHDWNNITTNKHGRLFKKYLSEELWNKVEATFSGSSIE
DNWQALYVSADLVHELGTFLADRLGFEYSHQHESDVRKYLDEVKN
>WP_014207881.1|FEATURES|NCBI|fosfomycin|FosA5|antibiotic inactivation|1
MKLSGLNHLTISVENVDRSFSFYKDVLGFTPRAKWNKGAYLSLGELWLCLSLDEVRITSD
YTHYCFSISEDDIDEFRQKIKLLNIREWKNNQSEGESIYFLDPNGHKLEVHVGNLSTRLD
SCKKNPYEGMVFFDE
>WP_019639548.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
RGPNPNEKYPIPGNTNLQFIKNTVTIPNIIAGDYSYYDALNGEAFEEQVLYHYEVLGTKL
IIGKFCSIAPETRFMMDGGNHRMDGSTFPFNLFGNGWEEFTPTLEELPIKGDTIIGNDVW
IGRRATIMPGVRIGDGAIVGAEAVVTKDVEPYTIVGGNPAKEIRKRFSPEVIQELLEIKW
WDRDIELIQQNIGAIVSGNLNILREMKR
>WP_006677628.1|FEATURES|NCBI|macrolide-lincosamide-streptogramin|VatI|antibiotic inactivation|1
TGPNPQDKYPIPGNNNVQFIRNVITMPNIVAGEYSYYDAMNGESFEEQVLYHYEAIGTKL
IIGKFCSIAPEARFIMGGGNHRMDGSTYPFNIFGHGWEIHAPSLEQLPLKGDTVVGNDVW
IGRRATIMPGVTIGDGAIIGAEAVVVRDVEPYTIVGGNPAREIRRRFSPEVIAELLEIRW
WDCGIELINRYIGAIVSGDMAQLREMKR
>WP_061107820.1|FEATURES|NCBI|qa_compound|Qac|antibiotic efflux|0
MKGYVALGIATISEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
AIWSGVGTALTALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>WP_010710386.1|FEATURES|NCBI|trimethoprim|dfrC|antibiotic target replacement|1
MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
IVLTSNPDYRAEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHE
TFEGDTFFPEIDWFVWEKVATVPGVVDEKNLYAHDYETYHRNDK
>WP_011767294.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|1
MSRADAPAPSSLRIYFRLLGYVRPYVGQFVLSIVGFLIFASSQPMLAGVIKYFVDGLNDP
GATPFTGVPLLASLPLMSAVPVLIILIVVWQGIGSYLGNYFLAKVSLGLVHDLRMALFDS
LLRLPNRYFDNHNSGHLVSRITFNVTMVTGAATDAIKVVIREGLTVVFLFGYLLWMNWKL
TLVMVAILPVIGLMVTSASRKFRKQSKKIQVAMGDVTHIASETIQGYRVVRSFGGEAYES
RRFQAASEDNTAKQLRMVKTGATYTPMLQLVTYVAMAALLFLVLLLRGDASPGDLVAYIT
AAGLLPKPIRQLSEVSSTVQKGVAGAESIFEQLDEPAELDRGTVERERIAGRLEVRGLSF
RYPGTERVVLDDISFVVEPGQMVALVGRSGSGKSTLASLVPRFYHHEQGQILLDGVEVED
YTLRNLRRHIALVTQQVTLFNDTVANNIAYGDLAEAPRAQVEAAAEAAYAREFIDRLPQG
FDTLVGENGVMLSGGQRQRLAIARALLKDAPILILDEATSALDTESERHIQAALDSAMRG
RTTLVIAHRLSTIEKADVIMVMEQGRIVERGSHAELLAAGGAYARLHAMQFRDEAEAAES
>WP_011766047.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|1
MKDAVTLYRRLLGSLAPYRGVVALSLLAMVAAAALEPVLPALLKPLVDDSLIARRTAAQW
QVPLLILLAFVAKGVAEYVASVSSQWIANKAITDLRRRVFRHQLHLPLAVHQAEAGGRML
SRILYDIPQVGAALSTAWIVVIRDACIIVGLVGYLVYTAWELTVLIVAIAPLVAWLIRIA
SRKLRGTNRAMQETTGAVTGAVEESLAGIREIKLFGSHDWEDARFATLAERLRKQTMRSV
RIAAANAPLVQILAAAAVSAVIWVASLLSAENRLTPGEFVAFVTAMAMLFEPIRRLTNIN
AVIQRGLAGAQSLFELLDTPAEADATGGTDQRPPARGELRLEHVGFRYPGQDTPALDDFS
LTVRPGETVALVGASGSGKSTLVNLVARFHQPQHGRILLDGDALDALPLAWLRSQIAWVG
QQVVLFDDTVAANIAYGRPDVSRTAIEAAARAAHAWDFIAALPQGLDTRIGHDGDQLSGG
QRQRIAIARAFLRDAPILLLDEATSALDNASERAVKDALDRLRRQRTTLVIAHRLSTVRD
ADRIMVMAHGRIVESGTHDELVAAGGAYARLLAGGGQAEPALALAEPA
>YP_001707102.1|FEATURES|resfam|multidrug|msbA|antibiotic efflux|1
MNQDFKVYLRLISYLKPYWGVALLVLIGFGMNSATEVSVAKLIKFIIDAIQNASRADLDW
FPLLIILLVFFRGLGLFMGGYYTAVISRSLVFSIRQEVYAKLLRLPAQYYLDNSSGHITA
KIMYNVEQLTAASSESLKTIVRDGMITLGLLGYLFYTNWRLTICIMVFLPVIGILVRKAS
KRMRKLSMQVQDTMGDVNHVVQESINGNAVVKSFAGEESEQERFYKSSEENLKRGLKMVI
VQNLNSPVVQVVMACAMALIVWLALRPQILGNTTAGEFVAYITAAGLLSKPVKNLTDVNE
KLQRGLAAAHSVFELLDLPEEQNSGELKPQLQGAIRFDHVVLNYADGTQAIKDFSLDIRP
GETVALVGRSGAGKTSLVNMLVLFQEVSSGQIYLDDLPIRDIELSSLRTQIAMVNQQVVL
FNRTVRENIAYGQLHNASDEDVIAAAKAAYAHDFIMNLPNGYDTVLGAQGLNLSGGQRQR
IAIARAILKNAPILILDEATSALDNESEHFIQQAFDEAMQDRTTIVIAHRLSTIENADRI
VVMDRGQIVEQGTHQELLAKHGAYYQLHQRNFEDH
>YP_185624.1|FEATURES|NCBI|multidrug|sav1866|antibiotic efflux|1
MKTRLKFQVDKDLLLAIVVGVCGSLVALAMFFLSGYMVTQSALGAPLYALMILVVTVKLF
GFLRAITRYVERLISHKATFTMLRDIRVQFFGKLVNVIPNVYRKLSSSDLISRMISRVEA
LQNIYLRVYYPPVVIGLTALVTVIVLAFISIGHALLIMVSMLFTLLIVPWLSSKKARTLK
KHAANEQARFLNHFYDYKAGMDELRRFNQINHYRDNLMAKLNHFDKLQLKEQRFLTIYDF
ILNIIAMLSIFGSLVLGLIQINAGQLNIIYMTSIVLMVLTLFEQAVPMTNVAYYKADTDQ
ALHDINEVISVPSTNGKKRLNDKYDATNIYEVKDASFKYWNQQTYVLSDINFNVNRGEKI
AIVGPSGSGKSTLLQIMAGLYQLDSGSVRFENMDMFEIDDKDKFESLNVLLQSQQLFDGT
IRQNLFTDEKDEAVQAIFKQLDLEHLALERQIDLDGHTLSGGEIQRLAITRMLLKDTAST
WILDEPTTALDKQNSLKVMDLIEAHAETLIVATHDLTLLSRFETIIVMINGKIVEKGNYQ
QLLANQGALWNMIQYNA
>AAP23225.1|FEATURES|resfam|aminoglycoside|aadA|antibiotic inactivation|1
MRVAVTIEISNRLSEVLSVIERHLESTLLAVHLYGSAEDGGLKPYSDIDLLVTVAVKLDE
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLA
SRADHLEELIRFVKGEIIKSVGK
>WP_001255866.1|FEATURES|resfam|aminoglycoside|aad(6)|antibiotic inactivation|1
MTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPE
EKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVR
KPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFK
LSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAY
PEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ
>WP_002056912.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MWEQIYHVDCLLSVIALLEKEAAKKGAIIVKKKMILKVGLCASILGFSQFASSILPVQAA
EKVEQIKNKDQEKDVSISQLHPKVWMHTSIGVVNGTRIPANGLILETSKGLVLIDTPWND
TLTDQLLQILKKQFPTKEVTEAIVTHAHDDRIGGIKTLIKKGVKVHSTALTADLAEKQGF
DKPLGDLKKRDNMRFGDINVETFYPGKGHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQ
TPGSYVSNWSKAIKKVEKKYNDINMIVPGHGDPGDNRLFTHTLNLLKNNEN
>WP_003198347.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKMKKKLILKVGLCASILGISQFASSIFPVQAAEKVEQIKNKDQEKDVSISQLYPKVWMH
TSIGVVNGTRIPANGLILETSKGLVLIDTPWNDDLTDQLLQILKKQFPTKEVTEAIVTHA
HDDRIGGIKTLTKKGVKVHSTALTADLAEKQGFDKPLGDLKKRDNMRFGDINVETFYPGK
GHTQDNITVWLPKYKILFGGCLIKSLDTQEIVQTPGSYVSNWSKAIKKVEKKYSDINIIV
PGHGDPGDSRLFTHTLNLLKNNEN
>1DXK_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
DKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGY
EEPLGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGSLVKSTSAKDLGN
VADAYVNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>2NZE_A|FEATURES|NCBI|beta_lactam|BcII|antibiotic inactivation|1
KTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTK
ELIEMVEKKFQKRVTDVIITHAHADHIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLG
DLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILVGGSLVKSTSAKDLGNVADAY
VNEWSTSIENVLKRYRNINAVVPGHGEVGDKGLLLHTLDLLK
>YP_003973246.1|FEATURES|NCBI|beta_lactam|BAGA_16895|antibiotic inactivation|1
MKISKGWIGKVVFSLLLTLSVFMTSFNDQMIAQSKKSPPTQITNPDKTIVLTKLDDKVWA
HTSYNDWNGTTYDHDQKTEELLKMIKKHFKKKVVLALITHAHDDSISGIRALLNQGIDVR
STLLTAKLAKEYGYPSPSPTLDVKPVMKVGNTVIEAFYPGEGHSSDNITVWLPQYNLLFG
GCFIKSLDAKDLGNLSDANVEQWDESVKKVIEKYRDVKTVVPGHGNWGDESLLFHTIDLI
KQHTHNKS
>NP_772870.1|FEATURES|NCBI|beta_lactam|BJP-1|antibiotic inactivation|1
MRRLTAALCALTLLSTGAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKLILNTHAHLDHTGGFAEIKKETGAQ
LVAGERDKPLLEGGYYPGDEKNEDLAFPAVKVDRAVKEGDRVTLGDTTLTAHATPGHSPG
CTSWEMTVKDGKEDREVLFFCSGTVALNRLVGQPTYAGIVDDYRATFAKAKAMKIDVLLG
PHPEVYGMQAKRAEMKDGAPNPFIKPGELVTYATSLSEDFDKQLAKQTAALEKK
>WP_005799525.1|FEATURES|NCBI|beta_lactam|cepA|antibiotic inactivation|1
DLVKDLDTSRQTKNLNKLLIRILLHLQVEFSQRTQSYMQKRLIHLSIIFFLLCPALVVAQ
NSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDIHYPMMSVFKFHQALALADYMHHQ
KQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQG
GPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFDKEY
KNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHA
YSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>WP_000626897.1|FEATURES|resfam|multidrug|cfr|antibiotic target alteration|1
MITAEKKKKNKFLPNFDKQSIYSLRFDEMQNWLVEQGQQKFRAKQIFEWLYQKRVDSIDE
MTNLSKDLRQLLKDNFTVTTLTTVVKQESKDGTIKFLFELQDGYTIETVLMRHDYGNSVC
VTTQVGCRIGCTFCASTLGGLKRNLEAGEIVSQVLTVQKALDATEERVSQIVIMGIGEPF
ENYDEMMDFLRIVNDDNSLNIGARHITVSTSGIIPRIYDFADEDIQINFAVSLHAAKDEV
RSRLMPINRAYNVEKLIEAIQYYQEKTNRRVTFEYGLFGGVNDQLEHARELAHLIKGLNC
HVNLIPVNHVPERNYVKTAKNDIFKFEKELKRLGINATIRREQGSDIDAACGQLRAKERQ
VETR
>WP_000132359.1|FEATURES|resfam|chloramphenicol|catB2|antibiotic inactivation|1
MTDSLLKYREQHKHRLNYMPWLYWTLKPKHRVWAEEWQKEYQAYLMDMETVEIGENCFIS
PLAHIFAEPGRKIKIGNNCFIAADCSLHGPLEIGNEVAINHHCILDGGRAGIKLHDQVRI
AAYCHLYAFDHGMQLDRPLYQQPVRSQGIEIEKDVWLGAHVGIKDGIKIGKHAVVGMNSM
VTKDVEPYHIVGGNPAKFIRLRE
>NP_822052.1|FEATURES|NCBI|multidrug|lsaB|antibiotic inactivation|0
MADVIVLNGGSSSGKSGIVRCLQAVLPDPWLALGTDTLVDAMPASMQASDAGIEFAPDGE
VIVGPEFRTLEAAWIEGVAAMARAGARVIVDEVFLGGADSQQRWQKALRDLRVLWVGVRC
DGAVAAGREIARGDRVIGMAASQADVVHRGVVYDLEVDTTHAESMECARAIATHVR
>NP_104819.1|FEATURES|resfam|chloramphenicol|chloramphenicol_phosphotransferase|antibiotic inactivation|0
MRSGSGSTIVPPPMSSARNCRASAGPVWWCATGSSIRSRIVFLLRVVESCSEAASKVKAR
IVLLNGVGSAGKSSIARALQTITAAPFLHVQMDSFLEMLPDALQDHADGFSYETVRQDGK
PAVVIRAGPVGERTLRGMRHAIAAMAGQGNDLIVDDVLCNGELSDCVDLLSAFDFHLVGV
MAPLEVLEAREARRADRLPGLARWQYERVHAGISYDLEVDTSQSTPLECARRIQQRFQL
>YP_749578.1|FEATURES|NCBI|beta_lactam|SFB-1|antibiotic inactivation|1
MFSRILILLIGFICCMPLAISAESSGQLTITPLSSNALVKANQAQATQIQLFEYQSYFKT
DDFGLVDANGLVVVEGKDAYLIDTPWSEKDTIALVEWIKQQNFILKASISTHSHADRTAG
ISYLNSIGVSTHVSAMTQKILTTQHKALASQPFDGDSFTLANGLLEARYLGAGHTIDNIV
VWLPKAQLLFGGCLVKSAHSKSMGYIAEASLTDWPVTISKVKATFVDAEVVVPGHGAIGN
AGLLNHTQELVNIYLSKHQLD
>ACU65239.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILIGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>ACU65237.1|FEATURES|NCBI|beta_lactam|IMP-6|antibiotic inactivation|1
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDGTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPGHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>YP_003085783.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MQNHILTCLLALVCAYAHAQTPDKSFKTDDLIVQKLTDHTYQHLTYLQTQTFGKVPCNGL
IVFDGGEAVIFDTPADDATSEKVIRWVEDSLKCKVKAVIATHFHEDCVGGLKAFHEHGIP
SYATNKTIAFDKEHKFPVPQKGFDNKLELNVGTKPVVAAFYGEGHTRDNIIGYFPSEKVM
FGGCLIKEVDATKGNLADANVDVWPATVANIRKQYSDVKVVIPGHGKIGGSELLDYTIKL
FSQK
>YP_003861292.1|FEATURES|NCBI|beta_lactam|CcrA|antibiotic inactivation|1
MKIKYTLFLVSLILIIGCKAQNSTNSSFESENLRIKQLTENTYVHISYLETDTWGKVPCK
GMIVTDNGEAIVFDTPTNDVASVELLNWLKNDLKYQVNAVVATHFHVDCIGGLKEFHKNN
IPSYATNMTIDLMKNGVVPENGFDKYLELKVGNKKVVSQYFGGGHTSDNIVGYFSSEKVL
FGGCLVKSIGAGKGNLEDADVQAWSKTVENVKKQFKKVEVVIPGHGEAGNAGLLDYTIEL
FKQE
>AAY46154.1|FEATURES|NCBI|beta_lactam|IMP-4|antibiotic inactivation|1
DLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDAEAYLIDTPFTAKDTEKLVTWFVE
RGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVNYWL
VKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKPYGLGNLGDANLEGWPKSAK
>ABE01851.1|FEATURES|NCBI|beta_lactam|imiS|antibiotic inactivation|1
LTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKGVSRKPVLEV
INTNYHTDRAGGNAYWKSIGAKVISTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPN
VVHEGDFTLQEGKLLAFYAGPAHTPDGIFVYCPDQQVLYGNCILKEKLGNLSFADVKAYP
QTLERLKAMKLPIKTVVGGHDSPLHGPELI
>1JT1_A|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
AYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFK
FSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFT
QSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPG
YKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLSKGQNNPFVDPT
GCKNYIEQKANDFYTELKKQETG
>CAC15063.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGITYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGAR
>ABC02083.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRSTLLAFALAAALPFAQAHAAEAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTQELT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAKVVANAESPVLLARGGSDDLHFGDGITYPPASADRIIMDGEVFSIGGIDFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKDNPRYPRLIEDYKRTFATVRGLPCD
LLLTPHPGASNWSYAAGSKASANALTCKAYADAAEKKFEAQLAKETAGAR
>ABO61003.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRS
GAQVVANAETAVLLPRGGSNVLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKGTTGAR
>BAE44415.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMAGHLLDNMKLRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAHVAANAETAVLLARGGSNDLHFGDSITFPPVSPDRIIMDGEVVNVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVQDYRRSFAMVRG
LPCDLLLTPHPGASNWNYAAGSNASEKVLSCK
>BAE44413.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
EDLTALLVQTADGAVLLDGGMPQMASHLISNMKVRDVAPQDLRLILLSHAHADHAGPVAE
LKRRTGAMVVANAESAVLLARGGSNDLHFGDSITFPPASTDRIIMDGEVVTVGGIAFTAH
FMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPYLVEDYRRSFATVRG
LPCDLLLTPHPGASNWNYAAGSKASDKALNCK
>BAE44419.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
ENLTALLVQTAEGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAE
LKRRSGAHVVANAESAVLLARGGSDDLHFGDGITYPPASADRIVMDGEVVEVGGIEFTAH
FMPGHTPGSTAWTWTDTREGKPLRIAYADSLSAPGYQLQGNARYPRLVEDYKRSFATVRA
LPCDVLLTPHPGASNWDYAAGARAGAKALTCK
>WP_007150152.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MLLVSAAQAEPVTPLPQLEAYTVPEAWLQPMAPLQIADNVWQIGTDELTSLLLKTRDGAI
LIDGGMPQSAEHLLANMEAVGVAPQTLKWILVSHGHGDHAGSLAAIKQATGARLVANAET
AMLMADGGANDIHFGDDILYPPVRVDRQIQDGEQVSLGNLTLTAHFIPGHTPGSMAWTWQ
SMRDGEKVDIAYVDSLTAPGYQLVDNPRYPHIVEAFTGTFKTVKQLPCDLLLTPHPGASG
WNYTDVTQSTRMDCADYAKKAEKTLREQRKAQQAD
>ADC79558.1|FEATURES|NCBI|beta_lactam|BL3_l|antibiotic inactivation|1
MRTLTTLGLALLLAQPAVAAQAVLPQLQPYTAPAAWLTPVAPLHIADNTWHIGTASITAL
LVKTPEGAVLLDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATG
AQLVSNAESAVLLQRGDSQDIHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHT
PGSLSWTWTDRRDGKPLRIAYSDSLSAPGYSLWMNPRFPKIAEAFRSGFAAVRALPCDLL
ITPHAEASGWDYTNAEHPNPSPMSCKAYADK
>YP_001817999.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MCRNFLGPLFHLCVWFATFVGPAVSAQPTELWRSWNQPVAPFRIVENVYYVGASDIAAYL
ITTPDGHILLETGFAETVPLVRASLRQLGIEPRDIRILLTSHAHIDHAGGLKAMKALTGA
RLIASAPEAAALARGGRGDFHYGDQLAFEPVTVDEIVADGGTVTLGGVTLTAHLTPGHTP
GSTTWTCRVRTGGRELDVVFAASVSAPGYQLVNNAAYPDIWRDLQASIAALRALPCDVFL
APHGQVFGLTNKARRLAEHPETHPFIDPDGYRAFCDDAEARLRKQHAEQAAALEARNKR
>WP_001082968.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_001590783.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDVLPFPPVTTDKIIHNQESISLGGITVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQP
>NP_458189.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MNRYVLFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
NLSSILLTTPAGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLSSHARLDQAGGMARL
KAWSGAQLVASQPNADQMARGGRQDFALGDALPFPLVTTDKIIHNQESISLGGVTVTALF
TPGHLPGSTSWRVTLRNGKTLIYADSLATPDYLLINNKNYPDLVTDIQSSFKTLAAQHVD
IFIANKGDRFGLLEKRQQLRNGDTQAFFDSNGLQQYVERSRQRFITQLTAQQPQ
>YP_002762743.1|FEATURES|NCBI|beta_lactam|Rm3|antibiotic inactivation|1
MSFCIPLSRSQRAAMALAWCVASSALLLGGPVGVSAQSATRAVVTPVPPTPNCPDCAEWN
APHAPFRIFGNSYYVGTHGLSAILVTSPDGHVLVDGALPESAPQIVAGIEAMGFRVGDIK
IIVNSHAHFDHAGALAEIQRLSGATVAASPSSARWLMAGQSSNDDPQYGMNPGFAKVPRV
RVLRDGEVVKVGTLSLTAHFTGGHTPGGTSWSWRSCEGTQCLDLVYADSQTPVSADDFFY
TRSTTYRTGVADFRRGQALLSRLSCDILITPHPAASSLWERLASSDRSASPAGARPALVD
REACRRYASRAAEALEKRIAKEKIAPR
>YP_003732270.1|FEATURES|NCBI|beta_lactam|CAU-1|antibiotic inactivation|1
MTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQALLIDTGLPENT
EKIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQQDVKALEIGKPI
GENTFQTIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWSTEIKSNGKNLTV
VFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLISHPEVADVLGNKARKDA
GQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>YP_002129188.1|FEATURES|NCBI|beta_lactam|SPG-1|antibiotic inactivation|1
MRNLFLALALATATAAPSVSIAQDAAQRAEWNRPAAPFRIAGPVYYVGTEGLGAYLVADP
GGHALIDGGLPESAPLIAANIEALGFKLEDVRYLLVNHAHFDHAGGLAELKRRTGAALVA
SAGDAPDLGAGRTLGRPELDGFPAVAVDQVVADGDTLRLGQASLTAHVTPGHTRGCTSWS
LAGPSGTVLFACSLTVAGQKLHGDPAYPDAAADFRRTFARLRTLHADYFLNFHPEFFDMA
GKRARRAAGEPDPFRDPAELARQVDRAEAMFERELARQAAR
>1L9Y_A|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
AYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINSDLEANVPMIKASIKKLGFK
FSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVILSGGKSDFHYANDSSTYFT
QSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLKDHGKQYQAVIIGSIGVNPG
AKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDLKNKYVLLSKGQNNPFVDPT
GCKNYIEQKANDFYTELKKQETG
>YP_826370.1|FEATURES|NCBI|beta_lactam|LRA-19|antibiotic inactivation|1
MKISILMAAMVLTCMAADPPEWRQPFAAHRVVGNIYYVGTYDLASFLIVTPAGNVLINGG
MGDSVPLMRKSVADLGFQWKDIRWMLTTQAHADHVAAFAEIQRTTGAKVMATEADAKLLE
DGGKSDFHFTGAEYHYAPVKVVERLHDGQTLKFGGTEITVYLHPGHTKGSASYAIPVTEG
GRTYRVLIANIGTINPGVKLLGEKNYPGIAADYAMTFEKQKALSCDIFLSSHAGQYGLHS
KYKPGAPYDPARFVDPAGYQKAVAGAEAAYRKQLAEEKAAH
>ABK64020.1|FEATURES|NCBI|beta_lactam|THIN-B|antibiotic inactivation|1
MTLLAKLMLATVATMAAGTVQAKTPVPVQDKPVNCDNCKEWNAPVKPFNVYGNTWYVGTA
GLSAVLVTSPQGHILLDGALPQSAPLIIASIKALGFRIEDVKYILNSHAHWDHAGGIAAL
QRASGATVMASAAAAPVLQSGTNGKDDPQYQADPVVHVAKVSKVSLVGEGDTVKVGPLTL
TAHMTPGHTPGGTTWTWTSCEGQRCLDVVYADSLNPYASGDFRYTGKGAGKGGSPDVSAS
FEASIAKVAALPCDIIIPVHPGTTDVLGKAAKRSGTDNPLIDANACRAYAAEAGGMLAKR
LAKERGVAVPAEAKGAAHAH
>YP_592954.1|FEATURES|NCBI|beta_lactam|FEZ-1|antibiotic inactivation|1
MSARLRTLIAALFFVVVCLSGMAKENPDYTAALPPFRIADNLYYVGSRDLAAYLVTTPAG
NILINANLESSPPLIRASVEKLGFSWKNTKILLNGQAHSDHMGGAAQVIRETRAQDMVMD
GDADVVSSGGRKDFAFGTDGLTTYPPARVDRVLHDGDTVLLGGVTLTAHRTAGHTRGCTT
WTLRAHIASDPAGRLRDVVIVGGWRALSQYQIVGTPGHPASYPGINEDFEKTFATLRALP
CDIFLGAHGVYFDLLPKLKRMPTEGEAAFVDPKGYAEAVNAAQADFEKTVAAQRAKK
>YP_003084992.1|FEATURES|NCBI|beta_lactam|PEDO-1|antibiotic inactivation|1
MPSIKKSLFTTLIAGAILAPFATEAQNKPRKLPYVQQEWTKEYRPFRIAGNLYYVGTYDL
ACYLIATPKGHILINTGLESSVPVIRKHVQALGFKFEDIKILLATHAHYDHVEGMAAIKQ
ATGARLLIQEKDGKAMTDGGASDYALGGHGSTFEPVTPDQLLKNGEIIKLGTMQVKLLHH
PGHTPGASSFSFTVRDEKRAYKVFIANMPSILDETKLSGMPGYPEVGKDYAKTLAVMKNE
RFDIWLSSHASQFALHQKHKPGSPYRPEAFFDQAGYDSALAGLKKRYDEKSKEK
>YP_001085388.1|FEATURES|resfam|beta_lactam|ampC|antibiotic inactivation|1
MAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDD
TPGKYWKVLKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEY
RQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQEN
QPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQ
ALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIP
KENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>ABB64281.1|FEATURES|resfam|beta_lactam|WRSd3_03658|antibiotic inactivation|1
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHISPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLHQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARSVKAITPPTPAVRASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAO16528.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMKKSLTGVLLLGASFSIFAAPQTAEQLRELVNQTITPLMKEQTIPGMAVAVIYRGKPYY
FTWGQADVAGQRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQ
WQGISLLHLATYTAGGLPLQVPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGA
LAVKPSGMSFEQAMSQRVLQPLKLSHTWINVPPAQSKDYAWGYRDGKAVHVSPGQLDAEA
YGVKSSIEDMAHWVLANMNSEAVQDKNLRQGIQLAQSRYWRAGEMYQGLGWEMLNWPVPA
EVVINGSDNKVALAATPVTAVNPPAPSVKASWVHKTGSTGGFGSYVAFIPQQDLGIVMLA
NKSYPNPERVKAAYHILEALQ
>YP_001006653.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MMKKSIINTLIFTAIATFPLYTLAQTKLTQQQVATIVNNTLTPLLEKQDIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKALWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAANDKLKEAIIASQSRYFQAGDMFQGLGWEM
YNWPINPQRVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>YP_349452.1|FEATURES|NCBI|beta_lactam|ampC|antibiotic inactivation|1
MSSTNLRKLKSYSAFGLFFSAATCLAAPQTDDQLQALVKATVTPVMQQQDIAGLAVAVTV
NGKAHYFNYGVADKSTGQAVSENTLFEIGSVSKTFTAILAAYAQASGKLQLSDKASQHWP
ELKGSAFDHISLLQLGTYSAGGLPLQFPDAADSADKMLGYYQQWKPTYPAGSHRLYSNPS
IGLFGYLAAKSLGQPFNQVMTETLLPKLGLKHTFLSVPASEQKLYAQGYDKNNKPIRVSP
GALDSEAYGVKTSAADLLQYVQANLDTAKLETPLQKAIALTHTGYYTVGDMTQGLGWERY
AYPISLDRLLDGNSTPMAMEAHKVKWLNPPQPEPANVLLNKTGSTGGYGAYVAFVPSKKV
GIVILANRNYPNGERVKIAHRILGELTR
>YP_001346277.1|FEATURES|NCBI|multidrug|mexi|antibiotic efflux|1
MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQ
GFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLP
ERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQ
RLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDF
REMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGEPAVHLGLFPTPTGNPLVIVDGIR
KLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALVIVVLVIYLCLGSLRSVLI
PVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPV
AAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTL
SPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPL
LYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVGTWIINGTD
GPAASFGGINLAAWDKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQLV
LRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQIRIDRAKANSLGIRMQDI
GESLAVLVGENYINRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVR
VELKVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDEVARGLPAGFSHDWQSDSRQY
TQEGNTLAFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIY
TQIGLVTLIGLISKHGILMVEFANELQVHERLDRRAAILRAAQIRLRPVLMTTAAMVFGL
VPLLFASGAGAASRFGLGVVIVCGMLVGTLFTLFVLPTVYTLLARNHAEVDQSPRNRQLA
EADLLVNKT
>YP_606823.1|FEATURES|NCBI|multidrug|mexW|antibiotic efflux|1
MAFTDPFIRRPVLACVVSLLILLLGAQAWSKLQIRQYPQMENALITVTTAYPGANAETIQ
GYITQPLQQSLASADGIDYMTSVSRQNFSVISVYARIGSDTDRLFTQLLAKANEVRNKLP
QDSEDPVLSKEAADASALMYISFYSNEMSNPQITDYLSRVIQPKLATLPGMAEAQILGNQ
LFAMRIWIDPVKLAGFGLSAVDVTNAVRHYNFLAAAGEVKGEYVVTSVNATTELKSAEAF
AALPVKIAGDSRVLLGDVARIEMGAENYDTVSSFDGTPSVYIGIKATPAANPLQVIKEVR
RIMPQLEEQLPSGLKVSIAYDATLFIQASINEVIKTLGEAVLIVIVVVFLFLGALRSVLI
PVVTIPLSMIGVLFFMQMMGYSLNLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKTPR
DAALEGAREIALPVVSMTITLAAVYAPIGFLTGLTGALFKEFALTLAGAVIISGVVALTL
SPMMCALLLRHEQNPSGLAHRLDVLFEQLKVRYQRLLHGTLNSRPVVLVFAVIILGLIPV
LLKFTQSELAPNEDQGVIFMMSNSPQTANLDYLNAYTDEFTPLFKTFPEYYSSFQINGFN
GVQSGIGGFLLKPWSERQRTQMELLPLVQAKLEEVGGLQIFGFNLPSLPGTGEGLPFQFV
INTAGDYTALLEVAQRVKERAQASGKFAFLDIDLAFDKPEVMIDIDRAKAAQMGVSMDTL
GGTLATLLGEAEINRFTLEGRSYKVIAQVERAYRATPGWLNNYYVKNEQGQLLPLSTLIT
LSDRARPRQLNQFQQLNSAIIQGVPLVSMGEALDTVRTIAHEEAPEGFAVDYAGTARQFV
QEGSALWVTFGLALAMIFLVLAAQFESFRDPLVILVTVPLSICGALVPLFLGVSSMNIYT
QVGLVTLIGLITKHGILIVEFANQLREEKGLGVREAIEEAAAIRLRPVLMTTAAMVFGMV
PLILATGAGAVSRFDIGTVIATGMSVGTLFTLFVLPCIYTVLAHRGGREVA
>WP_000592290.1|FEATURES|resfam|multidrug|mdtb|antibiotic efflux|1
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTSMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTLAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKTSASNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVTTIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKIDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGDIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_000592298.1|FEATURES|resfam|multidrug|MuxC|antibiotic efflux|1
MIKKLLQFSLGNKFAIFLMVVLVVLGGVYASAKLKLELLPNVQNPVISVTTTMPGATPQS
TQDEISSKIDNQVRSLAYVKNVKTQSIQNASIVTVEYENNTDMDKAEEQLKKEIDKIKFK
DEVGQPELRRNSMDAFPVLAYSFSNKENDLKKVTKVLNEQLIPKLQTVDGVQNAQLNGQT
NREITLKFKQNELEKYGLTADDVENYLKTATRTTPLGLFQFGDKDKSIVVDGQYQSVDAF
KNINIPLTFAGGQGQSQSQSDNKQNSAMSDVNQASPQQNSKASAPNNISGMPTAKLGDLA
DITVGDVRTSISKTNGKDAVNLQITKAQDANTVQVAKDVQRKIDTFVDENKDFNVTKTMD
TAKPVEKSLYTMVEKASLGTIVAIIVILLFLRNIRTTAISIISIPLSLLMALIALKLSDV
SLNILTLGALTVAIGRVIDDSIVVVENIYRRLTDSEEQLKGENLIISATTEVFKPIMSST
LVTIIVFLPLVFVSGSVGEMFRPFALAIAFSLLASLLVSITLVPALAATLFKKGVKRRNK
QHQEGLGVVSTTYKKVLHWSLNHKWIVIILSTLILVVTIVFGGPRLGTSFISAGDDKFLA
ITYTPKPGETEQAVLNHAKDVEKYLKQKKHVKTIQYSVGGSSPVDPTGSTNSMAIMVEYD
NDTPNFDVEADKVIKHADGFKHPGEWKNQDLGTGAGNKSVEVTVKGPSMDAIKSTVKDIE
QKMKQVKGLANVKSDLSQTYDQYEIKVDQNKAAENGISASQLAMHLNENLPEKTVTTVKE
NGKTVDVKVKQNKQTDWSEDKLNNITLKKPTGGTIKLGNIATLVKTTTPSKLTQEQGDYA
TTVSAKVTNKDVGGTTRQVMSKINNLDKPNNVKVNIGGASDDINNAMTQLAFAMLAAIII
VYLILVITFKGGLAPFTILFSLPFTVIGVIIALLITGETISVPSLIGMLMLIGIVVTNAI
VLIDRVINNEQQGMEMKEALIEAGGTRIRPILMTAIATIGALVPLLFGQDSSILISKGLA
ATVIGGLISSTLLTLVVVPVIYEILFTLKKRFTKR
>WP_011766859.1|FEATURES|resfam|multidrug|mexW|antibiotic efflux|1
MVLSEICIKRPVFATVLSLMVLLVGLMSYSRLTVREYPNIDEPVVTVETLYTGASAEIVE
SQVTKPLEDSLAGIEGVDVLSSISRQERSQITVRFRIERDADSAAADVRDRVSRVRRRLP
DDVEEPVIAKVEADASPIIWVAFASDRHSALEMSDVASRIIKPRLQTLPGAADARVFGER
RYAMRIWLDRDRLAAFGLTPQDVEDAIRRQNIELPAGRIESREREFAVVARTDLAEPAQF
EAVVVRQAGTPGGYPVRIRDIGRVEVAPADERTSVRFMGKPAISLGLIKQSTANPLDLKR
GLMELLPRLEEELPAGMTMSIANDSTVFIERSIASVFSTIWEAVVLVALVCLFFLRNWRA
MLVPLVTIPVSLVGAFALMLVFGFSINTLTLLALVLAIGLVVDDAIVVLENIYRHIEDGM
APLAAAFRGAKEIGFAVVAMTITLAAVYAPVAFMTGRTGKLFTEFALTLAGAVIVSGFVA
LTLSPMMCSRLLRHEPRHGRVYNAIEGFLEWLTAGYRRALEAMLGLRWVVMLAFVAVAAF
AGLLLTQMKSELSPIEDRGRVMAIFNGPEGATIDYMTRYAGQIEDIFSRTGDVDRYFVVA
GNPTVSQGISFIGFNDWSQRKRSAQEIAAELQPQLRAIPGLNAFPVLPAAFGQSPRTRPV
SFVIVTSASYDELAAYTERMLDEMHRHPGFVSPDTDLKLTKPELAVEVDRDRAADLGVSV
EVIGRTLETMLGGRQVTRYKKDAEQYDVLVQVAAGERAGPRDIRDIFVRARGGDMVPLAS
LVRVQETVSPRELNHFGQRRAVTISANLAPGFALGEALDFLDAAAARILPPGYTTDYDGM
SREFKTSSASLALAFVLALAFIYLVLAAQFESFRDPLIIMLTVPLSMAGALAALRLTGGT
LNVYSQIGLVTLVGLITKHGILIVEFANQLREQGRALREALVEAAVLRLRPILMTTGAMV
LGAIPLALATGAGAESRQQIGWVIVGGLSLGTFFTLFVVPTVYTLLARREREHDSDTVES
ASAGMAG
>resfam_SHV-113|FEATURES|resfam|beta_lactam|SHV-113|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAAKLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHV-127|FEATURES|resfam|beta_lactam|SHV-127|antibiotic inactivation|1
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNNAERMVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ACN39713.1|FEATURES|resfam|beta_lactam|SHVL-2|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWKTELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-10|FEATURES|resfam|beta_lactam|SHVL-10|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKNGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAU84950.1|FEATURES|resfam|beta_lactam|SHVL-17|antibiotic inactivation|1
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERVVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>resfam_SHVL-62|FEATURES|resfam|beta_lactam|SHVL-62|antibiotic inactivation|1
WVIFPIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERF
PMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAA
ITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASM
AATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIV
ALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAA
>AAV91755.1|FEATURES|resfam|beta_lactam|SHVL-70|antibiotic inactivation|1
LEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDQ
QLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLT
AFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQ
WMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPAS
MAERNQQI
>ABY81266.1|FEATURES|resfam|beta_lactam|TEML-43|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDDRNR
>ABQ14418.1|FEATURES|resfam|beta_lactam|TEML-51|antibiotic inactivation|1
ALIPFFVAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14393.1|FEATURES|resfam|beta_lactam|TEML-53|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWIEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14404.1|FEATURES|resfam|beta_lactam|TEML-54|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQRLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14417.1|FEATURES|resfam|beta_lactam|TEML-57|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWVEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14441.1|FEATURES|resfam|beta_lactam|TEML-59|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
AFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14432.1|FEATURES|resfam|beta_lactam|TEML-67|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPHLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14409.1|FEATURES|resfam|beta_lactam|TEML-68|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLPLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14390.1|FEATURES|resfam|beta_lactam|TEML-70|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNGERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14412.1|FEATURES|resfam|beta_lactam|TEML-72|antibiotic inactivation|1
ALIPFLAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14386.1|FEATURES|resfam|beta_lactam|TEML-76|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEEHFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14394.1|FEATURES|resfam|beta_lactam|TEML-77|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHCSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14402.1|FEATURES|resfam|beta_lactam|TEML-83|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMG
TLKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTM
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14396.1|FEATURES|resfam|beta_lactam|TEML-84|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFRVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHPTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIG
>ABQ14433.1|FEATURES|resfam|beta_lactam|TEML-85|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESLRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSSVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>ABQ14444.1|FEATURES|resfam|beta_lactam|TEML-91|antibiotic inactivation|1
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRIDAGQEQLGRRIRYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIITALG
PDSKPSRIVVIYTTGSQATMDERNRQIAEIGA
>WP_075985685.1|FEATURES|resfam|beta_lactam|TEM-36|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-108|FEATURES|resfam|beta_lactam|TEM-108|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAELSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTSELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERSRQIAEIGASLIKHW
>resfam_TEM-39|FEATURES|resfam|beta_lactam|TEM-39|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>resfam_TEM-59|FEATURES|resfam|beta_lactam|TEM-59|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_052944427.1|FEATURES|resfam|beta_lactam|TEM-32|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>resfam_TEM-38|FEATURES|resfam|beta_lactam|TEM-38|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDELNRQIAEIGASLIKHW
>AAB83984.1|FEATURES|resfam|beta_lactam|TEML-122|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PPAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAD49603.1|FEATURES|resfam|beta_lactam|TEML-138|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERSPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAW48997.1|FEATURES|resfam|beta_lactam|TEML-144|antibiotic inactivation|1
MSFQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGGILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLRNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>ADW95860.1|FEATURES|resfam|beta_lactam|TEML-156|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCDTLLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDESDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKRSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAK28131.1|FEATURES|resfam|beta_lactam|TEML-159|antibiotic inactivation|1
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCHTLLSRIDAGQEQLGRRARYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDESDTTM
PVAMPTTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>1JVJ_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_N132A_mutation_(N-23)_[_N132A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDATAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1PZP_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_N100R_mutation_(N-23)_[_N100R]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVD
AGQEQLGRRIHYSQRDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>1XXM_A|FEATURES|resfam|beta_lactam|TEM-1_with_artificial_V84I,_E104A,_Y105A_mutations_(N-23)_[_V84I_E104A_Y105A]|antibiotic inactivation|1
HPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRID
AGQEQLGRRIHYSQNDLVAASPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
KELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
QLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTG
SQATMDERNRQIAEIGASLIKHW
>resfam_S19_tetX|FEATURES|resfam|tetracycline|tetX|antibiotic inactivation|1
MIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIY
EQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCH
FNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYF
SIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQF
LRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQG
NNLALVGAYILAGELKAAEGNYKLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKE
VAEERSNRILQKVQIISNAIKLPEYE
>WP_000046678.1|FEATURES|resfam|multidrug|adeJ|antibiotic efflux|1
MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENT
VTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPE
DVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGG
SYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLL
QTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANAL
DTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQ
NWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVM
SEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVL
SLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGK
IFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFF
MNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIK
DASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPN
GQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGS
RMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGD
AMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESW
SIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEF
AKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLG
GVLSATFLGIFFIPVFYVWIRSIFKYKPKTINTQEHKS
>WP_050976143.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MRPVVFGLALTGVAACSLAPPYELPALPVESRYPADAPVAPAAQRAADTSWQDYFADPAL
RRLIGQALDNSRDLRAAVLRVEEARAAFGIRRADRFPTVGLGFEGVRGRTPADLSITGEA
VTSGQYQMGISLASWELDLWGRVRSLEGAALEEFLATEAARRAVTVSVVAQVADAYLTLR
ELDERIVLAQRTIDTRQESFRIFSRRVEVGATSRLDLAQVETLLTQAQALGAQLEQARAL
QAHALAVLVGAPLDLPAAATRLDDDLILHELDAGLPSELLTGRPDIVAAEHRLKAAHASI
GAARAAFFPRIALTASAGSASAALDGLFEPGSGAWRFAPTISLPIFDAGRNRAGLDLAEV
RRDLAVASYEKTVQQAFREVADALAARHWLEAQLGIQRAALATQVERARLAKLRYDNGAA
RYLEVLDAQRDLLAAEQQVVQTRRALLSSRVALYAALGGGAQEPERTPR
>WP_011763981.1|FEATURES|resfam|multidrug|oprM|antibiotic efflux|0
MPLKTLAVALAAASLGACSTLAPDYERPAAPVAAAWPAEPAQPAAGTPSADAVAWRSFFA
DERLRQVVDLALANNRDLRVSALNIERARALYQIQRAELVPWIGVGGGQSAQRLPADLTQ
RGEPTISRQYSATVGFSSYELDFFGRIRSLRDAALEQYLATEDARRSAQISLVAEAANAW
LTLAADRERLDLARRTYETQQQSYELTKKSFDFGAVSAIDLRQAQTARESARADLAAYTT
QVARDINALNLVAGAAVPDELLPTALTDKVSAVGDLPAGLPSEVLVSRPDILAAERQLRA
AYANIGAARAAFFPSITLTAAAGTASASLEGLFKAGSGTWSFAPQINLPIFQGGRLLANL
QVAKVDREIAVADYEKAIQSAFREVADALAERANVGEELDARRALVEATAETYRLSEARY
RSGVDSYLGLLDAQRTLYSAEQGLISVRLADAANRVALYRVLGGGAQ
>YP_001084783.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKN
AQVWNAAIAHELRTPITILQGRLQGIIDGVFKLDEVLFKSLLNQVEGLSHLVEDLRTLSL
VENQQLRLNYELFDFKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIAL
IDNAIRYSNAGKLKISSEVVSQNWILKIEDEGPGIATEFQDDLYKPFFRLEESRNKEFGG
TGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEIG
>WP_000837449.1|FEATURES|resfam|multidrug|adeS|antibiotic efflux|0
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
WIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMS
ELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSL
LNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDL
TSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRD
DLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQYSNQGSKSVFTIKISMGHEEM
G
>WP_012300504.1|FEATURES|resfam|multidrug|smeS|antibiotic efflux|0
MNVLRVPIALRLFLTVLLTTLLIATASLSVLHWTMQKNFAKYVADVEMQKLDRLITNLGN
VYTVYHDWGNAIQAQILQIEGTAAPDDYDRLSQWWLRRQYDIAIQQHSFDEHTLINISPD
AGTVNKNSIFSDEELRTLEQNLPSEYQPFEGLRFPLSANQFRPSDDKNKSKKGSLKDIET
QNGKKRFIALPDRLGLSSRLSLYDAKHQFVVGEPPSSDQMSYRPIMVNSQVVGYLGLKPV
LDKEDALSINFFSNQKRYLLLIYALTLLSSLVAALLMATYFKKPIQRLLNATNELTKGNY
QHQVVIKRNDELGDLSTQLNHLAEILHQHEESRRQWVADTSHELKTPLAVLQAQIEAMQD
GIRKATPEHLDAMMRQVSSLKKLTQDLADLAQADAQQLKCYLSSVNPWEVILQEVENFRP
KLEQAGLEIEVEGEGASLLLDRDRFKQIIVNLIGNSIRYTETGGKIHIHTNQTSQEWTLY
VDDSPFGLSDEQLSRLGERFYRVDDSRTRSTGGTGLGLALSCKIAQALGGTLSFEHSPLG
GLRCVLTFKKQS
>YP_001706191.1|FEATURES|resfam|multidrug|smeS|antibiotic efflux|0
MNVLRVPIALRLFLTVLLTTLLIATASLSVLHWTMQKNFAKYVADVEMQKLDRLITNLGN
VYTVYHDWGNAIQAQILQIEGTAAPDDYDRLSQWWLRRQYDIAIQQHSFDEHTLINISPD
AGTVNKNSIFSDEELRTLEQNLPSEYQPFEGLRFPLSANQFRPSDDKNKSKKGSLKDIET
QNGKKRFIALPDRLGLSSRLSLYDAKHQFVVGEPPSSDQMSNRPIMVNSQVVGYLGLKPV
LDKEDALSINFFSNQKRYLLLIYALTLLSSLVAALLMATYFKKLIQRLLNATNELTKGNY
QHQVVIKRNDELGDLSTQLNHLAEILHQHEESRRQWVADTSHELKTPLAVLQAQIEAMQD
GIRKATPEHLDAMMRQVSSLKKLTQDLADLAQADAQQLKCYLSSVNPWEVILQEVENFRP
KLEQAGLEIEVEGEGASLLLDRDRFKQIIVNLIGNSIRYTETGGKIHIHTNQTPQEWTLY
VDDSPFGLSDEQLSRLGERFYRVDDSRTRSTGGTGLGLALSCKIAQALGGTLSFEHSPLG
GLRCVLTFKKQS
>NP_878024.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>YP_536856.1|FEATURES|resfam|beta_lactam|mecR1|antibiotic target replacement|1
MAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTMLAGLIPFIPIKFSFIKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVIWIVLVIILRFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLKTPFSNKNILSHSFNGKKSLLKSRLINIKE
ADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYKKPLQSDYQILDESKNFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNSRMSWNHKHYL
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNDQ
>WP_000213874.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|lmrB|antibiotic efflux|1
MTTTFIISYIILALIIVGVINLFLIRSRKKGKRQQKEQQFTTRQSNQSKFKASDLDKTTD
QSTQRMTHEELRVDNQDDHSQVSLNGYTKGSEKDQEAFTNNKDEEAVAAKNPESEEYKVN
EKIKKEHKNFIFGEGVSRGKILAALLFGMFIAILNQTLLNVALPKINTEFNISASTGQWL
MTGFMLVNGILIPITAYLFNKYSYRKLFLVALVLFTIGSLICAISMNFPIMMVGRVLQAI
GAGVLMPLGSIVIITIYPPEKRGAAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGM
FIIGIIAILIGFVWFKLYQYTTNPKADIPGIIFSTIGFGALLYGFSEAGNKGWGSVEIET
MFAIGIIFIILFVIRELRMKSPMLNLEVLKFPTFTLTTIINMVVMLSLYGGMILLPIYLQ
NLRGFSALDSGLLLLPGSLIMGLLGPFAGKLLDTIGLKPLAIFGIAVMTYATWELTKLNM
DTPYMTIMGIYVLRSFGMAFIMMPMVTAAINALPGRLASHGNAFLNTMRQLAGSIGTAIL
VTVMTTQTTQHLSAFGEELDKTNPVVQDHMRELASQYGGQEGAMKVLLQFVNKLATVEGI
NDAFIVATIFSIIALILCLFLQSNKKAKATAQKLDADNSINHE
>WP_041642270.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macA|antibiotic efflux|0
MFGNGDPTALYQFATVSRGDIEDVVTATGTLQPREYVDVGAQVSGQLKKIHVEVGSLVKN
GDLLGEIDSTVYLSKVDASRAQLRNLRAQLKEREAQVALAQVQFKRQTALMAEDATTTET
LQTAEATLKSAEAQLEALRAQIEQYESTLRGDEANLQYARIMSPMTGTVVSITARQGQTL
NTNQSAPTILRVADLTTMTVQTQVSEADVSRLKLGMAAYFTTLGGHGKRWYGKLDKIEPT
PTVTNNVVLYNALFDVPNDDNLLMTQMTAQVFFIVAQAKDVLQIPLAAVSQGARGPRAGA
QPAAGGAPAGAARGNGPRRATVKVLRADNTLEEREVQIGVSNRVQAQVLDGLQEGERVVT
GLLSAPAPAASTTSNRQGPPPRL
>WP_011764567.1|FEATURES|resfam|macrolide-lincosamide-streptogramin|macB|antibiotic efflux|0
MSPRDTLRFAAGAAFGYPLRTALMVLAMAIGVAAVVVLTALGDGARRYVVGEFASLGANL
IIVLPGRNETGGVNAGSFVTSTPRDLTVADASALLRAPLAARMAPLSVGNSEIAVGGKLR
EVMVLGTSADYLDIRHYSLSQGRFLPREDLNRAGAVAVIGDKLREELFGNEPAVGRMVRV
GDTRLRIIGVMARGAQGLGLNTDELVIVPVATALAMFNTNTLFRIMVEARSREALGPAQK
QMEDILRARHDGELDVTLITQDAVLGTFDRILGALTMAVAGIAAISLAVAGILVMNVMLV
AVTQRTGEIGLLKALGASARTIRLAFLTEAALLSLAGALVGYGLGQLGAWAIRLTWPVLP
AWPPDWAVVAGLGTALGTGLLFGVLPARRAARLDPVQALAKR
>WP_000677758.1|FEATURES|resfam|multidrug|TolC|antibiotic efflux|0
MKGMKPFNTRFLTLRHALYLGVLLVSNTHAMTLDEALSASLRHESQLEVSRLSVNQSTAM
LEQAKQRDGLKVNLVGQLDYERINTPSHVLFPTEGNRKGRSLQLQADYPIYTSGRHRLGI
DIAESQLSAQHQGLSDQRSETILNTVMVYTDVLKKKAILELRQKTMANLQRSLYESKRRF
DVGMITRADLAQVLAQVAQGQADITQAQSNLTVSEAQFYQVTGITPDNLVPINQLPTIPA
NLDEILAQTKNHPALMRAKYEKQAAEKQYALTKRELWPTVMLTSRAGKQDEASYIGSESN
NYMVGVQLNVPLYDDGLNRANVKKAQADIDLAAQKIRSLELDLNKRTRTTYAQLQTIRQN
KDALANAIEAASIAFVYTRKEFDVGTKTTFDLLNTEQKLLDAQTQKTVNDQDEVVFVYQL
LDQMGRLNNLVPMQTAQQVNNE
>AAF71277.2|FEATURES|resfam|glycopeptide|vanRG|antibiotic target alteration|0
MRDPICIADDDRESADIMELHLERTVMKSINLTMDRCRRCAESEKMDLAMLDVMLPDVEG
FHICQKIREGYFDPTIMRTAKEEDADKNTGLTIGADDYITKPFIPVEVAAGVKTQLRRHV
GYNNAAAIDKEHVLVTEYDINGLVLHENTHKCTPYGKAVTLTPIEFSVLCDQCENQGKQR
FLQRMIKAIVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE
>AAM80542.1|FEATURES|resfam|glycopeptide|vanSO|antibiotic target alteration|0
MRVHRAPGMSVRLKFTLSYAGFVMLAGTLMLVTVWVYLLRGLPDAASSPNGLVPVRAIVL
HAYAPATAVVLALLLVFGLLGGWLLAGRMLAPLTRITDATRTAANGSLSHRIELEGRKDE
FRELADAFDTMLARLEAHVAEQRRFAATASHELRTPLAITKALLEVTINGPGRDLGELIG
RLHNVNARAIDLTEALLLLSRADQRSFTREPVDLSLNVEEAVETLLPLAEKHGVAIEASG
DITPAMGSRALLLQLTVNLIHNAIVHNLHGRGIVRVTTGIESGSVTLSVENTGEVLPAQL
VSTLTEPFRRGTERIRQDHAGVGLGLAIVKSITEAHDGTLTIVPRPGGGLQVTVRLPAAP
PPETLNR
>CAA54269.1|FEATURES|NCBI|chloramphenicol|ND00_04320|antibiotic inactivation|1
MFRAMRPKRHELPTDESVGILKRMTNGTLALHGDGDYPYAVPVSYVYSDGRIYFHTATQG
HKVDALMRNDKVSFCVVEQDDVKSAEFTTYFRSVIPFGRARILTDETENGAALQLLADKY
SSGMPGLEAVIAKGFRHLLMVEIDIEHLTGKESIELVREKNDM
>CAC20135.1|FEATURES|NCBI|tetracycline|tetE|antibiotic efflux|1
VMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRW
SDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPE
ESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHN
ANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDG
VMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVFTQSWMVCP
VLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRET
WNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQ
>AAK50437.1|FEATURES|NCBI|fosfomycin|fosX|antibiotic inactivation|1
MTTFLCDGLGAREVYDSAGHNYSLSREKFFVLGGVWLAAMEGVPPSERSYQHVAFRVSES
DLAVYQARLGSLGVEIRPPRPRVNGEGLSLYFYDFDNHLFELHTGTLEQRLARYGAGR
>ABN79416.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAISVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>ACF06164.1|FEATURES|NCBI|sulfonamide|sul1|antibiotic target replacement|1
MEVAAEADAMVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHP
DARPVSPADEIRRIAPLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPAL
YPDIAEADCRLVVMHSAQRDGIATRTGHLRLEDALDEIVRFFEARVSALRRSGVAADRLI
LDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKSFLGATVGLPVKDLGPASL
AAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDARDRGLDHA
>CAQ58207.1|FEATURES|NCBI|tetracycline|tetW|antibiotic target protection|1
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMN
IPTVIFINKIDQAGVDLQSVVQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIE
NNDKLLEKYIAGEPISREKLVREEQRRVQDASLFPVYYGSAKKGLGIQPLMDAVTGLFQP
IGEQGSAALCGSVFKVEYTDCGQRRVYLRLYSGTLRLRDTVALAGREKLKITEMRIPSKG
EIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREA
LLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIY
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQ
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA
>ACZ52983.1|FEATURES|NCBI|trimethoprim|dfrA17|antibiotic target replacement|1
MKISLISAVSENGVIGSGPDIPWSAKGEQLIFKALTYNQWLLVGRKTFDSMGVLPNRKYA
VVSKNGISGSNENVLVFPSIENALQELSKITDHVYISGGGQIYESLIEKADIIHLSTIHV
EVEGDIKFPILPEGFNLVFEQFFVSNINYTYQIWKKG
>BAI97006.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MSLPRRLIFAALLLAAPAAAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIETESGGRL
GVALVDGKGALILGFNRDERFAMCSTFKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDY
APVVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDR
NEPSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWLNASTTGANRIKAGL
PKGWISGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALD
FVDKAQKTGLE
>AEG48329.1|FEATURES|NCBI|beta_lactam|BEL-1|antibiotic inactivation|1
MPRRLLLAALLLAGPASAQQEAPRQSLLPPPPRYMVSESAMKSVRNPKEIESESGGRLGV
ALVDSKGALILGFNRDERFAMCSTFKAPLAAAVLSGAEGNKFGLEGQIGFTKADLLDHAP
VVKKNARRGRMSMEELAAAAVEVSDNSAANLLLPMIGGPEGFTRYVRAHGDNVTRLDRTE
PALNENAEGDERDTTSPAAMAGLMRRLIFTDLKPESAARLRGWLNASTTGGNRIKAGLPK
DWTSGSKTGTCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFV
GKAQKTGLE
>BAK53071.1|FEATURES|NCBI|beta_lactam|mecC|antibiotic target replacement|1
MMKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGE
VEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKE
DGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVS
KKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETE
SRNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRV
TIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLA
LVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTL
DDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKF
EKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALE
NNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSG
TAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYEN
GNKKYDIDE
>WP_004683508.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MPKILKHLGLCASVMIGLTLLGCQNLQAPTQSAVSKKHDQTEIASLFQHAQTVGVFVTYD
GQTLQEYGNALSRSNTAYIPASTFKMLNALIGIQHHKSSPNEVFKWDGKKRAFASWEKDL
TLAEAMQASAVPVYQELARRIGLELMANEVKRVGFGNAEIGTQVDDFWLVGPLKITPVEE
VKFAYALAHKQLTFDQSVQEQVKQMVLVDEVKGTKIYAKSGWGMDVTPQVGWWTGWIEQP
NGQVIAFSLNMQINNSKQGDARKAIVYQALQQLKLLETQ
>WP_004776204.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQAQDQIATAFENIQTTGVLVTYD
GKNFQRYGNDLSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEQDL
TLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQNIGTQFDNFWLVGPLEITPVEE
VKFAYALAKQQLPFAPSTQQQVRDMLLIENVQGTRIYAKSGWGMDVNPQVGWWTGWVEQP
NGQITAFSLNMEMKKAEHADARKAIVYQALQQLGLLPQ
>WP_005209448.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQESEQQQIASLFQNAQTSGVLVIYD
GKKIQKFGNDVHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKVTAFSLNMEMSRPEHAEARKAIVYQALQQLDLLAN
>WP_005282462.1|FEATURES|NCBI|beta_lactam|F889_02977|antibiotic inactivation|1
MLFNFIVMPKKLKLLALSVVVMPSIILLGCQNIQPHVQALVTQKQTEDQIATAFENIQTS
GVLVTYDGKAIQKYGNALNRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAF
TSWEKDLTLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQSIGTQVDNFWLVGPL
EITPVEEVKFAYALAKKQLAFDSSTQQQVKDMLLIEDIQGTKIYAKSGWGMDVKPQVGWW
TGWVEQPNGQVTAFSLNMEMKKAAHAEARKAIVYQALQQLGLLPQ
>WP_005317413.1|FEATURES|NCBI|beta_lactam|F895_00180|antibiotic inactivation|1
MMMSKKLKCLAFFTAIFFAIPMTACQSFSQQKQQLSTQKNEQQQISSLFQSAQTNGVLVI
YDGKKIQKFGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEK
DLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPI
EEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIE
QPNGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH
>WP_025577435.1|FEATURES|NCBI|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQNTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKTTRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>WP_031841337.1|FEATURES|NCBI|beta_lactam|CARB-18|antibiotic inactivation|1
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDESNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AKI29909.1|FEATURES|NCBI|beta_lactam|OXA-184|antibiotic inactivation|1
MKKIILFLWILNFAFGQDKILEDFFKDYNTSGTFIIFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSNKSQEEVK
KLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AKQ05891.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVL
IEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGER
FCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLI
IGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDK
NPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVS
QVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNE
LLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE
>AKQ05897.1|FEATURES|NCBI|tetracycline|tetX|antibiotic inactivation|1
MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMN
IYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIP
CHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVC
FGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQ
LLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQ
GNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSK
EVAEERSNKILQEVKIVSNMISLPEYE
>ALA99192.1|FEATURES|NCBI|beta_lactam|OXA-62|antibiotic inactivation|1
MKKTLSRWRRGALALRLLGALASPVVFAMPGHAAEPAHSSAVRIAERADWGKYFADEGVK
GTVIVLDGRTQTYQAYDAARAERRMSPASTYKIFNSLLALESGALDNEREVIPWDGKPRR
VKAWNAALDLRNAFRVSCLPCYQVVSHKIPRQYAQAKLNEAGYGNRTIGRAAHAYWIDDS
LQISAREQVDFLQRLATGTLPFSARSQDIVRNISIVEANVDYVLHGKTGWFTEKKPDIGW
WVGWLERDGNLTMIALNIDIQTDADAPKRARIVRNVLKDLKLI
>ALN12426.1|FEATURES|NCBI|fosfomycin|FosB3|antibiotic inactivation|1
MIKGINHITYSVSNIAKSIEFYRDILEADILVESETSAYFNLGGIWLALNEEKNIPRSEI
KYSYTHIAFTISDNDFEDWYNWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGS
LEDRLSYYKEAKPHMNFYI
>AMM74625.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYMVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>AMP42440.1|FEATURES|NCBI|tetracycline|tetD|antibiotic efflux|1
MNKFAITALTITALDAMGIGLIMPVLPTLLREYVSAENLANHYGILLALYAIMQVFFAPL
LGKWSDKFGRRPILLLSLAGAAVDYTLLALSSSLWMLYVGRLISGVTGATGAVAASVIAD
NTASQERTKWFGRLGAAFGIGLIAGPAIGGFTGQFSAHLPFIIAAILNALSFLVIMLIFK
DNKIKNTEKNTTETAENSRPFLQVIKPVILLLFIFFMTQMIGQIPATTWVLFTEHRFQWG
SMEVGLSLAGLGIMHALFQAFVAGAIAKKFNEKVTIIVGFVVDGAAFIILSLLTKGWMIY
PTLILLAGGSIALPALQGLMSAQVNQTNQGKLQGVLVSLTNTTGVIGPLLFSFIFGQTLA
SWDGWIWMIGAIMYVLLIVFILSFYRSTKKIVKIAKLPAS
>AOE23835.1|FEATURES|NCBI|quinolone|QnrB19|antibiotic target protection|1
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LKDAIFKSCDLSMADFRNVTALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTN
LSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSE
LGDLDIRGVDLQGVKLDSYRASLLMERLGIAVIG
>AON96419.1|FEATURES|NCBI|multidrug|salA|antibiotic target protection|1
MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
TLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESRSMVDEVRTVFKTLIDM
ENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPI
SEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRM
FLNRIVDKVYEIEWGKTKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFR
YKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTP
LAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
TNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFV
QSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQ
YDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM
>APZ75411.1|FEATURES|NCBI|beta_lactam|NDM-1|antibiotic inactivation|1
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDQRFGDLVFRQLA
PNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVAL
AVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAP
NFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARA
FGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR
>AQQ11622.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
AMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDL
LNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYA
SFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASTPKDTIYHAKDAVQATKPDMRKPRLV
VFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADE
YDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNP
YNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELA
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
PNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFI
R
>ATM29809.1|FEATURES|NCBI|polymyxin|MCR-1|antibiotic target alteration|1
MMQHTSVVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLF
GAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKD
LLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHY
ASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRL
VVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGAD
EYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTN
PYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNEL
AKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHG
MPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAF
IR
>AVM85875.1|FEATURES|NCBI|polymyxin|PmrC|antibiotic target alteration|1
MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTG
LLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVRE
ASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMD
VLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQQGRRPRA
LVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRD
YDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLD
EILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEAL
VNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDE
QIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATC
RKGQPQ
>ACQ59476.1|FEATURES|megares|elfamycin|tufab|antibiotic target alteration|1
MRGHLKSHLNPYLEGQLMSKEKFERTKPHVNVGTIGHVDHGKTTLTAAICTVLAKVYGGK
ARDFASIDNAPEERERGITINTSHVEYDTPNRHYAHVDCPGHADYVKNMITGAAQMDGGI
LVVAATDGPMPQTREHILLGRQVGIPYIIVFMNKCDMVDDEELLELVEMEVRELLSEYDF
PGDDLPVIQGSALGALNGEAQWEAKIVELAEALDTYIPEPERAVDMAFLMPIEDVFSIQG
RGTVVTGRIERGILKVGDEVAIVGIKETVKTTCTGVEMFRKLLDEGRAGENVGALLRGTK
REEVERGQVLAKPGSITPHTKFESEVYVLSKDEGGRHTPFFKGYRPQFYFRTTDVTGSIE
LPEGVEMVMPGDNVKMVVDLIAPIAMDEGLRFAIREGGRTVGAGVVAKIIA
